PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sharma, A; Sen, JM				Sharma, A.; Sen, J. M.			Molecular basis for the tissue specificity of beta-catenin oncogenesis	ONCOGENE			English	Article						beta-catenin; hypocellular thymus; p53; apoptosis; intestinal adenoma; c-Myc	ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL DEVELOPMENT; MULTIPLE INTESTINAL NEOPLASIA; IN-VIVO; MEDIATED TRANSCRIPTION; THYMOCYTE DEVELOPMENT; APC(MIN/+) MOUSE; GENE-EXPRESSION; APC DEFICIENCY; MYC DELETION	Wnt-beta-catenin-T-cell factor signaling is causally linked to c-myc-dependent tumorigenesis in mouse and human colon epithelial cells. By contrast, beta-catenin is not similarly associated with oncogenic transformation of other tissues, including T cells. The molecular basis for tissue specificity of beta-catenin-dependent oncogenesis is unknown. Here, we demonstrate that adenomatous polyposis coli mutant APC(Min/-) mice, which have increased expression of beta-catenin in all tissues, develop severe intestinal neoplasia, but fail to develop thymic lymphoma. Whereas beta-catenin-dependent signals elicit a proliferative response from intestinal cells, thymocytes experience oncogene-induced senescence (OIS), growth arrest and apoptosis. We demonstrate that the differential cellular response of thymocytes and intestinal epithelial cells is a direct consequence of the gene expression elicited by beta-catenin expression in each tissue. We find that whereas intestinal cells induce genes that promote proliferation thymocytes induce expression of genes associated with OIS, growth arrest and p53-dependent apoptosis. We correlate gene expression pattern with the role beta-catenin plays in the development of each tissue and suggest that susceptibility of transformation by beta-catenin is intimately related to its function during development. We propose that when oncogenes are used as signaling molecules, safety nets in the form of OIS, growth arrest and apoptosis prevent accidental transformation. Oncogene (2013) 32, 1901-1909; doi:10.1038/onc.2012.215; published online 11 June 2012	[Sharma, A.; Sen, J. M.] NIA, Lymphocyte Dev Unit, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, JM (corresponding author), NIA, Lymphocyte Dev Unit, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	Jyoti-Sen@NIH.GOV	Sharma, Archna/R-9377-2016	Sharma, Archna/0000-0003-4745-0220	National Institute on Aging; National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000772, ZIAAG000768, ZIAAG000771] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Q Yu for doing IP BrdU injections; R Wersto and the FACS facility team for cell sorting; the animal facility of National Institute on Aging for maintaining animals; S Luo and team for genotyping. This research was supported by Intramural Research Program of the National Institute on Aging and National Institutes of Health.	Bellei B, 2004, MODERN PATHOL, V17, P1275, DOI 10.1038/modpathol.3800181; CASTROP J, 1995, BLOOD, V86, P3050, DOI 10.1182/blood.V86.8.3050.bloodjournal8683050; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; Cole AM, 2010, EMBO MOL MED, V2, P472, DOI 10.1002/emmm.201000101; Coletta PL, 2004, BLOOD, V103, P1050, DOI 10.1182/blood-2003-03-0707; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Dorfman DM, 2003, AM J PATHOL, V162, P1539, DOI 10.1016/S0002-9440(10)64287-3; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Groen RWJ, 2008, CANCER RES, V68, P6969, DOI 10.1158/0008-5472.CAN-08-1322; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; LUONGO C, 1994, CANCER RES, V54, P5947; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Pajari AM, 2003, INT J CANCER, V106, P653, DOI 10.1002/ijc.11270; Polakis P, 2000, GENE DEV, V14, P1837; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Serinsoz E, 2004, BRIT J HAEMATOL, V126, P313, DOI 10.1111/j.1365-2141.2004.05049.x; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Staal FJT, 2008, HAEMATOLOGICA, V93, P493, DOI 10.3324/haematol.12917; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; Tsutsui J, 1996, J BIOCHEM-TOKYO, V120, P1034; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Weerkamp F, 2006, LEUKEMIA, V20, P1197, DOI 10.1038/sj.leu.2404255; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Xu M, 2008, MOL CELL BIOL, V28, P1713, DOI 10.1128/MCB.01360-07; Xu M, 2009, J IMMUNOL, V182, P759, DOI 10.4049/jimmunol.182.2.759; Xu M, 2009, J IMMUNOL, V182, P751, DOI 10.4049/jimmunol.182.2.751; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Xu YY, 2003, EUR J IMMUNOL, V33, P12, DOI 10.1002/immu.200390002; You L, 2008, MOL CANCER THER, V7, P1633, DOI 10.1158/1535-7163.MCT-08-0155; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2	54	14	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 11	2013	32	15					1901	1909		10.1038/onc.2012.215	http://dx.doi.org/10.1038/onc.2012.215			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22689057	Green Accepted			2022-12-25	WOS:000317599900004
J	Kurt, S; Sausbier, M; Ruttiger, L; Brandt, N; Moeller, CK; Kindler, J; Sausbier, U; Zimmermann, U; van Straaten, H; Neuhuber, W; Engel, J; Knipper, M; Ruth, P; Schulze, H				Kurt, Simone; Sausbier, Matthias; Ruettiger, Lukas; Brandt, Niels; Moeller, Christoph K.; Kindler, Jennifer; Sausbier, Ulrike; Zimmermann, Ulrike; van Straaten, Harald; Neuhuber, Winfried; Engel, Jutta; Knipper, Marlies; Ruth, Peter; Schulze, Holger			Critical role for cochlear hair cell BK channels for coding the temporal structure and dynamic range of auditory information for central auditory processing	FASEB JOURNAL			English	Article						hair cell-specific BK channel-knockout mice; in vivo electrophysiology; inferior colliculus; discrimination learning	THYROID-HORMONE DEFICIENCY; K+ CHANNELS; MOUSE; EXPRESSION; MICE; HEARING; MEMBRANE; DEAFNESS; CURRENTS; PRESTIN	Large conductance, voltage-and Ca2+ activated K+ (BK) channels in inner hair cells (IHCs) of the cochlea are essential for hearing. However, germline deletion of BK alpha, the pore-forming subunit KCNMA1 of the BK channel, surprisingly did not affect hearing thresholds in the first postnatal weeks, even though altered IHC membrane time constants, decreased IHC receptor potential alternating current/direct current ratio, and impaired spike timing of auditory fibers were reported in these mice. To investigate the role of IHC BK channels for central auditory processing, we generated a conditional mouse model with hair cell-specific deletion of BK alpha from postnatal day 10 onward. This had an unexpected effect on temporal coding in the central auditory system: neuronal single and multiunit responses in the inferior colliculus showed higher excitability and greater precision of temporal coding that may be linked to the improved discrimination of temporally modulated sounds observed in behavioral training. The higher precision of temporal coding, however, was restricted to slower modulations of sound and reduced stimulus-driven activity. This suggests a diminished dynamic range of stimulus coding that is expected to impair signal detection in noise. Thus, BK channels in IHCs are crucial for central coding of the temporal fine structure of sound and for detection of signals in a noisy environment.-Kurt, S., Sausbier, M., Ruttiger, L., Brandt, N., Moeller, C. K., Kindler, J., Sausbier, U., Zimmermann, U., van Straaten, H., Neuhuber, W., Engel, J., Knipper, M., Ruth, P., Schulze, H. Critical role for cochlear hair cell BK channels for coding the temporal structure and dynamic range of auditory information for central auditory processing. FASEB J. 26, 3834-3843 (2012). www.fasebj.org	[Kurt, Simone] Univ Ulm, Inst Neurobiol, D-80081 Ulm, Germany; [Sausbier, Matthias; Sausbier, Ulrike; Ruth, Peter] Univ Tubingen, Dept Pharmacol & Toxicol, Inst Pharm, Tubingen, Germany; [Ruettiger, Lukas; Zimmermann, Ulrike; van Straaten, Harald; Knipper, Marlies] Univ Tubingen, Dept Otorhinolaryngol, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Inst Physiol 2, D-7400 Tubingen, Germany; [Brandt, Niels; Zimmermann, Ulrike; van Straaten, Harald; Engel, Jutta; Knipper, Marlies] Univ Tubingen, Tubingen Hearing Res Ctr, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Saarland, Dept Biophys, D-6650 Homburg, Germany; [Moeller, Christoph K.; Kindler, Jennifer; Schulze, Holger] Univ Erlangen Nurnberg, Dept Expt Otolaryngol, D-91054 Erlangen, Germany; [Neuhuber, Winfried] Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany; [Moeller, Christoph K.; Schulze, Holger] Leibniz Inst Neurobiol, Magdeburg, Germany	Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Saarland University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Leibniz Institut fur Neurobiologie (LIN)	Kurt, S (corresponding author), Univ Ulm, Inst Neurobiol, Albert Einstein Allee 11, D-80081 Ulm, Germany.	simone.kurt@uni-ulm.de		Kurt, Simone/0000-0002-1820-2597	Deutsche Forschungsgemeinschaft (DFG) [DFG Kni316/4-1, DFG Ru571/4-1, SFB 894 TP A8]; University of Tubingen; American Lebanese Syrian Associated Charities (ALSAC); U.S. National Institutes of Health (NIH) [CA21765, DC05168, DC008800, DC06471]; Hartwell Foundation; Thyssen Foundation; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC005168, R21DC008800] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Tubingen; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; Thyssen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Jian Zhou (St. Jude Children's Research Hospital, Memphis, TN, USA) for providing PCre mice. The authors thank Karin Rohbock, Iris Kopschall, and Sylvia Kasperek for excellent technical assistance; Clement Kabagema for maintaining and genotyping hair cell-specific BK channel-knockout mice; Stefan Munkner for stimulating discussions, and Michael J. Shipston for critical reading of the manuscript and giving helpful advice. This work was supported by the Deutsche Forschungsgemeinschaft (DFG), grants DFG Kni316/4-1, DFG Ru571/4-1, SFB 894 TP A8; Graduate Program of the University of Tubingen; American Lebanese Syrian Associated Charities (ALSAC); U.S. National Institutes of Health (NIH) grants CA21765, DC05168, DC008800, and DC06471; the Hartwell Foundation; and the Thyssen Foundation.	Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Jia SP, 2007, J NEUROSCI, V27, P1006, DOI 10.1523/JNEUROSCI.5452-06.2007; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kirk C. E., 2003, JARO-J ASSOC RES OTO, V4, P445; Knipper M, 1998, DEVELOPMENT, V125, P3709; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Marida K. V., 1972, J PHYSL, V188, P285; May BJ, 2004, ARCH OTOLARYNGOL, V130, P660, DOI 10.1001/archotol.130.5.660; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Oliver D, 2003, J NEUROSCI, V23, P2141; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Smith D. W., 2004, AUDITORY SIGNAL PROC; STIEBLER I, 1985, J COMP NEUROL, V238, P65, DOI 10.1002/cne.902380106; Tian Y, 2004, DEV DYNAM, V231, P199, DOI 10.1002/dvdy.20106; Walton JP, 2002, J NEUROPHYSIOL, V88, P565, DOI 10.1152/jn.2002.88.2.565; Wersinger E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013836; Winter H, 2009, J NEUROSCI, V29, P2581, DOI 10.1523/JNEUROSCI.3557-08.2009	33	20	20	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3834	3843		10.1096/fj.11-200535	http://dx.doi.org/10.1096/fj.11-200535			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22691916	Green Published, hybrid			2022-12-25	WOS:000308391600023
J	Oh, E; Kalwat, MA; Kim, MJ; Verhage, M; Thurmond, DC				Oh, Eunjin; Kalwat, Michael A.; Kim, Min-Jung; Verhage, Matthijs; Thurmond, Debbie C.			Munc18-1 Regulates First-phase Insulin Release by Promoting Granule Docking to Multiple Syntaxin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; MEMBRANE-FUSION; SNARE COMPLEX; N-PEPTIDE; TYROSINE PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; SEC1/MUNC18 PROTEINS; SECRETORY GRANULES; NEGATIVE REGULATOR; PLASMA-MEMBRANE	Attenuated levels of the Sec1/Munc18 (SM) protein Munc18-1 in human islet beta-cells is coincident with type 2 diabetes, although how Munc18-1 facilitates insulin secretion remains enigmatic. Herein, using conventional Munc18-1(-/-) and beta-cell specific Munc18-1(-/-) knock-out mice, we establish that Munc18-1 is required for the first phase of insulin secretion. Conversely, human islets expressing elevated levels of Munc18-1 elicited significant potentiation of only first-phase insulin release. Insulin secretory changes positively correlated with insulin granule number at the plasma membrane: Munc18-1-deficient cells lacked 35% of the normal component of pre-docked insulin secretory granules, whereas cells with elevated levels of Munc18-1 exhibited a similar to 20% increase in pre-docked granule number. Pre-docked syntaxin 1-based SNARE complexes bound by Munc18-1 were detected in beta-cell lysates but, surprisingly, were reduced by elevation of Munc18-1 levels. Paradoxically, elevated Munc18-1 levels coincided with increased binding of syntaxin 4 to VAMP2 at the plasma membrane. Accordingly, syntaxin 4 was a requisite for Munc18-1 potentiation of insulin release. Munc18c, the cognate SM isoform for syntaxin 4, failed to bind SNARE complexes. Given that Munc18-1 does not pair with syntaxin 4, these data suggest a novel indirect role for Munc18-1 in facilitating syntaxin 4-mediated granule pre-docking to support first-phase insulin exocytosis.	[Oh, Eunjin; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr, Indianapolis, IN 46202 USA; [Kalwat, Michael A.; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kim, Min-Jung] Korea Food & Drug Adm, Recombinant Prot Prod Div, Biopharmaceut & Herbal Med Bur, Chungcheongbuk Do 363700, South Korea; [Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam, Dept Clin Genet, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Thurmond, DC (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu	Kalwat, Michael/GRJ-4422-2022; Kalwat, Michael A/H-3184-2013	Kalwat, Michael A/0000-0002-8349-9470; verhage, matthijs/0000-0002-6085-7503	National Institutes of Health [DK067912, DK076614]; Showalter Trust of Indiana University School of Medicine; American Heart Association [10PRE3040010]; Korean Government Overseas Research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076614, R01DK067912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Trust of Indiana University School of Medicine; American Heart Association(American Heart Association); Korean Government Overseas Research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK067912 and DK076614 (to D. C. T.). This work was also supported by the Showalter Trust of Indiana University School of Medicine (to E. O.), American Heart Association Grant 10PRE3040010 (to M. A. K.), and the Korean Government Overseas Research fellowship (to M. J. K.).	Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Betz A, 1997, J BIOL CHEM, V272, P2520; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Gladycheva SE, 2004, J PHYSIOL-LONDON, V558, P857, DOI 10.1113/jphysiol.2004.067249; Groffen AJA, 2004, J BIOL CHEM, V279, P23740, DOI 10.1074/jbc.M400731200; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Mandic SA, 2011, J BIOL CHEM, V286, P28026, DOI 10.1074/jbc.M111.235366; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Mistry AC, 2009, AM J PHYSIOL-RENAL, V297, pF292, DOI 10.1152/ajprenal.00196.2009; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shi L, 2011, MOL BIOL CELL, V22, P4150, DOI 10.1091/mbc.E11-02-0150; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Straub SG, 2004, DIABETES, V53, P3179, DOI 10.2337/diabetes.53.12.3179; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wiseman DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214031; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200	62	48	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25821	25833		10.1074/jbc.M112.361501	http://dx.doi.org/10.1074/jbc.M112.361501			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685295	Green Published, hybrid			2022-12-25	WOS:000306916300012
J	Barber, BR; Xu, JW; Perez-Losada, M; Jara, CG; Crandall, KA				Barber, Brian R.; Xu, Jiawu; Perez-Losada, Marcos; Jara, Carlos G.; Crandall, Keith A.			Conflicting Evolutionary Patterns Due to Mitochondrial Introgression and Multilocus Phylogeography of the Patagonian Freshwater Crab Aegla neuquensis	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; SOUTHERN; GENE; GLACIATIONS; INFERENCE; AEGLIDAE; MAXIMUM; ANOMURA; NUCLEAR; DNA	Background: Multiple loci and population genetic methods were employed to study the phylogeographic history of the Patagonian freshwater crab Aegla neuquensis (Aeglidae: Decopoda). This taxon occurs in two large river systems in the Patagonian Steppe, from the foothills of the Andes Mountains east to the Atlantic Ocean. Methodology/Principal Findings: A nuclear phylogeny and multilocus nested clade phylogeographic analysis detected a fragmentation event between the Negro and Chico-Chubut river systems. This event occurred approximately 137 thousand years ago. An isolation-with-migration analysis and maximum-likelihood estimates of gene flow showed asymmetrical exchange of genetic material between these two river systems exclusively in their headwaters. We used information theory to determine the best-fit demographic history between these two river systems under an isolation-with-migration model. The best-fit model suggests that the Negro and the ancestral populations have the same effective population sizes; whereas the Chico-Chubut population is smaller and shows that gene flow from the Chico-Chubut into the Negro is four times higher than in the reverse direction. Much of the Chico-Chubut system appears to have only been recently colonized while the Negro populations appear to have been in place for most of the evolutionary history of this taxon. Conclusions/Significance: Due to mitochondrial introgression, three nuclear loci provided different phylogeographic resolution than the three mitochondrial genes for an ancient fragmentation event observed in the nuclear phylogeny. However, the mitochondrial locus provided greater resolution on more recent evolutionary events. Our study, therefore, demonstrates the need to include both nuclear and mitochondrial loci for a more complete understanding of evolutionary histories and associated phylogeographic events. Our results suggest that gene flow between these systems, before and after fragmentation was through periodic paleolakes that formed in the headwaters region. Fragmentation between the Negro and Chico-Chubut systems was driven by the disappearance of these paleolakes during the Patagonian Glaciation.	[Barber, Brian R.; Xu, Jiawu; Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Jara, Carlos G.] Univ Austral Chile, Inst Zool, Valdivia, Chile; [Crandall, Keith A.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Perez-Losada, Marcos] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal	Brigham Young University; Universidad Austral de Chile; Brigham Young University; Universidade do Porto	Barber, BR (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	brbarber76@gmail.com	Crandall, Keith A./H-2789-2019; Xu, Jiawu/K-5276-2013; Perez-Losada, Marcos/I-4407-2013	Crandall, Keith A./0000-0002-0836-3389; Xu, Jiawu/0000-0002-0424-0736; Perez-Losada, Marcos/0000-0002-2585-4657	U.S. National Science Foundation (NSF) PIRE for research on Patagonian Biodiversity	U.S. National Science Foundation (NSF) PIRE for research on Patagonian Biodiversity(National Science Foundation (NSF))	This work was funded by a grant from the U.S. National Science Foundation (NSF) PIRE for research on Patagonian Biodiversity to support collaboration among the following institutions (listed alphabetically): Brigham Young University, Centro Nacional Patagonico (AR), Dalhousie University, Instituto Botanico Darwinion (AR), Universidad Austral de Chile, Universidad Nacional del Comahue, Universidad de Concepcion, and George Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2004, MOL MARKERS NATURAL; Avise JC, 2000, PHYLOGEOGRAPHY HIST, Vviii; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barber BR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-343; Barrowclough GF, 2009, MOL ECOL, V18, P2934, DOI 10.1111/j.1365-294X.2009.04271.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli Peter, 2009, V17, P42; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Carstens BC, 2009, MOL ECOL, V18, P4270, DOI 10.1111/j.1365-294X.2009.04327.x; CLAPPERTON C. M., 1993, QUATERNARY GEOLOGY G; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Edwards SV, 2000, EVOLUTION, V54, P1839; Ponce JF, 2011, BIOL J LINN SOC, V103, P363, DOI 10.1111/j.1095-8312.2011.01653.x; Fetzner JW, 2003, EVOLUTION, V57, P2101; Folguera A, 2011, BIOL J LINN SOC, V103, P250, DOI 10.1111/j.1095-8312.2011.01687.x; Garrick RC, 2008, MOL ECOL, V17, P1401, DOI 10.1111/j.1365-294X.2008.03675.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; HUNT WG, 1973, HEREDITY, V31, P11; John HM, 1991, ADAPTIVE PROTEIN EVO; Johnson JB, 2009, MOL ECOL, V18, P4137, DOI 10.1111/j.1365-294X.2009.04328.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knowles LL, 2008, EVOLUTION, V62, P2713, DOI 10.1111/j.1558-5646.2008.00481.x; Laurent E, 2006, ARLEQUIN VER 3 1 INT; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; Morrone J, 1994, J BIOGEOGR, V21, P13; Perez-Losada M, 2004, SYST BIOL, V53, P767, DOI 10.1080/10635150490522331; Perez-Losada M, 2002, BIOL CONSERV, V105, P345, DOI 10.1016/S0006-3207(01)00218-X; Perez-Losada M, 2002, J CRUSTACEAN BIOL, V22, P304, DOI 10.1651/0278-0372(2002)022[0304:PRATSO]2.0.CO;2; Perez-Losada M, 2009, CONSERV BIOL, V23, P692, DOI 10.1111/j.1523-1739.2008.01161.x; Perez-Losada M, 2011, CRUSTACEAN ISS, V19, P291; Perry WL, 2001, EVOLUTION, V55, P1153; Petit RJ, 2008, MOL ECOL, V17, P516, DOI 10.1111/j.1365-294X.2007.03589.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Rabassa J, 2011, BIOL J LINN SOC, V103, P316, DOI 10.1111/j.1095-8312.2011.01681.x; Rambaut A, 2014, TRACER V1 6; Rice RW, 1989, ANAL TABLES STAT TES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P514, DOI 10.1111/j.1095-8312.2011.01682.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P221, DOI 10.1111/j.1095-8312.2011.01693.x; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Singer BS, 2004, GEOL SOC AM BULL, V116, P434, DOI 10.1130/B25177.1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sugden DE, 2005, GEOGR ANN A, V87A, P273, DOI 10.1111/j.0435-3676.2005.00259.x; Tamura K, MOL BIOL EVOLUTION, V28, P2731; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Teske PR, 2009, MOL ECOL RESOUR, V9, P774, DOI 10.1111/j.1755-0998.2009.02534.x; Unmack PJ, 2009, BIOL J LINN SOC, V97, P876, DOI 10.1111/j.1095-8312.2009.01224.x; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x; Zink RM, 2004, PHILOS T ROY SOC B, V359, P215, DOI 10.1098/rstb.2003.1392; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	72	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37105	10.1371/journal.pone.0037105	http://dx.doi.org/10.1371/journal.pone.0037105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685541	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700005
J	Machne, R; Murray, DB				Machne, Rainer; Murray, Douglas B.			The Yin and Yang of Yeast Transcription: Elements of a Global Feedback System between Metabolism and Chromatin	PLOS ONE			English	Article							CYCLE-REGULATED GENES; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REMODELING COMPLEX; EUKARYOTIC GENOME; RESPIRATORY OSCILLATIONS; BIDIRECTIONAL PROMOTERS; NUCLEOSOME ORGANIZATION; ENVIRONMENTAL-CHANGES; ESCHERICHIA-COLI	When grown in continuous culture, budding yeast cells tend to synchronize their respiratory activity to form a stable oscillation that percolates throughout cellular physiology and involves the majority of the protein-coding transcriptome. Oscillations in batch culture and at single cell level support the idea that these dynamics constitute a general growth principle. The precise molecular mechanisms and biological functions of the oscillation remain elusive. Fourier analysis of transcriptome time series datasets from two different oscillation periods (0.7 h and 5 h) reveals seven distinct co-expression clusters common to both systems (34% of all yeast ORF), which consolidate into two superclusters when correlated with a compilation of 1,327 unrelated transcriptome datasets. These superclusters encode for cell growth and anabolism during the phase of high, and mitochondrial growth, catabolism and stress response during the phase of low oxygen uptake. The promoters of each cluster are characterized by different nucleotide contents, promoter nucleosome configurations, and dependence on ATP-dependent nucleosome remodeling complexes. We show that the ATP: ADP ratio oscillates, compatible with alternating metabolic activity of the two superclusters and differential feedback on their transcription via activating (RSC) and repressive (Isw2) types of promoter structure remodeling. We propose a novel feedback mechanism, where the energetic state of the cell, reflected in the ATP: ADP ratio, gates the transcription of large, but functionally coherent groups of genes via differential effects of ATP-dependent nucleosome remodeling machineries. Besides providing a mechanistic hypothesis for the delayed negative feedback that results in the oscillatory phenotype, this mechanism may underpin the continuous adaptation of growth to environmental conditions.	[Machne, Rainer] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Murray, Douglas B.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	University of Vienna; Keio University	Machne, R (corresponding author), Univ Vienna, Inst Theoret Chem, Vienna, Austria.	raim@tbi.univie.ac.at	Machne, Rainer/AAY-2159-2020	Machne, Rainer/0000-0002-1274-5099	Vienna Science and Technology Fund (WWTF) [MA07-30]; Marie Curie Actions Network project HARVEST [238017]; SFB 618 Theoretical Biology; AMS Redergasse; Tsuruoka City; Yamagata Prefecture; Japan Science and Technology agency	Vienna Science and Technology Fund (WWTF); Marie Curie Actions Network project HARVEST; SFB 618 Theoretical Biology; AMS Redergasse; Tsuruoka City(Tsuruoka City Government); Yamagata Prefecture; Japan Science and Technology agency(Japan Science & Technology Agency (JST))	RM acknowledges support by the Vienna Science and Technology Fund (WWTF), project #MA07-30, the Marie Curie Actions Network project HARVEST, project #238017, the SFB 618 Theoretical Biology, and AMS Redergasse. DBM thanks Tsuruoka City, Yamagata Prefecture and the Japan Science and Technology agency for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Aon MA, 2007, FEBS LETT, V581, P8, DOI 10.1016/j.febslet.2006.11.068; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; FINN R. K., 1954, BULL MATH BIOPHYS, V16, P181, DOI 10.1007/BF02478374; FINN RK, 1954, J AGR FOOD CHEM, V2, P66, DOI 10.1021/jf60022a003; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim BR, 2006, CURR GENOMICS, V7, P197, DOI 10.2174/138920206777780229; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Ladurner AG, 2009, CELL, V138, P18, DOI 10.1016/j.cell.2009.06.025; Lai LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-627; LARSSON CM, 1979, PLANT CELL PHYSIOL, V20, P145; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lelandais G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000409; Li CM, 2006, P NATL ACAD SCI USA, V103, P16254, DOI 10.1073/pnas.0604860103; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lloyd D, 2006, NAT REV MOL CELL BIO, V7, pA1, DOI 10.1038/nrm1980-cl; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Minorsky N., 1942, J APPL MECH, V9, pA65, DOI 10.1115/1.4009185; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; MUNCH T, 1992, J BIOTECHNOL, V22, P329, DOI 10.1016/0168-1656(92)90150-8; Murray DB, 2007, BIOSYSTEMS, V90, P287, DOI 10.1016/j.biosystems.2006.09.032; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Murray DB, 2006, NAT REV MOL CELL BIO, V7, pB1, DOI 10.1038/nrm1980-c2; Murtagh F., 1985, COMPSTAT LECT, V4; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Patnaik PR, 2003, BIOTECHNOL ADV, V21, P183, DOI 10.1016/S0734-9750(03)00022-3; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Ptitsyn AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S10; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Sirinakis G, 2011, EMBO J; Slavov N, 2011, P NATL ACAD SCI US; Slavov N, 2011, MOL BIOL CELL, V22, P1997, DOI 10.1091/mbc.E11-02-0132; Sohn HY, 2001, YEAST, V18, P125, DOI 10.1002/1097-0061(20010130)18:2<125::AID-YEA655>3.0.CO;2-9; Sonnenschein N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-40; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2007, TRENDS GENET, V23, P318, DOI 10.1016/j.tig.2007.03.015; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Trifonov E, 2011, PHYS LIFE REV; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TU BP, 2006, NAT REV MOL CELL BIO, V7; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; vanWorkum M, 1996, MOL MICROBIOL, V20, P351; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Wang JQ, 2000, FEMS MICROBIOL LETT, V189, P9, DOI 10.1111/j.1574-6968.2000.tb09198.x; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; WIJKER JE, 1995, BIOPHYS CHEM, V55, P153, DOI 10.1016/0301-4622(94)00148-D; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	110	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37906	10.1371/journal.pone.0037906	http://dx.doi.org/10.1371/journal.pone.0037906			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685547	Green Published, gold			2022-12-25	WOS:000305351700010
J	Silva, AX; Jander, G; Samaniego, H; Ramsey, JS; Figueroa, CC				Silva, Andrea X.; Jander, Georg; Samaniego, Horacio; Ramsey, John S.; Figueroa, Christian C.			Insecticide Resistance Mechanisms in the Green Peach Aphid Myzus persicae (Hemiptera: Aphididae) I: A Transcriptomic Survey	PLOS ONE			English	Article							POTATO APHID; GENE-EXPRESSION; ESTERASE GENES; INSENSITIVE ACETYLCHOLINESTERASE; PYRETHROID INSECTICIDES; DETOXIFICATION ENZYMES; KNOCKDOWN RESISTANCE; HSP70 EXPRESSION; SULZER HEMIPTERA; MOLECULAR-BASIS	Background: Insecticide resistance is one of the best examples of rapid micro-evolution found in nature. Since the development of the first synthetic insecticide in 1939, humans have invested considerable effort to stay ahead of resistance phenotypes that repeatedly develop in insects. Aphids are a group of insects that have become global pests in agriculture and frequently exhibit insecticide resistance. The green peach aphid, Myzus persicae, has developed resistance to at least seventy different synthetic compounds, and different insecticide resistance mechanisms have been reported worldwide. Methodology/Principal Findings: To further characterize this resistance, we analyzed genome-wide transcriptional responses in three genotypes of M. persicae, each exhibiting different resistance mechanisms, in response to an anticholinesterase insecticide. The sensitive genotype (exhibiting no resistance mechanism) responded to the insecticide by up-regulating 183 genes primarily ones related to energy metabolism, detoxifying enzymes, proteins of extracellular transport, peptidases and cuticular proteins. The second genotype (resistant through a kdr sodium channel mutation), up-regulated 17 genes coding for detoxifying enzymes, peptidase and cuticular proteins. Finally, a multiply resistant genotype (carrying kdr and a modified acetylcholinesterase), up-regulated only 7 genes, appears not to require induced insecticide detoxification, and instead down-regulated many genes. Conclusions/Significance: This study suggests strongly that insecticide resistance in M. persicae is more complex that has been described, with the participation of a broad array of resistance mechanisms. The sensitive genotype exhibited the highest transcriptional plasticity, accounting for the wide range of potential adaptations to insecticides that this species can evolve. In contrast, the multiply resistant genotype exhibited a low transcriptional plasticity, even for the expression of genes encoding enzymes involved in insecticide detoxification. Our results emphasize the value of microarray studies to search for regulated genes in insects, but also highlights the many ways those different genotypes can assemble resistant phenotypes depending on the environmental pressure.	[Silva, Andrea X.; Figueroa, Christian C.] Univ Austral Chile, Inst Ciencias Ambient & Evolutivas, Fac Ciencias, Valdivia, Chile; [Jander, Georg; Ramsey, John S.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Samaniego, Horacio] Univ Austral Chile, Inst Silvicultura, Fac Ciencias Forestales & Recursos Nat, Valdivia, Chile; [Samaniego, Horacio] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	Universidad Austral de Chile; Cornell University; Boyce Thompson Institute for Plant Research; Universidad Austral de Chile; United States Department of Energy (DOE); Los Alamos National Laboratory	Silva, AX (corresponding author), Univ Austral Chile, Inst Ciencias Ambient & Evolutivas, Fac Ciencias, Valdivia, Chile.	christianfigueroa@uach.cl	Li, Shiguang/G-7471-2012; Jander, Georg/E-7101-2012; Samaniego, Horacio/O-8820-2015; Figueroa, Christian C./A-1170-2008	Samaniego, Horacio/0000-0002-2485-9827; Figueroa, Christian C./0000-0001-9218-5564; Silva, Andrea/0000-0002-4346-5524	Comision Nacional de Investigacion Cientifica y Tecnologica; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090378]; United States Department of Agriculture [2005-35604-15446]	Comision Nacional de Investigacion Cientifica y Tecnologica; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was funded by Comision Nacional de Investigacion Cientifica y Tecnologica doctoral grant to AXS, by Fondo Nacional de Desarrollo Cientifico y Tecnologico grant No1090378 to CCF, and by the United States Department of Agriculture grant No2005-35604-15446 to GJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2006, PEST MANAG SCI, V62, P805, DOI 10.1002/ps.1225; Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anstead JA, 2004, INSECT BIOCHEM MOLEC, V34, P871, DOI 10.1016/j.ibmb.2004.06.002; Anstead JA, 2008, AGR FOREST ENTOMOL, V10, P291, DOI 10.1111/j.1461-9563.2008.00388.x; Anthony N, 1998, MOL GEN GENET, V260, P165, DOI 10.1007/s004380050882; Artigas J, 1994, INSECTOS INTERES AGR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; Blackman R. L., 1994, APHID WORLDS TREES I; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Bluthgen H, 2005, GENOME INFORM, V16, P106; Bluthgen N, 2005, NUCLEIC ACIDS RES, V33, P272, DOI 10.1093/nar/gki167; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Caillaud M., 2004, PROPOSAL SEQUENCE GE; Casals B. P., 2000, Revista Fruticola, V21, P5; Casals B. P., 1999, Agro-Ciencia, V15, P55; Castaneda LE, 2011, PHYSIOL ENTOMOL, V36, P253, DOI 10.1111/j.1365-3032.2011.00793.x; Choi J, 2002, PESTIC BIOCHEM PHYS, V74, P117, DOI 10.1016/S0048-3575(02)00154-2; Chowdhuri DK, 1999, PESTIC BIOCHEM PHYS, V63, P15, DOI 10.1006/pest.1998.2390; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Criniti A, 2008, PESTIC BIOCHEM PHYS, V90, P168, DOI 10.1016/j.pestbp.2007.11.005; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DEVONSHIRE AL, 1992, B ENTOMOL RES, V82, P459, DOI 10.1017/S0007485300042516; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eleftherianos I, 2008, B ENTOMOL RES, V98, P183, DOI 10.1017/S0007485307005524; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Field LM, 1998, BIOCHEM J, V330, P169; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2003, BIOL J LINN SOC, V79, P107, DOI 10.1046/j.1095-8312.2003.00178.x; Field LM, 1997, BIOCHEM J, V322, P867, DOI 10.1042/bj3220867; FIELD LM, 1993, BIOCHEM J, V294, P569, DOI 10.1042/bj2940569; FIELD LM, 1988, BIOCHEM J, V251, P309, DOI 10.1042/bj2510309; Field LM, 1999, BIOCHEM J, V339, P737, DOI 10.1042/0264-6021:3390737; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; Finney D.J, 1952, STAT METHOD BIOL ASS; Foster SP, 2011, B ENTOMOL RES, V101, P659, DOI 10.1017/S0007485310000623; Foster SP, 1997, B ENTOMOL RES, V87, P573, DOI 10.1017/S0007485300038669; Foster SP, 1996, B ENTOMOL RES, V86, P17, DOI 10.1017/S0007485300052159; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Fuentes-Contreras E, 2004, B ENTOMOL RES, V94, P11, DOI 10.1079/BER2003275; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Georghiou G, 1991, OCCURRENCE RESISTANC; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; Guillemaud T, 2003, B ENTOMOL RES, V93, P289, DOI 10.1079/BER2003241; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hardstone MC, 2009, J EVOLUTION BIOL, V22, P416, DOI 10.1111/j.1420-9101.2008.01661.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hodgson E, 2003, J BIOCHEM MOL TOXIC, V17, P201, DOI 10.1002/jbt.10080; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jackson CJ, 2010, ANTICHOLINESTERASE PESTICIDES: METABOLISM, NEUROTOXICITY, AND EPIDEMIOLOGY, P57; Klein C., 2000, CANBERRA ACIAR MONOG, V68; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Lertkiatmongkol P, 2010, J VECTOR ECOL, V35, P197, DOI 10.1111/j.1948-7134.2010.00047.x; LESK AM, 2007, INTRO GENOMICS; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lopes KVG, 2010, J INSECT PHYSIOL, V56, P1050, DOI 10.1016/j.jinsphys.2010.02.020; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Martinez-Torres D, 1999, INSECT MOL BIOL, V8, P339, DOI 10.1046/j.1365-2583.1999.83121.x; MartinezTorres D, 1997, PESTIC SCI, V51, P265, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;265::AID-PS626&gt;3.0.CO;2-P; MCKENZIE JA, 1994, TRENDS ECOL EVOL, V9, P166, DOI 10.1016/0169-5347(94)90079-5; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; McKenzie JA, EVOLUTIONARY ECOLOGY, P347; Medina P, 2002, ARCH INSECT BIOCHEM, V51, P91, DOI 10.1002/arch.10053; MOORES GD, 1994, PESTIC BIOCHEM PHYS, V49, P114, DOI 10.1006/pest.1994.1038; Moores GD, 2000, PROC BRIGHTON CROP, V1-3, P447; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Nauen R, 2003, B ENTOMOL RES, V93, P47, DOI 10.1079/BER2002215; Nazir A, 2001, ARCH ENVIRON CON TOX, V41, P443, DOI 10.1007/s002440010270; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Onstad D, 2008, INSECTICIDE RESISTAN, V1; Pedra JHF, 2005, PROTEOMICS, V5, P258, DOI 10.1002/pmic.200400914; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Philippou D, 2010, PEST MANAG SCI, V66, P390, DOI 10.1002/ps.1888; POTTER C, 1952, ANN APPL BIOL, V39, P1, DOI 10.1111/j.1744-7348.1952.tb00993.x; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Saleem AM, 1994, PAK J ZOOL, V26, P327; Schoonhoven L. M., 2005, Insect-plant biology; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Silva LB, 2010, COMP BIOCHEM PHYS B, V157, P80, DOI 10.1016/j.cbpb.2010.05.008; Simon JC, 2001, P 6 INT S APH; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sogorb MA, 2010, ANTICHOLINESTERASE PESTICIDES: METABOLISM, NEUROTOXICITY, AND EPIDEMIOLOGY, P121; Somwang P, 2011, PARASITOL RES, V109, P531, DOI 10.1007/s00436-011-2280-0; Srigiriraju L, 2010, CROP PROT, V29, P197, DOI 10.1016/j.cropro.2009.11.006; *STATSOFT I, STATISTICA DAT AN SO; Stevens M., 1996, British Sugar Beet Review, V64, P34; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Valles SM, 2000, PESTIC BIOCHEM PHYS, V66, P195, DOI 10.1006/pest.1999.2462; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Vasquez B., 1995, BOOK INSECTS RECORDS; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; WALTER CM, 1989, COMP BIOCHEM PHYS C, V94, P419, DOI 10.1016/0742-8413(89)90091-1; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhu YC, 2011, J INVERTEBR PATHOL, V106, P296, DOI 10.1016/j.jip.2010.10.007	118	138	151	4	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e36366	10.1371/journal.pone.0036366	http://dx.doi.org/10.1371/journal.pone.0036366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685538	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700002
J	Li, ZL; Liu, JC; Liu, SB; Li, XQ; Yi, DH; Zhao, MG				Li, Zi-lin; Liu, Jin-cheng; Liu, Shui-bing; Li, Xiao-qiang; Yi, Ding-hua; Zhao, Ming-gao			Improvement of Vascular Function by Acute and Chronic Treatment with the GPR30 Agonist G1 in Experimental Diabetes Mellitus	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-COUPLED RECEPTOR; ENDOTHELIUM-DEPENDENT VASODILATATION; PANCREATIC-ISLETS; MICE LACKING; ESTROGEN; ACTIVATION; PHOSPHORYLATION; CELLS; 17-BETA-ESTRADIOL	The G-protein coupled estrogen receptor 30 (GPR30) is a seven-transmembrane domain receptor that mediates rapid estrogen responses in a wide variety of cell types. This receptor is highly expressed in the cardiovascular system, and exerts vasodilatory effects. The objective of the present study was to investigate the effects of GPR30 on vascular responsiveness in diabetic ovariectomized (OVX) rats and elucidate the possible mechanism involved. The roles of GPR30 were evaluated in the thoracic aorta and cultured endothelial cells. The GPR30 agonist G1 induced a dose-dependent vasodilation in the thoracic aorta of the diabetic OVX rats, which was partially attenuated by the nitric oxide synthase (NOS) inhibitor, nitro-L-arginine methylester (L-NAME) and the GPR30-selective antagonist G15. Dose-dependent vasoconstrictive responses to phenylephrine were attenuated significantly in the rings of the thoracic aorta following the acute G1 administration in the diabetic OVX rats. This effect of G1 was abolished partially by L-NAME and G15. The acute administration of G1 increased significantly the eNOS activity and the concentration of NO in the endothelial cells exposed to high glucose. G1 treatment induced an enhanced endothelium-dependent relaxation to acetylcholine (Ach) in the diabetic OVX rats. Further examination revealed that G1 induced vasodilation in the diabetic OVX rats by increasing the phosphorylation of eNOS. These findings provide preliminary evidence that GPR30 activation leads to eNOS activation, as well as vasodilation, to a certain degree and has beneficial effects on vascular function in diabetic OVX rats.	[Li, Zi-lin; Liu, Jin-cheng; Yi, Ding-hua] Fourth Mil Med Univ, Sch Pharm, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Liu, Shui-bing; Li, Xiao-qiang; Zhao, Ming-gao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Li, Zi-lin] PLA 452 Hosp, Dept Cardiothorac Surg, Chengdu, Sichuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, ZL (corresponding author), Fourth Mil Med Univ, Sch Pharm, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China.	dhyi@fmmu.edu.cn; minggao@fmmu.edu.cn	Li, Xiao-Qiang/AAA-5094-2019	Zhao, Ming-gao/0000-0002-7539-3887	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atochin DN, 2010, ENDOTHELIAL NITRIC O; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chen L, 2008, NEUROPHARMACOLOGY, V54, P1175, DOI 10.1016/j.neuropharm.2008.03.007; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Freedman JE, 1999, CIRC RES, V84, P1416; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang PL, 2005, CIRC RES, V96, P1129, DOI 10.1161/01.RES.0000170705.56583.45; Huang PL, 2000, SEMIN PERINATOL, V24, P87, DOI 10.1016/S0146-0005(00)80064-6; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Kumar R, 2011, ENDOCRINOLOGY, V152, P2568, DOI 10.1210/en.2010-1361; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lindsey SH, 2011, J CARDIOVASC PHARM, V57, P598, DOI 10.1097/FJC.0b013e3182135f1c; Liu SB, 2011, CLIN EXP PHARMACOL P, V38, P577, DOI 10.1111/j.1440-1681.2011.05549.x; Meyer MR, 2012, HYPERTENSION, V59, P507, DOI 10.1161/HYPERTENSIONAHA.111.184606; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Natali A, 2005, EUR HEART J, V26, P464, DOI 10.1093/eurheartj/ehi113; Prossnitz ER, 2011, NAT REV ENDOCRINOL; Prossnitz ER, 2008, TRENDS PHARMACOL SCI, V29, P116, DOI 10.1016/j.tips.2008.01.001; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Skyrme-Jones RAP, 2000, J AM COLL CARDIOL, V35, P292, DOI 10.1016/S0735-1097(99)00547-1; Takenouchi Y, 2009, J PHARMACOL SCI, V111, P91, DOI 10.1254/jphs.09133FP; Zhong WL, 2010, DIABETES RES CLIN PR, V89, P38, DOI 10.1016/j.diabres.2010.03.013	36	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38787	10.1371/journal.pone.0038787	http://dx.doi.org/10.1371/journal.pone.0038787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679517	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900065
J	Huang, F; He, ZG				Huang, Feng; He, Zheng-Guo			Characterization of a Conserved Interaction between DNA Glycosylase and ParA in Mycobacterium smegmatis and M. tuberculosis	PLOS ONE			English	Article							BACTERIAL CHROMOSOME SEGREGATION; ESCHERICHIA-COLI; GENOME SEQUENCE; PROTEIN DNAA; PLASMID; REPAIR; IDENTIFICATION; TRANSFORMATION; PURIFICATION; REPLICATION	The chromosome partitioning proteins, ParAB, ensure accurate segregation of genetic materials into daughter cells and most bacterial species contain their homologs. However, little is known about the regulation of ParAB proteins. In this study, we found that 3-methyladenine DNA glycosylase I MsTAG(Ms5082) regulates bacterial growth and cell morphology by directly interacting with MsParA (Ms6939) and inhibiting its ATPase activity in Mycobacterium smegmatis. Using bacterial two-hybrid and pull-down techniques in combination with co-immunoprecipitation assays, we show that MsTAG physically interacts with MsParA both in vitro and in vivo. Expression of MsTAG under conditions of DNA damage induction exhibited similar inhibition of growth as the deletion of the parA gene in M. smegmatis. Further, the effect of MsTAG on mycobacterial growth was found to be independent of its DNA glycosylase activity, and to result instead from direct inhibition of the ATPase activity of MsParA. Co-expression of these two proteins could counteract the growth defect phenotypes observed in strains overexpressing MsTAG alone in response to DNA damage induction. Based on protein co-expression and fluorescent co-localization assays, MsParA and MsTAG were further found to co-localize in mycobacterial cells. In addition, the interaction between the DNA glycosylase and ParA, and the regulation of ParA by the glycosylase were conserved in M. tuberculosis and M. smegmatis. Our findings provide important new insights into the regulatory mechanism of cell growth and division in mycobacteria.	[Huang, Feng; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014		National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program	This work was supported by the National Natural Science Foundation of China (31025002 and 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (To He Z-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BJELLAND S, 1987, NUCLEIC ACIDS RES, V15, P2787, DOI 10.1093/nar/15.7.2787; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Davis MA, 1996, MOL MICROBIOL, V21, P1029, DOI 10.1046/j.1365-2958.1996.721423.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2006, TRENDS BIOCHEM SCI, V31, P247, DOI 10.1016/j.tibs.2006.03.002; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; Huang F, 2010, NUCLEIC ACIDS RES, V38, P8219, DOI 10.1093/nar/gkq737; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lewis PJ, 2001, MICROBIOL-UK, V147, P519, DOI 10.1099/00221287-147-3-519; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Pan WW, 2010, J VIROL METHODS, V163, P465, DOI 10.1016/j.jviromet.2009.11.015; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scholefield G, 2012, EMBO J, V31, P1542, DOI 10.1038/emboj.2012.6; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Yang MY, 2011, DNA REPAIR, V10, P595, DOI 10.1016/j.dnarep.2011.03.007; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	39	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38276	10.1371/journal.pone.0038276	http://dx.doi.org/10.1371/journal.pone.0038276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675536	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700055
J	Roth, C; Stuckrath, I; Pantel, K; Izbicki, JR; Tachezy, M; Schwarzenbach, H				Roth, Carina; Stueckrath, Isabel; Pantel, Klaus; Izbicki, Jakob R.; Tachezy, Michael; Schwarzenbach, Heidi			Low Levels of Cell-Free Circulating miR-361-3p and miR-625*as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors	PLOS ONE			English	Article							CANCER; MICRORNAS; BIOMARKERS; DIAGNOSIS; THERAPY; SERUM; BETA	The high mortality rate of lung cancer patients is mainly due to the late stage at which lung cancer is diagnosed. For effective cancer prevention programs and early diagnosis, better blood-based markers are needed. Hence, blood-based microarray profiling of microRNA (miR) expression was performed in preoperative serum of 21 non-small cell lung cancer (NSCLC) patients and 11 healthy individuals by microfluid biochips containing 1158 different miRs. Two out of the 30 most dysregulated miRs were further validated in serum of 97 NSCLC patients, 20 patients with benign lung diseases and 30 healthy individuals by TaqMan MicroRNA Assays. Microarray profiling showed that miR-361-3p and miR-625* were significantly down-regulated in serum of lung cancer patients. Their further evaluation by quantitative RT-PCR showed that the levels of miR-361-3p and miR-625* were lower in NSCLC than in benign disease (p = 0.0001) and healthy individuals (p = 0.0001, p = 0.0005, respectively). Moreover, the levels of miR-625* were significantly lower in patients with large cell lung cancer (LCLC, p = 0.014) and smoking patients (p = 0.030) than in patients with adenocarcinoma and non-smoking patients, respectively. A rise in the levels of both miRs was observed in the postoperative samples compared with the preoperative levels (p = 0.0001). Functional analyses showed that Smad2 and TGFss1 are not dysregulated by miR-361-3p and miR-625* in the lung cell line A549, respectively. Our present pilot study suggests that miR-361-3p and miR-625* might have a protective influence on the development of NSCLC, and the quantitative assessment of these miRs in blood serum might have diagnostic potential to detect NSCLC, in particular in smokers.	[Roth, Carina; Stueckrath, Isabel; Pantel, Klaus; Schwarzenbach, Heidi] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Izbicki, Jakob R.; Tachezy, Michael] Univ Med Ctr Hamburg Eppendorf, Gen Visceral & Thorac Surg Dept & Clin, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Roth, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	hschwarz@uke.uni-hamburg.de	Tachezy, Michael/AAD-6759-2022		Erich und Gertrud Roggenbuck-Stiftung, Hamburg	Erich und Gertrud Roggenbuck-Stiftung, Hamburg	The study was supported by the Erich und Gertrud Roggenbuck-Stiftung, Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bianchi F, 2011, EMBO MOL MED; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cohen EEW, 2012, CLIN LUNG CANCER, V13, P123, DOI 10.1016/j.cllc.2011.10.001; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gao W, 2011, CLIN LUNG CANCER, V12, P14, DOI 10.3816/CLC.2011.n.001; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heegaard NH, 2011, INT J CANC; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Liu X, 2011, TRANSL RES, V157, P200, DOI 10.1016/j.trsl.2011.01.001; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Planchard D, 2011, EUR J CANCER, V47, pS272, DOI 10.1016/S0959-8049(11)70173-3; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	34	64	72	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38248	10.1371/journal.pone.0038248	http://dx.doi.org/10.1371/journal.pone.0038248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675530	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700050
J	Wang, Q; Chen, JZ; Wang, Y; Han, X; Chen, XW				Wang, Qian; Chen, Jizheng; Wang, Yun; Han, Xiao; Chen, Xinwen			Hepatitis C Virus Induced a Novel Apoptosis-Like Death of Pancreatic Beta Cells through a Caspase 3-Dependent Pathway	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; EXTRAHEPATIC MANIFESTATIONS; INFECTION; REPLICATION; ASSOCIATION; PREVALENCE; FAILURE	Epidemiological and experimental studies have suggested that Hepatitis C virus (HCV) infection is associated with the development of type 2 diabetes. Pancreatic beta cell failure is central to the progression of type 2 diabetes. Using virus infection system, we investigate the influence of HCV infection on the fate of the insulinoma cell line, MIN6. Our experiments demonstrate that the HCV virion itself is indispensable and has a dose- and time-dependent cytopathic effect on the cells. HCV infection inhibits cell proliferation and induces death of MIN6 cells with apoptotic characteristics, including cell surface exposure of phosphatidylserine, decreased mitochondrial membrane potential, activation of caspase 3 and poly (ADP-ribose) polymerase, and DNA fragmentation in the nucleus. However, the fact that HCV-infected cells exhibit a dilated, low-density nucleus with intact plasma and nuclear membrane indicates that a novel apoptosis-like death occurs. HCV infection also causes endoplasmic reticulum (ER) stress. Further, HCV RNA replication was detected in MIN6 cells, although the infection efficiency is very low and no progeny virus particle generates. Taken together, our data suggest that HCV infection induces death of pancreatic beta cells through an ER stress-involved, caspase 3-dependent, special pathway.	[Wang, Qian; Chen, Jizheng; Wang, Yun; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wang, Qian; Han, Xiao] Nanjing Med Univ, Sch Basic Med Sci, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Nanjing Medical University	Wang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	chenxw@wh.iov.cn			National Basic Research Program of China (973 Program) [2006CB933100, 2007CB512901]; Nature Science Foundations of Jiangsu Province [BK2008441]; China Postdoctoral Science Foundation [20080430175]; Open Research Fund Program of the State Key Laboratory of Virology [2010008]; National Nature Science Foundations of China [30800044]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature Science Foundations of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Open Research Fund Program of the State Key Laboratory of Virology; National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2006CB933100, 2007CB512901) (URL:http://www.973.gov.cn/AreaAppl.aspx), the Nature Science Foundations of Jiangsu Province (BK2008441)(http://www.jsnsf.gov.cn/index.aspx), the China Postdoctoral Science Foundation (20080430175)(http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx) and the Open Research Fund Program of the State Key Laboratory of Virology (2010008)(http://www.virology.chinalab.gov.cn/), the National Nature Science Foundations of China (30800044) (URL:http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; BIRD GLA, 1990, ANN INTERN MED, V112, P917, DOI 10.7326/0003-4819-112-12-917; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Caronia S, 1999, HEPATOLOGY, V30, P1059, DOI 10.1002/hep.510300416; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Corbett J, 1997, DIABETOLOGIA, V40, pB27, DOI 10.1007/BF03168183; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Galossi A, 2007, J GASTROINTEST LIVER, V16, P65; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gu BH, 2003, J VIROL, V77, P5352, DOI 10.1128/JVI.77.9.5352-5359.2003; GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Huang JF, 2007, AM J GASTROENTEROL, V102, P1237, DOI 10.1111/j.1572-0241.2007.01181.x; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Laskus T, 1998, HEPATOLOGY, V28, P1398, DOI 10.1002/hep.510280531; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Lecube A, 2004, DIABETES CARE, V27, P1171, DOI 10.2337/diacare.27.5.1171; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; MARINOS G, 1995, GASTROENTEROLOGY, V108, P1453, DOI 10.1016/0016-5085(95)90694-0; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Masini M, 2005, DIABETES CARE, V28, P940, DOI 10.2337/diacare.28.4.940; Mason AL, 1999, HEPATOLOGY, V29, P328, DOI 10.1002/hep.510290235; Mehta SH, 2000, ANN INTERN MED, V133, P592, DOI 10.7326/0003-4819-133-8-200010170-00009; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ratziu V, 2005, ALIMENT PHARM THERAP, V22, P56, DOI 10.1111/j.1365-2036.2005.02598.x; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rumin S, 1999, J GEN VIROL, V80, P3007, DOI 10.1099/0022-1317-80-11-3007; SALEH MG, 1994, HEPATOLOGY, V20, P1399, DOI 10.1002/hep.1840200604; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; WAN CP, 1994, J IMMUNOL METHODS, V173, P265, DOI 10.1016/0022-1759(94)90305-0; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154	55	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38522	10.1371/journal.pone.0038522	http://dx.doi.org/10.1371/journal.pone.0038522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675572	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700084
J	Kitaguchi, Y; Taraseviciene-Stewart, L; Hanaoka, M; Natarajan, R; Kraskauskas, D; Voelkel, NF				Kitaguchi, Yoshiaki; Taraseviciene-Stewart, Laimute; Hanaoka, Masayuki; Natarajan, Ramesh; Kraskauskas, Donatas; Voelkel, Norbert F.			Acrolein Induces Endoplasmic Reticulum Stress and Causes Airspace Enlargement	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; ENDOTHELIAL GROWTH-FACTOR; CIGARETTE-SMOKE; ALPHA,BETA-UNSATURATED ALDEHYDES; CELL APOPTOSIS; TOBACCO-SMOKE; LUNG-FUNCTION; EXPRESSION; EXPOSURE; PATHWAY	Background: Given the relative abundance and toxic potential of acrolein in inhaled cigarette smoke, it is surprising how little is known about the pulmonary and systemic effects of acrolein. Here we test the hypothesis whether systemic administration of acrolein could cause endoplasmic reticulum (ER) stress, and lung cell apoptosis, leading to the enlargement of the alveolar air spaces in rats. Methods: Acute and chronic effects of intraperitoneally administered acrolein were tested. Mean alveolar airspace area was measured by using light microscopy and imaging system software. TUNEL staining and immunohistochemistry (IHC) for active caspase 3 and Western blot analysis for active caspase 3, and caspase 12 were performed to detect apoptosis. The ER-stress related gene expression in the lungs was determined by Quantitative real-time PCR analysis. Acrolein-protein adducts in the lung tissue were detected by IHC. Results: Acute administration of acrolein caused a significant elevation of activated caspase 3, upregulation of VEGF expression and induced ER stress proteins in the lung tissue. The chronic administration of acrolein in rats led to emphysematous lung tissue remodeling. TUNEL staining and IHC for cleaved caspase 3 showed a large number of apoptotic septal cells in the acrolein-treated rat lungs. Chronic acrolein administration cause the endoplasmic reticulum stress response manifested by significant upregulation of ATF4, CHOP and GADd34 expression. In smokers with COPD there was a considerable accumulation of acrolein-protein adducts in the inflammatory, airway and vascular cells. Conclusions: Systemic administration of acrolein causes endoplasmic reticulum stress response, lung cell apoptosis, and chronic administration leads to the enlargement of the alveolar air spaces and emphysema in rats. The substantial accumulation of acrolein-protein adducts in the lungs of COPD patients suggest a role of acrolein in the pathogenesis of emphysema.	[Kitaguchi, Yoshiaki; Natarajan, Ramesh; Kraskauskas, Donatas; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Lab Obstruct Lung Dis Res, Pulm & Crit Care Med Div, Richmond, VA 23284 USA; [Kitaguchi, Yoshiaki; Hanaoka, Masayuki] Sinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano, Japan; [Taraseviciene-Stewart, Laimute] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA	Virginia Commonwealth University; Shinshu University; University of Colorado System; University of Colorado Anschutz Medical Campus	Kitaguchi, Y (corresponding author), Virginia Commonwealth Univ, Victoria Johnson Lab Obstruct Lung Dis Res, Pulm & Crit Care Med Div, Richmond, VA 23284 USA.	Laima.Taraseviciene@ucdenver.edu		Natarajan, Ramesh/0000-0002-3431-9971; Kitaguchi, Yoshiaki/0000-0002-3922-4082	Victoria Johnson Laboratory for Obstructive Lung Research; Flight Attendant Medical Research Institute [CIA-072053]	Victoria Johnson Laboratory for Obstructive Lung Research; Flight Attendant Medical Research Institute	The Victoria Johnson Laboratory for Obstructive Lung Research (to NFV) and Flight Attendant Medical Research Institute CIA-072053 (to LTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Barnes RL, 2007, NICOTINE TOB RES, V9, P995, DOI 10.1080/14622200701488392; Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; Berry KAZ, 2007, CHEM RES TOXICOL, V20, P1342, DOI 10.1021/tx700102n; Borchers MT, 2007, EXP MOL PATHOL, V83, P301, DOI 10.1016/j.yexmp.2007.08.020; Burcham PC, 2010, CHEM-BIOL INTERACT, V183, P416, DOI 10.1016/j.cbi.2009.12.006; Carmella SG, 2007, CHEM RES TOXICOL, V20, P986, DOI 10.1021/tx700075y; COSTA DL, 1986, AM REV RESPIR DIS, V133, P286; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Gunther M, 2008, J CELL MOL MED, V12, P2704, DOI 10.1111/j.1582-4934.2008.00255.x; Haberzettl P, 2009, TOXICOL APPL PHARM, V234, P14, DOI 10.1016/j.taap.2008.09.019; HALBOWER AC, 1994, LAB INVEST, V71, P149; Hengstermann A, 2008, FREE RADICAL BIO MED, V44, P1097, DOI 10.1016/j.freeradbiomed.2007.12.009; Ishii T, 2007, FREE RADICAL RES, V41, P1253, DOI 10.1080/10715760701678652; JERMINI C, 1976, INT ARCH OCC ENV HEA, V36, P169, DOI 10.1007/BF00378272; Jones AP, 1999, ATMOS ENVIRON, V33, P4535, DOI 10.1016/S1352-2310(99)00272-1; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Kuo WW, 2005, ENVIRON HEALTH PERSP, V113, P1349, DOI 10.1289/ehp.7479; Landau LI, 2008, PAEDIATR RESPIR REV, V9, P39, DOI 10.1016/j.prrv.2007.11.002; Li B, 2008, MOL VIS, V14, P1122; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P209, DOI 10.1002/jnr.20863; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Matsunaga T, 2004, J BIOL CHEM, V279, P28614, DOI 10.1074/jbc.M400977200; Misonou Y, 2006, NITRIC OXIDE-BIOL CH, V14, P180, DOI 10.1016/j.niox.2005.09.004; Nana-Sinkam SP, 2007, AM J RESP CRIT CARE, V175, P676, DOI 10.1164/rccm.200605-724OC; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pawlowicz AJ, 2008, CHEM BIODIVERS, V5, P177, DOI 10.1002/cbdv.200890009; PENN A, 1994, CIRCULATION, V90, P1363, DOI 10.1161/01.CIR.90.3.1363; Petrache Irina, 2006, Proc Am Thorac Soc, V3, P510, DOI 10.1513/pats.200603-071MS; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Ramu K, 1996, TOXICOL APPL PHARM, V140, P487, DOI 10.1006/taap.1996.0245; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy J, 2009, CHEM-BIOL INTERACT, V181, P154, DOI 10.1016/j.cbi.2009.07.001; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; STEDMAN RL, 1968, CHEM REV, V68, P153, DOI 10.1021/cr60252a002; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P41, DOI 10.1513/pats.200512-124JH; Volpi G, 2011, BRIT J PHARMACOL, V163, P649, DOI 10.1111/j.1476-5381.2011.01253.x; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; Wu CH, 2006, ARCH TOXICOL, V80, P328, DOI 10.1007/s00204-005-0050-4; Zhang SY, 2011, CHEM RES TOXICOL, V24, P119, DOI 10.1021/tx100321y	53	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38038	10.1371/journal.pone.0038038	http://dx.doi.org/10.1371/journal.pone.0038038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675432	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500079
J	Parsa, S; Ccanto, R; Olivera, E; Scurrah, M; Alcazar, J; Rosenheim, JA				Parsa, Soroush; Ccanto, Raul; Olivera, Edgar; Scurrah, Maria; Alcazar, Jesus; Rosenheim, Jay A.			Explaining Andean Potato Weevils in Relation to Local and Landscape Features: A Facilitated Ecoinformatics Approach	PLOS ONE			English	Article							PEST; MANAGEMENT	Background: Pest impact on an agricultural field is jointly influenced by local and landscape features. Rarely, however, are these features studied together. The present study applies a "facilitated ecoinformatics" approach to jointly screen many local and landscape features of suspected importance to Andean potato weevils (Premnotrypes spp.), the most serious pests of potatoes in the high Andes. Methodology/Principal Findings: We generated a comprehensive list of predictors of weevil damage, including both local and landscape features deemed important by farmers and researchers. To test their importance, we assembled an observational dataset measuring these features across 138 randomly-selected potato fields in Huancavelica, Peru. Data for local features were generated primarily by participating farmers who were trained to maintain records of their management operations. An information theoretic approach to modeling the data resulted in 131,071 models, the best of which explained 40.2-46.4% of the observed variance in infestations. The best model considering both local and landscape features strongly outperformed the best models considering them in isolation. Multi-model inferences confirmed many, but not all of the expected patterns, and suggested gaps in local knowledge for Andean potato weevils. The most important predictors were the field's perimeter-to-area ratio, the number of nearby potato storage units, the amount of potatoes planted in close proximity to the field, and the number of insecticide treatments made early in the season. Conclusions/Significance: Results underscored the need to refine the timing of insecticide applications and to explore adjustments in potato hilling as potential control tactics for Andean weevils. We believe our study illustrates the potential of ecoinformatics research to help streamline IPM learning in agricultural learning collaboratives.	[Parsa, Soroush] CIAT, Cali, Colombia; [Ccanto, Raul; Olivera, Edgar; Scurrah, Maria] Grp Yanapai, Lima, Peru; [Alcazar, Jesus] CIP, Lima, Peru; [Parsa, Soroush; Rosenheim, Jay A.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Potato Center (CIP); University of California System; University of California Davis	Parsa, S (corresponding author), CIAT, Cali, Colombia.	s.parsa@cgiar.org		Ccanto Retamozo, Raul Carlos/0000-0003-1396-213X	UC Davis University Outreach and International Programs (UOIP); McKnight Foundation Collaborative Crop Research Program (CCRP)	UC Davis University Outreach and International Programs (UOIP); McKnight Foundation Collaborative Crop Research Program (CCRP)	This project was funded by the UC Davis University Outreach and International Programs (UOIP) and the McKnight Foundation Collaborative Crop Research Program (CCRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Alcazar J., 1999, Impact on a changing world. International Potato Center Program Report 1997-1998., P141; Alcazar J, 1997, PROGRAM REPORT 1995, P169; Allen KC, 2009, CROP PROT, V28, P722, DOI 10.1016/j.cropro.2009.04.007; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; BJORNSTAD O, 2004, NCF PACKAGE ANAL SPA; Calderon R, 2004, DESARROLLO COMPONENT; Ewell PT, 1990, FARMER MANAGEMENT PO; HARRIS MK, 1980, TEX AES MISC PUBL, P23; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; Jimenez D, 2009, COMPUT ELECTRON AGR, V69, P198, DOI 10.1016/j.compag.2009.08.008; Kaya H. K., 2009, FRUIT VEG CEREAL SCI, V3, P39, DOI DOI 10.1016/J.BIOCONTROL.2006.04.003; Kroschel J, 2009, CROP PROT, V28, P466, DOI 10.1016/j.cropro.2009.01.008; Kuhne M, 2007, ANDEAN POTATO WEEVIL; Lacy J, 2011, AGR SYST, V104, P562, DOI 10.1016/j.agsy.2011.04.005; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Ortiz O., 1996, Case studies of the economic impact of CIP-related technologies., P95; Ostman O, 2001, BASIC APPL ECOL, V2, P365, DOI 10.1078/1439-1791-00072; Parsa S, 2006, BIOL CONTROL, V39, P171, DOI 10.1016/j.biocontrol.2006.04.003; Parsa Soroush, 2010, American Entomologist, V56, P242; Parsa S, 2011, ECOL APPL, V21, P539, DOI 10.1890/10-0393.1; Prasifka JR, 2004, LANDSCAPE ECOL, V19, P709, DOI 10.1007/s10980-005-0279-7; Rios A, J APPL ENTO IN PRESS; Rochester WA, 2002, COMPUT ELECTRON AGR, V35, P139, DOI 10.1016/S0168-1699(02)00015-7; Rosenheim JA, 2011, J ECON ENTOMOL, V104, P331, DOI 10.1603/EC10380; SAS Institute, 2007, JMP US GUID REL 7; SPEIGHT MR, 1983, AGR ECOSYST ENVIRON, V10, P183, DOI 10.1016/0167-8809(83)90061-0; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; TOSI J, 1960, ZONAS VIDA NATURAL P; Zaller JG, 2008, AGR ECOSYST ENVIRON, V123, P233, DOI 10.1016/j.agee.2007.07.002; Zwald NR, 2006, J DAIRY SCI, V89, P330, DOI 10.3168/jds.S0022-0302(06)72098-7	33	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36533	10.1371/journal.pone.0036533	http://dx.doi.org/10.1371/journal.pone.0036533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693551	Green Published, gold			2022-12-25	WOS:000305338500012
J	Sievers, C; Willing, EM; Hoffmann, M; Dreyer, C; Ramnarine, I; Magurran, A				Sievers, Caya; Willing, Eva-Maria; Hoffmann, Margarete; Dreyer, Christine; Ramnarine, Indar; Magurran, Anne			Reasons for the Invasive Success of a Guppy (Poecilia reticulata) Population in Trinidad	PLOS ONE			English	Article							GENE FLOW; ARTIFICIAL INTRODUCTION; SOCIAL RECOGNITION; CONSEQUENCES; BEHAVIOR; HYBRIDIZATION; PREFERENCES; DIVERGENCE; TRAITS; CHOICE	The introduction of non-native species into new habitats poses a major threat to native populations. Of particular interest, though often overlooked, are introductions of populations that are not fully reproductively isolated from native individuals and can hybridize with them. To address this important topic we used different approaches in a multi-pronged study, combining the effects of mate choice, shoaling behaviour and genetics. Here we present evidence that behavioural traits such as shoaling and mate choice can promote population mixing if individuals do not distinguish between native and foreign conspecifics. We examined this in the context of two guppy (Poecilia reticulata) populations that have been subject to an introduction and subsequent population mixing event in Trinidad. The introduction of Guanapo River guppies into the Turure River more than 50 years ago led to a marked reduction of the original genotype. In our experiments, female guppies did not distinguish between shoaling partners when given the choice between native and foreign individuals. Introduced fish are therefore likely to benefit from the protection of a shoal and will improve their survival chances as a result. The additional finding that male guppies do not discriminate between females on the basis of origin will further increase the process of population mixing, especially if males encounter mixed shoals. In a mesocosm experiment, in which the native and foreign populations were allowed to mate freely, we found, as expected on the basis of these behavioural interactions, that the distribution of offspring genotypes could be predicted from the proportions of the two types of founding fish. This result suggests that stochastic and environmental processes have reinforced the biological ones to bring about the genetic dominance of the invading population in the Turure River. Re-sampling the Turure for genetic analysis using SNP markers confirmed the population mixing process and showed that it is an on-going process in this river and has led to the nearly complete disappearance of the original genotype.	[Sievers, Caya; Magurran, Anne] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Willing, Eva-Maria; Hoffmann, Margarete; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Ramnarine, Indar] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago	University of St Andrews; Max Planck Society; University West Indies Mona Jamaica; University West Indies Saint Augustine	Sievers, C (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland.	cs583@st-andrews.ac.uk	Magurran, Anne E/D-7463-2013	Magurran, Anne/0000-0002-0036-2795	European Research Council [BioTIME 250189]	European Research Council(European Research Council (ERC)European Commission)	AEM acknowledges financial support from the European Research Council (project BioTIME 250189). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Becher SA, 2000, J FISH BIOL, V56, P241, DOI 10.1111/j.1095-8649.2000.tb02103.x; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Daehler CC, 2001, BIOTIC HOMOGENIZATION, P81; diCastri F, 1989, BIOL INVASIONS GLOBA, P1; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Echelle AA, 1997, CONSERV BIOL, V11, P153, DOI 10.1046/j.1523-1739.1997.95427.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; GODIN JGJ, 1995, ANIM BEHAV, V49, P1427, DOI 10.1016/0003-3472(95)90063-2; GOLDSCHMIDT T, 1993, CONSERV BIOL, V7, P686, DOI 10.1046/j.1523-1739.1993.07030686.x; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; Hanfling B, 2005, FRESHWATER BIOL, V50, P403, DOI 10.1111/j.1365-2427.2004.01330.x; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Kelley JL, 1999, NATURE, V401, P661, DOI 10.1038/44314; Ludlow AM, 2006, P ROY SOC B-BIOL SCI, V273, P2477, DOI 10.1098/rspb.2006.3605; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAGURRAN AE, 1994, J FISH BIOL, V45, P401, DOI 10.1111/j.1095-8649.1994.tb01322.x; Magurran AE, 1996, BEHAVIOUR, V133, P503, DOI 10.1163/156853996X00189; MAGURRAN AE, 1992, P ROY SOC B-BIOL SCI, V248, P117, DOI 10.1098/rspb.1992.0050; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Ojanguren AF, 2004, P ROY SOC B-BIOL SCI, V271, pS427, DOI 10.1098/rsbl.2004.0207; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Russell ST, 2006, J EVOLUTION BIOL, V19, P1294, DOI 10.1111/j.1420-9101.2005.01069.x; Russell ST, 2006, BIOL J LINN SOC, V88, P397, DOI 10.1111/j.1095-8312.2006.00628.x; Schories S, 2009, ZOOTAXA, P35, DOI 10.11646/zootaxa.2266.1.2; SHAW E, 1978, AM SCI, V66, P166; SHAW PW, 1992, P ROY SOC B-BIOL SCI, V248, P111, DOI 10.1098/rspb.1992.0049; Simberloff Daniel, 1997, P221; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Suarez Andrew V., 1999, Biological Invasions, V1, P43, DOI 10.1023/A:1010038413690; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Valero A, 2008, BIOL LETTERS, V4, P149, DOI 10.1098/rsbl.2007.0604; Ward AJW, 2009, BEHAV ECOL, V20, P511, DOI 10.1093/beheco/arp025; Ward AJW, 2007, P ROY SOC B-BIOL SCI, V274, P1071, DOI 10.1098/rspb.2006.0231; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x	46	15	15	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38404	10.1371/journal.pone.0038404	http://dx.doi.org/10.1371/journal.pone.0038404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693621	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500144
J	Stevens, B; Chen, CL; Farrell, I; Zhang, HB; Kaur, J; Broitman, SL; Smilansky, Z; Cooperman, BS; Goldman, YE				Stevens, Benjamin; Chen, Chunlai; Farrell, Ian; Zhang, Haibo; Kaur, Jaskiran; Broitman, Steven L.; Smilansky, Zeev; Cooperman, Barry S.; Goldman, Yale E.			FRET-Based Identification of mRNAs Undergoing Translation	PLOS ONE			English	Article							RIBOSOMAL L1 STALK; IN-VIVO; PROTEIN; DYNAMICS; LIGASE; CELLS	We present proof-of-concept in vitro results demonstrating the feasibility of using single molecule fluorescence resonance energy transfer (smFRET) measurements to distinguish, in real time, between individual ribosomes programmed with several different, short mRNAs. For these measurements we use either the FRET signal generated between two tRNAs labeled with different fluorophores bound simultaneously in adjacent sites to the ribosome (tRNA-tRNA FRET) or the FRET signal generated between a labeled tRNA bound to the ribosome and a fluorescent derivative of ribosomal protein L1 (L1-tRNA FRET). With either technique, criteria were developed to identify the mRNAs, taking into account the relative activity of the mRNAs. These criteria enabled identification of the mRNA being translated by a given ribosome to within 95% confidence intervals based on the number of identified FRET traces. To upgrade the approach for natural mRNAs or more complex mixtures, the stoichiometry of labeling should be enhanced and photobleaching reduced. The potential for porting these methods into living cells is discussed.	[Stevens, Benjamin; Chen, Chunlai; Goldman, Yale E.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Stevens, Benjamin; Smilansky, Zeev] Anima Cell Metrol Inc, Bernardsville, NJ USA; [Farrell, Ian; Zhang, Haibo; Kaur, Jaskiran; Cooperman, Barry S.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Broitman, Steven L.] W Chester Univ Penn, Dept Biol, W Chester, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania	Stevens, B (corresponding author), Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA.	goldmany@mail.med.upenn.edu	Chen, Chunlai/F-8410-2012		National Institute for Standards and Technology (NIST) Advanced Technology Program [70NANB7H7011]; NIH [R01GM080376]; American Heart Association Postdoctoral Fellowship [12POST8910014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080376] Funding Source: NIH RePORTER	National Institute for Standards and Technology (NIST) Advanced Technology Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by a National Institute for Standards and Technology (NIST) Advanced Technology Program grant 70NANB7H7011 to Anima Cell Metrology, Inc., NIH grant R01GM080376 to BSC and YEG, and American Heart Association Postdoctoral Fellowship (12POST8910014 to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Barhoom S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr601; Betteridge T, 2007, RNA, V13, P1594, DOI 10.1261/rna.475407; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Chattopadhaya S, 2009, BIOORGAN MED CHEM, V17, P981, DOI 10.1016/j.bmc.2008.01.043; Chen CL, 2011, P NATL ACAD SCI USA, V108, P16980, DOI 10.1073/pnas.1106999108; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Haller A, 2011, ACCOUNTS CHEM RES, V44, P1339, DOI 10.1021/ar200035g; Hikida Y, 2010, NAT PROTOC, V5, P1312, DOI 10.1038/nprot.2010.77; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kaur J, 2011, RNA, V17, P1393, DOI 10.1261/rna.2670811; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Lin XC, 2008, SPECTROSC SPECT ANAL, V28, P2615, DOI 10.3964/j.issn.1000-0593(2008)11-2615-04; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Marks KM, 2004, CHEM BIOL, V11, P347, DOI 10.1016/j.chembiol.2004.03.004; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; Motorin Y, 2011, NUCLEIC ACIDS RES, V39, P1943, DOI 10.1093/nar/gkq825; ODOM OW, 1980, BIOCHEMISTRY-US, V19, P5947, DOI 10.1021/bi00567a001; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pan DL, 2009, RNA, V15, P346, DOI 10.1261/rna.1257509; Qin HO, 2009, BIOCHEMISTRY-US, V48, P4699, DOI 10.1021/bi900222e; RHEINBERGER HJ, 1986, J BIOL CHEM, V261, P9133; RHEINBERGER HJ, 1986, J BIOL CHEM, V261, P9140; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Wang Y, 2007, BIOCHEMISTRY-US, V46, P10767, DOI 10.1021/bi700657d; WINTERMEYER W, 1979, EUR J BIOCHEM, V98, P465	37	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38344	10.1371/journal.pone.0038344	http://dx.doi.org/10.1371/journal.pone.0038344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693619	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500136
J	Weber, T; Renzland, I; Baur, M; Monks, S; Herrmann, E; Huppert, V; Nurnberg, F; Schonig, K; Bartsch, D				Weber, Tillmann; Renzland, Insa; Baur, Max; Moenks, Simon; Herrmann, Elke; Huppert, Verena; Nuernberg, Frank; Schoenig, Kai; Bartsch, Dusan			Tetracycline Inducible Gene Manipulation in Serotonergic Neurons	PLOS ONE			English	Article							CONDITIONAL MOUSE MODEL; CRE-RECOMBINASE; IN-VIVO; TRANSGENIC MICE; EXPRESSION; SYSTEM; RECEPTOR; REVERSAL; DISEASE; CELLS	The serotonergic (5-HT) neuronal system has important and diverse physiological functions throughout development and adulthood. Its dysregulation during development or later in adulthood has been implicated in many neuropsychiatric disorders. Transgenic animal models designed to study the contribution of serotonergic susceptibility genes to a pathological phenotype should ideally allow to study candidate gene overexpression or gene knockout selectively in serotonergic neurons at any desired time during life. For this purpose, conditional expression systems such as the tet-system are preferable. Here, we generated a transactivator (tTA) mouse line (TPH2-tTA) that allows temporal and spatial control of tetracycline (Ptet) controlled transgene expression as well as gene deletion in 5-HT neurons. The tTA cDNA was inserted into a 196 kb PAC containing a genomic mouse Tph2 fragment (177 kb) by homologous recombination in E. coli. For functional analysis of Ptet-controlled transgene expression, TPH2-tTA mice were crossed to a Ptet-regulated lacZ reporter line (Ptet-nLacZ). In adult double-transgenic TPH2-tTA/Ptet-nLacZ mice, TPH2-tTA founder line L62-20 showed strong serotonergic beta-galactosidase expression which could be completely suppressed with doxycycline (Dox). Furthermore, Ptet-regulated gene expression could be reversibly activated or inactivated when Dox was either withdrawn or added to the system. For functional analysis of Ptet-controlled, Cre-mediated gene deletion, TPH2-tTA mice (L62-20) were crossed to double transgenic Ptet-Cre/R26R reporter mice to generate TPH2-tTA/Ptet-Cre/R26R mice. Without Dox, 5-HT specific recombination started at E12.5. With permanent Dox administration, Ptet-controlled Cre-mediated recombination was absent. Dox withdrawal either postnatally or during adulthood induced efficient recombination in serotonergic neurons of all raphe nuclei, respectively. In the enteric nervous system, recombination could not be detected. We generated a transgenic mouse tTA line (TPH2-tTA) which allows both inducible and reversible transgene expression and inducible Cre-mediated gene deletion selectively in 5-HT neurons throughout life. This will allow precise delineation of serotonergic gene functions during development and adulthood.	[Weber, Tillmann; Renzland, Insa; Baur, Max; Moenks, Simon; Herrmann, Elke; Huppert, Verena; Schoenig, Kai; Bartsch, Dusan] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany; [Weber, Tillmann] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany; [Weber, Tillmann] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Nuernberg, Frank] Mannheim Univ Appl Sci, Fac Informat, Inst Appl Math, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Weber, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany.	dusan.bartsch@zi-mannheim.de			EU [HEALTH-F2-2007-201714DEVANX]; BMBF Bernstein Center for Computational Neuroscience Heidelberg/Mannheim [01GQ1003A]; BMBF NGFN-Plus grant [01GS0851]	EU(European Commission); BMBF Bernstein Center for Computational Neuroscience Heidelberg/Mannheim(Federal Ministry of Education & Research (BMBF)); BMBF NGFN-Plus grant(Federal Ministry of Education & Research (BMBF))	EU HEALTH-F2-2007-201714DEVANX, BMBF Bernstein Center for Computational Neuroscience Heidelberg/Mannheim 01GQ1003A, BMBF NGFN-Plus grant (01GS0851) to Dusan Bartsch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KB, 2010, TRANSGENIC RES, V19, P715, DOI 10.1007/s11248-009-9342-4; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Buchanan GF, 2010, P NATL ACAD SCI USA, V107, P16354, DOI 10.1073/pnas.1004587107; Burgess K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017090; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; DEMERS P, 1968, CAN MED ASSOC J, V99, P849; Dequen F, 2010, HUM MOL GENET, V19, P2616, DOI 10.1093/hmg/ddq149; Eckenstein FP, 2006, EXP NEUROL, V198, P338, DOI 10.1016/j.expneurol.2005.12.020; Erdmann G, 2008, ENDOCRINOLOGY, V149, P3446, DOI 10.1210/en.2007-1786; Finger EC, 2007, NEUROPSYCHOPHARMACOL, V32, P206, DOI 10.1038/sj.npp.1301182; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hengstler JG, 1999, DRUG METAB REV, V31, P917, DOI 10.1081/DMR-100101946; Hensler J. G., 2006, BASIC NEUROCHEMISTRY, P227; Hirsimaki Pirkko, 2002, Breast J, V8, P92, DOI 10.1046/j.1524-4741.2002.08204.x; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Le LQ, 2011, CANCER RES, V71, P4686, DOI 10.1158/0008-5472.CAN-10-4577; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mejia JM, 2002, BIOL PSYCHIAT, V52, P811, DOI 10.1016/S0006-3223(02)01418-X; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miro-Murillo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022589; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Perea J, 2001, HUM MOL GENET, V10, P1007, DOI 10.1093/hmg/10.10.1007; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Robertson A, 2002, GENE, V282, P65, DOI 10.1016/S0378-1119(01)00793-4; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schonig K, 2011, TRANSGENIC RES, V20, P709, DOI 10.1007/s11248-010-9427-0; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Siddiqui M A, 2002, J Pak Med Assoc, V52, P211; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vogt MA, 2008, EXP NEUROL, V211, P25, DOI 10.1016/j.expneurol.2007.12.012; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028283; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	77	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38193	10.1371/journal.pone.0038193	http://dx.doi.org/10.1371/journal.pone.0038193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693598	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500106
J	Clouard, C; Jouhanneau, M; Meunier-Salaun, MC; Malbert, CH; Val-Laillet, D				Clouard, Caroline; Jouhanneau, Melanie; Meunier-Salauen, Marie-Christine; Malbert, Charles-Henri; Val-Laillet, David			Exposures to Conditioned Flavours with Different Hedonic Values Induce Contrasted Behavioural and Brain Responses in Pigs	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DORSOLATERAL PREFRONTAL CORTEX; PARABRACHIAL NUCLEUS LESIONS; TASTE-AVERSION; INSULAR CORTEX; HUMAN AMYGDALA; UNPLEASANT ODORS; CHORDA TYMPANI; PREFERENCE; RATS	This study investigated the behavioural and brain responses towards conditioned flavours with different hedonic values in juvenile pigs. Twelve 30-kg pigs were given four three-day conditioning sessions: they received three different flavoured meals paired with intraduodenal (i.d.) infusions of 15% glucose (F-Glu), lithium chloride (F-LiCl), or saline (control treatment, F-NaCl). One and five weeks later, the animals were subjected to three two-choice feeding tests without reinforcement to check the acquisition of a conditioned flavour preference or aversion. In between, the anaesthetised pigs were subjected to three (18)FDG PET brain imaging coupled with an olfactogustatory stimulation with the conditioned flavours. During conditioning, the pigs spent more time lying inactive, and investigated their environment less after the F-LiCl than the F-NaCl or F-Glu meals. During the two-choice tests performed one and five weeks later, the F-NaCl and F-Glu foods were significantly preferred over the F-LiCl food even in the absence of i.d. infusions. Surprisingly, the F-NaCl food was also preferred over the F-Glu food during the first test only, suggesting that, while LiCl i.d. infusions led to a strong flavour aversion, glucose infusions failed to induce flavour preference. As for brain imaging results, exposure to aversive or less preferred flavours triggered global deactivation of the prefrontal cortex, specific activation of the posterior cingulate cortex, as well as asymmetric brain responses in the basal nuclei and the temporal gyrus. In conclusion, postingestive visceral stimuli can modulate the flavour/food hedonism and further feeding choices. Exposure to flavours with different hedonic values induced metabolism differences in neural circuits known to be involved in humans in the characterization of food palatability, feeding motivation, reward expectation, and more generally in the regulation of food intake.	[Clouard, Caroline; Jouhanneau, Melanie; Malbert, Charles-Henri; Val-Laillet, David] INRA, ADNC Alimentat & Adaptat Digest Nerveuses & Compo, St Gilles, France; [Clouard, Caroline; Jouhanneau, Melanie; Meunier-Salauen, Marie-Christine] INRA, PEGASE Physiol Environm & Genet Anim & Syst Eleva, St Gilles, France; [Clouard, Caroline; Jouhanneau, Melanie; Meunier-Salauen, Marie-Christine] Agrocampus Ouest, PEGASE Physiol Environm & Genet Anim & Syst Eleva, Rennes, France	INRAE; INRAE; Institut Agro; Agrocampus Ouest	Clouard, C (corresponding author), INRA, ADNC Alimentat & Adaptat Digest Nerveuses & Compo, St Gilles, France.	david.val-laillet@rennes.inra.fr	VAL-LAILLET, David/AAH-6454-2021; Clouard, Caroline/K-1255-2014	Clouard, Caroline/0000-0002-5562-6057; Malbert, Charles-Henri/0000-0002-0665-4545	INRA (Department of Human Alimentation); INRA (Department of Animal Physiology and Livestock Systems); Brittany Region (Region Bretagne); CRITT Sante Bretagne (Centre Regional d'Innovation et de Transfert de Technologies)	INRA (Department of Human Alimentation); INRA (Department of Animal Physiology and Livestock Systems); Brittany Region (Region Bretagne)(Region Bretagne); CRITT Sante Bretagne (Centre Regional d'Innovation et de Transfert de Technologies)	This study was supported by a grant from INRA (Department of Human Alimentation; Department of Animal Physiology and Livestock Systems) and the Brittany Region (Region Bretagne), and especially by the CRITT Sante Bretagne (Centre Regional d'Innovation et de Transfert de Technologies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroff K, 2001, PHYSIOL BEHAV, V72, P691, DOI 10.1016/S0031-9384(01)00442-5; Ackroff K, 2011, PHYSIOL BEHAV, V102, P548, DOI 10.1016/j.physbeh.2011.01.004; Ackroff K, 2010, PHYSIOL BEHAV, V99, P402, DOI 10.1016/j.physbeh.2009.12.012; Ackroff K, 2009, PHYSIOL BEHAV, V97, P406, DOI 10.1016/j.physbeh.2009.03.014; Anderson AK, 2003, NEURON, V39, P581, DOI 10.1016/S0896-6273(03)00504-X; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Del Parigi A, 2002, ANN NY ACAD SCI, V967, P389; Desgranges B, 2009, EUR J NEUROSCI, V29, P1654, DOI 10.1111/j.1460-9568.2009.06711.x; Dwyer DM, 2010, PHYSIOL BEHAV, V101, P403, DOI 10.1016/j.physbeh.2010.07.004; Faurion A, 1999, NEUROSCI LETT, V277, P189, DOI 10.1016/S0304-3940(99)00881-2; Galef BG, 2003, LEARN MEMORY, P147; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Gaultier A, 2011, EUR J NEUROSCI, V34, P1500, DOI 10.1111/j.1460-9568.2011.07848.x; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Gautier JF, 1999, AM J CLIN NUTR, V70, P806; Gilbert PE, 2003, NEUROBIOL LEARN MEM, V79, P118, DOI 10.1016/S1074-7427(02)00013-8; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Henkin RI, 2001, J COMPUT ASSIST TOMO, V25, P493, DOI 10.1097/00004728-200107000-00001; Kringelbach ML, 2004, NEUROIMAGE, V21, P781, DOI 10.1016/j.neuroimage.2003.09.063; Kringelbach ML, 2010, DISCOV MED, V9, P579; LAWRENCE A, 1987, ANIM BEHAV, V35, P293, DOI 10.1016/S0003-3472(87)80236-1; Le DSNT, 2006, AM J CLIN NUTR, V84, P725, DOI 10.1093/ajcn/84.4.725; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Myers KP, 2007, APPETITE, V48, P123, DOI 10.1016/j.appet.2006.07.077; Myers KP, 2006, DEV PSYCHOBIOL, V48, P380, DOI 10.1002/dev.20147; Navarro M, 2003, BRAIN RES, V990, P195, DOI 10.1016/S0006-8993(03)03530-3; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; Reilly S, 1999, BRAIN RES BULL, V48, P239, DOI 10.1016/S0361-9230(98)00173-7; Reilly S, 2000, BRAIN RES BULL, V52, P269, DOI 10.1016/S0361-9230(00)00263-X; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Reiner G, 2009, APPL ANIM BEHAV SCI, V118, P222, DOI 10.1016/j.applanim.2009.02.010; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Roman C, 2009, BRAIN RES, V1259, P68, DOI 10.1016/j.brainres.2008.12.058; Royet JP, 2004, CHEM SENSES, V29, P731, DOI 10.1093/chemse/bjh067; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Royet JP, 2000, J NEUROSCI, V20, P7752; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sclafani A, 2001, BEHAV NEUROSCI, V115, P920, DOI 10.1037//0735-7044.115.4.920; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; St-Onge MP, 2005, J NUTR, V135, P1014, DOI 10.1093/jn/135.5.1014; Stafstrom-Davis CA, 2001, LEARN MEMORY, V8, P272, DOI 10.1101/lm.42101; Touzani K, 2005, EUR J NEUROSCI, V22, P1767, DOI 10.1111/j.1460-9568.2005.04360.x; Touzani K, 2002, EUR J NEUROSCI, V16, P2425, DOI 10.1046/j.1460-9568.2002.02404.x; Touzani K, 2002, BEHAV NEUROSCI, V116, P256, DOI 10.1037//0735-7044.116.2.256; Touzani K, 2001, BEHAV NEUROSCI, V115, P84, DOI 10.1037//0735-7044.115.1.84; Touzani K, 2007, EUR J NEUROSCI, V26, P1692, DOI 10.1111/j.1460-9568.2007.05798.x; Touzani K, 2010, NEUROBIOL LEARN MEM, V94, P214, DOI 10.1016/j.nlm.2010.05.009; Touzani K, 2009, NEUROBIOL LEARN MEM, V92, P464, DOI 10.1016/j.nlm.2009.06.006; Touzani K, 2009, EUR J NEUROSCI, V30, P289, DOI 10.1111/j.1460-9568.2009.06829.x; Veldhuizen MG, 2010, CHEM SENSES, V35, P121, DOI 10.1093/chemse/bjp089; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; WARWICK ZS, 1994, PHYSIOL BEHAV, V55, P501, DOI 10.1016/0031-9384(94)90107-4; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; Weary DM, 2006, APPL ANIM BEHAV SCI, V100, P64, DOI 10.1016/j.applanim.2006.04.013; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5	71	21	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37968	10.1371/journal.pone.0037968	http://dx.doi.org/10.1371/journal.pone.0037968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685528	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300149
J	Chartrain, M; Riond, JL; Stennevin, A; Vandenberghe, I; Gomes, B; Lamant, L; Meyer, N; Gairin, JE; Guilbaud, N; Annereau, JP				Chartrain, Marine; Riond, Joele; Stennevin, Aline; Vandenberghe, Isabelle; Gomes, Bruno; Lamant, Laurence; Meyer, Nicolas; Gairin, Jean Edouard; Guilbaud, Nicolas; Annereau, Jean Philippe			Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells	PLOS ONE			English	Article							MEMBRANE-TRANSPORT PROTEINS; P-GLYCOPROTEIN EXPRESSION; CANCER STEM-CELLS; MULTIDRUG-RESISTANCE; ABCB5; GENE; EPIDEMIOLOGY; ACTIVATION; FUSION	Metastatic melanoma is the most aggressive skin cancer. Recently, phenotypically distinct subpopulations of tumor cells were identified. Among them, ABCB5-expressing cells were proposed to display an enhanced tumorigenicity with stem cell-like properties. In addition, ABCB5(+) cells are thought to participate to chemoresistance through a potential efflux function of ABCB5. Nevertheless, the fate of these cells upon drugs that are used in melanoma chemotherapy remains to be clarified. Here we explored the effect of anti-melanoma treatments on the ABCB5-expressing cells. Using a melanoma xenograft model (WM266-4), we observed in vivo that ABCB5-expressing cells are enriched after a temozolomide treatment that induces a significant tumor regression. These results were further confirmed in a preliminary study conducted on clinical samples from patients that received dacarbazine. In vitro, we showed that ABCB5-expressing cells selectively survive when exposed to dacarbazine, the reference treatment of metastatic melanoma, but also to vemurafenib, a new inhibitor of the mutated kinase V600E BRAF and other various chemotherapeutic drugs. Our results show that anti-melanoma chemotherapy might participate to the chemoresistance acquisition by selecting tumor cell subpopulations expressing ABCB5. This is of particular importance in understanding the relapses observed after anti-melanoma treatments and reinforces the interest of ABCB5 and ABCB5-expressing cells as potential therapeutic targets in melanoma.	[Chartrain, Marine; Riond, Joele; Gairin, Jean Edouard] UMR 2587, CNRS Pierre Fabre, ISTMT, Toulouse, France; [Chartrain, Marine; Stennevin, Aline; Vandenberghe, Isabelle; Gomes, Bruno; Guilbaud, Nicolas; Annereau, Jean Philippe] Ctr Rech & Dev Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France; [Riond, Joele] USR 3388, CNRS Pierre Fabre, Ctr Rech & Dev Pierre Fabre, Toulouse, France; [Lamant, Laurence] INSERM, U563, CHU Purpan, Toulouse, France; [Meyer, Nicolas] Hop Larrey, Toulouse, France; [Gairin, Jean Edouard] Univ Toulouse III, Fac Pharmacie, UMR152, IRD UPS PHARMA DEV, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chartrain, M (corresponding author), UMR 2587, CNRS Pierre Fabre, ISTMT, Toulouse, France.	jelle.riond@dr14.cnrs.fr	Riond, Joelle/R-6414-2016; Meyer, Nicolas/A-1174-2013	Riond, Joelle/0000-0002-6281-2376; 				Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; Arancia G, 1998, CYTOTECHNOLOGY, V27, P95, DOI 10.1023/A:1008040117882; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; BERGER W, 1994, INT J CANCER, V59, P717, DOI 10.1002/ijc.2910590522; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen KG, 2005, PIGM CELL RES, V18, P102, DOI 10.1111/j.1600-0749.2005.00214.x; Cheung PFY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028246; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Fukunaga-Kalabis M, 2010, ONCOGENE; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Ichihashi N, 2001, BRIT J DERMATOL, V144, P745, DOI 10.1046/j.1365-2133.2001.04129.x; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Molinari A, 1998, INT J CANCER, V75, P885, DOI 10.1002/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; SCHADENDORF D, 1995, BRIT J DERMATOL, V132, P551; SCHADENDORF D, 1995, AM J PATHOL, V147, P1545; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Walsh N, 2010, BRIT J CANCER, V102, P1157, DOI 10.1038/sj.bjc.6605590; Wilson BJ, 2011, CANC RES; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Zheng XQ, 2010, INT J ONCOL, V37, P307, DOI 10.3892/ijo_00000679	36	71	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36762	10.1371/journal.pone.0036762	http://dx.doi.org/10.1371/journal.pone.0036762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22675422	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900004
J	Ebert, SM; Dyle, MC; Kunkel, SD; Bullard, SA; Bongers, KS; Fox, DK; Dierdorff, JM; Foster, ED; Adams, CM				Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.			Stress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; GENE-EXPRESSION; UBIQUITIN LIGASES; PATHWAY; PROTEIN; COACTIVATORS; DEGRADATION; PGC-1-ALPHA; ACTIVATION; GENERATION	Diverse stresses including starvation and muscle disuse cause skeletal muscle atrophy. However, the molecular mechanisms of muscle atrophy are complex and not well understood. Here, we demonstrate that growth arrest and DNA damage-inducible 45a protein (Gadd45a) is a critical mediator of muscle atrophy. We identified Gadd45a through an unbiased search for potential downstream mediators of the stress-inducible, pro-atrophy transcription factor ATF4. We show that Gadd45a is required for skeletal muscle atrophy induced by three distinct skeletal muscle stresses: fasting, muscle immobilization, and muscle denervation. Conversely, forced expression of Gadd45a in muscle or cultured myotubes induces atrophy in the absence of upstream stress. We show that muscle-specific ATF4 knock-out mice have a reduced capacity to induce Gadd45a mRNA in response to stress, and as a result, they undergo less atrophy in response to fasting or muscle immobilization. Interestingly, Gadd45a is a myonuclear protein that induces myonuclear remodeling and a comprehensive program for muscle atrophy. Gadd45a represses genes involved in anabolic signaling and energy production, and it induces pro-atrophy genes. As a result, Gadd45a reduces multiple barriers to muscle atrophy (including PGC-1 alpha, Akt activity, and protein synthesis) and stimulates pro-atrophy mechanisms (including autophagy and caspase-mediated proteolysis). These results elucidate a critical stress-induced pathway that reprograms muscle gene expression to cause atrophy.	[Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biophys, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Kunkel, Steven D.; Bullard, Steven A.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Adams, CM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212; Bongers, Kale/0000-0002-9297-9185	National Institutes of Health [NIAMS 1R01AR059115-01, T32 GM07361]; Cardiovascular Interdisciplinary Research Fellowship [HL007121]; Doris Duke Charitable Foundation; American Diabetes Association; Department of Veterans Affairs; Fraternal Order of Eagles Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Interdisciplinary Research Fellowship; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); Fraternal Order of Eagles Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NIAMS 1R01AR059115-01 and T32 GM07361, and Cardiovascular Interdisciplinary Research Fellowship HL007121, the Doris Duke Charitable Foundation, the American Diabetes Association, the Department of Veterans Affairs, and the Fraternal Order of Eagles Diabetes Research Center.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Dedkov EI, 2003, J GERONTOL A-BIOL, V58, P984; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Easwaran HP, 2010, COLD SH Q B, V75, P507, DOI 10.1101/sqb.2010.75.031; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gundersen K, 2008, J PHYSIOL-LONDON, V586, P2675, DOI 10.1113/jphysiol.2008.154369; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Korenyi-Both A. L., 1983, MUSCLE PATHOLOGY NEU; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laure L, 2009, FEBS J, V276, P669, DOI 10.1111/j.1742-4658.2008.06814.x; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Malmberg SE, 2008, J BIOL CHEM, V283, P19229, DOI 10.1074/jbc.M801331200; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Plant PJ, 2009, J APPL PHYSIOL, V107, P224, DOI 10.1152/japplphysiol.90932.2008; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sytnikova YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014500; Tian JM, 2011, J CLIN INVEST, V121, P4491, DOI 10.1172/JCI38760; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Verhees KJP, 2011, AM J PHYSIOL-CELL PH, V301, pC995, DOI 10.1152/ajpcell.00520.2010; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	58	131	138	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27290	27301		10.1074/jbc.M112.374777	http://dx.doi.org/10.1074/jbc.M112.374777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22692209	hybrid, Green Published			2022-12-25	WOS:000307840700002
J	Teichmann, A; Rutz, C; Kreuchwig, A; Krause, G; Wiesner, B; Schulein, R				Teichmann, Anke; Rutz, Claudia; Kreuchwig, Annika; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf			The Pseudo Signal Peptide of the Corticotropin-releasing Factor Receptor Type 2A Prevents Receptor Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; DELTA-OPIOID RECEPTORS; HORMONE-RECEPTOR; TRANSMEMBRANE DOMAIN; PROTEIN; DIMERIZATION; EXPRESSION; VARIANT; STRESS; CELL	N-terminal signal peptides mediate the interaction of native proteins with the translocon complex of the endoplasmic reticulum membrane and are cleaved off during early protein biogenesis. The corticotropin-releasing factor receptor type 2a (CRF2(a)R) possesses an N-terminal pseudo signal peptide, which represents a so far unique domain within the large protein family of G protein-coupled receptors (GPCRs). In contrast to a conventional signal peptide, the pseudo signal peptide remains uncleaved and consequently forms a hydrophobic extension at the N terminus of the receptor. The functional consequence of the presence of the pseudo signal peptide is not understood. Here, we have analyzed the significance of this domain for receptor dimerization/oligomerization in detail. To this end, we took the CRF2(a)R and the homologous corticotropin-releasing factor receptor type 1 (CRF1R) possessing a conventional cleaved signal peptide and conducted signal peptide exchange experiments. Using single cell and single molecule imaging methods (fluorescence resonance energy transfer and fluorescence cross-correlation spectroscopy, respectively) as well as biochemical experiments, we obtained two novel findings; we could show that (i) the CRF2(a)R is expressed exclusively as a monomer, and (ii) the presence of the pseudo signal peptide prevents its oligomerization. Thus, we have identified a novel functional domain within the GPCR protein family, which plays a role in receptor oligomerization and which may be useful to study the functional significance of this process in general.	[Teichmann, Anke; Rutz, Claudia; Kreuchwig, Annika; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wiesner, B (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	wiesner@fmp-berlin.de; schuelein@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SCHU 1116/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU 1116/2-1.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Charles AC, 2003, MOL PHARMACOL, V63, P89, DOI 10.1124/mol.63.1.89; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Evans RT, 2009, ENDOCRINOLOGY, V150, P4191, DOI 10.1210/en.2009-0285; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Heinze KG, 2000, P NATL ACAD SCI USA, V97, P10377, DOI 10.1073/pnas.180317197; Khelashvili G, 2010, BIOINFORMATICS, V26, P1804, DOI 10.1093/bioinformatics/btq264; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kraetke O, 2005, J RECEPT SIG TRANSD, V25, P251, DOI 10.1080/10799890500468838; Kreuchwig A, 2011, MOL ENDOCRINOL, V25, P707, DOI 10.1210/me.2010-0510; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Li HW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3484751; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Maurice P, 2010, EMBO J, V29, P3646, DOI 10.1038/emboj.2010.236; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J, 2001, MOL CLONING LAB MANU; Schulz K, 2010, J BIOL CHEM, V285, P32878, DOI 10.1074/jbc.M110.129627; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Skrabanek L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-177; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vrecl M, 2006, J RECEPT SIG TRANSD, V26, P505, DOI 10.1080/10799890600932253; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200	47	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27265	27274		10.1074/jbc.M112.360594	http://dx.doi.org/10.1074/jbc.M112.360594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689579	Green Published, hybrid			2022-12-25	WOS:000307386000078
J	Belyi, Y; Tartakovskaya, D; Tais, A; Fitzke, E; Tzivelekidis, T; Jank, T; Rospert, S; Aktories, K				Belyi, Yury; Tartakovskaya, Dina; Tais, Arlette; Fitzke, Edith; Tzivelekidis, Tina; Jank, Thomas; Rospert, Sabine; Aktories, Klaus			Elongation Factor 1A Is the Target of Growth Inhibition in Yeast Caused by Legionella pneumophila Glucosyltransferase Lgt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SACCHAROMYCES-CEREVISIAE; LEGIONNAIRES DISEASE; SHUTTLE VECTORS; PROTEIN IMPORT; TRANSLATION; MUTATIONS; COMPLEX; PHOSPHORYLATION; EEF1A	Legionella is a pathogenic Gram-negative bacterium that can multiply inside of eukaryotic cells. It translocates numerous bacterial effector proteins into target cells to transform host phagocytes into a niche for replication. One effector of Legionella pneumophila is the glucosyltransferase Lgt1, which modifies serine 53 in mammalian elongation factor 1A (eEF1A), resulting in inhibition of protein synthesis and cell death. Here, we demonstrate that similar to mammalian cells, Lgt1 was severely toxic when produced in yeast and effectively inhibited in vitro protein synthesis. Saccharomyces cerevisiae strains, which were deleted of endogenous eEF1A but harbored a mutant eEF1A not glucosylated by Lgt1, were resistant toward the bacterial effector. In contrast, deletion of Hbs1, which is also an in vitro substrate of the glucosyltransferase, did not influence the toxic effects of Lgt1. Serial mutagenesis in yeast showed that Phe(54), Tyr(56) and Trp(58), located immediately downstream of serine 53 of eEF1A, are essential for the function of the elongation factor. Replacement of serine 53 by glutamic acid, mimicking phosphorylation, produced a non-functional eEF1A, which failed to support growth of S. cerevisiae. Our data indicate that Lgt1-induced lethal effect in yeast depends solely on eEF1A. The region of eEF1A encompassing serine 53 plays a critical role in functioning of the elongation factor.	[Tzivelekidis, Tina; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Belyi, Yury; Tartakovskaya, Dina] NF Gamalei Inst Epidemiol & Microbiol, Moscow 123098, Russia; [Tais, Arlette; Fitzke, Edith; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mikrobiol, Zentrum Biochem & Mol Zellforsch, D-79102 Freiburg, Germany	University of Freiburg; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Belyi, Yury/AAU-8092-2020; Aktories, Klaus/CAJ-5682-2022; Jank, Thomas/R-9627-2017	Aktories, Klaus/0000-0002-5397-0436; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft; Center for Biological Signaling Studies (BIOSS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biological Signaling Studies (BIOSS)	This work was supported by the Deutsche Forschungsgemeinschaft and the Center for Biological Signaling Studies (BIOSS).	Belyi I, 2003, INFECT IMMUN, V71, P181, DOI 10.1128/IAI.71.1.181-186.2003; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00076; Belyi Y, 2009, J BIOL CHEM, V284, P20167, DOI 10.1074/jbc.M109.008441; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRENNER DJ, 1979, ANN INTERN MED, V90, P656, DOI 10.7326/0003-4819-90-4-656; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; Dinman JD, 1997, RNA, V3, P870; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; GARCIA PD, 1991, METHOD ENZYMOL, V194, P675; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Hurtado-Guerrero R, 2010, BIOCHEM J, V426, P281, DOI 10.1042/BJ20091351; Jules M, 2007, FEBS LETT, V581, P2829, DOI 10.1016/j.febslet.2007.05.026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu W, 2010, J MOL BIOL, V396, P321, DOI 10.1016/j.jmb.2009.11.044; Magazinnik T, 2005, NUCLEIC ACIDS RES, V33, P4584, DOI 10.1093/nar/gki765; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Piazzi M, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.003152; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tzivelekidis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029525; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	41	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26029	26037		10.1074/jbc.M112.372672	http://dx.doi.org/10.1074/jbc.M112.372672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685293	hybrid, Green Published			2022-12-25	WOS:000306916300030
J	Peng, C; Zhu, F; Wen, WH; Yao, K; Li, SQ; Zykova, T; Liu, KD; Li, X; Ma, WY; Bode, AM; Dong, ZG				Peng, Cong; Zhu, Feng; Wen, Weihong; Yao, Ke; Li, Shengqing; Zykova, Tatyana; Liu, Kangdong; Li, Xiang; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang			Tumor Necrosis Factor Receptor-associated Factor Family Protein 2 Is a Key Mediator of the Epidermal Growth Factor-induced Ribosomal S6 Kinase 2/cAMP-responsive Element-binding Protein/Fos Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; ACTIVATION; RSK2; PHOSPHORYLATION; TRAF2; UBIQUITINATION; TRANSFORMATION; REGULATOR; APOPTOSIS; CELLS	TRAF2 has an important function in mediating the TNF-R signaling pathway toward activation of NF-kappa B and JNKs. Here we reveal a novel function of TRAF2 in the epidermal growth factor (EGF) signaling pathway. Knockdown of TRAF2 blocked EGF-induced AP-1 activity and anchorage-independent cell transformation. Notably, we showed that EGF induces ribosomal S6 kinase 2 (RSK2) ubiquitination, and knocking down TRAF2 suppresses ubiquitination of RSK2 induced by EGF. We also found that TRAF2 affects RSK2 activity through RSK2 ubiquitination. RSK2 plays a critical role in AP-1 activity mediated through CREB and c-Fos, which regulates anchorage-independent cell transformation. In addition, TRAF2 is overexpressed in colon cancer and required for colon cancer development, suggesting that TRAF2 might be a potential molecular target for cancer prevention and treatment.	[Peng, Cong; Zhu, Feng; Wen, Weihong; Yao, Ke; Li, Shengqing; Zykova, Tatyana; Liu, Kangdong; Li, Xiang; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	温, 家琦/GYV-3177-2022; ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA007646, CA111536, CA120388, R37CA081064, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, F32CA007646, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA007646, CA111536, CA120388, R37CA081064, and ES016548. This work was also supported by The Hormel Foundation.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bekes M, 2009, CELL, V137, P604, DOI 10.1016/j.cell.2009.04.052; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Kako K, 1996, NEUROSCI LETT, V216, P159, DOI 10.1016/S0304-3940(96)13018-4; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Lee ZH, 2000, MOL PHARMACOL, V58, P1536, DOI 10.1124/mol.58.6.1536; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Peng C, 2011, J BIOL CHEM, V286, P6946, DOI 10.1074/jbc.M110.172338; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	37	13	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25881	25892		10.1074/jbc.M112.359521	http://dx.doi.org/10.1074/jbc.M112.359521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685297	Green Published, hybrid			2022-12-25	WOS:000306916300017
J	Ohnishi, H; Tochio, H; Kato, Z; Kawamoto, N; Kimura, T; Kubota, K; Yamamoto, T; Funasaka, T; Nakano, H; Wong, RW; Shirakawa, M; Kondo, N				Ohnishi, Hidenori; Tochio, Hidehito; Kato, Zenichiro; Kawamoto, Norio; Kimura, Takeshi; Kubota, Kazuo; Yamamoto, Takahiro; Funasaka, Tatsuyoshi; Nakano, Hiroshi; Wong, Richard W.; Shirakawa, Masahiro; Kondo, Naomi			TRAM Is Involved in IL-18 Signaling and Functions as a Sorting Adaptor for MyD88	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; NF-KAPPA-B; TIR-DOMAIN; ENDOTOXIN TOLERANCE; INTERFERON-BETA; TRIF; TOLL-LIKE-RECEPTOR-4; MOLECULE; TLR4; TRANSDUCTION	MyD88, a Toll/interleukin-1 receptor homology (TIR) domain-containing adaptor protein, mediates signals from the Toll-like receptors (TLR) or IL-1/IL-18 receptors to downstream kinases. In MyD88-dependent TLR4 signaling, the function of MyD88 is enhanced by another TIR domain-containing adaptor, Mal/TIRAP, which brings MyD88 to the plasma membrane and promotes its interaction with the cytosolic region of TLR4. Hence, Mal is recognized as the "sorting adaptor" for MyD88. In this study, a direct interaction between MyD88-TIR and another membrane-sorting adaptor, TRAM/TICAM-2, was demonstrated in vitro. Cell-based assays including RNA interference experiments and TRAM deficient mice revealed that the interplay between MyD88 and TRAM in cells is important in mediating IL-18 signal transduction. Live cell imaging further demonstrated the co-localized accumulation of MyD88 and TRAM in the membrane regions in HEK293 cells. These findings suggest that TRAM serves as the sorting adaptor for MyD88 in IL-18 signaling, which then facilitates the signal transduction. The binding sites for TRAM are located in the TIR domain of MyD88 and actually overlap with the binding sites for Mal. MyD88, the multifunctional signaling adaptor that works together with most of the TLR members and with the IL-1/IL-18 receptors, can interact with two distinct sorting adaptors, TRAM and Mal, in a conserved manner in a distinct context.	[Ohnishi, Hidenori; Kato, Zenichiro; Kawamoto, Norio; Kimura, Takeshi; Kubota, Kazuo; Yamamoto, Takahiro; Kondo, Naomi] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto, Japan; [Funasaka, Tatsuyoshi; Nakano, Hiroshi; Wong, Richard W.] Kanazawa Univ, Sch Nat Syst, Dept Biol, Mol & Cellular Biol Lab, Kanazawa, Ishikawa, Japan	Gifu University; Kyoto University; Kanazawa University	Ohnishi, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan.	ohnishih@gifu-u.ac.jp; tochio@moleng.kyoto-u.ac.jp	Wong, Richard W./E-9155-2011; Tochio, Hidehito/GWV-0429-2022; Kawamoto, Norio/AAN-5302-2021	Tochio, Hidehito/0000-0003-3843-3330; Kawamoto, Norio/0000-0002-3482-7781	Ministry of Education, Sports Science, Culture and Technology of Japan; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [24650611, 24121710] Funding Source: KAKEN	Ministry of Education, Sports Science, Culture and Technology of Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Sports Science, Culture and Technology of Japan and by Health and Labour Science Research Grants for Research on Intractable Disease from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sacre SM, 2007, J IMMUNOL, V178, P2148, DOI 10.4049/jimmunol.178.4.2148; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	30	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38423	10.1371/journal.pone.0038423	http://dx.doi.org/10.1371/journal.pone.0038423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685567	gold, Green Submitted, Green Published			2022-12-25	WOS:000305351700030
J	Panseri, S; Cunha, C; D'Alessandro, T; Sandri, M; Russo, A; Giavaresi, G; Marcacci, M; Hung, CT; Tampieri, A				Panseri, Silvia; Cunha, Carla; D'Alessandro, Teresa; Sandri, Monica; Russo, Alessandro; Giavaresi, Gianluca; Marcacci, Maurilio; Hung, Clark T.; Tampieri, Anna			Magnetic Hydroxyapatite Bone Substitutes to Enhance Tissue Regeneration: Evaluation In Vitro Using Osteoblast-Like Cells and In Vivo in a Bone Defect	PLOS ONE			English	Article							GROWTH-FACTOR DELIVERY; GRAFT SUBSTITUTES; NANOPARTICLES; SCAFFOLDS; FORCE; DNA	In case of degenerative disease or lesion, bone tissue replacement and regeneration is an important clinical goal. In particular, nowadays, critical size defects rely on the engineering of scaffolds that are 3D structural supports, allowing cellular infiltration and subsequent integration with the native tissue. Several ceramic hydroxyapatite (HA) scaffolds with high porosity and good osteointegration have been developed in the past few decades but they have not solved completely the problems related to bone defects. In the present study we have developed a novel porous ceramic composite made of HA that incorporates magnetite at three different ratios: HA/Mgn 95/5, HA/Mgn 90/10 and HA/Mgn 50/50. The scaffolds, consolidated by sintering at high temperature in a controlled atmosphere, have been analysed in vitro using human osteoblast-like cells. Results indicate high biocompatibility, similar to a commercially available HA bone graft, with no negative effects arising from the presence of magnetite or by the use of a static magnetic field. HA/Mgn 90/10 was shown to enhance cell proliferation at the early stage. Moreover, it has been implanted in vivo in a critical size lesion of the rabbit condyle and a good level of histocompatibility was observed. Such results identify this scaffold as particularly relevant for bone tissue regeneration and open new perspectives for the application of a magnetic field in a clinical setting of bone replacement, either for magnetic scaffold fixation or magnetic drug delivery.	[Panseri, Silvia; Cunha, Carla; Russo, Alessandro; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, Bologna, Italy; [Panseri, Silvia; Cunha, Carla; D'Alessandro, Teresa; Sandri, Monica; Tampieri, Anna] CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy; [Giavaresi, Gianluca] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, Bologna, Italy; [Giavaresi, Gianluca] Rizzoli Orthopaed Inst, Lab Biocompatibil Innovat Technol & Adv Therapies, Bologna, Italy; [Hung, Clark T.] Columbia Univ, Dept Biomed Engn, New York, NY USA	IRCCS Istituto Ortopedico Rizzoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR); IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Columbia University	Panseri, S (corresponding author), Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, Bologna, Italy.	s.panseri@biomec.ior.it	Sandri, Monica/AAY-4322-2020; Panseri, Silvia/AAW-2856-2020; russo, alessandro ar/K-5778-2018; Giavaresi, Gianluca/J-5583-2016; Cunha, Carla/I-1884-2013	Panseri, Silvia/0000-0002-8099-7132; russo, alessandro ar/0000-0002-1580-2829; Giavaresi, Gianluca/0000-0001-7843-5969; Cunha, Carla/0000-0002-9096-5644; Sandri, Monica/0000-0001-5782-3137; Panseri, Sara/0000-0001-6970-2009; MARCACCI, MAURILIO/0000-0002-7484-1246	European Union project "MAGISTER" [NMP3-LA-2008-214685]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046568] Funding Source: NIH RePORTER	European Union project "MAGISTER"; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors strongly acknowledge the financial support from European Union project "MAGISTER" NMP3-LA-2008-214685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirfazli A, 2007, NAT NANOTECHNOL, V2, P467, DOI 10.1038/nnano.2007.234; Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1; Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011; Foy SP, 2010, ACS NANO, V4, P5217, DOI 10.1021/nn101427t; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Glossop JR, 2010, J TISSUE ENG REGEN M, V4, P577, DOI 10.1002/term.293; Gould P, 2006, NANO TODAY, V1, P34, DOI 10.1016/S1748-0132(06)70115-3; Hua MY, 2010, BIOMATERIALS, V31, P7355, DOI 10.1016/j.biomaterials.2010.05.061; Jain TK, 2008, MOL PHARMACEUT, V5, P316, DOI 10.1021/mp7001285; Kanczler JM, 2010, TISSUE ENG PT A, V16, P3241, DOI [10.1089/ten.tea.2009.0638, 10.1089/ten.TEA.2009.0638]; Khaled E G, 2011, Open Orthop J, V5 Suppl 2, P289, DOI 10.2174/1874325001105010289; Khan W.S., 2012, STEM CELLS INT; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509; Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y; Nandi SK, 2010, INDIAN J MED RES, V132, P15; Ngiam M, 2011, ANN ACAD MED SINGAP, V40, P213; Panseri S., 2011, KNEE SURG SPORTS TRA; Phillips MA, 2010, NANO TODAY, V5, P143, DOI 10.1016/j.nantod.2010.03.003; Polyak B, 2008, P NATL ACAD SCI USA, V105, P698, DOI 10.1073/pnas.0708338105; Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4; Shimizu K, 2007, J BIOMED MATER RES B, V82B, P471, DOI 10.1002/jbm.b.30752; Sun CR, 2010, ACS NANO, V4, P2402, DOI 10.1021/nn100190v; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241; TEIXEIRA CC, 1995, CALCIFIED TISSUE INT, V56, P252, DOI 10.1007/BF00298620; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu Y, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/1/015001; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047	32	82	86	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38710	10.1371/journal.pone.0038710	http://dx.doi.org/10.1371/journal.pone.0038710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685602	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700065
J	Westesson, O; Holmes, I				Westesson, Oscar; Holmes, Ian			Developing and Applying Heterogeneous Phylogenetic Models with XRate	PLOS ONE			English	Article							EVOLUTIONARY RATES; PREDICTION; GENERATION	Modeling sequence evolution on phylogenetic trees is a useful technique in computational biology. Especially powerful are models which take account of the heterogeneous nature of sequence evolution according to the "grammar" of the encoded gene features. However, beyond a modest level of model complexity, manual coding of models becomes prohibitively labor-intensive. We demonstrate, via a set of case studies, the new built-in model-prototyping capabilities of XRate (macros and Scheme extensions). These features allow rapid implementation of phylogenetic models which would have previously been far more labor-intensive. XRate 's new capabilities for lineage-specific models, ancestral sequence reconstruction, and improved annotation output are also discussed. XRate 's flexible model-specification capabilities and computational efficiency make it well-suited to developing and prototyping phylogenetic grammar models. XRate is available as part of the DART software package: http://biowiki.org/DART.	[Westesson, Oscar; Holmes, Ian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Westesson, O (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	ihh@berkeley.edu		Holmes, Ian/0000-0001-7639-5369	NIH [R01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded from an NIH Research Project Grant Program (R01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WIGGLE TRACK FORMAT; Ayres D. L., 2011, SYSTEMATIC BIOL; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Bradley RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006478; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Garber M, 2009, BIOINFORMATICS; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heger A, 2009, MOL BIOL EVOL, V26, P1715, DOI 10.1093/molbev/msp080; JUKES T H, 1969, P21; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klosterman PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-428; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Lunter G, 2007, BIOINFORMATICS, V23, P2485, DOI 10.1093/bioinformatics/btm350; Meyer IM, 2004, NUCLEIC ACIDS RES, V32, P776, DOI 10.1093/nar/gkh211; Pedersen JS, 2004, NUCL ACIDS RES, V32, P4925; Penn O, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000214; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Searls D B, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P341; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Varadarajan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r147; Watts J, 2009, NATURE; Yang ZH, 2000, GENETICS, V155, P431; ZUKER M, 1989, METHOD ENZYMOL, V180, P262; GFF EXCHANGE FORMAT	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36898	10.1371/journal.pone.0036898	http://dx.doi.org/10.1371/journal.pone.0036898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693624	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900004
J	Foster, BL; Nagatomo, KJ; Nociti, FH; Fong, HS; Dunn, D; Tran, AB; Wang, W; Narisawa, S; Millan, JL; Somerman, MJ				Foster, Brian L.; Nagatomo, Kanako J.; Nociti, Francisco H., Jr.; Fong, Hanson; Dunn, Daisy; Tran, Anne B.; Wang, Wei; Narisawa, Sonoko; Millan, Jose Luis; Somerman, Martha J.			Central Role of Pyrophosphate in Acellular Cementum Formation	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; DENTIN MATRIX PROTEIN-1; CELL MEMBRANE GLYCOPROTEIN-1; HUMAN PERIODONTAL-LIGAMENT; INORGANIC PYROPHOSPHATE; IN-VITRO; INFANTILE HYPOPHOSPHATASIA; HYDROXYAPATITE FORMATION; MECHANICAL-PROPERTIES; ATTACHMENT APPARATUS	Background: Inorganic pyrophosphate (PPi) is a physiologic inhibitor of hydroxyapatite mineral precipitation involved in regulating mineralized tissue development and pathologic calcification. Local levels of PPi are controlled by antagonistic functions of factors that decrease PPi and promote mineralization (tissue-nonspecific alkaline phosphatase, Alpl/TNAP), and those that increase local PPi and restrict mineralization (progressive ankylosis protein, ANK; ectonucleotide pyrophosphatase phosphodiesterase-1, NPP1). The cementum enveloping the tooth root is essential for tooth function by providing attachment to the surrounding bone via the nonmineralized periodontal ligament. At present, the developmental regulation of cementum remains poorly understood, hampering efforts for regeneration. To elucidate the role of PPi in cementum formation, we analyzed root development in knock-out ((-/-)) mice featuring PPi dysregulation. Results: Excess PPi in the Alpl(-/-) mouse inhibited cementum formation, causing root detachment consistent with premature tooth loss in the human condition hypophosphatasia, though cementoblast phenotype was unperturbed. Deficient PPi in both Ank and Enpp1(-/-) mice significantly increased cementum apposition and overall thickness more than 12-fold vs. controls, while dentin and cellular cementum were unaltered. Though PPi regulators are widely expressed, cementoblasts selectively expressed greater ANK and NPP1 along the root surface, and dramatically increased ANK or NPP1 in models of reduced PPi output, in compensatory fashion. In vitro mechanistic studies confirmed that under low PPi mineralizing conditions, cementoblasts increased Ank (5-fold) and Enpp1 (20-fold), while increasing PPi inhibited mineralization and associated increases in Ank and Enpp1 mRNA. Conclusions: Results from these studies demonstrate a novel developmental regulation of acellular cementum, wherein cementoblasts tune cementogenesis by modulating local levels of PPi, directing and regulating mineral apposition. These findings underscore developmental differences in acellular versus cellular cementum, and suggest new approaches for cementum regeneration.	[Foster, Brian L.; Nociti, Francisco H., Jr.; Tran, Anne B.; Somerman, Martha J.] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Lab Oral Connect Tissue Biol, NIH, Bethesda, MD 20892 USA; [Nagatomo, Kanako J.; Dunn, Daisy] Univ Washington, Sch Dent, Dept Periodont, Seattle, WA 98195 USA; [Nociti, Francisco H., Jr.] Univ Estadual Campinas, Sch Dent Piracicaba, Div Periodont, Sao Paulo, Brazil; [Wang, Wei; Narisawa, Sonoko; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Washington; University of Washington Seattle; Universidade Estadual de Campinas; Sanford Burnham Prebys Medical Discovery Institute	Foster, BL (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Lab Oral Connect Tissue Biol, NIH, Bethesda, MD 20892 USA.	brian.foster@nih.gov	Nociti, Francisco/G-4907-2015; Foster, Brian/AAV-4336-2020; Foster, Brian L/H-8375-2015	Foster, Brian/0000-0003-3444-0576; Foster, Brian L/0000-0003-3444-0576; Nociti, Francisco/0000-0001-6809-8866	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH); NIH [R01DE15109, R01 AR47908, R01 DE12889]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047908, ZIAAR041196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015109] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH). Grants R01DE15109 (MJS), R01 AR47908 and R01 DE12889 (JLM) were received from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J ORAL BIOSCI, V46, P125; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Addison WN, 2010, BONE, V46, P1100, DOI 10.1016/j.bone.2010.01.367; ALATLIKUT I, 1994, SCAND J DENT RES, V102, P260; Beertsen W, 1999, J DENT RES, V78, P1221, DOI 10.1177/00220345990780060501; BEERTSEN W, 1985, AM J ANAT, V174, P83, DOI 10.1002/aja.1001740107; BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K; BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E; Berendsen AD, 2010, CELLS TISSUES ORGANS, V192, P116, DOI 10.1159/000289585; Berry JE, 2003, CONNECT TISSUE RES, V44, P97, DOI 10.1080/03008200390152160; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Bosshardt DD, 2005, J DENT RES, V84, P390, DOI 10.1177/154405910508400501; Bosshardt DD, 2009, PERIODONTOL 2000, V51, P208, DOI 10.1111/j.1600-0757.2009.00317.x; BRONCKERS ALJJ, 1994, J BONE MINER RES, V9, P833; BRUCKNER R. J. N. H. RICKLES, 1962, ORAL SURG ORAL MED AND ORAL PATHOL, V15, P1351, DOI 10.1016/0030-4220(62)90356-0; CHAPPLE ILC, 1993, J CLIN PERIODONTOL, V20, P615, DOI 10.1111/j.1600-051X.1993.tb00705.x; D'Errico JA, 2000, J PERIODONTOL, V71, P63, DOI 10.1902/jop.2000.71.1.63; Diekwisch TGH, 2001, INT J DEV BIOL, V45, P695; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub3; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Fong H, 2009, ARCH ORAL BIOL, V54, P570, DOI 10.1016/j.archoralbio.2009.02.011; Fong H, 2009, J PERIODONTOL, V80, P1348, DOI 10.1902/jop.2009.090129; Fong H, 2009, ARCH ORAL BIOL; Foster BL, 2011, CELLS TISSUES ORGANS; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Foster Brian L., 2008, Birth Defects Research, V84, P281, DOI 10.1002/bdrc.20136; Gaengler P, 2007, DEV FUNCTION EVOLUTI, P173; Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; GROENEVELD MC, 1995, J DENT RES, V74, P1374, DOI 10.1177/00220345950740070901; Gurley KA, 2006, J BONE MINER RES, V21, P1238, DOI 10.1359/JBMR.060515; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Jayawardena CK, 2002, EUR J ORAL SCI, V110, P261, DOI 10.1034/j.1600-0447.2002.21239.x; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Johnson K, 1999, J BONE MINER RES, V14, P883, DOI 10.1359/jbmr.1999.14.6.883; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kaipatur NR, 2008, J DENT RES, V87, P839, DOI 10.1177/154405910808700907; Lillie RD, 1965, HISTOCHEMISTRY TECHN; Luan X, 2006, DEV DYN; Luan XH, 2009, EVOL DEV, V11, P247, DOI 10.1111/j.1525-142X.2009.00327.x; MacNeil R L, 1995, Connect Tissue Res, V33, P1, DOI 10.3109/03008209509016974; Marchesan JT, 2011, ARCH ORAL BIOL; McIntosh JE, 2002, MICROSC RES TECHNIQ, V59, P449, DOI 10.1002/jemt.10222; McKee MD, 1996, ANAT RECORD, V245, P293, DOI 10.1002/(SICI)1097-0185(199606)245:2<293::AID-AR13>3.0.CO;2-K; McKee MD, 2011, J DENT RES; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Millan J.L., 2006, MAMMALIAN ALKALINE P; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; Nociti FH, 2002, J DENT RES, V81, P817, DOI 10.1177/154405910208101204; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Osathanon T, 2009, BIOMATERIALS, V30, P4513, DOI 10.1016/j.biomaterials.2009.05.022; Reibel A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-6; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Rodrigues TL, 2011, J PERIODONTOL; ROSENTHAL AK, 1991, ARTHRITIS RHEUM, V34, P904, DOI 10.1002/art.1780340717; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; TENENBAUM HC, 1987, BONE MINER, V3, P13; TENENBAUM HC, 1981, J DENT RES, V60, P1586, DOI 10.1177/002203458106000308011; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; van den Bos T, 2005, J DENT RES, V84, P1021, DOI 10.1177/154405910508401110; van den Bos T, 1999, J PERIODONTAL RES, V34, P1; Whyte M.P, 2002, PRINCIPLES BONE BIOL, V2, P1569, DOI 10.1016/B978-012098652-1.50172-4; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Ye L, 2008, J DENT RES, V87, P624, DOI 10.1177/154405910808700708	80	93	98	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38393	10.1371/journal.pone.0038393	http://dx.doi.org/10.1371/journal.pone.0038393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675556	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700069
J	Hoffmann, D; Schwarck, D; Banning, C; Brenner, M; Mariyanna, L; Krepstakies, M; Schindler, M; Millar, DP; Hauber, J				Hoffmann, Dirk; Schwarck, Doreen; Banning, Carina; Brenner, Matthias; Mariyanna, Lakshmikanth; Krepstakies, Marcel; Schindler, Michael; Millar, David P.; Hauber, Joachim			Formation of Trans-Activation Competent HIV-1 Rev:RRE Complexes Requires the Recruitment of Multiple Protein Activation Domains	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REV-RESPONSE ELEMENT; NUCLEAR EXPORT SIGNALS; VIRAL MESSENGER-RNA; GENE-EXPRESSION REQUIRES; TYPE-1 REV; TRANS-ACTIVATOR; CELLULAR COFACTOR; TARGET SEQUENCE; STRUCTURED REGION	The HIV-1 Rev trans-activator is a nucleocytoplasmic shuttle protein that is essential for virus replication. Rev directly binds to unspliced and incompletely spliced viral RNA via the cis-acting Rev Response Element (RRE) sequence. Subsequently, Rev oligomerizes cooperatively and interacts with the cellular nuclear export receptor CRM1. In addition to mediating nuclear RNA export, Rev also affects the stability, translation and packaging of Rev-bound viral transcripts. Although it is established that Rev function requires the multimeric assembly of Rev molecules on the RRE, relatively little is known about how many Rev monomers are sufficient to form a trans-activation competent Rev:RRE complex, or which specific activity of Rev is affected by its oligomerization. We here analyzed by functional studies how homooligomer formation of Rev affects the trans-activation capacity of this essential HIV-1 regulatory protein. In a gain-of-function approach, we fused various heterologous dimerization domains to an otherwise oligomerization-defective Rev mutant and were able to demonstrate that oligomerization of Rev is not required per se for the nuclear export of this viral trans-activator. In contrast, however, the formation of Rev oligomers on the RRE is a precondition to trans-activation by directly affecting the nuclear export of Rev-regulated mRNA. Moreover, experimental evidence is provided showing that at least two protein activation domains are required for the formation of trans-activation competent Rev: RRE complexes. The presented data further refine the model of Rev trans-activation by directly demonstrating that Rev oligomerization on the RRE, thereby recruiting at least two protein activation domains, is required for nuclear export of unspliced and incompletely spliced viral RNA.	[Hoffmann, Dirk; Schwarck, Doreen; Banning, Carina; Mariyanna, Lakshmikanth; Krepstakies, Marcel; Schindler, Michael; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Brenner, Matthias] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Millar, David P.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Heinrich Pette Institute; University of Erlangen Nuremberg; Scripps Research Institute	Hoffmann, D (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	joachim.hauber@hpi.uni-hamburg.de	Mariyanna, Lakshmikanth/ABG-4596-2021; Schindler, Michael/C-1647-2015	Mariyanna, Lakshmikanth/0000-0001-5969-1246; Schindler, Michael/0000-0001-8989-5813; Mariyanna, Lakshmikanth/0000-0001-6561-2049	Deutsche Forschungsgemeinschaft [HA2580/2-2]; Free and Hanseatic City of Hamburg; Federal Ministry of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Free and Hanseatic City of Hamburg; Federal Ministry of Health	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (HA2580/2-2 to JH). The Heinrich Pette Institute is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; BERGER J, 1991, VIROLOGY, V183, P630, DOI 10.1016/0042-6822(91)90992-K; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Blanco FJ, 2001, J MOL BIOL, V313, P845, DOI 10.1006/jmbi.2001.5067; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Cochrane Alan, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P287, DOI 10.2174/1568008043339677; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; COLE JL, 1993, BIOCHEMISTRY-US, V32, P11769, DOI 10.1021/bi00095a004; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DAEFLER S, 1990, P NATL ACAD SCI USA, V87, P4571, DOI 10.1073/pnas.87.12.4571; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P8945, DOI 10.1021/bi00085a028; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; Dayton A I, 2000, Adv Pharmacol, V49, P199; Dayton AI, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-62; Edgcomb SP, 2008, PROTEIN SCI, V17, P420, DOI 10.1110/ps.073246608; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grewe B, 2010, J GEN VIROL, V91, P1893, DOI 10.1099/vir.0.022509-0; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; HAMMERSCHMID M, 1994, J VIROL, V68, P7329, DOI 10.1128/JVI.68.11.7329-7335.1994; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; HOPE TJ, 1990, P NATL ACAD SCI USA, V87, P7787, DOI 10.1073/pnas.87.19.7787; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; HOPE TJ, 1992, J VIROL, V66, P1849, DOI 10.1128/JVI.66.4.1849-1855.1992; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; KALLAND KH, 1994, MOL CELL BIOL, V14, P7436, DOI 10.1128/MCB.14.11.7436; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Kjems J, 2000, Adv Pharmacol, V48, P251; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Li JL, 2002, J VIROL, V76, P8374, DOI 10.1128/JVI.76.16.8374-8382.2002; Loflin PT, 1999, METHODS, V17, P11, DOI 10.1006/meth.1998.0702; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MALIM MH, 1993, MOL CELL BIOL, V13, P6180, DOI 10.1128/MCB.13.10.6180; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; OLSEN HS, 1990, GENE DEV, V4, P1357, DOI 10.1101/gad.4.8.1357; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pallesen J, 2009, FEBS J, V276, P4223, DOI 10.1111/j.1742-4658.2009.07130.x; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; POWELL DM, 1995, J ACQ IMMUN DEF SYND, V10, P317; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; RICHARD N, 1994, VIROLOGY, V204, P123, DOI 10.1006/viro.1994.1516; RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0; Robertson-Anderson RM, 2011, J MOL BIOL, V410, P959, DOI 10.1016/j.jmb.2011.04.026; ROSEN CA, 1988, P NATL ACAD SCI USA, V85, P2071, DOI 10.1073/pnas.85.7.2071; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Surendran R, 2004, BIOPHYS CHEM, V108, P101, DOI 10.1016/j.bpc.2003.10.013; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; TILEY LS, 1992, GENE DEV, V6, P2077, DOI 10.1101/gad.6.11.2077; VENKATESAN S, 1992, J VIROL, V66, P7469, DOI 10.1128/JVI.66.12.7469-7480.1992; VENKATESH LK, 1990, VIROLOGY, V178, P327, DOI 10.1016/0042-6822(90)90414-M; WEICHSELBRAUN I, 1992, J VIROL, V66, P2583, DOI 10.1128/JVI.66.4.2583-2587.1992; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; WITHERELL GW, 1990, BIOCHEMISTRY-US, V29, P11051, DOI 10.1021/bi00502a006; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zemmel RW, 1996, J MOL BIOL, V258, P763, DOI 10.1006/jmbi.1996.0285	100	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38305	10.1371/journal.pone.0038305	http://dx.doi.org/10.1371/journal.pone.0038305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675540	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700057
J	Kasermann, F; Boerema, DJ; Ruegsegger, M; Hofmann, A; Wymann, S; Zuercher, AW; Miescher, S				Kaesermann, Fabian; Boerema, David J.; Rueegsegger, Monika; Hofmann, Andreas; Wymann, Sandra; Zuercher, Adrian W.; Miescher, Sylvia			Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIINFLAMMATORY ACTIVITY; GAMMA-GLOBULIN; AUTOIMMUNE; IMMUNODEFICIENCIES; THERAPY	It has been proposed that the anti-inflammatory effects of intravenous immunoglobulin (IVIG) might be due to the small fraction of Fc-sialylated IgG. In this study we biochemically and functionally characterized sialic acid-enriched IgG obtained by Sambucus nigra agglutinin (SNA) lectin fractionation. Two main IgG fractions isolated by elution with lactose (E1) or acidified lactose (E2) were analyzed for total IgG, F(ab')(2) and Fc-specific sialic acid content, their pattern of specific antibodies and anti-inflammatory potential in a human in vitro inflammation system based on LPS- or PHA-stimulated whole blood. HPLC and LC-MS testing revealed an increase of sialylated IgG in E1 and more substantially in the E2 fraction. Significantly, the increased amount of sialic acid residues was primarily found in the Fab region whereas only a minor increase was observed in the Fc region. This indicates preferential binding of the Fab sialic acid to SNA. ELISA analyses of a representative range of pathogen and auto-antigens indicated a skewed antibody pattern of the sialylated IVIG fractions. Finally, the E2 fraction exerted a more profound anti-inflammatory effect compared to E1 or IVIG, evidenced by reduced CD54 expression on monocytes and reduced secretion of MCP-1 (CCL2); again these effects were Fab- but not Fc-dependent. Our results show that SNA fractionation of IVIG yields a minor fraction (approx. 10%) of highly sialylated IgG, wherein the sialic acid is mainly found in the Fab region. The tested anti-inflammatory activity was associated with Fab not Fc sialylation.	[Kaesermann, Fabian; Rueegsegger, Monika; Hofmann, Andreas; Wymann, Sandra; Zuercher, Adrian W.; Miescher, Sylvia] CSL Behring AG, Res & Dev, Bern, Switzerland; [Boerema, David J.] CSL Behring LLC, Res & Dev, Kankakee, IL USA	CSL; CSL	Kasermann, F (corresponding author), CSL Behring AG, Res & Dev, Bern, Switzerland.	fabian.kaesermann@cslbehring.com		Kasermann, Fabian/0000-0002-4255-9350				Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Araujo LM, 2011, J IMMUNOL, V186, P3289, DOI 10.4049/jimmunol.1003076; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Baerenwaldt A, 2010, EXPERT REV CLIN IMMU, V6, P425, DOI [10.1586/eci.10.9, 10.1586/ECI.10.9]; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Hartung HP, 2009, CLIN EXP IMMUNOL, V158, P23, DOI [10.1111/j.1365-2249.2009.04024.X, 10.1111/j.1365-2249.2009.04024.x]; Hartung HP, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-3002-0; IMBACH P, 1981, LANCET, V1, P1228; Imbach P, 2010, VOX SANG, V98, P385, DOI 10.1111/j.1423-0410.2009.01264.x; Jordan SC, 2009, TRANSPLANTATION, V88, P1, DOI 10.1097/TP.0b013e3181a9e89a; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Kaveri SV, 2011, CLIN EXP IMMUNOL, V164, P2, DOI 10.1111/j.1365-2249.2011.04387.x; Kaveri SV, 2008, NEW ENGL J MED, V359, P307, DOI 10.1056/NEJMcibr0803649; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Leontyev D, 2012, TRANSFUSION IN PRESS; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Padet L, 2011, CLIN EXP IMMUNOL, V166, P352, DOI 10.1111/j.1365-2249.2011.04476.x; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; Schwab I, 2012, EUR J IMMUNOL; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Tackenberg B, 2010, J CLIN IMMUNOL, V30, pS65, DOI 10.1007/s10875-010-9398-1; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; Zuercher AW, 2011, PRINCIPLES IMMUNOPHA, P271	36	92	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37243	10.1371/journal.pone.0037243	http://dx.doi.org/10.1371/journal.pone.0037243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675478	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700010
J	Echauri-Espinosa, RO; Callejas-Negrete, OA; Roberson, RW; Bartnicki-Garcia, S; Mourino-Perez, RR				Echauri-Espinosa, Ramon O.; Callejas-Negrete, Olga A.; Roberson, Robert W.; Bartnicki-Garcia, Salomon; Mourino-Perez, Rosa R.			Coronin Is a Component of the Endocytic Collar of Hyphae of Neurospora crassa and Is Necessary for Normal Growth and Morphogenesis	PLOS ONE			English	Article							TIP GROWTH; ACTIN CYTOSKELETON; CIRCADIAN CLOCK; SPITZENKORPER; MICROTUBULES; ORGANIZATION; DYNAMICS; ARP2/3; MICROSCOPY; MACHINERY	Coronin plays a major role in the organization and dynamics of actin in yeast. To investigate the role of coronin in a filamentous fungus (Neurospora crassa), we examined its subcellular localization using fluorescent proteins and the phenotypic consequences of coronin gene (crn-1) deletion in hyphal morphogenesis, Spitzenkorper behavior and endocytosis. Coronin-GFP was localized in patches, forming a subapical collar near the hyphal apex; significantly, it was absent from the apex. The subapical patches of coronin colocalized with fimbrin, Arp2/3 complex, and actin, altogether comprising the endocytic collar. Deletion of crn-1 resulted in reduced hyphal growth rates, distorted hyphal morphology, uneven wall thickness, and delayed establishment of polarity during germination; it also affected growth directionality and increased branching. The Spitzenkorper of Dcrn-1 mutant was unstable; it appeared and disappeared intermittently giving rise to periods of hyphoid-like and isotropic growth respectively. Uptake of FM4-64 in Dcrn-1 mutant indicated a partial disruption in endocytosis. These observations underscore coronin as an important component of F-actin remodeling in N. crassa. Although coronin is not essential in this fungus, its deletion influenced negatively the operation of the actin cytoskeleton involved in the orderly deployment of the apical growth apparatus, thus preventing normal hyphal growth and morphogenesis.	[Echauri-Espinosa, Ramon O.; Callejas-Negrete, Olga A.; Bartnicki-Garcia, Salomon; Mourino-Perez, Rosa R.] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Roberson, Robert W.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Arizona State University; Arizona State University-Tempe	Echauri-Espinosa, RO (corresponding author), CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	rmourino@cicese.mx	Bartnicki-Garcia, Salomon/J-3446-2016; Mouriño-Pérez, Rosa Reyna Reyna/F-9192-2014	Mouriño-Pérez, Rosa Reyna Reyna/0000-0002-7958-2212; Callejas-Negrete, Olga Alicia/0000-0002-9285-7014	Consejo Nacional de Ciencia y Tecnologia-DFG; CONACYT-Ciencia Basica [134771]; Arizona State University [LM5100R1]	Consejo Nacional de Ciencia y Tecnologia-DFG; CONACYT-Ciencia Basica; Arizona State University	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia-DFG to R. R. M. P. and CONACYT-Ciencia Basica (134771) S. B. G. and from Arizona State University (LM5100R1) to R. W. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; ARPAIA G, 1995, MOL GEN GENET, V247, P157, DOI 10.1007/BF00705645; Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Baldo ET, 2005, EXP PARASITOL, V110, P114, DOI 10.1016/j.exppara.2005.02.007; Bartnicki-Garcia S, 2002, MYCOLOGY S, V15, P29; Bartnicki-Garcia S, 1990, BIOCH CELL WALLS MEM, P43; Bartnicki-Garcia Salomon, 1996, P105; BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bharathi V, 2004, J CELL SCI, V117, P1911, DOI 10.1242/jcs.01034; Bracker CE, 1997, P SOC PHOTO-OPT INS, V2983, P67, DOI 10.1117/12.274325; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Davis R.H., 2000, NEUROSPORA CONTRIBUT; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; de Hostos Eugenio L., 2008, V48, P31, DOI 10.1007/978-0-387-09595-0_4; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; GIRBARDT M, 1957, PLANTA, V50, P47, DOI 10.1007/BF01912343; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Grove SN, 1981, MYCOL SOC AM NEWSLET, V32, P33; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hoffmann J, 1998, FUNGAL GENET BIOL, V24, P77, DOI 10.1006/fgbi.1998.1059; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; HOWARD RJ, 1981, J CELL SCI, V48, P89; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McDaniel DP, 2000, FUNGAL GENET BIOL, V31, P233, DOI 10.1006/fgbi.2000.1249; Mourino-Perez RR, 2006, FUNGAL GENET BIOL, V43, P389, DOI 10.1016/j.fgb.2005.10.007; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Riquelme M, 1998, FUNGAL GENET BIOL, V24, P101, DOI 10.1006/fgbi.1998.1074; ROBERSON RW, 1992, MYCOLOGIA, V84, P41, DOI 10.2307/3760400; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; Virag A, 2004, FUNGAL GENET BIOL, V41, P213, DOI 10.1016/j.fgb.2003.10.010; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	53	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38237	10.1371/journal.pone.0038237	http://dx.doi.org/10.1371/journal.pone.0038237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693603	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500114
J	Barr, I; Hurt, A; Kelso, A; Reading, P; Ly, S; Seng, H; Buchy, P; Ung, SA; Shu, YL; Xu, CL; Xu, Z; Wang, DY; Kama, M; Singh, P; Fujisaki, S; Odagiri, T; Tashiro, M; Archkhawongs, S; Khamphaphongphanh, B; Vongphrachanh, P; Kheong, CC; Ismail, N; Burmaa, A; Darmaa, B; Nymadawa, P; Grangeon, JP; Gourinat, AC; Huang, QS; Lopez, LD; Lopez, JM; Olveda, RM; Roque, V; Jennings, L; Kang, C; Lin, C; Lin, R; Tee, WSN; Balish, A; Corwin, A; Kapella, BK; Kitsutani, P; McFarland, J; Moen, A; Xu, XY; Vu, MPH; Long, NL; Mai, LQ; Le, KHN; Nguyen, HA; Nguyen, TL; Nguyen, TN; Asgari, N; Dawainavesi, A; Denehy, EJ; Dominguez, MN; Jamsran, M; Kasai, T; Kool, J; Lewis, H; Luo, DP; Olowokure, B; Partridge, J; Pavlin, B; Samaan, G; Singh, H; Tsuyuoka, R; Vakacegu, A; Zhang, WQ				Barr, Ian; Hurt, Aeron; Kelso, Anne; Reading, Patrick; Ly, Sovann; Seng, Heng; Buchy, Philippe; Ung, Sam An; Shu, Yuelong; Xu, Cuiling; Xu, Zhen; Wang, Dayan; Kama, Mike; Singh, Prem; Fujisaki, Seiichiro; Odagiri, Takato; Tashiro, Masato; Archkhawongs, Sibounhom; Khamphaphongphanh, Bouaphanh; Vongphrachanh, Phengta; Kheong, Chong Chee; Ismail, Norizah; Burmaa, Alexanderyn; Darmaa, Badarchiin; Nymadawa, Pagbajabyn; Grangeon, Jean-Paul; Gourinat, Ann-Claire; Huang, Qiu Sue; Lopez, Liza D.; Lopez, Juan M.; Olveda, Remigio M.; Roque, Vito; Jennings, Lance; Kang, Chun; Lin, Cui; Lin, Raymond; Tee, Wen Sim Nancy; Balish, Amanda; Corwin, Andrew; Kapella, Bryan K.; Kitsutani, Paul; McFarland, Jeffrey; Moen, Ann; Xu, Xiyan; Vu Mai Phuong Hoang; Ngoc Long Long; Le Quynh Mai; Le Khanh Hang Nguyen; Hoang Anh Nguyen; Thanh Long Nguyen; Thu Ngoc Nguyen; Asgari, Nima; Dawainavesi, Akanisi; Denehy, Emma Jane; Dominguez, Maria Nerissa; Jamsran, Mendsaikhan; Kasai, Takeshi; Kool, Jacob; Lewis, Hannah; Luo, Dapeng; Olowokure, Babatunde; Partridge, Jeffrey; Pavlin, Boris; Samaan, Gina; Singh, Harpal; Tsuyuoka, Reiko; Vakacegu, Apaitia; Zhang, Wenqing		Western Pacific Region Global Infl	Epidemiological and Virological Characteristics of Influenza in the Western Pacific Region of the World Health Organization, 2006-2010	PLOS ONE			English	Article							DYNAMICS	Background: Influenza causes yearly seasonal epidemics and periodic pandemics. Global systems have been established to monitor the evolution and impact of influenza viruses, yet regional analysis of surveillance findings has been limited. This study describes epidemiological and virological characteristics of influenza during 2006-2010 in the World Health Organization's Western Pacific Region. Methodology/Principal Findings: Influenza-like illness (ILI) and influenza virus data were obtained from the 14 countries with National Influenza Centres. Data were obtained directly from countries and from FluNet, the web-based tool of the Global Influenza Surveillance and Response System. National influenza surveillance and participation in the global system increased over the five years. Peaks in ILI reporting appeared to be coincident with the proportion of influenza positive specimens. Temporal patterns of ILI activity and the proportion of influenza positive specimens were clearly observed in temperate countries: Mongolia, Japan and the Republic of Korea in the northern hemisphere, and Australia, New Zealand, Fiji and New Caledonia (France) in the southern hemisphere. Two annual peaks in activity were observed in China from 2006 through the first quarter of 2009. A temporal pattern was less evident in tropical countries, where influenza activity was observed year-round. Influenza A viruses accounted for the majority of viruses reported between 2006 and 2009, but an equal proportion of influenza A and influenza B viruses was detected in 2010. Conclusions/Significance: Despite differences in surveillance methods and intensity, commonalities in ILI and influenza virus circulation patterns were identified. Patterns suggest that influenza circulation may be dependent on a multitude of factors including seasonality and population movement. Dominant strains in Southeast Asian countries were later detected in other countries. Thus, timely reporting and regional sharing of information about influenza may serve as an early warning, and may assist countries to anticipate the potential severity and burden associated with incoming strains.	[Ung, Sam An] Natl Inst Publ Hlth, Phnom Penh, Cambodia; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Jennings, Lance] Univ Otago, Christchurch, New Zealand; [Kang, Chun] Korea Ctr Dis Control & Prevent, Seoul, South Korea; [Lin, Cui; Lin, Raymond; Tee, Wen Sim Nancy] Minist Hlth, Singapore, Singapore; [Balish, Amanda; Corwin, Andrew; Kapella, Bryan K.; Kitsutani, Paul; McFarland, Jeffrey; Moen, Ann; Xu, Xiyan] Ctr Dis Control & Prevent, Atlanta, GA USA; [Asgari, Nima; Dawainavesi, Akanisi; Denehy, Emma Jane; Dominguez, Maria Nerissa; Jamsran, Mendsaikhan; Kasai, Takeshi; Kool, Jacob; Lewis, Hannah; Luo, Dapeng; Olowokure, Babatunde; Partridge, Jeffrey; Pavlin, Boris; Samaan, Gina; Singh, Harpal; Tsuyuoka, Reiko; Vakacegu, Apaitia; Zhang, Wenqing] WHO, Washington, DC USA	University of Otago; Korea Centers for Disease Control & Prevention (KCDC); Ministry of Health-Singapore; Centers for Disease Control & Prevention - USA; World Health Organization		partridgej@wpro.who.int	Dawainavesi, Akanisi/AAB-5972-2021; zhang, wenqing/GYA-0786-2022; Nymadawa, Pagbajab/AAE-7344-2019; Cook, Alex/B-5941-2011	Dawainavesi, Akanisi/0000-0001-5902-8145; Nymadawa, Pagbajab/0000-0002-3189-2772; BUCHY, Philippe/0000-0003-1372-3008; Asgari-Jirhandeh, Nima/0000-0002-4743-4194; Reading, Patrick/0000-0002-8860-5308; Kool, Jacob/0000-0002-9605-2918; Huang, Q. Sue/0000-0002-3923-5195; Hurt, Aeron/0000-0003-1826-4314; Kelso, Anne/0000-0002-3166-3267; Barr, Ian/0000-0002-7351-418X; Cook, Alex/0000-0002-6271-5832				Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; Heymann D, 2010, CONTROL COMMUNICABLE; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Mardy S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-168; McCallum L, 2010, W PACIFIC SURVEILLAN, V1; Oshitani H, 2010, WEST PAC SURVEILL RE, V1, P3, DOI [10.5365/WPSAR.2010.1.1.005, 10.5365/wpsar.2010.1.1.005]; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; World Health Organization, 2011, BIR PLAN FURTH STREN; Yang L, 2011, VACCINE, V29, P8909, DOI 10.1016/j.vaccine.2011.09.071	17	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37568	10.1371/journal.pone.0037568	http://dx.doi.org/10.1371/journal.pone.0037568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22675427	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349600020
J	Bergfeld, AK; Pearce, OMT; Diaz, SL; Pham, T; Varki, A				Bergfeld, Anne K.; Pearce, Oliver M. T.; Diaz, Sandra L.; Tho Pham; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups ELUCIDATING THE INTRACELLULAR FATE OF THE NON-HUMAN SIALIC ACID N-GLYCOLYLNEURAMINIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANGANUTZIU-DEICHER ANTIGEN; SIALATE PYRUVATE-LYASE; ACETYLNEURAMINIC ACID; MOUSE-LIVER; ACETYLGLUCOSAMINE KINASE; GLYCOLOYLNEURAMINIC ACID; GLCNAC 2-EPIMERASE; MOLECULAR-CLONING; CELL LINE; CANCER	The two major mammalian sialic acids are N-acetylneuraminic acid and N-glycolylneuraminic acid (Neu5Gc). The only known biosynthetic pathway generating Neu5Gc is the conversion of CMP-N-acetylneuraminic acid into CMP-Neu5Gc, which is catalyzed by the CMP-Neu5Ac hydroxylase enzyme. Given the irreversible nature of this reaction, there must be pathways for elimination or degradation of Neu5Gc, which would allow animal cells to adjust Neu5Gc levels to their needs. Although humans are incapable of synthesizing Neu5Gc due to an inactivated CMAH gene, exogenous Neu5Gc from dietary sources can be metabolically incorporated into tissues in the face of an anti-Neu5Gc antibody response. However, the metabolic turnover of Neu5Gc, which apparently prevents human cells from continued accumulation of this immunoreactive sialic acid, has not yet been elucidated. In this study, we show that pre-loaded Neu5Gc is eliminated from human cells over time, and we propose a conceivable Neu5Gc-degrading pathway based on the well studied metabolism of N-acetylhexosamines. We demonstrate that murine tissue cytosolic extracts harbor the enzymatic machinery to sequentially convert Neu5Gc into N-glycolylmannosamine, N-glycolylglucosamine, and N-glycolylglucosamine 6-phosphate, whereupon irreversible de-N-glycolylation of the latter results in the ubiquitous metabolites glycolate and glucosamine 6-phosphate. We substantiate this finding by demonstrating activity of recombinant human enzymes in vitro and by studying the fate of radiolabeled pathway intermediates in cultured human cells, suggesting that this pathway likely occurs in vivo. Finally, we demonstrate that the proposed degradative pathway is partially reversible, showing that N-glycolylmannosamine and N-glycolylglucosamine (but not glycolate) can serve as precursors for biosynthesis of endogenous Neu5Gc.	[Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu		Pearce, Oliver/0000-0003-3953-1629	National Institutes of Health [R01GM32373, R01CA38701]; Deutsche Forschungsgemeinschaft [BE 4643/1-1]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and R01CA38701 (to A. V.). This work was also supported by Deutsche Forschungsgemeinschaft Research Fellowship BE 4643/1-1 (to A. K. B.) and a Cancer Research Institute/Samuel and Ruth Engelberg Fellowship (to O. M. T. P.). A. V. is a co-founder of and consultant for Sialix Inc., a biotech startup company interested in the practical implications of Neu5Gc uptake in humans.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; BRUNETTI P, 1962, J BIOL CHEM, V237, P2447; Bulai T, 2002, BIOCHIMIE, V84, P655, DOI 10.1016/S0300-9084(02)01436-0; CAMPBELL P, 1987, ANAL BIOCHEM, V166, P134, DOI 10.1016/0003-2697(87)90555-0; Choo A, 2006, J BIOTECHNOL, V122, P130, DOI 10.1016/j.jbiotec.2005.09.008; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; DEVINE PL, 1991, CANCER RES, V51, P5826; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Fujita A, 2007, BIOCHEM BIOPH RES CO, V355, P174, DOI 10.1016/j.bbrc.2007.01.139; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; GHOSH S, 1965, J BIOL CHEM, V240, P1531; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; HIGA HH, 1985, J BIOL CHEM, V260, P8838; HIGASHI H, 1985, CANCER RES, V45, P3796; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P614; Inoue S, 2010, GLYCOBIOLOGY, V20, P752, DOI 10.1093/glycob/cwq030; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; JOURDIAN GW, 1962, J BIOL CHEM, V237, P2442; KAWACHI S, 1988, INT ARCH ALLER A IMM, V85, P381, DOI 10.1159/000234536; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; KEAN EL, 1966, J BIOL CHEM, V241, P5643; KENT PW, 1968, BIOCHEM J, V106, P645, DOI 10.1042/bj1060645; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Koda Tetsuzo, 2003, Int J Clin Oncol, V8, P317, DOI 10.1007/s10147-003-0346-4; KOZUTSUMI Y, 1990, J BIOCHEM, V108, P704, DOI 10.1093/oxfordjournals.jbchem.a123268; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; Luchansky SJ, 2003, J BIOL CHEM, V278, P8035, DOI 10.1074/jbc.M212127200; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Matuszek M, 2001, Med Sci Monit, V7, P377; MENEZES J, 1975, BIOMEDICINE, V22, P276; MIYOSHI I, 1986, MOL IMMUNOL, V23, P631, DOI 10.1016/0161-5890(86)90100-8; Munster-Kuhnel AK, 2004, GLYCOBIOLOGY, V14, p43R, DOI 10.1093/glycob/cwh113; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; PALADINI AC, 1952, BIOCHEM J, V51, P426, DOI 10.1042/bj0510426; Pearce OMT, 2010, CARBOHYD RES, V345, P1225, DOI 10.1016/j.carres.2010.04.003; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Sampathkumar SG, 2006, NAT CHEM BIOL, V2, P149, DOI 10.1038/nchembio770; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Schauer R, 1978, Methods Enzymol, V50, P64; Schauer R, 1999, BIOSCIENCE REP, V19, P373, DOI 10.1023/A:1020256004616; Schauer R, 1996, BIOL CHEM H-S, V377, P293, DOI 10.1515/bchm3.1996.377.5.293; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; SHAW L, 1992, EUR J BIOCHEM, V206, P269, DOI 10.1111/j.1432-1033.1992.tb16925.x; SHAW L, 1994, EUR J BIOCHEM, V219, P1001, DOI 10.1111/j.1432-1033.1994.tb18583.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; SINAY P, 1971, CARBOHYD RES, V16, P113, DOI 10.1016/S0008-6215(00)86104-2; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Sommer U, 1999, GLYCOCONJUGATE J, V16, P425, DOI 10.1023/A:1007030627948; Takahashi S, 1999, J BIOCHEM-TOKYO, V125, P348, DOI 10.1093/oxfordjournals.jbchem.a022293; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; TREVELYAN WE, 1950, NATURE, V166, P444, DOI 10.1038/166444b0; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; VAMECQ J, 1992, J BIOCHEM, V111, P579, DOI 10.1093/oxfordjournals.jbchem.a123800; VAMECQ J, 1990, BIOCHEM CELL BIOL, V68, P846, DOI 10.1139/o90-125; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Watanabe M, 2006, HISTOL HISTOPATHOL, V21, P1135, DOI 10.14670/HH-21.1135; WAZER DE, 1995, P NATL ACAD SCI USA, V92, P3687, DOI 10.1073/pnas.92.9.3687; Weidanz JA, 1996, BRIT J HAEMATOL, V95, P645, DOI 10.1046/j.1365-2141.1996.d01-1955.x; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Willett W C, 2000, Oncologist, V5, P393, DOI 10.1634/theoncologist.5-5-393; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; Zhang JJ, 2005, NUTR CANCER, V53, P65, DOI 10.1207/s15327914nc5301_8	90	52	67	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28865	28881		10.1074/jbc.M112.363549	http://dx.doi.org/10.1074/jbc.M112.363549			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692205	Green Published, hybrid			2022-12-25	WOS:000308074600058
J	Lo, YH; Ho, PC; Wang, SC				Lo, Yuan-Hung; Ho, Po-Chun; Wang, Shao-Chun			Epidermal Growth Factor Receptor Protects Proliferating Cell Nuclear Antigen from Cullin 4A Protein-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL4-DDB1 UBIQUITIN LIGASE; DNA-DAMAGE; CDT1 DEGRADATION; TYROSINE PHOSPHORYLATION; MAMMALIAN-CELLS; S-PHASE; PCNA; REPLICATION; DESTRUCTION; COMPLEX	Proliferating cell nuclear antigen (PCNA) is an essential component for DNA synthesis upon growth stimulation. It has been shown that phosphorylation of PCNA at Tyr-211 by the EGF receptor (EGFR) protects PCNA from polyubiquitylation and degradation, whereas blocking phosphorylation induces ubiquitylation-mediated degradation of the chromatin-bound, but not the -unbound, PCNA, and suppresses cell proliferation. However, the ubiquitin E3 ligase linking growth signaling to the proteolysis of PCNA and the underlying regulatory mechanism remain to be identified. Here we show that, in the absence of Tyr-211 phosphorylation, PCNA is subject to polyubiquitylation at Lys-164 by the CUL4A E3 ligase, resulting in the degradation of PCNA. Mutation of Lys-164 to arginine prevents PCNA ubiquitylation and rescues the degradation of the K164R/Y211F PCNA double mutant. Activation of EGFR inhibits the interaction of PCNA with CUL4A, whereas inhibition of EGFR leads to increased CUL4A-PCNA interaction and CUL4A-dependent ubiquitin-mediated degradation of PCNA. Substitution of endogenous PCNA with the Y211F mutant PCNA conveys enhanced sensitization to EGFR inhibition. Our findings identify CUL4A as the ubiquitin ligase linking the down-regulation of cell surface receptor tyrosine kinase to the nuclear DNA replication machinery in cancer cells.	[Lo, Yuan-Hung; Ho, Po-Chun; Wang, Shao-Chun] Univ Cincinnati, Dept Canc & Cell Biol, Coll Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Wang, SC (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Coll Med, 3125 Eden Ave, Cincinnati, OH 45267 USA.	shao-chun.wang@uc.edu	Wang, Shao-Chun/P-9904-2019	Wang, Shao-Chun/0000-0002-5477-1682	Susan G. Komen Research Award [KG080540]; Department of Defense Prostate Cancer Research Award [PC073951]; Marlene Harris-Ride Cincinnati pilot grant; University of Cincinnati; Cincinnati Children's Hospital Medical Center for Clinical and Translational Science and Training (CCTST) Junior Investigator pilot grant; Public Health Service Grant [P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Susan G. Komen Research Award(Susan G. Komen Breast Cancer Foundation); Department of Defense Prostate Cancer Research Award(United States Department of Defense); Marlene Harris-Ride Cincinnati pilot grant; University of Cincinnati; Cincinnati Children's Hospital Medical Center for Clinical and Translational Science and Training (CCTST) Junior Investigator pilot grant; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Susan G. Komen Research Award KG080540, the Department of Defense Prostate Cancer Research Award PC073951, the Marlene Harris-Ride Cincinnati pilot grant, the University of Cincinnati and Cincinnati Children's Hospital Medical Center for Clinical and Translational Science and Training (CCTST) Junior Investigator pilot grant (to S.-C. W.), and Public Health Service Grant P30 DK078392.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Dai QA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-14; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Sugasawa K, 2009, MOL CELL, V34, P403, DOI 10.1016/j.molcel.2009.05.009; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	42	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27148	27157		10.1074/jbc.M112.388843	http://dx.doi.org/10.1074/jbc.M112.388843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692198	Green Published, hybrid			2022-12-25	WOS:000307386000067
J	Takeo, K; Watanabe, N; Tomita, T; Iwatsubo, T				Takeo, Koji; Watanabe, Naoto; Tomita, Taisuke; Iwatsubo, Takeshi			Contribution of the gamma-Secretase Subunits to the Formation of Catalytic Pore of Presenilin 1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN 1; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PAL MOTIF; COMPLEX; ACTIVATION; BINDING; ENDOPROTEOLYSIS	gamma-Secretase is an intramembrane-cleaving protease related to the etiology of Alzheimer disease. gamma-Secretase is a membrane protein complex composed of presenilin (PS) and three indispensable subunits: nicastrin, Aph-1, and Pen-2. PS functions as a protease subunit forming a hydrophilic catalytic pore structure within the lipid bilayer. However, it remains unclear how other subunits are involved in the pore formation. Here, we show that the hydrophilic pore adopted with an open conformation has already been formed by PS within the immature gamma-secretase complex. The binding of the subunits induces the close proximity between transmembrane domains facing the catalytic pore. We propose a model in which the gamma-secretase subunits restrict the arrangement of the transmembrane domains of PS during the formation of the functional structure of the catalytic pore.	[Tomita, Taisuke] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	Japan Society for the Promotion of Science (JSPS); Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST); Core Research for Evolutional Science and Technology of JST; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24659028, 24111511] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST); Core Research for Evolutional Science and Technology of JST; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for young scientists (S) (to T. T.) from the Japan Society for the Promotion of Science (JSPS), by the Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST) (to T. T. and T. I.), by Core Research for Evolutional Science and Technology of JST (to T. T. and T. I.), and by the Strategic Research Program for Brain Sciences "Analysis of the molecular basis of brain aging and degeneration due to failure in metabolic homeostasis and environmental stress" by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang KW, 2008, NEUROCHEM RES, V33, P1964, DOI 10.1007/s11064-008-9705-x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287	51	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25834	25843		10.1074/jbc.M111.336347	http://dx.doi.org/10.1074/jbc.M111.336347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689582	hybrid, Green Published			2022-12-25	WOS:000306916300013
J	Moon, DC; Choi, CH; Lee, SM; Lee, JH; Kim, SI; Kim, DS; Lee, JC				Moon, Dong Chan; Choi, Chul Hee; Lee, Su Man; Lee, Jung Hwa; Kim, Seung Il; Kim, Dong Sun; Lee, Je Chul			Nuclear Translocation of Acinetobacter baumannii Transposase Induces DNA Methylation of CpG Regions in the Promoters of E-cadherin Gene	PLOS ONE			English	Article							NONNEOPLASTIC GASTRIC-MUCOSA; OUTER-MEMBRANE VESICLES; NF-KAPPA-B; HELICOBACTER-PYLORI; IMMUNE-RESPONSES; EPITHELIAL-CELLS; PROTEIN; CANCER; LOCALIZATION; PROGRESSION	Nuclear targeting of bacterial proteins has emerged as a pathogenic mechanism whereby bacterial proteins induce host cell pathology. In this study, we examined nuclear targeting of Acinetobacter baumannii transposase (Tnp) and subsequent epigenetic changes in host cells. Tnp of A. baumannii ATCC 17978 possesses nuclear localization signals (NLSs), 225RKRKRK230. Transient expression of A. baumannii Tnp fused with green fluorescent protein (GFP) resulted in the nuclear localization of these proteins in COS-7 cells, whereas the truncated Tnp without NLSs fused with GFP were exclusively localized in the cytoplasm. A. baumannii Tnp was found in outer membrane vesicles, which delivered this protein to the nucleus of host cells. Nuclear expression of A. baumannii Tnp fused with GFP in A549 cells induced DNA methylation of CpG regions in the promoters of E-cadherin (CDH1) gene, whereas the cytoplasmic localization of the truncated Tnp without NLSs fused with GFP did not induce DNA methylation. DNA methylation in the promoters of E-cadherin gene induced by nuclear targeting of A. baumannii Tnp resulted in down-regulation of gene expression. In conclusion, our data show that nuclear traffic of A. baumannii Tnp induces DNA methylation of CpG regions in the promoters of E-cadherin gene, which subsequently down-regulates gene expression. This study provides a new insight into the epigenetic control of host genes by bacterial proteins.	[Moon, Dong Chan; Lee, Jung Hwa; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Choi, Chul Hee] Univ Florida, Dept Periodontol, Gainesville, FL USA; [Lee, Su Man; Kim, Dong Sun] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea	Kyungpook National University; State University System of Florida; University of Florida; Kyungpook National University; Korea Basic Science Institute (KBSI)	Moon, DC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	doskim@knu.ac.kr; leejc@knu.ac.kr		Choi, Chul Hee/0000-0003-2373-048X; Kim, Dong Sun/0000-0003-4943-0901	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0016456]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0016456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bobetsis YA, 2007, J DENT RES, V86, P169, DOI 10.1177/154405910708600212; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Izaurralde E, 1998, RNA, V4, P351; Jacob S, 2002, BIOCHIMIE, V84, P27, DOI 10.1016/S0300-9084(01)01362-1; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kaise M, 2008, HELICOBACTER, V13, P35, DOI 10.1111/j.1523-5378.2008.00572.x; Kerr KM, 2007, DIS MARKERS, V23, P5, DOI 10.1155/2007/985474; Kim DS, 2007, CANCER-AM CANCER SOC, V110, P2785, DOI 10.1002/cncr.23113; Kim DS, 2007, LUNG CANCER, V58, P1, DOI 10.1016/j.lungcan.2007.04.008; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2009, J MICROBIOL, V47, P641, DOI 10.1007/s12275-009-0217-4; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Moon DC, 2012, RES MICROBIOL, V163, P279, DOI 10.1016/j.resmic.2012.02.001; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Nardone G, 2007, DIGEST DIS, V25, P225, DOI 10.1159/000103890; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SEIFERT H, 1995, MEDICINE, V74, P340, DOI 10.1097/00005792-199511000-00004; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38974	10.1371/journal.pone.0038974	http://dx.doi.org/10.1371/journal.pone.0038974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685614	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700078
J	Fountzilas, G; Dafni, U; Bobos, M; Batistatou, A; Kotoula, V; Trihia, H; Malamou-Mitsi, V; Miliaras, S; Chrisafi, S; Papadopoulos, S; Sotiropoulou, M; Filippidis, T; Gogas, H; Koletsa, T; Bafaloukos, D; Televantou, D; Kalogeras, KT; Pectasides, D; Skarlos, DV; Koutras, A; Dimopoulos, MA				Fountzilas, George; Dafni, Urania; Bobos, Mattheos; Batistatou, Anna; Kotoula, Vassiliki; Trihia, Helen; Malamou-Mitsi, Vassiliki; Miliaras, Spyros; Chrisafi, Sofia; Papadopoulos, Savvas; Sotiropoulou, Maria; Filippidis, Theodoros; Gogas, Helen; Koletsa, Triantafyllia; Bafaloukos, Dimitrios; Televantou, Despina; Kalogeras, Konstantine T.; Pectasides, Dimitrios; Skarlos, Dimosthenis V.; Koutras, Angelos; Dimopoulos, Meletios A.			Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel	PLOS ONE			English	Article							RANDOMIZED PHASE-III; DENSE SEQUENTIAL CHEMOTHERAPY; PROTEIN EXPRESSION; NEOADJUVANT CHEMOTHERAPY; TISSUE MICROARRAYS; PROGNOSTIC VALUE; DOCETAXEL; RISK; EPIRUBICIN; SURVIVAL	Background: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes defined by immunohistochemistry (IHC). Materials and Methods: Formalin-fixed paraffin-embedded (FFPE) tumor tissue samples from 1,039 patients participating in two adjuvant dose-dense sequential chemotherapy phase III trials were centrally assessed in tissue micro-arrays by IHC for 6 biological markers, that is, estrogen receptor (ER), progesterone receptor (PgR), HER2, Ki67, cytokeratin 5 (CK5), and EGFR. The majority of the cases were further evaluated for HER2 amplification by FISH. Patients were classified as: luminal A (ER/PgR-positive, HER2-negative, Ki67(low)); luminal B (ER/PgR-positive, HER2-negative, Ki67(high)); luminal-HER2 (ER/PgR-positive, HER2-positive); HER2-enriched (ER-negative, PgR-negative, HER2-positive); triple-negative (TNBC) (ER-negative, PgR-negative, HER2-negative); and basal core phenotype (BCP) (TNBC, CK5-positive and/or EGFR-positive). Results: After a median follow-up time of 105.4 months the 5-year disease-free survival (DFS) and overall survival (OS) rates were 73.1% and 86.1%, respectively. Among patients with HER2-enriched tumors there was a significant benefit in both DFS and OS (log-rank test; p = 0.021 and p = 0.006, respectively) for those treated with paclitaxel. The subtype classification was found to be of both predictive and prognostic value. Setting luminal A as the referent category, the adjusted for prognostic factors HR for relapse for patients with TNBC was 1.91 (95% CI: 1.31-2.80, Wald's p = 0.001) and for death 2.53 (95% CI: 1.62-3.60, p, 0.001). Site of and time to first relapse differed according to subtype. Locoregional relapses and brain metastases were more frequent in patients with TNBC, while liver metastases were more often seen in patients with HER2-enriched tumors. Conclusions: Triple-negative phenotype is of adverse prognostic value for DFS and OS in patients treated with adjuvant dose-dense sequential chemotherapy. In the pre-trastuzumab era, the HER2-enriched subtype predicts favorable outcome following paclitaxel-containing treatment.	[Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Dafni, Urania] Univ Athens, Sch Nursing, Lab Biostat, Athens, Greece; [Bobos, Mattheos; Chrisafi, Sofia; Televantou, Despina] Aristotle Univ Thessaloniki, Mol Oncol Lab, Hellen Fdn Canc Res, Sch Med, GR-54006 Thessaloniki, Greece; [Batistatou, Anna; Malamou-Mitsi, Vassiliki] Ioannina Univ Hosp, Dept Pathol, Ioannina, Greece; [Kotoula, Vassiliki; Koletsa, Triantafyllia] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Trihia, Helen] Metaxas Canc Hosp, Dept Pathol, Piraeus, Greece; [Miliaras, Spyros] Aristotle Univ Thessaloniki, Sch Med, Dept Surg 1, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Papadopoulos, Savvas] Hygeia Hosp, Dept Pathol, Athens, Greece; [Sotiropoulou, Maria] Alexandra Hosp, Dept Pathol, Athens, Greece; [Filippidis, Theodoros] Micromed Histopathol Lab, Athens, Greece; [Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, Laiko Gen Hosp, GR-11527 Athens, Greece; [Bafaloukos, Dimitrios] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece; [Kalogeras, Konstantine T.] Data Off, Hellen Cooperat Oncol Grp, Translat Res Sect, Athens, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Skarlos, Dimosthenis V.] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Koutras, Angelos] Univ Patras, Sch Med, Univ Hosp, Div Oncol,Dept Med, GR-26110 Patras, Greece; [Dimopoulos, Meletios A.] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece	Aristotle University of Thessaloniki; Papageorgiou Hospital; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University Hospital Ioannina; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Papageorgiou Hospital; Hygeia Hospital; Alexandra Hospital; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Hellenic Cooperative Oncology Group; Hippokration General Hospital; University of Patras; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens	Fountzilas, G (corresponding author), Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece.	fountzil@auth.gr	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Fountzilas, George/ABF-2139-2020; Chrisafi, Sofia/AAH-2823-2020; Dafni, Ourania/AAH-4453-2019; Bobos, Mattheos/L-5702-2019	Dafni, Ourania/0000-0003-4367-4497; Bobos, Mattheos/0000-0001-5662-9201; Dimopoulos, Meletios/0000-0001-8990-3254; `miliaras, spiros/0000-0003-4983-6821; Koletsa, Triantafyllia/0000-0002-4435-3532; Fountzilas, George/0000-0001-8045-2186	internal Hellenic Cooperative Oncology Group (HeCOG) [HE R_10/10]	internal Hellenic Cooperative Oncology Group (HeCOG)	This work has been supported by an internal Hellenic Cooperative Oncology Group (HeCOG) grant (HE R_10/10), allocated to the conduct of this work. The Hellenic Cooperative Oncology Group was therefore directly involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Bedard PL, 2010, NAT REV CLIN ONCOL, V7, P22, DOI 10.1038/nrclinonc.2009.186; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Citron ML, 2004, CANCER INVEST, V22, P555, DOI 10.1081/CNV-200027134; Coombes RC, 2011, J CLIN ONCOL, V29, P3247, DOI 10.1200/JCO.2010.32.7254; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; Diallo-Danebrock R, 2007, CLIN CANCER RES, V13, P488, DOI 10.1158/1078-0432.CCR-06-1842; Eiermann W, 2011, J CLIN ONCOL, V29, P3877, DOI 10.1200/JCO.2010.28.5437; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fountzilas G, 2000, CANCER INVEST, V18, P503, DOI 10.3109/07357900009012188; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 1997, EUR J CANCER, V33, P1893, DOI 10.1016/S0959-8049(97)00217-7; GIANNI L, 1995, J NATL CANCER I, V87, P1169, DOI 10.1093/jnci/87.15.1169; Gianni L, 2009, J CLIN ONCOL, V27, P4798, DOI 10.1200/JCO.2008.21.4791; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Iwata H, 2011, JPN J CLIN ONCOL, V41, P867, DOI 10.1093/jjco/hyr081; Jacquemier J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3051; Jacquin JP, 2012, BREAST CANCER RES TR, V134, P903, DOI 10.1007/s10549-011-1933-0; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KALLIONIEMI OP, 1991, INT J CANCER, V49, P650, DOI 10.1002/ijc.2910490504; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kosmidis PA, 2011, ANN ONCOL, V22, P827, DOI 10.1093/annonc/mdq445; Kostopoulos I, 2006, BREAST CANCER RES TR, V96, P251, DOI 10.1007/s10549-005-9062-2; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Martin M, 2010, BREAST CANCER RES TR, V123, P149, DOI 10.1007/s10549-009-0663-z; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Norton L, 2001, ONCOLOGIST, V6, P30; O'Shaughnessy J, 2002, ONCOLOGIST, V7, P4; Orzano Jennifer A, 2005, Clin Breast Cancer, V6, P402, DOI 10.3816/CBC.2005.n.044; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pestalozzi BC, 2006, ANN ONCOL, V17, P935, DOI 10.1093/annonc/mdl064; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Qin YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026946; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Schippinger W, 2007, AM J CLIN PATHOL, V128, P630, DOI 10.1309/51KPD70348RP6XTE; Seidman AD, 2005, CANCER CHEMOTH PHARM, V56, pS78, DOI 10.1007/s00280-005-0109-1; Sihto H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2944; Skacel M, 2002, APPL IMMUNOHISTO M M, V10, P1, DOI 10.1097/00022744-200203000-00001; Skarlos P, 2012, CANCER CHEMOTH PHARM, V69, P533, DOI 10.1007/s00280-011-1730-9; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zauderer M, 2009, BREAST CANCER RES TR, V117, P205, DOI 10.1007/s10549-008-0116-0	56	53	55	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37946	10.1371/journal.pone.0037946	http://dx.doi.org/10.1371/journal.pone.0037946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679488	Green Published, gold			2022-12-25	WOS:000305343900015
J	Wei, K; Gao, SL; Zhong, SC; Ma, H				Wei, Kun; Gao, Shilong; Zhong, Suchuan; Ma, Hong			Fractional Dynamics of Globally Slow Transcription and Its Impact on Deterministic Genetic Oscillation	PLOS ONE			English	Article							TIME; EQUATION; MODELS; MEMORY; END	In dynamical systems theory, a system which can be described by differential equations is called a continuous dynamical system. In studies on genetic oscillation, most deterministic models at early stage are usually built on ordinary differential equations (ODE). Therefore, gene transcription which is a vital part in genetic oscillation is presupposed to be a continuous dynamical system by default. However, recent studies argued that discontinuous transcription might be more common than continuous transcription. In this paper, by appending the inserted silent interval lying between two neighboring transcriptional events to the end of the preceding event, we established that the running time for an intact transcriptional event increases and gene transcription thus shows slow dynamics. By globally replacing the original time increment for each state increment by a larger one, we introduced fractional differential equations (FDE) to describe such globally slow transcription. The impact of fractionization on genetic oscillation was then studied in two early stage models - the Goodwin oscillator and the Rossler oscillator. By constructing a "dual memory" oscillator - the fractional delay Goodwin oscillator, we suggested that four general requirements for generating genetic oscillation should be revised to be negative feedback, sufficient nonlinearity, sufficient memory and proper balancing of timescale. The numerical study of the fractional Rossler oscillator implied that the globally slow transcription tends to lower the chance of a coupled or more complex nonlinear genetic oscillatory system behaving chaotically.	[Wei, Kun; Gao, Shilong; Zhong, Suchuan; Ma, Hong] Sichuan Univ, Coll Math, Chengdu, Sichuan, Peoples R China; [Wei, Kun] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wei, K (corresponding author), Sichuan Univ, Coll Math, Chengdu, Sichuan, Peoples R China.	kunwei@ymail.com; mahong@scu.edu.cn		Zhong, Suchuan/0000-0002-2798-3700	China Postdoctoral Science Foundation	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research is funded by China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulier F, 2007, LECT NOTES COMPUT SC, V4545, P66; Brickner JH, 2010, CURR BIOL, V20, pR20, DOI 10.1016/j.cub.2009.11.013; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Jolma IW, 2010, WIRES SYST BIOL MED, V2, P533, DOI 10.1002/wsbm.81; Jumarie G, 2009, NONLINEAR ANAL-MODEL, V14, P177, DOI 10.15388/NA.2009.14.2.14520; Jumarie G, 2007, PHYS LETT A, V363, P5, DOI 10.1016/j.physleta.2006.10.085; Jumarie G, 2006, MATH COMPUT MODEL, V44, P231, DOI 10.1016/j.mcm.2005.10.003; Khan S, 2005, PHYSICA A, V350, P183, DOI 10.1016/j.physa.2004.11.067; Kilbas AA, 2006, THEORY APPL FRACTION, P96; Kim HS, 1999, PHYSICA D, V127, P48, DOI 10.1016/S0167-2789(98)00240-1; Kugiumtzis D, 1996, PHYSICA D, V95, P13, DOI 10.1016/0167-2789(96)00054-1; LI TY, 1975, AM MATH MON, V82, P985, DOI 10.2307/2318254; MACDONALD N, 1977, J THEOR BIOL, V67, P549, DOI 10.1016/0022-5193(77)90056-X; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Monje CA, 2010, ADV IND CONTROL, P3, DOI 10.1007/978-1-84996-335-0; Morant PE, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068104; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oustaloup A, 2000, IEEE T CIRCUITS-I, V47, P25, DOI 10.1109/81.817385; Podlubny I., 1999, FRACTIONAL DIFFERENT; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; ROSSLER OE, 1977, B MATH BIOL, V39, P275, DOI 10.1016/S0092-8240(77)80015-3; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Sharkovsky A. N., 1964, UKR MAT ZH, V16, P61; Sokolov IM, 2002, PHYS TODAY, V55, P48, DOI 10.1063/1.1535007; Suter DM, 2011, CURR OPIN CELL BIOL, V23, P657, DOI 10.1016/j.ceb.2011.09.004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tenreiro Machado J., 2010, FRACT CALC APPL ANAL, V13, P447; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Xue D, 2007, ADV DES CONTROL, P1, DOI 10.1137/1.9780898718621; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38383	10.1371/journal.pone.0038383	http://dx.doi.org/10.1371/journal.pone.0038383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679500	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900033
J	Chen, HT; Tsou, HK; Chang, CH; Tang, CH				Chen, Hsien-Te; Tsou, Hsi-Kai; Chang, Chia-Hao; Tang, Chih-Hsin			Hepatocyte Growth Factor Increases Osteopontin Expression in Human Osteoblasts through PI3K, Akt, c-Src, and AP-1 Signaling Pathway	PLOS ONE			English	Article							PARTIAL-PURIFICATION; GENE-EXPRESSION; CELLS; ACTIVATION; KINASE; SURVIVAL; BONE; DIFFERENTIATION; ASSOCIATION; FIBROBLAST	Background: Hepatocyte growth factor (HGF) has been demonstrated to stimulate osteoblast proliferation and participated bone remodeling. Osteopontin (OPN) is a secreted phosphoglycoprotein that belongs to the SIBLING family and is present during bone mineralization. However, the effects of HGF on OPN expression in human osteoblasts are large unknown. Methodology/Principal Findings: Here we found that HGF induced OPN expression in human osteoblasts dose-dependently. HGF-mediated OPN production was attenuated by c-Met inhibitor and siRNA. Pretreatment of osteoblasts with PI3K inhibitor (Ly294002), Akt inhibitor, c-Src inhibitor (PP2), or AP-1 inhibitor (curcumin) blocked the potentiating action of HGF. Stimulation of osteoblasts with HGF enhanced PI3K, Akt, and c-Src activation. In addition, incubation of cells with HGF also increased c-Jun phosphorylation, AP-1-luciferase activity, and c-Jun binding to the AP-1 element on the OPN promoter. HGF-mediated AP-1-luciferase activity and c-Jun binding to the AP-1 element was reduced by c-Met inhibitor, Ly294002, Akt inhibitor, and PP2. Conclusions/Significance: Our results suggest that the interaction between HGF and c-Met increases OPN expression in human osteoblasts via the PI3K, Akt, c-Src, c-Jun, and AP-1 signaling pathway.	[Chen, Hsien-Te] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Hsien-Te] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Chen, Hsien-Te; Tsou, Hsi-Kai] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan; [Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Ctr Gen Educ, Miaoli Cty, Taiwan; [Chang, Chia-Hao] Chang Hwa Hosp, Dept Orthoped Surg, Dept Hlth Execut Yuan, Chang Hwa Cty, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Feng Chia University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan	Chen, HT (corresponding author), China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3, NSC100-2320-B-039-032]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; NSC100-2320-B-039-028-MY3; NSC100-2320-B-039-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barizzone N, 2011, HUM IMMUNOL, V72, P930, DOI 10.1016/j.humimm.2011.06.009; Buitenhuis M, 2011, CURR OPIN HEMATOL, V18, P226, DOI 10.1097/MOH.0b013e32834760e5; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Grotegut S, 2010, INT J ONCOL, V36, P1261, DOI 10.3892/ijo_00000610; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jiang WG, 1997, HISTOL HISTOPATHOL, V12, P537; Jin W, 2008, J BIOL CHEM, V283, P1391, DOI 10.1074/jbc.M705052200; Lane NE, 2003, ARTHRITIS RES THER, V5, P214, DOI 10.1186/ar797; LUETTEKE NC, 1985, CANCER RES, V45, P6331; Mahtouk K, 2010, BBA-REV CANCER, V1806, P208, DOI 10.1016/j.bbcan.2010.07.006; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nakayama H, 2011, HYPERTENS RES, V34, P1141, DOI 10.1038/hr.2011.102; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Taichman RS, 2001, BRIT J HAEMATOL, V112, P438, DOI 10.1046/j.1365-2141.2001.02568.x; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200	32	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38378	10.1371/journal.pone.0038378	http://dx.doi.org/10.1371/journal.pone.0038378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675553	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700067
J	Chen, JW; Scaria, J; Chang, YF				Chen, Jenn-Wei; Scaria, Joy; Chang, Yung-Fu			Phenotypic and Transcriptomic Response of Auxotrophic Mycobacterium avium Subsp paratuberculosis leuD Mutant under Environmental Stress	PLOS ONE			English	Article							IMMUNE-RESPONSES; HIGH-THROUGHPUT; BIOCHEMICAL CHARACTERISTICS; RECOMBINANT ANTIGENS; ALLELIC EXCHANGE; IN-VITRO; TUBERCULOSIS; ENVELOPE; VIRULENCE; BACTERIUM	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of severe gastroenteritis in cattle. To gain a better understanding of MAP virulence, we investigated the role of leuD gene in MAP metabolism and stress response. For this, we have constructed an auxotrophic strain of MAP by deleting the leuD gene using allelic exchange. The wildtype and mutant strains were then compared for metabolic phenotypic changes using Biolog phenotype microarrays. The responses of both strains to physiologically relevant stress conditions were assessed using DNA microarrays. Transcriptomic data was then analyzed in the context of cellular metabolic pathways and gene networks. Our results showed that deletion of leuD gene has a global effect on both MAP phenotypic and transcriptome response. At the metabolic level, the mutant strain lost the ability to utilize most of the carbon, nitrogen, sulphur, phosphorus and nutrient supplements as energy source. At the transcriptome level, more than 100 genes were differentially expressed in each of the stress condition tested. Systems level network analysis revealed that the differentially expressed genes were distributed throughout the gene network, thus explaining the global impact of leuD deletion in metabolic phenotype. Further, we find that leuD deletion impacted metabolic pathways associated with fatty acids. We verified this by experimentally estimating the total fatty acid content of both mutant and wildtype. The mutant strain had 30% less fatty acid content when compared to wildtype, thus supporting the results from transcriptional and computational analyses. Our results therefore reveal the intricate connection between the metabolism and virulence in MAP.	[Chen, Jenn-Wei; Scaria, Joy; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Chen, JW (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu		Scaria, Joy/0000-0002-5299-8074	Biotechnology Research and Development Corporation (BRDC); NYS Department of Agriculture and Markets; USDA-APHIS; National Research Initiative (NRI) of the USDA Cooperative State Research, Education and Extension Service [2008-35204-04626]; Agriculture and Food Research Initiative (AFRI) of the USDA Cooperative State Research, Education and Extension Service [2009-65119-05993]; Animal Formula Fund [NY-478455]	Biotechnology Research and Development Corporation (BRDC); NYS Department of Agriculture and Markets; USDA-APHIS(United States Department of Agriculture (USDA)); National Research Initiative (NRI) of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Agriculture and Food Research Initiative (AFRI) of the USDA Cooperative State Research, Education and Extension Service; Animal Formula Fund	This work was supported by the Biotechnology Research and Development Corporation (BRDC), a contract through a cooperative agreement between the NYS Department of Agriculture and Markets, the USDA-APHIS, the National Research Initiative (NRI) of the USDA Cooperative State Research, Education and Extension Service (2008-35204-04626), the Agriculture and Food Research Initiative (AFRI) of the USDA Cooperative State Research, Education and Extension Service (2009-65119-05993) and the Animal Formula Fund (NY-478455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr MA, 2008, CURR OPIN GASTROEN, V24, P17, DOI 10.1097/MOG.0b013e3282f1dcc4; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Bull TJ, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-25; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Cavaignac SM, 2000, ARCH MICROBIOL, V173, P229, DOI 10.1007/s002039900132; Chen JW, 2011, VACCINE; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; CHIODINI RJ, 1986, AM J VET RES, V47, P1442; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Grant IR, 2002, APPL ENVIRON MICROB, V68, P2428, DOI 10.1128/AEM.68.5.2428-2435.2002; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hayashi D, 2010, FEMS MICROBIOL LETT, V306, P103, DOI 10.1111/j.1574-6968.2010.01947.x; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; IZUMORI K, 1976, J BACTERIOL, V128, P587, DOI 10.1128/JB.128.2.587-591.1976; Janagama HK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-561; Janagama HK, 2009, MICROBIOL-SGM, V155, P3683, DOI 10.1099/mic.0.031948-0; Johnson DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000211; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kathaperumal K, 2009, VACCINE, V27, P123, DOI 10.1016/j.vaccine.2008.10.019; Kathaperumal K, 2008, VACCINE, V26, P1652, DOI 10.1016/j.vaccine.2008.01.015; Khare S, 2007, VACCINE, V25, P1743, DOI 10.1016/j.vaccine.2006.11.036; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MILLS JA, 1994, J BACTERIOL, V176, P4803, DOI 10.1128/jb.176.16.4803-4808.1994; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Otero J, 2003, APPL ENVIRON MICROB, V69, P5039, DOI 10.1128/AEM.69.9.5039-5044.2003; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Panas P, 2007, J APPL MICROBIOL, V103, P237, DOI 10.1111/j.1365-2672.2006.03213.x; Park KT, 2008, APPL ENVIRON MICROB, V74, P1687, DOI 10.1128/AEM.01208-07; Park SU, 2008, VACCINE, V26, P4329, DOI 10.1016/j.vaccine.2008.06.016; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rodriguez-Rojas A, 2009, J BACTERIOL, V191, P844, DOI 10.1128/JB.01081-08; Scandurra GM, 2010, INFECT IMMUN, V78, P1383, DOI 10.1128/IAI.01020-09; Shin SJ, 2005, INFECT IMMUN, V73, P5074, DOI 10.1128/IAI.73.8.5074-5085.2005; SLIJKHUIS H, 1984, J GEN MICROBIOL, V130, P2035; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang C, 2011, J LIPIDS, V2011, DOI 10.1155/2011/676535; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Wu CW, 2007, J BACTERIOL, V189, P7877, DOI 10.1128/JB.00780-07; YAMORI S, 1991, MICROBIOL IMMUNOL, V35, P921, DOI 10.1111/j.1348-0421.1991.tb02031.x; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37884	10.1371/journal.pone.0037884	http://dx.doi.org/10.1371/journal.pone.0037884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675497	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700026
J	Oberthuer, D; Melero-Garcia, E; Dierks, K; Meyer, A; Betzel, C; Garcia-Caballero, A; Gavira, JA				Oberthuer, Dominik; Melero-Garcia, Emilio; Dierks, Karsten; Meyer, Arne; Betzel, Christian; Garcia-Caballero, Alfonso; Gavira, Jose A.			Monitoring and Scoring Counter-Diffusion Protein Crystallization Experiments in Capillaries by in situ Dynamic Light Scattering	PLOS ONE			English	Article							GLUCOSE-ISOMERASE; CRYSTAL-GROWTH; POLYHEDRAL INSTABILITY; VAPOR DIFFUSION; NUCLEATION; MICROGRAVITY; AGGREGATION; KINETICS	In this paper, we demonstrate the feasibility of using in situ Dynamic Light Scattering (DLS) to monitor counter-diffusion crystallization experiments in capillaries. Firstly, we have validated the quality of the DLS signal in thin capillaries, which is comparable to that obtained in standard quartz cuvettes. Then, we have carried out DLS measurements of a counter-diffusion crystallization experiment of glucose isomerase in capillaries of different diameters (0.1, 0.2 and 0.3 mm) in order to follow the temporal evolution of protein supersaturation. Finally, we have compared DLS data with optical recordings of the progression of the crystallization front and with a simulation model of counter-diffusion in 1D.	[Oberthuer, Dominik; Betzel, Christian] Univ Hamburg, Lab Struct Biol Infect & inflammat, Inst Biochem & Mol Biol, Hamburg, Germany; [Melero-Garcia, Emilio; Garcia-Caballero, Alfonso; Gavira, Jose A.] Univ Granada, Consejo Super Invest Cient, IACT, Lab Estudios Cristalog, Granada, Spain; [Dierks, Karsten; Meyer, Arne] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Lubeck, Germany	University of Hamburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; University of Lubeck	Oberthuer, D (corresponding author), Univ Hamburg, Lab Struct Biol Infect & inflammat, Inst Biochem & Mol Biol, Hamburg, Germany.	gavi@lec.csic.es	Betzel, Christian/G-8105-2018; Gavira, Jose A./C-2491-2009; Caballero, Alfonso Garcia/D-2463-2011; Oberthuer, Dominik/AAG-5059-2021	Betzel, Christian/0000-0002-3879-5019; Gavira, Jose A./0000-0002-7386-6484; Caballero, Alfonso Garcia/0000-0002-7217-0266; Oberthuer, Dominik/0000-0002-0894-9590	EU [LSHG-CT-2006-037793, 037793]; Deutsche Luft und Raumfahrtagentur, DLR [50WB1017]; "Factoria de Cristalizacion" of the Ministerio de Innovacion y Ciencia (MICINN) of Spain;  [BIO2010-16800]	EU(European Commission); Deutsche Luft und Raumfahrtagentur, DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); "Factoria de Cristalizacion" of the Ministerio de Innovacion y Ciencia (MICINN) of Spain; 	This work has been financed by the EU via the OptiCryst Project, LSHG-CT-2006-037793 (Contract No. 037793) and partially by a grant 50WB1017 of the Deutsche Luft und Raumfahrtagentur, DLR; the "Factoria de Cristalizacion" of the Ministerio de Innovacion y Ciencia (MICINN) of Spain and project BIO2010-16800 (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN ET, 1986, BIOPHYS J, V49, P47, DOI 10.1016/S0006-3495(86)83587-1; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Brown W., 1993, DYNAMIC LIGHT SCATTE; Cardinaux F, 2011, J PHYS CHEM B, V115, P7227, DOI 10.1021/jp112180p; CARRELL HL, 1989, P NATL ACAD SCI USA, V86, P4440, DOI 10.1073/pnas.86.12.4440; CASAY GA, 1992, J CRYST GROWTH, V122, P95, DOI 10.1016/0022-0248(92)90231-7; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Curtis RA, 1998, BIOTECHNOL BIOENG, V57, P11, DOI 10.1002/(SICI)1097-0290(19980105)57:1<11::AID-BIT2>3.0.CO;2-Y; Dierks K, 2008, CRYST GROWTH DES, V8, P1628, DOI 10.1021/cg701067r; Ducruix A., 1992, CRYSTALLIZATION NUCL; FERREDAMARE AR, 1994, STRUCTURE, V2, P357, DOI 10.1016/S0969-2126(00)00037-X; FerreDAmare AR, 1997, METHOD ENZYMOL, V276, P157, DOI 10.1016/S0076-6879(97)76056-7; Forsythe EL, 2002, ACTA CRYSTALLOGR D, V58, P1601, DOI 10.1107/S0907444902014208; Garcia-Ruiz JM, 2003, METHOD ENZYMOL, V368, P130, DOI 10.1016/S0076-6879(03)68008-0; Garcia-Ruiz JM, 2003, J STRUCT BIOL, V142, P22, DOI 10.1016/S1047-8477(03)00035-2; Garcia-Ruiz JM, 2001, J CRYST GROWTH, V232, P149, DOI 10.1016/S0022-0248(01)01144-7; Garcia-Ruiz JM, 1999, J CRYST GROWTH, V196, P703, DOI 10.1016/S0022-0248(98)00851-3; GEORGALIS Y, 1995, ADV COLLOID INTERFAC, V58, P57, DOI 10.1016/0001-8686(95)00244-K; Gliko O, 2007, J PHYS CHEM B, V111, P3106, DOI 10.1021/jp068827o; Gonzalez-Ramirez LA, 2008, CRYST GROWTH DES, V8, P4324, DOI 10.1021/cg800788e; HAMPEL A, 1968, SCIENCE, V162, P1384, DOI 10.1126/science.162.3860.1384; KADIMA W, 1990, BIOPHYS J, V57, P125, DOI 10.1016/S0006-3495(90)82513-3; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; MALKIN A, 1994, ACTA CRYSTALLOGR D, V50, P385, DOI 10.1107/S0907444993013319; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; MIKOL V, 1989, FEBS LETT, V258, P63, DOI 10.1016/0014-5793(89)81616-3; Ng JD, 2003, J STRUCT BIOL, V142, P218, DOI 10.1016/S1047-8477(03)00052-2; Otalora F, 1996, J CRYST GROWTH, V169, P361, DOI 10.1016/S0022-0248(96)00394-6; Otalora F, 1997, J CRYST GROWTH, V182, P141, DOI 10.1016/S0022-0248(97)00325-4; Otalora F, 2009, PROG BIOPHYS MOL BIO, V101, P26, DOI 10.1016/j.pbiomolbio.2009.12.004; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Rosenberger F, 1996, J CRYST GROWTH, V168, P1, DOI 10.1016/0022-0248(96)00358-2; Rupp B, 2010, BIOMOLECULAR CRYSTALLOGRAPHY: PRINCIPLES, PRACTICE, AND APPLICATION TO STRUCTURAL BIOLOGY, P1; SALEMME FR, 1972, ARCH BIOCHEM BIOPHYS, V151, P533, DOI 10.1016/0003-9861(72)90530-9; Sleutel M, 2009, CRYST GROWTH DES, V9, P497, DOI 10.1021/cg800756h; Sleutel M, 2009, CRYST GROWTH DES, V9, P335, DOI 10.1021/cg800728x; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Streets AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178102; Van Driessche AES, 2009, J CRYST GROWTH, V311, P3479, DOI 10.1016/j.jcrysgro.2009.04.023; Vekilov PG, 2010, CRYST GROWTH DES, V10, P5007, DOI 10.1021/cg1011633; Visuri K, 1999, BIOTECHNOL BIOENG, V64, P377, DOI 10.1002/(SICI)1097-0290(19990805)64:3<377::AID-BIT15>3.0.CO;2-C; Vivares D, 2007, CRYST GROWTH DES, V7, P1411, DOI 10.1021/cg060787q; Wessel T, 1998, P SOC PHOTO-OPT INS, V3199, P299, DOI 10.1117/12.301121; WILSON W W, 1990, Methods (Orlando), V1, P110, DOI 10.1016/S1046-2023(05)80154-9; Wilson WW, 2003, J STRUCT BIOL, V142, P56, DOI 10.1016/S1047-8477(03)00038-8; WISHAW BF, 1954, J AM CHEM SOC, V76, P2065, DOI 10.1021/ja01637a011; Yadav S, 2011, ANAL BIOCHEM, V411, P292, DOI 10.1016/j.ab.2010.12.014; Zhang J, 2003, J CHEM PHYS, V119, P10972, DOI 10.1063/1.1622380	48	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e33545	10.1371/journal.pone.0033545	http://dx.doi.org/10.1371/journal.pone.0033545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675464	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341700001
J	Alvar, J; Velez, ID; Bern, C; Herrero, M; Desjeux, P; Cano, J; Jannin, J; den Boer, M				Alvar, Jorge; Velez, Ivan D.; Bern, Caryn; Herrero, Merce; Desjeux, Philippe; Cano, Jorge; Jannin, Jean; den Boer, Margriet		WHO Leishmaniasis Control Team	Leishmaniasis Worldwide and Global Estimates of Its Incidence	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; PASSIVE CASE DETECTION; VISCERAL LEISHMANIASIS; CUTANEOUS-LEISHMANIASIS; KALA-AZAR; HEALTH; INFECTION; BURDEN; SUDAN; CONSEQUENCES	As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.	[Alvar, Jorge; Velez, Ivan D.; Jannin, Jean; den Boer, Margriet] WHO, Leishmaniasis Control Program, Dept Control Neglected Trop Dis HTM NTD IDM, CH-1211 Geneva, Switzerland; [Velez, Ivan D.] Univ Antioquia, PECET, Medellin, Colombia; [Bern, Caryn] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Natl Ctr Global Hlth, Atlanta, GA USA; [Herrero, Merce] WHO, Dis Prevent Programme, Addis Ababa, Ethiopia; [Herrero, Merce] WHO, Dis Control Programme, Addis Ababa, Ethiopia; [Desjeux, Philippe] Inst OneWorldHlth, San Francisco, CA USA; [Cano, Jorge] Inst Salud Carlos III, Natl Ctr Trop Med & Int Hlth, Madrid, Spain	World Health Organization; Universidad de Antioquia; Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; Instituto de Salud Carlos III	Alvar, J (corresponding author), WHO, Leishmaniasis Control Program, Dept Control Neglected Trop Dis HTM NTD IDM, CH-1211 Geneva, Switzerland.	alvarj@who.int	Cano, Jorge/AAV-6392-2020; Oliveira, Fabiano/B-4251-2009; Cano, Jorge/E-2962-2016	Cano, Jorge/0000-0001-9864-5058; Oliveira, Fabiano/0000-0002-7924-8038; Cano, Jorge/0000-0001-9864-5058				AbouZahr C, 2000, B WORLD HEALTH ORGAN, V78, P655; Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; [Anonymous], 2011, WHO STAT INF SYST; [Anonymous], GLOB BURD DIS INJ RI; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Ashford R.W., 1987, BIOL LEISHMANIASES B, V1, P366; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Cattand P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P451; Chicharro C, 2003, ANN TROP MED PARASIT, V97, P75, DOI 10.1179/000349803225002552; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Collin SM, 2006, TROP MED INT HEALTH, V11, P509, DOI 10.1111/j.1365-3156.2006.01589.x; Conteh L, 2010, LANCET, V375, P239, DOI 10.1016/S0140-6736(09)61422-7; COPELAND HW, 1990, AM J TROP MED HYG, V43, P257, DOI 10.4269/ajtmh.1990.43.257; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 1991, WHO LEISH, V30, P47; Hirve S, 2010, AM J TROP MED HYG, V83, P507, DOI 10.4269/ajtmh.2010.09-0685; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Kumar R, 1999, B WORLD HEALTH ORGAN, V77, P371; le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mosleh IM, 2008, TROP MED INT HEALTH, V13, P855, DOI 10.1111/j.1365-3156.2008.02063.x; Narain JP, 2010, B WORLD HEALTH ORGAN, V88, P206, DOI 10.2471/BLT.09.072322; NERONOV VM, 1987, FOLIA PARASIT, V34, P1; Reithinger R, 2003, EMERG INFECT DIS, V9, P727; Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI [10.1590/S0021-75572005000100014, 10.2223/JPED.1286]; Rose K, 2004, INT J PARASITOL, V34, P655, DOI 10.1016/j.ijpara.2004.03.001; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Sen Gupta P. C., 1947, Indian Medical Gazette, V82, P281; Shaw J, 1987, LEISHMANIASIS BIOL M, P292; Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; United Nations Development Programme, 2011, HUM DEV REP; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2022, GLOB BURD DIS 2004 U; World Bank, 1993, INV HLTH WORLD DEV R; World Health Assembly, 2007, WORLD HLTH ASS RES W; Yadon ZE, 2001, AM J TROP MED HYG, V65, P27, DOI 10.4269/ajtmh.2001.65.27; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	49	3285	3407	4	297	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35671	10.1371/journal.pone.0035671	http://dx.doi.org/10.1371/journal.pone.0035671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693548	Green Accepted, gold, Green Published			2022-12-25	WOS:000305338500009
J	Brophy, S; Rees, A; Knox, G; Baker, J; Thomas, NE				Brophy, Sinead; Rees, Anwen; Knox, Gareth; Baker, Julien; Thomas, Non E.			Child Fitness and Father's BMI Are Important Factors in Childhood Obesity: A School Based Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; RISK-FACTORS; METABOLIC SYNDROME; WEIGHT-GAIN; INVOLVEMENT; HEALTH; ASSOCIATION; ADOLESCENTS; PREVALENCE	Background: This study examines obesity and factors associated with obesity in children aged 11-13 years in the UK. Methods: 1147 children from ten secondary schools participated in a health survey that included blood samples, fitness test and anthropometric measures. Factors associated with obesity were examined using multilevel logistic regression. Findings: Of the children examined (490 male; 657 female) a third were overweight, 1 in 6 had elevated blood pressure, more than 1 in 10 had high cholesterol, 58% consumed more fat than recommended, whilst 37% were classified as unfit. Children in deprived areas had a higher proportion of risk factors; for example, they had higher blood pressure (20% (deprived) compared to 11% (non-deprived), difference: 9.0% (95%CI: 4.7%-13.4%)). Obesity is associated with risk factors for heart disease and diabetes. Maintaining fitness is associated with a reduction in the risk factors for heart disease (high blood pressure and cholesterol) but not on risk factors for diabetes (insulin levels). In order of importance, the main risk factors for childhood obesity are being unfit, having an obese father, and being large at birth. Conclusion: The high proportion of children with risk factors suggests future interventions need to focus on community and policy change to shift the population norm rather than targeting the behaviour of high risk individuals. Interventions need to focus on mothers' lifestyle in pregnancy, fathers' health, as well as promoting fitness among children. Obesity was not associated with deprivation. Therefore, strategies should be adopted in both deprived and non deprived areas.	[Brophy, Sinead] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Rees, Anwen; Knox, Gareth] Univ Wales Inst, Sch Sport, Cardiff, S Glam, Wales; [Baker, Julien] Univ W Scotland, Paisley, Renfrew, Scotland; [Thomas, Non E.] Swansea Univ, Ctr Children & Young Peoples Hlth & Well Being, Sch Human & Hlth Sci, Swansea, W Glam, Wales	Swansea University; University of West Scotland; Swansea University	Brophy, S (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	s.brophy@swansea.ac.uk	ibrahim, raquib/F-5078-2012	Brophy, Sinead/0000-0001-7417-2858	Welsh Assembly Government through the National Institute of Social Care and Health Research; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	Welsh Assembly Government through the National Institute of Social Care and Health Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the Welsh Assembly Government through the National Institute of Social Care and Health Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arluk SL, 2003, MIL MED, V168, P583, DOI 10.1093/milmed/168.7.583; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Boyce WT, 2006, J AM ACAD CHILD PSY, V45, P1510, DOI 10.1097/01.chi.0000237706.50884.8b; Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Eagle TF, 2010, AM HEART J, V160, P1185, DOI 10.1016/j.ahj.2010.09.019; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Flouri E, 2004, BRIT J EDUC PSYCHOL, V74, P141, DOI 10.1348/000709904773839806; Foot Standards Agency, 2002, MCCANC WIDD COMP FOO; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Freeman E, 2012, INT J OBES; Goldman R., 2005, FATHERS INVOLVEMENT; Goodman E, 2004, J PEDIATR-US, V145, P445, DOI 10.1016/j.jpeds.2004.04.059; Griffiths LJ, 2009, ARCH DIS CHILD, V94, P577, DOI 10.1136/adc.2008.137554; Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011; Hitze B, 2009, EUR J CLIN NUTR, V63, P739, DOI 10.1038/ejcn.2008.41; Hosmer DW, 2000, APPL LOGISTIC REGRES; Howarth S, 2008, 08045 NAT ASS WAL; Johannsen DL, 2006, OBESITY, V14, P431, DOI 10.1038/oby.2006.57; Kain J, 2005, OBES RES, V13, P2178, DOI 10.1038/oby.2005.270; LAUER RM, 1988, PEDIATRICS, V82, P309; LAUER RM, 1993, PEDIATR CLIN N AM, V40, P23; Major JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015538; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Newland LA, 2008, EARLY CHILD DEV CARE, V178, P785, DOI 10.1080/03004430802352186; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; Public Health England, 2021, MCCANCE WIDDOWSONS C; Rees A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-86; RIDDOCH C, 1990, NO IRELAND HLTH FITN; Saker Meriem, 2011, Maedica (Bucur), V6, P90; Sandercock G, 2010, ARCH DIS CHILD, V95, P46, DOI 10.1136/adc.2009.162107; Sarkadi A, 2008, ACTA PAEDIATR, V97, P153, DOI 10.1111/j.1651-2227.2007.00572.x; Shaw JE, 2006, DIABETES CARE, V29, P1170, DOI 10.2337/dc06-0013; Suttleworth I, 1995, BRIT EDUC RES J, V21, P487; Thomas NE, 2006, HLTH ED J, V65, P223; Thomas NE, 2007, PEDIATR EXERC SCI, V19, P93, DOI 10.1123/pes.19.1.93; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Wake M, 2007, PEDIATRICS, V120, pE1520, DOI 10.1542/peds.2006-3707; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	42	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36597	10.1371/journal.pone.0036597	http://dx.doi.org/10.1371/journal.pone.0036597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693553	Green Published, gold			2022-12-25	WOS:000305338500014
J	Kozul-Horvath, CD; Zandbergen, F; Jackson, BP; Enelow, RI; Hamilton, JW				Kozul-Horvath, Courtney D.; Zandbergen, Fokko; Jackson, Brian P.; Enelow, Richard I.; Hamilton, Joshua W.			Effects of Low-Dose Drinking Water Arsenic on Mouse Fetal and Postnatal Growth and Development	PLOS ONE			English	Article							IN-UTERO; ENDOCRINE DISRUPTOR; GENE-EXPRESSION; EXPOSURE; RECEPTOR; ALTERS; PREGNANCY; LIVER; MICE; ACTIVATION	Background: Arsenic (As) exposure is a significant worldwide environmental health concern. Chronic exposure via contaminated drinking water has been associated with an increased incidence of a number of diseases, including reproductive and developmental effects. The goal of this study was to identify adverse outcomes in a mouse model of early life exposure to low-dose drinking water As (10 ppb, current U. S. EPA Maximum Contaminant Level). Methodology and Findings: C57B6/J pups were exposed to 10 ppb As, via the dam in her drinking water, either in utero and/or during the postnatal period. Birth outcomes, the growth of the F1 offspring, and health of the dams were assessed by a variety of measurements. Birth outcomes including litter weight, number of pups, and gestational length were unaffected. However, exposure during the in utero and postnatal period resulted in significant growth deficits in the offspring after birth, which was principally a result of decreased nutrients in the dam's breast milk. Cross-fostering of the pups reversed the growth deficit. Arsenic exposed dams displayed altered liver and breast milk triglyceride levels and serum profiles during pregnancy and lactation. The growth deficits in the F1 offspring resolved following separation from the dam and cessation of exposure in male mice, but did not resolve in female mice up to six weeks of age. Conclusions/Significance: Exposure to As at the current U. S. drinking water standard during critical windows of development induces a number of adverse health outcomes for both the dam and offspring. Such effects may contribute to the increased disease risks observed in human populations.	[Kozul-Horvath, Courtney D.; Enelow, Richard I.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA; [Zandbergen, Fokko; Hamilton, Joshua W.] Marine Biol Lab, Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Jackson, Brian P.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; [Enelow, Richard I.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA	Dartmouth College; Marine Biological Laboratory - Woods Hole; Dartmouth College; Dartmouth College	Kozul-Horvath, CD (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA.	jhamilton@mbl.edu	Jackson, Brian/AAL-4166-2021		National Institute of Environmental Health Sciences at the National Institutes of Health [1F32 ES019070, P42 ES007373]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373, F32ES019070] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences at the National Institutes of Health grants 1F32 ES019070 (CDK-H) and P42 ES007373 (BPJ, JWH, RIE and CDK-H, Dartmouth Superfund Research Program Project Grant, Project 2 and Pilot Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Agency for Toxic Substances and Disease Registry (ATSDR), 2016, ADD TOX PROF ARS; Ahmad SA, 2001, ENVIRON HEALTH PERSP, V109, P629, DOI 10.2307/3455038; Andrew AS, 2007, TOXICOL SCI, V100, P75, DOI 10.1093/toxsci/kfm200; Bacq Y, 2011, CLIN RES HEPATOL GAS; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bodwell JE, 2006, CHEM RES TOXICOL, V19, P1619, DOI 10.1021/tx060122q; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Concha G, 1998, INT ARCH OCC ENV HEA, V71, P42, DOI 10.1007/s004200050248; Davey JC, 2008, ENVIRON HEALTH PERSP, V116, P165, DOI 10.1289/ehp.10131; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; Fangstrom B, 2008, ENVIRON HEALTH PERSP, V116, P963, DOI 10.1289/ehp.11094; FERM VH, 1977, ENVIRON HEALTH PERSP, V19, P215, DOI 10.2307/3428478; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gardner RM, 2011, REPROD TOXICOL, V31, P210, DOI 10.1016/j.reprotox.2010.11.002; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hamadani JD, 2010, INT J EPIDEMIOL, V39, P1206, DOI 10.1093/ije/dyp369; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Hopenhayn C, 2003, EPIDEMIOLOGY, V14, P593, DOI 10.1097/01.ede.0000072104.65240.69; Hopenhayn-Rich C, 2000, ENVIRON HEALTH PERSP, V108, P667, DOI 10.2307/3434889; Jin YP, 2006, ENVIRON RES, V101, P349, DOI 10.1016/j.envres.2005.11.006; Kaltreider RC, 2001, ENVIRON HEALTH PERSP, V109, P245, DOI 10.1289/ehp.01109245; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1108, DOI 10.1289/ehp.0800199; Lantz RC, 2009, TOXICOL APPL PHARM, V235, P105, DOI 10.1016/j.taap.2008.11.012; Markowski VP, 2011, BASIC CLIN PHARMACOL, V108, P326, DOI 10.1111/j.1742-7843.2010.00660.x; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; NRC, 1999, ARS DRINK WAT; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Srivastava S, 2007, REPROD TOXICOL, V23, P449, DOI 10.1016/j.reprotox.2007.01.005; Straub AC, 2008, J CLIN INVEST, V118, P3980, DOI 10.1172/JCI35092; Tofail F, 2009, ENVIRON HEALTH PERSP, V117, P288, DOI 10.1289/ehp.11670; Vahter Marie, 1999, Science Progress, V82, P69; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Xi SH, 2010, BIOL TRACE ELEM RES, V134, P84, DOI 10.1007/s12011-009-8455-1	43	57	57	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38249	10.1371/journal.pone.0038249	http://dx.doi.org/10.1371/journal.pone.0038249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693606	Green Published, gold			2022-12-25	WOS:000305338500117
J	Pearse, IS; Porensky, LM; Yang, LH; Stanton, ML; Karban, R; Bhattacharyya, L; Cox, R; Dove, K; Higgins, A; Kamoroff, C; Kirk, T; Knight, C; Koch, R; Parker, C; Rollins, H; Tanner, K				Pearse, Ian S.; Porensky, Lauren M.; Yang, Louie H.; Stanton, Maureen L.; Karban, Richard; Bhattacharyya, Lisa; Cox, Rosa; Dove, Karin; Higgins, August; Kamoroff, Corrina; Kirk, Travis; Knight, Christopher; Koch, Rebecca; Parker, Corwin; Rollins, Hilary; Tanner, Kelsey			Complex Consequences of Herbivory and Interplant Cues in Three Annual Plants	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; ROOT COMMUNICATION; KIN RECOGNITION; DEFENSE; VOLATILES; RESPONSES; COOPERATION	Information exchange (or signaling) between plants following herbivore damage has recently been shown to affect plant responses to herbivory in relatively simple natural systems. In a large, manipulative field study using three annual plant species (Achyrachaena mollis, Lupinus nanus, and Sinapis arvensis), we tested whether experimental damage to a neighboring conspecific affected a plant's lifetime fitness and interactions with herbivores. By manipulating relatedness between plants, we assessed whether genetic relatedness of neighboring individuals influenced the outcome of having a damaged neighbor. Additionally, in laboratory feeding assays, we assessed whether damage to a neighboring plant specifically affected palatability to a generalist herbivore and, for S. arvensis, a specialist herbivore. Our study suggested a high level of contingency in the outcomes of plant signaling. For example, in the field, damaging a neighbor resulted in greater herbivory to A. mollis, but only when the damaged neighbor was a close relative. Similarly, in laboratory trials, the palatability of S. arvensis to a generalist herbivore increased after the plant was exposed to a damaged neighbor, while palatability to a specialist herbivore decreased. Across all species, damage to a neighbor resulted in decreased lifetime fitness, but only if neighbors were closely related. These results suggest that the outcomes of plant signaling within multi-species neighborhoods may be far more context-specific than has been previously shown. In particular, our study shows that herbivore interactions and signaling between plants are contingent on the genetic relationship between neighboring plants. Many factors affect the outcomes of plant signaling, and studies that clarify these factors will be necessary in order to assess the role of plant information exchange about herbivory in natural systems.	[Pearse, Ian S.; Yang, Louie H.; Karban, Richard] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Porensky, Lauren M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Stanton, Maureen L.; Bhattacharyya, Lisa; Cox, Rosa; Dove, Karin; Higgins, August; Kamoroff, Corrina; Kirk, Travis; Knight, Christopher; Koch, Rebecca; Parker, Corwin; Rollins, Hilary; Tanner, Kelsey] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Pearse, IS (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	ispearse@ucdavis.edu	Koch, Rebecca E./AFJ-9118-2022	Koch, Rebecca E./0000-0002-9068-6231; Knight, Christopher/0000-0002-7522-4127; Yang, Louie/0000-0002-9237-5357; Mazumder, Lisa/0000-0002-1514-9882				Baldwin IT, 2002, CURR OPIN PLANT BIOL, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Darwin C, 1880, POWER MOVEMENT PLANT; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Fox J., 2019, R COMPANION APPL REG, V3rd ed; Futuyma D.J., 1991, P431; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Hamilton W.D., 1987, P81; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hickman JC., 1993, JEPSON MANUAL; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; MAHALL BE, 1992, ECOLOGY, V73, P2145, DOI 10.2307/1941462; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; Mateo JM, 2010, ANIM BEHAV, V80, P929, DOI 10.1016/j.anbehav.2010.08.019; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Penn DJ, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P55; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; R Core Development Team, 2008, R V 2 10 1; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2	33	17	17	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38105	10.1371/journal.pone.0038105	http://dx.doi.org/10.1371/journal.pone.0038105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675439	Green Published, gold			2022-12-25	WOS:000305338500088
J	Urich, E; Lazic, SE; Molnos, J; Wells, I; Freskgard, PO				Urich, Eduard; Lazic, Stanley E.; Molnos, Juliette; Wells, Isabelle; Freskgard, Per-Ola			Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LARGE T-ANTIGEN; CELLULAR-TRANSFORMATION; GENE-EXPRESSION; ELECTRICAL-RESISTANCE; LEUKOCYTE MIGRATION; ALZHEIMERS-DISEASE; NEUROVASCULAR UNIT; TIGHT JUNCTION; INTERFERON	Brain microvascular endothelial cells (BEC) constitute the blood-brain barrier (BBB) which forms a dynamic interface between the blood and the central nervous system (CNS). This highly specialized interface restricts paracellular diffusion of fluids and solutes including chemicals, toxins and drugs from entering the brain. In this study we compared the transcriptome profiles of the human immortalized brain endothelial cell line hCMEC/D3 and human primary BEC. We identified transcriptional differences in immune response genes which are directly related to the immortalization procedure of the hCMEC/D3 cells. Interestingly, astrocytic co-culturing reduced cell adhesion and migration molecules in both BECs, which possibly could be related to regulation of immune surveillance of the CNS controlled by astrocytic cells within the neurovascular unit. By matching the transcriptome data from these two cell lines with published transcriptional data from freshly isolated mouse BECs, we discovered striking differences that could explain some of the limitations of using cultured BECs to study BBB properties. Key protein classes such as tight junction proteins, transporters and cell surface receptors show differing expression profiles. For example, the claudin-5, occludin and JAM2 expression is dramatically reduced in the two human BEC lines, which likely explains their low transcellular electric resistance and paracellular leakiness. In addition, the human BEC lines express low levels of unique brain endothelial transporters such as Glut1 and Pgp. Cell surface receptors such as LRP1, RAGE and the insulin receptor that are involved in receptor-mediated transport are also expressed at very low levels. Taken together, these data illustrate that BECs lose their unique protein expression pattern outside of their native environment and display a more generic endothelial cell phenotype. A collection of key genes that seems to be highly regulated by the local surroundings of BEC within the neurovascular unit are presented and discussed.	[Urich, Eduard; Freskgard, Per-Ola] F Hoffmann La Roche Ltd, CNS Res, Basel, Switzerland; [Lazic, Stanley E.; Wells, Isabelle] F Hoffmann La Roche Ltd, Bioinformat & Exploratory Data Anal, Basel, Switzerland; [Molnos, Juliette] F Hoffmann La Roche Ltd, Translat Res Sci, Basel, Switzerland	Roche Holding; Roche Holding; Roche Holding	Urich, E (corresponding author), F Hoffmann La Roche Ltd, CNS Res, Basel, Switzerland.	per-ola.freskgard@roche.com	Lazic, Stanley/F-1160-2011; Freskgård, Per-Ola/AAY-4194-2021					Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; BASHAM TY, 1982, P NATL ACAD SCI-BIOL, V79, P3265, DOI 10.1073/pnas.79.10.3265; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Cooper I, 2011, METHODS MOL BIOL, V762, P347, DOI 10.1007/978-1-61779-185-7_25; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; DOLEI A, 1983, INFECT IMMUN, V40, P172, DOI 10.1128/IAI.40.1.172-176.1983; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Fasler-Kan E, 2010, BRAIN RES, V1354, P15, DOI 10.1016/j.brainres.2010.07.077; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Franke RM, 2010, CURR PHARM DESIGN, V16, P220, DOI 10.2174/138161210790112683; Gaillard PJ, 2000, PHARMACEUT RES, V17, P1198, DOI 10.1023/A:1026406528530; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; GREINER JW, 1984, CANCER RES, V44, P3208; Gresser I, 2007, BIOCHIMIE, V89, P723, DOI 10.1016/j.biochi.2007.03.005; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Hirase T, 1997, J CELL SCI, V110, P1603; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; LAPIERRE LA, 1988, J EXP MED, V167, P794, DOI 10.1084/jem.167.3.794; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Mae M, 2011, CURR PHARM DESIGN, V17, P2750, DOI 10.2174/138161211797440113; MALE D, 1988, IMMUNOLOGY, V63, P37; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neuwelt EA, 2004, NEUROSURGERY, V54, P131, DOI 10.1227/01.NEU.0000097715.11966.8E; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Pardridge WM, 2010, COLD SPRING HARB PRO, V2010; Partanen J, 1999, CURR TOP MICROBIOL, V237, P159; Persidsky Y, 1999, J NEUROVIROL, V5, P579, DOI 10.3109/13550289909021287; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; RISAU W, 1990, TRENDS NEUROSCI, V13, P174, DOI 10.1016/0166-2236(90)90043-A; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sato GH, 2010, IN VITRO CELL DEV-AN, V46, P590, DOI 10.1007/s11626-010-9315-1; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; SMITH QR, 1986, J NEUROCHEM, V46, P1732; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Stanimirovic DB, 2012, J CEREBRAL BLOOD FLO; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401	82	131	134	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38149	10.1371/journal.pone.0038149	http://dx.doi.org/10.1371/journal.pone.0038149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675443	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500095
J	Choi, JH; Choi, DK; Sohn, KC; Kwak, SS; Suk, J; Lim, JS; Shin, I; Kim, SW; Lee, JH; Joe, CO				Choi, Ji Hye; Choi, Dae-Kyoung; Sohn, Kyung-Cheol; Kwak, Sang Su; Suk, Jinkyu; Lim, Jong-Soon; Shin, Incheol; Kim, Sung-Woo; Lee, Jeung-Hoon; Joe, Cheol O.			Absence of a Human DnaJ Protein hTid-1(S) Correlates with Aberrant Actin Cytoskeleton Organization in Lesional Psoriatic Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; HYPOXIA-INDUCIBLE FACTORS; HEAT-SHOCK PROTEIN-27; NF-KAPPA-B; CELL-MIGRATION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HUMAN HOMOLOG; PHOSPHORYLATION; ACTIVATION	The biochemical mechanism by which the human tumorous imaginal disc1(S) (hTid-1(S)) interferes with actin cytoskeleton organization in keratinocytes of human skin epidermis was investigated. We found that hTid-1, specifically hTid-1(S), interacts with MK5, a p38-regulated/activated protein kinase, and inhibits the protein kinase activity of MK5 that phosphorylates heat shock protein HSP27 in cultured HeLa cells. Thus, hTid-1(S) expression inhibits the phosphorylation of HSP27 known to play important roles in F-actin polymerization and actin cytoskeleton organization. The interplay between MK5/HSP27 signaling and hTid-1(S) expression was supported by the inhibition of HSP27 phosphorylation and MK5 activity in HeLa cells in response to hypoxia during which hTid-1(S) expression was down-regulated. We also found that overexpression of hTid-1(S) results in the inhibition of HSP27 phosphorylation, F-actin polymerization, and actin cytoskeleton organization in transduced HaCaT keratinocytes. This study further proposes that the loss of hTid-1(S) expression in the basal layer of skin epidermis correlates with the enhanced HSP27 phosphorylation, keratinocyte hyperproliferation, and excess actin cytoskeleton organization in lesional psoriatic skin.	[Choi, Ji Hye; Kwak, Sang Su; Suk, Jinkyu; Joe, Cheol O.] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Dae-Kyoung; Sohn, Kyung-Cheol; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon 305764, South Korea; [Lim, Jong-Soon] Daejeon Univ, Inst Tradit Med & Biosci, Taejon 300716, South Korea; [Shin, Incheol] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Kim, Sung-Woo] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Daejeon University; Hanyang University; University of Calgary	Joe, CO (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	cojoe@kaist.ac.kr	Joe, Cheol O/C-1917-2011		National Research Foundation of Korea [2010-0011268, 2009-0085835]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2010-0011268 and 2009-0085835 (to C. O. J.).	Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Ferns G, 2006, INT J EXP PATHOL, V87, P253, DOI 10.1111/j.1365-2613.2006.00484.x; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Green H, 1980, Harvey Lect, V74, P101; Guay J, 1997, J CELL SCI, V110, P357; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1996, CANCER RES, V56, P273; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johansen C, 2005, J INVEST DERMATOL, V124, P1284, DOI 10.1111/j.0022-202X.2005.23749.x; Johansen C, 2005, BRIT J DERMATOL, V152, P37, DOI 10.1111/J.1365-2133.2004.06304.X; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; KUBLER MD, 1993, J INVEST DERMATOL, V100, P785, DOI 10.1111/1523-1747.ep12476492; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Perander M, 2008, FRONT BIOSCI-LANDMRK, V13, P4617; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Plavina T, 2008, CLIN CHEM, V54, P1805, DOI 10.1373/clinchem.2008.103770; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Tak H, 2007, CELL SIGNAL, V19, P2379, DOI 10.1016/j.cellsig.2007.07.016; Valdimarsson H, 2009, TRENDS IMMUNOL, V30, P494, DOI 10.1016/j.it.2009.07.008; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANGER L, 1978, ACTA DERM-VENEREOL, V58, P73; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001	51	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25954	25963		10.1074/jbc.M111.313809	http://dx.doi.org/10.1074/jbc.M111.313809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692211	hybrid, Green Published			2022-12-25	WOS:000306916300023
J	Fleetwood, MR; Ho, YG; Cooke, NE; Liebhaber, SA				Fleetwood, Margaret R.; Ho, Yugong; Cooke, Nancy E.; Liebhaber, Stephen A.			DNase I Hypersensitive Site II of the Human Growth Hormone Locus Control Region Mediates an Essential and Distinct Long-range Enhancer Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; TRANS-ACTING FACTOR; RNA-POLYMERASE-II; GENE-EXPRESSION; HGH-N; TETRACYCLINE RESISTANCE; ARTIFICIAL CHROMOSOME; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; ESCHERICHIA-COLI	Locus control regions (LCRs) comprise sets of DNA elements capable of establishing autonomous chromatin domains that support robust and physiologically appropriate expression of target genes, often working over extensive distances. Human growth hormone (hGH-N) expression in the pituitary is under the regulation of a well characterized LCR containing four DNase I hypersensitive sites (HSs). The two pituitary-specific HS, HSI and HSII, are located 14.5 and 15.5 kb 5' to the hGH-N promoter. HSI is essential for activation of hGH-N during pituitary development and for sustaining robust activity in the adult. To determine whether the closely linked HSII has a role in hGH-N expression, it was deleted from a previously validated hGH/P1 transgene. Analysis of three independent hGH/P1(Delta HSII) transgenic mouse lines revealed that this deletion had no adverse effect on the formation of HSI, yet resulted in a substantial loss (70%) in hGH-N mRNA expression. This loss of expression was accompanied by a corresponding reduction in recruitment of the pituitary-specific transcription factor Pit-1 to the hGH-N promoter and a selective decrease in promoter occupancy of the elongation-linked isoform of RNA polymerase II. Sufficiency of HSI and HSII in LCR activity was explored by establishing two additional sets of mouse transgenic lines in which DNA segments containing these HS were positioned within the lambda phage genome. In this "neutral" DNA context, HSII was required for the recruitment of HAT activity. These data establish HSII as a nonredundant component of the hGH LCR essential for establishment of robust levels of hGH-N gene expression.	Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Cooke, NE (corresponding author), Univ Penn, Sch Med, Dept Med, 547A Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	necooke@mail.med.upenn.edu		Ho, Yugong/0000-0002-7642-7700	National Institutes of Health Grants [R01HD/DK25147, R01HD/DK046737]; NIH Genetics Training Grant [T32-GM008216]; National Institutes of Health Center Grants [P30DK050306, P30DK019525, P30CA016520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD025147] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P30DK019525, R43DK046737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD/DK25147 and R01HD/DK046737 (to N.E.C. and S.A.L).; Supported by NIH Genetics Training Grant T32-GM008216.; We thank Dr. Brian Shewchuk (East Carolina University, Department of Biochemistry and Molecular Biology) for the lambda phage construct. We are grateful to the Transgenic and Chimeric Mouse Core of the University of Pennsylvania for generation of all transgenic lines (supported by National Institutes of Health Center Grants P30DK050306, P30DK019525, and P30CA016520).	Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; BENNANIBAITI IM, 1995, GENOMICS, V29, P647, DOI 10.1006/geno.1995.9954; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; Bresnick EH, 2006, PROG NUCLEIC ACID RE, V81, P435, DOI 10.1016/S0079-6603(06)81011-1; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CURTIN P, 1985, J CLIN INVEST, V76, P1554, DOI 10.1172/JCI112136; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Fang XD, 2007, J MOL BIOL, V365, P31, DOI 10.1016/j.jmb.2006.09.072; Fedosyuk H, 2007, BLOOD CELL MOL DIS, V39, P44, DOI 10.1016/j.bcmd.2007.02.006; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Ho YG, 2008, EMBO REP, V9, P891, DOI 10.1038/embor.2008.126; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Ho YG, 2011, MOL ENDOCRINOL, V25, P877, DOI 10.1210/me.2010-0411; Hunsaker TL, 2012, J MOL BIOL, V415, P29, DOI 10.1016/j.jmb.2011.11.001; Jin Y, 2011, DNA CELL BIOL, V30, P995, DOI 10.1089/dna.2011.1268; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kimura AP, 2004, MOL ENDOCRINOL, V18, P1018, DOI 10.1210/me.2003-0468; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; MAYO KE, 1988, MOL ENDOCRINOL, V2, P606, DOI 10.1210/mend-2-7-606; MCCLATCHEY AI, 1992, HUM MOL GENET, V1, P521; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Papachatzopoulou A, 2007, AM J HEMATOL, V82, P1005, DOI 10.1002/ajh.20979; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang XY, 2010, J MOL ENDOCRINOL, V45, P19, DOI 10.1677/JME-10-0017; Yoo EJ, 2006, MOL CELL BIOL, V26, P5569, DOI 10.1128/MCB.00405-06	47	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25454	25465		10.1074/jbc.M112.365825	http://dx.doi.org/10.1074/jbc.M112.365825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669946	Green Published, hybrid			2022-12-25	WOS:000306651700052
J	Cameron, DR; Cohen, BS; Morrison, SA				Cameron, D. Richard; Cohen, Brian S.; Morrison, Scott A.			An Approach to Enhance the Conservation-Compatibility of Solar Energy Development	PLOS ONE			English	Article							DANGEROUS CLIMATE-CHANGE; BIODIVERSITY OFFSETS; DESERT ECOSYSTEM; UNITED-STATES; IMPACTS; TECHNOLOGIES; MITIGATION; CALIFORNIA; PROJECTS	The rapid pace of climate change poses a major threat to biodiversity. Utility-scale renewable energy development (>1 MW capacity) is a key strategy to reduce greenhouse gas emissions, but development of those facilities also can have adverse effects on biodiversity. Here, we examine the synergy between renewable energy generation goals and those for biodiversity conservation in the 13 M ha Mojave Desert of the southwestern USA. We integrated spatial data on biodiversity conservation value, solar energy potential, and land surface slope angle (a key determinant of development feasibility) and found there to be sufficient area to meet renewable energy goals without developing on lands of relatively high conservation value. Indeed, we found nearly 200,000 ha of lower conservation value land below the most restrictive slope angle (<1%); that area could meet the state of California's current 33% renewable energy goal 1.8 times over. We found over 740,000 ha below the highest slope angle (<5%) - an area that can meet California's renewable energy goal seven times over. Our analysis also suggests that the supply of high quality habitat on private land may be insufficient to mitigate impacts from future solar projects, so enhancing public land management may need to be considered among the options to offset such impacts. Using the approach presented here, planners could reduce development impacts on areas of higher conservation value, and so reduce trade-offs between converting to a green energy economy and conserving biodiversity.	[Cameron, D. Richard; Cohen, Brian S.; Morrison, Scott A.] Nature Conservancy, San Francisco, CA USA	Nature Conservancy	Cameron, DR (corresponding author), Nature Conservancy, San Francisco, CA USA.	dcameron@tnc.org			Nature Conservancy, California; Nature Conservancy	Nature Conservancy, California; Nature Conservancy	This work was supported by the Nature Conservancy, California Program (www.nature.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank The Nature Conservancy for supporting this analysis. W. Christian, J. Kiesecker, M. Kramer, B. McKenney, J. Moore, E. O'Donoghue, S. Parker, C. Pienkos, J. Randall, R. Shaw, M. Sweeney, J. Ziegler, and especially L. Crane provided helpful discussions and review of earlier versions. Two anonymous reviewers also provided insightful and helpful comments which greatly improved the paper. We also appreciate the help of Catherine Darst in supporting our use of desert tortoise model data and providing Desert Tortoise Conservation Area data.	Alvarado A, 2011, PROPOSED ME IN PRESS; Andre J, 2009, SCI NEWSLETTER; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; BLM, 2005, W MOJ PLAN HAB CONS; BLM, 2004, MOH GROUND SQUIRR CO; BLM, 2010, RIGHT WAY APPL DAT; BROWN DE, 1986, AM MIDL NAT, V116, P411, DOI 10.2307/2425750; Bunn D, 2007, CALIFORNIA WILDLIFE; Calfire, 2006, MULT LAND COV DAT FV; Clark County NV, 2000, FIN CLARK COUNT MULT; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Edenhofer O., 2011, IPCC SPECIAL REPORT; EIA US, 2009, EN CONS SECT SOURC U; Environmental Systems Research Institute (ESRI), 2009, ARCGIS V 9 3 1; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Howard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011249; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kroeger T., 2007, EC BENEFITS PROVIDED; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Lowry JH, 2005, SW REGIONAL GAP ANAL; Mastrandrea MD, 2004, SCIENCE, V304, P571, DOI 10.1126/science.1094147; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Mehos MS, WORLD REN EN C 8 200; Miles SR, 1997, ECOLOGICAL SUBREGION; Nussear KE, 2009, MODELING HABIAT DESE; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pavlik B. M., 2008, CALIFORNIA DESERTS E; Perez R, 2002, SOL ENERGY, V73, P307, DOI 10.1016/S0038-092X(02)00122-6; Randall J.M., 2010, MOJAVE DESERT ECOREG; RETI, 2010, PHAS 2B FIN REP; RETI, 2008, PHAS 1B FIN REP; SCBD, 2008, BUS 2010 NEWSL BUS B, P3; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thorne JH, 2009, ENVIRON MANAGE, V43, P936, DOI 10.1007/s00267-008-9246-8; Tracy C.R., 2004, DESERT TORTOISE RECO; Tsoutsos T, 2005, ENERG POLICY, V33, P289, DOI 10.1016/S0301-4215(03)00241-6; USA National Geospatial-Intelligence Agency (NGA), 2000, USGS SHUTTL RAD TOP; USFWS, 2011, ASH MEAD NAT WILDL R; USFWS (U.S. Fish and Wildlife Service), 1994, DES TORT MOJ POP REC; USGS, 2010, LANDF EX VEG TYP GIS; USGS, 2010, PROT AR DAT V 1 1; Weber TC, 2010, LANDSCAPE URBAN PLAN, V96, P240, DOI 10.1016/j.landurbplan.2010.04.003; Wohlfahrt G, 2008, GLOBAL CHANGE BIOL, V14, P1475, DOI 10.1111/j.1365-2486.2008.01593.x	52	45	45	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38437	10.1371/journal.pone.0038437	http://dx.doi.org/10.1371/journal.pone.0038437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685568	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700031
J	Wang, SB; Shi, Q; Xu, Y; Xie, WL; Zhang, J; Tian, C; Guo, Y; Wang, K; Zhang, BY; Chen, C; Gao, C; Dong, XP				Wang, Shao-Bin; Shi, Qi; Xu, Yin; Xie, Wu-Ling; Zhang, Jin; Tian, Chan; Guo, Yan; Wang, Ke; Zhang, Bao-Yun; Chen, Cao; Gao, Chen; Dong, Xiao-Ping			Protein Disulfide Isomerase Regulates Endoplasmic Reticulum Stress and the Apoptotic Process during Prion Infection and PrP Mutant-Induced Cytotoxicity	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CELL-DEATH; MISFOLDED PROTEINS; NEUROTOXICITY; DYSFUNCTION; ACTIVATION; FEATURES; FAMILY	Background: Protein disulfide isomerase (PDI), is sorted to be enzymatic chaperone for reconstructing misfolded protein in endoplasmic reticulum lumen. Recently, PDI has been identified as a link between misfolded protein and neuron apoptosis. However, the potential for PDI to be involved in the pathogenesis of prion disease remains unknown. In this study, we propose that PDI may function as a pleiotropic regulator in the cytotoxicity induced by mutated prion proteins and in the pathogenesis of prion diseases. Methodology/Principal Findings: To elucidate potential alterations of PDI in prion diseases, the levels of PDI and relevant apoptotic executors in 263K infected hamsters brain tissues were evaluated with the use of Western blots. Abnormal upregulation of PDI, Grp78 and Grp58 was detected. Dynamic assays of PDI alteration identified that the upregulation of PDI started at the early stage and persistently increased till later stage. Obvious increases of PDI and Grp78 levels were also observed in cultured cells transiently expressing PrP mutants, PrP-KDEL or PrP-PG15, accompanied by significant cytotoxicities. Excessive expression of PDI partially eased ER stress and cell apoptosis caused by accumulation of PrP-KDEL, but had less effect on cytotoxicity induced by PrP-PG15. Knockdown of endogenous PDI significantly amended cytotoxicity of PrP-PG15, but had little influence on that of PrP-KDEL. A series of membrane potential assays found that apoptosis induced by misfolded PrP proteins could be regulated by PDI via mitochondrial dysfunction. Moreover, biotin-switch assays demonstrated active S-nitrosylted modifications of PDI (SNO-PDI) both in the brains of scrapie-infected rodents and in the cells with misfolded PrP proteins. Conclusion/Significance: Current data in this study highlight that PDI and its relevant executors may function as a pleiotropic regulator in the processes of different misfolded PrP proteins and at different stages during prion infection. SNO-PDI may feed as an accomplice for PDI apoptosis.	[Wang, Shao-Bin; Shi, Qi; Xu, Yin; Xie, Wu-Ling; Zhang, Jin; Tian, Chan; Guo, Yan; Wang, Ke; Zhang, Bao-Yun; Chen, Cao; Gao, Chen; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Dong, Xiao-Ping] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, SB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Xu, Yin/AAO-7503-2021; WANG, SHAO-BIN/Z-1810-2018; Dong, Xiaoping/H-4160-2015; Chen, Cao/CAF-1246-2022	WANG, SHAO-BIN/0000-0002-6699-9406; Dong, Xiaoping/0000-0002-2302-7711; Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [30800975, 81100980, 81101302, 31100117]; National Basic Research Program of China (973 Program) [2007CB310505]; China Mega-Project for Infectious Disease [2009ZX10004-101]; SKLID Development Grant [2008SKLID102, 2011SKLID211, 2011SKLID204]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Mega-Project for Infectious Disease; SKLID Development Grant	This work was supported by Chinese National Natural Science Foundation Grant (30800975, 81100980, 81101302 and 31100117), National Basic Research Program of China (973 Program) (2007CB310505), China Mega-Project for Infectious Disease (2009ZX10004-101) and SKLID Development Grant (2008SKLID102, 2011SKLID211 and 2011SKLID204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An R, 2008, SCI CHINA SER C, V51, P630, DOI 10.1007/s11427-008-0062-4; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Castilla J, 2005, FEBS LETT, V579, P6237, DOI 10.1016/j.febslet.2005.09.099; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Guo YJ, 2008, AM J MED SCI, V336, P519, DOI 10.1097/MAJ.0b013e3181643e50; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; Han Lu, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P208; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Liberski PP, 2008, FOLIA NEUROPATHOL, V46, P1; Martin SF, 2006, FEBS LETT, V580, P4097, DOI 10.1016/j.febslet.2006.06.054; Nunziante M, 2011, J BIOL CHEM; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Shi Q, 2011, PRION, V5; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Wang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014602; Xu K, 2011, J MOL NEUROSCI, V43, P225, DOI 10.1007/s12031-010-9387-0; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6	33	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38221	10.1371/journal.pone.0038221	http://dx.doi.org/10.1371/journal.pone.0038221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685557	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700020
J	Bailey, RI; Saldamando-Benjumea, CI; Tatsuta, H; Butlin, RK				Bailey, Richard I.; Saldamando-Benjumea, Clara I.; Tatsuta, Haruki; Butlin, Roger K.			Habitat Association and Seasonality in a Mosaic and Bimodal Hybrid Zone between Chorthippus brunneus and C. jacobsi (Orthoptera: Acrididae)	PLOS ONE			English	Article							FIRE-BELLIED TOADS; BOMBINA-BOMBINA; REPRODUCTIVE ISOLATION; GRASSHOPPERS; VARIEGATA; SELECTION; PATTERNS; ORIGINS; MODEL; SONG	Understanding why some hybrid zones are bimodal and others unimodal can aid in identifying barriers to gene exchange following secondary contact. The hybrid zone between the grasshoppers Chorthippus brunneus and C. jacobsi contains a mix of allopatric parental populations and inter-mingled bimodal and unimodal sympatric populations, and provides an ideal system to examine the roles of local selection and gene flow between populations in maintaining bimodality. However, it is first necessary to confirm, over a larger spatial scale, previously identified associations between population composition and season and habitat. Here we use cline-fitting of one morphological and one song trait along two valley transects, and intervening mountains, to confirm previously identified habitat associations (mountain versus valley) and seasonal changes in population composition. As expected from previous findings of studies on a smaller spatial scale, C. jacobsi dominated mountain habitats and mixed populations dominated valleys, and C. brunneus became more prevalent in August. Controlling for habitat and incorporating into the analysis seasonal changes in cline parameters and the standard errors of parental trait values revealed wider clines than previous studies (best estimates of 6.4 to 24.5 km in our study versus 2.8 to 4.7 km in previous studies) and increased percentage of trait variance explained (52.7% and 61.5% for transects 1 and 2 respectively, versus 17.6%). Revealing such strong and consistent patterns within a complex hybrid zone will allow more focused examination of the causes of variation in bimodality in mixed populations, in particular the roles of local selection versus habitat heterogeneity and gene flow between differentiated populations.	[Bailey, Richard I.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Saldamando-Benjumea, Clara I.] Univ Nacl Colombia, Fac Ciencias, Medellin, Colombia; [Tatsuta, Haruki] Univ Ryukyus, Grad Sch Agr, Dept Ecol & Environm Sci, Nishihara, Okinawa 90301, Japan; [Butlin, Roger K.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Oslo; Universidad Nacional de Colombia; University of the Ryukyus; University of Sheffield	Bailey, RI (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	r.i.bailey@bio.uio.no	Bailey, Richard/HHM-4964-2022; Butlin, Roger/F-7709-2013	Bailey, Richard/0000-0001-9870-410X; Butlin, Roger/0000-0003-4736-0954; Tatsuta, Haruki/0000-0001-8847-8874	British Council (Acciones integradas); Genetics Society; Japan Society for the Promotion of Science [12640604]; Colfuturo (Fundacion para el futuro de Colombia)	British Council (Acciones integradas); Genetics Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Colfuturo (Fundacion para el futuro de Colombia)	This work was funded from the grants of the British Council (Acciones integradas) and Genetics Society to Jose Bella, Roger Butlin and Clara Saldamando and from The Japan Society for the Promotion of Science grants to H. Tatsuta and H. Kishino (Grant No. 12640604). Clara Saldamando was funded by Colfuturo (Fundacion para el futuro de Colombia) during her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZEN JW, 1991, EVOLUTION, V45, P805, DOI 10.1111/j.1558-5646.1991.tb04352.x; Babik W, 2003, MOL ECOL, V12, P1913, DOI 10.1046/j.1365-294X.2003.01880.x; Bailey RI, 2004, J EVOLUTION BIOL, V17, P108, DOI 10.1046/j.1420-9101.2003.00648.x; Bailey RI, 2003, ECOL ENTOMOL, V28, P129, DOI 10.1046/j.1365-2311.2003.00504.x; Bailey RI, 2001, THESIS U LEEDS LEEDS; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1983, EVOLUTION, V37, P454, DOI 10.1111/j.1558-5646.1983.tb05563.x; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bridle JR, 2006, J EVOLUTION BIOL, V19, P1248, DOI 10.1111/j.1420-9101.2006.01080.x; Bridle JR, 2002, EVOLUTION, V56, P1184, DOI 10.1111/j.0014-3820.2002.tb01431.x; Bridle JR, 2002, ECOL ENTOMOL, V27, P499, DOI 10.1046/j.1365-2311.2002.00435.x; Bridle JR, 2001, EVOLUTION, V55, P1832, DOI 10.1111/j.0014-3820.2001.tb00832.x; Bridle JR, 1998, THESIS U LEEDS LEEDS; BUTLIN RK, 1991, PHILOS T R SOC B, V334, P297; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Harrison R.G., 1989, P111; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; HARRISON RG, 1990, OXF SURV EVOL BIOL, V7, P70; HEWITT GM, 1987, HEREDITY, V59, P457, DOI 10.1038/hdy.1987.156; HOWARD DJ, 1986, EVOLUTION, V40, P34, DOI 10.1111/j.1558-5646.1986.tb05715.x; HOWARD DJ, 1993, EVOLUTION, V47, P789, DOI 10.1111/j.1558-5646.1993.tb01234.x; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kruuk LEB, 1999, GENETICS, V153, P1959; Lunt DH, 1998, HEREDITY, V80, P633, DOI 10.1046/j.1365-2540.1998.00311.x; MacCallum CJ, 1998, EVOLUTION, V52, P227, DOI 10.1111/j.1558-5646.1998.tb05156.x; MALLET J, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P226; Ragge D.R, 1998, SONGS GRASSHOPPERS C; RAGGE DR, 1988, J NAT HIST, V22, P897, DOI 10.1080/00222938800770611; Ross CL, 2002, EVOLUTION, V56, P2296, DOI 10.1111/j.0014-3820.2002.tb00153.x; Saldamando CI, 2005, BIOL J LINN SOC, V84, P195, DOI 10.1111/j.1095-8312.2005.000424.x; Saldamando CI, 2005, J EVOLUTION BIOL, V18, P703, DOI 10.1111/j.1420-9101.2004.00838.x; SANDERSON N, 1992, EVOLUTION, V46, P595, DOI 10.1111/j.1558-5646.1992.tb02068.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shuker DM, 2005, P ROY SOC B-BIOL SCI, V272, P2491, DOI 10.1098/rspb.2005.3242; SZYMURA JM, 1991, EVOLUTION, V45, P237, DOI 10.1111/j.1558-5646.1991.tb04400.x; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; Tregenza T, 2000, EVOLUTION, V54, P1687, DOI 10.1111/j.0014-3820.2000.tb00713.x; Vines TH, 2003, EVOLUTION, V57, P1876; Voisin J.-F., 2003, ATLAS ORTHOPTERES MA	42	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37684	10.1371/journal.pone.0037684	http://dx.doi.org/10.1371/journal.pone.0037684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675485	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305341700018
J	Gronenschild, EHBM; Habets, P; Jacobs, HIL; Mengelers, R; Rozendaal, N; van Os, J; Marcelis, M				Gronenschild, Ed H. B. M.; Habets, Petra; Jacobs, Heidi I. L.; Mengelers, Ron; Rozendaal, Nico; van Os, Jim; Marcelis, Machteld			The Effects of FreeSurfer Version, Workstation Type, and Macintosh Operating System Version on Anatomical Volume and Cortical Thickness Measurements	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; MRI; SEGMENTATION; HIPPOCAMPAL; RELIABILITY; DISEASE	FreeSurfer is a popular software package to measure cortical thickness and volume of neuroanatomical structures. However, little if any is known about measurement reliability across various data processing conditions. Using a set of 30 anatomical T1-weighted 3T MRI scans, we investigated the effects of data processing variables such as FreeSurfer version (v4.3.1, v4.5.0, and v5.0.0), workstation (Macintosh and Hewlett-Packard), and Macintosh operating system version (OSX 10.5 and OSX 10.6). Significant differences were revealed between FreeSurfer version v5.0.0 and the two earlier versions. These differences were on average 8.8 +/- 6.6% (range 1.3-64.0%) (volume) and 2.8 +/- 1.3% (1.1-7.7%) (cortical thickness). About a factor two smaller differences were detected between Macintosh and Hewlett-Packard workstations and between OSX 10.5 and OSX 10.6. The observed differences are similar in magnitude as effect sizes reported in accuracy evaluations and neurodegenerative studies. The main conclusion is that in the context of an ongoing study, users are discouraged to update to a new major release of either FreeSurfer or operating system or to switch to a different type of workstation without repeating the analysis; results thus give a quantitative support to successive recommendations stated by FreeSurfer developers over the years. Moreover, in view of the large and significant cross-version differences, it is concluded that formal assessment of the accuracy of FreeSurfer is desirable.	[Gronenschild, Ed H. B. M.; Habets, Petra; Jacobs, Heidi I. L.; Mengelers, Ron; Rozendaal, Nico; van Os, Jim; Marcelis, Machteld] Maastricht Univ, Med Ctr, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci,Dept Psychiat & Neurop, Maastricht, Netherlands; [Gronenschild, Ed H. B. M.; Habets, Petra; Jacobs, Heidi I. L.; Mengelers, Ron; Rozendaal, Nico; van Os, Jim; Marcelis, Machteld] Maastricht Univ, European Grad Sch Neurosci EURON, Maastricht, Netherlands; [Jacobs, Heidi I. L.] Res Ctr Julich, Inst Neurosci & Med 3, Cognit Neurol Sect, Julich, Germany; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University; Helmholtz Association; Research Center Julich; University of London; King's College London	Gronenschild, EHBM (corresponding author), Maastricht Univ, Med Ctr, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci,Dept Psychiat & Neurop, Maastricht, Netherlands.	ed.gronenschild@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Jacobs, Heidi/E-9550-2011; Habets, Petra/AAZ-1258-2021; van Os, Jim/I-9496-2012	van Os, Jim/0000-0002-7245-1586; Jacobs, Heidi/0000-0001-7620-3822; Habets, Petra/0000-0001-9184-517X; van Os, Jim/0000-0002-7245-1586; Marcelis, Machteld/0000-0003-0045-9244	Geestkracht program of the Dutch Health Research Council (ZON-MW) [10-000-1002]; European Community's Seventh Framework Program (Project EU-GEI) [HEALTH-F2-2009-241909]	Geestkracht program of the Dutch Health Research Council (ZON-MW); European Community's Seventh Framework Program (Project EU-GEI)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002), and the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Echavarri C, 2011, BRAIN STRUCT FUNCT, V215, P265, DOI 10.1007/s00429-010-0283-8; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; NYLENNA M, 1991, BRIT MED J, V302, P1182, DOI 10.1136/bmj.302.6786.1182; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9	34	230	232	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38234	10.1371/journal.pone.0038234	http://dx.doi.org/10.1371/journal.pone.0038234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675527	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900018
J	Hindell, MA; Lydersen, C; Hop, H; Kovacs, KM				Hindell, Mark A.; Lydersen, Christian; Hop, Haakon; Kovacs, Kit M.			Pre-Partum Diet of Adult Female Bearded Seals in Years of Contrasting Ice Conditions	PLOS ONE			English	Article							ERIGNATHUS-BARBATUS; STABLE-ISOTOPES; ZOOPLANKTON COMMUNITY; FORAGING STRATEGIES; MARINE MAMMALS; FEEDING-HABITS; PHOCA-HISPIDA; BERING-SEA; SVALBARD; BEHAVIOR	Changing patterns of sea-ice distribution and extent have measurable effects on polar marine systems. Beyond the obvious impacts of key-habitat loss, it is unclear how such changes will influence ice-associated marine mammals in part because of the logistical difficulties of studying foraging behaviour or other aspects of the ecology of large, mobile animals at sea during the polar winter. This study investigated the diet of pregnant bearded seals (Erignathus barbatus) during three spring breeding periods (2005, 2006 and 2007) with markedly contrasting ice conditions in Svalbard using stable isotopes (delta C-13 and delta N-15) measured in whiskers collected from their newborn pups. The delta N-15 values in the whiskers of individual seals ranged from 11.95 to 17.45 parts per thousand, spanning almost 2 full trophic levels. Some seals were clearly dietary specialists, despite the species being characterised overall as a generalist predator. This may buffer bearded seal populations from the changes in prey distributions lower in the marine food web which seems to accompany continued changes in temperature and ice cover. Comparisons with isotopic signatures of known prey, suggested that benthic gastropods and decapods were the most common prey. Bayesian isotopic mixing models indicated that diet varied considerably among years. In the year with most fast-ice (2005), the seals had the greatest proportion of pelagic fish and lowest benthic invertebrate content, and during the year with the least ice (2006), the seals ate more benthic invertebrates and less pelagic fish. This suggests that the seals fed further offshore in years with greater ice cover, but moved in to the fjords when ice-cover was minimal, giving them access to different types of prey. Long-term trends of sea ice decline, earlier ice melt, and increased water temperatures in the Arctic are likely to have ecosystem-wide effects, including impacts on the forage bases of pagophilic seals.	[Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia; [Lydersen, Christian; Hop, Haakon; Kovacs, Kit M.] Norwegian Polar Res Inst, Tromso, Norway	University of Tasmania; Norwegian Polar Institute	Hindell, MA (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia.	mark.hindell@utas.edu.au	Hindell, Mark A/C-8368-2013; Hindell, Mark A/K-1131-2013	Hindell, Mark/0000-0002-7823-7185	Norwegian Research Council; Norwegian Polar Institute; Australian Academy of Science	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Polar Institute; Australian Academy of Science	Funding came from the Norwegian Research Council, the Norwegian Polar Institute and the Australian Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELIS GA, 1994, ARCTIC, V47, P74; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Bowman DMJS, 2010, J BIOGEOGR, V37, P499, DOI 10.1111/j.1365-2699.2009.02206.x; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Casper RM, 2006, J EXP MAR BIOL ECOL, V328, P228, DOI 10.1016/j.jembe.2005.07.009; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cooper MH, 2009, POLAR BIOL, V32, P1137, DOI 10.1007/s00300-009-0614-5; Cottier FR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029948; Dehn LA, 2007, POLAR BIOL, V30, P167, DOI 10.1007/s00300-006-0171-0; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Gjertz I, 2000, POLAR BIOL, V23, P559, DOI 10.1007/s003000000121; Gjertz I, 2000, POLAR BIOL, V23, P651, DOI 10.1007/s003000000143; Gradinger RR, 2004, POLAR BIOL, V27, P595, DOI 10.1007/s00300-004-0630-4; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hjelset AM, 1999, POLAR BIOL, V21, P186, DOI 10.1007/s003000050351; Hobson KA, 2004, MAR MAMMAL SCI, V20, P621, DOI 10.1111/j.1748-7692.2004.tb01183.x; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Kovacs KM, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P97; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Krafft BA, 2000, CAN J ZOOL, V78, P1408, DOI 10.1139/cjz-78-8-1408; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lavigne D.M., 1988, HARPS HOODS ICE BREE; Lydersen C, 1996, J COMP PHYSIOL B, V166, P405, DOI 10.1007/BF02337884; LYDERSEN C, 1994, CAN J ZOOL, V72, P96, DOI 10.1139/z94-013; Lydersen C, 2001, J MAMMAL, V82, P225, DOI 10.1644/1545-1542(2001)082<0225:RCBEBA>2.0.CO;2; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; MARKUS T, 2009, J GEOPHYS RES OCEANS, V114; Marshall CD, 2006, ANAT REC PART A, V288A, P13, DOI 10.1002/ar.a.20273; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Newland C., 2010, MARINE ECOLOGY PROGR, V424, P247; Newsome SD, 2010, MARINE MAMMAL SCI, P9999; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Robinson PW, 2007, DEEP SEA RES 2; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Smith T., 1987, CANADIAN B FISHERIES, V216, P1; Soreide JE, 2006, MAR ECOL PROG SER, V328, P17, DOI 10.3354/meps328017; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; Tverberg V, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005106; Walkusz W, 2009, POLAR RES, V28, P254, DOI 10.1111/j.1751-8369.2009.00107.x; Walsh JE, 2008, ECOL APPL, V18, pS3, DOI 10.1890/06-0503.1; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Willis KJ, 2008, POLAR BIOL, V31, P475, DOI 10.1007/s00300-007-0373-0	59	24	24	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38307	10.1371/journal.pone.0038307	http://dx.doi.org/10.1371/journal.pone.0038307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693616	gold, Green Published			2022-12-25	WOS:000305338500127
J	Turner, P; Turner, C; Jankhot, A; Helen, N; Lee, SJ; Day, NP; White, NJ; Nosten, F; Goldblatt, D				Turner, Paul; Turner, Claudia; Jankhot, Auscharee; Helen, Naw; Lee, Sue J.; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois; Goldblatt, David			A Longitudinal Study of Streptococcus pneumoniae Carriage in a Cohort of Infants and Their Mothers on the Thailand-Myanmar Border	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; EPIDEMIOLOGIC EVIDENCE; LATEX AGGLUTINATION; ACQUIRED-IMMUNITY; INVASIVE DISEASE; CHILDREN YOUNGER; COLONIZATION	Background: Pneumococcal disease is a major cause of childhood death. Almost a third of the world's children live in Southeast Asia, but there are few data from the region on pneumococcal colonization or disease. Our aim was to document the dynamics of pneumococcal carriage in a rural SE Asian birth cohort. Methods: We studied 234 Karen mother-infant pairs in Northwestern Thailand. Infants were followed from birth and nasopharyngeal swabs were taken from mother and infant at monthly intervals until 24 months old. Results: 8,386 swabs were cultured and 4,396 pneumococci characterized. Infants became colonized early (median 45.5 days; 95% confidence interval [CI] 44.5-46.0) and by 24 months had a median of seven (range 0-15) carriage episodes. Maternal smoking and young children in the house were associated with earlier colonization (hazard ratio [HR] 1.5 (95% CI 1.1-2.1) and 1.4 (95% CI 1.0-1.9)). For the four commonest serotypes and non-typeable pneumococci, previous exposure to homologous or heterologous serotypes resulted in an extended interval to reacquisition of the same serotype. Previous colonization by serotypes 14 and 19F was also associated with reduced carriage duration if subsequently reacquired (HR [first reacquisition] 4.1 (95% CI 1.4-12.6) and 2.6 (1.5-4.7)). Mothers acquired pneumococci less frequently, and carried them for shorter periods, than infants (acquisition rate 0.5 vs. 1.1/100 person-days, p<0.001; median duration 31.0 vs. 60.5 days, p = 0.001). 55.8% of pneumococci from infants were vaccine serotypes (13-valent pneumococcal conjugate vaccine, PCV13), compared with 27.5% from mothers (p<0.001). Non-typeable pneumococcal carriage was common, being carried at least once by 55.1% of infants and 32.0% of mothers. Conclusions: Pneumococcal carriage frequency and duration are influenced by previous exposure to both homologous and heterologous serotypes. These data will inform vaccination strategies in this population.	[Turner, Paul; Turner, Claudia; Jankhot, Auscharee; Helen, Naw; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Paul; Turner, Claudia; Lee, Sue J.; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Paul; Turner, Claudia; Lee, Sue J.; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England; [Goldblatt, David] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of London; University College London	Turner, P (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	pault@tropmedres.ac	Goldblatt, David/C-5972-2008; White, Nicholas J/I-4629-2012; Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019	Goldblatt, David/0000-0002-0769-5242; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Turner, Paul/0000-0002-1013-7815	Wellcome Trust of Great Britain [083735/Z/07/Z]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust of Great Britain (Grant No. 083735/Z/07/Z to PT). Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; ANIANSSON G, 1992, J INFECT DIS, V165, pS38, DOI 10.1093/infdis/165-Supplement_1-S38; [Anonymous], PNEUM ANT KIT INS; [Anonymous], 2011, 10 COUNTRIES INTRO A; Coles CL, 2001, PEDIATR INFECT DIS J, V20, P289, DOI 10.1097/00006454-200103000-00014; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; GRATTEN M, 1986, BIOL NEONATE, V50, P114, DOI 10.1159/000242576; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Guo Z, 2008, METHOD INFORM MED, V47, P107, DOI 10.3414/ME0478; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jebaraj R, 1999, EPIDEMIOL INFECT, V123, P383, DOI 10.1017/S0950268899003131; LAFONG AC, 1988, J CLIN PATHOL, V41, P230, DOI 10.1136/jcp.41.2.230; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lin TY, 2010, VACCINE, V28, P7589, DOI 10.1016/j.vaccine.2010.07.053; Lopez B, 1999, EUR J CLIN MICROBIOL, V18, P771, DOI 10.1007/s100960050399; Marsh R, 2010, J CLIN MICROBIOL, V48, P831, DOI 10.1128/JCM.01701-09; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Salter SJ, 2012, MICROBIOLOG IN PRESS; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Sleeman KL, 2005, PEDIATR INFECT DIS J, V24, P121, DOI 10.1097/01.inf.0000151030.10159.b1; Spellerberg B, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P412; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Turner P, 2012, CLIN MICROB IN PRESS; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; VENKATESWARAN PS, 1983, J INFECT DIS, V147, P1041, DOI 10.1093/infdis/147.6.1041; Vives M, 1997, PEDIATR INFECT DIS J, V16, P852, DOI 10.1097/00006454-199709000-00007; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	43	94	94	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38271	10.1371/journal.pone.0038271	http://dx.doi.org/10.1371/journal.pone.0038271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693610	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500121
J	Maicas, M; Vazquez, I; Vicente, C; Garcia-Sanchez, MA; Marcotegui, N; Urquiza, L; Calasanz, MJ; Odero, MD				Maicas, M.; Vazquez, I.; Vicente, C.; Garcia-Sanchez, M. A.; Marcotegui, N.; Urquiza, L.; Calasanz, M. J.; Odero, M. D.			Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription	ONCOGENE			English	Article						EVI1; promoter; AML; RUNX1; ELK1	POINT MUTATIONS; ETS FAMILY; EXPRESSION; DIFFERENTIATION; ONCOGENE; CELLS; PHOSPHORYLATION; ACTIVATION; GATA-1; DOMAIN	The EVI1 gene (3q26) codes for a transcription factor with important roles in normal hematopoiesis and leukemogenesis. High expression of EVI1 is a negative prognostic indicator of survival in acute myeloid leukemia (AML) irrespective of the presence of 3q26 rearrangements. However, the only known mechanisms that lead to EVI1 overexpression are 3q aberrations, and the MLL-ENL oncoprotein, which activates the transcription of EVI1 in hematopoietic stem cells. Our aim was to characterize the functional promoter region of EVI1, and to identify transcription factors involved in the regulation of this gene. Generation of seven truncated constructs and luciferase reporter assays allowed us to determine a 318-bp region as the minimal promoter region of EVI1. Site-directed mutagenesis and chromatin immunoprecipitation (ChIP) assays identified RUNX1 and ELK1 as putative transcription factors of EVI1. Furthermore, knockdown of RUNX1 and ELK1 led to EVI1 downregulation, and their overexpression to upregulation of EVI1. Interestingly, in a series of patient samples with AML at diagnosis, we found a significant positive correlation between EVI1 and RUNX1 at protein level. Moreover, we identified one of the roles of RUNX1 in the activation of EVI1 during megakaryocytic differentiation. EVI1 knockdown significantly inhibited the expression of megakaryocytic markers after treating K562 cells with TPA, as happens when knocking down RUNX1. In conclusion, we define the minimal promoter region of EVI1 and demonstrate that RUNX1 and ELK1, two proteins with essential functions in hematopoiesis, regulate EVI1 in AML. Furthermore, our results show that one of the mechanisms by which RUNX1 regulates the transcription of EVI1 is by acetylation of the histone H3 on its promoter region. This study opens new directions to further understand the mechanisms of EVI1 overexpressing leukemias. Oncogene (2013) 32, 2069-2078; doi:10.1038/onc.2012.222; published online 11 June 2012	[Maicas, M.; Vazquez, I.; Vicente, C.; Garcia-Sanchez, M. A.; Marcotegui, N.; Urquiza, L.; Odero, M. D.] Univ Navarra, CIMA, Div Oncol, Genet Lab, Pamplona 31008, Spain; [Maicas, M.; Calasanz, M. J.; Odero, M. D.] Univ Navarra, Dept Genet, Pamplona 31008, Spain	University of Navarra; University of Navarra	Odero, MD (corresponding author), Univ Navarra, CIMA, Div Oncol, Genet Lab, C Pio 12,55, Pamplona 31008, Spain.	modero@unav.es	Calasanz, MJ/R-5813-2016; Vicente, Carmen/AAA-7098-2021; Maicas, Miren/A-9836-2017; Garcia-Sanchez, Asuncion/AAE-8611-2019; Vázquez, Iria/AAD-4092-2020; Odero/ABG-9860-2020	Calasanz, MJ/0000-0002-0374-3008; Vicente, Carmen/0000-0002-3363-3459; Maicas, Miren/0000-0003-1404-5552; Garcia-Sanchez, Asuncion/0000-0002-9655-4918; Vázquez, Iria/0000-0003-0027-6384; Odero/0000-0002-8858-2054	Ministerio Educacion y Ciencia [AP2007-03879]; Ministerio Ciencia e Innovacion [PI081687]; Departamento Salud del Gobierno de Navarra [14/2008]; ISCIII-RTICC [RD06/0020/0078]; Fundacion para la Investigacion Medica Aplicada y UTE (Spain)	Ministerio Educacion y Ciencia(Spanish Government); Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departamento Salud del Gobierno de Navarra; ISCIII-RTICC(Instituto de Salud Carlos III); Fundacion para la Investigacion Medica Aplicada y UTE (Spain)	We thank Dr Hipskind (Hannover Medical School, Germany) for the plasmid pCDNA3-ELK1, Dr Zhang (Department of Molecular and Experimental Medicine, La Jolla, CA, USA) for the plasmid pFlagCMV2-AML1B (Addgene plasmid 12504), and Dr Arenas and Dr Guruceaga (Department of Proteomics, Genomics and Bioinformatics, CIMA) for technical support. This work was supported by Ministerio Educacion y Ciencia (AP2007-03879), Ministerio Ciencia e Innovacion (PI081687), Departamento Salud del Gobierno de Navarra (14/2008), ISCIII-RTICC (RD06/0020/0078) and Fundacion para la Investigacion Medica Aplicada y UTE (Spain).	Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Aytekin M, 2005, GENE, V356, P160, DOI 10.1016/j.gene.2005.04.032; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Bingemann SC, 2009, FEBS J, V276, P6810, DOI 10.1111/j.1742-4658.2009.07398.x; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; Goldfarb AN, 2009, J CELL BIOCHEM, V107, P377, DOI 10.1002/jcb.22142; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Haas K, 2008, GENE CHROMOSOME CANC, V47, P288, DOI 10.1002/gcc.20532; Langabeer SE, 2002, GENE CHROMOSOME CANC, V34, P24, DOI 10.1002/gcc.10031; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; Nucifora G, 2006, GENE, V368, P1, DOI 10.1016/j.gene.2005.09.020; Oakford PC, 2010, LEUKEMIA RES, V34, P1203, DOI 10.1016/j.leukres.2010.03.029; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Senyuk V, 2007, CANCER RES, V67, P5658, DOI 10.1158/0008-5472.CAN-06-3962; Shimizu S, 2002, BIOCHEM BIOPH RES CO, V292, P609, DOI 10.1006/bbrc.2002.6693; Terui K, 2000, TOHOKU J EXP MED, V192, P259, DOI 10.1620/tjem.192.259; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Yasar D, 2010, CANCER GENET CYTOGEN, V197, P122, DOI 10.1016/j.cancergencyto.2009.11.018; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang L, 2003, J BIOL CHEM, V278, P33097, DOI 10.1074/jbc.M303972200	35	13	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2069	2078		10.1038/onc.2012.222	http://dx.doi.org/10.1038/onc.2012.222			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22689058				2022-12-25	WOS:000317919900008
J	Adhikary, R; Yu, WN; Oda, M; Zimmermann, J; Romesberg, FE				Adhikary, Ramkrishna; Yu, Wayne; Oda, Masayuki; Zimmermann, Joerg; Romesberg, Floyd E.			Protein Dynamics and the Diversity of an Antibody Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; PHOTON-ECHO SPECTROSCOPY; MOONLIGHTING PROTEINS; MOLECULAR RECOGNITION; SOLVATION DYNAMICS; IMMUNOLOGICAL EVOLUTION; CATALYTIC PROMISCUITY; COMBINING SITE; FLEXIBILITY; BINDING	The immune system is remarkable in its ability to produce antibodies (Abs) with virtually any specificity from a limited repertoire of germ line precursors. Although the contribution of sequence diversity to this molecular recognition has been studied for decades, recent models suggest that protein dynamics may also broaden the range of targets recognized. To characterize the contribution of protein dynamics to immunological molecular recognition, we report the sequence, thermodynamic, and time-resolved spectroscopic characterization of a panel of eight Abs elicited to the chromophoric antigen 8-methoxypyrene-1,3,6-trisulfonate (MPTS). Based on the sequence data, three of the Abs arose from unique germ line Abs, whereas the remaining five comprise two sets of siblings that arose by somatic mutation of a common precursor. The thermodynamic data indicate that the Abs recognize MPTS via a variety of mechanisms. Although the spectroscopic data reveal small differences in protein dynamics, the anti-MPTS Abs generally show similar levels of flexibility and conformational heterogeneity, possibly representing the convergent evolution of the dynamics necessary for function. However, one Ab is significantly more rigid and conformationally homogeneous than the others, including a sibling Ab from which it differs by only five somatic mutations. This example of divergent evolution demonstrates that point mutations are capable of fixing significant differences in protein dynamics. The results provide unique insight into how high affinity Abs may be produced that bind virtually any target and possibly, from a more general perspective, how new protein functions are evolved.	[Adhikary, Ramkrishna; Yu, Wayne; Zimmermann, Joerg; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan	Scripps Research Institute; Kyoto Prefectural University	Zimmermann, J (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jzimm@scripps.edu; floyd@scripps.edu	Adhikary, Ramkrishna/F-3002-2011; Zimmermann, Joerg/B-7725-2009; Romesberg, Floyd/M-2821-2017	Romesberg, Floyd/0000-0001-6317-1315; Oda, Masayuki/0000-0002-8568-4223; Adhikary, Ramkrishna/0000-0003-0569-7890; Zimmermann, Joerg/0000-0002-1210-9471	National Science Foundation Grant [CHE-0848902]; Direct For Mathematical & Physical Scien [0848902] Funding Source: National Science Foundation	National Science Foundation Grant(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant CHE-0848902 (to F. E. R.).	Agarwal PK, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-2; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; Breinl F, 1930, H-S Z PHYSIOL CHEM, V192, P45, DOI 10.1515/bchm2.1930.192.1-3.45; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Cho MH, 1996, J PHYS CHEM-US, V100, P11944, DOI 10.1021/jp9601983; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; deBoeij WP, 1996, J PHYS CHEM-US, V100, P11806, DOI 10.1021/jp961039m; DePristo MA, 2007, HFSP J, V1, P94, DOI 10.2976/1.2754665; Dietzek B, 2006, CHEM-EUR J, V12, P5105, DOI 10.1002/chem.200501093; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fleming GR, 1996, ANNU REV PHYS CHEM, V47, P109, DOI 10.1146/annurev.physchem.47.1.109; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gao JL, 2004, TOP CURR CHEM, V238, P113, DOI 10.1007/b94541; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Groot ML, 1998, J PHYS CHEM B, V102, P5923, DOI 10.1021/jp9808680; HARLOW E, 1988, ANTIBODIES LABORATOR, P72; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; Jimenez R, 2004, P NATL ACAD SCI USA, V101, P3803, DOI 10.1073/pnas.0305745101; Jimenez R, 2002, J PHYS CHEM B, V106, P1090, DOI 10.1021/jp013110g; Jordanides XJ, 1999, J PHYS CHEM B, V103, P7995, DOI 10.1021/jp9910993; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kang JH, 2007, MOL IMMUNOL, V44, P3623, DOI 10.1016/j.molimm.2007.03.006; Larsen DS, 1999, J CHEM PHYS, V111, P8970, DOI 10.1063/1.480240; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Mukamel S., 1995, PRINCIPLES NONLINEAR; Nagasawa Y, 1997, J CHEM PHYS, V106, P4840, DOI 10.1063/1.473533; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Passino SA, 1997, J PHYS CHEM A, V101, P725, DOI 10.1021/jp9621383; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; Piatigorsky J., 2007, GENE SHARING EVOLUTI; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; Silverstein AM, 2003, NAT IMMUNOL, V4, P829, DOI 10.1038/ni0903-829; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Steele E. J., 1990, SOMATIC HYPERMUTATIO; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; ULRICH HD, 1995, P NATL ACAD SCI USA, V92, P11907, DOI 10.1073/pnas.92.25.11907; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WIEDERRECHT GP, 1995, J PHYS CHEM-US, V99, P8918, DOI 10.1021/j100021a069; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zimmermann J., 2009, PROTEIN ENG HDB, P147; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	60	22	22	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27139	27147		10.1074/jbc.M112.372698	http://dx.doi.org/10.1074/jbc.M112.372698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685303	Green Published, hybrid			2022-12-25	WOS:000307386000066
J	Cao, X; Yang, F; Zheng, J; Wang, KW				Cao, Xu; Yang, Fan; Zheng, Jie; Wang, Kewei			Intracellular Proton-mediated Activation of TRPV3 Channels Accounts for the Exfoliation Effect of alpha-Hydroxyl Acids on Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNELS; CAPSAICIN RECEPTOR; 2-AMINOETHOXYDIPHENYL BORATE; GLYCOLIC ACID; ION CHANNELS; NOCICEPTIVE NEURONS; COMMON ACTIVATOR; CHORDA TYMPANI; CATION CHANNEL; HAIR-GROWTH	alpha-Hydroxyl acids (AHAs) from natural sources act as proton donors and topical compounds that penetrate skin and are well known in the cosmetic industry for their use in chemical peels and improvement of the skin. However, little is known about how AHAs cause exfoliation to expose fresh skin cells. Here we report that the transient receptor potential vanilloid 3 (TRPV3) channel in keratinocytes is potently activated by intracellular acidification induced by glycolic acid. Patch clamp recordings and cell death assay of both human keratinocyte HaCaT cells and TRPV3-expressing HEK-293 cells confirmed that intracellular acidification led to direct activation of TRPV3 and promoted cell death. Site-directed mutagenesis revealed that an N-terminal histidine residue, His-426, known to be involved in 2-aminoethyl diphenylborinate-mediated TRPV3 activation, is critical for sensing intracellular proton levels. Taken together, our findings suggest that intracellular protons can strongly activate TRPV3, and TRPV3-mediated proton sensing and cell death in keratinocytes may serve as a molecular basis for the cosmetic use of AHAs and their therapeutic potential in acidic pH-related skin disorders.	[Cao, Xu; Yang, Fan; Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Cao, Xu; Wang, Kewei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Wang, Kewei] Peking Univ, Dept Mol & Cellular Pharmacol, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China	University of California System; University of California Davis; Peking University; Peking University	Zheng, J (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	jzheng@ucdavis.edu; wangkw@bjmu.edu.cn	Cao, Xu/G-6209-2015; Yang, Fan/J-4562-2015; Yang, Fan/AAA-6904-2022; Yang, Fan/GYU-4249-2022; Yang, Fan/C-6586-2012; Zhu, Ren-Yuan/V-8966-2019	Cao, Xu/0000-0003-1796-2735; Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-0520-5254; Yang, Fan/0000-0002-9406-7710; Zhu, Ren-Yuan/0000-0003-3091-7461	National Institutes of Health [R01NS072377]; National Science Foundation of China [30970919]; Ministry of Education of China 111 Project China [B07001]; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China 111 Project China; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS072377 (to J. Z.) and Research Grant 30970919 from the National Science Foundation of China, the Ministry of Education of China 111 Project China (B07001) (to K. W. W.), and the China Scholarship Council (to X. C.).	Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bang S, 2012, BRIT J PHARMACOL, V165, P683, DOI 10.1111/j.1476-5381.2011.01568.x; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Baumann TK, 2000, J NEUROSCI, V20; Bergfeld W., 1997, J AM ACAD DERMATOL, V36, P1011; Borbiro I, 2011, J INVEST DERMATOL, V131, P1605, DOI 10.1038/jid.2011.122; Boron W. F, 2005, MED PHYSL, P633; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2012, J BIOL CHEM, V287, P7279, DOI 10.1074/jbc.M111.305045; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clark CP, 1996, CLIN PLAST SURG, V23, P49; Colton C. K., 2007, V179, P173; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; Davidge KS, 2009, ADV MICROB PHYSIOL, V56, P85, DOI 10.1016/S0065-2911(09)05603-3; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; DiNardo JC, 1996, DERMATOL SURG, V22, P421, DOI 10.1111/j.1524-4725.1996.tb00341.x; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; GUTKNECHT J, 1992, MOL CELL BIOCHEM, V114, P3; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; Hamamoto T, 2008, ACTA OTO-LARYNGOL, V128, P685, DOI 10.1080/00016480701669489; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Imura K, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-17; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Kim Seong-Jin, 1998, Journal of Dermatology (Tokyo), V25, P85; Kurtzweil P, 1998, FDA Consum, V32, P30; Lee J, 2008, J DERMATOL SCI, V52, P160, DOI 10.1016/j.jdermsci.2008.06.007; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2011, J GEN PHYSIOL, V138, P509, DOI 10.1085/jgp.201110689; MAIDORN RP, 1993, BRIT J CANCER, V67, P297, DOI 10.1038/bjc.1993.56; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Montell C, 2010, CELL, V141, P218, DOI 10.1016/j.cell.2010.03.043; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; MOY LS, 1993, J DERMATOL SURG ONC, V19, P243, DOI 10.1111/j.1524-4725.1993.tb00343.x; Moy LS, 1996, DERMATOL SURG, V22, P439, DOI 10.1111/j.1524-4725.1996.tb00344.x; Nassini R, 2010, CURR OPIN INVEST DR, V11, P535; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Reilly RM, 2011, CURR TOP MED CHEM, V11, P2210; ROENIGK HH, 1995, DERMATOL CLIN, V13, P245, DOI 10.1016/S0733-8635(18)30079-2; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Shimada Shoichi, 2004, Nihon Shinkei Seishin Yakurigaku Zasshi, V24, P243; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Steinhoff M, 2009, J INVEST DERMATOL, V129, P531, DOI 10.1038/jid.2008.440; Thueson DO, 1998, DERMATOL SURG, V24, P641, DOI 10.1111/j.1524-4725.1998.tb04221.x; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tung R C, 2000, Am J Clin Dermatol, V1, P81, DOI 10.2165/00128071-200001020-00002; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Vidt DG, 1997, CLEV CLIN J MED, V64, P327, DOI 10.3949/ccjm.64.6.327; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	82	44	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25905	25916		10.1074/jbc.M112.364869	http://dx.doi.org/10.1074/jbc.M112.364869			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679014	hybrid, Green Published			2022-12-25	WOS:000306916300019
J	Hu, X; Paul, A; Wang, B				Hu, Xin; Paul, Atanu; Wang, Bin			Rap80 Protein Recruitment to DNA Double-strand Breaks Requires Binding to Both Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; TARGETS BRCA1; SITES; IDENTIFICATION; SUMOYLATION; PATHWAY; COMPLEX; CCDC98; REPAIR; UBC9	Ubiquitin (Ub) modifications at sites of DNA double-strand breaks (DSBs) play critical roles in the assembly of signaling and repair proteins. The Ub-interacting motif (UIM) domain of Rap80, which is a component of the BRCA1-A complex, interacts with Ub Lys-63 linkage conjugates and mediates the recruitment of BRCA1 to DSBs. Small ubiquitin-like modifier (SUMO) conjugation also occurs at DSBs and promotes Ub-dependent recruitment of BRCA1, but its molecular basis is not clear. In this study, we identified that Rap80 possesses a SUMO-interacting motif (SIM), capable of binding specifically to SUMO2/3 conjugates, and forms a tandem SIM-UIM-UIM motif at its N terminus. The SIM-UIM-UIM motif binds to both Ub Lys-63 linkage and SUMO2 conjugates. Both the SIM and UIM domains are required for efficient recruitment of Rap80 to DSBs immediately after damage and confer cellular resistance to ionizing radiation. These findings propose a model in which SUMO and Ub modification is coordinated to recruit Rap80 and BRCA1 to DNA damage sites.	[Hu, Xin; Paul, Atanu; Wang, Bin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Paul, Atanu; Wang, Bin] Univ Texas Grad Sch Biomed Sci, Genes & Dev Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bwang3@mdanderson.org	Paul, Atanu/J-5720-2019	Paul, Atanu/0000-0002-9967-6005	National Institutes of Health Grant from NCI [CA155025]; Mel Klein Family Fund; Sidney Kimmel scholar award; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA155025] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; Mel Klein Family Fund; Sidney Kimmel scholar award; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA155025 from NCI, the Mel Klein Family Fund, a Sidney Kimmel scholar award, and funds from University of Texas MD Anderson Cancer Center.	Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-6; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Yan J, 2007, BIOCHEM BIOPH RES CO, V362, P132, DOI 10.1016/j.bbrc.2007.07.158	31	57	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25510	25519		10.1074/jbc.M112.374116	http://dx.doi.org/10.1074/jbc.M112.374116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22689573	Green Published, hybrid			2022-12-25	WOS:000306651700057
J	Jinwal, UK; Abisambra, JF; Zhang, J; Dharia, S; O'Leary, JC; Patel, T; Braswell, K; Jani, T; Gestwicki, JE; Dickey, CA				Jinwal, Umesh K.; Abisambra, Jose F.; Zhang, Juan; Dharia, Sheetal; O'Leary, John C.; Patel, Tina; Braswell, Kaitlyn; Jani, Twisha; Gestwicki, Jason E.; Dickey, Chad A.			Cdc37/Hsp90 Protein Complex Disruption Triggers an Autophagic Clearance Cascade for TDP-43 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN-43; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; HEAT-SHOCK-PROTEIN; ALZHEIMERS-DISEASE; HSP90 COCHAPERONE; RECEPTOR FUNCTION; CELL-DEATH; NUCLEAR; TAU	The RNA-binding protein, trans-active response DNA-binding protein 43 (TDP-43), is normally found in the nucleus, but in amyotrophic lateral sclerosis, frontal temporal dementia, and some cases of Alzheimer disease it is cleaved and mislocalized to the cytosol, leading to accumulation. The mechanisms contributing to this are largely unknown. Here, we show that part of the normal clearance cascade for TDP-43 involves the Cdc37/Hsp90 complex. An Hsp90 inhibitor that disrupts the Cdc37/Hsp90 complex reduced TDP-43 levels to a greater extent than a standard Hsp90 ATPase inhibitor. When Cdc37 was depleted, TDP-43 underwent proteolytic clearance that was dependent on nuclear retrotranslocation and autophagic uptake. Accumulation of the microtubule-associated protein tau prevented the clearance of cleaved TDP-43, but not its production. This caused cleaved TDP-43 to accumulate, a feature observed in the brain of persons with Alzheimer disease. Clearance of cleaved TDP-43 was also prevented by knockdown of the autophagic inducer beclin1. Thus, in cells where TDP-43 clearance is normally needed, a system that employs manipulation of the Hsp90 complex and autophagy exists. But when tau accumulation is occurring, cleaved TDP-43 can no longer be cleared, perhaps explaining the emergence of these co-pathologies.	[Jinwal, Umesh K.; Zhang, Juan; Dharia, Sheetal; Patel, Tina; Braswell, Kaitlyn; Jani, Twisha] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Tampa, FL 33613 USA; [Abisambra, Jose F.; O'Leary, John C.; Dickey, Chad A.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Michigan System; University of Michigan	Jinwal, UK (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	ujinwal@health.usf.edu; cdickey@health.usf.edu	Abisambra, Jose/V-6860-2019; Abisambra, Joe/AAP-3269-2020	Abisambra, Jose/0000-0001-6341-679X; 	National Institutes of Health [NS059690]; University of Michigan Alzheimer's Disease Center; Alzheimer's Association [IIRG-07-60067]; National Institutes of Health through NIA through NINDS [R00AG031291, R01NS073899]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899, R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Alzheimer's Disease Center; Alzheimer's Association(Alzheimer's Association); National Institutes of Health through NIA through NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health Grant NS059690, the University of Michigan Alzheimer's Disease Center, and the Alzheimer's Association Grant IIRG-07-60067.; Supported by National Institutes of Health Grant NS059690 and National Institutes of Health Grants R00AG031291 through the NIA and R01NS073899 through the NINDS. To whom correspondence may be addressed:. Dept of Molecular Medicine, USF Health Byrd Alzheimer's Institute, University of South Florida, 4001 E. Fletcher Ave., MDC 36, Tampa, FL 33613. Tel.: 813-396-0639; Fax: 813-866-1601; E-mail: cdickey@health.usf.edu.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo Ana Maria, 2003, Sci Aging Knowledge Environ, V2003, ppe25, DOI 10.1126/sageke.2003.36.pe25; D'Mello SR, 2000, J NEUROSCI RES, V59, P24, DOI 10.1002/(SICI)1097-4547(20000101)59:1<24::AID-JNR4>3.3.CO;2-#; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Jinwal UK, 2011, J BIOL CHEM, V286, P16976, DOI 10.1074/jbc.M110.182493; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin YC, 2002, PHYTOCHEMISTRY, V59, P469, DOI 10.1016/S0031-9422(01)00470-8; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; PRATT WB, 1992, BIOESSAYS, V14, P841, DOI 10.1002/bies.950141209; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	47	49	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24814	24820		10.1074/jbc.M112.367268	http://dx.doi.org/10.1074/jbc.M112.367268			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22674575	Green Published, hybrid			2022-12-25	WOS:000306651100074
J	Khalili, S; Liu, YN; Kornete, M; Roescher, N; Kodama, S; Peterson, A; Piccirillo, CA; Tran, SD				Khalili, Saeed; Liu, Younan; Kornete, Mara; Roescher, Nienke; Kodama, Shohta; Peterson, Alan; Piccirillo, Ciriaco A.; Tran, Simon D.			Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjogren's-Like Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NONOBESE DIABETIC MICE; REGULATORY T-CELLS; STEM-CELLS; NOD MICE; AUTOIMMUNE-DISEASES; EPITHELIAL-CELLS; GLANDS; REVERSAL; PATHOGENESIS	Background: Non-obese diabetic (NOD) mice develop Sjogren's-like disease (SS-like) with loss of saliva flow and increased lymphocytic infiltrates in salivary glands (SGs). There are recent reports using multipotent mesenchymal stromal cells (MSCs) as a therapeutic strategy for autoimmune diseases due to their anti-inflammatory and immunomodulatory capabilities. This paper proposed a combined immuno-and cell-based therapy consisting of: A) an injection of complete Freund's adjuvant (CFA) to eradicate autoreactive T lymphocytes, and B) transplantations of MSCs to reselect lymphocytes. The objective of this was to test the effectiveness of CD45(-)/TER119(-) cells (MSCs) in re-establishing salivary function and in reducing the number of lymphocytic infiltrates (foci) in SGs. The second objective was to study if the mechanisms underlying a decrease in inflammation (focus score) was due to CFA, MSCs, or CFA+MSCs combined. Methodology/Principal Findings: Donor MSCs were isolated from bones of male transgenic eGFP mice. Eight week-old female NOD mice received one of the following treatments: insulin, CFA, MSC, or CFA+ MSC (combined therapy). Mice were followed for 14 weeks post-therapy. CD45(-)/TER119(-) cells demonstrated characteristics of MSCs as they were positive for Sca-1, CD106, CD105, CD73, CD29, CD44, negative for CD45, TER119, CD11b, had high number of CFU-F, and differentiated into osteocytes, chondrocytes and adipocytes. Both MSC and MSC+ CFA groups prevented loss of saliva flow and reduced lymphocytic infiltrations in SGs. Moreover, the influx of T and B cells decreased in all foci in MSC and MSC+CFA groups, while the frequency of Foxp3(+) (T-reg) cell was increased. MSC-therapy alone reduced inflammation (TNF-alpha, TGF-beta), but the combination of MSC+ CFA reduced inflammation and increased the regenerative potential of SGs (FGF-2, EGF). Conclusions/Significance: The combined use of MSC+ CFA was effective in both preventing saliva secretion loss and reducing lymphocytic influx in salivary glands.	[Khalili, Saeed; Liu, Younan; Tran, Simon D.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Kornete, Mara; Piccirillo, Ciriaco A.] Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kornete, Mara; Piccirillo, Ciriaco A.] FOCIS Ctr Excellence, Montreal, PQ, Canada; [Roescher, Nienke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kodama, Shohta] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Fukuoka 81401, Japan; [Peterson, Alan] McGill Univ, Fac Med, Montreal, PQ, Canada	McGill University; University of Amsterdam; Academic Medical Center Amsterdam; Fukuoka University; McGill University	Khalili, S (corresponding author), McGill Univ, Fac Dent, Montreal, PQ, Canada.	simon.tran@mcgill.ca			Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA); Canada Research Chairs (CRC); CIHR [MOP67211]; FRSQ doctoral fellowship; Grants-in-Aid for Scientific Research [22501054] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC)(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ doctoral fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA), and the Canada Research Chairs (CRC). The authors also acknowledge the financial support of CIHR grant MOP67211 (CP). MK is a recipient of a FRSQ doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayetto K, 2010, AUST DENT J, V55, P39, DOI 10.1111/j.1834-7819.2010.01197.x; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Delaleu N, 2005, EUR J ORAL SCI, V113, P101, DOI 10.1111/j.1600-0722.2004.00183.x; Delaleu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3313; Dieguez-Acuna F, 2007, LEUKEMIA, V21, P2192, DOI 10.1038/sj.leu.2404927; Dieguez-Acuna F, 2010, INT J BIOCHEM CELL B, V42, P1651, DOI 10.1016/j.biocel.2009.12.001; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Faustman DL, 2010, INT J BIOCHEM CELL B, V42, P1576, DOI 10.1016/j.biocel.2010.06.012; Fujisawa K, 2003, J ORAL PATHOL MED, V32, P358, DOI 10.1034/j.1600-0714.2003.t01-1-00111.x; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Jonsson MV, 2007, CLIN REV ALLERG IMMU, V32, P215, DOI 10.1007/s12016-007-8012-7; Jonsson MV, 2006, ARTHRITIS RHEUM, V54, P2300, DOI 10.1002/art.21945; Kagami H, 2000, Adv Dent Res, V14, P99; Khalili S, 2010, INT J BIOCHEM CELL B, V42, P1893, DOI 10.1016/j.biocel.2010.08.008; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Koski H, 2001, CLIN EXP RHEUMATOL, V19, P131; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lonyai A, 2008, HORM METAB RES, V40, P137, DOI 10.1055/s-2007-1022560; MacDonald GIA, 2011, ARTHRITIS RHEUM-US, V63, P2547, DOI 10.1002/art.30474; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Nakamura H, 2007, RHEUMATOL INT, V28, P127, DOI 10.1007/s00296-007-0411-9; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Roescher N, 2012, ORAL DIS, V18, P96, DOI 10.1111/j.1601-0825.2011.01852.x; Roescher N, 2009, ORAL DIS, V15, P519, DOI 10.1111/j.1601-0825.2009.01582.x; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Samuni Y, 2008, HUM GENE THER, V19, P279, DOI 10.1089/hum.2007.0136; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; Tran SD, 2006, TISSUE ENG, V12, P2939, DOI 10.1089/ten.2006.12.2939; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999	43	51	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38615	10.1371/journal.pone.0038615	http://dx.doi.org/10.1371/journal.pone.0038615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685592	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700055
J	Ortalli, AL; Fiore, L; Di Napoli, J; Rapacioli, M; Salierno, M; Etchenique, R; Flores, V; Sanchez, V; Carri, NG; Scicolone, G				Laura Ortalli, Ana; Fiore, Luciano; Di Napoli, Jennifer; Rapacioli, Melina; Salierno, Marcelo; Etchenique, Roberto; Flores, Vladimir; Sanchez, Viviana; Gabriel Carri, Nestor; Scicolone, Gabriel			EphA3 Expressed in the Chicken Tectum Stimulates Nasal Retinal Ganglion Cell Axon Growth and Is Required for Retinotectal Topographic Map Formation	PLOS ONE			English	Article							VISUAL-SYSTEM; IN-VIVO; OPTIC TECTUM; EPHRIN-AS; MULTIPLE MECHANISMS; REPULSIVE GUIDANCE; RETROVIRAL VECTORS; NEURAL MAP; RECEPTORS; GRADIENTS	Background: Retinotopic projection onto the tectum/colliculus constitutes the most studied model of topographic mapping and Eph receptors and their ligands, the ephrins, are the best characterized molecular system involved in this process. Ephrin-As, expressed in an increasing rostro-caudal gradient in the tectum/colliculus, repel temporal retinal ganglion cell (RGC) axons from the caudal tectum and inhibit their branching posterior to their termination zones. However, there are conflicting data regarding the nature of the second force that guides nasal axons to invade and branch only in the caudal tectum/colliculus. The predominant model postulates that this second force is produced by a decreasing rostro-caudal gradient of EphA7 which repels nasal optic fibers and prevents their branching in the rostral tectum/colliculus. However, as optic fibers invade the tectum/colliculus growing throughout this gradient, this model cannot explain how the axons grow throughout this repellent molecule. Methodology/Principal Findings: By using chicken retinal cultures we showed that EphA3 ectodomain stimulates nasal RGC axon growth in a concentration dependent way. Moreover, we showed that nasal axons choose growing on EphA3-expressing cells and that EphA3 diminishes the density of interstitial filopodia in nasal RGC axons. Accordingly, in vivo EphA3 ectodomain misexpression directs nasal optic fibers toward the caudal tectum preventing their branching in the rostral tectum. Conclusions: We demonstrated in vitro and in vivo that EphA3 ectodomain (which is expressed in a decreasing rostro-caudal gradient in the tectum) is necessary for topographic mapping by stimulating the nasal axon growth toward the caudal tectum and inhibiting their branching in the rostral tectum. Furthermore, the ability of EphA3 of stimulating axon growth allows understanding how optic fibers invade the tectum growing throughout this molecular gradient. Therefore, opposing tectal gradients of repellent ephrin-As and of axon growth stimulating EphA3 complement each other to map optic fibers along the rostro-caudal tectal axis.	[Laura Ortalli, Ana; Fiore, Luciano; Di Napoli, Jennifer; Flores, Vladimir; Sanchez, Viviana; Scicolone, Gabriel] Univ Buenos Aires, Sch Med, Inst Cell Biol & Neurosci Prof E De Robertis UBA, Dev Neurobiol Lab, Buenos Aires, DF, Argentina; [Gabriel Carri, Nestor] Inst Multidisciplinary Cell Biol CONICET CIC, La Plata, Buenos Aires, Argentina; [Rapacioli, Melina; Flores, Vladimir] Favaloro Univ, Dept Bioestruct Sci, Interdisciplinary Grp Theoret Biol, Buenos Aires, DF, Argentina; [Salierno, Marcelo; Etchenique, Roberto] Univ Buenos Aires, Fac Exact & Nat Sci, Dept Inorgan Analyt & Phys Chem INQUIMAE, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Ortalli, AL (corresponding author), Univ Buenos Aires, Sch Med, Inst Cell Biol & Neurosci Prof E De Robertis UBA, Dev Neurobiol Lab, Buenos Aires, DF, Argentina.	gscicolo@retina.ar	Salierno, Marcelo/AAA-7198-2021; Salierno, Marcelo J/E-5557-2016	Salierno, Marcelo J/0000-0003-3897-3177; Fiore, Luciano/0000-0002-7661-4549	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 03135]; University of Buenos Aires [M 096, M439]; Comision de Investigaciones Cientificas de la Provincia de Buenos Aires [CIC 2010-1]; Agencia Nacional de Promocion Cientifica y Tecnologica [PME-2006-00319]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 03135), University of Buenos Aires (M 096, M439), Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (CIC 2010-1 to Dr NG Carri) and Agencia Nacional de Promocion Cientifica y Tecnologica (PME-2006-00319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevins N, 2011, J NEUROSCI, V31, P10302, DOI 10.1523/JNEUROSCI.1652-11.2011; BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COHEN J, 1989, DEVELOPMENT, V107, P381; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; COWAN WM, 1961, J ANAT, V95, P545; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Gebhardt C, 2012, DEVELOPMENT, V139, P335, DOI 10.1242/dev.070474; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; HALFTER W, 1981, NATURE, V292, P67, DOI 10.1038/292067a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Carreres MI, 2011, J NEUROSCI, V31, P5673, DOI 10.1523/JNEUROSCI.0394-11.2011; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Marin O, 2001, DEV BIOL, V234, P289, DOI 10.1006/dbio.2001.0268; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Muhleisen TW, 2006, DEV BIOL, V297, P59, DOI 10.1016/j.ydbio.2006.04.466; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Poopalasundaram S, 2011, MOL CELL NEUROSCI, V47, P131, DOI 10.1016/j.mcn.2011.03.008; Rapacioli M, 2011, J MORPHOL, V272, P675, DOI 10.1002/jmor.10943; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Sakurai T, 2002, P NATL ACAD SCI USA, V99, P10795, DOI 10.1073/pnas.162161499; Scicolone G, 2006, J COMP NEUROL, V494, P1007, DOI 10.1002/cne.20878; Scicolone G, 1995, INT J DEV NEUROSCI, V13, P845, DOI 10.1016/0736-5748(95)00069-0; Scicolone G, 2009, BRAIN RES BULL, V79, P227, DOI 10.1016/j.brainresbull.2009.03.008; Simpson HD, 2009, CURR TOP DEV BIOL, V87, P1, DOI 10.1016/S0070-2153(09)01201-0; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; Takahashi H, 2009, DEV BIOL, V331, P300, DOI 10.1016/j.ydbio.2009.05.549; Tsigankov D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-155; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yoo S, 2011, EMBO J, V30, P1593, DOI 10.1038/emboj.2011.44; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	61	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38566	10.1371/journal.pone.0038566	http://dx.doi.org/10.1371/journal.pone.0038566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685584	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700047
J	Paratala, BS; Jacobson, BD; Kanakia, S; Francis, LD; Sitharaman, B				Paratala, Bhavna S.; Jacobson, Barry D.; Kanakia, Shruti; Deepak Francis, Leonard; Sitharaman, Balaji			Physicochemical Characterization, and Relaxometry Studies of Micro-Graphite Oxide, Graphene Nanoplatelets, and Nanoribbons	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; HIGH-RELAXIVITY; TEMPERATURE FERROMAGNETISM; CARBON NANOTUBES; CONTRAST AGENTS; GADOLINIUM; T-1; GADOFULLERENES; GADONANOTUBES; COMPLEXES	The chemistry of high-performance magnetic resonance imaging contrast agents remains an active area of research. In this work, we demonstrate that the potassium permanganate-based oxidative chemical procedures used to synthesize graphite oxide or graphene nanoparticles leads to the confinement (intercalation) of trace amounts of Mn2+ ions between the graphene sheets, and that these manganese intercalated graphitic and graphene structures show disparate structural, chemical and magnetic properties, and high relaxivity (up to 2 order) and distinctly different nuclear magnetic resonance dispersion profiles compared to paramagnetic chelate compounds. The results taken together with other published reports on confinement of paramagnetic metal ions within single-walled carbon nanotubes (a rolled up graphene sheet) show that confinement (encapsulation or intercalation) of paramagnetic metal ions within graphene sheets, and not the size, shape or architecture of the graphitic carbon particles is the key determinant for increasing relaxivity, and thus, identifies nano confinement of paramagnetic ions as novel general strategy to develop paramagnetic metal-ion graphitic-carbon complexes as high relaxivity MRI contrast agents.	[Paratala, Bhavna S.; Jacobson, Barry D.; Kanakia, Shruti; Sitharaman, Balaji] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11790 USA; [Deepak Francis, Leonard] Int Iberian Nanotechnol Lab, Braga, Portugal	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Iberian Nanotechnology Laboratory	Paratala, BS (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11790 USA.	bsitharaman@notes.cc.sunsyb.edu	INL, Citations/K-3436-2015; Francis, Leonard/I-5718-2013	INL, Citations/0000-0002-3745-5100; Francis, Leonard/0000-0002-3833-1775; Sitharaman, Balaji/0000-0001-8391-8076; Paratala, Bhavna S/0000-0002-7695-4500	National Institutes of Health [1DP2OD007394-01]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0521]; Wallace H Coulter Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Wallace H Coulter Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was sponsored by National Institutes of Health (grants No. 1DP2OD007394-01), Department of Defense Breast Cancer Research Program (W81XWH-10-1-0521), and the Wallace H Coulter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2002, J BIOL INORG CHEM, V7, P58, DOI 10.1007/s007750100265; Aime S, 1998, CHEM SOC REV, V27, P19, DOI 10.1039/a827019z; Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]; [Anonymous], SIGM ALDR 1 CERT AN; [Anonymous], 2008, INF GAD CONT CONTR A; Bie XF, 2010, SOLID STATE SCI, V12, P1364, DOI 10.1016/j.solidstatesciences.2010.05.010; BRESINSKA I, 1994, J PHYS CHEM-US, V98, P12989, DOI 10.1021/j100100a029; Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Caravan P, 2009, CONTRAST MEDIA MOL I, V4, P89, DOI 10.1002/cmmi.267; Datta A, 2009, ACCOUNTS CHEM RES, V42, P938, DOI 10.1021/ar800250h; Du J, 2006, NANOTECHNOLOGY, V17, P4923, DOI 10.1088/0957-4484/17/19/024; Esquinazi P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024429; Fatouros PP, 2006, RADIOLOGY, V240, P756, DOI 10.1148/radiol.2403051341; Geng Y, 2009, J COLLOID INTERF SCI, V336, P592, DOI 10.1016/j.jcis.2009.04.005; Hak S, 2009, EUR J PHARM BIOPHARM, V72, P397, DOI 10.1016/j.ejpb.2008.09.017; Higginbotham AL, 2010, ACS NANO, V4, P2059, DOI 10.1021/nn100118m; Hoff L, 2001, ACOUSTIC CHARACTERIZ; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Imaging Agents, IM AG; Kato H, 2003, J AM CHEM SOC, V125, P4391, DOI 10.1021/ja027555+; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Kundaliya DC, 2004, NAT MATER, V3, P709, DOI 10.1038/nmat1221; LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Makarova TL, 2004, SEMICONDUCTORS+, V38, P615, DOI 10.1134/1.1766362; Manus LM, 2010, NANO LETT, V10, P484, DOI 10.1021/nl903264h; Mao YL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/20/205708; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pan D, 2010, WILEY INTERDISCIPLIN; Raley JA, 2006, J ALLOY COMPD, V423, P184, DOI 10.1016/j.jallcom.2005.12.107; Rao SS, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113004; Richard C, 2008, NANO LETT, V8, P232, DOI 10.1021/nl072509z; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Schoenhalz AL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3119640; Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a; Sitharaman B, 2007, J BIOMED NANOTECHNOL, V3, P342, DOI 10.1166/jbn.2007.043; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; SUR SK, 1995, J PHYS CHEM-US, V99, P4900, DOI 10.1021/j100014a005; SWIFT TJ, 1962, J CHEM PHYS, V37, P307, DOI 10.1063/1.1701321; Toth E, 2005, J AM CHEM SOC, V127, P799, DOI 10.1021/ja044688h; Troughton JS, 2004, INORG CHEM, V43, P6313, DOI 10.1021/ic049559g; Wang J, 2004, ADV MATER, V16, P137, DOI 10.1002/adma.200306136; Wang S, 2008, NANO LETT, V8, P4020, DOI 10.1021/nl802810g; WHITNEY TM, 1993, SCIENCE, V261, P1316, DOI 10.1126/science.261.5126.1316; Zhou Z, 2010, THIN SOLID FILMS	46	53	53	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38185	10.1371/journal.pone.0038185	http://dx.doi.org/10.1371/journal.pone.0038185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685555	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700018
J	Silva, AX; Bacigalupe, LD; Luna-Rudloff, M; Figueroa, CC				Silva, Andrea X.; Bacigalupe, Leonardo D.; Luna-Rudloff, Manuela; Figueroa, Christian C.			Insecticide Resistance Mechanisms in the Green Peach Aphid Myzus persicae (Hemiptera: Aphididae) II: Costs and Benefits	PLOS ONE			English	Article							POTATO APHID; GENE-EXPRESSION; ESTERASE GENES; HOST-PLANT; HEAT-SHOCK; DETOXIFICATION ENZYMES; PHENOTYPIC PLASTICITY; TRANSGENIC DROSOPHILA; CYSTEINE PROTEASE; HSP70 EXPRESSION	Background: Among herbivorous insects that have exploited agro-ecosystems, the peach-potato aphid, Myzus persicae, is recognized as one of the most important agricultural pests worldwide. Uses over 400 plant species and has evolved different insecticides resistance mechanisms. As M. persicae feeds upon a huge diversity of hosts, it has been exposed to a wide variety of plant allelochemicals, which probably have promoted a wide range of detoxification systems. Methodology/Principal Findings: In this work we (i) evaluated whether insecticide resistance mutations (IRM) in M. persicae can give an advantage in terms of reproductive fitness when aphids face two hosts, pepper (Capsicum annuum) a suitable host and radish (Raphanus sativus) the unfavorable host and (ii) examined the transcriptional expression of six genes that are known to be up-regulated in response to insecticides. Our results show a significant interaction between host and IRM on the intrinsic rate of increase (r(m)). Susceptible genotypes (not carrying insensitivity mutations) had a higher r(m) on pepper, and the transcriptional levels of five genes increased on radish. The r(m) relationship was reversed on the unfavorable host; genotypes with multiple IRM exhibited higher r(m), without altering the transcriptional levels of the studied genes. Genotypes with one IRM kept a similar r(m) on both hosts, but they increased the transcriptional levels of two genes. Conclusions/Significance: Although we have studied only nine genotypes, overall our results are in agreement with the general idea that allelochemical detoxification systems could constitute a pre-adaptation for the development of insecticide resistance. Genotypes carrying IRM exhibited a higher r(m) than susceptible genotypes on radish, the more unfavorable host. Susceptible genotypes should be able to tolerate the defended host by up-regulating some metabolic genes that are also responding to insecticides. Hence, our results suggest that the trade-off among resistance mechanisms might be quite complex, with a multiplicity of costs and benefits depending on the environment.	[Silva, Andrea X.; Bacigalupe, Leonardo D.; Luna-Rudloff, Manuela; Figueroa, Christian C.] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Fac Ciencias, Valdivia, Chile	Universidad Austral de Chile	Silva, AX (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Fac Ciencias, Valdivia, Chile.	christianfigueroa@uach.cl	Figueroa, Christian C./A-1170-2008; Li, Shiguang/G-7471-2012	Figueroa, Christian C./0000-0001-9218-5564; Silva, Andrea/0000-0002-4346-5524	Comision Nacional de Investigacioen Cientifica y Tecnologica (CONICYT); Fondo Nacional de Desarrollo CientUfico y Tecnologico, (FONDECYT0) [1090378]; United States Department of Agriculture [2005-35604-15446]; MECESUP [AUS0805]; DID-UACh	Comision Nacional de Investigacioen Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrollo CientUfico y Tecnologico, (FONDECYT0)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); United States Department of Agriculture(United States Department of Agriculture (USDA)); MECESUP; DID-UACh	This research was funded by Comision Nacional de Investigacioen Cientifica y Tecnologica (CONICYT) doctoral grant to AXS, by Fondo Nacional de Desarrollo CientUfico y Tecnologico, (FONDECYT0 grant No1090378 to CCF and by the United States Department of Agriculture grant No2005-35604-15446 to GJ. The authors also thank partial funding from MECESUP grant AUS0805 and DID-UACh. The authors want to thank Dr. Eduardo Fuentes-Contreras for the insecticide tolerance bioassays.	Anstead JA, 2004, INSECT BIOCHEM MOLEC, V34, P871, DOI 10.1016/j.ibmb.2004.06.002; Anstead JA, 2008, AGR FOREST ENTOMOL, V10, P291, DOI 10.1111/j.1461-9563.2008.00388.x; Anthony N, 1998, MOL GEN GENET, V260, P165, DOI 10.1007/s004380050882; Atkinson B, 1985, CHANGES EUKARYOTIC G; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; Barillari J, 2005, J AGR FOOD CHEM, V53, P9890, DOI 10.1021/jf051465h; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; BERNAYS EA, 1989, EVOL ECOL, V3, P299, DOI 10.1007/BF02285261; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bizzaro D, 2005, PESTIC BIOCHEM PHYS, V81, P51, DOI 10.1016/j.pestbp.2004.09.005; Bjorling-Poulsen M, 2008, ENV HLTH, V7; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; BRATTSTEN LB, 1988, J CHEM ECOL, V14, P1919, DOI 10.1007/BF01013486; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Cabrera-Brandt MA, 2010, CHIL J AGR RES, V70, P567, DOI 10.4067/S0718-58392010000400006; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Castaneda LE, 2010, J EVOLUTION BIOL, V23, P2474, DOI 10.1111/j.1420-9101.2010.02112.x; Castaneda LE, 2011, PHYSIOL ENTOMOL, V36, P253, DOI 10.1111/j.1365-3032.2011.00793.x; Castaneda LE, 2010, J INSECT PHYSIOL, V56, P1058, DOI 10.1016/j.jinsphys.2010.02.019; Chougule NP, 2005, INSECT BIOCHEM MOLEC, V35, P355, DOI 10.1016/j.ibmb.2005.01.006; Chowdhuri DK, 1999, PESTIC BIOCHEM PHYS, V63, P15, DOI 10.1006/pest.1998.2390; Costa LG, 2008, FRONT BIOSCI-LANDMRK, V13, P1240, DOI 10.2741/2758; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Deraison C, 2004, INSECT MOL BIOL, V13, P165, DOI 10.1111/j.0962-1075.2004.00474.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; DEVONSHIRE AL, 1992, B ENTOMOL RES, V82, P459, DOI 10.1017/S0007485300042516; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; DEVONSHIRE AL, 1986, B ENTOMOL RES, V76, P97, DOI 10.1017/S0007485300015327; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Eleftherianos I, 2008, B ENTOMOL RES, V98, P183, DOI 10.1017/S0007485307005524; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fenton B, 2010, B ENTOMOL RES, V100, P451, DOI 10.1017/S0007485309990447; Fenton B, 2010, ECOL ENTOMOL, V35, P131, DOI 10.1111/j.1365-2311.2009.01150.x; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Field LM, 1998, BIOCHEM J, V330, P169; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2003, BIOL J LINN SOC, V79, P107, DOI 10.1046/j.1095-8312.2003.00178.x; Field LM, 1997, BIOCHEM J, V322, P867, DOI 10.1042/bj3220867; FIELD LM, 1993, BIOCHEM J, V294, P569, DOI 10.1042/bj2940569; Field LM, 1999, BIOCHEM J, V339, P737, DOI 10.1042/0264-6021:3390737; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; Foster SP, 2011, B ENTOMOL RES, V101, P659, DOI 10.1017/S0007485310000623; Foster SP, 1997, B ENTOMOL RES, V87, P573, DOI 10.1017/S0007485300038669; Foster SP, 2005, B ENTOMOL RES, V95, P37, DOI 10.1079/BER2004336; Foster SP, 2003, PEST MANAG SCI, V59, P1169, DOI 10.1002/ps.751; Foster SP, 1999, B ENTOMOL RES, V89, P133, DOI 10.1017/S0007485399000218; Foster SP, 2000, CROP PROT, V19, P873, DOI 10.1016/S0261-2194(00)00115-0; Foster SP, 1996, B ENTOMOL RES, V86, P17, DOI 10.1017/S0007485300052159; Foster SP, 2007, ANIM BEHAV, V74, P621, DOI 10.1016/j.anbehav.2006.12.018; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Francis F, 2005, ARCH INSECT BIOCHEM, V58, P166, DOI 10.1002/arch.20049; FUTUYMA D., 2009, EVOLUTION; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Goundoudaki S, 2003, AGR FOREST ENTOMOL, V5, P285, DOI 10.1046/j.1461-9563.2003.00190.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Hanlon PR, 2011, J FOOD SCI, V76, pC185, DOI 10.1111/j.1750-3841.2010.01972.x; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Krebs RA, 1997, J EXP BIOL, V200, P2007; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manson JS, 2009, ECOL ENTOMOL, V34, P421, DOI 10.1111/j.1365-2311.2009.01100.x; Margaritopoulos John T., 2009, BMC Ecology, V9, P13, DOI 10.1186/1472-6785-9-13; Martinez-Torres D, 1999, INSECT MOL BIOL, V8, P339, DOI 10.1046/j.1365-2583.1999.83121.x; Marutani-Hert M, 2010, FLA ENTOMOL, V93, P519, DOI 10.1653/024.093.0408; Mello Marcia O., 2002, Braz. J. Plant Physiol., V14, P71, DOI 10.1590/S1677-04202002000200001; MOORES GD, 1994, PESTIC BIOCHEM PHYS, V49, P114, DOI 10.1006/pest.1994.1038; Moores GD, 2000, PROC BRIGHTON CROP, V1-3, P447; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mosolov VV, 2001, APPL BIOCHEM MICRO+, V37, P115, DOI 10.1023/A:1002824527463; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Nazir A, 2003, BBA-GEN SUBJECTS, V1621, P218, DOI 10.1016/S0304-4165(03)00060-6; Nazir A, 2001, ARCH ENVIRON CON TOX, V41, P443, DOI 10.1007/s002440010270; Nielsen SA, 2006, ENVIRON ENTOMOL, V35, P837, DOI 10.1603/0046-225X-35.4.837; Nikolakakis NN, 2003, B ENTOMOL RES, V93, P235, DOI 10.1079/BER2003230; Olivares-Donoso R, 2007, B ENTOMOL RES, V97, P61, DOI 10.1017/S0007485307004774; Onstad D, 2008, INSECTICIDE RESISTAN, V1; Peppe FB, 2003, GENET MOL BIOL, V26, P189, DOI 10.1590/S1415-47572003000200012; Philippou D, 2010, PEST MANAG SCI, V66, P390, DOI 10.1002/ps.1888; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; ROPP M, 1983, CAN J BIOCHEM CELL B, V61, P456, DOI 10.1139/o83-061; RYAN MF, 1988, J CHEM ECOL, V14, P1965, DOI 10.1007/BF01013489; Schoonhoven L. M., 2005, Insect-plant biology; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Shapiro TA, 1998, CANCER EPIDEM BIOMAR, V7, P1091; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Srigiriraju L, 2010, CROP PROT, V29, P197, DOI 10.1016/j.cropro.2009.11.006; Steinberg C.E.W., 2011, STRESS ECOLOGY ENV S; Tomlin C., 1994, PESTICIDE MANUAL WOR, V10th ed.; Tsuji A, 2008, FEBS J, V275, P5429, DOI 10.1111/j.1742-4658.2008.06674.x; Valueva TA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1305, DOI 10.1007/s10541-005-0015-5; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; Vucetic A, 2008, ARCH BIOL SCI, V60, P493, DOI 10.2298/ABS0803493V; Wang LP, 2010, CROP PROT, V29, P1280, DOI 10.1016/j.cropro.2010.07.009; WYATT IJ, 1977, J APPL ECOL, V14, P757, DOI 10.2307/2402807; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Yang XM, 2001, J ECON ENTOMOL, V94, P381, DOI 10.1603/0022-0493-94.2.381; Yoshimi T, 2009, ENVIRON TOXICOL PHAR, V28, P294, DOI 10.1016/j.etap.2009.05.008; YU SJ, 1984, COMP BIOCHEM PHYS C, V78, P145, DOI 10.1016/0742-8413(84)90062-8; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x	117	28	33	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e36810	10.1371/journal.pone.0036810	http://dx.doi.org/10.1371/journal.pone.0036810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685539	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700003
J	Zhang, YC; Payne, JL				Zhang, Yichun; Payne, Jonathan L.			Size-Frequency Distributions along a Latitudinal Gradient in Middle Permian Fusulinoideans	PLOS ONE			English	Article							BODY-SIZE; THEORETICAL ECOSPACE; SPECIES RICHNESS; BERGMANNS RULE; CORAL FAUNAS; EVOLUTION; DIVERSITY; PATTERNS; GROWTH; FORAMINIFERA	Geographic gradients in body size within and among living species are commonly used to identify controls on the long-term evolution of organism size. However, the persistence of these gradients over evolutionary time remains largely unknown because ancient biogeographic variation in organism size is poorly documented. Middle Permian fusulinoidean foraminifera are ideal for investigating the temporal persistence of geographic gradients in organism size because they were diverse and abundant along a broad range of paleo-latitudes during this interval (similar to 275-260 million years ago). In this study, we determined the sizes of Middle Permian fusulinoidean fossils from three different paleo-latitudinal zones in order to examine the relationship between the size of foraminifers and regional environment. We recovered the following results: keriothecal fusulinoideans are substantially larger than nonkeriothecal fusulinoideans; fusulinoideans from the equatorial zone are typically larger than those from the north and south transitional zones; neoschwagerinid specimens within a single species are generally larger in the equatorial zone than those in both transitional zones; and the nonkeriothecal fusulinoideans Staffellidae and Schubertellidae have smaller size in the north transitional zone. Fusulinoidean foraminifers differ from most other marine taxa in exhibiting larger sizes closer to the equator, contrary to Bergmann's rule. Meridional variation in seasonality, water temperature, nutrient availability, and carbonate saturation level are all likely to have favored or enabled larger sizes in equatorial regions. Temporal variation in atmospheric oxygen concentrations have been shown to account for temporal variation in fusulinoidean size during Carboniferous and Permian time, but oxygen availability appears unlikely to explain biogeographic variation in fusulinoidean sizes, because dissolved oxygen concentrations in seawater typically increase away from the equator due to declining seawater temperatures. Consequently, our findings highlight the fact that spatial gradients in organism size are not always controlled by the same factors that govern temporal trends within the same clade.	[Zhang, Yichun] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Zhang, Yichun; Payne, Jonathan L.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Zhang, Yichun] Deakin Univ, Sch Life & Environm Sci, Melbourne, Australia	Chinese Academy of Sciences; Stanford University; Deakin University	Zhang, YC (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.	geozyc@yahoo.com	Payne, Jonathan L/A-1240-2007; Payne, Jonathan/B-8088-2012	Payne, Jonathan L/0000-0002-9601-3310; 	National Science Foundation of China [40902006, 40921091]; State Key Laboratory of Paleontology and Stratigraphy [20102103]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Paleontology and Stratigraphy	The current research is funded by National Science Foundation of China (40902006, 40921091) and State Key Laboratory of Paleontology and Stratigraphy (20102103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegret L, 2010, GEOL SOC AM BULL, V122, P1616, DOI 10.1130/B30055.1; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Ashton KG, 2004, INTEGR COMP BIOL, V44, P403, DOI 10.1093/icb/44.6.403; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barnes DKA, 2001, MAR ECOL PROG SER, V210, P85, DOI 10.3354/meps210085; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Blackburn TM, 1996, OIKOS, V77, P436, DOI 10.2307/3545933; Bower JR, 2002, VELIGER, V45, P309; Bush AM, 2007, PALEOBIOLOGY, V33, P76, DOI 10.1666/06013.1; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Clarke A, 2004, POLAR BIOL, V28, P62, DOI 10.1007/s00300-004-0647-8; Contreras H, 2000, REV CHIL HIST NAT, V73, P705; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; DAYTON PK, 1989, SCIENCE, V245, P1484, DOI 10.1126/science.245.4925.1484; Ebert TA, 1999, MAR ECOL PROG SER, V190, P189, DOI 10.3354/meps190189; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; FRANK PW, 1975, MAR BIOL, V31, P181, DOI 10.1007/BF00391630; Geslin E, 2011, J EXP MAR BIOL ECOL, V396, P108, DOI 10.1016/j.jembe.2010.10.011; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Groves JR, 2009, PALEOBIOLOGY, V35, P367, DOI 10.1666/0094-8373-35.3.367; HALLOCK P, 1985, PALEOBIOLOGY, V11, P195, DOI 10.1017/S0094837300011507; HALLOCK P, 1981, MAR BIOL, V62, P249, DOI 10.1007/BF00397691; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Hunt G, 2010, PALAEONTOLOGY, V53, P1255, DOI 10.1111/j.1475-4983.2010.01007.x; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Kaiho K, 1998, GEOLOGY, V26, P491, DOI 10.1130/0091-7613(1998)026<0491:GCFODS>2.3.CO;2; Kaiho K, 1999, MAR MICROPALEONTOL, V37, P53, DOI 10.1016/S0377-8398(99)00011-0; Kobayashi F., 1997, CUSHMAN FDN FORAMINI, V36, P73; Kotlyar G.V., 2003, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Geologicheskii, V78, P33; LINDSEY CC, 1966, EVOLUTION, V20, P456, DOI 10.1111/j.1558-5646.1966.tb03380.x; Linse K, 2006, DEEP-SEA RES PT II, V53, P921, DOI 10.1016/j.dsr2.2006.03.006; Lockwood R, 2005, PALEOBIOLOGY, V31, P578, DOI 10.1666/0094-8373(2005)031[0578:BSEEAT]2.0.CO;2; MACPHERSON E, 1994, ECOGRAPHY, V17, P242, DOI 10.1111/j.1600-0587.1994.tb00099.x; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Novack-Gottshall PM, 2007, PALEOBIOLOGY, V33, P273, DOI 10.1666/06054.1; Olabarria C, 2003, MAR BIOL, V143, P723, DOI 10.1007/s00227-003-1116-6; Ozawa T., 1987, P45; Payne JL, EVOLUTION IN PRESS; Peck LS, 2010, MAR BIOL, V157, P2205, DOI 10.1007/s00227-010-1486-5; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ross C.A., 1982, P441; Ross C.A., 1977, AMERICAN ASSOCIATION OF PETROLEUM GEOLOGISTS STUDIES IN GEOLOGY, P219; Ross C.A., 1974, Proceedings int Coral Reef Symp, V2, P327; ROSS CA, 1972, J PALEONTOL, V46, P719; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; Roy K, 2001, J BIOGEOGR, V28, P485, DOI 10.1046/j.1365-2699.2001.00561.x; Schmidt DN, 2004, SCIENCE, V303, P207, DOI 10.1126/science.1090592; Schmidt DN, 2004, PALAEOGEOGR PALAEOCL, V212, P159, DOI 10.1016/j.palaeo.2004.06.002; Shen SZ, 2009, GLOBAL PLANET CHANGE, V65, P166, DOI 10.1016/j.gloplacha.2008.10.017; Shen SZ, 2004, PALAEOGEOGR PALAEOCL, V208, P235, DOI 10.1016/j.palaeo.2004.03.009; Shi GR, 2006, J ASIAN EARTH SCI, V26, P173, DOI 10.1016/j.jseaes.2005.12.001; Shi GR, 2010, PALAEOGEOGR PALAEOCL, V298, P1, DOI 10.1016/j.palaeo.2010.07.021; SHI GR, 1995, PALAEOGEOGR PALAEOCL, V114, P241, DOI 10.1016/0031-0182(94)00079-N; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; STEELE DH, 1988, INT REV GES HYDROBIO, V73, P235, DOI 10.1002/iroh.19880730209; Thurmond HV, 2004, INTRO OCEANOGRAPHY; Ueno K, 2003, PALAEOGEOGR PALAEOCL, V193, P1, DOI 10.1016/S0031-0182(02)00708-3; Vachard D, 2004, J FORAMIN RES, V34, P232, DOI 10.2113/34.3.232; Villeger S, 2011, ECOL LETT, V14, P561, DOI 10.1111/j.1461-0248.2011.01618.x; Wang XD, 2006, J ASIAN EARTH SCI, V26, P369, DOI 10.1016/j.jseaes.2005.11.011; Wang XD, 2002, J ASIAN EARTH SCI, V20, P589, DOI 10.1016/S1367-9120(01)00064-5; Ziegler A.M., 1997, LATE GLACIAL POSTGLA, P111	68	135	141	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38603	10.1371/journal.pone.0038603	http://dx.doi.org/10.1371/journal.pone.0038603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685590	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700053
J	Klecka, J; Boukal, DS				Klecka, Jan; Boukal, David S.			Who Eats Whom in a Pool? A Comparative Study of Prey Selectivity by Predatory Aquatic Insects	PLOS ONE			English	Article							FOOD-WEB; NICHE OVERLAP; BODY-SIZE; SPATIAL AGGREGATION; COMPARATIVE ECOLOGY; LARVAE; DIET; COLEOPTERA; DYTISCIDAE; PREFERENCE	Predatory aquatic insects are a diverse group comprising top predators in small fishless water bodies. Knowledge of their diet composition is fragmentary, which hinders the understanding of mechanisms maintaining their high local diversity and of their impacts on local food web structure and dynamics. We conducted multiple-choice predation experiments using nine common species of predatory aquatic insects, including adult and larval Coleoptera, adult Heteroptera and larval Odonata, and complemented them with literature survey of similar experiments. All predators in our experiments fed selectively on the seven prey species offered, and vulnerability to predation varied strongly between the prey. The predators most often preferred dipteran larvae; previous studies further reported preferences for cladocerans. Diet overlaps between all predator pairs and predator overlaps between all prey pairs were non-zero. Modularity analysis separated all primarily nectonic predator and prey species from two groups of large and small benthic predators and their prey. These results, together with limited evidence from the literature, suggest a highly interconnected food web with several modules, in which similarly sized predators from the same microhabitat are likely to compete strongly for resources in the field (observed Pianka's diet overlap indices >0.85). Our experiments further imply that ontogenetic diet shifts are common in predatory aquatic insects, although we observed higher diet overlaps than previously reported. Hence, individuals may or may not shift between food web modules during ontogeny.	[Klecka, Jan; Boukal, David S.] Univ S Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Klecka, Jan; Boukal, David S.] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Lab Theoret Ecol,Vvi, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Klecka, J (corresponding author), Univ S Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic.	kleckj01@prf.jcu.cz	Klečka, Jan/G-7738-2011; Klecka, Jan/H-7874-2014; Boukal, David/H-4762-2014	Klecka, Jan/0000-0003-0633-3896; Boukal, David/0000-0001-8181-7458	EU Marie Curie European Reintegration Grant 'AquaMod' [PERG04-GA-2008-239543]; Grant Agency of the University of South Bohemia [GAJU 145/2010/P]; Institute of Entomology [AV0Z50070508]	EU Marie Curie European Reintegration Grant 'AquaMod'; Grant Agency of the University of South Bohemia; Institute of Entomology(Czech Academy of Sciences)	The study was supported by the EU Marie Curie European Reintegration Grant 'AquaMod' to DSB (PERG04-GA-2008-239543; URL: http://cordis.europa. eu/mariecurie-actions/erg/home.html), the Grant Agency of the University of South Bohemia (grant no. GAJU 145/2010/P; URL: http://www.jcu.cz/research/gaju) and funding by the Institute of Entomology (AV0Z50070508; URL: http://www.entu.cas.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Batzer DP, 1996, ANNU REV ENTOMOL, V41, P75, DOI 10.1146/annurev.en.41.010196.000451; BAY EC, 1974, ANNU REV ENTOMOL, V19, P441, DOI 10.1146/annurev.en.19.010174.002301; BLOIS C, 1985, FRESHWATER BIOL, V15, P505, DOI 10.1111/j.1365-2427.1985.tb00220.x; Blunck H, 1923, Z WISS ZOOL ABT A, V121, P171; Boukal David S., 2007, Klapalekiana, V43, P1; Brose U., 2005, ECOLOGY, V86, P2545, DOI [DOI 10.1890/05-0379, 10.1890/05-0379]; Chandra G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-138; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Cobbaert D, 2010, HYDROBIOLOGIA, V644, P103, DOI 10.1007/s10750-010-0100-7; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COOPER SD, 1985, CAN J FISH AQUAT SCI, V42, P1720, DOI 10.1139/f85-216; COTHRAN ML, 1985, OIKOS, V44, P350, DOI 10.2307/3544710; Culler LE, 2009, FRESHWATER BIOL, V54, P2003, DOI 10.1111/j.1365-2427.2009.02230.x; CUMMINS KW, 1973, ANNU REV ENTOMOL, V18, P183, DOI 10.1146/annurev.en.18.010173.001151; De Roos AM, 2008, P NATL ACAD SCI USA, V105, P13930, DOI 10.1073/pnas.0803834105; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Entsminger G.L., 2001, ECOSIM NULL MODELS S; Febria CM, 2005, CAN ENTOMOL, V137, P723; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hamer TE, 2001, J RAPTOR RES, V35, P221; Hampton SE, 2001, HYDROBIOLOGIA, V446, P115, DOI 10.1023/A:1017543121353; HEINRICH B, 1976, ECOLOGY, V57, P874, DOI 10.2307/1941054; HENRIKSON BI, 1990, HOLARCTIC ECOL, V13, P201; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hutchinson G, 1993, TREATISE LIMNOLOGY, V4; Ibarra-Nunez G, 2001, SOCIOBIOLOGY, V37, P723; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; JOHANSSON A, 1992, HYDROBIOLOGIA, V248, P201, DOI 10.1007/BF00006148; JOHANSSON F, 1993, J INSECT BEHAV, V6, P253, DOI 10.1007/BF01051508; JOHANSSON F, 1991, HYDROBIOLOGIA, V209, P79, DOI 10.1007/BF00006721; JOHNSON DM, 1975, ECOLOGY, V56, P1081, DOI 10.2307/1936148; JULIANO SA, 1990, OECOLOGIA, V83, P535, DOI 10.1007/BF00317206; Kehl S, 2003, ARCH HYDROBIOL, V158, P109, DOI 10.1127/0003-9136/2003/0158-0109; Klecka J, 2011, ECOL INDIC, V11, P500, DOI 10.1016/j.ecolind.2010.07.005; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuhara N, 1999, OIKOS, V87, P27, DOI 10.2307/3546993; LARSON D J, 1990, Quaestiones Entomologicae, V26, P151; LAWTON JH, 1970, J ANIM ECOL, V39, P669, DOI 10.2307/2859; Leclair RJ, 1986, ENTOMOLOGICA BASILIE, V11, P669; Lim DH, 2001, BIOMETRICAL J, V43, P187, DOI 10.1002/1521-4036(200105)43:2<187::AID-BIMJ187>3.0.CO;2-Q; Luiselli L, 2008, OIKOS, V117, P321, DOI 10.1111/j.2007.0030-1299.16297.x; Lundkvist E, 2003, B ENTOMOL RES, V93, P219, DOI 10.1079/BER2003237; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; MANLY BFJ, 1995, BIOMETRICS, V51, P709, DOI 10.2307/2532956; MARTIN ID, 1982, CAN J ZOOL, V60, P783, DOI 10.1139/z82-108; MCPEEK MA, 1990, ECOLOGY, V71, P83, DOI 10.2307/1940249; Murdoch JD, 2010, MAMM BIOL, V75, P36, DOI 10.1016/j.mambio.2008.12.003; MURDOCH WW, 1984, J ANIM ECOL, V53, P791, DOI 10.2307/4660; Naisbit RE, 2011, ECOLOGY, V92, P2183, DOI 10.1890/10-2234.1; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Oksanen J, 2010, R PACKAGE VERSION 1; ORR BK, 1990, ECOLOGY, V71, P68, DOI 10.2307/1940248; Pace ML, 2007, LIMNOL OCEANOGR, V52, P2177, DOI 10.4319/lo.2007.52.5.2177; PAJUNEN VI, 1983, ANN ZOOL FENN, V20, P31; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PIANKA ER, 1976, COPEIA, P125; PIANKA ER, 1978, COPEIA, P691; Pianka ER, 1973, ANNU REV ECOL SYST, V4, P53, DOI [DOI 10.1146/ANNUREV.ES.04.110173.000413, 10.1146/annurev.es.04.110173.000413]; Pimentel CR, 2010, J FISH BIOL, V76, P2299, DOI 10.1111/j.1095-8649.2010.02586.x; R Core Development Team, 2010, R LANG ENV STAT COMP; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Rozkosny R., 1980, KLIC VODNICH LAREV H; Rubbo MJ, 2006, J ZOOL, V269, P1, DOI 10.1111/j.1469-7998.2006.00080.x; Rudolf VHW, 2011, ECOL LETT, V14, P75, DOI 10.1111/j.1461-0248.2010.01558.x; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCOTT MA, 1983, LIMNOL OCEANOGR, V28, P352, DOI 10.4319/lo.1983.28.2.0352; Shaalan EAS, 2009, TROP BIOMED, V26, P223; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Takahashi KH, 2005, OIKOS, V109, P125, DOI 10.1111/j.0030-1299.2005.13594.x; THOMPSON DJ, 1978, J ANIM ECOL, V47, P769, DOI 10.2307/3670; Turner AM, 2007, OECOLOGIA, V153, P407, DOI 10.1007/s00442-007-0736-9; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Velasco J, 1998, AQUAT INSECT, V20, P85, DOI 10.1076/aqin.20.2.85.4500; Walsh EJ, 2006, INVERTEBR BIOL, V125, P325, DOI 10.1111/j.1744-7410.2006.00064.x; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; Wathne JA, 2000, MAR ECOL PROG SER, V194, P233, DOI 10.3354/meps194233; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wertheim B, 2000, J ANIM ECOL, V69, P335, DOI 10.1046/j.1365-2656.2000.00396.x; Woodward G, 2005, ADV ECOL RES, V36, P85, DOI 10.1016/S0065-2504(05)36002-8; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Woodward G, 2001, J ANIM ECOL, V70, P273, DOI 10.1046/j.1365-2656.2001.00497.x; Yee DA, 2010, HYDROBIOLOGIA, V637, P33, DOI 10.1007/s10750-009-9982-7	90	77	79	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37741	10.1371/journal.pone.0037741	http://dx.doi.org/10.1371/journal.pone.0037741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679487	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900012
J	Paquette, SG; Banner, D; Zhao, Z; Fang, Y; Huang, SSH; Leon, AJ; Ng, DCK; Almansa, R; Martin-Loeches, I; Ramirez, P; Socias, L; Loza, A; Blanco, J; Sansonetti, P; Rello, J; Andaluz, D; Shum, B; Rubino, S; de Lejarazu, RO; Tran, D; Delogu, G; Fadda, G; Krajden, S; Rubin, BB; Bermejo-Martin, JF; Kelvin, AA; Kelvin, DJ				Paquette, Stephane G.; Banner, David; Zhao, Zhen; Fang, Yuan; Huang, Stephen S. H.; Leon, Alberto J.; Ng, Derek C. K.; Almansa, Raquel; Martin-Loeches, Ignacio; Ramirez, Paula; Socias, Lorenzo; Loza, Ana; Blanco, Jesus; Sansonetti, Paola; Rello, Jordi; Andaluz, David; Shum, Bianche; Rubino, Salvatore; Ortiz de Lejarazu, Raul; Tran, Dat; Delogu, Giovanni; Fadda, Giovanni; Krajden, Sigmund; Rubin, Barry B.; Bermejo-Martin, Jesus F.; Kelvin, Alyson A.; Kelvin, David J.			Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection	PLOS ONE			English	Article							ANTIINFLAMMATORY CYTOKINE; RESPIRATORY-FAILURE; RESPONSES; IL-6; VIRUSES; DISEASE; TUBERCULOSIS; IMMUNITY; SEPSIS	Pandemic H1N1 influenza A (H1N1pdm) is currently a dominant circulating influenza strain worldwide. Severe cases of H1N1pdm infection are characterized by prolonged activation of the immune response, yet the specific role of inflammatory mediators in disease is poorly understood. The inflammatory cytokine IL-6 has been implicated in both seasonal and severe pandemic H1N1 influenza A (H1N1pdm) infection. Here, we investigated the role of IL-6 in severe H1N1pdm infection. We found IL-6 to be an important feature of the host response in both humans and mice infected with H1N1pdm. Elevated levels of IL-6 were associated with severe disease in patients hospitalized with H1N1pdm infection. Notably, serum IL-6 levels associated strongly with the requirement of critical care admission and were predictive of fatal outcome. In C57BL/6J, BALB/cJ, and B6129SF2/J mice, infection with A/Mexico/4108/2009 (H1N1pdm) consistently triggered severe disease and increased IL-6 levels in both lung and serum. Furthermore, in our lethal C57BL/6J mouse model of H1N1pdm infection, global gene expression analysis indicated a pronounced IL-6 associated inflammatory response. Subsequently, we examined disease and outcome in IL-6 deficient mice infected with H1N1pdm. No significant differences in survival, weight loss, viral load, or pathology were observed between IL-6 deficient and wild-type mice following infection. Taken together, our findings suggest IL-6 may be a potential disease severity biomarker, but may not be a suitable therapeutic target in cases of severe H1N1pdm infection due to our mouse data.	[Paquette, Stephane G.; Banner, David; Fang, Yuan; Huang, Stephen S. H.; Leon, Alberto J.; Ng, Derek C. K.; Kelvin, David J.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Paquette, Stephane G.; Kelvin, David J.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Zhao, Zhen; Leon, Alberto J.; Kelvin, David J.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Guangdong, Peoples R China; [Fang, Yuan; Huang, Stephen S. H.; Kelvin, David J.] Univ Toronto, Dept Immunol, Fac Med, Toronto, ON, Canada; [Almansa, Raquel; Ortiz de Lejarazu, Raul; Bermejo-Martin, Jesus F.] Hosp Clin Univ, Inst Estudios Ciencias Salud Castilla & Leon, Infect & Immun Med Invest Unit, Valladolid, Spain; [Martin-Loeches, Ignacio] Sabadell Univ Hosp, Crit Care Ctr Parc Tauli, Sabadell, Spain; [Ramirez, Paula] Hosp Univ La Fe, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Valencia, Spain; [Socias, Lorenzo] Hosp Son Llatzer, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Palma De Mallorca, Spain; [Loza, Ana] Hosp N Sra de Valme, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Seville, Spain; [Blanco, Jesus] Hosp Univ Rio Hortega Salud Junta Castilla & Leon, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Valladolid, Spain; [Blanco, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Valladolid, Spain; [Sansonetti, Paola; Delogu, Giovanni; Fadda, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Rello, Jordi] Univ Autonoma Barcelona, Soc Espanola Med Intensiva Crit & Unidades Corona, Ctr Invest Biomed Red Enfermedades Resp,Area Gen, Crit Care Dept,Hosp Vall dHebron,Inst Recerca Val, E-08193 Barcelona, Spain; [Andaluz, David] Hosp Clin Univ Salud Junta Castilla & Leon, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Valladolid, Spain; [Shum, Bianche; Krajden, Sigmund] St Josephs Hlth Ctr, Dept Microbiol, Toronto, ON, Canada; [Rubino, Salvatore; Kelvin, David J.] Univ Sassari, Sez Microbiol Sperimentale & Clin, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Tran, Dat] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Rubin, Barry B.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Vasc Surg,Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Kelvin, Alyson A.; Kelvin, David J.] Immune Diagnost & Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Shantou University; University of Toronto; Hospital Universitari i Politecnic La Fe; Hospital Universitari Son Llatzer; Hospital del Rio Hortega; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Sassari; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Paquette, SG (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Expt Therapeut, Toronto, ON, Canada.	dkelvin@jidc.org	martin-loeches, ignacio m/Q-6645-2018; Ramírez, Paula/N-8337-2015; Rubino, Salvatore/AAC-5848-2022; Bermejo-Martin, Jesus F/J-4574-2019; Fadda, Giovanni/K-6224-2012; Almansa, Raquel/T-3414-2019; Delogu, Giovanni/I-3701-2012; Barac, Aleksandra/W-9785-2019; Matrin-Loeches, Ignacio/H-4633-2013; Rello, Jordi/P-2402-2019	martin-loeches, ignacio m/0000-0002-5834-4063; Ramírez, Paula/0000-0002-7598-3350; Bermejo-Martin, Jesus F/0000-0002-7998-6268; Delogu, Giovanni/0000-0003-0182-8267; Rello, Jordi/0000-0003-0676-6210; Almansa, Raquel/0000-0002-4144-7808	Li Ka Shing Foundation; Immune Diagnostics Research	Li Ka Shing Foundation; Immune Diagnostics Research	This work was supported by the Li Ka Shing Foundation and Immune Diagnostics & Research. Dr. Alyson A. Kelvin is the Scientific Director for Immune Diagnostics & Research and had input into experimental design and write-up of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; FERRARA JLM, 1993, CURR OPIN IMMUNOL, V5, P794, DOI 10.1016/0952-7915(93)90139-J; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gentile D, 1998, CLIN DIAGN LAB IMMUN, V5, P604, DOI 10.1128/CDLI.5.5.604-608.1998; Gilsdorf A, 2009, EUROSURVEILLANCE, V14, P19318; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Health Protection Agency Health Protection Scotland National Public Health Service for Wales HPA Northern Ireland Swine Influenza Investigation Teams, 2009, EUROSURVEILLANCE, V14, P19232; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Kmietowicz Z, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4393; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kramarz P, 2009, EUROSURVEILLANCE, V14; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Lin WC, 2010, EXP BIOL MED, V235, P57, DOI 10.1258/ebm.2009.009256; NAPOLITANO LM, 2009, MMWR-MORBID MORTAL W, V58, P749; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; RYAN GB, 1977, AM J PATHOL, V86, P183; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Theoharides TC, 2002, INT ARCH ALLERGY IMM, V128, P344, DOI 10.1159/000063858; TILG H, 1994, BLOOD, V83, P113; Uyeki TM, 2009, NEW ENGL J MED, V361, P2558, DOI 10.1056/NEJMcpc0905545; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004	43	99	99	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38214	10.1371/journal.pone.0038214	http://dx.doi.org/10.1371/journal.pone.0038214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679491	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900021
J	Tian, XJ; Liu, F; Zhang, XP; Li, J; Wang, W				Tian, Xiao-Jun; Liu, Feng; Zhang, Xiao-Peng; Li, Jun; Wang, Wei			A Two-Step Mechanism for Cell Fate Decision by Coordination of Nuclear and Mitochondrial p53 Activities	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TUMOR-SUPPRESSOR; MDM2-MEDIATED UBIQUITINATION; TRANSCRIPTIONAL ACTIVATION; P53-MEDIATED APOPTOSIS; PROTECTS MICE; CYCLE ARREST; MDM2; PATHWAY; DEATH	The tumor suppressor p53 has a crucial role in the DNA damage response. Here, we proposed an integrated model of the p53 network and explored how the nuclear and mitochondrial p53 pathways are coordinated to determine cell fates after gamma-irradiation in radiosensitive tissues. Using numerical simulations, we found that depending on the extent of DNA damage, cells may survive, commit apoptosis after cell cycle arrest, or undergo apoptosis soon after irradiation. There exists a large cell-to-cell variability in outcome because of stochasticity in the generation and repair of DNA damage as well as cellular heterogeneity. At the cell population level, there occur two waves of apoptosis: a fast wave mediated by mitochondrial p53 within three hours postirradiation, and a slow wave mediated by nuclear p53 after eight hours postirradiation. Thus, we propose a two-step mechanism for cell fate decision. The first step is to decide whether DNA damage is severe enough to trigger apoptosis directly through the mitochondrial p53 pathway, while the second step is to determine whether the damage is fixed after cell cycle arrest. Such a mechanism may represent an efficient and reliable control mode, avoiding unnecessary death or greatly promoting the execution of apoptosis. It was also demonstrated that nuclear p53 can inhibit the pro-apoptotic activity of mitochondrial p53 by transactivating p21, and Mdm2 can facilitate apoptosis by promoting the mono-ubiquitination of p53. These results are either in good agreement with experimental observations or experimentally testable. Our work suggests that both the transcription-independent and -dependent p53 activities are indispensable for a reliable choice of cell fate and also provides clues to therapeutic manipulation of the p53 pathway in cancer treatment.	[Tian, Xiao-Jun] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing, Jiangsu, Peoples R China; Nanjing Univ, Dept Phys, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Tian, XJ (corresponding author), Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing, Jiangsu, Peoples R China.	fliu@nju.edu.cn; wangwei@nju.edu.cn	Tian, Xiaojun/M-9242-2014; Liu, Feng/E-1462-2011; Zhang, Xiao-Peng/E-1973-2011; tian, xiaojun/AAW-4984-2020	Tian, Xiaojun/0000-0002-5601-2057; Zhang, Xiao-Peng/0000-0001-8170-1236; tian, xiaojun/0000-0002-5601-2057; Zhang, Xiao-Peng/0000-0002-0183-2760	National Basic Research Program of China [2007CB814806]; National Natural Science Foundation of China [11175084]; Natural Science Foundation of Jiangsu Province [BK2009008]; Program for New Century Excellent Talents in Universities [NCET-08-0269]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Basic Research Program of China (2007CB814806), the National Natural Science Foundation of China (11175084), the Natural Science Foundation of Jiangsu Province (BK2009008), the Program for New Century Excellent Talents in Universities (NCET-08-0269), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2006, INT J RADIAT BIOL, V82, P761, DOI 10.1080/09553000600949624; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Deb SP, 2003, MOL CANCER RES, V1, P1009; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Janicke RU, 2007, CELL CYCLE, V6, P407; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pu T, 2010, BIOPHYS J, V99, P1696, DOI 10.1016/j.bpj.2010.07.042; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steele AJ, 2008, BLOOD, V112, P3827, DOI 10.1182/blood-2008-05-156380; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	55	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38164	10.1371/journal.pone.0038164	http://dx.doi.org/10.1371/journal.pone.0038164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679490	gold, Green Published			2022-12-25	WOS:000305343900019
J	van Beekum, O; Gao, Y; Berger, R; Koppen, A; Kalkhoven, E				van Beekum, Olivier; Gao, Yuan; Berger, Ruud; Koppen, Arjen; Kalkhoven, Eric			A Novel RNAi Lethality Rescue Screen to Identify Regulators of Adipogenesis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; PPAR-GAMMA; TRANSCRIPTION FACTOR; ADIPOSE CONVERSION; INSULIN-RESISTANCE; MAMMALIAN-CELLS; LIPID DROPLETS; KEY REGULATOR; DIFFERENTIATION; ADIPOCYTES	Adipogenesis, the differentiation of fibroblast-like mesenchymal stem cells into mature adipocytes, is tightly regulated by a complex cascade of transcription factors, including the nuclear receptor Peroxisome proliferator activator receptor gamma (PPAR gamma). RNAi-mediated knock down libraries may present an atractive method for the identification of additional adipogenic factors. However, using in vitro adipogenesis model systems for high-throughput screening with siRNA libraries is limited since (i) differentiation is not homogeneous, but results in mixed cell populations, and (ii) the expression levels (and activity) of adipogenic regulators is highly dynamic during differentiation, indicating that the timing of RNAi-mediated knock down during differentiation may be extremely critical. Here we report a proof-of-principle for a novel RNAi screening method to identify regulators of adipogenesis that is based on lethality rescue rather than differentiation, using microRNA expression driven by a PPAR gamma responsive RNA polymerase II promoter. We validated this novel method through screening of a dedicated deubiquitinase knock down library, resulting in the identification of UCHL3 as an essential deubiquitinase in adipogenesis. This system therefore enables the identification of novel genes regulating PPAR gamma-mediated adipogenesis in a high-throughput setting.	[van Beekum, Olivier; Gao, Yuan; Berger, Ruud; Koppen, Arjen; Kalkhoven, Eric] Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Dept Metab Dis, Utrecht, Netherlands; [Kalkhoven, Eric] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	van Beekum, O (corresponding author), Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Dept Metab Dis, Utrecht, Netherlands.	E.Kalkhoven@umcutrecht.nl	Koppen, Arjen/GLV-6743-2022		research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)	research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)	This study was supported by the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Fajas L, 2003, ONCOGENE, V22, P4186, DOI 10.1038/sj.onc.1206530; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gijsbers L, 2011, ANALBIOCHEM; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hegele RA, 2005, INT J OBESITY, V29, pS31, DOI 10.1038/sj.ijo.0802911; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Koppen A, 2009, MOL CELL PROTEOMICS, V8, P2212, DOI 10.1074/mcp.M900209-MCP200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li FF, 2010, FEBS J, V277, P4173, DOI 10.1111/j.1742-4658.2010.07806.x; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Osawa Y, 2001, BIOCHEM BIOPH RES CO, V283, P627, DOI 10.1006/bbrc.2001.4841; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Park KW, 2010, J LIPID RES, V51, P2775, DOI 10.1194/jlr.M008490; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; Setsuie R, 2009, FASEB J, V23, P4148, DOI 10.1096/fj.09-132217; Shigematsu S, 2001, J BIOL CHEM, V276, P15292, DOI 10.1074/jbc.M009684200; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suzuki M, 2009, ENDOCRINOLOGY, V150, P5230, DOI 10.1210/en.2009-0332; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	56	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37680	10.1371/journal.pone.0037680	http://dx.doi.org/10.1371/journal.pone.0037680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679485	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343900010
J	Chan, CL; Renia, L; Tan, KSW				Chan, Chuu Ling; Renia, Laurent; Tan, Kevin S. W.			A Simplified, Sensitive Phagocytic Assay for Malaria Cultures Facilitated by Flow Cytometry of Differentially-Stained Cell Populations	PLOS ONE			English	Article							FALCIPARUM-PARASITIZED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; ANEMIA; MACROPHAGES; MONOCYTES; DESTRUCTION; PROTECTION; SURFACE; MICE	Background: Phagocytosis of infected and uninfected erythrocytes is an important feature of malaria infections. Flow cytometry is a useful tool for studying phagocytic uptake of malaria-infected erythrocytes in vitro. However, current approaches are limited by the inability to discriminate between infected and uninfected erythrocytes and a failure to stain the early developmental ring stages of infected erythrocytes. The majority of infected erythrocytes in circulation are of the ring stage and these are therefore important targets to study. Methodology/Principal Findings: In vitro P. falciparum cultures comprising infected and uninfected erythrocytes were labeled and exposed to cells derived from the human monocytic THP-1 cell line. Phagocytosis was assayed by flow cytometry. Dual labeling of Plasmodium DNA and erythrocyte cytoplasm with dihydroethidium and CellTrace (TM) Violet respectively allowed, for the first time, the detection and enumeration of phagocytes with ingested erythrocytes from both early ring-and late schizont-stage P, falciparum cultures. The sensitivity of the method was tested using varying conditions including phagocyte type (monocytes versus macrophages), parasite stage (rings versus schizonts), and negative (incubation with cytochalasin D) and positive (incubation with immune sera) effectors of phagocytosis. The current assay clearly demonstrated uptake of infected and uninfected erythrocytes exposed to phagocytes; the extent of which was dependent on the conditions mentioned. Conclusions: We describe a simple, sensitive and rapid method for quantifying phagocytosis of P. falciparum-infected erythrocytes, by flow cytometry. This approach can be applied for studying parasite-phagocyte interactions under a variety of conditions. The investigation of phagocytosis of P. falciparum-infected erythrocytes can extend from looking solely at late-staged infected erythrocytes to include early-staged ones as well. It does away with the need to purify infected cells, allowing the study of effects on neighboring uninfected cells. This method may also be translated for use with different types of phagocytes.	[Chan, Chuu Ling; Renia, Laurent; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117595, Singapore; [Renia, Laurent] Singapore Immunol Network, Lab Malaria Immunobiol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Chan, CL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117595, Singapore.	mictank@nus.edu.sg	Tan, Kevin/C-9653-2014; Renia, Laurent/E-2117-2011	Renia, Laurent/0000-0003-0349-1557	Biomedical Research Council [08-017]; National Medical Research Council (NMRC) [EDG/1038/2011, NMRC/1310/2011]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This project was generously funded by research grants from the Biomedical Research Council (SIgN 08-017) and the National Medical Research Council (NMRC EDG/1038/2011 and NMRC/1310/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Ayi K, 2005, INFECT IMMUN, V73, P2559, DOI 10.1128/IAI.73.4.2559-2563.2005; Bettiol E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-64; BUCANA CD, 1990, EXP CELL RES, V190, P69, DOI 10.1016/0014-4827(90)90145-Z; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; HOMMEL M, 1988, BIOL CELL, V64, P183, DOI 10.1016/0248-4900(88)90078-0; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Mota MM, 1998, INFECT IMMUN, V66, P4080; Nagao T, 1996, AM J TROP MED HYG, V55, P562, DOI 10.4269/ajtmh.1996.55.562; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Omi K, 2002, PARASITOL INT, V51, P361, DOI 10.1016/S1383-5769(02)00040-5; Omodeo-Sale F, 2003, BLOOD, V102, P705, DOI 10.1182/blood-2002-08-2437; Organisation WH, 1997, WEEKLY EPIDEMIOL REC, V72, P269; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Serghides L, 2003, TRENDS PARASITOL, V19, P461, DOI 10.1016/j.pt.2003.08.006; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Taraschi T F, 1999, Novartis Found Symp, V226, P114; Taraschi TF, 1999, NOVART FDN SYMP, V226, P121; Tippett E, 2007, J IMMUNOL METHODS, V325, P42, DOI 10.1016/j.jim.2007.05.012; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80	41	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38523	10.1371/journal.pone.0038523	http://dx.doi.org/10.1371/journal.pone.0038523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675573	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700085
J	Fournie, G; Guitian, J; Desvaux, S; Mangtani, P; Ly, S; Cong, VC; San, S; Dung, DH; Holl, D; Pfeiffer, DU; Vong, S; Ghani, AC				Fournie, Guillaume; Guitian, Javier; Desvaux, Stephanie; Mangtani, Punam; Ly, Sowath; Vu Chi Cong; San, Sorn; Do Huu Dung; Holl, Davun; Pfeiffer, Dirk U.; Vong, Sirenda; Ghani, Azra C.			Identifying Live Bird Markets with the Potential to Act as Reservoirs of Avian Influenza A (H5N1) Virus: A Survey in Northern Viet Nam and Cambodia	PLOS ONE			English	Article							HIGHLY PATHOGENIC H5N1; POULTRY MARKETS; HONG-KONG; OUTBREAKS; EVOLUTION; IMPACT; EGYPT; KOREA; CHINA; GENE	Wet markets are common in many parts of the world and may promote the emergence, spread and maintenance of livestock pathogens, including zoonoses. A survey was conducted in order to assess the potential of Vietnamese and Cambodian live bird markets (LBMs) to sustain circulation of highly pathogenic avian influenza virus subtype H5N1 (HPAIV H5N1). Thirty Vietnamese and 8 Cambodian LBMs were visited, and structured interviews were conducted with the market managers and 561 Vietnamese and 84 Cambodian traders. Multivariate and cluster analysis were used to construct a typology of traders based on their poultry management practices. As a result of those practices and large poultry surplus (unsold poultry reoffered for sale the following day), some poultry traders were shown to promote conditions favorable for perpetuating HPAIV H5N1 in LBMs. More than 80% of these traders operated in LBMs located in the most densely populated areas, Ha Noi and Phnom Penh. The profiles of sellers operating at a given LBM could be reliably predicted using basic information about the location and type of market. Consequently, LBMs with the largest combination of risk factors for becoming virus reservoirs could be easily identified, potentially allowing control strategies to be appropriately targeted. These findings are of particular relevance to resource-scarce settings with extensively developed LBM systems, commonly found in South-East Asia.	[Fournie, Guillaume; Guitian, Javier; Pfeiffer, Dirk U.] Univ London, Dept Vet Clin Sci, Royal Vet Coll, London WC1E 7HU, England; [Desvaux, Stephanie] Ctr Cooperat Int Rech Agronom Dev, UR Anim & Gest Integree Risques, Montpellier, France; [Mangtani, Punam] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Ly, Sowath; Vong, Sirenda] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia; [San, Sorn] Natl Inst Anim Sci, Hanoi, Vietnam; [San, Sorn; Holl, Davun] Minist Agr Fisheries & Forestry, Natl Inst Vet Res, Phnom Penh, Cambodia; [Do Huu Dung] Dept Anim Hlth, Hanoi, Vietnam; [Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England	University of London; University of London Royal Veterinary College; CIRAD; University of London; London School of Hygiene & Tropical Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Imperial College London	Fournie, G (corresponding author), Univ London, Dept Vet Clin Sci, Royal Vet Coll, London WC1E 7HU, England.	gfournie@rvc.ac.uk	Pfeiffer, Dirk U/C-5002-2009; Guitian, Javier/O-1185-2019; Guitian, Javier/C-3022-2009; Ghani, Azra/B-8560-2009; Guitian, Javier/O-5744-2019	Pfeiffer, Dirk U/0000-0001-7000-0530; Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Fournie, Guillaume/0000-0002-6998-1201; Mangtani, Punam/0000-0001-7074-2999; Ghani, Azra/0000-0002-0007-4910	Bloomsbury consortium; University of London Central Research Fund; UK Medical Research Council; Medical Research Council [G0600719B] Funding Source: researchfish	Bloomsbury consortium; University of London Central Research Fund; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Guillaume Fournie thanks support from the Bloomsbury consortium and the University of London Central Research Fund. Azra C. Ghani acknowledges support from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2010, AVIAN DIS, V54, P911, DOI 10.1637/9099-100809-RESNOTE.1; Amonsin A, 2008, EMERG INFECT DIS, V14, P1739, DOI 10.3201/eid1411.080683; Bertrand F., 2007, CS BIGS, V1, P183; Buchy P, 2009, EMERG INFECT DIS, V15, P1641, DOI 10.3201/eid1510.090115; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen JJ, 2009, VIRUS RES, V146, P19, DOI 10.1016/j.virusres.2009.08.010; Choi YK, 2005, VIROLOGY, V332, P529, DOI 10.1016/j.virol.2004.12.002; Davis CT, 2010, AVIAN DIS, V54, P307, DOI 10.1637/8801-040109-ResNote.1; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; General Statistics Office of Vietnam, 2010, POP POP DENS 2009 PR; General Statistics Office of Vietnam, 2010, NUMB POULTR PROV 200; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Kim HR, 2010, VET MICROBIOL, V141, P362, DOI 10.1016/j.vetmic.2009.09.011; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee HJ, 2010, AVIAN DIS, V54, P738, DOI 10.1637/8785-040109-ResNote.1; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Magalhaes RJS, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-10; Manly B. F. J., 2005, MULTIVARIATE STAT ME; Meleigy M, 2007, LANCET, V370, P553, DOI 10.1016/S0140-6736(07)61274-4; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; [OIE World Organisation for Animal Health], 2011, H5N1 NOT DOM POULTR; Peyre Marisa, 2009, J Mol Genet Med, V3, P198; PP J, 2004, REV STAT APPL, V52, P93; ProMED-mail, 2008, AV INFL 122 CAMB CHI; R Development Core Team, 2010, LANG ENV STAT COMP G; Shortridge KF, 1999, VACCINE, V17, pS26, DOI 10.1016/S0264-410X(99)00102-4; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820	38	53	56	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37986	10.1371/journal.pone.0037986	http://dx.doi.org/10.1371/journal.pone.0037986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675502	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305341700031
J	Inagaki, T; Kaneko, N; Zukin, RS; Castillo, PE; Etgen, AM				Inagaki, Tomoko; Kaneko, Naoki; Zukin, R. Suzanne; Castillo, Pablo E.; Etgen, Anne M.			Estradiol Attenuates Ischemia-Induced Death of Hippocampal Neurons and Enhances Synaptic Transmission in Aged, Long-Term Hormone-Deprived Female Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GLOBAL-ISCHEMIA; SELECTIVE VULNERABILITY; NEUROPROTECTIVE ACTIONS; POSTMENOPAUSAL WOMEN; BRAIN; STROKE; DAMAGE; PLASTICITY; THERAPY	Background: Transient global forebrain ischemia causes selective, delayed death of hippocampal CA1 pyramidal neurons, and the ovarian hormone 17 beta-estradiol (E2) reduces neuronal loss in young and middle-aged females. The neuroprotective efficacy of E2 after a prolonged period of hormone deprivation is controversial, and few studies examine this issue in aged animals given E2 treatment after induction of ischemia. Methodology/Principal Findings: The present study investigated the neuroprotective effects of E2 administered immediately after global ischemia in aged female rats (15-18 months) after 6 months of hormone deprivation. We also used electrophysiological methods to assess whether CA1 synapses in the aging hippocampus remain responsive to E2 after prolonged hormone withdrawal. Animals were ovariohysterectomized and underwent 10 min global ischemia 6 months later. A single dose of E2 (2.25 mu g) infused intraventricularly after reperfusion significantly increased cell survival, with 45% of CA1 neurons surviving vs 15% in controls. Ischemia also induced moderate loss of CA3/CA4 pyramidal cells. Bath application of 1 nM E2 onto brain slices derived from non-ischemic aged females after 6 months of hormone withdrawal significantly enhanced excitatory transmission at CA1 synapses evoked by Schaffer collateral stimulation, and normal long-term potentiation (LTP) was induced. The magnitude of LTP and of E2 enhancement of field excitatory postsynaptic potentials was indistinguishable from that recorded in slices from young rats. Conclusions/Significance: The data demonstrate that 1) acute post-ischemic infusion of E2 into the brain ventricles is neuroprotective in aged rats after 6 months of hormone deprivation; and 2) E2 enhances synaptic transmission in CA1 pyramidal neurons of aged long-term hormone deprived females. These findings provide evidence that the aging hippocampus remains responsive to E2 administered either in vivo or in vitro even after prolonged periods of hormone withdrawal.	[Inagaki, Tomoko; Kaneko, Naoki; Zukin, R. Suzanne; Castillo, Pablo E.; Etgen, Anne M.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Inagaki, T (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	Anne.Etgen@einstein.yu.edu		Castillo, Pablo/0000-0002-9834-1801	National Institutes of Health [R01 AG027702]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant R01 AG027702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Adams MM, 2003, CEREB CORTEX, V13, P1271, DOI 10.1093/cercor/bhg078; Adams MM, 2001, P NATL ACAD SCI USA, V98, P8071, DOI 10.1073/pnas.141215898; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Brann D, 2012, J NEUROENDOCRINOL, V24, P34, DOI 10.1111/j.1365-2826.2011.02185.x; Carswell HVO, 2005, J STEROID BIOCHEM, V96, P89, DOI 10.1016/j.jsbmb.2005.02.016; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; De Butte-Smith M, 2009, HORM BEHAV, V55, P442, DOI 10.1016/j.yhbeh.2008.11.011; Driscoll I, 2008, NEUROBIOL AGING, V29, P1847, DOI 10.1016/j.neurobiolaging.2007.04.025; Eckel LA, 2011, PHYSIOL BEHAV, V104, P517, DOI 10.1016/j.physbeh.2011.04.014; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Etgen AM, 2011, FRONT NEUROENDOCRIN, V32, P336, DOI 10.1016/j.yfrne.2010.12.005; Farr TD, 2007, BRAIN RES, V1185, P275, DOI 10.1016/j.brainres.2007.09.009; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Garcia-Segura LM, 2007, PSYCHONEUROENDOCRINO, V32, pS57, DOI 10.1016/j.psyneuen.2007.03.001; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Grassi S, 2011, NEUROSCIENCE, V192, P67, DOI 10.1016/j.neuroscience.2011.06.078; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2008, MOL CELL ENDOCRINOL, V290, P31, DOI 10.1016/j.mce.2008.04.017; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kenealy BP, 2011, ENDOCRINOLOGY, V152, P3182, DOI 10.1210/en.2011-0097; Kharlamov A, 2000, J GERONTOL A-BIOL, V55, pB135, DOI 10.1093/gerona/55.3.B135; KIRINO T, 1985, PROG BRAIN RES, V63, P39; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Liu SB, 2012, J NEUROSCI, V32, P4887, DOI 10.1523/JNEUROSCI.5828-11.2012; MacLean PS, 2010, OBESITY, V18, P696, DOI 10.1038/oby.2009.307; McCullough LD, 2003, J NEUROSCI, V23, P8701; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Mukai H, 2006, NEUROSCIENCE, V138, P757, DOI 10.1016/j.neuroscience.2005.09.010; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Pines A, 2002, HUM REPROD UPDATE, V8, P161, DOI 10.1093/humupd/8.2.161; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Roepke TA, 2011, FRONT BIOSCI-LANDMRK, V16, P1560, DOI 10.2741/3805; Ronnekleiv OK, 2007, SEMIN REPROD MED, V25, P165, DOI 10.1055/s-2007-973429; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rune GM, 2005, NEUROSCIENCE, V136, P833, DOI 10.1016/j.neuroscience.2005.03.056; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Saleh TM, 2005, NEUROSCIENCE, V135, P1141, DOI 10.1016/j.neuroscience.2005.06.061; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Scott E, 2012, FRONT NEUROENDOCRIN, V33, P85, DOI 10.1016/j.yfrne.2011.10.001; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Smith CC, 2010, P NATL ACAD SCI USA, V107, P19543, DOI 10.1073/pnas.1009307107; Strom JO, 2011, INT J MOL SCI, V12, P1533, DOI 10.3390/ijms12031533; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Tu YF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-40; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wappler EA, 2010, BEHAV BRAIN RES, V209, P42, DOI 10.1016/j.bbr.2010.01.010; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Xu K, 2007, ADV EXP MED BIOL, V599, P199; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Yi KD, 2011, BRAIN RES, V1379, P61, DOI 10.1016/j.brainres.2010.11.058; Yildirim M, 2011, BRAIN RES, V1379, P98, DOI 10.1016/j.brainres.2010.07.053; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang M, 2011, NEUROCHEM INT, V59, P1019, DOI 10.1016/j.neuint.2011.08.023; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhou L, 2010, ENDOCRINOLOGY, V151, P1153, DOI 10.1210/en.2009-0254	74	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38018	10.1371/journal.pone.0038018	http://dx.doi.org/10.1371/journal.pone.0038018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675505	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700034
J	Park, TIH; Monzo, H; Mee, EW; Bergin, PS; Teoh, HH; Montgomery, JM; Faull, RLM; Curtis, MA; Dragunow, M				Park, Thomas In-Hyeup; Monzo, Hector; Mee, Edward W.; Bergin, Peter S.; Teoh, Hoon H.; Montgomery, Johanna M.; Faull, Richard L. M.; Curtis, Maurice A.; Dragunow, Mike			Adult Human Brain Neural Progenitor Cells (NPCs) and Fibroblast-Like Cells Have Similar Properties In Vitro but Only NPCs Differentiate into Neurons	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; EMBRYONIC HUMAN CNS; STEM-CELLS; SUBVENTRICULAR ZONE; STEM/PROGENITOR CELLS; INDUCED NEUROGENESIS; CELLULAR COMPOSITION; OLFACTORY-BULB; GLIAL CULTURES; DENTATE GYRUS	The ability to culture neural progenitor cells from the adult human brain has provided an exciting opportunity to develop and test potential therapies on adult human brain cells. To achieve a reliable and reproducible adult human neural progenitor cell (AhNPC) culture system for this purpose, this study fully characterized the cellular composition of the AhNPC cultures, as well as the possible changes to this in vitro system over prolonged culture periods. We isolated cells from the neurogenic subventricular zone/hippocampus (SVZ/HP) of the adult human brain and found a heterogeneous culture population comprised of several types of post-mitotic brain cells (neurons, astrocytes, and microglia), and more importantly, two distinct mitotic cell populations; the AhNPCs, and the fibroblast-like cells (FbCs). These two populations can easily be mistaken for a single population of AhNPCs, as they both proliferate under AhNPC culture conditions, form spheres and express neural progenitor cell and early neuronal markers, all of which are characteristics of AhNPCs in vitro. However, despite these similarities under proliferating conditions, under neuronal differentiation conditions, only the AhNPCs differentiated into functional neurons and glia. Furthermore, AhNPCs showed limited proliferative capacity that resulted in their depletion from culture by 5-6 passages, while the FbCs, which appear to be from a neurovascular origin, displayed a greater proliferative capacity and dominated the long-term cultures. This gradual change in cellular composition resulted in a progressive decline in neurogenic potential without the apparent loss of self-renewal in our cultures. These results demonstrate that while AhNPCs and FbCs behave similarly under proliferative conditions, they are two different cell populations. This information is vital for the interpretation and reproducibility of AhNPC experiments and suggests an ideal time frame for conducting AhNPC-based experiments.	[Park, Thomas In-Hyeup; Dragunow, Mike] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Park, Thomas In-Hyeup; Monzo, Hector; Montgomery, Johanna M.; Faull, Richard L. M.; Curtis, Maurice A.; Dragunow, Mike] Univ Auckland, Ctr Brain Res, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Park, Thomas In-Hyeup; Monzo, Hector; Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Dept Anat & Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Mee, Edward W.] Auckland City Hosp, Dept Neurosurg, Auckland, New Zealand; [Bergin, Peter S.] Auckland City Hosp, Dept Neurol, Auckland, New Zealand; [Teoh, Hoon H.] Labtests, Auckland, New Zealand; [Montgomery, Johanna M.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital; Auckland City Hospital; University of Auckland	Park, TIH (corresponding author), Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand.	m.dragunow@auckland.ac.nz		Faull, Richard/0000-0003-3385-9498; Park, Thomas In-Hyeup/0000-0002-7995-8865; Curtis, Maurice/0000-0003-4496-0233	Marsden Grant; New Zealand Tertiary Education Commission; Lynette Sullivan HD Research Fund; Health Research Council of New Zealand; Coker Charitable Trust; Hugh Green Charitable Trust Biobank; New Zealand Neurological Foundation	Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Tertiary Education Commission; Lynette Sullivan HD Research Fund; Health Research Council of New Zealand(Health Research Council of New Zealand); Coker Charitable Trust; Hugh Green Charitable Trust Biobank; New Zealand Neurological Foundation	This work was supported by: Marsden Grant (http://www.royalsociety.org.nz/programmes/funds/marsden); New Zealand Tertiary Education Commission Top Achievers Scholarship; Lynette Sullivan HD Research Fund; The Health Research Council of New Zealand (http://www.hrc.govt.nz); The Coker Charitable Trust; Hugh Green Charitable Trust Biobank and the New Zealand Neurological Foundation (http://www.neurological.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bifari F, 2009, J CELL MOL MED, V13, P3195, DOI 10.1111/j.1582-4934.2009.00706.x; BLACK RS, 1994, J NEUROCHEM, V62, P2132; BLASS JP, 1994, J NEUROL SCI, V121, P132, DOI 10.1016/0022-510X(94)90341-7; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Brewer GJ, 2001, J NEUROSCI METH, V107, P15, DOI 10.1016/S0165-0270(01)00342-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Coras R, 2010, BRAIN; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; D'Alessio L, 2010, SEIZURE-EUR J EPILEP, V19, P567, DOI 10.1016/j.seizure.2010.09.004; DEGIORGIO LA, 1994, J NEUROL SCI, V124, P141, DOI 10.1016/0022-510X(94)90319-0; DeGiorgio LA, 1997, INT J DEV NEUROSCI, V15, P231, DOI 10.1016/S0736-5748(96)00076-7; DeGroot CJA, 1997, J NEUROSCI RES, V49, P342, DOI 10.1002/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Emond MR, 2010, J PHYSIOL-LONDON, V588, P1929, DOI 10.1113/jphysiol.2010.187229; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Gibbons HA, 2007, J NEUROSCI METH, V166, P89, DOI 10.1016/j.jneumeth.2007.07.005; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2010, HIPPOCAMPUS, V20, P97, DOI 10.1002/hipo.20594; Hirohata S, 2001, J LEUKOCYTE BIOL, V70, P413; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Inoue H, 2010, EXP CELL RES; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Joannides A, 2003, J HEMATOTH STEM CELL, V12, P681, DOI 10.1089/15258160360732704; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Laywell ED, 2005, J COMP NEUROL, V493, P321, DOI 10.1002/cne.20722; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Liu YWJ, 2007, CURR PHARM BIOTECHNO, V8, P187; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Lue LF, 1996, NEUROBIOL AGING, V17, P421, DOI 10.1016/0197-4580(96)00006-1; Mamaeva D, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-99; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Park IHT, METHODS MOL IN PRESS; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2006, ACTA NEUROCHIR, V148, P773, DOI 10.1007/s00701-006-0778-5; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Roy NS, 2000, NAT MED, V6, P271; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P985, DOI 10.1152/jn.1992.68.4.985; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Waldvogel HJ, 2006, NAT PROTOC, V1, P2719, DOI 10.1038/nprot.2006.354; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X	83	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37742	10.1371/journal.pone.0037742	http://dx.doi.org/10.1371/journal.pone.0037742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675489	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700021
J	Patten, TM; Rennie, CJ; Robinson, PA; Gong, P				Patten, Timothy M.; Rennie, Christopher J.; Robinson, Peter A.; Gong, Pulin			Human Cortical Traveling Waves: Dynamical Properties and Correlations with Responses	PLOS ONE			English	Article							EVOKED-POTENTIALS; SYNCHRONIZATION; PATTERNS; PHASE	The spatiotemporal behavior of human EEG oscillations is investigated. Traveling waves in the alpha and theta ranges are found to be common in both prestimulus and poststimulus EEG activity. The dynamical properties of these waves, including their speeds, directions, and durations, are systematically characterized for the first time, and the results show that there are significant changes of prestimulus spontaneous waves in the presence of an external stimulus. Furthermore, the functional relevance of these waves is examined by studying how they are correlated with reaction times on a single trial basis; prestimulus alpha waves traveling in the frontal-to-occipital direction are found to be most correlated to reaction speeds. These findings suggest that propagating waves of brain oscillations might be involved in mediating long-range interactions between widely distributed parts of human cortex.	[Patten, Timothy M.; Rennie, Christopher J.; Robinson, Peter A.; Gong, Pulin] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Rennie, Christopher J.; Robinson, Peter A.] Univ Sydney, Brain Dynam Ctr, Sydney Med Sch Western, Westmead, NSW 2145, Australia; [Gong, Pulin] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Patten, TM (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	p.gong@physics.usyd.edu.au		Gong, Pulin/0000-0002-1960-3245; Robinson, Peter/0000-0002-5050-9804				Alexander DM, 2006, J NEUROSCI METH, V156, P111, DOI 10.1016/j.jneumeth.2006.02.016; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Aurlien H, 2004, CLIN NEUROPHYSIOL, V115, P665, DOI 10.1016/j.clinph.2003.10.019; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BEURLE RL, 1956, PHILOS T ROY SOC B, V240, P55, DOI 10.1098/rstb.1956.0012; Burkitt GR, 2000, CLIN NEUROPHYSIOL, V111, P246, DOI 10.1016/S1388-2457(99)00194-7; Buzsaki G., 2006, RHYTHMS BRAIN; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Farley BG, 1961, P 4 LOND S INF THEOR; Ferezou I, 2006, NEURON, V29, P33; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Freeman WJ, 1974, MASS ACTION NERVOUS; GOLDMAN S, 1949, SCIENCE, V109, P524, DOI 10.1126/science.109.2838.524; Gong P, 2003, NEUROSCI LETT, V336, P33, DOI 10.1016/S0304-3940(02)01247-8; Gong PL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000611; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P64, DOI 10.1177/155005940503600205; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Ito J, 2007, HUM BRAIN MAPP, V28, P904, DOI 10.1002/hbm.20316; Jirsa VK, 1996, PHYS REV LETT, V77, P960, DOI 10.1103/PhysRevLett.77.960; Kerr CC, 2011, CLIN NEUROPHYSIOL, V122, P134, DOI 10.1016/j.clinph.2010.05.030; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Linkenkaer-Hansen K, 2004, J NEUROSCI, V25, P2858; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nikolaev AR, 2010, CEREB CORTEX, V20, P365, DOI 10.1093/cercor/bhp107; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Robinson PA, 2008, BIOL CYBERN, V98, P1, DOI 10.1007/s00422-007-0191-z; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Albada SJ, 2010, CLIN NEUROPHYSIOL, V121, P21, DOI 10.1016/j.clinph.2009.09.021; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; von der Malsburg C., 2010, DYNAMIC COORDINATION; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wiener N, 1952, ARCH I CARDIOL MEX, V16, P204; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	48	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38392	10.1371/journal.pone.0038392	http://dx.doi.org/10.1371/journal.pone.0038392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675555	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700068
J	Perego, UA; Lancioni, H; Tribaldos, M; Angerhofer, N; Ekins, JE; Olivieri, A; Woodward, SR; Pascale, JM; Cooke, R; Motta, J; Achilli, A				Perego, Ugo A.; Lancioni, Hovirag; Tribaldos, Maribel; Angerhofer, Norman; Ekins, Jayne E.; Olivieri, Anna; Woodward, Scott R.; Pascale, Juan Miguel; Cooke, Richard; Motta, Jorge; Achilli, Alessandro			Decrypting the Mitochondrial Gene Pool of Modern Panamanians	PLOS ONE			English	Article							NATIVE-AMERICAN POPULATIONS; Y-CHROMOSOME; COSTA-RICA; LATE PLEISTOCENE; MTDNA VARIATION; NORTH-AMERICA; DNA; DIVERSITY; EVOLUTIONARY; HISTORY	The Isthmus of Panama-the narrow neck of land connecting the northern and southern American landmasses-was an obligatory corridor for the Paleo-Indians as they moved into South America. Archaeological evidence suggests an unbroken link between modern natives and their Paleo-Indian ancestors in some areas of Panama, even if the surviving indigenous groups account for only 12.3% of the total population. To evaluate if modern Panamanians have retained a larger fraction of the native pre-Columbian gene pool in their maternally-inherited mitochondrial genome, DNA samples and historical records were collected from more than 1500 volunteer participants living in the nine provinces and four indigenous territories of the Republic. Due to recent gene-flow, we detected similar to 14% African mitochondrial lineages, confirming the demographic impact of the Atlantic slave trade and subsequent African immigration into Panama from Caribbean islands, and a small European (similar to 2%) component, indicating only a minor influence of colonialism on the maternal side. The majority (similar to 83%) of Panamanian mtDNAs clustered into native pan-American lineages, mostly represented by haplogroup A2 (51%). These findings reveal an overwhelming native maternal legacy in today's Panama, which is in contrast with the overall concept of personal identity shared by many Panamanians. Moreover, the A2 sub-clades A2ad and A2af (with the previously named 6 bp Huetar deletion), when analyzed at the maximum level of resolution (26 entire mitochondrial genomes), confirm the major role of the Pacific coastal path in the peopling of North, Central and South America, and testify to the antiquity of native mitochondrial genomes in Panama.	[Perego, Ugo A.; Angerhofer, Norman; Ekins, Jayne E.; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Lancioni, Hovirag; Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Tribaldos, Maribel; Pascale, Juan Miguel; Motta, Jorge] Inst Conmemorativo Gorgas Estudios Salud, Panama City, Panama; [Angerhofer, Norman; Woodward, Scott R.] Ancestry, Provo, UT USA; [Olivieri, Anna] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Cooke, Richard] Smithsonian Trop Res Inst, Apdo, Ancon, Panama	University of Perugia; Instituto Conmemorativo Gorgas de Estudios de la Salud; University of Pavia; Smithsonian Institution; Smithsonian Tropical Research Institute	Perego, UA (corresponding author), Sorenson Mol Geneal Fdn, Salt Lake City, UT USA.	alessandro.achilli@unipg.it	OLIVIERI, ANNA/I-9235-2012; Perego, Ugo/AAG-9327-2019; Motta, Jorge Alejandro/ABI-6006-2020; Achilli, Alessandro/I-9236-2012; Lancioni, Hovirag/F-9067-2014; Tribaldos Causadias de Suarez, Maribel/L-8560-2016	OLIVIERI, ANNA/0000-0002-3941-8098; Achilli, Alessandro/0000-0001-6871-3451; Lancioni, Hovirag/0000-0001-5514-1853; Tribaldos Causadias de Suarez, Maribel/0000-0001-5212-0061	Instituto Conmemorativo Gorgas de Estudios de la Salud; Gorgas Internal Grant for Genealogy Studies; Italian Ministry of the University: FIRB-Futuro in Ricerca; Progetti Ricerca Interesse Nazionale; Sorenson Molecular Genealogy Foundation	Instituto Conmemorativo Gorgas de Estudios de la Salud; Gorgas Internal Grant for Genealogy Studies; Italian Ministry of the University: FIRB-Futuro in Ricerca; Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Sorenson Molecular Genealogy Foundation	This research received support from the Instituto Conmemorativo Gorgas de Estudios de la Salud (to JM), Gorgas Internal Grant for Genealogy Studies (to JMP), the Italian Ministry of the University: FIRB-Futuro in Ricerca 2008 (to AA and AO), Progetti Ricerca Interesse Nazionale 2009 (to AA), and the Sorenson Molecular Genealogy Foundation (to UAP, NA and SRW). The authors are grateful to all the donors for providing biological specimens, and to everyone at the Instituto Conmemorativo Gorgas and at the Sorenson Molecular Genealogy Foundation for their work on the preliminary data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ascunce MS, 2008, HUM BIOL, V80, P287, DOI 10.3378/1534-6617-80.3.287; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bodner M, 2012, GENOME RES; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Constenla Umana A., 1991, LENGUAS AREA INTERME; Cooke R, 2005, J ARCHAEOL RES, V13, P129, DOI 10.1007/s10804-005-2486-4; Crawford MH, 1998, ORIGINS NATIVE AM EV, VXV, P308; Dalton R, 2011, NATURE, V469, P462, DOI 10.1038/469462a; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Forster P, 1996, AM J HUM GENET, V59, P935; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Harding RC, 2006, HIST PANAMA, Vxviii, P153; Kashani BH, 2012, AM J PHYS ANTHROPOL, V147, P35, DOI 10.1002/ajpa.21614; Kaufman T, 2000, AM AM PRESENT GENES, P47; KOLMAN CJ, 1995, GENETICS, V140, P275; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; O'Rourke DH, 2009, CURR BIOL, V19, pR203, DOI 10.1016/j.cub.2009.01.021; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Piperno DR, 2011, S-P B ENVIRON SCI, P185; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Romoli Kathleen, 1987, LENGUA CUEVA; Ruiz-Narvaez EA, 2005, HUM BIOL, V77, P71, DOI 10.1353/hub.2005.0032; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006882; SANTOS M, 1994, HUM BIOL, V66, P963; SANTOS M, 1994, AM J HUM GENET, V55, P413; SANTOS M, 1994, HUM GENET, V93, P435; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, HUM MUTAT, V30, pE386; WALLACE DC, 1992, HUM BIOL, V64, P403; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; [No title captured]	57	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38337	10.1371/journal.pone.0038337	http://dx.doi.org/10.1371/journal.pone.0038337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675545	Green Published, gold			2022-12-25	WOS:000305341700060
J	Pitman, RT; Fong, JT; Billman, P; Puri, N				Pitman, Ryan T.; Fong, Jason T.; Billman, Penny; Puri, Neelu			Knockdown of the Fat Mass and Obesity Gene Disrupts Cellular Energy Balance in a Cell-Type Specific Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FTO GENE; FOOD-INTAKE; GLUCOSE-UPTAKE; INHIBITION; VARIANT; MUSCLE; AMPK; DIFFERENTIATION; OVEREXPRESSION	Recent studies suggest that FTO variants strongly correlate with obesity and mainly influence energy intake with little effect on the basal metabolic rate. We suggest that FTO influences eating behavior by modulating intracellular energy levels and downstream signaling mechanisms which control energy intake and metabolism. Since FTO plays a particularly important role in adipocytes and in hypothalamic neurons, SH-SY5Y neuronal cells and 3T3-L1 adipocytes were used to understand how siRNA mediated knockdown of FTO expression alters cellular energy homeostasis. Cellular energy status was evaluated by measuring ATP levels using a luminescence assay and uptake of fluorescent glucose. FTO siRNA in SH-SY5Y cells mediated mRNA knockdown (-82%), increased ATP concentrations by up to 46% (P = 0.013) compared to controls, and decreased phosphorylation of AMPk and Akt in SH-SY5Y by -52% and -46% respectively as seen by immunoblotting. In contrast, FTO siRNA in 3T3-L1 cells decreased ATP concentration by -93% (p<0.0005), and increased AMPk and Akt phosphorylation by 204% and 70%, respectively suggesting that FTO mediates control of energy levels in a cell-type specific manner. Furthermore, glucose uptake was decreased in both SH-SY5Y (-51% p = 0.015) and 3T3-L1 cells (-30%, p = 0.0002). We also show that FTO knockdown decreases NPY mRNA expression in SH-SY5Y cells (-21%) through upregulation of pSTAT3 (118%). These results provide important evidence that FTO-variant linked obesity may be associated with altered metabolic functions through activation of downstream metabolic mediators including AMPk.	[Pitman, Ryan T.; Fong, Jason T.; Billman, Penny; Puri, Neelu] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Pitman, RT (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	neelupur@uic.edu		Pitman, Ryan/0000-0003-4468-4347	University of Illinois at Chicago	University of Illinois at Chicago	The authors would like to acknowledge the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Coll AP, 2009, MOL CELL ENDOCRINOL, V300, P147, DOI 10.1016/j.mce.2008.09.007; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Grunnet LG, 2009, J CLIN ENDOCR METAB, V94, P596, DOI 10.1210/jc.2008-1592; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Jing M, 2006, AM J PHYSIOL-CELL PH, V290, pC484, DOI 10.1152/ajpcell.00321.2005; Kohno D, 2011, NEUROSCI LETT, V499, P194, DOI 10.1016/j.neulet.2011.05.060; Kola B, 2008, J NEUROENDOCRINOL, V20, P942, DOI 10.1111/j.1365-2826.2008.01745.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Poritsanos NJ, 2010, BIOCHEM BIOPH RES CO, V400, P713, DOI 10.1016/j.bbrc.2010.08.133; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Ropelle ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003856; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; Rutters F, 2010, PATIENT EDUC COUNS, V79, P367, DOI 10.1016/j.pec.2010.03.013; SADOWSKI HB, 1992, J BIOL CHEM, V267, P4722; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Shah AK, 2011, ARCH BIOCHEM BIOPHYS, V509, P142, DOI 10.1016/j.abb.2011.03.005; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Tews D, 2010, HORM METAB RES, V43, P17; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	41	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38444	10.1371/journal.pone.0038444	http://dx.doi.org/10.1371/journal.pone.0038444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675562	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700074
J	Uronis, JM; Osada, T; McCall, S; Yang, XY; Mantyh, C; Morse, MA; Lyerly, HK; Clary, BM; Hsu, DS				Uronis, Joshua M.; Osada, Takuya; McCall, Shannon; Yang, Xiao Yi; Mantyh, Christopher; Morse, Michael A.; Lyerly, H. Kim; Clary, Bryan M.; Hsu, David S.			Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants	PLOS ONE			English	Article							HUMAN COLON-CANCER; MODELS; XENOGRAFTS; EXPRESSION; ESTABLISHMENT; CHEMOTHERAPY; BIOMARKERS; TUMORS	Mouse models have been developed to investigate colorectal cancer etiology and evaluate new anti-cancer therapies. While genetically engineered and carcinogen-induced mouse models have provided important information with regard to the mechanisms underlying the oncogenic process, tumor xenograft models remain the standard for the evaluation of new chemotherapy and targeted drug treatments for clinical use. However, it remains unclear to what extent explanted colorectal tumor tissues retain inherent pathological features over time. In this study, we have generated a panel of 27 patient-derived colorectal cancer explants (PDCCEs) by direct transplantation of human colorectal cancer tissues into NOD-SCID mice. Using this panel, we performed a comparison of histology, gene expression and mutation status between PDCCEs and the original human tissues from which they were derived. Our findings demonstrate that PDCCEs maintain key histological features, basic gene expression patterns and KRAS/BRAF mutation status through multiple passages. Altogether, these findings suggest that PDCCEs maintain similarity to the patient tumor from which they are derived and may have the potential to serve as a reliable preclinical model that can be incorporated into future strategies to optimize individual therapy for patients with colorectal cancer.	[Uronis, Joshua M.; Hsu, David S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Osada, Takuya; Yang, Xiao Yi; Mantyh, Christopher; Lyerly, H. Kim; Clary, Bryan M.] Duke Univ, Dept Surg, Durham, NC USA; [McCall, Shannon] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Morse, Michael A.; Hsu, David S.] Duke Univ, Div Med Oncol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Uronis, JM (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA.	hsu00018@dm.duke.edu	mantyh, christopher/AAJ-9140-2021; Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; McCall, Shannon/0000-0003-3957-061X	American Cancer Society [119824-MRSG-10-195-01-TBG]	American Cancer Society(American Cancer Society)	This work was supported by grants from the Mentored Research Scholars Grant (119824-MRSG-10-195-01-TBG) from the American Cancer Society (www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein BA, 2011, EUR J CANCER, V47, P1343, DOI 10.1016/j.ejca.2011.03.031; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; DRUCKREY H, 1967, NATURWISSENSCHAFTEN, V54, P285, DOI 10.1007/BF00620890; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kendall SD, 2006, CELL CYCLE, V5, P1074, DOI 10.4161/cc.5.10.2734; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Kim M, 2012, MOL CANC TH IN PRESS; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Mischek D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/437284; Mnejja M, 2011, EUR ANN OTORHINOLARY, V128, P269, DOI 10.1016/j.anorl.2011.02.005; Papanikolaou A, 1998, CANCER LETT, V130, P29, DOI 10.1016/S0304-3835(98)00101-3; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Uronis JM, 2009, MAMM GENOME, V20, P261, DOI 10.1007/s00335-009-9186-5	21	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38422	10.1371/journal.pone.0038422	http://dx.doi.org/10.1371/journal.pone.0038422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675560	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700072
J	Karve, TM; Preet, A; Sneed, R; Salamanca, C; Li, X; Xu, JW; Kumar, D; Rosen, EM; Saha, T				Karve, Tejaswita M.; Preet, Anju; Sneed, Rosie; Salamanca, Clara; Li, Xin; Xu, Jingwen; Kumar, Deepak; Rosen, Eliot M.; Saha, Tapas			BRCA1 Regulates Follistatin Function in Ovarian Cancer and Human Ovarian Surface Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVIN-BINDING PROTEIN; TGF-BETA; BREAST-CANCER; POSTMENOPAUSAL WOMEN; TUMOR-SUPPRESSOR; II RECEPTORS; FEMALE REPRODUCTION; GENE-EXPRESSION; SERUM INHIBIN	Follistatin (FST), a folliculogenesis regulating protein, is found in relatively high concentrations in female ovarian tissues. FST acts as an antagonist to Activin, which is often elevated in human ovarian carcinoma, and thus may serve as a potential target for therapeutic intervention against ovarian cancer. The breast cancer susceptibility gene 1 (BRCA1) is a known tumor suppressor gene in human breast cancer; however its role in ovarian cancer is not well understood. We performed microarray analysis on human ovarian carcinoma cell line SKOV3 that stably overexpress wild-type BRCA1 and compared with the corresponding empty vector-transfected clones. We found that stable expression of BRCA1 not only stimulates FST secretion but also simultaneously inhibits Activin expression. To determine the physiological importance of this phenomenon, we further investigated the effect of cellular BRCA1 on the FST secretion in immortalized ovarian surface epithelial (IOSE) cells derived from either normal human ovaries or ovaries of an ovarian cancer patient carrying a mutation in BRCA1 gene. Knock-down of BRCA1 in normal IOSE cells demonstrates down-regulation of FST secretion along with the simultaneous up-regulation of Activin expression. Furthermore, knock-down of FST in IOSE cell lines as well as SKOV3 cell line showed significantly reduced cell proliferation and decreased cell migration when compared with the respective controls. Thus, these findings suggest a novel function for BRCA1 as a regulator of FST expression and function in human ovarian cells.	[Karve, Tejaswita M.; Preet, Anju; Xu, Jingwen; Rosen, Eliot M.; Saha, Tapas] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Karve, Tejaswita M.] Georgetown Univ, Sch Med, Dept Biochem & Cellular & Mol Biol, Washington, DC USA; [Sneed, Rosie; Kumar, Deepak] Univ Dist Columbia, Washington, DC USA; [Salamanca, Clara] BC Canc Res Ctr, Canadian Ovarian Tissue Bank, Vancouver, BC, Canada; [Li, Xin] Georgetown Univ, Sch Med, Dept Biostat Bioinformat & Biomath, Washington, DC USA	Georgetown University; Georgetown University; University of the District of Columbia; British Columbia Cancer Agency; Georgetown University	Karve, TM (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.	ts283@georgetown.edu	xu, jing/GRR-8698-2022		American Cancer Society [97-152-16-2]; Fisher Center for Familial Cancer Center; Lombardi Comprehensive Cancer Center; Georgetown University; National Institutes of Health [1U56CA101429-01]; USPHS [R01-CA150646]; Susan G. Komen for the Cure [KG110580]; Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10069]; NATIONAL CANCER INSTITUTE [U56CA101429, R01CA150646] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Fisher Center for Familial Cancer Center; Lombardi Comprehensive Cancer Center; Georgetown University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Tapas Saha is thankful to American Cancer Society (IRG #97-152-16-2), Fisher Center for Familial Cancer Center, Lombardi Comprehensive Cancer Center, Georgetown University for financial support. This work was supported, in part, by National Institutes of Health Grants 1U56CA101429-01 (to Dr. Peter Shield, Deepak Kumar and Dr. Carolyn Cousin). Eliot M. Rosen has been supported, in part, by research grants from the USPHS (R01-CA150646), Susan G. Komen for the Cure (KG110580), Living in Pink, and the World Class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Antony ML, 2010, J CANCER RES CLIN, V136, P351, DOI 10.1007/s00432-009-0703-4; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Berchuck A, 1996, AM J OBSTET GYNECOL, V175, P738; BERCHUCK A, 1992, AM J OBSTET GYNECOL, V166, P676, DOI 10.1016/0002-9378(92)91697-9; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bloise E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-320; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Brunsvold Amy N, 2005, J Am Acad Nurse Pract, V17, P518, DOI 10.1111/j.1745-7599.2005.00091.x; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Calp MK, 2003, GEN COMP ENDOCR, V132, P142, DOI 10.1016/S0016-6480(03)00060-1; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen T, 2001, CANCER RES, V61, P4679; Cipriano SC, 2000, ENDOCRINOLOGY, V141, P2319, DOI 10.1210/en.141.7.2319; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Dignass AU, 2002, SCAND J GASTROENTERO, V37, P936, DOI 10.1080/003655202760230900; DiSimone N, 1996, ENDOCRINOLOGY, V137, P486, DOI 10.1210/en.137.2.486; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELLIOTT WM, 1993, IN VITRO CELL DEV-AN, V29A, P9; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; Gao XW, 2007, FEBS LETT, V581, P5505, DOI 10.1016/j.febslet.2007.10.059; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HEALY DL, 1993, NEW ENGL J MED, V329, P1539, DOI 10.1056/NEJM199311183292104; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Karve TM, 2012, FUNCT INTEGR GENOMIC, V12, P63, DOI 10.1007/s10142-011-0251-2; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; Kozian DH, 1997, LAB INVEST, V76, P267; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; KRUK PA, 1990, LAB INVEST, V63, P132; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007091; LINDSELL CE, 1994, J REPROD FERTIL, V100, P591, DOI 10.1530/jrf.0.1000591; Mabuchi Y, 2006, ONCOL REP, V16, P373; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Menon U, 2000, BRIT J OBSTET GYNAEC, V107, P1069, DOI 10.1111/j.1471-0528.2000.tb11102.x; Metcalfe KA, 2009, BRIT J CANCER, V100, P421, DOI 10.1038/sj.bjc.6604830; Muttukrishna S, 2004, MOL CELL ENDOCRINOL, V225, P45, DOI 10.1016/j.mce.2004.02.012; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Ong A, 2000, INT J CANCER, V85, P430, DOI 10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q; Otsuka F, 2001, BIOCHEM BIOPH RES CO, V289, P961, DOI 10.1006/bbrc.2001.6103; Razanajaona D, 2007, CANCER RES, V67, P7223, DOI 10.1158/0008-5472.CAN-07-0805; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Robertson DM, 2002, J CLIN ENDOCR METAB, V87, P816, DOI 10.1210/jc.87.2.816; Rossmanith W, 2002, MOL CARCINOGEN, V35, P1, DOI 10.1002/mc.10068; Ruspita I, 2008, J MED INVESTIG, V55, P87, DOI 10.2152/jmi.55.87; Saha T, 2006, ONCOGENE, V25, P693, DOI 10.1038/sj.onc.1209123; Saha T, 2010, J BIOL CHEM, V25; Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sonoyama K, 2003, AM J PHYSIOL-GASTR L, V284, pG989, DOI 10.1152/ajpgi.00384.2002; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; Tinelli A, 2009, CURR GENOMICS, V10, P240, DOI 10.2174/138920209788488553; Tsigkou A, 2007, J CLIN ENDOCR METAB, V92, P2526, DOI 10.1210/jc.2007-0235; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Vale W., 1990, HDB EXPT PHARM, P211; Wang D, 2000, CANCER RES, V60, P4507; Wang D, 2000, INT J ONCOL, V17, P1087; Welt CK, 2002, CURR OPIN OBSTET GYN, V14, P317, DOI 10.1097/00001703-200206000-00012; Welt CK, 1997, J CLIN ENDOCR METAB, V82, P3720, DOI 10.1210/jc.82.11.3720; Whittemore AS, 1997, AM J HUM GENET, V60, P496; Xu CF, 1996, SEMIN CANCER BIOL, V7, P33, DOI 10.1006/scbi.1996.0005; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; ZHOU L, 1992, BIOCHIM BIOPHYS ACTA, V1180, P130, DOI 10.1016/0925-4439(92)90061-Q	72	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37697	10.1371/journal.pone.0037697	http://dx.doi.org/10.1371/journal.pone.0037697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22685544	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339900007
J	Li, H; Song, Y; Zhang, LJ; Gu, Y; Li, FF; Pan, SY; Jiang, LN; Liu, F; Ye, J; Li, Q				Li, Hang; Song, Yue; Zhang, Li-Jun; Gu, Yu; Li, Fan-Fan; Pan, Shu-Yi; Jiang, Li-Na; Liu, Fang; Ye, Jing; Li, Qing			LSDP5 Enhances Triglyceride Storage in Hepatocytes by Influencing Lipolysis and Fatty Acid beta-Oxidation of Lipid Droplets	PLOS ONE			English	Article							CELL-DEATH; PROTEIN; ADIPOCYTES; EXPRESSION; LIVER; DIFFERENTIATION; LIPOGENESIS; DISORDERS; TISSUES; OBESITY	Lipid storage droplet protein 5 (LSDP5) is a lipid droplet-associated protein of the PAT (perilipin, adipophilin, and TIP47) family that is expressed in the liver in a peroxisome proliferator-activated receptor alpha (PPAR alpha)-dependent manner; however, its exact function has not been elucidated. We noticed that LSDP5 was localized to the surface of lipid droplets in hepatocytes. Overexpression of LSDP5 enhanced lipid accumulation in the hepatic cell line AML12 and in primary hepatocytes. Knock-down of LSDP5 significantly decreased the triglyceride content of lipid droplets, stimulated lipolysis, and modestly increased the mitochondrial content and level of fatty-acid beta-oxidation in the mitochondria. The expression of PPARa was increased in LSDP5-deficient cells and required for the increase in the level of fatty acid b-oxidation in LSDP5-deficient cells. Using serial deletions of LSDP5, we determined that the lipid droplet-targeting domain and the domain directing lipid droplet clustering overlapped and were localized to the 188 amino acid residues at the N-terminus of LSDP5. Our findings suggest that LSDP5, a novel lipid droplet protein, may contribute to triglyceride accumulation by negatively regulating lipolysis and fatty acid oxidation in hepatocytes.	[Li, Hang; Song, Yue; Gu, Yu; Li, Fan-Fan; Jiang, Li-Na; Liu, Fang; Ye, Jing; Li, Qing] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Li, Hang; Song, Yue; Gu, Yu; Li, Fan-Fan; Jiang, Li-Na; Liu, Fang; Ye, Jing; Li, Qing] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Zhang, Li-Jun] Fourth Mil Med Univ, Tangdu Hosp, Dept Clin Lab, Xian 710032, Peoples R China; [Li, Hang; Pan, Shu-Yi] Chinese Peoples Liberat Army, Hyperbar Oxygen Ctr, Navy Gen Hosp, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital	Li, H (corresponding author), Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China.	yejing@fmmu.edu.cn; liqing@fmmu.edu.cn		, Yue/0000-0003-2731-3464	National Natural Science Foundation of China [30671087, 30700268, 30772261, 81000171, 81070249]; National Special Foundation for Key Drug Innovation of China [2009ZX09102-226]; Natural Science Foundation of Shaanxi Province [2007C204]; Fourth Military Medical University [2008D03];  [CBSKL2008006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Foundation for Key Drug Innovation of China; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fourth Military Medical University; 	This work was supported by grants from the National Natural Science Foundation of China (30671087, 30700268, 30772261, 81000171 and 81070249), the National Special Foundation for Key Drug Innovation of China (2009ZX09102-226), the Natural Science Foundation of Shaanxi Province (2007C204), and the Doctoral Assistant Fund of the Fourth Military Medical University (2008D03) and CBSKL2008006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Grasselli E, 2010, INT J MOL MED, V25, P505, DOI 10.3892/ijmm_00000370; Kohjima M, 2007, INT J MOL MED, V20, P351; Li FF, 2010, FEBS J, V277, P4173, DOI 10.1111/j.1742-4658.2010.07806.x; Li H, 2010, INT J MOL MED, V26, P231, DOI 10.3892/ijmm_00000457; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Liu Fang, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P438; Liu Fang, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P306; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhang LY, 2009, INT J ONCOL, V35, P25, DOI 10.3892/ijo_00000309	36	30	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36712	10.1371/journal.pone.0036712	http://dx.doi.org/10.1371/journal.pone.0036712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675471	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900003
J	Punnoose, A; McConnell, LA; Liu, W; Mutter, AC; Koder, RL				Punnoose, Alexander; McConnell, Liza A.; Liu, Wei; Mutter, Andrew C.; Koder, Ronald L.			Fundamental Limits on Wavelength, Efficiency and Yield of the Charge Separation Triad	PLOS ONE			English	Article							ELECTRON-TRANSFER; ENERGY; PHOTOSYNTHESIS; RECOMBINATION; MOLECULES; CHEMISTRY; PROTEIN	In an attempt to optimize a high yield, high efficiency artificial photosynthetic protein we have discovered unique energy and spatial architecture limits which apply to all light-activated photosynthetic systems. We have generated an analytical solution for the time behavior of the core three cofactor charge separation element in photosynthesis, the photosynthetic cofactor triad, and explored the functional consequences of its makeup including its architecture, the reduction potentials of its components, and the absorption energy of the light absorbing primary-donor cofactor. Our primary findings are two: First, that a high efficiency, high yield triad will have an absorption frequency more than twice the reorganization energy of the first electron transfer, and second, that the relative distance of the acceptor and the donor from the primary-donor plays an important role in determining the yields, with the highest efficiency, highest yield architecture having the light absorbing cofactor closest to the acceptor. Surprisingly, despite the increased complexity found in natural solar energy conversion proteins, we find that the construction of this central triad in natural systems matches these predictions. Our analysis thus not only suggests explanations for some aspects of the makeup of natural photosynthetic systems, it also provides specific design criteria necessary to create high efficiency, high yield artificial protein-based triads.	[Punnoose, Alexander] Univ Estadual Paulista, Inst Fis Teor, BR-01405 Sao Paulo, Brazil; [Punnoose, Alexander; McConnell, Liza A.; Liu, Wei; Mutter, Andrew C.; Koder, Ronald L.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	Universidade Estadual Paulista; City University of New York (CUNY) System; City College of New York (CUNY)	Punnoose, A (corresponding author), Univ Estadual Paulista, Inst Fis Teor, Rua Pamplona 145, BR-01405 Sao Paulo, Brazil.	alexander.punnoose@gmail.com; koder@sci.ccny.cuny.edu	Mutter, Andrew/AAB-6082-2020; Koder, Ronald L/A-6089-2008	Koder, Ronald/0000-0003-0868-4972	Air Force Office of Scientific Research [FA9550-10-1-0350]; NIH National Center for Research Resources [NIH 5G12 RR03060]; Center for Exploitation of Nanostructures in Sensor and Energy Systems (CENSES) under NSF [0833180]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Exploitation of Nanostructures in Sensor and Energy Systems (CENSES) under NSF; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	RLK gratefully acknowledges support by the following grants: FA9550-10-1-0350 from the Air Force Office of Scientific Research and the NIH National Center for Research Resources to CCNY (NIH 5G12 RR03060). ACM gratefully acknowledges support from the Center for Exploitation of Nanostructures in Sensor and Energy Systems (CENSES) under NSF Cooperative Agreement Award Number 0833180. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Braun P, 2011, PROTEINS, V79, P463, DOI 10.1002/prot.22895; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; CHO MH, 1995, J CHEM PHYS, V103, P595, DOI 10.1063/1.470094; Conlan B, 2009, BBA-BIOENERGETICS, V1787, P1112, DOI 10.1016/j.bbabio.2009.04.011; DEVAULT D, 1967, NATURE, V215, P642, DOI 10.1038/215642a0; Fry HC, 2010, J AM CHEM SOC, V132, P3997, DOI 10.1021/ja907407m; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; GUST D, 1986, J AM CHEM SOC, V108, P8028, DOI 10.1021/ja00285a025; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Hay S, 2004, P NATL ACAD SCI USA, V101, P17675, DOI 10.1073/pnas.0406192101; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; Imahori H, 2001, J AM CHEM SOC, V123, P6617, DOI 10.1021/ja004123v; Kiang NY, 2007, ASTROBIOLOGY, V7, P222, DOI 10.1089/ast.2006.0105; Koder RL, 2006, DALTON T, P3045, DOI 10.1039/b514972j; Kodis G, 2006, J AM CHEM SOC, V128, P1818, DOI 10.1021/ja055903c; Malak RA, 2004, J AM CHEM SOC, V126, P13888, DOI 10.1021/ja0401040; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; McConnell I, 2010, CHEM BIOL, V17, P434, DOI 10.1016/j.chembiol.2010.05.005; MEYER TJ, 1989, ACCOUNTS CHEM RES, V22, P163, DOI 10.1021/ar00161a001; Moore GF, 2008, J AM CHEM SOC, V130, P10466, DOI 10.1021/ja803015m; Moser C C, 2000, Subcell Biochem, V35, P1; Moser CC, 2005, PHOTOCH PHOTOBIO SCI, V4, P933, DOI 10.1039/b507352a; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Moser CC, 2010, BIOCH BOPHYSICA ACTA, V1797, P1537; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Myshkin E, 2002, BIOPHYS J, V82, P3305, DOI 10.1016/S0006-3495(02)75671-3; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; REDI M, 1980, J CHEM PHYS, V72, P6651, DOI 10.1063/1.439124; Williamson A, 2011, PHOTOSYNTH RES, V107, P71, DOI 10.1007/s11120-010-9559-3; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; Xu Q, 2000, J PHYS CHEM B, V104, P8035, DOI 10.1021/jp000543v; Zusman LD, 1999, J CHEM PHYS, V110, P10468, DOI 10.1063/1.478976	39	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36065	10.1371/journal.pone.0036065	http://dx.doi.org/10.1371/journal.pone.0036065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675467	Green Published, gold			2022-12-25	WOS:000305339900001
J	Aitta-Aho, T; Moykkynen, TP; Panhelainen, AE; Vekovischeva, OY; Backstrom, P; Korpi, ER				Aitta-aho, Teemu; Moykkynen, Tommi P.; Panhelainen, Anne E.; Vekovischeva, Olga Yu; Backstrom, Pia; Korpi, Esa R.			Importance of GluA1 Subunit-Containing AMPA Glutamate Receptors for Morphine State-Dependency	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; CONDITIONED PLACE PREFERENCE; LONG-TERM POTENTIATION; DOPAMINE NEURONS; DEFICIENT MICE; NMDA RECEPTOR; KNOCKOUT MICE; IN-VIVO; MEMORY; GLUR1	In state-dependency, information retrieval is most efficient when the animal is in the same state as it was during the information acquisition. State-dependency has been implicated in a variety of learning and memory processes, but its mechanisms remain to be resolved. Here, mice deficient in AMPA-type glutamate receptor GluA1 subunits were first conditioned to morphine (10 or 20 mg/kg s.c. during eight sessions over four days) using an unbiased procedure, followed by testing for conditioned place preference at morphine states that were the same as or different from the one the mice were conditioned to. In GluA1 wildtype littermate mice the same-state morphine dose produced the greatest expression of place preference, while in the knockout mice no place preference was then detected. Both wildtype and knockout mice expressed moderate morphine-induced place preference when not at the morphine state (saline treatment at the test); in this case, place preference was weaker than that in the same-state test in wildtype mice. No correlation between place preference scores and locomotor activity during testing was found. Additionally, as compared to the controls, the knockout mice showed unchanged sensitization to morphine, morphine drug discrimination and brain regional mu-opioid receptor signal transduction at the G-protein level. However, the knockout mice failed to show increased AMPA/NMDA receptor current ratios in the ventral tegmental area dopamine neurons of midbrain slices after a single injection of morphine (10 mg/kg, s.c., sliced prepared 24 h afterwards), in contrast to the wildtype mice. The results indicate impaired druginduced state-dependency in GluA1 knockout mice, correlating with impaired opioid-induced glutamate receptor neuroplasticity.	[Aitta-aho, Teemu; Moykkynen, Tommi P.; Panhelainen, Anne E.; Vekovischeva, Olga Yu; Backstrom, Pia; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki	Aitta-Aho, T (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	teemu.aitta-aho@helsinki.fi		Aitta-aho, Teemu/0000-0001-9332-3340; Korpi, Esa R./0000-0003-0683-4009; Panhelainen, Anne/0000-0001-5082-4006	Finnish Foundation for Alcohol Studies; Academy of Finland; Sigrid Juselius Foundation; Finnish Graduate School of Neuroscience; Helsinki Biomedical Graduate School	Finnish Foundation for Alcohol Studies; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Graduate School of Neuroscience; Helsinki Biomedical Graduate School	The study was supported by the Finnish Foundation for Alcohol Studies (TA, TPM), the Academy of Finland (ERK), and the Sigrid Juselius Foundation (ERK). The support of the Finnish Graduate School of Neuroscience (TPM) and the Helsinki Biomedical Graduate School (AEP) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitta-aho T, 2009, PHARMACOL BIOCHEM BE, V92, P283, DOI 10.1016/j.pbb.2008.12.015; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bespalov AY, 1999, PSYCHOPHARMACOLOGY, V141, P118, DOI 10.1007/s002130050815; Bettinger JC, 2004, GENES BRAIN BEHAV, V3, P266, DOI 10.1111/j.1601-183X.2004.00080.x; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Cowen MS, 2003, NEUROPHARMACOLOGY, V45, P325, DOI 10.1016/S0028-3908(03)00174-6; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; EICH JE, 1980, MEM COGNITION, V8, P157, DOI 10.3758/BF03213419; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Hyytia P, 1999, N-S ARCH PHARMACOL, V360, P391, DOI 10.1007/s002109900070; Koks S, 1999, NEUROPEPTIDES, V33, P63, DOI 10.1054/npep.1999.0015; Laitinen JT, 1998, J NEUROCHEM, V71, P808; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mead AN, 2005, PSYCHOPHARMACOLOGY, V179, P164, DOI 10.1007/s00213-004-2071-8; Mead AN, 2003, J NEUROSCI, V23, P1041; Mead AN, 1999, J PHARMACOL EXP THER, V290, P9; Nikam SS, 2001, CURR MED CHEM, V8, P155, DOI 10.2174/0929867013373877; OVERTON DA, 1991, BEHAV PHARMACOL, V2, P253; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Panhelainen AE, 2011, NEUROSCIENCE, V192, P312, DOI 10.1016/j.neuroscience.2011.07.004; Patti CL, 2010, SLEEP, V33, P1669, DOI 10.1093/sleep/33.12.1669; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Procaccini C, 2011, EUR J NEUROSCI, V33, P161, DOI 10.1111/j.1460-9568.2010.07485.x; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sakoori K, 2005, BEHAV BRAIN RES, V160, P34, DOI 10.1016/j.bbr.2004.11.013; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; Slot LAB, 2003, BEHAV PHARMACOL, V14, P167, DOI 10.1097/01.fbp.0000063264.43827.d0; Slot LAB, 1999, J NEUROSCI, V19, P10520; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vekovischeva OY, 2001, J NEUROSCI, V21, P4451, DOI 10.1523/JNEUROSCI.21-12-04451.2001; Vezina P, 1987, PSYCHOPHARMACOLOGY, P93; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zarrindast MR, 2006, NEUROBIOL LEARN MEM, V86, P286, DOI 10.1016/j.nlm.2006.04.002; Zarrindast MR, 2005, BEHAV BRAIN RES, V163, P100, DOI 10.1016/j.bbr.2005.04.006; Zhou RL, 2009, EUR J NEUROSCI, V30, P2318, DOI 10.1111/j.1460-9568.2009.07022.x	45	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38325	10.1371/journal.pone.0038325	http://dx.doi.org/10.1371/journal.pone.0038325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675452	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500131
J	Loganathan, R; Potetz, BR; Rongish, BJ; Little, CD				Loganathan, Rajprasad; Potetz, Brian R.; Rongish, Brenda J.; Little, Charles D.			Spatial Anisotropies and Temporal Fluctuations in Extracellular Matrix Network Texture during Early Embryogenesis	PLOS ONE			English	Article							CELL-SHAPE CHANGES; MOVEMENT; EMBRYO; MORPHOGENESIS; ORGANIZATION; FIBRONECTIN; DIRECTION	Early stages of vertebrate embryogenesis are characterized by a remarkable series of shape changes. The resulting morphological complexity is driven by molecular, cellular, and tissue-scale biophysical alterations. Operating at the cellular level, extracellular matrix (ECM) networks facilitate cell motility. At the tissue level, ECM networks provide material properties required to accommodate the large-scale deformations and forces that shape amniote embryos. In other words, the primordial biomaterial from which reptilian, avian, and mammalian embryos are molded is a dynamic composite comprised of cells and ECM. Despite its central importance during early morphogenesis we know little about the intrinsic micrometer-scale surface properties of primordial ECM networks. Here we computed, using avian embryos, five textural properties of fluorescently tagged ECM networks - (a) inertia, (b) correlation, (c) uniformity, (d) homogeneity, and (e) entropy. We analyzed fibronectin and fibrillin-2 as examples of fibrous ECM constituents. Our quantitative data demonstrated differences in the surface texture between the fibronectin and fibrillin-2 network in Day 1 (gastrulating) embryos, with the fibronectin network being relatively coarse compared to the fibrillin-2 network. Stage-specific regional anisotropy in fibronectin texture was also discovered. Relatively smooth fibronectin texture was exhibited in medial regions adjoining the primitive streak (PS) compared with the fibronectin network investing the lateral plate mesoderm (LPM), at embryonic stage 5. However, the texture differences had changed by embryonic stage 6, with the LPM fibronectin network exhibiting a relatively smooth texture compared with the medial PS-oriented network. Our data identify, and partially characterize, stage-specific regional anisotropy of fibronectin texture within tissues of a warm-blooded embryo. The data suggest that changes in ECM textural properties reflect orderly time-dependent rearrangements of a primordial biomaterial. We conclude that the ECM microenvironment changes markedly in time and space during the most important period of amniote morphogenesis-as determined by fluctuating textural properties.	[Loganathan, Rajprasad; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Loganathan, Rajprasad; Potetz, Brian R.] Univ Kansas, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas Medical Center; University of Kansas	Loganathan, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	rlogana2@jhmi.edu	Rongish, Brenda/G-7637-2016; Loganathan, Rajprasad/V-9993-2018	Rongish, Brenda/0000-0002-1559-2876; Loganathan, Rajprasad/0000-0001-5618-4222	National Institutes of Health [HL068855, HL085694, GM76692]; G Harold & Leila Y Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068855, R01HL085694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G Harold & Leila Y Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health RO1 grants HL068855 (CDL), HL085694 (BJR), GM76692 (CDL, PI is James A. Glazier, Indiana University); and the G Harold & Leila Y Mathers Charitable Foundation (CDL and BJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Alberts B, 2002, MOL BIOL CELL; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Butusov OB, 2006, THEOR FOUND CHEM EN+, V40, P291, DOI 10.1134/S0040579506030109; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573; Davidson L, 2009, INT J BIOCHEM CELL B, V41, P2147, DOI 10.1016/j.biocel.2009.04.015; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Fleury Vincent, 2007, Organogenesis, V3, P49; GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gjorevski N, 2009, CYTOKINE GROWTH F R, V20, P459, DOI 10.1016/j.cytogfr.2009.10.013; Gonzalez RC, 2002, DIGITAL IMAGE PROCES, P643; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Krafts KP, 2010, ORGANOGENESIS, V6, P225, DOI 10.4161/org.6.4.12555; Kurpios NA, 2008, P NATL ACAD SCI USA, V105, P8499, DOI 10.1073/pnas.0803578105; Little CD, 2000, METH MOL B, V135, P183; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; MOILLIET JL, 1967, NATURE, V213, P260, DOI 10.1038/213260a0; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; POOLE TJ, 1982, DEV BIOL, V92, P144, DOI 10.1016/0012-1606(82)90159-2; Ramos JW, 1996, DEVELOPMENT, V122, P2873; Rongish BJ, 1998, DEV DYNAM, V212, P461; Rosenfield A, 1970, VISUAL TEXTURE ANAL, P70; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; STERN CD, 2004, GASTRULATION CELLS E, P219; Szabo A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045006; Thiery JP, 1989, BIOL EXTRACELLULAR M, P181; Tomita F., 1990, COMPUTER ANAL VISUAL; Tsuda T, 1996, DEV BIOL, V173, P39, DOI 10.1006/dbio.1996.0005; Tuceryan M, HDB PATTERN RECOGNIT, P207; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; WUNSCH AM, 1994, DEV BIOL, V165, P585, DOI 10.1006/dbio.1994.1278; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38266	10.1371/journal.pone.0038266	http://dx.doi.org/10.1371/journal.pone.0038266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693609	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500120
J	Martinelli, F; Uratsu, SL; Albrecht, U; Reagan, RL; Phu, ML; Britton, M; Buffalo, V; Fass, J; Leicht, E; Zhao, WX; Lin, DW; D'Souza, R; Davis, CE; Bowman, KD; Dandekar, AM				Martinelli, Federico; Uratsu, Sandra L.; Albrecht, Ute; Reagan, Russell L.; Phu, My L.; Britton, Monica; Buffalo, Vincent; Fass, Joseph; Leicht, Elizabeth; Zhao, Weixiang; Lin, Dawei; D'Souza, Raissa; Davis, Cristina E.; Bowman, Kim D.; Dandekar, Abhaya M.			Transcriptome Profiling of Citrus Fruit Response to Huanglongbing Disease	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER-ASIATICUS; SAO-PAULO STATE; GENE-EXPRESSION; PCR DETECTION; CROSS-TALK; PROTEIN; SUGAR; SEQUENCE; IDENTIFICATION; CARBOHYDRATE	Huanglongbing (HLB) or "citrus greening" is the most destructive citrus disease worldwide. In this work, we studied host responses of citrus to infection with Candidatus Liberibacter asiaticus (CaLas) using next-generation sequencing technologies. A deep mRNA profile was obtained from peel of healthy and HLB-affected fruit. It was followed by pathway and protein-protein network analysis and quantitative real time PCR analysis of highly regulated genes. We identified differentially regulated pathways and constructed networks that provide a deep insight into the metabolism of affected fruit. Data mining revealed that HLB enhanced transcription of genes involved in the light reactions of photosynthesis and in ATP synthesis. Activation of protein degradation and misfolding processes were observed at the transcriptomic level. Transcripts for heat shock proteins were down-regulated at all disease stages, resulting in further protein misfolding. HLB strongly affected pathways involved in source-sink communication, including sucrose and starch metabolism and hormone synthesis and signaling. Transcription of several genes involved in the synthesis and signal transduction of cytokinins and gibberellins was repressed while that of genes involved in ethylene pathways was induced. CaLas infection triggered a response via both the salicylic acid and jasmonic acid pathways and increased the transcript abundance of several members of the WRKY family of transcription factors. Findings focused on the fruit provide valuable insight to understanding the mechanisms of the HLB-induced fruit disorder and eventually developing methods based on small molecule applications to mitigate its devastating effects on fruit production.	[Martinelli, Federico; Uratsu, Sandra L.; Reagan, Russell L.; Phu, My L.; Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Albrecht, Ute; Bowman, Kim D.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA; [Leicht, Elizabeth; Zhao, Weixiang; D'Souza, Raissa; Davis, Cristina E.] Univ Calif Davis, Mech & Aerosp Engn Dept, Davis, CA 95616 USA; [Leicht, Elizabeth; D'Souza, Raissa] Univ Calif Davis, Ctr Computat Sci & Engn, Davis, CA 95616 USA; [Britton, Monica; Buffalo, Vincent; Fass, Joseph; Lin, Dawei] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Martinelli, Federico] Univ Palermo, Dipartimento Sistemi Agroambientali, Palermo, Italy	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Palermo	Martinelli, F (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	amdandekar@ucdavis.edu	Buffalo, Vince/J-1647-2019; Davis, Cristina E/C-4437-2008; Martinelli, Federico/F-7697-2013	Buffalo, Vince/0000-0003-4510-1609; Dandekar, Abhaya/0000-0001-7925-4086	Florida Citrus Advanced Technology Program	Florida Citrus Advanced Technology Program	This work was supported by a grant received from the Florida Citrus Advanced Technology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2008, 11 INT CITR C ICC WU; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; ALMOGUERA C, 1995, PLANT PHYSIOL, V107, P765, DOI 10.1104/pp.107.3.765; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Boccara M, 2007, BIOCHIMIE, V89, P1252, DOI 10.1016/j.biochi.2007.04.011; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Duan Y, 2009, PHYTOPATHOLOGY, V99, pS157; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gibly A, 2004, MOL PLANT MICROBE IN, V17, P1212, DOI 10.1094/MPMI.2004.17.11.1212; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Goffard N, 2007, NUCLEIC ACIDS RES, V35, pW176, DOI 10.1093/nar/gkm261; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; Holzmuller P, 2008, ANN NY ACAD SCI, V1149, P66, DOI 10.1196/annals.1428.061; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Kanzaki H, 2008, PLANTA, V228, P977, DOI 10.1007/s00425-008-0797-y; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lin H, 2008, MOL CELL PROBE, V22, P30, DOI 10.1016/j.mcp.2007.06.006; Lucas WJ, 1999, CURR OPIN PLANT BIOL, V2, P192, DOI 10.1016/S1369-5266(99)80035-1; Mercke P, 2004, PLANT PHYSIOL, V135, P2012, DOI 10.1104/pp.104.048116; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; NIELSEN KK, 1994, PLANT MOL BIOL, V25, P241, DOI 10.1007/BF00023241; Panthee DR, 2007, FUNCT INTEGR GENOMIC, V7, P291, DOI 10.1007/s10142-007-0045-8; Perata P, 1997, PLANT CELL, V9, P2197, DOI 10.1105/tpc.9.12.2197; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rosales R, 2011, J PLANT GROWTH REGUL, V30, P312, DOI 10.1007/s00344-011-9193-0; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; SADKA A, 1994, PLANT CELL, V6, P737, DOI 10.1105/tpc.6.5.737; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; STITT M, 1995, ANNU REV PLANT PHYS, V46, P341, DOI 10.1146/annurev.pp.46.060195.002013; Strommer Judith, 1993, P49; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; van den Brule S, 2002, PLANTA, V216, P95, DOI 10.1007/s00425-002-0889-z; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang Z, 2006, PLANT PATHOL, V55, P630, DOI 10.1111/j.1365-3059.2006.01438.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	67	131	145	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38039	10.1371/journal.pone.0038039	http://dx.doi.org/10.1371/journal.pone.0038039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675433	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500080
J	Schwartz, NU; Zhong, LX; Bellemer, A; Tracey, WD				Schwartz, Nicholas U.; Zhong, Lixian; Bellemer, Andrew; Tracey, W. Daniel			Egg Laying Decisions in Drosophila Are Consistent with Foraging Costs of Larval Progeny	PLOS ONE			English	Article							MELANOGASTER; BEHAVIOR; RECEPTORS; TREHALOSE; SELECTION; SIMULANS; GENE	Decision-making is defined as selection amongst options based on their utility, in a flexible and context-dependent manner. Oviposition site selection by the female fly, Drosophila melanogaster, has been suggested to be a simple and genetically tractable model for understanding the biological mechanisms that implement decisions [1]. Paradoxically, female Drosophila have been found to avoid oviposition on sugar which contrasts with known Drosophila feeding preferences [1]. Here we demonstrate that female Drosophila prefer egg laying on sugar, but this preference is sensitive to the size of the egg laying substrate. With larger experimental substrates, females preferred to lay eggs directly on sugar containing media over other (plain, bitter or salty) media. This was in contrast to smaller substrates with closely spaced choices where females preferred non-sweetened media. We show that in small egg laying chambers newly hatched first instar larvae are able to migrate along a diffusion gradient to the sugar side. In contrast, in contexts where females preferred egg laying directly on sugar, larvae were unable to migrate to find the sucrose if released on the sugar free side of the chamber. Thus, where larval foraging costs are high, female Drosophila choose to lay their eggs directly upon the nutritious sugar substrate. Our results offer a powerful model for female decision-making.	[Schwartz, Nicholas U.; Tracey, W. Daniel] Duke Univ, Trinity Coll Arts & Sci, Neurosci Program, Durham, NC 27710 USA; [Zhong, Lixian; Tracey, W. Daniel] Duke Univ, Pharmacol Sci Training Program, Durham, NC USA; [Tracey, W. Daniel] Duke Univ, Dept Neurobiol, Durham, NC USA; [Tracey, W. Daniel] Duke Univ, Dept Cell Biol, Durham, NC USA; [Bellemer, Andrew; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Schwartz, NU (corresponding author), Duke Univ, Trinity Coll Arts & Sci, Neurosci Program, Durham, NC 27710 USA.	dan.tracey@duke.edu		Tracey, W. Daniel/0000-0003-4666-8199; Zhong, Lixian/0000-0003-2048-122X	NIGMS NIH HHS [T32 GM008600] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008600] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; DEBELLE JS, 1989, GENETICS, V123, P157; GRUWEZ G, 1971, EXPERIENTIA, V27, P1414, DOI 10.1007/BF02154262; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; SOKOLOWSKI MB, 1983, BEHAV GENET, V13, P159, DOI 10.1007/BF01065664; SOKOLOWSKI MB, 1983, BEHAV GENET, V13, P169, DOI 10.1007/BF01065665; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	14	54	54	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37910	10.1371/journal.pone.0037910	http://dx.doi.org/10.1371/journal.pone.0037910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693584	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500065
J	Shamoun-Baranes, J; Bom, R; van Loon, EE; Ens, BJ; Oosterbeek, K; Bouten, W				Shamoun-Baranes, Judy; Bom, Roeland; van Loon, E. Emiel; Ens, Bruno J.; Oosterbeek, Kees; Bouten, Willem			From Sensor Data to Animal Behaviour: An Oystercatcher Example	PLOS ONE			English	Article							HAEMATOPUS-OSTRALEGUS; ENERGY-EXPENDITURE; ACCELERATION DATA; PELAGIC SEABIRD; FLIGHT; MOVEMENTS; MIGRATION; INSIGHTS; TRACKING; BIRDS	Animal-borne sensors enable researchers to remotely track animals, their physiological state and body movements. Accelerometers, for example, have been used in several studies to measure body movement, posture, and energy expenditure, although predominantly in marine animals. In many studies, behaviour is often inferred from expert interpretation of sensor data and not validated with direct observations of the animal. The aim of this study was to derive models that could be used to classify oystercatcher (Haematopus ostralegus) behaviour based on sensor data. We measured the location, speed, and tri-axial acceleration of three oystercatchers using a flexible GPS tracking system and conducted simultaneous visual observations of the behaviour of these birds in their natural environment. We then used these data to develop three supervised classification trees of behaviour and finally applied one of the models to calculate time-activity budgets. The model based on accelerometer data developed to classify three behaviours (fly, terrestrial locomotion, and no movement) was much more accurate (cross-validation error = 0.14) than the model based on GPS-speed alone (cross-validation error = 0.35). The most parsimonious acceleration model designed to classify eight behaviours could distinguish five: fly, forage, body care, stand, and sit (cross-validation error = 0.28); other behaviours that were observed, such as aggression or handling of prey, could not be distinguished. Model limitations and potential improvements are discussed. The workflow design presented in this study can facilitate model development, be adapted to a wide range of species, and together with the appropriate measurements, can foster the study of behaviour and habitat use of free living animals throughout their annual routine.	[Shamoun-Baranes, Judy; Bom, Roeland; van Loon, E. Emiel; Bouten, Willem] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Bom, Roeland] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol & Evolut, Ab Den Burg, Texel, Netherlands; [Ens, Bruno J.; Oosterbeek, Kees] SOVON Dutch Ctr Field Ornithol, Coastal Ecol Team, Ab Den Burg, Texel, Netherlands	University of Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Shamoun-Baranes, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	shamoun@uva.nl	Shamoun-Baranes, Judy/C-6921-2013; van Loon, Emiel/T-3858-2019; Shamoun-Baranes, Judy/Q-1311-2019; Bouten, Willem/G-4383-2018	Shamoun-Baranes, Judy/0000-0002-1652-7646; van Loon, Emiel/0000-0002-8895-0427; Shamoun-Baranes, Judy/0000-0002-1652-7646; Bouten, Willem/0000-0002-5250-8872				Aviles JM, 2004, BIODIVERS CONSERV, V13, P2015, DOI 10.1023/B:BIOC.0000039999.57645.23; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Blair MJ, EBCC ATLAS EUROPEAN; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; BREIMAN L., 1984, CRC PRESS; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Bruderer B, 2010, IBIS, V152, P272, DOI 10.1111/j.1474-919X.2010.01014.x; Camphuysen K, 2012, BIOL CONSERV, V156, P22, DOI 10.1016/j.biocon.2011.12.024; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cumming GS, 2008, ECOL SOC, V13; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; ENS BJ, 1992, J ANIM ECOL, V61, P703, DOI 10.2307/5625; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Gleiss AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1350; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; Hastie T., 2009, UNSUPERVISED LEARNIN; Heg D, 2000, BEHAVIOUR, V137, P473, DOI 10.1163/156853900502187; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; Kersten M, 1996, ARDEA, V84A, P291; Kersten M, 1996, ARDEA, V84A, P57; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Millspaugh JJ, RADIO TRACKING ANIMA; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Yan, 2010, Endangered Species Research, V10, P21, DOI 10.3354/esr00188; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Schwemmer P, 2011, MAR BIOL, V158, P541, DOI 10.1007/s00227-010-1579-1; Shamoun-Baranes J, 2003, J AVIAN BIOL, V34, P97, DOI 10.1034/j.1600-048X.2003.03079.x; Shamoun-Baranes J, 2006, J EXP BIOL, V209, P3489, DOI 10.1242/jeb.02385; Shamoun-Baranes J, 2012, BIOL LETTERS, V8, P6, DOI 10.1098/rsbl.2011.0764; Shamoun-Baranes J, 2011, IBIS, V153, P411, DOI 10.1111/j.1474-919X.2010.01096.x; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Themeau T. M., 1997, INTRO RECURSIVE PART; Thorup K, 2006, BEHAV ECOL, V17, P497, DOI 10.1093/beheco/arj054; van de Pol M, 2010, EVOLUTION, V64, P836, DOI 10.1111/j.1558-5646.2009.00859.x; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2003, J ANIM ECOL, V72, P500, DOI 10.1046/j.1365-2656.2002.00720.x; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Witte TH, 2004, J BIOMECH, V37, P1891, DOI 10.1016/j.jbiomech.2004.02.031; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2001, J EXP BIOL, V204, P685; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	68	94	99	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37997	10.1371/journal.pone.0037997	http://dx.doi.org/10.1371/journal.pone.0037997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693586	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500070
J	Tetreault, MP; Alrabaa, R; McGeehan, M; Katz, JP				Tetreault, Marie-Pier; Alrabaa, Rami; McGeehan, Megan; Katz, Jonathan P.			Kruppel-Like Factor 5 Protects against Murine Colitis and Activates JAK-STAT Signaling In Vivo	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR KLF5; CANCER-CELLS; PROLIFERATION; KRUPPEL-LIKE-FACTOR-5; EXPRESSION; MICE; PROGRESSION; HOMEOSTASIS	Inflammatory bowel disease (IBD), which is characterized by chronic or recurring inflammation of the gastrointestinal tract, affects 1.4 million persons in the United States alone. KLF5, a Kruppel-like factor (KLF) family member, is expressed within the epithelia of the gastrointestinal tract and has been implicated in rapid cell proliferation, migration, and remodeling in a number of tissues. Given these functions, we hypothesized that constitutive Klf5 expression would protect against the development of colitis in vivo. To examine the role of KLF5 in vivo, we used the Villin promoter to target Klf5 to the entire horizontal axis of the small intestine and colon. Villin-Klf5 transgenic mice were born at normal Mendelian ratios and appeared grossly normal to at least 1 year of age. Surprisingly, there were no significant changes in cell proliferation or in the differentiation of any of the intestinal lineages within the duodenum, jejunum, ileum, and colon of Villin-Klf5 mice, compared to littermate controls. However, when Villin-Klf5 mice were treated with dextran sodium sulfate (DSS) to induce colitis, they developed less colonic injury and significantly reduced disease activity scores than littermate controls. The mechanism for this decreased injury may come via JAK-STAT signaling, the activation of which was increased in colonic mucosa of DSS treated Villin-Klf5 mice compared to controls. Thus, KLF5 and its downstream mediators may provide therapeutic targets and disease markers for IBD or other diseases characterized by injury and disruption of intestinal epithelia.	[Tetreault, Marie-Pier; Alrabaa, Rami; McGeehan, Megan; Katz, Jonathan P.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Tetreault, MP (corresponding author), Univ Penn, Perelman Sch Med, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA.	jpkatz@mail.med.upenn.edu	Tetreault, Marie-Pier/K-7950-2013		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [R01 DK080031, DK080031-02S1]; NIDDK [P30 DK050306]; University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases; Molecular Biology/Gene Expression Core; National Cancer Institute (NCI) of the National Institutes of Health [P01 CA098101]; NATIONAL CANCER INSTITUTE [P01CA098101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK080031] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases; Molecular Biology/Gene Expression Core; National Cancer Institute (NCI) of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health through R01 DK080031 and DK080031-02S1 to JPK; the NIDDK through P30 DK050306, the University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases, which includes the Molecular Pathology and Imaging Core, the Cell Culture Core, the Transgenic and Chimeric Mouse Facility, and the Molecular Biology/Gene Expression Core; and the National Cancer Institute (NCI) of the National Institutes of Health through P01 CA098101 ("Mechanisms of Esophageal Carcinogenesis"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; COOPER HS, 1993, LAB INVEST, V69, P238; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gibson DL, 2010, GASTROENTEROLOGY, V139, P1277, DOI 10.1053/j.gastro.2010.06.057; Goldsmith JR, 2011, AM J PATHOL, V179, P673, DOI 10.1016/j.ajpath.2011.04.032; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; KARAM SM, 1999, FRONT BIOSCI, V4, P286; Katz JP, 2002, GASTROENTEROL CLIN N, V31, P379, DOI 10.1016/S0889-8553(02)00006-7; Kumekawa M, 2008, BIOL PHARM BULL, V31, P1609, DOI 10.1248/bpb.31.1609; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Neufert C, 2010, CELL CYCLE, V9, P652, DOI 10.4161/cc.9.4.10615; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tetreault MP, 2008, J CELL PHYSIOL, V214, P545, DOI 10.1002/jcp.21239; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Yang YZ, 2011, CANCER RES, V71, P6475, DOI 10.1158/0008-5472.CAN-11-1702; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090	48	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38338	10.1371/journal.pone.0038338	http://dx.doi.org/10.1371/journal.pone.0038338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675454	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500134
J	Zeng, XF; Wang, T; Zhu, CR; Xing, XB; Ye, YX; Lai, XQ; Song, B; Zeng, YY				Zeng, Xiangfeng; Wang, Tong; Zhu, Cairong; Xing, Xiaobo; Ye, Yanxia; Lai, Xinqiang; Song, Bing; Zeng, Yaoying			Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro	PLOS ONE			English	Article							NITRIC-OXIDE; MEMBRANE-VESICLES; CHEMOKINE RECEPTOR; FTY720; INFLAMMATION; ATHEROSCLEROSIS; MODULATION; FINGOLIMOD; EXPRESSION; CYTOKINES	Abnormal inflammations are central therapeutic targets in numerous infectious and autoimmune diseases. Dendritic cells (DCs) are involved in these inflammations, serving as both antigen presenters and proinflammatory cytokine providers. As an immuno-suppressor applied to the therapies of multiple sclerosis and allograft transplantation, fingolimod (FTY720) was shown to affect DC migration and its crosstalk with T cells. We posit FTY720 can induce an anergy-polarized phenotype switch on DCs in vitro, especially upon endotoxic activation. A lipopolysaccharide (LPS)-induced mouse bone marrow-derived dendritic cell (BMDC) activation model was employed to test FTY720-induced phenotypic changes on immature and mature DCs. Specifically, methods for morphology, nanostructure, cytokine production, phagocytosis, endocytosis and specific antigen presentation studies were used. FTY720 induced significant alterations of surface markers, as well as decline of shape indices, cell volume, surface roughness in LPS-activated mature BMDCs. These phenotypic, morphological and topographical changes were accompanied by FTY720-mediated down-regulation of proinflammatory cytokines, including IL-6, TNF-alpha, IL-12 and MCP-1. Together with suppressed nitric oxide (NO) production and CCR7 transcription in FTY720-treated BMDCs with or without LPS activation, an inhibitory mechanism of NO and cytokine reciprocal activation was suggested. This implication was supported by the impaired phagocytotic, endocytotic and specific antigen presentation abilities observed in the FTY720-treated BMDCs. In conclusion, we demonstrated FTY720 can induce anergy-polarization in both immature and LPS-activated mature BMDCs. A possible mechanism is FTY720-mediated reciprocal suppression on the intrinsic activation pathway and cytokine production with endpoint exhibitions on phagocytosis, endocytosis, antigen presentation as well as cellular morphology and topography.	[Zeng, Xiangfeng; Wang, Tong; Ye, Yanxia; Lai, Xinqiang; Song, Bing; Zeng, Yaoying] Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China; [Wang, Tong] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Xing, Xiaobo] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Zhu, Cairong] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Xing, Xiaobo] S China Normal Univ, MOE, Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Xing, Xiaobo] S China Normal Univ, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University; South China Normal University; South China Normal University	Zeng, XF (corresponding author), Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China.	tzengyy@jnu.edu.cn	Wang, Tong/A-2750-2011	Wang, Tong/0000-0002-5980-3380	National Natural and Science Foundation of China [81000516]; University of Washington Center for AIDS Research New Investigator Award (UW Centers for AIDS Research National Institute on Aging, National Institutes of Health) [P30 AI027757]; Fundamental Research Funds for the Central Universities of China; Doctoral Fund of Ministry of Education of China [20104401120008]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China; Science and Technology Planning Project of Guangdong Province, China [2011B061300065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Washington Center for AIDS Research New Investigator Award (UW Centers for AIDS Research National Institute on Aging, National Institutes of Health); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Science and Technology Planning Project of Guangdong Province, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural and Science Foundation of China (81000516), the University of Washington Center for AIDS Research New Investigator Award (UW Centers for AIDS Research National Institute on Aging, National Institutes of Health grant P30 AI027757), the Fundamental Research Funds for the Central Universities of China, the Doctoral Fund of Ministry of Education of China (20104401120008), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China to TW; as well as Science and Technology Planning Project of Guangdong Province, China (2011B061300065) to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2007, PERSPECT MED CHEM, V1, P11; Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cai XF, 2010, MICRON, V41, P257, DOI 10.1016/j.micron.2009.08.011; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Chen JK, 1999, CHEM BIOL, V6, P221, DOI 10.1016/S1074-5521(99)80038-6; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chino T, 2009, J LEUKOCYTE BIOL, V86, P933, DOI 10.1189/jlb.0708419; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; DEAKIN AM, 1995, CYTOKINE, V7, P408, DOI 10.1006/cyto.1995.0056; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Ferlazzo G, 2001, IMMUNOL LETT, V76, P37, DOI 10.1016/S0165-2478(00)00323-0; FUJITA T, 1994, J ANTIBIOT, V47, P208, DOI 10.7164/antibiotics.47.208; Giordano D, 2006, BLOOD, V107, P1537, DOI 10.1182/blood-2005-07-2901; Glasser SW, 2008, J IMMUNOL, V181, P621, DOI 10.4049/jimmunol.181.1.621; Gorantla S, 2008, GLIA, V56, P223, DOI 10.1002/glia.20607; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Heng Y, 2010, TRANSPL INT, V23, P1259, DOI 10.1111/j.1432-2277.2010.01119.x; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Karp CL, 1998, EUR J IMMUNOL, V28, P3128, DOI 10.1002/(SICI)1521-4141(199810)28:10<3128::AID-IMMU3128>3.0.CO;2-T; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kobayashi M, 2001, J IMMUNOL, V167, P3585, DOI 10.4049/jimmunol.167.7.3585; Koltsova EK, 2011, TRENDS IMMUNOL, V32, P540, DOI 10.1016/j.it.2011.07.001; Lan YY, 2005, AM J TRANSPLANT, V5, P2649, DOI 10.1111/j.1600-6143.2005.01085.x; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lin Y, 2005, J REPROD IMMUNOL, V68, P39, DOI 10.1016/j.jri.2005.05.002; Ludewig B, 2000, P NATL ACAD SCI USA, V97, P12752, DOI 10.1073/pnas.220427097; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Marsolais D, 2011, MOL PHARMACOL, V79, P61, DOI 10.1124/mol.110.066811; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2011, ANN NEUROL, V69, P408, DOI 10.1002/ana.22352; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Paolucci C, 2000, J BIOL CHEM, V275, P19638, DOI 10.1074/jbc.M000511200; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sozzani S, 1997, J IMMUNOL, V159, P1993; Sun JS, 2010, CIRCULATION, V122, P808, DOI 10.1161/CIRCULATIONAHA.109.891887; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Wang Q, 2011, SCANNING; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Wang T, 2008, J NEUROIMMUNE PHARM, V3, P173, DOI 10.1007/s11481-008-9110-x; Wysocka M, 2001, J IMMUNOL, V166, P7504, DOI 10.4049/jimmunol.166.12.7504; Xing FY, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-455; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Ye YX, 2011, IMMUNOBIOLOGY, V216, P1044, DOI 10.1016/j.imbio.2011.03.001	61	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e34830	10.1371/journal.pone.0034830	http://dx.doi.org/10.1371/journal.pone.0034830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693544	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500005
J	Sluijter, M; Estevao, S; Hoogenboezem, T; Hartwig, NG; van Rossum, AMC; Vink, C				Sluijter, Marcel; Estevao, Silvia; Hoogenboezem, Theo; Hartwig, Nico G.; van Rossum, Annemarie M. C.; Vink, Cornelis			The RuvA Homologues from Mycoplasma genitalium and Mycoplasma pneumoniae Exhibit Unique Functional Characteristics	PLOS ONE			English	Article							HOLLIDAY-JUNCTION RESOLVASE; ESCHERICHIA-COLI RUVA; SINGLE-STRANDED-DNA; REPETITIVE CHROMOSOMAL SEQUENCES; IN-VITRO; CRYSTAL-STRUCTURE; BRANCH MIGRATION; ANTIGENIC VARIATION; HELICASE ACTIVITY; BINDING-PROTEIN	The DNA recombination and repair machineries of Mycoplasma genitalium and Mycoplasma pneumoniae differ considerably from those of gram-positive and gram-negative bacteria. Most notably, M. pneumoniae is unable to express a functional RecU Holliday junction (HJ) resolvase. In addition, the RuvB homologues from both M. pneumoniae and M. genitalium only exhibit DNA helicase activity but not HJ branch migration activity in vitro. To identify a putative role of the RuvA homologues of these mycoplasmas in DNA recombination, both proteins (RuvA(Mpn) and RuvA(Mge), respectively) were studied for their ability to bind DNA and to interact with RuvB and RecU. In spite of a high level of sequence conservation between RuvA(Mpn) and RuvA(Mge) (68.8% identity), substantial differences were found between these proteins in their activities. First, RuvA(Mge) was found to preferentially bind to HJs, whereas RuvA(Mpn) displayed similar affinities for both HJs and single-stranded DNA. Second, while RuvA(Mpn) is able to form two distinct complexes with HJs, RuvA(Mge) only produced a single HJ complex. Third, RuvA(Mge) stimulated the DNA helicase and ATPase activities of RuvB(Mge), whereas RuvA(Mpn) did not augment RuvB activity. Finally, while both RuvA(Mge) and RecU(Mge) efficiently bind to HJs, they did not compete with each other for HJ binding, but formed stable complexes with HJs over a wide protein concentration range. This interaction, however, resulted in inhibition of the HJ resolution activity of RecUMge.	[Sluijter, Marcel; Estevao, Silvia; Hoogenboezem, Theo; Hartwig, Nico G.; van Rossum, Annemarie M. C.; Vink, Cornelis] Erasmus MC Sophia Childrens Hosp, Lab Pediat Pediat Infect Dis & Immun, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Sluijter, M (corresponding author), Erasmus MC Sophia Childrens Hosp, Lab Pediat Pediat Infect Dis & Immun, Rotterdam, Netherlands.	c.vink@erasmusmc.nl	Hartwig, Nico/ABI-5467-2020; van Rossum, Annemarie/AAC-7050-2019	van Rossum, Annemarie/0000-0002-1259-477X	European Society for Pediatric Infectious Diseases; ZonMW; Erasmus MC	European Society for Pediatric Infectious Diseases; ZonMW(Netherlands Organization for Health Research and Development); Erasmus MC	AMCvR is supported by grants of the European Society for Pediatric Infectious Diseases, ZonMW, and the Erasmus MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carvalho FM, 2005, GENE, V360, P111, DOI 10.1016/j.gene.2005.06.012; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Estevao S, 2011, J BACTERIOL, V193, P6425, DOI 10.1128/JB.06003-11; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Ingleston SM, 2002, EUR J BIOCHEM, V269, P1525, DOI 10.1046/j.1432-1033.2002.02805.x; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Kelly SJ, 2007, PROTEINS, V68, P961, DOI 10.1002/prot.21418; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Maquelin K, 2009, MICROBIOL-SGM, V155, P2068, DOI 10.1099/mic.0.026724-0; McGregor N, 2005, STRUCTURE, V13, P1341, DOI 10.1016/j.str.2005.05.011; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Morimatsu K, 2002, P NATL ACAD SCI USA, V99, P11688, DOI 10.1073/pnas.142404499; MULLER B, 1993, J BIOL CHEM, V268, P17185; Nishino T, 1998, STRUCTURE, V6, P11, DOI 10.1016/S0969-2126(98)00003-3; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; PETERSON SN, 1995, P NATL ACAD SCI USA, V92, P11829, DOI 10.1073/pnas.92.25.11829; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Privezentzev CV, 2005, J BIOL CHEM, V280, P3365, DOI 10.1074/jbc.M409256200; RADDING CM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P131, DOI 10.1016/0167-4781(80)90001-9; Rafferty JB, 1998, J MOL BIOL, V278, P105, DOI 10.1006/jmbi.1998.1697; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; RULAND K, 1990, NUCLEIC ACIDS RES, V18, P6311, DOI 10.1093/nar/18.21.6311; SHAH R, 1994, NUCLEIC ACIDS RES, V22, P2490, DOI 10.1093/nar/22.13.2490; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; Sluijter M, 2011, J BACTERIOL, V193, P3941, DOI 10.1128/JB.00247-11; Sluijter M, 2010, MOL MICROBIOL, V77, P1261, DOI 10.1111/j.1365-2958.2010.07288.x; Sluijter M, 2009, INFECT IMMUN, V77, P4905, DOI 10.1128/IAI.00747-09; Sluijter M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-167; Spuesens EBM, 2011, MICROBIOL-SGM, V157, P473, DOI 10.1099/mic.0.045591-0; Spuesens EBM, 2010, J CLIN MICROBIOL, V48, P680, DOI 10.1128/JCM.02078-09; Spuesens EBM, 2009, MICROBIOL-SGM, V155, P2182, DOI 10.1099/mic.0.028506-0; SU CJ, 1988, INFECT IMMUN, V56, P3157, DOI 10.1128/IAI.56.12.3157-3161.1988; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; TSANEVA IR, 1994, J BIOL CHEM, V269, P26552; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x; WENZEL R, 1988, NUCLEIC ACIDS RES, V16, P8337, DOI 10.1093/nar/16.17.8337; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38301	10.1371/journal.pone.0038301	http://dx.doi.org/10.1371/journal.pone.0038301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666500	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400111
J	Boyer, S; Brown, SDJ; Collins, RA; Cruickshank, RH; Lefort, MC; Malumbres-Olarte, J; Wratten, SD				Boyer, Stephane; Brown, Samuel D. J.; Collins, Rupert A.; Cruickshank, Robert H.; Lefort, Marie-Caroline; Malumbres-Olarte, Jagoba; Wratten, Stephen D.			Sliding Window Analyses for Optimal Selection of Mini-Barcodes, and Application to 454-Pyrosequencing for Specimen Identification from Degraded DNA	PLOS ONE			English	Article							IN-SILICO APPROACH; LAND SNAIL; MITOCHONDRIAL PSEUDOGENES; SEQUENCES; DIET; PREY; PCR; PREDATION; RDNA; PHYLOGENETICS	DNA barcoding remains a challenge when applied to diet analyses, ancient DNA studies, environmental DNA samples and, more generally, in any cases where DNA samples have not been adequately preserved. Because the size of the commonly used barcoding marker (COI) is over 600 base pairs (bp), amplification fails when the DNA molecule is degraded into smaller fragments. However, relevant information for specimen identification may not be evenly distributed along the barcoding region, and a shorter target can be sufficient for identification purposes. This study proposes a new, widely applicable, method to compare the performance of all potential 'mini-barcodes' for a given molecular marker and to objectively select the shortest and most informative one. Our method is based on a sliding window analysis implemented in the new R package SPIDER (Species IDentity and Evolution in R). This method is applicable to any taxon and any molecular marker. Here, it was tested on earthworm DNA that had been degraded through digestion by carnivorous landsnails. A 100 bp region of 16 S rDNA was selected as the shortest informative fragment (mini-barcode) required for accurate specimen identification. Corresponding primers were designed and used to amplify degraded earthworm (prey) DNA from 46 landsnail (predator) faeces using 454-pyrosequencing. This led to the detection of 18 earthworm species in the diet of the snail. We encourage molecular ecologists to use this method to objectively select the most informative region of the gene they aim to amplify from degraded DNA. The method and tools provided here, can be particularly useful (1) when dealing with degraded DNA for which only small fragments can be amplified, (2) for cases where no consensus has yet been reached on the appropriate barcode gene, or (3) to allow direct analysis of short reads derived from massively parallel sequencing without the need for bioinformatic consolidation.	[Boyer, Stephane; Cruickshank, Robert H.; Malumbres-Olarte, Jagoba] Lincoln Univ, Fac Agr & Life Sci, Dept Ecol, Lincoln, New Zealand; [Brown, Samuel D. J.; Collins, Rupert A.; Lefort, Marie-Caroline; Wratten, Stephen D.] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand	Lincoln University - New Zealand; Lincoln University - New Zealand	Boyer, S (corresponding author), Lincoln Univ, Fac Agr & Life Sci, Dept Ecol, Lincoln, New Zealand.	stephane.boyer@lincoln.ac.nz	Brown, Samuel/P-8847-2017; Wratten, Steve D/J-3467-2013; Malumbres-Olarte, Jagoba/Q-2927-2016; Boyer, Stéphane/H-8624-2013	Brown, Samuel/0000-0001-7112-421X; Wratten, Steve D/0000-0002-5168-8277; Malumbres-Olarte, Jagoba/0000-0002-6878-5719; Boyer, Stéphane/0000-0002-0750-4864; Collins, Rupert A./0000-0002-9135-1169	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University; Solid Energy New Zealand Limited as part of the rehabilitation of the Stockton mine	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University; Solid Energy New Zealand Limited as part of the rehabilitation of the Stockton mine	This work was supported by Solid Energy New Zealand Limited, the Department of Ecology at Lincoln University, and the Bio-Protection Research Centre at Lincoln University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was partly supported by Solid Energy New Zealand Limited as part of the rehabilitation of the Stockton mine. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bekaert M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn191; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; BOORE JL, 1995, GENETICS, V141, P305; Bouche M.B., 1972, LOMBRICIENS FRANCE E; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2011, ZOOTAXA, P21; Boyer S, 2011, PEDOBIOLOGIA, V54, pS99, DOI 10.1016/j.pedobi.2011.09.006; Boyer S, 2011, PEDOBIOLOGIA, V54, pS153, DOI 10.1016/j.pedobi.2011.08.002; Boyer S, 2010, ZOOL MIDDLE EAST, P31; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Buckley TR, 2011, MOL PHYLOGENET EVOL, V58, P85, DOI 10.1016/j.ympev.2010.09.024; Chen W, 2009, MOL ECOL RESOUR, V9, P114, DOI 10.1111/j.1755-0998.2009.02638.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Dunshea G, 2008, B ENTOMOL RES, V98, P239, DOI 10.1017/S0007485308005993; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; Klarica J, 2012, SOIL BIOL BIOCHEM, V45, P23, DOI 10.1016/j.soilbio.2011.09.018; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Pop AA, 2007, EUR J SOIL BIOL, V43, pS43, DOI 10.1016/j.ejsobi.2007.08.007; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Riaz T, 2011, NUCLEIC ACIDS RES, V2011, P1; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stringer IAN, 2003, INVERTEBR BIOL, V122, P241; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Walker KJ, 2008, J ROY SOC NEW ZEAL, V38, P163, DOI 10.1080/03014220809510553; Zbawicka M, 2007, GENE, V406, P191, DOI 10.1016/j.gene.2007.10.003; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	60	33	35	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38215	10.1371/journal.pone.0038215	http://dx.doi.org/10.1371/journal.pone.0038215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666489	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600074
J	Huang, JM; Nagatomo, I; Suzuki, E; Mizuno, T; Kumagai, T; Berezov, A; Zhang, H; Karlan, B; Greene, MI; Wang, Q				Huang, J-M; Nagatomo, I.; Suzuki, E.; Mizuno, T.; Kumagai, T.; Berezov, A.; Zhang, H.; Karlan, B.; Greene, M. I.; Wang, Q.			YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14	ONCOGENE			English	Article						ovarian cancer; YAP; PTPN14; EGFR; survivin; erlotinib	YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; WW DOMAIN; HIPPO PATHWAY; TRANSCRIPTIONAL COACTIVATOR; SIZE-CONTROL; ORGAN SIZE; TGF-BETA; GROWTH; TAZ	The Yes-associated protein (YAP) is a transcriptional factor involved in tissue development and tumorigenesis. Although YAP has been recognized as a key element of the Hippo signaling pathway, the mechanisms that regulate YAP activities remain to be fully characterized. In this study, we demonstrate that the non-receptor type protein tyrosine phosphatase 14 (PTPN14) functions as a negative regulator of YAP. We show that YAP forms a protein complex with PTPN14 through the WW domains of YAP and the PPXY motifs of PTPN14. In addition, PTPN14 inhibits YAP-mediated transcriptional activities. Knockdown of YAP sensitizes cancer cells to various anti-cancer agents, such as cisplatin, the EGFR tyrosine kinase inhibitor erlotinib and the small-molecule antagonist of survivin, S12. YAP-targeted modalities may be used in combination with other cancer drugs to achieve maximal therapeutic effects. Oncogene (2013) 32, 2220-2229; doi:10.1038/onc.2012.231; published online 11 June 2012	[Huang, J-M; Karlan, B.; Wang, Q.] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Womens Canc Program, Los Angeles, CA USA; [Nagatomo, I.; Kumagai, T.; Zhang, H.; Greene, M. I.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Suzuki, E.; Mizuno, T.; Berezov, A.; Greene, M. I.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center	Greene, MI (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 36th Hamilton Walk,252 John Morgan Bldg, Philadelphia, PA 19104 USA.	greene@reo.med.upenn.edu; qiang.wang@cshs.org	Wang, Qiang/N-7310-2015	Wang, Qiang/0000-0001-9409-0251; Zhang, Hongtao/0000-0001-9173-0049	Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute of the Cedars-Sinai Medical Center; Donna and Jesse Garber Award for Cancer Research; National Cancer Institute [R01CA089481, R01 CA055306]; Breast Cancer Research Foundation; Abramson Family Cancer Research Institute at the University of Pennsylvania; Abramson Cancer Center [P30CA016520]; CEET [ES013508-04]; NATIONAL CANCER INSTITUTE [R01CA055306, R01CA089481, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute of the Cedars-Sinai Medical Center; Donna and Jesse Garber Award for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Abramson Family Cancer Research Institute at the University of Pennsylvania; Abramson Cancer Center; CEET; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has been supported by funds from the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute of the Cedars-Sinai Medical Center (QW), the Donna and Jesse Garber Award for Cancer Research (QW), R01CA089481 and R01 CA055306 from the National Cancer Institute (MIG), the Breast Cancer Research Foundation, and the Abramson Family Cancer Research Institute at the University of Pennsylvania (MIG). We thank these investigators for providing plasmids Masato Ogata (murine PTPN14/ PEZ), Joan Brugge (YAP), Kunliang Guan (Gal4- TEAD4) and Marius Sudol (LATS1). We thank Dr Chao-Xing Yuan for performing proteomics analysis at the proteomics core facility at the University of Pennsylvania. The Proteomics Core was supported by grant P30CA016520 (Abramson Cancer Center) and by grant ES013508-04 (CEET). We also thank the members of the Women's Cancer Program (Cedars-Sinai) and the Greene laboratory (UPenn) for helpful discussion.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Andersen J, 2010, DANCING TIMES, V100, P55; Barr AJ, 2006, PROTEINS, V63, P1132, DOI 10.1002/prot.20958; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Berezov A, 2012, ONCOGENE, V31, P1938, DOI 10.1038/onc.2011.377; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Carlucci A, 2010, J BIOL CHEM, V285, P39260, DOI 10.1074/jbc.M110.174706; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; Fernandez LA, 2011, ONCOGENE, P29; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Laczmanska I, 2011, ACTA BIOCHIM POL, V58, P467; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Niedergethmann M, 2007, BRIT J CANCER, V97, P1432, DOI 10.1038/sj.bjc.6604031; Ogata M, 1999, J BIOL CHEM, V274, P12905, DOI 10.1074/jbc.274.18.12905; Ogata M, 1999, J BIOL CHEM, V274, P20717, DOI 10.1074/jbc.274.29.20717; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; SMITH AL, 1995, BIOCHEM BIOPH RES CO, V209, P959, DOI 10.1006/bbrc.1995.1591; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wadham C, 2000, J CELL SCI, V113, P3117; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P262, DOI 10.1016/j.bcp.2010.03.029; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoneda T, 2006, DNA CELL BIOL, V25, P530, DOI 10.1089/dna.2006.25.530; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	64	114	119	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2220	2229		10.1038/onc.2012.231	http://dx.doi.org/10.1038/onc.2012.231			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22689061	Green Accepted			2022-12-25	WOS:000318062800011
J	Davies, LRL; Pearce, OMT; Tessier, MB; Assar, S; Smutova, V; Pajunen, M; Sumida, M; Sato, C; Kitajima, K; Finne, J; Gagneux, P; Pshezhetsky, A; Woods, R; Varki, A				Davies, Leela R. L.; Pearce, Oliver M. T.; Tessier, Matthew B.; Assar, Siavash; Smutova, Victoria; Pajunen, Maria; Sumida, Mizuki; Sato, Chihiro; Kitajima, Ken; Finne, Jukka; Gagneux, Pascal; Pshezhetsky, Alexey; Woods, Robert; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups RESISTANCE OF alpha 2-8-LINKED N-GLYCOLYLNEURAMINIC ACID TO ENZYMATIC CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; THIN-LAYER-CHROMATOGRAPHY; UNNATURAL SIALIC ACIDS; POLYSIALIC ACID; GLYCOLYLNEURAMINIC-ACID; BRAIN GANGLIOSIDES; ACETYLNEURAMINIC ACID; STRUCTURAL-CHARACTERIZATION; MONOCLONAL-ANTIBODY; NEURAMINIC ACID	The sialic acid (Sia) N-acetylneuraminic acid (Neu5Ac) and its hydroxylated derivative N-glycolylneuraminic acid (Neu5Gc) differ by one oxygen atom. CMP-Neu5Gc is synthesized from CMP-Neu5Ac, with Neu5Gc representing a highly variable fraction of total Sias in various tissues and among different species. The exception may be the brain, where Neu5Ac is abundant and Neu5Gc is reported to be rare. Here, we confirm this unusual pattern and its evolutionary conservation in additional samples from various species, concluding that brain Neu5Gc expression has been maintained at extremely low levels over hundreds of millions of years of vertebrate evolution. Most explanations for this pattern do not require maintaining neural Neu5Gc at such low levels. We hypothesized that resistance of alpha 2-8-linked Neu5Gc to vertebrate sialidases is the detrimental effect requiring the relative absence of Neu5Gc from brain. This linkage is prominent in polysialic acid (polySia), a molecule with critical roles in vertebrate neural development. We show that Neu5Gc is incorporated into neural polySia and does not cause in vitro toxicity. Synthetic polymers of Neu5Ac and Neu5Gc showed that mammalian and bacterial sialidases are much less able to hydrolyze alpha 2-8-linked Neu5Gc at the nonreducing terminus. Notably, this difference was not seen with acid-catalyzed hydrolysis of polySias. Molecular dynamics modeling indicates that differences in the three-dimensional conformation of terminal saccharides may partly explain reduced enzymatic activity. In keeping with this, polymers of N-propionylneuraminic acid are sensitive to sialidases. Resistance of Neu5Gc-containing polySia to sialidases provides a potential explanation for the rarity of Neu5Gc in the vertebrate brain.	[Davies, Leela R. L.; Pearce, Oliver M. T.; Assar, Siavash; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Davies, Leela R. L.; Pearce, Oliver M. T.; Assar, Siavash; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tessier, Matthew B.; Woods, Robert] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tessier, Matthew B.; Woods, Robert] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Smutova, Victoria; Pshezhetsky, Alexey] Univ Montreal, Ctr Hosp Univ St Justine, Div Med Genet, Montreal, PQ H3T 1C5, Canada; [Pajunen, Maria; Finne, Jukka] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FI-00014 Helsinki, Finland; [Sumida, Mizuki; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Woods, Robert] Natl Univ Ireland, Sch Chem, Galway, Ireland	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Helsinki; Nagoya University; Ollscoil na Gaillimhe-University of Galway	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Woods, Robert/F-4962-2015; SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Finne, Jukka/B-6881-2008	Naganawa, Shinji/0000-0002-0214-613X; Finne, Jukka/0000-0002-8076-3344; Pearce, Oliver/0000-0003-3953-1629; Woods, Robert/0000-0002-2400-6293; Pajunen, Maria/0000-0001-5484-2228	National Institutes of Health [R01GM32373, R01CA38701, GM094919]; CARTA; Mathers Foundation of New York; Cancer Research Institute; Finnish Academy; Science Foundation of Ireland [08/IN.1/B2070]; European Research Development Fund; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373, R01GM094919, P41GM103390, R01GM095882] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570133] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CARTA; Mathers Foundation of New York; Cancer Research Institute; Finnish Academy(Academy of Finland); Science Foundation of Ireland(Science Foundation Ireland); European Research Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and R01CA38701 (to A. V.) and GM094919 (EUREKA) (to R. J. W.).; Supported by a CARTA fellowship funded by the Mathers Foundation of New York.; Recipient of a Samuel and Ruth Engelberg Fellowship from the Cancer Research Institute.; Supported by the Finnish Academy.; Supported by Science Foundation of Ireland Grant 08/IN.1/B2070 and the European Research Development Fund.	ANDO S, 1978, ANAL BIOCHEM, V89, P437, DOI 10.1016/0003-2697(78)90373-1; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Basma M, 2001, J COMPUT CHEM, V22, P1125, DOI 10.1002/jcc.1072; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bork K, 2007, J NEUROCHEM, V103, P65, DOI 10.1111/j.1471-4159.2007.04711.x; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Cabezas J. A., 2011, AN REAL ACAD NAC F, V77, P72; Cao HZ, 2009, ORG BIOMOL CHEM, V7, P5137, DOI 10.1039/b916305k; Case D.A., 2010, AMBER 12 2012, P1; Casellato R, 1995, EUR J BIOCHEM, V234, P786, DOI 10.1111/j.1432-1033.1995.786_a.x; Charter NW, 2000, GLYCOBIOLOGY, V10, P1049, DOI 10.1093/glycob/10.10.1049; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; CHIGORNO V, 1982, NEUROCHEM INT, V4, P397, DOI 10.1016/0197-0186(82)90082-1; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; CORFIELD AP, 1981, BIOCHEM J, V197, P293, DOI 10.1042/bj1970293; CORFIELD AP, 1982, SIALIC ACIDS CHEM ME, P5; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; DAHIYA R, 1988, LIPIDS, V23, P863, DOI 10.1007/BF02536206; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FINNE J, 1987, J IMMUNOL, V138, P4402; FURUKAWA K, 1988, J BIOL CHEM, V263, P14939; GHIDONI R, 1976, J NEUROCHEM, V27, P511, DOI 10.1111/j.1471-4159.1976.tb12275.x; Gottschalk A., 1960, CHEMISTRY BIOLOGY SI, P30; HASHIMOTO Y, 1983, J BIOCHEM-TOKYO, V94, P2043, DOI 10.1093/oxfordjournals.jbchem.a134559; HASHIMOTO Y, 1982, J BIOCHEM-TOKYO, V91, P1039, DOI 10.1093/oxfordjournals.jbchem.a133753; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; HIGA HH, 1985, J BIOL CHEM, V260, P8838; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; INOUE S, 1980, BIOCHEM BIOPH RES CO, V93, P162, DOI 10.1016/S0006-291X(80)80260-9; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; IWAMORI M, 1978, J BIOCHEM-TOKYO, V84, P1609, DOI 10.1093/oxfordjournals.jbchem.a132287; IWAMORI M, 1981, BIOCHIM BIOPHYS ACTA, V665, P214, DOI 10.1016/0005-2760(81)90005-9; IWAMORI M, 1978, BIOCHIM BIOPHYS ACTA, V528, P257; Jokilammi A, 2004, J IMMUNOL METHODS, V295, P149, DOI 10.1016/j.jim.2004.10.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katoh S, 1999, J IMMUNOL, V162, P5058; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; KOIZUMI N, 1988, JPN J EXP MED, V58, P21; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; LEPERS A, 1990, EUR J BIOCHEM, V193, P715, DOI 10.1111/j.1432-1033.1990.tb19391.x; Li YH, 2011, MOL BIOSYST, V7, P1060, DOI 10.1039/c0mb00244e; Magesh S, 2009, BIOORGAN MED CHEM, V17, P4595, DOI 10.1016/j.bmc.2009.04.065; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; MANZI AE, 1994, J BIOL CHEM, V269, P23617; MARTENSSON E, 1958, BIOCHIM BIOPHYS ACTA, V30, P124, DOI 10.1016/0006-3002(58)90248-8; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MCCOY RD, 1985, J BIOL CHEM, V260, P2695; MENZELEEV RF, 1993, BIOORG KHIM+, V19, P817; Mikami T, 1998, J BIOCHEM, V123, P487; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Muhlenhoff M, 2003, J BIOL CHEM, V278, P12634, DOI 10.1074/jbc.M212048200; MURAYAMA JI, 1982, J BIOCHEM, V91, P1829, DOI 10.1093/oxfordjournals.jbchem.a133879; NAGAI K, 1985, J BIOCHEM-TOKYO, V98, P545, DOI 10.1093/oxfordjournals.jbchem.a135309; NAKAO T, 1991, BIOCHIM BIOPHYS ACTA, V1086, P305, DOI 10.1016/0005-2760(91)90174-G; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Osthoff G, 2008, COMP BIOCHEM PHYS B, V150, P74, DOI 10.1016/j.cbpb.2008.01.010; Pearce OMT, 2010, CARBOHYD RES, V345, P1225, DOI 10.1016/j.carres.2010.04.003; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; Raymond JB, 2005, J BIOL CHEM, V280, P326, DOI 10.1074/jbc.M411006200; Rizzo AM, 2002, GLYCOCONJUGATE J, V19, P53, DOI 10.1023/A:1022584914778; ROY R, 1990, GLYCOCONJUGATE J, V7, P3, DOI 10.1007/BF01050399; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANAI Y, 1988, BIOCHIM BIOPHYS ACTA, V958, P368, DOI 10.1016/0005-2760(88)90222-6; SATO C, 1993, J BIOL CHEM, V268, P23675; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; SCHAUER R, 1968, H-S Z PHYSIOL CHEM, V349, P645, DOI 10.1515/bchm2.1968.349.1.645; Schauer R, 1978, Methods Enzymol, V50, P64; Schulz EC, 2010, J MOL BIOL, V397, P341, DOI 10.1016/j.jmb.2010.01.028; SEKI T, 1991, ANAT EMBRYOL, V184, P395, DOI 10.1007/BF00957900; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Song KH, 2010, BIOCHEM J, V427, P179, DOI 10.1042/BJ20090835; Spichtig V, 2010, ANAL BIOCHEM, V405, P28, DOI 10.1016/j.ab.2010.06.010; Spiro RG, 1996, BIOCHEM J, V319, P209, DOI 10.1042/bj3190209; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Tao NA, 2011, J PROTEOME RES, V10, P1548, DOI 10.1021/pr1009367; TERABAYASHI T, 1992, COMP BIOCHEM PHYS B, V103, P721, DOI 10.1016/0305-0491(92)90396-9; TROY FA, 1979, ANNU REV MICROBIOL, V33, P519, DOI 10.1146/annurev.mi.33.100179.002511; Uemura Y, 2006, COMP BIOCHEM PHYS A, V145, P468, DOI 10.1016/j.cbpa.2006.08.001; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Vyas AA, 2001, BIOCHIMIE, V83, P677, DOI 10.1016/S0300-9084(01)01308-6; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; WANG D, 1990, JPN J VET SCI, V52, P567; WARREN L, 1961, J HISTOCHEM CYTOCHEM, V9, P400, DOI 10.1177/9.4.400; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamakawa N, 2007, BIOCHIMIE, V89, P1396, DOI 10.1016/j.biochi.2007.04.010; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039; Yongye AB, 2008, BIOCHEMISTRY-US, V47, P12493, DOI 10.1021/bi800431c; YU RK, 1972, J LIPID RES, V13, P680; YU RK, 1970, J LIPID RES, V11, P506; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zhang Y, 1999, J BIOL CHEM, V274, P6183, DOI 10.1074/jbc.274.10.6183	113	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28917	28931		10.1074/jbc.M112.365056	http://dx.doi.org/10.1074/jbc.M112.365056			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692207	hybrid, Green Published			2022-12-25	WOS:000308074600061
J	Tecalco-Cruz, AC; Sosa-Garrocho, M; Vazquez-Victorio, G; Ortiz-Garcia, L; Dominguez-Huttinger, E; Macias-Silva, M				Tecalco-Cruz, Angeles C.; Sosa-Garrocho, Marcela; Vazquez-Victorio, Genaro; Ortiz-Garcia, Layla; Dominguez-Huettinger, Elisa; Macias-Silva, Marina			Transforming Growth Factor-beta/SMAD Target Gene SKIL Is Negatively Regulated by the Transcriptional Cofactor Complex SNON-SMAD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; ANAPHASE-PROMOTING COMPLEX; FACTOR-BETA; DOWN-REGULATION; SMAD PROTEINS; SNON ONCOPROTEIN; TUMOR-SUPPRESSOR; CANCER-CELLS; GENOME-WIDE; DEGRADATION	The human SKI-like (SKIL) gene encodes the SMAD transcriptional corepressor SNON that antagonizes TGF-beta signaling. SNON protein levels are tightly regulated by the TGF-beta pathway: whereas a short stimulation with TGF-beta decreases SNON levels by its degradation via the proteasome, longer TGF-beta treatment increases SNON levels by inducing SKIL gene expression. Here, we investigated the molecular mechanisms involved in the self-regulation of SKIL gene expression by SNON. Bioinformatics analysis showed that the human SKIL gene proximal promoter contains a TGF-beta response element (TRE) bearing four groups of SMAD-binding elements that are also conserved in mouse. Two regions of 408 and 648 bp of the human SKIL gene (similar to 2.4 kb upstream of the ATG initiation codon) containing the core promoter, transcription start site, and the TRE were cloned for functional analysis. Binding of SMAD and SNON proteins to the TRE region of the SKIL gene promoter after TGF-beta treatment was demonstrated by ChIP and sequential ChIP assays. Interestingly, the SNON-SMAD4 complex negatively regulated basal SKIL gene expression through binding the promoter and recruiting histone deacetylases. In response to TGF-beta signal, SNON is removed from the SKIL gene promoter, and then the activated SMAD complexes bind the promoter to induce SKIL gene expression. Subsequently, the up-regulated SNON protein in complex with SMAD4 represses its own expression as part of the negative feedback loop regulating the TGF-beta pathway. Accordingly, when the SNON-SMAD4 complex is absent as in some cancer cells lacking SMAD4 the regulation of some TGF-beta target genes is modified.	[Tecalco-Cruz, Angeles C.; Sosa-Garrocho, Marcela; Vazquez-Victorio, Genaro; Ortiz-Garcia, Layla; Dominguez-Huettinger, Elisa; Macias-Silva, Marina] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Macias-Silva, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico.	mmacias@ifc.unam.mx	Tecalco-Cruz, Angeles C./ABA-7761-2020; TECALCO-CRUZ, ANGELES C./K-1983-2019	TECALCO-CRUZ, ANGELES C./0000-0001-9199-3834; Macias-Silva, Marina/0000-0002-3972-0983; Dominguez Huttinger, Elisa/0000-0002-9086-099X; Vazquez-Victorio, Genaro/0000-0002-2319-8772	Universidad Nacional Autonoma de Mexico/Direccion General Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Program [IN222909, IN206012]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [49493-Q, 101826]; CONACyT	Universidad Nacional Autonoma de Mexico/Direccion General Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Program; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by Universidad Nacional Autonoma de Mexico/Direccion General Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Program Grants IN222909 and IN206012 and Consejo Nacional de Ciencia y Tecnologia (CONACyT) Grants 49493-Q and 101826.; Recipient of a Ph.D. fellowship from CONACyT.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Briones-Orta MA, 2006, BIOCHEM BIOPH RES CO, V341, P889, DOI 10.1016/j.bbrc.2006.01.041; Briones-Orta Marco A, 2011, Curr Mol Pharmacol, V4, P141; Cohen SB, 1999, NUCLEIC ACIDS RES, V27, P1006, DOI 10.1093/nar/27.4.1006; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; Edmiston JS, 2005, CANCER RES, V65, P4782, DOI 10.1158/0008-5472.CAN-04-4354; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; HernandezDamian J., 2010, CURR CHEM BIOL, V4, P124; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Kalari Krishna R., 2006, In Silico Biology, V6, P237; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin Xia, 2008, P287; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Muller N, 2002, ONCOGENE, V21, P6049, DOI 10.1038/sj.onc.1205766; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; NAGASE T, 1993, J BIOL CHEM, V268, P13710; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pearson-White S, 2003, MOL CELL BIOL, V23, P5446, DOI 10.1128/MCB.23.15.5446-5459.2003; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Tan RY, 2007, J AM SOC NEPHROL, V18, P2340, DOI 10.1681/ASN.2007010128; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Vazquez-Macias A, 2005, FEBS LETT, V579, P3701, DOI 10.1016/j.febslet.2005.05.057; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Yang G, 2010, INT J BIOL SCI, V6, P1; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	58	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26764	26776		10.1074/jbc.M112.386599	http://dx.doi.org/10.1074/jbc.M112.386599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22674574	Green Published, hybrid			2022-12-25	WOS:000307386000026
J	Chien, CH; Gao, QZ; Cooper, AJL; Lyu, JH; Sheu, SY				Chien, Chin-Hsiang; Gao, Quan-Ze; Cooper, Arthur J. L.; Lyu, Jyun-Hong; Sheu, Sheh-Yi			Structural Insights into the Catalytic Active Site and Activity of Human Nit2/omega-Amidase KINETIC ASSAY AND MOLECULAR DYNAMICS SIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE TUMOR-SUPPRESSOR; LIVER OMEGA-AMIDASE; RAT-LIVER; GLUTAMINE TRANSAMINASE; ALPHA-KETOGLUTARAMATE; CRYSTAL-STRUCTURE; PROTEIN; ACID; IDENTIFICATION; ASPARAGINE	Human nitrilase-like protein 2 (hNit2) is a putative tumor suppressor, recently identified as omega-amidase. hNit2/omega-amidase plays a crucial metabolic role by catalyzing the hydrolysis of alpha-ketoglutaramate (the alpha-keto analog of glutamine) and alpha-ketosuccinamate (the alpha-keto analog of asparagine), yielding alpha-ketoglutarate and oxaloacetate, respectively. Transamination between glutamine and alpha-keto-gamma-methiolbutyrate closes the methionine salvage pathway. Thus, hNit2/omega-amidase links sulfur metabolism to the tricarboxylic acid cycle. To elucidate the catalytic specificity of hNit2/omega-amidase, we performed molecular dynamics simulations on the wild type enzyme and its mutants to investigate enzyme-substrate interactions. Binding free energies were computed to characterize factors contributing to the substrate specificity. The predictions resulting from these computations were verified by kinetic analyses and mutational studies. The activity of hNit2/omega-amidase was determined with alpha-ketoglutaramate and succinamate as substrates. We constructed three catalytic triad mutants (E43A, K112A, and C153A) and a mutant with a loop 116-128 deletion to validate the role of key residues and the 116-128 loop region in substrate binding and turnover. The molecular dynamics simulations successfully verified the experimental trends in the binding specificity of hNit2/omega-amidase toward various substrates. Our findings have revealed novel structural insights into the binding of substrates to hNit2/omega-amidase. A catalytic triad and the loop residues 116-128 of hNit2 play an essential role in supporting the stability of the enzyme-substrate complex, resulting in the generation of the catalytic products. These observations are predicted to be of benefit in the design of new inhibitors or activators for research involving cancer and hyperammonemic diseases.	[Sheu, Sheh-Yi] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Sheu, Sheh-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chien, Chin-Hsiang] Natl Yang Ming Univ, Dept Biochem, Sch Med, Taipei 112, Taiwan; [Gao, Quan-Ze; Sheu, Sheh-Yi] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; New York Medical College	Sheu, SY (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	sysheu@ym.edu.tw	Cooper, Arthur J.L./H-5171-2016		National Science Council of Taiwan [NSC-99-2113-M-010-002-MY3, NSC 99-2311-B-010-001]; National Yang-Ming University [98A-D-N309]; Aim for the Top University Plan at the National Yang-Ming University; Ministry of Education, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Aim for the Top University Plan at the National Yang-Ming University; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported in part by the National Science Council of Taiwan Grants NSC-99-2113-M-010-002-MY3 and NSC 99-2311-B-010-001 (to S. Y. S. and C. H. C.), National Yang-Ming University International Collaboration Grant 98A-D-N309 (to C. H. C.), and the Aim for the Top University Plan at the National Yang-Ming University supported by the Ministry of Education, Taiwan.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; BERTINO JR, 1979, CANCER-AM CANCER SOC, V43, P2136; BOLLETER WT, 1961, ANAL CHEM, V33, P592, DOI 10.1021/ac60172a034; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; COOPER AJL, 1977, J BIOL CHEM, V252, P2032; COOPER AJL, 1981, COMP BIOCHEM PHYS B, V69, P137, DOI 10.1016/0305-0491(81)90223-6; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; COOPER AJL, 1987, ANAL BIOCHEM, V167, P312, DOI 10.1016/0003-2697(87)90170-9; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUFFY TE, 1974, J BIOL CHEM, V249, P7603; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HERSH LB, 1971, BIOCHEMISTRY-US, V10, P2884, DOI 10.1021/bi00791a014; HERSH LB, 1972, BIOCHEMISTRY-US, V11, P2251, DOI 10.1021/bi00762a007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaisson S, 2009, BIOCHIMIE, V91, P1066, DOI 10.1016/j.biochi.2009.07.002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krasnikov BF, 2009, BIOCHIMIE, V91, P1072, DOI 10.1016/j.biochi.2009.07.003; Krasnikov BF, 2009, ANAL BIOCHEM, V391, P144, DOI 10.1016/j.ab.2009.05.025; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1843, DOI 10.1007/s00216-011-4688-x; Kumaran D, 2003, PROTEINS, V52, P283, DOI 10.1002/prot.10417; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MEISTER A, 1953, J BIOL CHEM, V200, P571; MEISTER A, 1955, J BIOL CHEM, V215, P441; Novo C, 2002, BIOCHEM J, V365, P731, DOI 10.1042/BJ20011714; OTANI TT, 1957, J BIOL CHEM, V224, P137; Pace HC, 2000, CURR BIOL, V10, P907, DOI 10.1016/S0960-9822(00)00621-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Szeliga M, 2009, NEUROCHEM INT, V55, P71, DOI 10.1016/j.neuint.2009.01.008; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vergara F, 1973, Trans Assoc Am Physicians, V86, P255; VERGARA F, 1974, SCIENCE, V183, P81, DOI 10.1126/science.183.4120.81; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	47	12	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25715	25726		10.1074/jbc.M111.259119	http://dx.doi.org/10.1074/jbc.M111.259119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22674578	Green Published, hybrid			2022-12-25	WOS:000306916300003
J	Hammerstingl, C; Schueler, R; Bors, L; Momcilovic, D; Pabst, S; Nickenig, G; Skowasch, D				Hammerstingl, Christoph; Schueler, Robert; Bors, Lisa; Momcilovic, Diana; Pabst, Stefan; Nickenig, Georg; Skowasch, Dirk			Diagnostic Value of Echocardiography in the Diagnosis of Pulmonary Hypertension	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; FREE-WALL; RECOMMENDATIONS; GUIDELINES; STRAIN	Aims: To determine the value of echocardiography including tissue Doppler imaging (TDI) and right ventricular (RV) speckle tracking analysis for the diagnosis of pulmonary hypertension (PH) and discrimination between pre- and postcapillary PH. Methods and Results: 155 consecutive patients (mean age 70.5 +/- 13.0 years, 81 [52%] male gender, BMI 27.2 +/- 6.1 kg/m(2)) with PH undergoing right heart catheterization (RHC) and transthoracic echocardiography (TTE) with TDI between January 2008 and December 2009 were retrospectively evaluated including offline speckle tracking analysis of RV contractility. After RHC 23.2% of patients (36) were diagnosed with precapillary PH. Invasive results from RHC were significantly correlated to TTE measurements (E/e, postcapillary wedge pressure [PCWP], r = 0.61, P < 0.001; mean, systolic pulmonary arterial pressure [mPAP, sPAP], r = 0.43, P < 0.001). Single echocardiographic parameters were of good predictive value for final PH-diagnosis (sPAP, area under the curve [AUC] 0.63, P = 0.025; lateral apical RV longitudinal strain [RVaSl)], AUC 0.76, P = 0.001; E/e, AUC 0.84, P < 0.001) which could be increased by combining most predictive parameters after receiver operating curves (ROC) cut off analysis (sPAP >69 mmHg, E/e <12, RVaSl >=-8.4%). TTE had a sensitivity of 33.33% and a specificity of 100% to identify patients with precapillary PH, and a negative predictive value of 84.72% to rule out precapilary PH. Conclusion: Echocardiography allows feasible and reliable estimation of PH and seems helpful to distinguish between pre- and postcapillary PH. Further prospective studies on patients with different manifestations of PH must validate the predictive value of echocardiography in this clinical setting.	[Hammerstingl, Christoph; Schueler, Robert; Bors, Lisa; Momcilovic, Diana; Pabst, Stefan; Nickenig, Georg; Skowasch, Dirk] Univ Bonn, Dept Internal Med 2, Bonn, Germany	University of Bonn	Hammerstingl, C (corresponding author), Univ Bonn, Dept Internal Med 2, Bonn, Germany.	robert.schueler@ukb.uni-bonn.de	Hammerstingl, Christoph/GQQ-3316-2022; Schueler, Robert/D-7407-2017		Actelion Pharmaceuticals Deutschland GmbH; Actelion Pharmaceuticals Germany	Actelion Pharmaceuticals Deutschland GmbH; Actelion Pharmaceuticals Germany	This study has been supported by an unrestricted grand of Actelion Pharmaceuticals Deutschland GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have received an unrestricted grant from Actelion Pharmaceuticals Germany. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmad H, 2011, ECHOCARDIOG IN PRESS; [Anonymous], 2009, J Am Coll Cardiol, V54, pS1; Bonderman D, 2011, EUR RESPIR J, V37, P1096, DOI 10.1183/09031936.00089610; Danbrauskaite V, 2007, J AM SOC ECHOCARDIOG, V20, P1172, DOI 10.1016/j.echo.2007.02.005; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fukuda Y, 2011, J AM SOC ECHOCARDIOG, V24, P1101, DOI 10.1016/j.echo.2011.06.005; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hadano Y, 2005, CIRC J, V69, P432, DOI 10.1253/circj.69.432; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Lang IM, 2010, JACC-CARDIOVASC IMAG, V3, P1287, DOI 10.1016/j.jcmg.2010.09.013; Lopez-Candales A, 2009, CAN J CARDIOL, V25, pE73, DOI 10.1016/S0828-282X(09)70045-5; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Ruan QY, 2007, CHEST, V131, P395, DOI 10.1378/chest.06-1556; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]	18	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38519	10.1371/journal.pone.0038519	http://dx.doi.org/10.1371/journal.pone.0038519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685577	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700040
J	Li, J; Zucker, S; Pulkoski-Gross, A; Kuscu, C; Karaayvaz, M; Ju, JF; Yao, HR; Song, EW; Cao, J				Li, Jian; Zucker, Stanley; Pulkoski-Gross, Ashleigh; Kuscu, Cem; Karaayvaz, Mihriban; Ju, Jingfang; Yao, Herui; Song, Erwei; Cao, Jian			Conversion of Stationary to Invasive Tumor Initiating Cells (TICs): Role of Hypoxia in Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) Trafficking	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO PROPAGATION; MATRIX-METALLOPROTEINASE; PROSPECTIVE IDENTIFICATION; MESENCHYMAL TRANSITION; E-CADHERIN; EXPRESSION; GROWTH; ACTIVATION; REGULATORS	Emerging evidence has implicated the role of tumor initiating cells (TICs) in the process of cancer metastasis. The mechanism underlying the conversion of TICs from stationary to invasive remains to be characterized. In this report, we employed less invasive breast cancer TICs, SK-3rd, that displays CD44(high)/CD24(low) with high mammosphere-forming and tumorigenic capacities, to investigate the mechanism by which stationary TICs are converted to invasive TICs. Invasive ability of SK-3rd TICs was markedly enhanced when the cells were cultured under hypoxic conditions. Given the role of membrane type 1-matrix metalloproteinase (MT1-MMP) in cancer invasion/metastasis, we explored a possible involvement of MT1-MMP in hypoxia-induced TIC invasion. Silencing of MT1-MMP by a shRNA approach resulted in diminution of hypoxia-induced cell invasion in vitro and metastasis in vivo. Under hypoxic conditions, MT1-MMP redistributed from cytoplasmic storage pools to the cell surface of TICs, which coincides with the increased cell invasion. In addition, CD44, a cancer stem-like cell marker, inversely correlated with increased cell surface MT1-MMP. Interestingly, cell surface MT1-MMP gradually disappeared when the hypoxia-treated cells were switched to normoxia, suggesting the plasticity of TICs in response to oxygen content. Furthermore, we dissected the pathways leading to upregulated MT1-MMP in cytoplasmic storage pools under normoxic conditions, by demonstrating a cascade involving Twist1-miR10b-HoxD10 leading to enhanced MT1-MMP expression in SK-3rd TICs. These observations suggest that MT1-MMP is a key molecule capable of executing conversion of stationary TICs to invasive TICs under hypoxic conditions and thereby controlling metastasis.	[Li, Jian; Pulkoski-Gross, Ashleigh; Kuscu, Cem; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY USA; [Karaayvaz, Mihriban; Ju, Jingfang; Cao, Jian] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Yao, Herui; Song, Erwei] Sun Yat Sen Univ, Mem Hosp, Dept Breast Surg, Guangzhou 510275, Guangdong, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Sun Yat Sen University	Li, J (corresponding author), SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA.	s_zucker@yahoo.com; jian.cao@sunysb.edu		KUSCU, CEM/0000-0001-7154-6762; Ju, Jingfang/0000-0002-4821-7458; Karaayvaz, Mihriban/0000-0002-6264-2477	NIH/NCI [R01CA113553, R01CA166936]; Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113553, R01CA166936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, T32GM092714] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIH/NCI grants (R01CA113553 and R01CA166936) and the Carol Baldwin Breast Cancer Foundation (to J.C.); and a Merit Review grant from the Department of Veterans Affairs (to S.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; GUO YJ, 1994, CANCER RES, V54, P1561; Han JS, 2009, INT J ONCOL, V34, P1449, DOI 10.3892/ijo_00000273; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koga F, 2007, CELL CYCLE, V6, P1393, DOI 10.4161/cc.6.11.4296; Koshikawa N, 2006, ONCOGENE, V25, P917, DOI 10.1038/sj.onc.1209128; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Martin MD, 2010, MOL CANC RES; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Moon EJ, 2007, ANTIOXID REDOX SIGN, V9, P1237, DOI 10.1089/ars.2007.1623; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Noda K, 2005, INVEST OPHTH VIS SCI, V46, P3817, DOI 10.1167/iovs.04-1528; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Toth M, 2005, BIOCHEM J, V387, P497, DOI 10.1042/BJ20041324; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	52	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38403	10.1371/journal.pone.0038403	http://dx.doi.org/10.1371/journal.pone.0038403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679501	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900036
J	Milia, N; Congiu, A; Anagnostou, P; Montinaro, F; Capocasa, M; Sanna, E; Bisol, GD				Milia, Nicola; Congiu, Alessandra; Anagnostou, Paolo; Montinaro, Francesco; Capocasa, Marco; Sanna, Emanuele; Bisol, Giovanni Destro			Mine, Yours, Ours? Sharing Data on Human Genetic Variation	PLOS ONE			English	Article							POPULATION; EVOLUTION; DISEASE; TOOLS	The achievement of a robust, effective and responsible form of data sharing is currently regarded as a priority for biological and bio-medical research. Empirical evaluations of data sharing may be regarded as an indispensable first step in the identification of critical aspects and the development of strategies aimed at increasing availability of research data for the scientific community as a whole. Research concerning human genetic variation represents a potential forerunner in the establishment of widespread sharing of primary datasets. However, no specific analysis has been conducted to date in order to ascertain whether the sharing of primary datasets is common-practice in this research field. To this aim, we analyzed a total of 543 mitochondrial and Y chromosomal datasets reported in 508 papers indexed in the Pubmed database from 2008 to 2011. A substantial portion of datasets (21.9%) was found to have been withheld, while neither strong editorial policies nor high impact factor proved to be effective in increasing the sharing rate beyond the current figure of 80.5%. Disaggregating datasets for research fields, we could observe a substantially lower sharing in medical than evolutionary and forensic genetics, more evident for whole mtDNA sequences (15.0% vs 99.6%). The low rate of positive responses to e-mail requests sent to corresponding authors of withheld datasets (28.6%) suggests that sharing should be regarded as a prerequisite for final paper acceptance, while making authors deposit their results in open online databases which provide data quality control seems to provide the best-practice standard. Finally, we estimated that 29.8% to 32.9% of total resources are used to generate withheld datasets, implying that an important portion of research funding does not produce shared knowledge. By making the scientific community and the public aware of this important aspect, we may help popularize a more effective culture of data sharing.	[Milia, Nicola; Congiu, Alessandra; Anagnostou, Paolo; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Milia, Nicola; Congiu, Alessandra; Sanna, Emanuele] Univ Cagliari, Dipartimento Biol Sperimentale, Cagliari, Italy; [Anagnostou, Paolo; Montinaro, Francesco; Capocasa, Marco; Bisol, Giovanni Destro] Ist Italiano Antropol, Rome, Italy	Sapienza University Rome; University of Cagliari	Milia, N (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	destrobisol@uniroma1.it	Montinaro, Francesco/HDM-8551-2022; Capocasa, Marco/AAF-8315-2021	Montinaro, Francesco/0000-0002-4506-963X; Destro Bisol, Giovanni/0000-0002-4232-9715; Anagnostou, Paolo/0000-0003-0768-4612	Universita di Roma "La Sapienza"; Istituto Italiano di Antropologia; Ministero dell'Istruzione, dell'Universita e della Ricerca [200975T9EW]	Universita di Roma "La Sapienza"; Istituto Italiano di Antropologia; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Universita di Roma "La Sapienza", Istituto Italiano di Antropologia, and the Ministero dell'Istruzione, dell'Universita e della Ricerca (Prin project 200975T9EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 1996, INT STRAT M HUM GEN, P3; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Carracedo A, 2010, FORENSIC SCI INT-GEN, V4, P145, DOI 10.1016/j.fsigen.2010.02.001; Destro-Bisol G, 2010, J ANTHROPOL SCI, V88, P93; DOE, 1993, HUMAN GENOME NEW JAN, P4; Fischer BA, 2010, SCI ENG ETHICS, V16, P783, DOI 10.1007/s11948-010-9239-x; Giffels J, 2010, SCI ENG ETHICS, V16, P801, DOI 10.1007/s11948-010-9230-6; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; MARSHALL E, 1990, SCIENCE, V248, P952, DOI 10.1126/science.2343306; Merton Robert K., 1972, SOCIOLOGY SCI THEORE; Mishmar D, 2010, BBA-BIOENERGETICS, V1797, P1099, DOI 10.1016/j.bbabio.2010.01.003; Murdoch CJ, 2009, GENOME MED, V1, DOI 10.1186/gm22; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; NORMAN C, 1985, SCIENCE, V229, P632, DOI 10.1126/science.229.4714.632; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Parson W, 2004, FORENSIC SCI INT, V139, P215, DOI 10.1016/j.forsciint.2003.11.008; Parson W, 2010, INT J LEGAL MED, V124, P505, DOI 10.1007/s00414-010-0492-y; Peltonen L, 2001, Pharmacogenomics J, V1, P5; Pennisi E, 2009, SCIENCE, V324, P1000, DOI 10.1126/science.324_1000b; Piwowar H. A., 2008, P ELPUB 2008 C EL PU; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Tofanelli S, 2011, J ANTHROPOL SCI, V89, P201, DOI 10.4436/jass.89017; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017	36	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37552	10.1371/journal.pone.0037552	http://dx.doi.org/10.1371/journal.pone.0037552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679483	Green Published, gold			2022-12-25	WOS:000305343900008
J	Riegl, BM; Sheppard, CRC; Purkis, SJ				Riegl, Bernhard M.; Sheppard, Charles R. C.; Purkis, Sam J.			Human Impact on Atolls Leads to Coral Loss and Community Homogenisation: A Modeling Study	PLOS ONE			English	Article							ACANTHASTER-PLANCI; CLIMATE-CHANGE; REEFS; MORTALITY; RECOVERY; ECOLOGY; FUTURE; OCEAN; POPULATIONS; OUTBREAKS	We explore impacts on pristine atolls subjected to anthropogenic near-field (human habitation) and far-field (climate and environmental change) pressure. Using literature data of human impacts on reefs, we parameterize forecast models to evaluate trajectories in coral cover under impact scenarios that primarily act via recruitment and increased mortality of larger corals. From surveys across the Chagos, we investigate the regeneration dynamics of coral populations distant from human habitation after natural disturbances. Using a size-based mathematical model based on a time-series of coral community and population data from 1999-2006, we provide hind-and forecast data for coral population dynamics within lagoons and on ocean-facing reefs verified against monitoring from 1979-2009. Environmental data (currents, temperatures) were used for calibration. The coral community was simplified into growth typologies: branching and encrusting, arboresent and massive corals. Community patterns observed in the field were influenced by bleaching-related mortality, most notably in 1998. Survival had been highest in deep lagoonal settings, which suggests a refuge. Recruitment levels were higher in lagoons than on ocean-facing reefs. When adding stress by direct human pressure, climate and environmental change as increased disturbance frequency and modified recruitment and mortality levels (due to eutrophication, overfishing, pollution, heat, acidification, etc), models suggest steep declines in coral populations and loss of community diversification among habitats. We found it likely that degradation of lagoonal coral populations would impact regeneration potential of all coral populations, also on ocean-facing reefs, thus decreasing reef resilience on the entire atoll.	[Riegl, Bernhard M.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Sheppard, Charles R. C.] Univ Warwick, Dept Biol, Coventry CV4 7AL, W Midlands, England	Nova Southeastern University; University of Warwick	Riegl, BM (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	rieglb@nova.edu	Purkis, Sam/B-8552-2013	Riegl, Bernhard/0000-0002-6003-9324; sheppard, charles/0000-0002-2579-5124	National Oceanic and Atmospheric Administration [NA16OA1443]; OTEP	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); OTEP	BR and SP were supported by National Oceanic and Atmospheric Administration grant NA16OA1443 to NCRI. NCRI publication #146. Work by CS was supported by a grant from OTEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonius A, 1996, ATOLL RES B, V48, P1; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Burke L., 2011, REEFS RISK REVISITED; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell W, 1998, ECOL APPL, V8, P1226, DOI 10.2307/2640975; Connell J.H., 1973, P205; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Donner Simon D., 2009, V205, P159; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fichez R, 2005, AQUAT LIVING RESOUR, V18, P125, DOI 10.1051/alr:2005015; Friedlander Alan, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P263; Ginsburg RN, 1993, P C GLOB ASP COR REE, pi; Haapkyla J, 2007, VIE MILIEU, V57, P95; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013913; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kittinger JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025460; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Loya Y., 1976, COELENTERATE ECOLOGY, P89; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Riegl B, 1999, CORAL REEFS, V18, P241, DOI 10.1007/s003380050188; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; SHEPPARD CRC, 1982, MAR ECOL PROG SER, V7, P83, DOI 10.3354/meps007083; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018	51	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36921	10.1371/journal.pone.0036921	http://dx.doi.org/10.1371/journal.pone.0036921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679482	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900005
J	Mohseni, HR; Smith, PP; Parsons, CE; Young, KS; Hyam, JA; Stein, A; Stein, JF; Green, AL; Aziz, TZ; Kringelbach, ML				Mohseni, Hamid R.; Smith, Penny P.; Parsons, Christine E.; Young, Katherine S.; Hyam, Jonathan A.; Stein, Alan; Stein, John F.; Green, Alexander L.; Aziz, Tipu Z.; Kringelbach, Morten L.			MEG Can Map Short and Long-Term Changes in Brain Activity following Deep Brain Stimulation for Chronic Pain	PLOS ONE			English	Article							ANTERIOR CINGULATE; PRINCIPLES	Deep brain stimulation (DBS) has been shown to be clinically effective for some forms of treatment-resistant chronic pain, but the precise mechanisms of action are not well understood. Here, we present an analysis of magnetoencephalography (MEG) data from a patient with whole-body chronic pain, in order to investigate changes in neural activity induced by DBS for pain relief over both short-and long-term. This patient is one of the few cases treated using DBS of the anterior cingulate cortex (ACC). We demonstrate that a novel method, null-beamforming, can be used to localise accurately brain activity despite the artefacts caused by the presence of DBS electrodes and stimulus pulses. The accuracy of our source localisation was verified by correlating the predicted DBS electrode positions with their actual positions. Using this beamforming method, we examined changes in whole-brain activity comparing pain relief achieved with deep brain stimulation (DBS ON) and compared with pain experienced with no stimulation (DBS OFF). We found significant changes in activity in pain-related regions including the pre-supplementary motor area, brainstem (periaqueductal gray) and dissociable parts of caudal and rostral ACC. In particular, when the patient reported experiencing pain, there was increased activity in different regions of ACC compared to when he experienced pain relief. We were also able to demonstrate long-term functional brain changes as a result of continuous DBS over one year, leading to specific changes in the activity in dissociable regions of caudal and rostral ACC. These results broaden our understanding of the underlying mechanisms of DBS in the human brain.	[Mohseni, Hamid R.; Parsons, Christine E.; Young, Katherine S.; Stein, Alan; Kringelbach, Morten L.] Univ Oxford, Univ Dept Psychiat, Oxford, England; [Mohseni, Hamid R.; Smith, Penny P.] Univ Oxford, Inst Biomed Engn, Sch Engn Sci, Oxford, England; [Mohseni, Hamid R.; Parsons, Christine E.; Young, Katherine S.; Hyam, Jonathan A.; Kringelbach, Morten L.] Aarhus Univ, CFIN, Aarhus, Denmark; [Mohseni, Hamid R.; Stein, John F.; Green, Alexander L.; Aziz, Tipu Z.; Kringelbach, Morten L.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England; [Mohseni, Hamid R.; Parsons, Christine E.; Young, Katherine S.; Kringelbach, Morten L.] Univ Oxford, Dept Psychiat, Oxford Ctr Human Brain Act OHBA, Oxford, England	University of Oxford; University of Oxford; Aarhus University; University of Oxford; University of Oxford	Mohseni, HR (corresponding author), Univ Oxford, Univ Dept Psychiat, Oxford, England.	Morten.Kringelbach@psych.ox.ac.uk	Kringelbach, Morten L/AAF-5508-2020; Parsons, Christine/G-9286-2016; Young, Katherine/O-9198-2017; Kringelbach, Morten/AAW-5847-2021; Parsons, Christine/V-3571-2019	Parsons, Christine/0000-0003-2856-6308; Young, Katherine/0000-0002-1378-6415; Kringelbach, Morten/0000-0002-3908-6898; Parsons, Christine/0000-0003-2856-6308; Stein, Alan/0000-0001-8207-2822	Wellcome Trust; Engineering and Physical Sciences Research Council UK (EPSRC) [WT 088877/Z/09/Z]; TrygFonden Charitable Foundation; Medical Research Council; Norman Collisson Foundation; Charles Wolfson Charitable Trust	Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council UK (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); TrygFonden Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norman Collisson Foundation; Charles Wolfson Charitable Trust	This work is funded by The Wellcome Trust and Engineering and Physical Sciences Research Council UK (EPSRC) under grant number WT 088877/Z/09/Z. MLK is funded by the TrygFonden Charitable Foundation and TZA is funded by the Medical Research Council, the Norman Collisson Foundation and the Charles Wolfson Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalal SS, 2006, IEEE T BIO-MED ENG, V53, P1357, DOI 10.1109/TBME.2006.873752; Davis KD, 2000, J NEUROSURG, V92, P64, DOI 10.3171/jns.2000.92.1.0064; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Hansen P.C., 2010, MEG INTRO METHODS; Haykin S., 2002, ADAPTIVE FILTER THEO; Henson RN, 2009, NEUROIMAGE, V47, P581, DOI 10.1016/j.neuroimage.2009.04.063; Hirschmann J, 2011, NEUROIMAGE, V55, P1159, DOI 10.1016/j.neuroimage.2010.11.063; KESELMAN HJ, 1980, PSYCHOPHYSIOLOGY, V17, P499, DOI 10.1111/j.1469-8986.1980.tb00190.x; Kringelbach ML, 2009, J PAIN MANAGEMENT, V2, P301; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kringelbach ML, 2007, NEUROREPORT, V18, P223, DOI 10.1097/WNR.0b013e328010dc3d; Kringelbach ML, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00008; Kringelbach ML, 2010, EUR J NEUROSCI, V32, P1070, DOI 10.1111/j.1460-9568.2010.07419.x; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Litvak V, 2010, NEUROIMAGE, V50, P1578, DOI 10.1016/j.neuroimage.2009.12.115; Makela JP., 2007, INT C SERIES, V1300, P345, DOI DOI 10.1016/J.ICS.2007.02.003; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Mohseni HR, 2012, IEEE T BIOM IN PRESS; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Popescu M, 2008, IEEE T BIO-MED ENG, V55, P1092, DOI 10.1109/TBME.2007.906504; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ray NJ, 2009, J CLIN NEUROSCI, V16, P32, DOI 10.1016/j.jocn.2008.03.004; Ray Nj, 2007, Biomed Imaging Interv J, V3, pe25, DOI 10.2349/biij.3.1.e25; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	30	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37993	10.1371/journal.pone.0037993	http://dx.doi.org/10.1371/journal.pone.0037993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675503	gold, Green Published			2022-12-25	WOS:000305341700032
J	Takahashi, M; Elbarbary, RA; Abe, M; Sato, M; Yoshida, T; Yamada, Y; Tamura, M; Nashimoto, M				Takahashi, Masayuki; Elbarbary, Reyad A.; Abe, Mayumi; Sato, Mari; Yoshida, Tetsuo; Yamada, Yoji; Tamura, Masato; Nashimoto, Masayuki			Elimination of Specific miRNAs by Naked 14-nt sgRNAs	PLOS ONE			English	Article							3' PROCESSING ENDORIBONUCLEASE; RNA CLEAVAGE; MULTIPLE-MYELOMA; GENE-EXPRESSION; TRNASE Z(L); MICRORNAS; NUCLEOTIDES; DISCOVERY; HEPTAMERS; DIRECTION	tRNase Z(L)-utilizing efficacious gene silencing (TRUE gene silencing) is a newly developed technology to suppress mammalian gene expression. TRUE gene silencing works on the basis of a unique enzymatic property of mammalian tRNase Z(L), which is that it can recognize a pre-tRNA-like or micro-pre-tRNA-like complex formed between target RNA and artificial small guide RNA (sgRNA) and can cleave any target RNA at any desired site. There are four types of sgRNA, 5'-half-tRNA, RNA heptamer, hook RNA, and similar to 14-nt linear RNA. Here we show that a 14-nt linear-type sgRNA against human miR-16 can guide tRNase Z(L) cleavage of miR-16 in vitro and can downregulate the miR-16 level in HEK293 cells. We also demonstrate that the 14-nt sgRNA can be efficiently taken up without any transfection reagents by living cells and can exist stably in there for at least 24 hours. The naked 14-nt sgRNA significantly reduced the miR-16 level in HEK293 and HL60 cells. Three other naked 14-nt sgRNAs against miR-142-3p, miR-206, and miR-19a/b are also shown to downregulate the respective miRNA levels in various mammalian cell lines. Our observations suggest that in general we can eliminate a specific cellular miRNA at least by similar to 50% by using a naked 14-nt sgRNA on the basis of TRUE gene silencing.	[Takahashi, Masayuki; Elbarbary, Reyad A.; Abe, Mayumi; Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Sato, Mari; Tamura, Masato] Hokkaido Univ, Grad Sch Dent Med, Dept Biochem & Mol Biol, Sapporo, Hokkaido, Japan; [Yoshida, Tetsuo; Yamada, Yoji] Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Machida, Tokyo, Japan	Niigata University; Hokkaido University; Kyowa Kirin Ltd	Takahashi, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mnashimoto@nupals.ac.jp	tamura, masato/B-7304-2009	tamura, masato/0000-0003-3700-5203; Rzq, kareem/0000-0003-3784-9430	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Elbarbary RA, 2009, FEBS LETT, V583, P3241, DOI 10.1016/j.febslet.2009.09.015; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; GALLAGHER R, 1979, BLOOD, V54, P713; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Habu Y, 2005, NUCLEIC ACIDS RES, V33, P235, DOI 10.1093/nar/gki164; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; NASHIMOTO M, 1995, NUCLEIC ACIDS RES, V23, P3642, DOI 10.1093/nar/23.18.3642; Nashimoto M, 1999, J MOL BIOL, V287, P727, DOI 10.1006/jmbi.1999.2639; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; NASHIMOTO M, 1996, RNA, V2, P2523; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	30	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38496	10.1371/journal.pone.0038496	http://dx.doi.org/10.1371/journal.pone.0038496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675569	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700081
J	Villar, S; Ortiz-Cuaran, S; Abedi-Ardekani, B; Gouas, D; da Costa, AN; Plymoth, A; Khuhaprema, T; Kalalak, A; Sangrajrang, S; Friesen, MD; Groopman, JD; Hainaut, P				Villar, Stephanie; Ortiz-Cuaran, Sandra; Abedi-Ardekani, Behnoush; Gouas, Doriane; da Costa, Andre Nogueira; Plymoth, Amelie; Khuhaprema, Thiravud; Kalalak, Anant; Sangrajrang, Suleeporn; Friesen, Marlin D.; Groopman, John D.; Hainaut, Pierre			Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis	PLOS ONE			English	Article							P53 MUTATIONS; PLASMA; DNA; INFECTION; CANCER; B-1	Primary Liver Cancer (PLC) is the leading cause of death by cancer among males in Thailand and the 3rd among females. Most cases are hepatocellular carcinoma (HCC) but cholangiocarcinomas represent between 4 and 80% of liver cancers depending upon geographic area. Most HCC are associated with chronic infection by Hepatitis B Virus while a G -> T mutation at codon 249 of the TP53 gene, R249S, specific for exposure to aflatoxin, is detected in tumors for up to 30% of cases. We have used Short Oligonucleotide Mass Analysis (SOMA) to quantify free circulating R249S-mutated DNA in plasma using blood specimens collected in a hospital case: control study. Plasma R249S-mutated DNA was detectable at low concentrations (>= 67 copies/mL) in 53 to 64% of patients with primary liver cancer or chronic liver disease and in 19% of controls. 44% of patients with HCC and no evidence of cirrhosis had plasma concentrations of R249S-mutated DNA >= 150 copies/mL, compared to 21% in patients with both HCC and cirrhosis, 22% in patients with cholangiocarcinoma, 12% in patients with non-cancer chronic liver disease and 3% of subjects in the reference group. Thus, plasma concentrations of R249S-mutated DNA >= 150 copies/mL tended to be more common in patients with HCC developing without pre-existing cirrhosis (p = 0.027). Overall, these results support the preferential occurrence of R249S-mutated DNA in HCC developing in the absence of cirrhosis in a context of HBV chronic infection.	[Villar, Stephanie; Ortiz-Cuaran, Sandra; Abedi-Ardekani, Behnoush; Gouas, Doriane; da Costa, Andre Nogueira; Hainaut, Pierre] Int Agcy Res Canc, F-69372 Lyon, France; [Plymoth, Amelie] Karolinska Inst, Stockholm, Sweden; [Khuhaprema, Thiravud; Kalalak, Anant; Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok, Thailand; [Friesen, Marlin D.; Groopman, John D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); Karolinska Institutet; National Cancer Institute - Thailand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Villar, S (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	pierre.hainaut@i-pri.org	Hainaut, Pierre/B-6018-2012; Abedi-Ardekani, Behnoush/O-7829-2016; /X-4205-2019; Friesen, Marlin D/D-7328-2012	Hainaut, Pierre/0000-0002-1303-1610; Abedi-Ardekani, Behnoush/0000-0002-0980-0587; /0000-0003-4690-2133; Ortiz-Cuaran, Sandra/0000-0003-1152-5681	IARC; Ligue Contre le Cancer, Departement du Rhone, France	IARC; Ligue Contre le Cancer, Departement du Rhone, France	This work was supported by funds from IARC and from Ligue Contre le Cancer, Departement du Rhone, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 CANC I; [Anonymous], 2008, WORLD CANC REP; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Galy O, 2011, HEPAT RES TREAT; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Gouas D, 2009, CANCER LETT, V286, P29, DOI 10.1016/j.canlet.2009.02.057; Groopman John D., 2005, Cancer Biomarkers, V1, P5; International Agency for Research on Cancer, 2009, REV HUM CARC B; International Agency for Research on Cancer, 2002, SOM TRAD HERB MED SO; Kirk GD, 2000, JNCI-J NATL CANCER I, V92, P148, DOI 10.1093/jnci/92.2.148; Kuang SY, 2005, CANCER EPIDEM BIOMAR, V14, P380, DOI 10.1158/1055-9965.EPI-04-0380; Lipigorngoson S, 2003, FOOD ADDIT CONTAM A, V20, P838, DOI 10.1080/0265203031000156060; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Lleonart ME, 2005, CANCER EPIDEM BIOMAR, V14, P2956, DOI 10.1158/1055-9965.EPI-05-0612; Poovorawan Y, 2011, J VIRAL HEPATITIS, V18, P369, DOI 10.1111/j.1365-2893.2010.01312.x; Poovorawan Y, 2000, VACCINE, V19, P943, DOI 10.1016/S0264-410X(00)00216-4; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; SRIVATANAKUL P, 1991, INT J CANCER, V48, P329, DOI 10.1002/ijc.2910480303; Srivatanakul Petcharin, 2004, Asian Pac J Cancer Prev, V5, P118; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Umoh NJ, 2011, LIVER INT, V31, P215, DOI 10.1111/j.1478-3231.2010.02418.x; Villar S, 2011, ENV HLTH PERSPECT; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264	24	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37707	10.1371/journal.pone.0037707	http://dx.doi.org/10.1371/journal.pone.0037707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675488	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700020
J	Driskell, EA; Pickens, JA; Humberd-Smith, J; Gordy, JT; Bradley, KC; Steinhauer, DA; Berghaus, RD; Stallknecht, DE; Howerth, EW; Tompkins, SM				Driskell, Elizabeth A.; Pickens, Jennifer A.; Humberd-Smith, Jennifer; Gordy, James T.; Bradley, Konrad C.; Steinhauer, David A.; Berghaus, Roy D.; Stallknecht, David E.; Howerth, Elizabeth W.; Tompkins, Stephen Mark			Low Pathogenic Avian Influenza Isolates from Wild Birds Replicate and Transmit via Contact in Ferrets without Prior Adaptation	PLOS ONE			English	Article							POLYMERASE SUBUNIT PB2; SINGLE AMINO-ACID; A VIRUSES; RECEPTOR SPECIFICITY; HONG-KONG; HEMAGGLUTININ RESIDUES; GENETIC COMPATIBILITY; RESPIRATORY-TRACT; HUMAN INFECTION; ANIMAL-MODELS	Direct transmission of avian influenza viruses to mammals has become an increasingly investigated topic during the past decade; however, isolates that have been primarily investigated are typically ones originating from human or poultry outbreaks. Currently there is minimal comparative information on the behavior of the innumerable viruses that exist in the natural wild bird host. We have previously demonstrated the capacity of numerous North American avian influenza viruses isolated from wild birds to infect and induce lesions in the respiratory tract of mice. In this study, two isolates from shorebirds that were previously examined in mice (H1N9 and H6N1 subtypes) are further examined through experimental inoculations in the ferret with analysis of viral shedding, histopathology, and antigen localization via immunohistochemistry to elucidate pathogenicity and transmission of these viruses. Using sequence analysis and glycan binding analysis, we show that these avian viruses have the typical avian influenza binding pattern, with affinity for cell glycoproteins/glycolipids having terminal sialic acid (SA) residues with alpha 2,3 linkage [Neu5Ac(alpha 2,3)Gal]. Despite the lack of alpha 2,6 linked SA binding, these AIVs productively infected both the upper and lower respiratory tract of ferrets, resulting in nasal viral shedding and pulmonary lesions with minimal morbidity. Moreover, we show that one of the viruses is able to transmit to ferrets via direct contact, despite its binding affinity for alpha 2,3 linked SA residues. These results demonstrate that avian influenza viruses, which are endemic in aquatic birds, can potentially infect humans and other mammals without adaptation. Finally this work highlights the need for additional study of the wild bird subset of influenza viruses in regard to surveillance, transmission, and potential for reassortment, as they have zoonotic potential.	[Driskell, Elizabeth A.; Howerth, Elizabeth W.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Pickens, Jennifer A.; Humberd-Smith, Jennifer; Gordy, James T.; Tompkins, Stephen Mark] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Bradley, Konrad C.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Berghaus, Roy D.; Stallknecht, David E.] Univ Georgia, Dept Populat Hlth, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University; University System of Georgia; University of Georgia	Driskell, EA (corresponding author), Univ Georgia, Dept Pathol, Athens, GA 30602 USA.	smt@uga.edu	Gordy, James/AAV-4024-2020; Berghaus, Roy/GPX-7566-2022; Tompkins, Stephen/A-3317-2008	Berghaus, Roy/0000-0002-8813-3056; Tompkins, Stephen/0000-0002-1523-5588; Gordy, James/0000-0003-2588-0756; Bradley, Konrad/0000-0001-8761-6219	Centers for Disease Control (CDC) [5U19Cl00040102]; National Institutes of Health [HHSN266200700006C]	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Centers for Disease Control (CDC) grant 5U19Cl00040102 and National Institutes of Health contract HHSN266200700006C. The CDC provided CDC approval of animal protocols for this study and reviewed this manuscript prior to submission for publication. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kemink S A G, 2004, Ned Tijdschr Geneeskd, V148, P2190; Klopfleisch R, 2007, VET PATHOL, V44, P261, DOI 10.1354/vp.44-3-261; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; McBrayer A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-149; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Nam JH, 2011, J VIROL, V85, P13271, DOI 10.1128/JVI.05038-11; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Oh J., 2008, EMERG INFECT DIS, V14, P741, DOI [10.3201/eid1405.071471, DOI 10.3201/eid1405.071471]; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith JH, 2011, J VIROL, V85, P7572, DOI 10.1128/JVI.00512-11; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; SUZUKI Y, 1985, J BIOL CHEM, V260, P1362; SWEET C, 1985, ARCH VIROL, V85, P305, DOI 10.1007/BF01314239; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Uyeki TM, 2002, EMERG INFECT DIS, V8, P154, DOI 10.3201/eid0802.010148; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	66	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38067	10.1371/journal.pone.0038067	http://dx.doi.org/10.1371/journal.pone.0038067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675507	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900011
J	Louapre, P; Bittebiere, AK; Clement, B; Pierre, JS; Mony, C				Louapre, Philipe; Bittebiere, Anne-Kristel; Clement, Bernard; Pierre, Jean-Sebastien; Mony, Cendrine			How Past and Present Influence the Foraging of Clonal Plants?	PLOS ONE			English	Article							DIVISION-OF-LABOR; ENVIRONMENTAL HETEROGENEITY; MORPHOLOGICAL PLASTICITY; LIGHT QUALITY; GROWTH; INTEGRATION; AVAILABILITY; EVOLUTION; RESPONSES; BEHAVIOR	Clonal plants spreading horizontally and forming a network structure of ramets exhibit complex growth patterns to maximize resource uptake from the environment. They respond to spatial heterogeneity by changing their internode length or branching frequency. Ramets definitively root in the soil but stay interconnected for a varying period of time thus allowing an exchange of spatial and temporal information. We quantified the foraging response of clonal plants depending on the local soil quality sampled by the rooting ramet (i.e. the present information) and the resource variability sampled by the older ramets (i.e. the past information). We demonstrated that two related species, Potentilla reptans and P. anserina, responded similarly to the local quality of their environment by decreasing their internode length in response to nutrient-rich soil. Only P. reptans responded to resource variability by decreasing its internode length. In both species, the experience acquired by older ramets influenced the plastic response of new rooted ramets: the internode length between ramets depended not only on the soil quality locally sampled but also on the soil quality previously sampled by older ramets. We quantified the effect of the information perceived at different time and space on the foraging behavior of clonal plants by showing a non-linear response of the ramet rooting in the soil of a given quality. These data suggest that the decision to grow a stolon or to root a ramet at a given distance from the older ramet results from the integration of the past and present information about the richness and the variability of the environment.	[Louapre, Philipe; Bittebiere, Anne-Kristel; Clement, Bernard; Pierre, Jean-Sebastien; Mony, Cendrine] Univ Rennes 1, UMR CNRS ECOBIO 6553, UMS OSUR 3343, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite Rennes 2; Universite de Rennes	Louapre, P (corresponding author), Univ Rennes 1, UMR CNRS ECOBIO 6553, UMS OSUR 3343, Rennes, France.	philippe.louapre@mail-univscience.com			Agence Nationale de la Recherche [ANR-08-SYSC-012]; CNRS [UMR 6553 EcoBio]; University of Rennes 1 [UMR 6553 EcoBio]	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	This research was funded as a part of the program from the Agence Nationale de la Recherche for CM (ANR-08-SYSC-012). PL was supported by UMR 6553 EcoBio allocated by CNRS and University of Rennes 1. There were no additional external funding sources for this study. The funders did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; Alpi A, 2007, TRENDS PLANT SCI, V12, P135, DOI 10.1016/j.tplants.2007.03.002; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; CAIN ML, 1994, ECOLOGY, V75, P933, DOI 10.2307/1939417; Garzon PC, 2011, ADAPT BEHAV, V19, P155, DOI 10.1177/1059712311409446; CHAZDON RL, 1988, AM J BOT, V75, P1459, DOI 10.2307/2444696; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; D'Hertefeldt T, 1998, OIKOS, V81, P229, DOI 10.2307/3547044; DEKROON H, 1994, FOLIA GEOBOT PHYTOTX, V29, P123, DOI 10.1007/BF02803790; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; ERIKSSON O, 1988, J ECOL, V76, P522, DOI 10.2307/2260610; ERIKSSON O, 1986, VEGETATIO, V67, P17; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Gardner SN, 1999, ECOLOGY, V80, P1202, DOI 10.1890/0012-9658(1999)080[1202:MIISCO]2.0.CO;2; GROSS KL, 1995, J ECOL, V83, P357, DOI 10.2307/2261590; HARTNETT DC, 1985, J ECOL, V73, P415, DOI 10.2307/2260484; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hill MO, 1997, J VEG SCI, V8, P579, DOI 10.2307/3237210; Huber H, 1996, FUNCT ECOL, V10, P401, DOI 10.2307/2390290; Huber H, 1999, PLANT ECOL, V141, P107, DOI 10.1023/A:1009861521047; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; JACKSON RB, 1993, J ECOL, V81, P683, DOI 10.2307/2261666; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; MACDONALD SE, 1993, J ECOL, V81, P769, DOI 10.2307/2261674; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; McNickle GG, 2009, TRENDS ECOL EVOL, V24, P419, DOI 10.1016/j.tree.2009.03.004; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; NOBLE JC, 1983, J ECOL, V71, P865, DOI 10.2307/2259598; Oborny B, 2004, COMPLEXITY, V9, P22, DOI 10.1002/cplx.20012; PRICE EAC, 1992, J ECOL, V80, P25, DOI 10.2307/2261060; Sachs T, 2001, EVOL ECOL, V15, P485, DOI 10.1023/A:1016053402813; SLADE AJ, 1987, J ECOL, V75, P95, DOI 10.2307/2260538; SLADE AJ, 1987, J ECOL, V75, P639, DOI 10.2307/2260196; Stuefer JF, 1998, OECOLOGIA, V117, P1, DOI 10.1007/s004420050624; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer JF, 2002, J EVOLUTION BIOL, V15, P880, DOI 10.1046/j.1420-9101.2002.00435.x; Sutherland W. J., 1990, Living in a patchy environment., P45; SUTHERLAND WJ, 1988, OIKOS, V52, P239, DOI 10.2307/3565196; SVENSSON BM, 1994, FOLIA GEOBOT PHYTOTX, V29, P159, DOI 10.1007/BF02803792; Trewavas A, 2005, NATURWISSENSCHAFTEN, V92, P401, DOI 10.1007/s00114-005-0014-9; Trewavas A, 2005, TRENDS PLANT SCI, V10, P413, DOI 10.1016/j.tplants.2005.07.005; TURKINGTON R, 1991, OECOLOGIA, V86, P183, DOI 10.1007/BF00317530; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Van Kleunen M, 2003, J EVOLUTION BIOL, V16, P474, DOI 10.1046/j.1420-9101.2003.00532.x; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	53	30	31	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38288	10.1371/journal.pone.0038288	http://dx.doi.org/10.1371/journal.pone.0038288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675539	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900022
J	Murtagh, MJ; Watson, DLB; Jenkings, KN; Lie, MLS; Mackintosh, JE; Ford, GA; Thomson, RG				Murtagh, Madeleine J.; Watson, Duika L. Burges; Jenkings, K. Neil; Lie, Mabel L. S.; Mackintosh, Joan E.; Ford, Gary A.; Thomson, Richard G.			Situationally-Sensitive Knowledge Translation and Relational Decision Making in Hyperacute Stroke: A Qualitative Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; THROMBOLYSIS; ENCOUNTER; AUTONOMY; CONSENT; SUPPORT; TRIAL	Stroke is a leading cause of disability. Early treatment of acute ischaemic stroke with rtPA reduces the risk of longer term dependency but carries an increased risk of causing immediate bleeding complications. To understand the challenges of knowledge translation and decision making about treatment with rtPA in hyperacute stroke and hence to inform development of appropriate decision support we interviewed patients, their family and health professionals. The emergency setting and the symptomatic effects of hyper-acute stroke shaped the form, content and manner of knowledge translation to support decision making. Decision making about rtPA in hyperacute stroke presented three conundrums for patients, family and clinicians. 1) How to allow time for reflection in a severely time-limited setting. 2) How to facilitate knowledge translation regarding important treatment risks and benefits when patient and family capacity is blunted by the effects and shock of stroke. 3) How to ensure patient and family views are taken into account when the situation produces reliance on the expertise of clinicians. Strategies adopted to meet these conundrums were fourfold: face to face communication; shaping decisions; incremental provision of information; and communication tailored to the individual patient. Relational forms of interaction were understood to engender trust and allay anxiety. Shaping decisions with patients was understood as an expression of confidence by clinicians that helped alleviate anxiety and offered hope and reassurance to patients and their family experiencing the shock of the stroke event. Neutral presentations of information and treatment options promoted uncertainty and contributed to anxiety. 'Drip feeding' information created moments for reflection: clinicians literally made time. Tailoring information to the particular patient and family situation allowed clinicians to account for social and emotional contexts. The principal responses to the challenges of decision making about rtPA in hyperacute stroke were relational decision support and situationally-sensitive knowledge translation.	[Murtagh, Madeleine J.; Watson, Duika L. Burges; Jenkings, K. Neil; Lie, Mabel L. S.; Mackintosh, Joan E.; Thomson, Richard G.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murtagh, Madeleine J.] Univ Leicester, Coll Med Biol Sci & Psychol, Dept Hlth Sci, Leicester, Leics, England; [Watson, Duika L. Burges] Univ Durham, Wolfson Res Inst, Ctr Translat Res, Stockton, CA USA; [Ford, Gary A.] Newcastle Univ, Fac Med Sci, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Gary A.] Newcastle upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Lie, Mabel L. S.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University of Leicester; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Murtagh, MJ (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mm399@le.ac.uk	Ford, Gary/AAY-6405-2020; Burges Watson, Duika/C-4899-2009	Ford, Gary/0000-0001-8719-4968; Burges Watson, Duika/0000-0002-5791-9670	National Institute for Health Research (NIHR) [RP-PG-0606-1241]; National Institute for Health Research [RP-PG-0606-1241] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (RP-PG-0606-1241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams K., 1998, WILLIAM MARY LAW REV, V40, P805; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, Vseventh; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Ciccone A, 2003, LANCET NEUROL, V2, P375, DOI 10.1016/S1474-4422(03)00412-5; Coulter A., 2009, IMPLEMENTING SHARED; Cruikshank B, 1999, WILL EMPOWER DEMOCRA; Davies M, 2008, HEALTH CARE ANAL, V16, P315, DOI 10.1007/s10728-007-0075-3; Dodds S, 2000, RELATIONAL AUTONOMY; Entwistle VA, 2010, J GEN INTERN MED, P1; Farnworth A, 2008, PATIENT EDUC COUNS, V71, P116, DOI 10.1016/j.pec.2007.11.020; Forsyth R, 2011, QUALITATIVE HLTH RES; Gobo G, 2004, QUALITATIVE RES PRAC; GRECO M, 1993, ECON SOC, V22, P357, DOI 10.1080/03085149300000024; GROFMAN B, 1985, THEOR DECIS, V19, P31, DOI 10.1007/BF00134353; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Lang ES, 2007, ACAD EMERG MED, V14, P919, DOI 10.1197/j.aem.2007.07.002; Legare F, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-2; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lown BA, 2009, HEALTH EXPECT, V12, P160, DOI 10.1111/j.1369-7625.2008.00525.x; Murtagh MJ, 2003, SOC SCI MED, V56, P1643, DOI 10.1016/S0277-9536(02)00172-7; Murtagh MJ, 2011, HUM GENET, P1; National Audit Office, 2005, RED BRAIN DAM FAST A; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Potter J., 1996, REPRESENTING REALITY; Rapley T, 2006, SOC SCI MED, V62, P2267, DOI 10.1016/j.socscimed.2005.10.011; Rosenbaum JR, 2004, STROKE, V35, pE353, DOI 10.1161/01.STR.0000136555.28503.55; Ruiz-Moral R, 2010, HEALTH EXPECT, V13, P33, DOI 10.1111/j.1369-7625.2009.00578.x; Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003; Silverman D., 2009, DOING QUALITATIVE RE; Stake R.E., 2005, SAGE HDB QUALITATIVE, V3rd, P119; Stoljar Natalie, 2000, RELATIONAL AUTONOMY, P98; Straus SE, 2009, KNOWLEDGE TRANSLATIO; Watson DB, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-5	34	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37066	10.1371/journal.pone.0037066	http://dx.doi.org/10.1371/journal.pone.0037066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UI	22675477	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305339900005
J	Champagne, CD; Houser, DS; Costa, DP; Crocker, DE				Champagne, Cory D.; Houser, Dorian S.; Costa, Daniel P.; Crocker, Daniel E.			The Effects of Handling and Anesthetic Agents on the Stress Response and Carbohydrate Metabolism in Northern Elephant Seals	PLOS ONE			English	Article							HEPATIC GLUCOSE-PRODUCTION; PLASMA-CORTISOL; HEART-RATE; FORAGING BEHAVIOR; HARBOR SEAL; BASE-LINE; KETAMINE; MECHANISMS; ENERGETICS; LACTATION	Free-ranging animals often cope with fluctuating environmental conditions such as weather, food availability, predation risk, the requirements of breeding, and the influence of anthropogenic factors. Consequently, researchers are increasingly measuring stress markers, especially glucocorticoids, to understand stress, disturbance, and population health. Studying free-ranging animals, however, comes with numerous difficulties posed by environmental conditions and the particular characteristics of study species. Performing measurements under either physical restraint or chemical sedation may affect the physiological variable under investigation and lead to values that may not reflect the standard functional state of the animal. This study measured the stress response resulting from different handling conditions in northern elephant seals and any ensuing influences on carbohydrate metabolism. Endogenous glucose production (EGP) was measured using [6(-3) H] glucose and plasma cortisol concentration was measured from blood samples drawn during three-hour measurement intervals. These measurements were conducted in weanlings and yearlings with and without the use of chemical sedatives-under chemical sedation, physical restraint, or unrestrained. We compared these findings with measurements in adult seals sedated in the field. The method of handling had a significant influence on the stress response and carbohydrate metabolism. Physically restrained weanlings and yearlings transported to the lab had increased concentrations of circulating cortisol (F-11,F- (46) = 25.2, p < 0.01) and epinephrine (F-3,F- (12) = 5.8, p = 0.01). Physical restraint led to increased EGP (t = 3.1, p = 0.04) and elevated plasma glucose levels (t = 8.2, p < 0.01). Animals chemically sedated in the field typically did not exhibit a cortisol stress response. The combination of anesthetic agents (Telazol, ketamine, and diazepam) used in this study appeared to alleviate a cortisol stress response due to handling in the field without altering carbohydrate metabolism. Measures of hormone concentrations and metabolism made under these conditions are more likely to reflect basal values.	[Champagne, Cory D.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Houser, Dorian S.; Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA	University of California System; University of California Santa Cruz; California State University System; Sonoma State University	Champagne, CD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	champagn@biology.ucsc.edu	Houser, Dorian/AAG-6359-2020; Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782; Houser, Dorian/0000-0002-0960-8528	National Science Foundation (NSF) [0818018]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported by National Science Foundation (NSF) grant #0818018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai S, 1999, J ACOUST SOC AM, V105, P2029, DOI 10.1121/1.426736; Ambrisko TD, 2005, AM J VET RES, V66, P406, DOI 10.2460/ajvr.2005.66.406; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Atkinson S, 2011, GEN COMP ENDOCR, V172, P277, DOI 10.1016/j.ygcen.2011.03.014; Baker JD, 2002, MAR MAMMAL SCI, V18, P500, DOI 10.1111/j.1748-7692.2002.tb01051.x; Bennett KA, 2012, COMP BIOCHEM PHYS A, V161, P69, DOI 10.1016/j.cbpa.2011.09.003; BHAT GK, 1995, NEUROENDOCRINOLOGY, V62, P178, DOI 10.1159/000127003; Boyd IL, 1999, AM J PHYSIOL-HEART C, V276, pH844, DOI 10.1152/ajpheart.1999.276.3.H844; BUTLER PC, 1989, ENDOCRIN METAB CLIN, V18, P1; CASTRO MI, 1981, P SOC EXP BIOL MED, V168, P389; Champagne CD, 2005, J EXP BIOL, V208, P859, DOI 10.1242/jeb.01476; Champagne CD, 2006, AM J PHYSIOL-REG I, V291, pR1129, DOI 10.1152/ajpregu.00570.2005; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; COSTA DP, 1988, CAN J ZOOL, V66, P45, DOI 10.1139/z88-006; Costa DP, 2004, ANNU REV PHYSIOL, V66, P209, DOI 10.1146/annurev.physiol.66.032102.114245; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; DAVIS RW, 1983, J COMP PHYSIOL, V153, P275, DOI 10.1007/BF00689631; DAVIS RW, 1991, J COMP PHYSIOL B, V160, P627, DOI 10.1007/BF00571260; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Engelhard GH, 2002, J COMP PHYSIOL B, V172, P315, DOI 10.1007/s00360-002-0257-0; Exton J H, 1979, Monogr Endocrinol, V12, P535; Fowler MA, 2008, J EXP BIOL, V211, P2943, DOI 10.1242/jeb.018176; Green JA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P551, DOI 10.1086/519961; Harcourt RG, 2010, J COMP PHYSIOL A, V196, P147, DOI 10.1007/s00359-009-0501-0; Hassrick JL, 2007, DEEP-SEA RES PT II, V54, P369, DOI 10.1016/j.dsr2.2006.12.001; HECHTER O, 1965, ANNU REV PHYSIOL, V27, P133, DOI 10.1146/annurev.ph.27.030165.001025; Heinrichs M, 2002, STRESS, V5, P195, DOI 10.1080/1025389021000010530; Hergovich N, 2001, NEUROPSYCHOPHARMACOL, V24, P590, DOI 10.1016/S0893-133X(00)00194-9; Houser DS, 2007, AM J PHYSIOL-REG I, V293, pR2376, DOI 10.1152/ajpregu.00403.2007; Houser DS, 2001, J COMP PHYSIOL B, V171, P635, DOI 10.1007/s003600100214; JEZOVA D, 1991, NEUROENDOCRINOLOGY, V54, P488; Kelso EJ, J EXP BIOL IN PRESS; KEMNITZ JW, 1982, AM J PRIMATOL, V3, P201, DOI 10.1002/ajp.1350030118; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Lehmann R, 1997, J MED PRIMATOL, V26, P312, DOI 10.1111/j.1600-0684.1997.tb00060.x; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; LENINAN F, 1988, J COMP PHYSIOL B, V158, P395, DOI 10.1007/BF00691136; Lidgard DC, 2008, HORM BEHAV, V53, P241, DOI 10.1016/j.yhbeh.2007.10.003; LIGHTMAN SL, 1992, ANN NY ACAD SCI, V652, P340, DOI 10.1111/j.1749-6632.1992.tb34365.x; Maestripieri D, 2008, HORM BEHAV, V53, P170, DOI 10.1016/j.yhbeh.2007.09.013; Mateo JM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1069, DOI 10.1086/432855; McMahon C, 2005, AMBIO, V34, P426, DOI 10.1639/0044-7447(2005)034[0426:HIATSA]2.0.CO;2; MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105; Meir JU, 2008, J EXP BIOL, V211, P1169, DOI 10.1242/jeb.013235; Mellish Jo-Ann E., 2006, Aquatic Mammals, V32, P58, DOI 10.1578/AM.32.1.2006.58; MORTON DJ, 1995, VET REC, V136, P60, DOI 10.1136/vr.136.3.60; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NORDOY ES, 1991, ACTA PHYSIOL SCAND, V141, P565, DOI 10.1111/j.1748-1716.1991.tb09118.x; Noren DP, 2003, J COMP PHYSIOL B, V173, P443, DOI 10.1007/s00360-003-0353-9; Opazo JC, 2004, COMP BIOCHEM PHYS A, V137, P57, DOI 10.1016/j.cbpb.2003.09.007; Ortiz RM, 2003, GEN COMP ENDOCR, V130, P78, DOI 10.1016/S0016-6480(02)00572-5; Ortiz RM, 2001, AM J PHYSIOL-REG I, V280, pR790, DOI 10.1152/ajpregu.2001.280.3.R790; Petrauskas L, 2008, J EXP ZOOL PART A, V309A, P73, DOI 10.1002/jez.435; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Pride RE, 2005, BIOL LETT-UK, V1, P60, DOI 10.1098/rsbl.2004.0245; Robinson PW, PLOS ONE IN PRESS; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Spee M, 2011, AM J PHYSIOL-REG I, V300, pR1241, DOI 10.1152/ajpregu.00762.2010; Stevenson RD, 2005, INTEGR COMP BIOL, V45, P1, DOI 10.1093/icb/45.1.1; UMMINGER BL, 1975, COMP BIOCHEM PHYS A, V52, P455, DOI 10.1016/S0300-9629(75)80065-X; van Berckel BNM, 1998, PSYCHOPHARMACOLOGY, V137, P271, DOI 10.1007/s002130050620; Viscarra JA, 2011, J ENDOCRINOL, V209, P317, DOI 10.1530/JOE-11-0017; Viscarra JA, 2011, AM J PHYSIOL-REG I, V300, pR150, DOI 10.1152/ajpregu.00478.2010; Walker BG, 2005, INTEGR COMP BIOL, V45, P12, DOI 10.1093/icb/45.1.12; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; Wenzel B, 2008, GLUCOSE TURNOVER FAS; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Wolfe RR., 2005, ISOTOPE TRACERS META, V2; WORTHY GAJ, 1992, J ZOOL, V227, P257, DOI 10.1111/j.1469-7998.1992.tb04821.x; Zeno RL, 2008, J ZOOL, V274, P180, DOI 10.1111/j.1469-7998.2007.00371.x	91	45	46	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38442	10.1371/journal.pone.0038442	http://dx.doi.org/10.1371/journal.pone.0038442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693622	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500148
J	Chen, HY; Yao, K; Nadas, J; Bode, AM; Malakhova, M; Oi, N; Li, HT; Lubet, RA; Dong, ZG				Chen, Hanyong; Yao, Ke; Nadas, Janos; Bode, Ann M.; Malakhova, Margarita; Oi, Naomi; Li, Haitao; Lubet, Ronald A.; Dong, Zigang			Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; LIGAND DOCKING; PROTEIN; INHIBITOR; MYRICETIN; PHYTOCHEMICALS; PHYTOESTROGENS; TRANSFORMATION; PROLIFERATION; RESVERATROL	Plant-based polyphenols (i.e., phytochemicals) have been used as treatments for human ailments for centuries. The mechanisms of action of these plant-derived compounds are now a major area of investigation. Thousands of phytochemicals have been isolated, and a large number of them have shown protective activities or effects in different disease models. Using conventional approaches to select the best single or group of best chemicals for studying the effectiveness in treating or preventing disease is extremely challenging. We have developed and used computational-based methodologies that provide efficient and inexpensive tools to gain further understanding of the anticancer and therapeutic effects exerted by phytochemicals. Computational methods involving virtual screening, shape and pharmacophore analysis and molecular docking have been used to select chemicals that target a particular protein or enzyme and to determine potential protein targets for well-characterized as well as for novel phytochemicals.	[Chen, Hanyong; Yao, Ke; Nadas, Janos; Bode, Ann M.; Malakhova, Margarita; Oi, Naomi; Li, Haitao; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Lubet, Ronald A.] NCI, Bethesda, MD 20892 USA	University of Minnesota System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, HY (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu			Hormel Foundation; National Institutes of Health [R37 CA081064, CA120388, ES016548, CA0227501]; National Cancer Institute [HHSN-261200533001C-NO1-CN-53301]; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Hormel Foundation and National Institutes of Health grants R37 CA081064, CA120388, ES016548, CA0227501 and National Cancer Institute Contract No. HHSN-261200533001C-NO1-CN-53301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; [Anonymous], 2011, GLIDE V5 6 SCHRODING; [Anonymous], 2011, PHASE V3 3 SCHRODING; [Anonymous], 2011, SCHRODINGER SUITE; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003; Chen X, 2004, CURR CANCER DRUG TAR, V4, P267, DOI 10.2174/1568009043333041; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2004, CANCER RES, V64, P3855, DOI 10.1158/0008-5472.CAN-04-0201; Clark DE, 2005, CANCER RES, V65, P3108; Cui Y, 2008, CANCER-AM CANCER SOC, V112, P2241, DOI 10.1002/cncr.23398; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DOWNS GM, 1994, J CHEM INF COMP SCI, V34, P1094, DOI 10.1021/ci00021a011; Fitch BG, 2006, LECT NOTES COMPUT SC, V3992, P846, DOI 10.1007/11758525_113; Germain RS, 2005, 2005 International Conference on Hardware/Software Codesign and System Synthesis, P207; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899; Jung SK, 2010, CARCINOGENESIS, V31, P911, DOI 10.1093/carcin/bgp221; Jung SK, 2010, BIOCHEM PHARMACOL, V79, P1455, DOI 10.1016/j.bcp.2010.01.004; Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Kinoshita T, 2006, BIOFACTORS, V26, P179, DOI 10.1002/biof.5520260303; Kwon JY, 2009, CARCINOGENESIS, V30, P1932, DOI 10.1093/carcin/bgp216; Lee DE, 2011, CARCINOGENESIS, V32, P629, DOI 10.1093/carcin/bgr008; Lee DE, 2010, J BIOL CHEM, V285, P21458, DOI 10.1074/jbc.M109.094797; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee KM, 2010, BIOCHEM PHARMACOL, V80, P2042, DOI 10.1016/j.bcp.2010.06.042; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Malakhova M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008044; Oi N, 2010, CANCER RES, V70, P9755, DOI 10.1158/0008-5472.CAN-10-2858; Ososki AL, 2003, PHYTOTHER RES, V17, P845, DOI 10.1002/ptr.1364; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Rester U, 2008, CURR OPIN DRUG DISC, V11, P559; Reynaud J, 2005, NAT PROD REP, V22, P504, DOI 10.1039/b416248j; Rolo-Naranjo A, 2010, J CHEM INF MODEL, V50, P924, DOI 10.1021/ci900358z; Smith JA, 2005, CANCER RES, V65, P1027; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Urusova D, 2011, CANC PREV R IN PRESS; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211	55	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38261	10.1371/journal.pone.0038261	http://dx.doi.org/10.1371/journal.pone.0038261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693608	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500119
J	Kuypers, E; Collins, JJP; Jellema, RK; Wolfs, TGAM; Kemp, MW; Nitsos, I; Pillow, JJ; Polglase, GR; Newnham, JP; Germeraad, WTV; Kallapur, SG; Jobe, AH; Kramer, BW				Kuypers, Elke; Collins, Jennifer J. P.; Jellema, Reint K.; Wolfs, Tim G. A. M.; Kemp, Matthew W.; Nitsos, Ilias; Pillow, J. Jane; Polglase, Graeme R.; Newnham, John P.; Germeraad, Wilfred T. V.; Kallapur, Suhas G.; Jobe, Alan H.; Kramer, Boris W.			Ovine Fetal Thymus Response to Lipopolysaccharide-Induced Chorioamnionitis and Antenatal Corticosteroids	PLOS ONE			English	Article							NEONATAL DEXAMETHASONE TREATMENT; T-CELL DEVELOPMENT; HYPOTHALAMOPITUITARY-ADRENAL AXIS; PRETERM LAMBS; INTRAAMNIOTIC ENDOTOXIN; CORD BLOOD; BRONCHOPULMONARY DYSPLASIA; THYMOCYTE DIFFERENTIATION; IMMUNE-SYSTEM; BETAMETHASONE	Rationale: Chorioamnionitis is associated with preterm delivery and involution of the fetal thymus. Women at risk of preterm delivery receive antenatal corticosteroids which accelerate fetal lung maturation and improve neonatal outcome. However, the effects of antenatal corticosteroids on the fetal thymus in the settings of chorioamnionitis are largely unknown. We hypothesized that intra-amniotic exposure to lipopolysaccharide (LPS) causes involution of the fetal thymus resulting in persistent effects on thymic structure and cell populations. We also hypothesized that antenatal corticosteroids may modulate the effects of LPS on thymic development. Methods: Time-mated ewes with singleton fetuses received an intra-amniotic injection of LPS 7 or 14 days before preterm delivery at 120 days gestational age (term = 150 days). LPS and corticosteroid treatment groups received intra-amniotic LPS either preceding or following maternal intra-muscular betamethasone. Gestation matched controls received intra-amniotic and maternal intra-muscular saline. The fetal intra-thoracic thymus was evaluated. Results: Intra-amniotic LPS decreased the cortico-medullary (C/M) ratio of the thymus and increased Toll-like receptor (TLR) 4 mRNA and CD3 expression indicating involution and activation of the fetal thymus. Increased TLR4 and CD3 expression persisted for 14 days but Foxp3 expression decreased suggesting a change in regulatory T-cells. Sonic hedgehog and bone morphogenetic protein 4 mRNA, which are negative regulators of T-cell development, decreased in response to intra-amniotic LPS. Betamethasone treatment before LPS exposure attenuated some of the LPS-induced thymic responses but increased cleaved caspase-3 expression and decreased the C/M ratio. Betamethasone treatment after LPS exposure did not prevent the LPS-induced thymic changes. Conclusion: Intra-amniotic exposure to LPS activated the fetal thymus which was accompanied by structural changes. Treatment with antenatal corticosteroids before LPS partially attenuated the LPS-induced effects but increased apoptosis in the fetal thymus. Corticosteroid administration after the inflammatory stimulus did not inhibit the LPS effects on the fetal thymus.	[Kuypers, Elke; Collins, Jennifer J. P.; Jellema, Reint K.; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ Med Ctr, Dept Pediat, Maastricht, Netherlands; [Kemp, Matthew W.; Nitsos, Ilias; Pillow, J. Jane; Polglase, Graeme R.; Newnham, John P.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Germeraad, Wilfred T. V.] Maastricht Univ Med Ctr, Div Haematol, Dept Internal Med, Maastricht, Netherlands; [Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Div Pulm Biol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Maastricht University; Maastricht University Medical Centre (MUMC); University of Western Australia; Maastricht University; Maastricht University Medical Centre (MUMC); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Kuypers, E (corresponding author), Maastricht Univ Med Ctr, Dept Pediat, Maastricht, Netherlands.	b.kramer@mumc.nl	Pillow, Jane/A-3335-2009; Kramer, Boris/AAO-3183-2021; Jellema, Reint/AAW-1214-2020	Pillow, Jane/0000-0002-6500-0138; Jellema, Reint/0000-0002-6918-0930; Collins, Jennifer/0000-0002-7556-0526; Wolfs, Tim/0000-0003-4417-4144; Polglase, Graeme/0000-0002-8906-614X; Newnham, John/0000-0001-9983-7457	National Institutes of Health (NIH), United States of America [NIH HD-57869]; National Health and Medical Research Council of Australia; Women and Infants Research Foundation, Western Australia; Dutch Scientific Research Organization [Veni BWK 016.096.141]; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	National Institutes of Health (NIH), United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Women and Infants Research Foundation, Western Australia; Dutch Scientific Research Organization; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NIH HD-57869 (SGK) from the National Institutes of Health (NIH), United States of America, the National Health and Medical Research Council of Australia, the Women and Infants Research Foundation, Western Australia, Veni BWK 016.096.141 from the Dutch Scientific Research Organization and the Research School for Oncology and Developmental Biology (GROW), Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker JM, 2000, J IMMUNOL, V165, P5932, DOI 10.4049/jimmunol.165.10.5932; Bakker JM, 1995, J NEUROIMMUNOL, V63, P183, DOI 10.1016/0165-5728(95)00152-2; Bakker JM, 2001, J NEUROIMMUNOL, V112, P47, DOI 10.1016/S0165-5728(00)00406-9; Bakker JM, 1997, J NEUROIMMUNOL, V74, P69, DOI 10.1016/S0165-5728(96)00207-X; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Been JV, 2010, BJOG, V118, P113; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; Chabra S, 1998, BIOL NEONATE, V74, P200, DOI 10.1159/000014025; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Crowther CA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub2; Dave VP, 2009, IMMUNOL REV, V232, P22, DOI 10.1111/j.1600-065X.2009.00835.x; De Felice C, 1999, J PEDIATR-US, V135, P384, DOI 10.1016/S0022-3476(99)70140-X; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Getahun D, 2010, ARCH PEDIAT ADOL MED, V164, P187, DOI 10.1001/archpediatrics.2009.238; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Graf D, 2002, J EXP MED, V196, P163, DOI 10.1084/jem.20020276; Gutierrez-Frias C, 2004, J IMMUNOL, V173, P5046, DOI 10.4049/jimmunol.173.8.5046; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hanson ML, 2010, TOXICOL APPL PHARM, V242, P136, DOI 10.1016/j.taap.2009.09.023; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2003, AM J PHYSIOL-LUNG C, V284, pL633, DOI 10.1152/ajplung.00344.2002; Kavelaars A, 1999, PEDIATR RES, V45, P306, DOI 10.1203/00006450-199903000-00003; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Kramer BW, 2009, INNATE IMMUN-LONDON, V15, P101, DOI 10.1177/1753425908100455; Kramer BW, 2004, PEDIATR RES, V55, P764, DOI 10.1203/01.PDR.0000120678.72485.19; Kramer BW, 2005, AM J RESP CRIT CARE, V171, P73, DOI 10.1164/rccm.200406-745OC; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Kramer BW, 2009, AM J OBSTET GYNECOL, V202, P77; Kumar R, 2008, J ALLERGY CLIN IMMUN, V121, p[878, e876]; Kunzmann S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.035; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Michie CA, 1998, ARCH DIS CHILD-FETAL, V79, pF159, DOI 10.1136/fn.79.2.F159a; Newnham JP, 2003, AM J OBSTET GYNECOL, V189, P1458, DOI 10.1067/S0002-9378(03)00758-0; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Quinlivan J A, 1998, J Obstet Gynaecol Res, V24, P173; Rosen D, 2006, AM J RESP CRIT CARE, V174, P75, DOI 10.1164/rccm.200511-1784OC; Sacedon R, 2003, J HISTOCHEM CYTOCHEM, V51, P1557, DOI 10.1177/002215540305101115; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Sloboda DM, 2000, J ENDOCRINOL, V165, P79, DOI 10.1677/joe.0.1650079; SMOLDERSDEHAAS H, 1990, PEDIATRICS, V86, P65; Tonomura N, 2003, J IMMUNOL, V170, P2469, DOI 10.4049/jimmunol.170.5.2469; Toti P, 2000, HUM PATHOL, V31, P1121, DOI 10.1053/hupa.2000.16676; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837; WU FF, 1993, FETAL DIAGN THER, V8, P89, DOI 10.1159/000263754; Yinon Y, 2007, ULTRASOUND OBST GYN, V29, P639, DOI 10.1002/uog.4022	51	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38257	10.1371/journal.pone.0038257	http://dx.doi.org/10.1371/journal.pone.0038257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693607	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500118
J	Meyer-Rath, G; Schnippel, K; Long, L; MacLeod, W; Sanne, I; Stevens, W; Pillay, S; Pillay, Y; Rosen, S				Meyer-Rath, Gesine; Schnippel, Kathryn; Long, Lawrence; MacLeod, William; Sanne, Ian; Stevens, Wendy; Pillay, Sagie; Pillay, Yogan; Rosen, Sydney			The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa	PLOS ONE			English	Article							TUBERCULOSIS; DIAGNOSIS; IMPLEMENTATION; RESISTANCE	Objective: We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa. Methods: We parameterised a population-level decision model with data from national-level TB databases (n = 199,511) and implementation studies. The model follows cohorts of TB suspects from diagnosis to treatment under current diagnostic guidelines or an algorithm that includes Xpert. Assumptions include the number of TB suspects, symptom prevalence of 5.5%, annual suspect growth rate of 10%, and 2010 public-sector salaries and drug and service delivery costs. Xpert test costs are based on data from an in-country pilot evaluation and assumptions about when global volumes allowing cartridge discounts will be reached. Results: At full scale, Xpert will increase the number of TB cases diagnosed per year by 30%-37% and the number of MDR-TB cases diagnosed by 69%-71%. It will diagnose 81% of patients after the first visit, compared to 46% currently. The cost of TB diagnosis per suspect will increase by 55% to USD 60-61 and the cost of diagnosis and treatment per TB case treated by 8% to USD 797-873. The incremental capital cost of the Xpert scale-up will be USD 22 million and the incremental recurrent cost USD 287-316 million over six years. Conclusion: Xpert will increase both the number of TB cases diagnosed and treated and the cost of TB diagnosis. These results do not include savings due to reduced transmission of TB as a result of earlier diagnosis and treatment initiation.	[Meyer-Rath, Gesine; Schnippel, Kathryn; Long, Lawrence; MacLeod, William; Sanne, Ian; Rosen, Sydney] Univ Witwatersrand, Dept Med, Fac Hlth Sci, HE2RO, ZA-2001 Johannesburg, South Africa; [Meyer-Rath, Gesine; MacLeod, William; Sanne, Ian; Rosen, Sydney] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Stevens, Wendy; Pillay, Sagie] Natl Hlth Lab Serv, Johannesburg, South Africa; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa	University of Witwatersrand; Boston University; National Health Laboratory Service; University of Witwatersrand	Meyer-Rath, G (corresponding author), Univ Witwatersrand, Dept Med, Fac Hlth Sci, HE2RO, ZA-2001 Johannesburg, South Africa.	gesine@bu.edu	Sanne, Ian/ABH-2231-2020	Long, Lawrence/0000-0003-4986-4988; Rosen, Sydney/0000-0002-6560-2964; Meyer-Rath, Gesine/0000-0003-0439-381X; MacLeod, William/0000-0001-8003-8874; Schnippel, Kathryn/0000-0003-0757-4325	South Africa Mission of the US Agency for International Development (USAID) [674-A-00-09-00018-00, GHS-A-00-03-00020, 674-A-00-08-0007-00]; Fogarty International Center/National Institutes of Health, ICOHRTA AIDS/TB [U2RTW007373]; FOGARTY INTERNATIONAL CENTER [U2RTW007373] Funding Source: NIH RePORTER	South Africa Mission of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Fogarty International Center/National Institutes of Health, ICOHRTA AIDS/TB; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding for this study was provided by the South Africa Mission of the US Agency for International Development (USAID) under the terms of Associate Cooperative Agreement No. 674-A-00-09-00018-00 under Country Research Activity Leader Award No. GHS-A-00-03-00020 (GMR, KB, LL, WM and SR) and under Agreement No. 674-A-00-08-0007-00 to Right to Care (IS). KB received additional training support from Fogarty International Center/National Institutes of Health, ICOHRTA AIDS/TB Grant No. U2RTW007373. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001063; Erasmus LK, 2011, INT J TUBERC LUNG S3, V15, pS61; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Mann GH, 2011, INT J TUBERC LUNG D, V15, P715, DOI 10.5588/ijtld.10.0749; Matsoso L. G., 2010, Southern African Journal of Epidemiology & Infection, V25, P12; Meyer-Rath G, 2011, 42 UN WORLD C LUNG H; Motsoaledi A., 2011, COMMUNICATION   0531; National Department of Health Republic of South Africa, 2009, NAT TUB MAN GUID; National Department of Health Republic of South Africa, 2011, MULT RES TUB POL FRA; National Department of Health Republic of South Africa, 2011, NAT STRAT PLAN HIV A, P2012; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Sohn H, 2006, EXPERT REV ANTI-INFE, V7, P723; [TB Control Programme National Department of Health Republic of South Africa], 2010, PROV Q TB PROGR REP; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases/Foundation for Innovative New Diagnostics, 2006, DIAGN TUB GLOB DEM M; WHO, STOPTB PLANN BUDG TB; WHO, 2011, GLOB TUB CONTR REP; WHO, 2010, TUB DIAGN XPERT MTB; World Health Organization, 2010, ROADM ROL XPERT MTB	24	119	119	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36966	10.1371/journal.pone.0036966	http://dx.doi.org/10.1371/journal.pone.0036966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693561	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500023
J	Tang, L; Sun, J; Zhang, HC; Zhang, CS; Yu, LN; Bi, J; Zhu, F; Liu, SF; Yang, QL				Tang, Lin; Sun, Jie; Zhang, Hui Cui; Zhang, Chu Shu; Yu, Li Na; Bi, Jie; Zhu, Feng; Liu, Shao Fang; Yang, Qing Li			Evaluation of Physicochemical and Antioxidant Properties of Peanut Protein Hydrolysate	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; GELATION; PH	Peanut protein and its hydrolysate were compared with a view to their use as food additives. The effects of pH, temperature and protein concentration on some of their key physicochemical properties were investigated. Compared with peanut protein, peanut peptides exhibited a significantly higher solubility and significantly lower turbidity at pH values 2-12 and temperature between 30 and 80 degrees C. Peanut peptide showed better emulsifying capacity, foam capacity and foam stability, but had lower water holding and fat adsorption capacities over a wide range of protein concentrations (2-5 g/100 ml) than peanut protein isolate. In addition, peanut peptide exhibited in vitro antioxidant properties measured in terms of reducing power, scavenging of hydroxyl radical, and scavenging of DPPH radical. These results suggest that peanut peptide appeared to have better functional and antioxidant properties and hence has a good potential as a food additive.	[Tang, Lin; Zhang, Hui Cui] Shandong Normal Univ, Jinan, Peoples R China; [Sun, Jie; Zhang, Hui Cui; Zhang, Chu Shu; Yu, Li Na; Bi, Jie; Zhu, Feng; Liu, Shao Fang; Yang, Qing Li] Shandong Peanut Res Inst, Qingdao, Peoples R China	Shandong Normal University	Tang, L (corresponding author), Shandong Normal Univ, Jinan, Peoples R China.	rice407@sohu.com			National Natural Science Foundation of China [31100205, 31000728]; China Agriculture Research System [CARS-14]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Qingdao Municipal Science and Technology Plan Project [11-2-3-26-nsh, 11-2-3-25-nsh, 11-2-4-9-(3)-jch]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Natural Science Fund of Shangdong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from the National Natural Science Foundation of China (31100205; 31000728), the China Agriculture Research System (CARS-14), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), Qingdao Municipal Science and Technology Plan Project (11-2-3-26-nsh; 11-2-3-25-nsh; 11-2-4-9-(3)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyare KK, 2009, FOOD HYDROCOLLOID, V23, P72, DOI 10.1016/j.foodhyd.2007.11.012; Ahmedna M, 1999, J AGR FOOD CHEM, V47, P1340, DOI 10.1021/jf981098s; Akintayo ET, 1999, FOOD CHEM, V66, P51, DOI 10.1016/S0308-8146(98)00155-1; Arogundade LA, 2006, FOOD HYDROCOLLOID, V20, P831, DOI 10.1016/j.foodhyd.2005.07.012; Benjakul S, 2001, J SCI FOOD AGR, V81, P1039, DOI 10.1002/jsfa.887; Carrasco-Castilla J, 2012, FOOD CHEM, V131, P1157, DOI 10.1016/j.foodchem.2011.09.084; Cumby N, 2008, FOOD CHEM, V109, P144, DOI 10.1016/j.foodchem.2007.12.039; DAMAME SV, 1990, PLANT FOOD HUM NUTR, V40, P143, DOI 10.1007/BF02193772; Dong XH, 2011, INNOV FOOD SCI EMERG, V12, P478, DOI 10.1016/j.ifset.2011.07.002; Hettiarachchy NS, 1996, CEREAL CHEM, V73, P364; Hwang JY, 2010, LWT-FOOD SCI TECHNOL, V43, P285, DOI 10.1016/j.lwt.2009.08.020; LUSAS EW, 1979, J AM OIL CHEM SOC, V56, P425, DOI 10.1007/BF02671530; Nielsen PM, 2001, J FOOD SCI, V66, P642, DOI 10.1111/j.1365-2621.2001.tb04614.x; PATIL UG, 1993, PLANT FOOD HUM NUTR, V43, P157, DOI 10.1007/BF01087919; PEARCE KN, 1978, J AGR FOOD CHEM, V26, P716, DOI 10.1021/jf60217a041; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Siddhuraju P, 2007, FOOD CHEM, V101, P10, DOI 10.1016/j.foodchem.2006.01.004; Tang CH, 2007, J FOOD ENG, V82, P568, DOI 10.1016/j.jfoodeng.2007.01.029; Tomotake H, 2002, J AGR FOOD CHEM, V50, P2125, DOI 10.1021/jf011248q; Yin Y. R., 1996, Food Science, China, V17, P3; Zhang YuHao, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P258; Zhao GL, 2011, FOOD CHEM, V127, P1438, DOI 10.1016/j.foodchem.2011.01.046	23	22	26	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37863	10.1371/journal.pone.0037863	http://dx.doi.org/10.1371/journal.pone.0037863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693580	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500061
J	Xia, ZL; Sun, KL; Wang, MP; Wu, K; Zhang, H; Wu, JY				Xia, Zongliang; Sun, Kaile; Wang, Meiping; Wu, Ke; Zhang, Hua; Wu, Jianyu			Overexpression of a Maize Sulfite Oxidase Gene in Tobacco Enhances Tolerance to Sulfite Stress via Sulfite Oxidation and CAT-Mediated H2O2 Scavenging	PLOS ONE			English	Article							CYTOCHROME C OXIDOREDUCTASE; THIOBACILLUS-NOVELLUS; MOLYBDENUM-COFACTOR; CHICKEN LIVER; PURIFICATION; IDENTIFICATION; METABOLISM; EXPRESSION; ENZYME; PLANTS	Sulfite oxidase (SO) plays an important role in sulfite metabolism. To date, the molecular mechanisms of sulfite metabolism in plants are largely unknown. Previously, a full-length cDNA of the putative sulfite oxidase gene from maize (ZmSO) was cloned, and its response to SO2/sulfite stress at the transcriptional level was characterized. In this study, the recombinant ZmSO protein was purified from E. coli. It exhibited sulfite-dependent activity and had strong affinity for the substrate sulfite. Over-expression (OE) of ZmSO in tobacco plants enhanced their tolerance to sulfite stress. The plants showed much less damage, less sulfite accumulation, but greater amounts of sulfate. This suggests that tolerance of transgenic plants to sulfite was enhanced by increasing SO expression levels. Interestingly, H2O2 accumulation levels by histochemical detection and quantitative determination in the OE plants were much less than those in the wild-type upon sulfite stress. Furthermore, reductions of catalase levels detected in the OE lines were considerably less than in the wild-type plants. This indicates that SO may play an important role in protecting CAT from inhibition by excess sulfite. Collectively, these data demonstrate that transgenic tobacco plants over-expressing ZmSO enhance tolerance to excess sulfite through sulfite oxidation and catalase-mediated hydrogen peroxide scavenging. This is the first SO gene from monocots to be functionally characterized.	[Xia, Zongliang; Sun, Kaile; Wang, Meiping; Wu, Ke; Zhang, Hua; Wu, Jianyu] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Xia, Zongliang; Wu, Jianyu] Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Xia, ZL (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China.	xiazl08@163.com; wujianyu40@126.com		Wu, Jianyu/0000-0002-9090-2512	National Natural Science Foundation of China [30971548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (30971548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; ANDERSON MD, 1995, PLANT PHYSIOL, V109, P1247, DOI 10.1104/pp.109.4.1247; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; Brychkova G, 2007, PLANT J, V50, P696, DOI 10.1111/j.1365-313X.2007.03080.x; Byrne RS, 2009, J BIOL CHEM, V284, P35479, DOI 10.1074/jbc.M109.067355; COHEN HJ, 1971, J BIOL CHEM, V246, P367; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; COHEN HJ, 1971, J BIOL CHEM, V246, P359; D'Errico G, 2006, J BACTERIOL, V188, P694, DOI 10.1128/JB.188.2.694-701.2006; de Jong GAH, 2000, J MOL CATAL B-ENZYM, V8, P61, DOI 10.1016/S1381-1177(99)00067-3; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; FERGUSON IB, 1983, PLANT PHYSIOL, V71, P182, DOI 10.1104/pp.71.1.182; GARRETT RM, 1994, J BIOL CHEM, V269, P272; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hansch R, 2007, PLANT BIOLOGY, V9, P589, DOI 10.1055/s-2007-965433; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Lang C, 2007, PLANT CELL ENVIRON, V30, P447, DOI 10.1111/j.1365-3040.2006.01632.x; Liu L, 1996, ENV SCI, V17, P16; LYRIC RM, 1970, CAN J BIOCHEM CELL B, V48, P334, DOI 10.1139/o70-056; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Nowak K, 2004, PLANT CELL PHYSIOL, V45, P1889, DOI 10.1093/pcp/pch212; Pasqualini S, 2007, PLANT CELL ENVIRON, V30, P1545, DOI 10.1111/j.1365-3040.2007.01730.x; Purnell MP, 2005, PLANTA, V222, P167, DOI 10.1007/s00425-005-1510-z; Randewig D, 2012, PLANT CELL ENVIRON, V35, P100, DOI 10.1111/j.1365-3040.2011.02420.x; Rea G, 2004, PLANT PHYSIOL, V134, P1414, DOI 10.1104/pp.103.036764; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; TOGHROL F, 1983, J BIOL CHEM, V258, P6762; Xia ZL, 2012, MOL BIOL REP, V39, P2429, DOI 10.1007/s11033-011-0993-x; Xia ZongLiang, 2009, Scientia Agricultura Sinica, V42, P2643	37	25	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37383	10.1371/journal.pone.0037383	http://dx.doi.org/10.1371/journal.pone.0037383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693572	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500035
J	Kim, Y; Kim, K; Park, D; Lee, E; Lee, H; Lee, YS; Choe, J; Jeoung, D				Kim, Youngmi; Kim, Kyungjong; Park, Deokbum; Lee, Eunmi; Lee, Hansoo; Lee, Yun-Sil; Choe, Jongseon; Jeoung, Dooil			Histone Deacetylase 3 Mediates Allergic Skin Inflammation by Regulating Expression of MCP1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MAST-CELLS; VASCULAR-PERMEABILITY; GENE-EXPRESSION; AIRWAY INFLAMMATION; TYROSINE KINASES; ANGIOGENESIS; ACTIVATION; INHIBITION; MEMBRANE	We have shown the induction of histone deacetylase 3 (HDAC3) in antigen-stimulated rat basophilic leukemia cells via NF-kappa B. We investigated the role of HDAC3 in allergic skin inflammation. We used a BALB/c mouse model of triphasic cutaneous anaphylaxis (triphasic cutaneous reaction; TpCR) and passive cutaneous anaphylaxis (PCA) to examine the role of HDAC3 in allergic skin inflammation. Triphasic cutaneous reaction involved induction of HDAC3 and was mediated by HDAC3. HDAC3 showed an interaction with Fc epsilon RI beta. Trichostatin A (TSA), an inhibitor of HDAC(s), disrupted this interaction. Cytokine array analysis showed that the down-regulation of HDAC3 led to the decreased secretion of monocyte chemoattractant protein 1 (MCP1). Fc epsilon RI was necessary for induction of HDAC3 and MCP1. ChIP assays showed that HDAC3, in association with Sp1 and c-Jun, was responsible for induction of MCP1 expression. TSA exerted a negative effect on induction of MCP1. HDAC3 exerted a negative regulation on expression of HDAC2 via interaction with Rac1. The down-regulation of HDAC3 or inactivation of Rac1 induced binding of HDAC2 to MCP1 promoter sequences. TSA exerted a negative effect on HDAC3-mediated TpCR. The BALB/c mouse model of PCA involved induction of HDAC3 and MCP1. HDAC3 and MCP1 were necessary for PCA that involved ear swelling, enhanced vascular permeability, and angiogenesis. Recombinant MCP1 enhanced beta-hexosaminidase activity and histamine release and also showed angiogenic potential. TSA exerted a negative effect on PCA. Our data show HDAC3 as a valuable target for the development of allergic skin inflammation therapeutics.	[Jeoung, Dooil] Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Dept Biochem, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon] Kangwon Natl Univ, Coll Med, Chunchon 200701, South Korea; [Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Dept Biochem, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Korea Research Foundation [C1007988-01-02, C1007565-01-02]; Regional Innovation Center Program of the Ministry of Education, Science, and Technology	Korea Research Foundation(National Research Foundation of Korea); Regional Innovation Center Program of the Ministry of Education, Science, and Technology	This work was supported by Korea Research Foundation Grants C1007988-01-02 and C1007565-01-02 and a grant from the Regional Innovation Center Program of the Ministry of Education, Science, and Technology.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Albrecht EA, 2004, AM J PATHOL, V164, P849, DOI 10.1016/S0002-9440(10)63173-2; Bao WJ, 2002, MOL CELL BIOL, V22, P4587, DOI 10.1128/MCB.22.13.4587-4597.2002; Benhamou M, 1996, J LEUKOCYTE BIOL, V59, P461, DOI 10.1002/jlb.59.3.461; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Chandrasekaran S, 2009, FASEB J, V23, P3851, DOI 10.1096/fj.09-132415; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Garcia-Roman J, 2010, BIOCHEM BIOPH RES CO, V401, P262, DOI 10.1016/j.bbrc.2010.09.047; Glenn DJ, 2009, HYPERTENSION, V53, P549, DOI 10.1161/HYPERTENSIONAHA.108.125088; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Inagaki N, 1997, GEN PHARMACOL-VASC S, V28, P93, DOI 10.1016/S0306-3623(96)00166-8; Inagaki N, 2009, J PHARMACOL SCI, V110, P251, DOI 10.1254/jphs.09R01FM; Ito K., 2001, FASEB Journal, V15, P1110; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kim DY, 2010, J IMMUNOL, V185, P273, DOI 10.4049/jimmunol.1000991; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Kinugasa F, 2010, TRANSPL IMMUNOL, V23, P18, DOI 10.1016/j.trim.2010.02.003; Li LB, 2010, AM J RESP CRIT CARE, V182, P877, DOI 10.1164/rccm.201001-0015OC; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Lores P, 2010, FEBS J, V277, P1453, DOI 10.1111/j.1742-4658.2010.07575.x; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Meja KK, 2008, AM J RESP CELL MOL, V39, P312, DOI 10.1165/rcmb.2008-0012OC; Melgarejo E, 2007, CELL MOL LIFE SCI, V64, P2690, DOI 10.1007/s00018-007-7331-4; N'Guessan PD, 2009, ARTERIOSCL THROM VAS, V29, P380, DOI 10.1161/ATVBAHA.108.178319; Nico B, 2008, STEM CELLS DEV, V17, P19, DOI 10.1089/scd.2007.0132; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Orecchia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024307; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Ribatti D, 2011, INT J DEV BIOL, V55, P99, DOI 10.1387/ijdb.103138dr; SAKURAI T, 1994, LIFE SCI, V54, pPL291, DOI 10.1016/0024-3205(94)00859-0; Stoeltzing O, 2003, CANCER RES, V63, P3370; Suzuki M, 1996, INT ARCH ALLERGY IMM, V111, P18, DOI 10.1159/000237339; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Tovar-Castillo LE, 2007, INT J DERMATOL, V46, P239, DOI 10.1111/j.1365-4632.2006.02962.x; Utrera-Barillas D, 2010, EXP MOL PATHOL, V89, P190, DOI 10.1016/j.yexmp.2010.06.002; Warkentin TE, 2009, EXPERT OPIN DRUG SAF, V8, P129, DOI [10.1517/14740330902778180, 10.1517/14740330902778180 ]; Zhang J, 2011, ENDOCRINOLOGY, V152, P1829, DOI 10.1210/en.2010-0828	48	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25844	25859		10.1074/jbc.M112.348284	http://dx.doi.org/10.1074/jbc.M112.348284			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679019	hybrid, Green Published			2022-12-25	WOS:000306916300014
J	Gianoli, E; Saldana, A; Jimenez-Castillo, M				Gianoli, Ernesto; Saldana, Alfredo; Jimenez-Castillo, Mylthon			Ecophysiological Traits May Explain the Abundance of Climbing Plant Species across the Light Gradient in a Temperate Rainforest	PLOS ONE			English	Article							TROPICAL FOREST; LARGE LIANAS; AVAILABILITY; SHADE; TREES; EVOLUTION; RESPONSES; PATTERNS; HISTORY; VINES	Climbing plants are a key component of rainforests, but mechanistic approaches to their distribution and abundance are scarce. In a southern temperate rainforest, we addressed whether the dominance of climbing plants across light environments is associated with the expression of ecophysiological traits. In mature forest and canopy gaps, we measured leaf size, specific leaf area, photosynthetic rate, and dark respiration in six of the most abundant woody vines. Mean values of traits and their phenotypic change (%) between mature forest and canopy gaps were predictor variables. Leaf size and specific leaf area were not significantly associated with climbing plant dominance. Variation in gas-exchange traits between mature forest and canopy gaps explained, at least partly, the dominance of climbers in this forest. A greater increase in photosynthetic rate and a lower increase in dark respiration rate when canopy openings occur were related to the success of climbing plant species. Dominant climbers showed a strategy of maximizing exploitation of resource availability but minimizing metabolic costs. Results may reflect phenotypic plasticity or genetic differentiation in ecophysiological traits between light environments. It is suggested that the dominant climbers in this temperate rainforest would be able to cope with forest clearings due to human activities.	[Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile; [Gianoli, Ernesto; Saldana, Alfredo] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gianoli, Ernesto] Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [Jimenez-Castillo, Mylthon] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Valdivia, Chile	Universidad de La Serena; Universidad de Concepcion; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Gianoli, E (corresponding author), Univ La Serena, Dept Biol, La Serena, Chile.	egianoli@userena.cl	Saldaña, Alfredo/C-8826-2011; Gianoli, Ernesto/A-7984-2015	Gianoli, Ernesto/0000-0003-4246-8640; Jimenez-Castillo, Mylthon/0000-0003-4328-3904; Saldana, Alfredo/0000-0001-5161-5150	FONDECYT-Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [1070503]	FONDECYT-Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by FONDECYT-Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico) grant number 1070503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BP, 2007, FOREST ECOL MANAG, V242, P17, DOI 10.1016/j.foreco.2007.01.027; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Cai ZQ, 2007, ANN BOT-LONDON, V100, P831, DOI 10.1093/aob/mcm179; Carrasco-Urra F, 2009, J VEG SCI, V20, P1155, DOI 10.1111/j.1654-1103.2009.01115.x; CARTER GA, 1988, AM J BOT, V75, P1011, DOI 10.2307/2443769; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; Domingues TF, 2007, PLANT ECOL, V193, P101, DOI 10.1007/s11258-006-9251-z; Dorsch K., 2003, THESIS LUDWIG MAXIMI; Gentry A.H., 1991, BIOL VINES, P3; Gianoli E, 2004, P ROY SOC B-BIOL SCI, V271, P2011, DOI 10.1098/rspb.2004.2827; Gianoli E, 2010, J VEG SCI, V21, P66, DOI 10.1111/j.1654-1103.2009.01124.x; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Londre RA, 2006, ECOLOGY, V87, P2973, DOI 10.1890/0012-9658(2006)87[2973:TDOLAT]2.0.CO;2; Lusk CH, 2006, OIKOS, V112, P131, DOI 10.1111/j.0030-1299.2006.13922.x; Lusk CH, 2002, OECOLOGIA, V132, P188, DOI 10.1007/s00442-002-0974-9; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Munoz AA, 2003, AUST J BOT, V51, P381, DOI 10.1071/BT02070; Phillips OL, 2005, ECOLOGY, V86, P1250, DOI 10.1890/04-1446; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Saldana A, 2003, REV CHIL HIST NAT, V76, P639; Saldana A, 2005, OECOLOGIA, V145, P251, DOI 10.1007/s00442-005-0116-2; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Swaine MD, 2007, PLANT ECOL, V192, P271, DOI 10.1007/s11258-007-9319-4; Teramura A.H., 1991, PHYSL ECOLOGY MESIC, P245; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2011, ANN BOT-LONDON, V108, P231, DOI 10.1093/aob/mcr132; van der Heijden GMF, 2008, GLOBAL ECOL BIOGEOGR, V17, P372, DOI 10.1111/j.1466-8238.2007.00376.x; van der Heijden GMF, 2008, J VEG SCI, V19, P747, DOI 10.3170/2008-8-18459; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757	36	21	23	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38831	10.1371/journal.pone.0038831	http://dx.doi.org/10.1371/journal.pone.0038831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685611	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700075
J	Mrak, LN; Zielinska, AK; Beenken, KE; Mrak, IN; Atwood, DN; Griffin, LM; Lee, CY; Smeltzer, MS				Mrak, Lara N.; Zielinska, Agnieszka K.; Beenken, Karen E.; Mrak, Ian N.; Atwood, Danielle N.; Griffin, Linda M.; Lee, Chia Y.; Smeltzer, Mark S.			saeRS and sarA Act Synergistically to Repress Protease Production and Promote Biofilm Formation in Staphylococcus aureus	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; EXTRACELLULAR PROTEASES; MUTANTS; PHENOTYPE; AGR; OSTEOMYELITIS; INFECTION; SYSTEM; IMPACT	Mutation of the staphylococcal accessory regulator (sarA) limits biofilm formation in diverse strains of Staphylococcus aureus, but there are exceptions. One of these is the commonly studied strain Newman. This strain has two defects of potential relevance, the first being mutations that preclude anchoring of the fibronectin-binding proteins FnbA and FnbB to the cell wall, and the second being a point mutation in saeS that results in constitutive activation of the saePQRS regulatory system. We repaired these defects to determine whether either plays a role in biofilm formation and, if so, whether this could account for the reduced impact of sarA in Newman. Restoration of surface-anchored FnbA enhanced biofilm formation, but mutation of sarA in this fnbA-positive strain increased rather than decreased biofilm formation. Mutation of sarA in an saeS-repaired derivative of Newman (P18L) or a Newman saeRS mutant (Delta saeRS) resulted in a biofilm-deficient phenotype like that observed in clinical isolates, even in the absence of surface-anchored FnbA. These phenotypes were correlated with increased production of extracellular proteases and decreased accumulation of FnbA and/or Spa in the P18L and Delta saeRS sarA mutants by comparison to the Newman sarA mutant. The reduced accumulation of Spa was reversed by mutation of the gene encoding aureolysin, while the reduced accumulation of FnbA was reversed by mutation of the sspABC operon. These results demonstrate that saeRS and sarA act synergistically to repress the production of extracellular proteases that would otherwise limit accumulation of critical proteins that contribute to biofilm formation, with constitutive activation of saeRS limiting protease production, even in a sarA mutant, to a degree that can be correlated with increased enhanced capacity to form a biofilm. Although it remains unclear whether these effects are mediated directly or indirectly, studies done with an sspA:: lux reporter suggest they are mediated at a transcriptional level.	[Mrak, Lara N.; Zielinska, Agnieszka K.; Beenken, Karen E.; Mrak, Ian N.; Atwood, Danielle N.; Griffin, Linda M.; Lee, Chia Y.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Mrak, LN (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692	NIAID [RO1-AI074935]; Clinical and Translational Sciences Award [RR0298884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074935, R01AI067857] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clinical and Translational Sciences Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grant RO1-AI074935 to MSS. Support was also obtained from resources provided through the Clinical and Translational Sciences Award (RR0298884) to the University of Arkansas for Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Beenken KE, 2012, INFECT IMMUN; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Blevins JS, 1999, MOL MICROBIOL, V33, P317, DOI 10.1046/j.1365-2958.1999.01475.x; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Casillas-Ituarte NN, 2012, J BIOL CHEM, V287, P6693, DOI 10.1074/jbc.M111.285692; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Cierny G, 2011, PLAST RECONSTR SURG, V127, p190S, DOI 10.1097/PRS.0b013e3182025070; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Nagarajan V, 2009, FEMS MICROBIOL LETT, V295, P204, DOI 10.1111/j.1574-6968.2009.01595.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Schafer D, 2009, J BACTERIOL, V191, P7306, DOI 10.1128/JB.00630-09; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	35	61	63	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38453	10.1371/journal.pone.0038453	http://dx.doi.org/10.1371/journal.pone.0038453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685571	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700034
J	Tian, LC; Lei, B; Shao, J; Wei, L; Kijlstra, A; Yang, PZ				Tian, Lichun; Lei, Bo; Shao, Ju; Wei, Lin; Kijlstra, Aize; Yang, Peizeng			AAV2-Mediated Combined Subretinal Delivery of IFN-alpha and IL-4 Reduces the Severity of Experimental Autoimmune Uveoretinitis	PLOS ONE			English	Article							REGULATORY T-CELLS; ADENOASSOCIATED VIRUS; GENE-TRANSFER; THERAPY; UVEITIS; RECEPTOR; CYTOKINES; PREVENTS; EFFICACY; SAFETY	We previously showed that adeno-associated virus 2 (AAV2) mediated subretinal delivery of human interferon-alpha (IFN-alpha) could effectively inhibit experimental autoimmune uveoretinitis (EAU). In this study we investigated whether subretinal injection of both AVV2. IFN-alpha and AAV2. IL-4 had a stronger inhibition on EAU activity. B10RIII mice were subretinally injected with AAV2. IFN-alpha alone (1.5x10(7) vg), AAV2. IL-4 alone (3.55x10(7) vg), and AAV2. IFN-alpha combined with AAV2. IL-4. PBS, AAV2 vector encoding green fluorescent protein (AAV2. GFP) (5x10(7) vg) was subretinally injected as a control. IFN-alpha and IL-4 were effectively expressed in the eyes from three weeks to three months following subretinal injection of AAV2 vectors either alone or following combined administration and significantly attenuated EAU activity clinically and histopathologically. AAV2. IL-4 showed a better therapeutic effect as compared to AAV2. IFN-alpha. The combination of AAV2. IL-4 and AAV2. IFN-alpha was not significantly different as compared to AAV2. IL-4 alone. There was no difference concerning DTH (delayed-type hypersensitivity) reaction, lymphocyte proliferation and IL-17 production among the investigated treatment groups, suggesting that local retinal gene delivery did not affect the systemic immune response.	[Tian, Lichun; Lei, Bo; Shao, Ju; Wei, Lin; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Tian, Lichun; Lei, Bo; Shao, Ju; Wei, Lin; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Tian, Lichun] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013	Lei, Bo/0000-0002-5497-0905	Key Project of Medical Science and Technology of Chongqing; Key Project of Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Natural Science Foundation Major International (Regional) Joint Research Project [30910103912]; National Natural Science Foundation Project [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; PAR-EU Scholars Program	Key Project of Medical Science and Technology of Chongqing; Key Project of Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Natural Science Foundation Major International (Regional) Joint Research Project; National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; PAR-EU Scholars Program	This study was supported by the funds of Key Project of Medical Science and Technology of Chongqing, Key Project of Health Bureau of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC,2008CA5003), Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), National Natural Science Foundation Project (30973242), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Broderick CA, 2005, MOL THER, V12, P369, DOI 10.1016/j.ymthe.2005.03.018; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Cottard V, 2000, GENE THER, V7, P1930, DOI 10.1038/sj.gt.3301324; Dick AD, 1997, BRIT J OPHTHALMOL, V81, P1107, DOI 10.1136/bjo.81.12.1107; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; Goldstein H, 1980, ADV OPHTHALMOL, V40, P1; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Gueudry J, 2008, AM J OPHTHALMOL, V146, P837, DOI 10.1016/j.ajo.2008.08.038; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kosar A, 1999, RHEUMATOL INT, V19, P11, DOI 10.1007/s002960050091; Kotter I, 1998, BRIT J OPHTHALMOL, V82, P488, DOI 10.1136/bjo.82.5.488; Lei B, 2009, MOL VIS, V15, P1374; Mackensen F, 2011, OPHTHALMOLOGE, V108, P213, DOI 10.1007/s00347-010-2260-2; Mackensen F, 2009, CLIN OPHTHALMOL, V3, P559; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Rehman KK, 2008, MOL THER, V16, P1409, DOI 10.1038/mt.2008.116; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Tian LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019542; Trittibach P, 2008, GENE THER, V15, P1478, DOI 10.1038/gt.2008.109; WACKER WB, 1965, NATURE, V206, P253, DOI 10.1038/206253a0; Wang W, 2008, CLIN CANCER RES, V14, P8314, DOI 10.1158/1078-0432.CCR-08-0705; Yang DSF, 2008, BRIT J HOSP MED, V69, P575, DOI 10.12968/hmed.2008.69.10.31317	32	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37995	10.1371/journal.pone.0037995	http://dx.doi.org/10.1371/journal.pone.0037995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685550	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700013
J	Nadler, C; Koby, S; Peleg, A; Johnson, AC; Suddala, KC; Sathiyamoorthy, K; Smith, BE; Saper, MA; Rosenshine, I				Nadler, Chen; Koby, Simi; Peleg, Adi; Johnson, Austin C.; Suddala, Krishna C.; Sathiyamoorthy, Karthik; Smith, Bennett E.; Saper, Mark A.; Rosenshine, Ilan			Cycling of Etk and Etp Phosphorylation States Is Involved in Formation of Group 4 Capsule by Escherichia coli	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GRAM-NEGATIVE BACTERIA; POLYSACCHARIDE EXPORT; KINASE WZC; EXOPOLYSACCHARIDE; IDENTIFICATION; MECHANISM; REVEALS	Capsules frequently play a key role in bacterial interactions with their environment. Escherichia coli capsules were categorized as groups 1 through 4, each produced by a distinct mechanism. Etk and Etp are members of protein families required for the production of group 1 and group 4 capsules. These members function as a protein tyrosine kinase and protein tyrosine phosphatase, respectively. We show that Etp dephosphorylates Etk in vivo, and mutations rendering Etk or Etp catalytically inactive result in loss of group 4 capsule production, supporting the notion that cyclic phosphorylation and dephosphorylation of Etk is required for capsule formation. Notably, Etp also becomes tyrosine phosphorylated in vivo and catalyzes rapid auto-dephosphorylation. Further analysis identified Tyr121 as the phosphorylated residue of Etp. Etp containing Phe, Glu or Ala in place of Tyr121 retained phosphatase activity and catalyzed dephosphorylation of Etp and Etk. Although EtpY121E and EtpY121A still supported capsule formation, EtpY121F failed to do so. These results suggest that cycles of phosphorylation and dephosphorylation of Etp, as well as Etk, are involved in the formation of group 4 capsule, providing an additional regulatory layer to the complex control of capsule production.	[Nadler, Chen; Koby, Simi; Peleg, Adi; Rosenshine, Ilan] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Johnson, Austin C.; Suddala, Krishna C.; Sathiyamoorthy, Karthik] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Smith, Bennett E.; Saper, Mark A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Hebrew University of Jerusalem; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nadler, C (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	saper@umich.edu; ilanr@ekmd.huji.ac.il	Sathiyamoorthy, Karthik/K-6190-2015; Suddala, Krishna Chaitanya/I-2545-2019	Sathiyamoorthy, Karthik/0000-0002-5736-8709; Suddala, Krishna Chaitanya/0000-0003-1597-2622	United States-Israel Binational Science Foundation; Abisch-Frenkel Foundation; Israel Academy of Science and Humanities; National Institute of Allergy and Infectious Disease, National Institutes of Health [R21AI088543]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088543] Funding Source: NIH RePORTER	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Abisch-Frenkel Foundation; Israel Academy of Science and Humanities; National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States-Israel Binational Science Foundation (to I. R. and M. A. S.), the Abisch-Frenkel Foundation (to C.N. and I. R.), and the Israel Academy of Science and Humanities (I. R.). Partial support was provided by grant R21AI088543 (M. A. S.) from the National Institute of Allergy and Infectious Disease, National Institutes of Health. I. R. is the Etta Rosensohn Professor of Bacteriology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Blobel J, 2009, FEBS J, V276, P4346, DOI 10.1111/j.1742-4658.2009.07139.x; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; LEVINE MM, 1978, LANCET, V1, P1119; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Rigacci S, 1996, J BIOL CHEM, V271, P1278, DOI 10.1074/jbc.271.3.1278; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Schwarzer D, 2006, J AM CHEM SOC, V128, P4192, DOI 10.1021/ja0585174; Shifrin Y, 2008, J BACTERIOL, V190, P5063, DOI 10.1128/JB.00440-08; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200	24	69	70	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37984	10.1371/journal.pone.0037984	http://dx.doi.org/10.1371/journal.pone.0037984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675501	Green Published, gold			2022-12-25	WOS:000305341700030
J	Tome, HVV; Martins, GF; Lima, MAP; Campos, LAO; Guedes, RNC				Tome, Hudson Vaner V.; Martins, Gustavo F.; Lima, Maria Augusta P.; Campos, Lucio Antonio O.; Guedes, Raul Narciso C.			Imidacloprid-Induced Impairment of Mushroom Bodies and Behavior of the Native Stingless Bee Melipona quadrifasciata anthidioides	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; NEONICOTINOID INSECTICIDES; LEARNING PERFORMANCES; RISK-ASSESSMENT; COLONY LOSSES; PESTICIDES; HYMENOPTERA; TOXICITY; BRAIN; POLLINATION	Declines in pollinator colonies represent a worldwide concern. The widespread use of agricultural pesticides is recognized as a potential cause of these declines. Previous studies have examined the effects of neonicotinoid insecticides such as imidacloprid on pollinator colonies, but these investigations have mainly focused on adult honey bees. Native stingless bees (Hymenoptera: Apidae: Meliponinae) are key pollinators in neotropical areas and are threatened with extinction due to deforestation and pesticide use. Few studies have directly investigated the effects of pesticides on these pollinators. Furthermore, the existing impact studies did not address the issue of larval ingestion of contaminated pollen and nectar, which could potentially have dire consequences for the colony. Here, we assessed the effects of imidacloprid ingestion by stingless bee larvae on their survival, development, neuromorphology and adult walking behavior. Increasing doses of imidacloprid were added to the diet provided to individual worker larvae of the stingless bee Melipona quadrifasciata anthidioides throughout their development. Survival rates above 50% were only observed at insecticide doses lower than 0.0056 mu g active ingredient (a.i.)/bee. No sublethal effect on body mass or developmental time was observed in the surviving insects, but the pesticide treatment negatively affected the development of mushroom bodies in the brain and impaired the walking behavior of newly emerged adult workers. Therefore, stingless bee larvae are particularly susceptible to imidacloprid, as it caused both high mortality and sublethal effects that impaired brain development and compromised mobility at the young adult stage. These findings demonstrate the lethal effects of imidacloprid on native stingless bees and provide evidence of novel serious sublethal effects that may compromise colony survival. The ecological and economic importance of neotropical stingless bees as pollinators, their susceptibility to insecticides and the vulnerability of their larvae to insecticide exposure emphasize the importance of studying these species.	[Tome, Hudson Vaner V.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Martins, Gustavo F.; Campos, Lucio Antonio O.] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Lima, Maria Augusta P.] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Tome, HVV (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Lima, Maria Augusta P./F-9038-2012; Tomé, Hudson V.V./E-6957-2014; Serrano, Jose/A-2854-2009; Martins, Gustavo Ferreira/AAL-7744-2020; Guedes, Raul Narciso Carvalho/L-3924-2013; Martins, Gustavo F/L-9107-2015	Serrano, Jose/0000-0002-1565-5216; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Martins, Gustavo F/0000-0003-0614-8551; Pereira Lima, Maria Augusta/0000-0002-7044-7671	Minas Gerais State Foundation for Research Aid; National Council of Scientific and Technological Development (CNPq - PQ); CAPES Foundation [AUX PE - PROEX 191/2009]	Minas Gerais State Foundation for Research Aid; National Council of Scientific and Technological Development (CNPq - PQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by awards from the Minas Gerais State Foundation for Research Aid, the National Council of Scientific and Technological Development (CNPq - PQ) and the CAPES Foundation (AUX PE - PROEX 191/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; [Anonymous], SAS STAT US GUID V8; Antonini Y., 2006, Braz. J. Biol., V66, P463, DOI 10.1590/S1519-69842006000300012; Armengaud C, 2000, BRAIN RES, V859, P390, DOI 10.1016/S0006-8993(00)02016-3; ATKINS EL, 1986, J APICULT RES, V25, P242, DOI 10.1080/00218839.1986.11100725; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; dos Santos SAB, 2009, GENET MOL RES, V8, P751; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Brittain CA, 2010, BASIC APPL ECOL, V11, P106, DOI 10.1016/j.baae.2009.11.007; Brodsgaard HF, 2003, APIDOLOGIE, V34, P139, DOI 10.1051/apido:2003003; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Casida JE, 2004, J PESTIC SCI, V29, P81, DOI 10.1584/jpestics.29.81; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cra-Api, 2009, REL SULL SVOLT PRIM; Croft B. A., 1990, ARTHROPOD BIOL CONTR; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; DERUIJTER A, 1987, APIDOLOGIE, V18, P356; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Goldberg B, 1999, J PHYSL, V514, P759; Guez D, 2001, NEUROBIOL LEARN MEM, V76, P183, DOI 10.1006/nlme.2000.3995; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Koch H, 1997, APIDOLOGIE, V28, P439, DOI 10.1051/apido:19970610; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; MACIEIRA OJD, 1989, J APICULT RES, V28, P3, DOI 10.1080/00218839.1989.11100813; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Malun D, 2002, J NEUROBIOL, V50, P31, DOI 10.1002/neu.10015; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; MENZEL R, 1993, APIDOLOGIE, V24, P157, DOI 10.1051/apido:19930301; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Michener C.D., 2000, BEES WORLD, V1st; Ministerio da Agricultura Pecuaria e Abastecimento, 2011, AGROFIT SIST AGR FIT; Mizunami Makoto, 1993, P199; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Moo-Valle H, 2004, APIDOLOGIE, V35, P587, DOI 10.1051/apido:2004054; Moraes Simone S., 2000, Anais da Sociedade Entomologica do Brasil, V29, P31, DOI 10.1590/S0301-80592000000100004; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; [NRC] National Research Council, 2006, STAT POLL N AM; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Valdovinos-Nunez GR, 2009, J ECON ENTOMOL, V102, P1737, DOI 10.1603/029.102.0502; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sigg D, 1997, J NEUROSCI, V17, P7148; Siqueira MAL, 2008, THESIS U FEDERAL VIC; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Waldschmidt AM, 1995, THESIS U FEDERAL VIC; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	84	87	89	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38406	10.1371/journal.pone.0038406	http://dx.doi.org/10.1371/journal.pone.0038406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675559	Green Published, gold			2022-12-25	WOS:000305341700071
J	Wali, RK; Kunte, DP; De La Cruz, M; Tiwari, AK; Brasky, J; Weber, CR; Gibson, TP; Patel, A; Savkovic, SD; Brockstein, BE; Roy, HK				Wali, Ramesh K.; Kunte, Dhananjay P.; De La Cruz, Mart; Tiwari, Ashish K.; Brasky, Jeffrey; Weber, Christopher R.; Gibson, Tina P.; Patel, Amir; Savkovic, Suzana D.; Brockstein, Bruce E.; Roy, Hemant K.			Topical Polyethylene Glycol as a Novel Chemopreventive Agent for Oral Cancer via Targeting of Epidermal Growth Factor Response	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR EXPRESSION; TRANS-RETINOIC ACID; COLON CARCINOGENESIS; MOLECULAR-BIOLOGY; HIGH-RISK; PHASE-II; HEAD; TRIAL; INHIBITION	Head and neck squamous cell carcinoma (HNSCC) is a major cause of morbidity and mortality underscoring the need for safe and effective chemopreventive strategies. Targeting epidermal growth factor receptor (EGFR) is attractive in that it is an early critical event in HNSCC pathogenesis. However, current agents lack efficacy or have unacceptable toxicity. Several groups have demonstrated that the over-the-counter medication, polyethylene glycol (PEG) has remarkable chemopreventive efficacy against colon carcinogenesis. Importantly, we reported that this effect is mediated through EGFR internalization/degradation. In the current study, we investigated the chemopreventive efficacy of this agent against HNSCC, using both the well validated animal model 4-NQO (4-nitroquinoline 1-oxide) rat model and cell culture with the human HNSCC cell line SCC-25. We demonstrated that daily topical application of 10% PEG-8000 in the oral cavity (tongue and cavity wall) post 4NQO initiation resulted in a significant reduction in tumor burden (both, tumor size and tumors/tumor bearing rat) without any evidence of toxicity. Immunohistochemical studies depicted decreased proliferation (number of Ki67-positive cells) and reduced expression of EGFR and its downstream effectors cyclin D1 in the tongue mucosa of 4NQO-rats treated with PEG. We showed that EGFR was also markedly downregulated in SCC-25 cells by PEG-8000 with a concomitant induction of G1-S phase cell-cycle arrest, which was potentially mediated through upregulated p21(cip1/waf1). In conclusion, we demonstrate, for the first time, that PEG has promising efficacy and safety as a chemopreventive efficacy against oral carcinogenesis.	[Wali, Ramesh K.; Kunte, Dhananjay P.; De La Cruz, Mart; Tiwari, Ashish K.; Brasky, Jeffrey; Gibson, Tina P.; Patel, Amir; Savkovic, Suzana D.; Brockstein, Bruce E.; Roy, Hemant K.] NorthShore Univ Healthsyst, Dept Med, Evanston, IL USA; [Weber, Christopher R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	NorthShore University Health System; University of Chicago	Wali, RK (corresponding author), NorthShore Univ Healthsyst, Dept Med, Evanston, IL USA.	rwali@northshore.org	Roy, Hemant/AAC-9096-2020	Weber, Christopher/0000-0002-2117-3184	National Institute of Health [U01CA111257, R21CA141112, 1R21CA156944-01, RO3CA139528, RO1CA156186]; NATIONAL CANCER INSTITUTE [R21CA141112, R01CA156186, R21CA156944, U01CA111257, R03CA139528] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institute of Health U01CA111257, R21CA141112, 1R21CA156944-01, RO3CA139528, RO1CA156186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE; Benchekroun MT, 2010, CANCER PREV RES, V3, P800, DOI 10.1158/1940-6207.CAPR-09-0163; Chang SS, 2008, J SURG ONCOL, V97, P640, DOI 10.1002/jso.21023; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Choi Y, 2003, INT J CANCER, V107, P145, DOI 10.1002/ijc.11354; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Corpet DE, 1999, CARCINOGENESIS, V20, P915, DOI 10.1093/carcin/20.5.915; Corpet DE, 2000, CANCER RES, V60, P3160; Dannenberg AJ, 2001, ANN NY ACAD SCI, V952, P109, DOI 10.1111/j.1749-6632.2001.tb02731.x; Dorval E, 2006, GASTROEN CLIN BIOL, V30, P1196, DOI 10.1016/S0399-8320(06)73511-4; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gu XB, 2008, CLIN CANCER RES, V14, P1840, DOI 10.1158/1078-0432.CCR-07-1811; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; Lee JJ, 2000, CLIN CANCER RES, V6, P1702; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Long NK, 2007, ONCOL REP, V17, P879; Mallery SR, 2008, CANCER RES, V68, P4945, DOI 10.1158/0008-5472.CAN-08-0568; Mulshine JL, 2004, CLIN CANCER RES, V10, P1565, DOI 10.1158/1078-0432.CCR-1020-3; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Papaclimitrakopoulou VA, 2008, CLIN CANCER RES, V14, P2095, DOI 10.1158/1078-0432.CCR-07-4024; Papadimitrakopoulou VA, 2009, J CLIN ONCOL, V27, P599, DOI 10.1200/JCO.2008.17.1850; Park K, 2005, J CONTROL RELEASE, V104, P167, DOI 10.1016/j.jconrel.2005.01.013; Parnaud G, 2001, INT J CANCER, V92, P63, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1158>3.3.CO;2-#; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Putti TC, 2002, HISTOPATHOLOGY, V41, P144, DOI 10.1046/j.1365-2559.2002.01436.x; Roesch-Ely M, 2010, J PATHOL, V221, P462, DOI 10.1002/path.2726; Rosin MP, 2010, CANCER PREV RES, V3, P797, DOI 10.1158/1940-6207.CAPR-10-0114; Roy HK, 2006, MOL CANCER THER, V5, P2060, DOI 10.1158/1535-7163.MCT-06-0054; Roy HK, 2011, INT J ONCOL, V38, P529, DOI 10.3892/ijo.2010.875; Roy HK, 2004, CANCER LETT, V215, P35, DOI 10.1016/j.canlet.2004.05.012; SHIN DM, 1994, CANCER RES, V54, P3153; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tanaka T, 2011, PATHOLOG RES INT; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Wali RK, 2008, MOL CANCER THER, V7, P3103, DOI 10.1158/1535-7163.MCT-08-0434	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38047	10.1371/journal.pone.0038047	http://dx.doi.org/10.1371/journal.pone.0038047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675506	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700035
J	Czernik, C; Rhode, S; Metze, B; Schmalisch, G; Buhrer, C				Czernik, Christoph; Rhode, Stefanie; Metze, Boris; Schmalisch, Gerd; Buehrer, Christoph			Persistently Elevated Right Ventricular Index of Myocardial Performance in Preterm Infants with Incipient Bronchopulmonary Dysplasia	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; CONGENITAL HEART-DISEASE; DOPPLER ASSESSMENT; NORMAL-CHILDREN; TEI-INDEX; ECHOCARDIOGRAPHY; CIRCULATION; PRESSURE; DAMAGE	Objectives: Elevated pulmonary vascular resistance occurs during the first days after birth in all newborn infants and persists in infants at risk for bronchopulmonary dysplasia (BPD). It is difficult to measure in a non-invasive fashion. We assessed the usefulness of the right ventricular index of myocardial performance (RIMP) to estimate pulmonary vascular resistance in very low birth weight infants. Study Design: Prospective echocardiography on day of life (DOL) 2, 7, 14, and 28 in 121 preterm infants (median [quartiles] gestational age 28 [26-29] weeks, birth weight 998 [743-1225] g) of whom 36 developed BPD (oxygen supplementation at 36 postmenstrual weeks). Results: RIMP derived by conventional pulsed Doppler technique was unrelated to heart rate or mean blood pressure. RIMP on DOL 2 was similar in infants who subsequently did (0.39 [0.33-0.55]) and did not develop BPD (0.39 [0.28-0.51], p = 0.467). RIMP declined steadily in non-BPD infants but not in BPD infants (DOL 7: 0.31[0.22-0.39] vs. 0.35[0.29-0.48], p = 0.014; DOL 14: 0.23[0.17-0.30] vs. 0.35[0.25-0.43], p<0.001; DOL 28: 0.21[0.15-0.28] vs. 0.31 [0.21-0.35], p = 0.015). Conclusions: In preterm infants, a decline in RIMP after birth was not observed in those with incipient BPD. The pattern of RIMP measured in preterm infants is commensurate with that of pulmonary vascular resistance.	[Czernik, Christoph; Rhode, Stefanie; Metze, Boris; Schmalisch, Gerd; Buehrer, Christoph] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Czernik, C (corresponding author), Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany.	christoph.czernik@charite.de		Metze, Boris/0000-0001-8864-1969				Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Blanchard DG, 2009, JACC-CARDIOVASC IMAG, V2, P143, DOI 10.1016/j.jcmg.2008.10.012; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Eidem BW, 1998, J AM SOC ECHOCARDIOG, V11, P849, DOI 10.1016/S0894-7317(98)70004-5; Eto GY, 1999, J AM SOC ECHOCARDIOG, V12, P1058, DOI 10.1016/S0894-7317(99)70102-1; Filbrun AG, 2011, PEDIATR PULM, V46, P369, DOI 10.1002/ppul.21378; Gao YS, 2010, PHYSIOL REV, V90, P1291, DOI 10.1152/physrev.00032.2009; HARADA K, 1995, AM J CARDIOL, V76, P634, DOI 10.1016/S0002-9149(99)80175-1; HISLOP AA, 1990, PEDIATR PULM, V9, P152, DOI 10.1002/ppul.1950090306; Horton KD, 2009, J AM SOC ECHOCARDIOG, V22, P776, DOI 10.1016/j.echo.2009.04.027; Huez S, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-9; Ishii M, 2000, PEDIATR CARDIOL, V21, P416, DOI 10.1007/s002460010100; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kozak-Barany A, 2001, J PEDIATR-US, V139, P539, DOI 10.1067/mpd.2001.118199; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Melek M, 2006, ECHOCARDIOGR-J CARD, V23, P120, DOI 10.1111/j.1540-8175.2006.00180.x; Mourani PM, 2004, AM J RESP CRIT CARE, V170, P1006, DOI 10.1164/rccm.200310-1483oc; Murase M, 2000, PEDIATR CARDIOL, V21, P452, DOI 10.1007/s002460010107; Murase M, 2009, PEDIATR CARDIOL, V30, P928, DOI 10.1007/s00246-009-9464-8; Sahni Rakesh, 2005, J Perinatol, V25, P41, DOI 10.1038/sj.jp.7211210; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Su BH, 1997, ARCH DIS CHILD-FETAL, V77, pF23, DOI 10.1136/fn.77.1.F23; Sugiura T, 2003, PEDIATR RES, V53, P927, DOI 10.1203/01.PDR.0000061540.81669.2A; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Tsutsumi T, 1999, PEDIATR INT, V41, P722, DOI 10.1046/j.1442-200x.1999.01155.x; Vonk MC, 2007, EUR J ECHOCARDIOGR, V8, P317, DOI 10.1016/j.euje.2006.06.002; Yates AR, 2008, J PEDIATR-US, V152, P766, DOI 10.1016/j.jpeds.2007.11.039; Yeo TC, 1998, AM J CARDIOL, V81, P1157, DOI 10.1016/S0002-9149(98)00140-4	32	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38352	10.1371/journal.pone.0038352	http://dx.doi.org/10.1371/journal.pone.0038352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675548	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900025
J	Bates, JG; Salzman, J; May, D; Garcia, PB; Hogan, GJ; McIntosh, M; Schlissel, MS; Brown, PO				Bates, Jamie G.; Salzman, Julia; May, Damon; Garcia, Patty B.; Hogan, Gregory J.; McIntosh, Martin; Schlissel, Mark S.; Brown, Pat O.			Extensive Gene-Specific Translational Reprogramming in a Model of B Cell Differentiation and Abl-Dependent Transformation	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; PHILADELPHIA-CHROMOSOME; TYROSINE KINASE; HEMATOPOIETIC-CELLS; STATISTICAL-MODEL; INTEGRIN FUNCTION; MAMMALIAN TARGET; BINDING-PROTEIN; IN-VIVO	To what extent might the regulation of translation contribute to differentiation programs, or to the molecular pathogenesis of cancer? Pre-B cells transformed with the viral oncogene v-Abl are suspended in an immortalized, cycling state that mimics leukemias with a BCR-ABL1 translocation, such as Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Inhibition of the oncogenic Abl kinase with imatinib reverses transformation, allowing progression to the next stage of B cell development. We employed a genome-wide polysome profiling assay called Gradient Encoding to investigate the extent and potential contribution of translational regulation to transformation and differentiation in v-Abl-transformed pre-B cells. Over half of the significantly translationally regulated genes did not change significantly at the level of mRNA abundance, revealing biology that might have been missed by measuring changes in transcript abundance alone. We found extensive, gene-specific changes in translation affecting genes with known roles in B cell signaling and differentiation, cancerous transformation, and cytoskeletal reorganization potentially affecting adhesion. These results highlight a major role for gene-specific translational regulation in remodeling the gene expression program in differentiation and malignant transformation.	[Bates, Jamie G.; Salzman, Julia; Hogan, Gregory J.; Brown, Pat O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Bates, Jamie G.; Salzman, Julia; Hogan, Gregory J.; Brown, Pat O.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [May, Damon; McIntosh, Martin] Fred Hutchinson Canc Res Ctr, Computat Prote Lab, Seattle, WA 98104 USA; [Garcia, Patty B.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Fred Hutchinson Cancer Center; University of California System; University of California Berkeley	Bates, JG (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@stanford.edu		May, Damon/0000-0001-6902-3153	PHS by the National Cancer Institute DHHS [T32 CA09151]; National Cancer Institute [CA07797]; National Institutes of Health (NIH) [RO1CA111487, RO1HL48702, RO1CA150974]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA111487, T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER	PHS by the National Cancer Institute DHHS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JGB acknowledges PHS Grant Number T32 CA09151, awarded by the National Cancer Institute DHHS. POB acknowledges National Cancer Institute grant CA07797, National Institutes of Health (NIH) grant RO1CA111487, and the Howard Hughes Medical Institute. POB is an investigator of the Howard Hughes Medical Institute. MSS acknowledges NIH grants RO1HL48702 and RO1CA150974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON HT, 1970, CANCER RES, V30, P2213; An WG, 2000, CELL GROWTH DIFFER, V11, P355; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Bazzoni G, 1996, J CLIN INVEST, V98, P521, DOI 10.1172/JCI118820; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Goebel P, 2002, J IMMUNOL, V169, P2477, DOI 10.4049/jimmunol.169.5.2477; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Green M, 2009, LEUKEMIA RES, V33, P731, DOI 10.1016/j.leukres.2008.09.007; Hakansson P, 2004, EXP HEMATOL, V32, P476, DOI 10.1016/j.exphem.2004.02.012; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hsieh AC, 2012, NATURE; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hu JS, 2008, FRONT BIOSCI-LANDMRK, V13, P7123, DOI 10.2741/3215; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Jongen-Lavrencic M, 2005, LEUKEMIA, V19, P373, DOI 10.1038/sj.leu.2403626; KANTARJIAN HM, 1993, BLOOD, V82, P691; Kaul-Ghanekar R, 2004, NUCLEIC ACIDS RES, V32, P4862, DOI 10.1093/nar/gkh807; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Klein F, 2004, J EXP MED, V199, P673, DOI 10.1084/jem.20031637; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Lundell BI, 1996, BLOOD, V87, P2450, DOI 10.1182/blood.V87.6.2450.bloodjournal8762450; Lundell BI, 1997, LEUKEMIA, V11, P822, DOI 10.1038/sj.leu.2400653; Ly C, 2003, CANCER RES, V63, P5716; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; May D, 2009, J PROTEOME RES, V8, P3212, DOI 10.1021/pr900169w; Mayne M, 2004, EUR J IMMUNOL, V34, P1217, DOI 10.1002/eji.200324726; Mcgee AM, 2011, BIOCHEM J, V433, P119, DOI 10.1042/BJ20101431; Meng XB, 2007, J PROTEOME RES, V6, P744, DOI 10.1021/pr060382t; Meric F, 2002, MOL CANCER THER, V1, P971; Miller SL, 2007, ONCOGENE, V26, P4668, DOI 10.1038/sj.onc.1210264; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; NOWELL PC, 1960, SCIENCE, V132, P1497; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Perrotti D, 2004, ONCOGENE, V23, P3222, DOI 10.1038/sj.onc.1207543; Perrotti D, 2002, ONCOGENE, V21, P8577, DOI 10.1038/sj.onc.1206085; Prabhu S, 2007, ONCOGENE, V26, P1188, DOI 10.1038/sj.onc.1209901; Psatha MI, 2007, CELL CALCIUM, V41, P593, DOI 10.1016/j.ceca.2006.10.009; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Salesse S, 2002, ONCOGENE, V21, P8605, DOI 10.1038/sj.onc.1206088; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Seipel K, 2001, J CELL SCI, V114, P389; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SKLAR MD, 1975, NATURE, V253, P550, DOI 10.1038/253550a0; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Wang Y, 2010, ONCOGENE, V29, P3044, DOI 10.1038/onc.2010.78; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wang ZY, 1999, MOL CELL BIOL, V19, P284; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08	105	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37108	10.1371/journal.pone.0037108	http://dx.doi.org/10.1371/journal.pone.0037108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693568	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500030
J	Fu, LZ; Sun, GH; Fiorentino, M; Shi, YB				Fu, Liezhen; Sun, Guihong; Fiorentino, Maria; Shi, Yun-Bo			Characterization of Xenopus Tissue Inhibitor of Metalloproteinases-2: A Role in Regulating Matrix Metalloproteinase Activity during Development	PLOS ONE			English	Article							DUPLICATED MATRIX-METALLOPROTEINASE-9 GENES; IMPLICATES DISTINCT FUNCTIONS; HORMONE RESPONSE GENES; THYROID-HORMONE; AMPHIBIAN METAMORPHOSIS; TRANSCRIPTIONAL REGULATION; ANURAN METAMORPHOSIS; EXPRESSION PROFILES; STROMELYSIN-3 GENE; FROG METAMORPHOSIS	Background: Frog metamorphosis is totally dependent on thyroid hormone (T3) and mimics the postembryonic period around birth in mammals. It is an excellent model to study the molecular basis of postembryonic development in vertebrate. We and others have shown that many, if not all, matrix metalloproteinases (MMPs), which cleave proteins of the extracellular matrix as well as other substrates, are induced by T3 and important for metamorphosis. MMP activity can be inhibited by tissue inhibitors of metalloproteinase (TIMPs). There are 4 TIMPs in vertebrates and their roles in postembryonic development are poorly studied. Methodology/Principal Findings: We analyzed the TIMP2 genes in Xenopus laevis and the highly related species Xenopus tropicalis and discovered that TIMP2 is a single copy gene in Xenopus tropicalis as in mammals but is duplicated in Xenopus laevis. Furthermore, the TIMP2 locus in Xenopus tropicalis genome is different from that in human, suggesting an evolutionary reorganization of the locus. More importantly, we found that the duplicated TIMP2 genes were similarly regulated in the developing limb, remodeling intestine, resorbing tail during metamorphosis. Unexpectedly, like its MMP target genes, the TIMP2 genes were upregulated by T3 during both natural and T3-induced metamorphosis. Conclusions/Significance: Our results indicate that TIMP2 is highly conserved among vertebrates and that the TIMP2 locus underwent a chromosomal reorganization during evolution. Furthermore, the unexpected upregulation of TIMP2 genes during metamorphosis suggests that proper balance of MMP activity is important for metamorphosis.	[Fu, Liezhen; Sun, Guihong; Fiorentino, Maria; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA; [Sun, Guihong] Wuhan Univ, Sch Med, Key Lab Allergy & Immune Related Dis, Wuhan 430072, Peoples R China; [Sun, Guihong] Wuhan Univ, Sch Med, Med Res Ctr, Wuhan 430072, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wuhan University; Wuhan University	Fu, LZ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA.	Shi@helix.nih.gov	Fiorentino, Maria/AAV-9514-2020	Fiorentino, Maria R/0000-0001-5318-7313; Shi, Yun-Bo/0000-0002-6330-0639	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; Amano T, 2005, CELL RES, V15, P150, DOI 10.1038/sj.cr.7290280; BARRETT J, 1998, HDB PROTEOLYTIC ENZY; Berry DL, 1998, DEV BIOL, V203, P12, DOI 10.1006/dbio.1998.8974; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Damjanovski S, 2000, FASEB J, V14, P503, DOI 10.1096/fasebj.14.3.503; Damjanovski S, 2001, DEV DYNAM, V221, P37, DOI 10.1002/dvdy.1123; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Fu Liezhen, 2007, Organogenesis, V3, P14; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fujimoto K, 2006, DEV GROWTH DIFFER, V48, P223, DOI 10.1111/j.1440-169x.2006.00859.x; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Hammoud L, 2006, BIOCHEM CELL BIOL, V84, P167, DOI 10.1139/O05-175; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hasebe T, 2007, DEV DYNAM, V236, P2338, DOI 10.1002/dvdy.21252; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; IshizuyaOka A, 1996, CELL TISSUE RES, V283, P325, DOI 10.1007/s004410050542; Jung JC, 2002, DEV DYNAM, V223, P402, DOI 10.1002/dvdy.10069; Li JW, 1998, NUCLEIC ACIDS RES, V26, P3018, DOI 10.1093/nar/26.12.3018; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1998, Cell Res, V8, P179; Noel A, 2000, ONCOGENE, V19, P1605, DOI 10.1038/sj.onc.1203465; Oofusa K, 1996, ROUX ARCH DEV BIOL, V205, P243, DOI 10.1007/BF00365802; OOFUSA K, 1994, INT J DEV BIOL, V38, P345; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; Sato H, 1996, J BIOCHEM-TOKYO, V119, P209; Seiki M, 1999, APMIS, V107, P137, DOI 10.1111/j.1699-0463.1999.tb01536.x; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, CELL RES, V11, P245, DOI 10.1038/sj.cr.7290093; Shi YB, 1998, INT J MOL MED, V2, P273; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Stolow MA, 1996, MOL BIOL CELL, V7, P1471, DOI 10.1091/mbc.7.10.1471; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walsh LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001000; WANG Z, 1993, J BIOL CHEM, V268, P16270; Werb Z, 1996, KIDNEY INT, V49, pS68; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	57	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36707	10.1371/journal.pone.0036707	http://dx.doi.org/10.1371/journal.pone.0036707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693555	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500016
J	Shanmugam, NKN; Ellenbogen, S; Trebicka, E; Wang, LJ; Mukhopadhyay, S; Lacy-Hulbert, A; Gallini, CA; Garrett, WS; Cherayil, BJ				Shanmugam, Nanda Kumar N.; Ellenbogen, Shiri; Trebicka, Estela; Wang, Lijian; Mukhopadhyay, Subhankar; Lacy-Hulbert, Adam; Gallini, Carey Ann; Garrett, Wendy S.; Cherayil, Bobby J.			Tumor Necrosis Factor alpha Inhibits Expression of the Iron Regulating Hormone Hepcidin in Murine Models of Innate Colitis	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; ULCERATIVE-COLITIS; IN-VIVO; INFLAMMATION; HFE; DISEASE; GROWTH; STAT3; MACROPHAGES; HOMEOSTASIS	Background: Abnormal expression of the liver peptide hormone hepcidin, a key regulator of iron homeostasis, contributes to the pathogenesis of anemia in conditions such as inflammatory bowel disease (IBD). Since little is known about the mechanisms that control hepcidin expression during states of intestinal inflammation, we sought to shed light on this issue using mouse models. Methodology/Principal Findings: Hepcidin expression was evaluated in two types of intestinal inflammation caused by innate immune activation-dextran sulfate sodium (DSS)-induced colitis in wild-type mice and the spontaneous colitis occurring in T-bet/Rag2-deficient (TRUC) mice. The role of tumor necrosis factor (TNF) alpha was investigated by in vivo neutralization, and by treatment of a hepatocyte cell line, as well as mice, with the recombinant cytokine. Expression and activation of Smad1, a positive regulator of hepcidin transcription, were assessed during colitis and following administration or neutralization of TNF alpha. Hepcidin expression progressively decreased with time during DSS colitis, correlating with changes in systemic iron distribution. TNF alpha inhibited hepcidin expression in cultured hepatocytes and non-colitic mice, while TNF alpha neutralization during DSS colitis increased it. Similar results were obtained in TRUC mice. These effects involved a TNF alpha-dependent decrease in Smad1 protein but not mRNA. Conclusions/Significance: TNF alpha inhibits hepcidin expression in two distinct types of innate colitis, with down-regulation of Smad1 protein playing an important role in this process. This inhibitory effect of TNF alpha may be superseded by other factors in the context of T cell-mediated colitis given that in the latter form of intestinal inflammation hepcidin is usually upregulated.	[Shanmugam, Nanda Kumar N.; Ellenbogen, Shiri; Trebicka, Estela; Wang, Lijian; Cherayil, Bobby J.] Massachusetts Gen Hosp, Mucosal Immunol Lab, Boston, MA 02114 USA; [Mukhopadhyay, Subhankar; Lacy-Hulbert, Adam] Massachusetts Gen Hosp, Dept Pediat, Dev Immunol Lab, Boston, MA 02114 USA; [Mukhopadhyay, Subhankar] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lacy-Hulbert, Adam; Garrett, Wendy S.; Cherayil, Bobby J.] Harvard Univ, Sch Med, Boston, MA USA; [Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Shanmugam, NKN (corresponding author), Massachusetts Gen Hosp, Mucosal Immunol Lab, Boston, MA 02114 USA.	cherayil@helix.mgh.harvard.edu		Navalpur Shanmugam, Nanda Kumar/0000-0003-2916-8563; Lacy-Hulbert, Adam/0000-0003-2162-0156; Mukhopadhyay, Subhankar/0000-0002-7110-6473; Garrett, Wendy/0000-0002-5092-0150	National Institutes of Health [R56AI089700, R01AI089700, RO1CA154426, K08AI078942]; Wellcome Trust Flexible Travel Award Fellowship; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089700, K08AI078942, R01AI089700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Flexible Travel Award Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by grants from the National Institutes of Health to BJC (R56AI089700, R01AI089700) and to WSG (RO1CA154426, K08AI078942). SM was supported by a Wellcome Trust Flexible Travel Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arnold J, 2009, EUR J GASTROEN HEPAT, V21, P335, DOI 10.1097/MEG.0b013e32830e2885; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bitzer M, 2000, GENE DEV, V14, P187; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Constante M, 2007, AM J PATHOL, V170, P497, DOI 10.2353/ajpath.2007.060437; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Hiasa Y, 2006, J VIROL METHODS, V132, P195, DOI 10.1016/j.jviromet.2005.10.014; Koening CL, 2009, BLOOD, V114, P1913, DOI 10.1182/blood-2009-03-209577; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205; Leso V, 2010, EUR J GASTROEN HEPAT, V22, P779, DOI 10.1097/MEG.0b013e328331b654; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Olakanmi O, 2007, J LEUKOCYTE BIOL, V81, P195, DOI 10.1189/jlb.0606405; Oustamanolakis P, 2011, EUR J GASTROEN HEPAT, V23, P262, DOI 10.1097/MEG.0b013e328343b885; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schumann K, 2010, J TRACE ELEM MED BIO, V24, P58, DOI 10.1016/j.jtemb.2009.10.002; Semrin G, 2006, INFLAMM BOWEL DIS, V12, P1101, DOI 10.1097/01.mib.0000235097.86360.04; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; Wang HZ, 2011, J IMMUNOL, V187, P6410, DOI 10.4049/jimmunol.1101436; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	41	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38136	10.1371/journal.pone.0038136	http://dx.doi.org/10.1371/journal.pone.0038136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675442	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500091
J	Shirtcliffe, NJ; McHale, G; Newton, MI				Shirtcliffe, Neil J.; McHale, Glen; Newton, Michael I.			Wet Adhesion and Adhesive Locomotion of Snails on Anti-Adhesive Non-Wetting Surfaces	PLOS ONE			English	Article							GASTROPOD PEDAL MUCUS; CONTACT-ANGLE	Creating surfaces capable of resisting liquid-mediated adhesion is extremely difficult due to the strong capillary forces that exist between surfaces. Land snails use this to adhere to and traverse across almost any type of solid surface of any orientation (horizontal, vertical or inverted), texture (smooth, rough or granular) or wetting property (hydrophilic or hydrophobic) via a layer of mucus. However, the wetting properties that enable snails to generate strong temporary attachment and the effectiveness of this adhesive locomotion on modern super-slippy superhydrophobic surfaces are unclear. Here we report that snail adhesion overcomes a wide range of these microscale and nanoscale topographically structured non-stick surfaces. For the one surface which we found to be snail resistant, we show that the effect is correlated with the wetting response of the surface to a weak surfactant. Our results elucidate some critical wetting factors for the design of anti-adhesive and bio-adhesion resistant surfaces.	[Shirtcliffe, Neil J.; McHale, Glen; Newton, Michael I.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Nottingham Trent University	Shirtcliffe, NJ (corresponding author), Hsch Rhein Waal, Fac Technol & Bion, Kleve, Germany.	Neil.Shirtcliffe@hochschule-rhein-waal.de	Shirtcliffe, Neil J/A-3846-2008; Shirtcliffe, Neil/K-7724-2017; Newton, Michael I/B-8866-2008; McHale, Glen/B-6397-2016	Shirtcliffe, Neil J/0000-0003-3877-3474; Shirtcliffe, Neil/0000-0003-3877-3474; Newton, Michael I/0000-0003-4231-1002; McHale, Glen/0000-0002-8519-7986	EPSRC (Engineering and Physical Sciences Research Council) [EP/E063489/1]; EPSRC [EP/E063489/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E063489/1] Funding Source: researchfish	EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funded by EPSRC (Engineering and Physical Sciences Research Council) platform grant EP/E063489/1 Exploiting the Solid-Liquid Interface (http://gow.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A. W., 1967, PHYS CHEM SURFACES; Chan B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2102927; Chan B, 2007, J INTEL MAT SYST STR, V18, P111, DOI 10.1177/1045389X06063464; Chang FM, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779092; De Souza EJ, 2008, LANGMUIR, V24, P1391, DOI 10.1021/la702188t; DENNY M, 1980, NATURE, V285, P160, DOI 10.1038/285160a0; DENNY M, 1980, SCIENCE, V208, P1288, DOI 10.1126/science.208.4449.1288; DENNY MW, 1981, J EXP BIOL, V91, P195; DUSSAN EB, 1983, J FLUID MECH, V137, P1, DOI 10.1017/S002211208300227X; Ewoldt RH, 2007, SOFT MATTER, V3, P634, DOI 10.1039/b615546d; Ewoldt RH, 2009, INTEGR COMP BIOL, V49, P40, DOI 10.1093/icb/icp010; Ferrari M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226771; Ferrari M, 2010, ADV COLLOID INTERFAC, V161, P22, DOI 10.1016/j.cis.2010.09.002; Gao LC, 2008, LANGMUIR, V24, P9183, DOI 10.1021/la8014578; GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629; Kobayashi A, 2003, TRIBOLOGICAL RESEARCH AND DESIGN FOR ENGINEERING SYSTEMS, P429; MCFARLANE JS, 1950, PROC R SOC LON SER-A, V202, P224, DOI 10.1098/rspa.1950.0096; Mohammadi R, 2004, LANGMUIR, V20, P9657, DOI 10.1021/la049268k; Pawlicki JM, 2004, J EXP BIOL, V207, P1127, DOI 10.1242/jeb.00859; Quere D, 2003, NANOTECHNOLOGY, V14, P1109, DOI 10.1088/0957-4484/14/10/307; Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p; Shirtcliffe NJ, 2007, MATER CHEM PHYS, V103, P112, DOI 10.1016/j.matchemphys.2007.01.018; Shirtcliffe NJ, 2011, J POLYM SCI POL PHYS, V49, P1203, DOI 10.1002/polb.22286; Smith AM, 2002, BIOL BULL-US, V203, P338, DOI 10.2307/1543576; 't Mannetje DJCM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3533362	25	17	19	7	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36983	10.1371/journal.pone.0036983	http://dx.doi.org/10.1371/journal.pone.0036983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693563	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000305338500025
J	Coluzza, I; MacDonald, JT; Sadowski, MI; Taylor, WR; Goldstein, RA				Coluzza, Ivan; MacDonald, James T.; Sadowski, Michael I.; Taylor, William R.; Goldstein, Richard A.			Analytic Markovian Rates for Generalized Protein Structure Evolution	PLOS ONE			English	Article							SEQUENCE SPACE; POTENTIALS; MODEL	A general understanding of the complex phenomenon of protein evolution requires the accurate description of the constraints that define the sub-space of proteins with mutations that do not appreciably reduce the fitness of the organism. Such constraints can have multiple origins, in this work we present a model for constrained evolutionary trajectories represented by a Markovian process throughout a set of protein-like structures artificially constructed to be topological intermediates between the structure of two natural occurring proteins. The number and type of intermediate steps defines how constrained the total evolutionary process is. By using a coarse-grained representation for the protein structures, we derive an analytic formulation of the transition rates between each of the intermediate structures. The results indicate that compact structures with a high number of hydrogen bonds are more probable and have a higher likelihood to arise during evolution. Knowledge of the transition rates allows for the study of complex evolutionary pathways represented by trajectories through a set of intermediate structures.	[Coluzza, Ivan] Univ Vienna, Dept Phys, Vienna, Austria; [MacDonald, James T.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England; [MacDonald, James T.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England; [Sadowski, Michael I.; Taylor, William R.; Goldstein, Richard A.] Natl Inst Med Res, Ridgeway, London NW7 1AA, England	University of Vienna; Imperial College London; Imperial College London	Coluzza, I (corresponding author), Univ Vienna, Dept Phys, Vienna, Austria.	ivan.coluzza@univie.ac.at	Sadowski, Michael/F-4475-2010; Coluzza, Ivan/I-4170-2015	Sadowski, Michael/0000-0002-4546-2159; Coluzza, Ivan/0000-0001-7728-6033; Goldstein, Richard/0000-0001-5148-4672; MacDonald, James/0000-0001-9675-4429	Medical Research Council (National Institute for Medical Research), United Kingdom [U117581331]; Medical Research Council [MC_U117573805] Funding Source: researchfish; MRC [MC_U117573805] Funding Source: UKRI	Medical Research Council (National Institute for Medical Research), United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by the Medical Research Council (National Institute for Medical Research), United Kingdom. (U117581331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Coluzza I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051917; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2005, CHEMPHYSCHEM, V6, P1779, DOI 10.1002/cphc.200400629; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; Deeds EJ, 2007, P NATL ACAD SCI USA, V104, P14952, DOI 10.1073/pnas.0702766104; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Frenkel D, 2004, P NATL ACAD SCI USA, V101, P17571, DOI 10.1073/pnas.0407950101; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Koehl P, 2002, P NATL ACAD SCI USA, V99, P1280, DOI 10.1073/pnas.032405199; Lobkovsky AE, 2010, P NATL ACAD SCI USA, V107, P2983, DOI 10.1073/pnas.0910445107; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Meyerguz L, 2007, P NATL ACAD SCI USA, V104, P11627, DOI 10.1073/pnas.0701393104; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Taylor WR, 2008, PROTEINS, V70, P1610, DOI 10.1002/prot.21913; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Viksna J, 2007, BIOINFORMATICS, V23, P832, DOI 10.1093/bioinformatics/btm022; Wroe R, 2007, HFSP J, V1, P79, DOI [10.2976/1.2739116, 10.2976/1.2739116/10.2976/1]	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e34228	10.1371/journal.pone.0034228	http://dx.doi.org/10.1371/journal.pone.0034228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22693543	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800004
J	Li, N; Zoubeidi, A; Beraldi, E; Gleave, ME				Li, N.; Zoubeidi, A.; Beraldi, E.; Gleave, M. E.			GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer	ONCOGENE			English	Article						ER stress; GRP78; clusterin; cancer; retrotranslocation; apoptosis	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CELL-SURVIVAL; N-GLYCANASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; CHAPERONE GRP78; EXPRESSION; GENE; SUPPRESSION	Expression of clusterin (CLU) closely correlates with the regulation of apoptosis in cancer. Although endoplasmic reticulum (ER) stress-induced upregulation and retrotranslocation of cytoplasmic CLU (presecretory (psCLU) and secreted (sCLU) forms) has been linked to its anti-apoptotic properties, mechanisms mediating these processes remain undefined. Here, we show using human prostate cancer cells that GRP78 (Bip) associates with CLU under ER stress conditions to facilitate its retrotranslocation and redistribution to the mitochondria. Many ER stress inducers, including thapsigargin, MG132 or paclitaxel, increased expression levels of GRP78 and CLU, as well as post-translationally modified hypoglycosylated CLU forms. ER stress increased association between GRP78 and CLU, which led to increased cytoplasmic CLU levels, while reducing sCLU levels secreted into the culture media. GRP78 stabilized CLU protein and its hypoglycosylated forms, in particular after paclitaxel treatment. Moreover, subcellular fractionation and confocal microscopy with CLUGFP indicated that GRP78 increased stress-induced CLU retrotranslocation from the ER with co-localized redistribution to the mitochondria, thereby reducing stress-induced apoptosis by cooperatively stabilizing mitochondrial membrane integrity. GRP78 silencing reduced CLU protein, but not mRNA levels, and enhanced paclitaxel-induced cell apoptosis. Taken together, these findings reveal novel dynamic interactions between GRP78 and CLU under ER stress conditions that govern CLU trafficking and redistribution to the mitochondria, elucidating how GRP78 and CLU cooperatively promote survival during treatment stress in prostate cancer. Oncogene (2013) 32, 1933-1942; doi:10.1038/onc.2012.212; published online 11 June 2012	[Li, N.; Zoubeidi, A.; Beraldi, E.; Gleave, M. E.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V5Z 3J5, Canada	University of British Columbia	Gleave, ME (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, 2660 Oak St, Vancouver, BC V5Z 3J5, Canada.	m.gleave@ubc.ca		Gleave, Martin/0000-0003-4235-0167				Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Gleave M, 2005, WORLD J UROL, V23, P38, DOI 10.1007/s00345-004-0474-0; Graves TK, 2001, J CELL SCI, V114, P3685; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836; Lamoureux F, 2011, CANCER RES, V71, P5838, DOI 10.1158/0008-5472.CAN-11-0994; Lee DH, 2011, BIOCHEM BIOPH RES CO, V408, P541, DOI 10.1016/j.bbrc.2011.04.054; Leung SYL, 2000, PROSTATE, V44, P156, DOI 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Miyake H, 2000, CANCER RES, V60, P2547; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shiota M, 2011, MOL CANCER RES, V9, P1755, DOI 10.1158/1541-7786.MCR-11-0379; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Stanley P., 2009, ESSENTIALS GLYCOBIOL, V1; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Wacker I, 1997, J CELL SCI, V110, P1453; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	49	75	77	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 11	2013	32	15					1933	1942		10.1038/onc.2012.212	http://dx.doi.org/10.1038/onc.2012.212			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22689054				2022-12-25	WOS:000317599900007
J	Zhao, YL; Chen, SR; Chen, H; Pan, HL				Zhao, Yi-Lin; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin			Chronic Opioid Potentiates Presynaptic but Impairs Postsynaptic N-Methyl-D-aspartic Acid Receptor Activity in Spinal Cords IMPLICATIONS FOR OPIOID HYPERALGESIA AND TOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LONG-LASTING HYPERALGESIA; NMDA RECEPTORS; DORSAL-HORN; MORPHINE-TOLERANCE; SENSORY NEURONS; INTRATHECAL MORPHINE; OPIATE TOLERANCE; UP-REGULATION; RATS	Opioids are the most effective analgesics for the treatment of moderate to severe pain. However, chronic opioid treatment can cause both hyperalgesia and analgesic tolerance, which limit their clinical efficacy. In this study, we determined the role of pre- and postsynaptic NMDA receptors (NMDARs) in controlling increased glutamatergic input in the spinal cord induced by chronic systemic morphine administration. Whole-cell voltage clamp recordings of excitatory postsynaptic currents (EPSCs) were performed on dorsal horn neurons in rat spinal cord slices. Chronic morphine significantly increased the amplitude of monosynaptic EPSCs evoked from the dorsal root and the frequency of spontaneous EPSCs, and these changes were largely attenuated by blocking NMDARs and by inhibiting PKC, but not PKA. Also, blocking NR2A- or NR2B-containing NMDARs significantly reduced the frequency of spontaneous EPSCs and the amplitude of evoked EPSCs in morphine-treated rats. Strikingly, morphine treatment largely decreased the amplitude of evoked NMDAR-EPSCs and NMDAR currents of dorsal horn neurons elicited by puff NMDA application. The reduction in postsynaptic NMDAR currents caused by morphine was prevented by resiniferatoxin pretreatment to ablate TRPV1-expressing primary afferents. Furthermore, intrathecal injection of the NMDAR antagonist significantly attenuated the development of analgesic tolerance and the reduction in nociceptive thresholds induced by chronic morphine. Collectively, our findings indicate that chronic opioid treatment potentiates presynaptic, but impairs postsynaptic, NMDAR activity in the spinal cord. PKC-mediated increases in NMDAR activity at nociceptive primary afferent terminals in the spinal cord contribute critically to the development of opioid hyperalgesia and analgesic tolerance.	[Zhao, Yi-Lin; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Pain & Neurosci Res, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Program Neurosci, Grad Sch Biomed Sci, Houston, TX 77225 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Program Expt Therapeut, Grad Sch Biomed Sci, Houston, TX 77225 USA; [Zhao, Yi-Lin] Tongji Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Pain & Neurosci Res, Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM064830, NS073935]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830 and NS073935 (to H. L. P.). This work was also supported by the N. G. and Helen T. Hawkins Endowment (to H. L. P.).	Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen SR, 2007, NEUROSCIENCE, V145, P676, DOI 10.1016/j.neuroscience.2006.12.016; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Chen SR, 2006, BRAIN RES, V1081, P119, DOI 10.1016/j.brainres.2006.01.053; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Chen SR, 2003, ANESTHESIOLOGY, V99, P1409, DOI 10.1097/00000542-200312000-00026; Chia YT, 1999, CAN J ANAESTH, V46, P872, DOI 10.1007/BF03012978; Colpaert FC, 1996, PHARMACOL REV, V48, P355; CONNELLY PA, 1987, J BIOL CHEM, V262, P4324; Devulder J, 1997, J NEUROSURG ANESTH, V9, P146, DOI 10.1097/00008506-199704000-00007; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Granados-Soto V, 2000, PAIN, V85, P395, DOI 10.1016/S0304-3959(99)00281-X; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Jolas T, 2000, NEUROSCIENCE, V95, P433; Kimura R, 2008, J PHYSIOL-LONDON, V586, P3195, DOI 10.1113/jphysiol.2008.151894; Kramer HK, 1999, J NEUROCHEM, V72, P585; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Larcher A, 1998, NEUROSCIENCE, V84, P583, DOI 10.1016/S0306-4522(97)00556-3; Laulin JP, 1999, NEUROSCIENCE, V89, P631, DOI 10.1016/S0306-4522(98)00652-6; Li DP, 2008, J PHYSIOL-LONDON, V586, P1637, DOI 10.1113/jphysiol.2007.149732; Li DP, 2012, J NEUROSCI, V32, P372, DOI 10.1523/JNEUROSCI.3222-11.2012; MAO J, 1994, J NEUROSCI, V14, P2301; MAYER DJ, 1995, PAIN, V61, P365, DOI 10.1016/0304-3959(95)00023-L; Momiyama A, 2000, J PHYSIOL-LONDON, V523, P621, DOI 10.1111/j.1469-7793.2000.t01-1-00621.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; OLVERMAN HJ, 1984, NATURE, V307, P460, DOI 10.1038/307460a0; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Stubhaug A, 1997, ACTA ANAESTH SCAND, V41, P1124, DOI 10.1111/j.1399-6576.1997.tb04854.x; Szallasi A, 1999, MOL PHARMACOL, V56, P581, DOI 10.1124/mol.56.3.581; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Van Elstraete AC, 2005, ANESTH ANALG, V101, P1750, DOI 10.1213/01.ANE.0000184136.08194.9B; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Xie CW, 1997, J NEUROPHYSIOL, V78, P759, DOI 10.1152/jn.1997.78.2.759; YAKSH TL, 1986, ANESTHESIOLOGY, V64, P590, DOI 10.1097/00000542-198605000-00008; YAKSH TL, 1988, J PHARMACOL EXP THER, V244, P501; Ye ZY, 2012, J BIOL CHEM, V287, P17438, DOI 10.1074/jbc.M111.331165; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou HY, 2009, J NEUROCHEM, V108, P305, DOI 10.1111/j.1471-4159.2008.05772.x	56	65	68	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25073	25085		10.1074/jbc.M112.378737	http://dx.doi.org/10.1074/jbc.M112.378737			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679016	Green Published, hybrid			2022-12-25	WOS:000306651700020
J	Brannelly, LA; Chatfield, MWH; Richards-Zawacki, CL				Brannelly, Laura A.; Chatfield, Matthew W. H.; Richards-Zawacki, Corinne L.			Field and Laboratory Studies of the Susceptibility of the Green Treefrog (Hyla cinerea) to Batrachochytrium dendrobatidis Infection	PLOS ONE			English	Article							AMPHIBIAN DECLINES; EMERGING DISEASE; WATER-LOSS; CHYTRIDIOMYCOSIS; MORTALITY; TEMPERATURE; RESISTANCE; IMMUNITY; ECOLOGY; FROGS	Amphibians worldwide are experiencing devastating declines, some of which are due to the amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd). Populations in the southeastern United States, however, have not been noticeably affected by the pathogen. The green treefrog (Hyla cinerea) is abundant and widespread in the southeastern United States, but has not been documented to harbor Bd infection. This study examined the susceptibility of H. cinerea to two strains of Bd in the lab and the prevalence of infection in wild populations of this species in southeastern Louisiana. Although we were able to infect H. cinerea with Bd in the lab, we did not observe any clinical signs of chytridiomycosis. Furthermore, infection by Bd does not appear to negatively affect body condition or growth rate of post-metamorphic individuals. We found no evidence of infection in surveys of wild H. cinerea. Our results suggest that H. cinerea is not susceptible to chytridiomycosis post-metamorphosis and probably is not an important carrier of the fungal pathogen Bd in the southeastern United States, although susceptibility at the larval stage remains unknown.	[Brannelly, Laura A.; Chatfield, Matthew W. H.; Richards-Zawacki, Corinne L.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	Tulane University	Brannelly, LA (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	lbrannel@tulane.edu	Brannelly, Laura A/V-2589-2019; Richards-Zawacki, Corinne/F-2731-2011	Brannelly, Laura A/0000-0003-2975-9494; Richards-Zawacki, Corinne/0000-0002-4212-041X				Ackleh AS, 2010, ECOL MODEL, V221, P281, DOI 10.1016/j.ecolmodel.2009.10.012; Beasley VR, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P75; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, CLIN TRIALS IN PRESS; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Chatfield MWH, 2011, DIS AQUAT ORGAN, V94, P235, DOI 10.3354/dao02337; Conlon JM, 2011, CELL TISSUE RES, V343, P201, DOI 10.1007/s00441-010-1014-4; FREED AN, 1980, PHYSIOL ZOOL, V53, P433, DOI 10.1086/physzool.53.4.30157881; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Gahl MK, 2011, CONSERV BIOL, P1; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Lannoo MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022211; Lehtinen RM, 2006, COPEIA, P159, DOI 10.1643/0045-8511(2006)6[159:TEDOBC]2.0.CO;2; McCallum ML, 2007, HERPETOLOGICA, V63, P269, DOI 10.1655/0018-0831(2007)63[269:PTBIAR]2.0.CO;2; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Richter SC, 2009, COPEIA, P799, DOI 10.1643/CH-09-070; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, pE117; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Timpe Elizabeth K., 2008, Herpetological Review, V39, P447; Voyles J, 2009, PHD THESIS J COOK U; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; WYGODA M, 1988, HERPETOLOGICA, V44, P251; WYGODA ML, 1991, HERPETOLOGICA, V47, P328; WYGODA ML, 1993, HERPETOLOGICA, V49, P365; Zacharow M, 2003, SOUTHEAST NAT, V2, P575, DOI 10.1656/1528-7092(2003)002[0575:UGPPTM]2.0.CO;2	36	21	23	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38473	10.1371/journal.pone.0038473	http://dx.doi.org/10.1371/journal.pone.0038473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685572	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700035
J	Yang, CR; Wei, YC; Qi, ST; Chen, L; Zhang, QH; Ma, JY; Luo, YB; Wang, YP; Hou, Y; Schatten, H; Liu, ZH; Sun, QY				Yang, Cai-Rong; Wei, Yanchang; Qi, Shu-Tao; Chen, Lei; Zhang, Qing-Hua; Ma, Jun-Yu; Luo, Yi-Bo; Wang, Ya-Peng; Hou, Yi; Schatten, Heide; Liu, Zhong-Hua; Sun, Qing-Yuan			The G Protein Coupled Receptor 3 Is Involved in cAMP and cGMP Signaling and Maintenance of Meiotic Arrest in Porcine Oocytes	PLOS ONE			English	Article							MOUSE OOCYTES; KINASE-A; MAMMALIAN OOCYTES; PROPHASE ARREST; XENOPUS OOCYTES; G(S) PROTEIN; CYCLIC-AMP; MATURATION; RESUMPTION; GPR3	The arrest of meiotic prophase in mammalian oocytes within fully grown follicles is dependent on cyclic adenosine monophosphate (cAMP) regulation. A large part of cAMP is produced by the Gs-linked G-protein-coupled receptor (GPR) pathway. In the present study, we examined whether GPR3 is involved in the maintenance of meiotic arrest in porcine oocytes. Expression and distribution of GPR3 were examined by western blot and immunofluorescence microscopy, respectively. The results showed that GPR3 was expressed at various stages during porcine oocyte maturation. At the germinal vesicle (GV) stage, GPR3 displayed a maximal expression level, and its expression remained stable from prometaphase I (MI) to metaphase II (MII). Immunofluorescence staining showed that GPR3 was mainly distributed at the nuclear envelope during the GV stage and localized to the plasma membrane at pro-MI, MI and MII stages. RNA interference (RNAi) was used to knock down the GPR3 expression within oocytes. Injection of small interfering double-stranded RNA (siRNA) targeting GPR3 stimulated meiotic resumption of oocytes. On the other hand, overexpression of GPR3 inhibited meiotic maturation of porcine oocytes, which was caused by increase of cGMP and cAMP levels and inhibition of cyclin B accumulation. Furthermore, incubation of porcine oocytes with the GPR3 ligand sphingosylphosphorylcholine (SPC) inhibited oocyte maturation. We propose that GPR3 is required for maintenance of meiotic arrest in porcine oocytes through pathways involved in the regulation of cAMP and cGMP.	[Yang, Cai-Rong; Ma, Jun-Yu; Liu, Zhong-Hua] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Yang, Cai-Rong; Wei, Yanchang; Qi, Shu-Tao; Chen, Lei; Zhang, Qing-Hua; Ma, Jun-Yu; Luo, Yi-Bo; Wang, Ya-Peng; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Missouri System; University of Missouri Columbia	Yang, CR (corresponding author), NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China.	sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021	Yang, Cairong/0000-0001-9594-0529; Chen, Lei/0000-0002-9993-0894; Qi, Shutao/0000-0002-4073-1161	National Basic Research Program of China [2012CB944404, 2011CB944501]; National Natural Science Foundation of China [30930065]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China(2012CB944404, 2011CB944501) and National Natural Science Foundation of China (No. 30930065) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, RES REPROD, V18, P1; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; DAAR I, 1993, J CELL BIOL, V120, P1197, DOI 10.1083/jcb.120.5.1197; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; DiLuigi A, 2008, BIOL REPROD, V78, P667, DOI 10.1095/biolreprod.107.066019; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Eppig J J, 1989, J Reprod Fertil Suppl, V38, P3; Eppig J. J., 2004, OVARY, P113, DOI DOI 10.1016/B978-012444562-8/50008-2; Fan HY, 2002, MOL REPROD DEV, V63, P480, DOI 10.1002/mrd.10194; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Kalinowski RR, 2004, DEV BIOL, V267, P1, DOI 10.1016/j.ydbio.2003.11.011; Kostenis E, 2004, PHARMACOL THERAPEUT, V102, P243, DOI 10.1016/j.pharmthera.2004.04.005; Kostenis E, 2004, J CELL BIOCHEM, V92, P923, DOI 10.1002/jcb.20092; Kuroda T, 2004, BIOL REPROD, V70, P154, DOI 10.1095/biolreprod.103.021519; Laforest MF, 2005, MOL REPROD DEV, V70, P361, DOI 10.1002/mrd.20203; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Li M, 2008, BIOL REPROD, V79, P897, DOI 10.1095/biolreprod.108.069245; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Miao YL, 2009, ENVIRON MOL MUTAGEN, V50, P666, DOI 10.1002/em.20506; Morikawa M, 2007, J REPROD DEVELOP, V53, P1151, DOI 10.1262/jrd.19055; Morrill GA, 1999, STEROIDS, V64, P157, DOI 10.1016/S0039-128X(98)00093-2; NAITO K, 1991, J REPROD FERTIL, V93, P467, DOI 10.1530/jrf.0.0930467; Nogueira D, 2003, BIOL REPROD, V69, P2045, DOI 10.1095/biolreprod.103.021105; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; Richard FJ, 2007, J ANIM SCI, V85, pE4, DOI 10.2527/jas.2006-475; Rios-Cardona D, 2008, DEV BIOL, V317, P380, DOI 10.1016/j.ydbio.2008.02.047; SCHULTZ RM, 1983, DEV BIOL, V95, P294, DOI 10.1016/0012-1606(83)90030-1; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; STRUM JC, 1995, J BIOL CHEM, V270, P13541, DOI 10.1074/jbc.270.22.13541; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; TORNELL J, 1990, ACTA PHYSIOL SCAND, V139, P511, DOI 10.1111/j.1748-1716.1990.tb08953.x; Tsafriri A., 1994, MOL BIOL FEMALE REPR, P207; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Vaccari S, 2008, DEV BIOL, V316, P124, DOI 10.1016/j.ydbio.2008.01.018; VIVARELLI E, 1983, CELL DIFFER DEV, V12, P271, DOI 10.1016/0045-6039(83)90023-4; Wang J, 2006, CELL CYCLE, V5, P213, DOI 10.4161/cc.5.2.2365; Wang S, 2008, FRONT BIOSCI, V13, P7087, DOI 10.2741/3212; Xu BZ, 2009, ANIM REPROD SCI, V111, P17, DOI 10.1016/j.anireprosci.2008.02.010; Yang CR, PLOS ONE, V5	49	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38807	10.1371/journal.pone.0038807	http://dx.doi.org/10.1371/journal.pone.0038807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685609	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700073
J	Oberthuer, A; Donmez, F; Oberhauser, F; Hahn, M; Hoppenz, M; Hoehn, T; Roth, B; Laudes, M				Oberthuer, Andre; Doenmez, Fatma; Oberhaeuser, Frank; Hahn, Moritz; Hoppenz, Marc; Hoehn, Thomas; Roth, Bernhard; Laudes, Matthias			Hypoadiponectinemia in Extremely Low Gestational Age Newborns with Severe Hyperglycemia - A Matched-Paired Analysis	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; ADIPONECTIN LEVELS; RISK-FACTOR; HUMAN-MILK; TERM	Background: Hyperglycemia is commonly observed in extremely low gestational age newborns (ELGANs) and is associated with both increased morbidity and mortality. The objective of this study was to examine the relationship between neonatal hyperglycemia and adiponectin levels in ELGANs. Methodology/Principal Findings: Ten preterm infants between 22+6/7 and 27+3/7 weeks' gestation with neonatal hyperglycemia (defined as pre-feeding blood glucose levels above 200mg/dl on two consecutive measurements with a maximum parenteral glucose infusion of 4mg/kg*min(-1)) formed the case cohort of this study. To every single patient of this case cohort a patient with normal fasting (=pre-feeding) blood glucose levels was matched in terms of gestational age and gender. Adiponectin ELISAs were performed both at onset of hyperglycemia and at term-equivalent age. In the case cohort 9/10 patients had to be treated with insulin for 1-26 days (range 0.01-0.4 IU/kg*h(-1)). Compared to matched-paired controls, significant hypoadiponectinemia was observed at onset of hyperglycemia in these affected patients (6.9 mu g/ml versus 15.1 mu g/ml, p = 0.009). At term equivalent age, normoglycemia without any insulin treatment was found in both groups. Moreover, adiponectin levels at that time were no longer significantly different (12.3 mu g/ml versus 20.0 mu g/ml; p = 0.051) possibly indicating a mechanistic relevance of this adipokine in regulating insulin sensitivity in ELGANs. Conclusions/Significance: Decreased circulating adiponectin levels are correlated with hyperglycemia in ELGANs and may contribute to the pathogenesis of impaired glucose homeostasis in these infants. These findings suggest that adiponectin might be a potential future drug target for the potentially save treatment of hyperglycemia in pre-term infants.	[Oberthuer, Andre; Roth, Bernhard] Univ Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, D-50931 Cologne, Germany; [Doenmez, Fatma; Hoppenz, Marc] City Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, Cologne, Germany; [Oberhaeuser, Frank] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Hahn, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dept Gen Pediat, Dusseldorf, Germany; [Laudes, Matthias] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, Kiel, Germany	University of Cologne; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; University of Kiel; Schleswig Holstein University Hospital	Oberthuer, A (corresponding author), Univ Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, D-50931 Cologne, Germany.	andre.oberthuer@uk-koeln.de	Laudes, Matthias/C-8885-2011					Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Cianfarani S, 2004, J CLIN ENDOCR METAB, V89, P1346, DOI 10.1210/jc.2003-031704; Hays SP, 2006, PEDIATRICS, V118, P1811, DOI 10.1542/peds.2006-0628; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Kajantie E, 2004, J CLIN ENDOCR METAB, V89, P4031, DOI 10.1210/jc.2004-0018; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Kao LS, 2006, J PERINATOL, V26, P730, DOI 10.1038/sj.jp.7211593; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Newburg DS, 2010, J PEDIATR-US, V156, pS41, DOI 10.1016/j.jpeds.2009.11.020; Saito M, 2011, NEONATOLOGY, V100, P93, DOI 10.1159/000322654; Siahanidou T, 2007, ARCH DIS CHILD-FETAL, V92, P286, DOI 10.1136/adc.2006.106112; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283	13	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38481	10.1371/journal.pone.0038481	http://dx.doi.org/10.1371/journal.pone.0038481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679509	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900047
J	Teixeira, S; Serrao, EA; Arnaud-Haond, S				Teixeira, Sara; Serrao, Ester A.; Arnaud-Haond, Sophie			Panmixia in a Fragmented and Unstable Environment: The Hydrothermal Shrimp Rimicaris exoculata Disperses Extensively along the Mid-Atlantic Ridge	PLOS ONE			English	Article							DEEP-SEA VENT; LARVAL DISPERSAL; POPULATION BOTTLENECKS; MICROSATELLITE MARKERS; MUSSELS BIVALVIA; EASTERN PACIFIC; GENE FLOW; CONNECTIVITY; BRESILIIDAE; DECAPODA	Dispersal plays a fundamental role in the evolution and persistence of species, and especially for species inhabiting extreme, ephemeral and highly fragmented habitats as hydrothermal vents. The Mid-Atlantic Ridge endemic shrimp species Rimicaris exoculata was studied using microsatellite markers to infer connectivity along the 7100-Km range encompassing the sampled sites. Astonishingly, no genetic differentiation was found between individuals from the different geographic origins, supporting a scenario of widespread large-scale dispersal despite the habitat distance and fragmentation. We hypothesize that delayed metamorphosis associated to temperature differences or even active directed migration dependent on physical and/or chemical stimuli could explain these results and warrant further studies on adaptation and dispersal mechanisms.	[Teixeira, Sara; Arnaud-Haond, Sophie] IFREMER, Ctr Brest, DEEP, Brest, France; [Teixeira, Sara; Serrao, Ester A.] Univ Algarve, CIMAR, Ctr Marine Sci, Faro, Portugal	Ifremer; Universidade do Algarve	Teixeira, S (corresponding author), IFREMER, Ctr Brest, DEEP, Brest, France.	steixeira@ualg.pt	Arnaud-Haond, Sophie/B-2479-2008; Teixeira, Sara/M-3424-2013; Serrao, Ester A/C-6686-2012	Arnaud-Haond, Sophie/0000-0001-5814-8452; Teixeira, Sara/0000-0003-0419-2348; Serrao, Ester A/0000-0003-1316-658X	Census of Marine Life project; DeepOases project; ANR (l'Agence Nationale de la Recherche, France); EU; FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)	Census of Marine Life project; DeepOases project; ANR (l'Agence Nationale de la Recherche, France)(French National Research Agency (ANR)); EU(European Commission); FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)(Portuguese Foundation for Science and Technology)	This research was supported by Census of Marine Life project and DeepOases project funded by ANR (l'Agence Nationale de la Recherche, France), the EU FP7 Hermione project, and a postdoctoral fellowship (to ST) from FCT (Fundacao para a Ciencia e a Tecnologia, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DK, 2011, SCIENCE, V332, P580, DOI 10.1126/science.1201066; Allen CE, 2001, MAR ECOL-P S Z N I, V22, P241, DOI 10.1046/j.1439-0485.2001.01755.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Audzijonyte A, 2010, EVOLUTION, V64, P2369, DOI 10.1111/j.1558-5646.2010.00987.x; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Beerli P, 1999, GENETICS, V152, P763; Beerli Peter, 2009, V17, P42; Belkhir K., 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRKY CW, 1983, GENETICS, V103, P513; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Copley JTP, 1997, MAR BIOL, V129, P723, DOI 10.1007/s002270050215; Cornuet JM, 1996, GENETICS, V144, P2001; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Creasey S, 1996, MAR BIOL, V125, P473; Daguin C, 2005, MOL ECOL NOTES, V5, P780, DOI 10.1111/j.1471-8286.2005.01061.x; Dixon DR, 1998, CAH BIOL MAR, V39, P383; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; Fusaro AJ, 2008, MOL ECOL RESOUR, V8, P132, DOI 10.1111/j.1471-8286.2007.01897.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Herring PJ, 1998, CAH BIOL MAR, V39, P387; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Jollivet D, 1999, EVOLUTION, V53, P1128, DOI 10.1111/j.1558-5646.1999.tb04527.x; Jollivet D, 2000, J MAR BIOL ASSOC UK, V80, P55, DOI 10.1017/S0025315499001563; Khripounoff A, 2008, DEEP-SEA RES PT I, V55, P532, DOI 10.1016/j.dsr.2008.01.001; Kingsford MJ, 2002, B MAR SCI, V70, P309; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; LUTZ RA, 1979, AM ZOOL, V19, P927; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; MARUYAMA T, 1984, GENETICS, V108, P745; Moalic Y, 2012, SYST BIOL, V61, P127, DOI 10.1093/sysbio/syr088; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Nielsen R, 1997, GENETICS, V146, P711; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Pond D, 1997, MAR ECOL PROG SER, V146, P289, DOI 10.3354/meps146289; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RENNINGER GH, 1995, BIOL BULL, V189, P69, DOI 10.2307/1542456; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Teixeira S, 2011, CONS GENET RES, V4, P84; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Thurnherr AM, 2008, J MAR RES, V66, P347, DOI 10.1357/002224008786176034; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Tyler PA, 2000, J MAR BIOL ASSOC UK, V80, P739, DOI 10.1017/S0025315400002605; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 1989, NATURE, V337, P458, DOI 10.1038/337458a0; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Waser PM, 2011, MOL ECOL, V20, P1277, DOI 10.1111/j.1365-294X.2011.05002.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zelnio KA, 2010, CONSERV GENET RESOUR, V2, P223, DOI 10.1007/s12686-010-9243-0	70	50	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38521	10.1371/journal.pone.0038521	http://dx.doi.org/10.1371/journal.pone.0038521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679511	Green Published, gold			2022-12-25	WOS:000305343900054
J	Bista, M; Smithson, D; Pecak, A; Salinas, G; Pustelny, K; Min, J; Pirog, A; Finch, K; Zdzalik, M; Waddell, B; Wladyka, B; Kedracka-Krok, S; Dyer, MA; Dubin, G; Guy, RK				Bista, Michal; Smithson, David; Pecak, Aleksandra; Salinas, Gabriella; Pustelny, Katarzyna; Min, Jaeki; Pirog, Artur; Finch, Kristin; Zdzalik, Michal; Waddell, Brett; Wladyka, Benedykt; Kedracka-Krok, Sylwia; Dyer, Michael A.; Dubin, Grzegorz; Guy, R. Kiplin			On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53	PLOS ONE			English	Article							MOLECULE; RECEPTOR; LIGANDS; PATHWAY	SJ-172550 (1) was previously discovered in a biochemical high throughput screen for inhibitors of the interaction of MDMX and p53 and characterized as a reversible inhibitor (J. Biol. Chem. 2010; 285:10786). Further study of the biochemical mode of action of 1 has shown that it acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates, and other factors that influence the conformational stability of the protein. This complex mechanism of action hinders the further development of compound 1 as a selective MDMX inhibitor.	[Bista, Michal] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Bista, Michal; Pecak, Aleksandra; Pustelny, Katarzyna; Wladyka, Benedykt] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Smithson, David; Salinas, Gabriella; Min, Jaeki; Finch, Kristin; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Pirog, Artur; Kedracka-Krok, Sylwia] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Finch, Kristin; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Zdzalik, Michal; Dubin, Grzegorz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Waddell, Brett] St Jude Childrens Res Hosp, Hartwell Ctr Biotechnol, Memphis, TN 38105 USA; [Kedracka-Krok, Sylwia; Dubin, Grzegorz] Malopolska Ctr Biotechnol, Krakow, Poland; [Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Max Planck Society; Jagiellonian University; St Jude Children's Research Hospital; Jagiellonian University; St Jude Children's Research Hospital; Jagiellonian University; St Jude Children's Research Hospital; Jagiellonian University; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute	Bista, M (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	kip.guy@stjude.org	Dubin, Grzegorz/J-8168-2014; Władyka, Benedykt/T-7039-2019; Guy, Rodney/J-7107-2013; Dyer, Michael/N-8134-2018	Dubin, Grzegorz/0000-0002-5535-5760; Władyka, Benedykt/0000-0002-9075-3529; Guy, Rodney/0000-0002-9638-2060; Pustelny, Katarzyna/0000-0001-8430-8608; Min, Jaeki/0000-0002-0083-3198; Bista, Michal/0000-0002-0411-2275; Bista, Michal/0000-0001-9237-1199; Pirog, Artur/0000-0001-5049-043X	Polish National Centre for Research and Development [77/L-1/09]; Polish Ministry of Science and Higher Education [2023/B/P01/2010/39, K/PBW/000676]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08]; American Lebanese Syrian Associated Charities (ALSAC); St Jude Children's Research Hospital	Polish National Centre for Research and Development; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St Jude Children's Research Hospital	This work was supported by grants 77/L-1/09 from the Polish National Centre for Research and Development (to G.D.); 2023/B/P01/2010/39 (K/PBW/000676) from the Polish Ministry of Science and Higher Education (to S.K.-K.); the European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08); and the American Lebanese Syrian Associated Charities (ALSAC) and St Jude Children's Research Hospital. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Artz JD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-478; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Bose P, 2009, EXPERT OPIN INV DRUG, V18, P1735, DOI 10.1517/13543780903305428; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Hwang JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200436; Hwang JY, 2009, J MED CHEM, V52, P3892, DOI 10.1021/jm9002704; Hwang JY, 2012, J MED CHEM; Kuhn DJ, 2011, CURR CANCER DRUG TAR, V11, P285; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Ocana A, 2009, CANCER TREAT REV, V35, P685, DOI 10.1016/j.ctrv.2009.08.001; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Reed D, 2010, J BIOL CHEM, V285, P10786, DOI 10.1074/jbc.M109.056747; Senisterra G, 2011, ASSAY DRUG DEV TECHN; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527	24	43	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37518	10.1371/journal.pone.0037518	http://dx.doi.org/10.1371/journal.pone.0037518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675482	gold, Green Published			2022-12-25	WOS:000305341700015
J	Bartpho, T; Wongsurawat, T; Wongratanacheewin, S; Talaat, AM; Karoonuthaisiri, N; Sermswan, RW				Bartpho, Thanatchaporn; Wongsurawat, Thidathip; Wongratanacheewin, Surasakdi; Talaat, Adel M.; Karoonuthaisiri, Nitsara; Sermswan, Rasana W.			Genomic Islands as a Marker to Differentiate between Clinical and Environmental Burkholderia pseudomallei	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; PLASTICITY; MELIOIDOSIS; NORMALIZATION; VIRULENCE; IDENTIFICATION; EPIDEMIOLOGY; STREPTOMYCES; EVOLUTION	Burkholderia pseudomallei, as a saprophytic bacterium that can cause a severe sepsis disease named melioidosis, has preserved several extra genes in its genome for survival. The sequenced genome of the organism showed high diversity contributed mainly from genomic islands (GIs). Comparative genome hybridization (CGH) of 3 clinical and 2 environmental isolates, using whole genome microarrays based on B. pseudomallei K96243 genes, revealed a difference in the presence of genomic islands between clinical and environmental isolates. The largest GI, GI8, of B. pseudomallei was observed as a 2 sub-GI named GIs8.1 and 8.2 with distinguishable %GC content and unequal presence in the genome. GIs8.1, 8.2 and 15 were found to be more common in clinical isolates. A new GI, GI16c, was detected on chromosome 2. Presences of GIs8.1, 8.2, 15 and 16c were evaluated in 70 environmental and 64 clinical isolates using PCR assays. A combination of GIs8.1 and 16c (positivity of either GI) was detected in 70% of clinical isolates and 11.4% of environmental isolates (P<0.001). Using BALB/c mice model, no significant difference of time to mortality was observed between K96243 isolate and three isolates without GIs under evaluation (P>0.05). Some virulence genes located in the absent GIs and the difference of GIs seems to contribute less to bacterial virulence. The PCR detection of 2 GIs could be used as a cost effective and rapid tool to detect potentially virulent isolates that were contaminated in soil.	[Bartpho, Thanatchaporn; Wongratanacheewin, Surasakdi] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Bartpho, Thanatchaporn; Wongratanacheewin, Surasakdi; Sermswan, Rasana W.] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Wongsurawat, Thidathip; Karoonuthaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Talaat, Adel M.] Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI USA; [Sermswan, Rasana W.] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Wisconsin System; University of Wisconsin Madison; Khon Kaen University	Bartpho, T (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	rasana@kku.ac.th	Simawaranon Bartpho, Theeraya/GYI-9839-2022; Wongsurawat, Thidathip/K-5590-2019	Simawaranon Bartpho, Theeraya/0000-0001-9803-3588; 	Thailand Research Fund [RMU4980044]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0116/2548]	Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	Funding was provided by Thailand Research Fund RMU4980044, Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster (SHeP-GMS), Khon Kaen University, and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0116/2548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Bengtsson H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-177; Bengtsson H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-100; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jayapal KP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-229; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Loprasert S, 2003, ARCH MICROBIOL, V180, P498, DOI 10.1007/s00203-003-0621-9; Loprasert S, 2002, GENE, V296, P161, DOI 10.1016/S0378-1119(02)00854-5; Madigan M.T., 2006, BROCK BIOL MICROORGA; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Ong C, 2004, GENOME RES, V14, P2295, DOI 10.1101/gr.1608904; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; Samosornsuk N, 1999, AM J TROP MED HYG, V61, P735, DOI 10.4269/ajtmh.1999.61.735; Sarkar-Tyson M, 2007, J MED MICROBIOL, V56, P1005, DOI 10.1099/jmm.0.47043-0; Sarmiento-Rubiano LA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-504; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Tan P, 2002, TRENDS MICROBIOL, V10, P484, DOI 10.1016/S0966-842X(02)02465-4; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Vanaporn M, 2008, FEMS MICROBIOL LETT, V284, P191, DOI 10.1111/j.1574-6968.2008.01216.x; Vellasamy KM, 2009, MICROB PATHOGENESIS, V47, P111, DOI 10.1016/j.micpath.2009.06.003; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Weaver D, 2004, MOL MICROBIOL, V51, P1535, DOI 10.1111/j.1365-2958.2003.03920.x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Woo PCY, 2002, DIAGN MICR INFEC DIS, V44, P143, DOI 10.1016/S0732-8893(02)00439-X; Woods DE, 2002, TRENDS MICROBIOL, V10, P483, DOI 10.1016/S0966-842X(02)02464-2; Wu CW, 2006, J BACTERIOL, V188, P711, DOI 10.1128/JB.188.2.711-723.2006; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37762	10.1371/journal.pone.0037762	http://dx.doi.org/10.1371/journal.pone.0037762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675491	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900008
J	Clement, JAJ; Magalon, H; Glais, I; Jacquot, E; Andrivon, D				Clement, Julie A. J.; Magalon, Helene; Glais, Isabelle; Jacquot, Emmanuel; Andrivon, Didier			To Be or Not to Be Solitary: Phytophthora infestans' Dilemma for Optimizing its Reproductive Fitness in Multiple Infections	PLOS ONE			English	Article							WITHIN-HOST COMPETITION; INTRASPECIFIC COMPETITION; LATE BLIGHT; VIRULENCE; EVOLUTION; PARASITE; DYNAMICS; EPIDEMIOLOGY; ALLOCATION; SELECTION	The success of parasitic life lies in an optimal exploitation of the host to satisfy key functions directly involved in reproductive fitness. Resource availability generally decreases over time with host mortality, but also during multiple infections, where different strains of parasite share host resources. During multiple infections, the number of parasite strains and their genetic relatedness are known to influence their reproductive rates. Using infections of the potato plant Solanum tuberosum with the parasite Phytophthora infestans, we set up an experimental design to separate dose effects (double-vs. single-site infections) from genetic relatedness (different vs. identical genotypes) on the reproductive fitness of competing parasite genotypes. We showed the existence of two basic response patterns - increase or decrease in reproductive fitness in multiple infections-depending on the parasite genotype. In all cases, the intensity of the response of any genotype depended on the genotype of the competing strain. This diversity of responses to multiple infections is probably maintained by the fluctuating frequencies of multiple infections in nature, arising from variations in disease pressure over the course of an epidemic and between successive epidemics. It allows a rapid response of parasitic populations to changing environments, which are particularly intense in agricultural systems.	[Clement, Julie A. J.; Magalon, Helene; Glais, Isabelle; Jacquot, Emmanuel; Andrivon, Didier] Univ Rennes 1, Agrocampus Ouest, Inst Natl Rech Agron, Inst Genet Environm & Plant Protect, Le Rheu, France	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes	Clement, JAJ (corresponding author), Univ Perpignan Via Domitia, Ctr Natl Rech Sci, Lab Ecol & Evolut Interact, Perpignan, France.	jajclement@gmail.com	Clement, Julie/P-5978-2017; Magalon, Helene/ABH-1252-2020; Jacquot, Emmanuel/AAH-4367-2021	Magalon, Helene/0000-0002-7061-955X; Clement, Julie A.J./0000-0002-3243-9718	INRA; BBSRC; BIOExploit (EU) [FOOD-CT-2005-513959]; EMERFUNDIS (Agence Nationale de la Recherche) [07-BDIV-003]	INRA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BIOExploit (EU); EMERFUNDIS (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This research was part of the projects 'Invasion and persistence of plant pathogens' funded by INRA and BBSRC, EMERFUNDIS (Agence Nationale de la Recherche grant 07-BDIV-003) and BIOExploit (EU integrated project FOOD-CT-2005-513959). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andanson A, 2010, THESIS U NANCY 1 H P; ANDRIVON D, 1995, PHYTOPATHOLOGY, V85, P1053; Balmer O, 2009, ECOLOGY, V90, P3367, DOI 10.1890/08-2291.1; Bashey F, 2011, OIKOS, V120, P1539, DOI 10.1111/j.1600-0706.2011.19304.x; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Bonsall MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012440; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; BULL JJ, 1991, EVOLUTION, V45, P875, DOI [10.1111/j.1558-5646.1991.tb04356.x, 10.2307/2409695]; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Chamberlain M, 1997, ADV BOT RES, V24, P71; Choisy M, 2010, AM NAT, V175, pE105, DOI 10.1086/651587; Clement JAJ, 2010, J EVOLUTIONARY BIOL; Clement JAJ, 2011, REPROD STRATEGY HETE; Crawley MJ., 2007, R BOOK; Davies CM, 2002, PARASITOLOGY, V124, P31, DOI 10.1017/S0031182001008873; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; GALLEGLY ME, 1958, PHYTOPATHOLOGY, V48, P274; Gower CM, 2005, EVOLUTION, V59, P544, DOI 10.1111/j.0014-3820.2005.tb01014.x; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Maziero JMN, 2009, PLANT DIS, V93, P459, DOI 10.1094/PDIS-93-5-0459; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mideo N, 2009, TRENDS PARASITOL, V25, P261, DOI 10.1016/j.pt.2009.03.001; Pariaud B, 2009, PLANT PATHOL, V58, P409, DOI 10.1111/j.1365-3059.2009.02039.x; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; R Development Core Team, 2005, R LANG ENV STAT COMP; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Robertson NF, 1991, PHYTOPHTHORA INFESTA, V10, P1; Roff Derek A., 1992; Staves PA, 2010, EVOLUTION, V64, P2643, DOI 10.1111/j.1558-5646.2010.00999.x; Stearns S.C., 1992, pi; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; Vizoso DB, 2005, OECOLOGIA, V143, P157, DOI 10.1007/s00442-004-1771-4; Wargo AR, 2007, P ROY SOC B-BIOL SCI, V274, P2629, DOI 10.1098/rspb.2007.0873	43	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37838	10.1371/journal.pone.0037838	http://dx.doi.org/10.1371/journal.pone.0037838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675493	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900009
J	Cicek, MS; Cunningham, JM; Fridley, BL; Serie, DJ; Bamlet, WR; Diergaarde, B; Haile, RW; Le Marchand, L; Krontiris, TG; Younghusband, HB; Gallinger, S; Newcomb, PA; Hopper, JL; Jenkins, MA; Casey, G; Schumacher, F; Chen, Z; DeRycke, MS; Templeton, AS; Winship, I; Green, RC; Green, JS; Macrae, FA; Parry, S; Young, GP; Young, JP; Buchanan, D; Thomas, DC; Bishop, DT; Lindor, NM; Thibodeau, SN; Potter, JD; Goode, EL				Cicek, Mine S.; Cunningham, Julie M.; Fridley, Brooke L.; Serie, Daniel J.; Bamlet, William R.; Diergaarde, Brenda; Haile, Robert W.; Le Marchand, Loic; Krontiris, Theodore G.; Younghusband, H. Banfield; Gallinger, Steven; Newcomb, Polly A.; Hopper, John L.; Jenkins, Mark A.; Casey, Graham; Schumacher, Fredrick; Chen, Zhu; DeRycke, Melissa S.; Templeton, Allyson S.; Winship, Ingrid; Green, Roger C.; Green, Jane S.; Macrae, Finlay A.; Parry, Susan; Young, Graeme P.; Young, Joanne P.; Buchanan, Daniel; Thomas, Duncan C.; Bishop, D. Timothy; Lindor, Noralane M.; Thibodeau, Stephen N.; Potter, John D.; Goode, Ellen L.		Colon CFR	Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DEFECTIVE MISMATCH REPAIR; FAMILIAL COLON-CANCER; SUSCEPTIBILITY LOCI; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; GENES; SCAN; HEREDITARY; RISK	A substantial proportion of familial colorectal cancer (CRC) is not a consequence of known susceptibility loci, such as mismatch repair (MMR) genes, supporting the existence of additional loci. To identify novel CRC loci, we conducted a genome-wide linkage scan in 356 white families with no evidence of defective MMR (i.e., no loss of tumor expression of MMR proteins, no microsatellite instability (MSI)-high tumors, or no evidence of linkage to MMR genes). Families were ascertained via the Colon Cancer Family Registry multi-site NCI-supported consortium (Colon CFR), the City of Hope Comprehensive Cancer Center, and Memorial University of Newfoundland. A total of 1,612 individuals (average 5.0 per family including 2.2 affected) were genotyped using genome-wide single nucleotide polymorphism linkage arrays; parametric and non-parametric linkage analysis used MERLIN in a priori-defined family groups. Five lod scores greater than 3.0 were observed assuming heterogeneity. The greatest were among families with mean age of diagnosis less than 50 years at 4q21.1 (dominant HLOD = 4.51, alpha = 0.84, 145.40 cM, rs10518142) and among all families at 12q24.32 (dominant HLOD = 3.60, alpha = 0.48, 285.15 cM, rs952093). Among families with four or more affected individuals and among clinic-based families, a common peak was observed at 15q22.31 (101.40 cM, rs1477798; dominant HLOD = 3.07, alpha = 0.29; dominant HLOD = 3.03, alpha = 0.32, respectively). Analysis of families with only two affected individuals yielded a peak at 8q13.2 (recessive HLOD = 3.02, alpha = 0.51, 132.52 cM, rs1319036). These previously unreported linkage peaks demonstrate the continued utility of family-based data in complex traits and suggest that new CRC risk alleles remain to be elucidated.	[Cicek, Mine S.; Cunningham, Julie M.; Fridley, Brooke L.; Serie, Daniel J.; Bamlet, William R.; DeRycke, Melissa S.; Lindor, Noralane M.; Thibodeau, Stephen N.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Lab Med & Pathol & Med Genet, Coll Med, Rochester, MN 55905 USA; [Diergaarde, Brenda] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Haile, Robert W.; Casey, Graham; Schumacher, Fredrick; Chen, Zhu; Thomas, Duncan C.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Krontiris, Theodore G.] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA USA; [Younghusband, H. Banfield; Green, Roger C.; Green, Jane S.] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Gallinger, Steven] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Newcomb, Polly A.; Templeton, Allyson S.; Potter, John D.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Hopper, John L.; Jenkins, Mark A.; Winship, Ingrid] Univ Melbourne, Dept Publ Hlth, Melbourne, Vic 3010, Australia; [Hopper, John L.; Jenkins, Mark A.; Winship, Ingrid] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Macrae, Finlay A.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Parry, Susan] Auckland City Hosp, New Zealand Familial GI Canc Registry, Auckland, New Zealand; [Young, Graeme P.] Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA 5001, Australia; [Young, Joanne P.; Buchanan, Daniel] Queensland Inst Med Res, Familial Canc Lab, Brisbane, Qld 4006, Australia; [Bishop, D. Timothy] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol, Auckland 6, New Zealand	Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; City of Hope; Beckman Research Institute of City of Hope; Memorial University Newfoundland; University of Toronto; Fred Hutchinson Cancer Center; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Auckland City Hospital; Flinders University South Australia; QIMR Berghofer Medical Research Institute; University of Leeds; Massey University	Cicek, MS (corresponding author), Mayo Clin, Dept Hlth Sci Res, Lab Med & Pathol & Med Genet, Coll Med, Rochester, MN 55905 USA.	egoode@mayo.edu	Gallinger, Steven/E-4575-2013; Winship, Ingrid M/D-7204-2016; Jenkins, Mark/P-7803-2015; Young, Joanne P/H-7774-2014; Fridley, Brooke L/D-8315-2015; Schumacher, Fredrick/R-6043-2019	Jenkins, Mark/0000-0002-8964-6160; Fridley, Brooke L/0000-0001-7739-7956; Schumacher, Fredrick/0000-0002-3073-7463; Bishop, Tim/0000-0002-8752-8785; Diergaarde, Brenda/0000-0002-3578-6547; Buchanan, Daniel/0000-0003-2225-6675; Winship, Ingrid/0000-0001-8535-6003; Young, Graeme/0000-0001-9458-8383; Young, Joanne/0000-0002-1514-1522; Potter, John/0000-0001-5439-1500; Bamlet, William/0000-0003-2903-1284	Colon Cancer Family Registry and PIs [R01-CA104667]; NATIONAL CANCER INSTITUTE [U24CA074783, U01CA078296, U24CA074799, P30CA015704, U24CA074800, U01CA097735, U01CA074800, U01CA074783, U24CA074806, R25CA092049, U01CA074794, U24CA074794, U24CA097735, U01CA074806, U01CA074799, R01CA104667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019876] Funding Source: NIH RePORTER; Cancer Research UK [10589] Funding Source: researchfish	Colon Cancer Family Registry and PIs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK)	This work was supported by R01-CA104667 through cooperative agreements with the members of the Colon Cancer Family Registry and PIs. Collaborating centers include the Australian Colorectal Cancer Family Registry (UO1 CA097735), the USC Familial Colorectal Neoplasia Collaborative Group (UO1 CA074799), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (UO1 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (UO1 CA074783), Seattle Colorectal Cancer Family Registry (UO1 CA074794), University of Hawaii Colorectal Cancer Family Registry (UO1 CA074806), and University of California Irvine Informatics Center (UO1 CA078296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Boland CR, 1998, CANCER RES, V58, P5248; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Daley D, 2008, AM J HUM GENET, V82, P723, DOI 10.1016/j.ajhg.2008.01.007; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Djureinovic T, 2006, GUT, V55, P362, DOI 10.1136/gut.2005.075333; Easton DF, 2003, PROSTATE, V57, P261, DOI 10.1002/pros.10300; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Goode EL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S82; Gray-McGuire C, 2010, CANCER RES, V70, P5409, DOI 10.1158/0008-5472.CAN-10-0188; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Hemminki K, 2001, BRIT J CANCER, V84, P388, DOI 10.1054/bjoc.2000.1585; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jenkins MA, 2002, INT J CANCER, V102, P166, DOI 10.1002/ijc.10670; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Kemp ZE, 2006, CANCER RES, V66, P5003, DOI 10.1158/0008-5472.CAN-05-4074; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lu L, 2011, PROSTATE; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Middeldorp A, 2010, GENE CHROMOSOME CANC, V49, P539, DOI 10.1002/gcc.20763; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Neklason DW, 2008, CANCER RES, V68, P8993, DOI 10.1158/0008-5472.CAN-08-1376; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Nomoto H, 2003, J BIOCHEM, V134, P231, DOI 10.1093/jb/mvg135; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J., 1999, ANAL HUMAN GENETIC L; Perea J, 2010, WORLD J GASTROENTERO, V16, P3697, DOI 10.3748/wjg.v16.i29.3697; Peters U, 2011, HUMAN GENETICS; Picelli S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-87; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; RISCH N, 1990, AM J HUM GENET, V46, P229; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Siegel R., 2011, CA CANC J CLIN; Skoglund J, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.033928; Stuckless S, 2007, FAM CANCER, V6, P1, DOI 10.1007/s10689-006-0014-8; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	58	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38175	10.1371/journal.pone.0038175	http://dx.doi.org/10.1371/journal.pone.0038175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675446	Green Published, Green Accepted, gold			2022-12-25	WOS:000305338500103
J	Cloutier, S; Laverdiere, M; Chou, MN; Boilard, N; Chow, C; Papadopoulou, B				Cloutier, Serge; Laverdiere, Maxime; Chou, Marie-Noelle; Boilard, Nathalie; Chow, Conan; Papadopoulou, Barbara			Translational Control through eIF2alpha Phosphorylation during the Leishmania Differentiation Process	PLOS ONE			English	Article							IN-VITRO CULTIVATION; GENE-EXPRESSION; AXENIC AMASTIGOTES; DONOVANI; STAGE; INITIATION; STRESS; MODEL; PROMASTIGOTE; KINASES	The parasitic protozoan Leishmania alternates between an invertebrate and a mammalian host. Upon their entry to mammalian macrophages, Leishmania promastigotes differentiate into amastigote forms within the harsh environment of the phagolysosomal compartment. Here, we provide evidence for the importance of translational control during the Leishmania differentiation process. We find that exposure of promastigotes to a combined elevated temperature and acidic pH stress, a key signal triggering amastigote differentiation, leads to a marked decrease in global translation initiation, which is associated with eIF2 alpha phosphorylation. Interestingly, we show that amastigotes adapted to grow in a cell-free medium exhibit lower levels of protein synthesis in comparison to promastigotes, suggesting that amastigotes have to enter a slow growth state to adapt to the stressful conditions encountered inside macrophages. Reconversion of amastigotes back to promastigote growth results in upregulation of global translation and a decrease in eIF2 alpha phosphorylation. In addition, we show that while general translation is reduced during amastigote differentiation, translation of amastigote-specific transcripts such as A2 is preferentially upregulated. We find that A2 developmental gene regulation is triggered by temperature changes in the environment and that occurs mainly at the level of translation. Upon elevated temperature, the A2 transcript is stabilized through its association with polyribosomes leading to high levels of translation. When temperature decreases during amastigote to promastigote differentiation, the A2 transcript is not longer associated with translating polyribosomes and is being gradually degraded. Overall, these findings contribute to our better understanding of the adaptive responses of Leishmania to stress during its development and highlight the importance of translational control in promastigote to amastigote differentiation and vice-versa.	[Papadopoulou, Barbara] Univ Laval, CHUL Res Ctr, Infect Dis Res Ctr, Quebec City, PQ, Canada; Univ Laval, Fac Med, Dept Microbiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Cloutier, S (corresponding author), Univ Laval, CHUL Res Ctr, Infect Dis Res Ctr, Quebec City, PQ, Canada.	barbara.papadopoulou@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) [MOP-12182]; CIHR Research Doctoral Fellowship; Centre for Host-Parasite Interactions of the "Fonds Quebecois de la Recherche sur la Nature et les Technologies"; CIHR [STP-53924]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Research Doctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Centre for Host-Parasite Interactions of the "Fonds Quebecois de la Recherche sur la Nature et les Technologies"; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (MOP-12182) awarded to BP. SC was awarded by a CIHR Research Doctoral Fellowship and by a doctoral research bridging award from the Centre for Host-Parasite Interactions of the "Fonds Quebecois de la Recherche sur la Nature et les Technologies". CC was awarded by a postdoctoral fellowship from the CIHR STP-53924 Strategic Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea Pedro J, 2010, BMC Genomics, V11, P31, DOI 10.1186/1471-2164-11-31; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; BATES PA, 1994, EXP PARASITOL, V79, P215, DOI 10.1006/expr.1994.1084; BATES PA, 1992, PARASITOLOGY, V105, P193, DOI 10.1017/S0031182000074102; CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cohen-Freue G, 2007, INT J PARASITOL, V37, P1077, DOI 10.1016/j.ijpara.2007.04.011; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Gupta N, 2001, TRENDS PARASITOL, V17, P150, DOI 10.1016/S1471-4922(00)01811-0; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hem S, 2010, PROTEOMICS, V10, P3868, DOI 10.1002/pmic.201000305; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; McCall LI, 2010, MOL MICROBIOL, V77, P518, DOI 10.1111/j.1365-2958.2010.07229.x; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; McConville MJ, 2011, ANN REV MICROBIOL; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; McNicoll F, 2006, PROTEOMICS, V6, P3567, DOI 10.1002/pmic.200500853; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Paape D, 2008, MOL CELL PROTEOMICS, V7, P1688, DOI 10.1074/mcp.M700343-MCP200; RAINEY PM, 1991, MOL BIOCHEM PARASIT, V49, P111, DOI 10.1016/0166-6851(91)90134-R; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saxena A, 2007, MOL BIOCHEM PARASIT, V152, P53, DOI 10.1016/j.molbiopara.2006.11.011; Sereno D, 1998, ANTIMICROB AGENTS CH, V42, P3097, DOI 10.1128/AAC.42.12.3097; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P972, DOI 10.1128/AAC.41.5.972; Somanna A, 2002, ACTA TROP, V83, P37, DOI 10.1016/S0001-706X(02)00054-2; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; TURCO SJ, 1991, MOL BIOCHEM PARASIT, V45, P91, DOI 10.1016/0166-6851(91)90030-A; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	50	41	41	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35085	10.1371/journal.pone.0035085	http://dx.doi.org/10.1371/journal.pone.0035085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693545	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500006
J	Liu, Y; Wang, L; Long, ZY; Zeng, L; Wu, YM				Liu, Yuan; Wang, Li; Long, Zaiyun; Zeng, Lin; Wu, Yamin			Protoplasmic Astrocytes Enhance the Ability of Neural Stem Cells to Differentiate into Neurons In Vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; GROWTH-FACTORS; PROLIFERATION; REPAIR; CNS; PROGENITORS; ROLES	Protoplasmic astrocytes have been reported to exhibit neuroprotective effects on neurons, but there has been no direct evidence for a functional relationship between protoplasmic astrocytes and neural stem cells (NSCs). In this study, we examined neuronal differentiation of NSCs induced by protoplasmic astrocytes in a co-culture model. Protoplasmic astrocytes were isolated from new-born and NSCs from the E13-15 cortex of rats respectively. The differentiated cells labeled with neuron-specific marker beta-tubulin III, were dramatically increased at 7 days in the co-culture condition. Blocking the effects of brain-derived neurotrophic factor (BDNF) with an anti-BDNF antibody reduced the number of neurons differentiated from NSCs when co-cultured with protoplasmic astrocytes. In fact, the content of BDNF in the supernatant obtained from protoplasmic astrocytes and NSCs co-culture media was significantly greater than that from control media conditions. These results indicate that protoplasmic astrocytes promote neuronal differentiation of NSCs, which is driven, at least in part, by BDNF.	[Liu, Yuan; Wang, Li; Long, Zaiyun; Zeng, Lin; Wu, Yamin] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Daping Hosp, Inst Surg,Dept Res 3, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Daping Hosp, Inst Surg,Dept Res 3, Chongqing, Peoples R China.	yaminwu65@hotmail.com			National Natural Science Foundation of China [81000682]; Chongqing National Natural Science Fund [2008BB5276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing National Natural Science Fund	This work was supported by a grant from the National Natural Science Foundation of China (#81000682) and Chongqing National Natural Science Fund (#2008BB5276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Emsley JG, 2004, TRENDS NEUROSCI, V27, P238, DOI 10.1016/j.tins.2004.02.008; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4; Konagaya S, 2011, BIOMATERIALS, V32, P5015, DOI 10.1016/j.biomaterials.2011.03.066; Leng J, 2009, BRAIN RES, V1272, P14, DOI 10.1016/j.brainres.2009.03.048; Lepore AC, 2006, NEUROSCIENCE, V142, P285, DOI 10.1016/j.neuroscience.2005.12.068; Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047; Lu HX, 2008, BRAIN RES BULL, V77, P158, DOI 10.1016/j.brainresbull.2008.02.037; Meng XT, 2007, CELL BIOL INT, V31, P691, DOI 10.1016/j.cellbi.2006.11.038; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Naoko K, 2010, NEURON, V67, P213; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; ROSEWATER K, 1994, BRAIN RES, V636, P73, DOI 10.1016/0006-8993(94)90177-5; Sasaki R, 2010, NEUROSCI LETT, V479, P126, DOI 10.1016/j.neulet.2010.05.042; SHEHAB SAS, 1990, BRAIN RES, V518, P347, DOI 10.1016/0006-8993(90)90996-O; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wang L, 2011, J NEUROSCI METH, V194, P274, DOI 10.1016/j.jneumeth.2010.10.025; Wang Y, 2010, NEUROSCI LETT, V476, P74, DOI 10.1016/j.neulet.2010.04.006; Willerth SM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt58; Xuan AG, 2008, NEUROSCI LETT, V440, P331, DOI 10.1016/j.neulet.2008.05.107; Zeng WR, 2011, NEUROCHEM INT, V59, P394, DOI 10.1016/j.neuint.2011.04.002; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070	31	10	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38243	10.1371/journal.pone.0038243	http://dx.doi.org/10.1371/journal.pone.0038243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693605	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500116
J	Tweedie-Cullen, RY; Brunner, AM; Grossmann, J; Mohanna, S; Sichau, D; Nanni, P; Panse, C; Mansuy, IM				Tweedie-Cullen, Ry Y.; Brunner, Andrea M.; Grossmann, Jonas; Mohanna, Safa; Sichau, David; Nanni, Paolo; Panse, Christian; Mansuy, Isabelle M.			Identification of Combinatorial Patterns of Post-Translational Modifications on Individual Histones in the Mouse Brain	PLOS ONE			English	Article							DISSOCIATION MASS-SPECTROMETRY; LONG-TERM-MEMORY; PROTEIN-PHOSPHORYLATION; LYSINE-METHYLATION; H3 VARIANTS; CHROMATIN; ACETYLATION; CODE; H4; COGNITION	Post-translational modifications (PTMs) of proteins are biochemical processes required for cellular functions and signalling that occur in every sub-cellular compartment. Multiple protein PTMs exist, and are established by specific enzymes that can act in basal conditions and upon cellular activity. In the nucleus, histone proteins are subjected to numerous PTMs that together form a histone code that contributes to regulate transcriptional activity and gene expression. Despite their importance however, histone PTMs have remained poorly characterised in most tissues, in particular the brain where they are thought to be required for complex functions such as learning and memory formation. Here, we report the comprehensive identification of histone PTMs, of their combinatorial patterns, and of the rules that govern these patterns in the adult mouse brain. Based on liquid chromatography, electron transfer, and collision-induced dissociation mass spectrometry, we generated a dataset containing a total of 10,646 peptides from H1, H2A, H2B, H3, H4, and variants in the adult brain. 1475 of these peptides carried one or more PTMs, including 141 unique sites and a total of 58 novel sites not described before. We observed that these PTMs are not only classical modifications such as serine/threonine (Ser/Thr) phosphorylation, lysine (Lys) acetylation, and Lys/arginine (Arg) methylation, but also include several atypical modifications such as Ser/Thr acetylation, and Lys butyrylation, crotonylation, and propionylation. Using synthetic peptides, we validated the presence of these atypical novel PTMs in the mouse brain. The application of data-mining algorithms further revealed that histone PTMs occur in specific combinations with different ratios. Overall, the present data newly identify a specific histone code in the mouse brain and reveal its level of complexity, suggesting its potential relevance for higher-order brain functions.	[Tweedie-Cullen, Ry Y.; Brunner, Andrea M.; Mohanna, Safa; Sichau, David; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Fac Med, Zurich, Switzerland; [Tweedie-Cullen, Ry Y.; Brunner, Andrea M.; Mohanna, Safa; Sichau, David; Mansuy, Isabelle M.] ETH, Dept Biol, Zurich, Switzerland; [Grossmann, Jonas; Nanni, Paolo; Panse, Christian] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Tweedie-Cullen, RY (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, Boston, MA 02115 USA.	mansuy@hifo.uzh.ch	Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371; Brunner, Andrea Mizzi/0000-0002-2801-1751; Nanni, Paolo/0000-0001-8429-3557	University Zurich; Swiss Federal Institute of Technology; Swiss National Foundation; The National Centre for Competence in Research "Neural Plasticity and Repair"; Slack-Gyr Foundation; Bitterlin Foundation	University Zurich; Swiss Federal Institute of Technology; Swiss National Foundation(Swiss National Science Foundation (SNSF)); The National Centre for Competence in Research "Neural Plasticity and Repair"; Slack-Gyr Foundation; Bitterlin Foundation	The lab of IMM is funded by the University Zurich, the Swiss Federal Institute of Technology, the Swiss National Foundation, The National Centre for Competence in Research "Neural Plasticity and Repair", the Slack-Gyr Foundation, and the Bitterlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, P 1993 ACM SIGMOD IN, P207, DOI [10.1145/170035.170072, DOI 10.1145/170035.170072]; Baker M, 2011, NAT METHODS, V8, P717, DOI 10.1038/nmeth.1673; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bode AM, 2005, INDUCIBLE COVALENT P, pre4; Bodon F, 2006, SURVEY FREQUENT ITEM; Brunner AM, 2012, EPIGENETIC IN PRESS; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; Garcia BA, 2008, J PROTEOME RES, V7, P4225, DOI 10.1021/pr800044q; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia Benjamin A, 2009, Front Biosci (Schol Ed), V1, P142, DOI 10.2741/s14; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Graff J, 2010, LEARN MEMORY, V17, P355, DOI 10.1101/lm.1766510; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lieber DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014444; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Thomas T, 2008, MOL CELL BIOL, V28, P5093, DOI 10.1128/MCB.02202-07; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Tweedie-Cullen R. Y., 2009, POSTTRANSLATIONAL MO, P233; Tweedie-Cullen RY, 2010, AMINO ACIDS, V39, P1117, DOI 10.1007/s00726-010-0723-z; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200	56	111	112	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36980	10.1371/journal.pone.0036980	http://dx.doi.org/10.1371/journal.pone.0036980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693562	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305338500024
J	Armeanu-Ebinger, S; Wenz, J; Seitz, G; Leuschner, I; Handgretinger, R; Mau-Holzmann, UA; Bonin, M; Sipos, B; Fuchs, J; Warmann, SW				Armeanu-Ebinger, Sorin; Wenz, Julia; Seitz, Guido; Leuschner, Ivo; Handgretinger, Rupert; Mau-Holzmann, Ulrike A.; Bonin, Michael; Sipos, Bence; Fuchs, Joerg; Warmann, Steven W.			Characterisation of the Cell Line HC-AFW1 Derived from a Pediatric Hepatocellular Carcinoma	PLOS ONE			English	Article							BETA-CATENIN GENE; HUMAN HEPATOBLASTOMA; LIVER-TUMORS; CHILDHOOD; EXPRESSION; CANCER; HETEROZYGOSITY; ESTABLISHMENT; PATHWAYS; CHILDREN	Current treatment of paediatric hepatocellular carcinoma (HCC) is often inefficient due to advanced disease at diagnosis and resistance to common drugs. The aim of this study was to generate a cell line derived from a paediatric HCC in order to expand research in this field. We established the HC-AFW1 cell line from a liver neoplasm of a 4-year-old boy through culturing of primary tumor specimens. The cell line has been stable for over one year of culturing and has a doubling time of 40 h. The tumour cells have an epithelial histology and express HCC-associated proteins such as Alpha-fetoprotein (AFP), Glypican 3, E-cadherin, CD10, CD326, HepPar1 and Vimentin. Forty-nine amino acids in exon 3 of beta-Catenin that involve the phosphorylation sites of GSK3 were absent and beta-Catenin is detectable in the cell nuclei. Cytogenetic analysis revealed large anomalies in the chromosomal map. Several alterations of gene copy numbers were detected by genome-wide SNP array. Among the different drugs tested, cisplatin and irinotecan showed effective inhibition of tumour cell growth in a proliferation assay at concentrations below 5 mu g/ml. Subcutaneous xenotransplantation of HC-AFW1 cells into NOD/SCID mice resulted in fast growing dedifferentiated tumours with high levels of serum AFP. Histological analyses of the primary tumour and xenografts included national and international expert pathological review. Consensus reading characterised the primary tumour and the HC-AFW1-derived tumours as HCC. HC-AFW1 is the first cell line derived from a paediatric HCC without a background of viral hepatitis or cirrhosis and represents a valuable tool for investigating the biology of and therapeutic strategies for childhood HCC.	[Armeanu-Ebinger, Sorin; Wenz, Julia; Seitz, Guido; Fuchs, Joerg; Warmann, Steven W.] Univ Childrens Hosp Tubingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany; [Leuschner, Ivo] Univ Hosp Schleswig Holstein, Dept Pediat Pathol, Kiel, Germany; [Handgretinger, Rupert] Univ Childrens Hosp, Dept Pediat Oncol Hematol, Tubingen, Germany; [Mau-Holzmann, Ulrike A.; Bonin, Michael] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Sipos, Bence] Univ Tubingen, Dept Pathol, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Armeanu-Ebinger, S (corresponding author), Univ Childrens Hosp Tubingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany.	armeanu@uni-tuebingen.de	Seitz, Guido/G-2742-2015; Seitz, Guido/AAH-5460-2019	Seitz, Prof. Dr. Guido/0000-0001-9280-1451	Department of Pediatric Surgery, University Children's Hospital Tubingen	Department of Pediatric Surgery, University Children's Hospital Tubingen	This work was suported by the Department of Pediatric Surgery, University Children's Hospital Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Adesina AM, 2009, HUM PATHOL, V40, P843, DOI 10.1016/j.humpath.2008.10.022; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Brummendorf TH, 2001, ANN NY ACAD SCI, V938, P293; Chen TTL, 2009, PEDIATR BLOOD CANCER, V53, P1040, DOI 10.1002/pbc.22187; Crawley JJ, 2002, GENOME BIOL, V3; Czauderna P, 2002, MED PEDIATR ONCOL, V39, P519, DOI 10.1002/mpo.10178; Czauderna P, 2002, J CLIN ONCOL, V20, P2798, DOI 10.1200/JCO.2002.06.102; DOI I, 1976, GANN, V67, P1; Eicher C, 2011, INT J ONCOL, V38, P447, DOI 10.3892/ijo.2010.860; Fuchs J, 1996, J PEDIATR SURG, V31, P1241, DOI 10.1016/S0022-3468(96)90242-0; Gupta AA, 2011, PEDIATR BLOOD CANCER, V56, P1013, DOI 10.1002/pbc.22893; Kim H, 2000, LIVER, V20, P173, DOI 10.1034/j.1600-0676.2000.020002173.x; Koch A, 1999, CANCER RES, V59, P269; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Legoix P, 1999, ONCOGENE, V18, P4044, DOI 10.1038/sj.onc.1202800; Lopez-Terrada D, 2009, HUM PATHOL, V40, P1512, DOI 10.1016/j.humpath.2009.07.003; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Miyoshi Y, 1998, CANCER RES, V58, P2524; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Pietsch T, 1996, LAB INVEST, V74, P809; Prokurat A, 2002, MED PEDIATR ONCOL, V39, P510, DOI 10.1002/mpo.10177; Scheil S, 2003, INT J CANCER, V105, P347, DOI 10.1002/ijc.11082; Schmidt A, 2011, TOXICOLOGY, V281, P7, DOI 10.1016/j.tox.2011.01.006; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Van Nhieu JT, 1999, AM J PATHOL, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Wang LL, 2010, AM J SURG PATHOL, V34, P287, DOI 10.1097/PAS.0b013e3181ce5f1e; Warmann SW, 2008, J SURG RES, V144, P43, DOI 10.1016/j.jss.2007.03.054; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yu CW, 2006, BIOORG MED CHEM LETT, V16, P1686, DOI 10.1016/j.bmcl.2005.12.019; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	33	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38223	10.1371/journal.pone.0038223	http://dx.doi.org/10.1371/journal.pone.0038223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666492	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400105
J	Koenecke, C; Prinz, I; Bubke, A; Schreder, A; Lee, CW; Pabst, O; Forster, R				Koenecke, Christian; Prinz, Immo; Bubke, Anja; Schreder, Alina; Lee, Chun-Wei; Pabst, Oliver; Foerster, Reinhold			Shift of Graft-Versus-Host-Disease Target Organ Tropism by Dietary Vitamin A	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; BONE-MARROW-TRANSPLANTATION; ALLOREACTIVE T-CELLS; IN-VIVO; CHEMOKINE TECK; RECEPTOR CCR9; MECHANISMS; EXPRESSION; INTEGRIN; TREG	Gut-homing of donor T cells is causative for the development of intestinal GvHD in recipients of allogeneic hematopoietic stem cell transplantation (HSCT). Expression of the gut-specific homing receptors integrin-alpha 4 beta 7 and chemokine receptor CCR9 on T cells is imprinted in gut-associated lymphoid tissues (GALT) under the influence of the vitamin A metabolite retinoic acid. Here we addressed the role of vitamin A deficiency in HSCT-recipients for donor T cell migration in the course of experimental GvHD. Vitamin A-deficient (VAD) mice were prepared by feeding them a vitamin A-depleted diet. Experiments were performed in a C57BL/6 into BALB/c model of acute GvHD. We found that expression of integrin-alpha 4 beta 7 and CCR9 in GALT was reduced in VAD recipients after HSCT. Competitive in vivo homing assays showed that allogeneic T cells primed in VAD mice did not home as efficiently to the intestine as T cells primed in mice fed with standard diet (STD). The course of GvHD was ameliorated in VAD HSCT-recipients and, consequently, their survival was prolonged compared to recipients receiving STD. However, VAD-recipients were not protected and died of clinical GvHD. We found reduced numbers of donor T cells in the intestine but increased cell counts and tissue damage in other organs of VAD-recipients. Furthermore, we observed high IFN-gamma(+)CD4(+) and low FoxP3(+)CD4(+) frequencies of total donor CD4(+) T cells in VAD as compared to STD recipients. Taken together, these results indicate that dietary vitamin A deficiency in HSCT-recipients changed target organ tropism in GvHD but also resulted in fatal inflammation after HSCT.	[Koenecke, Christian; Prinz, Immo; Bubke, Anja; Schreder, Alina; Lee, Chun-Wei; Pabst, Oliver; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany	Hannover Medical School	Koenecke, C (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	koenecke.christian@mh-hannover.de	Förster, Reinhold/D-6770-2011; Prinz, Immo/A-3026-2010; Pabst, Oliver/H-5014-2016; Koenecke, Christian/C-3138-2009	Prinz, Immo/0000-0002-8789-9578; Pabst, Oliver/0000-0002-5533-883X; Koenecke, Christian/0000-0001-7025-1735; Forster, Reinhold/0000-0001-6190-7923	Deutsche Forschungsgemeinschaft [KO 3582/3-1]; Deutsche Krebshilfe [109451];  [SFB738-B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); 	This work was supported by grants from Deutsche Forschungsgemeinschaft KO 3582/3-1 (CK) URL: www.dfg.de, Deutsche Krebshilfe Nr. 109451 (CK) URL: www.krebshilfe.de, and SFB738-B5 (RF) URL: www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hammerschmidt SI, 2011, J CLIN INVEST, V178, P7211, DOI [10.1172/JCI44262DS1, DOI 10.1172/JCI44262DS1]; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kang SG, 2009, GASTROENTEROLOGY, V137, P1391, DOI 10.1053/j.gastro.2009.06.063; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Menning A, 2010, EUR J IMMUNOL, V40, P2539, DOI 10.1002/eji.200939938; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Tallman MS, 2005, NEW STRATEGIES TREAT, P143, DOI [10.1182/asheducation-2005.1.143, DOI 10.1182/ASHEDUCATION-2005.1.143]; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; Waldman E, 2006, BLOOD, V107, P1703, DOI 10.1182/blood-2005-08-3445; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; YASMINEH WG, 1989, TRANSPLANTATION, V48, P809, DOI 10.1097/00007890-198911000-00017; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	34	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38252	10.1371/journal.pone.0038252	http://dx.doi.org/10.1371/journal.pone.0038252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666498	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400110
J	Fredriksson, K; Fielhaber, JA; Lam, JK; Yao, XL; Meyer, KS; Keeran, KJ; Zywicke, GJ; Qu, X; Yu, ZX; Moss, J; Kristof, AS; Levine, SJ				Fredriksson, Karin; Fielhaber, Jill A.; Lam, Jonathan K.; Yao, Xianglan; Meyer, Katharine S.; Keeran, Karen J.; Zywicke, Gayle J.; Qu, Xuan; Yu, Zu-Xi; Moss, Joel; Kristof, Arnold S.; Levine, Stewart J.			Paradoxical Effects of Rapamycin on Experimental House Dust Mite-Induced Asthma	PLOS ONE			English	Article							MAMMALIAN TARGET; ALLERGIC INFLAMMATION; AIRWAY INFLAMMATION; IN-VITRO; MTOR; SIROLIMUS; PHOSPHORYLATION; EOSINOPHILS; SUPPRESSOR; THERAPY	The mammalian target of rapamycin (mTOR) modulates immune responses and cellular proliferation. The objective of this study was to assess whether inhibition of mTOR with rapamycin modifies disease severity in two experimental murine models of house dust mite (HDM)-induced asthma. In an induction model, rapamycin was administered to BALB/c mice coincident with nasal HDM challenges for 3 weeks. In a treatment model, nasal HDM challenges were performed for 6 weeks and rapamycin treatment was administered during weeks 4 through 6. In the induction model, rapamycin significantly attenuated airway inflammation, airway hyperreactivity (AHR) and goblet cell hyperplasia. In contrast, treatment of established HDM-induced asthma with rapamycin exacerbated AHR and airway inflammation, whereas goblet cell hyperplasia was not modified. Phosphorylation of the S6 ribosomal protein, which is downstream of mTORC1, was increased after 3 weeks, but not 6 weeks of HDM-challenge. Rapamycin reduced S6 phosphorylation in HDM-challenged mice in both the induction and treatment models. Thus, the paradoxical effects of rapamycin on asthma severity paralleled the activation of mTOR signaling. Lastly, mediastinal lymph node re-stimulation experiments showed that treatment of rapamycin-naive T cells with ex vivo rapamycin decreased antigen-specific Th2 cytokine production, whereas prior exposure to in vivo rapamycin rendered T cells refractory to the suppressive effects of ex vivo rapamycin. We conclude that rapamycin had paradoxical effects on the pathogenesis of experimental HDM-induced asthma. Thus, consistent with the context-dependent effects of rapamycin on inflammation, the timing of mTOR inhibition may be an important determinant of efficacy and toxicity in HDM-induced asthma.	[Fredriksson, Karin; Lam, Jonathan K.; Yao, Xianglan; Meyer, Katharine S.; Moss, Joel; Levine, Stewart J.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Keeran, Karen J.; Zywicke, Gayle J.] NHLBI, Lab Anim Med & Surg, NIH, Bethesda, MD 20892 USA; [Qu, Xuan; Yu, Zu-Xi] NHLBI, Pathol Core Facil, NIH, Bethesda, MD 20892 USA; [Fielhaber, Jill A.; Kristof, Arnold S.] McGill Univ, Dept Med, Ctr Hlth, Crit Care Div, Montreal, PQ, Canada; [Fielhaber, Jill A.; Kristof, Arnold S.] McGill Univ, Dept Med, Ctr Hlth, Div Resp, Montreal, PQ, Canada; [Fielhaber, Jill A.; Kristof, Arnold S.] McGill Univ, Meakins Christie Labs, Dept Med, Ctr Hlth, Montreal, PQ, Canada	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); McGill University; McGill University; McGill University	Fredriksson, K (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	levines@nhlbi.nih.gov			Division of Intramural Research of the National Heart, Lung, and Blood Institute of the National Institutes of Health; LAM Foundation; Tuberous Sclerosis Alliance; Canadian Institutes of Health; National Institutes of Health [R01 CA125436]; National Institutes of Health (NIH) [60/528,340]; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541, ZIAHL006056, ZIGHL006020, ZICHL005904] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); LAM Foundation; Tuberous Sclerosis Alliance; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Division of Intramural Research of the National Heart, Lung, and Blood Institute of the National Institutes of Health. ASK has received research support from the LAM Foundation, the Tuberous Sclerosis Alliance, the Canadian Institutes of Health, and the National Institutes of Health (R01 CA125436). ASK also has received funding through a National Institutes of Health Intramural Research Program Contract. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.; JM has received royalties from a patent (United States Provisional Patent Application No. 60/528,340 filed 09 Dec 2003) licensed from the National Institutes of Health (NIH) that is related to the topic of this manuscript. ASK has received research support from the LAM Foundation, the Canadian Institutes of Health, and the NIH (R01 CA125436). ASK also has received funding through a NIH Intramural Research Program Contract. ASK has a patent on a topic related to this manuscript (United States Provisional Patent Application No. 60/528,340 filed 09 Dec 2003). SJL has two patents that are unrelated to the topic of this manuscript (United States Patent 7,135,303, Filed February 28, 2001 and United States Patent 7,655,752 B2, Filed March 24, 2006). These competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the PLoS One guide for authors.	Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; De Alba J, 2010, EUR RESPIR J, V35, P1377, DOI 10.1183/09031936.00022908; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dittrich E, 2004, TRANSPL INT, V17, P215, DOI 10.1007/s00147-004-0700-0; Eynott PR, 2003, IMMUNOLOGY, V109, P461, DOI 10.1046/j.1365-2567.2003.01672.x; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Fujitani Y, 2003, AM J RESP CRIT CARE, V167, P193, DOI 10.1164/rccm.200205-455OC; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Ho IC, 2009, IMMUNITY, V30, P759, DOI 10.1016/j.immuni.2009.06.002; HOM JT, 1993, CLIN IMMUNOL IMMUNOP, V68, P293, DOI 10.1006/clin.1993.1130; Huang TJ, 2002, EUR J PHARMACOL, V437, P187, DOI 10.1016/S0014-2999(02)01295-5; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Korfhagen TR, 2009, AM J RESP CELL MOL, V41, P562, DOI 10.1165/rcmb.2008-0377OC; Kristof AS, 2010, LYMPHAT RES BIOL, V8, P33, DOI 10.1089/lrb.2009.0019; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Morelon E, 2000, NEW ENGL J MED, V343, P225, DOI 10.1056/NEJM200007203430317; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Thaunat O, 2005, TRANSPLANTATION, V80, P1212, DOI 10.1097/01.tp.0000179106.07382.6a; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Walters EH, 2008, CURR OPIN ALLERGY CL, V8, P39, DOI 10.1097/ACI.0b013e3282f42696; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Ying S, 1999, J IMMUNOL, V163, P3976; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC	43	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e33984	10.1371/journal.pone.0033984	http://dx.doi.org/10.1371/journal.pone.0033984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685525	Green Published, gold, Green Submitted			2022-12-25	WOS:000305342300002
J	Brown, J; Clasen, T				Brown, Joe; Clasen, Thomas			High Adherence Is Necessary to Realize Health Gains from Water Quality Interventions	PLOS ONE			English	Article							DRINKING-WATER; DEVELOPING-COUNTRIES; DIARRHEA; IMPACT; SANITATION; HOME	Background: Safe drinking water is critical for health. Household water treatment (HWT) has been recommended for improving access to potable water where existing sources are unsafe. Reports of low adherence to HWT may limit the usefulness of this approach, however. Methods and Findings: We constructed a quantitative microbial risk model to predict gains in health attributable to water quality interventions based on a range of assumptions about pre-treatment water quality; treatment effectiveness in reducing bacteria, viruses, and protozoan parasites; adherence to treatment interventions; volume of water consumed per person per day; and other variables. According to mean estimates, greater than 500 DALYs may be averted per 100,000 person-years with increased access to safe water, assuming moderately poor pre-treatment water quality that is a source of risk and high treatment adherence (>90% of water consumed is treated). A decline in adherence from 100% to 90% reduces predicted health gains by up to 96%, with sharpest declines when pre-treatment water quality is of higher risk. Conclusions: Results suggest that high adherence is essential in order to realize potential health gains from HWT.	[Brown, Joe; Clasen, Thomas] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Brown, J (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England.	joe.brown@lshtm.ac.uk			Unilever, Ltd.; Hindustan Unilever, Ltd.	Unilever, Ltd.; Hindustan Unilever, Ltd.	This research was supported in part by Unilever, Ltd., whose subsidiary, Hindustan Unilever, Ltd., (www.hul.co.in) manufactures and sells water treatment products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was supported in part by a grant to the London School of Hygiene & Tropical Medicine by Unilever, Ltd., which produces and sells point-of-use water treatment products including the Pureit (R) water filter. Unilever had no role in the design of the study, analysis of the data, or preparation and submission of the manuscript for publication. As an employee of LSHTM and otherwise, TC and JB provide research and consulting services to UN organizations, government agencies, NGOs and private companies that promote water, sanitation and hygiene interventions including point-of-use water treatment products. These include, without limitation, the World Health Organization, UNICEF, the United States Agency for International Development, the Department for International Development, Medentech, Unilever and Vestergaard-Frandsen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2009, DIARRH WHY CHILDR AR; [Anonymous], SAFE WATER ALL HARNE; [Anonymous], 2002, MANAGING WATER HOME; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; Brown J., 2007, USE CERAMIC WATER FI, Vvol. 1; Brown J, 2008, AM J TROP MED HYG, V79, P394, DOI 10.4269/ajtmh.2008.79.394; CHRISTIAN RR, 1983, APPL ENVIRON MICROB, V45, P603, DOI 10.1128/AEM.45.2.603-609.1983; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Colindres RE, 2007, J WATER HEALTH, V5, P367, DOI 10.2166/wh.2007.032; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Haas CN, 1996, WATER RES, V30, P1036, DOI 10.1016/0043-1354(95)00228-6; Havelaar A., 2003, QUANTIFYING PUBLIC H; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; Luby S, 2001, Int J Infect Dis, V5, P144, DOI 10.1016/S1201-9712(01)90089-X; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Mong Y, 2001, AM J PUBLIC HEALTH, V91, P1577, DOI 10.2105/AJPH.91.10.1577; NSF (National Sanitation Foundation now NSF-International), 2003, NSF P231 MICR WAT PU; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; US Environmental Protection Agency, 1987, GUID STAND PROT TEST; Waddington H., 2009, WATER SANITATION HYG; WHO, 2011, GUID DRINK WAT QUAL; WHO, 2011, EV HOUS WAT TREATM O; WHO UNICEF, 2012, PROGR SAN DRINK WAT; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2007, COMB WAT DIS HOUS LE; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	35	55	55	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36735	10.1371/journal.pone.0036735	http://dx.doi.org/10.1371/journal.pone.0036735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22685574	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305335000052
J	Akbay, EA; Pena, CG; Ruder, D; Michel, JA; Nakada, Y; Pathak, S; Multani, AS; Chang, S; Castrillon, DH				Akbay, E. A.; Pena, C. G.; Ruder, D.; Michel, J. A.; Nakada, Y.; Pathak, S.; Multani, A. S.; Chang, S.; Castrillon, D. H.			Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis	ONCOGENE			English	Article						endometrial cancer; shelterin; p53; telomeres; pot1a; mouse models	CELL-LINE; CANCER; DYSFUNCTION; COMPLEX; LENGTH; TRANSLOCATIONS; INSTABILITY; MUTATIONS; CARCINOMA; PTEN	Type II endometrial cancer (EMCA) represents only 10% of all EMCAs, but accounts for 40% of EMCA-related mortality. Previous studies of human tumors have shown an association between Type II tumors and damaged telomeres. We hypothesized that the lack of murine Type II EMCA models is due to the extremely long telomeres in laboratory mouse strains. We previously showed that telomerase-null mice with critically short telomeres developed endometrial lesions histologically resembling endometrial intraepithelial carcinoma (EIC), the accepted precursor for Type II EMCA. However, these mice did not develop invasive endometrial adenocarcinoma, and instead succumbed prematurely to multi-organ failure. Here, we modeled critical telomere attrition by conditionally inactivating Pot1a, a component of the shelterin complex that stabilizes telomeres, within endometrial epithelium. Inactivation of Pot1a by itself did not stimulate endometrial carcinogenesis, and did not result in detectable DNA damage or apoptosis in endometrium. However, simultaneous inactivation of Pot1a and p53 resulted in EIC-like lesions by 9 months indistinguishable from those seen in late generation telomerase-null mice. These lesions progressed to invasive endometrial adenocarcinomas as early as 9 months of age with metastatic disease in 100% of the animals by 15 months. These tumors were poorly differentiated endometrial adenocarcinomas with prominent nuclear atypia, resembling human Type II cancers. Furthermore, these tumors were aneuploid with double-stranded DNA breaks and end-to-end telomere fusions and most were tetraploid or near-tetraploid. These studies lend further support to the hypothesis that telomeric instability has a critical role in Type II endometrial carcinogenesis and provides an intriguing in-vivo correlate to recent studies implicating telomere-dependent tetraploidization as an important mechanism in carcinogenesis. Oncogene (2013) 32, 2211-2219; doi:10.1038/onc.2012.232; published online 11 June 2012	[Akbay, E. A.; Pena, C. G.; Ruder, D.; Michel, J. A.; Nakada, Y.; Castrillon, D. H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Akbay, E. A.; Pena, C. G.; Ruder, D.; Michel, J. A.; Nakada, Y.; Castrillon, D. H.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Pathak, S.] Univ Texas MD Anderson Canc Ctr, Cellular Genet Lab, Houston, TX 77030 USA; [Multani, A. S.] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Chang, S.] Yale Univ, Sch Med, Dept Lab Med & Pathol, New Haven, CT USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University	Castrillon, DH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	diego.castrillon@utsouthwestern.edu		Akbay, Esra/0000-0002-4149-2529; Ruder, Dennis/0000-0001-7605-111X	MD Anderson Molecular Cytogenetics Core for cytogenetic services (under Cancer Center Support) [NCI CA016672]; NCI [RO1CA129037]; Michal and Betty Kadoorie Cancer Genetic Research Program; NIH [NCI R01CA137181, NCI U01CA141576]; Cancer Prevention Research Institute of Texas [RP100550]; NATIONAL CANCER INSTITUTE [R01CA129037, P30CA016672, R01CA137181, U01CA141576] Funding Source: NIH RePORTER	MD Anderson Molecular Cytogenetics Core for cytogenetic services (under Cancer Center Support); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michal and Betty Kadoorie Cancer Genetic Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Florence Sibetya for help with the ploidy analyses, Teresa Gallardo for technical assistance, and the MD Anderson Molecular Cytogenetics Core for cytogenetic services (under Cancer Center Support Grant NCI CA016672). SC acknowledges support from the NCI (RO1CA129037) and the Michal and Betty Kadoorie Cancer Genetic Research Program. This work was supported by grants to DHC from the NIH (NCI R01CA137181, NCI U01CA141576) and the Cancer Prevention Research Institute of Texas (RP100550).	Akbay EA, 2008, AM J PATHOL, V173, P536, DOI 10.2353/ajpath.2008.071179; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Baerlocher GM, 2004, METHOD CELL BIOL, V75, P719; Batista LFZ, 2009, CANCER CELL, V15, P455, DOI 10.1016/j.ccr.2009.05.006; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Cirisano FD, 1999, GYNECOL ONCOL, V74, P385, DOI 10.1006/gyno.1999.5505; Clement PB, 2004, ADV ANAT PATHOL, V11, P117, DOI 10.1097/00125480-200405000-00001; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; DePinho RA, 2003, J CLIN INVEST, V111, pS9; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Friel Anne M, 2010, Front Biosci (Elite Ed), V2, P882; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HARKER WG, 1983, CANCER RES, V43, P4943; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kendellen MF, 2009, MOL CELL BIOL, V29, P5611, DOI 10.1128/MCB.00286-09; Kim TH, 2010, J ONCOL, V2010, DOI 10.1155/2010/139087; Lax S F, 2002, Zentralbl Gynakol, V124, P10; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; MacDonald ND, 2000, CANCER RES, V60, P1750; Meyer LA, 2009, CANCER CONTROL, V16, P14, DOI 10.1177/107327480901600103; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; NOUMOFF JS, 1988, GYNECOL ONCOL, V31, P217, DOI 10.1016/0090-8258(88)90297-1; Okuda T, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/984013; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pradhan M, 2006, MODERN PATHOL, V19, P1227, DOI 10.1038/modpathol.3800641; Qi L, 2005, NAT CELL BIOL, V7, P706, DOI 10.1038/ncb1276; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; RISINGER JI, 1993, CANCER RES, V53, P5100; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Soliman PT, 2007, OBSTET GYN CLIN N AM, V34, P701, DOI 10.1016/j.ogc.2007.09.003; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tashiro H, 1997, AM J PATHOL, V150, P177; Thanasoula M, 2010, CURR BIOL, V20, P521, DOI 10.1016/j.cub.2010.01.046; Ueda SM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.075; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037	56	22	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2211	2219		10.1038/onc.2012.232	http://dx.doi.org/10.1038/onc.2012.232			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22689059	Green Published, hybrid			2022-12-25	WOS:000318062800010
J	Khalimonchuk, O; Kim, H; Watts, T; Perez-Martinez, X; Winge, DR				Khalimonchuk, Oleh; Kim, Hyung; Watts, Talina; Perez-Martinez, Xochitl; Winge, Dennis R.			Oligomerization of Heme o Synthase in Cytochrome Oxidase Biogenesis Is Mediated by Cytochrome Oxidase Assembly Factor Coa2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL MATRIX; YEAST; COX1; BIOSYNTHESIS; EXPRESSION; FARNESYLTRANSFERASE; DEFICIENCY; MATURATION	The synthesis of the heme a cofactor used in cytochrome c oxidase (CcO) is dependent on the sequential action of heme o synthase (Cox10) and heme a synthase (Cox15). The active state of Cox10 appears to be a homo-oligomeric complex, and formation of this complex is dependent on the newly synthesized CcO subunit Cox1 and the presence of an early Cox1 assembly intermediate. Cox10 multimerization is triggered by progression of Cox1 from the early assembly intermediate to downstream intermediates. The CcOassembly factor Coa2 appears important in coupling the presence of newly synthesized Cox1 to Cox10 oligomerization. Cells lacking Coa2 are impaired in Cox10 complex formation as well as the formation of a high mass Cox15 complex. Increasing Cox1 synthesis in coa2 Delta cells restores respiratory function if Cox10 protein levels are elevated. The C-terminal segment of Cox1 is important in triggering Cox10 oligomerization. Expression of the C-terminal 54 residues of Cox1 appended to a heterologous matrix protein leads to efficient Cox10 complex formation in coa2 Delta cells, but it fails to induce Cox15 complex formation. The state of Cox10 was evaluated in mutants, which predispose human patients to CcO deficiency and the neurological disorder Leigh syndrome. The presence of the D336V mutation in the yeast Cox10 backbone results in a catalytically inactive enzyme that is fully competent to oligomerize. Thus, Cox10 oligomerization and catalytic activation are separate processes and can be uncoupled.	[Khalimonchuk, Oleh; Kim, Hyung; Watts, Talina; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Khalimonchuk, Oleh; Kim, Hyung; Watts, Talina; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Dept Mol Genet, Mexico City 04510, DF, Mexico	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Universidad Nacional Autonoma de Mexico	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, SOM 5C 426, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health from the NIEHS [ES03817]; American Heart Association [10POST4300044]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN82505];  [T32 DK007115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; American Heart Association(American Heart Association); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES03817 from the NIEHS (to D. R. W.) and Training Grant T32 DK007115 (to H. K.). This work was also supported by American Heart Association Grant 10POST4300044 (to O. K.) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico Grant IN82505 (to X. P.-M.).	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAUM G, 1982, J BIOL CHEM, V257, P3028; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Mogi T, 2009, J BIOCHEM, V145, P669, DOI 10.1093/jb/mvp024; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Vempati UD, 2008, METHODS, V46, P241, DOI 10.1016/j.ymeth.2008.09.008; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	31	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26715	26726		10.1074/jbc.M112.377200	http://dx.doi.org/10.1074/jbc.M112.377200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22669974	Green Published, hybrid			2022-12-25	WOS:000307386000022
J	Beam, M; Silva, MC; Morimoto, RI				Beam, Monica; Catarina Silva, M.; Morimoto, Richard I.			Dynamic Imaging by Fluorescence Correlation Spectroscopy Identifies Diverse Populations of Polyglutamine Oligomers Formed in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-LIKE FIBRILS; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; MUTANT HUNTINGTIN; ALPHA-SYNUCLEIN; MONOMERIC POLYGLUTAMINE; AGGREGATION NUCLEATION; PEPTIDE AGGREGATION; PROTEIN AGGREGATION; INCLUSION FORMATION	Protein misfolding and aggregation are exacerbated by aging and diseases of protein conformation including neurodegeneration, metabolic diseases, and cancer. In the cellular environment, aggregates can exist as discrete entities, or heterogeneous complexes of diverse solubility and conformational state. In this study, we have examined the in vivo dynamics of aggregation using imaging methods including fluorescence microscopy, fluorescence recovery after photobleaching (FRAP), and fluorescence correlation spectroscopy (FCS), to monitor the diverse biophysical states of expanded polyglutamine (polyQ) proteins expressed in Caenorhabditis elegans. We show that monomers, oligomers and aggregates co-exist at different concentrations in young and aged animals expressing different polyQ-lengths. During aging, when aggregation and toxicity are exacerbated, FCS-based burst analysis and purified single molecule FCS detected a populational shift toward an increase in the frequency of brighter and larger oligomeric species. Regardless of age or polyQ-length, oligomers were maintained in a heterogeneous distribution that spans multiple orders of magnitude in brightness. We employed genetic suppressors that prevent polyQ aggregation and observed a reduction in visible immobile species with the persistence of heterogeneous oligomers, yet our analysis did not detect the appearance of any discrete oligomeric states associated with toxicity. These studies reveal that the reversible transition from monomers to immobile aggregates is not represented by discrete oligomeric states, but rather suggests that the process of aggregation involves a more complex pattern of molecular interactions of diverse intermediate species that can appear in vivo and contribute to aggregate formation and toxicity.	[Beam, Monica; Catarina Silva, M.; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA; [Catarina Silva, M.] Univ Lisbon, Fac Ciencias, Dept Chem & Biochem, P-1749016 Lisbon, Portugal; [Beam, Monica] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Northwestern University; Universidade de Lisboa; Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu			National Institute of Health (NIGMS); Huntington's Disease Society of America Coalition for the Cure; Ellison Foundation; Daniel F. and Ada L. Rice Foundation; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/28461/2006]; National Institute of Health (NIA); National Institute of Health (NINDS); NATIONAL INSTITUTE ON AGING [R37AG026647] Funding Source: NIH RePORTER	National Institute of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Huntington's Disease Society of America Coalition for the Cure; Ellison Foundation(Lawrence Ellison Foundation); Daniel F. and Ada L. Rice Foundation; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the National Institutes of Health (NIGMS, NIA, NINDS), the Huntington's Disease Society of America Coalition for the Cure, the Ellison Foundation, and the Daniel F. and Ada L. Rice Foundation (to R. I. M).), and the Portuguese Fundacao para a Ciencia e Tecnologia SFRH/BD/28461/2006 (to M. C. S).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bernacki JP, 2011, BIOCHEMISTRY-US, V50, P9200, DOI 10.1021/bi201155g; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Boukari H, 2003, BIOCHEMISTRY-US, V42, P1292, DOI 10.1021/bi026751q; BRENNER S, 1974, GENETICS, V77, P71; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Elson EL, 2004, J BIOMED OPT, V9, P857, DOI 10.1117/1.1779234; Esler WP, 2000, J STRUCT BIOL, V130, P174, DOI 10.1006/jsbi.2000.4276; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Haustein E, 2004, CURR OPIN STRUC BIOL, V14, P531, DOI 10.1016/j.sbi.2004.09.004; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Herrera Federico, 2011, PLoS Curr, V3, pRRN1210, DOI 10.1371/currents.RRN1210; Inouye H, 2000, J STRUCT BIOL, V130, P123, DOI 10.1006/jsbi.2000.4258; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; Kubota H, 2011, METHODS, V53, P267, DOI 10.1016/j.ymeth.2010.12.035; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Laurence TA, 2007, BIOPHYS J, V92, P2184, DOI 10.1529/biophysj.106.093591; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Vitalis A, 2011, BIOPHYS CHEM, V159, P14, DOI 10.1016/j.bpc.2011.04.006; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Wang ZF, 2006, BIOPHYS J, V91, P343, DOI 10.1529/biophysj.105.077891; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	84	18	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26136	26145		10.1074/jbc.M112.362764	http://dx.doi.org/10.1074/jbc.M112.362764			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669943	Green Published, hybrid			2022-12-25	WOS:000306916300041
J	Khan, SK; Xu, HY; Ukai-Tadenuma, M; Burton, B; Wang, YM; Ueda, HR; Liu, AC				Khan, Sanjoy K.; Xu, Haiyan; Ukai-Tadenuma, Maki; Burton, Brittany; Wang, Yongmei; Ueda, Hiroki R.; Liu, Andrew C.			Identification of a Novel Cryptochrome Differentiating Domain Required for Feedback Repression in Circadian Clock Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; GENE-EXPRESSION; MAMMALIAN CRY1; PROTEIN; MCRY2; PHOSPHORYLATION; MECHANISMS; TIME; PHOTORECEPTOR	Circadian clocks in mammals are based on a negative feedback loop in which transcriptional repression by the cryptochromes, CRY1 and CRY2, lies at the heart of the mechanism. Despite similarities in sequence, domain structure, and biochemical activity, they play distinct roles in clock function. However, detailed biochemical studies have not been straightforward and Cry function has not been examined in real clock cells using kinetic measurements. In this study, we demonstrate, through cell-based genetic complementation and real-time molecular recording, that Cry1 alone is able to maintain cell-autonomous circadian rhythms, whereas Cry2 cannot. Using this novel functional assay, we identify a cryptochrome differentiating alpha-helical domain within the photolyase homology region (PHR) of CRY1, designated as CRY1-PHR(313-426), that is required for clock function and distinguishes CRY1 from CRY2. Contrary to speculation, the divergent carboxyl-terminal tail domain (CTD) is dispensable, but serves to modulate rhythm amplitude and period length. Finally, we identify the biochemical basis of their distinct function; CRY1 is a much more potent transcriptional repressor than CRY2, and the strength of repression by various forms of CRY proteins significantly correlates with rhythm amplitude. Taken together, our results demonstrate that CRY1-PHR(313-426), not the divergent CTD, is critical for clock function. These findings provide novel insights into the evolution of the diverse functions of the photolyase/cryptochrome family of flavoproteins and offer new opportunities for mechanistic studies of CRY function.	[Khan, Sanjoy K.; Xu, Haiyan; Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Burton, Brittany; Wang, Yongmei] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Ukai-Tadenuma, Maki; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Memphis; University of Memphis; RIKEN; RIKEN; RIKEN	Liu, AC (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	acliu@memphis.edu	Wang, Yongmei/B-7071-2008; Liu, Andrew C/B-3548-2009; Ueda, Hiroki R/C-5037-2014	Wang, Yongmei/0000-0002-7418-9489; Liu, Andrew C/0000-0003-1927-0900; Ueda, Hiroki R/0000-0001-8342-9176	National Science Foundation [IOS-0920417]; RIKEN Center for Developmental Biology (CDB); MEXT, Japan [23115006]	National Science Foundation(National Science Foundation (NSF)); RIKEN Center for Developmental Biology (CDB); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Science Foundation Grant IOS-0920417 (to A. C. L.), an intramural Grant-in-aid from the RIKEN Center for Developmental Biology (CDB) (to H. R. U.), and a Grant-in-aid for Scientific Research on Innovative Areas "Spying Minority in Biological Phenomena number 3306" (23115006) of MEXT, Japan (to H. R. U.).	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roy A., 2011, JOVE-J VIS EXP, V57, P3250; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Schalie EA, 2007, MOL CELL BIOL, V27, P2120, DOI 10.1128/MCB.01638-06; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	56	51	54	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25917	25926		10.1074/jbc.M112.368001	http://dx.doi.org/10.1074/jbc.M112.368001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692217	Green Published, hybrid			2022-12-25	WOS:000306916300020
J	Wang, JN; Han, XZ; Feng, XJ; Wang, ZH; Zhang, YW				Wang, Jingna; Han, Xiangzi; Feng, Xiujing; Wang, Zhenghe; Zhang, Youwei			Coupling Cellular Localization and Function of Checkpoint Kinase 1 (Chk1) in Checkpoints and Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATR; PHOSPHORYLATION	Chk1 plays a key role in regulating the replication checkpoint and DNA damage response. Recent evidence suggests that mammalian Chk1 regulates both the nuclear and cytoplasmic checkpoint events. However, mechanisms regulating cellular mobilization of Chk1 were not well understood. Here, we report the identification of regions of human Chk1 that regulate its protein cellular localization and checkpoint function. We demonstrate that the two highly conserved motifs (CM1 and CM2) at the C terminus of Chk1 function as a nuclear export signal and nuclear localization signal, respectively. Mutating five highly conserved residues within these two motifs of Chk1 resulted in its accumulation mainly in the cytoplasm. These cytoplasmic Chk1 mutants were less stable and exhibited significantly reduced phosphorylation by DNA damage treatment, yet they retained, at least partially, checkpoint function. Using an adenovirus-mediated gene targeting technique, we attempted to create an HCT116 cell line in which endogenous Chk1 is mutated so that it is expressed exclusively in the cytoplasm. However, we failed to obtain homozygous mutant cell lines. We found that even the heterozygous mutant cell lines showed cell survival defects accompanied by spontaneous cell death. Together, these results reveal novel regulatory mechanisms that couple protein cellular localization with the checkpoint response and cell viability of Chk1.	[Wang, Jingna; Han, Xiangzi; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Feng, Xiujing; Wang, Zhenghe] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, Wood Bldg,W343A,2109 Adelbert Rd, Cleveland, OH 44106 USA.	yxz169@case.edu			National Institutes of Health Howard Temin Career Development Award [R00CA126173]; NCI [R01 CA163214]; American Cancer Society Pilot Grant [IRG-91-022-15]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA163214, R00CA126173] Funding Source: NIH RePORTER	National Institutes of Health Howard Temin Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Pilot Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Howard Temin Career Development Award R00CA126173 and Grant R01 CA163214 from NCI (to Y. W. Z.). This work was also supported by American Cancer Society Pilot Grant IRG-91-022-15 (to Y. W. Z.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Enomoto M, 2009, J BIOL CHEM, V284, P34223, DOI 10.1074/jbc.C109.051540; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Takai H, 2000, GENE DEV, V14, P1439; Wang JN, 2011, CELL CYCLE, V10, P500, DOI 10.4161/cc.10.3.14753; Xu N, 2012, ONCOGENE, V31, P1086, DOI 10.1038/onc.2011.310; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2006, CELL CYCLE, V5, P125, DOI 10.4161/cc.5.2.2308; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	29	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25501	25509		10.1074/jbc.M112.350397	http://dx.doi.org/10.1074/jbc.M112.350397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22692200	Green Published, hybrid			2022-12-25	WOS:000306651700056
J	Ekeowa-Anderson, AL; Purdie, KJ; Gibbon, K; Byrne, CR; Arbeit, JM; Harwood, CA; O'Shaughnessy, RFL				Ekeowa-Anderson, Arucha L.; Purdie, Karin J.; Gibbon, Karen; Byrne, Carolyn R.; Arbeit, Jeffrey M.; Harwood, Catherine A.; O'Shaughnessy, Ryan F. L.			AKT1 Loss Correlates with Episomal HPV16 in Vulval Intraepithelial Neoplasia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NONMELANOMA SKIN-CANCER; VIRAL INTEGRATION; LESIONS; INFECTION; PCR; IDENTIFICATION; INDIVIDUALS; CARCINOMA; INCREASE	Anogenital malignancy has a significant association with high-risk mucosal alpha-human papillomaviruses (alpha-PV), particularly HPV 16 and 18 whereas extragenital SCC has been linked to the presence of cutaneous beta and gamma-HPV types. Vulval skin may be colonised by both mucosal and cutaneous (beta-, mu-, nu-and gamma-) PV types, but there are few systematic studies investigating their presence and their relative contributions to vulval malignancy. Dysregulation of AKT, a serine/threonine kinase, plays a significant role in several cancers. Mucosal HPV types can increase AKT phosphorylation and activity whereas cutaneous HPV types down-regulate AKT1 expression, probably to weaken the cornified envelope to promote viral release. We assessed the presence of mucosal and cutaneous HPV in vulval malignancy and its relationship to AKT1 expression in order to establish the corresponding HPV and AKT1 profile of normal vulval skin, vulval intraepithelial neoplasia (VIN) and vulval squamous cell carcinoma (vSCC). We show that HPV16 is the principle HPV type present in VIN, there were few detectable beta types present and AKT1 loss was not associated with the presence of these cutaneous HPV. We show that HPV16 early gene expression reduced AKT1 expression in transgenic mouse epidermis. AKT1 loss in our VIN cohort correlated with presence of high copy number, episomal HPV16. Maintained AKT1 expression correlated with low copy number, an increased frequency of integration and increased HPV16E7 expression, a finding we replicated in another untyped cohort of vSCC. Since expression of E7 reflects tumour progression, these findings suggest that AKT1 loss associated with episomal HPV16 may have positive prognostic implications in vulval malignancy.	[Ekeowa-Anderson, Arucha L.; Purdie, Karin J.; Gibbon, Karen; Byrne, Carolyn R.; Harwood, Catherine A.; O'Shaughnessy, Ryan F. L.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London, England; [Ekeowa-Anderson, Arucha L.; Gibbon, Karen] Whipps Cross Univ Hosp, Dept Dermatol, London, England; [O'Shaughnessy, Ryan F. L.] UCL, Inst Child Hlth, Dept Immunobiol, London, England; [O'Shaughnessy, Ryan F. L.] UCL, Inst Child Hlth, Dept Dermatol, London, England; [Arbeit, Jeffrey M.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Washington University (WUSTL)	Ekeowa-Anderson, AL (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London, England.	r.oshaughnessy@ich.ucl.ac.uk	Arbeit, Jeffrey/K-6920-2019	Harwood, Catherine/0000-0002-1375-0965; O'Shaughnessy, Ryan/0000-0002-3701-0267	Wellcome Trust; Barts and the London Charitable Foundation; Cancer Research UK; British Skin Foundation; Cancer Research UK [13044] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W0907] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Barts and the London Charitable Foundation; Cancer Research UK(Cancer Research UK); British Skin Foundation; Cancer Research UK(Cancer Research UK); Great Ormond Street Hospital Childrens Charity	ROS is funded by the Wellcome Trust and Barts and the London Charitable Foundation, CB is funded by Cancer Research UK, KJP and CAH are funded by Cancer Research UK, the British Skin Foundation and Barts and the London Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Davy C, 2009, VIROLOGY, V394, P266, DOI 10.1016/j.virol.2009.08.035; De Koning M, 2005, METH MOLEC MED, V119, P115; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Flores R, 2006, INT J CANCER, V118, P1187, DOI 10.1002/ijc.21477; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; Harwood CA, 2002, CURR OPIN INFECT DIS, V15, P101, DOI 10.1097/00001432-200204000-00002; Jones RW, 2001, EUR J GYNAECOL ONCOL, V22, P393; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Menges CW, 2006, CANCER RES, V66, P5555, DOI 10.1158/0008-5472.CAN-06-0499; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; O'Shaughnessy RFL, 2007, CANCER RES, V67, P8207, DOI 10.1158/0008-5472.CAN-07-0755; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; Raj K, 2004, J VIROL, V78, P7199, DOI 10.1128/JVI.78.13.7199-7207.2004; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Scurry J, 1999, INT J GYNECOL CANCER, V9, P187; Shtilbans V, 2008, ANN DIAGN PATHOL, V12, P153, DOI 10.1016/j.anndiagpath.2007.12.001; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Theelen W, 2010, AM J PATHOL, V177, P2022, DOI 10.2353/ajpath.2010.090901; van de Nieuwenhof HP, 2008, CRIT REV ONCOL HEMAT, V68, P131, DOI 10.1016/j.critrevonc.2008.02.012; Weissenborn SJ, 2003, J CLIN MICROBIOL, V41, P2763, DOI 10.1128/JCM.41.6.2763-2767.2003; Winder DM, 2007, J PATHOL, V213, P27, DOI 10.1002/path.2206	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38608	10.1371/journal.pone.0038608	http://dx.doi.org/10.1371/journal.pone.0038608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685591	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700054
J	Leen, EN; Baeza, G; Curry, S				Leen, Eoin N.; Baeza, Gabriela; Curry, Stephen			Structure of a Murine Norovirus NS6 Protease-Product Complex Revealed by Adventitious Crystallisation	PLOS ONE			English	Article							VIRUS 3C PROTEASE; RAY CRYSTALLOGRAPHIC STRUCTURE; DISEASE VIRUS; CRYSTAL-STRUCTURE; CLEAVAGE SITES; NONSTRUCTURAL POLYPROTEIN; 3C-LIKE PROTEASE; BINDING SITE; ACTIVE-SITE; FOOT	Murine noroviruses have emerged as a valuable tool for investigating the molecular basis of infection and pathogenesis of the closely related human noroviruses, which are the major cause of non-bacterial gastroenteritis. The replication of noroviruses relies on the proteolytic processing of a large polyprotein precursor into six non-structural proteins (NS1-2, NS3, NS4, NS5, NS6(pro), NS7(pol)) by the virally-encoded NS6 protease. We report here the crystal structure of MNV NS6(pro), which has been determined to a resolution of 1.6 angstrom. Adventitiously, the crystal contacts are mediated in part by the binding of the C-terminus of NS6(pro) within the peptide-binding cleft of a neighbouring molecule. This insertion occurs for both molecules in the asymmetric unit of the crystal in a manner that is consistent with physiologically-relevant binding, thereby providing two independent views of a protease-peptide complex. Since the NS6(pro) C-terminus is formed in vivo by NS6 pro processing, these crystal contacts replicate the protease-product complex that is formed immediately following cleavage of the peptide bond at the NS6-NS7 junction. The observed mode of binding of the C-terminal product peptide yields new insights into the structural basis of NS6(pro) specificity.	[Leen, Eoin N.; Baeza, Gabriela; Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Leen, EN (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England.	s.curry@imperial.ac.uk		Curry, Stephen/0000-0002-0552-8870; Leen, Eoin/0000-0002-1845-5949	Wellcome trust United Kingdom [GR083248]; Biotechnology and Biological Sciences Research Council [BB/J001708/1]; BBSRC [BB/J001708/1] Funding Source: UKRI	Wellcome trust United Kingdom(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Wellcome trust United Kingdom (Ref. GR083248) and the Biotechnology and Biological Sciences Research Council Ref BB/J001708/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Blakeney SJ, 2003, VIROLOGY, V308, P216, DOI 10.1016/S0042-6822(03)00004-7; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curry S, 2007, INT J BIOCHEM CELL B, V39, P1, DOI 10.1016/j.biocel.2006.07.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Hardy ME, 2002, VIRUS RES, V89, P29, DOI 10.1016/S0168-1702(02)00114-4; Hussey RJ, 2010, BIOCHEMISTRY; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahan SM, 2011, VIROLOGY, V421, P202, DOI 10.1016/j.virol.2011.09.030; Liu BL, 1996, J VIROL, V70, P2605, DOI 10.1128/JVI.70.4.2605-2610.1996; Liu BL, 1999, J GEN VIROL, V80, P291, DOI 10.1099/0022-1317-80-2-291; Lu GW, 2011, J VIROL, V85, P10319, DOI 10.1128/JVI.00787-11; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Nakamura K, 2005, J VIROL, V79, P13685, DOI 10.1128/JVI.79.21.13685-13693.2005; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHAFFER FL, 1980, J GEN VIROL, V47, P215, DOI 10.1099/0022-1317-47-1-215; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sharp TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013130; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P65; Sweeney TR, 2007, J VIROL, V81, P115, DOI 10.1128/JVI.01587-06; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; WIRBLICH C, 1995, J VIROL, V69, P7159, DOI 10.1128/JVI.69.11.7159-7168.1995; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yin J, 2005, J MOL BIOL, V354, P854, DOI 10.1016/j.jmb.2005.09.074; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; Zeitler CE, 2006, J VIROL, V80, P5050, DOI 10.1128/JVI.80.10.5050-5058.2006; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200; Zunszain PA, 2010, J MOL BIOL, V395, P375, DOI 10.1016/j.jmb.2009.10.048	45	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38723	10.1371/journal.pone.0038723	http://dx.doi.org/10.1371/journal.pone.0038723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685603	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700066
J	Smit, LAM; van der Sman-de Beer, F; Opstal-van Winden, AWJ; Hooiveld, M; Beekhuizen, J; Wouters, IM; Yzermans, J; Heederik, D				Smit, Lidwien A. M.; van der Sman-de Beer, Femke; Opstal-van Winden, Annemieke W. J.; Hooiveld, Mariette; Beekhuizen, Johan; Wouters, Inge M.; Yzermans, Joris; Heederik, Dick			Q Fever and Pneumonia in an Area with a High Livestock Density: A Large Population-Based Study	PLOS ONE			English	Article							ANIMAL FEEDING OPERATIONS; NETHERLANDS; OUTBREAK; HEALTH; EPIDEMIOLOGY; EXPOSURE; HISTORY; SYSTEM	Concerns about public health risks of intensive animal production in the Netherlands continue to rise, in particular related to outbreaks of infectious diseases. The aim was to investigate associations between the presence of farm animals around the home address and Q fever and pneumonia. Electronic medical record data for the year 2009 of all patients of 27 general practitioners (GPs) in a region with a high density of animal farms were used. Density of farm animals around the home address was calculated using a Geographic Information System. During the study period, a large Q fever outbreak occurred in this region. Associations between farm exposure variables and pneumonia or 'other infectious disease', the diagnosis code used by GPs for registration of Q fever, were analyzed in 22,406 children (0-17 y) and 70,142 adults (18-70 y), and adjusted for age and sex. In adults, clear exposure-response relationships between the number of goats within 5 km of the home address and pneumonia and 'other infectious disease' were observed. The association with 'other infectious disease' was particularly strong, with an OR [95% CI] of 12.03 [8.79-16.46] for the fourth quartile (>17,190 goats) compared with the first quartile (<2,251 goats). The presence of poultry within 1 km was associated with an increased incidence of pneumonia among adults (OR [95% CI] 1.25 [1.06-1.47]). A high density of goats in a densely populated region was associated with human Q fever. The use of GP records combined with individual exposure estimates using a Geographic Information System is a powerful approach to assess environmental health risks.	[Smit, Lidwien A. M.; Opstal-van Winden, Annemieke W. J.; Beekhuizen, Johan; Wouters, Inge M.; Heederik, Dick] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands; [van der Sman-de Beer, Femke; Hooiveld, Mariette; Yzermans, Joris] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	Utrecht University; Netherlands Institute for Health Services Research	Smit, LAM (corresponding author), Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands.	L.A.Smit@uu.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; Wouters, Inge M./0000-0001-7834-9390; Heederik, Dick/0000-0002-4550-1437	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Ministry of Health, Welfare and Sport	Funding for this study was provided by the Dutch Ministry of Economic Affairs, Agriculture and Innovation, and the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; Bamberg WM, 2007, VECTOR-BORNE ZOONOT, V7, P394, DOI 10.1089/vbz.2007.0104; Biermans MCJ, 2008, INT J MED INFORM, V77, P431, DOI 10.1016/j.ijmedinf.2007.08.002; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Dutch Federation of Biomedical Scientific Societies, 2004, COD COND US DAT HLTH; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835; Heederik DJJ, 2011, POTENTIAL EFFECTS IN; Hellenbrand W, 2001, EMERG INFECT DIS, V7, P789, DOI 10.3201/eid0705.010504; Hofhuis A, 2010, INFECTIEZIEKTEN B, V3, P84; Hogerwerf L, 2011, EMERG INFECT DIS, V17, P379, DOI 10.3201/eid1703.101157; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; Lamberts H., 1987, ICPC INT CLASSIFICAT; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Morroy G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-97; Muskens J, 2011, Vet Rec, V168, P79, DOI 10.1136/vr.c6106; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Steenland K, 2004, EPIDEMIOLOGY, V15, P63, DOI 10.1097/01.ede.0000100287.45004.e7; Stirbu-Wagner I, 2010, NATL INFORM NETWORK; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; Wallensten A, 2010, EUROSURVEILLANCE, V15, P16; Wouters IM, EPIDEMIOLOG IN PRESS; Zelikoff JT, 2003, INHAL TOXICOL, V15, P131, DOI 10.1080/08958370304478	31	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38843	10.1371/journal.pone.0038843	http://dx.doi.org/10.1371/journal.pone.0038843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685612	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700076
J	Mikalsen, AB; Haugland, O; Rode, M; Solbakk, IT; Evensen, O				Mikalsen, Aase B.; Haugland, Oyvind; Rode, Marit; Solbakk, Inge Tom; Evensen, Oystein			Atlantic Salmon Reovirus Infection Causes a CD8 T Cell Myocarditis in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; TROUT ONCORHYNCHUS-MYKISS; DICENTRARCHUS-LABRAX L.; EXPRESSION ANALYSIS; MOLECULAR-CLONING; RAINBOW-TROUT; DIFFERENTIAL EXPRESSION; CARDIOMYOPATHY SYNDROME; TCR CORECEPTOR; COMMON CARP	Heart and skeletal inflammation (HSMI) of farmed Atlantic salmon (Salmo salar L.) is a disease characterized by a chronic myocarditis involving the epicardium and the compact and spongious part of the heart ventricle. Chronic myositis of the red skeletal muscle is also a typical finding of HSMI. Piscine reovirus (PRV) has been detected by real-time PCR from farmed and wild salmon with and without typical changes of HSMI and thus the causal relationship between presence of virus and the disease has not been fully determined [1]. In this study we show that the Atlantic salmon reovirus (ASRV), identical to PRV, can be passaged in GF-1 cells and experimental challenge of naive Atlantic salmon with cell culture passaged reovirus results in cardiac and skeletal muscle pathology typical of HSMI with onset of pathology from 6 weeks, peaking by 9 weeks post challenge. ASRV replicates in heart tissue and the peak level of virus replication coincides with peak of heart lesions. We further demonstrate mRNA transcript assessment and in situ characterization that challenged fish develop a CD8(+) T cell myocarditis.	[Mikalsen, Aase B.; Haugland, Oyvind; Evensen, Oystein] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Rode, Marit; Solbakk, Inge Tom] PHARMAQ AS, Oslo, Norway	Norwegian University of Life Sciences	Mikalsen, AB (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	oystein.evensen@nvh.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Mikalsen, Aase B./0000-0001-6367-9629	Research Council of Norway [190473]	Research Council of Norway(Research Council of Norway)	This work was performed with financial support from the Research Council of Norway, project no. 190473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2004, AUTOIMMUN REV, V3, P476, DOI 10.1016/j.autrev.2004.08.009; Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Buonocore F, 2006, FISH SHELLFISH IMMUN, V20, P637, DOI 10.1016/j.fsi.2005.08.006; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Chi SC, 1999, J FISH DIS, V22, P173, DOI 10.1046/j.1365-2761.1999.00152.x; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Djikeng A, 2009, FUTURE VIROL, V4, P47, DOI 10.2217/17460794.4.1.47; Evans Donald L., 1992, Annual Review of Fish Diseases, V2, P109, DOI 10.1016/0959-8030(92)90059-7; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fischer U, 2006, FISH SHELLFISH IMMUN, V20, P209, DOI 10.1016/j.fsi.2005.03.013; Forlenza M, 2008, MOL IMMUNOL, V45, P1531, DOI 10.1016/j.molimm.2007.10.010; GRIMHOLT U, 1993, IMMUNOGENETICS, V37, P469, DOI 10.1007/BF00222473; Grimholt U, 2000, DEV COMP IMMUNOL, V24, P751, DOI 10.1016/S0145-305X(00)00034-3; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hansen JD, 2000, J IMMUNOL, V164, P3132, DOI 10.4049/jimmunol.164.6.3132; Haugland O, 2005, VACCINE, V23, P5488, DOI 10.1016/j.vaccine.2005.07.034; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; HORDVIK I, 1993, IMMUNOGENETICS, V37, P437, DOI 10.1007/BF00222467; Ingerslev HC, 2009, SCAND J IMMUNOL, V69, P90, DOI 10.1111/j.1365-3083.2008.02201.x; Inoue Y, 2005, FISH SHELLFISH IMMUN, V18, P335, DOI 10.1016/j.fsi.2004.08.004; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Larsen R, 2004, J VIROL, V78, P7938, DOI 10.1128/JVI.78.15.7938-7944.2004; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Martin SAM, 2007, PHYSIOL GENOMICS, V32, P33, DOI 10.1152/physiolgenomics.00064.2007; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Moore LJ, 2009, FISH SHELLFISH IMMUN, V26, P10, DOI 10.1016/j.fsi.2008.09.019; Moore LJ, 2005, MOL IMMUNOL, V42, P1225, DOI 10.1016/j.molimm.2004.11.017; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Pinto RD, 2007, MOL IMMUNOL, V44, P2056, DOI 10.1016/j.molimm.2006.09.014; Praveen K, 2006, MOL IMMUNOL, V43, P1152, DOI 10.1016/j.molimm.2005.07.027; Praveen K, 2004, J MOL EVOL, V58, P449, DOI 10.1007/s00239-003-2566-7; Randelli E, 2006, AQUACULTURE, V256, P631, DOI 10.1016/j.aquaculture.2006.02.013; Robertsen B, 2008, FISH SHELLFISH IMMUN, V25, P351, DOI 10.1016/j.fsi.2008.02.004; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; Savan R, 2003, EUR J BIOCHEM, V270, P4647, DOI 10.1046/j.1432-1033.2003.03854.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Somamoto T, 2005, DEV COMP IMMUNOL, V29, P693, DOI 10.1016/j.dci.2004.11.006; Somamoto T, 2006, VIROLOGY, V348, P370, DOI 10.1016/j.virol.2006.01.019; Suetake H, 2004, IMMUNOGENETICS, V56, P368, DOI 10.1007/s00251-004-0694-x; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; Utke K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/j.fsi.2006.04.008; Wen Y, 2011, CELL MOL LIFE SCI, V68, P2615, DOI 10.1007/s00018-010-0574-5; Zhang DC, 2005, J BIOCHEM MOL BIOL, V38, P571; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2003, IMMUNOGENETICS, V55, P325, DOI 10.1007/s00251-003-0580-y	55	49	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37269	10.1371/journal.pone.0037269	http://dx.doi.org/10.1371/journal.pone.0037269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693625	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900006
J	Nabuurs, RJA; Rutgers, KS; Welling, MM; Metaxas, A; de Backer, ME; Rotman, M; Bacskai, BJ; van Buchem, MA; van der Maarel, SM; van der Weerd, L				Nabuurs, Rob J. A.; Rutgers, Kim S.; Welling, Mick M.; Metaxas, Athanasios; de Backer, Maaike E.; Rotman, Maarten; Bacskai, Brian J.; van Buchem, Mark A.; van der Maarel, Silvere M.; van der Weerd, Louise			In Vivo Detection of Amyloid-beta Deposits Using Heavy Chain Antibody Fragments in a Transgenic Mouse Model for Alzheimer's Disease	PLOS ONE			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; SINGLE-DOMAIN ANTIBODIES; PLAQUES; BRAIN; MICE; ANGIOPATHY; IMMUNOTHERAPY; PREVENTION; NANOBODIES; PEPTIDES	This study investigated the in vivo properties of two heavy chain antibody fragments (VHH), ni3A and pa2H, to differentially detect vascular or parenchymal amyloid-beta deposits characteristic for Alzheimer's disease and cerebral amyloid angiopathy. Blood clearance and biodistribution including brain uptake were assessed by bolus injection of radiolabeled VHH in APP/PS1 mice or wildtype littermates. In addition, in vivo specificity for A beta was examined in more detail with fluorescently labeled VHH by circumventing the blood-brain barrier via direct application or intracarotid co-injection with mannitol. All VHH showed rapid renal clearance (10-20 min). Twenty-four hours post-injection Tc-99m-pa2H resulted in a small yet significant higher cerebral uptake in the APP/PS1 animals. No difference in brain uptake were observed for Tc-99m-ni3A or DTPA(In-111)-pa2H, which lacked additional peptide tags to investigate further clinical applicability. In vivo specificity for A beta was confirmed for both fluorescently labeled VHH, where pa2H remained readily detectable for 24 hours or more after injection. Furthermore, both VHH showed affinity for parenchymal and vascular deposits, this in contrast to human tissue, where ni3A specifically targeted only vascular A beta. Despite a brain uptake that is as yet too low for in vivo imaging, this study provides evidence that VHH detect A beta deposits in vivo, with high selectivity and favorable in vivo characteristics, making them promising tools for further development as diagnostic agents for the distinctive detection of different A beta deposits.	[Nabuurs, Rob J. A.; Welling, Mick M.; de Backer, Maaike E.; van Buchem, Mark A.; van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Rutgers, Kim S.; Rotman, Maarten; van der Maarel, Silvere M.; van der Weerd, Louise] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Metaxas, Athanasios] Free Univ Amsterdam, Med Ctr, Radionuclide Ctr, Amsterdam, Netherlands; [Bacskai, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Bacskai, Brian J.] Harvard Univ, Sch Med, Charlestown, MA USA; [van der Weerd, Louise] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; Harvard University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nabuurs, RJA (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	R.J.A.Nabuurs@LUMC.nl	Bacskai, Brian/AAE-9583-2021; van Buchem, Mark/AAC-9843-2022; Welling, Mick/A-4582-2012; Rotman, Maarten/Q-2349-2019; van der Maarel, Silvere/X-3631-2018; van der Weerd, Louise/B-5421-2014; Metaxas, Athanasios/G-8198-2011	van Buchem, Mark/0000-0003-1881-1998; Welling, Mick/0000-0002-2249-5601; Rotman, Maarten/0000-0002-4987-7298; van der Maarel, Silvere/0000-0001-8103-711X; Metaxas, Athanasios/0000-0002-8747-7068; van der Weerd, Louise/0000-0002-5997-2125	Center for Translational Molecular Medicine, LeARN; Innovatiegericht OnderzoeksProgramma (IOP)Genomics [IGE05005]; Center for Medical Systems Biology, CMSB2; Netherlands Organisation for Scientific Research (NWO) Athena [700.58.801]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER	Center for Translational Molecular Medicine, LeARN; Innovatiegericht OnderzoeksProgramma (IOP)Genomics; Center for Medical Systems Biology, CMSB2; Netherlands Organisation for Scientific Research (NWO) Athena; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research was supported by: (1) the Center for Translational Molecular Medicine, LeARN, http://www.ctmm.nl; (2) Innovatiegericht OnderzoeksProgramma (IOP)Genomics, IGE05005, http://www.agentschapnl.nl/nl/programmas-regelingen/iop-genomics; (3) the Center for Medical Systems Biology, CMSB2, http://www.cmsb.nl; and (4) The Netherlands Organisation for Scientific Research (NWO) Athena, 700.58.801, http://www.nwo.nl/nwohome.nsf/pages/NWOA_6ZXCX3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Behr TM, 1998, EUR J NUCL MED, V25, P201, DOI 10.1007/s002590050216; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Chartier A, 2009, HUM MOL GENET, V18, P1849, DOI 10.1093/hmg/ddp101; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gainkam LOT, 2008, J NUCL MED, V49, P788, DOI 10.2967/jnumed.107.048538; Greenberg SM, 2003, NAT MED, V9, P389, DOI 10.1038/nm847; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Huang L, 2010, EXPERT REV MOL DIAGN, V10, P777, DOI 10.1586/ERM.10.62; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jicha GA, 2009, EXPERT OPIN BIOL TH, V9, P481, DOI [10.1517/14712590902828285 , 10.1517/14712590902828285]; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Leskovjan AC, 2009, NEUROIMAGE, V47, P1215, DOI 10.1016/j.neuroimage.2009.05.063; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Natte R, 2001, ANN NEUROL, V50, P765, DOI 10.1002/ana.10040; Richardson James A, 2002, ILAR J, V43, P89; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Rutgers KS, 2011, NEUROSCIENCE, V190, P37, DOI 10.1016/j.neuroscience.2011.05.076; Rutgers KS, 2011, NEUROBIOL AGING, V32, P1774, DOI 10.1016/j.neurobiolaging.2009.11.012; Skoch J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846075; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; Wadghiri Youssef Zaim, 2004, V299, P365; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Welling MM, 2005, J LABELLED COMPD RAD, V48, P683, DOI 10.1002/jlcr.961; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036	41	31	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38284	10.1371/journal.pone.0038284	http://dx.doi.org/10.1371/journal.pone.0038284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675537	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700056
J	Roy, A; Bauer, SM; Lawrence, BP				Roy, Anirban; Bauer, Stephen M.; Lawrence, B. Paige			Developmental Exposure to Bisphenol A Modulates Innate but Not Adaptive Immune Responses to Influenza A Virus Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; T-CELL RESPONSES; IN-VITRO; PERINATAL EXPOSURE; INTERFERON-GAMMA; DENDRITIC CELLS; TOBACCO-SMOKE; HUMAN HEALTH; CD8(+); ACTIVATION	Bisphenol A (BPA) is used in numerous products, such as plastic bottles and food containers, from which it frequently leaches out and is consumed by humans. There is a growing public concern that BPA exposure may pose a significant threat to human health. Moreover, due to the widespread and constant nature of BPA exposure, not only adults but fetuses and neonates are also exposed to BPA. There is mounting evidence that developmental exposures to chemicals from our environment, including BPA, contribute to diseases late in life; yet, studies of how early life exposures specifically alter the immune system are limited. Herein we report an examination of how maternal exposure to a low, environmentally relevant dose of BPA affects the immune response to infection with influenza A virus. We exposed female mice during pregnancy and through lactation to the oral reference dose for BPA listed by the US Environmental Protection Agency, and comprehensively examined immune parameters directly linked to disease outcomes in adult offspring following infection with influenza A virus. We found that developmental exposure to BPA did not compromise disease-specific adaptive immunity against virus infection, or reduce the host's ability to clear the virus from the infected lung. However, maternal exposure to BPA transiently reduced the extent of infection-associated pulmonary inflammation and anti-viral gene expression in lung tissue. From these observations, we conclude that maternal exposure to BPA slightly modulates innate immunity in adult offspring, but does not impair the anti-viral adaptive immune response, which is critical for virus clearance and survival following influenza virus infection.	[Roy, Anirban; Bauer, Stephen M.; Lawrence, B. Paige] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA	University of Rochester	Roy, A (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA.	Paige_lawrence@urmc.rochester.edu			National Institutes of Health (NIH) [RC2-ES018750, R01-ES017250, R01-HL097141, T32-ES07026, T32-HL066988, P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097141, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R01ES017250, RC2ES018750, T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the following National Institutes of Health (NIH) grants: RC2-ES018750, R01-ES017250, R01-HL097141, T32-ES07026, T32-HL066988, and P30-ES01247. The funders had no role in data collection, analysis, decision to publish or preparation of this manuscript. In conjunction with other scientists examining potential health effects of early life BPA exposure, the National Institute of Environmental Health Science (NIEHS) coordinated meetings of grantees, who jointly agreed upon exposure dose ranges, time frame, and proper environmental controls to minimize BPA exposure from animal housing and feed.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Dietert RR, 2009, CHEM RES TOXICOL, V22, P17, DOI 10.1021/tx800198m; Fernandez MA, 2008, J IMMUNOL, V180, P1556, DOI 10.4049/jimmunol.180.3.1556; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gallo D, 2008, MENOPAUSE, V15, P718, DOI 10.1097/gme.0b013e318167b92a; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Glasser R, 2009, J ALLERGY CLIN IMMUN, V123, P1117, DOI 10.1016/j.jaci.2009.01.043; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2136, DOI 10.1271/bbb.70004; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Guo HC, 2010, CELL MOL IMMUNOL, V7, P227, DOI 10.1038/cmi.2010.14; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heilmann C, 2006, PLOS MED, V3, P1352, DOI 10.1371/journal.pmed.0030311; Heilmann C, 2010, ENVIRON HEALTH PERSP, V118, P1434, DOI 10.1289/ehp.1001975; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Integrated Risk Information System United States Environmental Protection Agency (EPA), BISPH A CASRN 80 05; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541; Kim JY, 2003, CANCER LETT, V196, P69, DOI 10.1016/S0304-3835(03)00219-2; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lawrence BP, 2007, VIRAL IMMUNOL, V20, P231, DOI 10.1089/vim.2007.0013; Lawrence BP, 2006, J IMMUNOL, V177, P5819, DOI 10.4049/jimmunol.177.9.5819; Lawrence BP, 2004, TOXICOL SCI, V79, P304, DOI 10.1093/toxsci/kfh094; Lawrence BP, 2000, J TOXICOL ENV HEAL A, V61, P39, DOI 10.1080/00984100050116771; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Mielke H, 2009, TOXICOL LETT, V190, P32, DOI 10.1016/j.toxlet.2009.06.861; Miller TE, 1998, TOXICOL SCI, V42, P129, DOI 10.1093/toxsci/42.2.129; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Mortaz E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-47; *NIH, 2008, NIH PUBL; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Ohshima Y, 2007, PEDIATR RES, V62, P60, DOI 10.1203/PDR.0b013e3180674dae; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Penn AL, 2007, ENVIRON HEALTH PERSP, V115, P548, DOI 10.1289/ehp.9780; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Raherison C, 2007, RESP MED, V101, P107, DOI 10.1016/j.rmed.2006.04.010; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Roy A, 2007, J VIROL, V81, P1110, DOI 10.1128/JVI.01964-06; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan LK, 2000, PHOTOCHEM PHOTOBIOL, V72, P497, DOI 10.1562/0031-8655(2000)072<0497:ETUREM>2.0.CO;2; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sawai C, 2003, ENVIRON HEALTH PERSP, V111, P1883, DOI 10.1289/ehp.6359; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Sharkhuu T, 2011, J IMMUNOTOXICOL, V8, P183, DOI 10.3109/1547691X.2011.568978; Sharkhuu T, 2010, TOXICOL LETT, V196, P12, DOI 10.1016/j.toxlet.2010.03.017; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Sugita-Konishi Y, 2003, TOXICOL LETT, V136, P217, DOI 10.1016/S0378-4274(02)00388-0; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Takahashi O, 2000, ENVIRON HEALTH PERSP, V108, P931, DOI 10.2307/3435050; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Teske S, 2005, AM J PHYSIOL-LUNG C, V289, pL111, DOI 10.1152/ajplung.00318.2004; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Winans B, 2011, REPROD TOXICOL, V31, P327, DOI 10.1016/j.reprotox.2010.09.004; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025448; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yin DQ, 2007, J ENVIRON SCI, V19, P232, DOI 10.1016/S1001-0742(07)60038-2; Yoshino S, 2004, IMMUNOLOGY, V112, P489, DOI 10.1111/j.1365-2567.2004.01900.x	76	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38448	10.1371/journal.pone.0038448	http://dx.doi.org/10.1371/journal.pone.0038448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675563	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700075
J	Saul, MC; Gessay, GM; Gammie, SC				Saul, Michael C.; Gessay, Griffin M.; Gammie, Stephen C.			A New Mouse Model for Mania Shares Genetic Correlates with Human Bipolar Disorder	PLOS ONE			English	Article							GENOME-WIDE SCAN; REAL-TIME PCR; SINGLE-NUCLEOTIDE POLYMORPHISMS; CONVERGENT FUNCTIONAL GENOMICS; WHEEL-RUNNING BEHAVIOR; ANIMAL-MODEL; LINKAGE SCAN; GLN460ARG POLYMORPHISM; SUSCEPTIBILITY LOCUS; SUGGESTIVE LINKAGE	Bipolar disorder (BPD) is a debilitating heritable psychiatric disorder. Contemporary rodent models for the manic pole of BPD have primarily utilized either single locus transgenics or treatment with psychostimulants. Our lab recently characterized a mouse strain termed Madison (MSN) that naturally displays a manic phenotype, exhibiting elevated locomotor activity, increased sexual behavior, and higher forced swimming relative to control strains. Lithium chloride and olanzapine treatments attenuate this phenotype. In this study, we replicated our locomotor activity experiment, showing that MSN mice display generationally-stable mania relative to their outbred ancestral strain, hsd:ICR (ICR). We then performed a gene expression microarray experiment to compare hippocampus of MSN and ICR mice. We found dysregulation of multiple transcripts whose human orthologs are associated with BPD and other psychiatric disorders including schizophrenia and ADHD, including: Epor, Smarca4, Cmklr1, Cat, Tac1, Npsr1, Fhit, and P2rx7. RT-qPCR confirmed dysregulation for all of seven transcripts tested. Using a novel genome enrichment algorithm, we found enrichment in genome regions homologous to human loci implicated in BPD in replicated linkage studies including homologs of human cytobands 1p36, 3p14, 3q29, 6p21-22, 12q24, 16q24, and 17q25. Using a functional network analysis, we found dysregulation of a gene system related to chromatin packaging, a result convergent with recent human findings on BPD. Our findings suggest that MSN mice represent a polygenic model for the manic pole of BPD showing much of the genetic systems complexity of the corresponding human disorder. Further, the high degree of convergence between our findings and the human literature on BPD brings up novel questions about evolution by analogy in mammalian genomes.	[Saul, Michael C.; Gessay, Griffin M.; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Saul, MC (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	csaul@wisc.edu	Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619	University of Wisconsin-Madison Vilas Associate's Award; National Institutes of Health [MH0856427]	University of Wisconsin-Madison Vilas Associate's Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by a University of Wisconsin-Madison Vilas Associate's Award to SCG. Additional funding was provided by a National Institutes of Health R01 to SCG (MH0856427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jamra R, 2007, AM J HUM GENET, V81, P974, DOI 10.1086/521690; Andreazza AC, 2007, J PSYCHIATR RES, V41, P523, DOI 10.1016/j.jpsychires.2006.07.013; Angst J, 2003, EUR NEUROPSYCHOPHARM, V13, pS43, DOI 10.1016/S0924-977X(03)00077-4; Badenhop R, 2002, MOL PSYCHIATR, V7, P851, DOI 10.1038/sj.mp.4001114; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Baum AE, 2008, MOL PSYCHIATR, V13, P466, DOI 10.1038/mp.2008.16; BERGGREN U, 1981, J NEURAL TRANSM, V50, P157, DOI 10.1007/BF01249137; BERRETTINI WH, 1985, BIOL PSYCHIAT, V20, P965, DOI 10.1016/0006-3223(85)90193-3; Bertolino A, 2003, BIOL PSYCHIAT, V53, P906, DOI 10.1016/S0006-3223(02)01911-X; Bondy B, 2003, BIOL PSYCHIAT, V53, P538, DOI 10.1016/S0006-3223(02)01544-5; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; BOWMAN MB, 1982, NEUROSCI BIOBEHAV R, V6, P321, DOI 10.1016/0149-7634(82)90044-6; Braw Y, 2006, PSYCHONEUROENDOCRINO, V31, P1105, DOI 10.1016/j.psyneuen.2006.07.003; Bronikowski AM, 2004, EVOLUTION, V58, P2079, DOI 10.1111/j.0014-3820.2004.tb00491.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buttenchon HN, 2010, PSYCHIAT GENET, V20, P93, DOI 10.1097/YPG.0b013e32833a2066; Cheng R, 2006, MOL PSYCHIATR, V11, P252, DOI 10.1038/sj.mp.4001778; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Detera-Wadleigh SD, 2011, PHARMACOPSYCHIATRY, V44, pS35, DOI 10.1055/s-0031-1275275; Detera-Wadleigh SD, 1999, AM J MED GENET, V88, P255, DOI 10.1002/(SICI)1096-8628(19990618)88:3<255::AID-AJMG8>3.0.CO;2-V; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Doyle AE, 2010, J AM ACAD CHILD PSY, V49, P378, DOI 10.1016/j.jaac.2010.01.008; Edgar PF, 2000, MOL PSYCHIATR, V5, P85, DOI 10.1038/sj.mp.4000580; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Einat H, 2006, J PSYCHOPHARMACOL, V20, P714, DOI 10.1177/0269881106060241; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Ewald H, 2005, AM J MED GENET B, V133B, P25, DOI 10.1002/ajmg.b.30106; Ewald H, 1998, PSYCHIATR GENET, V8, P131, DOI 10.1097/00041444-199800830-00002; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Flaisher-Grinberg S, 2010, J PSYCHOPHARMACOL, V24, P437, DOI 10.1177/0269881108097905; Flaisher-Grinberg Shlomit, 2010, Front Psychiatry, V1, P10, DOI 10.3389/fpsyt.2010.00010; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Frey BN, 2007, PROG NEURO-PSYCHOPH, V31, P283, DOI 10.1016/j.pnpbp.2006.06.011; Fullerton JM, 2010, BIOL PSYCHIAT, V67, P478, DOI 10.1016/j.biopsych.2009.10.022; FURUKAWA T, 1975, PSYCHOPHARMACOLOGIA, V42, P243, DOI 10.1007/BF00421263; Gammie SC, 2003, HORM BEHAV, V44, P209, DOI 10.1016/S0018-506X(03)00140-5; Gammie SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001974; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Hannah-Poquette C, 2011, BEHAV BRAIN RES, V223, P222, DOI 10.1016/j.bbr.2011.04.047; Harrison-Read PE, 2009, J PSYCHOPHARMACOL, V23, P334, DOI 10.1177/0269881108089840; Hasegawa S, 2006, NEUROCHEM INT, V48, P358, DOI 10.1016/j.neuint.2005.11.012; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kandaswamy R, 2012, AM J MED GENET B, V159B, P201, DOI 10.1002/ajmg.b.32014; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Le-Niculescu H, 2007, NEUROSCI BIOBEHAV R, V31, P897, DOI 10.1016/j.neubiorev.2007.05.008; Lien YJ, 2010, AM J MED GENET B, V153B, P1, DOI 10.1002/ajmg.b.30948; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Lyons-Warren A, 2005, MOL PSYCHIATR, V10, P807, DOI 10.1038/sj.mp.4001703; MAES M, 1992, J AFFECT DISORDERS, V24, P183, DOI 10.1016/0165-0327(92)90066-F; Mahon PB, 2011, AM J MED GENET B, V156B, P370, DOI 10.1002/ajmg.b.31172; Marcheco-Teruel B, 2006, AM J MED GENET B, V141B, P833, DOI 10.1002/ajmg.b.30314; McCarthy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032091; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Miskowiak KW, 2012, PSYCHOPHARMACOLOGY, V219, P687, DOI 10.1007/s00213-011-2511-1; Miskowiak KW, 2009, PSYCHOPHARMACOLOGY, V207, P133, DOI 10.1007/s00213-009-1641-1; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; OVERSTREET DH, 1995, PSYCHOPHARMACOLOGY, V121, P27, DOI 10.1007/BF02245589; Pato CN, 2004, AM J MED GENET B, V127B, P30, DOI 10.1002/ajmg.b.30001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; REGLAND B, 1994, J NEURAL TRANSM-GEN, V98, P143, DOI 10.1007/BF01277017; Reinscheid RK, 2005, FEBS J, V272, P5689, DOI 10.1111/j.1742-4658.2005.04982.x; Reinscheid RK, 2005, MOL INTERV, V5, P42, DOI 10.1124/mi5.1.8; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Romanos M, 2008, MOL PSYCHIATR, V13, P522, DOI 10.1038/mp.2008.12; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rudan I, 2010, PSYCHIAT DANUB, V22, P190; Schosser A, 2004, J PSYCHIATR RES, V38, P357, DOI 10.1016/j.jpsychires.2003.11.004; Schulze TG, 2004, BIOL PSYCHIAT, V56, P18, DOI 10.1016/j.biopsych.2004.04.004; Schumacher J, 2005, AM J HUM GENET, V77, P1102, DOI 10.1086/498619; Scotti MAL, 2011, PHYSIOL BEHAV, V103, P376, DOI 10.1016/j.physbeh.2011.03.005; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Tomas C, 2006, PSYCHIAT GENET, V16, P145; Virit O, 2008, KLIN PSIKOFARMAKOL B, V18, P282; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wegener G, 2010, INT J NEUROPSYCHOPH, V13, P461, DOI 10.1017/S1461145709990241; Won H, 2011, NAT MED, V17, P566, DOI 10.1038/nm.2330; Zandi PP, 2007, MOL PSYCHIATR, V12, P630, DOI 10.1038/sj.mp.4002027; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	104	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38128	10.1371/journal.pone.0038128	http://dx.doi.org/10.1371/journal.pone.0038128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675514	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700040
J	Fu, GY; Hu, CS; Wang, QD; Quinn, PC; Lee, K				Fu, Genyue; Hu, Chao S.; Wang, Qiandong; Quinn, Paul C.; Lee, Kang			Adults Scan Own- and Other-Race Faces Differently	PLOS ONE			English	Article							NEOCLASSICAL FACIAL CANONS; CATEGORIZATION; RECOGNITION; CHINESE; INFANCY; MEMORY	It is well established that individuals show an other-race effect (ORE) in face recognition: they recognize own-race faces better than other-race faces. The present study tested the hypothesis that individuals would also scan own-and other-race faces differently. We asked Chinese participants to remember Chinese and Caucasian faces and we tested their memory of the faces over five testing blocks. The participants' eye movements were recorded with the use of an eye tracker. The data were analyzed with an Area of Interest approach using the key AOIs of a face (eyes, nose, and mouth). Also, we used the iMap toolbox to analyze the raw data of participants' fixation on each pixel of the entire face. Results from both types of analyses strongly supported the hypothesis. When viewing target Chinese or Caucasian faces, Chinese participants spent a significantly greater proportion of fixation time on the eyes of other-race Caucasian faces than the eyes of own-race Chinese faces. In contrast, they spent a significantly greater proportion of fixation time on the nose and mouth of Chinese faces than the nose and mouth of Caucasian faces. This pattern of differential fixation, for own-and other-race eyes and nose in particular, was consistent even as participants became increasingly familiar with the target faces of both races. The results could not be explained by the perceptual salience of the Chinese nose or Caucasian eyes because these features were not differentially salient across the races. Our results are discussed in terms of the facial morphological differences between Chinese and Caucasian faces and the enculturation of mutual gaze norms in East Asian cultures.	[Fu, Genyue; Hu, Chao S.; Wang, Qiandong] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China; [Quinn, Paul C.] Univ Delaware, Dept Psychol, Newark, DE USA; [Lee, Kang] Univ Toronto, Dr Eric Jackman Inst Child Study, Toronto, ON, Canada; [Lee, Kang] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	Zhejiang Normal University; University of Delaware; University of Toronto; University of California System; University of California San Diego	Fu, GY (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China.	kang.lee@utoronto.ca	Hu, Chao S./I-2666-2019	Hu, Chao S./0000-0003-3315-9651	Natural Sciences and Engineering Research Council of Canada; National Institutes of Health (NIH) [R01HD046526]; National Science Foundation of China [30528027, 31028010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The present study was supported by a grant from the Natural Sciences and Engineering Research Council of Canada, the National Institutes of Health (NIH) (R01HD046526), and the National Science Foundation of China (30528027 and 31028010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzures G, 2010, DEVELOPMENTAL SCI, V13, P553, DOI 10.1111/j.1467-7687.2009.00900.x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Caharel S, 2011, INT J PSYCHOPHYSIOL, V79, P266, DOI 10.1016/j.ijpsycho.2010.10.018; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Farkas LG, 2000, AESTHET PLAST SURG, V24, P179, DOI 10.1007/s002660010029; Feingold GA, 1914, J AM INST CRIM LAW C, V5, P39, DOI 10.2307/1133283; Ferguson KT, 2009, INFANCY, V14, P263, DOI 10.1080/15250000902839369; Frank MC, 2009, COGNITION, V110, P160, DOI 10.1016/j.cognition.2008.11.010; Ge LZ, 2009, PERCEPTION, V38, P1199, DOI 10.1068/p6136; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Goodman GS, 2007, J EXP CHILD PSYCHOL, V98, P233, DOI 10.1016/j.jecp.2007.08.004; Hajnis Karle, 1994, P201; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hayden A, 2009, PSYCHON B REV, V16, P270, DOI 10.3758/PBR.16.2.270; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; Kinzler KD, 2009, SOC COGNITION, V27, P623, DOI 10.1521/soco.2009.27.4.623; Kisilevsky BS, 1998, DEV PSYCHOL, V34, P629, DOI 10.1037/0012-1649.34.4.629; Le TT, 2002, AESTHET PLAST SURG, V26, P64, DOI 10.1007/s00266-001-0033-7; Lee K., 2012, OXF HDB FACE PERCEPT, V8, P1, DOI [10.1093/oxfordhb/9780199559053.001.0001, DOI 10.1093/OXFORDHB/9780199559053.013.0039, 10.1093/oxfordhb/9780199559053.013.0039]; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Natu V, 2011, NEUROIMAGE, V54, P2547, DOI 10.1016/j.neuroimage.2010.10.006; Sangrigoli S, 2004, DEVELOPMENTAL SCI, V7, P74, DOI 10.1111/j.1467-7687.2004.00324.x; Shutts K, 2007, PSYCHOL SCI, V18, P763, DOI 10.1111/j.1467-9280.2007.01975.x; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	34	57	58	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37688	10.1371/journal.pone.0037688	http://dx.doi.org/10.1371/journal.pone.0037688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UI	22675486	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339900006
J	Gray, EE; Friend, S; Suzuki, K; Phan, TG; Cyster, JG				Gray, Elizabeth E.; Friend, Sherree; Suzuki, Kazuhiro; Tri Giang Phan; Cyster, Jason G.			Subcapsular Sinus Macrophage Fragmentation and CD169(+) Bleb Acquisition by Closely Associated IL-17-Committed Innate-Like Lymphocytes	PLOS ONE			English	Article							LYMPH-NODES; B-CELL; DENDRITIC CELLS; T-CELLS; IMMUNE-COMPLEXES; MARGINAL ZONE; RECEPTOR; ANTIGEN; EXPRESSION; INFECTION	Subcapsular sinus macrophages (SSMs) in lymph nodes are rapidly exposed to antigens arriving in afferent lymph and have a role in their capture and display to B cells. In tissue sections SSMs exhibit long cellular processes and express high amounts of CD169. Here, we show that many of the cells present in lymph node cell suspensions that stain for CD169 are not macrophages but lymphocytes that have acquired SSM-derived membrane blebs. The CD169 bleb(+) lymphocytes are enriched for IL-17 committed IL-7R alpha(hi)CCR6(+) T cells and NK cells. In addition, the CD169 staining detected on small numbers of CD11c(hi) dendritic cells is frequently associated with membrane blebs. Counter intuitively the CD169 bleb(+) lymphocytes are mostly CD4 and CD8 negative whereas many SSMs express CD4. In situ, many IL-7R alpha(hi) cells are present at the subcapsular sinus and interfollicular regions and migrate in close association with CD169(+) macrophages. These findings suggest SSMs undergo fragmentation during tissue preparation and release blebs that are acquired by closely associated cells. They also suggest an intimate crosstalk between SSMs and IL-17 committed innate-like lymphocytes that may help provide early protection of the lymph node against lymph-borne invaders.	[Gray, Elizabeth E.; Suzuki, Kazuhiro; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Gray, Elizabeth E.; Suzuki, Kazuhiro; Cyster, Jason G.] UCSF, Dept Microbiol & Immunol, San Francisco, CA USA; [Friend, Sherree] Amnis Corp, Seattle, WA USA; [Tri Giang Phan] Garvan Inst Med Res, Sydney, NSW, Australia; [Tri Giang Phan] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Garvan Institute of Medical Research; University of New South Wales Sydney	Gray, EE (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Phan, Tri Giang/G-3937-2012	Phan, Tri Giang/0000-0002-4909-2984; Suzuki, Kazuhiro/0000-0002-9081-538X	National Institutes of Health [AI45073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI45073. JGC is an Investigator of the Howard Hughes Medical Institute. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Asano K, 2010, IMMUNITY; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CROCKER PR, 1995, J CLIN INVEST, V95, P635, DOI 10.1172/JCI117708; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; FOSSUM S, 1983, ANAT EMBRYOL, V167, P229, DOI 10.1007/BF00298513; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; STEER HW, 1987, J ANAT, V152, P23; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; WOOD GS, 1983, J IMMUNOL, V131, P212; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	55	64	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38258	10.1371/journal.pone.0038258	http://dx.doi.org/10.1371/journal.pone.0038258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675532	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339900020
J	Valdez-Moreno, M; Quintal-Lizama, C; Gomez-Lozano, R; Garcia-Rivas, MD				Valdez-Moreno, Martha; Quintal-Lizama, Carolina; Gomez-Lozano, Ricardo; del Carmen Garcia-Rivas, Maria			Monitoring an Alien Invasion: DNA Barcoding and the Identification of Lionfish and Their Prey on Coral Reefs of the Mexican Caribbean	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; CRUSTACEA DECAPODA CARIDEA; PTEROIS-VOLITANS; RED LIONFISH; SCORPAENIDAE; DENDROCHIRUS; PREDATION; RATES	Background: In the Mexican Caribbean, the exotic lionfish Pterois volitans has become a species of great concern because of their predatory habits and rapid expansion onto the Mesoamerican coral reef, the second largest continuous reef system in the world. This is the first report of DNA identification of stomach contents of lionfish using the barcode of life reference database (BOLD). Methodology/Principal Findings: We confirm with barcoding that only Pterois volitans is apparently present in the Mexican Caribbean. We analyzed the stomach contents of 157 specimens of P. volitans from various locations in the region. Based on DNA matches in the Barcode of Life Database (BOLD) and GenBank, we identified fishes from five orders, 14 families, 22 genera and 34 species in the stomach contents. The families with the most species represented were Gobiidae and Apogonidae. Some prey taxa are commercially important species. Seven species were new records for the Mexican Caribbean: Apogon mosavi, Coryphopterus venezuelae, C. thrix, C. tortugae, Lythrypnus minimus, Starksia langi and S. ocellata. DNA matches, as well as the presence of intact lionfish in the stomach contents, indicate some degree of cannibalism, a behavior confirmed in this species by the first time. We obtained 45 distinct crustacean prey sequences, from which only 20 taxa could be identified from the BOLD and GenBank databases. The matches were primarily to Decapoda but only a single taxon could be identified to the species level, Euphausia americana. Conclusions/Significance: This technique proved to be an efficient and useful method, especially since prey species could be identified from partially-digested remains. The primary limitation is the lack of comprehensive coverage of potential prey species in the region in the BOLD and GenBank databases, especially among invertebrates.	[Valdez-Moreno, Martha; Quintal-Lizama, Carolina] El Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico; [Gomez-Lozano, Ricardo; del Carmen Garcia-Rivas, Maria] Comis Nacl Areas Nat Protegidas, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Valdez-Moreno, M (corresponding author), El Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico.	mvaldez@ecosur.mx			Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO) [HE009]; Consejo Nacional de Ciencia y Tecnologia (CONACYT thru Mexican Barcode of Life, MEXBOL); Genome Canada through the Biodiversity Institute of Ontario	Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO); Consejo Nacional de Ciencia y Tecnologia (CONACYT thru Mexican Barcode of Life, MEXBOL); Genome Canada through the Biodiversity Institute of Ontario(Genome Canada)	Genome Canada through the Biodiversity Institute of Ontario supported sequencing. Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO HE009) and Consejo Nacional de Ciencia y Tecnologia (CONACYT thru Mexican Barcode of Life, MEXBOL) funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Perera A, 2010, AQUAT INVASIONS, V5, pS9, DOI 10.3391/ai.2010.5.S1.003; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Carreon-Martinez L, 2011, J FISH BIOL, V78, P1170, DOI 10.1111/j.1095-8649.2011.02925.x; Castellanos I, 2002, REV BIOL TROP, V50, P77; Castellanos Osorio Ivan A., 1998, Caribbean Marine Studies, V6, P1; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Arias-Gonzalez JE, 2011, ENVIRON RES, V111, P917, DOI 10.1016/j.envres.2011.07.008; Fishelson L, 1997, ENVIRON BIOL FISH, V50, P391, DOI 10.1023/A:1007331304122; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Freshwater D. Wilson, 2009, Journal of the North Carolina Academy of Science, V125, P39; FROESE R., 2012, FISHBASE; Garcia-Madrigal M., 2002, UNIV CIENC, V36, P140; GREENFIELD D W, 1979, Fieldiana Zoology, V73, P9; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2003, MOL PHYLOGENET EVOL, V28, P396, DOI 10.1016/S1055-7903(02)00444-X; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lavett SC, 2003, ATOLL RES B, V497, P1; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; MARKHAM J C, 1990, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V61, P405; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Roman-Contreras R, 2010, HIDROBIOLOGICA, V20, P222; Roman-Contreras R, 2010, REV MEX BIODIVERS, V81, P43; Roman-Contreras R, 2009, HIDROBIOLOGICA, V19, P119; Ruiz-Carus R, 2006, BIOL CONSERV, V128, P384, DOI 10.1016/j.biocon.2005.10.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitter-Soto Juan Jacobo, 2000, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V71, P143; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289; Wilson JJ, 2011, BMC ECOLOGY, P11; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	46	100	108	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36636	10.1371/journal.pone.0036636	http://dx.doi.org/10.1371/journal.pone.0036636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675470	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339900002
J	Wang, INE; Wang, X; Ge, XH; Anderson, J; Ho, M; Ashley, E; Liu, JW; Butte, MJ; Yazawa, M; Dolmetsch, RE; Quertermous, T; Yang, PC				Wang, I-Ning E.; Wang, Xiang; Ge, Xiaohu; Anderson, Joshua; Ho, Michael; Ashley, Euan; Liu, Jianwei; Butte, Manish J.; Yazawa, Masayuki; Dolmetsch, Ricardo E.; Quertermous, Thomas; Yang, Phillip C.			Apelin Enhances Directed Cardiac Differentiation of Mouse and Human Embryonic Stem Cells	PLOS ONE			English	Article							RECEPTOR APJ; HEART; MYOCARDIUM; LIGAND; CONTRACTILITY; ACTIVATION; MECHANISMS; DISEASE; PROMISE; GENE	Apelin is a peptide ligand for an orphan G-protein coupled receptor (APJ receptor) and serves as a critical gradient for migration of mesodermal cells fated to contribute to the myocardial lineage. The present study was designed to establish a robust cardiac differentiation protocol, specifically, to evaluate the effect of apelin on directed differentiation of mouse and human embryonic stem cells (mESCs and hESCs) into cardiac lineage. Different concentrations of apelin (50, 100, 500 nM) were evaluated to determine its differentiation potential. The optimized dose of apelin was then combined with mesodermal differentiation factors, including BMP-4, activin-A, and bFGF, in a developmentally specific temporal sequence to examine the synergistic effects on cardiac differentiation. Cellular, molecular, and physiologic characteristics of the apelin-induced contractile embryoid bodies (EBs) were analyzed. It was found that 100 nM apelin resulted in highest percentage of contractile EB for mESCs while 500 nM had the highest effects on hESCs. Functionally, the contractile frequency of mESCs-derived EBs (mEBs) responded appropriately to increasing concentration of isoprenaline and diltiazem. Positive phenotype of cardiac specific markers was confirmed in the apelin-treated groups. The protocol, consisting of apelin and mesodermal differentiation factors, induced contractility in significantly higher percentage of hESC-derived EBs (hEBs), up-regulated cardiac-specific genes and cell surface markers, and increased the contractile force. In conclusion, we have demonstrated that the treatment of apelin enhanced cardiac differentiation of mouse and human ESCs and exhibited synergistic effects with mesodermal differentiation factors.	[Wang, I-Ning E.; Wang, Xiang; Ge, Xiaohu; Anderson, Joshua; Ho, Michael; Ashley, Euan; Quertermous, Thomas; Yang, Phillip C.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Liu, Jianwei; Butte, Manish J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Yazawa, Masayuki; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wang, INE (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	iewang@stanford.edu	Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; Quertermous, Thomas/0000-0002-7645-9067	National Institute of Health [1R01HL097516-01]; Katherine McCormick Postdoctoral Fellowship for Women in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077676, R01HL097516] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katherine McCormick Postdoctoral Fellowship for Women in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research is supported by National Institute of Health (1R01HL097516-01, PI: PYang), and Katherine McCormick Postdoctoral Fellowship for Women in Medicine (IEWang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir G, 2008, ANN THORAC SURG, V86, P1311, DOI 10.1016/j.athoracsur.2008.06.058; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Barnes G, 2010, HEART, V96, P1011, DOI 10.1136/hrt.2009.191122; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; Dai TY, 2006, EUR J PHARMACOL, V553, P222, DOI 10.1016/j.ejphar.2006.09.034; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hendry SL, 2008, J THORAC CARDIOV SUR, V136, P1028, DOI 10.1016/j.jtcvs.2007.12.053; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Segev H, 2005, DEV GROWTH DIFFER, V47, P295; Suzuki Y, 2007, MAGN RESON MED, V57, P1173, DOI 10.1002/mrm.21219; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tempel D, 2010, SCI SESS 2010 AM HEA; Thygesen K, 2007, EUR HEART J, V28, P2525; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang C, 2008, AM J PHYSIOL-HEART C, V294, pH2540, DOI 10.1152/ajpheart.00046.2008; Wang Xiang, 2008, J Vis Exp, DOI 10.3791/825; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zhang FX, 2008, BIODRUGS, V22, P361, DOI 10.2165/0063030-200822060-00003; Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005	42	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38328	10.1371/journal.pone.0038328	http://dx.doi.org/10.1371/journal.pone.0038328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675543	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900024
J	Gosselin-Badaroudine, P; Keller, DI; Huang, H; Pouliot, V; Chatelier, A; Osswald, S; Brink, M; Chahine, M				Gosselin-Badaroudine, Pascal; Keller, Dagmar I.; Huang, Hai; Pouliot, Valerie; Chatelier, Aurelien; Osswald, Stefan; Brink, Marijke; Chahine, Mohamed			A Proton Leak Current through the Cardiac Sodium Channel Is Linked to Mixed Arrhythmia and the Dilated Cardiomyopathy Phenotype	PLOS ONE			English	Article							SICK SINUS SYNDROME; LONG-QT SYNDROME; SCN5A MUTATION; CONDUCTION DISORDER; MOLECULAR-MECHANISM; BRUGADA-SYNDROME; XENOPUS OOCYTES; GENETIC-BASIS; GATING PORE; HEART	Cardiac Na+ channels encoded by the SCN5A gene are essential for initiating heart beats and maintaining a regular heart rhythm. Mutations in these channels have recently been associated with atrial fibrillation, ventricular arrhythmias, conduction disorders, and dilated cardiomyopathy (DCM). We investigated a young male patient with a mixed phenotype composed of documented conduction disorder, atrial flutter, and ventricular tachycardia associated with DCM. Further family screening revealed DCM in the patient's mother and sister and in three of the mother's sisters. Because of the complex clinical phenotypes, we screened SCN5A and identified a novel mutation, R219H, which is located on a highly conserved region on the fourth helix of the voltage sensor domain of Na(v)1.5. Three family members with DCM carried the R219H mutation. The wild-type (WT) and mutant Na+ channels were expressed in a heterologous expression system, and intracellular pH (pHi) was measured using a pH-sensitive electrode. The biophysical characterization of the mutant channel revealed an unexpected selective proton leak with no effect on its biophysical properties. The H+ leak through the mutated Nav1.5 channel was not related to the Na+ permeation pathway but occurred through an alternative pore, most probably a proton wire on the voltage sensor domain. We propose that acidification of cardiac myocytes and/or downstream events may cause the DCM phenotype and other electrical problems in affected family members. The identification of this clinically significant H+ leak may lead to the development of more targeted treatments.	[Gosselin-Badaroudine, Pascal; Huang, Hai; Pouliot, Valerie; Chatelier, Aurelien; Chahine, Mohamed] Univ Laval, Robert Giffard Res Ctr, Quebec City, PQ, Canada; [Keller, Dagmar I.] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; [Keller, Dagmar I.; Osswald, Stefan] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Keller, Dagmar I.; Brink, Marijke] Univ Basel Hosp, Cardiobiol Res Labs, CH-4031 Basel, Switzerland; [Chahine, Mohamed] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Zurich; University Zurich Hospital; University of Basel; University of Basel; Laval University	Gosselin-Badaroudine, P (corresponding author), Univ Laval, Robert Giffard Res Ctr, Quebec City, PQ, Canada.	mohamed.chahine@phc.ulaval.ca	Chatelier, Aurelien/P-5056-2016; Osswald, Stefan/A-6904-2018	Osswald, Stefan/0000-0002-9240-6731; Brink, Marijke/0000-0002-1790-0190; chatelier, aurelien/0000-0002-7441-1182	Heart and Stroke Foundation of Quebec; Canadian Institutes of Health Research [MT-13181]; Stiftung fur Kardiovaskulare Forschung; University Hospital Basel, Switzerland	Heart and Stroke Foundation of Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stiftung fur Kardiovaskulare Forschung; University Hospital Basel, Switzerland	This work was supported by grants from the Heart and Stroke Foundation of Quebec and Canadian Institutes of Health Research Grant MT-13181. D. I. Keller was supported by a grant from Stiftung fur Kardiovaskulare Forschung, University Hospital Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2006, PACE, V29, P1130, DOI 10.1111/j.1540-8159.2006.00507.x; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; Chahine M, 2005, J MOL CELL CARDIOL, V38, P571, DOI 10.1016/j.yjmcc.2005.01.003; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cheng JD, 2010, CTS-CLIN TRANSL SCI, V3, P287, DOI 10.1111/j.1752-8062.2010.00249.x; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Ge JB, 2008, CIRC-ARRHYTHMIA ELEC, V1, P83, DOI 10.1161/CIRCEP.107.750752; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; KEELING PJ, 1995, BRIT HEART J, V73, P417; KOHMOTO O, 1990, CIRC RES, V66, P622, DOI 10.1161/01.RES.66.3.622; Li QJ, 2009, BIOCHEM BIOPH RES CO, V380, P132, DOI 10.1016/j.bbrc.2009.01.052; Makita N, 2006, CIRCULATION, V114, P505; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Nguyen TP, 2008, CIRC RES, V102, P364, DOI 10.1161/CIRCRESAHA.107.164673; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; PIWNICAWORMS D, 1985, J GEN PHYSIOL, V85, P43, DOI 10.1085/jgp.85.1.43; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; Schonberger J, 2001, AM J HUM GENET, V69, P249, DOI 10.1086/321978; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shi RM, 2008, EUROPACE, V10, P1329, DOI 10.1093/europace/eun202; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Struyk AF, 2007, J GEN PHYSIOL, V130, P11, DOI 10.1085/jgp.200709755; Surber R, 2008, CARDIOVASC RES, V77, P740, DOI 10.1093/cvr/cvm096; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	46	73	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38331	10.1371/journal.pone.0038331	http://dx.doi.org/10.1371/journal.pone.0038331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675453	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500132
J	Lo, CC; Schwartz, JA; Johnson, DJ; Yu, MC; Aidarus, N; Mujib, S; Benko, E; Hyrcza, M; Kovacs, C; Ostrowski, MA				Lo, Calvin C.; Schwartz, Jordan A.; Johnson, Dylan J.; Yu, Monica; Aidarus, Nasra; Mujib, Shariq; Benko, Erika; Hyrcza, Martin; Kovacs, Colin; Ostrowski, Mario A.			HIV Delays IFN-alpha Production from Human Plasmacytoid Dendritic Cells and Is Associated with SYK Phosphorylation	PLOS ONE			English	Article							INHIBITS TLR9-MEDIATED ACTIVATION; INTERFERON-ALPHA; SIMIAN IMMUNODEFICIENCY; CHEMOKINE PRODUCTION; AIDS VIRUS; CPG DNA; INFLUENZA; INFECTION; TLR7; EXPRESSION	Plasmacytoid dendritic cells (pDC) are the major producers of type I interferons (IFNs) in humans and rapidly produce IFN-alpha in response to virus exposure. Although HIV infection is associated with pDC activation, it is unclear why the innate immune response is unable to effectively control viral replication. We systematically compared the effect of HIV, Influenza, Sendai, and HSV-2 at similar target cell multiplicity of infection (M.O.I.) on human pDC function. We found that Influenza, Sendai, HSV-2 and imiquimod are able to rapidly induce IFN-alpha production within 4 hours to maximal levels, whereas HIV had a delayed induction that was maximal only after 24 hours. In addition, maximal IFN-alpha induction by HIV was at least 10 fold less than that of the other viruses in the panel. HIV also induced less TNF-alpha and MIP-1 beta but similar levels of IP-10 compared to other viruses, which was also mirrored by delayed upregulation of pDC activation markers CD83 and CD86. BDCA-2 has been identified as an inhibitory receptor on pDC, signaling through a pathway that involves SYK phosphorylation. We find that compared to Influenza, HIV induces the activation of the SYK pathway. Thus, HIV delays pDC IFN-alpha production and pDC activation via SYK phosphorylation, allowing establishment of viral populations.	[Lo, Calvin C.; Schwartz, Jordan A.; Johnson, Dylan J.; Yu, Monica; Mujib, Shariq; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Aidarus, Nasra; Mujib, Shariq; Benko, Erika; Hyrcza, Martin; Kovacs, Colin; Ostrowski, Mario A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Benko, Erika; Kovacs, Colin] Maple Leaf Med Clin, Toronto, ON, Canada; [Ostrowski, Mario A.] St Michaels Hosp, Li Ka Shing Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Lo, CC (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	mario.ostrowski@gmail.com		Mujib, Shariq/0000-0002-6206-5622; Lo, Calvin/0000-0002-0743-8895; Schwartz, Jordan/0000-0001-9658-5282	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Beignon AS, 2005, J CLIN INVEST; Benlahrech A, 2011, CURR OPIN HIV AIDS, V6, P373, DOI 10.1097/COH.0b013e328349592a; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cox K, 2005, J LEUKOCYTE BIOL, V78, P1142, DOI 10.1189/jlb.1103-532; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Dobson-Belaire WN, 2010, CELL MICROBIOL; Donhauser N, 2010, AIDS RES HUM RETROV, V26, P161, DOI 10.1089/aid.2008.0278; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gondois-Rey F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004319; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; O'Brien M, 2011, J CLIN INVEST, V121, P1088, DOI 10.1172/JCI44960; Osawa Y, 2006, J IMMUNOL, V177, P4841, DOI 10.4049/jimmunol.177.7.4841; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Penna G, 2002, J IMMUNOL, V169, P6673, DOI 10.4049/jimmunol.169.12.6673; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Porcu P, 1998, P NATL ACAD SCI USA, V95, P4538, DOI 10.1073/pnas.95.8.4538; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Sadaka C, 2009, BLOOD, V113, P2127, DOI 10.1182/blood-2008-10-178152; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sheth PM, 2006, J INFECT DIS, V193, P45, DOI 10.1086/498576; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37052	10.1371/journal.pone.0037052	http://dx.doi.org/10.1371/journal.pone.0037052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693567	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500029
J	Tang, F; Zhang, R; He, YM; Zou, MJ; Guo, L; Xi, T				Tang, Feng; Zhang, Rui; He, Yunmian; Zou, Meijuan; Guo, Le; Xi, Tao			MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; RHO-GTPASES; STEM-CELLS; EXPRESSION AFFECTS; INHIBITS INVASION; PROLIFERATION; GROWTH; MIGRATION; PROTEIN; DIFFERENTIATION	MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression by targeting mRNAs to trigger either translation repression or mRNA degradation. miR-125b is down-regulated in human breast cancer cells compared with the normal ones except highly metastatic tumor cells MDA-MB-231. However, few functional studies were designed to investigate metastatic potential of miR-125b. In this study, the effects of miR-125b on metastasis in human breast cancer cells were studied, and the targets of miR-125b were also explored. Transwell migration assay, cell wound healing assay, adhesion assay and nude mice model of metastasis were utilized to investigate the effects of miR-125b on metastasis potential in vitro and in vivo. In addition, it was implied STARD13 (DLC2) was a direct target of miR-125b by Target-Scan analysis, luciferase reporter assay and western blot. Furthermore, activation of STARD13 was identified responsible for metastasis induced by miR-125b through alpha a siRNA targeting STARD13. qRT-PCR, immunofluorescent assay and western blot was used to observe the variation of Vimentin and alpha-SMA in breast cancer cells. In summary, our study provided new insights into the function of miR-125b during the metastasis of breat cancer cells and also suggested the role of miR-125b in pro-metastasis by targeting STARD13.	[Tang, Feng; Zhang, Rui; He, Yunmian; Zou, Meijuan; Guo, Le; Xi, Tao] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Tang, Feng; Zhang, Rui; He, Yunmian; Zou, Meijuan; Guo, Le; Xi, Tao] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Tang, F (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	leileitang1984@163.com; xi_tao18@sina.com		Xi, Tao/0000-0001-8065-2639	Fundamental Research Funds for the Central Universities [JYK2011029]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities (Program No. JYK2011029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bockmeyer CL, 2011, BREAST CANC RES TREA; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Guan Y, 2010, INT J CANC, V23; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Leung THY, 2010, LIVER INT, V30, P1315, DOI 10.1111/j.1478-3231.2010.02307.x; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Liu F, 2010, MOL IMAGING BIOL, V12, P595, DOI 10.1007/s11307-010-0305-1; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Nagaraja GM, 2004, BIOCHEM BIOPH RES CO, V313, P654, DOI 10.1016/j.bbrc.2003.12.001; Nock Nora L, 2009, BMC Proc, V3 Suppl 7, pS50; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togawa H, 2011, AM J PHYSIOL-RENAL, V300, pF511, DOI 10.1152/ajprenal.00038.2010; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Virtanen SS, 2002, CANCER RES, V62, P2708; Voss MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-158; Wilbert ML, 2010, WILEY INTERDISCIP RE; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yang BF, 2009, CLIN EXP PHARMACOL P, V36, P951, DOI 10.1111/j.1440-1681.2009.05245.x; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	50	104	115	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35435	10.1371/journal.pone.0035435	http://dx.doi.org/10.1371/journal.pone.0035435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693547	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500008
J	Wu, YC; Wang, XJ; Yu, L; Chan, FKL; Cheng, ASL; Yu, J; Sung, JJY; Wu, WKK; Cho, CH				Wu, Ya C.; Wang, Xiao J.; Yu, Le; Chan, Francis K. L.; Cheng, Alfred S. L.; Yu, Jun; Sung, Joseph J. Y.; Wu, William K. K.; Cho, Chi H.			Hydrogen Sulfide Lowers Proliferation and Induces Protective Autophagy in Colon Epithelial Cells	PLOS ONE			English	Article							ULCERATIVE-COLITIS; IN-VITRO; CANCER; PROTEIN; HUMANS	Hydrogen sulfide (H2S) is a gaseous bacterial metabolite that reaches high levels in the large intestine. In the present study, the effect of H2S on the proliferation of normal and cancerous colon epithelial cells was investigated. An immortalized colon epithelial cell line (YAMC) and a panel of colon cancer cell lines (HT-29, SW1116, HCT116) were exposed to H2S at concentrations similar to those found in the human colon. H2S inhibited normal and cancerous colon epithelial cell proliferation as measured by MTT assay. The anti-mitogenic effect of H2S was accompanied by G(1)-phase cell cycle arrest and the induction of the cyclin-dependent kinase inhibitor p21(Cip). Moreover, exposure to H2S led to features characteristic of autophagy, including increased formation of LC3B(+) autophagic vacuoles and acidic vesicular organelles as determined by immunofluorescence and acridine orange staining, respectively. Abolition of autophagy by RNA interference targeting Vps34 or Atg7 enhanced the anti-proliferative effect of H2S. Further mechanistic investigation revealed that H2S stimulated the phosphorylation of AMP-activated protein kinase (AMPK) and inhibited the phosphorylation of mammalian target of rapamycin (mTOR) and S6 kinase. Inhibition of AMPK significantly reversed H2S-induced autophagy and inhibition of cell proliferation. Collectively, we demonstrate that H2S inhibits colon epithelial cell proliferation and induces protective autophagy via the AMPK pathway.	[Wu, Ya C.; Yu, Le; Cho, Chi H.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Wang, Xiao J.; Chan, Francis K. L.; Cheng, Alfred S. L.; Yu, Jun; Sung, Joseph J. Y.; Wu, William K. K.] Chinese Univ Hong Kong, Inst Digest Dis, LKS Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wang, Xiao J.; Chan, Francis K. L.; Cheng, Alfred S. L.; Yu, Jun; Sung, Joseph J. Y.; Wu, William K. K.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, YC (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	wukakei@cuhk.edu.hk	Cheng, Alfred SL/C-3327-2014; Wu, William K.K./A-3277-2009; Cho, Chi Hin/C-6543-2014; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018; wu, william/HII-5817-2022; Yu, Jun/D-8569-2015	Cheng, Alfred SL/0000-0003-2345-6951; Wu, William K.K./0000-0002-5662-5240; Cho, Chi Hin/0000-0002-7658-3260; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153				Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Magee EA, 2000, AM J CLIN NUTR, V72, P1488; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Picton R, 2007, DIGEST DIS SCI, V52, P373, DOI 10.1007/s10620-006-9529-y; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Turk HF, 2011, INT J CANCER, V128, P63, DOI 10.1002/ijc.25323; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295	24	82	88	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37572	10.1371/journal.pone.0037572	http://dx.doi.org/10.1371/journal.pone.0037572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22679478	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349600021
J	Smani, Y; Docobo-Perez, F; Lopez-Rojas, R; Dominguez-Herrera, J; Ibanez-Martinez, J; Pachon, J				Smani, Younes; Docobo-Perez, Fernando; Lopez-Rojas, Rafael; Dominguez-Herrera, Juan; Ibanez-Martinez, Jose; Pachon, Jeronimo			Platelet-activating Factor Receptor Initiates Contact of Acinetobacter baumannii Expressing Phosphorylcholine with Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; MEMBRANE PROTEIN-A; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-GONORRHOEAE; ABIOTIC SURFACES; PAF RECEPTOR; IN-VITRO; LIPOPOLYSACCHARIDE	Adhesion is an initial and important step in Acinetobacter baumannii causing infections. However, the exact molecular mechanism of such a step between A. baumannii and the host cells remains unclear. Here, we demonstrated that the phosphorylcholine (ChoP)-containing outer membrane protein of A. baumannii binds to A549 cells through platelet-activating factor receptor (PAFR), resulting in activation of G protein and intracellular calcium. Upon A. baumannii expressing ChoP binding to PAFR, clathrin and beta-arrestins, proteins involved in the direction of the vacuolar movement, are activated during invasion of A. baumannii. PAFR antagonism restricts the dissemination of A. baumannii in the pneumonia model. These results define a role for PAFR in A. baumannii interaction with host cells and suggest a mechanism for the entry of A. baumannii into the cytoplasm of host cells.	[Smani, Younes; Docobo-Perez, Fernando; Lopez-Rojas, Rafael; Dominguez-Herrera, Juan; Pachon, Jeronimo] Univ Seville, Univ Hosp Virgen del Rocio, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS,CSIC, Seville 41013, Spain; [Ibanez-Martinez, Jose] Univ Hosp Virgen Macarena, Dept Pathol, Seville 41007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario Virgen Macarena	Smani, Y (corresponding author), Univ Seville, Univ Hosp Virgen del Rocio, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS,CSIC, Av Manuel Siurot S-N, Seville 41013, Spain.	y_smani@hotmail.com	, Smani/G-5314-2013; Dominguez-Herrera, Juan/T-6416-2018; Pachon, Jeronimo/M-4337-2014; Docobo-Perez, Fernando/R-2534-2016	, Smani/0000-0001-9302-8384; Dominguez-Herrera, Juan/0000-0002-2562-1415; Docobo-Perez, Fernando/0000-0003-4038-6764; Pachon, Jeronimo/0000-0002-8166-5308	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008/0000]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases	Funded by the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, co-financed by the European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases (Grant REIPI RD06/0008/0000). To whom correspondence should be addressed: Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio. Av. Manuel Siurot s/n, 41013 Seville, Spain. Tel.: 34-955-923100; E-mail: y_smani@hotmail.com or ysmani-ibis@us.es.	Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Barbier M, 2008, EUR RESPIR J, V32, P1283, DOI 10.1183/09031936.00020608; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; Buommino E, 1999, INFECT IMMUN, V67, P4794, DOI 10.1128/IAI.67.9.4794-4800.1999; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Cuenca FF, 2003, J BASIC MICROB, V43, P194, DOI 10.1002/jobm.200390022; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Karlsson C, 1998, EUR J BIOCHEM, V255, P296, DOI 10.1046/j.1432-1327.1998.2550296.x; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2007, BIOCHEM PHARMACOL, V74, P86, DOI 10.1016/j.bcp.2007.02.012; Luke NR, 2010, INFECT IMMUN, V78, P2017, DOI 10.1128/IAI.00016-10; Lysenko E, 2000, MOL MICROBIOL, V35, P234, DOI 10.1046/j.1365-2958.2000.01707.x; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Rijneveld AW, 2004, J INFECT DIS, V189, P711, DOI 10.1086/381392; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Roca I, 2011, ANTIMICROB AGENTS CH, V55, P1285, DOI 10.1128/AAC.01142-10; Rodriguez-Hernandez MJ, 2000, J ANTIMICROB CHEMOTH, V45, P493, DOI 10.1093/jac/45.4.493; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Serino L, 2000, MOL MICROBIOL, V35, P1550, DOI 10.1046/j.1365-2958.2000.01825.x; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Smani Y, 2012, CLIN MICROBIOL INFEC, V18, pE1, DOI 10.1111/j.1469-0691.2011.03695.x; Smani Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033073; Smani Y, 2011, J INFECT DIS, V203, P1110, DOI 10.1093/infdis/jiq159; Smani Y, 2011, MICROB PATHOGENESIS, V50, P224, DOI 10.1016/j.micpath.2011.01.008; Sukumaran SK, 2003, J BIOL CHEM, V278, P45753, DOI 10.1074/jbc.M307374200; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Swords WE, 2001, CELL MICROBIOL, V3, P525, DOI 10.1046/j.1462-5822.2001.00132.x; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Valero C, 2001, Eur J Intern Med, V12, P425, DOI 10.1016/S0953-6205(01)00150-9; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; Weiser JN, 1998, INFECT IMMUN, V66, P4263; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	50	36	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26901	26910		10.1074/jbc.M112.344556	http://dx.doi.org/10.1074/jbc.M112.344556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689572	hybrid, Green Published			2022-12-25	WOS:000307386000038
J	Spoerri, L; Vella, LJ; Pham, CLL; Barnham, KJ; Cappai, R				Spoerri, Loredana; Vella, Laura J.; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto			The Amyloid Precursor Protein Copper Binding Domain Histidine Residues 149 and 151 Mediate APP Stability and Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; BETA-PEPTIDE; BREFELDIN-A; CEREBROSPINAL-FLUID; ALPHA-SECRETASE; MESSENGER-RNA; CLEAVAGE	One of the key pathological hallmarks of Alzheimer disease (AD) is the accumulation of the APP-derived amyloid beta peptide A beta) in the brain. Altered copper homeostasis has also been reported in AD patients and is thought to increase oxidative stress and to contribute to toxic A beta accumulation and regulate APP metabolism. The potential involvement of the N-terminal APP copper binding domain CuBD) in these events has not been investigated. Based on the tertiary structure of the APP CuBD, we examined the histidine residues of the copper binding site His(147), His(149), and His(151)). We report that histidines 149 and 151 are crucial for CuBD stability and APP metabolism. Co-mutation of the APP CuBD His(149) and His(151) to asparagine decreased APP proteolytic processing, impaired APP endoplasmic reticulum-to-Golgi trafficking, and promoted aberrant APP oligomerization in HEK293 cells. Expression of the triple H147N/H149N/H151N-APP mutant led to up-regulation of the unfolded protein response. Using recombinant protein encompassing the APP CuBD, we found that insertion of asparagines at positions 149 and 151 altered the secondary structure of the domain. This study identifies two APP CuBD residues that are crucial for APP metabolism and suggests an additional role of this domain in APP folding and stability besides its previously identified copper binding activity. These findings are of major significance for the design of novel AD therapeutic drugs targeting this APP domain.	[Spoerri, Loredana; Vella, Laura J.; Pham, Chi L. L.; Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Spoerri, Loredana; Vella, Laura J.; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Mental Hlth Res Inst Victoria, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Cappai, R (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	r.cappai@unimelb.edu.au	Spoerri, Loredana/G-4862-2014; Vella, laura/N-2733-2017; Cappai, Roberto/B-3347-2010	Spoerri, Loredana/0000-0003-0756-9390; Vella, laura/0000-0002-1869-6291; Cappai, Roberto/0000-0002-9505-8496	Australian Research Council; National Health and Medical Research Council; Melbourne International Fee Remission Scholarship; Beaney Scholarship; May Stewart Bursary postgraduate scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Fee Remission Scholarship; Beaney Scholarship; May Stewart Bursary postgraduate scholarship	This work was supported by grants from the Australian Research Council and the National Health and Medical Research Council.; Recipient of a Melbourne International Fee Remission Scholarship, a Beaney Scholarship, and a May Stewart Bursary postgraduate scholarship.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; ANDERSON JP, 1992, J NEUROCHEM, V59, P2328; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Berg J. M., 2002, BIOCHEMISTRY-US, P64; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Botelho HM, 2009, FEBS J, V276, P1776, DOI 10.1111/j.1742-4658.2009.06912.x; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; CLARK AW, 1989, CAN J NEUROL SCI, V16, P477, DOI 10.1017/S0317167100029802; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Kong GKW, 2005, ACTA CRYSTALLOGR F, V61, P93, DOI 10.1107/S1744309104029744; Koo EH, 1996, J CELL SCI, V109, P991; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Low LY, 2002, J MOL BIOL, V319, P87, DOI 10.1016/S0022-2836(02)00236-X; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MERUTKA G, 1989, BIOCHEMISTRY-US, V28, P352, DOI 10.1021/bi00427a048; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Preece P, 2004, MOL BRAIN RES, V122, P1, DOI 10.1016/j.molbrainres.2003.08.022; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Sodhi CP, 2008, BRAIN RES, V1198, P204, DOI 10.1016/j.brainres.2008.01.031; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Squitti R, 2004, ARCH NEUROL-CHICAGO, V61, P738, DOI 10.1001/archneur.61.5.738; Squitti R, 2002, NEUROLOGY, V59, P1153, DOI 10.1212/WNL.59.8.1153; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; VITEK MP, 1989, NEUROBIOL AGING, V10, P471, DOI 10.1016/0197-4580(89)90102-4; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	62	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26840	26853		10.1074/jbc.M112.355743	http://dx.doi.org/10.1074/jbc.M112.355743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685292	Green Published, hybrid			2022-12-25	WOS:000307386000033
J	Tokmakov, AA; Kurotani, A; Takagi, T; Toyama, M; Shirouzu, M; Fukami, Y; Yokoyama, S				Tokmakov, Alexander A.; Kurotani, Atsushi; Takagi, Tetsuo; Toyama, Mitsutoshi; Shirouzu, Mikako; Fukami, Yasuo; Yokoyama, Shigeyuki			Multiple Post-translational Modifications Affect Heterologous Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL GENOMICS; SUCCESSFUL EXPRESSION; TRANSLATION SYSTEM; RECEPTOR-BINDING; SWISS-MODEL; PREDICTION; IDENTIFICATION; PURIFICATION; PROTEOMICS	Post-translational modifications (PTMs) are required for proper folding of many proteins. The low capacity for PTMs hinders the production of heterologous proteins in the widely used prokaryotic systems of protein synthesis. Until now, a systematic and comprehensive study concerning the specific effects of individual PTMs on heterologous protein synthesis has not been presented. To address this issue, we expressed 1488 human proteins and their domains in a bacterial cell-free system, and we examined the correlation of the expression yields with the presence of multiple PTM sites bioinformatically predicted in these proteins. This approach revealed a number of previously unknown statistically significant correlations. Prediction of some PTMs, such as myristoylation, glycosylation, palmitoylation, and disulfide bond formation, was found to significantly worsen protein amenability to soluble expression. The presence of other PTMs, such as aspartyl hydroxylation, C-terminal amidation, and Tyr sulfation, did not correlate with the yield of heterologous protein expression. Surprisingly, the predicted presence of several PTMs, such as phosphorylation, ubiquitination, SUMOylation, and prenylation, was associated with the increased production of properly folded soluble proteins. The plausible rationales for the existence of the observed correlations are presented. Our findings suggest that identification of potential PTMs in polypeptide sequences can be of practical use for predicting expression success and optimizing heterologous protein synthesis. In sum, this study provides the most compelling evidence so far for the role of multiple PTMs in the stability and solubility of heterologously expressed recombinant proteins.	[Tokmakov, Alexander A.; Fukami, Yasuo] Kobe Univ, Res Ctr Environm Genom, Nada 6578501, Japan; [Tokmakov, Alexander A.; Fukami, Yasuo] Kobe Univ, Grad Sch Sci, Nada 6578501, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tokmakov, Alexander A.; Kurotani, Atsushi; Takagi, Tetsuo; Toyama, Mitsutoshi; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Kurotani, Atsushi] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Kobe University; Kobe University; University of Tokyo; RIKEN; RIKEN	Tokmakov, AA (corresponding author), Kobe Univ, Res Ctr Environm Genom, Nada Ku, Rokko Dai 1-1, Kobe, Hyogo 6578501, Japan.	tokmak@phoenix.kobe-u.ac.jp	Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the RIKEN Structural Genomics/Proteomics Initiative and National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amaya M, 2011, BIOCHEM BIOPH RES CO, V416, P1, DOI 10.1016/j.bbrc.2011.10.142; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Chikayama E, 2004, BIOINFORMATICS, V20, P2836, DOI 10.1093/bioinformatics/bth276; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding HT, 2002, ACTA CRYSTALLOGR D, V58, P2102, DOI 10.1107/S0907444902016359; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Eckart MR, 1996, CURR OPIN BIOTECH, V7, P525, DOI 10.1016/S0958-1669(96)80056-5; Edison AS, 1999, J NEUROSCI, V19, P6318; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; Farrokhi Naser, 2009, V513, P175, DOI 10.1007/978-1-59745-427-8_10; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Gao JH, 2009, AM J TRANSL RES, V1, P312; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gigoux V, 1999, J BIOL CHEM, V274, P20457, DOI 10.1074/jbc.274.29.20457; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; He MY, 2008, NEW BIOTECHNOL, V25, P126, DOI 10.1016/j.nbt.2008.08.004; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Idicula-Thomas S, 2006, BIOINFORMATICS, V22, P278, DOI 10.1093/bioinformatics/bti810; In Y, 2005, FEBS J, V272, P5079, DOI 10.1111/j.1742-4658.2005.04919.x; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim DM, 2004, BIOTECHNOL BIOENG, V85, P122, DOI 10.1002/bit.10865; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marsden Russell L., 2008, V426, P3, DOI 10.1007/978-1-60327-058-8_1; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Merrick WC, 2007, METHOD ENZYMOL, V429, P1, DOI 10.1016/S0076-6879(07)29001-9; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Mikami S, 2006, J BIOTECHNOL, V127, P65, DOI 10.1016/j.jbiotec.2006.06.018; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seibert C, 2008, BIOPOLYMERS, V90, P459, DOI 10.1002/bip.20821; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Xu B, 2010, DEV BIOL, V348, P3, DOI 10.1016/j.ydbio.2010.08.018; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Yokoyama Shigeyuki, 2005, Tanpakushitsu Kakusan Koso, V50, P836; Yokoyama Shigeyuki, 2008, Tanpakushitsu Kakusan Koso, V53, P632; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	68	43	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27106	27116		10.1074/jbc.M112.366351	http://dx.doi.org/10.1074/jbc.M112.366351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22674579	hybrid, Green Published			2022-12-25	WOS:000307386000063
J	Yoon, SI; Jones, BC; Logsdon, NJ; Harris, BD; Kuruganti, S; Walter, MR				Yoon, Sung Il; Jones, Brandi C.; Logsdon, Naomi J.; Harris, Bethany D.; Kuruganti, Srilalitha; Walter, Mark R.			Epstein-Barr Virus IL-10 Engages IL-10R1 by a Two-step Mechanism Leading to Altered Signaling Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INTERLEUKIN-10 RECEPTOR; STIMULATORY FACTOR; UP-REGULATION; EXPRESSION; REVEALS; BINDING; CELL; HOMOLOGY; COMPLEX	Human interleukin-10 (hIL-10) is a pleiotropic cytokine that is able to suppress or activate cellular immune responses to protect the host from invading pathogens. Epstein-Barr virus (EBV) encodes a viral IL-10 (ebvIL-10) in its genome that has retained the immunosuppressive activities of hIL-10 but lost the ability to induce immunostimulatory activities on some cells. These functional differences are at least partially due to the similar to 1000-fold difference in hIL-10 and ebvIL-10 binding affinity for the IL-10R1.IL-10R2 cell surface receptors. Despite weaker binding to IL-10R1, ebvIL-10 is more active than hIL-10 in inducing B-cell proliferation. To explore this counterintuitive observation further, a series of monomeric and dimeric ebvIL-10.hIL-10 chimeric proteins were produced and characterized for receptor binding and cellular proliferation on TF-1/hIL-10R1 cells that express high levels of the IL-10R1 chain. On this cell line, monomeric chimeras elicited cell proliferation in accordance with how tightly they bound to the IL-10R1 chain. In contrast, dimeric chimeras exhibiting the highest affinity for IL-10R1 exhibited reduced proliferative activity. These distinct activity profiles are correlated with kinetic analyses that reveal that the ebvIL-10 dimer is impaired in its ability to form a 1:2 ebvIL-10.IL-10R1 complex. As a result, the ebvIL-10 dimer functions like a monomer at low IL-10R1 levels, which prevents efficient signaling. At high IL-10R1 levels, the ebvIL-10 dimer is able to induce signaling responses greater than hIL-10. Thus, the ebvIL-10 dimer scaffold is essential to prevent activation of cells with low IL-10R1 levels but to maintain or enhance activity on cells with high IL-10R1 levels.	[Yoon, Sung Il; Kuruganti, Srilalitha; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Yoon, Sung Il; Jones, Brandi C.; Logsdon, Naomi J.; Harris, Bethany D.; Walter, Mark R.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Yoon, Sung Il] Kangwon Natl Univ, Dept Syst Immunol, Coll Biomed Sci, Chunchon 200701, South Korea; [Yoon, Sung Il] Kangwon Natl Univ, Inst Antibody Res, Coll Biomed Sci, Chunchon 200701, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Kangwon National University; Kangwon National University	Walter, MR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 1025 18th St S, Birmingham, AL 35294 USA.	walter@uab.edu			National Institutes of Health Grants [RO1 AI047300, RO 1AI047300-S1]; National Science Foundation of Korea Grant [2012R1A1A1003701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of Korea Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI047300 and RO 1AI047300-S1 (to M.R.W.). This work was also supported by National Science Foundation of Korea Grant 2012R1A1A1003701 (to S.I.Y.).	Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Crepaldi L, 2001, J IMMUNOL, V167, P2312, DOI 10.4049/jimmunol.167.4.2312; DING L, 1993, J IMMUNOL, V151, P1224; Ding YZ, 2000, J EXP MED, V191, P213, DOI 10.1084/jem.191.2.213; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HO ASY, 1995, MOL CELL BIOL, V15, P5043; Il Yoon S, 2007, PROTEIN EXPRES PURIF, V53, P132, DOI 10.1016/j.pep.2006.12.001; Jiang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027464; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; KITAMURA T, 1991, INT IMMUNOL, V3, P571, DOI 10.1093/intimm/3.6.571; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kumar KGS, 2003, EMBO J, V22, P5480; Liu Y, 1997, J IMMUNOL, V158, P604; Logsdon NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028127; Logsdon NJ, 2002, J INTERF CYTOK RES, V22, P1099, DOI 10.1089/10799900260442520; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1991, J EXP MED, V174, P915; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Roughan JE, 2010, J VIROL, V84, P1158, DOI 10.1128/JVI.01780-09; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Salek-Ardakani S, 2002, VIROLOGY, V304, P342, DOI 10.1006/viro.2002.1716; STUART AD, 1995, ONCOGENE, V11, P1711; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Thorley-Lawson DA, 2008, TRENDS IMMUNOL, V29, P195, DOI 10.1016/j.it.2008.01.006; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; Wei SHY, 2006, J INTERF CYTOK RES, V26, P281, DOI 10.1089/jir.2006.26.281; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	48	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26586	26595		10.1074/jbc.M112.376707	http://dx.doi.org/10.1074/jbc.M112.376707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692218	hybrid, Green Published			2022-12-25	WOS:000307386000011
J	Beven, L; Charenton, C; Dautant, A; Bouyssou, G; Labroussaa, F; Skollermo, A; Persson, A; Blanchard, A; Sirand-Pugnet, P				Beven, Laure; Charenton, Claire; Dautant, Alain; Bouyssou, Guillaume; Labroussaa, Fabien; Skollermo, Anna; Persson, Anja; Blanchard, Alain; Sirand-Pugnet, Pascal			Specific Evolution of F-1-Like ATPases in Mycoplasmas	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; SUBSP MYCOIDES SC; ESCHERICHIA-COLI; ATP SYNTHASE; MAXIMUM-LIKELIHOOD; ORIC PLASMIDS; F-TYPE; STRAINS; HYOPNEUMONIAE	F1F0 ATPases have been identified in most bacteria, including mycoplasmas which have very small genomes associated with a host-dependent lifestyle. In addition to the typical operon of eight genes encoding genuine F1F0 ATPase (Type 1), we identified related clusters of seven genes in many mycoplasma species. Four of the encoded proteins have predicted structures similar to the alpha, beta, gamma and e subunits of F-1 ATPases and could form an F-1-like ATPase. The other three proteins display no similarity to any other known proteins. Two of these proteins are probably located in the membrane, as they have three and twelve predicted transmembrane helices. Phylogenomic studies identified two types of F-1-like ATPase clusters, Type 2 and Type 3, characterized by a rapid evolution of sequences with the conservation of structural features. Clusters encoding Type 2 and Type 3 ATPases were assumed to originate from the Hominis group of mycoplasmas. We suggest that Type 3 ATPase clusters may spread to other phylogenetic groups by horizontal gene transfer between mycoplasmas in the same host, based on phylogeny and genomic context. Functional analyses in the ruminant pathogen Mycoplasma mycoides subsp. mycoides showed that the Type 3 cluster genes were organized into an operon. Proteomic analyses demonstrated that the seven encoded proteins were produced during growth in axenic media. Mutagenesis and complementation studies demonstrated an association of the Type 3 cluster with a major ATPase activity of membrane fractions. Thus, despite their tendency toward genome reduction, mycoplasmas have evolved and exchanged specific F-1-like ATPases with no known equivalent in other bacteria. We propose a model, in which the F-1-like structure is associated with a hypothetical X-0 sector located in the membrane of mycoplasma cells.	[Beven, Laure; Charenton, Claire; Bouyssou, Guillaume; Labroussaa, Fabien; Blanchard, Alain; Sirand-Pugnet, Pascal] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Beven, Laure; Charenton, Claire; Bouyssou, Guillaume; Labroussaa, Fabien; Blanchard, Alain; Sirand-Pugnet, Pascal] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Dautant, Alain] Univ Bordeaux, IBGC, UMR 5095, Bordeaux, France; [Dautant, Alain] IBMC, CNRS, UMR 5095, Bordeaux, France; [Skollermo, Anna; Persson, Anja] AlbaNova Univ Ctr, KTH Royal Inst Technol, Dept Prote, Sch Biotechnol, Stockholm, Sweden	UDICE-French Research Universities; Universite de Bordeaux; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Royal Institute of Technology	Beven, L (corresponding author), Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France.	sirand@bordeaux.inra.fr	Labroussaa, Fabien/AAN-2833-2021; Beven, Laure/Q-1096-2018; Blanchard, Alain/I-3916-2019; Blanchard, Alain/C-6130-2009	Labroussaa, Fabien/0000-0002-8712-3024; Beven, Laure/0000-0003-4407-3255; Blanchard, Alain/0000-0003-4223-5185; Blanchard, Alain/0000-0003-4223-5185; SIRAND-PUGNET, Pascal/0000-0003-2613-0762	Institut National de Recherche Agronomique; Region Aquitaine; University Bordeaux Segalen; Agence Nationale pour la Recherche [EVOLMYCO ANR-07-GMGE-001]	Institut National de Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); University Bordeaux Segalen; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Institut National de Recherche Agronomique (http://www.inra.fr/), the Region Aquitaine (http://aquitaine.fr/), the University Bordeaux Segalen (http://www.univ-bordeauxsegalen.fr/fr/index.html) and the Agence Nationale pour la Recherche (grant EVOLMYCO ANR-07-GMGE-001, http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdo EM, 2000, CLIN DIAGN LAB IMMUN, V7, P588, DOI 10.1128/CDLI.7.4.588-595.2000; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dibrova DV, 2010, BIOINFORMATICS, V26, P1473, DOI 10.1093/bioinformatics/btq234; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; Dybvig K, 2010, FEMS MICROBIOL LETT, V311, P51, DOI 10.1111/j.1574-6968.2010.02078.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; Freund EA, 1983, METHODS MYCOPLASMOLO, P127, DOI DOI 10.1016/B978-0-12-583801-6.50029-9; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hamsten C, 2009, MOL CELL PROTEOMICS, V8, P2544, DOI 10.1074/mcp.M900009-MCP200; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; Janis C, 2008, MICROBIOL-SGM, V154, P2427, DOI 10.1099/mic.0.2008/017640-0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KING KW, 1994, PLASMID, V31, P308, DOI 10.1006/plas.1994.1033; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Miyata M, 2008, TRENDS MICROBIOL, V16, P6, DOI 10.1016/j.tim.2007.11.002; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Nakane D, 2007, P NATL ACAD SCI USA, V104, P19518, DOI 10.1073/pnas.0704280104; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Oneal MJ, 2008, MICROBIOL-SGM, V154, P2581, DOI 10.1099/mic.0.2008/020230-0; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Shirvan M H, 1993, Subcell Biochem, V20, P261; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Voigt W, 2006, J CLIN MICROBIOL, V44, P2247, DOI 10.1128/JCM.00330-05; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	59	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38793	10.1371/journal.pone.0038793	http://dx.doi.org/10.1371/journal.pone.0038793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685606	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700070
J	Ciesielski, F; Davis, B; Rittig, M; Bonev, BB; O'Shea, P				Ciesielski, Filip; Davis, Benjamin; Rittig, Michael; Bonev, Boyan B.; O'Shea, Paul			Receptor-Independent Interaction of Bacterial Lipopolysaccharide with Lipid and Lymphocyte Membranes; the Role of Cholesterol	PLOS ONE			English	Article							LATERAL DIFFUSION; LPS; BINDING; RAFTS; MICRODOMAINS; RECOGNITION; INSERTION; PHASES; MODEL; TLR4	Lipopolysaccharide (LPS) is a major constituent of bacterial outer membranes where it makes up the bulk of the outer leaflet and plays a key role as determinant of bacterial interactions with the host. Membrane-free LPS is known to activate T-lymphocytes through interactions with Toll-like receptor 4 via multiprotein complexes. In the present study, we investigate the role of cholesterol and membrane heterogeneities as facilitators of receptor-independent LPS binding and insertion, which underpin bacterial interactions with the host in symbiosis, pathogenesis and cell invasion. We use fluorescence spectroscopy to investigate the interactions of membrane-free LPS from intestinal Gram-negative organisms with cholesterol-containing model membranes and with T-lymphocytes. LPS preparations from Klebsiella pneumoniae and Salmonella enterica were found to bind preferentially to mixed lipid membranes by comparison to pure PC bilayers. The same was observed for LPS from the symbiote Escherichia coli but with an order of magnitude higher dissociation constant. Insertion of LPS into model membranes confirmed the preference for sphimgomyelin/cholesterol-containing systems. LPS insertion into Jurkat T-lymphocyte membranes reveals that they have a significantly greater LPS-binding capacity by comparison to methyl-b-cyclodextrin cholesterol-depleted lymphocyte membranes, albeit at slightly lower binding rates.	[Ciesielski, Filip; Rittig, Michael; Bonev, Boyan B.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Davis, Benjamin; O'Shea, Paul] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Ciesielski, F (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	Boyan.Bonev@nottingham.ac.uk; Paul.OShea@nottingham.ac.uk		Bonev, Boyan/0000-0001-7156-2412; O'Shea, paul/0000-0001-9313-8313; Davis, Benjamin/0000-0001-6121-1635	United Kingdom Medical Research Council through a Doctoral Training Award; Institute of Infection and Immunity, Nottingham	United Kingdom Medical Research Council through a Doctoral Training Award; Institute of Infection and Immunity, Nottingham	The authors (BBB and MR) would like to acknowledge the financial contribution of the United Kingdom Medical Research Council in supporting FC through a Doctoral Training Award, and the Institute of Infection and Immunity, Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam JM, 2011, CHEM PHYS LIPIDS, V164, P166, DOI 10.1016/j.chemphyslip.2010.12.008; ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Davis BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013522; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Filippov A, 2004, BIOPHYS J, V86, P891, DOI 10.1016/S0006-3495(04)74164-8; Filippov A, 2003, BIOPHYS J, V84, P3079, DOI 10.1016/S0006-3495(03)70033-2; Golding C, 1996, BIOCHEMISTRY-US, V35, P10931, DOI 10.1021/bi960905i; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MAYER LD, 1986, CHEM PHYS LIPIDS, V40, P333, DOI 10.1016/0009-3084(86)90077-0; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Richardson G, 2007, BIOPHYS J, V92, P4145, DOI 10.1529/biophysj.106.090233; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2002, J CELL SCI, V115, P2603; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WALL J, 1995, J CELL SCI, V108, P2673; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	34	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38677	10.1371/journal.pone.0038677	http://dx.doi.org/10.1371/journal.pone.0038677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685597	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700060
J	Le Page, C; Marineau, A; Bonza, PK; Rahimi, K; Cyr, L; Labouba, I; Madore, J; Delvoye, N; Mes-Masson, AM; Provencher, DM; Cailhier, JF				Le Page, Cecile; Marineau, Alexandre; Bonza, Patrick K.; Rahimi, Kurosh; Cyr, Louis; Labouba, Ingrid; Madore, Jason; Delvoye, Nathalie; Mes-Masson, Anne-Marie; Provencher, Diane M.; Cailhier, Jean-Francois			BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GYNECOLOGIC-ONCOLOGY-GROUP; POOR-PROGNOSIS; MAMMARY-GLAND; MESSENGER-RNA; GENE FAMILY; B7 FAMILY; BUTYROPHILIN; MACROPHAGES; ACTIVATION	BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC). Here, we evaluated the prognostic value of BT3.2 at the protein level in specimen from 199 HG-EOC patients. As the only known role of butyrophilin proteins is in immune regulation, we evaluated the association between BT3.2 expression and intratumoral infiltration of immune cells by immunohistochemistry with specific antibodies against BT3.2, CD3, CD4, CD8, CD20, CD68 and CD206. Epithelial BT3.2 expression was significantly associated with longer overall survival and lower risk of disease progression (HR = 0.651, p = 0.006 and HR = 0.642, p = 0.002, respectively) and significantly associated with a higher density of infiltrating T cells, particularly CD4+ cells (0.272, p < 0.001). We also observed a strong association between the relative density of CD206+ cells, as evaluated by the ratio of intratumoral CD206+/CD68+ expression, and risk of disease progression (HR = 1.355 p = 0.044, respectively). In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206+/CD68+ expression is associated with high risk of disease progression. While the role of BT3.2 is still unknown, our result suggest that BT3.2 expression by epithelial cells may modulates the intratumoral infiltration of immune cells.	[Le Page, Cecile; Marineau, Alexandre; Bonza, Patrick K.; Cyr, Louis; Labouba, Ingrid; Madore, Jason; Delvoye, Nathalie; Mes-Masson, Anne-Marie; Provencher, Diane M.; Cailhier, Jean-Francois] CRCHUM, Montreal, PQ, Canada; [Le Page, Cecile; Marineau, Alexandre; Bonza, Patrick K.; Cyr, Louis; Labouba, Ingrid; Madore, Jason; Delvoye, Nathalie; Mes-Masson, Anne-Marie; Provencher, Diane M.; Cailhier, Jean-Francois] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Rahimi, Kurosh] CHUM, Dept Pathol, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie; Cailhier, Jean-Francois] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Provencher, Diane M.] CHUM, Div Gynecol Oncol, Montreal, PQ, Canada; [Cailhier, Jean-Francois] CHUM, Div Nephrol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Le Page, C (corresponding author), CRCHUM, Montreal, PQ, Canada.	jf.cailhier@umontreal.ca	Le Page, Cecile/B-3215-2010	Le Page, Cecile/0000-0002-8020-1544; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Marineau, Alexandre/0000-0003-0163-8391; Madore, Jason/0000-0002-3499-474X	Cancer Research Society; Fondation Carole Epstein; Fonds de Recherche en Sante du Quebec	Cancer Research Society; Fondation Carole Epstein; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Cancer Research Society and Fondation Carole Epstein. Dr. Cailhier holds a clinicien-chercheur scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Al-Attar A, 2010, PATHOL ONCOL RES, V16, P361, DOI 10.1007/s12253-009-9230-5; Allavena P, 2011, EXP CELL RES, V317, P664, DOI 10.1016/j.yexcr.2010.11.013; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Banghart LR, 1998, J BIOL CHEM, V273, P4171, DOI 10.1074/jbc.273.7.4171; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bas A, 2011, P NATL ACAD SCI USA, V108, P4376, DOI 10.1073/pnas.1010647108; Bosmuller H, 2011, VIRCHOWS ARCH, V459, P183, DOI 10.1007/s00428-011-1110-1; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; Cubillos-Ruiz JR, 2011, CELL CYCLE, V10, P368, DOI 10.4161/cc.10.3.14565; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Gavalas NG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/791603; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Le Page C, 2008, CANCER EPIDEM BIOMAR, V17, P913, DOI 10.1158/1055-9965.EPI-07-0692; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; Loos M, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/683875; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Messal N, 2011, EUR J IMMUNOL, V41, P3443, DOI 10.1002/eji.201141404; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Stumpf M, 2009, BRIT J CANCER, V101, P1513, DOI 10.1038/sj.bjc.6605274; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; TaziAhnini R, 1997, IMMUNOGENETICS, V47, P55, DOI 10.1007/s002510050326; Tetu B, 2008, MODERN PATHOL, V21, P1002, DOI 10.1038/modpathol.2008.80; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Wakabayashi Mark T, 2008, J Natl Compr Canc Netw, V6, P803; Wakabayashi MT, 2008, J NATL COMPR CANC NE, V6, P811; Winter WE, 2008, J CLIN ONCOL, V26, P83, DOI 10.1200/JCO.2007.13.1953; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Yamashiro H, 2010, J LEUKOCYTE BIOL, V88, P757, DOI 10.1189/jlb.0309156; Yamazaki T, 2010, J IMMUNOL, V185, P5907, DOI 10.4049/jimmunol.1000835; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zietarska M, 2010, HISTOPATHOLOGY, V57, P323, DOI 10.1111/j.1365-2559.2010.03602.x	50	69	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38541	10.1371/journal.pone.0038541	http://dx.doi.org/10.1371/journal.pone.0038541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685580	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700043
J	de Kleijn, S; Kox, M; Sama, IE; Pillay, J; van Diepen, A; Huijnen, MA; van der Hoeven, JG; Ferwerda, G; Hermans, PWM; Pickkers, P				de Kleijn, Stan; Kox, Matthijs; Sama, Iziah Edwin; Pillay, Janesh; van Diepen, Angela; Huijnen, Martijn A.; van der Hoeven, Johannes G.; Ferwerda, Gerben; Hermans, Peter W. M.; Pickkers, Peter			Transcriptome Kinetics of Circulating Neutrophils during Human Experimental Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; EXPRESSION; APOPTOSIS; SEPSIS; HETEROGENEITY; INHIBITION; CYTOSCAPE; CELLS	Polymorphonuclear cells (neutrophils) play an important role in the systemic inflammatory response syndrome and the development of sepsis. These cells are essential for the defense against microorganisms, but may also cause tissue damage. Therefore, neutrophil numbers and activity are considered to be tightly regulated. Previous studies have investigated gene transcription during experimental endotoxemia in whole blood and peripheral blood mononuclear cells. However, the gene transcription response of the circulating pool of neutrophils to systemic inflammatory stimulation in vivo is currently unclear. We examined neutrophil gene transcription kinetics in healthy human subjects (n = 4) administered a single dose of endotoxin (LPS, 2 ng/kg iv). In addition, freshly isolated neutrophils were stimulated ex vivo with LPS, TNF alpha, G-CSF and GM-CSF to identify stimulus-specific gene transcription responses. Whole transcriptome microarray analysis of circulating neutrophils at 2, 4 and 6 hours after LPS infusion revealed activation of inflammatory networks which are involved in signaling of TNF alpha and IL-1 alpha and IL-1 beta. The transcriptome profile of inflammatory activated neutrophils in vivo reflects extended survival and regulation of inflammatory responses. These changes in neutrophil transcriptome suggest a combination of early activation of circulating neutrophils by TNF alpha and G-CSF and a mobilization of young neutrophils from the bone marrow.	[de Kleijn, Stan; van Diepen, Angela; Ferwerda, Gerben; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Sama, Iziah Edwin; Huijnen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Pillay, Janesh] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [van Diepen, Angela] Leiden Univ, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Kleijn, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	J.Ferwerda@cukz.umcn.nl	Ferwerda, J.G./L-4305-2015; Hermans, Peter W.M./H-8042-2014; Kox, Matthijs/L-4454-2015; van der Hoeven, J.G./H-8048-2014; Huijnen, M.A./H-8051-2014; Pickkers, P./H-8080-2014	Pickkers, P./0000-0002-1104-4303; Pillay, Janesh/0000-0001-8037-6638; Sama, Iziah/0000-0002-9056-7152	ZonMW, The Netherlands [85100003]; VIRGO consortium, an Innovative Cluster; Dutch Government, The Netherlands [BSIK 03012]	ZonMW, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); VIRGO consortium, an Innovative Cluster; Dutch Government, The Netherlands(Netherlands Government)	SdK is supported by ZonMW, The Netherlands, Grant No. 85100003. IES was supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Kox M, 2011, CRIT CARE MED; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Paunel-Gorgulu A, 2011, CRIT CARE, V15, DOI 10.1186/cc9965; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Sama IE, 2010, BIOINFORMATICS, V26, P2737, DOI 10.1093/bioinformatics/btq474; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Theilgaard-Monch K, 2006, BLOOD, V108, P353, DOI 10.1182/blood-2005-09-3890; van der Meer W, 2007, J ENDOTOXIN RES, V13, P94, DOI 10.1177/0968051907079101; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Raam BJ, 2008, BLOOD, V112, P2046, DOI 10.1182/blood-2008-04-149575; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6; Zhang P, 2005, SHOCK, V23, P344, DOI 10.1097/01.shk.0000158960.93832.de	34	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38255	10.1371/journal.pone.0038255	http://dx.doi.org/10.1371/journal.pone.0038255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679495	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900025
J	Gao, Y; Chen, SH; Hu, MY; Hu, QB; Luo, JJ; Li, YA				Gao, Yan; Chen, Shaohua; Hu, Meiying; Hu, Qiongbo; Luo, Jianjun; Li, Yanan			Purification and Characterization of a Novel Chlorpyrifos Hydrolase from Cladosporium cladosporioides Hu-01	PLOS ONE			English	Article							METHYL PARATHION HYDROLASE; DEGRADING BACTERIUM; STRAIN; BIODEGRADATION; BIOREMEDIATION; CLONING; 3,5,6-TRICHLORO-2-PYRIDINOL; GENE; CYPERMETHRIN; DEGRADATION	Chlorpyrifos is of great environmental concern due to its widespread use in the past several decades and its potential toxic effects on human health. Thus, the degradation study of chlorpyrifos has become increasing important in recent years. A fungus capable of using chlorpyrifos as the sole carbon source was isolated from organophosphate-contaminated soil and characterized as Cladosporium cladosporioides Hu-01 (collection number: CCTCC M 20711). A novel chlorpyrifos hydrolase from cell extract was purified 35.6-fold to apparent homogeneity with 38.5% overall recovery by ammoniumsulfate precipitation, gel filtration chromatography and anion-exchange chromatography. It is a monomeric structure with a molecular mass of 38.3 kDa. The pI value was estimated to be 5.2. The optimal pH and temperature of the purified enzyme were 6.5 and 40 degrees C, respectively. No cofactors were required for the chlorpyrifos-hydrolysis activity. The enzyme was strongly inhibited by Hg2+, Fe3+, DTT, beta-mercaptoethanol and SDS, whereas slight inhibitory effects (5-10% inhibition) were observed in the presence of Mn2+, Zn2+, Cu2+, Mg2+, and EDTA. The purified enzyme hydrolyzed various organophosphorus insecticides with P-O and P-S bond. Chlorpyrifos was the preferred substrate. The Km and Vmax values of the enzyme for chlorpyrifos were 6.7974 mu M and 2.6473 mu mol-min(-1), respectively. Both NH2-terminal sequencing and matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometer (MALDI-TOF-MS) identified an amino acid sequence MEPDGELSALTQGANS, which shared no similarity with any reported organophosphate-hydrolyzing enzymes. These results suggested that the purified enzyme was a novel hydrolase and might conceivably be developed to fulfill the practical requirements to enable its use in situ for detoxification of chlorpyrifos. Finally, this is the first described chlorpyrifos hydrolase from fungus.	[Gao, Yan; Chen, Shaohua; Hu, Meiying; Hu, Qiongbo; Luo, Jianjun; Li, Yanan] S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China; [Gao, Yan] Guangdong Acad Agr Sci, Guangdong Prov Key Lab High Technol Plant Protect, Plant Protect Res Inst, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Gao, Y (corresponding author), S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation [30871660]; Project of Scientific Technological Planning of Guangdong Province, People's Republic of China [2009B020310005, 2009B020310003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Scientific Technological Planning of Guangdong Province, People's Republic of China	The authors gratefully acknowledge the grants from the National Natural Science Foundation (No.30871660) and the Project of Scientific Technological Planning of Guangdong Province (No.2009B020310005, 2009B020310003), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar S, 2009, J HAZARD MATER, V168, P400, DOI 10.1016/j.jhazmat.2009.02.059; Bicker W, 2005, TOXICOL LETT, V159, P235, DOI 10.1016/j.toxlet.2005.05.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chen SH, 2012, APPL MICROBIOL BIOT, V94, P505, DOI 10.1007/s00253-011-3640-5; Chen SH, 2012, BIORESOURCE TECHNOL, V110, P97, DOI 10.1016/j.biortech.2012.01.106; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; CHENG TC, 1993, APPL ENVIRON MICROB, V59, P3138, DOI 10.1128/AEM.59.9.3138-3140.1993; COCHRAN RC, 1995, FOOD CHEM TOXICOL, V33, P165, DOI 10.1016/0278-6915(94)00124-7; Cui ZL, 2001, APPL ENVIRON MICROB, V67, P4922; Cycon M, 2009, CHEMOSPHERE, V76, P494, DOI 10.1016/j.chemosphere.2009.03.023; DEFRANK JJ, 1991, J BACTERIOL, V173, P1938, DOI 10.1128/jb.173.6.1938-1943.1991; Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Fang H, 2008, INT BIODETER BIODEGR, V61, P294, DOI 10.1016/j.ibiod.2007.10.001; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Howard PH, 1991, HDB ENV FATE EXPOSUR; Kulshrestha G, 2011, BIOL FERT SOILS, V47, P219, DOI 10.1007/s00374-010-0505-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JQ, 2010, BIORESOURCE TECHNOL, V101, P7479, DOI 10.1016/j.biortech.2010.04.030; Li XH, 2008, INT BIODETER BIODEGR, V62, P331, DOI 10.1016/j.ibiod.2008.03.001; Li XH, 2007, RES MICROBIOL, V158, P143, DOI 10.1016/j.resmic.2006.11.007; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Megharaj M, 2011, ENVIRON INT, V37, P1362, DOI 10.1016/j.envint.2011.06.003; Mohan SV, 2007, ECOTOX ENVIRON SAFE, V68, P252, DOI 10.1016/j.ecoenv.2007.06.002; Oliver GR, 2000, NEUROTOXICOLOGY, V21, P203; Peng Y, 2009, APPL MICROBIOL BIOT, V85, P85, DOI 10.1007/s00253-009-2061-1; Singh BK, 2004, APPL ENVIRON MICROB, V70, P4855, DOI 10.1128/AEM.70.8.4855-4863.2004; Singh BK, 2006, SOIL BIOL BIOCHEM, V38, P2682, DOI 10.1016/j.soilbio.2006.04.019; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Sorensen SR, 2008, APPL ENVIRON MICROB, V74, P2332, DOI 10.1128/AEM.02687-07; Theriot CM, 2011, APPL MICROBIOL BIOT, V89, P35, DOI 10.1007/s00253-010-2807-9; VARGHESE G, 1983, ANAL BIOCHEM, V132, P481, DOI 10.1016/0003-2697(83)90037-4; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Xu GM, 2008, INT BIODETER BIODEGR, V62, P51, DOI 10.1016/j.ibiod.2007.12.001; Yang C, 2006, FEMS MICROBIOL LETT, V265, P118, DOI 10.1111/j.1574-6968.2006.00478.x; Yang L, 2005, FEMS MICROBIOL LETT, V251, P67, DOI 10.1016/j.femsle.2005.07.031; Yang L, 2011, BIOL FERT SOILS, V47, P917, DOI 10.1007/s00374-011-0602-0; Yu YL, 2006, BIODEGRADATION, V17, P487, DOI 10.1007/s10532-005-9020-z; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P7139, DOI 10.1016/j.biortech.2011.03.086	45	64	66	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38137	10.1371/journal.pone.0038137	http://dx.doi.org/10.1371/journal.pone.0038137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693630	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900018
J	Inoue, K; Shimozono, S; Yoshida, H; Kurata, H				Inoue, Kentaro; Shimozono, Shinichi; Yoshida, Hideaki; Kurata, Hiroyuki			Application of Approximate Pattern Matching in Two Dimensional Spaces to Grid Layout for Biochemical Network Maps	PLOS ONE			English	Article							BIOLOGICAL NETWORKS; GRAPH LAYOUT; ANALYSIS TOOL; VISUALIZATION; ALGORITHM; CYTOSCAPE; CADLIVE; ENVIRONMENT; NOTATION; SYSTEM	Background: For visualizing large-scale biochemical network maps, it is important to calculate the coordinates of molecular nodes quickly and to enhance the understanding or traceability of them. The grid layout is effective in drawing compact, orderly, balanced network maps with node label spaces, but existing grid layout algorithms often require a high computational cost because they have to consider complicated positional constraints through the entire optimization process. Results: We propose a hybrid grid layout algorithm that consists of a non-grid, fast layout (preprocessor) algorithm and an approximate pattern matching algorithm that distributes the resultant preprocessed nodes on square grid points. To demonstrate the feasibility of the hybrid layout algorithm, it is characterized in terms of the calculation time, numbers of edge-edge and node-edge crossings, relative edge lengths, and F-measures. The proposed algorithm achieves outstanding performances compared with other existing grid layouts. Conclusions: Use of an approximate pattern matching algorithm quickly redistributes the laid-out nodes by fast, non-grid algorithms on the square grid points, while preserving the topological relationships among the nodes. The proposed algorithm is a novel use of the pattern matching, thereby providing a breakthrough for grid layout. This application program can be freely downloaded from http//www.cadlive.jp/hybridlayout/hybridlayout.html.	[Inoue, Kentaro; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Shimozono, Shinichi; Yoshida, Hideaki] Kyushu Inst Technol, Dept Artificial Intelligence, Iizuka, Fukuoka, Japan; [Kurata, Hiroyuki] Kyushu Inst Technol, Biomed Informat R&D Ctr, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology; Kyushu Institute of Technology; Kyushu Institute of Technology	Inoue, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp	Inoue, Kentaro/P-4920-2016	Inoue, Kentaro/0000-0002-7447-5856	Japan Society for the Promotion of Science [22300101]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23134506]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (B) (22300101) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/) and Grant-in-Aid for Scientific Research on Innovative Areas (23134506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T., 1999, Combinatorial Pattern Matching. 10th Annual Symposium, CPM 99. Proceedings (Lecture Notes in Computer Science Vol.1645), P212; Archambault D, 2007, IEEE T VIS COMPUT GR, V13, P305, DOI 10.1109/TVCG.2007.46; Baitaluk M, 2006, NUCLEIC ACIDS RES, V34, pW466, DOI 10.1093/nar/gkl308; Balasundaram B, 2008, WILEY SERIES BIOINFO, P65; Barsky A, 2008, IEEE T VIS COMPUT GR, V14, P1253, DOI 10.1109/TVCG.2008.117; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Bartel G, 2011, LECT NOTES COMPUT SC, V6502, P80, DOI 10.1007/978-3-642-18469-7_8; Becker MY, 2001, BIOINFORMATICS, V17, P461, DOI 10.1093/bioinformatics/17.5.461; Bourqui R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-29; Brandes U, 2009, LECT NOTES COMPUT SC, V5417, P218, DOI 10.1007/978-3-642-00219-9_21; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Deckard A, 2006, BIOINFORMATICS, V22, P2966, DOI 10.1093/bioinformatics/btl520; Demir E, 2002, BIOINFORMATICS, V18, P996, DOI 10.1093/bioinformatics/18.7.996; Dobkin D. P., 1997, Graph Drawing. 5th International Symposium, GD '97. Proceedings, P262, DOI 10.1007/3-540-63938-1_68; Dogrusoz U, 2006, BIOINFORMATICS, V22, P374, DOI 10.1093/bioinformatics/bti776; Dogrusoz U, 2004, LECT NOTES COMPUT SC, V3383, P442; Doi Atsushi, 2003, Appl Bioinformatics, V2, P185; Dwyer T, 2006, LECT NOTES COMPUT SC, V3843, P153; Dwyer T, 2008, LECT NOTES COMPUT SC, V4875, P219; Dwyer T, 2006, IEEE T VIS COMPUT GR, V12, P821, DOI 10.1109/TVCG.2006.156; EADES P, 1993, INFORM PROCESS LETT, V47, P319, DOI 10.1016/0020-0190(93)90079-O; Eades P., 1984, C NUMERANTIUM, V42, P149; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Finkel R. A., 1974, Acta Informatica, V4, P1, DOI 10.1007/BF00288933; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gajer P., 2002, Journal of Graph Algorithms and Applications, V6, DOI 10.7155/jgaa.00052; Gansner ER, 2004, LECT NOTES COMPUT SC, V3383, P239; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Goesmann A, 2002, BIOINFORMATICS, V18, P124, DOI 10.1093/bioinformatics/18.1.124; Gursoy A, 2000, LECT NOTES COMPUT SC, V1900, P234; Hachul S, 2006, LECT NOTES COMPUT SC, V3843, P235; Hachul S, 2004, LECT NOTES COMPUT SC, V3383, P285; He S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-31; Hoffmann F., 1998, Proceedings of the Fourteenth Annual Symposium on Computational Geometry, P231, DOI 10.1145/276884.276911; Holford M, 2005, BIOINFORMATICS, V21, P1596, DOI 10.1093/bioinformatics/bti153; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468; Inoue K, 2011, BIOCHEM ENG J, V54, P200, DOI 10.1016/j.bej.2011.02.022; Iragne F, 2005, BIOINFORMATICS, V21, P272, DOI 10.1093/bioinformatics/bth494; Ju BH, 2003, BIOINFORMATICS, V19, P317, DOI 10.1093/bioinformatics/19.2.317; Ju BH, 2003, BIOINFORMATICS, V19, pi177, DOI 10.1093/bioinformatics/btg1022; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Karp PD., 1994, 3 INT C BIOINF GEN R, P225; Kojima K, 2008, BIOINFORMATICS, V24, P1433, DOI 10.1093/bioinformatics/btn196; Kojima K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-76; Kojima K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-335; Koren Y, 2003, LECT NOTES COMPUT SC, V2697, P496; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Kurata H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm769; Li WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002541; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; Lu ZP, 2009, LECT NOTES COMPUT SC, V5482, P1; Makinen V, 2001, EIGHTH SYMPOSIUM ON STRING PROCESSING AND INFORMATION RETRIEVAL, PROCEEDINGS, P153, DOI 10.1109/SPIRE.2001.989751; Mei J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/043025; Meyer B, 1998, LECT NOTES COMPUT SC, V1547, P246; Nagasaki Masao, 2003, Appl Bioinformatics, V2, P181; Salamonsen W, 1999, Pac Symp Biocomput, P392; Schacherer F, 2001, BIOINFORMATICS, V17, P1053, DOI 10.1093/bioinformatics/17.11.1053; Schreiber F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-375; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; SUGIYAMA K, 1981, IEEE T SYST MAN CYB, V11, P109, DOI 10.1109/TSMC.1981.4308636; Vismara L, 2000, SOFTWARE PRACT EXPER, V30, P1235, DOI 10.1002/1097-024X(200009)30:11<1235::AID-SPE339>3.0.CO;2-B; von Landesberger T, 2011, COMPUT GRAPH FORUM, V30, P1719, DOI 10.1111/j.1467-8659.2011.01898.x; Wegner K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-212; Wybrow M, 2006, LECT NOTES COMPUT SC, V3843, P446; Yamada T, 2003, P 20 INT C MACH LEAR	73	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37739	10.1371/journal.pone.0037739	http://dx.doi.org/10.1371/journal.pone.0037739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679486	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900011
J	Wang, LL; Li, B; Zhao, XH; Chen, CX; Cao, JJ				Wang, Lili; Li, Bin; Zhao, Xiaohong; Chen, Chunxia; Cao, Jingjing			Effect of Rare Earth Ions on the Properties of Composites Composed of Ethylene Vinyl Acetate Copolymer and Layered Double Hydroxides	PLOS ONE			English	Article							STRUCTURAL-CHARACTERIZATION; THERMAL-DECOMPOSITION; PARTIAL OXIDATION; AL; HYDROTALCITE; MG; INTERCALATION; CATALYSTS; RELEASE; NITRATE	Background: The study on the rare earth (RE)-doped layered double hydroxides (LDHs) has received considerable attention due to their potential applications in catalysts. However, the use of RE-doped LDHs as polymer halogen-free flame retardants was seldom investigated. Furthermore, the effect of rare earth elements on the hydrophobicity of LDHs materials and the compatibility of LDHs/polymer composite has seldom been reported. Methodology/Principal Findings: The stearate sodium surface modified Ni-containing LDHs and RE-doped Ni-containing LDHs were rapidly synthesized by a coprecipitation method coupled with the microwave hydrothermal treatment. The influences of trace amounts of rare earth ions La, Ce and Nd on the amount of water molecules, the crystallinity, the morphology, the hydrophobicity of modified Ni-containing LDHs and the adsorption of modifier in the surface of LDHs were investigated by TGA, XRD, TEM, contact angle and IR, respectively. Moreover, the effects of the rare earth ions on the interfacial compatibility, the flame retardancy and the mechanical properties of ethylene vinyl acetate copolymer (EVA)/LDHs composites were also explored in detail. Conclusions/Significance: S-Ni0.1MgAl-La displayed more uniform dispersion and better interfacial compatibility in EVA matrix compared with other LDHs. Furthermore, the S-Ni0.1MgAl-La/EVA composite showed the best fire retardancy and mechanical properties in all composites.	[Wang, Lili; Li, Bin; Zhao, Xiaohong; Chen, Chunxia; Cao, Jingjing] NE Forestry Univ, Heilongjiang Key Lab Mol Design & Preparat Flame, Coll Sci, Harbin, Peoples R China	Northeast Forestry University - China	Wang, LL (corresponding author), NE Forestry Univ, Heilongjiang Key Lab Mol Design & Preparat Flame, Coll Sci, Harbin, Peoples R China.	libinzh62@163.com			Fundamental Research Funds for the Central Universities [DL10BB04]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by the Fundamental Research Funds for the Central Universities (No. DL10BB04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Pagano M, 2003, J MATER CHEM, V13, P1988, DOI 10.1039/b302747n; Agroui K, 2006, SOL ENERG MAT SOL C, V90, P2509, DOI 10.1016/j.solmat.2006.03.023; Ardanuy M, 2011, APPL CLAY SCI, V51, P341, DOI 10.1016/j.clay.2010.12.024; Auxilio AR, 2007, POLYHEDRON, V26, P3479, DOI 10.1016/j.poly.2007.03.019; Babizhetskyy V, 2010, J SOLID STATE CHEM, V183, P2343, DOI 10.1016/j.jssc.2010.07.046; Becker CM, 2011, COMPOS PART A-APPL S, V42, P196, DOI 10.1016/j.compositesa.2010.11.005; Benito P, 2006, MICROPOR MESOPOR MAT, V94, P148, DOI 10.1016/j.micromeso.2006.03.038; Benito P, 2006, J SOLID STATE CHEM, V179, P3784, DOI 10.1016/j.jssc.2006.08.010; Arizaga GGC, 2008, J COLLOID INTERF SCI, V320, P238, DOI 10.1016/j.jcis.2007.12.025; Arizaga GGC, 2010, J SOLID STATE CHEM, V183, P2324, DOI 10.1016/j.jssc.2010.07.050; Cecen V, 2008, EUR POLYM J, V44, P3827, DOI 10.1016/j.eurpolymj.2008.07.053; Chen YF, 2011, J LUMIN, V131, P701, DOI 10.1016/j.jlumin.2010.11.021; Chen YF, 2010, J SOLID STATE CHEM, V183, P2222, DOI 10.1016/j.jssc.2010.07.042; Cota I, 2010, APPL CATAL A-GEN, V382, P272, DOI 10.1016/j.apcata.2010.05.006; del Arco M, 2010, J SOLID STATE CHEM, V183, P3002, DOI 10.1016/j.jssc.2010.10.017; Guessoum K, 2011, CORROS SCI, V53, P1639, DOI 10.1016/j.corsci.2011.01.006; Guo K, 2011, CHEM PHYS, V380, P54, DOI 10.1016/j.chemphys.2010.12.006; Guo QH, 2007, J CONTROL RELEASE, V118, P318, DOI 10.1016/j.jconrel.2006.12.030; Ha JU, 2011, INT J PHARMACEUT, V414, P321, DOI 10.1016/j.ijpharm.2011.05.028; He HM, 2010, J COLLOID INTERF SCI, V343, P225, DOI 10.1016/j.jcis.2009.11.004; Herrero M, 2007, J SOLID STATE CHEM, V180, P873, DOI 10.1016/j.jssc.2006.12.011; Hu LH, 2011, MATER RES BULL, V46, P244, DOI 10.1016/j.materresbull.2010.11.002; Jaubertie C, 2006, CHEM MATER, V18, P3114, DOI 10.1021/cm060512y; Kameda T, 2011, J COLLOID INTERF SCI, V362, P497, DOI 10.1016/j.jcis.2011.06.065; Kloprogge JT, 2002, AM MINERAL, V87, P623; Kovanda F, 2010, APPL CLAY SCI, V48, P260, DOI 10.1016/j.clay.2009.11.012; Lezhnina MM, 2010, OPT MATER, V33, P4, DOI 10.1016/j.optmat.2010.07.005; Li QZ, 2010, MATER CHEM PHYS, V120, P676, DOI 10.1016/j.matchemphys.2009.12.025; Lucredio AF, 2010, APPL CATAL A-GEN, V388, P77, DOI 10.1016/j.apcata.2010.08.026; Lucredio AF, 2007, APPL CATAL A-GEN, V333, P90, DOI 10.1016/j.apcata.2007.09.009; Millange F, 2000, J MATER CHEM, V10, P1713, DOI 10.1039/b002827o; Mokhtar M, 2010, J ALLOY COMPD, V493, P376, DOI 10.1016/j.jallcom.2009.12.106; Nguyen HL, 2010, COMP MATER SCI, V50, P2, DOI 10.1016/j.commatsci.2010.03.002; Nyambo C, 2009, POLYM DEGRAD STABIL, V94, P513, DOI 10.1016/j.polymdegradstab.2009.01.028; Ohnishi T, 2010, J ALLOY COMPD, V506, P27, DOI 10.1016/j.jallcom.2010.07.004; Palmer SJ, 2009, J COLLOID INTERF SCI, V329, P404, DOI 10.1016/j.jcis.2008.09.065; Panda HS, 2008, MATER RES BULL, V43, P1448, DOI 10.1016/j.materresbull.2007.06.037; Prasad BE, 2010, J COLLOID INTERF SCI, V348, P216, DOI 10.1016/j.jcis.2010.04.038; Prasanna SV, 2010, J COLLOID INTERF SCI, V344, P508, DOI 10.1016/j.jcis.2010.01.013; Tao RT, 2010, J COLLOID INTERF SCI, V351, P501, DOI 10.1016/j.jcis.2009.12.025; Triantafyllidis KS, 2010, J COLLOID INTERF SCI, V342, P427, DOI 10.1016/j.jcis.2009.10.063; Violante A, 2009, J COLLOID INTERF SCI, V333, P63, DOI 10.1016/j.jcis.2009.01.004; Wang DY, 2011, POLYM DEGRAD STABIL, V96, P285, DOI 10.1016/j.polymdegradstab.2010.03.003; Wang DY, 2011, J ALLOY COMPD, V509, P3497, DOI 10.1016/j.jallcom.2010.12.138; Wang J, 2010, J ALLOY COMPD, V494, P271, DOI 10.1016/j.jallcom.2010.01.007; Wang LL, 2011, J COLLOID INTERF SCI, V356, P519, DOI 10.1016/j.jcis.2011.01.048; Wang LJ, 2010, POLYM DEGRAD STABIL, V95, P572, DOI 10.1016/j.polymdegradstab.2009.12.012; Wang SF, 2004, J APPL POLYM SCI, V91, P1571, DOI 10.1002/app.13265; Wypych F, 2005, J COLLOID INTERF SCI, V283, P130, DOI 10.1016/j.jcis.2004.08.125; Xiang X, 2010, J ALLOY COMPD, V499, P30, DOI 10.1016/j.jallcom.2010.03.125; Ye L, 2008, POLYM DEGRAD STABIL, V93, P918, DOI 10.1016/j.polymdegradstab.2008.02.002; Yuan Y, 2011, APPL CLAY SCI, V53, P608, DOI 10.1016/j.clay.2011.05.010; Zhang G, 2007, POLYM DEGRAD STABIL, V92, P1715, DOI 10.1016/j.polymdegradstab.2007.06.004; Zhang J, 2010, INT J HYDROGEN ENERG, V35, P11776, DOI 10.1016/j.ijhydene.2010.08.025; Zhang M, 2008, MATER CHEM PHYS, V109, P206, DOI 10.1016/j.matchemphys.2007.11.013; Zubitur M, 2009, POLYM DEGRAD STABIL, V94, P804, DOI 10.1016/j.polymdegradstab.2009.01.026	56	18	18	7	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37781	10.1371/journal.pone.0037781	http://dx.doi.org/10.1371/journal.pone.0037781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693627	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900013
J	Mihara, M; Hara, H; Araki, J; Kikuchi, K; Narushima, M; Yamamoto, T; Iida, T; Yoshimatsu, H; Murai, N; Mitsui, K; Okitsu, T; Koshima, I				Mihara, Makoto; Hara, Hisako; Araki, Jun; Kikuchi, Kazuki; Narushima, Mitsunaga; Yamamoto, Takumi; Iida, Takuya; Yoshimatsu, Hidehiko; Murai, Noriyuki; Mitsui, Kito; Okitsu, Taro; Koshima, Isao			Indocyanine Green (ICG) Lymphography Is Superior to Lymphoscintigraphy for Diagnostic Imaging of Early Lymphedema of the Upper Limbs	PLOS ONE			English	Article							LOWER-EXTREMITY LYMPHEDEMA; QUALITY-OF-LIFE; BREAST-CANCER; DYE	Background: Secondary lymphedema causes swelling in limbs due to lymph retention following lymph node dissection in cancer therapy. Initiation of treatment soon after appearance of edema is very important, but there is no method for early diagnosis of lymphedema. In this study, we compared the utility of four diagnostic imaging methods: magnetic resonance imaging (MRI), computed tomography (CT), lymphoscintigraphy, and Indocyanine Green (ICG) lymphography. Patients and Methods: Between April 2010 and November 2011, we examined 21 female patients (42 arms) with unilateral mild upper limb lymphedema using the four methods. The mean age of the patients was 60.4 years old (35-81 years old). Biopsies of skin and collecting lymphatic vessels were performed in 7 patients who underwent lymphaticovenous anastomosis. Results: The specificity was 1 for all four methods. The sensitivity was 1 in ICG lymphography and MRI, 0.62 in lymphoscintigraphy, and 0.33 in CT. These results show that MRI and ICG lymphography are superior to lymphoscintigraphy or CT for diagnosis of lymphedema. In some cases, biopsy findings suggested abnormalities in skin and lymphatic vessels for which lymphoscintigraphy showed no abnormal findings. ICG lymphography showed a dermal backflow pattern in these cases. Conclusions: Our findings suggest the importance of dual diagnosis by examination of the lymphatic system using ICG lymphography and evaluation of edema in subcutaneous fat tissue using MRI.	[Mihara, Makoto; Hara, Hisako; Araki, Jun; Kikuchi, Kazuki; Narushima, Mitsunaga; Yamamoto, Takumi; Iida, Takuya; Yoshimatsu, Hidehiko; Koshima, Isao] Univ Tokyo, Dept Plast Surg & Reconstruct Surg, Tokyo, Japan; [Murai, Noriyuki; Mitsui, Kito] Saiseikai Kawaguchi Hosp, Dept Vasc Surg, Saitama, Japan; [Okitsu, Taro] Keio Univ, Dept Rehabil Med, Tokyo, Japan	University of Tokyo; Keio University	Mihara, M (corresponding author), Univ Tokyo, Dept Plast Surg & Reconstruct Surg, Tokyo, Japan.	mihara@keiseigeka.name	Yamamoto, Takumi/Y-7658-2019; Yoshimatsu, Hidehiko/AAA-8955-2020		Japanese funding program for next generation world-leading research [LS039]	Japanese funding program for next generation world-leading research	The study was supported by a grant from the Japanese funding program for next generation world-leading research (project number: LS039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; [Anonymous], 2009, LYMPHOLOGY, V42, P51; Beveridge N, 2010, CLIN NUCL MED, V35, P579, DOI 10.1097/RLU.0b013e3181e4dc3c; Chang L, 2011, CLIN NUCL MED, V36, pE11, DOI 10.1097/RLU.0b013e31820aa35a; Das IJ, 2011, RADIOTHER ONCOL, V100, P293, DOI 10.1016/j.radonc.2010.09.016; DUEWELL S, 1992, RADIOLOGY, V184, P227, DOI 10.1148/radiology.184.1.1609085; Finnane A, 2011, EXPERT REV PHARM OUT, V11, P287, DOI [10.1586/ERP.11.30, 10.1586/erp.11.30]; Jensen MR, 2010, CLIN PHYSIOL FUNCT I, V30, P389, DOI 10.1111/j.1475-097X.2010.00969.x; Kim DS, 2010, ARCH PHYS MED REHAB, V91, P1844, DOI 10.1016/j.apmr.2010.09.008; Maegawa J, 2010, MICROSURG, V30, P437, DOI 10.1002/micr.20772; Marotel M, 1998, LYMPHOLOGY, V31, P180; Nesvold IL, 2010, ACTA ONCOL, V49, P347, DOI 10.3109/02841860903302905; Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Ogunbiyi SO, 2009, BRIT J SURG, V96, P1274, DOI 10.1002/bjs.6716; Partsch Hugo, 2003, Lymphat Res Biol, V1, P71, DOI 10.1089/15396850360495727; Ridner SH, 2011, SUPPORT CARE CANCER, V19, P631, DOI 10.1007/s00520-010-0870-5; Rockson SG, 2010, ANN NY ACAD SCI, V1207, pE2, DOI 10.1111/j.1749-6632.2010.05804.x; Sadeghi R, 2010, HELL J NUCL MED, V13, P6; Tomczak H, 2005, NUCL MED REV, V8, P37; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df	26	155	160	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38182	10.1371/journal.pone.0038182	http://dx.doi.org/10.1371/journal.pone.0038182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675520	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700043
J	Liu, DJ; Huang, LP; Wang, YL; Wang, W; Wehrens, XHT; Belousova, T; Abdelrahim, M; DiMattia, G; Sheikh-Hamad, D				Liu, Dajun; Huang, Luping; Wang, Yanlin; Wang, Wei; Wehrens, Xander H. T.; Belousova, Tatiana; Abdelrahim, Maen; DiMattia, Gabriel; Sheikh-Hamad, David			Human Stanniocalcin-1 Suppresses Angiotensin II-Induced Superoxide Generation in Cardiomyocytes through UCP3-Mediated Anti-Oxidant Pathway	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING PROTEINS; METABOLIC GENE-EXPRESSION; FAILING HUMAN HEART; OXIDATIVE-PHOSPHORYLATION; DILATED CARDIOMYOPATHY; ENERGY-METABOLISM; SKELETAL-MUSCLE; TRANSGENIC MICE; CELLS; MEMBRANE	Rationale: We have previously shown increased cardiac stanniocalcin-1 (STC1) in patients with idiopathic dilated cardiomyopathy. STC1 localizes to the inner mitochondrial membrane and transgenic over-expression of STC1 is associated with increased energy utilization. Objective: We examined the hypothesis that STC1 uncouples mitochondrial oxidative phosphorylation - to suppress superoxide generation and modulate neurohormonal effects on cardiomyocytes. Methods and Results: Compared to WT mouse heart, STC1 Tg heart displays: 2-fold higher uncoupling protein 3 (UCP3) levels, but no effect on UCP2 protein; 40% lower ATP levels; but similar activities of respiratory chain complexes I-IV. In cultured adult rat and freshly-isolated mouse cardiomyocytes, rSTC1 induces UCP3, but not UCP2. Treatment of cardiomyocytes with STC1 decreases mitochondrial membrane potential and suppresses baseline and angiotensin II (Ang II)-induced superoxide generation. Furthermore, baseline superoxide generation is higher in freshly-isolated adult UCP3(-/-) mouse cardiomyocytes compared to WT, suggesting an important role for UCP3 in regulating cardiomyocyte ROS under physiologic conditions. Treatment of UCP3(-/-) cardiomyocytes with rSTC1 failed to suppress superoxide generation, suggesting that the effects of STC1 on superoxide generation in cardiomyocytes are UCP3-dependent. Conclusion: STC1 activates a novel anti-oxidant pathway in cardiac myocytes through induction of UCP3, and may play an important role in suppressing ROS in the heart under normal physiologic conditions and ameliorate the deleterious effects of Ang II-mediated cardiac injury. Importantly, our data point to a critical role for the mitochondria in regulating ROS generation in response to Ang II.	[Liu, Dajun; Huang, Luping; Wang, Yanlin; Belousova, Tatiana; Sheikh-Hamad, David] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Wang, Wei; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Abdelrahim, Maen] Univ Texas MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL USA; [DiMattia, Gabriel] Univ Western Ontario, Dept Oncol, London, ON, Canada; [DiMattia, Gabriel] Univ Western Ontario, Dept Biochem, London, ON, Canada	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Liu, DJ (corresponding author), China Med Univ, Sheng Jing Hosp, Shenyang, Peoples R China.	lupingh@bcm.edu; sheikh@bcm.tmc.edu	Wehrens, Xander/AAQ-9574-2020	Wehrens, Xander/0000-0001-5044-672X	National Institute of Health [R01-DK080306, R01-HL089598, T32 DK62703, R01-HL091947]; American Heart Association [0455120Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089598, R01HL091947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080306] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants R01-DK080306, R01-HL089598, T32 DK62703, and R01-HL091947; American Heart Association Grant-in-Aid #0455120Y. Dr. Wehrens is a W.M. Keck Foundation Distinguished Young Scholar in Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; Elkayam U, 1998, CARDIOLOGY, V89, P38, DOI 10.1159/000047278; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Fosslien E, 2003, ANN CLIN LAB SCI, V33, P371; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Jacobson SL, 1989, ISOLATED ADULT CARDI, P43; James K, 2005, KIDNEY INT, V67, P477, DOI 10.1111/j.1523-1755.2005.67104.x; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; Jiang N, 2009, FREE RADICAL BIO MED, V46, P138, DOI 10.1016/j.freeradbiomed.2008.09.026; Kim-Han JS, 2005, ANTIOXID REDOX SIGN, V7, P1173, DOI 10.1089/ars.2005.7.1173; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lu ZJ, 2009, CIRCULATION, V120, P318, DOI 10.1161/CIRCULATIONAHA.109.873380; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; McCudden CR, 2002, J BIOL CHEM, V277, P45249, DOI 10.1074/jbc.M205954200; MOHAZZAB HK, 1997, CIRCULATION, V96, P614; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Neubauer S, 1997, CIRCULATION, V96, P2190; NOHL H, 1987, FEBS LETT, V214, P269, DOI 10.1016/0014-5793(87)80068-6; Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Re RN, 2010, AM J PHYSIOL-HEART C, V299, pH577, DOI 10.1152/ajpheart.00421.2010; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Sazonova O, 2008, AM J PHYSIOL-RENAL, V294, pF788, DOI 10.1152/ajprenal.00553.2007; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Taegtmeyer H, 2002, CIRCULATION, V106, P2043, DOI 10.1161/01.CIR.0000036760.42319.3F; Thompson MP, 2004, FEBS LETT, V568, P4, DOI 10.1016/j.febslet.2004.05.011; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang YL, 2009, J LEUKOCYTE BIOL, V86, P981, DOI 10.1189/jlb.0708454; Westberg JA, 2007, AM J PHYSIOL-HEART C, V293, pH1766, DOI 10.1152/ajpheart.00017.2007; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Zhang JL, 1998, PROTEIN EXPRES PURIF, V12, P390, DOI 10.1006/prep.1997.0857; [No title captured]	48	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36994	10.1371/journal.pone.0036994	http://dx.doi.org/10.1371/journal.pone.0036994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693564	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500026
J	Riegl, BM; Bruckner, AW; Rowlands, GP; Purkis, SJ; Renaud, P				Riegl, Bernhard M.; Bruckner, Andrew W.; Rowlands, Gwilym P.; Purkis, Sam J.; Renaud, Philip			Red Sea Coral Reef Trajectories over 2 Decades Suggest Increasing Community Homogenization and Decline in Coral Size	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; CLIMATE-CHANGE; DISTRIBUTIONS; PARAMETERS; GROWTH	Three independent line intercept transect surveys on northern Red Sea reef slopes conducted in 1988/9 and 1997/8 in Egypt and from 2006-9 in Saudi Arabia were used to compare community patterns and coral size. Coral communities showed scale-dependent variability, highest at fine spatial and taxonomic scale (species-specific within and among reef patterns). At coarser scale (generic pattern across regions), patterns were more uniform (regionally consistent generic dominance on differently exposed reef slopes and at different depths). Neither fine-nor coarse-scale patterns aligned along the sampled 1700 km latitudinal gradient. Thus, a latitudinal gradient that had been described earlier from comparable datasets, separating the Red Sea into three faunistic zones, was no longer apparent. This may indicate subtle changes in species distributions. Coral size, measured as corrected average intercept of corals in transects, had decreased from 1997 to 2009, after having remained constant from 1988 to 1997. Recruitment had remained stable (similar to 12 juvenile corals per m(2)). Size distributions had not changed significantly but large corals had declined over 20 years. Thus, data from a wide range of sites taken over two decades support claims by others that climate change is indeed beginning to show clear effects on Red Sea reefs.	[Riegl, Bernhard M.; Rowlands, Gwilym P.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Bruckner, Andrew W.; Renaud, Philip] Khaled Bin Sultan Living Oceans Fdn, Landover, MD USA	Nova Southeastern University	Riegl, BM (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	rieglb@nova.edu	Purkis, Sam/B-8552-2013	Riegl, Bernhard/0000-0002-6003-9324	Khlaed bin Sultan Living Oceans Foundation	Khlaed bin Sultan Living Oceans Foundation	The previous funding source was the Khlaed bin Sultan Living Oceans Foundation, www.livingoceansfoundation.org. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2005, ECOLOGY, V86, P2586, DOI 10.1890/05-0045; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; DeVantier L., 2000, P INT WORKSH EXT IMP; DeVantier Lyndon, 2000, Fauna of Arabia, V18, P23; Edwards AJ, 1987, RED SEA KEYS ENV; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Jameson S. C., 2007, Journal of Sustainable Tourism, V15, P309, DOI 10.2167/jost719.0; Jongman RHG, 1995, DATA ANAL COMMUNITY; Klaus R, 2008, P 11 INT COR REEF S, P722; Kleemann K., 1992, Facies, V26, P1, DOI 10.1007/BF02539790; Loya Y, 2004, CORAL HEALTH AND DISEASE, P1; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; Loya Y, 1971, S ZOOL SOC LONDON, V28, P117; Loya Y, 1978, UNESCO MONOGRAPHS OC, V5, P197; MARSH LM, 1984, CORAL REEFS, V2, P175; MERGNER H, 1985, HELGOLANDER MEERESUN, V39, P375, DOI 10.1007/BF01987409; Mergner H., 1992, P 7 INT COR REEF S G, V1, P104; Ormond R.F.G., 1984, REPORT DISTRIBUTION; ORMOND RFG, 1973, NATURE, V246, P167, DOI 10.1038/246167a0; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Reinicke GB, 2003, FACIES, V49, P271; RIEGL B, 1991, HYDROBIOLOGIA, V216, P249, DOI 10.1007/BF00026471; Riegl B, 1999, CORAL REEFS, V18, P241, DOI 10.1007/s003380050188; Riegl B, 1997, FACIES, V36, P141, DOI 10.1007/BF02536881; Riegl B, 1998, MAR POLLUT BULL, V37, P488; RIEGL B, 1994, MAR ECOL-P S Z N I, V15, P213, DOI 10.1111/j.1439-0485.1994.tb00054.x; Rowlands G, 2012, MAR POLLUT BULL, V64, P1222, DOI 10.1016/j.marpolbul.2012.03.003; SCHUHMACHER H, 1985, HELGOLANDER MEERESUN, V39, P419, DOI 10.1007/BF01987411; Schuhmacher Helmut, 1995, Beitraege zur Palaeontologie, V20, P89; Sheppard C.R.C., 1985, Fauna of Saudi Arabia, V7, P37; Sheppard C.R.C., 1985, Fauna of Saudi Arabia, V7, P17; Sheppard C. R. C., 1991, FAUNA SAUDI ARABIA, V12, P170; Tilot de Grissac V, 2000, P 9 INT COR REE S, V2, P867; VELIMIROV B, 1974, HELGOLAND WISS MEER, V26, P18, DOI 10.1007/BF01613302; Veron J.E.N., 2000, CORALS WORLD, V1-3; Zvuloni A, 2008, LIMNOL OCEANOGR-METH, V6, P144, DOI 10.4319/lom.2008.6.144; [No title captured]	39	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38396	10.1371/journal.pone.0038396	http://dx.doi.org/10.1371/journal.pone.0038396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693620	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500143
J	Slominski, AT; Kim, TK; Shehabi, HZ; Semak, I; Tang, EKY; Nguyen, MN; Benson, HAE; Korik, E; Janjetovic, Z; Chen, JJ; Yates, CR; Postlethwaite, A; Li, W; Tuckey, RC				Slominski, Andrzej T.; Kim, Tae-Kang; Shehabi, Haleem Z.; Semak, Igor; Tang, Edith K. Y.; Nguyen, Minh N.; Benson, Heather A. E.; Korik, Elena; Janjetovic, Zorica; Chen, Jianjun; Yates, Charles R.; Postlethwaite, Arnold; Li, Wei; Tuckey, Robert C.			In vivo evidence for a novel pathway of vitamin D-3 metabolism initiated by P450scc and modified by CYP27B1	FASEB JOURNAL			English	Article						20-hydroxyvitamin D; CYP11A1; placenta; adrenals; keratinocytes	KAPPA-B ACTIVITY; CYTOCHROME P450SCC; INHIBITS PROLIFERATION; 7-DEHYDROCHOLESTEROL; PRODUCT; SKIN; D-3; D3; TRANSFORMATION; HYDROXYLATION	We define previously unrecognized in vivo pathways of vitamin D-3 (D3) metabolism generating novel D3-hydroxyderivatives different from 25-hydroxyvitamin D-3 [25(OH)D3] and 1,25(OH)(2)D3. Their novel products include 20-hydroxyvitamin D-3 [20(OH) D3], 22(OH)D3, 20,23(OH)(2)D3, 20,22(OH)(2)D3, 1,20(OH)(2)D3, 1,20,23(OH)(3)D3, and 17,20,23(OH)(3)D3 and were produced by placenta, adrenal glands, and epidermal keratinocytes. We detected the predominant metabolite [20(OH)D3] in human serum with a relative concentration similar to 20 times lower than 25(OH)D3. Use of inhibitors and studies performed with isolated mitochondria and purified enzymes demonstrated involvement of the steroidogenic enzyme cytochrome P450scc (CYP11A1) as well as CYP27B1 (1 alpha-hydroxylase). In placenta and adrenal glands with high CYP11A1 expression, the predominant pathway was D3 -> 20(OH) D3 -> 20,23(OH)(2)D3 -> 17,20,23(OH)(3)D3 with further 1 alpha-hydroxylation, and minor pathways were D3 v 25(OH) D3 -> 1,25(OH)(2)D3 and D3 -> 22(OH) D3 -> 20,22(OH)(2)D3. In epidermal keratinocytes, we observed higher proportions of 22(OH)D3 and 20,22(OH)(2)D3. We also detected endogenous production of 20(OH)D3, 22(OH) D3, 20,23(OH)(2)D3, 20,22(OH)(2)D3, and 17,20,23(OH)(3)D3 by immortalized human keratinocytes. Thus, we provide in vivo evidence for novel pathways of D3 metabolism initiated by CYP11A1, with the product profile showing organ/cell type specificity and being modified by CYP27B1 activity. These findings define the pathway intermediates as natural products/endogenous bioregulators and break the current dogma that vitamin D is solely activated through the sequence D3 -> 25(OH)D3 -> 1,25(OH)(2)D3.-Slominski, A. T., Kim, T.-K., Shehabi, H. Z., Semak, I., Tang, E. K. Y., Nguyen, M. N., Benson, H. A. E., Korik, E., Janjetovic, Z., Chen, J., Yates, C. R., Postlethwaite, A., Li, W., Tuckey, R. C. In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 26, 3901-3915 (2012). www.fasebj.org	[Slominski, Andrzej T.; Postlethwaite, Arnold] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Chen, Jianjun; Yates, Charles R.; Li, Wei] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Shehabi, Haleem Z.; Benson, Heather A. E.] Curtin Univ Technol, Sch Pharm, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Semak, Igor; Korik, Elena] Belarusian State Univ, Dept Biochem, Minsk 220050, BELARUS; [Tang, Edith K. Y.; Nguyen, Minh N.; Tuckey, Robert C.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Slominski, Andrzej T.; Kim, Tae-Kang; Janjetovic, Zorica] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Curtin University; Belarusian State University; University of Western Australia; University of Tennessee System; University of Tennessee Health Science Center	Slominski, AT (corresponding author), Dept Pathol, 930 Madison Ave,RM525, Memphis, TN 38163 USA.	aslominski@uthsc.edu	Semak, Igor/AAT-9273-2020; Tuckey, Robert/H-5983-2014	Semak, Igor/0000-0001-9430-8492; Korik, Elena/0000-0002-7888-4518; Slominski, Andrzej/0000-0001-8963-3995; Li, Wei/0000-0002-9522-4474; Tuckey, Robert/0000-0002-5022-4729	U.S. National Institutes of Health (NIH) [R01AR052190]; University of Western Australia; College of Pharmacy at the University of Tennessee Health Science Center; Curtin University of Perth; NIH [1R01AR056666-01A2]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056666, R01AR052190] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Western Australia; College of Pharmacy at the University of Tennessee Health Science Center; Curtin University of Perth; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. D. D. Bikle, T. C. Chen, and H. F. DeLuca for valuable information on vitamin D<INF>3</INF> metabolism in placenta and adrenal glands. The project was supported by U.S. National Institutes of Health (NIH) grant R01AR052190 to A. S., by the University of Western Australia, by the College of Pharmacy at the University of Tennessee Health Science Center, and by Curtin University of Perth. Additional partial support was also obtained from NIH grant 1R01AR056666-01A2 to A.S.	Bikle DD, 2008, J INVEST DERMATOL, V128, P2357, DOI 10.1038/jid.2008.249; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HOLICK MF, 1995, P NATL ACAD SCI USA, V92, P3124, DOI 10.1073/pnas.92.8.3124; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janjetovic Z, 2011, BRIT J CANCER, V105, P1874, DOI 10.1038/bjc.2011.458; Janjetovic Z, 2010, J CELL PHYSIOL, V223, P36, DOI 10.1002/jcp.21992; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Kubodera N, 2009, MINI-REV MED CHEM, V9, P1416, DOI 10.2174/138955709789957486; Li W, 2010, STEROIDS, V75, P926, DOI 10.1016/j.steroids.2010.05.021; Nguyen MN, 2009, DRUG METAB DISPOS, V37, P761, DOI 10.1124/dmd.108.025619; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; PONCHON G, 1969, J CLIN INVEST, V48, P2032, DOI 10.1172/JCI106168; SEINO Y, 1987, BONE MINER, V2, P479; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2011, J INVEST DERMATOL, V131, P1167, DOI 10.1038/jid.2010.425; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Slominski AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004309; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tang EKY, 2010, DRUG METAB DISPOS, V38, P1553, DOI 10.1124/dmd.110.034389; Tang EKY, 2010, J STEROID BIOCHEM, V119, P171, DOI 10.1016/j.jsbmb.2010.02.022; TUCKER G, 1973, ARCH BIOCHEM BIOPHYS, V155, P47, DOI 10.1016/S0003-9861(73)80008-6; Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012; Tuckey RC, 1999, EUR J BIOCHEM, V263, P319, DOI 10.1046/j.1432-1327.1999.00483.x; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Tuckey RC, 2012, DRUG METAB DISPOS, V40, P436, DOI 10.1124/dmd.111.042515; Tuckey RC, 2011, DRUG METAB DISPOS, V39, P1577, DOI 10.1124/dmd.111.040071; Tuckey RC, 2008, J STEROID BIOCHEM, V112, P213, DOI 10.1016/j.jsbmb.2008.10.005; Wang J, 2012, ANTICANCER RES, V32, P739; Yamamoto K, 2005, J BIOL CHEM, V280, P30511, DOI 10.1074/jbc.M505244200; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4; Zmijewski MA, 2011, STEROIDS, V76, P193, DOI 10.1016/j.steroids.2010.10.009; Zmijewski MA, 2009, STEROIDS, V74, P218, DOI 10.1016/j.steroids.2008.10.017	39	213	216	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3901	3915		10.1096/fj.12-208975	http://dx.doi.org/10.1096/fj.12-208975			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22683847	Green Published			2022-12-25	WOS:000308391600030
J	Zhou, LJ; Barao, S; Laga, M; Bockstael, K; Borgers, M; Gijsen, H; Annaert, W; Moechars, D; Mercken, M; Gevaer, K; De Strooper, B				Zhou, Lujia; Barao, Soraia; Laga, Mathias; Bockstael, Katrijn; Borgers, Marianne; Gijsen, Harry; Annaert, Wim; Moechars, Diederik; Mercken, Marc; Gevaer, Kris; De Strooper, Bart			The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; OLFACTORY SENSORY NEURONS; PERIPHERAL NERVOUS-SYSTEM; GATED SODIUM-CHANNELS; SPINAL-CORD-INJURY; CLOSE HOMOLOG; NEURITE OUTGROWTH; GAMMA-SECRETASE; MICE DEFICIENT	The beta-site amyloid precursor protein-cleaving enzyme BACE1 is a prime drug target for Alzheimer disease. However, the function and the physiological substrates of BACE1 remain largely unknown. In this work, we took a quantitative proteomic approach to analyze the secretome of primary neurons after acute BACE1 inhibition, and we identified several novel substrate candidates for BACE1. Many of these molecules are involved in neuronal network formation in the developing nervous system. We selected the adhesion molecules L1 and CHL1, which are crucial for axonal guidance and maintenance of neural circuits, for further validation as BACE1 substrates. Using both genetic BACE1 knock-out and acute pharmacological BACE1 inhibition in mice and cell cultures, we show that L1 and CHL1 are cleaved by BACE1 under physiological conditions. The BACE1 cleavage sites at the membrane-proximal regions of L1 (between Tyr(1086) and Glu(1087)) and CHL1 (between Gln(1061) and Asp(1062)) were determined by mass spectrometry. This work provides molecular insights into the function and the pathways in which BACE1 is involved, and it will help to predict or interpret possible side effects of BACE1 inhibitor drugs in current clinical trials.	[Zhou, Lujia; Barao, Soraia; Bockstael, Katrijn; Annaert, Wim; De Strooper, Bart] KULeuven, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Zhou, Lujia; Barao, Soraia; Bockstael, Katrijn; Annaert, Wim; De Strooper, Bart] KULeuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Zhou, Lujia; Barao, Soraia; Bockstael, Katrijn; Annaert, Wim; De Strooper, Bart] KULeuven, LIND, B-3000 Louvain, Belgium; [Laga, Mathias; Gevaer, Kris] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Laga, Mathias; Gevaer, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Borgers, Marianne; Gijsen, Harry; Moechars, Diederik; Mercken, Marc] Janssen Pharmaceut, Johnson & Johnson Pharmaceut Res & Dev, Neurosci Dept, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Johnson & Johnson; Janssen Pharmaceuticals	De Strooper, B (corresponding author), KULeuven, VIB Ctr Biol Dis, Herestr 49, B-3000 Louvain, Belgium.	Bart.DeStrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Gevaert, Kris/D-6489-2017	De Strooper, Bart/0000-0001-5455-5819; Gevaert, Kris/0000-0002-4237-0283	IWT Flanders; Fund for Scientific Research, Flanders; KU Leuven; Flemish Government; Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office; Fundacao para a Ciencia e a Tecnologia (Portugal); Arthur Bax and Anna Vanluffelen chair for Alzheimer disease	IWT Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research, Flanders(FWO); KU Leuven(KU Leuven); Flemish Government(European Commission); Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Arthur Bax and Anna Vanluffelen chair for Alzheimer disease	This work was supported in part by IWT Flanders, the Fund for Scientific Research, Flanders, KU Leuven, a Methusalem grant from KU Leuven and the Flemish Government, the Foundation for Alzheimer Research (SAO/FRMA), the Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office, and Fundacao para a Ciencia e a Tecnologia (Portugal).; Supported by the Arthur Bax and Anna Vanluffelen chair for Alzheimer disease. To whom correspondence should be addressed: VIB Center for the Biology of Disease and Center for Human Genetics, KULeuven, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-373-102; Fax: 32-16-330-827; E-mail: Bart.DeStrooper@cme.vib-kuleuven.be.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Beer S, 1999, J CELL SCI, V112, P2667; Buhusi M, 2008, J NEUROSCI, V28, P177, DOI 10.1523/JNEUROSCI.3573-07.2008; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Colaert N, 2010, PROTEOMICS, V10, P1226, DOI 10.1002/pmic.200900379; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Demyanenko GP, 2011, CEREB CORTEX, V21, P401, DOI 10.1093/cercor/bhq115; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Farah MH, 2011, J NEUROSCI, V31, P5744, DOI 10.1523/JNEUROSCI.6810-10.2011; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Hitt BD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-31; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Irintchev A., 2011, NEUROSCIENTIST, V1; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Karagogeos D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1304, DOI 10.2741/1214; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kobayashi D, 2008, NEUROBIOL AGING, V29, P861, DOI 10.1016/j.neurobiolaging.2007.01.002; Kobayashi NJ, 2007, Aminodihydrothiazine derivative. International Patent Application>, Patent No. [WO2007049532A1, 2007049532, WO2007/ 049532]; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kurumaji A, 2001, AM J MED GENET, V105, P99; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lopes LV, 1999, J NEUROPHYSIOL, V82, P3196, DOI 10.1152/jn.1999.82.6.3196; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Miller SFC, 2007, GENE EXPR PATTERNS, V7, P635, DOI 10.1016/j.modgep.2006.12.002; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schlomann U, 2000, J NEUROSCI, V20, P7964; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; Suetterlin P, 2012, SEMIN CELL DEV BIOL, V23, P1, DOI 10.1016/j.semcdb.2011.10.015; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Yamanaka H, 2011, J COMP NEUROL, V519, P1597, DOI 10.1002/cne.22588; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P14883, DOI 10.1073/pnas.0505164102; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	87	133	140	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25927	25940		10.1074/jbc.M112.377465	http://dx.doi.org/10.1074/jbc.M112.377465			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692213	Green Published, hybrid			2022-12-25	WOS:000306916300021
J	Azad, MB; Lissitsyn, Y; Miller, GE; Becker, AB; HayGlass, KT; Kozyrskyj, AL				Azad, Meghan B.; Lissitsyn, Yuri; Miller, Gregory E.; Becker, Allan B.; HayGlass, Kent T.; Kozyrskyj, Anita L.			Influence of Socioeconomic Status Trajectories on Innate Immune Responsiveness in Children	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EARLY-LIFE ORIGINS; CIRCULATING INTERLEUKIN-6; INFLAMMATORY MARKERS; CHILDHOOD ASTHMA; STRESS; RISK; DISEASE; OBESITY; HEALTH	Objectives: Lower socioeconomic status (SES) is consistently associated with poor health, yet little is known about the biological mechanisms underlying this inequality. In children, we examined the impact of early-life SES trajectories on the intensity of global innate immune activation, recognizing that excessive activation can be a precursor to inflammation and chronic disease. Methods: Stimulated interleukin-6 production, a measure of immune responsiveness, was analyzed ex vivo for 267 Canadian schoolchildren from a 1995 birth cohort in Manitoba, Canada. Childhood SES trajectories were determined from parent-reported housing data using a longitudinal latent-class modeling technique. Multivariate regression was conducted with adjustment for potential confounders. Results: SES was inversely associated with innate immune responsiveness (p = 0.003), with persistently low-SES children exhibiting responses more than twice as intense as their high-SES counterparts. Despite initially lower SES, responses from children experiencing increasing SES trajectories throughout childhood were indistinguishable from high-SES children. Low-SES effects were strongest among overweight children (p<0.01). Independent of SES trajectories, immune responsiveness was increased in First Nations children (p<0.05) and urban children with atopic asthma (p<0.01). Conclusions: These results implicate differential immune activation in the association between SES and clinical outcomes, and broadly imply that SES interventions during childhood could limit or reverse the damaging biological effects of exposure to poverty during the preschool years.	[Azad, Meghan B.; Kozyrskyj, Anita L.] Univ Alberta, Dept Pediat, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Lissitsyn, Yuri; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, Winnipeg, MB R3T 2N2, Canada; [Miller, Gregory E.] Univ British Columbia, Dept Physiol, Vancouver, BC, Canada; [Becker, Allan B.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada	University of Alberta; University of Manitoba; University of British Columbia; University of Manitoba	Azad, MB (corresponding author), Univ Alberta, Dept Pediat, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.	kozyrsky@ualberta.ca	Azad, Meghan/H-7226-2019	Azad, Meghan/0000-0002-5942-4444; HayGlass, Kent/0000-0002-4621-7737	Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Killam Trusts; Women and Children's Health Research Institute/Stollery Children's Hospital Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Killam Trusts; Women and Children's Health Research Institute/Stollery Children's Hospital Foundation	This study was funded by the Canadian Institutes of Health Research (CIHR-www.cihr.ca). MA is supported by CIHR, Alberta Innovates Health Solutions (www.aihealthsolutions.ca), and the Killam Trusts (www.killamtrusts.ca) YL is an associate member of the CIHR National Training Program in Allergy and Asthma. KTH holds a Canada Research Chair in Immunology (http://www.chairs-chaires.gc.ca/). ALK holds a Research Chair supported by the Women and Children's Health Research Institute/Stollery Children's Hospital Foundation (wchri.srv.ualberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilyo G, 2011, J PERINATOL, V31, P30, DOI 10.1038/jp.2010.53; Arad I, 2010, ISR MED ASSOC J, V12, P419; Atlanta: Centers for Disease Control and Prevention, 2000, CDC GROWTH CHARTS US, P314; Autenrieth C, 2009, MED SCI SPORT EXER, V41, P1706, DOI 10.1249/MSS.0b013e3181a15512; Barnabe C, 2008, J RHEUMATOL, V35, P1145; Bruce SG, 2010, CHRONIC DIS CAN, V31, P27; Carroll JE, 2011, BRAIN BEHAV IMMUN, V25, P1468, DOI 10.1016/j.bbi.2011.05.016; Chen E, 2009, THORAX, V64, P38, DOI 10.1136/thx.2007.095091; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chen Y, 2010, J ASTHMA, V47, P263, DOI 10.3109/02770900903427011; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA16; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; de Pablo Raul, 2011, J Intensive Care Med, V26, P125, DOI 10.1177/0885066610384465; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Gimeno D, 2007, EUR J EPIDEMIOL, V22, P675, DOI 10.1007/s10654-007-9171-9; Gold DR, 2009, J ALLERGY CLIN IMMUN, V124, P1078, DOI 10.1016/j.jaci.2009.08.021; Guzman C, 2010, OPEN NEUROENDOCRINOL, V3, P152; Haddy N, 2005, EUR J HUM GENET, V13, P109, DOI 10.1038/sj.ejhg.5201294; Herberth G, 2007, J PSYCHOSOM RES, V63, P451, DOI 10.1016/j.jpsychores.2007.06.012; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Howe LD, 2010, INT J OBESITY, V34, P1149, DOI 10.1038/ijo.2010.52; Huttunen K, 2010, J ENVIRON MONITOR, V12, P1368, DOI 10.1039/c002579h; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keavney B, 2006, INT J EPIDEMIOL, V35, P935, DOI 10.1093/ije/dyl114; Keavney B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d144; Kozyrskyj AL, 2011, J DEV ORIG HLTH DIS, V2, P72, DOI 10.1017/S2040174410000723; Kozyrskyj AL, 2009, ALLERGY, V64, P1185, DOI 10.1111/j.1398-9995.2009.02033.x; Kozyrskyj AL, 2010, AM J PUBLIC HEALTH, V100, P540, DOI 10.2105/AJPH.2008.150771; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Larcombe L, 2005, GENES IMMUN, V6, P140, DOI 10.1038/sj.gene.6364157; Lissitsyn Y, 2007, CAN J PHYSIOL PHARM, V85, P739, DOI 10.1139/Y07-064; Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012; Manfredi B, 1998, BRAIN BEHAV IMMUN, V12, P201, DOI 10.1006/brbi.1998.0525; Marin TJ, 2008, PSYCHOSOM MED, V70, P152, DOI 10.1097/PSY.0b013e3181647d16; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Noakes PS, 2003, ALLERGY, V58, P1053, DOI 10.1034/j.1398-9995.2003.00290.x; Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Radon K, 2007, PEDIATRICS, V120, P354, DOI 10.1542/peds.2006-3624; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Saxton KB, 2011, BRAIN BEHAV IMMUN; Scheede-Bergdahl C, 2011, CLIN NUTR; Scott NM, 2009, J IMMUNOL, V182, P1411, DOI 10.4049/jimmunol.182.3.1411; Scrivo R, 2010, AUTOIMMUN REV; Sears B, 2011, J OBES, V2011, DOI 10.1155/2011/431985; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Townsend MS, 2006, J AM DIET ASSOC, V106, P34, DOI 10.1016/j.jada.2005.11.008; Whiteley W, 2011, STROKE; Williams MJA, 2006, J EPIDEMIOL COMMUN H, V60, P146, DOI 10.1136/jech.2005.039222; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wong GWK, 2008, PEDIATR PULM, V43, P107, DOI 10.1002/ppul.20755; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC; YOKOYAMA A, 1995, AM J RESP CRIT CARE, V151, P1354, DOI 10.1164/ajrccm.151.5.7735584; Young TK, 2000, CAN MED ASSOC J, V163, P561	62	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38669	10.1371/journal.pone.0038669	http://dx.doi.org/10.1371/journal.pone.0038669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XO	22685596	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700059
J	Lima, L; Ortiz, PA; da Silva, FM; Alves, JMP; Serrano, MG; Cortez, AP; Alfieri, SC; Buck, GA; Teixeira, MMG				Lima, Luciana; Ortiz, Paola A.; da Silva, Flavia Maia; Alves, Joao Marcelo P.; Serrano, Myrna G.; Cortez, Alane P.; Alfieri, Silvia C.; Buck, Gregory A.; Teixeira, Marta M. G.			Repertoire, Genealogy and Genomic Organization of Cruzipain and Homologous Genes in Trypanosoma cruzi, T. cruzi-Like and Other Trypanosome Species	PLOS ONE			English	Article							MAJOR CYSTEINE PROTEINASE; PHYLOGENETIC ANALYSIS; PROTEASE INHIBITORS; CELL RESPONSES; CHAGAS-DISEASE; CYTOCHROME-B; INVASION; SEQUENCE; DIONISII; IDENTIFICATION	Trypanosoma cruzi, the agent of Chagas disease, is a complex of genetically diverse isolates highly phylogenetically related to T. cruzi-like species, Trypanosoma cruzi marinkellei and Trypanosoma dionisii, all sharing morphology of blood and culture forms and development within cells. However, they differ in hosts, vectors and pathogenicity: T. cruzi is a human pathogen infective to virtually all mammals whilst the other two species are non-pathogenic and bat restricted. Previous studies suggest that variations in expression levels and genetic diversity of cruzipain, the major isoform of cathepsin L-like (CATL) enzymes of T. cruzi, correlate with levels of cellular invasion, differentiation, virulence and pathogenicity of distinct strains. In this study, we compared 80 sequences of genes encoding cruzipain from 25 T. cruzi isolates representative of all discrete typing units (DTUs TcI-TcVI) and the new genotype Tcbat and 10 sequences of homologous genes from other species. The catalytic domain repertoires diverged according to DTUs and trypanosome species. Relatively homogeneous sequences are found within and among isolates of the same DTU except TcV and TcVI, which displayed sequences unique or identical to those of TcII and TcIII, supporting their origin from the hybridization between these two DTUs. In network genealogies, sequences from T. cruzi clustered tightly together and closer to T. c. marinkellei than to T. dionisii and largely differed from homologues of T. rangeli and T. b. brucei. Here, analysis of isolates representative of the overall biological and genetic diversity of T. cruzi and closest T. cruzi-like species evidenced DTU- and species-specific polymorphisms corroborating phylogenetic relationships inferred with other genes. Comparison of both phylogenetically close and distant trypanosomes is valuable to understand host-parasite interactions, virulence and pathogenicity. Our findings corroborate cruzipain as valuable target for drugs, vaccine, diagnostic and genotyping approaches.	[Lima, Luciana; Ortiz, Paola A.; da Silva, Flavia Maia; Alves, Joao Marcelo P.; Cortez, Alane P.; Alfieri, Silvia C.; Teixeira, Marta M. G.] Univ Sao Paulo, ICB, Dept Parasitol, Sao Paulo, Brazil; [Alves, Joao Marcelo P.; Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Coll Med, Dept Microbiol & Immunol, Richmond, VA USA; [Cortez, Alane P.] Univ Fed Goias, Fac Farm, Goiania, Go, Brazil	Universidade de Sao Paulo; Virginia Commonwealth University; Universidade Federal de Goias	Lima, L (corresponding author), Univ Sao Paulo, ICB, Dept Parasitol, Sao Paulo, Brazil.	mmgteix@icb.usp.br	Alfieri, Silvia/G-2132-2012; Alves, Joao M.P./G-8927-2011; Teixeira, Marta M G/B-1115-2009	Alfieri, Silvia/0000-0001-9574-2151; Alves, Joao M.P./0000-0001-5914-2087; Ortiz Vargas, Paola Andrea/0000-0002-3450-3429	Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); NSF (USA); CNPq-PROTAX (Programa Nacional de Taxonomia do CNPq); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil)	Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF (USA)(National Science Foundation (NSF)); CNPq-PROTAX (Programa Nacional de Taxonomia do CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by grants from Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to MMGT and from the NSF (USA) Grant: Assembling the Tree of Life: Phylum Euglenozoa (GAB, PI). PAO is doctorate fellow sponsored by CNPq-PROTAX (Programa Nacional de Taxonomia do CNPq). LL, APC and FMS are postdoctoral fellows sponsored by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez VE, 2012, BBA-PROTEINS PROTEOM, V1824, P195, DOI 10.1016/j.bbapap.2011.05.011; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; ARNHOLDT ACV, 1993, J IMMUNOL, V151, P3171; Atayde VD, 2004, INT J PARASITOL, V34, P851, DOI 10.1016/j.ijpara.2004.03.003; Atkinson HJ, 2009, TRENDS PARASITOL, V25, P573, DOI 10.1016/j.pt.2009.09.006; Baker J.R., 1985, Parasitology Today, V1, P111, DOI 10.1016/0169-4758(85)90006-7; BAKER JR, 1978, J GEN MICROBIOL, V104, P79, DOI 10.1099/00221287-104-1-79; Barnabe C, 2003, INFECT GENET EVOL, V2, P201, DOI 10.1016/S1567-1348(02)00130-2; BONALDO MC, 1991, PARASITOL RES, V77, P567, DOI 10.1007/BF00931014; Branquinha MH, 1999, MOL BIOCHEM PARASIT, V102, P179, DOI 10.1016/S0166-6851(99)00107-3; BRANQUINHA MH, 1994, BRAZ J MED BIOL RES, V27, P495; Caffrey CR, 2009, MOL BIOCHEM PARASIT, V167, P12, DOI 10.1016/j.molbiopara.2009.04.009; CAMPETELLA O, 1992, MOL BIOCHEM PARASIT, V50, P225, DOI 10.1016/0166-6851(92)90219-A; Cavazzana M, 2010, INT J PARASITOL, V40, P345, DOI 10.1016/j.ijpara.2009.08.015; Cazorla SI, 2008, VACCINE, V26, P1999, DOI 10.1016/j.vaccine.2008.02.011; Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872; Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI [10.1586/erv.09.45, 10.1586/ERV.09.45]; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006; Cortez AP, 2009, MOL CELL PROBE, V23, P44, DOI 10.1016/j.mcp.2008.11.003; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; da Silva FM, 2009, ACTA TROP, V109, P199, DOI 10.1016/j.actatropica.2008.11.005; Oliveira MPD, 2009, ACTA TROP, V110, P65, DOI 10.1016/j.actatropica.2009.01.008; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; Doyle PS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002139; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Fampa P, 2010, VECTOR-BORNE ZOONOT, V10, P839, DOI 10.1089/vbz.2009.0223; Fampa P, 2010, PARASITOL RES, V107, P443, DOI 10.1007/s00436-010-1888-9; Ferreira RC, 2012, INFECT GENET EVOL, V12, P1064, DOI 10.1016/j.meegid.2012.03.010; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; Garcia HA, 2011, INT J PARASITOL, V41, P1385, DOI 10.1016/j.ijpara.2011.09.001; GLAUERT AM, 1982, J CELL SCI, V56, P371; Gomes SAO, 2009, PARASITOL RES, V105, P743, DOI 10.1007/s00436-009-1446-5; Hamilton PB, 2011, INFECT GENET EVOL, V11, P44, DOI 10.1016/j.meegid.2010.10.012; Hamilton PB, 2012, TRENDS PARASITOL, V28, P136, DOI 10.1016/j.pt.2012.01.006; Haolla FA, 2009, VACCINE, V27, P5644, DOI 10.1016/j.vaccine.2009.07.013; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Higo H, 2007, PARASITOL RES, V100, P1023, DOI 10.1007/s00436-006-0376-8; Hoare C.A., 1972, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-54; Kikuchi SA, 2010, EXP PARASITOL, V126, P540, DOI 10.1016/j.exppara.2010.06.005; Lima APCA, 2001, MOL BIOCHEM PARASIT, V114, P41, DOI 10.1016/S0166-6851(01)00236-5; LIMA APCD, 1994, MOL BIOCHEM PARASIT, V67, P333, DOI 10.1016/0166-6851(94)00144-8; Lima L, 2012, PROTIST IN PRESS; Maeda FY, 2012, ACTA TROP, V121, P141, DOI 10.1016/j.actatropica.2011.10.017; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; MARTINEZ J, 1991, INFECT IMMUN, V59, P4275, DOI 10.1128/IAI.59.11.4275-4277.1991; MARTINEZ J, 1995, FEMS MICROBIOL LETT, V129, P135, DOI 10.1016/0378-1097(95)00147-W; McKerrow JH, 2009, MEM I OSWALDO CRUZ, V104, P263, DOI 10.1590/S0074-02762009000900034; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Molyneux D.H., 1991, P195; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; Ortiz PA, 2009, ACTA TROP, V112, P249, DOI 10.1016/j.actatropica.2009.07.036; PETRY K, 1987, J NEUROIMMUNOL, V16, P237, DOI 10.1016/0165-5728(87)90078-6; Pillay D, 2010, PROTEIN EXPRES PURIF, V74, P264, DOI 10.1016/j.pep.2010.06.021; Rodrigues AC, 2010, PARASITOL INT, V59, P318, DOI 10.1016/j.parint.2010.03.002; Rozas N, 2008, PARASITOLOGY, V135, P1157, DOI 10.1017/S0031182008004794; Ruszczyk A, 2008, FISH SHELLFISH IMMUN, V24, P205, DOI 10.1016/j.fsi.2007.10.015; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336; SCHARFSTEIN J, 1983, J IMMUNOL, V131, P972; Scharfstein Julio, 2008, V47, P140; Schnapp AR, 2002, MICROBES INFECT, V4, P805, DOI 10.1016/S1286-4579(02)01600-3; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	82	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38385	10.1371/journal.pone.0038385	http://dx.doi.org/10.1371/journal.pone.0038385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685565	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700028
J	Vaitaitis, GM; Wagner, DH				Vaitaitis, Gisela M.; Wagner, David H., Jr.			Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity	PLOS ONE			English	Article							N-GLYCOSYLATION; LIGAND; ACTIVATION; EXPRESSION; PROMOTES; INFLAMMATION; REPERTOIRE; POPULATION; RESPONSES; IMMUNITY	While it has long been understood that CD40 plays a critical role in the etiology of autoimmunity, glycobiology is emerging as an important contributor. CD40 signaling is also gaining further interest in transplantation and cancer therapies. Work on CD40 signaling has focused on signaling outcomes and blocking of its ligand, CD154, while little is known about the actual receptor itself and its control. We demonstrated that CD40 is in fact several receptors occurring as constellations of differentially glycosylated forms of the protein that can sometimes form hybrid receptors with other proteins. An enticing area of autoimmunity is differential glycosylation of immune molecules leading to altered signaling. Galectins interact with carbohydrates on proteins to effect such signaling alterations. Studying autoimmune prone NOD and non-autoimmune BALB/c mice, here we reveal that in-vivo CD40 signals alter the glycosylation status of non-autoimmune derived CD4 T cells to resemble that of autoimmune derived CD4 T cells. Galectin-9 interacts with CD40 and, at higher concentrations, prevents CD40 induced proliferative responses of CD4(lo)CD40(+) effector T cells and induces cell death through a Tim-3 independent mechanism. Interestingly, galectin-9, at lower concentrations, alters the surface expression of CD3, CD4, and TCR, regulating access to those molecules and thereby redirects the inflammatory cytokine phenotype and CD3 induced proliferation of autoimmune CD4(lo)CD40(+) T cells. Understanding the dynamics of the CD40 receptor(s) and the impact of glycosylation status in immunity will gain insight into how to maintain useful CD40 signals while shutting down detrimental ones.	[Vaitaitis, Gisela M.; Wagner, David H., Jr.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Vaitaitis, Gisela M.; Wagner, David H., Jr.] Univ Colorado Denver, Webb Waring Ctr, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Vaitaitis, GM (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.	david.wagner@ucdenver.edu		Vaitaitis, Gisela/0000-0001-6413-8322	American Diabetes Association [1-08-CD-19]; National Institute of Diabetes, Digestive and Kidney Diseases [5 R01 DK075013]; Amercian Recovery and Reinvestment Act [3 R01 DK075013-03S2]; Kleberg Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075013] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amercian Recovery and Reinvestment Act; Kleberg Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Diabetes Association (award number 1-08-CD-19; www.diabetes.org), the National Institute of Diabetes, Digestive and Kidney Diseases (award number 5 R01 DK075013; www.niddk.nih.gov), the Amercian Recovery and Reinvestment Act (award number 3 R01 DK075013-03S2; www.recovery.gov), and the Kleberg Foundation awarded to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RL, 2008, J AUTOIMMUN, V31, P385, DOI 10.1016/j.jaut.2008.09.001; Balasa B, 1997, J IMMUNOL, V159, P4620; Barr T, 2006, VACCINE S2, V24, pS2; Carlring J, 2004, VACCINE, V22, P3323, DOI 10.1016/j.vaccine.2004.02.043; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hatzifoti C, 2007, IMMUNOLOGY, V122, P98, DOI 10.1111/j.1365-2567.2007.02617.x; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; HOXIE JA, 1986, J IMMUNOL, V137, P1194; Klyosov AA, 2008, GALECTINS; Law CL, 2009, ADV EXP MED BIOL, V647, P8, DOI 10.1007/978-0-387-89520-8_2; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Loskog ASI, 2009, SEMIN IMMUNOL, V21, P301, DOI 10.1016/j.smim.2009.07.001; Margolles-Clark E, 2009, J MOL MED, V87, P1133, DOI 10.1007/s00109-009-0519-3; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Niwa H, 2009, CLIN IMMUNOL, V132, P184, DOI 10.1016/j.clim.2009.04.012; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Vaitaitis GM, 2010, MOL IMMUNOL, V47, P2303, DOI 10.1016/j.molimm.2010.05.288; Vaitaitis GM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002076; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vonderheide RH, 2007, CLIN CANCER RES, V13, P1083, DOI 10.1158/1078-0432.CCR-06-1893; Wagner DH, 2009, DIABETOLOGIA, V52, P997, DOI 10.1007/s00125-009-1357-0; Wagner DH, 2007, CLIN IMMUNOL, V123, P1, DOI 10.1016/j.clim.2006.08.006; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wagner DH, 1999, INT J MOL MED, V4, P231; Waid DM, 2008, J LEUKOCYTE BIOL, V84, P431, DOI 10.1189/jlb.1207857; Waid DM, 2007, CLIN IMMUNOL, V124, P138, DOI 10.1016/j.clim.2007.05.003; Waid DM, 2004, EUR J IMMUNOL, V34, P1488, DOI 10.1002/eji.200324703; Wang JF, 2009, J IMMUNOL, V182, P4036, DOI 10.4049/jimmunol.0802981; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	43	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38708	10.1371/journal.pone.0038708	http://dx.doi.org/10.1371/journal.pone.0038708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685601	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700064
J	Bruce, T; Meirelles, PM; Garcia, G; Paranhos, R; Rezende, CE; de Moura, RL; Filho, RF; Coni, EOC; Vasconcelos, AT; Amado, G; Hatay, M; Schmieder, R; Edwards, R; Dinsdale, E; Thompson, FL				Bruce, Thiago; Meirelles, Pedro M.; Garcia, Gizele; Paranhos, Rodolfo; Rezende, Carlos E.; de Moura, Rodrigo L.; Filho, Ronaldo-Francini; Coni, Ericka O. C.; Vasconcelos, Ana Tereza; Amado Filho, Gilberto; Hatay, Mark; Schmieder, Robert; Edwards, Robert; Dinsdale, Elizabeth; Thompson, Fabiano L.			Abrolhos Bank Reef Health Evaluated by Means of Water Quality, Microbial Diversity, Benthic Cover, and Fish Biomass Data	PLOS ONE			English	Article							CORAL-REEFS; NUTRIENT ENRICHMENT; ORGANIC-MATTER; MARINE RESERVE; PHASE-SHIFTS; HERBIVORY; BACTERIOPLANKTON; PROCHLOROCOCCUS; EUTROPHICATION; COMMUNITIES	The health of the coral reefs of the Abrolhos Bank (southwestern Atlantic) was characterized with a holistic approach using measurements of four ecosystem components: (i) inorganic and organic nutrient concentrations, [1] fish biomass, [1] macroalgal and coral cover and (iv) microbial community composition and abundance. The possible benefits of protection from fishing were particularly evaluated by comparing sites with varying levels of protection. Two reefs within the well-enforced no-take area of the National Marine Park of Abrolhos (Parcel dos Abrolhos and California) were compared with two unprotected coastal reefs (Sebastiao Gomes and Pedra de Leste) and one legally protected but poorly enforced coastal reef (the "paper park" of Timbebas Reef). The fish biomass was lower and the fleshy macroalgal cover was higher in the unprotected reefs compared with the protected areas. The unprotected and protected reefs had similar seawater chemistry. Lower vibrio CFU counts were observed in the fully protected area of California Reef. Metagenome analysis showed that the unprotected reefs had a higher abundance of archaeal and viral sequences and more bacterial pathogens, while the protected reefs had a higher abundance of genes related to photosynthesis. Similar to other reef systems in the world, there was evidence that reductions in the biomass of herbivorous fishes and the consequent increase in macroalgal cover in the Abrolhos Bank may be affecting microbial diversity and abundance. Through the integration of different types of ecological data, the present study showed that protection from fishing may lead to greater reef health. The data presented herein suggest that protected coral reefs have higher microbial diversity, with the most degraded reef (Sebastiao Gomes) showing a marked reduction in microbial species richness. It is concluded that ecological conditions in unprotected reefs may promote the growth and rapid evolution of opportunistic microbial pathogens.	[Bruce, Thiago; Meirelles, Pedro M.; Garcia, Gizele; Paranhos, Rodolfo; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Dept Marine Biol, Rio De Janeiro, Brazil; [Rezende, Carlos E.] Univ Estadual Norte Fluminense, Biosci & Biotechnol Ctr, Rio De Janeiro, Brazil; [de Moura, Rodrigo L.] Univ Estadual Santa Cruz, Dept Ecol, Ilheus, BA, Brazil; [Filho, Ronaldo-Francini; Coni, Ericka O. C.] Univ Fed Paraiba UFPB, Appl Sci & Educ Ctr, Joao Pessoa, Paraiba, Brazil; [Vasconcelos, Ana Tereza] Lab Nacl Comp Cient, Petropolis, Rio De Janeiro, Brazil; [Amado Filho, Gilberto] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Hatay, Mark; Dinsdale, Elizabeth] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schmieder, Robert; Edwards, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Estadual de Santa Cruz; Universidade Federal da Paraiba; Laboratorio Nacional de Computacao Cientifica (LNCC); Jardim Botanico do Rio de Janeiro; California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Bruce, T (corresponding author), Univ Fed Rio de Janeiro, Dept Marine Biol, Rio De Janeiro, Brazil.	fabiano.thompson@biologia.ufrj.br	Tmcocean, Inct/J-8735-2013; Francini-Filho, Ronaldo/I-5708-2012; Meirelles, Pedro/GRY-0806-2022; Meirelles, Pedro/AAL-4542-2020; FILHO, GILBERTO M AMADO/I-1324-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; de Moura, Rodrigo Leao/AAL-5781-2020; Meirelles, Pedro/AAK-5942-2021; Rodrigues, Thiago/J-6363-2013; Paranhos, Rodolfo/F-1927-2011; Vasconcelos, Ana Tereza R/I-1011-2012; Edwards, Robert/Q-1691-2019; de Rezende, Carlos E/I-1893-2015	Francini-Filho, Ronaldo/0000-0002-7678-6797; de Moura, Rodrigo Leao/0000-0002-5597-6196; Meirelles, Pedro/0000-0002-1306-0331; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Edwards, Robert/0000-0001-8383-8949; dinsdale, elizabeth/0000-0002-2177-203X; de Rezende, Carlos/0000-0003-2804-8930; Thompson, Fabiano/0000-0002-7562-1683	CNPq (Equivalent of NSF in Brazil); CAPES (Equivalent of NSF in Brazil); FAPERJ (Equivalent of NSF in Rio de Janeiro); USA Embassy; NSF; International Foundation of Science (IFS)	CNPq (Equivalent of NSF in Brazil); CAPES (Equivalent of NSF in Brazil); FAPERJ (Equivalent of NSF in Rio de Janeiro); USA Embassy; NSF(National Science Foundation (NSF)); International Foundation of Science (IFS)(International Foundation for Science)	Funding was provided by CNPq (Equivalent of NSF in Brazil); CAPES (Equivalent of NSF in Brazil); FAPERJ (Equivalent of NSF in Rio de Janeiro); USA Embassy; NSF; and International Foundation of Science (IFS). All are government agencies, not commercial sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Andrade L, 2007, BRAZ J MICROBIOL, V38, P330, DOI 10.1590/S1517-83822007000200028; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Barash Y, 2005, BACTERIAL STRAIN BA; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bell PRF, 2007, AMBIO, V36, P416, DOI 10.1579/0044-7447(2007)36[416:ROESFT]2.0.CO;2; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Bourne DG, 2011, ISME J, V5, P559, DOI 10.1038/ismej.2010.143; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Cherrier J, 1996, MAR ECOL PROG SER, V139, P267, DOI 10.3354/meps139267; Costa OS, 2006, J MARINE SYST, V60, P63, DOI 10.1016/j.jmarsys.2005.11.006; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Costa OS, 2008, J S AM EARTH SCI, V25, P257, DOI 10.1016/j.jsames.2007.10.002; de Castro AP, 2010, MICROB ECOL, V59, P658, DOI 10.1007/s00248-010-9646-1; De Moura RL, 2009, COAST MANAGE, V37, P617, DOI 10.1080/08920750903194165; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Dutra GF, 2010, BRASIL ATLANTICO PAI, P200; Edgar GJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P730, DOI 10.1111/j.1466-8238.2010.00642.x; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Francini-Filho RB, 2010, FORAGING ACTIVITY RO; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hutchings P, 2001, MAR POLLUT BULL, V42, P81, DOI 10.1016/S0025-326X(00)00182-X; Ivars-Martinez E, 2008, MOL ECOL, V17, P4092, DOI 10.1111/j.1365-294X.2008.03883.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Koroleff F., 1976, METHODS SEAWATER ANA, P117; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V298, P275, DOI 10.1016/S0022-0981(03)00363-0; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lewis JB, 1997, MAR POLLUT BULL, V34, P622, DOI 10.1016/S0025-326X(96)00184-1; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minte-Vera CV, 2008, MAR ECOL PROG SER, V367, P283, DOI 10.3354/meps07511; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Moura RL, 2007, AREAS PROTEGIDAS, P168; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Ovalle ARC, 1999, GEO-MAR LETT, V19, P179, DOI 10.1007/s003670050107; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Rezende CE, 2006, CARACTERISTICAS HIDR; Rohwer F., 2010, CORAL REEFS MICROBIA; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sandin SA, 2011, OECOLOGIA, P1; Schloss PD, 2005, INTRO DOTUR COMPUTER, P1501; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIEBURTH J M, 1969, Journal of Experimental Marine Biology and Ecology, V3, P290, DOI 10.1016/0022-0981(69)90052-5; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singer E, 2011, APPL ENVIRON MICROB, V77, P2763, DOI 10.1128/AEM.01866-10; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SMITH SV, 1981, PAC SCI, V35, P279; Sondergaard M, 2000, LIMNOL OCEANOGR, V45, P1097, DOI 10.4319/lo.2000.45.5.1097; Sotka EE, 2009, CORAL REEFS, V28, P555, DOI 10.1007/s00338-009-0529-1; SUMMERHAYES CP, 1976, J SEDIMENT PETROL, V46, P819; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Wagner D, 2008, B MAR SCI, V83, P553; Zar JH, 1999, BIOSTATISTICAL ANAL	84	105	105	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36687	10.1371/journal.pone.0036687	http://dx.doi.org/10.1371/journal.pone.0036687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679480	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343900001
J	McArthur, MA; Sztein, MB				McArthur, Monica A.; Sztein, Marcelo B.			Heterogeneity of Multifunctional IL-17A Producing S. Typhi-Specific CD8+T Cells in Volunteers following Ty21a Typhoid Immunization	PLOS ONE			English	Article							CD8(+) T-CELLS; ATTENUATED VACCINE STRAINS; DRUG-RESISTANCE; TH17 CELLS; RESPONSES; IMMUNITY; VIRUS; EFFECTOR; SUBSET; INTERLEUKIN-17	Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, continues to cause significant morbidity and mortality world-wide. CD8+ T cells are an important component of the cell mediated immune (CMI) response against S. Typhi. Recently, interleukin (IL)-17A has been shown to contribute to mucosal immunity and protection against intracellular pathogens. To investigate multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, we developed multiparametric flow cytometry methods to detect up to 6 cytokines/chemokines (IL-10, IL-17A, IL-2, interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and macrophage inflammatory protein-1 beta (MIP-1 beta)) simultaneously. Five volunteers were immunized with a 4 dose regimen of live-attenuated S. Typhi vaccine (Ty21a), peripheral blood mononuclear cells (PBMC) were isolated before and at 11 time points after immunization, and CMI responses were evaluated. Of the 5 immunized volunteers studied, 3 produced detectable CD8+ T cell responses following stimulation with S. Typhi-infected autologous B lymphoblastoid cell lines (B-LCL). Additionally, 2 volunteers had detectable levels of intracellular cytokines in response to stimulation with S. Typhi-infected HLA-E restricted cells. Although the kinetics of the responses differed among volunteers, all of the responses were bi- or tri-phasic and included multifunctional CD8+ T cells. Virtually all of the IL-17A detected was derived from multifunctional CD8+ T cells. The presence of these multifunctional IL-17A+ CD8+ T cells was confirmed using an unsupervised analysis program, flow cytometry clustering without K (FLOCK). This is the first report of IL-17A production in response to S. Typhi in humans, indicating the presence of a Tc17 response which may be important in protection. The presence of IL-17A in multifunctional cells co-producing Tc1 cytokines (IL-2, IFN-gamma and TNF-Phi) may also indicate that the distinction between Tc17 and Tc1 responses in humans is not as clearly delineated as suggested by in vitro experiments and animal models.	[McArthur, Monica A.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [McArthur, Monica A.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	McArthur, MA (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	msztein@medicine.umaryland.edu	McArthur, Monica/AAD-9682-2019		National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) [R01 AI036525, U19 AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082655, R01AI036525] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) federal research grants R01 AI036525 and U19 AI082655 (CCHI) to MBS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Atkins BL, 1998, JAMA-J AM MED ASSOC, V279, P579, DOI 10.1001/jama.279.8.579; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; Bhutta ZA, 2009, JAMA-J AM MED ASSOC, V302, P898, DOI 10.1001/jama.2009.1259; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Harish BN, 2011, INDIAN J MED MICROBI, V29, P223, DOI 10.4103/0255-0857.83904; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Lee N, 1998, J IMMUNOL, V160, P4951; LEVINE MM, 1989, PEDIATR INFECT DIS J, V8, P374, DOI 10.1097/00006454-198906000-00010; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Marques JM, 2011, IMMUNOBIOLOGY; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; Salerno-Goncalves R, 2005, INFECT IMMUN, V73, P3521, DOI 10.1128/IAI.73.6.3521-3530.2005; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Salerno-Goncalves R, 2003, J IMMUNOL, V170, P2734, DOI 10.4049/jimmunol.170.5.2734; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Salerno-Goncalves R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005879; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Sztein MB, 2007, CLIN INFECT DIS, V45, pS15, DOI 10.1086/518140; SZTEIN MB, 1994, J INFECT DIS, V170, P1508, DOI 10.1093/infdis/170.6.1508; SZTEIN MB, 1995, J IMMUNOL, V155, P3987; Wahid R, 2008, MUCOSAL IMMUNOL, V1, P389, DOI 10.1038/mi.2008.30; Wahid R, 2007, VACCINE, V25, P1416, DOI 10.1016/j.vaccine.2006.10.040; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818	41	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38408	10.1371/journal.pone.0038408	http://dx.doi.org/10.1371/journal.pone.0038408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679502	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900037
J	Voorham, J; Haaijer-Ruskamp, FM; Wolffenbuttel, BHR; de Zeeuw, D; Stolk, RP; Denig, P				Voorham, Jaco; Haaijer-Ruskamp, Flora M.; Wolffenbuttel, Bruce H. R.; de Zeeuw, Dick; Stolk, Ronald P.; Denig, Petra			Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus - A Cohort Study	PLOS ONE			English	Article							QUALITY-OF-CARE; TREATMENT INTENSIFICATION; TREATMENT DECISIONS; CLINICAL INERTIA; BLOOD-PRESSURE; HYPERTENSION; MANAGEMENT; THERAPY; IMPACT; BURDEN	Background: Comorbidity is often mentioned as interfering with "optimal" treatment decisions in diabetes care. It is suggested that diabetes-related comorbidity will increase adequate treatment, whereas diabetes-unrelated comorbidity may decrease this process of care. We hypothesized that these effects differ according to expected priority of the conditions. Methods: We evaluated the relationship between comorbidity and treatment intensification in a study of 11,248 type 2 diabetes patients using the GIANTT (Groningen Initiative to Analyse type 2 diabetes Treatment) database. We formed a cohort of patients with a systolic blood pressure >= 140 mmHg (6,820 hypertensive diabetics), and a cohort of patients with an HbA1c >= 7% (3,589 hyperglycemic diabetics) in 2007. We differentiated comorbidity by diabetes-related or unrelated conditions and by priority. High priority conditions include conditions that are life-interfering, incident or requiring new medication treatment. We performed Cox regression analyses to assess association with treatment intensification, defined as dose increase, start, or addition of drugs. Results: In both the hypertensive and hyperglycemic cohort, only patients with incident diabetes-related comorbidity had a higher chance of treatment intensification (HR 4.48, 2.33-8.62 (p<0.001) for hypertensives; HR 2.37, 1.09-5.17 (p = 0.030) for hyperglycemics). Intensification of hypertension treatment was less likely when a new glucose-regulating drug was prescribed (HR 0.24, 0.06-0.97 (p = 0.046)). None of the prevalent or unrelated comorbidity was significantly associated with treatment intensification. Conclusions: Diabetes-related comorbidity induced better risk factor treatment only for incident cases, implying that appropriate care is provided more often when complications occur. Diabetes-unrelated comorbidity did not affect hypertension or hyperglycemia management, even when it was incident or life-interfering. Thus, the observed "undertreatment" in diabetes care cannot be explained by constraints caused by such comorbidity.	[Voorham, Jaco; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Dept Clin Pharmacol, Groningen, Netherlands; [Voorham, Jaco; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Dept Epidemiol, Groningen, Netherlands; [Voorham, Jaco; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Stolk, Ronald P.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Hlth Res, Groningen, Netherlands; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Fac Med Sci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Voorham, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Dept Clin Pharmacol, Groningen, Netherlands.	j.voorham@umcg.nl	Stolk, Ronald P/B-2341-2013; Wolffenbuttel, Bruce/A-8419-2011; Denig, Petra/L-9865-2014; de Zeeuw, Dick/E-9080-2014	Stolk, Ronald P/0000-0002-0518-1205; Wolffenbuttel, Bruce/0000-0001-9262-6921; Denig, Petra/0000-0002-7929-4739; de Zeeuw, Dick/0000-0003-3434-7777; Voorham, Jaco/0000-0001-9002-1865	Graduate School for Health Research, University of Groningen, The Netherlands	Graduate School for Health Research, University of Groningen, The Netherlands(Netherlands Government)	Funding for this research was obtained from the Graduate School for Health Research, University of Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolen SD, 2008, J GEN INTERN MED, V23, P543, DOI 10.1007/s11606-008-0507-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Caughey GE, 2010, DIABETES RES CLIN PR, V87, P385, DOI 10.1016/j.diabres.2009.10.019; Cayea D, 2007, DRUG AGING, V24, P851, DOI 10.2165/00002512-200724100-00005; Chaudhry SI, 2005, J AM GERIATR SOC, V53, P1214, DOI 10.1111/j.1532-5415.2005.53370.x; Conwell LJ, 2008, POPUL HEALTH MANAG, V11, P217, DOI 10.1089/pop.2007.0017; Grant RW, 2002, AM J MED, V112, P603, DOI 10.1016/S0002-9343(02)01103-8; Halanych JH, 2007, DIABETES CARE, V30, P2999, DOI 10.2337/dc06-1836; Hicks PC, 2006, DIABETES CARE, V29, P2580, DOI 10.2337/dc06-1124; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Krein SL, 2009, J GEN INTERN MED, V24, P911, DOI 10.1007/s11606-009-1020-y; Lagu T, 2008, J GEN INTERN MED, V23, P1208, DOI 10.1007/s11606-008-0647-4; Lamberts H., 1987, ICPC INT CLASSIFICAT; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Parchman ML, 2006, ANN FAM MED, V4, P40, DOI 10.1370/afm.422; Parnes BL, 2004, DIABETES CARE, V27, P13, DOI 10.2337/diacare.27.1.13; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Safford MM, 2007, J GEN INTERN MED, V22, P1648, DOI 10.1007/s11606-007-0433-8; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sidorenkov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024278; Turchin A, 2008, CIRCULATION, V117, P623, DOI 10.1161/CIRCULATIONAHA.107.733949; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Vitry AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014024; Voorham J, 2010, QUAL SAF HEALTH CARE, V19, P411, DOI 10.1136/qshc.2008.030106; Voorham J, 2008, DIABETES CARE, V31, P501, DOI 10.2337/dc07-1043; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Voorham J, 2010, PHARMACOEPIDEM DR S, V19, P1078, DOI 10.1002/pds.2023; Wang PS, 2005, HYPERTENSION, V46, P273, DOI 10.1161/01.HYP.0000172753.96583.e1; WHO Collaborating Centre for Drug Statistics Methodology, 2010, GUID ATC CLASS DDD A; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38707	10.1371/journal.pone.0038707	http://dx.doi.org/10.1371/journal.pone.0038707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679516	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900064
J	Cencini, M; Pigolotti, S; Munoz, MA				Cencini, Massimo; Pigolotti, Simone; Munoz, Miguel A.			What Ecological Factors Shape Species-Area Curves in Neutral Models?	PLOS ONE			English	Article							SPATIAL MODELS; SPECIATION; PATTERNS; BIOGEOGRAPHY	Understanding factors that shape biodiversity and species coexistence across scales is of utmost importance in ecology, both theoretically and for conservation policies. Species-area relationships (SARs), measuring how the number of observed species increases upon enlarging the sampled area, constitute a convenient tool for quantifying the spatial structure of biodiversity. While general features of species-area curves are quite universal across ecosystems, some quantitative aspects can change significantly. Several attempts have been made to link these variations to ecological forces. Within the framework of spatially explicit neutral models, here we scrutinize the effect of varying the local population size (i.e. the number of individuals per site) and the level of habitat saturation (allowing for empty sites). We conclude that species-area curves become shallower when the local population size increases, while habitat saturation, unless strongly violated, plays a marginal role. Our findings provide a plausible explanation of why SARs for microorganisms are flatter than those for larger organisms.	[Cencini, Massimo] CNR, Ist Sistemi Complessi, Rome, Italy; [Pigolotti, Simone] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Munoz, Miguel A.] Univ Granada, Inst Carlos I Fsica Teor & Computac, Fac Ciencias, Granada, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Universitat Politecnica de Catalunya; University of Granada	Cencini, M (corresponding author), CNR, Ist Sistemi Complessi, Rome, Italy.	mamunoz@onsager.ugr.es	Munoz, Miguel A/J-9627-2012; Cencini, Massimo/C-1191-2008; Pigolotti, Simone/AAU-2395-2021; MUÑOZ, MIGUEL A/M-4099-2015	Munoz, Miguel A/0000-0002-0529-6221; Cencini, Massimo/0000-0001-7073-5000; Pigolotti, Simone/0000-0002-6157-6906; MUÑOZ, MIGUEL A/0000-0003-0152-9080	Spanish MICINN [FIS2009-08451]; Junta de Andalucia, Proyecto de Excelencia [P09-FQM4682]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia, Proyecto de Excelencia(Junta de Andalucia)	This work was supported by Spanish MICINN project FIS2009-08451 and Junta de Andalucia, Proyecto de Excelencia P09-FQM4682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1953, ANN REP NATL I GENET, DOI DOI 10.1023/A:1003933603879; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bramson M, 1996, ANN PROBAB, V24, P1727; Brose U, 2004, NATURE, V428, P167, DOI 10.1038/nature02297; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2007, OIKOS, V116, P241, DOI [10.1111/j.2007.0030-1299.15438.x, 10.1111/j.0030-1299.2007.15438.x]; Etienne RS, 2011, THEOR ECOL-NETH, V4, P87, DOI 10.1007/s12080-010-0076-y; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gillespie J. H., 2004, POPULATION GENETICS; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hubbell Stephen P., 2001, V32, pi; Kopp M, 2010, BIOESSAYS, V32, P564, DOI 10.1002/bies.201000023; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; MARTINS ML, 1991, PHYS REV LETT, V66, P2045, DOI 10.1103/PhysRevLett.66.2045; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Pigolotti S, 2009, J THEOR BIOL, V260, P83, DOI 10.1016/j.jtbi.2009.05.023; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2008, ECOL INFORM, V3, P259, DOI 10.1016/j.ecoinf.2008.05.001; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Rosindell J, 2010, ECOL LETT, V13, P716, DOI 10.1111/j.1461-0248.2010.01463.x; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; Schoener T. W., 1976, P 16 INT ORNITHOLOGI, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Tilman D., 1982, Monographs in Population Biology, pi; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Vanpeteghem D, 2010, J MATH BIOL, V61, P323, DOI 10.1007/s00285-009-0303-6; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Warren PB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051922; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; Zillio T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098101	47	17	17	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38232	10.1371/journal.pone.0038232	http://dx.doi.org/10.1371/journal.pone.0038232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675526	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700048
J	Denoyer, A; Godefroy, D; Celerier, I; Frugier, J; Degardin, J; Harrison, JK; Brignole-Baudouin, F; Picaud, S; Baleux, F; Sahel, JA; Rostene, W; Baudouin, C				Denoyer, Alexandre; Godefroy, David; Celerier, Isabelle; Frugier, Julie; Degardin, Julie; Harrison, Jeffrey K.; Brignole-Baudouin, Francoise; Picaud, Serge; Baleux, Francoise; Sahel, Jose A.; Rostene, William; Baudouin, Christophe			CXCR3 Antagonism of SDF-1(5-67) Restores Trabecular Function and Prevents Retinal Neurodegeneration in a Rat Model of Ocular Hypertension	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL-NERVOUS-SYSTEM; MESHWORK CELLS; AQUEOUS-HUMOR; CHEMOKINE RECEPTOR; IN-VITRO; EXTRACELLULAR-MATRIX; T-LYMPHOCYTES; SDF-1; EXPRESSION	Glaucoma, the most common cause of irreversible blindness, is a neuropathy commonly initiated by pathological ocular hypertension due to unknown mechanisms of trabecular meshwork degeneration. Current antiglaucoma therapy does not target the causal trabecular pathology, which may explain why treatment failure is often observed. Here we show that the chemokine CXCL12, its truncated form SDF-1(5-67), and the receptors CXCR4 and CXCR3 are expressed in human glaucomatous trabecular tissue and a human trabecular cell line. SDF-1(5-67) is produced under the control of matrix metallo-proteinases, TNF-alpha, and TGF-beta 2, factors known to be involved in glaucoma. CXCL12 protects in vitro trabecular cells from apoptotic death via CXCR4 whereas SDF-1(5-67) induces apoptosis through CXCR3 and caspase activation. Ocular administration of SDF-1(5-67) in the rat increases intraocular pressure. In contrast, administration of a selective CXCR3 antagonist in a rat model of ocular hypertension decreases intraocular pressure, prevents retinal neurodegeneration, and preserves visual function. The protective effect of CXCR3 antagonism is related to restoration of the trabecular function. These data demonstrate that proteolytic cleavage of CXCL12 is involved in trabecular pathophysiology, and that local administration of a selective CXCR3 antagonist may be a beneficial therapeutic strategy for treating ocular hypertension and subsequent retinal degeneration.	[Denoyer, Alexandre; Godefroy, David; Frugier, Julie; Degardin, Julie; Brignole-Baudouin, Francoise; Picaud, Serge; Sahel, Jose A.; Rostene, William; Baudouin, Christophe] Univ Paris 06, UPMC, Inst Vis, UMRS968, Paris, France; [Denoyer, Alexandre; Godefroy, David; Frugier, Julie; Degardin, Julie; Brignole-Baudouin, Francoise; Picaud, Serge; Sahel, Jose A.; Rostene, William; Baudouin, Christophe] INSERM, U968, Paris, France; [Denoyer, Alexandre; Godefroy, David; Frugier, Julie; Degardin, Julie; Brignole-Baudouin, Francoise; Picaud, Serge; Sahel, Jose A.; Rostene, William; Baudouin, Christophe] CNRS, U7210, Paris, France; [Denoyer, Alexandre; Sahel, Jose A.; Baudouin, Christophe] Quinze Vingts Natl Ophthalmol Hosp, Paris, France; [Celerier, Isabelle] INSERM, Ctr Rech Cordeliers, Team 1, U872, Paris, France; [Harrison, Jeffrey K.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Brignole-Baudouin, Francoise] Univ Paris 05, Fac Biol & Pharmacol Sci, Dept Toxicol, Paris, France; [Baleux, Francoise] Inst Pasteur, CNRS 2128, Unite Chim Biomol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; State University System of Florida; University of Florida; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Denoyer, A (corresponding author), Univ Paris 06, UPMC, Inst Vis, UMRS968, Paris, France.	alexandre.denoyer@gmail.com	Sahel, Jose-Alain/F-3172-2017; DENOYER, Alexandre/AAS-6605-2021; Rostene, William/F-2754-2017; Picaud, Serge/H-4012-2014	Sahel, Jose-Alain/0000-0002-4831-1153; Picaud, Serge/0000-0002-0548-5145; Baudouin, Christophe/0000-0003-1743-6698; BRIGNOLE-BAUDOUIN, FRANCOISE/0000-0002-2006-5384; ROSTENE, WILLIAM/0000-0003-0409-5361; Godefroy, David/0000-0003-4706-2711; DENOYER, Alexandre/0000-0003-4730-0425	INSERM; UPMC; NIH [AI058256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058256] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by INSERM grants for AD, DG, JD, WR and CB, by a UPMC grant for IC and JF, and by an NIH grant for JKH (AI058256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baleriola J, 2008, MOL VIS, V14, P1513; Barbieri F, 2006, ANN NY ACAD SCI, V1090, P332, DOI 10.1196/annals.1378.037; Bhutto IA, 2006, BRIT J OPHTHALMOL, V90, P906, DOI 10.1136/bjo.2006.090357; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Bourcier T, 2003, MOL VIS, V9, P96; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cedrone C, 2008, PROG BRAIN RES, V173, P3, DOI 10.1016/S0079-6123(08)01101-1; Crane IJ, 2000, J IMMUNOL, V165, P4372, DOI 10.4049/jimmunol.165.8.4372; Curnow SJ, 2004, J IMMUNOL, V172, P7154, DOI 10.4049/jimmunol.172.11.7154; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P642; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; GRIERSON I, 1987, EYE, V1, P204, DOI 10.1038/eye.1987.38; Hamard P, 2003, GRAEF ARCH CLIN EXP, V241, P1037, DOI 10.1007/s00417-003-0777-7; Hamard P, 2002, BRIT J OPHTHALMOL, V86, P1046, DOI 10.1136/bjo.86.9.1046; Heise CE, 2005, J PHARMACOL EXP THER, V313, P1263, DOI 10.1124/jpet.105.083683; HERNANDEZ MR, 1987, INVEST OPHTH VIS SCI, V28, P1655; JONES RF, 1966, EXP EYE RES, V5, P208, DOI 10.1016/S0014-4835(66)80009-X; Jopling LA, 2007, BRIT J PHARMACOL, V152, P1260, DOI 10.1038/sj.bjp.0707519; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Liu C, 2011, CARCINOGENESIS, V32, P129, DOI 10.1093/carcin/bgq224; Lu Z, 2008, EXP EYE RES, V86, P271, DOI 10.1016/j.exer.2007.10.018; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; MEDINA J, 2004, 29 NAT MED CHEM S; Morrison JC, 2011, EXP EYE RES, V93, P156, DOI 10.1016/j.exer.2010.08.005; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nissirios N, 2008, INVEST OPHTH VIS SCI, V49, P2478, DOI 10.1167/iovs.07-0965; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROHEN JW, 1993, EXP EYE RES, V56, P683, DOI 10.1006/exer.1993.1085; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; SHERWOOD ME, 1988, EXP EYE RES, V46, P881, DOI 10.1016/S0014-4835(88)80040-X; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Van Wanrooij EJA, 2008, ARTERIOSCL THROM VAS, V28, P251, DOI 10.1161/ATVBAHA.107.147827; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; YABLONSKI ME, 1978, EXP EYE RES, V27, P135, DOI 10.1016/0014-4835(78)90083-0; Yu SY, 2006, EXP EYE RES, V83, P758, DOI 10.1016/j.exer.2006.03.014; Zhang H, 2011, J NEUROSCI, V9, P143; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhang YY, 2009, EXP EYE RES, V89, P748, DOI 10.1016/j.exer.2009.06.015; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819	62	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37873	10.1371/journal.pone.0037873	http://dx.doi.org/10.1371/journal.pone.0037873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675496	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700025
J	Klingseisen, L; Ehrenschwender, M; Heigl, U; Wajant, H; Hehlgans, T; Schutze, S; Schneider-Brachert, W				Klingseisen, Laura; Ehrenschwender, Martin; Heigl, Ulrike; Wajant, Harald; Hehlgans, Thomas; Schuetze, Stefan; Schneider-Brachert, Wulf			E3-14.7K Is Recruited to TNF-Receptor 1 and Blocks TNF Cytolysis Independent from Interaction with Optineurin	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; E3 14.7-KILODALTON PROTEIN; MYOSIN-VI; APOPTOSIS; CELLS; COMPARTMENTALIZATION; INHIBITOR; BINDING; 14.7K	Escape from the host immune system is essential for intracellular pathogens. The adenoviral protein E3-14.7K (14.7K) is known as a general inhibitor of tumor necrosis factor (TNF)-induced apoptosis. It efficiently blocks TNF-receptor 1 (TNFR1) internalization but the underlying molecular mechanism still remains elusive. Direct interaction of 14.7K and/or associated proteins with the TNFR1 complex has been discussed although to date not proven. In our study, we provide for the first time evidence for recruitment of 14.7K and the 14.7K interacting protein optineurin to TNFR1. Various functions have been implicated for optineurin such as regulation of receptor endocytosis, vesicle trafficking, regulation of the nuclear factor kappa B (NF-kappa B) pathway and antiviral signaling. We therefore hypothesized that binding of optineurin to 14.7K and recruitment of both proteins to the TNFR1 complex is essential for protection against TNF-induced cytotoxic effects. To precisely dissect the individual role of 14.7K and optineurin, we generated and characterized a 14.7K mutant that does not confer TNF-resistance but is still able to interact with optineurin. In H1299 and KB cells expressing 14.7K wild-type protein, neither decrease in cell viability nor cleavage of caspases was observed upon stimulation with TNF. In sharp contrast, cells expressing the non-protective mutant of 14.7K displayed reduced viability and cleavage of initiator and effector caspases upon TNF treatment, indicating ongoing apoptotic cell death. Knockdown of optineurin in 14.7K expressing cells did not alter the protective effect as measured by cell viability and caspase activation. Taken together, we conclude that optineurin despite its substantial role in vesicular trafficking, endocytosis of cell surface receptors and recruitment to the TNFR1 complex is dispensable for the 14.7K-mediated protection against TNF-induced apoptosis.	[Klingseisen, Laura; Ehrenschwender, Martin; Heigl, Ulrike; Schneider-Brachert, Wulf] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany; [Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany; [Hehlgans, Thomas] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Schuetze, Stefan] Univ Kiel, Inst Immunol, Kiel, Germany	University of Regensburg; University of Wurzburg; University of Regensburg; University of Kiel	Klingseisen, L (corresponding author), Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany.	wulf.schneider@klinik.uni-regensburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Ehrenschwender, Martin/0000-0003-4681-8628	Deutsche Forschungsgemeinschaft (DFG) [HE3116/8, PDFG-SFB 877, SCHN697/3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by grants of the Deutsche Forschungsgemeinschaft (DFG) HE3116/8 to TH, PDFG-SFB 877 project B1 to SS, and SCHN697/3 to WSB. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Burgert HG, 2000, VIRUS GENES, V21, P13, DOI 10.1023/A:1008135928310; GOODING LR, 1990, J IMMUNOL, V145, P3080; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HORTON TM, 1991, J VIROL, V65, P2629, DOI 10.1128/JVI.65.5.2629-2639.1991; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Kim HJ, 2002, PROTEIN SCI, V11, P1117, DOI 10.1110/ps.4180102; Li HY, 2011, MOL VIS, V17, P3314; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MOSSELMANS R, 1988, J IMMUNOL, V141, P3096; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; RANHEIM TS, 1993, J VIROL, V67, P2159, DOI 10.1128/JVI.67.4.2159-2167.1993; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swarup G, 2010, J BIOSCIENCES, V35, P501, DOI 10.1007/s12038-010-0056-9; WONG GHW, 1992, J IMMUNOL, V149, P3350; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041; ZILLI D, 1992, BIOCHEM BIOPH RES CO, V188, P177, DOI 10.1016/0006-291X(92)92366-6	24	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38348	10.1371/journal.pone.0038348	http://dx.doi.org/10.1371/journal.pone.0038348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675546	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700061
J	Cui, W; Wang, K; Ruan, JS; Qi, Z; Feng, Y; Shao, YM; Tuszynski, JA				Cui, Wei; Wang, Kui; Ruan, Jishou; Qi, Zhi; Feng, Yi; Shao, Yiming; Tuszynski, Jack A.			The Molecular Mechanism of Action of the CR6261-Azichromycin Combination Found through Computational Analysis	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; AUTOMATED DOCKING; MONOCLONAL-ANTIBODIES; FLEXIBLE LIGANDS; INDUCTION; PROTEINS	Background: CR6261 was found in 2008 and F10 was found in 2009. In 2010 Friesen et al experimentally showed that Oseltamivir/Zanamivir may improve the therapeutic efficacy of CR6261. As a result, the use of CR6261 combined with a drug to provide an antibody-based therapy against all influenza A viruses was proposed. Although CR8020 may neutralize group 2 influenza viruses and FI6 may neutralize both group 1 and group 2 influenza viruses as determined in 2011, the insight of Friesen et al is still interesting. Here, we address the following questions: how to uncover the molecular mechanism of a drug, which improves the therapeutic efficacy of mAbs and how to find drugs that enable CR6261 (CR8020, F10) to become a universal mAb. Methods and Findings: Using the 3D structures of 3 gbn, 3 gbm, 3 ztn, 3 ztj, 3 fku and 3 sdy, we separate the 3D structures of CR6261, F10, CR8020 and FI6, and the 3D structures of trimer HAs of H3N2 and H5N1. Based on the experimental result of Friesen et al, we have found many clues, which reveal the molecular mechanism of action for a drug and an HA-mAb complex. Conclusions: Oseltamivir/Zanamivir may congruously improve the therapeutic efficacies of CR6261, F10, CR8020 and FI6 by providing an additional affinity to compensate for the loss of affinity between HA and mAb resulting from mutations. However, Oseltamivir or Zanamivir are not expected to generally widen the spectrum of these mAbs. In order to enhance CR6261, CR8020, or for F10 to become universal, we may select Azichromycin, Oseltamivir, or the combination of Azichromycin and Oseltamivir, respectively.	[Cui, Wei; Wang, Kui; Ruan, Jishou] Nankai Univ, Coll Math Sci, LPMC, Tianjin 300071, Peoples R China; [Qi, Zhi; Feng, Yi; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Tuszynski, Jack A.] Cross Canc Inst, Div Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of Alberta; Nankai University	Cui, W (corresponding author), Nankai Univ, Coll Math Sci, LPMC, Tianjin 300071, Peoples R China.	jsruan@nankai.edu.cn; yshao08@gmail.com	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429	International Development Research Center, Ottawa, Canada [104519-010]; China CDC [2008SKLID203]; National Nature Science Foundation of China; NSFC [10671100, 68075049, 31050110432];  [08ZCHHZ00200]	International Development Research Center, Ottawa, Canada; China CDC; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); 	This work was carried out with the aid of a grant (No. 104519-010) from the International Development Research Center, Ottawa, Canada. All authors acknowledge the project of the China CDC (2008SKLID203). JRuan group would like to specifically thank for the support received from National Nature Science Foundation of China, NSFC (10671100, 68075049 and 31050110432), the project for the innovative groups administered by China Ministry of Education and 08ZCHHZ00200. Websites: IDRC www.idrc.ca, NSFC www.nsfc.gov.cn, China CDC www.chinacdc.cn, and TSTC www.tstc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Bourquard T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018541; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Notredame C, 1996, NUCLEIC ACIDS RES, V24, P1515, DOI 10.1093/nar/24.8.1515; Notredame C, 1998, BIOINFORMATICS, V14, P407, DOI 10.1093/bioinformatics/14.5.407; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Zhang M, 2005, COMPUT BIOL CHEM, V29, P175, DOI 10.1016/j.compbiolchem.2004.12.005	27	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37790	10.1371/journal.pone.0037790	http://dx.doi.org/10.1371/journal.pone.0037790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693576	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500056
J	Hladik, W; Barker, J; Ssenkusu, JM; Opio, A; Tappero, JW; Hakim, A; Serwadda, D; Grp, CS				Hladik, Wolfgang; Barker, Joseph; Ssenkusu, John M.; Opio, Alex; Tappero, Jordan W.; Hakim, Avi; Serwadda, David; Grp, Crane Survey			HIV Infection among Men Who Have Sex with Men in Kampala, Uganda-A Respondent Driven Sampling Survey	PLOS ONE			English	Article							INCOME; RISK; GAY	Background: Uganda's generalized HIV epidemic is well described, including an estimated adult male HIV prevalence in Kampala of 4.5%, but no data are available on the prevalence of and risk factors for HIV infection among men who have sex with men (MSM). Methodology/Principal Findings: From May 2008 to February 2009, we used respondent-driven sampling to recruit MSM >= 18 years old in Kampala who reported anal sex with another man in the previous three months. We collected demographic and HIV-related behavioral data through audio computer-assisted self-administered interviews. Laboratory testing included biomarkers for HIV and other sexually transmitted infections. We obtained population estimates adjusted for the non-random sampling frame using RDSAT and STATA. 300 MSM were surveyed over 11 waves; median age was 25 years (interquartile range, 21-29 years). Overall HIV prevalence was 13.7% (95% confidence interval [CI] 7.9%-20.1%), and was higher among MSM >= 25 years (22.4%) than among MSM aged 18-24 years (3.9%, odds ratio [OR] 5.69, 95% CI 2.02-16.02). In multivariate analysis, MSM >= 25 years (adjusted OR [aOR] 4.32, 95% CI 1.33-13.98) and those reporting ever having been exposed to homophobic abuse (verbal, moral, sexual, or physical abuse; aOR 5.38, 95% CI 1.95-14.79) were significantly more likely to be HIV infected. Conclusions/Significance: MSM in Kampala are at substantially higher risk for HIV than the general adult male population. MSM reporting a lifetime history of homophobic abuse are at increased risk of being HIV infected. Legal challenges and stigma must be overcome to provide access to tailored HIV prevention and care services.	[Hladik, Wolfgang; Barker, Joseph; Ssenkusu, John M.; Tappero, Jordan W.] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Entebbe, Uganda; [Hladik, Wolfgang] Univ Amsterdam, Dept Clin Epidemiol, Acad Med Ctr, Amsterdam, Netherlands; [Opio, Alex] Minist Hlth, Kampala, Uganda; [Hakim, Avi] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Entebbe, Uganda; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of Amsterdam; Academic Medical Center Amsterdam; Makerere University	Hladik, W (corresponding author), Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Entebbe, Uganda.	wfh3@cdc.gov		Ssenkusu, John/0000-0003-0499-5642	US President's Emergency Plan for AIDS Relief	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the US President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Friedman MS, 2008, AIDS BEHAV, V12, P891, DOI 10.1007/s10461-007-9319-3; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; HECKATHORN D, 2004, SOCIAL METHODS, V34, P208; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; International Gay and Lesbian Human Rights Commission, 2008, UG LGBT ARR INT HIV; International Gay and Lesbian Human Rights Commission, 2008, UG DEM END OFF HAR L; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; Makerere University School of Public Health, 2010, CRAN SURV REP HIGH R; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Ministry of Health (MoH) STD/AIDS Control Programme, 2011, HIV AIDS SER SURV FI; Ministry of Health (MOH) [Uganda] ORC Macro, 2006, UG HIV AIDS SER SURV; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07	21	97	98	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38143	10.1371/journal.pone.0038143	http://dx.doi.org/10.1371/journal.pone.0038143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693590	Green Published, gold			2022-12-25	WOS:000305338500093
J	Pathania, M; Torres-Reveron, J; Yan, L; Kimura, T; Lin, TV; Gordon, V; Teng, ZQ; Zhao, XY; Fulga, TA; Van Vactor, D; Bordey, A				Pathania, Manavendra; Torres-Reveron, Juan; Yan, Lily; Kimura, Tomoki; Lin, Tiffany V.; Gordon, Valerie; Teng, Zhao-Qian; Zhao, Xinyu; Fulga, Tudor A.; Van Vactor, David; Bordey, Angelique			miR-132 Enhances Dendritic Morphogenesis, Spine Density, Synaptic Integration, and Survival of Newborn Olfactory Bulb Neurons	PLOS ONE			English	Article							ADULT NEUROGENESIS; MICRORNAS; TRANSCRIPTION	An array of signals regulating the early stages of postnatal subventricular zone (SVZ) neurogenesis has been identified, but much less is known regarding the molecules controlling late stages. Here, we investigated the function of the activity-dependent and morphogenic microRNA miR-132 on the synaptic integration and survival of olfactory bulb (OB) neurons born in the neonatal SVZ. In situ hybridization revealed that miR-132 expression occurs at the onset of synaptic integration in the OB. Using in vivo electroporation we found that sequestration of miR-132 using a sponge-based strategy led to a reduced dendritic complexity and spine density while overexpression had the opposite effects. These effects were mirrored with respective changes in the frequency of GABAergic and glutamatergic synaptic inputs reflecting altered synaptic integration. In addition, timely directed overexpression of miR-132 at the onset of synaptic integration using an inducible approach led to a significant increase in the survival of newborn neurons. These data suggest that miR-132 forms the basis of a structural plasticity program seen in SVZ-OB postnatal neurogenesis. miR-132 overexpression in transplanted neurons may thus hold promise for enhancing neuronal survival and improving the outcome of transplant therapies.	[Pathania, Manavendra; Torres-Reveron, Juan; Yan, Lily; Kimura, Tomoki; Lin, Tiffany V.; Gordon, Valerie; Bordey, Angelique] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Pathania, Manavendra; Torres-Reveron, Juan; Yan, Lily; Kimura, Tomoki; Lin, Tiffany V.; Gordon, Valerie; Bordey, Angelique] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Teng, Zhao-Qian; Zhao, Xinyu] Univ New Mexico, Dept Neurosci, Sch Med, Albuquerque, NM 87131 USA; [Fulga, Tudor A.; Van Vactor, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Yale University; Yale University; University of New Mexico; Harvard University; Harvard Medical School	Pathania, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	angelique.bordey@yale.edu	Yan, Lily/AAR-6163-2021; Teng, Zhao-Qian/AAD-1033-2021; Teng, Zhao-Qian/J-6260-2015	Yan, Lily/0000-0001-6363-7920; Teng, Zhao-Qian/0000-0002-7232-3381; Teng, Zhao-Qian/0000-0002-7232-3381; Fulga, Tudor/0000-0002-1056-0082; Torres-Reveron, Juan/0000-0002-3269-1067; Van Vactor, Jr., David L./0000-0001-8156-9482; Pathania, Manav/0000-0001-5635-5028	National Institutes of Health (NIH) [R01 DC007681, P30 NS-052519]; McKnight disorder award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069695, P30NS052519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007681] Funding Source: NIH RePORTER; Medical Research Council [G0902418] Funding Source: researchfish; MRC [G0902418] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight disorder award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Institutes of Health (NIH) R01 DC007681 and McKnight disorder award (AB), and NIH P30 NS-052519 (FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordey A, 2006, CELL CYCLE, V5, P722, DOI 10.4161/cc.5.7.2614; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feliciano DM, 2012, HUM MOL GENET, V21, P799, DOI 10.1093/hmg/ddr511; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pathania M, 2010, NEUROPHARMACOLOGY, V58, P865, DOI 10.1016/j.neuropharm.2010.01.010; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pignatelli A., 2010, NEUROBIOLOGY OLFACTI; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	29	100	102	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38174	10.1371/journal.pone.0038174	http://dx.doi.org/10.1371/journal.pone.0038174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693596	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500102
J	McCartney-Melstad, E; Waller, T; Micucci, PA; Barros, M; Draque, J; Amato, G; Mendez, M				McCartney-Melstad, Evan; Waller, Tomas; Micucci, Patricio A.; Barros, Mariano; Draque, Juan; Amato, George; Mendez, Martin			Population Structure and Gene Flow of the Yellow Anaconda (Eunectes notaeus) in Northern Argentina	PLOS ONE			English	Article							MALE-BIASED DISPERSAL; MITOCHONDRIAL-DNA; UNSAMPLED POPULATIONS; MIGRATION RATES; BOA-CONSTRICTOR; F-STATISTICS; SNAKE; DIFFERENTIATION; REGRESSION; SOFTWARE	Yellow anacondas (Eunectes notaeus) are large, semiaquatic boid snakes found in wetland systems in South America. These snakes are commercially harvested under a sustainable management plan in Argentina, so information regarding population structuring can be helpful for determination of management units. We evaluated genetic structure and migration using partial sequences from the mitochondrial control region and mitochondrial genes cyt-b and ND4 for 183 samples collected within northern Argentina. A group of landscape features and environmental variables including several treatments of temperature and precipitation were explored as potential drivers of observed genetic patterns. We found significant population structure between most putative population comparisons and bidirectional but asymmetric migration in several cases. The configuration of rivers and wetlands was found to be significantly associated with yellow anaconda population structure (IBD), and important for gene flow, although genetic distances were not significantly correlated with the environmental variables used here. More in-depth analyses of environmental data may be needed to fully understand the importance of environmental conditions on population structure and migration. These analyses indicate that our putative populations are demographically distinct and should be treated as such in Argentina's management plan for the harvesting of yellow anacondas.	[McCartney-Melstad, Evan] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [McCartney-Melstad, Evan; Amato, George] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Waller, Tomas; Micucci, Patricio A.; Barros, Mariano; Draque, Juan] Fdn Biodiversidad Argentina, Buenos Aires, DF, Argentina; [Mendez, Martin] Wildlife Conservat Soc, Bronx, NY USA	Columbia University; American Museum of Natural History (AMNH); Wildlife Conservation Society	McCartney-Melstad, E (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mmendez@wcs.org	McCartney-Melstad, Evan/G-4860-2014	McCartney-Melstad, Evan/0000-0002-1803-1126	Office veterinaire federal of Switzerland; Yellow Anaconda Management Program; Alfred P. Sloan Foundation	Office veterinaire federal of Switzerland; Yellow Anaconda Management Program; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	The Office veterinaire federal of Switzerland and the Yellow Anaconda Management Program funded field work. The Alfred P. Sloan Foundation funded laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bates PD, 2000, J HYDROL, V236, P54, DOI 10.1016/S0022-1694(00)00278-X; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; BONETTO A A, 1989, Regulated Rivers Research and Management, V4, P333, DOI 10.1002/rrr.3450040402; Burkart R., 1999, ECOREGIONES ARGENTIN, P42; Cardozo G, 2008, BIOL CONSERV, V141, P3050, DOI 10.1016/j.biocon.2008.08.026; Cardozo Gabriela, 2007, P328; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; da Paz AR, 2011, HYDROL PROCESS, V25, P1498, DOI 10.1002/hyp.7926; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Douglas DA, 2006, ZOOL SCR, V35, P545, DOI 10.1111/j.1463-6409.2006.00257.x; Dubey S, 2008, MOL ECOL, V17, P3506, DOI 10.1111/j.1365-294X.2008.03859.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Goudet J, 1996, GENETICS, V144, P1933; Hellborg L, 2005, MOL ECOL, V14, P2025, DOI 10.1111/j.1365-294X.2005.02559.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holling CrawfordS., 1978, ADAPTIVE ENV ASSESSM; Howes BJ, 2009, CONSERV GENET, V10, P407, DOI 10.1007/s10592-008-9607-0; Johnson BL, 1999, CONSERV ECOL, V3; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Manier MK, 2005, MOL ECOL, V14, P3965, DOI 10.1111/j.1365-294X.2005.02734.x; MANTEL N, 1967, CANCER RES, V27, P209; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meister B, 2010, BIOL J LINN SOC, V101, P51, DOI 10.1111/j.1095-8312.2010.01474.x; Mendez M, 2007, BIOL BOAS PYTHONS, P405; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Micucci P. A., 2007, IGUANA, V14, P161; Micucci PA, 2006, MANEJO FAUNA SILVEST, P77; Morello J, 1971, SERIES FITOGEOGRAFIC, V11, P113; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Narum S., 2006, CONSERV GENET, V7, P811, DOI [10.1007/s10592-006-9189-7, DOI 10.1007/S10592-006-9189-7]; Nei M., 1987, MOL EVOLUTIONARY GEN; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Prosser MR, 1999, MOL ECOL, V8, P329, DOI 10.1046/j.1365-294X.1999.00530.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rivas Jesus A., 2007, P312; Rivas Jesus A., 2007, P128; Rivera PC, 2006, AUSTRAL ECOL, V31, P948, DOI 10.1111/j.1442-9993.2006.01661.x; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Rousset F, 1997, GENETICS, V145, P1219; Sanchez-Fernandez D, 2011, BIOL J LINN SOC, V103, P891, DOI 10.1111/j.1095-8312.2011.01668.x; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VOGLER AP, 1994, CONSERV BIOL, V8, P354, DOI 10.1046/j.1523-1739.1994.08020354.x; Waller Tomas, 2007, P340; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright S, 1943, GENETICS, V28, P114	67	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37473	10.1371/journal.pone.0037473	http://dx.doi.org/10.1371/journal.pone.0037473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22675425	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338900026
J	Meisner, S; Lehur, PA; Moran, B; Martins, L; Jemec, GBE				Meisner, Soren; Lehur, Paul-Antoine; Moran, Brendan; Martins, Lina; Jemec, Gregor Borut Ernst			Peristomal Skin Complications Are Common, Expensive, and Difficult to Manage: A Population Based Cost Modeling Study	PLOS ONE			English	Article							STOMA-RELATED COMPLICATIONS; OSTOMY PATIENTS; COLOSTOMY; LIFE	Background: Peristomal skin complications (PSCs) are the most common post-operative complications following creation of a stoma. Living with a stoma is a challenge, not only for the patient and their carers, but also for society as a whole. Due to methodological problems of PSC assessment, the associated health-economic burden of medium to longterm complications has been poorly described. Aim: The aim of the present study was to create a model to estimate treatment costs of PSCs using the standardized assessment Ostomy Skin Tool as a reference. The resultant model was applied to a real-life global data set of stoma patients (n = 3017) to determine the prevalence and financial burden of PSCs. Methods: Eleven experienced stoma care nurses were interviewed to get a global understanding of a treatment algorithm that formed the basis of the cost analysis. The estimated costs were based on a seven week treatment period. PSC costs were estimated for five underlying diagnostic categories and three levels of severity. The estimated treatment costs of severe cases of PSCs were increased 2-5 fold for the different diagnostic categories of PSCs compared with mild cases. French unit costs were applied to the global data set. Results: The estimated total average cost for a seven week treatment period (including appliances and accessories) was 263 is an element of for those with PSCs (n = 1742) compared to 215 is an element of for those without PSCs (n = 1172). A co-variance analysis showed that leakage level had a significant impact on PSC cost from 'rarely/never' to 'always/often' p < 0.00001 and from 'rarely/never' to 'sometimes' p = 0.0115. Conclusion: PSCs are common and troublesome and the consequences are substantial, both for the patient and from a health economic viewpoint. PSCs should be diagnosed and treated at an early stage to prevent long term, debilitating and expensive complications.	[Meisner, Soren] Bispebjerg Hosp, Stoma Care Clin, Copenhagen, Denmark; [Lehur, Paul-Antoine] Univ Hosp Nantes, Inst Digest Dis, Nantes, France; [Moran, Brendan] N Hampshire Hosp, Pelican Canc Fdn, Basingstoke, Hants, England; [Martins, Lina] London Hlth Sci Ctr, London, ON, Canada; [Jemec, Gregor Borut Ernst] Univ Copenhagen, Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Nantes Universite; CHU de Nantes; London Health Sciences Centre; University of Copenhagen	Meisner, S (corresponding author), Bispebjerg Hosp, Stoma Care Clin, Copenhagen, Denmark.	smei0001@bbh.regionh.dk	Jemec, Gregor/H-6702-2019	Jemec, Gregor/0000-0002-0712-2540	Coloplast A/S	Coloplast A/S	Coloplast A/S supported the work of this study by providing funding for external consultancy for unit cost collection, data analysis and preparation of the manuscript. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2011, GASTROENTEROL NURS, V9, P4; Colwell J C, 2001, J Wound Ostomy Continence Nurs, V28, P6, DOI 10.1067/mjw.2001.112082; Davis J.S., 2011, GASTROINTESTINAL NUR, V9, P14, DOI [10.12968/gasn.2011.9.Sup2.14, DOI 10.12968/gasn.2011.9.Sup2.14]; HELLMAN J, 1990, INT J DERMATOL, V29, P129, DOI 10.1111/j.1365-4362.1990.tb04085.x; Holm EA, 2004, PEDIATR DERMATOL, V21, P623, DOI 10.1111/j.0736-8046.2004.21601.x; Jemec GB, 2011, BRIT J DERMATOL, V164, P330, DOI 10.1111/j.1365-2133.2010.10093.x; Jemec GBE, 2008, BRIT J DERMATOL, V159, P1211, DOI 10.1111/j.1365-2133.2008.08839.x; LONDONOSCHIMMER EE, 1994, DIS COLON RECTUM, V37, P916, DOI 10.1007/BF02052598; Martins L., 2011, GASTROINTEST NURS, V9, P9; Martins L, 2010, BR J NURS, V19, P932; Martins L, 2008, WORLD COUNCIL ENTERO, P28; Martins Lina, 2010, Br J Nurs, V19, P932; Nybaek H, 2010, J EUR ACAD DERMATOL, V24, P249, DOI 10.1111/j.1468-3083.2010.03566.x; Nybaek H, 2009, ACTA DERM-VENEREOL, V89, P64, DOI 10.2340/00015555-0536; Persson E, 2010, COLORECTAL DIS, V12, P971, DOI 10.1111/j.1463-1318.2009.01941.x; Pittman J, 2008, J WOUND OSTOMY CONT, V35, P493, DOI 10.1097/01.WON.0000335961.68113.cb; Porrett T, 2013, GASTROINTESTINAL NUR, V9, P19, DOI [10.12968/gasn.2011.9.Sup2.19, DOI 10.12968/GASN.2011.9.SUP2.19]; Price P, 2004, BR J NURS, V1, P10; Prieto L, 2005, HLTH QUALITY LIFE OU, P3; Robertson I, 2005, COLORECTAL DIS, V7, P279, DOI 10.1111/j.1463-1318.2005.00785.x; Shabbir J, 2010, COLORECTAL DIS, V12, P958, DOI 10.1111/j.1463-1318.2009.02006.x; Wille-Jorgensen P, 2010, COLORECTAL DIS, V12, P957, DOI 10.1111/j.1463-1318.2010.02376.x	22	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37813	10.1371/journal.pone.0037813	http://dx.doi.org/10.1371/journal.pone.0037813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22679479	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338900047
J	Serrano-Sanchez, JA; Lera-Navarro, A; Dorado-Garcia, C; Gonzalez-Henriquez, JJ; Sanchis-Moysi, J				Antonio Serrano-Sanchez, Jose; Lera-Navarro, Angela; Dorado-Garcia, Cecilia; Jose Gonzalez-Henriquez, Juan; Sanchis-Moysi, Joaquin			Contribution of Individual and Environmental Factors to Physical Activity Level among Spanish Adults	PLOS ONE			English	Article							NATIONALLY REPRESENTATIVE SAMPLE; SOCIAL-COGNITIVE DETERMINANTS; LEISURE-TIME; OUTCOME EXPECTATIONS; PUBLIC-HEALTH; ACTIVITY RECOMMENDATIONS; ACTIVITY QUESTIONNAIRE; PERCEIVED ENVIRONMENT; EXERCISE FACILITIES; BUILT ENVIRONMENT	Background: Lack of physical activity (PA) is a major risk for chronic disease and obesity. The main aims of the present study were to identify individual and environmental factors independently associated with PA and examine the relative contribution of these factors to PA level in Spanish adults. Methodology/Principal Findings: A population-based cross-sectional sample of 3,000 adults (18-75 years old) from Gran Canaria (Spain) was selected using a multistage stratified random sampling method. The participants were interviewed at home using a validated questionnaire to assess PA as well as individual and environmental factors. The data were analyzed using bivariate and multivariate logistic regression. One demographic variable (education), two cognitive (self-efficacy and perceived barriers), and one social environmental (organized format) were independently associated with PA in both genders. Odds ratios ranged between 1.76-2.07 in men and 1.35-2.50 in women (both p<0.05). Individual and environmental factors explained about one-third of the variance in PA level. Conclusions/Significance: Self-efficacy and perceived barriers were the most significant factors to meet an adequate level of PA. The risk of insufficient PA was twofold greater in men with primary or lesser studies and who are employed. In women, living in rural environments increased the risk of insufficient PA. The promotion of organized PA may be an efficient way to increase the level of PA in the general population. Improvement in the access to sport facilities and places for PA is a prerequisite that may be insufficient and should be combined with strategies to improve self-efficacy and overcome perceived barriers in adulthood.	[Antonio Serrano-Sanchez, Jose; Dorado-Garcia, Cecilia; Sanchis-Moysi, Joaquin] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Lera-Navarro, Angela] Univ A Coruna, Dept Phys Educ, La Coruna, Spain; [Jose Gonzalez-Henriquez, Juan] Univ Las Palmas Gran Canaria, Dept Math, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidade da Coruna; Universidad de Las Palmas de Gran Canaria	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Spain.	jserrano@def.ulpgc.es	González-Henríquez, Juan José jjgh/K-8808-2014; Serrano-Sanchez, Jose A/L-3691-2014; Henríquez, Juan José González/AAZ-7810-2020; Dorado García, Cecilia/ABC-2792-2021; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Dorado Garcia, Cecilia/B-4586-2010	González-Henríquez, Juan José jjgh/0000-0002-0622-5580; Serrano-Sanchez, Jose A/0000-0002-4868-8751; Henríquez, Juan José González/0000-0002-0622-5580; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Dorado Garcia, Cecilia/0000-0001-6616-6810	Government of Gran Canaria [35/03/22034]	Government of Gran Canaria	This study was supported by the Government of Gran Canaria (contract no 35/03/22034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anderson ES, 2006, HEALTH PSYCHOL, V25, P510, DOI 10.1037/0278-6133.25.4.510; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Badland H, 2006, HEALTH PLACE, V12, P538, DOI 10.1016/j.healthplace.2005.08.007; Ball K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-33; Ball K, 2006, J SCI MED SPORT, V9, P367, DOI 10.1016/j.jsams.2006.06.010; Bandura A., 1986, SOCIAL FDN THOUGHT A, DOI DOI 10.4135/9781446221129.N6; Bauman A, 1999, AUST NZ J PUBL HEAL, V23, P322, DOI 10.1111/j.1467-842X.1999.tb01265.x; Bergman P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-367; Bergman P, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-8; Blanchard CM, 2005, INT J OBESITY, V29, P720, DOI 10.1038/sj.ijo.0802927; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; Castro CM, 1999, PSYCHOL HEALTH, V14, P277, DOI 10.1080/08870449908407328; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Cleland VJ, 2010, HEALTH EDUC RES, V25, P268, DOI 10.1093/her/cyn054; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Deforche B, 2000, J SPORT MED PHYS FIT, V40, P362; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Duncan M, 2005, PREV MED, V40, P363, DOI 10.1016/j.ypmed.2004.06.017; Duncan Mitch J, 2005, Int J Behav Nutr Phys Act, V2, P11, DOI 10.1186/1479-5868-2-11; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Eyler AA, 1999, SOC SCI MED, V49, P781, DOI 10.1016/S0277-9536(99)00137-9; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Giles-Corti B, 2002, SOC SCI MED, V54, P1793, DOI 10.1016/S0277-9536(01)00150-2; Giles-Corti B, 2006, J SCI MED SPORT, V9, P357, DOI 10.1016/j.jsams.2006.06.021; Godin G, 1994, ADV EXERCISE ADHEREN, P113; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Handy SL, 1997, ENVIRON PLANN A, V29, P1175, DOI 10.1068/a291175; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; HOSMER DW, 2000, WILEY PS TX, P1; Humpel N, 2004, AM J HEALTH PROMOT, V18, P239, DOI 10.4278/0890-1171-18.3.239; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Leslie E, 1999, PREV MED, V28, P20, DOI 10.1006/pmed.1998.0375; Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046; Margetts BM, 1999, PUBLIC HEALTH NUTR, V2, P97, DOI 10.1017/S1368980099000142; Marquez DX, 2006, J BEHAV MED, V29, P281, DOI 10.1007/s10865-006-9055-6; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; MCAULEY E, 1992, J BEHAV MED, V15, P65, DOI 10.1007/BF00848378; McAuley E, 2010, ARCH PHYS MED REHAB, V91, P100, DOI 10.1016/j.apmr.2009.09.011; McCormack GR, 2009, J PHYS ACT HEALTH, V6, P657, DOI 10.1123/jpah.6.5.657; McNeill LH, 2006, ANN BEHAV MED, V31, P36, DOI 10.1207/s15324796abm3101_7; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Merrill RM, 2004, PERCEPT MOTOR SKILL, V99, P1277, DOI 10.2466/PMS.99.7.1277-1289; Meseguer CM, 2011, REV ESP CARDIOL, V64, P21, DOI [10.1016/j.recesp.2010.07.007, 10.1016/j.rec.2010.06.010]; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Molina-Garcia J, 2010, PREV MED, V51, P136, DOI 10.1016/j.ypmed.2010.05.009; Pan SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-21; Panter J, 2008, PREV MED, V46, P303, DOI 10.1016/j.ypmed.2007.11.005; Pascual C, 2009, HEALTH PLACE, V15, P553, DOI 10.1016/j.healthplace.2008.08.007; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Prodaniuk Tricia R, 2004, Int J Behav Nutr Phys Act, V1, P7, DOI 10.1186/1479-5868-1-7; Reed JA, 2005, J AM COLL HEALTH, V53, P285, DOI 10.3200/JACH.53.6.285-290; Resnick B, 2000, J GERONTOL B-PSYCHOL, V55, pS352, DOI 10.1093/geronb/55.6.S352; Ronda G, 2001, HEALTH PROMOT INT, V16, P305, DOI 10.1093/heapro/16.4.305; Rovniak LS, 2002, ANN BEHAV MED, V24, P149, DOI 10.1207/S15324796ABM2402_12; Rutten A, 2001, J EPIDEMIOL COMMUN H, V55, P139, DOI 10.1136/jech.55.2.139; SALLIS J F, 1988, Health Education Research, V3, P283, DOI 10.1093/her/3.3.283; Sallis J.F., 1997, HLTH BEHAV HLTH ED T, P403; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; SALLIS JF, 1989, PREV MED, V18, P20, DOI 10.1016/0091-7435(89)90051-0; SALLIS JF, 1990, PUBLIC HEALTH REP, V105, P179; Sallis JF., 1999, PHYS ACTIVITY BEHAV, Vvol. 3; Santos R, 2008, PREV MED, V47, P83, DOI 10.1016/j.ypmed.2008.02.027; Serrano-Sanchez JA, 2006, P 4 C SPAN SOC SPORT, P179; Shibata A, 2009, J PHYS ACT HEALTH, V6, P24, DOI 10.1123/jpah.6.1.24; Shibata A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-60; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Taymoori P, 2010, HEALTH EDUC RES, V25, P257, DOI 10.1093/her/cyn051; Troped PJ, 2001, PREV MED, V32, P191, DOI 10.1006/pmed.2000.0788; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Watts P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-128; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; World Health Organization, 2004, GLOB STRAT DIET PHYS; Zunft HJF, 1999, PUBLIC HEALTH NUTR, V2, P153, DOI 10.1017/S1368980099000208	84	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38693	10.1371/journal.pone.0038693	http://dx.doi.org/10.1371/journal.pone.0038693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XO	22685598	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700061
J	Fan, JY; Zhang, YS; Chuang-Smith, ON; Frank, KL; Guenther, BD; Kern, M; Schlievert, PM; Herzberg, MC				Fan, Jingyuan; Zhang, Yongshu; Chuang-Smith, Olivia N.; Frank, Kristi L.; Guenther, Brian D.; Kern, Marissa; Schlievert, Patrick M.; Herzberg, Mark C.			Ecto-5 '-Nucleotidase: A Candidate Virulence Factor in Streptococcus sanguinis Experimental Endocarditis	PLOS ONE			English	Article							ADENOSINE RECEPTOR AGONISTS; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; PLATELET-AGGREGATION; INFECTIVE ENDOCARDITIS; LEISHMANIA-AMAZONENSIS; VIRIDANS STREPTOCOCCI; ENDOTHELIAL-CELLS; HUMAN MONOCYTES; INHIBITS IL-12	Streptococcus sanguinis is the most common cause of infective endocarditis (IE). Since the molecular basis of virulence of this oral commensal bacterium remains unclear, we searched the genome of S. sanguinis for previously unidentified virulence factors. We identified a cell surface ecto-5'-nucleotidase (Nt5e), as a candidate virulence factor. By colorimetric phosphate assay, we showed that S. sanguinis Nt5e can hydrolyze extracellular adenosine triphosphate to generate adenosine. Moreover, a nt5e deletion mutant showed significantly shorter lag time (P<0.05) to onset of platelet aggregation than the wild-type strain, without affecting platelet-bacterial adhesion in vitro (P=0.98). In the absence of nt5e, S. sanguinis caused IE (4 d) in a rabbit model with significantly decreased mass of vegetations (P<0.01) and recovered bacterial loads (log(10)CFU, P=0.01), suggesting that Nt5e contributes to the virulence of S. sanguinis in vivo. As a virulence factor, Nt5e may function by (i) hydrolyzing ATP, a pro-inflammatory molecule, and generating adenosine, an immunosuppressive molecule to inhibit phagocytic monocytes/macrophages associated with valvular vegetations. (ii) Nt5e-mediated inhibition of platelet aggregation could also delay presentation of platelet microbicidal proteins to infecting bacteria on heart valves. Both plausible Nt5e-dependent mechanisms would promote survival of infecting S. sanguinis. In conclusion, we now show for the first time that streptococcal Nt5e modulates S. sanguinis-induced platelet aggregation and may contribute to the virulence of streptococci in experimental IE.	[Fan, Jingyuan; Zhang, Yongshu; Guenther, Brian D.; Kern, Marissa; Herzberg, Mark C.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Chuang-Smith, Olivia N.; Frank, Kristi L.; Schlievert, Patrick M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Herzberg, Mark C.] Minneapolis Vet Affairs Med Ctr, Mucosal & Vaccine Res Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Fan, JY (corresponding author), Univ Rochester, Eastman Inst Oral Hlth, Div Periodontol, Rochester, NY 14627 USA.	mcherzb@umn.edu		Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health/National Institute of Dental and Craniofacial Research [R01DE08590, AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008590] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grants R01DE08590 (MCH) and AI074283 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; CRISTALLI G, 1994, J MED CHEM, V37, P1720, DOI 10.1021/jm00037a024; Davies JR, 2009, MICROBIOL-SGM, V155, P1977, DOI 10.1099/mic.0.027854-0; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; ERICKSON PR, 1990, J BIOL CHEM, V265, P14080; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; GOULD K, 1975, J CLIN INVEST, V56, P1364, DOI 10.1172/JCI108216; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; HERZBERG MC, 1983, INFECT IMMUN, V40, P120, DOI 10.1128/IAI.40.1.120-125.1983; HERZBERG MC, 1983, INFECT IMMUN, V39, P1457, DOI 10.1128/IAI.39.3.1457-1469.1983; HERZBERG MC, 1990, INFECT IMMUN, V58, P515, DOI 10.1128/IAI.58.2.515-522.1990; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; HERZBERG MC, 1993, CRIT REV ORAL BIOL M, V4, P435, DOI 10.1177/10454411930040032501; Imai M, 2000, BIOCHEM BIOPH RES CO, V270, P272, DOI 10.1006/bbrc.2000.2410; Iyu D, 2011, ARTERIOSCL THROM VAS, V31, P416, DOI 10.1161/ATVBAHA.110.219501; Kawashima Y, 2000, BLOOD, V96, P2157; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Ki MR, 2011, J MICROBIOL BIOTECHN, V21, P483, DOI 10.4014/jmb.1101.01017; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; LeMoine O, 1996, J IMMUNOL, V156, P4408; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; MACFARLANE GD, 1994, ORAL MICROBIOL IMMUN, V9, P180, DOI 10.1111/j.1399-302X.1994.tb00056.x; MACRINA FL, 1983, GENE, V25, P145; Meyer MW, 1998, INFECT IMMUN, V66, P5906, DOI 10.1128/IAI.66.12.5906-5914.1998; MEYER MW, 1995, THROMB HAEMOSTASIS, V73, P680; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; SOBERAY AH, 1987, THROMB HAEMOSTASIS, V57, P222; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Veltrop MHAM, 2000, INFECT IMMUN, V68, P4818, DOI 10.1128/IAI.68.8.4818-4821.2000; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yeaman MR, 1999, DRUG RESIST UPDATE, V2, P116, DOI 10.1054/drup.1999.0069; Yeaman MR, 1997, INFECT IMMUN, V65, P1023, DOI 10.1128/IAI.65.3.1023-1031.1997; YEAMAN MR, 1994, INFECT IMMUN, V62, P3416, DOI 10.1128/IAI.62.8.3416-3423.1994; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yeaman MR, 1997, CLIN INFECT DIS, V25, P969; Yokota M, 2001, MICROBIOL IMMUNOL, V45, P699, DOI 10.1111/j.1348-0421.2001.tb01304.x; Zhang YS, 2004, INFECT IMMUN, V72, P3489, DOI 10.1128/IAI.72.6.3489-3494.2004; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	52	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38059	10.1371/journal.pone.0038059	http://dx.doi.org/10.1371/journal.pone.0038059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685551	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700014
J	Khan, AA; Rodriguez, A; Sebert, S; Kaakinen, M; Cauchi, S; Froguel, P; Hartikainen, AL; Pouta, A; Jarvelin, MR				Khan, Anokhi Ali; Rodriguez, Alina; Sebert, Sylvain; Kaakinen, Marika; Cauchi, Stephane; Froguel, Philippe; Hartikainen, Anna-Liisa; Pouta, Anneli; Jarvelin, Marjo-Riitta			The Interplay of Variants Near LEKR and CCNL1 and Social Stress in Relation to Birth Size	PLOS ONE			English	Article							PERINATAL OUTCOMES; WEIGHT; GROWTH	Background: We previously identified via a genome wide association study variants near LEKR and CCNL1 and in the ADCY5 genes lead to lower birthweight. Here, we study the impact of these variants and social stress during pregnancy, defined as social adversity and neighborhood disparity, on infant birth size. We aimed to determine whether the addition of genetic variance magnified the observed associations. Methodology/Principal Findings: We analyzed data from the Northern Finland Birth Cohort 1986 (n = 5369). Social adversity was defined by young maternal age (<20 years), low maternal education (<11 years), and/or single marital status. Neighborhood social disparity was assessed by discrepancy between neighborhoods relative to personal socio-economic status. These variables are indicative of social and socioeconomic stress, but also of biological risk. The adjusted multiple regression analysis showed smaller birth size in both infants of mothers who experienced social adversity (birthweight by -40.4 g, 95% CI -61.4, -19.5; birth length -0.14 cm, 95% CI -0.23, -0.05; head circumference -0.09 cm 95% CI -0.15, -0.02) and neighborhood disparity (birthweight -28.8 g, 95% CI -47.7, -10.0; birth length -0.12 cm, 95% CI -0.20, -0.05). The birthweight-lowering risk allele (SNP rs900400 near LEKR and CCNL1) magnified this association in an additive manner. However, likely due to sample size restriction, this association was not significant for the SNP rs9883204 in ADCY5. Birth size difference due to social stress was greater in the presence of birthweight-lowering alleles. Conclusions/Significance: Social adversity, neighborhood disparity, and genetic variants have independent associations with infant birth size in the mutually adjusted analyses. If the newborn carried a risk allele rs900400 near LEKR/CCNL1, the impact of stress on birth size was stronger. These observations give support to the hypothesis that individuals with genetic or other biological risk are more vulnerable to environmental influences. Our study indicates the need for further research to understand the mechanisms by which genes impact individual vulnerability to environmental insults.	[Khan, Anokhi Ali; Rodriguez, Alina; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, Hlth Protect Agcy, Med Res Council,Dept Epidemiol & Biostat, London, England; [Rodriguez, Alina] Kings Coll London, Social Genet Dev Psychiat Ctr, Med Res Council, London, England; [Rodriguez, Alina] Mid Sweden Univ, Dept Social Sci Psychol, Ostersund, Sweden; [Sebert, Sylvain; Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Cauchi, Stephane; Froguel, Philippe] Univ Lille 2, Inst Pasteur, Inst Biol Lille, Ctr Natl Rech Sci,Unites Mixte Rech 8199, F-59800 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland	Health Protection Agency; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; Mid-Sweden University; University of Oulu; University of Oulu; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; University of Oulu; Finland National Institute for Health & Welfare	Khan, AA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, Hlth Protect Agcy, Med Res Council,Dept Epidemiol & Biostat, London, England.	m.jarvelin@imperial.ac.uk	Fazli, Ghazal/AAE-8320-2022; Rodriguez, Alina/B-3541-2015; FROGUEL, Philippe/O-6799-2017	Rodriguez, Alina/0000-0003-1209-8802; FROGUEL, Philippe/0000-0003-2972-0784; Kaakinen, Marika/0000-0002-9228-0462; Sebert, Sylvain/0000-0001-6681-6983; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Ali Khan, Anokhi/0000-0003-3671-4550	Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter; University of Oulu, Finland [75617]; European Commission (EURO-BLCS, Framework 5 award) [QLG1-CT-2000-01643]; Medical Research Council, UK [G0500539, G0600705]; Biocentrum Helsinki; VINNMER [P32925-1]; FAS; French Government (Agence Nationale de la Recherche); French Region of Nord Pas De Calais; Programme Hospitalier de Recherche Clinique (French Ministry of Health); Association Francaise des Diabetiques; Programme National de Recherche sur le Diabete; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Divisional Grant Imperial College London [G24038];  [HEALTH-F4-2007-201413]; MRC [G0600705] Funding Source: UKRI	Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu, Biocenter; University of Oulu, Finland; European Commission (EURO-BLCS, Framework 5 award); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biocentrum Helsinki; VINNMER; FAS; French Government (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French Region of Nord Pas De Calais(Region Hauts-de-France); Programme Hospitalier de Recherche Clinique (French Ministry of Health); Association Francaise des Diabetiques; Programme National de Recherche sur le Diabete; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Divisional Grant Imperial College London; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was received from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE). ENGAGE project and grant agreement HEALTH-F4-2007-201413. The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. Dr Rodriguez received support partly from VINNMER (P32925-1) and FAS. Part of this work was conducted while Dr Rodriguez was at Uppsala University, Sweden. This work was in part supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets Etat-Region), Programme Hospitalier de Recherche Clinique (French Ministry of Health), and the following charities: Association Francaise des Diabetiques, Programme National de Recherche sur le Diabete, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques. Ali Khan was funded via Divisional Grant Imperial College London [G24038]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; Andersson EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027096; Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Auger N, 2008, J EPIDEMIOL COMMUN H, V62, P402, DOI 10.1136/jech.2007.064535; Avison WR, 1997, CAN MED ASSOC J, V156, P661; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2; Bird ST, 2000, FAM PLANN PERSPECT, V32, P281, DOI 10.2307/2648196; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; Briggs MM, 2007, J OBSTET GYNAECOL CA, V29, P546, DOI 10.1016/S1701-2163(16)32506-3; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Chadio SE, 2007, J ENDOCRINOL, V192, P495, DOI 10.1677/JOE-06-0172; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Chandra PC, 2002, INT J GYNECOL OBSTET, V79, P117, DOI 10.1016/S0020-7292(02)00240-0; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; COTTERRELL M, 1972, J NEUROCHEM, V19, P2151, DOI 10.1111/j.1471-4159.1972.tb05124.x; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; Engel SM, 2005, PAEDIATR PERINAT EP, V19, P334, DOI 10.1111/j.1365-3016.2005.00676.x; Englert RC, 2008, BIOL PSYCHOL, V77, P32, DOI 10.1016/j.biopsycho.2007.08.011; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Fairley L, 2006, J EPIDEMIOL COMMUN H, V60, P31, DOI 10.1136/jech.2005.038380; Fiocco AJ, 2007, PSYCHONEUROENDOCRINO, V32, P1158, DOI 10.1016/j.psyneuen.2007.08.008; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Glover V, 2009, PSYCHONEUROENDOCRINO, V34, P430, DOI 10.1016/j.psyneuen.2008.10.005; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gudmundsson S, 1997, ACTA OBSTET GYN SCAN, V76, P318, DOI 10.1111/j.1600-0412.1997.tb07985.x; Haldre K, 2007, EUR J OBSTET GYN R B, V131, P45, DOI 10.1016/j.ejogrb.2006.05.002; Halileh S, 2008, MATERN CHILD HLTH J, V12, P606, DOI 10.1007/s10995-007-0226-z; Hansen AM, 2009, BASIC CLIN PHARMACOL, V105, P73, DOI 10.1111/j.1742-7843.2009.00444.x; Harville EW, 2008, ULTRASOUND OBST GYN, V32, P23, DOI 10.1002/uog.5344; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Holt V, 2003, PAEDIAT PERINATAL S, VS1, P31; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Kongnyuy EJ, 2008, MATERN CHILD HLTH J, V12, P149, DOI 10.1007/s10995-007-0235-y; Koubovec D, 2005, Curr Psychiatry Rep, V7, P274, DOI 10.1007/s11920-005-0081-9; KOUTA-database (koulun tilastoaineisto), 1993, KOUTA DAT; Law CM, 1996, J HYPERTENS, V14, P935; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; Luo ZC, 2004, OBSTET GYNECOLOGY, V6; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; Miech R, 2007, ANN EPIDEMIOL, V17, P289, DOI 10.1016/j.annepidem.2006.07.015; Mollborn S, 2009, J HEALTH SOC BEHAV, V50, P310, DOI 10.1177/002214650905000305; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Mortensen LH, 2008, J EPIDEMIOL COMMUN H, V62, P325, DOI 10.1136/jech.2007.061473; Moss TJM, 2005, AM J OBSTET GYNECOL, V192, P146, DOI 10.1016/j.ajog.2004.06.065; Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Pearl M, 2001, AM J PUBLIC HEALTH, V91, P1808, DOI 10.2105/AJPH.91.11.1808; Peterson J, 2006, EARLY HUM DEV, V82, P325, DOI 10.1016/j.earlhumdev.2005.09.014; Raatikainen K, 2005, BJOG-INT J OBSTET GY, V112, P1411, DOI 10.1111/j.1471-0528.2005.00667.x; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rodriguez A, 2009, J CHILD PSYCHOL PSYC, V50, P1073, DOI 10.1111/j.1469-7610.2009.02071.x; Salzman BE, 2006, PRIMARY CARE, V33, P1, DOI 10.1016/j.pop.2005.11.014; Sawchuk LA, 1997, J ADOLESCENT HEALTH, V21, P259, DOI 10.1016/S1054-139X(97)00114-6; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; Sellstrom E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-267; SHOHAMYAKUBOVICH I, 1988, INT J EPIDEMIOL, V17, P370, DOI 10.1093/ije/17.2.370; STROBINO DM, 1995, AM J EPIDEMIOL, V142, P504, DOI 10.1093/oxfordjournals.aje.a117668; Sundquist J, 2011, ARCH DIS CHILD, V96, P380, DOI 10.1136/adc.2009.180042; Tapia-Rombo CA, 2001, ARCH MED RES, V32, P304, DOI 10.1016/S0188-4409(01)00281-8; Torres-Arreola LP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-20; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; Vik T, 1996, ARCH DIS CHILD, V1, p33F	73	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38216	10.1371/journal.pone.0038216	http://dx.doi.org/10.1371/journal.pone.0038216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685556	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305351700019
J	Love, KR; Politano, TJ; Panagiotou, V; Jiang, B; Stadheim, TA; Love, JC				Love, Kerry Routenberg; Politano, Timothy J.; Panagiotou, Vasiliki; Jiang, Bo; Stadheim, Terrance A.; Love, J. Christopher			Systematic Single-Cell Analysis of Pichia pastoris Reveals Secretory Capacity Limits Productivity	PLOS ONE			English	Article							PROTEIN EXPRESSION; GENE DOSAGE; SELECTION; SEQUENCE; NOISE	Biopharmaceuticals represent the fastest growing sector of the global pharmaceutical industry. Cost-efficient production of these biologic drugs requires a robust host organism for generating high titers of protein during fermentation. Understanding key cellular processes that limit protein production and secretion is, therefore, essential for rational strain engineering. Here, with single-cell resolution, we systematically analysed the productivity of a series of Pichia pastoris strains that produce different proteins both constitutively and inducibly. We characterized each strain by qPCR, RT-qPCR, microengraving, and imaging cytometry. We then developed a simple mathematical model describing the flux of folded protein through the ER. This combination of single-cell measurements and computational modelling shows that protein trafficking through the secretory machinery is often the rate-limiting step in single-cell production, and strategies to enhance the overall capacity of protein secretion within hosts for the production of heterologous proteins may improve productivity.	[Love, Kerry Routenberg; Politano, Timothy J.; Panagiotou, Vasiliki; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, Dept Chem Engn, Cambridge, MA USA; [Jiang, Bo; Stadheim, Terrance A.] GlycoFi, Lebanon, NH USA	Massachusetts Institute of Technology (MIT)	Love, KR (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Chem Engn, Cambridge, MA USA.	clove@mit.edu			Merck Co.; Merck	Merck Co.(Merck & Company); Merck(Merck & Company)	This study was funded by Merck & Co. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was funded by Merck. BJ and TAS are paid employees of GlycoFi, a wholly-owned subsidiary of Merck & Co. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abad S, 2010, BIOTECHNOL J, V5, P413, DOI 10.1002/biot.200900233; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Claeyssens S, 2003, AM J PHYSIOL-GASTR L, V285, pG840, DOI 10.1152/ajpgi.00060.2003; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Farid SS, 2007, J CHROMATOGR B, V848, P8, DOI 10.1016/j.jchromb.2006.07.037; Gasser B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-179; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gasser B, 2006, BIOTECHNOL BIOENG, V94, P353, DOI 10.1002/bit.20851; Goodman M, 2009, NAT REV DRUG DISCOV, V8, P837, DOI 10.1038/nrd3040; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Harding HP, 1999, NATURE, V398, P90, DOI 10.1038/18057; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hohenblum H, 2004, BIOTECHNOL BIOENG, V85, P367, DOI 10.1002/bit.10904; Inan M, 2006, BIOTECHNOL BIOENG, V93, P771, DOI 10.1002/bit.20762; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Klabunde J, 2007, FEMS YEAST RES, V7, P1168, DOI 10.1111/j.1567-1364.2007.00271.x; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Lorsch JR, 1999, EMBO J, V18, P6705, DOI 10.1093/emboj/18.23.6705; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Love KR, 2010, BIOTECHNOL BIOENG, V106, P319, DOI 10.1002/bit.22688; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mattanovich D., 2009, MICROBIAL CELL FACTO, V8; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Papanikou E, 2009, FEBS LETT, V583, P3746, DOI 10.1016/j.febslet.2009.10.072; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Pomerening JR, 2008, CURR OPIN BIOTECH, V19, P381, DOI 10.1016/j.copbio.2008.06.009; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Resina D, 2007, MICROBIAL CELL FACTO, P6; Sheridan C, 2010, NAT BIOTECHNOL, V28, P307, DOI 10.1038/nbt0410-307; Stadlmayr G, 2010, BIOTECHNOL BIOENG, V105, P543, DOI 10.1002/bit.22573; Sumi A, 1999, BIOSEPARATION, V8, P195, DOI 10.1023/A:1008081314112; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vinci F, 2004, J BIOL CHEM, V279, P15059, DOI 10.1074/jbc.M311480200; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x	51	51	52	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37915	10.1371/journal.pone.0037915	http://dx.doi.org/10.1371/journal.pone.0037915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685548	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700011
J	Wu, Y; Lu, WL; Lin, W; Leng, G; Feng, JF				Wu, Yu; Lu, Wenlian; Lin, Wei; Leng, Gareth; Feng, Jianfeng			Bifurcations of Emergent Bursting in a Neuronal Network	PLOS ONE			English	Article							NEURAL OSCILLATIONS; SPIKING NEURONS; THETA RHYTHM; SYNCHRONIZATION; INHIBITION; MECHANISM; DYNAMICS; METASTABILITY; ASSEMBLIES; CHAINS	Complex neuronal networks are an important tool to help explain paradoxical phenomena observed in biological recordings. Here we present a general approach to mathematically tackle a complex neuronal network so that we can fully understand the underlying mechanisms. Using a previously developed network model of the milk-ejection reflex in oxytocin cells, we show how we can reduce a complex model with many variables and complex network topologies to a tractable model with two variables, while retaining all key qualitative features of the original model. The approach enables us to uncover how emergent synchronous bursting can arise from a neuronal network which embodies known biological features. Surprisingly, the bursting mechanisms are similar to those found in other systems reported in the literature, and illustrate a generic way to exhibit emergent and multiple time scale oscillations at the membrane potential level and the firing rate level.	[Wu, Yu; Lu, Wenlian; Lin, Wei; Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Wu, Yu; Lu, Wenlian; Lin, Wei; Feng, Jianfeng] Fudan Univ, Sch Math Sci, Shanghai 200433, Peoples R China; [Lu, Wenlian; Lin, Wei] Fudan Univ, Key Lab Math Nonlinear Sci, Shanghai 200433, Peoples R China; [Lu, Wenlian; Lin, Wei] Minist Educ China, Shanghai, Peoples R China; [Leng, Gareth] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Wu, Yu; Lu, Wenlian; Feng, Jianfeng] Univ Warwick, Ctr Comp Sci, Coventry CV4 7AL, W Midlands, England; [Wu, Yu; Lu, Wenlian; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	Fudan University; Fudan University; Fudan University; Ministry of Education, China; University of Edinburgh; University of Warwick; University of Warwick	Wu, Y (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	jffeng@fudan.edu.cn	Lin, Wei/C-9640-2011; Leng, Gareth/C-6688-2011	Lin, Wei/0000-0002-1863-4306; Leng, Gareth/0000-0002-2388-8466; feng, jianfeng/0000-0002-9328-5732	China Scholarship Council (CSC); European Commission [FP7-PEOPLE-2011-IIF-302421]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [200921]; Shanghai Rising-Star Program [11QA1400400]; Shanghai Guidance of Science and Technology (SGST) [09DZ2272900]; NSF of China [10971035]; Talent Programs [10SG02, NCET-11-0109, 11QH1400200]; Wellcome Trust; Royal Society; EU; UK EPSRC; National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences	China Scholarship Council (CSC)(China Scholarship Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Rising-Star Program; Shanghai Guidance of Science and Technology (SGST); NSF of China(National Natural Science Foundation of China (NSFC)); Talent Programs; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); EU(European Commission); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences	YW was supported by the China Scholarship Council (CSC). WLL (Wenlian Lu) was jointly supported by the Marie Curie International Incoming Fellowship from the European Commission (FP7-PEOPLE-2011-IIF-302421), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 200921), the Shanghai Rising-Star Program (No. 11QA1400400), and the Shanghai Guidance of Science and Technology (SGST) (No. 09DZ2272900). WL (Wei Lin) was supported by the NSF of China (No. 10971035) and the Talent Programs (Nos. 10SG02, NCET-11-0109 and 11QH1400200). GL was supported by the Wellcome Trust. JF is a Royal Society Wolfson Research Merit Award holder, partially supported by a EU Grant BION, a UK EPSRC grant and National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund N, 2007, NONLINEARITY, V20, P2551, DOI 10.1088/0951-7715/20/11/006; BERTRAM R, 1995, B MATH BIOL, V57, P413, DOI 10.1007/BF02460633; BERTRAM R, 1994, BIOL CYBERN, V70, P359, DOI 10.1007/BF00200333; Bertram R, 2008, B MATH BIOL, V70, P1979, DOI 10.1007/s11538-008-9335-0; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Buzsaki G., 2006, RHYTHMS BRAIN; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Ermentrout B, 2003, NEURAL COMPUT, V15, P2483, DOI 10.1162/089976603322385054; ERMENTROUT GB, 1984, SIAM J APPL MATH, V44, P80, DOI 10.1137/0144007; Ermentrout GB, 2002, PHYSIOL BEHAV, V77, P629, DOI 10.1016/S0031-9384(02)00898-3; Feng J, 2010, FRONTIERS COMPUTATIO; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Kuznetsov, 2013, ELEMENTS APPL BIFURC; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Medvedev GS, 2001, SIAM J APPL MATH, V61, P1762, DOI 10.1137/S0036139900368807; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Olypher AV, 2010, J COMPUT NEUROSCI, V28, P361, DOI 10.1007/s10827-010-0213-z; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Shilnikov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048101; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Smerieri A, 2010, J NEUROSCI, V30, P14173, DOI 10.1523/JNEUROSCI.0945-10.2010; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tabak J, 2010, J NEUROPHYSIOL, V103, P2208, DOI 10.1152/jn.00857.2009; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, COMMUNICATION; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vladimirski BB, 2008, J COMPUT NEUROSCI, V25, P39, DOI 10.1007/s10827-007-0064-4; Wang XJ, 1996, J NEUROSCI, V16, P6402; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Zhang X, PLOS ONE IN PRESS	40	47	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38402	10.1371/journal.pone.0038402	http://dx.doi.org/10.1371/journal.pone.0038402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685566	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700029
J	Burrell, K; Hill, RP; Zadeh, G				Burrell, Kelly; Hill, Richard P.; Zadeh, Gelareh			High-Resolution In-Vivo Analysis of Normal Brain Response to Cranial Irradiation	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL PROGENITOR CELLS; BLOOD PARTITION-COEFFICIENT; MARROW STROMAL CELLS; UMBILICAL-CORD BLOOD; ADULT BONE-MARROW; STEM-CELLS; SPINAL-CORD; INTRACEREBRAL TRANSPLANTATION	Radiation therapy (RT) is a widely accepted treatment strategy for many central nervous system (CNS) pathologies. However, despite recognized therapeutic success, significant negative consequences are associated with cranial irradiation (CR), which manifests months to years post-RT. The pathophysiology and molecular alterations that culminate in the long-term detrimental effects of CR are poorly understood, though it is thought that endothelial injury plays a pivotal role in triggering cranial injury. We therefore explored the contribution of bone marrow derived cells (BMDCs) in their capacity to repair and contribute to neo-vascularization following CR. Using high-resolution in vivo optical imaging we have studied, at single-cell resolution, the spatio-temporal response of BMDCs in normal brain following CR. We demonstrate that BMDCs are recruited specifically to the site of CR, in a radiation dose and temporal-spatial manner. We establish that BMDCs do not form endothelial cells but rather they differentiate predominantly into inflammatory cells and microglia. Most notably we provide evidence that more than 50% of the microglia in the irradiated region of the brain are not resident microglia but recruited from the bone marrow following CR. These results have invaluable therapeutic implications as BMDCs may be a primary therapeutic target to block acute and long-term inflammatory response following CR. Identifying the critical steps involved in the sustained recruitment and differentiation of BMDCs into microglia at the site of CR can provide new insights into the mechanisms of injury following CR offering potential therapeutic strategies to counteract the long-term adverse effects of CR.	[Burrell, Kelly] SickKids Res Inst, Brain Tumor Res Ctr, Toronto, ON, Canada; [Hill, Richard P.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Hill, Richard P.] Univ Hlth Network, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Hill, Richard P.; Zadeh, Gelareh] Univ Toronto, Toronto, ON, Canada; [Zadeh, Gelareh] Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Burrell, K (corresponding author), SickKids Res Inst, Brain Tumor Res Ctr, Toronto, ON, Canada.	Gelareh.zadeh@uhn.on.ca		Hill, Richard Peter/0000-0001-5331-8045	Canadian Institute of Health Research; Sickkids funding group b.r.a.i.n.child	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Sickkids funding group b.r.a.i.n.child	Funding for this work was provided by Canadian Institute of Health Research funding body and the Sickkids funding group b.r.a.i.n.child. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, MOL THER, V12, P994, DOI 10.1016/j.ymthe.2005.07.693; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; [Anonymous], 2010, NAT MED, V16, P1380; Asahara T, 1999, CIRCULATION; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Brush J, 2007, SEMIN RADIAT ONCOL, V17, P121, DOI 10.1016/j.semradonc.2006.11.008; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davoust N, 2008, TRENDS IMMUNOL, V29, P227, DOI 10.1016/j.it.2008.01.010; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Elkabes S, 1996, J NEUROSCI, V16, P2508; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Gaber MW, 2003, INT J RADIAT BIOL, V79, P359, DOI 10.1080/0955300031000114738; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gaspar LE, 2010, J NEURO-ONCOL, V96, P17, DOI 10.1007/s11060-009-0060-9; Gondi V, 2010, CURR OPIN NEUROL, V23, P556, DOI 10.1097/WCO.0b013e32833f8cb5; HaimovitzFriedman A, 1997, STEM CELLS, V15, P43; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Hong JH, 2003, INT J RADIAT BIOL, V79, P159, DOI 10.1080/0955300031000076894; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Le Bourhis X, 2010, BREAST CANCER RES TR, V120, P17, DOI 10.1007/s10549-009-0686-5; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P1821, DOI 10.1038/jcbfm.2010.160; Li YQ, 2003, CANCER RES, V63, P5950; Li YQ, 1996, CANCER RES, V56, P5417; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; MYERS R, 1986, BRIT J CANCER, V53, P221; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rivest Serge, 2011, Expert Rev Neurother, V11, P783, DOI 10.1586/ern.11.64; Rotolo JA, 2009, BLOOD, V114, P3693, DOI 10.1182/blood-2008-11-191148; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Siegal T, 1996, INT J RADIAT ONCOL, V36, P649, DOI 10.1016/S0360-3016(96)00357-4; Simard AR, 2006, MOL PSYCHIATR, V11, P327, DOI 10.1038/sj.mp.4001809; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sun YP, 2004, MAGN RESON MED, V51, P893, DOI 10.1002/mrm.20029; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; VANDERKOGEL AJ, 1986, BRIT J CANCER, V53, P207; Zhang HR, 2009, J NEURO-ONCOL, V93, P165, DOI 10.1007/s11060-008-9757-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	65	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38366	10.1371/journal.pone.0038366	http://dx.doi.org/10.1371/journal.pone.0038366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675549	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700063
J	Musel, B; Chauvin, A; Guyader, N; Chokron, S; Peyrin, C				Musel, Benoit; Chauvin, Alan; Guyader, Nathalie; Chokron, Sylvie; Peyrin, Carole			Is Coarse-to-Fine Strategy Sensitive to Normal Aging?	PLOS ONE			English	Article							SPATIAL-FREQUENCY CHANNELS; AGE-RELATED MACULOPATHY; DEVELOPMENTAL-CHANGES; GLOBAL PRECEDENCE; HOME-ENVIRONMENT; SCENE; INFORMATION; PERCEPTION; CATEGORIZATION; CELLS	Theories on visual perception agree that visual recognition begins with global analysis and ends with detailed analysis. Different results from neurophysiological, computational, and behavioral studies all indicate that the totality of visual information is not immediately conveyed, but that information analysis follows a predominantly coarse-to-fine processing sequence (low spatial frequencies are extracted first, followed by high spatial frequencies). We tested whether such processing continues to occur in normally aging subjects. Young and aged participants performed a categorization task (indoor vs. outdoor scenes), using dynamic natural scene stimuli, in which they resorted to either a coarse-to-fine (CtF) sequence or a reverse fine-to-coarse sequence (FtC). The results show that young participants categorized CtF sequences more quickly than FtC sequences. However, sequence processing interacts with semantic category only for aged participants. The present data support the notion that CtF categorization is effective even in aged participants, but is constrained by the spatial features of the scenes, thus highlighting new perspectives in visual models.	[Musel, Benoit; Chauvin, Alan; Peyrin, Carole] Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & Neurocognit, Grenoble, France; [Guyader, Nathalie] CNRS, UMR 5216, GIPSA Lab, Grenoble, France; [Chokron, Sylvie] Fdn Ophtalmol Rothschild, Unite Fonct Vis & Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Musel, B (corresponding author), Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & Neurocognit, Grenoble, France.	benoit.musel@upmf-grenoble.fr	Chauvin, Alan/AAJ-8531-2020; Chauvin, Alan/D-2731-2012	Chauvin, Alan/0000-0002-6498-2766; Chauvin, Alan/0000-0002-6498-2766; Peyrin, Carole/0000-0001-7792-092X	Region Rhone-Alpes	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by Region Rhone-Alpes. We thank Catherine Dal Molin for the English revision of the manuscript.	BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bruyer R, 2000, EXP AGING RES, V26, P285, DOI 10.1080/036107300750015705; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; DINEEN JT, 1980, DEV PSYCHOBIOL, V13, P123, DOI 10.1002/dev.420130204; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GINSBURG AP, 1986, HDB PERCEPTION HUMAN, V2, P1; GORKANI MM, 1994, INT C PATT RECOG, P459, DOI 10.1109/ICPR.1994.576325; Gosselin F, 2002, TRENDS COGN SCI, V6, P70, DOI 10.1016/S1364-6613(00)01838-6; Guerin-Dugue A, 2000, PATTERN RECOGN LETT, V21, P1135, DOI 10.1016/S0167-8655(00)00074-X; Guyader N, 2004, CR BIOL, V327, P313, DOI 10.1016/j.crvi.2004.02.006; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Herault J., 1997, 5th European Symposium on Artificial Neural Networks ESANN '97. Proceedings, P91; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; KENNEDY H, 1985, J NEUROSCI, V5, P2815; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; LAMB MR, 1993, PERCEPT PSYCHOPHYS, V54, P773, DOI 10.3758/BF03211802; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Lux S, 2008, CORTEX, V44, P21, DOI 10.1016/j.cortex.2005.08.001; Mayer, 1999, BERLIN AGING STUDY A, P384; Mermillod Martial, 2005, Brain Cogn, V57, P151, DOI 10.1016/j.bandc.2004.08.035; Musel B, 2011, VISUAL NEUROSCI, V28, P529, DOI 10.1017/S0952523811000435; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Oken BS, 1999, J GERIATR PSYCH NEUR, V12, P76, DOI 10.1177/089198879901200207; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; PARKER DM, 1992, PERCEPTION, V21, P147, DOI 10.1068/p210147; Parker DM, 1996, J EXP PSYCHOL HUMAN, V22, P1448, DOI 10.1037/0096-1523.22.6.1448; Parker DM, 1999, CURR PSYCHOL, V18, P118, DOI 10.1007/s12144-999-1021-3; Parker DM, 1997, PERCEPTION, V26, P1169, DOI 10.1068/p261169; Peyrin C, 2005, NEUROIMAGE, V28, P464, DOI 10.1016/j.neuroimage.2005.06.006; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; POGGIO GF, 1972, INVEST OPHTH VISUAL, V11, P368; Poirel N, 2008, DEV PSYCHOL, V44, P245, DOI 10.1037/0012-1649.44.1.245; Poirel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020879; Renforth P., 2004, AUSTR OCCUPATIONAL T, V67, P488; Renninger LW, 2004, VISION RES, V44, P2301, DOI 10.1016/j.visres.2004.04.006; Roux F, 2001, BRAIN COGNITION, V46, P383, DOI 10.1006/brcg.2001.1296; Rubenstein LZ, 1999, J AM GERIATR SOC, V47, P111, DOI 10.1111/j.1532-5415.1999.tb01911.x; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Shams L, 2002, VISION RES, V42, P2547, DOI 10.1016/S0042-6989(02)00202-X; SHULMAN GL, 1986, PERCEPTION, V15, P259, DOI 10.1068/p150259; Stark S, 2001, DISABIL SOC, V16, P37, DOI 10.1080/713662037; Staudinger MR, 2011, CORTEX, V47, P854, DOI 10.1016/j.cortex.2010.08.001; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; Van Essen David C., 1995, P383; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057	55	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38493	10.1371/journal.pone.0038493	http://dx.doi.org/10.1371/journal.pone.0038493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675568	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700080
J	Ping, LY; Mavridou, DAI; Emberly, E; Westermann, M; Ferguson, SJ				Ping, Liyan; Mavridou, Despoina A. I.; Emberly, Eldon; Westermann, Martin; Ferguson, Stuart J.			Vital Dye Reaction and Granule Localization in Periplasm of Escherichia coli	PLOS ONE			English	Article							5-CYANO-2,3-DITOLYL TETRAZOLIUM CHLORIDE; GREEN FLUORESCENT PROTEIN; SUBCELLULAR-LOCALIZATION; ELECTRON-TRANSPORT; CELLULAR REDUCTION; CRYSTAL-STRUCTURE; CELLS; BACTERIA; SYSTEM; MTT	Background: Tetrazolium salts are widely used in biology as indicators of metabolic activity - hence termed vital dyes - but their reduction site is still debated despite decades of intensive research. The prototype, 2,3,5-triphenyl tetrazolium chloride, which was first synthesized a century ago, often generates a single formazan granule at the old pole of Escherichia coli cells after reduction. So far, no explanation for their pole localization has been proposed. Method/Principal Findings: Here we provide evidence that the granules form in the periplasm of bacterial cells. A source of reducing power is deduced to be thiol groups destined to become disulfides, since deletion of dsbA, coding for thiol-oxidase, enhances the formation of reduced formazan. However, pervasive reduction did not result in a random distribution of formazan aggregates. In filamentous cells, large granules appear at regular intervals of about four normal cell-lengths, consistent with a diffusion-to-capture model. Computer simulations of a minimal biophysical model showed that the pole localization of granules is a spontaneous process, i.e. small granules in a normal size bacterium have lower energy at the poles. This biased their diffusion to the poles. They kept growing there and eventually became fixed. Conclusions: We observed that formazan granules formed in the periplasm after reduction of tetrazolium, which calls for re-evaluation of previous studies using cell-free systems that liberate inaccessible intracellular reductant and potentially generate artifacts. The localization of formazan granules in E. coli cells can now be understood. In living bacteria, the seeds formed at or migrated to the new pole would become visible only when that new pole already became an old pole, because of the relatively slow growth rate of granules relative to cell division.	[Ping, Liyan] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Mavridou, Despoina A. I.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Emberly, Eldon] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Westermann, Martin] Univ Jena, Ctr Electron Microscopy, Univ Hosp, Jena, Germany	Max Planck Society; University of Oxford; Simon Fraser University; Friedrich Schiller University of Jena	Ping, LY (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	lping@ice.mpg.de; eemberly@sfu.ca; stuart.ferguson@bioch.ox.ac.uk	Mavridou, Despoina/ABG-5940-2020; Karamati, Rezaei/C-3197-2009	Mavridou, Despoina/0000-0002-7449-1151; Karamati, Rezaei/0000-0002-6052-9753	NSERC; Canadian Institute for Advanced Research (CIFAR); Wellcome Trust [092532]; Max-Planck Society	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Wellcome Trust(Wellcome TrustEuropean Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by NSERC and the Canadian Institute for Advanced Research (CIFAR), the Wellcome Trust (grant number 092532) and the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F. M., 1988, CURRENT PROTOCOLS MO; BARNES EM, 1956, J GEN MICROBIOL, V14, P57, DOI 10.1099/00221287-14-1-57; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1995, P NATL ACAD SCI USA, V92, P477, DOI 10.1073/pnas.92.2.477; Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Bernas T, 1999, BBA-MOL CELL RES, V1451, P73, DOI 10.1016/S0167-4889(99)00071-3; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; CURRIER HB, 1954, SCIENCE, V119, P817, DOI 10.1126/science.119.3101.817; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Johno H, 2010, APPL BIOCHEM BIOTECH, V162, P1529, DOI 10.1007/s12010-010-8934-z; KAPRELYANTS AS, 1993, APPL ENVIRON MICROB, V59, P3187, DOI 10.1128/AEM.59.10.3187-3196.1993; LEDERBERG J, 1948, J BACTERIOL, V56, P695, DOI 10.1128/JB.56.5.695-695.1948; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; MADDOCK JR, 1993, J BACTERIOL, V175, P7125, DOI 10.1128/JB.175.22.7125-7129.1993; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; PERIANIN A, 1984, CLIN EXP IMMUNOL, V57, P244; Ping LY, 2008, MOL MICROBIOL, V69, P1427, DOI 10.1111/j.1365-2958.2008.06372.x; Ping LY, 2010, J MOL BIOL, V397, P906, DOI 10.1016/j.jmb.2010.02.008; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Prisco U, 2005, J R SOC INTERFACE, V2, P169, DOI 10.1098/rsif.2005.0032; Ramamurthi KS, 2009, P NATL ACAD SCI US; ROBERTS LW, 1951, SCIENCE, V113, P692, DOI 10.1126/science.113.2946.692; ROBERTS LW, 1955, STAIN TECHNOL, V30, P291, DOI 10.3109/10520295509114481; Saberi S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000986; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; SCHAULE G, 1993, APPL ENVIRON MICROB, V59, P3850, DOI 10.1128/AEM.59.11.3850-3857.1993; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Smith JJ, 1997, J MICROBIOL METH, V29, P161, DOI 10.1016/S0167-7012(97)00036-5; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; THRONEBERRY GO, 1953, SCIENCE, V117, P13, DOI 10.1126/science.117.3027.13-a; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218101; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412	51	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38427	10.1371/journal.pone.0038427	http://dx.doi.org/10.1371/journal.pone.0038427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675561	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700073
J	Wildsmith, KR; Basak, JM; Patterson, BW; Pyatkivskyy, Y; Kim, J; Yarasheski, KE; Wang, JX; Mawuenyega, KG; Jiang, H; Parsadanian, M; Yoon, H; Kasten, T; Sigurdson, WC; Xiong, CJ; Goate, A; Holtzman, DM; Bateman, RJ				Wildsmith, Kristin R.; Basak, Jacob M.; Patterson, Bruce W.; Pyatkivskyy, Yuriy; Kim, Jungsu; Yarasheski, Kevin E.; Wang, Jennifer X.; Mawuenyega, Kwasi G.; Jiang, Hong; Parsadanian, Maia; Yoon, Hyejin; Kasten, Tom; Sigurdson, Wendy C.; Xiong, Chengjie; Goate, Alison; Holtzman, David M.; Bateman, Randall J.			In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; E APOE POLYMORPHISM; BETA-AMYLOID LEVELS; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; E GENOTYPE; TARGETED REPLACEMENT; CLEARANCE RATES; TRANSGENIC MICE; E METABOLISM	Apolipoprotein E (ApoE) is the strongest genetic risk factor for Alzheimer's disease and has been implicated in the risk for other neurological disorders. The three common ApoE isoforms (ApoE2, E3, and E4) each differ by a single amino acid, with ApoE4 increasing and ApoE2 decreasing the risk of Alzheimer's disease (AD). Both the isoform and amount of ApoE in the brain modulate AD pathology by altering the extent of amyloid beta (Ab) peptide deposition. Therefore, quantifying ApoE isoform production and clearance rates may advance our understanding of the role of ApoE in health and disease. To measure the kinetics of ApoE in the central nervous system (CNS), we applied in vivo stable isotope labeling to quantify the fractional turnover rates of ApoE isoforms in 18 cognitively-normal adults and in ApoE3 and ApoE4 targeted-replacement mice. No isoform-specific differences in CNS ApoE3 and ApoE4 turnover rates were observed when measured in human CSF or mouse brain. However, CNS and peripheral ApoE isoform turnover rates differed substantially, which is consistent with previous reports and suggests that the pathways responsible for ApoE metabolism are different in the CNS and the periphery. We also demonstrate a slower turnover rate for CSF ApoE than that for amyloid beta, another molecule critically important in AD pathogenesis.	[Wildsmith, Kristin R.; Basak, Jacob M.; Pyatkivskyy, Yuriy; Kim, Jungsu; Mawuenyega, Kwasi G.; Jiang, Hong; Parsadanian, Maia; Yoon, Hyejin; Kasten, Tom; Sigurdson, Wendy C.; Goate, Alison; Holtzman, David M.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Patterson, Bruce W.; Yarasheski, Kevin E.; Wang, Jennifer X.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Xiong, Chengjie] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA; [Goate, Alison] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Goate, Alison; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Goate, Alison; Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wildsmith, KR (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	batemanr@neuro.wustl.edu	Yarasheski, Kevin E/A-3025-2008; Yoon, Hyejin/AAI-8641-2021; Yarasheski, Kevin/AAC-7450-2021; Kim, Jungsu/F-2457-2012	Yarasheski, Kevin/0000-0001-5436-2451; Kim, Jungsu/0000-0002-6931-8581; Bateman, Randall/0000-0002-7729-1702; Goate, Alison/0000-0002-0576-2472; Patterson, Bruce W/0000-0001-9261-0233	Alzheimer's Disease Research (American Health Assistance Foundation) [A2008-345]; Hope Center for Neurological Disorders at Washington University; NIA [K23 AG030946, AG13956]; NINDS [RO1-NS065667]; NIH [UL1 RR024992, TL1 RR024995, KL2 RR 024994]; Washington University Biomedical Mass Spectrometry Research Facility [P30NS069329, P30-RR000954, DK020579]; Washington University ADRC Genetics Core [P50-AG05681]; Washington University Nutrition Obesity Research Center [DK056341]; Eli Lilly; Pfizer; Astra-Zeneca; Astrazeneca; Merck; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992, KL2RR024994, TL1RR024995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667, P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG030946, P50AG005681, R01AG013956, R37AG013956] Funding Source: NIH RePORTER	Alzheimer's Disease Research (American Health Assistance Foundation); Hope Center for Neurological Disorders at Washington University; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Biomedical Mass Spectrometry Research Facility; Washington University ADRC Genetics Core; Washington University Nutrition Obesity Research Center; Eli Lilly(Eli Lilly); Pfizer(Pfizer); Astra-Zeneca(AstraZeneca); Astrazeneca(AstraZeneca); Merck(Merck & Company); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Alzheimer's Disease Research (a program of the American Health Assistance Foundation) Grant A2008-345 (KRW and RJB) and a postdoctoral fellowship (JK); the Hope Center for Neurological Disorders at Washington University (RJB); NIA K23 AG030946 (RJB), AG13956 (DMH), NINDS RO1-NS065667 (RJB), and NIH-supported UL1 RR024992, TL1 RR024995 and KL2 RR 024994 (ICTS CRU), P30NS069329 (JK) Washington University Biomedical Mass Spectrometry Research Facility (P30-RR000954, DK020579), Washington University ADRC Genetics Core (P50-AG05681), and Washington University Nutrition Obesity Research Center (DK056341) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DMH co-founded C2N Diagnostics, and is on the scientific advisory board of C2N Diagnostics, and Pfizer, and receives grants that did not support this work from Eli Lilly, Pfizer, and Astra-Zeneca. RJB co-founded C2N Diagnostics and is on the scientific advisory board of C2N Diagnostics and receives grants that did not support this work from Astrazeneca, and Merck. BWP provides consultation services for tracer turnover kinetics for C2N Diagnostics. KRW now works for Genentech, which did not provide any funding for this study, and did not have any involvement or influence in data production, data analysis, decision to publish, or manuscript preparation. None of the above stated competing interests alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bateman RJ, 2007, J AM SOC MASS SPECTR, V18, P997, DOI 10.1016/j.jasms.2007.02.009; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dinkel RE, 2006, NUTR METAB CARDIOVAS, V16, P215, DOI 10.1016/j.numecd.2005.06.004; Elbert DL, 2011, NAT MED, V17, P1179, DOI 10.1038/nm.2496; Elias N, 2000, ARTERIOSCL THROM VAS, V20, P1309, DOI 10.1161/01.ATV.20.5.1309; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fishman RA., 1992, CEREBROSPINAL FLUID; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Fukumoto H, 2003, EXP NEUROL, V183, P249, DOI 10.1016/S0014-4886(03)00088-8; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; GREGG RE, 1981, SCIENCE, V211, P584, DOI 10.1126/science.7455696; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; GREGG RE, 1984, J LIPID RES, V25, P1167; Harr SD, 1996, J NEUROCHEM, V66, P2429; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Ikewaki K, 2002, J LAB CLIN MED, V140, P369, DOI 10.1067/mlc.2002.129066; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Korwek KM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-21; KRUL ES, 1988, J LIPID RES, V29, P1309; LEHTIMAKI T, 1995, HUM GENET, V95, P39; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Millar JS, 1998, METABOLISM, V47, P922, DOI 10.1016/S0026-0495(98)90345-6; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Ramakrishnan R, 2006, J LIPID RES, V47, P2738, DOI 10.1194/jlr.M600302-JLR200; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Wahrle SE, 2003, EXP NEUROL, V183, P4, DOI 10.1016/S0014-4886(03)00185-7; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049; Wolfe RR., 2005, ISOTOPE TRACERS META, V2; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; Yamauchi K, 1999, CLIN CHEM, V45, P497; YARASHESKI KE, 1992, BIOL MASS SPECTROM, V21, P486, DOI 10.1002/bms.1200211004; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	55	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38013	10.1371/journal.pone.0038013	http://dx.doi.org/10.1371/journal.pone.0038013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675504	Green Published, gold			2022-12-25	WOS:000305341700033
J	Safdar, H; Cheung, KL; Vos, HL; Gonzalez, FJ; Reitsma, PH; Inoue, Y; van Vlijmen, BJM				Safdar, Huma; Cheung, Ka Lei; Vos, Hans L.; Gonzalez, Frank J.; Reitsma, Pieter H.; Inoue, Yusuke; van Vlijmen, Bart J. M.			Modulation of Mouse Coagulation Gene Transcription following Acute In Vivo Delivery of Synthetic Small Interfering RNAs Targeting HNF4 alpha and C/EBP alpha	PLOS ONE			English	Article							NUCLEAR FACTOR 4-ALPHA; ESTROGEN-RECEPTOR-ALPHA; BINDING-PROTEIN-ALPHA; LIPID HOMEOSTASIS; LIVER-FUNCTION; KNOCKOUT MICE; HEMOPHILIA-B; EXPRESSION; PROMOTER; DISRUPTION	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) and CCAAT/enhancer-binding protein alpha (C/EBP alpha) are important for the transcriptional control of coagulation factors. To determine in vivo the direct role of HNF4 alpha and C/EBP alpha in control of genes encoding coagulation factors, a synthetic small interfering (si) RNA approach was used that enabled strong reduction of mouse hepatic HNF4 alpha and C/EBP alpha under conditions that minimized target-related secondary effects. For both HNF4 alpha and C/EBP alpha, intravenous injection of specific synthetic siRNAs (siHNF4 alpha and siC/EBP alpha) resulted in more than 75% reduction in their liver transcript and protein levels 2 days post-injection. For siHNF4 alpha, this coincided with marked and significantly reduced transcript levels of the coagulation genes Hrg, Proz, Serpina5, F11, F12, F13b, Serpinf2, F5, and F9 (in order of magnitude of effect) as compared to levels in control siRNA injected animals. Significant decreases in HNF4 alpha target gene mRNA levels were also observed at 5 days post-siRNA injection, despite a limited level of HNF4 alpha knockdown at this time point. Compared to HNF4 alpha, C/EBP alpha knockdown had a modest impact on genes encoding coagulation factors. A strong reduction in C/EBP alpha transcript and protein levels resulted in significantly affected transcript levels of the control genes Pck1 and Fasn and a modest downregulation for coagulation genes Fba, Fbg and F5. F5 and F11 were the sole coagulation genes that were significantly affected upon prolonged (5 day) C/EBP alpha knockdown. We conclude that in the mouse, HNF4 alpha has a direct and essential regulatory role for multiple hepatic coagulation genes, while a role for C/EBP alpha is more restricted. In addition, this study demonstrates that synthetic siRNA provides a simple and fast means for determining liver transcription factor involvement in vivo.	[Safdar, Huma; Cheung, Ka Lei; Vos, Hans L.; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA; [Inoue, Yusuke] Gunma Univ Kiryu, Grad Sch Engn, Dept Chem & Chem Biol, Gunma, Japan	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gunma University	Safdar, H (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	h.safdar@lumc.nl	Inoue, Yusuke/O-6207-2018	Inoue, Yusuke/0000-0002-9710-7482; Safdar, Huma/0000-0002-0716-3895	Dutch Organization for Scientific Research (NWO-TOP) [40-00812-98-07-045]	Dutch Organization for Scientific Research (NWO-TOP)	This project is financially supported by the Dutch Organization for Scientific Research (NWO-TOP Grant #40-00812-98-07-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbini AA, 1997, BLOOD, V89, P176, DOI 10.1182/blood.V89.1.176.176_176_182; Begbie M, 2000, THROMB HAEMOSTASIS, V84, P216; Ceelie H, 2003, J THROMB HAEMOST, V1, P1688, DOI 10.1046/j.1538-7836.2003.00393.x; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; Davies N, 1997, BRIT J HAEMATOL, V99, P578, DOI 10.1046/j.1365-2141.1997.4603263.x; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; FernandezRachubinski FA, 1996, J BIOL CHEM, V271, P29502, DOI 10.1074/jbc.271.46.29502; FIGUEIREDO MS, 1995, J BIOL CHEM, V270, P11828, DOI 10.1074/jbc.270.20.11828; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Hall AJ, 2006, BRIT J HAEMATOL, V135, P538, DOI 10.1111/j.1365-2141.2006.06327.x; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; MIAO CH, 1992, J BIOL CHEM, V267, P7395; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Nagai N, 2008, THROMB RES, V122, P549, DOI 10.1016/j.thromres.2007.12.017; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; Safdar H, 2010, J THROMB HAEMOST, V8, P2839, DOI 10.1111/j.1538-7836.2010.04080.x; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Sugawara H, 2007, J THROMB HAEMOST, V5, P2250, DOI 10.1111/j.1538-7836.2007.02738.x; Tarumi T, 2002, J BIOL CHEM, V277, P18510, DOI 10.1074/jbc.M201886200; van Rossenberg SMW, 2003, BIOCONJUGATE CHEM, V14, P1077, DOI 10.1021/bc0340417; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	35	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38104	10.1371/journal.pone.0038104	http://dx.doi.org/10.1371/journal.pone.0038104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675511	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900013
J	Lau, EHY; Cheng, CKY; Ip, DKM; Cowling, BJ				Lau, Eric H. Y.; Cheng, Calvin K. Y.; Ip, Dennis K. M.; Cowling, Benjamin J.			Situational Awareness of Influenza Activity Based on Multiple Streams of Surveillance Data Using Multivariate Dynamic Linear Model	PLOS ONE			English	Article								Background: Multiple sources of influenza surveillance data are becoming more available; however integration of these data streams for situational awareness of influenza activity is less explored. Methods and Results: We applied multivariate time-series methods to sentinel outpatient and school absenteeism surveillance data in Hong Kong during 2004-2009. School absenteeism data and outpatient surveillance data experienced interruptions due to school holidays and changes in public health guidelines during the pandemic, including school closures and the establishment of special designated flu clinics, which in turn provided 'drop-in' fever counts surveillance data. A multivariate dynamic linear model was used to monitor influenza activity throughout epidemics based on all available data. The inferred level followed influenza activity closely at different times, while the inferred trend was less competent with low influenza activity. Correlations between inferred level and trend from the multivariate model and reference influenza activity, measured by the product of weekly laboratory influenza detection rates and weekly general practitioner influenza-like illness consultation rates, were calculated and compared with those from univariate models. Over the whole study period, there was a significantly higher correlation (rho = 0.82, p <= 0.02) for the inferred trend based on the multivariate model compared to other univariate models, while the inferred trend from the multivariate model performed as well as the best univariate model in the pre-pandemic and the pandemic period. The inferred trend and level from the multivariate model was able to match, if not outperform, the best univariate model albeit with missing data plus drop-in and drop-out of different surveillance data streams. An overall influenza index combining level and trend was constructed to demonstrate another potential use of the method. Conclusions: Our results demonstrate the potential use of multiple streams of influenza surveillance data to promote situational awareness about the level and trend of seasonal and pandemic influenza activity.	[Lau, Eric H. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lau, EHY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	ehylau@hku.hk	Cowling, Benjamin John/C-4263-2009; Lau, Eric/AAJ-6588-2021; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Ip, Dennis Kai Ming/0000-0003-3592-8709	Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong Special Administrative Region Government [11101092]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong Special Administrative Region Government; Area of Excellence Scheme of the University Grants Committee; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was in part funded by the Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong Special Administrative Region Government (grant no. 11101092), the Area of Excellence Scheme of the University Grants Committee (grant no. AoE/M-12/06), and the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant number U54 GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Buckeridge DL, 2008, J AM MED INFORM ASSN, V15, P760, DOI 10.1197/jamia.M2799; Centers for Disease Control and Prevention, 2011, FLU ACT SURV; Cheng CKY, 2012, EMERG INFECT DIS, V18, P885, DOI 10.3201/eid1805.111796; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; International Society for Disease Surveillance, 2011, DISTR; Lau EHY, 2008, EMERG INFECT DIS, V14, P1154, DOI 10.3201/eid1407.080060; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mnatsakanyan ZR, 2009, J AM MED INFORM ASSN, V16, P855, DOI 10.1197/jamia.M2647; Paul M, 2011, STAT MED, V30, P1118, DOI 10.1002/sim.4177; Schmidt WP, 2010, EUROSURVEILLANCE, V15, P4; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Vergu E, 2006, EMERG INFECT DIS, V12, P416, DOI 10.3201/eid1203.050573; West M., 2006, BAYESIAN FORECASTING; WHO, 2011, MAN LAB DIAGN VIR SU; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	18	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38346	10.1371/journal.pone.0038346	http://dx.doi.org/10.1371/journal.pone.0038346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675456	Green Published, gold			2022-12-25	WOS:000305338500137
J	Bhargava, A; Voronov, I; Wang, YQ; Glogauer, M; Kartner, N; Manolson, MF				Bhargava, Ajay; Voronov, Irina; Wang, Yongqiang; Glogauer, Michael; Kartner, Norbert; Manolson, Morris F.			Osteopetrosis Mutation R444L Causes Endoplasmic Reticulum Retention and Misprocessing of Vacuolar H+-ATPase a3 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; RENAL TUBULAR-ACIDOSIS; UNFOLDED PROTEIN RESPONSE; CYSTIC-FIBROSIS MUTATION; YEAST V-ATPASE; QUALITY-CONTROL; HUMAN-DISEASES; GENE ENCODES; PROTON PUMP; MEMBRANE	Osteopetrosis is a genetic bone disease characterized by increased bone density and fragility. The R444L missense mutation in the human V-ATPase a3 subunit (TCIRG1) is one of several known mutations in a3 and other proteins that can cause this disease. The autosomal recessive R444L mutation results in a particularly malignant form of infantile osteopetrosis that is lethal in infancy, or early childhood. We have studied this mutation using the pMSCV retroviral vector system to integrate the cDNA construct for green fluorescent protein (GFP)-fused a3(R445L) mutant protein into the RAW 264.7 mouse osteoclast differentiation model. In comparison with wild-type a3, the mutant glycoprotein localized to the ER instead of lysosomes and its oligosaccharide moiety was misprocessed, suggesting inability of the core-glycosylated glycoprotein to traffic to the Golgi. Reduced steady-state expression of the mutant protein, in comparison with wild type, suggested that the former was being degraded, likely through the endoplasmic reticulum-associated degradation pathway. In differentiated osteoclasts, a3(R445L) was found to degrade at an increased rate over the course of osteoclastogenesis. Limited proteolysis studies suggested that the R445L mutation alters mouse a3 protein conformation. Together, these data suggest that Arg-445 plays a role in protein folding, or stability, and that infantile malignant osteopetrosis caused by the R444L mutation in the human V-ATPase a3 subunit is another member of the growing class of protein folding diseases. This may have implications for early-intervention treatment, using protein rescue strategies.	[Bhargava, Ajay; Voronov, Irina; Wang, Yongqiang; Glogauer, Michael; Kartner, Norbert; Manolson, Morris F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON M5G 1G6, Canada; [Manolson, Morris F.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5G 1G6, Canada	University of Toronto; University of Toronto	Manolson, MF (corresponding author), Univ Toronto, Fac Dent, Dent Res Inst, 124 Edward St, Toronto, ON M5G 1G6, Canada.	m.manolson@utoronto.ca	Glogauer, Michael/D-2504-2011	Manolson, Morris/0000-0001-8755-5460; Glogauer, Michael/0000-0002-6248-5977	Canadian Institutes of Health Research [FRN-79322]; Canadian Institutes of Health Research Senior Investigator Award [SOW-90384]; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Senior Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported in part by Operating Grant FRN-79322 from the Canadian Institutes of Health Research.; Supported by Canadian Institutes of Health Research Senior Investigator Award SOW-90384. Graduate student and postdoctoral fellowship support was provided in part by the Canadian Arthritis Network. To whom correspondence should be addressed: Faculty of Dentistry, University of Toronto, 124 Edward St., Toronto, Ontario M5G 1G6, Canada. Tel.: 416-979-4900; Fax: 416-979-4936; E-mail: m.manolson@utoronto.ca.	BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brown D, 1997, J EXP BIOL, V200, P257; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Clarke M, 2002, J CELL SCI, V115, P2893; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; deCarvalho ACV, 2002, MOL MED, V8, P75, DOI 10.1007/BF03402077; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Driessen GJA, 2003, BONE MARROW TRANSPL, V32, P657, DOI 10.1038/sj.bmt.1704194; Fasth A, 1999, Pediatr Transplant, V3 Suppl 1, P102; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Li XH, 1998, PLANT CELL, V10, P119, DOI 10.1105/tpc.10.1.119; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Nakamura I, 1997, FEBS LETT, V401, P207, DOI 10.1016/S0014-5793(96)01454-8; NORDSTROM T, 1995, J BIOL CHEM, V270, P2203, DOI 10.1074/jbc.270.5.2203; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Ochotny N, 2006, J BIOL CHEM, V281, P26102, DOI 10.1074/jbc.M601118200; Ochotny N, 2011, J BONE MINER RES, V26, P1484, DOI 10.1002/jbmr.355; OGUR G, 1995, PRENATAL DIAG, V15, P477; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Phadke SR, 2010, INDIAN J MED RES, V131, P508; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vostrikov VV, 2010, J BIOL CHEM, V285, P31723, DOI 10.1074/jbc.M110.152470; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XL, 2012, J NEUROSCI, V32, P8633, DOI 10.1523/JNEUROSCI.0556-12.2012; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	55	29	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26829	26839		10.1074/jbc.M112.345702	http://dx.doi.org/10.1074/jbc.M112.345702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685294	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000307386000032
J	Purohit, AA; Li, WQ; Qu, C; Dwyer, T; Shao, QQ; Guan, KL; Liu, GF				Purohit, Anish A.; Li, Weiquan; Qu, Chao; Dwyer, Trisha; Shao, Qiangqiang; Guan, Kun-Liang; Liu, Guofa			Down Syndrome Cell Adhesion Molecule (DSCAM) Associates with Uncoordinated-5C (UNC5C) in Netrin-1-mediated Growth Cone Collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NETRIN RECEPTOR; COLORECTAL-CANCER; SELF-AVOIDANCE; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; COMMISSURAL AXONS; DROSOPHILA DSCAM; SPINAL-CORD; DCC; MOUSE	In the developing nervous system, neuronal growth cones explore the extracellular environment for guidance cues, which can guide them along specific trajectories toward their targets. Netrin-1, a bifunctional guidance cue, binds to deleted in colorectal cancer (DCC) and DSCAM mediating axon attraction, and UNC5 mediating axon repulsion. Here, we show that DSCAM interacts with UNC5C and this interaction is stimulated by netrin-1 in primary cortical neurons and postnatal cerebellar granule cells. DSCAM partially co-localized with UNC5C in primary neurons and brain tissues. Netrin-1 induces axon growth cone collapse of mouse cerebellum external granule layer (EGL) cells, and the knockdown of DSCAM or UNC5C by specific shRNAs or blocking their signaling by overexpressing dominant negative mutants suppresses netrin-1-induced growth cone collapse. Similarly, the simultaneous knockdown of DSCAM and UNC5C also blocks netrin-1-induced growth cone collapse in EGL cells. Netrin-1 increases tyrosine phosphorylation of endogenous DSCAM, UNC5C, FAK, Fyn, and PAK1, and promotes complex formation of DSCAM with these signaling molecules in primary postnatal cerebellar neurons. Inhibition of Src family kinases efficiently reduces the interaction of DSCAM with UNC5C, FAK, Fyn, and PAK1 and tyrosine phosphorylation of these proteins as well as growth cone collapse of mouse EGL cells induced by netrin-1. The knockdown of DSCAM inhibits netrin-induced tyrosine phosphorylation of UNC5C and Fyn as well as the interaction of UNC5C with Fyn. The double knockdown of both receptors abolishes the induction of Fyn tyrosine phosphorylation by netrin-1. Our study reveals the first evidence that DSCAM coordinates with UNC5C in netrin-1 repulsion.	[Purohit, Anish A.; Qu, Chao; Dwyer, Trisha; Shao, Qiangqiang; Liu, Guofa] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Li, Weiquan] Univ Michigan, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, Dept Pharmacol, La Jolla, CA 92093 USA	University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Liu, GF (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Guofa.Liu@utoledo.edu	Guan, Kun-Liang/ADK-7088-2022; Li, Weiquan/B-4897-2011; Shao, Qiangqiang/GXZ-6789-2022	Shao, Qiangqiang/0000-0002-0674-1868	National Institutes of Health; Whitehall Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation	This work was supported, in whole or in part, by the National Institutes of Health (to G. L. and K. G.) and the Whitehall Foundation (to G. L.).	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Barlow GM, 2002, BIOCHEM BIOPH RES CO, V293, P881, DOI 10.1016/S0006-291X(02)00307-8; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Cooper HM, 1995, ONCOGENE, V11, P2243; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guijarro P, 2006, MOL CELL NEUROSCI, V33, P389, DOI 10.1016/j.mcn.2006.08.010; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Killeen M, 2002, DEV BIOL, V251, P348, DOI 10.1006/dbio.2002.0825; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2006, J CELL SCI, V119, P47, DOI 10.1242/jcs.02697; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li WQ, 2004, J BIOL CHEM, V279, P32824, DOI 10.1074/jbc.M401878200; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Matthews BJ, 2011, CURR BIOL, V21, P1480, DOI 10.1016/j.cub.2011.07.040; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Williams ME, 2003, J NEUROSCI, V23, P11279; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	73	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27126	27138		10.1074/jbc.M112.340174	http://dx.doi.org/10.1074/jbc.M112.340174			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685302	hybrid, Green Published			2022-12-25	WOS:000307386000065
J	Hayashi, H; Eguchi, Y; Fukuchi-Nakaishi, Y; Takeya, M; Nakagata, N; Tanaka, K; Vance, JE; Tanihara, H				Hayashi, Hideki; Eguchi, Yuko; Fukuchi-Nakaishi, Yuko; Takeya, Motohiro; Nakagata, Naomi; Tanaka, Kohichi; Vance, Jean E.; Tanihara, Hidenobu			A Potential Neuroprotective Role of Apolipoprotein E-containing Lipoproteins through Low Density Lipoprotein Receptor-related Protein 1 in Normal Tension Glaucoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; GLIAL LIPOPROTEINS; VISUAL IMPAIRMENT; GROWTH-FACTOR; EXPRESSION; JAPANESE; NEURONS; CHOLESTEROL	Glaucoma is an optic neuropathy and the second major cause of blindness worldwide next to cataracts. The protection from retinal ganglion cell (RGC) loss, one of the main characteristics of glaucoma, would be a straightforward treatment for this disorder. However, the clinical application of neuroprotection has not, so far, been successful. Here, we report that apolipoprotein E-containing lipoproteins (E-LPs) protect primary cultured RGCs from Ca2+-dependent, and mitochondrion-mediated, apoptosis induced by glutamate. Binding of E-LPs to the low density lipoprotein receptor-related protein 1 recruited the N-methyl-D-aspartate receptor, blocked intracellular Ca2+ elevation, and inactivated glycogen synthase kinase 3 beta, thereby inhibiting apoptosis. When compared with contralateral eyes treated with phosphate-buffered saline, intravitreal administration of E-LPs protected against RGC loss in glutamate aspartate transporter-deficient mice, a model of normal tension glaucoma that causes glaucomatous optic neuropathy without elevation of intraocular pressure. Although the presence of alpha 2-macroglobulin, another ligand of the low density lipoprotein receptor-related protein 1, interfered with the neuroprotective effect of E-LPs against glutamate-induced neurotoxicity, the addition of E-LPs overcame the inhibitory effect of alpha 2-macroglobulin. These findings may provide a potential therapeutic strategy for normal tension glaucoma by an LRP1-mediated pathway.	[Hayashi, Hideki; Eguchi, Yuko] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608556, Japan; [Fukuchi-Nakaishi, Yuko] Kumamoto Univ, Dept Ophthalmol & Visual Sci, Kumamoto 8608556, Japan; [Takeya, Motohiro] Kumamoto Univ, Dept Cell Pathol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto 8608556, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo 1138510, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1138510, Japan; [Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Alberta; University of Alberta	Hayashi, H (corresponding author), Kumamoto Univ, Prior Org Innovat & Excellence, 509 Gen Res Bldg,1-1-1 Honjo, Kumamoto 8608556, Japan.	hhayashi@kumamoto-u.ac.jp		Nakagata, Naomi/0000-0002-5737-9993	Ministry of Education, Culture, Sport, Science and Technology of Japan [22790254, 24500441]; Life Science Foundation of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aids for Young Scientists B 22790254, Scientific Research C 24500441, the Special Coordination Funds for Promoting Science and Technology, the "Understanding of molecular and environmental bases for brain health" project under the Strategic Research Program for Brain Sciences, and the Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit) from the Ministry of Education, Culture, Sport, Science and Technology of Japan, the Life Science Foundation of Japan, and the Takeda Science Foundation.	Almeida S, 2004, NEUROBIOL DIS, V17, P435, DOI 10.1016/j.nbd.2004.07.002; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Bai YJ, 2011, INVEST OPHTH VIS SCI, V52, P5260, DOI 10.1167/iovs.10-6691; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bessero AC, 2010, CURR OPIN NEUROL, V23, P10, DOI 10.1097/WCO.0b013e3283344461; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Fernandez-Monreal M, 2004, MOL CELL NEUROSCI, V25, P594, DOI 10.1016/j.mcn.2003.11.002; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Krumbiegel M, 2010, J GLAUCOMA, V19, P561, DOI 10.1097/IJG.0b013e3181ca76c4; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Mabuchi F, 2005, MOL VIS, V11, P609; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mansberger SL, 2005, AM J PUBLIC HEALTH, V95, P881, DOI 10.2105/AJPH.2004.054221; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Orgul S, 2005, OPHTHALMOLOGICA, V219, P317, DOI 10.1159/000088372; Pekmezci M, 2009, ARCH OPHTHALMOL-CHIC, V127, P167, DOI 10.1001/archophthalmol.2008.593; Petegnief V, 2001, NEUROSCIENCE, V104, P223, DOI 10.1016/S0306-4522(01)00046-X; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schmidt KG, 2008, CURR NEUROPHARMACOL, V6, P164, DOI 10.2174/157015908784533851; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Zetterberg M, 2007, AM J OPHTHALMOL, V143, P1059, DOI 10.1016/j.ajo.2007.01.031	42	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25395	25406		10.1074/jbc.M112.370130	http://dx.doi.org/10.1074/jbc.M112.370130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22674573	Green Published, hybrid			2022-12-25	WOS:000306651700047
J	Tong, X; Buelow, K; Guha, A; Rausch, R; Yin, L				Tong, Xin; Buelow, Katie; Guha, Anirvan; Rausch, Rebecca; Yin, Lei			USP2a Protein Deubiquitinates and Stabilizes the Circadian Protein CRY1 in Response to Inflammatory Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WIDE EXPRESSION ANALYSIS; REV-ERB-ALPHA; GENE-EXPRESSION; TNF-ALPHA; CLOCK GENES; PROSTATE-CANCER; ENZYME USP2A; MOUSE-LIVER; DEGRADATION; CRYPTOCHROME	The mammalian circadian clock coordinates various physiological activities with environmental cues to achieve optimal adaptation. The clock manifests oscillations of key clock proteins, which are under dynamic control at multiple post-translational levels. As a major post-translational regulator, the ubiquitination-dependent proteasome degradation system is counterbalanced by a large group of deubiquitin proteases with distinct substrate preference. Until now, whether deubiquitination by ubiquitin-specific proteases can regulate the clock protein stability and circadian pathways remains largely unclear. The mammalian clock protein, cryptochrome 1 (CRY1), is degraded via the FBXL3-mediated ubiquitination pathway, suggesting that it is also likely to be targeted by the deubiquitination pathway. Here, we identified that USP2a, a circadian-controlled deubiquitinating enzyme, interacts with CRY1 and enhances its protein stability via deubiquitination upon serum shock. Depletion of Usp2a by shRNA greatly enhances the ubiquitination of CRY1 and dampens the oscillation amplitude of the CRY1 protein during a circadian cycle. By stabilizing the CRY1 protein, USP2a represses the Per2 promoter activity as well as the endogenous Per2 gene expression. We also demonstrated that USP2a-dependent deubiquitination and stabilization of the CRY1 protein occur in the mouse liver. Interestingly, the pro-inflammatory cytokine, TNF-alpha, increases the CRY1 protein level and inhibits circadian gene expression in a USP2a-dependent fashion. Therefore, USP2a potentially mediates circadian disruption by suppressing the CRY1 degradation during inflammation.	[Tong, Xin; Buelow, Katie; Guha, Anirvan; Rausch, Rebecca; Yin, Lei] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48103 USA.	leiyin@umich.edu		Guha, Anirvan/0000-0001-6018-1438; Buelow, Katie/0000-0002-2616-1756; TONG, XIN/0000-0002-4832-8940	National Institutes of Health Grant [K99/R00 DK077449]; Michigan Gastrointestinal Hormone Research Core Center [5P3ODKO34933]; University of Michigan Diabetes and Research Training Center [P60DK020572]	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Gastrointestinal Hormone Research Core Center; University of Michigan Diabetes and Research Training Center	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 DK077449 (to L.Y.). This work was also supported by Pilot Grant 5P3ODKO34933 (to L.Y.) from Michigan Gastrointestinal Hormone Research Core Center and Pilot Grant P60DK020572 from University of Michigan Diabetes and Research Training Center.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2004, J IMMUNOL, V172, P2811, DOI 10.4049/jimmunol.172.5.2811; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baggs JE, 2010, CURR OPIN GENET DEV, V20, P581, DOI 10.1016/j.gde.2010.08.009; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Chaves I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023447; Cutolo M, 2008, AUTOIMMUN REV, V7, P223, DOI 10.1016/j.autrev.2007.11.019; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Haimerl F, 2009, J BIOL CHEM, V284, P495, DOI 10.1074/jbc.M803533200; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Kaneko K, 2009, BRAIN RES, V1263, P58, DOI 10.1016/j.brainres.2008.12.071; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Sun YM, 2006, J BIOMED SCI, V13, P845, DOI 10.1007/s11373-006-9108-4; Sun YM, 2006, IMMUNOLOGY, V119, P451, DOI 10.1111/j.1365-2567.2006.02456.x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamanini Filippo, 2007, Methods Mol Biol, V362, P443; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Treeck O, 2008, BRIT J CANCER, V99, P1246, DOI 10.1038/sj.bjc.6604692; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Wang SX, 2010, PATHOL INT, V60, P184, DOI 10.1111/j.1440-1827.2010.02496.x; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yang YL, 2007, INT J NANOTECHNOL, V4, P4, DOI 10.1504/IJNT.2007.012313; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	77	44	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25280	25291		10.1074/jbc.M112.340786	http://dx.doi.org/10.1074/jbc.M112.340786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669941	Green Published, hybrid			2022-12-25	WOS:000306651700036
J	Bonfiglio, S; Ginja, C; De Gaetano, A; Achilli, A; Olivieri, A; Colli, L; Tesfaye, K; Agha, SH; Gama, LT; Cattonaro, F; Penedo, MCT; Ajmone-Marsan, P; Torroni, A; Ferretti, L				Bonfiglio, Silvia; Ginja, Catarina; De Gaetano, Anna; Achilli, Alessandro; Olivieri, Anna; Colli, Licia; Tesfaye, Kassahun; Agha, Saif Hassan; Gama, Luis T.; Cattonaro, Federica; Penedo, M. Cecilia T.; Ajmone-Marsan, Paolo; Torroni, Antonio; Ferretti, Luca			Origin and Spread of Bos taurus: New Clues from Mitochondrial Genomes Belonging to Haplogroup T1	PLOS ONE			English	Article							CREOLE CATTLE; GENETIC DIVERSITY; AFRICAN; SEQUENCE; MTDNA; DNA; MATRILINEAGES	Background: Most genetic studies on modern cattle have established a common origin for all taurine breeds in the Near East, during the Neolithic transition about 10 thousand years (ka) ago. Yet, the possibility of independent and/or secondary domestication events is still debated and is fostered by the finding of rare mitochondrial DNA (mtDNA) haplogroups like P, Q and R. Haplogroup T1, because of its geographic distribution, has been the subject of several investigations pointing to a possible independent domestication event in Africa and suggesting a genetic contribution of African cattle to the formation of Iberian and Creole cattle. Whole mitochondrial genome sequence analysis, with its proven effectiveness in improving the resolution of phylogeographic studies, is the most appropriate tool to investigate the origin and structure of haplogroup T1. Methodology: A survey of >2200 bovine mtDNA control regions representing 28 breeds (15 European, 10 African, 3 American) identified 281 subjects belonging to haplogroup T1. Fifty-four were selected for whole mtDNA genome sequencing, and combined with ten T1 complete sequences from previous studies into the most detailed T1 phylogenetic tree available to date. Conclusions: Phylogenetic analysis of the 64 T1 mitochondrial complete genomes revealed six distinct sub-haplogroups (T1a-T1f). Our data support the overall scenario of a Near Eastern origin of the T1 sub-haplogroups from as much as eight founding T1 haplotypes. However, the possibility that one sub-haplogroup (T1d) arose in North Africa, in domesticated stocks, shortly after their arrival from the Near East, can not be ruled out. Finally, the previously identified "African-derived American" (AA) haplotype turned out to be a sub-clade of T1c (T1c1a1). This haplotype was found here for the first time in Africa (Egypt), indicating that it probably originated in North Africa, reached the Iberian Peninsula and sailed to America, with the first European settlers.	[Bonfiglio, Silvia; De Gaetano, Anna; Olivieri, Anna; Torroni, Antonio; Ferretti, Luca] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Ginja, Catarina] Univ Lisbon, Inst Nacl Recursos Biol, Mol Biol Grp, INIA, P-1699 Lisbon, Portugal; [Ginja, Catarina] Univ Lisbon, Environm Biol Ctr, Fac Sci, P-1699 Lisbon, Portugal; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ctr Ric Biodivers & DNA Ant BioDNA, Piacenza, Italy; [Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, Piacenza, Italy; [Tesfaye, Kassahun] Univ Addis Ababa, Fac Life Sci, Microbial Cellular & Mol Biol Program Unit, Addis Ababa, Ethiopia; [Agha, Saif Hassan] Ain Shams Univ, Fac Agr, Dept Anim Prod, Cairo, Egypt; [Gama, Luis T.] Univ Tecn Lisboa, Fac Med Vet, Lisbon, Portugal; [Cattonaro, Federica] Appl Genom Inst IGA, Udine, Italy; [Penedo, M. Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA	University of Pavia; Universidade de Lisboa; Universidade de Lisboa; University of Perugia; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Addis Ababa University; Egyptian Knowledge Bank (EKB); Ain Shams University; Universidade de Lisboa; University of California System; University of California Davis	Bonfiglio, S (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	luca.ferretti@unipv.it	De Gaetano, Anna/GWC-1521-2022; Ferretti, Luca/D-2337-2013; Gama, Luis T/N-4172-2018; Achilli, Alessandro/I-9236-2012; Bonfiglio, Silvia/AAC-1988-2019; Colli, Licia/AAC-2985-2021; OLIVIERI, ANNA/I-9235-2012; Torroni, Antonio/E-1557-2011; AJMONE MARSAN, Paolo/M-2466-2018	Gama, Luis T/0000-0003-3894-3488; Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Ginja, Catarina/0000-0003-2278-7089; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Agha, Saif/0000-0003-3373-146X; Bonfiglio, Silvia/0000-0002-4422-1580; Ferretti, Luca/0000-0001-5044-8442	Italian Ministry of Education, University and Research: Progetti FIRB-Futuro in Ricerca; Fondazione Alma Mater Ticinensis	Italian Ministry of Education, University and Research: Progetti FIRB-Futuro in Ricerca; Fondazione Alma Mater Ticinensis	This research received support from the Italian Ministry of Education, University and Research: Progetti FIRB-Futuro in Ricerca 2008 (to AA and AO) and Fondazione Alma Mater Ticinensis (to AT and LF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bonfiglio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015760; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Caramelli D., 2006, HUM EVOL, V21, P107; Carvajal-Carmona LG, 2003, GENETICS, V165, P1457; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Cortes O, 2008, ANIM GENET, V39, P649, DOI 10.1111/j.1365-2052.2008.01782.x; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Dadi H, 2009, ANIM GENET, V40, P556, DOI 10.1111/j.1365-2052.2009.01866.x; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Douglas KC, 2011, MITOCHONDRION, V11, P166, DOI 10.1016/j.mito.2010.09.005; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Lari M, 2011, BMC EVOL BIOL, V11, P32; Liron JP, 2006, ANIM GENET, V37, P379, DOI 10.1111/j.1365-2052.2006.01452.x; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Miretti MM, 2004, J HERED, V95, P450, DOI 10.1093/jhered/esh070; Miretti MM, 2002, J HERED, V93, P323, DOI 10.1093/jhered/93.5.323; Mirol PM, 2003, HEREDITY, V91, P248, DOI 10.1038/sj.hdy.6800312; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088	28	56	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38601	10.1371/journal.pone.0038601	http://dx.doi.org/10.1371/journal.pone.0038601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685589	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700052
J	Krintel, SB; Essioux, L; Wool, A; Johansen, JS; Schreiber, E; Zekharya, T; Akiva, P; Ostergaard, M; Hetland, ML				Krintel, Sophine B.; Essioux, Laurent; Wool, Assaf; Johansen, Julia S.; Schreiber, Ehud; Zekharya, Tomer; Akiva, Pinchas; Ostergaard, Mikkel; Hetland, Merete L.			CD6 and Syntaxin Binding Protein 6 Variants and Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							ANTI-TNF TREATMENT; GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; DIFFERENTIAL RESPONSE; CANDIDATE GENES; THERAPY; METHOTREXATE; ADALIMUMAB; INFLIXIMAB; RECEPTOR	Background: TNF alpha inhibitor therapy has greatly improved the treatment of patients with rheumatoid arthritis, however at least 30% do not respond. We aimed to investigate insertions and deletions (INDELS) associated with response to TNF alpha inhibitors in patients with rheumatoid arthritis (RA). Methodology and Principal Findings: In the DANBIO Registry we identified 237 TNF alpha inhibitor naive patients with RA (81% women; median age 56 years; disease duration 6 years) who initiated treatment with infliximab (n = 160), adalimumab (n = 56) or etanercept (n = 21) between 1999 and 2008 according to national treatment guidelines. Clinical response was assessed at week 26 using EULAR response criteria. Based on literature, we selected 213 INDELS potentially related to RA and treatment response using the GeneVa (R) (Compugen) in silico database of 350,000 genetic variations in the human genome. Genomic segments were amplified by polymerase chain reaction (PCR), and genotyped by Sanger sequencing or fragment analysis. We tested the association between genotypes and EULAR good response versus no response, and EULAR good response versus moderate/no response using Fisher's exact test. At baseline the median DAS28 was 5.1. At week 26, 68 (29%) patients were EULAR good responders, while 81 (34%) and 88 (37%) patients were moderate and non-responders, respectively. A 19 base pair insertion within the CD6 gene was associated with EULAR good response vs. no response (OR = 4.43, 95% CI: 1.99-10.09, p = 7.211 x 10(-5)) and with EULAR good response vs. moderate/no response (OR = 4.54, 95% CI: 2.29-8.99, p = 3.336 x 10(-6)). A microsatellite within the syntaxin binding protein 6 (STXBP6) was associated with EULAR good response vs. no response (OR = 4.01, 95% CI: 1.92-8.49, p = 5.067 x 10(-5)). Conclusion: Genetic variations within CD6 and STXBP6 may influence response to TNF alpha inhibitors in patients with RA.	[Krintel, Sophine B.; Ostergaard, Mikkel; Hetland, Merete L.] Copenhagen Univ Hosp Glostrup, DANBIO Registry, Copenhagen, Denmark; [Krintel, Sophine B.; Ostergaard, Mikkel; Hetland, Merete L.] Copenhagen Univ Hosp Glostrup, Dept Rheumatol, Copenhagen, Denmark; [Essioux, Laurent] Hoffmann La Roche Ag, CH-4002 Basel, Switzerland; [Wool, Assaf; Schreiber, Ehud; Zekharya, Tomer; Akiva, Pinchas] Compugen Ltd, Tel Aviv, Israel; [Johansen, Julia S.] Univ Copenhagen, Copenhagen Univ Hosp Herlev, Dept Med, Copenhagen, Denmark; [Johansen, Julia S.] Univ Copenhagen, Copenhagen Univ Hosp Herlev, Dept Oncol, Copenhagen, Denmark; [Johansen, Julia S.; Ostergaard, Mikkel; Hetland, Merete L.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Roche Holding; University of Copenhagen; University of Copenhagen; University of Copenhagen	Krintel, SB (corresponding author), Copenhagen Univ Hosp Glostrup, DANBIO Registry, Copenhagen, Denmark.	krintel@sophine.dk	Hetland, Merete L/AAE-5297-2019	Hetland, Merete L/0000-0003-4229-6818	Danish Rheumatism Association; Research Council at Herlev Hospital, Denmark; Hoffmann-La Roche; Abbott; Amgen; Bristol-Myers Squibb; Centocor; Genmab; Glaxo-Smith-Kline; Mundipharma; Novo; Pfizer; Roche; Schering-Plough; UCB; Wyeth; Centocor/Janssen; MSD/Schering-Plough; Pfizer/Wyeth; Research Council at Herlev Hospital, Copenhagen, Denmark	Danish Rheumatism Association; Research Council at Herlev Hospital, Denmark; Hoffmann-La Roche(Hoffmann-La Roche); Abbott(Abbott Laboratories); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Centocor; Genmab(Genmab); Glaxo-Smith-Kline(GlaxoSmithKline); Mundipharma; Novo; Pfizer(Pfizer); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); UCB(UCB Pharma SA); Wyeth(Wyeth); Centocor/Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD/Schering-Plough(Merck & CompanySchering Plough Corporation); Pfizer/Wyeth(WyethPfizer); Research Council at Herlev Hospital, Copenhagen, Denmark	This study was supported by grants from The Danish Rheumatism Association, The Research Council at Herlev Hospital, Denmark, and Hoffmann-La Roche. Data analysis was performed in collaboration with employees of Compugen and Roche. The funders had no influence on data collection and decisions to publish. The study design and data analysis were conducted in collaboration between all co-authors.; The authors have read the journal's policy and have the following conflicts: MO has received consulting fees, speaking fees and/or research grants from Abbott, Amgen, Bristol-Myers Squibb, Centocor, Genmab, Glaxo-Smith-Kline, Mundipharma, Novo, Pfizer, Roche, Schering-Plough, UCB and Wyeth. MLH has received consulting fees, speaking fees and/or research grants from Abbott, Bristol-Myers Squibb, Centocor/Janssen, Glaxo-Smith-Kline, MSD/Schering-Plough, Pfizer/Wyeth, Roche, UCB. AW, ES, TZ, and PA are full time employees at Compugen. LE is a full time employee at Roche. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; The expert technical assistance of Teresa Rozenfeld, Department of Rheumatology, Copenhagen University Hospitals at Hvidovre and Glostrup, Copenhagen, Denmark is gratefully acknowledged. Henrik Skjodt, Inge Juul Sorensen, Uffe Moller Dohn, Lene Surland Knudsen, Michael Sejer Hansen, Soren Jacobsen, and Gina Kollerup are acknowledged for recruiting patients at the Copenhagen University Hospitals at Hvidovre, Herlev, Rigshospitalet, Bispebjerg and Gentofte, Copenhagen, Denmark. We also thank the patients who participated in this study. The study was supported by grants from The Danish Rheumatism Association, The Research Council at Herlev Hospital, Copenhagen, Denmark, and Hoffmann-La Roche.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bowes JD, 2009, PHARMACOGENET GENOM, V19, P319, DOI 10.1097/FPC.0b013e328328d51f; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cole SM, 2008, AM J MED GENET B, V147B, P86, DOI 10.1002/ajmg.b.30564; Coulthard LR, 2011, ANN RHEUM DIS, V70, P98, DOI 10.1136/ard.2010.133249; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cuchacovich M, 2006, SCAND J RHEUMATOL, V35, P435, DOI 10.1080/03009740600904284; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Dohn UM, 2009, ANN RHEUM DIS, V68, P1585, DOI 10.1136/ard.2008.097048; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Grant SFA, 2007, EXPERT REV MOL DIAGN, V7, P371, DOI 10.1586/14737159.7.4.371; Hammaker D, 2012, ARTHRITIS RHEUM-US, V64, P678, DOI 10.1002/art.33359; Hansen NT, 2009, CLIN PHARMACOL THER, V86, P183, DOI 10.1038/clpt.2009.42; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Ku CS, 2010, J HUM GENET, V55, P403, DOI 10.1038/jhg.2010.55; Landewe RBM, 2003, ARTHRITIS RHEUM, V48, P1, DOI 10.1002/art.10732; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Maxwell JR, 2008, HUM MOL GENET, V17, P3532, DOI 10.1093/hmg/ddn245; Mugnier B, 2003, ARTHRITIS RHEUM, V48, P1849, DOI 10.1002/art.11168; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nair P, 2010, CLIN EXP IMMUNOL, V162, P116, DOI 10.1111/j.1365-2249.2010.04235.x; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Padyukov L, 2003, ANN RHEUM DIS, V62, P526, DOI 10.1136/ard.62.6.526; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plenge RM, 2008, CURR OPIN RHEUMATOL, V20, P145, DOI 10.1097/BOR.0b013e3282f5135b; Potter C, 2010, ANN RHEUM DIS, V69, P1315, DOI 10.1136/ard.2009.117309; Potter C, 2010, PHARMACOGENET GENOM, V20, P338, DOI 10.1097/FPC.0b013e32833878d7; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantalaiho V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3060; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Scales SJ, 2002, J BIOL CHEM, V277, P28271, DOI 10.1074/jbc.M204929200; Soto L, 2011, CLIN RHEUMATOL, V30, P391, DOI 10.1007/s10067-011-1679-4; Suarez-Gestal M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2990; Tan RJL, 2010, ANN RHEUM DIS, V69, P1029, DOI 10.1136/ard.2009.118406; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1174, DOI 10.1136/ard.2008.088138; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	46	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38539	10.1371/journal.pone.0038539	http://dx.doi.org/10.1371/journal.pone.0038539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685579	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700042
J	Zug, R; Hammerstein, P				Zug, Roman; Hammerstein, Peter			Still a Host of Hosts for Wolbachia: Analysis of Recent Data Suggests That 40% of Terrestrial Arthropod Species Are Infected	PLOS ONE			English	Article							DIVERSITY; POPULATIONS; COLEOPTERA; PHYLOGENY; DIPTERA	Wolbachia are intracellular bacteria that manipulate the reproduction of their arthropod hosts in remarkable ways. They are predominantly transmitted vertically from mother to offspring but also occasionally horizontally between species. In doing so, they infect a huge range of arthropod species worldwide. Recently, a statistical analysis estimated the infection frequency of Wolbachia among arthropod hosts to be 66%. At the same time, the authors of this analysis highlighted some weaknesses of the underlying data and concluded that in order to improve the estimate, a larger number of individuals per species should be assayed and species be chosen more randomly. Here we apply the statistical approach to a more appropriate data set from a recent survey that tested both a broad range of species and a sufficient number of individuals per species. Indeed, we find a substantially different infection frequency: We now estimate the proportion of Wolbachia-infected species to be around 40% which is lower than the previous estimate but still points to a surprisingly high number of arthropods harboring the bacteria. Notwithstanding this difference, we confirm the previous result that, within a given species, typically most or only a few individuals are infected. Moreover, we extend our analysis to include several reproductive parasites other than Wolbachia that were also screened for in the aforementioned empirical survey. For these symbionts we find a large variation in estimated infection frequencies and corroborate the finding that Wolbachia are the most abundant endosymbionts among arthropod species.	[Zug, Roman; Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany	Humboldt University of Berlin	Zug, R (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	roman.zug@biologie.hu-berlin.de	Zug, Roman/ADE-3784-2022	Zug, Roman/0000-0002-9506-5362	Deutsche Forschungsgemeinschaft [SFB 618]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp), SFB 618: "Theoretical Biology: Robustness, Modularity and Evolutionary Design of Living Systems." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hughes GL, 2011, APPL ENVIRON MICROB, V77, P2165, DOI 10.1128/AEM.02878-10; Kondo NI, 2011, ZOOL SCI, V28, P501, DOI 10.2108/zsj.28.501; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; Sun X, 2007, ENVIRON ENTOMOL, V36, P1283, DOI 10.1603/0046-225X(2007)36[1283:DAPOWI]2.0.CO;2; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wiwatanaratanabutr I, 2009, ZOOL SCI, V26, P171, DOI 10.2108/zsj.26.171; Yun Y, 2011, NEOTROP ENTOMOL, V40, P164, DOI 10.1590/S1519-566X2011000200002	17	579	609	6	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38544	10.1371/journal.pone.0038544	http://dx.doi.org/10.1371/journal.pone.0038544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685581	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700044
J	Langlois-Klassen, D; Kunimoto, D; Saunders, LD; Chui, L; Boffa, J; Menzies, D; Long, R				Langlois-Klassen, Deanne; Kunimoto, Dennis; Saunders, L. Duncan; Chui, Linda; Boffa, Jody; Menzies, Dick; Long, Richard			A Population-Based Cohort Study of Mycobacterium tuberculosis Beijing Strains: An Emerging Public Health Threat in an Immigrant-Receiving Country?	PLOS ONE			English	Article							DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; TREATMENT FAILURE; FAMILY GENOTYPES; FOREIGN-BORN; ASSOCIATION; VIETNAM; LINEAGE; EPIDEMIOLOGY; SUBLINEAGES	Introduction: Mycobacterium tuberculosis Beijing strains are frequently associated with tuberculosis outbreaks and drug resistance. However, contradictory evidence and limited study generalizability make it difficult to foresee if the emergence of Beijing strains in high-income immigrant-receiving countries poses an increased public health threat. The purpose of this study was to determine if Beijing strains are associated with high risk disease presentations relative to other strains within Canada. Methods: This was a retrospective population-based study of culture-confirmed active TB cases in a major immigrant-receiving province of Canada in 1991 through 2007. Of 1,852 eligible cases, 1,826 (99%) were successfully genotyped. Demographic, clinical, and mycobacteriologic surveillance data were combined with molecular diagnostic data. The main outcome measures were site of disease, lung cavitation, sputum smear positivity, bacillary load, and first-line antituberculosis drug resistance. Results: A total of 350 (19%) patients had Beijing strains; 298 (85%) of these were born in the Western Pacific. Compared to non-Beijing strains, Beijing strains were significantly more likely to be associated with polyresistance (aOR 1.8; 95% CI 1.0-3.3; p = 0.046) and multidrug-resistance (aOR 3.4; 1.0-11.3; p = 0.049). Conversely, Beijing strains were no more likely than non-Beijing strains to be associated with respiratory disease (aOR 1.3; 1.0-1.8; p = 0.053), high bacillary load (aOR 1.2; 0.6-2.7), lung cavitation (aOR 1.0; 0.7-1.5), immediately life-threatening forms of tuberculosis (aOR 0.8; 0.5-1.6), and monoresistance (aOR 0.9; 0.6-1.3). In subgroup analyses, Beijing strains only had a significant association with multidrug-resistant tuberculosis (aOR 6.1; 1.2-30.4), and an association of borderline significance with polyresistant tuberculosis (aOR 1.8; 1.0-3.5; p = 0.062), among individuals born in the Western Pacific. Conclusion: Other than an increased risk of polyresistant or multidrug-resistant tuberculosis, Beijing strains appear to pose no more of a public health threat than non-Beijing strains within a high-income immigrant-receiving country.	[Langlois-Klassen, Deanne; Saunders, L. Duncan; Long, Richard] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Langlois-Klassen, Deanne; Boffa, Jody; Long, Richard] Univ Alberta, TB Program Evaluat & Res Unit, Edmonton, AB, Canada; [Kunimoto, Dennis; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Chui, Linda] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Chui, Linda] Prov Lab Publ Hlth, Edmonton, AB, Canada; [Menzies, Dick] McGill Univ, Ctr Hlth, Div Resp, Montreal, PQ, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; McGill University	Langlois-Klassen, D (corresponding author), Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada.	deanne.langlois-klassen@ualberta.ca		Langlois-Klassen, Deanne/0000-0002-4095-4234; Boffa, Jody/0000-0002-8183-6461; Kunimoto, Dennis/0000-0002-7691-5448	Canadian Institutes of Health Research (CIHR); Health Canada, First Nations and Inuit Health Branch (FNIHB); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship - Doctoral Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Health Canada, First Nations and Inuit Health Branch (FNIHB); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship - Doctoral Award(Canadian Institutes of Health Research (CIHR))	This investigation was supported by grants from the Canadian Institutes of Health Research (CIHR) and Health Canada, First Nations and Inuit Health Branch (FNIHB). D. Langlois-Klassen was also supported by the CIHR Frederick Banting and Charles Best Canada Graduate Scholarship - Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Borgdorff MW, 2003, EMERG INFECT DIS, V9, P1310; Borydorff MW, 2004, TUBERCULOSIS, V84, P337, DOI 10.1016/j.tube.2003.10.002; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Citizenship and Immigration Canada, 2009, ANN REP PARL IMM; Citizenship and Immigration Canada. Canada, 2009, FACTS FIG 2008 IMM O; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012259; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Jou RW, 2005, J CLIN MICROBIOL, V43, P95, DOI 10.1128/JCM.43.1.95-100.2005; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Kato-Maeda M, 2010, INT J TUBERC LUNG D, V14, P538; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Langlois-Klassen D, 2011, EUR RESPIR J, V38, P895, DOI 10.1183/09031936.00196610; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Li GL, 2010, BIOMED ENVIRON SCI, V23, P188, DOI 10.1016/S0895-3988(10)60051-7; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Long R, 2001, AM J EPIDEMIOL, V153, P903, DOI 10.1093/aje/153.9.903; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Martinez-Gamboa A, 2008, ARCH MED RES, V39, P809, DOI 10.1016/j.arcmed.2008.08.006; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Pepperell CS, 2011, P NATL ACAD SCI USA, V108, P6526, DOI 10.1073/pnas.1016708108; Public Health Agency of Canada, 2007, CAN TUB STAND; Qian LS, 1999, J CLIN MICROBIOL, V37, P471, DOI 10.1128/JCM.37.2.471-474.1999; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Statistics Canada, 2006, CUM PROF 2006 PROV T; Sun YJ, 2006, EPIDEMIOL INFECT, V134, P329, DOI 10.1017/S095026880500525X; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Crevel R, 2001, EMERG INFECT DIS, V7, P880; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; World Health Organization Regional Office for the Western Pacific, 2011, WHO W PAC REG COUNTR	62	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38431	10.1371/journal.pone.0038431	http://dx.doi.org/10.1371/journal.pone.0038431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679504	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900041
J	Martin-Rufian, M; Tosina, M; Campos-Sandoval, JA; Manzanares, E; Lobo, C; Segura, JA; Alonso, FJ; Mates, JM; Marquez, J				Martin-Rufian, Mercedes; Tosina, Marta; Campos-Sandoval, Jose A.; Manzanares, Elisa; Lobo, Carolina; Segura, J. A.; Alonso, Francisco J.; Mates, Jose M.; Marquez, Javier			Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism	PLOS ONE			English	Article							RAT HEPATIC GLUTAMINASE; MOLECULAR-CLONING; START SITES; EXPRESSION; METABOLISM; PROTEIN; IDENTIFICATION; LOCALIZATION; METHYLOME; SEQUENCE	Background: Glutaminase is expressed in most mammalian tissues and cancer cells, but the regulation of its expression is poorly understood. An essential step to accomplish this goal is the characterization of its species- and cell-specific isoenzyme pattern of expression. Our aim was to identify and characterize transcript variants of the mammalian glutaminase Gls2 gene. Methodology/Principal Findings: We demonstrate for the first time simultaneous expression of two transcript variants from the Gls2 gene in human, rat and mouse. A combination of RT-PCR, primer-extension analysis, bioinformatics, real-time PCR, in vitro transcription and translation and immunoblot analysis was applied to investigate GLS2 transcripts in mammalian tissues. Short (LGA) and long (GAB) transcript forms were isolated in brain and liver tissue of human, rat and mouse. The short LGA transcript arises by a combination of two mechanisms of transcriptional modulation: alternative transcription initiation and alternative promoter. The LGA variant contains both the transcription start site (TSS) and the alternative promoter in the first intron of the Gls2 gene. The full human LGA transcript has two in-frame ATGs in the first exon, which are missing in orthologous rat and mouse transcripts. In vitro transcription and translation of human LGA yielded two polypeptides of the predicted size, but only the canonical full-length protein displayed catalytic activity. Relative abundance of GAB and LGA transcripts showed marked variations depending on species and tissues analyzed. Conclusions/Significance: This is the first report demonstrating expression of alternative transcripts of the mammalian Gls2 gene. Transcriptional mechanisms giving rise to GLS2 variants and isolation of novel GLS2 transcripts in human, rat and mouse are presented. Results were also confirmed at the protein level, where catalytic activity was demonstrated for the human LGA protein. Relative abundance of GAB and LGA transcripts was species-and tissue-specific providing evidence of a differential regulation of GLS2 transcripts in mammals.	[Martin-Rufian, Mercedes; Tosina, Marta; Campos-Sandoval, Jose A.; Manzanares, Elisa; Lobo, Carolina; Segura, J. A.; Alonso, Francisco J.; Mates, Jose M.; Marquez, Javier] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, Lab Quim Prot, E-29071 Malaga, Spain	Universidad de Malaga	Martin-Rufian, M (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, Lab Quim Prot, E-29071 Malaga, Spain.	marquez@uma.es	Matés, José M./L-1350-2014; Campos-Sandoval, José/I-7375-2018; marquez, javier/K-3289-2012	Matés, José M./0000-0001-9795-1993; Campos-Sandoval, José/0000-0002-2457-9884; marquez, javier/0000-0003-3317-3963; Tosina Garcia, Marta/0000-0001-5057-2291; Alonso Carrion, Francisco Jose/0000-0002-9431-163X	Ministry of Science and Innovation of Spain [SAF2010-17573]; regional Andalusian government (Junta de Andalucia) [CVI-6656]; RTA RETICS (Universitat de les Illes Balears and Red Tematica de Investigacion Cooperativa en Salud network from the Spanish Health Institute Carlos III) [RD06/1012]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional Andalusian government (Junta de Andalucia)(Junta de Andalucia); RTA RETICS (Universitat de les Illes Balears and Red Tematica de Investigacion Cooperativa en Salud network from the Spanish Health Institute Carlos III)	This work was supported by Grant SAF2010-17573 from the Ministry of Science and Innovation of Spain, Excellence Grant CVI-6656 from the regional Andalusian government (Junta de Andalucia), and Grant RD06/1012 of the RTA RETICS (Universitat de les Illes Balears and Red Tematica de Investigacion Cooperativa en Salud network from the Spanish Health Institute Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledo JC, 2000, MAMM GENOME, V11, P1107, DOI 10.1007/s003350010190; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campos JA, 2003, BBA-PROTEINS PROTEOM, V1648, P17, DOI 10.1016/S1570-9639(03)00026-8; Campos-Sandoval JA, 2007, INT J BIOCHEM CELL B, V39, P765, DOI 10.1016/j.biocel.2006.12.002; Castell L, 2004, J BIOL CHEM, V279, P13305, DOI 10.1074/jbc.M309520200; ChungBok MI, 1997, BIOCHEM J, V324, P193, DOI 10.1042/bj3240193; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; de la Rosa V, 2009, NEUROCHEM INT, V55, P76, DOI 10.1016/j.neuint.2009.02.021; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gomez-Fabre PM, 2000, BIOCHEM J, V345, P365, DOI 10.1042/0264-6021:3450365; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; Marquez Javier, 2010, Biomol Concepts, V1, P3, DOI 10.1515/bmc.2010.006; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; Olalla L, 2002, J BIOL CHEM, V277, P38939, DOI 10.1074/jbc.C200373200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996; Perez-Gomez C, 2003, BIOCHEM J, V370, P771, DOI 10.1042/BJ20021445; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Porter LD, 2002, PHYSIOL GENOMICS, V9, P157, DOI 10.1152/physiolgenomics.00017.2002; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SMITH EM, 1990, J BIOL CHEM, V265, P10631; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Turner A, 2003, BIOCHEM J, V370, P403, DOI 10.1042/BJ20021360; Vousden KH, 2010, P NATL ACAD SCI USA, V107, P7117, DOI 10.1073/pnas.1002656107; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yamashita R, 2005, GENE, V350, P129, DOI 10.1016/j.gene.2005.01.012; YOUNG RA, 1981, CELL, V23, P451, DOI 10.1016/0092-8674(81)90140-9	44	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38380	10.1371/journal.pone.0038380	http://dx.doi.org/10.1371/journal.pone.0038380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679499	Green Published, gold			2022-12-25	WOS:000305343900032
J	Atak, ZK; De Keersmaecker, K; Gianfelici, V; Geerdens, E; Vandepoel, R; Pauwels, D; Porcu, M; Lahortiga, I; Brys, V; Dirks, WG; Quentmeier, H; Cloos, J; Cuppens, H; Uyttebroeck, A; Vandenberghe, P; Cools, J; Aerts, S				Atak, Zeynep Kalender; De Keersmaecker, Kim; Gianfelici, Valentina; Geerdens, Ellen; Vandepoel, Roel; Pauwels, Daphnie; Porcu, Michael; Lahortiga, Idoya; Brys, Vanessa; Dirks, Willy G.; Quentmeier, Hilmar; Cloos, Jacqueline; Cuppens, Harry; Uyttebroeck, Anne; Vandenberghe, Peter; Cools, Jan; Aerts, Stein			High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes	PLOS ONE			English	Article							ACTIVATING MUTATIONS; JAK3; TET2; EXPRESSION; DISCOVERY; FREQUENCY; ALIGNMENT; NOTCH1; PTEN	With the advent of whole-genome and whole-exome sequencing, high-quality catalogs of recurrently mutated cancer genes are becoming available for many cancer types. Increasing access to sequencing technology, including bench-top sequencers, provide the opportunity to re-sequence a limited set of cancer genes across a patient cohort with limited processing time. Here, we re-sequenced a set of cancer genes in T-cell acute lymphoblastic leukemia (T-ALL) using Nimblegen sequence capture coupled with Roche/454 technology. First, we investigated how a maximal sensitivity and specificity of mutation detection can be achieved through a benchmark study. We tested nine combinations of different mapping and variant-calling methods, varied the variant calling parameters, and compared the predicted mutations with a large independent validation set obtained by capillary re-sequencing. We found that the combination of two mapping algorithms, namely BWA-SW and SSAHA2, coupled with the variant calling algorithm Atlas-SNP2 yields the highest sensitivity (95%) and the highest specificity (93%). Next, we applied this analysis pipeline to identify mutations in a set of 58 cancer genes, in a panel of 18 T-ALL cell lines and 15 T-ALL patient samples. We confirmed mutations in known T-ALL drivers, including PHF6, NF1, FBXW7, NOTCH1, KRAS, NRAS, PIK3CA, and PTEN. Interestingly, we also found mutations in several cancer genes that had not been linked to T-ALL before, including JAK3. Finally, we re-sequenced a small set of 39 candidate genes and identified recurrent mutations in TET1, SPRY3 and SPRY4. In conclusion, we established an optimized analysis pipeline for Roche/454 data that can be applied to accurately detect gene mutations in cancer, which led to the identification of several new candidate T-ALL driver mutations.	[Atak, Zeynep Kalender; De Keersmaecker, Kim; Gianfelici, Valentina; Geerdens, Ellen; Vandepoel, Roel; Pauwels, Daphnie; Porcu, Michael; Lahortiga, Idoya; Vandenberghe, Peter; Cools, Jan; Aerts, Stein] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Gianfelici, Valentina; Geerdens, Ellen; Vandepoel, Roel; Pauwels, Daphnie; Porcu, Michael; Lahortiga, Idoya; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium; [Brys, Vanessa; Cuppens, Harry] Univ Hosp Leuven, Louvain, Belgium; [Dirks, Willy G.; Quentmeier, Hilmar] Deutsch Sammlung Mikroorganismen & Zellkulturen G, Braunschweig, Germany; [Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Atak, ZK (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	jan.cools@cme.vib-kuleuven.be; stein.aerts@med.kuleuven.be	Atak, Zeynep Kalender/AAW-1560-2020; Aerts, Stein/A-1100-2009; Gianfelici, Valentina/AAA-8632-2020; De Keersmaecker, Kim/W-9702-2018	Atak, Zeynep Kalender/0000-0003-4761-8169; Aerts, Stein/0000-0002-8006-0315; De Keersmaecker, Kim/0000-0002-7420-9531; Dirks, Wilhelm/0000-0001-9781-0998; Gianfelici, Valentina/0000-0003-3326-091X; Cools, Jan/0000-0001-6626-5843; Cloos, Jacqueline/0000-0001-9150-8026; Vandenberghe, Peter/0000-0003-4719-1935; Porcu, Michael/0000-0002-9369-5547	Belgian federal government (Cancer Plan - Translational Research); K. U. Leuven [GOA/11/010, PF/10/016 SymBioSys]; Foundation Against Cancer [2010-154]; FWO-Vlaanderen [G.0287.07]; European Research Council (ERC); FWO-Vlaanderen; Agentschap voor Innovatie door Wetenschap en Technologie	Belgian federal government (Cancer Plan - Translational Research); K. U. Leuven(KU Leuven); Foundation Against Cancer; FWO-Vlaanderen(FWO); European Research Council (ERC)(European Research Council (ERC)European Commission); FWO-Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Technologie	This work was supported by the Belgian federal government (Cancer Plan - Translational Research), the K. U. Leuven (grant GOA/11/010 to J. Cools and PV; grant PF/10/016 SymBioSys to J. Cools and SA), the Foundation Against Cancer (grant 2010-154 to SA), the FWO-Vlaanderen (G.0287.07, J. Cools), and the European Research Council (ERC-starting grant to J. Cools). KDK is a postdoctoral researcher funded by the FWO-Vlaanderen, PV is a Senior Clinical Investigator supported by FWO-Vlaanderen, DP and MP are funded by Agentschap voor Innovatie door Wetenschap en Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Cornejo MG, 2009, BLOOD, V113, P2746, DOI 10.1182/blood-2008-06-164368; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Elliott NE, 2011, BLOOD, V118, P3911, DOI 10.1182/blood-2010-12-319467; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Heesch S, 2010, HAEMATOL-HEMATOL J, V95, P942, DOI 10.3324/haematol.2009.016386; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krieger D, 2010, HAEMATOL-HEMATOL J, V95, P158, DOI 10.3324/haematol.2009.007526; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117	38	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38463	10.1371/journal.pone.0038463	http://dx.doi.org/10.1371/journal.pone.0038463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675565	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700077
J	Germain, M; Saut, N; Oudot-Mellakh, T; Letenneur, L; Dupuy, AM; Bertrand, M; Alessi, MC; Lambert, JC; Zelenika, D; Emmerich, J; Tiret, L; Cambien, F; Lathrop, M; Amouyel, P; Morange, PE; Tregouet, DA				Germain, Marine; Saut, Noemie; Oudot-Mellakh, Tiphaine; Letenneur, Luc; Dupuy, Anne-Marie; Bertrand, Marion; Alessi, Marie-Christine; Lambert, Jean-Charles; Zelenika, Diana; Emmerich, Joseph; Tiret, Laurence; Cambien, Francois; Lathrop, Mark; Amouyel, Philippe; Morange, Pierre-Emmanuel; Tregouet, David-Alexandre			Caution in Interpreting Results from Imputation Analysis When Linkage Disequilibrium Extends over a Large Distance: A Case Study on Venous Thrombosi	PLOS ONE			English	Article							BLOOD-LOSS; ASSOCIATION; GENE	By applying an imputation strategy based on the 1000 Genomes project to two genome-wide association studies (GWAS), we detected a susceptibility locus for venous thrombosis on chromosome 11p11.2 that was missed by previous GWAS analyses that had been conducted on the same datasets. A comprehensive linkage disequilibrium and haplotype analysis of the whole locus where twelve SNPs exhibited association p-values lower than 2.23 10(-11) and the use of independent case-control samples demonstrated that the culprit variant was a rare variant located similar to 1 Mb away from the original hits, not tagged by current genome-wide genotyping arrays and even not well imputed in the original GWAS samples. This variant was in fact the rs1799963, also known as the FII G20210A prothrombin mutation. This work may be of major interest not only for its scientific impact but also for its methodological findings.	[Germain, Marine; Oudot-Mellakh, Tiphaine; Tiret, Laurence; Cambien, Francois; Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMR S 937, ICAN Inst, Paris, France; [Saut, Noemie; Alessi, Marie-Christine; Morange, Pierre-Emmanuel] Univ Mediterranee, INSERM, UMR S 1062, Marseille, France; [Letenneur, Luc] Univ Victor Segalen, INSERM, UMR S 897, Bordeaux, France; [Dupuy, Anne-Marie] Hop La Colombiere, INSERM, UMR S 888, Montpellier, France; [Bertrand, Marion] Univ Paris 06, INSERM, UMR S 708, Paris, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Inst Pasteur Lille, INSERM, UMR S 744, Lille, France; [Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atom, Evry, France; [Emmerich, Joseph] Univ Paris 05, Hop Europeen Georges Pompidou, INSERM, UMR S 765, Paris, France; [Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille	Germain, M (corresponding author), Univ Paris 06, INSERM, UMR S 937, ICAN Inst, Paris, France.	pierre.morange@ap-hm.fr; david.tregouet@upmc.fr	LETENNEUR, Luc/T-4424-2019; Trégouët, David-Alexandre/P-9210-2019; Cambien, Francois/AAP-9751-2020; ALESSI, Marie-christine/AAK-3582-2020; Tregouet, David-Alexandre/E-3961-2016; Lambert, jean-charles/A-9553-2014; Morange, Pierre/T-9070-2019; lambert, jean-charles/F-8787-2013	LETENNEUR, Luc/0000-0002-3274-937X; Trégouët, David-Alexandre/0000-0001-9084-7800; ALESSI, Marie-christine/0000-0003-3927-5792; Lambert, jean-charles/0000-0003-0829-7817; Morange, Pierre/0000-0002-9065-722X; lambert, jean-charles/0000-0003-0829-7817; Germain, Marine/0000-0002-8489-8916; Amouyel, Philippe/0000-0001-9088-234X; dupuy, anne marie/0000-0001-6538-3944	Agence Nationale pour la Recherche [ANR-07-MRAR-021]; Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV); Fondation pour la Recherche Medicale; Program Hospitalier de Recherche Clinique; Program Hospitalier de recherche Clinique [20002]; Fondation de France; Leducq Foundation; Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon; Ministry of Research-Inserm Programme 'Cohorts and collection of biological material	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Program Hospitalier de Recherche Clinique; Program Hospitalier de recherche Clinique; Fondation de France(Fondation de France); Leducq Foundation(Leducq Foundation); Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon(Region Occitanie); Ministry of Research-Inserm Programme 'Cohorts and collection of biological material	MG was supported by grants funded by the Agence Nationale pour la Recherche (Project ANR-07-MRAR-021) and the Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV). TOM was supported by a grant from the Fondation pour la Recherche Medicale. The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique and the FARIVE study by grants from the Fondation pour la Recherche Medicale, the Program Hospitalier de recherche Clinique (PHRC 20002; PHRC2009 RENOVA-TV), the Fondation de France, and the Leducq Foundation. The 3C Study is conducted under a partnership agreement between Inserm, the Victor Segalen -Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and first phase of the study. The 3C-Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, the Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme 'Cohorts and collection of biological material'. The Lille Genopole received an unconditional grant from Eisai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Day-Williams AG, 2011, AM J HUM GENET, V89, P446, DOI 10.1016/j.ajhg.2011.08.001; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Han S, 2011, HUM MOL GENET; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindqvist PG, 1998, THROMB HAEMOSTASIS, V79, P69; Lindqvist PG, 2001, THROMB HAEMOSTASIS, V86, P1122; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MANTEL N, 1959, J NATL CANCER I, V22, P719; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	20	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38538	10.1371/journal.pone.0038538	http://dx.doi.org/10.1371/journal.pone.0038538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675575	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700087
J	Linden, DEJ; Habes, I; Johnston, SJ; Linden, S; Tatineni, R; Subramanian, L; Sorger, B; Healy, D; Goebel, R				Linden, David E. J.; Habes, Isabelle; Johnston, Stephen J.; Linden, Stefanie; Tatineni, Ranjit; Subramanian, Leena; Sorger, Bettina; Healy, David; Goebel, Rainer			Real-Time Self-Regulation of Emotion Networks in Patients with Depression	PLOS ONE			English	Article							THOUGHT CONTROL; INDIVIDUAL-DIFFERENCES; CORTICAL ACTIVITY; BRAIN; VALIDATION; ACTIVATION; THERAPY; QUESTIONNAIRE; RESPONSES; REWARD	Many patients show no or incomplete responses to current pharmacological or psychological therapies for depression. Here we explored the feasibility of a new brain self-regulation technique that integrates psychological and neurobiological approaches through neurofeedback with functional magnetic resonance imaging (fMRI). In a proof-of-concept study, eight patients with depression learned to upregulate brain areas involved in the generation of positive emotions (such as the ventrolateral prefrontal cortex (VLPFC) and insula) during four neurofeedback sessions. Their clinical symptoms, as assessed with the 17-item Hamilton Rating Scale for Depression (HDRS), improved significantly. A control group that underwent a training procedure with the same cognitive strategies but without neurofeedback did not improve clinically. Randomised blinded clinical trials are now needed to exclude possible placebo effects and to determine whether fMRI-based neurofeedback might become a useful adjunct to current therapies for depression.	[Linden, David E. J.; Habes, Isabelle; Subramanian, Leena; Healy, David] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Sch Med, Cardiff, S Glam, Wales; [Linden, David E. J.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Linden, David E. J.; Habes, Isabelle; Sorger, Bettina; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Johnston, Stephen J.] Brunel Univ, Sch Social Sci, Uxbridge UB8 3PH, Middx, England; [Linden, Stefanie] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Tatineni, Ranjit; Healy, David] Betsi Cadwaladr Univ Hlth Board, Mental Hlth Serv, Bangor, Gwynedd, Wales	Cardiff University; Bangor University; Maastricht University; Brunel University; University of London; King's College London	Linden, DEJ (corresponding author), Cardiff Univ, Inst Psychol Med & Clin Neurosci, Sch Med, Cardiff, S Glam, Wales.	LindenD@cardiff.ac.uk	Linden, David/S-9948-2019; Linden, David E J/C-7355-2013	Linden, David/0000-0002-5638-9292; Linden, David E J/0000-0002-5638-9292; Sorger, Bettina/0000-0003-1393-3144; Johnston, Stephen/0000-0001-9360-8856; Goebel, Rainer/0000-0003-1780-2467	Wales Institute of Cognitive Neuroscience; Welsh Assembly Government; Medical Research Council [G1100629/1]; MRC [G1100629] Funding Source: UKRI; Medical Research Council [G0801418B, G1100629] Funding Source: researchfish	Wales Institute of Cognitive Neuroscience; Welsh Assembly Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wales Institute of Cognitive Neuroscience with funds from the Welsh Assembly Government and by the Medical Research Council (grant reference G1100629/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, MANUAL PROFILES MOOD; Bandura A, 1997, SELF EFFICACY EXERCI; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Heubeck BG, 1998, PERS INDIV DIFFER, V25, P785, DOI 10.1016/S0191-8869(98)00124-X; Jarrett RB, 2001, ARCH GEN PSYCHIAT, V58, P381, DOI 10.1001/archpsyc.58.4.381; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lang P. J., 1999, INT AFFECTIVE PICTUR; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Luciano JV, 2005, PERS INDIV DIFFER, V38, P997, DOI 10.1016/j.paid.2004.06.020; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Merkl A, 2009, EXP NEUROL, V219, P20, DOI 10.1016/j.expneurol.2009.04.027; Nyenhuis DL, 1999, J CLIN PSYCHOL, V55, P79, DOI 10.1002/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Ruhc HG, 2011, J CLIN PSYCHIAT 0809; Ruiz S, 2011, HUM BRAIN M IN PRESS; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; SELMI PM, 1990, AM J PSYCHIAT, V147, P51; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; WELLS A, 1994, BEHAV RES THER, V32, P871, DOI 10.1016/0005-7967(94)90168-6; Williams AD, 2010, J PSYCHOPATHOL BEHAV, V32, P397, DOI 10.1007/s10862-009-9171-z; Yoo SS, 2006, NEUROREPORT, V17, P1273, DOI 10.1097/01.wnr.0000227996.53540.22; Zotev V, 2010, PLOS ONE, V6, P1	44	245	247	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38115	10.1371/journal.pone.0038115	http://dx.doi.org/10.1371/journal.pone.0038115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675513	Green Accepted, Green Published, gold			2022-12-25	WOS:000305341700039
J	McCormick, A; Jacobsen, ID; Broniszewska, M; Beck, J; Heesemann, J; Ebel, F				McCormick, Allison; Jacobsen, Ilse D.; Broniszewska, Marzena; Beck, Julia; Heesemann, Juergen; Ebel, Frank			The Two-Component Sensor Kinase TcsC and Its Role in Stress Resistance of the Human-Pathogenic Mold Aspergillus fumigatus	PLOS ONE			English	Article							NIKA HISTIDINE KINASE; SIGNAL-TRANSDUCTION; RESPONSE REGULATORS; SYSTEM; INVOLVEMENT; ADAPTATION; PROTEINS; NIDULANS; GENES; SAKA	Two-component signaling systems are widespread in bacteria, but also found in fungi. In this study, we have characterized TcsC, the only Group III two-component sensor kinase of Aspergillus fumigatus. TcsC is required for growth under hyperosmotic stress, but dispensable for normal growth, sporulation and conidial viability. A characteristic feature of the Delta tcsC mutant is its resistance to certain fungicides, like fludioxonil. Both hyperosmotic stress and treatment with fludioxonil result in a TcsC-dependent phosphorylation of SakA, the final MAP kinase in the high osmolarity glycerol (HOG) pathway, confirming a role for TcsC in this signaling pathway. In wild type cells fludioxonil induces a TcsC-dependent swelling and a complete, but reversible block of growth and cytokinesis. Several types of stress, such as hypoxia, exposure to farnesol or elevated concentrations of certain divalent cations, trigger a differentiation in A. fumigatus toward a "fluffy" growth phenotype resulting in white, dome-shaped colonies. The Delta tcsC mutant is clearly more susceptible to these morphogenetic changes suggesting that TcsC normally antagonizes this process. Although TcsC plays a role in the adaptation of A. fumigatus to hypoxia, it seems to be dispensable for virulence.	[McCormick, Allison; Broniszewska, Marzena; Beck, Julia; Heesemann, Juergen; Ebel, Frank] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Jacobsen, Ilse D.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Heesemann, Juergen] Univ Munich, Ctr Integrated Prot Sci Munich, Fac Med, Munich, Germany	University of Munich; Hans Knoll Institute (HKI); University of Munich	McCormick, A (corresponding author), Univ Munich, Max von Pettenkofer Inst, Munich, Germany.	ebel@mvp.uni-meunchen.de	Ebel, Frank/AAF-2303-2022; Ebel, Frank/AFH-1488-2022; Jacobsen, Ilse/B-3155-2011	Ebel, Frank/0000-0002-1027-1440; Ebel, Frank/0000-0002-1027-1440; Jacobsen, Ilse/0000-0002-6033-9984; Seeger, Allison/0000-0002-5332-3722	LMUexcellent program [ZUK22]; Wilhelm-Sander-Foundation [2007.102.2]; Center of Integrated Protein Science (Munich) [Forschungssaule B]	LMUexcellent program; Wilhelm-Sander-Foundation; Center of Integrated Protein Science (Munich)	This work was supported by the LMUexcellent program (grant number: ZUK22; www.unimuenchen.de/excellent/), a grant of the Wilhelm-Sander-Foundation to F. E. (grant number: 2007.102.2; www.sanst.de/) and a grant of the Center of Integrated Protein Science (Munich) to J.H. (grant: Forschungssaule B; www.cipsm.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Ben-Ami R, 2010, VIRULENCE, V1, P164, DOI 10.4161/viru.1.3.11750; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Dichtl K, 2010, MOL MICROBIOL, V76, P1191, DOI 10.1111/j.1365-2958.2010.07170.x; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P844, DOI 10.1271/bbb.70051; Hagiwara D, 2009, BIOSCI BIOTECH BIOCH, V73, P1566, DOI 10.1271/bbb.90063; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; Hill TW., 2001, FUNGAL GENET NEWSL, V48, P20, DOI [DOI 10.4148/1941-4765.1173, 10.4148/1941-4765.1173]; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Kojima K, 2004, MOL MICROBIOL, V53, P1785, DOI 10.1111/j.1365-2958.2004.04244.x; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Li DM, 2010, CURR OPIN MICROBIOL, V13, P424, DOI 10.1016/j.mib.2010.04.007; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Santos J L, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.98.re1; Shimizu K, 2001, GENETICS, V157, P591; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; Vargas-Perez I, 2007, EUKARYOT CELL, V6, P1570, DOI 10.1128/EC.00085-07; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x	30	36	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38262	10.1371/journal.pone.0038262	http://dx.doi.org/10.1371/journal.pone.0038262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675534	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700053
J	Pena, J; Harris, E				Pena, Jose; Harris, Eva			Early Dengue Virus Protein Synthesis Induces Extensive Rearrangement of the Endoplasmic Reticulum Independent of the UPR and SREBP-2 Pathway	PLOS ONE			English	Article							STEROL REGULATORY ELEMENT; HEPATITIS-C VIRUS; FATTY-ACID SYNTHESIS; LIPID DROPLET; VIRAL REPLICATION; BINDING-PROTEIN; ER STRESS; MEMBRANE-ALTERATIONS; RNA REPLICATION; INFECTED CELLS	The rearrangement of intracellular membranes has been long reported to be a common feature in diseased cells. In this study, we used dengue virus (DENV) to study the role of the unfolded protein response (UPR) and sterol-regulatory-element-binding-protein-2 (SREBP-2) pathway in the rearrangement and expansion of the endoplasmic reticulum (ER) early after infection. Using laser scanning confocal and differential interference contrast microscopy, we demonstrate that rearrangement and expansion of the ER occurs early after DENV-2 infection. Through the use of mouse embryonic fibroblast cells deficient in XBP1 and ATF6, we show that ER rearrangement early after DENV infection is independent of the UPR. We then demonstrate that enlargement of the ER is independent of the SREBP-2 activation and upregulation of 3-hydroxy-3-methylglutaryl-Coenzyme-A reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway. We further show that this ER rearrangement is not inhibited by the treatment of DENV-infected cells with the cholesterol-inhibiting drug lovastatin. Using the transcription inhibitor actinomycin D and the translation elongation inhibitor cycloheximide, we show that de novo viral protein synthesis but not host transcription is necessary for expansion and rearrangement of the ER. Lastly, we demonstrate that viral infection induces the reabsorption of lipid droplets into the ER. Together, these results demonstrate that modulation of intracellular membrane architecture of the cell early after DENV-2 infection is driven by viral protein expression and does not require the induction of the UPR and SREBP-2 pathways. This work paves the way for further study of virally-induced membrane rearrangements and formation of cubic membranes.	[Pena, Jose; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Pena, Jose; Harris, Eva] Univ Calif Berkeley, Grad Grp Microbiol, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pena, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	jpena360@yahoo.com; eharris@berkeley.edu			National Institutes of Health [AI052324]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI052324 to EH and an National Institutes of Health supplemental grant to JP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almsherqi ZA, 2009, INT REV CEL MOL BIO, V274, P275, DOI 10.1016/S1937-6448(08)02006-6; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Chua JJE, 2004, VIRUS RES, V102, P151, DOI 10.1016/j.virusres.2004.01.025; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Deng Y, 2010, TRENDS CELL BIOL, V20, P371, DOI 10.1016/j.tcb.2010.04.001; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gouttenoire J, J VIROL, V84, P12529; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Higashi Y, 2003, J BIOL CHEM, V278, P21450, DOI 10.1074/jbc.M301376200; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Roingeard P, 2011, BIOL CELL, V103, P223, DOI 10.1042/BC20100119; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sandig G, 1999, DRUG METAB REV, V31, P393, DOI 10.1081/DMR-100101926; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	69	52	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38202	10.1371/journal.pone.0038202	http://dx.doi.org/10.1371/journal.pone.0038202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675522	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341700045
J	Wu, K; Dong, DD; Fang, H; Levillain, F; Jin, W; Mei, J; Gicquel, B; Du, YZ; Wang, KK; Gao, Q; Neyrolles, O; Zhang, J				Wu, Kang; Dong, Dandan; Fang, Hai; Levillain, Florence; Jin, Wen; Mei, Jian; Gicquel, Brigitte; Du, Yanzhi; Wang, Kankan; Gao, Qian; Neyrolles, Olivier; Zhang, Ji			An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; IFN-GAMMA; EXPRESSION; BIOINFORMATICS; VISUALIZATION; ACTIVATION; PROGRAMS; DRIVEN; SPREAD; FAMILY	The W-Beijing family of Mycobacterium tuberculosis (Mtb) strains is known for its high-prevalence and -virulence, as well as for its genetic diversity, as recently reported by our laboratories and others. However, little is known about how the immune system responds to these strains. To explore this issue, here we used reverse engineering and genome-wide expression profiling of human macrophage-like THP-1 cells infected by different Mtb strains of the W-Beijing family, as well as by the reference laboratory strain H37Rv. Detailed data mining revealed that host cell transcriptome responses to H37Rv and to different strains of the W-Beijing family are similar and overwhelmingly induced during Mtb infections, collectively typifying a robust gene expression signature ("THP1r2Mtb-induced signature"). Analysis of the putative transcription factor binding sites in promoter regions of genes in this signature identified several key regulators, namely STATs, IRF-1, IRF-7, and Oct-1, commonly involved in interferon-related immune responses. The THP1r2Mtb-induced signature appeared to be highly relevant to the interferon-inducible signature recently reported in active pulmonary tuberculosis patients, as revealed by cross-signature and cross-module comparisons. Further analysis of the publicly available transcriptome data from human patients showed that the signature appears to be relevant to active pulmonary tuberculosis patients and their clinical therapy, and be tuberculosis specific. Thus, our results provide an additional layer of information at the transcriptome level on mechanisms involved in host macrophage response to Mtb, which may also implicate the robustness of the cellular defense system that can effectively fight against genetic heterogeneity in this pathogen.	[Wu, Kang; Fang, Hai; Jin, Wen; Wang, Kankan; Zhang, Ji] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wu, Kang; Fang, Hai; Jin, Wen; Wang, Kankan; Zhang, Ji] Shanghai Jiao Tong Univ, Sino French Res Ctr Life Sci & Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wu, Kang; Fang, Hai; Du, Yanzhi; Zhang, Ji] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China; [Dong, Dandan; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Levillain, Florence; Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Levillain, Florence; Neyrolles, Olivier] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Mei, Jian] Shanghai Municipal CDC, Dept TB Control, Shanghai, Peoples R China; [Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wu, K (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	olivier.neyrolles@ipbs.fr; jizhang@sibs.ac.cn	Neyrolles, Olivier/AAG-3692-2019	Neyrolles, Olivier/0000-0003-0047-5885; Wu, Kang/0000-0002-9024-795X	European Community [200973, LSHP-CT-2006-037919]; National Natural Science Foundation Grants of China [90919059, 30730033, 31171257, 30971623, 81170503]; Chinese Academy of Sciences [KSCX1-YW-22-01, KSCX2-EW-Q-1-08]; Ministry of Science and Technology of China [2009CB825607]; Shanghai Commission of Science and Technology [09410706500]; Centre de la Recherche Scientifique (CNRS); Institut Pasteur; CNRS-ATIP	European Community(European Commission); National Natural Science Foundation Grants of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Centre de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); CNRS-ATIP(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by the European Community (FP7 project TB-VIR, grant no. 200973, and FP6 project TB-ADAPT, grant no. LSHP-CT-2006-037919). Also, this work was supported in part by National Natural Science Foundation Grants of China (90919059, 30730033, 31171257, 30971623, and 81170503), Chinese Academy of Sciences (KSCX1-YW-22-01, and KSCX2-EW-Q-1-08), Ministry of Science and Technology of China (2009CB825607), and the Shanghai Commission of Science and Technology (09410706500), the Centre de la Recherche Scientifique (CNRS) and the Institut Pasteur. ON is a fellow of a CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameixa C, 2001, INFECT IMMUN, V69, P2470, DOI 10.1128/IAI.69.4.2470-2476.2001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2002, GENOME BIOL, V3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang H, 2011, OMICS, V15, P483, DOI 10.1089/omi.2010.0066; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Lyadova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010469; Mesplede T, 2005, MOL CELL BIOL, V25, P8717, DOI 10.1128/MCB.25.19.8717-8731.2005; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Olmos S, 2010, J IMMUNOL, V184, P895, DOI 10.4049/jimmunol.0901230; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Remoli ME, 2002, J IMMUNOL, V169, P366, DOI 10.4049/jimmunol.169.1.366; Saito K, 2006, J IMMUNOL, V176, P2496, DOI 10.4049/jimmunol.176.4.2496; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schnappinger D, 2006, MICROBES INFECT, V8, P1132, DOI 10.1016/j.micinf.2005.10.027; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X	53	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38367	10.1371/journal.pone.0038367	http://dx.doi.org/10.1371/journal.pone.0038367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675550	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700064
J	Caroselli, E; Zaccanti, F; Mattioli, G; Falini, G; Levy, O; Dubinsky, Z; Goffredo, S				Caroselli, Erik; Zaccanti, Francesco; Mattioli, Guido; Falini, Giuseppe; Levy, Oren; Dubinsky, Zvy; Goffredo, Stefano			Growth and Demography of the Solitary Scleractinian Coral Leptopsammia pruvoti along a Sea Surface Temperature Gradient in the Mediterranean Sea	PLOS ONE			English	Article							BALANOPHYLLIA-EUROPAEA SCLERACTINIA; MASS-MORTALITY; POPULATION-DYNAMICS; SEXUAL REPRODUCTION; COLONY SIZE; DENSITY; DENDROPHYLLIIDAE; CALCIFICATION; RECRUITMENT; STRATEGIES	The demographic traits of the solitary azooxanthellate scleractinian Leptopsammia pruvoti were determined in six populations on a sea surface temperature (SST) gradient along the western Italian coasts. This is the first investigation of the growth and demography characteristics of an azooxanthellate scleractinian along a natural SST gradient. Growth rate was homogeneous across all populations, which spanned 7 degrees of latitude. Population age structures differed between populations, but none of the considered demographic parameters correlated with SST, indicating possible effects of local environmental conditions. Compared to another Mediterranean solitary scleractinian, Balanophyllia europaea, zooxanthellate and whose growth, demography and calcification have been studied in the same sites, L. pruvoti seems more tolerant to temperature increase. The higher tolerance of L. pruvoti, relative to B. europaea, may rely on the absence of symbionts, and thus the lack of an inhibition of host physiological processes by the heat-stressed zooxanthellae. However, the comparison between the two species must be taken cautiously, due to the likely temperature differences between the two sampling depths. Increasing research effort on determining the effects of temperature on the poorly studied azooxanthellate scleractinians may shed light on the possible species assemblage shifts that are likely to occur during the current century as a consequence of global climatic change.	[Caroselli, Erik; Zaccanti, Francesco; Goffredo, Stefano] Alma Mater Studiorum Univ Bologna, Dept Evolutionary & Expt Biol, Marine Sci Grp, Bologna, Italy; [Mattioli, Guido] Hosp Porretta Terme, Operat Unit Radiol & Diagnost Images, Porretta Terme, Italy; [Falini, Giuseppe] Univ Bologna, Dept Chem, Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	University of Bologna; University of Bologna; Bar Ilan University	Caroselli, E (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Evolutionary & Expt Biol, Marine Sci Grp, Bologna, Italy.	stefano.goffredo@marinesciencegroup.org	Caroselli, Erik/GXW-2445-2022	goffredo, stefano/0000-0002-5022-9503; CAROSELLI, ERIK/0000-0001-6434-5663	European Research Council under the European Union's Seventh Framework Programme [249930]; Associazione dei Tour Operator Italiani (ASTOI); Marine and Freshwater Science Group Association; Ministry of Education, University and Research (MIUR)	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Associazione dei Tour Operator Italiani (ASTOI); Marine and Freshwater Science Group Association; Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no [249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea]. This research was financed by the Associazione dei Tour Operator Italiani (ASTOI), the Marine and Freshwater Science Group Association, and the Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Bablet J. P., 1985, P 5 INT COR REEF S, V4, P361; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; BARNES DJ, 1988, J EXP MAR BIOL ECOL, V121, P37, DOI 10.1016/0022-0981(88)90022-6; Bastidas C, 2004, HYDROBIOLOGIA, V530, P433, DOI 10.1007/s10750-004-2663-7; BEVERTON R. J. H., 1956, RAPPORTS PROCES VERB, V140, P67; BOSSCHER H, 1993, CORAL REEFS, V12, P97, DOI 10.1007/BF00302109; Brahmi C, 2010, CORAL REEFS, V29, P175, DOI 10.1007/s00338-009-0557-x; Buddemeier R.W., 1976, Oceanography and Marine Biology an Annual Review, V14, P183; Caroselli E, 2011, ZOOLOGY, V114, P255, DOI 10.1016/j.zool.2011.04.003; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Chadwick-Furman NE, 2000, J EXP MAR BIOL ECOL, V249, P199, DOI 10.1016/S0022-0981(00)00204-5; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Connell J.H., 1973, P205; Cordes EE, 2001, MAR BIOL, V138, P491, DOI 10.1007/s002270000470; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Elahi R, 2007, J EXP MAR BIOL ECOL, V349, P183, DOI 10.1016/j.jembe.2007.05.007; FABENS AJ, 1965, GROWTH, V29, P265; FORD E., 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V19, P305; FOSTER AB, 1988, CORAL REEFS, V7, P37, DOI 10.1007/BF00301980; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; Gerrodette T, 1979, THESIS U CALIFORNIA; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2008, CORAL REEFS, V27, P751, DOI 10.1007/s00338-008-0391-6; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, CORAL REEFS, V23, P433, DOI 10.1007/s00338-004-0395-9; Goffredo S, 2003, MAR BIOL, V142, P411, DOI 10.1007/s00227-002-0980-9; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Goffredo S, 2007, MAR BIOL, V152, P351, DOI 10.1007/s00227-007-0695-z; Goffredo S, 2006, J EXP MAR BIOL ECOL, V336, P221, DOI 10.1016/j.jembe.2006.05.012; Goffredo S, 2011, MAR BIOL RES, V7, P272, DOI 10.1080/17451000.2010.492222; Goffredo S, 2010, MAR BIOL, V157, P2603, DOI 10.1007/s00227-010-1522-5; Goffredo S, 2009, ISR J ECOL EVOL, V55, P99, DOI 10.1560/IJEE.55.2.99; Goffredo S, 2009, LIMNOL OCEANOGR, V54, P930, DOI 10.4319/lo.2009.54.3.0930; GRIGG RW, 1974, ECOLOGY, V55, P387, DOI 10.2307/1935226; GRIGG RW, 1975, AM NAT, V109, P647, DOI 10.1086/283035; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hamel JF, 2010, CORAL REEFS, V29, P521, DOI 10.1007/s00338-010-0590-9; Harper J. L., 1977, Population biology of plants.; Helmle KP., 2000, PROC 9 INT CORAL REE, V1, P365; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; Hughes RN, 1989, FUNCTIONAL BIOL CLON; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; JOHNSON KG, 1992, J EXP MAR BIOL ECOL, V164, P171, DOI 10.1016/0022-0981(92)90173-8; KAIN JM, 1989, BRIT PHYCOL J, V24, P203, DOI 10.1080/00071618900650221; Knittweis L, 2009, CORAL REEFS, V28, P793, DOI 10.1007/s00338-009-0513-9; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; LASKER HR, 1981, BIOL BULL, V160, P292, DOI 10.2307/1540889; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Barros Monica Moraes Lins de, 2006, Braz. j. oceanogr., V54, P213, DOI 10.1590/S1679-87592006000300005; LOGAN A, 1991, B MAR SCI, V49, P847; LOYA Y, 1976, NATURE, V259, P478, DOI 10.1038/259478a0; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Metalpa RR, 2000, CORAL REEFS, V19, P24, DOI 10.1007/s003380050221; Mundet L, 2001, TOURISM MANAGE, V22, P501, DOI 10.1016/S0261-5177(01)00016-4; Nozawa Y, 2008, MAR ECOL PROG SER, V358, P151, DOI 10.3354/meps07342; Pauly D., 1984, FISH POPULATION DYNA; Peirano A, 1999, MAR ECOL PROG SER, V185, P195, DOI 10.3354/meps185195; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; QUEGUINER J, 1978, OCEAN MANAGE, V3, P179, DOI 10.1016/0302-184X(78)90003-3; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Rinkevich B, 1995, RESTOR ECOL, V3, P241, DOI 10.1111/j.1526-100X.1995.tb00091.x; Rogers A, 2011, INT EARTH SYST EXP W; ROSS MA, 1984, PSZNI MAR ECOL, V5, P75; Sakai K, 1998, BIOL BULL, V195, P319, DOI 10.2307/1543143; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sparre P, 1989, MANUAL FAO FISHERIES, V1, P1; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tsimplis MN, 2006, DEV EARTH ENV SCI, V4, P227; Tsounis G, 2007, ECOSYSTEMS, V10, P975, DOI 10.1007/s10021-007-9072-5; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; WALFORD LA, 1946, BIOL BULL, V90, P141, DOI 10.2307/1538217; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wetherall J.A., 1987, ICLARM Conference Proceedings, P53; Yamashiro H, 1998, J EXP MAR BIOL ECOL, V225, P253, DOI 10.1016/S0022-0981(97)00229-3; Zibrowius H, 1980, MEMOIRES I OCEANOGRA, V11, P1	85	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37848	10.1371/journal.pone.0037848	http://dx.doi.org/10.1371/journal.pone.0037848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675495	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339900010
J	Kottgen, A; Yang, Q; Shimmin, LC; Tin, A; Schaeffer, C; Coresh, J; Liu, X; Rampoldi, L; Hwang, SJ; Boerwinkle, E; Hixson, JE; Kao, WHL; Fox, CS				Koettgen, Anna; Yang, Qiong; Shimmin, Lawrence C.; Tin, Adrienne; Schaeffer, Celine; Coresh, Josef; Liu, Xuan; Rampoldi, Luca; Hwang, Shih-Jen; Boerwinkle, Eric; Hixson, James E.; Kao, W. H. Linda; Fox, Caroline S.			Association of Estimated Glomerular Filtration Rate and Urinary Uromodulin Concentrations with Rare Variants Identified by UMOD Gene Region Sequencing	PLOS ONE			English	Article							COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; SERUM CREATININE; KIDNEY-FUNCTION; ALL-CAUSE; RISK; MORTALITY; DISEASE; PROTEIN; DESIGN	Background: Recent genome-wide association studies (GWAS) have identified common variants in the UMOD region associated with kidney function and disease in the general population. To identify novel rare variants as well as common variants that may account for this GWAS signal, the exons and 4 kb upstream region of UMOD were sequenced. Methodology/Principal Findings: Individuals (n = 485) were selected based on presence of the GWAS risk haplotype and chronic kidney disease (CKD) in the ARIC Study and on the extremes of of the UMOD gene product, uromodulin, in urine (Tamm Horsfall protein, THP) in the Framingham Heart Study (FHS). Targeted sequencing was conducted using capillary based Sanger sequencing (3730 DNA Analyzer). Variants were tested for association with THP concentrations and estimated glomerular filtration rate (eGFR), and identified non-synonymous coding variants were genotyped in up to 22,546 follow-up samples. Twenty-four and 63 variants were identified in the 285 ARIC and 200 FHS participants, respectively. In both studies combined, there were 33 common and 54 rare (MAF<0.05) variants. Five non-synonymous rare variants were identified in FHS; borderline enrichment of rare variants was found in the extremes of THP (SKAT p-value = 0.08). Only V458L was associated with THP in the FHS general-population validation sample (p = 9* 10(-3), n = 2,522), but did not show directionconsistent and significant association with eGFR in both the ARIC (n = 14,635) and FHS (n = 7,520) validation samples. Pooling all non-synonymous rare variants except V458L together showed non-significant associations with THP and eGFR in the FHS validation sample. Functional studies of V458L revealed no alternations in protein trafficking. Conclusions/Significance: Multiple novel rare variants in the UMOD region were identified, but none were consistently associated with eGFR in two independent study samples. Only V458L had modest association with THP levels in the general population and thus could not account for the observed GWAS signal.	[Koettgen, Anna; Tin, Adrienne; Coresh, Josef; Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Koettgen, Anna] Freiburg Univ Clin, Div Renal, Freiburg, Germany; [Yang, Qiong; Liu, Xuan] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shimmin, Lawrence C.; Boerwinkle, Eric; Hixson, James E.] UT Houston Sch Publ Hlth, Div Epidemiol & Dis Control, Ctr Human Genet, Houston, TX USA; [Schaeffer, Celine; Rampoldi, Luca] Ist Sci San Raffaele, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Schaeffer, Celine; Rampoldi, Luca] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Coresh, Josef; Kao, W. H. Linda] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Hwang, Shih-Jen; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Hwang, Shih-Jen; Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Freiburg; Boston University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Johns Hopkins University; Johns Hopkins Medicine; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kottgen, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	foxca@nhlbi.nih.gov	Hwang, Shih-Jen/HGU-5826-2022; Schaeffer, Celine/AAU-5713-2020; Yang, Qiong/G-5438-2014; Rampoldi, Luca/AAN-6228-2020; Schaeffer, Celine/AAC-5208-2022; Rampoldi, Luca/L-3639-2018	Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Hixson, James/0000-0002-0849-9315	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institute of Diabetes and Digestive and Kidney Diseases [1 R01 DK076770-01]; Emmy Noether Programme of the German Research Foundation [KO 3598/2-1]; National Human Genome Research Institute [RC2 HG005697]; National Institutes of Health/National Heart, Lung, and Blood Institute [N01-HC-25195]; NHLBI; Fondazione Telethon Italy [TCR08006]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076770] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Emmy Noether Programme of the German Research Foundation(German Research Foundation (DFG)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondazione Telethon Italy(Fondazione Telethon); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ARIC: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. This study was additionally funded by the National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK076770-01), the Emmy Noether Programme of the German Research Foundation (KO 3598/2-1 to A.K.), and the National Human Genome Research Institute (RC2 HG005697 to JEH). FHS: This work was supported through National Institutes of Health/National Heart, Lung, and Blood Institute Contract N01-HC-25195 and the NHLBI division of intra- mural research. Functional studies: This work was supported by the Fondazione Telethon Italy (TCR08006 to LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bollee G, 2011, CLIN J AM SOC NEPHRO, V6, P2429, DOI 10.2215/CJN.01220211; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pattaro C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-41; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Shlipak MG, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-2; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	35	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38311	10.1371/journal.pone.0038311	http://dx.doi.org/10.1371/journal.pone.0038311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693617	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500128
J	Leshikar, ED; Duarte, A; Hertzog, C				Leshikar, Eric D.; Duarte, Audrey; Hertzog, Christopher			Task-Selective Memory Effects for Successfully Implemented Encoding Strategies	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PREFRONTAL CORTEX; EPISODIC SIMULATION; HIPPOCAMPAL SYSTEM; RELATIONAL MEMORY; PARIETAL CORTEX; MENTAL-IMAGERY; RETRIEVAL; ITEM; RECOLLECTION	Previous behavioral evidence suggests that instructed strategy use benefits associative memory formation in paired associate tasks. Two such effective encoding strategies-visual imagery and sentence generation-facilitate memory through the production of different types of mediators (e. g., mental images and sentences). Neuroimaging evidence suggests that regions of the brain support memory reflecting the mental operations engaged at the time of study. That work, however, has not taken into account self-reported encoding task success (i.e., whether participants successfully generated a mediator). It is unknown, therefore, whether task-selective memory effects specific to each strategy might be found when encoding strategies are successfully implemented. In this experiment, participants studied pairs of abstract nouns under either visual imagery or sentence generation encoding instructions. At the time of study, participants reported their success at generating a mediator. Outside of the scanner, participants further reported the quality of the generated mediator (e. g., images, sentences) for each word pair. We observed task-selective memory effects for visual imagery in the left middle occipital gyrus, the left precuneus, and the lingual gyrus. No such task-selective effects were observed for sentence generation. Intriguingly, activity at the time of study in the left precuneus was modulated by the self-reported quality (vividness) of the generated mental images with greater activity for trials given higher ratings of quality. These data suggest that regions of the brain support memory in accord with the encoding operations engaged at the time of study.	[Leshikar, Eric D.] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Duarte, Audrey; Hertzog, Christopher] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA	Brandeis University; University System of Georgia; Georgia Institute of Technology	Leshikar, ED (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	leshikar@Brandeis.edu		Duarte, Audrey/0000-0001-5293-4049	National Institutes of Health [T32 AG00175]; Center for Advanced Brain Imaging at the Georgia Institute of Technology [S091001]; NATIONAL INSTITUTE ON AGING [T32AG000175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Advanced Brain Imaging at the Georgia Institute of Technology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grant T32 AG00175 to E. D. Leshikar and by Grant S091001 from the Center for Advanced Brain Imaging at the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2006, NEUROIMAGE, V33, P1194, DOI 10.1016/j.neuroimage.2006.07.039; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2660, DOI 10.1016/j.neuropsychologia.2009.05.018; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Blumenfeld RS, 2011, J COGNITIVE NEUROSCI, V23, P257, DOI 10.1162/jocn.2010.21459; BOWER GH, 1970, PSYCHON SCI, V20, P119, DOI 10.3758/BF03335632; BOWER GH, 1970, J VERB LEARN VERB BE, V9, P529, DOI 10.1016/S0022-5371(70)80096-2; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Craik FIM, 2002, MEMORY, V10, P305, DOI 10.1080/09658210244000135; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Dobbins IG, 2005, CEREB CORTEX, V15, P1768, DOI 10.1093/cercor/bhi054; Dunlosky J, 2005, DEV PSYCHOL, V41, P389, DOI 10.1037/0012-1649.41.2.389; Dunlosky J, 1998, PSYCHOL AGING, V13, P597, DOI 10.1037/0882-7974.13.4.597; Dunlosky J, 2000, PSYCHOL AGING, V15, P462, DOI 10.1037//0882-7974.15.3.462; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Gold BT, 2005, CEREB CORTEX, V15, P1438, DOI 10.1093/cercor/bhi024; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hertzog C, 2006, ADV CONSC RES, V66, P259; Hertzog C, 2009, Q J EXP PSYCHOL, V62, P155, DOI 10.1080/17470210701855520; Huijbers W, 2011, NEUROPSYCHOLOGIA, V6; Johnson JD, 2007, CEREB CORTEX, V17, P2507, DOI 10.1093/cercor/bhl156; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kausler D. H., 1994, LEARNING MEMORY NORM; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Kirchhoff BA, 2006, NEURON, V51, P263, DOI 10.1016/j.neuron.2006.06.006; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; KOSSLYN SM, 1977, COGNITIVE PSYCHOL, V9, P52, DOI 10.1016/0010-0285(77)90004-4; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Lepage M, 2000, COGNITIVE BRAIN RES, V9, P271, DOI 10.1016/S0926-6410(00)00005-7; Leshikar ED, 2012, SOC NEUROSCI-UK, V7, P126, DOI 10.1080/17470919.2011.585242; Leshikar ED, 2010, CORTEX, V46, P507, DOI 10.1016/j.cortex.2009.07.011; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; Martin C. J., 1965, PSYCHONOMIC SCI, V3, P455; Moscovitch M., 2002, PRINCIPLES FRONTAL L, P188, DOI [10.1093/acprof:oso/9780195134971.003.0012, DOI 10.1093/ACPROF:OSO/9780195134971.003.0012]; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; Paivio A, 1971, IMAGERY VERBAL PROCE; Park H, 2008, LEARN MEMORY, V15, P417, DOI 10.1101/lm.878908; Parks CM, 2007, J MEM LANG, V57, P81, DOI 10.1016/j.jml.2007.03.003; Richardson JTE, 1998, PSYCHON B REV, V5, P597, DOI 10.3758/BF03208837; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Uncapher MR, 2009, J NEUROSCI, V29, P8270, DOI 10.1523/JNEUROSCI.1043-09.2009; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2009, NEUROREPORT, V20, P1295, DOI 10.1097/WNR.0b013e3283306798	56	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38160	10.1371/journal.pone.0038160	http://dx.doi.org/10.1371/journal.pone.0038160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693593	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500097
J	Wang, GH; Wang, CF; Hou, R; Zhou, XY; Li, GT; Zhang, SJ; Xu, JR				Wang, Guanghui; Wang, Chenfang; Hou, Rui; Zhou, Xiaoying; Li, Guotian; Zhang, Shijie; Xu, Jin-Rong			The AMT1 Arginine Methyltransferase Gene Is Important for Plant Infection and Normal Hyphal Growth in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; PROTEIN; YEAST; METHYLATION; KINASE; WHEAT; PATHOGENICITY; PATHOGENESIS; SUBSTRATE	Arginine methylation of non-histone proteins by protein arginine methyltransferase (PRMT) has been shown to be important for various biological processes from yeast to human. Although PRMT genes are well conserved in fungi, none of them have been functionally characterized in plant pathogenic ascomycetes. In this study, we identified and characterized all of the four predicted PRMT genes in Fusarium graminearum, the causal agent of Fusarium head blight of wheat and barley. Whereas deletion of the other three PRMT genes had no obvious phenotypes, the Delta amt1 mutant had pleiotropic defects. AMT1 is a predicted type I PRMT gene that is orthologous to HMT1 in Saccharomyces cerevisiae. The Delta amt1 mutant was slightly reduced in vegetative growth but normal in asexual and sexual reproduction. It had increased sensitivities to oxidative and membrane stresses. DON mycotoxin production and virulence on flowering wheat heads also were reduced in the Delta amt1 mutant. The introduction of the wild-type AMT1 allele fully complemented the defects of the Delta amt1 mutant and Amt1-GFP fusion proteins mainly localized to the nucleus. Hrp1 and Nab2 are two hnRNPs in yeast that are methylated by Hmt1 for nuclear export. In F. graminearum, AMT1 is required for the nuclear export of FgHrp1 but not FgNab2, indicating that yeast and F. graminearum differ in the methylation and nucleo-cytoplasmic transport of hnRNP components. Because AMT2 also is a predicted type I PRMT with limited homology to yeast HMT1, we generated the Delta amt1 Delta amt2 double mutants. The Delta amt1 single and Delta amt1 Delta amt2 double mutants had similar defects in all the phenotypes assayed, including reduced vegetative growth and virulence. Overall, data from this systematic analysis of PRMT genes suggest that AMT1, like its ortholog in yeast, is the predominant PRMT gene in F. graminearum and plays a role in hyphal growth, stress responses, and plant infection.	[Wang, Guanghui; Wang, Chenfang; Hou, Rui; Zhang, Shijie] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Wang, Guanghui; Zhou, Xiaoying; Li, Guotian; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, JR (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	jinrong@purdue.edu	zhang, shijie/HGF-0836-2022; zhang, shijie/AAA-3351-2019		National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Research Initiative of the United States Department of Agriculture (USDA) CSREES [2007-35319-102681]; China Scholarship Council fellowships	National Major Project of Breeding for New Transgenic Organisms; National Research Initiative of the United States Department of Agriculture (USDA) CSREES; China Scholarship Council fellowships	This work was supported by the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003) and a grant from the National Research Initiative of the United States Department of Agriculture (USDA) CSREES (#2007-35319-102681). Dr. Wang and Dr. Li were partially supported by China Scholarship Council fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bauer I, 2010, FUNGAL GENET BIOL, V47, P551, DOI 10.1016/j.fgb.2010.03.006; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Ben Lovely C, 2011, EUKARYOT CELL, V10, P869, DOI 10.1128/EC.00237-10; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Boisvert F, 2005, SCI STKE, V2005, pre2; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gross S, 2001, MOL CELL BIOL, V21, P8045, DOI 10.1128/MCB.21.23.8045-8055.2001; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Kang ZS, 2008, EUR J PLANT PATHOL, V120, P383, DOI 10.1007/s10658-007-9230-9; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Li YM, 2011, MOL PLANT MICROBE IN, V24, P487, DOI 10.1094/MPMI-10-10-0233; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Ochiai N, 2007, BIOCHEM BIOPH RES CO, V363, P639, DOI 10.1016/j.bbrc.2007.09.027; Pandolfi V, 2010, GENET MOL RES, V9, P1298, DOI 10.4238/vol9-3gmr828; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Wong CM, 2010, NUCLEIC ACIDS RES, V38, P2217, DOI 10.1093/nar/gkp1133; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yu MC, 2006, GENE DEV, V20, P3249, DOI 10.1101/gad.1495206; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhou X, 2011, METHOD MOL BIOL, P199; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	55	13	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38324	10.1371/journal.pone.0038324	http://dx.doi.org/10.1371/journal.pone.0038324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693618	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500130
J	Mehner, D; Osadnik, H; Lunsdorf, H; Bruser, T				Mehner, Denise; Osadnik, Hendrik; Luensdorf, Heinrich; Brueser, Thomas			The Tat System for Membrane Translocation of Folded Proteins Recruits the Membrane-stabilizing Psp Machinery in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE SIGNAL PEPTIDE; PHAGE-SHOCK; TRANSPORT SYSTEM; COMPONENT; EXPRESSION; PRECURSOR; COMPLEX; BINDING; STRESS; VIPP1	Tat systems transport folded proteins across energized membranes of bacteria, archaea, and plant plastids. In Escherichia coli, TatBC complexes recognize the transported proteins, and TatA complexes are recruited to facilitate transport. We achieved an abstraction of TatA from membranes without use of detergents and observed a co-purification of PspA, a membrane-stress response protein. The N-terminal transmembrane domain of TatA was required for the interaction. Electron microscopy displayed TatA complexes in direct contact with PspA. PspB and PspC were important for the TatA-PspA contact. The activator protein PspF was not involved in the PspA-TatA interaction, demonstrating that basal levels of PspA already interact with TatA. Elevated TatA levels caused membrane stress that induced a strictly PspBC- and PspF-dependent up-regulation of PspA. TatA complexes were found to destabilize membranes under these conditions. At native TatA levels, PspA deficiency clearly affected anaerobic TMAO respiratory growth, suggesting that energetic costs for transport of large Tat substrates such as TMAO reductase can become growth limiting in the absence of PspA. The physiological role of PspA recruitment to TatA may therefore be the control of membrane stress at active translocons.	[Mehner, Denise; Osadnik, Hendrik; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, D-30167 Hannover, Germany; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Leibniz University Hannover; Helmholtz Association; Helmholtz-Center for Infection Research	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Schneiderberg 50, D-30167 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Mehner-Breitfeld, Denise/0000-0002-6785-898X; Bruser, Thomas/0000-0002-5889-8306	Deutsche Forschungsgemeinschaft [BR2285/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (Grant BR2285/1-3).	Adams H, 2003, J BACTERIOL, V185, P1174, DOI 10.1128/JB.185.4.1174-1180.2003; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alder NN, 2003, CELL, V112, P231, DOI 10.1016/S0092-8674(03)00032-1; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; BERGLER H, 1994, MICROBIOL-SGM, V140, P1937, DOI 10.1099/13500872-140-8-1937; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; CARTER CW, 1974, J BIOL CHEM, V249, P4212; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Elderkin S, 2005, J BACTERIOL, V187, P3238, DOI 10.1128/JB.187.9.3238-3248.2005; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Gueguen E, 2009, MOL MICROBIOL, V74, P619, DOI 10.1111/j.1365-2958.2009.06885.x; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Jouhet J, 2009, PLANT SIGNAL BEHAV, V4, P986, DOI 10.4161/psb.4.10.9665; Jovanovic G, 2010, MICROBIOL-SGM, V156, P2920, DOI 10.1099/mic.0.040055-0; KLEEREBEZEM M, 1993, MOL MICROBIOL, V7, P947, DOI 10.1111/j.1365-2958.1993.tb01186.x; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Liu CM, 2005, MOL BIOL CELL, V16, P1165, DOI 10.1091/mbc.E04-08-0736; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; OVERMANN J, 1992, ARCH MICROBIOL, V157, P329, DOI 10.1007/BF00248677; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Vrancken K, 2008, J BACTERIOL, V190, P3475, DOI 10.1128/JB.01966-07; Vrancken K, 2007, APPL MICROBIOL BIOT, V73, P1150, DOI 10.1007/s00253-006-0571-7; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; WARNOCK DG, 1982, AM J PHYSIOL, V242, pF733, DOI 10.1152/ajprenal.1982.242.6.F733; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yamaguchi S, 2012, J MICROBIOL, V50, P1, DOI 10.1007/s12275-012-1578-7; Yamaguchi S, 2010, MOL MICROBIOL, V78, P429, DOI 10.1111/j.1365-2958.2010.07344.x	64	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27834	27842		10.1074/jbc.M112.374983	http://dx.doi.org/10.1074/jbc.M112.374983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22689583	Green Published, hybrid			2022-12-25	WOS:000307840700057
J	Ren, WY; Cheema, S; Du, KY				Ren, Wenying; Cheema, Sarwat; Du, Keyong			The Association of ClipR-59 Protein with AS160 Modulates AS160 Protein Phosphorylation and Adipocyte Glut4 Protein Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; RAT ADIPOSE-CELLS; INSULIN-RESISTANCE; PLASMA-MEMBRANE; GAP; TRAFFICKING; DOMAIN; AKT; GLUCOSE-TRANSPORTER-4; TARGET	ClipR-59 is a membrane-associated protein and has been implicated in membrane signaling and vesicle trafficking. Recently, we have identified ClipR-59 as an Akt-interacting protein, and we have found that, by interacting with Akt, ClipR-59 modulates Akt subcellular compartmentalization and Akt substrate AS160 phosphorylation, thereby promoting Glut4 membrane translocation. Here, we have further investigated the regulatory effects of ClipR-59 on AS160 phosphorylation and subsequent adipocyte glucose transport. Our data showed that ClipR-59 interacted with AS160, which was mediated by the ankyrin repeats of ClipR-59 and regulated by insulin signaling. Moreover, the data also demonstrated that the interaction of ClipR-59 with AS160 was required for ClipR-59 to modulate Glut4 membrane translocation as Delta ANK-ClipR-59, an AS160 interaction-defective mutant, failed to promote AS160 phosphorylation, Glut4 membrane translocation, and glucose transport induced by insulin in 3T3-L1 adipocytes. Because ClipR-59 also interacts with Akt and enhances the interaction between Akt and AS160, we suggest that ClipR-59 functions as a scaffold protein to facilitate Akt-mediated AS160 phosphorylation, thereby regulating glucose transport.	[Ren, Wenying; Cheema, Sarwat; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319, R56 DK084319]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319, R56DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK084319 and R56 DK084319 (to K. D.).; Recipient of a career development award from the American Diabetes Association. To whom correspondence should be addressed: Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington St., Boston, MA 02111. Tel.: 617-636-6476; Fax: 617-636-6127; E-mail: kdu@tuftsmedicalcenter.org.	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lin HV, 2011, DIABETES, V60, P700, DOI 10.2337/db10-1056; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	29	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26890	26900		10.1074/jbc.M112.357699	http://dx.doi.org/10.1074/jbc.M112.357699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689584	Green Published, hybrid			2022-12-25	WOS:000307386000037
J	Huang, W; Lv, XB; Liu, CY; Zha, ZY; Zhang, H; Jiang, Y; Xiong, Y; Lei, QY; Guan, KL				Huang, Wei; Lv, Xianbo; Liu, Chenying; Zha, Zhengyu; Zhang, Heng; Jiang, Ying; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCF beta-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL DIFFERENTIATION; BREAST-CANCER CELLS; TUMOR-SUPPRESSOR; HIPPO PATHWAY; TAZ INTERACTS; COACTIVATOR; PROMOTES; GROWTH; PHOSPHORYLATION	The Hippo tumor suppressor pathway plays a major role in development and organ size control, and its dysregulation contributes to tumorigenesis. TAZ (transcriptional co-activator with PDZ-binding motif; also known as WWTR1) is a transcription co-activator acting downstream of the Hippo pathway, and increased TAZ protein levels have been associated with human cancers, such as breast cancer. Previous studies have shown that TAZ is inhibited by large tumor suppressor (LATS)-dependent phosphorylation, leading to cytoplasmic retention and ubiquitin-dependent degradation. The LATS kinase, a core component of the Hippo pathway, phosphorylates the C-terminal phosphodegron in TAZ to promote its degradation. In this study, we have found that the N-terminal phosphodegron of TAZ also plays a role in TAZ protein level regulation, particularly in response to different status of cellular PI3K signaling. GSK3, which can be inhibited by high PI3K via AKT-dependent inhibitory phosphorylation, phosphorylates the N-terminal phosphodegron in TAZ, and the phosphorylated TAZ binds to beta-TrCP subunit of the SCF beta-TrCP E3 ubiquitin ligase, thereby leading to TAZ ubiquitylation and degradation. We observed that the TAZ protein level is elevated in tumor cells with high PI3K signaling, such as in PTEN mutant cancer cells. This study provides a novel mechanism of TAZ regulation and suggests a role of TAZ in modulating tissue growth and tumor development in response to PI3K signaling.	[Huang, Wei; Lv, Xianbo; Liu, Chenying; Zhang, Heng; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China; [Huang, Wei; Lv, Xianbo; Liu, Chenying; Zha, Zhengyu; Zhang, Heng; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Huang, Wei; Lv, Xianbo; Liu, Chenying; Zhang, Heng; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Jiang, Ying] Shanghai Fudan Univ, Shanghai Zhongshan Hosp, Dept Gen Surg, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Lei, QY (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; Huang, Wei/0000-0002-0750-969X; zha, zhengyu/0000-0002-8619-3661	973 Program [2009CB918401, 2011CB910600, NCET-09-0315]; National Science Foundation of China (NSFC) [31071192, 30972937]; NSFC-NIH [81110313]; 100 Talents Program of Shanghai Health [XBR2011041]; "Scholar of Dawn" Program of the Shanghai Education Commission; 985 Program and the Shanghai Leading Academic Discipline Project [B110]; National Institutes of Health [CA132809, CIRM RB2-01547]; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-NIH; 100 Talents Program of Shanghai Health; "Scholar of Dawn" Program of the Shanghai Education Commission; 985 Program and the Shanghai Leading Academic Discipline Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by 973 Program Grants 2009CB918401, 2011CB910600, and NCET-09-0315; National Science Foundation of China (NSFC) Grants 31071192 and 30972937; NSFC-NIH Grant 81110313; 100 Talents Program of Shanghai Health Grant XBR2011041; and the "Scholar of Dawn" Program of the Shanghai Education Commission (to Q. Y. L.). This work was also supported by the 985 Program and the Shanghai Leading Academic Discipline Project (Project B110). This work is also supported by National Institutes of Health Grants CA132809 and CIRM RB2-01547 (to K. L. G.).	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; ZHAO JJ, 2006, SCI STKE, pPE52, DOI DOI 10.1126/STKE.3652006PE52; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	36	114	116	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26245	26253		10.1074/jbc.M112.382036	http://dx.doi.org/10.1074/jbc.M112.382036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692215	Green Published, hybrid			2022-12-25	WOS:000306916300051
J	Mitchell, JE; Chetty, S; Govender, P; Pillay, M; Jaggernath, M; Kasmar, A; Ndung'u, T; Klenerman, P; Walker, BD; Kasprowicz, VO				Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Pillay, Mona; Jaggernath, Manjeetha; Kasmar, Anne; Ndung'u, Thumbi; Klenerman, Paul; Walker, Bruce D.; Kasprowicz, Victoria O.			Prospective Monitoring Reveals Dynamic Levels of T Cell Immunity to Mycobacterium Tuberculosis in HIV Infected Individuals	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; WITHIN-SUBJECT VARIABILITY; ELISPOT TEST; SKIN-TEST; DIAGNOSIS; RESPONSES; ENUMERATION; SENSITIVITY; PREVALENCE; EXPOSURE	Monitoring of latent Mycobacterium tuberculosis infection may prevent disease. We tested an ESAT-6 and CFP-10-specific IFN-gamma Elispot assay (RD1-Elispot) on 163 HIV-infected individuals living in a TB-endemic setting. An RD1-Elispot was performed every 3 months for a period of 3-21 months. 62% of RD1-Elispot negative individuals were positive by cultured Elispot. Fluctuations in T cell response were observed with rates of change ranging from -150 to +153 spot-forming cells (SFC)/200,000 PBMC in a 3-month period. To validate these responses we used an RD1-specific real time quantitative PCR assay for monokine-induced by IFN-gamma (MIG) and IFN-gamma inducible protein-10 (IP10) (MIG: r = 0.6527, p = 0.0114; IP-10: r = 0.6967, p = 0.0056; IP-10+MIG: r = 0.7055, p = 0.0048). During follow-up 30 individuals were placed on ARVs and 4 progressed to active TB. Fluctuations in SFC did not correlate with CD4 count, viral load, treatment initiation, or progression to active TB. The RD1-Elispot appears to have limited value in this setting.	[Mitchell, Jessica E.; Ndung'u, Thumbi; Walker, Bruce D.; Kasprowicz, Victoria O.] MIT, Ragon Inst MGH, Boston, MA USA; [Kasmar, Anne] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Kasprowicz, Victoria O.] Kwazulu Natal Res Inst TB & HIV K RITH, Nelson R Mandela Sch Med, Durban, South Africa; [Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Pillay, Mona; Jaggernath, Manjeetha; Ndung'u, Thumbi; Walker, Bruce D.; Kasprowicz, Victoria O.] Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Klenerman, Paul] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Klenerman, Paul] Univ Oxford, James Martin Sch 21st Century, Nuffield Dept Med, Oxford, England	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kwazulu Natal; University of Kwazulu Natal; University of Oxford; University of Oxford	Mitchell, JE (corresponding author), MIT, Ragon Inst MGH, Boston, MA USA.	vkasprowicz@partners.org		Ndung'u, Thumbi/0000-0003-2962-3992; klenerman, paul/0000-0003-4307-9161	Howard Hughes Medical Institute; Medical Research Council of South Africa; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); National Institutes of Health; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089858, P30AI060354] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council of South Africa(South African Medical Research Council); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to funders: The Howard Hughes Medical Institute, the Medical Research Council of South Africa, The KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Clark SA, 2007, CLIN EXP IMMUNOL, V150, P238, DOI 10.1111/j.1365-2249.2007.03477.x; Connell TG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-138; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kasprowicz V, 2006, J VIROL, V80, P11209, DOI 10.1128/JVI.01173-06; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kipfer B, 2008, SWISS MED WKLY, V138, P267, DOI 2008/17/smw-12051; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, J CLIN MICROBIOL, V44, P1197, DOI 10.1128/JCM.44.3.1197-1201.2006; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Richeldi L, 2007, PEDIATRICS, V119, pE1, DOI 10.1542/peds.2006-1057; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Smith SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007972; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Tuuminen T, 2010, CLIN VACCINE IMMUNOL, V17, P596, DOI 10.1128/CVI.00320-09; van Brummelen SE, 2010, CLIN VACCINE IMMUNOL, V17, P937, DOI 10.1128/CVI.00005-10; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; WHO, 2010, POL STAT PREV THER T; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242; Zwerling A, 2011, THORAX	49	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37920	10.1371/journal.pone.0037920	http://dx.doi.org/10.1371/journal.pone.0037920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685549	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700012
J	Caputi, A; Fuchs, EC; Allen, K; Le Magueresse, C; Monyer, H				Caputi, Antonio; Fuchs, Elke C.; Allen, Kevin; Le Magueresse, Corentin; Monyer, Hannah			Selective Reduction of AMPA Currents onto Hippocampal Interneurons Impairs Network Oscillatory Activity	PLOS ONE			English	Article							PHASE-PRECESSION; PATH-INTEGRATION; PYRAMIDAL CELLS; PLACE CELLS; THETA OSCILLATIONS; NEURONAL-ACTIVITY; SPATIAL WORKING; GAP-JUNCTIONS; GRID CELLS; MEMORY	Reduction of excitatory currents onto GABAergic interneurons in the forebrain results in impaired spatial working memory and altered oscillatory network patterns in the hippocampus. Whether this phenotype is caused by an alteration in hippocampal interneurons is not known because most studies employed genetic manipulations affecting several brain regions. Here we performed viral injections in genetically modified mice to ablate the GluA4 subunit of the AMPA receptor in the hippocampus (GluA4(HC-/-) mice), thereby selectively reducing AMPA receptor-mediated currents onto a subgroup of hippocampal interneurons expressing GluA4. This regionally selective manipulation led to a strong spatial working memory deficit while leaving reference memory unaffected. Ripples (125-250 Hz) in the CA1 region of GluA4(HC-/-) mice had larger amplitude, slower frequency and reduced rate of occurrence. These changes were associated with an increased firing rate of pyramidal cells during ripples. The spatial selectivity of hippocampal pyramidal cells was comparable to that of controls in many respects when assessed during open field exploration and zigzag maze running. However, GluA4 ablation caused altered modulation of firing rate by theta oscillations in both interneurons and pyramidal cells. Moreover, the correlation between the theta firing phase of pyramidal cells and position was weaker in GluA4(HC-/-) mice. These results establish the involvement of AMPA receptor-mediated currents onto hippocampal interneurons for ripples and theta oscillations, and highlight potential cellular and network alterations that could account for the altered working memory performance.	[Caputi, Antonio] Heidelberg Univ, Fac Med, Dept Clin Neurobiol, Heidelberg, Germany; German Canc Res Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Caputi, A (corresponding author), Heidelberg Univ, Fac Med, Dept Clin Neurobiol, Heidelberg, Germany.	h.monyer@dkfz-heidelberg.de		Allen, Kevin/0000-0001-5319-3721; Monyer, Hannah/0000-0002-9332-5749; Le Magueresse, Corentin/0000-0001-8418-4991	European Commission; European Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission)	KA held a Humboldt Research Fellowship for Postdoctoral Studies (http://www.humboldt-foundation.de). HM was supported by the Seventh Framework Programme of the European Commission (SPACEBRAIN; http://cordis.europa.eu/fp7/home_en.html) and a European Research Council Advanced Grant (GABACellsAndMemory; http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2011, J NEUROSCI, V31, P6542, DOI 10.1523/JNEUROSCI.6512-10.2011; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cacucci F, 2008, P NATL ACAD SCI USA, V105, P7863, DOI 10.1073/pnas.0802908105; Castro L, 2012, J COMPUT NEUROSCI; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cutsuridis V, 2012, HIPPOCAMPUS, V22, P1597, DOI 10.1002/hipo.21002; de Almeida L, 2012, HIPPOCAMPUS, V22, P200, DOI 10.1002/hipo.20882; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Fisher N., 1995, STAT ANAL CIRCULAR D; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Press W.H., 2007, NUMERICAL RECIPES AR; Racz A, 2009, J NEUROSCI, V29, P2563, DOI 10.1523/JNEUROSCI.5036-08.2009; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Schmitt WB, 2003, J NEUROSCI, V23, P3953; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Traub RD, 2000, J NEUROSCI, V20, P2086; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, J NEUROSCI, V15, P30	62	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37318	10.1371/journal.pone.0037318	http://dx.doi.org/10.1371/journal.pone.0037318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675480	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700012
J	Prescott, J; Thompson, DJ; Kraft, P; Chanock, SJ; Audley, T; Brown, J; Leyland, J; Folkerd, E; Doody, D; Hankinson, SE; Hunter, DJ; Jacobs, KB; Dowsett, M; Cox, DG; Easton, DF; De Vivo, I				Prescott, Jennifer; Thompson, Deborah J.; Kraft, Peter; Chanock, Stephen J.; Audley, Tina; Brown, Judith; Leyland, Jean; Folkerd, Elizabeth; Doody, Deborah; Hankinson, Susan E.; Hunter, David J.; Jacobs, Kevin B.; Dowsett, Mitch; Cox, David G.; Easton, Douglas F.; De Vivo, Immaculata			Genome-Wide Association Study of Circulating Estradiol, Testosterone, and Sex Hormone-Binding Globulin in Postmenopausal Women	PLOS ONE			English	Article							BREAST-CANCER RISK; COMMON GENETIC-VARIATION; STEROID-HORMONE; COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; SHBG GENE; ESTROGEN; METAANALYSIS; COHORT; REPRODUCIBILITY	Genome-wide association studies (GWAS) have successfully identified common genetic variants that contribute to breast cancer risk. Discovering additional variants has become difficult, as power to detect variants of weaker effect with present sample sizes is limited. An alternative approach is to look for variants associated with quantitative traits that in turn affect disease risk. As exposure to high circulating estradiol and testosterone, and low sex hormone-binding globulin (SHBG) levels is implicated in breast cancer etiology, we conducted GWAS analyses of plasma estradiol, testosterone, and SHBG to identify new susceptibility alleles. Cancer Genetic Markers of Susceptibility (CGEMS) data from the Nurses' Health Study (NHS), and Sisters in Breast Cancer Screening data were used to carry out primary meta-analyses among similar to 1600 postmenopausal women who were not taking postmenopausal hormones at blood draw. We observed a genome-wide significant association between SHBG levels and rs727428 (joint beta = -0.126; joint P = 2.09 x 10(-16)), downstream of the SHBG gene. No genome-wide significant associations were observed with estradiol or testosterone levels. Among variants that were suggestively associated with estradiol (P<10(-5)), several were located at the CYP19A1 gene locus. Overall results were similar in secondary meta-analyses that included similar to 900 NHS current postmenopausal hormone users. No variant associated with estradiol, testosterone, or SHBG at P<10(-5) was associated with postmenopausal breast cancer risk among CGEMS participants. Our results suggest that the small magnitude of difference in hormone levels associated with common genetic variants is likely insufficient to detectably contribute to breast cancer risk.	[Prescott, Jennifer; Hankinson, Susan E.; Hunter, David J.; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Prescott, Jennifer; Hankinson, Susan E.; Hunter, David J.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Prescott, Jennifer; Kraft, Peter; Hankinson, Susan E.; Hunter, David J.; Cox, David G.; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Thompson, Deborah J.; Audley, Tina; Brown, Judith; Leyland, Jean; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Chanock, Stephen J.; Jacobs, Kevin B.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Folkerd, Elizabeth; Doody, Deborah; Dowsett, Mitch] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England; [Hankinson, Susan E.] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Cox, David G.] Ctr Leon Berard, CNRS UMR5286, INSERM U1052, Canc Res Ctr Lyon, F-69373 Lyon, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; University of Massachusetts System; University of Massachusetts Amherst; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Prescott, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	david.cox@lyon.unicancer.fr	Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009	Cox, David G/0000-0002-2152-9259; Jacobs, Kevin/0000-0002-4657-6473; Cox, David/0000-0003-2047-4687; De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health (NIH) [CA87969, CA49449, CA128034, T32 CA 09001]; Cancer Research UK [C1287/A10118, C1287/8459]; la Ligue Contre le Cancer, Comite du Savoie; NATIONAL CANCER INSTITUTE [P01CA087969, R03CA128034, R01CA049449, ZIACP010201, U01CA049449, T32CA009001] Funding Source: NIH RePORTER; Cancer Research UK [11022, 10118] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); la Ligue Contre le Cancer, Comite du Savoie; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	The NHS was supported by the National Institutes of Health (NIH; http://grants.nih.gov/grants/oer.htm) [CA87969, CA49449, CA128034]. JP was supported by NIH training grant T32 CA 09001. SIBS was supported by programme grant C1287/A10118 and project grants from Cancer Research UK (http://science.cancerresearchuk.org/) [grant numbers C1287/8459]. DFE is a Principal Research Fellow of Cancer Research UK. DGC receives support from la Ligue Contre le Cancer, Comite du Savoie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beckmann L, 2011, J CLIN ENDOCR METAB, V96, pE360, DOI 10.1210/jc.2010-0912; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; Coviello AD, 2011, J CLIN ENDOCR METAB, V96, pE1491, DOI 10.1210/jc.2011-0050; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; DOWSETT M, 1987, CANCER RES, V47, P1957; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Haiman CA, 2005, J CLIN ENDOCR METAB, V90, P2198, DOI 10.1210/jc.2004-1417; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Hankinson Susan E, 2005, Breast Dis, V24, P3; HARADA N, 1992, AM J HUM GENET, V51, P666; HUNTER DJ, 2007, NAT GENET; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liao DJ, 2002, J STEROID BIOCHEM, V80, P175, DOI 10.1016/S0960-0760(01)00185-6; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LONNING PE, 1989, J STEROID BIOCHEM, V34, P551, DOI 10.1016/0022-4731(89)90143-X; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Mitamura R, 2000, J CLIN ENDOCR METAB, V85, P1074, DOI 10.1210/jc.85.3.1074; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reeves GK, 2009, BRIT J CANCER, V100, P538, DOI 10.1038/sj.bjc.6604853; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Shah NR, 2005, MENOPAUSE, V12, P668, DOI 10.1097/01.gme.0000184221.63459.e1; Stone J, 2009, J CLIN ENDOCR METAB, V94, P4793, DOI 10.1210/jc.2009-0713; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Thompson DJ, 2008, CANCER EPIDEM BIOMAR, V17, P3490, DOI 10.1158/1055-9965.EPI-08-0734; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zeleniuch-Jacquotte A, 2004, BRIT J CANCER, V90, P153, DOI 10.1038/sj.bjc.6601517	49	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37815	10.1371/journal.pone.0037815	http://dx.doi.org/10.1371/journal.pone.0037815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675492	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700023
J	Pinheiro, A; Nunes, MJ; Milagre, I; Rodrigues, E; Silva, MJ; de Almeida, IT; Rivera, I				Pinheiro, Ana; Nunes, Maria Joao; Milagre, Ines; Rodrigues, Elsa; Silva, Maria Joao; de Almeida, Isabel Tavares; Rivera, Isabel			Demethylation of the Coding Region Triggers the Activation of the Human Testis-Specific PDHA2 Gene in Somatic Tissues	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; OPEN READING FRAME; DNA METHYLATION; CPG DINUCLEOTIDES; E1-ALPHA SUBUNIT; INTRONLESS GENE; EXPRESSION; PROMOTER; TRANSCRIPTION; BINDING	Human PDHA2 is a testis-specific gene that codes for the E-1 alpha subunit of Pyruvate Dehydrogenase Complex (PDC), a crucial enzyme system in cell energy metabolism. Since activation of the PDHA2 gene in somatic cells could be a new therapeutic approach for PDC deficiency, we aimed to identify the regulatory mechanisms underlying the human PDHA2 gene expression. Functional deletion studies revealed that the -122 to -6 promoter region is indispensable for basal expression of this TATA-less promoter, and suggested a role of an epigenetic program in the control of PDHA2 gene expression. Indeed, treatment of SH-SY5Y cells with the hypomethylating agent 5-Aza-2'-deoxycytidine (DAC) promoted the reactivation of the PDHA2 gene, by inducing the recruitment of the RNA polymerase II to the proximal promoter region and the consequent increase in PDHA2 mRNA levels. Bisulfite sequencing analysis revealed that DAC treatment induced a significant demethylation of the CpG island II (nucleotides + 197 to +460) in PDHA2 coding region, while the promoter region remained highly methylated. Taken together with our previous results that show an in vivo correlation between PDHA2 expression and the demethylation of the CpG island II in testis germ cells, the present results show that internal methylation of the PDHA2 gene plays a part in its repression in somatic cells. In conclusion, our data support the novel finding that methylation of the PDHA2 coding region can inhibit gene transcription. This represents a key mechanism for absence of PDHA2 expression in somatic cells and a target for PDC therapy.	[Pinheiro, Ana; Nunes, Maria Joao; Milagre, Ines; Rodrigues, Elsa; Silva, Maria Joao; de Almeida, Isabel Tavares; Rivera, Isabel] Res Inst Med & Pharmaceut Sci iMed UL, Lisbon, Portugal; [Rodrigues, Elsa; Silva, Maria Joao; de Almeida, Isabel Tavares; Rivera, Isabel] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Pinheiro, A (corresponding author), Res Inst Med & Pharmaceut Sci iMed UL, Lisbon, Portugal.	iarivera@ff.ul.pt	iMed.ULisboa, CellFun/A-4244-2014; Nunes, Maria João/F-6766-2015; de Almeida, Isabel Tavares/F-8319-2014; Milagre, Ines/AAC-4409-2021; Rivera, Isabel/AAS-3204-2021; Rodrigues, Elsa/J-3100-2012; Rivera, Isabel/A-5863-2014; Silva, Maria João/F-7225-2015; iMed.ULisboa, MetGen/B-5293-2014; Nunes, Maria João/AAB-5062-2022	Nunes, Maria João/0000-0002-4922-633X; Rivera, Isabel/0000-0001-6892-729X; Rodrigues, Elsa/0000-0003-1669-365X; Rivera, Isabel/0000-0001-6892-729X; Silva, Maria João/0000-0002-2185-7762; Nunes, Maria João/0000-0002-4922-633X; Milagre, Ines/0000-0003-4753-5523; Tavares de Almeida, Isabel/0000-0002-4024-8305	Fundacao para a Ciencia e a Tecnologia (FCT), Lisboa, Portugal [SFRH/BD/31264/2006]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisboa, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by the PhD grant SFRH/BD/31264/2006, from the Fundacao para a Ciencia e a Tecnologia (FCT), Lisboa, Portugal, awarded to Ana Pinheiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BROWN GK, 1989, ANN NY ACAD SCI, V573, P360, DOI 10.1111/j.1749-6632.1989.tb15011.x; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; CHOI YC, 1991, J BIOL CHEM, V266, P20504; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Datta U, 1999, BBA-GENE STRUCT EXPR, V1447, P236, DOI 10.1016/S0167-4781(99)00158-X; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; De Smet C, 1999, MOL CELL BIOL, V19, P7327; del Mazo J, 1994, CHROMOSOME RES, V2, P147, DOI 10.1007/BF01553493; FITZGERALD J, 1993, GENOMICS, V18, P636, DOI 10.1016/S0888-7543(05)80366-0; Fitzgerald J, 1996, MOL BIOL EVOL, V13, P1023, DOI 10.1093/oxfordjournals.molbev.a025652; GRAESSMANN A, 1994, MOL CELL BIOL, V14, P2004, DOI 10.1128/MCB.14.3.2004; Hisano M, 2003, NUCLEIC ACIDS RES, V31, P4797, DOI 10.1093/nar/gkg670; Hohn T, 1996, P NATL ACAD SCI USA, V93, P8334, DOI 10.1073/pnas.93.16.8334; IANNELLO RC, 1992, BIOL REPROD, V47, P48, DOI 10.1095/biolreprod47.1.48; Iannello RC, 2000, J BIOL CHEM, V275, P19603, DOI 10.1074/jbc.M001867200; IANNELLO RC, 1994, REPROD FERT DEVELOP, V6, P599, DOI 10.1071/RD9940599; Iannello RC, 1995, REPROD FERT DEVELOP, V7, P705, DOI 10.1071/RD9950705; Iannello RC, 1997, MOL CELL BIOL, V17, P612, DOI 10.1128/MCB.17.2.612; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; Kroft TL, 2001, BIOL REPROD, V65, P1522, DOI 10.1095/biolreprod65.5.1522; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Pinheiro A, 2012, UNIQUE CASE FA UNPUB; Pinheiro A, 2010, MOL GENET METAB, V99, P425, DOI 10.1016/j.ymgme.2009.11.002; Robinson BH, 1996, J INHERIT METAB DIS, V19, P452, DOI 10.1007/BF01799106; ROCAMORA N, 1989, FEBS LETT, V247, P415, DOI 10.1016/0014-5793(89)81382-1; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38076	10.1371/journal.pone.0038076	http://dx.doi.org/10.1371/journal.pone.0038076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675509	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339900012
J	Gao, S; Hu, JH; Gong, DK; Chen, SF; Kendrick, KM; Yao, DZ				Gao, Shan; Hu, Jiehui; Gong, Diankun; Chen, Sifan; Kendrick, Keith M.; Yao, Dezhong			Integration of Consonant and Pitch Processing as Revealed by the Absence of Additivity in Mismatch Negativity	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; SPEECH-PERCEPTION; DIFFERENT REFERENCES; INFINITY REFERENCE; SENSORY MEMORY; HUMAN BRAIN; MUSIC; EEG; LANGUAGE; CORTEX	Consonants, unlike vowels, are thought to be speech specific and therefore no interactions would be expected between consonants and pitch, a basic element for musical tones. The present study used an electrophysiological approach to investigate whether, contrary to this view, there is integrative processing of consonants and pitch by measuring additivity of changes in the mismatch negativity (MMN) of evoked potentials. The MMN is elicited by discriminable variations occurring in a sequence of repetitive, homogeneous sounds. In the experiment, event-related potentials (ERPs) were recorded while participants heard frequently sung consonant-vowel syllables and rare stimuli deviating in either consonant identity only, pitch only, or in both dimensions. Every type of deviation elicited a reliable MMN. As expected, the two single-deviant MMNs had similar amplitudes, but that of the double-deviant MMN was also not significantly different from them. This absence of additivity in the double-deviant MMN suggests that consonant and pitch variations are processed, at least at a pre-attentive level, in an integrated rather than independent way. Domain-specificity of consonants may depend on higher-level processes in the hierarchy of speech perception.	[Gao, Shan; Hu, Jiehui; Gong, Diankun; Chen, Sifan; Kendrick, Keith M.; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Gao, Shan; Hu, Jiehui] Univ Elect Sci & Technol China, Sch Foreign Languages, Chengdu 610054, Peoples R China; [Chen, Sifan] Univ Elect Sci & Technol China, Mental Hlth Educ & Counseling Ctr, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Gao, S (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	kkendrick@uestc.edu.cn; dyao@uestc.edu.cn	Gao, Shan/AAI-1589-2019	Yao, Dezhong/0000-0002-8042-879X; Gong, Diankun/0000-0001-5598-3778; Kendrick, Keith/0000-0002-0371-5904	973 Project [2011CB707803]; NSFC [60736029]; PCSIRT; 111 Project; doctor Training Fund of MOE [20100185110016]; Chinese Ministry of Education Social Science Funding [11YJC880079]; Chinese National Educational Research Key Project [GPA115005]; Chinese Fundamental Research Funding for Central Universities [ZYGX2010J143, ZYGX2010J137]; Sichuan Provincial Research Funding of Sichuan Applied Psychological Research Center [CXSL-01002014]	973 Project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); doctor Training Fund of MOE; Chinese Ministry of Education Social Science Funding; Chinese National Educational Research Key Project; Chinese Fundamental Research Funding for Central Universities; Sichuan Provincial Research Funding of Sichuan Applied Psychological Research Center	This work is supported by the 973 Project No. 2011CB707803, the NSFC No. 60736029 (http://www.nsfc.gov.cn/Portal0/default106.htm), the PCSIRT and 111 Project, the doctor Training Fund of MOE No. 20100185110016, Chinese Ministry of Education Social Science Funding (11YJC880079), Chinese National Educational Research Key Project (GPA115005), Chinese Fundamental Research Funding for Central Universities (ZYGX2010J143, ZYGX2010J137), and Sichuan Provincial Research Funding (CXSL-01002014) of Sichuan Applied Psychological Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1997, PSYCHOPHYSIOLOGY, V34, P534, DOI 10.1111/j.1469-8986.1997.tb01740.x; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Czigler I, 1996, NEUROREPORT, V7, P2413, DOI 10.1097/00001756-199611040-00002; Di Carlo N.S., 2007, J SING, V63, P1; Fry DB, 1956, R JAKOBSON; Garner W. R., 1974, PROCESSING INFORM ST; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; Guitton MJ, 2010, COMPUT HUM BEHAV, V26, P1772, DOI 10.1016/j.chb.2010.07.004; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Knosche TR, 2002, NEUROIMAGE, V17, P1493, DOI 10.1006/nimg.2002.1262; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; Lei X, 2011, HUM BRAIN MAPP, V32, P1141, DOI 10.1002/hbm.21098; LEVANEN S, 1993, EXP BRAIN RES, V97, P177; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; Lidji P, 2010, CLIN NEUROPHYSIOL, V121, P533, DOI 10.1016/j.clinph.2009.12.018; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R., 1995, Brain Topography, V7, P315, DOI 10.1007/BF01195257; Paavilainen P, 2001, NEUROSCI LETT, V301, P179, DOI 10.1016/S0304-3940(01)01635-4; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Scotto di Carlo N., 2007, J SINGING, V63, P559; SHARMA A, 1993, ELECTROEN CLIN NEURO, V88, P64, DOI 10.1016/0168-5597(93)90029-O; Sharma Mridula, 2004, J Am Acad Audiol, V15, P616, DOI 10.3766/jaaa.15.9.3; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; STUDDERT.M, 1972, COGNITIVE PSYCHOL, V3, P455, DOI 10.1016/0010-0285(72)90017-5; Studdert-Kennedy M., 1974, CURR TRENDS LINGUIST, P2349; Takegata R, 1999, NEUROSCI LETT, V266, P109, DOI 10.1016/S0304-3940(99)00267-0; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Wolff C, 2001, NEUROSCI LETT, V311, P37, DOI 10.1016/S0304-3940(01)02135-8; WOOD CC, 1974, PERCEPT PSYCHOPHYS, V15, P501, DOI 10.3758/BF03199292; Wood CC, 1975, J EXPT PSYCHOLOGY HU, V1, P3; Xu P, 2007, IEEE T BIO-MED ENG, V54, P400, DOI 10.1109/TBME.2006.886640; Yao DZ, 2000, IEEE T BIO-MED ENG, V47, P964, DOI 10.1109/10.846691; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Ylinen S, 2005, NEUROREPORT, V16, P1857, DOI 10.1097/01.wnr.0000185959.11465.9b; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	47	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38289	10.1371/journal.pone.0038289	http://dx.doi.org/10.1371/journal.pone.0038289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693614	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500125
J	Guo, WB; Tao, J; Yang, C; Song, CJ; Geng, WT; Li, Q; Wang, YY; Kong, MM; Wang, SF				Guo, Wenbin; Tao, Jian; Yang, Chao; Song, Cunjiang; Geng, Weitao; Li, Qiang; Wang, Yuanyuan; Kong, Meimei; Wang, Shufang			Introduction of Environmentally Degradable Parameters to Evaluate the Biodegradability of Biodegradable Polymers	PLOS ONE			English	Article							SOIL; PHB	Environmentally Degradable Parameter (K-Ed) is of importance in the describing of biodegradability of environmentally biodegradable polymers (BDPs). In this study, a concept K-Ed was introduced. A test procedure of using the ISO 14852 method and detecting the evolved carbon dioxide as an analytical parameter was developed, and the calculated K-Ed was used as an indicator for the ultimate biodegradability of materials. Starch and polyethylene used as reference materials were defined as the K-Ed values of 100 and 0, respectively. Natural soil samples were inoculated into bioreactors, followed by determining the rates of biodegradation of the reference materials and 15 commercial BDPs over a 2-week test period. Finally, a formula was deduced to calculate the value of K-Ed for each material. The K-Ed values of the tested materials have a positive correlation to their biodegradation rates in the simulated soil environment, and they indicated the relative biodegradation rate of each material among all the tested materials. Therefore, the K-Ed was shown to be a reliable indicator for quantitatively evaluating the potential biodegradability of BDPs in the natural environment.	[Guo, Wenbin; Tao, Jian; Song, Cunjiang; Geng, Weitao; Li, Qiang; Wang, Yuanyuan] Nankai Univ, Coll Life Sci, Minist Educ, Dept Microbiol,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Yang, Chao; Kong, Meimei; Wang, Shufang] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Guo, WB (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Dept Microbiol,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	songcj@nankai.edu.cn; wangshufang@nankai.edu.cn	Lv, Yuanjie/AER-0767-2022	Guo, Wenbin/0000-0001-7197-6260	National Key Basic Research Program of China ("973" Program) [2012CB725204]; National High Technology Research and Development Program of China ("863" Program) [2012AA021505]; Natural Science Foundation of China [31070039, 51073081]; Project of Tianjin, China [1JCYBJC09500]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021505] Funding Source: NIH RePORTER	National Key Basic Research Program of China ("973" Program)(National Basic Research Program of China); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Tianjin, China; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors gratefully acknowledge the financial support from National Key Basic Research Program of China ("973" Program) 2012CB725204, National High Technology Research and Development Program of China ("863" Program) 2012AA021505, Natural Science Foundation of China grant nos. 31070039, 51073081 and 51073081, Project of Tianjin, China 1JCYBJC09500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai YP, 2009, MATER DESIGN, V30, P892, DOI 10.1016/j.matdes.2008.05.047; [Anonymous], 1999, 14851 ISO; [Anonymous], 1999, 14852 ISO; [Anonymous], 1997, 846 ISO; Ding Q, 2003, CARBOHYD POLYM, V51, P333, DOI 10.1016/S0144-8617(02)00190-X; Doi Y, 2002, NAT MATER, V1, P207, DOI 10.1038/nmat783; Goel R, 2008, INT BIODETER BIODEGR, V61, P167, DOI 10.1016/j.ibiod.2007.07.001; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Guo WB, 2010, POLYM TEST, V29, P832, DOI 10.1016/j.polymertesting.2010.07.004; Ishikuri S, 1992, NEW COMPILATION SOIL; *ISO, 1999, 14855 ISO; Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025; Mizuno W, 2003, KOBUNSHI RONBUNSHU, V60, P622, DOI 10.1295/koron.60.622; Montgomery R, 2004, BIORESOURCE TECHNOL, V91, P1, DOI 10.1016/S0960-8524(03)00154-8; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Nikolic MS, 2001, POLYM DEGRAD STABIL, V74, P263, DOI 10.1016/S0141-3910(01)00156-2; OTAKE Y, 1995, J APPL POLYM SCI, V56, P1789, DOI 10.1002/app.1995.070561309; Rodrigues G, 2008, CARBOHYD POLYM, V73, P74, DOI 10.1016/j.carbpol.2007.11.010; Rosa DD, 2004, J POLYM ENVIRON, V12, P239; Rubinstein M, 2003, POLYM PHYS; Ryan SM, 2006, APPL ENVIRON MICROB, V72, P5289, DOI 10.1128/AEM.00257-06; Shafiee S, 2009, ENERG POLICY, V37, P181, DOI 10.1016/j.enpol.2008.08.016; Song JH, 2009, PHILOS T R SOC B, V364, P2127, DOI 10.1098/rstb.2008.0289; Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P771, DOI 10.1023/B:BILE.0000025927.31028.e3; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Zhao Q, 2008, POLYM DEGRAD STABIL, V93, P1571, DOI 10.1016/j.polymdegradstab.2008.05.002	26	23	24	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38341	10.1371/journal.pone.0038341	http://dx.doi.org/10.1371/journal.pone.0038341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675455	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500135
J	Hanel, R; Pochacker, M; Scholling, M; Thurner, S				Hanel, Rudolf; Poechacker, Manfred; Schoelling, Manuel; Thurner, Stefan			A Self-Organized Model for Cell-Differentiation Based on Variations of Molecular Decay Rates	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; FOXO TRANSCRIPTION FACTORS; QUALITATIVE SIMULATION; PROTEIN-DEGRADATION; ESCHERICHIA-COLI; BOOLEAN NETWORKS; SYSTEMS BIOLOGY; EXPRESSION; DYNAMICS; OSCILLATIONS	Systemic properties of living cells are the result of molecular dynamics governed by so-called genetic regulatory networks (GRN). These networks capture all possible features of cells and are responsible for the immense levels of adaptation characteristic to living systems. At any point in time only small subsets of these networks are active. Any active subset of the GRN leads to the expression of particular sets of molecules (expression modes). The subsets of active networks change over time, leading to the observed complex dynamics of expression patterns. Understanding of these dynamics becomes increasingly important in systems biology and medicine. While the importance of transcription rates and catalytic interactions has been widely recognized in modeling genetic regulatory systems, the understanding of the role of degradation of biochemical agents (mRNA, protein) in regulatory dynamics remains limited. Recent experimental data suggests that there exists a functional relation between mRNA and protein decay rates and expression modes. In this paper we propose a model for the dynamics of successions of sequences of active subnetworks of the GRN. The model is able to reproduce key characteristics of molecular dynamics, including homeostasis, multi-stability, periodic dynamics, alternating activity, differentiability, and self-organized critical dynamics. Moreover the model allows to naturally understand the mechanism behind the relation between decay rates and expression modes. The model explains recent experimental observations that decay-rates (or turnovers) vary between differentiated tissue-classes at a general systemic level and highlights the role of intracellular decay rate control mechanisms in cell differentiation.	[Hanel, Rudolf; Poechacker, Manfred; Schoelling, Manuel; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, CeMSIIS, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA	Medical University of Vienna; The Santa Fe Institute	Hanel, R (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, CeMSIIS, Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Hanel, Rudolf/0000-0002-4045-9532	"Forum Integrativmedizin" (FIM) an initiative of the "Hilde Umdasch Privatstiftung"	"Forum Integrativmedizin" (FIM) an initiative of the "Hilde Umdasch Privatstiftung"	This work has been funded by the "Forum Integrativmedizin" (FIM) an initiative of the "Hilde Umdasch Privatstiftung" (http://www.integrativemedizin.at). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bhattacharjya A, 1996, PHYS REV LETT, V77, P1644, DOI 10.1103/PhysRevLett.77.1644; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Casey R, 2006, J MATH BIOL, V52, P27, DOI 10.1007/s00285-005-0338-2; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100007; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Glass L, 1998, EUROPHYS LETT, V41, P599, DOI 10.1209/epl/i1998-00199-0; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hanel R, 2010, PHILOS T R SOC A, V368, P5583, DOI 10.1098/rsta.2010.0267; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mitchell M., 1993, Complex Systems, V7, P89; Ozbudak EM, 2004, LETT NATURE, V427, P237; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Pigolotti S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088701; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ptashne M, 1992, GENETIC SWITCH PHAGE; Qian XN, 2010, BIOINFORMATICS, V26, P3098, DOI 10.1093/bioinformatics/btq575; Rewienski M, 2003, IEEE ACM T COMP AIDE, P252; Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Stokic D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061917; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; Viretta AU, 2004, BIOTECHNOL PROGR, V20, P670, DOI 10.1021/bp034323l; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; YAGIL G, 1971, BIOPHYS J, V11, P11, DOI 10.1016/S0006-3495(71)86192-1; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	56	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36679	10.1371/journal.pone.0036679	http://dx.doi.org/10.1371/journal.pone.0036679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693554	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500015
J	Ingles-Esteve, J; Morales, M; Dalmases, A; Garcia-Carbonell, R; Jene-Sanz, A; Lopez-Bigas, N; Iglesias, M; Ruiz-Herguido, C; Rovira, A; Rojo, F; Albanell, J; Gomis, RR; Bigas, A; Espinosa, L				Ingles-Esteve, Julia; Morales, Monica; Dalmases, Alba; Garcia-Carbonell, Ricard; Jene-Sanz, Alba; Lopez-Bigas, Nuria; Iglesias, Mar; Ruiz-Herguido, Cristina; Rovira, Ana; Rojo, Federico; Albanell, Joan; Gomis, Roger R.; Bigas, Anna; Espinosa, Lluis			Inhibition of Specific NF-kappa B Activity Contributes to the Tumor Suppressor Function of 14-3-3 sigma in Breast Cancer	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-PROLIFERATION; BONE METASTASIS; NUCLEAR EXPORT; IKK-ALPHA; ACTIVATION; INFLAMMATION; APOPTOSIS; PROGRESSION; CARCINOMA	14-3-3 sigma is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3 sigma in the termination of NF-kappa B signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3 sigma regulates nuclear export of p65-NF-kappa B following chronic TNF alpha stimulation. Restoration of 14-3-3 sigma in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNF alpha in a 14-3-3 sigma-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that overexpression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-kappa B activation strictly correlates with the absence of 14-3-3 sigma and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-kappa B targeting.	[Ingles-Esteve, Julia; Dalmases, Alba; Garcia-Carbonell, Ricard; Ruiz-Herguido, Cristina; Rovira, Ana; Rojo, Federico; Albanell, Joan; Bigas, Anna; Espinosa, Lluis] Hosp Mar Res Inst, IMIM, Canc Res Program, Barcelona, Spain; [Morales, Monica; Gomis, Roger R.] IRB, Barcelona, Spain; [Dalmases, Alba; Rovira, Ana; Albanell, Joan] Hosp Mar, Med Oncol Serv, Barcelona, Spain; [Garcia-Carbonell, Ricard; Iglesias, Mar] Hosp Mar, Dept Pathol, Barcelona, Spain; [Jene-Sanz, Alba; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain; [Rojo, Federico] IIS Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; ICREA; Fundacion Jimenez Diaz	Ingles-Esteve, J (corresponding author), Hosp Mar Res Inst, IMIM, Canc Res Program, Barcelona, Spain.	abigas@imim.es; lespinosa@imim.es	Lopez-Bigas, Nuria/F-6193-2011; Gasull, Martina/J-4076-2019; Morales-Ballús, Mònica/AAE-3086-2021; Gomis, Roger R/E-9788-2016; Ruiz, Cristina/AGV-9518-2022; Albanell, Joan/R-9470-2019; Rojo, Federico/S-6551-2016; Espinosa, Lluis/ABA-4564-2020; Bigas, Anna/A-7457-2014; Rovira, Ana/ABH-5661-2020	Lopez-Bigas, Nuria/0000-0003-4925-8988; Morales-Ballús, Mònica/0000-0002-9478-6280; Gomis, Roger R/0000-0001-6473-2858; Ruiz, Cristina/0000-0002-5133-3564; Espinosa, Lluis/0000-0002-2897-4099; Bigas, Anna/0000-0003-4801-6899; Rovira, Ana/0000-0003-1301-2599; Jene-Sanz, Alba/0000-0003-3665-8333; Rojo, Federico/0000-0001-9989-0290	ISCIII/FEDER-Subdireccion General de Evaluacion y Fomento de la Investigacion [PI07/0778, PI10/01128, PS09/1296, PS09/01285]; AGAUR [2009SGR23, 2009SGR321]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, Programa Consolider and Instituto de Salud Carlos III (ISCIII)/FEDER [RD06/0020/0098, RD06/0020/0109]; BBVA foundation and Asociacion Espanola Contra el Cancer; Spanish Ministry of Science and Technology [SAF2009-06954]; Science and Education Spanish Ministry (MEC) FPI predoctoral fellowship [BES-2008-001850]; ICREA Funding Source: Custom	ISCIII/FEDER-Subdireccion General de Evaluacion y Fomento de la Investigacion(Instituto de Salud Carlos III); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, Programa Consolider and Instituto de Salud Carlos III (ISCIII)/FEDER(Instituto de Salud Carlos III); BBVA foundation and Asociacion Espanola Contra el Cancer(BBVA Foundation); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science and Education Spanish Ministry (MEC) FPI predoctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); ICREA(ICREA)	This work was funded by ISCIII/FEDER-Subdireccion General de Evaluacion y Fomento de la Investigacion (PI07/0778, PI10/01128, PS09/1296 and PS09/01285), AGAUR (2009SGR23 and 2009SGR321) and Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, Programa Consolider and Instituto de Salud Carlos III (ISCIII)/FEDER (RD06/0020/0098 and RD06/0020/0109). Financial support was provided to RRG by BBVA foundation and Asociacion Espanola Contra el Cancer. NLB acknowledges funding from the Spanish Ministry of Science and Technology (SAF2009-06954). AJ-S was funded by Science and Education Spanish Ministry (MEC) FPI predoctoral fellowship (BES-2008-001850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Bengtsson H., 2008, 745 U CAL DEP STAT; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chan SYY, 2010, ONCOL REP, V24, P949, DOI 10.3892/or_00000941; Che XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-306; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Gundem G, 2012, GENOME MED, V4, DOI 10.1186/gm327; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Hodgson JG, 2005, CANCER RES, V65, P9695, DOI 10.1158/0008-5472.CAN-05-0755; Holland PM, 2010, CANCER BIOL THER, V9, P539, DOI 10.4161/cbt.9.7.11266; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lodygin D, 2005, CELL RES, V15, P237, DOI 10.1038/sj.cr.7290292; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nicolini A, 2009, MED RES REV, V29, P436, DOI 10.1002/med.20143; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; R Development Core Team, 2010, LANG ENV STAT COMP; Rivas MA, 2010, BREAST CANCER RES TR, V122, P111, DOI 10.1007/s10549-009-0546-3; Sangaletti S, 2010, CANCER RES, V70, P7764, DOI 10.1158/0008-5472.CAN-10-0471; Schaefer J., 2010, CORPCOR EFFICIENT ES; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Su CH, 2010, CANC RES; Sung B, 2010, INT J CANC; Tan W, 2011, NATURE; Therneau T, 2009, SURVIVAL SURVIVAL AN, P235; Tobinick EL, 2003, CLIN THER, V25, P2279, DOI 10.1016/S0149-2918(03)80219-9; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	60	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38347	10.1371/journal.pone.0038347	http://dx.doi.org/10.1371/journal.pone.0038347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675457	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500138
J	Wang, F; Ye, P; Luo, LM; Xu, RY; Bai, YY; Wu, HM				Wang, Fan; Ye, Ping; Luo, Leiming; Xu, Ruyi; Bai, Yongyi; Wu, Hongmei			Association of Glomerular Filtration Rate with High-Sensitivity Cardiac Troponin T in a Community-Based Population Study in Beijing	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; UNIVERSAL DEFINITION; RISK; ADULTS; INSUFFICIENCY; PREVALENCE; MORTALITY	Background: Reduced renal function is an independent risk factor for cardiovascular disease mortality, and persistently elevated cardiac troponin T (cTnT) is frequently observed in patients with end-stage renal disease. In the general population the relationship between renal function and cTnT levels may not be clear because of the low sensitivity of the assay. In this study, we investigated the level of cTnT using a highly sensitive assay (hs-cTnT) and evaluated the association of estimated glomerular filtration rate (eGFR) with detectable hs-cTnT levels in a community-based population. Methods: The serum hs-cTnT levels were measured in 1365 community dwelling population aged >= 45 years in Beijing, China. eGFR was determined by the Chinese modifying modification of diet in renal disease (C-MDRD) equation. Results: With the highly sensitive assay, cTnT levels were detectable (>= 3pg/mL) in 744 subjects (54.5%). The result showed that eGFR was associated with Log hs-cTnT (r = 20.14, P<0.001). After adjustment for the high predicted Framingham Coronary Heart Disease (CHD) risk (10-year risk >20%) and other prognostic indicators, moderate to severe reduced eGFR was independently associated with detectable hs-cTnT, whereas normal to mildly reduced eGFR was not independently associated with detectable hs-cTnT. In addition, after adjustment for other risk factors, the high predicted Framingham CHD risk was associated with detectable hs-cTnT in the subjects with different quartile levels of eGFR. Conclusion: The levels of hs-cTnT are detectable in a community-based Chinese population and low eGFR is associated with detectable hs-cTnT. Moreover, eGFR and high predicted Framingham CHD risk are associated with detectable hs-cTnT in subjects with moderate-to-severe reduced renal function.	[Wang, Fan; Ye, Ping; Luo, Leiming; Xu, Ruyi; Bai, Yongyi; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, F (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	3393d@sina.com	Luo, Leiming/AAD-5533-2019		Capital Medical Development Fund of Beijing [2009-2038]; National Basic Research Program of China [2012CB517503]	Capital Medical Development Fund of Beijing; National Basic Research Program of China(National Basic Research Program of China)	This study was supported by a grant from the Capital Medical Development Fund of Beijing (2009-2038) and the National Basic Research Program of China (2012CB517503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas NA, 2005, CLIN CHEM, V51, P2059, DOI 10.1373/clinchem.2005.055665; Alpert JS, 2008, NAT CLIN PRACT CARD, V5, P678, DOI 10.1038/ncpcardio1329; Antman EM, 2002, NEW ENGL J MED, V346, P2079, DOI 10.1056/NEJMe020049; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Berl T, 2006, CLIN J AM SOC NEPHRO, V1, P8, DOI 10.2215/CJN.00730805; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Cardiovascular Disease in Dialysis Patients Work Group, 2005, AM J KIDNEY DIS S, V45, pS7; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Conway B, 2005, NEPHROL DIAL TRANSPL, V20, P2759, DOI 10.1093/ndt/gfi125; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Everett BM, 2011, CIRCULATION, V123, P2811, DOI 10.1161/CIRCULATIONAHA.110.009928; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Gabr AEM, 2004, SAUDI MED J, V25, P1015; Hu J, 2009, PUBLIC HEALTH NURS, V26, P500, DOI 10.1111/j.1525-1446.2009.00810.x; Inrig JK, 2008, NEPHROL DIAL TRANSPL, V23, P934, DOI 10.1093/ndt/gfm689; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Kehl DW, 2011, CLIN RES CARDIOL, V100, P359, DOI 10.1007/s00392-010-0255-2; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shankar A, 2008, NEPHROL DIAL TRANSPL, V23, P1910, DOI 10.1093/ndt/gfm878; Sharma R, 2006, HEART, V92, P804, DOI 10.1136/hrt.2005.069666; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; Turakhia MP, 2009, EUR HEART J, V30, P2478, DOI 10.1093/eurheartj/ehp270; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xu R, 2011, INT J CARDIOL, V149, P253, DOI 10.1016/j.ijcard.2011.02.032; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763	38	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38218	10.1371/journal.pone.0038218	http://dx.doi.org/10.1371/journal.pone.0038218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675450	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500112
J	Ismail, Y; Mahendran, V; Octavia, S; Day, AS; Riordan, SM; Grimm, MC; Lan, RT; Lemberg, D; Tran, TAT; Zhang, L				Ismail, Yazan; Mahendran, Vikneswari; Octavia, Sophie; Day, Andrew S.; Riordan, Stephen M.; Grimm, Michael C.; Lan, Ruiting; Lemberg, Daniel; Tran, Thi Anh Tuyet; Zhang, Li			Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; CROHNS-DISEASE; II SECRETION; EPITHELIAL-CELLS; S-LAYER; IDENTIFICATION; CLASSIFICATION; HELICOBACTER; ATTACHMENT; ARCOBACTER	Background: Campylobacter concisus, a bacterium colonizing the human oral cavity, has been shown to be associated with inflammatory bowel disease (IBD). This study investigated if patients with IBD are colonized with specific oral C. concisus strains that have potential to cause enteric diseases. Methodology: Seventy oral and enteric C. concisus isolates obtained from eight patients with IBD and six controls were examined for housekeeping genes by multilocus sequence typing (MLST), Caco2 cell invasion by gentamicin-protection-assay, protein analysis by mass spectrometry and SDS-PAGE, and morphology by scanning electron microscopy. The whole genome sequenced C. concisus strain 13826 which was isolated from an individual with bloody diarrhea was included in MLST analysis. Principal Findings: MLST analysis showed that 87.5% of individuals whose C. concisus belonged to Cluster I had inflammatory enteric diseases (six IBD and one with bloody diarrhea), which was significantly higher than that in the remaining individuals (28.6%) (P < 0.05). Enteric invasive C. concisus (EICC) oral strain was detected in 50% of patients with IBD and none of the controls. All EICC strains were in Cluster 1. The C. concisus strain colonizing intestinal tissues of patient No. 1 was closely related to the oral C. concisus strain from patient No. 6 and had gene recombination with the patient's own oral C. concisus. The oral and intestinal C. concisus strains of patient No. 3 were the same strain. Some individuals were colonized with multiple oral C. concisus strains that have undergone natural recombination. Conclusions: This study provides the first evidence that patients with IBD are colonized with specific oral C. concisus strains, with some being EICC strains. C. concisus colonizing intestinal tissues of patients with IBD at least in some instances results from an endogenous colonization of the patient's oral C. concisus and that C. concisus strains undergo natural recombination.	[Ismail, Yazan; Mahendran, Vikneswari; Octavia, Sophie; Lan, Ruiting; Tran, Thi Anh Tuyet; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Day, Andrew S.; Lemberg, Daniel] Sydney Childrens Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Day, Andrew S.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Day, Andrew S.] Univ Otago, Dept Paediat, Christchurch, New Zealand; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Otago; University of New South Wales Sydney; University of New South Wales Sydney	Ismail, Y (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au		Zhang, Li/0000-0001-7506-8278; Lemberg, Daniel/0000-0002-8583-0956; Grimm, Michael/0000-0001-9426-3917; Lan, Ruiting/0000-0001-9834-5258; Ismail, Yazan/0000-0002-7020-3642; Octavia, Sophie/0000-0001-8506-9127	Broad Medical Research Program of the Broad Foundation [IBD0273-R]; Faculty of Science, University of New South Wales [FRG2011]; Al-Balaq' Applied University, Jordan	Broad Medical Research Program of the Broad Foundation; Faculty of Science, University of New South Wales; Al-Balaq' Applied University, Jordan	This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant no: IBD0273-R) and a research grant awarded to Dr Li Zhang from the Faculty of Science, University of New South Wales (FRG2011). Yazan Ismail is supported by a PhD scholarship from Al-Balaq' Applied University, Jordan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; BLASER MJ, 1994, MOL MICROBIOL, V14, P453, DOI 10.1111/j.1365-2958.1994.tb02180.x; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; CUMMINGS JH, 1983, LANCET, V1, P1206; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; GARCIA MM, 1995, J BACTERIOL, V177, P1976, DOI 10.1128/jb.177.8.1976-1980.1995; HALE TL, 1979, INFECT IMMUN, V24, P879, DOI 10.1128/IAI.24.3.879-886.1979; Istivan TS, 2004, J MED MICROBIOL, V53, P483, DOI 10.1099/jmm.0.45554-0; Iwobi A, 2003, INFECT IMMUN, V71, P1872, DOI 10.1128/IAI.71.4.1872-1879.2003; Kaakoush NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029045; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Karlyshev AV, 2004, MICROBIOL-SGM, V150, P1957, DOI 10.1099/mic.0.26721-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson CL, 2008, CAMPYLOBACTER; Lastovica AJ, 2006, CLIN MICROBIOL NEWSL, V28, P7; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lynch OA, 2011, INT J FOOD MICROBIOL, V150, P171, DOI 10.1016/j.ijfoodmicro.2011.07.037; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Matsheka MI, 2001, J CLIN MICROBIOL, V39, P3684, DOI 10.1128/JCM.39.10.3684-3689.2001; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Petersen RF, 2007, J APPL MICROBIOL, V103, P2601, DOI 10.1111/j.1365-2672.2007.03515.x; REEVES PR, 1994, COMPUT APPL BIOSCI, V10, P281; Russel M, 1998, J MOL BIOL, V279, P485, DOI 10.1006/jmbi.1998.1791; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Suerbaum S, 2001, J BACTERIOL, V183, P2553, DOI 10.1128/JB.183.8.2553-2559.2001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	52	53	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38217	10.1371/journal.pone.0038217	http://dx.doi.org/10.1371/journal.pone.0038217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666490	gold, Green Published, Green Submitted			2022-12-25	WOS:000305353400103
J	Kelly, GM; Buckley, DA; Kiely, PA; Adams, DR; O'Connor, R				Kelly, Geraldine M.; Buckley, Deirdre A.; Kiely, Patrick A.; Adams, David R.; O'Connor, Rosemary			Serine Phosphorylation of the Insulin-like Growth Factor I (IGF-1) Receptor C-terminal Tail Restrains Kinase Activity and Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CRYSTAL-STRUCTURE; TYROSINE KINASE; TUMOR-CELLS; TRANSFORMING ACTIVITIES; SUBSTRATE-SPECIFICITY; INTERACTING PROTEIN; CARBOXYL-TERMINUS; ACTIVATION-LOOP; AKT ACTIVATION	Insulin-like growth factor I receptor (IGF-1R) signaling is essential for cell, organ, and animal growth. The C-terminal tail of the IGF-1R exhibits regulatory function, but the mechanism is unknown. Here, we show that mutation of Ser-1248 (S1248A) enhances IGF-1R in vitro kinase activity, autophosphorylation, Akt/mammalian target of rapamycin activity, and cell growth. Ser-1248 phosphorylation is mediated by GSK-3 beta in a mechanism that involves a priming phosphorylation on Ser-1252. GSK-3 beta knock-out cells exhibit reduced IGF-1R cell surface expression, enhanced IGF-1R kinase activity, and signaling. Examination of crystallographic structures of the IGF-1R kinase domain revealed that the (SFYYS1252)-S-1248 motif adopts a conformation tightly packed against the kinase C-lobe when Ser-1248 is in the unphosphorylated state that favors kinase activity. S1248A mutation is predicted to lock the motif in this position. In contrast, phosphorylation of Ser-1248 will drive profound structural transition of the sequence, critically affecting connection of the C terminus as well as exposing potential protein docking sites. Decreased kinase activity of a phosphomimetic S1248E mutant and enhanced kinase activity in mutants of its predicted target residue Lys-1081 support this auto-inhibitory model. Thus, the SFYYS motif controls the organization of the IGF-1R C terminus relative to the kinase domain. Its phosphorylation by GSK-3 beta restrains kinase activity and regulates receptor trafficking and signaling.	[Kelly, Geraldine M.; Buckley, Deirdre A.; Kiely, Patrick A.; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland; [Adams, David R.] Heriot Watt Univ, Edinburgh EH14 4AS, Midlothian, Scotland	University College Cork; Heriot Watt University	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland.	r.oconnor@ucc.ie	O'Connor, Rosemary/B-7902-2014; Adams, David R/E-3916-2010	O'Connor, Rosemary/0000-0002-0687-3422; Adams, David R/0000-0002-7154-7332	Science Foundation Ireland; Health Research Board; Cancer Research Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Cancer Research Ireland	This work was supported by Science Foundation Ireland, The Health Research Board, and Cancer Research Ireland.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Baserga R, 2007, CELL CYCLE, V6, P814, DOI 10.4161/cc.6.7.4049; Blakesley VA, 1996, ENDOCRINOLOGY, V137, P410, DOI 10.1210/en.137.2.410; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Brodt P, 2001, J BIOL CHEM, V276, P33608, DOI 10.1074/jbc.M102754200; Chen H, 1998, CELL GROWTH DIFFER, V9, P939; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Craddock B. P., 2012, J SIGNAL T, P20121; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Du J, 2010, P NATL ACAD SCI USA, V107, P11573, DOI 10.1073/pnas.0913138107; Esposito DL, 1997, ENDOCRINOLOGY, V138, P2979, DOI 10.1210/en.138.7.2979; Farghaian H, 2011, J BIOL CHEM, V286, P25274, DOI 10.1074/jbc.M111.251629; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hongo A, 1996, ONCOGENE, V12, P1231; Hongo A, 1998, CANCER RES, V58, P2477; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Leahy M, 2004, J BIOL CHEM, V279, P18306, DOI 10.1074/jbc.M309234200; Li SL, 1998, FEBS LETT, V421, P45, DOI 10.1016/S0014-5793(97)01523-8; Li SW, 1996, J BIOL CHEM, V271, P12254, DOI 10.1074/jbc.271.21.12254; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu YM, 1998, CANCER RES, V58, P570; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Mayer SC, 2008, BIOORG MED CHEM LETT, V18, P3641, DOI 10.1016/j.bmcl.2008.04.044; Miller LM, 2009, BIOORG MED CHEM LETT, V19, P62, DOI 10.1016/j.bmcl.2008.11.037; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Munshi S, 2002, J BIOL CHEM, V277, P38797, DOI 10.1074/jbc.M205580200; Nemecek C, 2010, CHEM BIOL DRUG DES, V76, P100, DOI 10.1111/j.1747-0285.2010.00991.x; Niu XL, 2002, J BIOL CHEM, V277, P31768, DOI 10.1074/jbc.M203995200; O'Connor R, 2003, HORM METAB RES, V35, P771; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Pautsch A, 2001, STRUCTURE, V9, P955, DOI 10.1016/S0969-2126(01)00655-4; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sampognaro AJ, 2010, BIOORG MED CHEM LETT, V20, P5027, DOI 10.1016/j.bmcl.2010.07.045; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; SURMACZ E, 1995, EXP CELL RES, V218, P370, DOI 10.1006/excr.1995.1168; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Velaparthi U, 2007, BIOORG MED CHEM LETT, V17, P2317, DOI 10.1016/j.bmcl.2007.01.102; VOSKAS D, 2010, BIOL REP, V2, P82; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006	59	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28180	28194		10.1074/jbc.M112.385757	http://dx.doi.org/10.1074/jbc.M112.385757			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22685298	Green Published, hybrid			2022-12-25	WOS:000307840700091
J	Ahmad, E; Rabbani, G; Zaidi, N; Ahmad, B; Khan, RH				Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Ahmad, Basir; Khan, Rizwan Hasan			Pollutant-Induced Modulation in Conformation and beta-Lactamase Activity of Human Serum Albumin	PLOS ONE			English	Article							CIRCULAR-DICHROISM; LIGAND-BINDING; SECONDARY STRUCTURE; PROTEIN; SITE	Structural changes in human serum albumin (HSA) induced by the pollutants 1-naphthol, 2-naphthol and 8-quinolinol were analyzed by circular dichroism, fluorescence spectroscopy and dynamic light scattering. The alteration in protein conformational stability was determined by helical content induction (from 55 to 75%) upon protein-pollutant interactions. Domain plasticity is responsible for the temperature-mediated unfolding of HSA. These findings were compared to HSA-hydrolase activity. We found that though HSA is a monomeric protein, it shows heterotropic allostericity for beta-lactamase activity in the presence of pollutants, which act as K- and V-type non-essential activators. Pollutants cause conformational changes and catalytic modifications of the protein (increase in beta-lactamase activity from 100 to 200%). HSA-pollutant interactions mediate other protein-ligand interactions, such as HSA-nitrocefin. Therefore, this protein can exist in different conformations with different catalytic properties depending on activator binding. This is the first report to demonstrate the catalytic allostericity of HSA through a mechanistic approach. We also show a correlation with non-microbial drug resistance as HSA is capable of self-hydrolysis of beta-lactam drugs, which is further potentiated by pollutants due to conformational changes in HSA.	[Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Ahmad, Basir; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Ahmad, E (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022; Ahmad, Ejaz/L-1506-2013; Ahmad, Basir/O-9344-2017; Khan, Rizwan Hasan/F-8276-2014	Rabbani, Gulam/0000-0002-5293-8231; Ahmad, Ejaz/0000-0002-5713-6713; Ahmad, Basir/0000-0002-0120-5097; Khan, Rizwan Hasan/0000-0002-9965-8982; Zaidi, Dr Nida/0000-0003-2579-2190	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to E. Ahmad, G. Rabbani and N. Zaidi in the form of a Senior Research Fellowship was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. R.H. Khan is an Associate Professor in A.M.U., Aligarh. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Ahmad E, 2010, BIOCHIMIE, V92, P885, DOI 10.1016/j.biochi.2010.03.023; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BROWN JR, 1976, FED PROC, V35, P2141; CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x; Chadborn N, 1999, BIOPHYS J, V76, P2198, DOI 10.1016/S0006-3495(99)77375-3; CHEN RF, 1984, ANAL LETT PT B, V17, P857, DOI 10.1080/0003271811681085; CREAMER TP, 1992, P NATL ACAD SCI USA, V89, P5937, DOI 10.1073/pnas.89.13.5937; CREAMER TP, 1994, PROTEINS, V19, P85, DOI 10.1002/prot.340190202; DUMAS C, 1983, FEBS LETT, V153, P128, DOI 10.1016/0014-5793(83)80132-X; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Flora K, 1998, BIOPHYS J, V75, P1084, DOI 10.1016/S0006-3495(98)77598-8; HAYBALL PJ, 1992, BIOCHEM PHARMACOL, V44, P291, DOI 10.1016/0006-2952(92)90012-8; Kamal JKA, 2004, P NATL ACAD SCI USA, V101, P13411, DOI 10.1073/pnas.0405724101; Khrapunov S, 2002, BIOCHEMISTRY-US, V41, P9559, DOI 10.1021/bi0255773; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liu MF, 2000, J BACTERIOL, V182, P6509, DOI 10.1128/JB.182.22.6509-6513.2000; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; MANNING MC, 1991, BIOPOLYMERS, V31, P569, DOI 10.1002/bip.360310511; Musah RA, 2002, J MOL BIOL, V315, P845, DOI 10.1006/jmbi.2001.5287; Myers JK, 1998, PROTEIN SCI, V7, P383; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; NERLI B, 1994, BIOCHEM MOL BIOL INT, V32, P789; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3218; Oncley JL, 2003, BIOPHYS CHEM, V100, P151, DOI 10.1016/S0301-4622(02)00276-4; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Pico GA, 1997, INT J BIOL MACROMOL, V20, P63, DOI 10.1016/S0141-8130(96)01153-1; Rezaei-Tavirani M, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI 10.5483/BMBRep.2006.39.5.530; Salvi A, 1997, DRUG METAB DISPOS, V25, P395; Sardar PS, 2008, J PHYS CHEM B, V112, P3451, DOI 10.1021/jp074598+; Sinha SS, 2008, J PHYS CHEM B, V112, P4884, DOI 10.1021/jp709809b; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Thumser AEA, 1998, J LIPID RES, V39, P1033; Toniolo C, 1996, J AM CHEM SOC, V118, P2744, DOI 10.1021/ja9537383; Weljie AM, 2003, PROTEIN SCI, V12, P228, DOI 10.1110/ps.0226203; Yoder G, 1997, J AM CHEM SOC, V119, P10278, DOI 10.1021/ja971392l	43	68	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38372	10.1371/journal.pone.0038372	http://dx.doi.org/10.1371/journal.pone.0038372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685563	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700026
J	Jelfs, B; Banaji, M; Tachtsidis, I; Cooper, CE; Elwell, CE				Jelfs, Beth; Banaji, Murad; Tachtsidis, Ilias; Cooper, Chris E.; Elwell, Clare E.			Modelling Noninvasively Measured Cerebral Signals during a Hypoxemia Challenge: Steps towards Individualised Modelling	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; OXIDASE REDOX STATE; ADULT BRAIN; OXIDATIVE-PHOSPHORYLATION; NORMOBARIC HYPEROXIA; MATHEMATICAL-MODEL; PRESSURE CHANGES; BLOOD-FLOW; OXYGENATION; HEMODYNAMICS	Noninvasive approaches to measuring cerebral circulation and metabolism are crucial to furthering our understanding of brain function. These approaches also have considerable potential for clinical use "at the bedside". However, a highly nontrivial task and precondition if such methods are to be used routinely is the robust physiological interpretation of the data. In this paper, we explore the ability of a previously developed model of brain circulation and metabolism to explain and predict quantitatively the responses of physiological signals. The five signals all noninvasively-measured during hypoxemia in healthy volunteers include four signals measured using near-infrared spectroscopy along with middle cerebral artery blood flow measured using transcranial Doppler flowmetry. We show that optimising the model using partial data from an individual can increase its predictive power thus aiding the interpretation of NIRS signals in individuals. At the same time such optimisation can also help refine model parametrisation and provide confidence intervals on model parameters. Discrepancies between model and data which persist despite model optimisation are used to flag up important questions concerning the underlying physiology, and the reliability and physiological meaning of the signals.	[Jelfs, Beth; Tachtsidis, Ilias; Elwell, Clare E.] UCL, Dept Med Phys & Bioengn, London, England; [Banaji, Murad] Univ Portsmouth, Dept Math, Portsmouth, Hants, England; [Cooper, Chris E.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of London; University College London; University of Portsmouth; University of Essex	Jelfs, B (corresponding author), UCL, Dept Med Phys & Bioengn, London, England.	bjelfs@medphys.ucl.ac.uk	Tachtsidis, Ilias/N-2747-2018; Cooper, Chris/AAK-9729-2020; Jelfs, Beth/AAO-1191-2020	Tachtsidis, Ilias/0000-0002-8125-0313; Cooper, Chris/0000-0003-0381-3990; Jelfs, Beth/0000-0002-6844-7154; Elwell, Clare/0000-0002-7281-7234; Banaji, Murad/0000-0002-4983-0377	Department of Health's National Institute for Health Research Centres; Engineering and Physical Sciences Research Council [EP/D060982/1]; Medical Research Council (MRC) [G0701458]; Wellcome Trust [WT/089914/A/09/Z]; EPSRC [EP/D060982/1] Funding Source: UKRI; MRC [G0701458] Funding Source: UKRI; Medical Research Council [G0701458] Funding Source: researchfish	Department of Health's National Institute for Health Research Centres(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The initial study was undertaken at University College London Hospitals and partially funded by the Department of Health's National Institute for Health Research Centres funding scheme. Subsequent research in this paper was funded in part by the Engineering and Physical Sciences Research Council grant EP/D060982/1, Medical Research Council (MRC) grant G0701458 and Wellcome Trust grant WT/089914/A/09/Z. No additional external funding received for this study and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawi PG, 2006, STROKE, V37, P2720, DOI 10.1161/01.STR.0000244807.99073.ae; Banaj M, 2006, J THEOR BIOL, V243, P501, DOI 10.1016/j.jtbi.2006.07.006; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, PLOS COMPUT BIOL, V4; Banaji M, 2006, STUD MULTIDISCIP, V3, P247; Banaji M, 2010, ADV EXP MED BIOL, V662, P285, DOI 10.1007/978-1-4419-1241-1_41; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; COOPER CE, 1994, BIOCHEM SOC T, V22, P974, DOI 10.1042/bst0220974; Cooper CE, 1998, BIOCHEM J, V332, P627, DOI 10.1042/bj3320627; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Edmonds Harvey L Jr, 2004, Semin Cardiothorac Vasc Anesth, V8, P147; Edvinsson L., 2002, CEREBRAL BLOOD FLOW, V2nd ed; ELWELL CE, 1994, J APPL PHYSIOL, V77, P2753, DOI 10.1152/jappl.1994.77.6.2753; Heekeren HR, 1999, J CEREBR BLOOD F MET, V19, P592, DOI 10.1097/00004647-199906000-00002; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Hunt K, 2006, PHYSIOL MEAS, V27, P777, DOI 10.1088/0967-3334/27/9/002; Kakihana Y, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940583; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; MCPHERSON RW, 1987, AM J PHYSIOL, V253, pH890, DOI 10.1152/ajpheart.1987.253.4.H890; Moroz T, 2012, ADV EXP MED BIOL, V737, P293, DOI 10.1007/978-1-4614-1566-4_43; Nagdyman N, 2008, PEDIATR ANESTH, V18, P160, DOI 10.1111/j.1460-9592.2007.02365.x; Nollert G, 2000, THORAC CARDIOV SURG, V48, P247, DOI 10.1055/s-2000-6895; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; OLDENDORF WH, 1965, CIRC RES, V17, P532, DOI 10.1161/01.RES.17.6.532; Press W. H., 1992, ART SCI COMPUTING; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Smith M, 2011, PHILOS T R SOC A, V369, P4452, DOI 10.1098/rsta.2011.0242; Springett RJ, 2003, ADV EXP MED BIOL, V530, P555; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Tachtsidis I, 2007, PHYSIOL MEAS, V28, P199, DOI 10.1088/0967-3334/28/2/008; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P315, DOI 10.1007/978-0-387-85998-9_47; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tisdall MM, 2008, ADV EXP MED BIOL, V614, P217, DOI 10.1007/978-0-387-74911-2_25; Tisdall MM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718541; Tisdall MM, 2009, ANESTH ANALG, V109, P906, DOI 10.1213/ane.0b013e3181aedcdc; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; Ursino M, 2000, AM J PHYSIOL-HEART C, V279, pH2439, DOI 10.1152/ajpheart.2000.279.5.H2439; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38297	10.1371/journal.pone.0038297	http://dx.doi.org/10.1371/journal.pone.0038297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679497	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305343900028
J	Lyke, KE; Wang, A; Dabo, A; Arama, C; Daou, M; Diarra, I; Plowe, CV; Doumbo, OK; Sztein, MB				Lyke, Kirsten E.; Wang, Amy; Dabo, Abdoulaye; Arama, Charles; Daou, Modibo; Diarra, Issa; Plowe, Christopher V.; Doumbo, Ogobara K.; Sztein, Marcelo B.			Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children	PLOS ONE			English	Article							INFLAMMATORY MARKERS; INTERFERON-GAMMA; IMMUNE-COMPLEXES; REINFECTION; COINFECTION; C3D; ASSOCIATION; ACQUISITION; ACTIVATION; PROTECTION	Polyparasitism is common in the developing world. We have previously demonstrated that schistosomiasis-positive (SP) Malian children have age-dependent protection from malaria compared to matched schistosomiasis-negative (SN) children. Evidence of durable immunologic memory to malaria antigens is conflicting, particularly in young children and the effect of concomitant schistomiasis upon acquisition of memory is unknown. We examined antigen-specific B memory cell (MBC) frequencies (expressed as percentage of total number of IgG-secreting cells) in 84 Malian children aged 4-14 to malaria blood-stage antigens, apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP-1) and to schistosomal antigens, Soluble Worm Antigenic Preparation (SWAP) and Schistosoma Egg Antigen (SEA), at a time point during the malaria transmission season and a follow-up dry season visit. We demonstrate, for the first time, MBC responses to S. haematobium antigens in Malian children with urinary egg excretion and provide evidence of seasonal acquisition of immunologic memory, age-associated differences in MBC acquisition, and correlation with circulating S. haematobium antibody. Moreover, the presence of a parasitic co-infection resulted in older children, aged 9-14 years, with underlying S. haematobium infection having significantly more MBC response to malaria antigens (AMA1 and MSP1) than their age-matched SN counterparts. We conclude that detectable MBC response can be measured against both malaria and schistosomal antigens and that the presence of S. haematobium may be associated with enhanced MBC induction in an age-specific manner.	[Lyke, Kirsten E.; Wang, Amy; Plowe, Christopher V.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dabo, Abdoulaye; Arama, Charles; Daou, Modibo; Diarra, Issa; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Arama, Charles] Univ Stockholm, Dept Immunol, S-10691 Stockholm, Sweden; [Plowe, Christopher V.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University of Bamako; Stockholm University; Howard Hughes Medical Institute; Johns Hopkins University	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	KLyke@medicine.umaryland.edu			National Institute of Allergy and Infectious Diseases (NIAID/National Institutes of Health (NIH) [AI49203]; Doris Duke Clinical Development Award; NIAID/NIH [AI067954]; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI049203, R01AI067954] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Development Award; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical portion of the study was funded by a K23 award awarded by the National Institute of Allergy and Infectious Diseases (NIAID/National Institutes of Health (NIH) (AI49203). Immunologic assays were funded in part by a Doris Duke Clinical Development Award as well as an R-01 (AI067954) from NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the population of Bandiagara, Mali for their support and participation in this and many other trials. This abstract has been presented in part to the American Society of Tropical Medicine and Hygiene, Atlanta, GA, November 2010, abstract #1288. Dr. William Blackwelder kindly provided advice in regards to statistical analyses. S. haematobium proteins were obtained through the Schistosome Related Reagent Repository (SR3) sponsored by the National Institute of Allergy and Infectious Disease with special thanks to Dr. Fred Lewis. Apical membrane antigen 1 was kindly donated by Drs. David Lanar and Sheetij Dutta, and merozoite surface protein 1 (42) by Dr. Evelina Angov, of Walter Reed Army Institute of Research (WRAIR).	Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brabin B., 1990, Tropical Diseases Bulletin, V87, pR1; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; CAPRON A, 1992, ANNU REV MED, V43, P209, DOI 10.1146/annurev.me.43.020192.001233; CHANDIWANA SK, 1991, PARASITOLOGY, V102, P73, DOI 10.1017/S0031182000060364; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; ETARD JF, 1995, AM J TROP MED HYG, V52, P549, DOI 10.4269/ajtmh.1995.52.549; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; GRAU GE, 1994, RES IMMUNOL, V145, P441, DOI 10.1016/S0923-2494(94)80175-4; Grogan JL, 1998, J INFECT DIS, V177, P1433, DOI 10.1086/517832; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; Joshi AD, 2008, J LEUKOCYTE BIOL, V83, P314, DOI 10.1189/jlb.1007689; King CL, 1996, J IMMUNOL, V156, P4715; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Lyke KE, 2005, INFECT IMMUN, V73, P5799, DOI 10.1128/IAI.73.9.5799-5808.2005; Lyke KE, 2006, INFECT IMMUN, V74, P5718, DOI 10.1128/IAI.01822-05; Lyke KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031647; Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; McGregor I, 1986, CLIN TROP MED COMMUN, V1986, P1; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; MURPHY JR, 1989, J CLIN MICROBIOL, V27, P1434, DOI 10.1128/JCM.27.7.1434-1437.1989; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2; SANTORO F, 1980, CLIN EXP IMMUNOL, V42, P219; Simon JK, 2009, VACCINE, V27, P565, DOI 10.1016/j.vaccine.2008.10.081; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; VERROUST PJ, 1979, KIDNEY INT, V16, P9, DOI 10.1038/ki.1979.97; Wahid R, 2011, CLIN IMMUNOL, V138, P187, DOI 10.1016/j.clim.2010.11.006; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; WYLER AR, 1972, J NEUROSURG, V37, P185, DOI 10.3171/jns.1972.37.2.0185; Wyler D J, 1979, Bull World Health Organ, V57 Suppl 1, P239	46	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37868	10.1371/journal.pone.0037868	http://dx.doi.org/10.1371/journal.pone.0037868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693628	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900014
J	Liu, B; Faller, LL; Klitgord, N; Mazumdar, V; Ghodsi, M; Sommer, DD; Gibbons, TR; Treangen, TJ; Chang, YC; Li, S; Stine, OC; Hasturk, H; Kasif, S; Segre, D; Pop, M; Amar, S				Liu, Bo; Faller, Lina L.; Klitgord, Niels; Mazumdar, Varun; Ghodsi, Mohammad; Sommer, Daniel D.; Gibbons, Theodore R.; Treangen, Todd J.; Chang, Yi-Chien; Li, Shan; Stine, O. Colin; Hasturk, Hatice; Kasif, Simon; Segre, Daniel; Pop, Mihai; Amar, Salomon			Deep Sequencing of the Oral Microbiome Reveals Signatures of Periodontal Disease	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE PROFILE; PORPHYROMONAS-GINGIVALIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BACTERIAL DIVERSITY; GENETIC-ANALYSIS; FATTY-ACIDS; GENOME; PATHOGENS; IDENTIFICATION; PREVALENCE	The oral microbiome, the complex ecosystem of microbes inhabiting the human mouth, harbors several thousands of bacterial types. The proliferation of pathogenic bacteria within the mouth gives rise to periodontitis, an inflammatory disease known to also constitute a risk factor for cardiovascular disease. While much is known about individual species associated with pathogenesis, the system-level mechanisms underlying the transition from health to disease are still poorly understood. Through the sequencing of the 16S rRNA gene and of whole community DNA we provide a glimpse at the global genetic, metabolic, and ecological changes associated with periodontitis in 15 subgingival plaque samples, four from each of two periodontitis patients, and the remaining samples from three healthy individuals. We also demonstrate the power of whole-metagenome sequencing approaches in characterizing the genomes of key players in the oral microbiome, including an unculturable TM7 organism. We reveal the disease microbiome to be enriched in virulence factors, and adapted to a parasitic lifestyle that takes advantage of the disrupted host homeostasis. Furthermore, diseased samples share a common structure that was not found in completely healthy samples, suggesting that the disease state may occupy a narrow region within the space of possible configurations of the oral microbiome. Our pilot study demonstrates the power of high-throughput sequencing as a tool for understanding the role of the oral microbiome in periodontal disease. Despite a modest level of sequencing (similar to 2 lanes Illumina 76 bp PE) and high human DNA contamination ( up to similar to 90%) we were able to partially reconstruct several oral microbes and to preliminarily characterize some systems-level differences between the healthy and diseased oral microbiomes.	[Liu, Bo; Ghodsi, Mohammad; Sommer, Daniel D.; Gibbons, Theodore R.; Treangen, Todd J.; Pop, Mihai] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Liu, Bo; Ghodsi, Mohammad; Pop, Mihai] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Faller, Lina L.; Klitgord, Niels; Mazumdar, Varun; Chang, Yi-Chien; Kasif, Simon; Segre, Daniel; Amar, Salomon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Gibbons, Theodore R.; Pop, Mihai] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Li, Shan; Stine, O. Colin] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Kasif, Simon; Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Hasturk, Hatice] Forysth Inst, Dept Periodontol, Cambridge, MA USA; [Kasif, Simon] Harvard Massachusetts Inst Technol, Childrens Informat Program, Div Hlth Sci & Technol, Boston, MA USA; [Treangen, Todd J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Boston University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; Boston University; Boston University; Harvard University; Johns Hopkins University; Boston University	Liu, B (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	dsegre@bu.edu; mpop@umiacs.umd.edu; samar@bu.edu	Pop, Mihai/A-7987-2013; Segre, Daniel/A-1993-2009	Pop, Mihai/0000-0001-9617-5304; Segre, Daniel/0000-0003-4859-1914; Amar, Salomon/0000-0002-0017-5930	National Institutes of Health (NIH)-National Institute of Dental and Craniofacial Research [R01DE015345, R01DE014079]; NIH [R01-HG-04885, RC2-GM-092602-01]; National Science Foundation [IIS-0812111]; Bill and Melinda Gates Foundation; National Institute of General Medical Sciences [1RC2GM092602-01];  [PRJNA78025]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092602] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data Availability: The data described in this paper have been submitted to NCBI under project ID: PRJNA78025.; SA and HA were supported by National Institutes of Health (NIH)-National Institute of Dental and Craniofacial Research grants R01DE015345, and R01DE014079. MP, DDS, TJT, BL and TG were supported in part by the NIH grant R01-HG-04885, the National Science Foundation grant IIS-0812111 to MP, and by the Bill and Melinda Gates Foundation (PI Jim Nataro) subcontract to MP. DS, LF, VM and NK were partially supported by NIH grant RC2-GM-092602-01. The work of YC, SK, DS, LF and VM at Boston University was also supported in part by GO grant from National Institute of General Medical Sciences (1RC2GM092602-01 to COMBREX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Ali J, 2011, AUTOIMMUNITY REV; Barnes VM, 2009, J DENT RES, V88, P851, DOI 10.1177/0022034509341967; Bascones-Martinez A, 2011, MED ORAL PATOLOGIA O; Belda-Ferre P, 2011, ISME J, P1; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Campan P, 1997, J CLIN PERIODONTOL, V24, P907, DOI 10.1111/j.1600-051X.1997.tb01210.x; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chen YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-294; Cicek Y, 2005, PROSTAG LEUKOTR ESS, V72, P147, DOI 10.1016/j.plefa.2004.10.013; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Conly Jm, 2005, Can J Infect Dis Med Microbiol, V16, P159; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Darby I, 2001, PERIODONTOL 2000, V26, P33, DOI 10.1034/j.1600-0757.2001.2260103.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DELISLE AL, 1978, INFECT IMMUN, V20, P303, DOI 10.1128/IAI.20.1.303-306.1978; Diaz-Torres ML, 2006, FEMS MICROBIOL LETT, V258, P257, DOI 10.1111/j.1574-6968.2006.00221.x; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271; Glass EM, 2010, COLD SPRING HARBOR P; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jenkinson HF, 2011, ENVIRON MICROBIOL, V13, P3077, DOI 10.1111/j.1462-2920.2011.02573.x; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keijser B, 2008, J DENT RES, P87; Kesavalu L, 2007, ORAL MICROBIOL IMMUN, V22, P232, DOI 10.1111/j.1399-302X.2007.00346.x; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren S, 2011, BIOINFORMATICS; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li Yingrui, 2010, Human Genomics, V4, P271; Lipsitch M, 2001, TRENDS MICROBIOL, V9, P438, DOI 10.1016/S0966-842X(01)02130-8; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu Bo, 2011, BMC Proc, V5 Suppl 2, pS9, DOI 10.1186/1753-6561-5-S2-S9; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Maeda K, 2004, INFECT IMMUN, V72, P1341, DOI 10.1128/IAI.72.3.1341-1348.2004; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; Mineoka T, 2008, J PERIODONTOL, V79, P670, DOI [10.1902/jop.2008.070398, 10.1902/jop.2008.070398 ]; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Panina EM, 2003, FEMS MICROBIOL LETT, V222, P211, DOI 10.1016/S0378-1097(03)00303-3; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; PHILLIPS GJ, 1987, NUCLEIC ACIDS RES, V15, P2627, DOI 10.1093/nar/15.6.2627; Pike R, 2002, J ANTIMICROB CHEMOTH, V49, P777, DOI 10.1093/jac/dkf019; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts RJ, NUCL ACIDS RES, V39, pD11; Rodrigues RMJ, 2004, J CLIN PERIODONTOL, V31, P420, DOI 10.1111/j.1600-051X.2004.00493.x; Rosenstein ED, 2003, PROSTAG LEUKOTR ESS, V68, P213, DOI 10.1016/S0952-3278(02)00272-7; Siqueira JF, 2006, ORAL SURG ORAL MED O, V102, P259, DOI 10.1016/j.tripleo.2005.09.021; SLOTS J, 1979, J CLIN PERIODONTOL, V6, P351, DOI 10.1111/j.1600-051X.1979.tb01935.x; Socransky S, 1998, MICROBIAL COMPLEXES, P134; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stefanopoulos PK, 2004, ORAL SURG ORAL MED O, V98, P398, DOI 10.1016/j.tripleo.2004.01.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teles R, 2011, ORAL DIS; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Winkelhoff A J, 1999, Ned Tijdschr Tandheelkd, V106, P290; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	87	254	267	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37919	10.1371/journal.pone.0037919	http://dx.doi.org/10.1371/journal.pone.0037919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675498	Green Published, gold			2022-12-25	WOS:000305341700027
J	Munar, E; Nadal, M; Rossello, J; Flexas, A; Moratti, S; Maestu, F; Marty, G; Cela-Conde, CJ				Munar, Enric; Nadal, Marcos; Rossello, Jaume; Flexas, Albert; Moratti, Stephan; Maestu, Fernando; Marty, Gisele; Cela-Conde, Camilo J.			Lateral Orbitofrontal Cortex Involvement in Initial Negative Aesthetic Impression Formation	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL INDEXES; PROCESSING SYMMETRY; EVALUATIVE JUDGMENT; ACTIVATION; REPRESENTATIONS; PREFERENCE; CONTEXT; REWARD; MEG	It is well established that aesthetic appreciation is related with activity in several different brain regions. The identification of the neural correlates of beauty or liking ratings has been the focus of most prior studies. Not much attention has been directed towards the fact that humans are surrounded by objects that lead them to experience aesthetic indifference or leave them with a negative aesthetic impression. Here we explore the neural substrate of such experiences. Given the neuroimaging techniques that have been used, little is known about the temporal features of such brain activity. By means of magnetoencephalography we registered the moment at which brain activity differed while participants viewed images they considered to be beautiful or not. Results show that the first differential activity appears between 300 and 400 ms after stimulus onset. During this period activity in right lateral orbitofrontal cortex (lOFC) was greater while participants rated visual stimuli as not beautiful than when they rated them as beautiful. We argue that this activity is associated with an initial negative aesthetic impression formation, driven by the relative hedonic value of stimuli regarded as not beautiful. Additionally, our results contribute to the understanding of the nature of the functional roles of the lOFC.	[Munar, Enric; Nadal, Marcos; Rossello, Jaume; Flexas, Albert; Marty, Gisele; Cela-Conde, Camilo J.] Univ Balearic Isl, Human Evolut & Cognit Grp IFISC CSIC, Palma De Mallorca, Spain; [Moratti, Stephan; Maestu, Fernando] Univ Complutense, Ctr Biomed Technol, Cognit & Computat Neurosci Lab, E-28040 Madrid, Spain; [Moratti, Stephan; Maestu, Fernando] Politecn Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Complutense University of Madrid; Universidad Politecnica de Madrid	Munar, E (corresponding author), Univ Balearic Isl, Human Evolut & Cognit Grp IFISC CSIC, Palma De Mallorca, Spain.	enric.munar@uib.cat	Cela-Conde, Camilo J/J-7806-2015; Munar, Enric/AAK-4175-2021; Flexas, Albert/U-6228-2017; Rosselló, Jaume/AAA-6333-2020; maestu, fernando/M-7480-2019; Nadal, Marcos/A-5817-2009; Moratti, Stephan/A-5605-2019; Munar, Enric/C-7397-2011; Maestu, Fernando/E-3213-2012	Munar, Enric/0000-0001-7330-8389; Flexas, Albert/0000-0002-0104-7113; Rosselló, Jaume/0000-0003-4010-7868; maestu, fernando/0000-0002-3195-0071; Nadal, Marcos/0000-0002-9341-4688; Moratti, Stephan/0000-0003-0824-8759; Maestu, Fernando/0000-0002-3195-0071; /0000-0001-8350-7728	Ministerio de Economia y Competitividad (Spanish Government) [SEJ2007-64374/PSIC, FFI2010-20759]	Ministerio de Economia y Competitividad (Spanish Government)	This work was supported by two grants of the Ministerio de Economia y Competitividad (http://www.mineco.gob.es/) (Spanish Government): SEJ2007-64374/PSIC and FFI2010-20759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Cela-Conde CJ, 2004, P NATL ACAD SCI USA, V101, P6321, DOI 10.1073/pnas.0401427101; CHEVRIER J, 1980, PERCEPT MOTOR SKILL, V50, P839, DOI 10.2466/pms.1980.50.3.839; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2010, CEREB CORTEX, V20, P198, DOI 10.1093/cercor/bhp092; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; FRITH CD, 1974, J GEN PSYCHOL, V91, P163; Grabenhorst F, 2009, NEUROIMAGE, V48, P258, DOI 10.1016/j.neuroimage.2009.06.045; Hauk O, 2002, J NEUROSCI METH, V113, P111, DOI 10.1016/S0165-0270(01)00484-8; Hofel L, 2007, J PSYCHOPHYSIOL, V21, P9, DOI 10.1027/0269-8803.21.1.9; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kirk U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003754; Kirk U, 2009, NEUROIMAGE, V44, P1125, DOI 10.1016/j.neuroimage.2008.10.009; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Liang XY, 2010, SOC NEUROSCI-UK, V5, P320, DOI 10.1080/17470911003619916; Locher P, 2008, SPATIAL VISION, V21, P55, DOI 10.1163/156856808782713762; LOOFT WR, 1971, J GEN PSYCHOL, V85, P307, DOI 10.1080/00221309.1971.9920680; Maestu F, 2002, NEUROIMAGE, V17, P1579, DOI 10.1006/nimg.2002.1235; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; Munar E, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00185; Nadal M, 2008, SPATIAL VISION, V21, P379, DOI 10.1163/156856808784532653; Nadal M, 2011, BRAIN COGNITION, V76, P172, DOI 10.1016/j.bandc.2011.01.009; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P1198, DOI 10.1162/jocn.2006.18.7.1198; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	35	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38152	10.1371/journal.pone.0038152	http://dx.doi.org/10.1371/journal.pone.0038152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675517	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305341700042
J	Schnupf, P; Sansonetti, PJ				Schnupf, Pamela; Sansonetti, Philippe J.			Quantitative RT-PCR profiling of the Rabbit Immune Response: Assessment of Acute Shigella flexneri Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; HOST-DEFENSE; PROTECTIVE IMMUNITY; BACTERIAL PATHOGENS; GENE-EXPRESSION; MODEL; INNATE; CELLS; INFLAMMATION; SYSTEM	Quantitative reverse transcription PCR analysis is an important tool to monitor changes in gene expression in animal models. The rabbit is a widely accepted and commonly used animal model in the study of human diseases and infections by viral, fungal, bacterial and protozoan pathogens. Only a limited number of rabbit genes have, however, been analyzed by this method as the rabbit genome sequence remains unfinished. Recently, increasing coverage of the genome has permitted the prediction of a growing number of genes that are relevant in the context of the immune response. We hereby report the design of twenty-four quantitative PCR primer pairs covering common cytokines, chemoattractants, antimicrobials and enzymes for a rapid, sensitive and quantitative analysis of the rabbit immune response. Importantly, all primer pairs were designed to be used under identical experimental conditions, thereby enabling the simultaneous analysis of all genes in a high-throughput format. This tool was used to analyze the rabbit innate immune response to infection with the human gastrointestinal pathogen Shigella flexneri. Beyond the known inflammatory mediators, we identified IL-22, IL-17A and IL-17F as highly upregulated cytokines and as first responders to infection during the innate phase of the host immune response. This set of qPCR primers also provides a convenient tool for monitoring the rabbit immune response during infection with other pathogens and other inflammatory conditions.	[Schnupf, Pamela; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Schnupf, Pamela; Sansonetti, Philippe J.] Inst Pasteur, INSERM U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schnupf, P (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	psanson@pasteur.fr	Schnupf, Pamela/G-6040-2017	Schnupf, Pamela/0000-0003-4292-1257	European Molecular Biology Organization; Marie Curie Intra-European fellowship; European Research Council	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was funded by a European Molecular Biology Organization long term fellowship and a Marie Curie Intra-European fellowship to PS, and a European Research Council advanced grant (HOMEOPITH) to PJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Chakrabarti A, 1997, J MED VET MYCOL, V35, P295; Chandra J, 2011, VIRULENCE, V2, P466, DOI 10.4161/viru.2.5.16341; Christensen Neil D., 2005, Antiviral Chemistry & Chemotherapy, V16, P355; CONNER ME, 1988, J VIROL, V62, P1625, DOI 10.1128/JVI.62.5.1625-1633.1988; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; FOLEY DM, 1995, J CLIN INVEST, V96, P965, DOI 10.1172/JCI118144; Fong IW, 1997, J CLIN MICROBIOL, V35, P48, DOI 10.1128/JCM.35.1.48-52.1997; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Godornes C, 2007, CYTOKINE, V38, P1, DOI 10.1016/j.cyto.2007.04.002; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hamada S, 2008, IMMUNOLOGY, V125, P170, DOI 10.1111/j.1365-2567.2008.02841.x; Hanes DE, 2001, INFECT IMMUN, V69, P6523, DOI 10.1128/IAI.69.10.6523-6526.2001; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kang SJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/394730; KATAKURA S, 1990, APMIS, V98, P313, DOI 10.1111/j.1699-0463.1990.tb01038.x; Kreuter KA, 2008, COMPARATIVE MED, V58, P287; Le Negrate G, 2011, CELLULAR MICROBIOLOG; LOPEZREVILLA R, 1992, PARASITOL RES, V78, P260, DOI 10.1007/BF00931737; Manabe YC, 2008, TUBERCULOSIS, V88, P187, DOI 10.1016/j.tube.2007.10.006; Milhorn D, 2010, ANN NY ACAD SCI, V1194, P72, DOI 10.1111/j.1749-6632.2010.05491.x; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Pavan-Langston D, 1990, Trans Am Ophthalmol Soc, V88, P727; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Phinikaridou A, 2009, J LIPID RES, V50, P787, DOI 10.1194/jlr.M800460-JLR200; Raqib R, 2000, INFECT IMMUN, V68, P3620, DOI 10.1128/IAI.68.6.3620-3629.2000; Raqib R, 1996, ANN NY ACAD SCI, V797, P299, DOI 10.1111/j.1749-6632.1996.tb52985.x; Raqib R, 2002, INFECT IMMUN, V70, P3199, DOI 10.1128/IAI.70.6.3199-3207.2002; RAQIB R, 1995, INFECT IMMUN, V63, P289, DOI 10.1128/IAI.63.1.289-296.1995; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; SPIRA WM, 1981, INFECT IMMUN, V32, P739, DOI 10.1128/IAI.32.2.739-747.1981; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; TENDLER M, 1991, J PARASITOL, V77, P138, DOI 10.2307/3282571; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Woodruff-Pak DS, 2007, J ALZHEIMERS DIS, V11, P371; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	51	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36446	10.1371/journal.pone.0036446	http://dx.doi.org/10.1371/journal.pone.0036446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675469	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700005
J	Hartsock, A; Nelson, WJ				Hartsock, Andrea; Nelson, W. James			Competitive Regulation of E-Cadherin JuxtaMembrane Domain Degradation by p120-Catenin Binding and Hakai-Mediated Ubiquitination	PLOS ONE			English	Article							CELL-CELL ADHESION; PROTEASOME PATHWAY; P120 CATENIN; VE-CADHERIN; ENDOCYTOSIS; PROTEIN; RECEPTOR; CYTOSKELETON; MECHANISMS; EXPRESSION	p120-Catenin binding to, and Hakai-mediated ubiquitination of the E-cadherin juxtamembrane domain (JMD) are thought to be involved in regulating E-cadherin internalization and degradation. However, the relationship between these two pathways is not understood. We targeted the E-cadherin JMD to mitochondria (WT-JMD) to isolate this domain from the plasma membrane and internalization, and to examine protein modifications and degradation. WT-JMD localized to mitochondria, but did not accumulate there except when proteasome activity was inhibited. We found WT-JMD was ubiquitinated, and arginine substitution of lysines at position 5 (K5R) and 83 (K83R) resulted in the stable accumulation of mutant JMD at mitochondria. p120-Catenin did not localize, or bind to WT-JMD even upon proteasome inhibition, whereas the K5,83R-JMD mutant bound and localized p120-catenin to mitochondria. Mutation of the p120-catenin binding site in combination with these lysine mutations inhibited p120-catenin binding, but did not decrease JMD stability or its accumulation at mitochondria. Thus, increased stability of JMD lysine mutants was due to inhibition of ubiquitination and not to p120-catenin binding. Finally, mutation of these critical lysines in full length E-cadherin had similar effects on protein stability as WT-JMD. Our results indicate that ubiquitination of the JMD inhibits p120-catenin binding, and targets E-cadherin for degradation.	[Hartsock, Andrea; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Hartsock, A (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu			National Institutes of Health (NIH) [GM035527]; Research Supplement to Promote Diversity in Health-Related Research [GM035527-25S2]; Stanford University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Supplement to Promote Diversity in Health-Related Research; Stanford University(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM035527 to WJN, a Research Supplement to Promote Diversity in Health-Related Research (GM035527-25S2) to AH, and a D.A.R.E. Fellowship from Stanford University to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ferber A, 2002, EXP CELL RES, V274, P35, DOI 10.1006/excr.2001.5436; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Mimnaugh EG, 1999, ELECTROPHORESIS, V20, P418, DOI 10.1002/(SICI)1522-2683(19990201)20:2<418::AID-ELPS418>3.0.CO;2-N; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372	26	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37476	10.1371/journal.pone.0037476	http://dx.doi.org/10.1371/journal.pone.0037476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693575	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500038
J	Lavelle, D; Vaitkus, K; Ruiz, MA; Ibanez, V; Kouznetsova, T; Saunthararajah, Y; Mahmud, N; DeSimone, J				Lavelle, Donald; Vaitkus, Kestutis; Ruiz, Maria Armila; Ibanez, Vinzon; Kouznetsova, Tatiana; Saunthararajah, Yogen; Mahmud, Nadim; DeSimone, Joseph			Effect of AGM and Fetal Liver-Derived Stromal Cell Lines on Globin Expression in Adult Baboon (P. anubis) Bone Marrow-Derived Erythroid Progenitors	PLOS ONE			English	Article							SERUM-FREE CULTURE; HEMOGLOBIN-SYNTHESIS; GAMMA; ERYTHROPOIETIN; DIFFERENTIATE; STIMULATION; MATURATION; NICHES	This study was performed to investigate the hypothesis that the erythroid micro-environment plays a role in regulation of globin gene expression during adult erythroid differentiation. Adult baboon bone marrow and human cord blood CD34+ progenitors were grown in methylcellulose, liquid media, and in co-culture with stromal cell lines derived from different developmental stages in identical media supporting erythroid differentiation to examine the effect of the microenvironment on globin gene expression. Adult progenitors express high levels of gamma-globin in liquid and methylcellulose media but low, physiological levels in stromal cell co-cultures. In contrast, gamma-globin expression remained high in cord blood progenitors in stromal cell line co-cultures. Differences in gamma-globin gene expression between adult progenitors in stromal cell line co-cultures and liquid media required cell-cell contact and were associated with differences in rate of differentiation and gamma-globin promoter DNA methylation. We conclude that gamma-globin expression in adult-derived erythroid cells can be influenced by the micro-environment, suggesting new potential targets for HbF induction.	[Lavelle, Donald; Vaitkus, Kestutis; Ruiz, Maria Armila; Ibanez, Vinzon; Kouznetsova, Tatiana; Saunthararajah, Yogen; Mahmud, Nadim; DeSimone, Joseph] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Lavelle, Donald; Vaitkus, Kestutis; Ruiz, Maria Armila; Ibanez, Vinzon; Kouznetsova, Tatiana; DeSimone, Joseph] Jesse Brown VA Med Ctr, Chicago, IL USA; [Saunthararajah, Yogen] Cleveland Clin, Cleveland, OH 44106 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Cleveland Clinic Foundation	Lavelle, D (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	dlavelle@uic.edu			National Heart, Lung, and Blood Institute (NHLBI) [U54HL090513]; State of Illinois Sickle Cell Center funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090513, R01HL114561] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); State of Illinois Sickle Cell Center funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) (U54HL090513) and State of Illinois Sickle Cell Center funds. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ALKHATTI A, 1987, NEW ENGL J MED, V317, P415, DOI 10.1056/NEJM198708133170704; Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002; Atweh G, 2010, HEMATOL ONCOL CLIN N, V24, P1131, DOI 10.1016/j.hoc.2010.08.001; Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Bhanu NV, 2005, BLOOD, V105, P387, DOI 10.1182/blood-2004-04-1599; Chang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025761; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chin J, 2009, EXP HEMATOL, V37, P1131, DOI 10.1016/j.exphem.2009.06.007; DERON AT, 1985, EXP HEMATOL, V13, P919; DESIMONE J, 1979, BLOOD, V54, P1176; Dev A, 2010, BLOOD, V116, P5991; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; FUJIMORI Y, 1990, BLOOD, V75, P1718; Kusadasi N, 2002, LEUKEMIA, V16, P1782, DOI 10.1038/sj.leu.2402615; Lavelle D, 2001, EXP HEMATOL, V29, P156, DOI 10.1016/S0301-472X(00)00654-8; Lee KY, 2011, STEM CELLS DEV, V20, P31, DOI 10.1089/scd.2010.0196; LEONE L, 1985, J CHROMATOGR, V321, P407, DOI 10.1016/S0021-9673(01)90459-5; MIGLIACCIO AR, 1990, BLOOD, V76, P1150; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Ni H, 1999, EXP HEMATOL, V27, P46, DOI 10.1016/S0301-472X(98)00010-1; PAPAYANNOPOULOU T, 1981, BLOOD, V57, P531; PAPAYANNOPOULOU T, 1982, P NATL ACAD SCI-BIOL, V79, P6579, DOI 10.1073/pnas.79.21.6579; PAPAYANNOPOULOU T, 1976, P NATL ACAD SCI USA, V73, P2033, DOI 10.1073/pnas.73.6.2033; PAPAYANNOPOULOU T, 1986, CELL, V46, P469, DOI 10.1016/0092-8674(86)90667-7; PESCHLE C, 1993, BLOOD, V81, P328; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Saunthararajah Y, 2004, BRIT J HAEMATOL, V126, P629, DOI 10.1111/j.1365-2141.2004.05064.x; Singh M, 2007, EXP HEMATOL, V35, P48, DOI 10.1016/j.exphem.2006.09.001; Stamatoyannopoulos G, 2001, DISORDERS HEMOGLOBIN, P131; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; WOOD WG, 1985, NATURE, V313, P320, DOI 10.1038/313320a0; ZANJANI ED, 1982, NATURE, V295, P244, DOI 10.1038/295244a0	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36846	10.1371/journal.pone.0036846	http://dx.doi.org/10.1371/journal.pone.0036846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693559	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500021
J	Ragonnet-Cronin, M; Aris-Brosou, S; Joanisse, I; Merks, H; Vallee, D; Caminiti, K; Sandstrom, P; Brooks, J				Ragonnet-Cronin, Manon; Aris-Brosou, Stephane; Joanisse, Isabelle; Merks, Harriet; Vallee, Dominic; Caminiti, Kyna; Sandstrom, Paul; Brooks, James			Adaptive Evolution of HIV at HLA Epitopes Is Associated with Ethnicity in Canada	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE ESCAPE; GENETIC-VARIATION; CLASS-I; ADAPTATION; HAPLOTYPES; POLYMORPHISMS; POPULATIONS; RESPONSES; SELECTION	Host immune selection pressure influences the development of mutations that allow for HIV escape. Mutation patterns induced in HIV by the human leukocyte antigen (HLA) are HLA-allele specific. As ethnic groups have distinct and characteristic HLA allele frequencies, we can expect divergent viral evolution within ethnicities. Here, we have sequenced and analyzed the HIV pol gene from 1248 subtype B infected, treatment-naive individuals in Canada. Phylogenetic analysis showed no separation between pol sequences from five self-identified ethnic groups, yet fixation index (F-ST) values showed significant divergence between ethnicities. A total of 17 amino acid sites showed an ethnic-specific fixation pattern (0.015<F-ST <0.060, p<0.01), and 27 codons were inferred to be under positive selection (p<0.01), with each set of sites strongly associated with HLA sites (p = 1.78x10(-6) and p = 1.91x10(-7), respectively). Within the pol gene, eight sites under HLA selective pressure were correlated with ethnicity, indicating 'adaptive divergence' between the groups studied. Our findings highlight challenges in HIV vaccine design in ethnically diverse countries with subtype B epidemics.	[Ragonnet-Cronin, Manon; Joanisse, Isabelle; Merks, Harriet; Vallee, Dominic; Caminiti, Kyna; Sandstrom, Paul; Brooks, James] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Ragonnet-Cronin, Manon; Aris-Brosou, Stephane] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Brooks, James] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Public Health Agency of Canada; University of Ottawa; University of Ottawa	Ragonnet-Cronin, M (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	James.Brooks@phac-aspc.gc.ca	Ragonnet-Cronin, Manon/L-5394-2019	Aris-Brosou, Stephane/0000-0003-4987-0296; Ragonnet-Cronin, Manon/0000-0002-4879-2209	Canada Memorial Foundation; Natural Sciences Research Council of Canada; Canada Foundation for Innovation; Federal Initiative on HIV/AIDS in Canada	Canada Memorial Foundation; Natural Sciences Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Federal Initiative on HIV/AIDS in Canada	This work was supported by the Canada Memorial Foundation (MRC), the Natural Sciences Research Council of Canada (SAB), the Canada Foundation for Innovation (SAB), and the Federal Initiative on HIV/AIDS in Canada (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Avila-Rios S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-72; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartl D, 2007, PRINCIPLES POPULATIO, P288; ITESCU S, 1992, J ACQ IMMUN DEF SYND, V5, P37; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; Monsalve MV, 1998, HUM IMMUNOL, V59, P48, DOI 10.1016/S0198-8859(97)00251-6; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perez-Sweeney B, 2010, INFECT GENET EVOL, V10, P1155, DOI 10.1016/j.meegid.2010.07.010; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Public Health Agency of Canada, 2010, HIV AIDS CAN; R Core Team, 2022, R LANG ENV STAT COMP; Ragonnet-Cronin M, 2010, JAIDS-J ACQ IMM DEF, V55, P102, DOI 10.1097/QAI.0b013e3181e8c7b0; Salzano FN, 2002, AN ACAD BRAS CIENC, V74, P223, DOI 10.1590/S0001-37652002000200005; SPSS Inc, 2009, SPSS WIND VERS 18 0; Vina MAF, 2012, PHILOS T R SOC B, V367, P820, DOI 10.1098/rstb.2011.0320	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36933	10.1371/journal.pone.0036933	http://dx.doi.org/10.1371/journal.pone.0036933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693560	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500022
J	Rodriguez-Franco, EJ; Cantres-Rosario, YM; Plaud-Valentin, M; Romeu, R; Rodriguez, Y; Skolasky, R; Melendez, V; Cadilla, CL; Melendez, LM				Rodriguez-Franco, Eillen J.; Cantres-Rosario, Yisel M.; Plaud-Valentin, Marines; Romeu, Rafael; Rodriguez, Yolanda; Skolasky, Richard; Melendez, Viviana; Cadilla, Carmen L.; Melendez, Loyda M.			Dysregulation of Macrophage-Secreted Cathepsin B Contributes to HIV-1-Linked Neuronal Apoptosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-ASSOCIATED DEMENTIA; LYSOSOMAL CYSTEINE PROTEASES; CENTRAL-NERVOUS-SYSTEM; CYSTATIN-C; HIV-1-INFECTED MACROPHAGES; HIV-1-ASSOCIATED DEMENTIA; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E	Chronic HIV infection leads to the development of cognitive impairments, designated as HIV-associated neurocognitive disorders (HAND). The secretion of soluble neurotoxic factors by HIV-infected macrophages plays a central role in the neuronal dysfunction and cell death associated with HAND. One potentially neurotoxic protein secreted by HIV-1 infected macrophages is cathepsin B. To explore the potential role of cathepsin B in neuronal cell death after HIV infection, we cultured HIV-1ADA infected human monocyte-derived macrophages (MDM) and assayed them for expression and activity of cathepsin B and its inhibitors, cystatins B and C. The neurotoxic activity of the secreted cathepsin B was determined by incubating cells from the neuronal cell line SK-N-SH with MDM conditioned media (MCM) from HIV-1 infected cultures. We found that HIV-1 infected MDM secreted significantly higher levels of cathepsin B than did uninfected cells. Moreover, the activity of secreted cathepsin B was significantly increased in HIV-infected MDM at the peak of viral production. Incubation of neuronal cells with supernatants from HIV-infected MDM resulted in a significant increase in the numbers of apoptotic neurons, and this increase was reversed by the addition of either the cathepsin B inhibitor CA-074 or a monoclonal antibody to cathepsin B. In situ proximity ligation assays indicated that the increased neurotoxic activity of the cathepsin B secreted by HIV-infected MDM resulted from decreased interactions between the enzyme and its inhibitors, cystatins B and C. Furthermore, preliminary in vivo studies of human post-mortem brain tissue suggested an upregulation of cathepsin B immunoreactivity in the hippocampus and basal ganglia in individuals with HAND. Our results demonstrate that HIV-1 infection upregulates cathepsin B in macrophages, increases cathepsin B activity, and reduces cystatin-cathepsin interactions, contributing to neuronal apoptosis. These findings provide new evidence for the role of cathepsin B in neuronal cell death induced by HIV-infected macrophages.	[Rodriguez-Franco, Eillen J.; Cantres-Rosario, Yisel M.; Plaud-Valentin, Marines; Rodriguez, Yolanda; Melendez, Loyda M.] Univ Puerto Rico Med Sci Campus, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Cadilla, Carmen L.] Univ Puerto Rico Med Sci Campus, Dept Biochem, San Juan, PR USA; [Romeu, Rafael] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Melendez, Viviana] Univ Puerto Rico, Dept Biotechnol, Mayaguez, PR USA; [Skolasky, Richard] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Mayaguez; Johns Hopkins University	Rodriguez-Franco, EJ (corresponding author), Univ Puerto Rico Med Sci Campus, Dept Microbiol & Med Zool, San Juan, PR 00936 USA.	loyda.melendez@upr.edu		Cantres-Rosario, Yisel/0000-0002-0630-5695; Skolasky, Richard/0000-0002-2598-4427	National Institutes of Health [R01MH083516, U54NS043011, R25GM061838, S06GM08224, ISI0 RR-13705-01, DBI-0923132]; Translational Proteomics Center [NCRR-2G12-RR003051/NIMHHD 8G12-MD007600]; Department of Defense [52680-LS-ISP]; National Science Foundation [DBI-0115825]; University of Puerto Rico School of Medicine; Associate Deanship of Biomedical Sciences institutional funds; National Institutes of Mental Health; National Institute of Neurological Disorders and Stroke [U01MH083501, R24MH59724, 5U01MH083500, NS 38841, U01MH083506, R24MH59745, U01MH083545, N01MH32002]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008224, R25GM061838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083501, R24MH059724, R01MH083516, U01MH083500, U01MH083506, R24MH059745, U01MH083507, U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS045491, R24NS038841, U54NS043011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Proteomics Center; Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); University of Puerto Rico School of Medicine; Associate Deanship of Biomedical Sciences institutional funds; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants from the National Institutes of Health R01MH083516, U54NS043011, R25GM061838, S06GM08224, ISI0 RR-13705-01 and DBI-0923132 to establish and upgrade the Confocal Microscopy Facility at the University of Puerto Rico (CIF-UPR) and the NCRR-2G12-RR003051/NIMHHD 8G12-MD007600 Translational Proteomics Center and Confocal Facility at the at the UPR Medical Sciences Campus. This work was also supported in part by Department of Defense Grant 52680-LS-ISP, National Science Foundation Grant DBI-0115825, and University of Puerto Rico School of Medicine and the Associate Deanship of Biomedical Sciences institutional funds. This publication was also supported in part by the National Institutes of Mental Health and National Institute of Neurological Disorders and Stroke by the following grants: Manhattan HIV Brain Bank: U01MH083501, R24MH59724; Texas NeuroAIDS Research Center U01MH083507, R24 NS45491; National Neurological AIDS Bank 5U01MH083500, NS 38841; California NeuroAIDS Tissue Network U01MH083506, R24MH59745; Statistics and Data Coordinating Center U01MH083545, N01MH32002. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National NeuroAIDS Tissue Consortium or National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; ADLEBIASSETTE H, 1995, NEUROPATH APPL NEURO, V21, P218, DOI 10.1111/j.1365-2990.1995.tb01053.x; Akache B, 2007, MOL THER, V15, P330, DOI 10.1038/sj.mt.6300053; Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Burster T, 2007, INT IMMUNOL, V19, P645, DOI 10.1093/intimm/dxm030; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239; Furman LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-139; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Geeraerts T, 2006, NEUROSCI LETT, V399, P115, DOI 10.1016/j.neulet.2006.01.033; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; Gelman BB, 1997, AM J PATHOL, V151, P1437; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; Gisolf EH, 2000, AIDS, V14, P1583, DOI 10.1097/00002030-200007280-00014; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gonzalez RG, 2000, AIDS, V14, P2841, DOI 10.1097/00002030-200012220-00005; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Govindaraj J, 2010, INDIAN J EXP BIOL, V48, P133; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Heyes MP, 1998, FASEB J, V12, P881, DOI 10.1096/fasebj.12.10.881; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Houseweart MK, 2003, CELL DEATH DIFFER, V10, P1329, DOI 10.1038/sj.cdd.4401309; Irani DN, 2006, ANN NEUROL, V59, P237, DOI 10.1002/ana.20786; Ishimaru H, 1996, BRAIN RES, V709, P155, DOI 10.1016/0006-8993(95)01232-X; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Katakai K, 1997, J NEUROENDOCRINOL, V9, P247, DOI 10.1046/j.1365-2826.1997.t01-1-00566.x; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Laforge M, 2007, J VIROL, V81, P11426, DOI 10.1128/JVI.00597-07; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Luciano-Montalvo C, 2008, PLACENTA, V29, P1016, DOI 10.1016/j.placenta.2008.09.005; Lukasiuk K, 2002, EPILEPSIA, V43, P137, DOI 10.1046/j.1528-1157.43.s.5.20.x; Major EO, 2000, SCIENCE, V288, P440; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McArthur JC, 1999, SEMIN NEUROL, V19, P129, DOI 10.1055/s-2008-1040831; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Melendez LM, 2011, J NEUROIMMUNE PHARM, V6, P89, DOI 10.1007/s11481-010-9253-4; MELENDEZGUERRERO LM, 1990, AIDS RES HUM RETROV, V6, P731, DOI 10.1089/aid.1990.6.731; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Nagaraj NS, 2006, J CANCER RES CLIN, V132, P171, DOI 10.1007/s00432-005-0053-9; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; NOTTET HSLM, 1995, IMMUNOL TODAY, V16, P441, DOI 10.1016/0167-5699(95)80022-0; Noursadeghi M, 2009, J IMMUNOL, V182, P319, DOI 10.4049/jimmunol.182.1.319; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Prince PSM, 2009, EUR J PHARMACOL, V615, P139, DOI 10.1016/j.ejphar.2009.05.003; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; SARDAR AM, 1995, J NEUROCHEM, V64, P932; Schurigt Uta, 2005, Arthritis Res Ther, V7, pR174, DOI 10.1186/ar1466; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Skerget K, 2010, J BIOL CHEM, V285, P3201, DOI 10.1074/jbc.M109.024620; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; Tsai HT, 2009, FERTIL STERIL, V91, P549, DOI 10.1016/j.fertnstert.2007.12.076; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; Velazquez I, 2009, J NEUROIMMUNOL, V206, P106, DOI 10.1016/j.jneuroim.2008.10.013; Wang CF, 2008, TOXICOL LETT, V181, P196, DOI 10.1016/j.toxlet.2008.05.013; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Yeung MC, 1998, AIDS, V12, P349, DOI 10.1097/00002030-199804000-00002; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004	90	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36571	10.1371/journal.pone.0036571	http://dx.doi.org/10.1371/journal.pone.0036571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693552	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500013
J	Shao, LY; Wang, LS; Wei, ZY; Xiong, YY; Wang, Y; Tang, KF; Li, Y; Feng, GY; Xing, QH; He, L				Shao, Liyan; Wang, Lishan; Wei, Zhiyun; Xiong, Yuyu; Wang, Yang; Tang, Kefu; Li, Yang; Feng, Guoyin; Xing, Qinghe; He, Lin			Dynamic Network of Transcription and Pathway Crosstalk to Reveal Molecular Mechanism of MGd-Treated Human Lung Cancer Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; C-MYC; REGULATORY NETWORK; EXPRESSION; GROWTH; CARCINOMA; ALPHA; SP1; CONTRIBUTES; SENESCENCE	Recent research has revealed various molecular markers in lung cancer. However, the organizational principles underlying their genetic regulatory networks still await investigation. Here we performed Network Component Analysis (NCA) and Pathway Crosstalk Analysis (PCA) to construct a regulatory network in human lung cancer (A549) cells which were treated with 50 uM motexafin gadolinium (MGd), a metal cation-containing chemotherapeutic drug for 4, 12, and 24 hours. We identified a set of key TFs, known target genes for these TFs, and signaling pathways involved in regulatory networks. Our work showed that putative interactions between these TFs (such as ESR1/Sp1, E2F1/Sp1, c-MYC-ESR, Smad3/c-Myc, and NFKB1/RELA), between TFs and their target genes (such as BMP41/Est1, TSC2/Myc, APE1/Sp1/p53, RARA/HOXA1, and SP1/USF2), and between signaling pathways (such as PPAR signaling pathway and Adipocytokines signaling pathway). These results will provide insights into the regulatory mechanism of MGd-treated human lung cancer cells.	[Shao, Liyan; Wang, Lishan; Wei, Zhiyun; Xiong, Yuyu; Wang, Yang; Tang, Kefu; Li, Yang; Feng, Guoyin; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Xing, Qinghe; He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Shao, LY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	xingqinghesjtu@gmail.com; helin@bio-x.cn	Wei, Zhiyun/E-2008-2016; Wang, Yang/HCG-9543-2022; Li, Yang/R-9468-2018	Wei, Zhiyun/0000-0002-3554-4142; Li, Yang/0000-0002-1914-5598	973 Program [2010CB529600]; 863 Program [2009AA022701]; National Nature Science Foundation of China [81121001]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; National Key Technology Research & Devolopment Program [2006BAI05A09]; Shanghai Leading Academic Discipline Project [B205]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; National Key Technology Research & Devolopment Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 Program (2010CB529600), the 863 Program (2009AA022701), the National Nature Science Foundation of China (81121001), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the National Key Technology Research & Devolopment Program (2006BAI05A09), and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; Chang TH, 2000, CANCER RES, V60, P1129; Chen PH, 2011, ONCOGENE; Chen SF, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-110; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Choi KC, 2005, BIOCHEM BIOPH RES CO, V336, P747, DOI 10.1016/j.bbrc.2005.08.203; Coulson JM, 1999, BIOCHEM J, V344, P961, DOI 10.1042/0264-6021:3440961; Cui X, 2007, ONCOGENE, V26, P4253, DOI 10.1038/sj.onc.1210222; Elena C, 2010, BBA-MOL CELL BIOL L, V1801, P537, DOI 10.1016/j.bbalip.2010.01.005; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Flagiello D, 1997, FEBS LETT, V415, P263, DOI 10.1016/S0014-5793(97)01118-6; Fung H, 2001, J BIOL CHEM, V276, P42011, DOI 10.1074/jbc.M106423200; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Han SW, 2006, MOL CANCER THER, V5, P430, DOI 10.1158/1535-7163.MCT-05-0347; Hansson SR, 2006, MOL HUM REPROD, V12, P169, DOI 10.1093/molehr/gal011; Hayles B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009908; Hsu TI, 2011, ONCOGENE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Kim K, 2005, MOL ENDOCRINOL, V19, P843, DOI 10.1210/me.2004-0326; Kim TK, 2001, LUNG CANCER-J IASLC, V31, P181, DOI 10.1016/S0169-5002(00)00169-0; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Lin Q, 2009, J CANCER RES CLIN, V135, P1675, DOI 10.1007/s00432-009-0614-4; Liu HC, 1999, J BIOL CHEM, V274, P23617, DOI 10.1074/jbc.274.33.23617; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Magda D, 2005, CANCER RES, V65, P3837, DOI 10.1158/0008-5472.CAN-04-4099; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Su DM, 2011, BIOCHEM J, V433, P333, DOI 10.1042/BJ20100404; Tsou JH, 2008, NUCLEIC ACIDS RES, V36, P217, DOI 10.1093/nar/gkm1027; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Wang LS, 2010, NUCLEIC ACIDS RES, V38, pD665, DOI 10.1093/nar/gkp945; Yao M, 1999, ACTA MED OKAYAMA, V53, P245; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173	51	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e31984	10.1371/journal.pone.0031984	http://dx.doi.org/10.1371/journal.pone.0031984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693540	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500002
J	Sun, Q; Shi, L; Prescott, J; Chiuve, SE; Hu, FB; De Vivo, I; Stampfer, MJ; Franks, PW; Manson, JE; Rexrode, KM				Sun, Qi; Shi, Ling; Prescott, Jennifer; Chiuve, Stephanie E.; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Franks, Paul W.; Manson, Joann E.; Rexrode, Kathryn M.			Healthy Lifestyle and Leukocyte Telomere Length in US Women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; BREAST-CANCER; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PRIMARY PREVENTION; DIABETES-MELLITUS; HUMAN FIBROBLASTS; RISK-FACTORS	Context: Whether a healthy lifestyle may be associated with longer telomere length is largely unknown. Objectives: To examine healthy lifestyle practices, which are primary prevention measures against major age-related chronic diseases, in relation to leukocyte telomere length. Design and Setting: Cross-sectional analysis in the Nurses' Health Study (NHS). Participants: The population consisted of 5,862 women who participated in multiple prospective case-control studies within the NHS cohort. Z scores of leukocyte telomere length were derived within each case-control study. Based on prior work, we defined low-risk or healthy categories for five major modifiable factors assessed in 1988 or 1990: non-current smoking, maintaining a healthy body weight (body mass index in 18.5-24.9 kg/m(2)), engaging in regular moderate or vigorous physical activities (>= 150 minutes/week), drinking alcohol in moderation (1 drink/week to,2 drinks/day), and eating a healthy diet (Alternate Healthy Eating Index score in top 50%). We calculated difference (%) of the z scores contrasting low-risk groups with reference groups to evaluate the association of interest. Results: Although none of the individual low-risk factors was significantly associated with larger leukocyte telomere length z scores, we observed a significant, positive relationship between the number of low-risk factors and the z scores. In comparison with women who had zero low-risk factors (1.9% of the total population) and were, therefore, considered the least healthy group, the leukocyte telomere length z scores were 16.4%, 22.1%, 28.7%, 22.6%, and 31.2% (P for trend = 0.015) higher for women who had 1 to 5 low-risk factors, respectively. Conclusions: Adherence to a healthy lifestyle, defined by major modifiable risk factors, was associated with longer telomere length in leukocytes.	[Sun, Qi; Chiuve, Stephanie E.; Hu, Frank B.; Stampfer, Meir J.; Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sun, Qi; Prescott, Jennifer; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Manson, Joann E.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Sun, Qi; Prescott, Jennifer; Chiuve, Stephanie E.; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Manson, Joann E.; Rexrode, Kathryn M.] Harvard Univ, Sch Med, Boston, MA USA; [Shi, Ling] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Prescott, Jennifer; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Manson, Joann E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Chiuve, Stephanie E.; Manson, Joann E.; Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Lund University; Harvard University; Brigham & Women's Hospital	Sun, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	qisun@hsph.harvard.edu	Franks, Paul/AAA-3300-2020; Hu, Frank/C-1919-2013; Rexrode, Kathryn M/I-1177-2018	De Vivo, Immaculata/0000-0002-7185-7402; Chiuve, Stephanie/0000-0002-3524-8917; Rexrode, Kathryn/0000-0003-3387-8429; Franks, Paul/0000-0002-0520-7604	National Institutes of Health [CA87969, CA82838, CA4449, HL34594, HL088521]; National Heart, Lung, and Blood Institute [K99HL098459]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA082838] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL088521, K99HL098459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research grants CA87969, CA82838, CA4449, HL34594, and HL088521 from the National Institutes of Health. Dr. Sun was supported by a career development award K99HL098459 from the National Heart, Lung, and Blood Institute. Dr. Hu is a recipient of an American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2010, SEER CANC STAT REV 1; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J CLIN NUTR, V89, P1721, DOI 10.3945/ajcn.2009.27807; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, CANCER CAUSE CONTROL, V6, P217, DOI 10.1007/BF00051793; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Liang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023462; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Mychaleckyj JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-91; National Diabetes Foundation, 2011, NAT DIAB FACT SHEET; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; von Zglinicki T, 2003, NAT BIOTECHNOL, V21, P229, DOI 10.1038/nbt0303-229b; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1992, JAMA-J AM MED ASSOC, V268, P2037, DOI 10.1001/jama.268.15.2037; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	65	67	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38374	10.1371/journal.pone.0038374	http://dx.doi.org/10.1371/journal.pone.0038374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675460	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500141
J	Van Laar, TA; Lin, YH; Miller, CL; Karna, SLR; Chambers, JP; Seshu, J				Van Laar, Tricia A.; Lin, Ying-Han; Miller, Christine L.; Karna, S. L. Rajasekhar; Chambers, James P.; Seshu, J.			Effect of Levels of Acetate on the Mevalonate Pathway of Borrelia burgdorferi	PLOS ONE			English	Article							HMG-COA REDUCTASE; LYME-DISEASE SPIROCHETE; COENZYME-A REDUCTASE; OUTER-SURFACE PROTEIN; GENE-EXPRESSION; MURINE MODEL; CHOLESTERYL GALACTOSIDE; ISOPRENOID BIOSYNTHESIS; STAPHYLOCOCCUS-AUREUS; RESPONSE REGULATOR	Borrelia burgdorferi, the agent of Lyme disease, is a spirochetal pathogen with limited metabolic capabilities that survives under highly disparate host-specific conditions. However, the borrelial genome encodes several proteins of the mevalonate pathway (MP) that utilizes acetyl-CoA as a substrate leading to intermediate metabolites critical for biogenesis of peptidoglycan and post-translational modifications of proteins. In this study, we analyzed the MP and contributions of acetate in modulation of adaptive responses in B. burgdorferi. Reverse-transcription PCR revealed that components of the MP are transcribed as individual open reading frames. Immunoblot analysis using monospecific sera confirmed synthesis of members of the MP in B. burgdorferi. The rate-limiting step of the MP is mediated by HMG-CoA reductase (HMGR) via conversion of HMG-CoA to mevalonate. Recombinant borrelial HMGR exhibited a K-m value of 132 mu M with a V-max of 1.94 mu mol NADPH oxidized minute(-1) (mg protein)(-1) and was inhibited by statins. Total protein lysates from two different infectious, clonal isolates of B. burgdorferi grown under conditions that mimicked fed-ticks (pH 6.8/37 degrees C) exhibited increased levels of HMGR while other members of the MP were elevated under unfed-tick (pH 7.6/23 degrees C) conditions. Increased extra-cellular acetate gave rise to elevated levels of MP proteins along with RpoS, CsrA(Bb) and their respective regulons responsible for mediating vertebrate host-specific adaptation. Both lactone and acid forms of two different statins inhibited growth of B. burgdorferi strain B31, while overexpression of HMGR was able to partially overcome that inhibition. In summary, these studies on MP and contributions of acetate to host-specific adaptation have helped identify potential metabolic targets that can be manipulated to reduce the incidence of Lyme disease.	[Van Laar, Tricia A.] S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; Ctr Excellence Infect Genom, Dept Biol, San Antonio, TX USA; Univ Texas San Antonio, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Van Laar, TA (corresponding author), S Texas Ctr Emerging Infect Dis, San Antonio, TX USA.	j.seshu@utsa.edu	Karna, Sai Lakshmi Rajasekhar/AAG-6587-2019; Van Laar, Tricia/H-8177-2019	Karna, Sai Lakshmi Rajasekhar/0000-0002-1876-7117; Van Laar, Tricia/0000-0002-4654-8501	Public Health Service from the National Institute of Allergy and Infectious Diseases [SC1-AI-078559]; Army Research Office of the Department of Defense [W911NF-11-1-0136]; South Texas Center for Emerging Infectious Diseases; Center of Excellence in Infection Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI078559] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Army Research Office of the Department of Defense; South Texas Center for Emerging Infectious Diseases; Center of Excellence in Infection Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partly supported by Public Health Service grant SC1-AI-078559 from the National Institute of Allergy and Infectious Diseases, the Army Research Office of the Department of Defense under Contract No. W911NF-11-1-0136, predoctoral fellowships from the South Texas Center for Emerging Infectious Diseases (to TAV and SLRK) and predoctoral fellowships from the Center of Excellence in Infection Genomics (to TAV and CLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; BARBOUR AG, 1989, REV INFECT DIS, V11, pS1470; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Bischoff KM, 1996, J BACTERIOL, V178, P19, DOI 10.1128/jb.178.1.19-23.1996; BISCHOFF KM, 1992, BIOCHEM MED METAB B, V48, P149, DOI 10.1016/0885-4505(92)90060-C; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Bratton RL, 2008, MAYO CLIN PROC, V83, P566, DOI 10.4065/83.5.566; Brissette CA, 2009, MICROBIOL-SGM, V155, P863, DOI 10.1099/mic.0.024604-0; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Dandache P, 2008, INFECT DIS CLIN N AM, V22, P235, DOI 10.1016/j.idc.2007.12.012; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; ENDO A, 1992, J LIPID RES, V33, P1569; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Ghosh PM, 1997, BBA-MOL CELL RES, V1359, P13, DOI 10.1016/S0167-4889(97)00091-8; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hedl M, 2004, PROTEIN SCI, V13, P1693, DOI 10.1110/ps.03597504; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; LaRocca TJ, 2010, CELL HOST MICROBE, V8, P331, DOI 10.1016/j.chom.2010.09.001; Li C, 2011, INFECT IMMUN, V79, P1270; Liang KH, 2003, KIDNEY INT, V64, P192, DOI 10.1046/j.1523-1755.2003.00041.x; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Maruskova M, 2008, INFECT IMMUN, V76, P5274, DOI 10.1128/IAI.00803-08; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Nardelli DT, 2009, FUTURE MICROBIOL, V4, P457, DOI 10.2217/FMB.09.17; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Pitzer JE, 2011, INFECT IMMUN, V79, P1815, DOI 10.1128/IAI.00075-11; Raju BVS, 2011, INFECT IMMUN, V79, P3407, DOI 10.1128/IAI.05234-11; Ramamoorthy R, 2001, INFECT IMMUN, V69, P2739, DOI 10.1128/IAI.69.4.2739-2742.2001; Robinzon S, 2009, J VIROL, V83, P5495, DOI 10.1128/JVI.01880-08; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Schroder NWJ, 2003, J BIOL CHEM, V278, P33645, DOI 10.1074/jbc.M305799200; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seemanapalli SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015830; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Smythe CDW, 1998, J INVEST DERMATOL, V111, P139, DOI 10.1046/j.1523-1747.1998.00246.x; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stubs G, 2009, J BIOL CHEM, V284, P13326, DOI 10.1074/jbc.M809575200; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Takahashi S, 1999, J BACTERIOL, V181, P1256, DOI 10.1128/JB.181.4.1256-1263.1999; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Theivagt AE, 2006, BIOCHEMISTRY-US, V45, P14397, DOI 10.1021/bi0614636; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Voynova NE, 2004, J BACTERIOL, V186, P61, DOI 10.1128/JB.186.1.61-67.2004; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100	74	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38171	10.1371/journal.pone.0038171	http://dx.doi.org/10.1371/journal.pone.0038171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675445	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500100
J	Laukkanen, L; Leimu, R; Muola, A; Lilley, M; Salminen, JP; Mutikainen, P				Laukkanen, Liisa; Leimu, Roosa; Muola, Anne; Lilley, Marianna; Salminen, Juha-Pekka; Mutikainen, Pia			Plant Chemistry and Local Adaptation of a Specialized Folivore	PLOS ONE			English	Article							POPULATION-SIZE; MATING SYSTEM; HOST PLANTS; HERBIVORE; SELECTION; COEVOLUTION; HISTORY; FITNESS; METAANALYSIS; SPECIFICITY	Local adaptation is central for creating and maintaining spatial variation in plant-herbivore interactions. Short-lived insect herbivores feeding on long-lived plants are likely to adapt to their local host plants, because of their short generation time, poor dispersal, and geographically varying selection due to variation in plant defences. In a reciprocal feeding trial, we investigated the impact of geographic variation in plant secondary chemistry of a long-lived plant, Vincetoxicum hirundinaria, on among-population variation in local adaptation of a specialist leaf-feeding herbivore, Abrostola asclepiadis. The occurrence and degree of local adaptation varied among populations. This variation correlated with qualitative and quantitative differences in plant chemistry among the plant populations. These findings provide insights into the mechanisms driving variation in local adaptation in this specialized plant-herbivore interaction.	[Laukkanen, Liisa; Muola, Anne; Lilley, Marianna] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Leimu, Roosa] Univ Oxford, Dept Plant Sci, Oxford, England; [Salminen, Juha-Pekka] Univ Turku, Dept Chem, Turku, Finland; [Mutikainen, Pia] ETH Zentrum, ETH Zurich, Inst Integrat Biol, Zurich, Switzerland	University of Turku; University of Oxford; University of Turku; ETH Zurich	Laukkanen, L (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	liisa.laukkanen@utu.fi	Salminen, Juha-Pekka/N-3313-2017	Salminen, Juha-Pekka/0000-0002-2912-7094; Muola, Anne/0000-0003-1828-6425	Academy of Finland [8109859]	Academy of Finland(Academy of Finland)	This study was financially supported by the grant 8109859 of the Academy of Finland (http://www.aka.fi) for RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Barnett V., 1994, OUTLIERS STAT DATA; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berenbaum MR, 2006, ECOLOGY, V87, P3070, DOI 10.1890/0012-9658(2006)87[3070:PWAHPA]2.0.CO;2; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1983, J CHEM ECOL, V9, P475, DOI 10.1007/BF00990220; Del Campo ML, 2003, ECOL ENTOMOL, V28, P405, DOI 10.1046/j.1365-2311.2003.00524.x; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Etile E, 2008, OIKOS, V117, P135, DOI 10.1111/j.2007.0030-1299.16114.x; Evenden ML, 2006, ANN ENTOMOL SOC AM, V99, P837, DOI 10.1603/0013-8746(2006)99[837:BSAADI]2.0.CO;2; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Forare Jonas, 1995, Entomologisk Tidskrift, V116, P179; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; HANKS LM, 1994, ECOLOGY, V75, P2301, DOI 10.2307/1940885; HAUKIOJA E, 1985, ECOL ENTOMOL, V10, P267, DOI 10.1111/j.1365-2311.1985.tb00723.x; Hereford J, 2008, NEW PHYTOL, V178, P888, DOI 10.1111/j.1469-8137.2008.02405.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Karl I, 2010, POPUL ECOL, V52, P307, DOI 10.1007/s10144-009-0191-z; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; Leimu R, 2004, ANN BOT-LONDON, V93, P107, DOI 10.1093/aob/mch012; Leimu R, 2006, BASIC APPL ECOL, V7, P224, DOI 10.1016/j.baae.2005.09.002; Leimu R, 2005, ACTA OECOL, V28, P325, DOI 10.1016/j.actao.2005.06.004; Leimu R, 2005, CONSERV BIOL, V19, P349, DOI 10.1111/j.1523-1739.2005.00480.x; Leimu R, 2002, OIKOS, V98, P229, DOI 10.1034/j.1600-0706.2002.980205.x; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; MOPPER S, 1995, EVOLUTION, V49, P810, DOI [10.2307/2410404, 10.1111/j.1558-5646.1995.tb02317.x]; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Muola A, 2010, ECOLOGY, V91, P2650, DOI 10.1890/09-0589.1; Ortegon-Campos I, 2009, J EVOLUTION BIOL, V22, P2288, DOI 10.1111/j.1420-9101.2009.01847.x; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Rhoades DF, 1979, HERBIVORES THEIR INT, P1; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Spitzer B, 2006, EVOLUTION, V60, P1859, DOI 10.1111/j.0014-3820.2006.tb00529.x; Staerk D, 2000, J NAT PROD, V63, P1584, DOI 10.1021/np0003443; Strauss SY, 1997, OECOLOGIA, V110, P77, DOI 10.1007/s004420050135; Tack AJM, 2010, ECOLOGY, V91, P2253, DOI 10.1890/09-0080.1; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 1994, COEVOLUTIONARY PROCE; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Van Zandt PA, 2004, OIKOS, V104, P401, DOI 10.1111/j.0030-1299.2004.12964.x; Van Zandt PA, 1998, AM NAT, V152, P595, DOI 10.1086/286192; von Numers M, 1998, GLOBAL ECOL BIOGEOGR, V7, P421, DOI 10.2307/2997713; Zangerl AR, 2008, P NATL ACAD SCI USA, V105, P4547, DOI 10.1073/pnas.0710280105	53	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38225	10.1371/journal.pone.0038225	http://dx.doi.org/10.1371/journal.pone.0038225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666493	Green Published, gold, Green Submitted			2022-12-25	WOS:000305353400106
J	Ma, JC; Ibekwe, AM; Leddy, M; Yang, CH; Crowley, DE				Ma, Jincai; Ibekwe, A. Mark; Leddy, Menu; Yang, Ching-Hong; Crowley, David E.			Assimilable Organic Carbon (AOC) in Soil Water Extracts Using Vibrio harveyi BB721 and Its Implication for Microbial Biomass	PLOS ONE			English	Article							BIOCIDAL TREATMENTS; BACTERIAL-GROWTH; MATTER; METABOLISM; INDICATORS; NITROGEN	Assimilable organic carbon (AOC) is commonly used to measure the growth potential of microorganisms in water, but has not yet been investigated for measuring microbial growth potential in soils. In this study, a simple, rapid, and non-growth based assay to determine AOC in soil was developed using a naturally occurring luminous strain Vibrio harveyi BB721 to determine the fraction of low molecular weight organic carbon in soil water extract. Calibration of the assay was achieved by measuring the luminescence intensity of starved V. harveyi BB721 cells in the late exponential phase with a concentration range from 0 to 800 mu g l(-1) glucose (equivalent to 0-16.0 mg glucose C kg(-1) soil) with the detection limit of 10 mu g l(-1) equivalent to 0.20 mg glucose C kg(-1) soil. Results showed that bioluminescence was proportional to the concentration of glucose added to soil. The luminescence intensity of the cells was highly pH dependent and the optimal pH was about 7.0. The average AOC concentration in 32 soils tested was 2.9 +/- 2.2 mg glucose C kg(-1). Our data showed that AOC levels in soil water extracts were significantly correlated (P<0.05) with microbial biomass determined as microbial biomass carbon, indicating that the AOC concentrations determined by the method developed might be a good indicator of soil microbial biomass. Our findings provide a new approach that may be used to determine AOC in environmental samples using a non-growth bioluminescence based assay. Understanding the levels of AOC in soil water extract provides new insights into our ability to estimate the most available carbon pool to bacteria in soil that may be easily assimilated into cells for many metabolic processes and suggest possible the links between AOC, microbial regrowth potential, and microbial biomass in soils.	[Ma, Jincai; Ibekwe, A. Mark] US Dept Agr Agr Res Serv, US Salin Lab, Riverside, CA USA; [Ma, Jincai; Crowley, David E.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Leddy, Menu] Orange Cty Water Dist, Fountain Valley, CA USA; [Yang, Ching-Hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University of California System; University of California Riverside; University of Wisconsin System; University of Wisconsin Milwaukee	Ma, JC (corresponding author), US Dept Agr Agr Res Serv, US Salin Lab, Riverside, CA USA.	Mark.Ibekwe@ars.usda.gov	MA, JINCAI/D-1290-2013; MA, JINCAI/AAR-3734-2021; Crowley, David/C-1216-2014	MA, JINCAI/0000-0002-0792-0251; MA, JINCAI/0000-0002-0792-0251; Crowley, David/0000-0002-1805-8599; Ibekwe, Abasiofiok/0000-0003-3352-759X	National Institute of Food and Agriculture [2008-35201-18709]; United States Department of Agriculture-Agricultural Research Service; National Natural Science Foundation of China [40971255]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Institute of Food and Agriculture Agreement no. 2008-35201-18709 and the 214 Manure and Byproduct Utilization Project of the United States Department of Agriculture-Agricultural Research Service. Travel by Dr. Haizhen Wang to our Lab was funded by the National Natural Science Foundation of China (Nos. 40971255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Balaria A, 2009, SOIL SCI SOC AM J, V73, P812, DOI 10.2136/sssaj2008.0075; BASSLER BL, 1994, MOL MICROBIOL, V12, P403, DOI 10.1111/j.1365-2958.1994.tb01029.x; BELAS R, 1982, SCIENCE, V218, P791, DOI 10.1126/science.10636771; ELLIOTT LF, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P353; Escobar IC, 1999, J AM WATER WORKS ASS, V91, P76; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Greenberg A. E., 1993, STANDARD METHODS EXA; Haddix PL, 2004, APPL ENVIRON MICROB, V70, P850, DOI 10.1128/AEM.70.2.850-854.2004; Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hem LJ, 2001, WATER RES, V35, P1106, DOI 10.1016/S0043-1354(00)00354-7; Ilstedt U, 2005, SOIL BIOL BIOCHEM, V37, P1407, DOI 10.1016/j.soilbio.2005.01.002; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P167, DOI 10.1016/0038-0717(76)90001-8; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P209, DOI 10.1016/0038-0717(76)90005-5; JORET JC, 1991, WATER SCI TECHNOL, V24, P95, DOI 10.2166/wst.1991.0036; KAPLAN LA, 1993, APPL ENVIRON MICROB, V59, P1532, DOI 10.1128/AEM.59.5.1532-1539.1993; KILLHAM K, 1990, SOIL USE MANAGE, V6, P86, DOI 10.1111/j.1475-2743.1990.tb00811.x; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Klein G, 1998, MOL GEN GENET, V259, P179, DOI 10.1007/s004380050803; Klute A, 2001, AM SOC AGRONOMY AG 1, V9; Landgraf D, 2006, J PLANT NUTR SOIL SC, V169, P76, DOI 10.1002/jpln.200521711; LECHEVALLIER MW, 1993, APPL ENVIRON MICROB, V59, P1526, DOI 10.1128/AEM.59.5.1526-1531.1993; LeChevallier MW, 1996, APPL ENVIRON MICROB, V62, P2201, DOI 10.1128/AEM.62.7.2201-2211.1996; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; QUALLS RG, 1992, SOIL SCI SOC AM J, V56, P578, DOI 10.2136/sssaj1992.03615995005600020038x; SERVAIS P, 1987, WATER RES, V21, P445, DOI 10.1016/0043-1354(87)90192-8; Smith J. L., 1990, Soil biochemistry. Volume 6., P357; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; Van Der Kooij, 1990, DRINKING WATER MICRO; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; VANDERKOOIJ D, 1992, J AM WATER WORKS ASS, V84, P57, DOI 10.1002/j.1551-8833.1992.tb07305.x; Vital M, 2010, APPL ENVIRON MICROB, V76, P6477, DOI 10.1128/AEM.00794-10; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Weinrich LA, 2011, APPL ENVIRON MICROB, V77, P1148, DOI 10.1128/AEM.01829-10; Weinrich LA, 2009, APPL ENVIRON MICROB, V75, P7385, DOI 10.1128/AEM.01728-09; Yeomans CV, 1999, FEMS MICROBIOL LETT, V176, P79, DOI 10.1111/j.1574-6968.1999.tb13645.x	39	9	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e28519	10.1371/journal.pone.0028519	http://dx.doi.org/10.1371/journal.pone.0028519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22679477	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349800001
J	Kurusu, S; Sapirstein, A; Bonventre, JV				Kurusu, Shiro; Sapirstein, Adam; Bonventre, Joseph V.			Group IVA phospholipase A(2) optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2	FASEB JOURNAL			English	Article						PLA(2) isoforms; prostaglandin E-2; preovulatory follicle; female reproduction	HUMAN CHORIONIC-GONADOTROPIN; CYCLOOXYGENASE-2 EXPRESSION; ARACHIDONIC-ACID; GRANULOSA-CELLS; EICOSANOID GENERATION; FEEDBACK-CONTROL; GENE DISRUPTION; MICE LACKING; H SYNTHASE; E-2	Female mice lacking group IVA phospholipase A(2) (Pla2g4a(-/-)) have a smaller litter size, which is due, in part, to defective implantation. We examined PLA(2)G4A dependence of the processes of ovulation and fertilization. Following induction of ovulation by equine chorionic gonadotropin (eCG)/human CG (hCG) treatment and mating, ovulation and fertilization rates were reduced significantly in Pla2g4a(-/-) mice as compared to wild-type littermates. Human CG triggered robust ovarian prostaglandin (PG) E-2 production in the preovulatory period that was significantly attenuated in Pla2g4a(-/-) mice. Human CG transiently enhanced ovarian expression of PLA(2)G4A and prostaglandin endoperoxide synthase 2 (PTGS2) in wild-type mice. This PTGS2 induction was decreased in Pla2g4a(-/-) mice and also in immature rats treated with the PLA(2)G4A inhibitor, archidonyl trifluoromethyl ketone. A close spatiotemporal association of PLA(2)G4A with PTGS2 was found in mouse and rat preovulatory follicles examined by immunohistochemistry. Less association was observed with 4 other forms of PLA(2). Our data strongly suggest that PLA(2)G4A amplifies hCG induction of PTGS2 and colocalizes with the induced PTGS2, thus contributing to robust PG production required for optimal ovulation and fertilization in rodents.-Kurusu, S., Sapirstein, A., Bonventre, J. V. Group IVA phospholipase A(2) optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2. FASEB J. 26, 3800-3810 (2012). www.fasebj.org	[Kurusu, Shiro; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Sapirstein, Adam] Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kurusu, Shiro] Kitasato Univ, Sch Vet Med, Vet Physiol Lab, Towada, Aomori 034, Japan; [Sapirstein, Adam] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Bonventre, Joseph V.] Harvard Stem Cell Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kitasato University; Johns Hopkins University; Harvard University	Bonventre, JV (corresponding author), Harvard Inst Med, Div Renal, 4 Blackfan Cir,Rm 576, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu			U.S. National Institute of Health [DK39773, DK38452]; Japanese Society for the Promotion of Science; Kieikai Research Foundation; Nakayama Foundation for Human Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, R01DK039773, R37DK039773] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kieikai Research Foundation(Kieikai Research Foundation); Nakayama Foundation for Human Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors greatly thank E. O'Leary and X.-M. Sun and other members of the J.V.B. laboratory for technical assistance and useful suggestions; H. Satoh and M. Jinno for experimental help; Dr. M. Kawaminami (Kitasato University, Towada, Japan) for supplying experimental materials; Drs. A. Cybulsky (McGill University, Montreal, QC, Canada), K. Nomura (Shionogi Research Laboratories, Osaka, Japan), and I. Kudo (Showa University, Tokyo, Japan) and Wyeth Co. (Cambridge, MA, USA) for antibodies; and M. Nakata for assistance with manuscript preparation. The work with mice was supported by U.S. National Institute of Health grants DK39773 and DK38452 (to J.V.B.) and that with rats was by grants-in-aid for scientific research from the Japanese Society for the Promotion of Science and the Kieikai Research Foundation (to S. K.). S. K. received a fellowship for studies abroad from the Nakayama Foundation for Human Science. The authors declare no conflicts of interest.	Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brown N, 2009, BIOL REPROD, V81, P1131, DOI 10.1095/biolreprod.109.079061; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Davis BJ, 1999, ENDOCRINOLOGY, V140, P2685, DOI 10.1210/en.140.6.2685; Diouf MN, 2006, BIOL REPROD, V74, P1096, DOI 10.1095/biolreprod.105.048579; Duffy DM, 2005, J CLIN ENDOCR METAB, V90, P5858, DOI 10.1210/jc.2005-0980; Espey LL, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P425; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Funk CD, 2009, REPROD ENDOCRINOLOGY, P121; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; Halliwell R. J. A., 2004, PROSTAGLANDIN LEUKOT, V70, P140; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Inoue H, 2000, J BIOL CHEM, V275, P28028; Ishiguro Y, 1999, CARCINOGENESIS, V20, P1063, DOI 10.1093/carcin/20.6.1063; Joyce IM, 2001, ENDOCRINOLOGY, V142, P3187, DOI 10.1210/en.142.7.3187; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kishimoto K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-42; Kita Y, 2006, BBA-MOL CELL BIOL L, V1761, P1317, DOI 10.1016/j.bbalip.2006.08.001; Kol S, 1997, ENDOCRINOLOGY, V138, P322, DOI 10.1210/en.138.1.322; Kurusu S, 1998, PROSTAG LEUKOTR ESS, V58, P405, DOI 10.1016/S0952-3278(98)90161-2; Kurusu S, 2001, ENDOCRINE, V14, P337, DOI 10.1385/ENDO:14:3:337; Kurusu S, 2007, PROSTAG OTH LIPID M, V83, P139, DOI 10.1016/j.prostaglandins.2006.10.008; Kurusu S, 2011, BIOCHEM J, V439, P403, DOI 10.1042/BJ20102167; Kurusu S, 2009, REPRODUCTION, V137, P59, DOI 10.1530/REP-08-0257; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lappas M, 2004, PROSTAG LEUKOTR ESS, V70, P87, DOI 10.1016/j.plefa.2003.04.001; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Matsumoto H, 2001, BIOL REPROD, V64, P1557, DOI 10.1095/biolreprod64.5.1557; Mendonca LLF, 2000, RHEUMATOLOGY, V39, P880, DOI 10.1093/rheumatology/39.8.880; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NOMURA K, 1994, ENDOCRINOLOGY, V135, P603, DOI 10.1210/en.135.2.603; OCHIAI K, 1983, ENDOCRINOLOGY, V112, P1687, DOI 10.1210/endo-112-5-1687; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; Richmond BL, 2001, GASTROENTEROLOGY, V120, P1193, DOI 10.1053/gast.2001.23254; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sheldrick ELR, 2007, BIOCHEM J, V406, P175, DOI 10.1042/BJ20070089; SHERWOOD OD, 1985, ENDOCRINOLOGY, V116, P2554, DOI 10.1210/endo-116-6-2554; Sirois J, 2004, HUM REPROD UPDATE, V10, P373, DOI 10.1093/humupd/dmh032; SIROIS J, 1992, J BIOL CHEM, V267, P11586; Song H, 2002, DEVELOPMENT, V129, P2879; Stavreus-Evers A, 2005, FERTIL STERIL, V83, P156, DOI 10.1016/j.fertnstert.2004.06.057; Takahashi T, 2006, J BIOL CHEM, V281, P37117, DOI 10.1074/jbc.M608202200; Tilley SL, 1999, J CLIN INVEST, V103, P1539, DOI 10.1172/JCI6579; Tokuyama Osamu, 2003, Osaka City Medical Journal, V49, P39; Tsubouchi Y, 2001, BIOCHEM BIOPH RES CO, V283, P750, DOI 10.1006/bbrc.2001.4847; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WONG WYL, 1991, MOL ENDOCRINOL, V5, P1269, DOI 10.1210/mend-5-9-1269	57	14	14	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3800	3810		10.1096/fj.12-203968	http://dx.doi.org/10.1096/fj.12-203968			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22673578	Green Published			2022-12-25	WOS:000308391600020
J	Ren, CC; Amm, HM; DeVilliers, P; Wu, YX; Deatherage, JR; Liu, ZY; MacDougall, M				Ren, Changchun; Amm, Hope M.; DeVilliers, Patricia; Wu, Yixin; Deatherage, Joseph R.; Liu, Zhongyu; MacDougall, Mary			Targeting the Sonic Hedgehog Pathway in Keratocystic Odontogenic Tumor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENIGN CYSTIC NEOPLASM; SHH SIGNALING PATHWAY; AGGRESSIVE NATURE; ENAMEL MINERALIZATION; CANCER-CELLS; CYCLOPAMINE; MUTATIONS; GENE; PROLIFERATION; INHIBITION	Keratocystic odontogenic tumors (KCOT) may occur sporadically or associated with the nevoid basal cell carcinoma syndrome. It is a benign aggressive tumor of odontogenic epithelial origin with a high rate of recurrence. A primary human keratocystic odontogenic tumor cell population, KCOT-1, has been established from a tumor explant culture. The KCOT-1 cells were characterized by growth rate, gene expression profiles of major tooth enamel matrix proteins (EMPs), amelogenin (AMELX), enamelin (ENAM), ameloblastin (AMBN), amelotin (AMTN), tumor-related proteins enamelysin (MMP-20), kallikrein-4 (KLK-4), and odontogenic ameloblast-associated protein (ODAM) using quantitative real-time reverse transcription-polymerase chain reaction. Cytokeratin 14 (CK14) was examined by immunohistochemistry. In addition, expression of the members of the sonic hedgehog (SHH) pathway, SHH, patched (PTCH-1), smoothened (SMO), GLI-1, and GLI-2 and of the NOTCH signaling pathway, NOTCH-1, NOTCH-2, NOTCH-3, JAG-2 (Jagged-2), and Delta-like-1 (DLL-1) were evaluated. KCOT-1 cells were treated with SMO antagonist cyclopamine. We found that cyclopamine significantly arrested the growth of KCOT-1 cells in a dose-dependent manner and that the effects of cyclopamine were abolished by adding SHH protein. The protein expression of the SHH pathway was down-regulated by cyclopamine, further confirming that cyclopamine inhibits the SHH signaling pathway; SHH down-regulation correlated with the down-regulation of the NOTCH signaling pathway as well. In conclusion, using an established KCOT-1 cell population, we characterized the gene expression profiles related to the EMPs, SHH, and NOTCH signaling pathway and confirmed that cyclopamine significantly arrested the growth of KCOT-1 cells and may be a viable agent as a novel therapeutic.	[Ren, Changchun; Amm, Hope M.; Wu, Yixin; Liu, Zhongyu; MacDougall, Mary] Univ Alabama Birmingham, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Ren, Changchun; Deatherage, Joseph R.; MacDougall, Mary] Univ Alabama Birmingham, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA; [DeVilliers, Patricia] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	MacDougall, M (corresponding author), 1919 7th Ave,S Rm SDB 702, Birmingham, AL 35294 USA.	macdouga@uab.edu	MacDougall, Mary/ABG-8212-2021	Amm, Hope/0000-0003-2416-9575	Institute of Oral Health Research, School of Dentistry, University of Alabama at Birmingham; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER	Institute of Oral Health Research, School of Dentistry, University of Alabama at Birmingham; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Institute of Oral Health Research, School of Dentistry, University of Alabama at Birmingham.	BARNES L, 2005, WHO CLASSIFICATION T, P306; Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Diniz MG, 2009, ORAL ONCOL, V45, P291, DOI 10.1016/j.oraloncology.2008.05.020; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Heikinheimo K, 2007, J DENT RES, V86, P544, DOI 10.1177/154405910708600611; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katase N, 2007, J ORAL PATHOL MED, V36, P550, DOI 10.1111/j.1600-0714.2007.00578.x; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kolar Z, 2006, J ORAL PATHOL MED, V35, P75, DOI 10.1111/j.1600-0714.2006.00382.x; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Lench NJ, 1996, ORAL ONCOL, V32B, P202, DOI 10.1016/0964-1955(95)00053-4; Li TJ, 2008, ORAL DIS, V14, P174, DOI 10.1111/j.1601-0825.2007.01369.x; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; MEISELMAN F, 1994, J ORAL MAXIL SURG, V52, P960, DOI 10.1016/S0278-2391(10)80080-1; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Mitsiadis TA, 2005, ARCH ORAL BIOL, V50, P137, DOI 10.1016/j.archoralbio.2004.10.006; Mitsiadis TA, 1998, DEV BIOL, V204, P420, DOI 10.1006/dbio.1998.9092; Miyazaki KI, 2006, JPN J OPHTHALMOL, V50, P305, DOI 10.1007/s10384-006-0341-1; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Murphy CL, 2008, AMYLOID, V15, P89, DOI 10.1080/13506120802005965; Nishimaki H, 2004, BIOCHEM BIOPH RES CO, V314, P313, DOI 10.1016/j.bbrc.2003.12.097; Park JC, 2007, EUR J ORAL SCI, V115, P153, DOI 10.1111/j.1600-0722.2007.00435.x; Ren C, 2011, CELLS TISSUES ORGANS, V194, P296, DOI 10.1159/000324759; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Shear M, 2002, ORAL ONCOL, V38, P407, DOI 10.1016/S1368-8375(01)00067-7; Shear M, 2002, ORAL ONCOL, V38, P323, DOI 10.1016/S1368-8375(01)00066-5; Shear M, 2002, ORAL ONCOL, V38, P219, DOI 10.1016/S1368-8375(01)00065-3; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Sun LS, 2008, J DENT RES, V87, P575, DOI 10.1177/154405910808700616; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200; Zhang L, 2006, MED HYPOTHESES, V67, P1242, DOI 10.1016/j.mehy.2006.04.062	42	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27117	27125		10.1074/jbc.M112.367680	http://dx.doi.org/10.1074/jbc.M112.367680			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22679015	Green Published, hybrid			2022-12-25	WOS:000307386000064
J	Yao, X; Chong, HH; Zhang, C; Qiu, ZL; Qin, B; Han, RY; Waltersperger, S; Wang, MT; He, YX; Cui, S				Yao, Xue; Chong, Huihui; Zhang, Chao; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; Waltersperger, Sandro; Wang, Meitian; He, Yuxian; Cui, Sheng			Structural Basis of Potent and Broad HIV-1 Fusion Inhibitor CP32M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CORE STRUCTURE; MEMBRANE-FUSION; ANTIRETROVIRAL ACTIVITY; PEPTIDE INHIBITOR; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; RESISTANT HIV-1; COILED-COIL; ENFUVIRTIDE	CP32M is a newly designed peptide fusion inhibitor possessing potent anti-HIV activity, especially against T20-resistant HIV-1 strains. In this study, we show that CP32M can efficiently inhibit a large panel of diverse HIV-1 variants, including subtype B', CRF07_BC, and CRF01_AE recombinants and naturally occurring or induced T20-resistant viruses. To elucidate its mechanism of action, we determined the crystal structure of CP32M complexed with its target sequence. Differing from its parental peptide, CP621-652, the (VEWNEMT627)-V-621 motif of CP32M folds into two alpha-helix turns at the N terminus of the pocket-binding domain, forming a novel layer in the six-helix bundle structure. Prominently, the residue Asn-624 of the (VEWNEMT627)-V-621 motif is engaged in the polar interaction with a hydrophilic ridge that borders the hydrophobic pocket on the N-terminal coiled coil. The original inhibitor design of CP32M provides several intra- and salt bridge/hydrogen bond interactions favoring the stability of the helical conformation of CP32M and its interactions with N-terminal heptad repeat ( NHR) targets. We identified a novel salt bridge between Arg-557 on the NHR and Glu-648 of CP32M that is critical for the binding of CP32M and resistance against the inhibitor. Therefore, our data present important information for developing novel HIV-1 fusion inhibitors for clinical use.	[Yao, Xue; Chong, Huihui; Zhang, Chao; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; He, Yuxian; Cui, Sheng] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yao, Xue; Chong, Huihui; Zhang, Chao; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; He, Yuxian; Cui, Sheng] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	yhe@ipb.pumc.edu.cn; cui.sheng@ipb.pumc.edu.cn	Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	National Outstanding Youth Award of the Natural Science Foundation of China (NSFC) [81025009]; NSFC [30870123]; National 973 Program of China [2010CB530100]; Beijing Natural Science Foundation [7122116]	National Outstanding Youth Award of the Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Grants 81025009 from the National Outstanding Youth Award of the Natural Science Foundation of China (NSFC), 30870123 from the NSFC, 2010CB530100 from the National 973 Program of China, and 7122116 from the Beijing Natural Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883; Yu XW, 2012, J VIROL, V86, P589, DOI 10.1128/JVI.05066-11; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	48	20	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26618	26629		10.1074/jbc.M112.381079	http://dx.doi.org/10.1074/jbc.M112.381079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22679024	Green Published, hybrid			2022-12-25	WOS:000307386000014
J	Graham, LM; Gupta, V; Schafer, G; Reid, DM; Kimberg, M; Dennehy, KM; Hornsell, WG; Guler, R; Campanero-Rhodes, MA; Palma, AS; Feizi, T; Kim, SK; Sobieszczuk, P; Willment, JA; Brown, GD				Graham, Lisa M.; Gupta, Vandana; Schafer, Georgia; Reid, Delyth M.; Kimberg, Matti; Dennehy, Kevin M.; Hornsell, William G.; Guler, Reto; Campanero-Rhodes, Maria A.; Palma, Angelina S.; Feizi, Ten; Kim, Stella K.; Sobieszczuk, Peter; Willment, Janet A.; Brown, Gordon D.			The C-type Lectin Receptor CLECSF8 (CLEC4D) Is Expressed by Myeloid Cells and Triggers Cellular Activation through Syk Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTOR; BETA-GLUCAN RECEPTOR; DENDRITIC CELLS; CANDIDA-ALBICANS; GAMMA-CHAIN; DECTIN-1; MACROPHAGES; MONOCYTES; RESPONSES; MINCLE	CLECSF8 is a poorly characterized member of the "Dectin-2 cluster" of C-type lectin receptors and was originally thought to be expressed exclusively by macrophages. We show here that CLECSF8 is primarily expressed by peripheral blood neutrophils and monocytes and weakly by several subsets of peripheral blood dendritic cells. However, expression of this receptor is lost upon in vitro differentiation of monocytes into dendritic cells or macrophages. Like the other members of the Dectin-2 family, which require association of their transmembrane domains with signaling adaptors for surface expression, CLECSF8 is retained intracellularly when expressed in non-myeloid cells. However, we demonstrate that CLECSF8 does not associate with any known signaling adaptor molecule, including DAP10, DAP12, or the FcR gamma chain, and we found that the C-type lectin domain of CLECSF8 was responsible for its intracellular retention. Although CLECSF8 does not contain a signaling motif in its cytoplasmic domain, we show that this receptor is capable of inducing signaling via Syk kinase in myeloid cells and that it can induce phagocytosis, proinflammatory cytokine production, and the respiratory burst. These data therefore indicate that CLECSF8 functions as an activation receptor on myeloid cells and associates with a novel adaptor molecule. Characterization of the CLECSF8-deficient mice and screening for ligands using oligosaccharide microarrays did not provide further insights into the physiological function of this receptor.	[Willment, Janet A.; Brown, Gordon D.] Univ Aberdeen, Sect Immunol & Infect, Div Appl Med, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Graham, Lisa M.; Gupta, Vandana; Schafer, Georgia; Kimberg, Matti; Dennehy, Kevin M.; Hornsell, William G.; Guler, Reto; Willment, Janet A.; Brown, Gordon D.] Univ Cape Town, Inst Infect Dis & Mol Med, Cent Lab Serv, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Campanero-Rhodes, Maria A.; Palma, Angelina S.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, London W12 0NN, England; [Kim, Stella K.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA; [Sobieszczuk, Peter] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1142, New Zealand	University of Aberdeen; University of Cape Town; Imperial College London; University of California System; University of California San Francisco; University of Auckland	Willment, JA (corresponding author), Univ Aberdeen, Sect Immunol & Infect, Div Appl Med, Inst Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	janet.willment@abdn.ac.uk; gordon.brown@abdn.ac.uk	Horsnell, William GC/A-9512-2013; Campanero-Rhodes, María Asunción/M-3158-2014; Guler, Reto/A-4013-2011; Palma, Angelina S/D-2052-2013	Campanero-Rhodes, María Asunción/0000-0002-3373-0064; Palma, Angelina S/0000-0001-5797-6555; brown, gordon/0000-0002-0287-5383; Feizi, Ten/0000-0001-6495-0329; Graham, Lisa/0000-0002-7865-7833; Horsnell, William Gordon Charles/0000-0001-7172-408X; Willment, Janet/0000-0002-7040-0857	Wellcome Trust; National Research Foundation; Deutscher Akademischer Austauschdienst; University of Cape Town; UK Research Council Basic Technology Initiative "Glycoarrays" [GRS/79268]; UK Medical Research Council; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/26515/2006]; Consejo Superior de Investigaciones Cientificas, Programe "Junta para la Ampliacion de Estudios" [JaeDoc/098/2011]; Fondo Social Europeo; EPSRC [EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Research Foundation; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); University of Cape Town; UK Research Council Basic Technology Initiative "Glycoarrays"; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Consejo Superior de Investigaciones Cientificas, Programe "Junta para la Ampliacion de Estudios"; Fondo Social Europeo(European Social Fund (ESF)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Wellcome Trust, the National Research Foundation, the Deutscher Akademischer Austauschdienst, the University of Cape Town, the UK Research Council Basic Technology Initiative "Glycoarrays" (GRS/79268), and the UK Medical Research Council. A. S. P is a fellow of the Fundacao para a Ciencia e Tecnologia (SFRH/BPD/26515/2006, Portugal) and M. A. C. of the Consejo Superior de Investigaciones Cientificas, Programe "Junta para la Ampliacion de Estudios" (JaeDoc/098/2011) cofinanced by the Fondo Social Europeo.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	36	90	92	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25964	25974		10.1074/jbc.M112.384164	http://dx.doi.org/10.1074/jbc.M112.384164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689578	Green Published, hybrid			2022-12-25	WOS:000306916300024
J	Johnson, AE; Collier, SE; Ohi, MD; Gould, KL				Johnson, Alyssa E.; Collier, Scott E.; Ohi, Melanie D.; Gould, Kathleen L.			Fission Yeast Dma1 Requires RING Domain Dimerization for Its Ubiquitin Ligase Activity and Mitotic Checkpoint Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; CYTOKINESIS; RNF4; CHFR; EXIT; CELL; SIN	In fission yeast (Schizosaccharomyces pombe), the E3 ubiquitin ligase Dma1 delays cytokinesis if chromosomes are not properly attached to the mitotic spindle. Dma1 contains a C-terminal RING domain, and we have found that the Dma1 RING domain forms a stable homodimer. Although the RING domain is required for dimerization, residues in the C-terminal tail are also required to help form or stabilize the dimeric structure because mutation of specific residues in this region disrupts Dma1 dimerization. Further analyses showed that Dma1 dimerization is required for proper localization at spindle pole bodies and the cell division site, E3 ligase activity, and mitotic checkpoint function. Thus, Dma1 forms an obligate dimer via its RING domain, which is essential for efficient transfer of ubiquitin to its substrate(s). This study further supports the mechanistic paradigm that many RING E3 ligases function as RING dimers.	[Johnson, Alyssa E.; Gould, Kathleen L.] Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; [Johnson, Alyssa E.; Collier, Scott E.; Ohi, Melanie D.; Gould, Kathleen L.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Collier, Scott E.; Ohi, Melanie D.] Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gould, KL (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, 221 Kirkland Hall, Nashville, TN 37232 USA.	kathy.gould@vanderbilt.edu		Gould, Kathleen/0000-0002-3810-4070	National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program [T32 GM08554]; Molecular Biophysics Training Program [T32 GM008320]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biophysics Training Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program Grant T32 GM08554 (to A. E. J.) and Molecular Biophysics Training Program Grant T32 GM008320 (to S. E. C.). This work was also supported by the Howard Hughes Medical Institute.	Brooks L, 2008, CELL MOL LIFE SCI, V65, P3458, DOI 10.1007/s00018-008-8220-1; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Garcia-Cortes JC, 2009, J CELL BIOL, V186, P739, DOI 10.1083/jcb.200902116; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Guertin DA, 2002, DEV CELL, V3, P779, DOI 10.1016/S1534-5807(02)00367-2; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; James P, 1996, GENETICS, V144, P1425; Johnson AE, 2011, EMBO J, V30, P341, DOI 10.1038/emboj.2010.317; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Sohrmann M, 1998, GENE DEV, V12, P84, DOI 10.1101/gad.12.1.84; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	26	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25741	25748		10.1074/jbc.M112.349712	http://dx.doi.org/10.1074/jbc.M112.349712			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669973	hybrid, Green Published			2022-12-25	WOS:000306916300005
J	Johnson, X; Alric, J				Johnson, Xenie; Alric, Jean			Interaction between Starch Breakdown, Acetate Assimilation, and Photosynthetic Cyclic Electron Flow in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; FERMENTATIVE METABOLISM; CHLOROPLASTS; TRANSPORT; LIGHT; CHLORORESPIRATION; STABILIZATION; MITOCHONDRIA; CELLS; POOL	Spectroscopic studies on photosynthetic electron transfer generally are based upon the monitoring of dark to light changes in the electron transfer chain. These studies, which focus on the light reactions of photosynthesis, also indirectly provide information on the redox or metabolic state of the chloroplast in the dark. Here, using the unicellular microalga Chlamydomonas reinhardtii, we study the impact of heterotrophic/mixotrophic acetate feeding on chloroplast carbon metabolism by using the spectrophotometric detection of P700(+), the photooxidized primary electron donor of photosystem I. We show that, when photosynthetic linear and cyclic electron flows are blocked (DCMU inhibiting PSII and methylviologen accepting electrons from PSI), the post-illumination reduction kinetics of P700(+) directly reflect the dark metabolic production of reductants (mainly NAD(P)H) in the stroma of chloroplasts. Such results can be correlated to other metabolic studies: in the absence of acetate, for example, the P700(+) reduction rate matches the rate of starch breakdown reported previously, confirming the chloroplast localization of the upstream steps of the glycolytic pathway in Chlamydomonas. Furthermore, the question of the interplay between photosynthetic and non-photosynthetic carbon metabolism can be addressed. We show that cyclic electron flow around photosystem I is twice as fast in a starchless mutant fed with acetate than it is in the WT, and we relate how changes in the flux of electrons from carbohydrate metabolism modulate the redox poise of the plastoquinone pool in the dark through chlororespiration.	[Alric, Jean] Univ Paris 06, Inst Biol Physicochim, F-75005 Paris, France; CNRS, UMR 7141, F-75005 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Alric, J (corresponding author), Univ Paris 06, Inst Biol Physicochim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	jean.alric@ibpc.fr	Alric, Jean/E-3538-2013; Johnson, Xenie/T-7151-2019	Alric, Jean/0000-0003-3574-2234; Johnson, Xenie/0000-0003-3424-7047	Agence Nationale pour la Recherche [ANR-08-BIOE-002 ALGOMICS]; European Commission EUFP7 [SUNBIOPATH-GA-245070]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Commission EUFP7	This work was supported by Agence Nationale pour la Recherche ANR-08-BIOE-002 ALGOMICS and European Commission EUFP7 SUNBIOPATH-GA-245070.	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; ARNON DI, 1975, P NATL ACAD SCI USA, V72, P4961, DOI 10.1073/pnas.72.12.4961; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ball S., 1998, ADV PHOTOSYNTHESIS M, V7, P550; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Bukhov N, 2002, PLANTA, V215, P812, DOI 10.1007/s00425-002-0808-3; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1016, P253, DOI 10.1016/0005-2728(90)90066-D; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; FELL DA, 1984, TRENDS BIOCHEM SCI, V9, P515, DOI 10.1016/0968-0004(84)90277-9; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; GIBBS M, 1986, PLANT PHYSIOL, V82, P160, DOI 10.1104/pp.82.1.160; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HEBER U, 1974, ANNU REV PLANT PHYS, V25, P393, DOI 10.1146/annurev.pp.25.060174.002141; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Ivanov B, 2005, PLANTA, V220, P572, DOI 10.1007/s00425-004-1367-6; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; KLEIN U, 1986, PLANTA, V167, P81, DOI 10.1007/BF00446372; KLOCK G, 1991, BIOCHIM BIOPHYS ACTA, V1073, P410, DOI 10.1016/0304-4165(91)90150-F; LAVERGNE J, 1984, FEBS LETT, V173, P9, DOI 10.1016/0014-5793(84)81006-6; LENDZIAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P260, DOI 10.1016/0005-2728(75)90040-7; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; MAXWELL PC, 1976, BIOCHEMISTRY-US, V15, P3975, DOI 10.1021/bi00663a011; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; NEALE PJ, 1986, J PHYCOL, V22, P531, DOI 10.1111/j.1529-8817.1986.tb02497.x; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; PRINGSHEIM EG, 1960, NATURE, V188, P919, DOI 10.1038/188919a0; RACKER E, 1984, TRENDS BIOCHEM SCI, V9, P516, DOI 10.1016/0968-0004(84)90278-0; REBEILLE F, 1988, PLANT PHYSIOL, V88, P973, DOI 10.1104/pp.88.4.973; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Spalding MH, 2009, CHLAMYDOMONAS SOURCE, V2, P257; STITT M, 1981, PLANT PHYSIOL, V68, P755, DOI 10.1104/pp.68.3.755; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Toth SZ, 2007, PHOTOSYNTH RES, V93, P193, DOI 10.1007/s11120-007-9179-8; WALKER DA, 1967, NATURE, V216, P597, DOI 10.1038/216597a0; WIESSNER W, 1965, NATURE, V205, P56, DOI 10.1038/205056a0; WILLEFORD KO, 1989, PLANT PHYSIOL, V90, P1084, DOI 10.1104/pp.90.3.1084; Zabawinski C, 2001, J BACTERIOL, V183, P1069, DOI 10.1128/JB.183.3.1069-1077.2001	46	81	82	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26445	26452		10.1074/jbc.M112.370205	http://dx.doi.org/10.1074/jbc.M112.370205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692199	hybrid, Green Published			2022-12-25	WOS:000306916300069
J	Keicho, N; Matsushita, I; Tanaka, T; Shimbo, T; Nguyen, TLH; Sakurada, S; Kobayashi, N; Hijikata, M; Thuong, PH; Lien, LT				Keicho, Naoto; Matsushita, Ikumi; Tanaka, Takahiro; Shimbo, Takuro; Nguyen Thi Le Hang; Sakurada, Shinsaku; Kobayashi, Nobuyuki; Hijikata, Minako; Pham Huu Thuong; Luu Thi Lien			Circulating Levels of Adiponectin, Leptin, Fetuin-A and Retinol-Binding Protein in Patients with Tuberculosis: Markers of Metabolism and Inflammation	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; PLASMA LEPTIN; DIABETES-MELLITUS; EXPRESSION; OBESITY; RETINOL-BINDING-PROTEIN-4; MALNUTRITION; GLYCOPROTEIN; ASSOCIATION	Background: Wasting is known as a prominent feature of tuberculosis (TB). To monitor the disease state, markers of metabolism and inflammation are potentially useful. We thus analyzed two major adipokines, adiponectin and leptin, and two other metabolic markers, fetuin-A and retinol-binding protein 4 (RBP4). Methods: The plasma levels of these markers were measured using enzyme-linked immunosorbent assays in 84 apparently healthy individuals (= no-symptom group) and 46 patients with active pulmonary TB around the time of treatment, including at the midpoint evaluation (= active-disease group) and compared them with body mass index (BMI), C-reactive protein (CRP), chest radiographs and TB-antigen specific response by interferon-c release assay (IGRA). Results: In the no-symptom group, adiponectin and leptin showed negative and positive correlation with BMI respectively. In the active-disease group, at the time of diagnosis, leptin, fetuin-A and RBP4 levels were lower than in the no-symptom group [adjusted means 2.01 versus 4.50 ng/ml, P<0.0001; 185.58 versus 252.27 mu g/ml, P<0.0001; 23.88 versus 43.79 mu g/ml, P<0.0001, respectively]. High adiponectin and low leptin levels were associated with large infiltrates on chest radiographs even after adjustment for BMI and other covariates (P = 0.0033 and P = 0.0020). During treatment, adiponectin levels increased further and then decreased. Leptin levels remained low. Initial low levels of fetuin-A and RBP4 almost returned to the normal reference range in concert with reduced CRP. Conclusions: Our data and recent literature suggest that low fat store and underlying inflammation may regulate these metabolic markers in TB in a different way. Decreased leptin, increased adiponectin, or this ratio may be a promising marker for severity of the disease independent of BMI. We should further investigate pathological roles of the balance between these adipokines.	[Keicho, Naoto; Matsushita, Ikumi; Tanaka, Takahiro; Sakurada, Shinsaku; Hijikata, Minako] Natl Ctr Global Hlth & Med, Res Inst, Dept Resp Dis, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Clin Res & Informat, Tokyo, Japan; [Nguyen Thi Le Hang] Natl Ctr Global Hlth & Med, Bach Mai Hosp Med Collaborat Ctr, Hanoi, Vietnam; [Pham Huu Thuong; Luu Thi Lien] Hanoi Lung Hosp, Hanoi, Vietnam; [Kobayashi, Nobuyuki] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Keicho, N (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Resp Dis, Tokyo, Japan.	nkeicho-tky@umin.ac.jp	Tanaka, Takahiro/GRF-0016-2022; Keicho, Naoto/GQZ-0301-2022	Keicho, Naoto/0000-0001-8232-9448	Program of Japan Initiative for Global Research Network on Infectious Diseases, MEXT, Japan	Program of Japan Initiative for Global Research Network on Infectious Diseases, MEXT, Japan	This work was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; Bornstein SR, 1998, J INFECT DIS, V178, P887, DOI 10.1086/515349; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Buyukoglan H, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/64859; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Dai GX, 1998, INFECT IMMUN, V66, P3562, DOI 10.1128/IAI.66.8.3562-3568.1998; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Gangneux C, 2003, NUCLEIC ACIDS RES, V31, P5957, DOI 10.1093/nar/gkg788; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; Gualillo O, 2000, LIFE SCI, V67, P2433, DOI 10.1016/S0024-3205(00)00827-4; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; INGENBLEEK Y, 1975, CLIN CHIM ACTA, V63, P61, DOI 10.1016/0009-8981(75)90379-4; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Kim JH, 2010, CLIN NUTR, V29, P512, DOI 10.1016/j.clnu.2010.01.008; Klempel MC, 2011, NUTR REV, V69, P145, DOI 10.1111/j.1753-4887.2011.00373.x; Klimcakova E, 2010, OBES REV, V11, P446, DOI 10.1111/j.1467-789X.2009.00704.x; Koch A, 2010, CRIT CARE, V14, DOI 10.1186/cc9285; Kuo SM, 2011, INT J OBESITY, V35, P1487, DOI 10.1038/ijo.2011.20; Langouche L, 2009, CRIT CARE, V13, DOI 10.1186/cc7956; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Malli F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-152; Marshall WJ, 2008, J CLIN PATHOL, V61, P1083, DOI 10.1136/jcp.2007.051813; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Moriconi N, 2006, J CLIN ENDOCR METAB, V91, P1586, DOI 10.1210/jc.2005-2135; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Pitombo C, 2006, J ENDOCRINOL, V191, P699, DOI 10.1677/joe.1.07069; Prentice AM, 2008, J CLIN INVEST, V118, P1322, DOI 10.1172/JCI34034; Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021; Sakurada S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-31; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Schwenk A, 2003, AM J CLIN NUTR, V77, P392, DOI 10.1093/ajcn/77.2.392; Sood A, 2010, J APPL PHYSIOL, V108, P744, DOI 10.1152/japplphysiol.00838.2009; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; TVERDAL A, 1986, EUR J RESPIR DIS, V69, P355; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; van Lettow M, 2005, J CLIN ENDOCR METAB, V90, P4771, DOI 10.1210/jc.2004-2539; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Vitkova M, 2007, J CLIN ENDOCR METAB, V92, P2330, DOI 10.1210/jc.2006-2668; Walkey AJ, 2010, CRIT CARE MED, V38, P2329, DOI 10.1097/CCM.0b013e3181fa0561; Wallace AM, 2000, CYTOKINE, V12, P1042, DOI 10.1006/cyto.2000.0674; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yuksel I, 2003, ENDOCR RES, V29, P257, DOI 10.1081/ERC-120025033	54	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38703	10.1371/journal.pone.0038703	http://dx.doi.org/10.1371/journal.pone.0038703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685600	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700063
J	Lee, Y; Mick, J; Furdui, C; Beamer, LJ				Lee, Yingying; Mick, Jacob; Furdui, Cristina; Beamer, Lesa J.			A Coevolutionary Residue Network at the Site of a Functionally Important Conformational Change in a Phosphohexomutase Enzyme Family	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MUTUAL INFORMATION; LIPOOLIGOSACCHARIDE BIOSYNTHESIS; LIPOPOLYSACCHARIDE BIOSYNTHESIS; CATALYTIC-REACTION; PHOSPHOGLUCOMUTASE; PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE; NEISSERIA; DYNAMICS; PMM/PGM	Coevolution analyses identify residues that co-vary with each other during evolution, revealing sequence relationships unobservable from traditional multiple sequence alignments. Here we describe a coevolutionary analysis of phosphomannomutase/phosphoglucomutase (PMM/PGM), a widespread and diverse enzyme family involved in carbohydrate biosynthesis. Mutual information and graph theory were utilized to identify a network of highly connected residues with high significance. An examination of the most tightly connected regions of the coevolutionary network reveals that most of the involved residues are localized near an interdomain interface of this enzyme, known to be the site of a functionally important conformational change. The roles of four interface residues found in this network were examined via site-directed mutagenesis and kinetic characterization. For three of these residues, mutation to alanine reduces enzyme specificity to similar to 10% or less of wild-type, while the other has similar to 45% activity of wild-type enzyme. An additional mutant of an interface residue that is not densely connected in the coevolutionary network was also characterized, and shows no change in activity relative to wild-type enzyme. The results of these studies are interpreted in the context of structural and functional data on PMM/PGM. Together, they demonstrate that a network of coevolving residues links the highly conserved active site with the interdomain conformational change necessary for the multi-step catalytic reaction. This work adds to our understanding of the functional roles of coevolving residue networks, and has implications for the definition of catalytically important residues.	[Lee, Yingying; Beamer, Lesa J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Mick, Jacob; Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Furdui, Cristina] Wake Forest Univ Hlth Sci Winston Salem, Dept Internal Med, Winston Salem, NC USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Wake Forest University	Lee, Y (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	beamerl@missouri.edu		Furdui, Cristina M./0000-0003-3771-7999	 [MCB-0918389]		This work was supported by MCB-0918389 http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017459; Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Boehr DD, 2008, BIOCHEMISTRY-US, V47, P9227, DOI 10.1021/bi801102e; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Chen WY, 2011, IEEE T PATTERN ANAL, V33, P568, DOI 10.1109/TPAMI.2010.88; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fatakia SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027813; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; Kim SH, 2003, ARCH MICROBIOL, V180, P240, DOI 10.1007/s00203-003-0582-z; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; Monteiro MA, 2003, CARBOHYD RES, V338, P2905, DOI 10.1016/j.carres.2003.08.014; Naught LE, 2005, BIOCHEMISTRY-US, V44, P6831, DOI 10.1021/bi0501380; Naught LE, 2003, BIOCHEMISTRY-US, V42, P9946, DOI 10.1021/bi034673g; Naught LE, 2001, ARCH BIOCHEM BIOPHYS, V396, P111, DOI 10.1006/abbi.2001.2618; Olvera C, 1999, FEMS MICROBIOL LETT, V179, P85, DOI 10.1111/j.1574-6968.1999.tb08712.x; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; RAY WJ, 1990, BIOCHEMISTRY-US, V29, P2770, DOI 10.1021/bi00463a021; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Regni CA, 2000, ACTA CRYSTALLOGR D, V56, P761, DOI 10.1107/S0907444900004431; Regni C, 2006, ACTA CRYSTALLOGR F, V62, P722, DOI 10.1107/S1744309106025887; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; SANDLIN RC, 1994, J BACTERIOL, V176, P2930, DOI 10.1128/JB.176.10.2930-2937.1994; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Schramm AM, 2010, PROTEIN SCI, V19, P1235, DOI 10.1002/pro.402; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; Xu YB, 2010, PROTEINS, V78, P548, DOI 10.1002/prot.22576; ZHOU DG, 1994, J BIOL CHEM, V269, P11162	63	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38114	10.1371/journal.pone.0038114	http://dx.doi.org/10.1371/journal.pone.0038114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685552	Green Submitted, Green Published, gold			2022-12-25	WOS:000305351700015
J	Panicker, SP; Ganguly, T; Consolo, M; Price, V; Mirmirani, P; Honda, K; Karnik, P				Panicker, Sreejith P.; Ganguly, Taneeta; Consolo, Mary; Price, Vera; Mirmirani, Paradi; Honda, Kord; Karnik, Pratima			Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTOR-3; LIVER-X-RECEPTORS; LIPID-METABOLISM; RHEUMATOID-ARTHRITIS; INTERFERON SIGNATURE; LICHEN-PLANOPILARIS; SCARRING ALOPECIA; NUCLEAR RECEPTORS; GENE-EXPRESSION	Primary cicatricial alopecia (PCA) is a group of inflammatory hair disorders that cause scarring and permanent hair loss. Previous studies have implicated PPAR gamma, a transcription factor that integrates lipogenic and inflammatory signals, in the pathogenesis of PCA. However, it is unknown what triggers the inflammatory response in these disorders, whether the inflammation is a primary or secondary event in disease pathogenesis, and whether the inflammatory reaction reflects an autoimmune process. In this paper, we show that the cholesterol biosynthetic pathway is impaired in the skin and hair follicles of PCA patients. Treatment of hair follicle cells with BM15766, a cholesterol biosynthesis inhibitor, or 7-dehydrocholesterol (7-DHC), a sterol precursor, stimulates the expression of pro-inflammatory chemokine genes. Painting of mouse skin with 7-DHC or BM15766 inhibits hair growth, causes follicular plugging and induces the infiltration of inflammatory cells into the interfollicular dermis. Our results demonstrate that cholesterologenic changes within hair follicle cells trigger an innate immune response that is associated with the induction of toll-like receptor (TLR) and interferon (IFN) gene expression, and the recruitment of macrophages that surround the hair follicles and initiate their destruction. These findings reveal a previously unsuspected role for cholesterol precursors in PCA pathogenesis and identify a novel link between sterols and inflammation that may prove transformative in the diagnosis and treatment of these disorders.	[Panicker, Sreejith P.; Ganguly, Taneeta; Consolo, Mary; Price, Vera; Mirmirani, Paradi; Honda, Kord; Karnik, Pratima] Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Panicker, SP (corresponding author), Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA.	psk11@case.edu		Consolo, Mary/0000-0002-9095-5913	National Institutes of Health (NIH) [R01 AR056245]; National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) [P30 AR039750]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056245, P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the following grants: National Institutes of Health (NIH) R01 AR056245 to Dr. Karnik and P30 AR039750 from National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) http://www.niams.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, Tanpakushitsu Kakusan Koso, V46, P562; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Baker AD, 2010, BIOCHEM BIOPH RES CO, V393, P682, DOI 10.1016/j.bbrc.2010.02.056; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Evers BM, 2010, J INVEST DERMATOL, V130, P1237, DOI 10.1038/jid.2009.442; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Harii N, 2005, MOL ENDOCRINOL, V19, P1231, DOI 10.1210/me.2004-0100; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Jiang YJ, 2010, J LIPID RES, V51, P3185, DOI 10.1194/jlr.M006445; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Lee WS, 2011, J DERMATOL SCI, V64, P153, DOI 10.1016/j.jdermsci.2011.08.004; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; Mirmirani P, 2005, J AM ACAD DERMATOL, V52, P637, DOI 10.1016/j.jaad.2004.07.069; Mirmirani P, 2009, ARCH DERMATOL, V145, P1363, DOI 10.1001/archdermatol.2009.283; Mobini N, 2005, J CUTAN PATHOL, V32, P675, DOI 10.1111/j.0303-6987.2005.00399.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Otberg Nina, 2008, Skinmed, V7, P19, DOI 10.1111/j.1540-9740.2007.07163.x; Pasolli HA, 2011, MICROSC MICROANAL, V17, P513, DOI 10.1017/S1431927611000419; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Price VH, 2006, SEMIN CUTAN MED SURG, V25, P56, DOI 10.1016/j.sder.2006.01.008; Prummel MF, 2003, THYROID, V13, P547, DOI 10.1089/105072503322238809; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Stenn KS, 1999, ARCH DERMATOL, V135, P973, DOI 10.1001/archderm.135.8.973; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stenn KS, 2010, J INVEST DERMATOL, V130, P1205, DOI 10.1038/jid.2010.52; Thurlings RM, 2010, ARTHRITIS RHEUM-US, V62, P3607, DOI 10.1002/art.27702; Tiede S, 2007, EUR J CELL BIOL, V86, P355, DOI 10.1016/j.ejcb.2007.03.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uematsu Satoshi, 2008, V183, P1; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014	47	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38449	10.1371/journal.pone.0038449	http://dx.doi.org/10.1371/journal.pone.0038449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685570	gold, Green Published			2022-12-25	WOS:000305351700033
J	Tollis, M; Ausubel, G; Ghimire, D; Boissinot, S				Tollis, Marc; Ausubel, Gavriel; Ghimire, Dhruba; Boissinot, Stephane			Multi-Locus Phylogeographic and Population Genetic Analysis of Anolis carolinensis: Historical Demography of a Genomic Model Species	PLOS ONE			English	Article							ADAPTIVE RADIATION; BAYESIAN-INFERENCE; STATISTICAL-METHOD; LIZARD; SPECIATION; SOFTWARE; FRAGMENTATION; DIVERGENCE; EXPANSION; CLUSTERS	The green anole (Anolis carolinensis) has been widely used as an animal model in physiology and neurobiology but has recently emerged as an important genomic model. The recent sequencing of its genome has shed new light on the evolution of vertebrate genomes and on the process that govern species diversification. Surprisingly, the patterns of genetic diversity within natural populations of this widespread and abundant North American lizard remain relatively unknown. In the present study, we use 10 novel nuclear DNA sequence loci (N = 62 to 152) and one mitochondrial locus (N = 226) to delimit green anole populations and infer their historical demography. We uncovered four evolutionarily distinct and geographically restricted lineages of green anoles using phylogenetics, Bayesian clustering, and genetic distance methods. Molecular dating indicates that these lineages last shared a common ancestor similar to 2 million years ago. Summary statistics and analysis of the frequency distributions of DNA polymorphisms strongly suggest range-wide expansions in population size. Using Bayesian Skyline Plots, we inferred the timing of population size expansions, which differ across lineages, and found evidence for a relatively recent and rapid westward expansion of green anoles across the Gulf Coastal Plain during the mid-Pleistocene. One surprising result is that the distribution of genetic diversity is not consistent with a latitudinal shift caused by climatic oscillations as is observed for many co-distributed taxa. This suggests that the most recent Pleistocene glacial cycles had a limited impact on the geographic distribution of the green anole at the northern limits of its range.	[Tollis, Marc; Ausubel, Gavriel; Ghimire, Dhruba; Boissinot, Stephane] CUNY, Queens Coll, Dept Biol, Flushing, NY USA; [Tollis, Marc; Boissinot, Stephane] CUNY, Grad Ctr, Biol Program Ecol Evolutionary Biol & Behav, New York, NY 10021 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Tollis, M (corresponding author), CUNY, Queens Coll, Dept Biol, Flushing, NY USA.	stephane.boissinot@qc.cuny.edu	Tollis, Marc/AAX-2332-2020	Tollis, Marc/0000-0002-1917-2473; Boissinot, Stephane/0000-0002-8760-1284	PSC-CUNY [61542-00-39]; NIH [R15GM096267-01]; CUNY; American Museum of Natural History; City University of New York High Performance Computing Center under NSF [CNS-0855217, CNS-0958379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096267] Funding Source: NIH RePORTER	PSC-CUNY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUNY; American Museum of Natural History; City University of New York High Performance Computing Center under NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by PSC-CUNY grant 61542-00-39 and NIH grant R15GM096267-01 awarded to Stephane Boissinot. Funding for fieldwork was provided by a Doctoral Student Research Grant from CUNY and a Theodore Roosevelt Memorial Grant from the American Museum of Natural History awarded to Marc Tollis. Analyses were conducted in part with a grant of computer time by the City University of New York High Performance Computing Center under NSF grants CNS-0855217 and CNS-0958379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avise JC, 2000, PHYLOGEOGRAPHY HIST, Vviii, P447; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Church SA, 2003, EVOLUTION, V57, P372; Conant R, 1998, FIELD GUIDE REPTILES, Vxviii; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DRUMMOND AJ, 2010, GENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2011, CONSERVATION GENETIC; Eckalbar WL, 2012, DEV BIOL, V363, P308, DOI 10.1016/j.ydbio.2011.11.021; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fu YX, 1997, GENETICS, V147, P915; Fujita MK, 2011, GENOME BIOL EVOL, V3, P974, DOI 10.1093/gbe/evr072; Glor RE, 2005, MOL ECOL, V14, P2419, DOI 10.1111/j.1365-294X.2005.02550.x; Glor RE, 2004, P ROY SOC B-BIOL SCI, V271, P2257, DOI 10.1098/rspb.2004.2819; Gratz R, 1972, THESIS U NOTRE DAME; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holman J.A., 1995, PLEISTOCENE AMPHIBIA; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Janes DE, 2010, ANNU REV GENOM HUM G, V11, P239, DOI 10.1146/annurev-genom-082509-141646; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-90; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Losos JB, 2009, LIZARDS EVOLUTIONARY, Vxx; Lovern MB, 2004, ILAR J, V45, P54, DOI 10.1093/ilar.45.1.54; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Orozco-terWengel P, 2011, MOL ECOL, V20, P1108, DOI 10.1111/j.1365-294X.2010.04990.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2001, TRACER V1 4 MOL EVOL; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider CJ, 2008, INTEGR COMP BIOL, V48, P520, DOI 10.1093/icb/icn082; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smit A, 1996, REPEATMASKER OPEN 30; Sokal RR, 1995, BIOMETRY PRINCIPLES, pXIX; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; VANCE T, 1991, Bulletin of the Maryland Herpetological Society, V27, P43; WADE JK, 1983, COPEIA, P523; Walker D, 1998, ANNU REV ECOL SYST, V29, P23, DOI 10.1146/annurev.ecolsys.29.1.23; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Wood DA, 2011, MOL ECOL, V20, P3856, DOI 10.1111/j.1365-294X.2011.05211.x; Zamudio KR, 2003, EVOLUTION, V57, P1631	61	37	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38474	10.1371/journal.pone.0038474	http://dx.doi.org/10.1371/journal.pone.0038474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685573	Green Published, gold			2022-12-25	WOS:000305351700036
J	Matsuyoshi, D; Ikeda, T; Sawamoto, N; Kakigi, R; Fukuyama, H; Osaka, N				Matsuyoshi, Daisuke; Ikeda, Takashi; Sawamoto, Nobukatsu; Kakigi, Ryusuke; Fukuyama, Hidenao; Osaka, Naoyuki			Differential Roles for Parietal and Occipital Cortices in Visual Working Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; NEURAL MECHANISMS; PREFRONTAL CORTEX; INTRAPARIETAL SULCUS; OBJECT IDENTITY; ATTENTION; CAPACITY; INFORMATION; BRAIN	Visual working memory (VWM) is known as a highly capacity-limited cognitive system that can hold 3-4 items. Recent studies have demonstrated that activity in the intraparietal sulcus (IPS) and occipital cortices correlates with the number of representations held in VWM. However, differences among those regions are poorly understood, particularly when task-irrelevant items are to be ignored. The present fMRI-based study investigated whether memory load-sensitive regions such as the IPS and occipital cortices respond differently to task-relevant information. Using a change detection task in which participants are required to remember pre-specified targets, here we show that while the IPS exhibited comparable responses to both targets and distractors, the dorsal occipital cortex manifested significantly weaker responses to an array containing distractors than to an array containing only targets, despite that the number of objects presented was the same for the two arrays. These results suggest that parietal and occipital cortices engage differently in distractor processing and that the dorsal occipital, rather than parietal, activity appears to reflect output of stimulus filtering and selection based on behavioral relevance.	[Matsuyoshi, Daisuke; Ikeda, Takashi; Osaka, Naoyuki] Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Kyoto, Japan; [Matsuyoshi, Daisuke; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Matsuyoshi, Daisuke; Ikeda, Takashi] Osaka Univ, Dept Psychol, Grad Sch Human Sci, Suita, Osaka, Japan; [Sawamoto, Nobukatsu; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Sakyo Ku, Kyoto, Japan; [Kakigi, Ryusuke] Grad Univ Adv Studies, Dept Physiol Sci, Hayama, Kanagawa, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University; Kyoto University; Graduate University for Advanced Studies - Japan	Matsuyoshi, D (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Kyoto, Japan.	matsuyoshi@hus.osaka-u.ac.jp	Fukuyama, Hidenao/AAI-7118-2020; Sawamoto, Nobukatsu/W-2220-2019	Sawamoto, Nobukatsu/0000-0001-8695-0223	Osaka University Global Center of Excellence Program (Center of Human-friendly Robotics Based on Cognitive Neuroscience), Ministry of Education, Culture, Sports and Technology of Japan; Kyoto University Global Center of Excellence Program (Revitalizing Education for Dynamic Hearts and Minds), Ministry of Education, Culture, Sports and Technology of Japan; Hoso Bunka Foundation; Japan Society for the Promotion of Science [23700315, 22220003]; Grants-in-Aid for Scientific Research [23700315] Funding Source: KAKEN	Osaka University Global Center of Excellence Program (Center of Human-friendly Robotics Based on Cognitive Neuroscience), Ministry of Education, Culture, Sports and Technology of Japan; Kyoto University Global Center of Excellence Program (Revitalizing Education for Dynamic Hearts and Minds), Ministry of Education, Culture, Sports and Technology of Japan; Hoso Bunka Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by grants from the Osaka University Global Center of Excellence Program (Center of Human-friendly Robotics Based on Cognitive Neuroscience), Ministry of Education, Culture, Sports and Technology of Japan to DM http://www.gcoe-cnr.osaka-u.ac.jp/; the Kyoto University Global Center of Excellence Program (Revitalizing Education for Dynamic Hearts and Minds), Ministry of Education, Culture, Sports and Technology of Japan to DM and NO. http://www.educ.kyoto-u.ac.jp/gcoe/; Hoso Bunka Foundation Assistance Grants to DM. http://www.hbf.or.jp/; and Grant-in-aid for Scientific Research #23700315 to DM and #22220003 to NO from the Japan Society for the Promotion of Science http://www.jsps.go.jp/. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Bettencourt KC, 2011, J VISION, V11, DOI 10.1167/11.10.22; Caplovitz GP, 2007, CEREB CORTEX, V17, P1179, DOI 10.1093/cercor/bhl029; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2011, NEUROPSYCHOLOGIA, V49, P1401, DOI 10.1016/j.neuropsychologia.2011.01.035; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Cusack R, 2010, J COGNITIVE NEUROSCI, V22, P32, DOI 10.1162/jocn.2009.21194; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fougnie D, 2006, PSYCHOL SCI, V17, P526, DOI 10.1111/j.1467-9280.2006.01739.x; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Gao ZF, 2011, BRAIN RES, V1406, P30, DOI 10.1016/j.brainres.2011.06.049; Gloor P, 1975, Adv Neurol, V8, P59; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Harrison A, 2010, CEREB CORTEX, V20, P2478, DOI 10.1093/cercor/bhp314; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Matsuyoshi D, 2010, NEUROPSYCHOLOGIA, V48, P3094, DOI 10.1016/j.neuropsychologia.2010.06.021; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Miller EK, 1996, J NEUROSCI, V16, P5154; Mitchell DJ, 2008, CEREB CORTEX, V18, P1788, DOI 10.1093/cercor/bhm205; Olson IR, 2008, MEM COGNITION, V36, P1360, DOI 10.3758/MC.36.7.1360; Ploner CJ, 2001, EUR J NEUROSCI, V13, P357, DOI 10.1046/j.1460-9568.2001.01397.x; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Robitaille N, 2010, NEUROIMAGE, V53, P1334, DOI 10.1016/j.neuroimage.2010.07.027; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Schira MM, 2004, J NEUROPHYSIOL, V91, P1716, DOI 10.1152/jn.00380.2003; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Talairach J., 1988, COPLANAR STEREOTAXIC; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Vandenberghe R, 2005, BRAIN, V128, P2843, DOI 10.1093/brain/awh522; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; Xu YD, 2010, J NEUROSCI, V30, P14020, DOI 10.1523/JNEUROSCI.3011-10.2010; Xu YD, 2009, J COGNITIVE NEUROSCI, V21, P511, DOI 10.1162/jocn.2008.21024; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	54	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38623	10.1371/journal.pone.0038623	http://dx.doi.org/10.1371/journal.pone.0038623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679514	Green Published, gold			2022-12-25	WOS:000305343900062
J	Tello, JA; Newton, CL; Bouligand, J; Guiochon-Mantel, A; Millar, RP; Young, J				Tello, Javier A.; Newton, Claire L.; Bouligand, Jerome; Guiochon-Mantel, Anne; Millar, Robert P.; Young, Jacques			Congenital Hypogonadotropic Hypogonadism Due to GNRH Receptor Mutations in Three Brothers Reveal Sites Affecting Conformation and Coupling	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GENE; ACTIVATION; BINDING; RESISTANCE; AGONIST; DEFICIENCY; RHODOPSIN; PROTEINS; ETIOLOGY	Congenital hypogonadotropic hypogonadism (CHH) is characterized by low gonadotropins and failure to progress normally through puberty. Mutations in the gene encoding the GnRH receptor (GNRHR1) result in CHH when present as compound heterozygous or homozygous inactivating mutations. This study identifies and characterizes the properties of two novel GNRHR1 mutations in a family in which three brothers display normosmic CHH while their sister was unaffected. Molecular analysis in the proband and the affected brothers revealed two novel non-synonymous missense GNRHR1 mutations, present in a compound heterozygous state, whereas their unaffected parents possessed only one inactivating mutation, demonstrating the autosomal recessive transmission in this kindred and excluding X-linked inheritance equivocally suggested by the initial pedigree analysis. The first mutation at c.845 C>G introduces an Arg substitution for the conserved Pro 282 in transmembrane domain (TMD) 6. The Pro282Arg mutant is unable to bind radiolabeled GnRH analogue. As this conserved residue is important in receptor conformation, it is likely that the mutation perturbs the binding pocket and affects trafficking to the cell surface. The second mutation at c.968 A>G introduces a Cys substitution for Tyr 323 in the functionally crucial N/DPxxY motif in TMD 7. The Tyr323Cys mutant has an increased GnRH binding affinity but reduced receptor expression at the plasma membrane and impaired G protein-coupling. Inositol phosphate accumulation assays demonstrated absent and impaired G alpha(q/11) signal transduction by Pro282Arg and Tyr323Cys mutants, respectively. Pretreatment with the membrane permeant GnRHR antagonist NBI-42902, which rescues cell surface expression of many GNRHR1 mutants, significantly increased the levels of radioligand binding and intracellular signaling of the Tyr323Cys mutant but not Pro282Arg. Immunocytochemistry confirmed that both mutants are present on the cell membrane albeit at low levels. Together these molecular deficiencies of the two novel GNRHR1 mutations lead to the CHH phenotype when present as a compound heterozygote.	[Tello, Javier A.; Newton, Claire L.; Millar, Robert P.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Newton, Claire L.; Millar, Robert P.] Univ Cape Town, MRC, Receptor Biol Unit, ZA-7925 Cape Town, South Africa; [Bouligand, Jerome; Guiochon-Mantel, Anne; Young, Jacques] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Bouligand, Jerome; Guiochon-Mantel, Anne; Young, Jacques] INSERM, U693, IFR93, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Guiochon-Mantel, Anne] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Young, Jacques] Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	University of Edinburgh; University of Cape Town; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Pretoria	Tello, JA (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	robertpetermillar@gmail.com; jacques.young@bct.aphp.fr	Newton, Claire L/B-7114-2011; Newton, Claire/R-1783-2019; Guiochon-Mantel, Anne S/S-8408-2018; Tello, Javier Ananda A/B-3203-2012; Young, Jacques/T-2976-2018; Young, Jacques/N-5251-2019; BOULIGAND, Jérôme/S-5716-2018; Newton, Claire/AAC-4663-2019	Newton, Claire L/0000-0001-6050-556X; Newton, Claire/0000-0001-6050-556X; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Tello, Javier Ananda A/0000-0001-6637-2155; Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; Millar, Robert P/0000-0003-3606-2708	Medical Research Council, UK; Universite Paris-Sud (Bonus Qualite Recherche); Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche Genopath (ANR KALGENOPATH); Fondation pour la Recherche Medicale (FRM); Programme Hospitalier de Recherche Clinique (PHRC)	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universite Paris-Sud (Bonus Qualite Recherche); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche Genopath (ANR KALGENOPATH)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Programme Hospitalier de Recherche Clinique (PHRC)	The work was supported by the Medical Research Council, UK and by institutional grants from Universite Paris-Sud (Bonus Qualite Recherche), Institut National de la Sante et de la Recherche Medicale (INSERM), Agence Nationale de la Recherche Genopath (ANR KALGENOPATH), Fondation pour la Recherche Medicale (FRM), Programme Hospitalier de Recherche Clinique (PHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelli A, 2006, EUR J ENDOCRINOL, V155, P201, DOI 10.1530/eje.1.02198; Arora KK, 1996, MOL ENDOCRINOL, V10, P979, DOI 10.1210/me.10.8.979; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 1995, METHODS NEUROSCIENCE, DOI [10.1016/S1043-9471(05, DOI 10.1016/S1043-9471(05]; Bedecarrats GY, 2003, MOL CELL ENDOCRINOL, V205, P51, DOI 10.1016/S0303-7207(03)00201-6; Beranova M, 2001, J CLIN ENDOCR METAB, V86, P1580, DOI 10.1210/jc.86.4.1580; Bhattacharya S, 2008, J MOL BIOL, V382, P539, DOI 10.1016/j.jmb.2008.06.084; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Bouvattier C, 2012, NAT REV ENDOCRINOL, V8, P172, DOI 10.1038/nrendo.2011.164; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Caron P, 1999, J CLIN ENDOCR METAB, V84, P990, DOI 10.1210/jc.84.3.990; Chengalvala M, 1999, J BIOCHEM BIOPH METH, V38, P163, DOI 10.1016/S0165-022X(98)00046-3; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Costa EMF, 2001, J CLIN ENDOCR METAB, V86, P2680, DOI 10.1210/jc.86.6.2680; De Roux N, 1999, J CLIN ENDOCR METAB, V84, P567, DOI 10.1210/jc.84.2.567; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Janovick JA, 2010, P NATL ACAD SCI USA, V107, P4454, DOI 10.1073/pnas.0914261107; Karges B, 2003, J CLIN ENDOCR METAB, V88, P1873, DOI 10.1210/jc.2002-020005; Kottler ML, 2000, J CLIN ENDOCR METAB, V85, P3002, DOI 10.1210/jc.85.9.3002; Kottler ML, 1999, ARCH MED RES, V30, P481, DOI 10.1016/S0188-4409(99)00072-7; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; Layman LC, 2001, FERTIL STERIL, V75, P1148, DOI 10.1016/S0015-0282(01)01782-4; Leanos-Miranda A, 2002, J CLIN ENDOCR METAB, V87, P4825, DOI 10.1210/jc.2002-020961; Lu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200; Lu ZL, 2005, J BIOL CHEM, V280, P29796, DOI 10.1074/jbc.M413520200; Maya-Nunez G, 2002, J CLIN ENDOCR METAB, V87, P2144, DOI 10.1210/jc.87.5.2144; Meysing AU, 2004, J CLIN ENDOCR METAB, V89, P3189, DOI 10.1210/jc.2003-031808; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Morgan K, 2006, ENDOCRINOLOGY, V147, P5041, DOI 10.1210/en.2006-0222; Oliveira L, 1999, PROTEIN ENG, V12, P1087, DOI 10.1093/protein/12.12.1087; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pralong FP, 1999, J CLIN ENDOCR METAB, V84, P3811, DOI 10.1210/jc.84.10.3811; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Salenave S, 2008, J CLIN ENDOCR METAB, V93, P758, DOI 10.1210/jc.2007-1168; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Silveira LFG, 2002, J CLIN ENDOCR METAB, V87, P2973, DOI 10.1210/jc.87.6.2973; Soderlund D, 2001, CLIN ENDOCRINOL, V54, P493, DOI 10.1046/j.1365-2265.2001.01211.x; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Tabarin A, 2000, J CLIN INVEST, V105, P321, DOI 10.1172/JCI7212; Topaloglu AK, 2006, NEUROENDOCRINOLOGY, V84, P301, DOI 10.1159/000098147; Trabado S, 2011, FERTIL STERIL, V95, P2324, DOI 10.1016/j.fertnstert.2011.03.091; Vagenakis GA, 2005, FERTIL STERIL, V84, P1762, DOI 10.1016/j.fertnstert.2005.06.031; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38456	10.1371/journal.pone.0038456	http://dx.doi.org/10.1371/journal.pone.0038456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679506	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900044
J	James, MA; Wen, WD; Wang, YA; Byers, LA; Heymach, JV; Coombes, KR; Girard, L; Minna, J; You, M				James, Michael A.; Wen, Weidong; Wang, Yian; Byers, Lauren A.; Heymach, John V.; Coombes, Kevin R.; Girard, Luc; Minna, John; You, Ming			Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus	PLOS ONE			English	Article							CELL-DEATH; SUSCEPTIBILITY; BCL-X(L); EXPRESSION; APOPTOSIS; VARIANTS; INHIBITOR; CARCINOMA; ASSOCIATE; FAMILY	Cleft Lip and Palate Transmembrane Protein 1-Like (CLPTM1L), resides in a region of chromosome 5 for which copy number gain has been found to be the most frequent genetic event in the early stages of non-small cell lung cancer (NSCLC). This locus has been found by multiple genome wide association studies to be associated with lung cancer in both smokers and non-smokers. CLPTM1L has been identified as an overexpressed protein in human ovarian tumor cell lines that are resistant to cisplatin, which is the only insight thus far into the function of CLPTM1L. Here we find CLPTM1L expression to be increased in lung adenocarcinomas compared to matched normal lung tissues and in lung tumor cell lines by mechanisms not exclusive to copy number gain. Upon loss of CLPTM1L accumulation in lung tumor cells, cisplatin and camptothecin induced apoptosis were increased in direct proportion to the level of CLPTM1L knockdown. Bcl-xL accumulation was significantly decreased upon loss of CLPTM1L. Expression of exogenous Bcl-xL abolished sensitization to apoptotic killing with CLPTM1L knockdown. These results demonstrate that CLPTM1L, an overexpressed protein in lung tumor cells, protects from genotoxic stress induced apoptosis through regulation of Bcl-xL. Thus, this study implicates anti-apoptotic CLPTM1L function as a potential mechanism of susceptibility to lung tumorigenesis and resistance to chemotherapy.	[James, Michael A.; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, MCW Canc Ctr, Milwaukee, WI 53226 USA; [Wen, Weidong; Wang, Yian] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Byers, Lauren A.; Heymach, John V.; Coombes, Kevin R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Girard, Luc; Minna, John] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	Medical College of Wisconsin; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	James, MA (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, MCW Canc Ctr, Milwaukee, WI 53226 USA.	myou@mcw.edu	Heymach, John/AAG-2361-2019; James, Michael/L-7772-2019	Heymach, John/0000-0001-9068-8942; James, Michael/0000-0002-8112-1108; Coombes, Kevin/0000-0002-7630-2123	NCI Cancer Center [P30 CA91842]; Human Protein Atlas project; NCI [U19CA148127]; Knut and Alice Wallenberg Foundation; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA091842, U19CA148127] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Human Protein Atlas project; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by an NCI Cancer Center Support Grant #P30 CA91842, the Human Protein Atlas project, and NCI U19CA148127 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Julie DiMitry for assistance with flow cytometry experiments as well as Peter Vedell and Pengyuan Liu for advice on statistical methods. We would like to thank Haris Vikis and Jay Tichelaar for their discussion and comments on the manuscript. We thank the Tissue Procurement Core at Washington University and the Siteman Cancer Center for providing patient RNA and DNA samples, and the Human Protein Atlas project, funded by the Knut and Alice Wallenberg Foundation, for compiling protein expression profiles and annotated IHC images.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Hajji N, 2008, ONCOGENE, V27, P3134, DOI 10.1038/sj.onc.1210976; Ikuta K, 2005, ONCOL REP, V13, P1229; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Jourdain A, 2009, INT J BIOCHEM CELL B, V41, P1884, DOI 10.1016/j.biocel.2009.05.001; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Lei XY, 2007, ACTA BIOCH BIOPH SIN, V39, P344, DOI 10.1111/j.1745-7270.2007.00286.x; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; MIRABELLO L, 2010, HUM MUTAT; Morais C, 2010, APOPTOSIS, V15, P412, DOI 10.1007/s10495-009-0414-y; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Pooley KA, 2010, CANC EPIDEMIOL BIOMA; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; SCHOTT AF, 1995, ONCOGENE, V11, P1389; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Taylor JK, 1999, ONCOGENE, V18, P4495, DOI 10.1038/sj.onc.1202836; Turnbull C, 2010, NAT GENET; Varin E, 2010, CARCINOGENESIS, V31, P984, DOI 10.1093/carcin/bgq026; Vazquez-Mena O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032667; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	30	77	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36116	10.1371/journal.pone.0036116	http://dx.doi.org/10.1371/journal.pone.0036116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675468	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700004
J	Singh, M; Singh, P; Gaudray, G; Musumeci, L; Thielen, C; Vaira, D; Vandergeeten, C; Delacroix, L; Van Gulck, E; Vanham, G; de Leval, L; Rahmouni, S; Moutschen, M				Singh, Maneesh; Singh, Pratibha; Gaudray, Gilles; Musumeci, Lucia; Thielen, Caroline; Vaira, Dolores; Vandergeeten, Claire; Delacroix, Laurence; Van Gulck, Ellen; Vanham, Guido; de Leval, Laurence; Rahmouni, Souad; Moutschen, Michel			An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2R gamma(NULL) Mice Allows HIV Replication and Development of Anti-HIV Immune Responses	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; HUMANIZED MICE; T-CELLS; INFECTION; EXPRESSION; MOUSE; TRANSMISSION; LYMPHOCYTES; DEPLETION	Cord blood hematopoietic progenitor cells (CB-HPCs) transplanted immunodeficient NOD/LtsZ-scidIL2R gamma(null) (NSG) and NOD/SCID/IL2R gamma(null) (NOG) mice need efficient human cell engraftment for long-term HIV-1 replication studies. Total body irradiation (TBI) is a classical myeloablation regimen used to improve engraftment levels of human cells in these humanized mice. Some recent reports suggest the use of busulfan as a myeloablation regimen to transplant HPCs in neonatal and adult NSG mice. In the present study, we further ameliorated the busulfan myeloablation regimen with fresh CB-CD34+cell transplantation in 3-4 week old NSG mice. In this CB-CD34+transplanted NSG mice engraftment efficiency of human CD45+cell is over 90% in peripheral blood. Optimal engraftment promoted early and increased CD3+T cell levels, with better lymphoid tissue development and prolonged human cell chimerism over 300 days. These humanized NSG mice have shown long-lasting viremia after HIV-1JRCSF and HIV-1Bal inoculation through intravenous and rectal routes. We also saw a gradual decline of the CD4+T cell count, widespread immune activation, up-regulation of inflammation marker and microbial translocation after HIV-1 infection. Humanized NSG mice reconstituted according to our new protocol produced, moderate cellular and humoral immune responses to HIV-1 postinfection. We believe that NSG mice reconstituted according to our easy to use protocol will provide a better in vivo model for HIV-1 replication and anti-HIV-1 therapy trials.	[Singh, Maneesh; Singh, Pratibha; Gaudray, Gilles; Musumeci, Lucia; Vandergeeten, Claire; Delacroix, Laurence; Rahmouni, Souad; Moutschen, Michel] Univ Liege, Immunol & Infect Dis Unit GIGA I3, Liege, Belgium; [Thielen, Caroline; de Leval, Laurence] Univ Liege, Expt Pathol Unit GIGA Canc, Liege, Belgium; [Vaira, Dolores] Univ Liege, Liege AIDS Reference Ctr, Liege, Belgium; [Van Gulck, Ellen; Vanham, Guido] Univ Antwerp, Inst Trop Med, Virol Unit, Antwerp, Belgium	University of Liege; University of Liege; University of Liege; Institute of Tropical Medicine (ITM); University of Antwerp	Singh, M (corresponding author), Univ Liege, Immunol & Infect Dis Unit GIGA I3, Liege, Belgium.	michel.moutschen@ulg.ac.be	de Leval, Laurence/M-4889-2017; Singh, Pratibha/AAI-6066-2020; Singh, Pratibha/AAD-5680-2020	de Leval, Laurence/0000-0003-3994-516X; Singh, Pratibha/0000-0002-6919-8479; Moutschen, Michel/0000-0002-6405-1785; Delacroix, Laurence/0000-0003-3440-5359	Interuniversity Attraction Poles; Belgian National Fund for Scientific Research (FRS-FNRS); University of Liege	Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Belgian National Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege)	This work was supported by grants from The Interuniversity Attraction Poles, The Belgian National Fund for Scientific Research (FRS-FNRS) and The University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKINA RK, 1994, BLOOD, V84, P1393; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Choi B, 2011, J CLIN IMMUNOL, V31, P253, DOI 10.1007/s10875-010-9478-2; Choi B, 2011, CLIN IMMUNOL, V139, P321, DOI 10.1016/j.clim.2011.02.019; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; De Boer F, 1998, BONE MARROW TRANSPL, V22, P1103, DOI 10.1038/sj.bmt.1701495; Douek Daniel, 2007, Top HIV Med, V15, P114; FRANSEN K, 1994, MOL CELL PROBE, V8, P317, DOI 10.1006/mcpr.1994.1043; FRASER CC, 1995, BLOOD, V86, P1680, DOI 10.1182/blood.V86.5.1680.bloodjournal8651680; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; Hofer U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000867; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kim M, 2011, J CLIN IMMUNOL, V31, P699, DOI 10.1007/s10875-011-9538-2; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Long BR, 2012, J VIROL; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; MOSS GB, 1995, J INFECT DIS, V172, P1469, DOI 10.1093/infdis/172.6.1469; Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pflumio F, 1996, BLOOD, V88, P3731, DOI 10.1182/blood.V88.10.3731.bloodjournal88103731; PIWOWAR EM, 1995, CLIN DIAGN LAB IMMUN, V2, P236, DOI 10.1128/CDLI.2.2.236-237.1995; Schmidt MR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003192; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Sparrow RL, 2006, BONE MARROW TRANSPL, V38, P61, DOI 10.1038/sj.bmt.1705405; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050	35	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38491	10.1371/journal.pone.0038491	http://dx.doi.org/10.1371/journal.pone.0038491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675567	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700079
J	Collin, GB; Marshall, JD; King, BL; Milan, G; Maffei, P; Jagger, DJ; Naggert, JK				Collin, Gayle B.; Marshall, Jan D.; King, Benjamin L.; Milan, Gabriella; Maffei, Pietro; Jagger, Daniel J.; Naggert, Jurgen K.			The Alstrom Syndrome Protein, ALMS1, Interacts with alpha-Actinin and Components of the Endosome Recycling Pathway	PLOS ONE			English	Article							MYOSIN VB; CLEAVAGE FURROW; CYTOKINESIS; CILIOGENESIS; RAB11; LOCALIZATION; TRAFFICKING; CENTROSOME; MECHANISMS; OBESITY	Alstrom syndrome (ALMS) is a progressive multi-systemic disorder characterized by cone-rod dystrophy, sensorineural hearing loss, childhood obesity, insulin resistance and cardiac, renal, and hepatic dysfunction. The gene responsible for Alstrom syndrome, ALMS1, is ubiquitously expressed and has multiple splice variants. The protein encoded by this gene has been implicated in ciliary function, cell cycle control, and intracellular transport. To gain better insight into the pathways through which ALMS1 functions, we carried out a yeast two hybrid (Y2H) screen in several mouse tissue libraries to identify ALMS1 interacting partners. The majority of proteins found to interact with the murine carboxy-terminal end (19/32) of ALMS1 were alpha-actinin isoforms. Interestingly, several of the identified ALMS1 interacting partners (alpha-actinin 1, alpha-actinin 4, myosin Vb, rad50 interacting 1 and huntingtin associated protein1A) have been previously associated with endosome recycling and/or centrosome function. We examined dermal fibroblasts from human subjects bearing a disruption in ALMS1 for defects in the endocytic pathway. Fibroblasts from these patients had a lower uptake of transferrin and reduced clearance of transferrin compared to controls. Antibodies directed against ALMS1 N- and C-terminal epitopes label centrosomes and endosomal structures at the cleavage furrow of dividing MDCK cells, respectively, suggesting isoform-specific cellular functions. Our results suggest a role for ALMS1 variants in the recycling endosome pathway and give us new insights into the pathogenesis of a subset of clinical phenotypes associated with ALMS.	[Collin, Gayle B.; Marshall, Jan D.; King, Benjamin L.; Naggert, Jurgen K.] Jackson Lab, Bar Harbor, ME 04609 USA; [King, Benjamin L.] Mt Desert Isl Biol Lab, Salisbury, ME USA; [Milan, Gabriella; Maffei, Pietro] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Jagger, Daniel J.] UCL, UCL Ear Inst, London, England	Jackson Laboratory; Mount Desert Island Biological Laboratory; University of Padua; University of London; University College London	Collin, GB (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	juergen.naggert@jax.org	King, Benjamin/AAI-1492-2019; Jagger, Daniel/Q-3466-2019; Milan, Gabriella/AAB-6234-2022; Maffei, Pietro/O-1878-2013	Jagger, Daniel/0000-0003-2796-5526; Milan, Gabriella/0000-0001-8987-5310; King, Benjamin/0000-0001-6463-1336; Maffei, Pietro/0000-0002-1717-263X; Johnson, Colin/0000-0002-2979-8234	National Institutes of Health [HD036878]; Royal Society University Research Fellowship [516002.K5746.KK]; Executive Agency for Health and Consumer (EAHC), EURO-WABB [2010 12 05];  [CA34196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036878] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research Fellowship(Royal Society of London); Executive Agency for Health and Consumer (EAHC), EURO-WABB; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JKN, GBC, and JDM were supported by a grant from the National Institutes of Health (HD036878). DJ was supported by a Royal Society University Research Fellowship (Grant 516002.K5746.KK). PM and GM were funded by Executive Agency for Health and Consumer (EAHC), EURO-WABB, agreement number 2010 12 05. Core services at The Jackson Laboratory were supported by an institutional grant CA34196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Erkang, 2009, Communicative & Integrative Biology, V2, P444; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Araki N, 2000, J CELL SCI, V113, P3329; Chi RJ, 2008, J BIOL CHEM, V283, P20959, DOI 10.1074/jbc.M709621200; Chi RJ, 2005, INT J BIOCHEM CELL B, V37, P1470, DOI 10.1016/j.biocel.2005.02.014; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; FUJIWARA K, 1978, J CELL BIOL, V79, P268, DOI 10.1083/jcb.79.1.268; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Jagger D, 2011, HUM MOL GENET, V20, P466, DOI 10.1093/hmg/ddq493; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Kremerskothen J, 2002, BIOCHEM BIOPH RES CO, V295, P678, DOI 10.1016/S0006-291X(02)00734-9; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Marshall JD, 2007, HUM MUTAT, V28, P1114, DOI 10.1002/humu.20577; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Millman EE, 2008, TRAFFIC, V9, P1958, DOI 10.1111/j.1600-0854.2008.00813.x; Montagnac G, 2008, BIOCHEM SOC T, V36, P442, DOI 10.1042/BST0360442; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; SAGER PR, 1984, CELL, V39, P275, DOI 10.1016/0092-8674(84)90005-9; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Talior-Volodarsky I, 2008, J BIOL CHEM, V283, P25115, DOI 10.1074/jbc.M801750200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Zulato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019081	41	58	61	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37925	10.1371/journal.pone.0037925	http://dx.doi.org/10.1371/journal.pone.0037925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693585	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500066
J	Brunialti, MKC; Santos, MC; Rigato, O; Machado, FR; Silva, E; Salomao, R				Colo Brunialti, Milena Karina; Santos, Michelle Carolina; Rigato, Otelo; Machado, Flavia Ribeiro; Silva, Eliezer; Salomao, Reinaldo			Increased Percentages of T Helper Cells Producing IL-17 and Monocytes Expressing Markers of Alternative Activation in Patients with Sepsis	PLOS ONE			English	Article							WHOLE-BLOOD; CYTOKINE PRODUCTION; SERUM MARKERS; SEPTIC SHOCK; REQUIREMENT; NEUTROPHILS; BACTEREMIA; GENERATION; MORTALITY; APOPTOSIS	Background: A shift from Th1 to Th2 as well as an increase in Treg CD4+T cell subsets has been reported in septic patients (SP). Furthermore, these patients display modulation of monocyte function, with reduced production of pro-inflammatory cytokines upon LPS stimulus, which resembles the phenotype of alternatively activated macrophages. In this study, we evaluated the percentages of T cells differentiated into Th1, Th17 and Treg subsets, as well as the percentage of monocytes expressing markers of alternatively activated monocytes/macrophages (AAM) in SP. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMC) were obtained from 32 healthy volunteers (HV) and from SP at admission (D0, n=67) and after 7 days of therapy (D7, n=33). Th1 and Th17 (CD3+CD8-) lymphocytes were identified by the intracellular detection of IFN-gamma and IL-17, respectively, spontaneously and after PMA/Io stimulation, and Treg cells were identified by Foxp3+CD127-expression. Monocytes were evaluated for CD206 and CD163 expression. Absolute numbers of CD4+T lymphocytes were measured in whole blood samples by flow cytometry. The Mann-Whitney or Wilcoxon test was applied, as appropriate. The percentage of Th1 cells was lower in SP than in HV at admission after PMA/Io stimulation, whereas the percentage of Th17 cells was higher. In patients' follow-up samples, a higher percentage of Th1 cells and a lower percentage of Th17 cells were observed on D7 compared with the D0 samples. Treg cells remained unchanged. Septic patients showed a markedly increased proportion of monocytes expressing CD163 and CD206. Conclusions/Significance: Upon in vitro stimulus, the percentage of T helper lymphocytes producing IL-17 was higher in SP than in HV at admission, and the percentage producing IFN-gamma was lower, a pattern that was reversed during follow-up. The increased expression of CD163 and CD206 indicates that monocytes may acquire the AAM phenotype during sepsis.	[Colo Brunialti, Milena Karina; Santos, Michelle Carolina; Rigato, Otelo; Salomao, Reinaldo] Univ Fed Sao Paulo, Div Infect Dis, Dept Med, Escola Paulista Med,Hosp Sao Paulo, Sao Paulo, Brazil; [Rigato, Otelo] Hosp Sirio Libanes, Crit Care Unit, Sao Paulo, Brazil; [Machado, Flavia Ribeiro] Univ Fed Sao Paulo, Div Anesthesiol, Dept Surg, Escola Paulista Med,Hosp Sao Paulo, Sao Paulo, Brazil; [Silva, Eliezer] Hosp Albert Einstein, Crit Care Unit, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Sirio Libanes; Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein	Brunialti, MKC (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Dept Med, Escola Paulista Med,Hosp Sao Paulo, Sao Paulo, Brazil.	rsalomao@unifesp.br	Machado, Flavia R/G-4651-2012; Brunialti, Milena K C/C-4905-2012; Salomao, Reinaldo/C-6419-2013	Machado, Flavia R/0000-0002-2356-4867; Brunialti, Milena K C/0000-0003-2874-520X; Salomao, Reinaldo/0000-0003-1149-4598	Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP) [2006/58744-1, 2008/07511-2]	Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP - grants 2006/58744-1 and 2008/07511-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Beyer M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/734036; Bingold TM, 2010, SHOCK, V34, P337, DOI 10.1097/SHK.0b013e3181dc07b1; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fernandes ML, 2010, BRAZ J MED BIOL RES, V43, P860, DOI 10.1590/S0100-879X2010000900008; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Groselj-Grenc M, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/202646; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hein F, 2010, CRIT CARE, V14, DOI 10.1186/cc8876; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; LIN RY, 1993, CHEST, V104, P847, DOI 10.1378/chest.104.3.847; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Mendes ME, 2011, IMMUNOBIOLOGY, V216, P285, DOI 10.1016/j.imbio.2010.07.008; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; OSULLIVAN ST, 1995, ANN SURG, V222, P482; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomao R, 2002, J ENDOTOXIN RES, V8, P371, DOI 10.1179/096805102125000704; Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2010, SHOCK, V34, P358, DOI 10.1097/SHK.0b013e3181dc0977; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	53	33	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37393	10.1371/journal.pone.0037393	http://dx.doi.org/10.1371/journal.pone.0037393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693573	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500036
J	Lienhard, D; Lauterburg, M; Escher, G; Frey, FJ; Frey, BM				Lienhard, Daniel; Lauterburg, Meret; Escher, Genevieve; Frey, Felix J.; Frey, Brigitte M.			High Salt Intake Down-Regulates Colonic Mineralocorticoid Receptors, Epithelial Sodium Channels and 11 beta-Hydroxysteroid Dehydrogenase Type 2	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID-INDUCED KINASE; NA+ CHANNEL; RAT COLON; MESSENGER-RNA; DISTAL COLON; SUBCELLULAR-LOCALIZATION; DIFFERENTIAL REGULATION; GENE-EXPRESSION; ENAC SUBUNITS	Besides the kidneys, the gastrointestinal tract is the principal organ responsible for sodium homeostasis. For sodium transport across the cell membranes the epithelial sodium channel (ENaC) is of pivotal relevance. The ENaC is mainly regulated by mineralocorticoid receptor mediated actions. The MR activation by endogenous 11 beta-hydroxy-glucocorticoids is modulated by the 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2). Here we present evidence for intestinal segment specific 11 beta-HSD2 expression and hypothesize that a high salt intake and/or uninephrectomy (UNX) affects colonic 11 beta-HSD2, MR and ENaC expression. The 11 beta-HSD2 activity was measured by means of 3H-corticosterone conversion into 3H-11-dehydrocorticosterone in Sprague Dawley rats on a normal and high salt diet. The activity increased steadily from the ileum to the distal colon by a factor of about 3, an observation in line with the relevance of the distal colon for sodium handling. High salt intake diminished mRNA and protein of 11 beta-HSD2 by about 50% (p<0.001) and reduced the expression of the MR (p<0.01). The functionally relevant ENaC-beta and ENaC-gamma expression, a measure of mineralocorticoid action, diminished by more than 50% by high salt intake (p<0.001). The observed changes were present in rats with and without UNX. Thus, colonic epithelial cells appear to contribute to the protective armamentarium of the mammalian body against salt overload, a mechanism not modulated by UNX.	[Lienhard, Daniel; Lauterburg, Meret; Escher, Genevieve; Frey, Felix J.; Frey, Brigitte M.] Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Frey, Brigitte M.] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Lienhard, D (corresponding author), Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland.	brigitte.frey@dkf.unibe.ch		Escher, Genevieve/0000-0002-5125-2262	Swiss National Foundations for Scientific Research [320030-122135]	Swiss National Foundations for Scientific Research	This work was supported by the Swiss National Foundations for Scientific Research, No 320030-122135 (FJF and BMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Audige A, 2002, EUR J CLIN INVEST, V32, P411, DOI 10.1046/j.1365-2362.2002.01003.x; Bergann T, 2009, BIOCHEM BIOPH RES CO, V382, P280, DOI 10.1016/j.bbrc.2009.03.006; Bhargava A, 2001, ENDOCRINOLOGY, V142, P1587, DOI 10.1210/en.142.4.1587; Coric T, 2004, AM J PHYSIOL-GASTR L, V286, pG663, DOI 10.1152/ajpgi.00364.2003; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Epple HJ, 2000, AM J PHYSIOL-GASTR L, V278, pG718, DOI 10.1152/ajpgi.2000.278.5.G718; EPPLE HJ, 1995, AM J PHYSIOL-GASTR L, V269, pG42, DOI 10.1152/ajpgi.1995.269.1.G42; Escher G, 1998, ENDOCRINOLOGY, V139, P1533, DOI 10.1210/en.139.4.1533; Farese S, 2009, KIDNEY INT, V76, P877, DOI 10.1038/ki.2009.269; Ferrari P, 2001, HYPERTENSION, V38, P1330, DOI 10.1161/hy1101.096112; Frey FJ, 2004, CURR OPIN NEPHROL HY, V13, P451, DOI 10.1097/01.mnh.0000133976.32559.b0; Fukushima K, 2005, SCAND J GASTROENTERO, V40, P850, DOI 10.1080/00365520510015700; Fuller PJ, 2000, PFLUG ARCH EUR J PHY, V441, P94, DOI 10.1007/s004240000366; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Greig ER, 2002, PFLUG ARCH EUR J PHY, V444, P476, DOI 10.1007/s00424-002-0828-7; Hatch M, 2008, AM J PHYSIOL-GASTR L, V295, pG348, DOI 10.1152/ajpgi.00079.2008; Hundertmark S, 2001, HORM METAB RES, V33, P78, DOI 10.1055/s-2001-12429; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Norregaard R, 2003, AM J PHYSIOL-RENAL, V285, pF348, DOI 10.1152/ajprenal.00061.2003; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; Ono S, 1997, PFLUG ARCH EUR J PHY, V434, P756, DOI 10.1007/s004240050462; PACHA J, 1994, LIFE SCI, V54, P745, DOI 10.1016/0024-3205(94)90164-3; Pacha J, 1997, LIFE SCI, V61, P2391, DOI 10.1016/S0024-3205(97)00956-9; Pearce D, 2007, J CLIN INVEST, V117, P592, DOI 10.1172/JCI31538; Petrelli MD, 1997, ENDOCRINOLOGY, V138, P3077, DOI 10.1210/en.138.7.3077; RENARD S, 1995, PFLUG ARCH EUR J PHY, V430, P299, DOI 10.1007/BF00373903; SCHAEFER L, 1995, NEPHROL DIAL TRANSPL, V10, P801; Serra A, 2002, J AM SOC NEPHROL, V13, P191, DOI 10.1681/ASN.V131191; Sheppard KE, 1999, AM J PHYSIOL-GASTR L, V277, pG541, DOI 10.1152/ajpgi.1999.277.3.G541; Sheppard KE, 1998, AM J PHYSIOL-ENDOC M, V275, pE124, DOI 10.1152/ajpendo.1998.275.1.E124; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Smith RE, 1997, ENDOCRINOLOGY, V138, P540, DOI 10.1210/en.138.2.540; Soundararajan R, 2010, J BIOL CHEM, V285, P39905, DOI 10.1074/jbc.M110.161133; Stokes JB, 1998, AM J PHYSIOL-CELL PH, V274, pC1699, DOI 10.1152/ajpcell.1998.274.6.C1699; TOMKINS AM, 1975, GUT, V16, P277, DOI 10.1136/gut.16.4.277; TURNAMIAN SG, 1989, J CLIN INVEST, V84, P1924, DOI 10.1172/JCI114380; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WHORWOOD CB, 1994, ENDOCRINOLOGY, V135, P2533, DOI 10.1210/en.135.6.2533; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; WILL PC, 1985, AM J PHYSIOL, V248, pG124, DOI 10.1152/ajpgi.1985.248.1.G124	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37898	10.1371/journal.pone.0037898	http://dx.doi.org/10.1371/journal.pone.0037898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693583	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500064
J	van Hasselt, FN; de Visser, L; Tieskens, JM; Cornelisse, S; Baars, AM; Lavrijsen, M; Krugers, HJ; van den Bos, R; Joels, M				van Hasselt, Felisa N.; de Visser, Leonie; Tieskens, Jacintha M.; Cornelisse, Sandra; Baars, Annemarie M.; Lavrijsen, Marla; Krugers, Harm J.; van den Bos, Ruud; Joels, Marian			Individual Variations in Maternal Care Early in Life Correlate with Later Life Decision-Making and c-Fos Expression in Prefrontal Subregions of Rats	PLOS ONE			English	Article							IOWA GAMBLING TASK; PITUITARY-ADRENAL RESPONSES; AGRANULAR INSULAR CORTEX; EARLY PARENTAL LOSS; ORBITOFRONTAL CORTEX; DENDRITIC MORPHOLOGY; NUCLEUS-ACCUMBENS; SEX-DIFFERENCES; BASOLATERAL AMYGDALA; UNIPOLAR DEPRESSION	Early life adversity affects hypothalamus-pituitary-adrenal axis activity, alters cognitive functioning and in humans is thought to increase the vulnerability to psychopathology-e. g. depression, anxiety and schizophrenia-later in life. Here we investigated whether subtle natural variations among individual rat pups in the amount of maternal care received, i.e. differences in the amount of licking and grooming (LG), correlate with anxiety and prefrontal cortex-dependent behavior in young adulthood. Therefore, we examined the correlation between LG received during the first postnatal week and later behavior in the elevated plus maze and in decision-making processes using a rodent version of the Iowa Gambling Task (rIGT). In our cohort of male and female animals a high degree of LG correlated with less anxiety in the elevated plus maze and more advantageous choices during the last 10 trials of the rIGT. In tissue collected 2 hrs after completion of the task, the correlation between LG and c-fos expression (a marker of neuronal activity) was established in structures important for IGT performance. Negative correlations existed between rIGT performance and c-fos expression in the lateral orbitofrontal cortex, prelimbic cortex, infralimbic cortex and insular cortex. The insular cortex correlations between c-fos expression and decision-making performance depended on LG background; this was also true for the lateral orbitofrontal cortex in female rats. Dendritic complexity of insular or infralimbic pyramidal neurons did not or weakly correlate with LG background. We conclude that natural variations in maternal care received by pups may significantly contribute to later-life decision-making and activity of underlying brain structures.	[de Visser, Leonie; Cornelisse, Sandra; van den Bos, Ruud; Joels, Marian] UMC Utrecht, Rudolf Magnus Inst, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [van Hasselt, Felisa N.; Tieskens, Jacintha M.; Krugers, Harm J.] Univ Amsterdam, SILS CNS, Amsterdam, Netherlands; [Baars, Annemarie M.; Lavrijsen, Marla] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci,Rudolf Magnus Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Utrecht University	Joels, M (corresponding author), UMC Utrecht, Rudolf Magnus Inst, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.joels@umcutrecht.nl	Joëls, Marian/P-6415-2016	Tieskens, J.M./0000-0002-6418-4852; Joels, Marian/0000-0002-4826-6209	Hersenstichting [15F07]; Human Frontiers Science Program [RGP0039/2006]	Hersenstichting; Human Frontiers Science Program(Human Frontier Science Program)	This study was supported by Hersenstichting (https://www.hersenstichting.nl/homepage/index.html) grant #15F07 to MJ and HJK and Human Frontiers Science Program (http://www.hfsp.org/) grant #RGP0039/2006 to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bagot RC, 2009, NEUROBIOL LEARN MEM, V92, P292, DOI 10.1016/j.nlm.2009.03.004; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; BREIER A, 1988, ARCH GEN PSYCHIAT, V45, P987; Bremner J Douglas, 2002, Curr Psychiatry Rep, V4, P254, DOI 10.1007/s11920-996-0044-9; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cardinal RN, 2003, INT CONGR SER, V1250, P347, DOI 10.1016/S0531-5131(03)01013-6; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Claessens SE, PSYCHOPHARMACOLOGY B, V214, P141; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; De Visser L, 2011, NEUROSCIENCE, V184, P97, DOI 10.1016/j.neuroscience.2011.02.025; de Visser L, 2010, NEUROPSYCHOLOGIA, V48, P1598, DOI 10.1016/j.neuropsychologia.2010.01.027; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DIORIO D, 1993, J NEUROSCI, V13, P3839; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Olvera-Cortes ME, 2008, PROG BRAIN RES, V172, P567, DOI 10.1016/S0079-6123(08)00927-8; Fernandes C, 1999, PHARMACOL BIOCHEM BE, V64, P731, DOI 10.1016/S0091-3057(99)00139-2; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Fossati P, 1999, PSYCHIAT RES, V89, P171, DOI 10.1016/S0165-1781(99)00110-9; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Grachev ID, 2000, MOL PSYCHIATR, V5, P482, DOI 10.1038/sj.mp.4000778; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Homberg JR, 2008, NEUROPHARMACOLOGY, V55, P80, DOI 10.1016/j.neuropharm.2008.04.016; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kesner RP, 2007, NEUROBIOL LEARN MEM, V88, P82, DOI 10.1016/j.nlm.2007.02.002; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Li X, HUM BRAIN MAPP, V31, P410; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Mainen ZF, 2009, CURR OPIN NEUROBIOL, V19, P84, DOI 10.1016/j.conb.2009.03.010; MANN JJ, 1995, NEUROPSYCHOPHARMACOL, V13, P53, DOI 10.1016/0893-133X(95)00016-7; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Monroy E, 2010, J CHEM NEUROANAT, V40, P93, DOI 10.1016/j.jchemneu.2010.05.005; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Niwa M, 2010, INT J NEUROPSYCHOPH, P1, DOI DOI 10.1017/S1461145710001239.[; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Overman W, 2006, BEHAV NEUROSCI, V120, P817, DOI 10.1037/0735-7044.120.4.817; Pais-Vieira M, 2007, NEUROSCIENCE, V145, P225, DOI 10.1016/j.neuroscience.2006.11.058; Pascual R, 2007, ACTA NEUROBIOL EXP, V67, P471; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pechtel P, 2010, PSYCHOPHARMACOLOGY B; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Ragozzino ME, 1999, BEHAV BRAIN RES, V98, P103; Reavis R, 2001, BEHAV NEUROSCI, V115, P196, DOI 10.1037//0735-7044.115.1.196; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; Rivalan M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00022; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Shansky RM, 2009, BRAIN RES, V1293, P108, DOI 10.1016/j.brainres.2009.03.062; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Todtenkopf MS, 2006, J NEUROSCI, V26, P11665, DOI 10.1523/JNEUROSCI.3070-06.2006; Tran-Tu-Yen DAS, 2009, EUR J NEUROSCI, V30, P464, DOI 10.1111/j.1460-9568.2009.06834.x; van den Bos R, 2006, BIOL PSYCHOL, V71, P155, DOI 10.1016/j.biopsycho.2005.05.003; Van den Bos R, 2012, HDB PSYCHOL DECISION; Van den Bos R, 2006, BEHAV RES METHODS, V38, P470, DOI 10.3758/BF03192801; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; van Hasselt FN, 2012, J NEUROENDOCRINOL, V24, P331, DOI 10.1111/j.1365-2826.2011.02233.x; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; van Hasselt FN, 2012, PHYSL BEHAV; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weller JA, 2009, SOC NEUROSCI-UK, V4, P347, DOI 10.1080/17470910902934400; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097; Young JJ, 2009, BEHAV NEUROSCI, V123, P1028, DOI 10.1037/a0016822; Yu RJ, 2010, J NEUROSCI, V30, P14702, DOI 10.1523/JNEUROSCI.3772-10.2010; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011	97	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37820	10.1371/journal.pone.0037820	http://dx.doi.org/10.1371/journal.pone.0037820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693577	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500058
J	Roche, DB; Buenavista, MT; McGuffin, LJ				Roche, Daniel B.; Buenavista, Maria T.; McGuffin, Liam J.			FunFOLDQA: A Quality Assessment Tool for Protein-Ligand Binding Site Residue Predictions	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; LOCAL MODEL QUALITY; EVOLUTIONARY CONSERVATION; SEQUENCE; CASP8; ALIGNMENT; ANNOTATION; WEB; IDENTIFICATION; FIRESTAR	The estimation of prediction quality is important because without quality measures, it is difficult to determine the usefulness of a prediction. Currently, methods for ligand binding site residue predictions are assessed in the function prediction category of the biennial Critical Assessment of Techniques for Protein Structure Prediction (CASP) experiment, utilizing the Matthews Correlation Coefficient (MCC) and Binding-site Distance Test (BDT) metrics. However, the assessment of ligand binding site predictions using such metrics requires the availability of solved structures with bound ligands. Thus, we have developed a ligand binding site quality assessment tool, FunFOLDQA, which utilizes protein feature analysis to predict ligand binding site quality prior to the experimental solution of the protein structures and their ligand interactions. The FunFOLDQA feature scores were combined using: simple linear combinations, multiple linear regression and a neural network. The neural network produced significantly better results for correlations to both the MCC and BDT scores, according to Kendall's tau, Spearman's rho and Pearson's iota correlation coefficients, when tested on both the CASP8 and CASP9 datasets. The neural network also produced the largest Area Under the Curve score (AUC) when Receiver Operator Characteristic (ROC) analysis was undertaken for the CASP8 dataset. Furthermore, the FunFOLDQA algorithm incorporating the neural network, is shown to add value to FunFOLD, when both methods are employed in combination. This results in a statistically significant improvement over all of the best server methods, the FunFOLD method (6.43%), and one of the top manual groups (FN293) tested on the CASP8 dataset. The FunFOLDQA method was also found to be competitive with the top server methods when tested on the CASP9 dataset. To the best of our knowledge, FunFOLDQA is the first attempt to develop a method that can be used to assess ligand binding site prediction quality, in the absence of experimental data.	[Roche, Daniel B.; Buenavista, Maria T.; McGuffin, Liam J.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Buenavista, Maria T.] Med Res Council Harwell, Biocomp Sect, Harwell Oxford, Oxon, England; [Buenavista, Maria T.] Diamond Light Source, Beamline B23, Didcot, Oxon, England	University of Reading; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Diamond Light Source	Roche, DB (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	l.j.mcguffin@reading.ac.uk	McGuffin, Liam/A-5598-2008	McGuffin, Liam/0000-0003-4501-4767; Roche, Daniel/0000-0002-9204-1840	RCUK Academic Fellowship; Diamond Light Source Ltd; MRC [MC_U142684171] Funding Source: UKRI; Medical Research Council [MC_U142684171] Funding Source: researchfish	RCUK Academic Fellowship(UK Research & Innovation (UKRI)); Diamond Light Source Ltd; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by RCUK Academic Fellowship (to LJM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Funding was received from a commercial source, Diamond Light Source Ltd (to MTB), who is also the employer of MTB. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Andersson CD, 2010, PROTEINS, V78, P1408, DOI 10.1002/prot.22655; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, PROTEINS, V77, P173, DOI 10.1002/prot.22532; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Cheng JL, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22487; Chou WY, 2010, BIOINFORMATICS, V26, P1022, DOI 10.1093/bioinformatics/btq084; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Gentleman R, 2000, J COMPUT GRAPH STAT, V9, P491, DOI 10.2307/1390942; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Kalman M, 2010, BIOINFORMATICS, V26, P1299, DOI 10.1093/bioinformatics/btq114; Larsson P, 2009, PROTEINS, V77, P167, DOI 10.1002/prot.22476; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297; Lopez G, 2011, NUCLEIC ACIDS RES, V39, pW235, DOI 10.1093/nar/gkr437; Lopez G, 2009, PROTEINS, V77, P138, DOI 10.1002/prot.22557; McGuffin LJ, 2011, PROTEINS, V79, P137, DOI 10.1002/prot.23120; McGuffin LJ, 2010, BIOINFORMATICS, V26, P182, DOI 10.1093/bioinformatics/btp629; Miguel RN, 2004, BIOINFORMATICS, V20, P2380, DOI 10.1093/bioinformatics/bth255; Oh M, 2009, PROTEINS, V77, P152, DOI 10.1002/prot.22572; Pantazes RJ, 2011, CURR OPIN STRUC BIOL, V21, P467, DOI 10.1016/j.sbi.2011.04.005; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Roche DB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-160; Roche DB, 2010, BIOINFORMATICS, V26, P2920, DOI 10.1093/bioinformatics/btq543; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanders MPA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-332; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Schmidt T, 2011, PROTEINS, V79, P126, DOI 10.1002/prot.23174; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soro S, 2005, PROTEINS, V61, P201, DOI 10.1002/prot.20738; Spitzer R, 2011, PROTEINS, V79, P2746, DOI 10.1002/prot.23103; Talavera D, 2009, BIOINFORMATICS, V25, P1192, DOI 10.1093/bioinformatics/btp116; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Wang Z, 2011, BIOINFORMATICS, V27, P1715, DOI 10.1093/bioinformatics/btr268; Wang Z, 2009, PROTEINS, V75, P638, DOI 10.1002/prot.22275; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wass MN, 2009, PROTEINS, V77, P147, DOI 10.1002/prot.22513; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	41	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38219	10.1371/journal.pone.0038219	http://dx.doi.org/10.1371/journal.pone.0038219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666491	Green Published, gold, Green Accepted			2022-12-25	WOS:000305353400104
J	Le Goff, MM; Sutton, MJ; Slevin, M; Latif, A; Humphries, MJ; Bishop, PN				Le Goff, Magali M.; Sutton, Matthew J.; Slevin, Mark; Latif, Ayse; Humphries, Martin J.; Bishop, Paul N.			Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix Adhesiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MORPHOGENESIS; VASCULAR MORPHOGENESIS; ENDOGENOUS INHIBITOR; BINDING-SITES; IV COLLAGEN; ENDOSTATIN; ALPHA(V)BETA(3); ORGANIZATION; EXPRESSION; TUMSTATIN	Opticin is an extracellular matrix glycoprotein that we identified associated with the collagen network of the vitreous humor of the eye. Recently, we discovered that opticin possesses anti-angiogenic activity using a murine oxygen-induced retinopathy model: here, we investigate the underlying mechanism. Using an ex vivo chick chorioallantoic membrane assay, we show that opticin inhibits angiogenesis when stimulated by a range of growth factors. We show that it suppresses capillary morphogenesis, inhibits endothelial invasion, and promotes capillary network regression in three-dimensional matrices of collagen and Matrigel (TM). We then show that opticin binds to collagen and thereby competitively inhibits endothelial cell interactions with collagen via alpha(1)beta(1) and alpha(2)beta(1) integrins, thereby preventing the strong adhesion that is required for proangiogenic signaling via these integrins.	[Le Goff, Magali M.; Sutton, Matthew J.; Latif, Ayse; Bishop, Paul N.] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Latif, Ayse; Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Ctr Adv Discovery & Expt Therapeut, Manchester M13 9WH, Lancs, England; [Latif, Ayse; Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WH, Lancs, England; [Slevin, Mark] Manchester Metropolitan Univ, Sch Biol Chem & Hlth Sci, Manchester M1 5GD, Lancs, England; [Slevin, Mark] Hosp Santa Creu & Sant Pau, Inst Catala Ciencies Cardiovasc, Barcelona 08025, Spain	University of Manchester; University of Manchester; University of Manchester; Manchester Royal Eye Hospital; University of Manchester; Manchester Metropolitan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Bishop, PN (corresponding author), Univ Manchester, Fac Med & Human Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Paul.Bishop@manchester.ac.uk	Latif, A/U-4241-2019; Slevin, Mark/AFT-1420-2022; slevin, mark a/A-1593-2008	Latif, A/0000-0002-7245-8729; Humphries, Martin/0000-0002-4331-6967; Bishop, Paul/0000-0001-7937-7932	Manchester National Institute of Health Research Biomedical Research Centre; Manchester Royal Eye Hospital and Guide Dogs; Wellcome Trust [045225, 074941, 057940]; Diabetes UK; Banco Bilbao Vizcaya Argentaria Foundation	Manchester National Institute of Health Research Biomedical Research Centre; Manchester Royal Eye Hospital and Guide Dogs; Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); Banco Bilbao Vizcaya Argentaria Foundation	This work was supported by Manchester National Institute of Health Research Biomedical Research Centre and Manchester Royal Eye Hospital and Guide Dogs. This work was also supported by Wellcome Trust Grants 045225 and 074941 (to M.J.H.) and 057940 (to P.N.B.).; Supported by a grant from Diabetes UK and the Banco Bilbao Vizcaya Argentaria Foundation.	Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Colorado PC, 2000, CANCER RES, V60, P2520; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P3, DOI 10.4161/cam.3.1.7275; Frolova EI, 2004, GENE EXPR PATTERNS, V4, P335, DOI 10.1016/j.modgep.2003.10.002; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Guidetti GF, 2003, BBA-MOL CELL RES, V1640, P43, DOI 10.1016/S0167-4889(02)00401-9; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Hamano Y, 2005, BIOCHEM BIOPH RES CO, V333, P292, DOI 10.1016/j.bbrc.2005.05.130; Hindson VJ, 2005, INVEST OPHTH VIS SCI, V46, P4417, DOI 10.1167/iovs.05-0883; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; HOSODA Y, 1992, OPHTHALMIC RES, V24, P260, DOI 10.1159/000267176; Hurskainen M, 2005, FASEB J, V19, P1564, DOI 10.1096/fj.04-3101fje; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Laurens N, 2009, ANGIOGENESIS, V12, P275, DOI 10.1007/s10456-009-9150-8; Le Goff MM, 2012, INVEST OPHTH VIS SCI, V53, P228, DOI 10.1167/iovs.11-8514; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; LUTTY GA, 1983, INVEST OPHTH VIS SCI, V24, P52; Maatta M, 2007, GRAEF ARCH CLIN EXP, V245, P74, DOI 10.1007/s00417-006-0281-y; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; SATTAR A, 1992, SEMIN ARTHRITIS RHEU, V22, P37, DOI 10.1016/0049-0172(92)90047-H; Schonherr E, 2001, J CELL PHYSIOL, V187, P37, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1048>3.0.CO;2-W; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takanosu M, 2001, INVEST OPHTH VIS SCI, V42, P2202; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; VERNON RB, 1995, AM J PATHOL, V147, P873; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; WEST DC, 2001, METHODS MOL MED ANGI, P107; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Wickstrom SA, 2002, CANCER RES, V62, P5580; Wiegand S. J., 1884, INVEST OPHTHALMOL VI, V45; Wistow G, 2002, MOL VIS, V8, P185; WONG HC, 1989, GRAEF ARCH CLIN EXP, V227, P237, DOI 10.1007/BF02172755	55	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28027	28036		10.1074/jbc.M111.331157	http://dx.doi.org/10.1074/jbc.M111.331157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22669977	hybrid, Green Published			2022-12-25	WOS:000307840700076
J	Bennetts, B; Yu, YW; Chen, TY; Parker, MW				Bennetts, Brett; Yu, Yawei; Chen, Tsung-Yu; Parker, Michael W.			Intracellular beta-Nicotinamide Adenine Dinucleotide Inhibits the Skeletal Muscle ClC-1 Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; ATP INHIBITION; CBS DOMAINS; C-TERMINUS; PH; MUTATIONS; EXCITABILITY; MECHANISMS; DEPENDENCE; MOVEMENT	ClC-1 is the dominant sarcolemmal chloride channel and plays an important role in regulating membrane excitability that is underscored by ClC-1 mutations in congenital myotonia. Here we show that the coenzyme beta-nicotinamide adenine dinucleotide (NAD), an important metabolic regulator, robustly inhibits ClC-1 when included in the pipette solution in whole cell patch clamp experiments and when transiently applied to inside-out patches. The oxidized (NAD(+)) form of the coenzyme was more efficacious than the reduced (NADH) form, and inhibition by both was greatly enhanced by acidification. Molecular modeling, based on the structural coordinates of the homologous ClC-5 and CmClC proteins and in silico docking, suggest that NAD(+) binds with the adenine base deep in a cleft formed by ClC-1 intracellular cystathionine beta-synthase domains, and the nicotinamide base interacts with the membrane-embedded channel domain. Consistent with predictions from the models, mutation of residues in cystathionine beta-synthase and channel domains either attenuated (G200R, T636A, H847A) or abrogated (L848A) the effect of NAD(+). In addition, the myotonic mutations G200R and Y261C abolished potentiation of NAD(+) inhibition at low pH. Our results identify a new biological role for NAD and suggest that the main physiological relevance may be the exquisite sensitivity to intracellular pH that NAD(+) inhibition imparts to ClC-1 gating. These findings are consistent with the reduction of sarcolemmal chloride conductance that occurs upon acidification of skeletal muscle and suggest a previously unexplored mechanism in the pathophysiology of myotonia.	[Bennetts, Brett; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Yu, Yawei; Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Yu, Yawei; Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95618 USA; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	St. Vincent's Institute of Medical Research; University of California System; University of California Davis; University of California System; University of California Davis; University of Melbourne	Bennetts, B (corresponding author), St Vincents Inst Med Res, Biota Struct Biol Lab, 9 Princes St, Fitzroy, Vic 3065, Australia.	bbennetts@svi.edu.au	Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138	National Institutes of Health [R01GM065447]; Victorian Government Operational Infrastructure Support Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government Operational Infrastructure Support Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM065447 (to T.-Y. C.). This work was also supported by funding from the Victorian Government Operational Infrastructure Support Scheme to St Vincent's Institute (to T.-Y. C.).	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Accardi A, 2001, J PHYSIOL-LONDON, V534, P745, DOI 10.1111/j.1469-7793.2001.00745.x; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bennetts B, 2007, J BIOL CHEM, V282, P32780, DOI 10.1074/jbc.M703259200; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Chen MF, 1997, J PHYSIOL-LONDON, V504, P75, DOI 10.1111/j.1469-7793.1997.075bf.x; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Dutzler R, 2004, FEBS LETT, V564, P229, DOI 10.1016/S0014-5793(04)00210-8; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Grahnert A, 2009, PURINERG SIGNAL, V5, P309, DOI 10.1007/s11302-009-9144-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Klein C, 2009, CELL CALCIUM, V46, P263, DOI 10.1016/j.ceca.2009.08.004; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Li Y, 2005, BIOPHYS J, V88, P3936, DOI 10.1529/biophysj.104.055012; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Ma LL, 2011, BIOCHEM J, V436, P415, DOI 10.1042/BJ20102153; Mailander V, 1996, AM J HUM GENET, V58, P317; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; METZGER JM, 1987, J APPL PHYSIOL, V62, P1392, DOI 10.1152/jappl.1987.62.4.1392; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MOORE CE, 1969, ANAL BIOCHEM, V29, P149, DOI 10.1016/0003-2697(69)90018-9; Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pedersen TH, 2005, J GEN PHYSIOL, V125, P237, DOI 10.1085/jgp.200409173; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; ROOS A, 1978, AM J PHYSIOL, V235, pC49, DOI 10.1152/ajpcell.1978.235.1.C49; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Rychkov GY, 2001, J PHYSIOL-LONDON, V530, P379, DOI 10.1111/j.1469-7793.2001.0379k.x; SAHLIN K, 1978, J APPL PHYSIOL, V45, P474, DOI 10.1152/jappl.1978.45.3.474; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; THOMPSON LV, 1992, AM J PHYSIOL, V262, pC1507, DOI 10.1152/ajpcell.1992.262.6.C1507; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; Tseng PY, 2011, J GEN PHYSIOL, V137, P357, DOI 10.1085/jgp.201010495; Wellhauser L, 2006, BIOCHEM J, V398, P289, DOI 10.1042/BJ20060142; Wellhauser L, 2011, J BIOL CHEM, V286, P6733, DOI 10.1074/jbc.M110.175877; WILSON JR, 1988, J APPL PHYSIOL, V64, P2333, DOI 10.1152/jappl.1988.64.6.2333; Wollnik B, 1997, HUM MOL GENET, V6, P805, DOI 10.1093/hmg/6.5.805; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhang XD, 2008, J GEN PHYSIOL, V132, P421, DOI 10.1085/jgp.200810023; Zifarelli G, 2009, EMBO REP, V10, P1111, DOI 10.1038/embor.2009.159	59	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25808	25820		10.1074/jbc.M111.327551	http://dx.doi.org/10.1074/jbc.M111.327551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689570	Green Published, hybrid			2022-12-25	WOS:000306916300011
J	Cloutier, SC; Ma, WK; Nguyen, LT; Tran, EJ				Cloutier, Sara C.; Ma, Wai Kit; Nguyen, Luyen T.; Tran, Elizabeth J.			The DEAD-box RNA Helicase Dbp2 Connects RNA Quality Control with Repression of Aberrant Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTS; LONG NONCODING RNAS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CRYPTIC TRANSCRIPTION; ELONGATION-FACTORS; 3'-END FORMATION; SEN1 HELICASE; GENE LOOPS; PROTEIN	DEAD-box proteins are a class of RNA-dependent ATP hydrolysis enzymes that rearrange RNA and RNA-protein (ribonucleoprotein) complexes. In an effort to characterize the cellular function of individual DEAD-box proteins, our laboratory has uncovered a previously unrecognized link between the DEAD-box protein Dbp2 and the regulation of transcription in Saccharomyces cerevisiae. Here, we report that Dbp2 is a double-stranded RNA-specific ATPase that associates directly with chromatin and is required for transcriptional fidelity. In fact, loss of DBP2 results in multiple gene expression defects, including accumulation of noncoding transcripts, inefficient 3' end formation, and appearance of aberrant transcriptional initiation products. We also show that loss of DBP2 is synthetic lethal with deletion of the nuclear RNA decay factor, RRP6, pointing to a global role for Dbp2 in prevention of aberrant transcriptional products. Taken together, we present a model whereby Dbp2 functions to cotranscriptionally modulate RNA structure, a process that facilitates ribonucleoprotein assembly and clearance of transcripts from genomic loci. These studies suggest that Dbp2 is a missing link in RNA quality control that functions to maintain the fidelity of transcriptional processes.	[Tran, Elizabeth J.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tran, EJ (corresponding author), Purdue Univ, Dept Biochem, BCHM 305,175 S Univ St, W Lafayette, IN 47907 USA.	ejtran@purdue.edu	Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X	National Institutes of Health [R01GM097332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM097332 (to E. J. T.).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; BARTA I, 1995, EMBO J, V14, P3800, DOI 10.1002/j.1460-2075.1995.tb00049.x; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Bond AT, 2001, MOL CELL BIOL, V21, P7366, DOI 10.1128/MCB.21.21.7366-7379.2001; Brickner JH, 2009, CURR OPIN CELL BIOL, V21, P127, DOI 10.1016/j.ceb.2009.01.007; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Du HN, 2010, J BIOL CHEM, V285, P11704, DOI 10.1074/jbc.M109.085043; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Rougemaille M, 2010, ADV EXP MED BIOL, V702, P122, DOI 10.1007/978-1-4419-7841-7_10; Schmid M, 2010, WIRES RNA, V1, P474, DOI 10.1002/wrna.24; Sellick CA, 2008, INT REV CEL MOL BIO, V269, P111, DOI 10.1016/S1937-6448(08)01003-4; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinan S, 2011, J BIOL CHEM, V286, P37304, DOI 10.1074/jbc.M111.287706; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; TAJIMA M, 1986, MOL CELL BIOL, V6, P246, DOI 10.1128/MCB.6.1.246; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhou H, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26155	26166		10.1074/jbc.M112.383075	http://dx.doi.org/10.1074/jbc.M112.383075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679025	hybrid, Green Published			2022-12-25	WOS:000306916300043
J	Liu, ML; Zhou, LJ; Wei, L; Villarreal, R; Yang, X; Hu, DR; Riojas, RA; Holmes, BM; Langlais, PR; Lee, H; Dong, LQ				Liu, Meilian; Zhou, Lijun; Wei, Li; Villarreal, Ricardo; Yang, Xin; Hu, Derong; Riojas, Ramon A.; Holmes, Bekke M.; Langlais, Paul R.; Lee, Hakjoo; Dong, Lily Q.			Phosphorylation of Adaptor Protein Containing Pleckstrin Homology Domain, Phosphotyrosine Binding Domain, and Leucine Zipper Motif 1 (APPL1) at Ser(430) Mediates Endoplasmic Reticulum (ER) Stress-induced Insulin Resistance in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C ISOFORMS ALPHA; KINASE-C; ADIPONECTIN RECEPTORS; ACTIVATION; PATHWAY; CELLS; AKT; LOCALIZATION; INHIBITION; MUSCLES	APPL1 is an adaptor protein that plays a critical role in regulating adiponectin and insulin signaling. However, how APPL1 is regulated under normal and pathological conditions remains largely unknown. In this study, we show that APPL1 undergoes phosphorylation at Ser(430) and that this phosphorylation is enhanced in the liver of obese mice displaying insulin resistance. In cultured mouse hepatocytes, APPL1 phosphorylation at Ser(430) is stimulated by phorbol 12-myristate 13-acetate, an activator of classic PKC isoforms, and by the endoplasmic reticulum (ER) stress inducer, thapsigargin. Overexpression of wild-type but not dominant negative PKC alpha increases APPL1 phosphorylation at Ser(430) in mouse hepatocytes. In addition, suppressing PKC alpha expression by shRNA in hepatocytes reduces ER stress-induced APPL1 phosphorylation at Ser(430) as well as the inhibitory effect of ER stress on insulin-stimulated Akt phosphorylation. Consistent with a negative regulatory role of APPL1 phosphorylation at Ser(430) in insulin signaling, overexpression of APPL1(S430D) but not APPL1(S430A) impairs the potentiating effect of APPL1 on insulin-stimulated Akt phosphorylation at Thr(308). Taken together, our results identify APPL1 as a novel target in ER stress-induced insulin resistance and PKC alpha as the kinase mediating ER stress-induced phosphorylation of APPL1 at Ser(430).	[Liu, Meilian; Hu, Derong] UTHSCSA, Dept Pharmacol, San Antonio, TX 78229 USA; [Zhou, Lijun; Villarreal, Ricardo; Yang, Xin; Lee, Hakjoo; Dong, Lily Q.] UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Riojas, Ramon A.; Langlais, Paul R.] UTHSCSA, Dept Biochem, San Antonio, TX 78229 USA; [Holmes, Bekke M.] UTHSCSA, Dept Physiol, San Antonio, TX 78229 USA; [Wei, Li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University	Liu, ML (corresponding author), UTHSCSA, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	lium2@uthscsa.edu; DONGQ@uthscsa.edu	Zhou, Li/GSE-4531-2022		National Institutes of Health [DK080344, DK69930]; American Heart Association [11BGIA7620074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344, R01DK069930, R56DK069930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080344 and DK69930 (to L. Q.D.). This work was also supported in part by American Heart Association Beginning-in-Aid Award 11BGIA7620074 (to M. L.).	Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Buechler C, 2010, FEBS LETT, V584, P4280, DOI 10.1016/j.febslet.2010.09.035; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Gant-Branum RL, 2010, J PROTEOME RES, V9, P1541, DOI 10.1021/pr901043e; Kanoh Y, 2001, ENDOCRINOLOGY, V142, P1595, DOI 10.1210/en.142.4.1595; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rosenzweig T, 2002, DIABETES, V51, P1921, DOI 10.2337/diabetes.51.6.1921; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Xin X, 2011, AM J PHYSIOL-ENDOC M, V300, pE103, DOI 10.1152/ajpendo.00427.2010; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	25	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26087	26093		10.1074/jbc.M112.372292	http://dx.doi.org/10.1074/jbc.M112.372292			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685300	Green Published, hybrid			2022-12-25	WOS:000306916300036
J	Locatelli, D; Terao, M; Fratelli, M; Zanetti, A; Kurosaki, M; Lupi, M; Barzago, MM; Uggetti, A; Capra, S; D'Errico, P; Battaglia, GS; Garattini, E				Locatelli, Denise; Terao, Mineko; Fratelli, Maddalena; Zanetti, Adriana; Kurosaki, Mami; Lupi, Monica; Barzago, Maria Monica; Uggetti, Andrea; Capra, Silvia; D'Errico, Paolo; Battaglia, Giorgio S.; Garattini, Enrico			Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; RETINOIC ACID; NERVOUS-SYSTEM; MOUSE MODEL; CYCLE EXIT; DIFFERENTIATION; ACTIVATION; CHEMOKINES; ADULT; NEUROBLASTOMA	Spinal muscular atrophy is a fatal genetic disease of motoneurons due to loss of full-length survival of motor neuron protein, the main product of the disease gene SMN1. Axonal SMN (a-SMN) is an alternatively spliced isoform of SMN1, generated by retention of intron 3. To study a-SMN function, we generated cellular clones for the expression of the protein in mouse motoneuron-like NSC34 cells. The model was instrumental in providing evidence that a-SMN decreases cell growth and plays an important role in the processes of axon growth and cellular motility. In our conditions, low levels of a-SMN expression were sufficient to trigger the observed biological effects, which were not modified by further increasing the amounts of the expressed protein. Differential transcriptome analysis led to the identification of novel a-SMN-regulated factors, i.e. the transcripts coding for the two chemokines, C-C motif ligands 2 and 7 (CCL2 and CCL7), as well as the neuronal and myotrophic factor, insulin-like growth factor-1 (IGF1). a-SMN-dependent induction of CCL2 and IGF1 mRNAs resulted in increased intracellular levels and secretion of the respective protein products. Induction of CCL2 contributes to the a-SMN effects, mediating part of the action on axon growth and random cell motility, as indicated by chemokine knockdown and re-addition studies. Our results shed new light on a-SMN function and the underlying molecular mechanisms. The data provide a rational framework to understand the role of a-SMN deficiency in the etiopathogenesis of spinal muscular atrophy.	[Terao, Mineko; Fratelli, Maddalena; Zanetti, Adriana; Kurosaki, Mami; Barzago, Maria Monica; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy; [Lupi, Monica] Ist Ric Farmacol Mario Negri, Dept Oncol, I-20156 Milan, Italy; [Locatelli, Denise; Capra, Silvia; D'Errico, Paolo; Battaglia, Giorgio S.] Ist Neurol C Besta, Mol Neuroanat Lab, Dept Expt Neurophysiol & Epileptol, I-20133 Milan, Italy; [Uggetti, Andrea] Ist Neurol C Besta, Div Neuropathol, I-20126 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Garattini, E (corresponding author), Ist Ric Farmacol Mario Negri, Mol Biol Lab, Via La Masa 19, I-20156 Milan, Italy.	enrico.garattini@marionegri.it	KUROSAKI, Mami/ABG-2224-2020; Terao, Mineko/AAA-6415-2020; Garattini, Enrico/AAI-1998-2019; terao, mineko/AAU-8089-2020; Barzago, Maria Monica/AAA-6402-2020; Fratelli, Maddalena/AAA-6446-2020; adriana, zanetti/ABA-1189-2020; Locatelli, Denise/J-8655-2016; Lupi, Monica/AAH-5704-2019	KUROSAKI, Mami/0000-0001-8231-713X; Terao, Mineko/0000-0002-9976-9869; Barzago, Maria Monica/0000-0002-6952-0069; Fratelli, Maddalena/0000-0002-1769-3427; adriana, zanetti/0000-0002-5825-9707; Locatelli, Denise/0000-0001-9783-7111; Garattini, Enrico/0000-0001-8983-886X; Lupi, Monica/0000-0002-9835-7870	Telethon-Italy Foundation [GGP07223]; Fondazione Cariplo [2008_2307]; Italian Ministry of Health [RF-INN-2007-644440]; Fondazione Italo Monzino, Girotondo/Onlus and Smarathon/ONLUS; Negri-Weizmann Foundation; Ministero della Salute	Telethon-Italy Foundation(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Italo Monzino, Girotondo/Onlus and Smarathon/ONLUS; Negri-Weizmann Foundation; Ministero della Salute(Ministry of Health, Italy)	This work was supported by Telethon-Italy Foundation Grant GGP07223, Fondazione Cariplo Grant 2008_2307, Italian Ministry of Health Grant RF-INN-2007-644440, the Fondazione Italo Monzino, Girotondo/Onlus and Smarathon/ONLUS, the Negri-Weizmann Foundation, and in part by Ministero della Salute.	Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Comini-Frota ER, 2011, CNS DRUGS, V25, P971, DOI 10.2165/11595060-000000000-00000; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; ELEMER GS, 1994, J BIOL CHEM, V269, P3159; Farrar NR, 2009, J NEUROSCI, V29, P14136, DOI 10.1523/JNEUROSCI.2921-09.2009; Gianni M, 2000, CELL DEATH DIFFER, V7, P447, DOI 10.1038/sj.cdd.4400673; Giavazzi A, 2006, J NEUROPATH EXP NEUR, V65, P267, DOI 10.1097/01.jnen.0000205144.54457.a3; Gomez TM, 2004, NEURON, V42, P1, DOI 10.1016/S0896-6273(04)00188-6; Gordon RJ, 2012, EXP NEUROL, V233, P587, DOI 10.1016/j.expneurol.2011.11.029; Gunadi, 2008, ANN HUM GENET, V72, P288, DOI 10.1111/j.1469-1809.2007.00409.x; Hall AA, 2009, GLIA, V57, P744, DOI 10.1002/glia.20802; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Johnson-Farley NN, 2006, J PHARMACOL EXP THER, V316, P1062, DOI 10.1124/jpet.105.094433; Kapfhammer Josef P., 1992, Current Opinion in Cell Biology, V4, P863, DOI 10.1016/0955-0674(92)90112-P; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Kim MD, 2002, J NEUROSCI, V22, P1794, DOI 10.1523/JNEUROSCI.22-05-01794.2002; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Locatelli D, 2012, J NEUROCHEM, V121, P465, DOI 10.1111/j.1471-4159.2012.07689.x; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Marzinke MA, 2012, EXP CELL RES, V318, P85, DOI 10.1016/j.yexcr.2011.10.002; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Mirabelli-Badenier M, 2011, THROMB HAEMOSTASIS, V105, P409, DOI 10.1160/TH10-10-0662; Murakami M, 2010, J NEUROCHEM, V112, P511, DOI 10.1111/j.1471-4159.2009.06486.x; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ogawa C, 2009, J BIOL CHEM, V284, P14609, DOI 10.1074/jbc.M809031200; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Reimer MM, 2009, J NEUROSCI, V29, P15073, DOI 10.1523/JNEUROSCI.4748-09.2009; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sendtner M, 2010, NAT NEUROSCI, V13, P795, DOI 10.1038/nn.2565; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Simic G, 2008, ACTA NEUROPATHOL, V115, P313, DOI 10.1007/s00401-007-0327-1; Terao M, 2011, J BIOL CHEM, V286, P4027, DOI 10.1074/jbc.M110.184994; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Valerio A, 2004, J NEUROSCI RES, V78, P371, DOI 10.1002/jnr.20250; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Vogt DL, 2007, MOL CELL NEUROSCI, V36, P332, DOI 10.1016/j.mcn.2007.07.004; Yahiaoui L, 2008, J PHYSIOL-LONDON, V586, P3991, DOI 10.1113/jphysiol.2008.152090; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; Zhou Y, 2011, J NEUROCHEM, V116, P406, DOI 10.1111/j.1471-4159.2010.07121.x	63	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25782	25794		10.1074/jbc.M112.362830	http://dx.doi.org/10.1074/jbc.M112.362830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669976	hybrid, Green Published			2022-12-25	WOS:000306916300009
J	Nie, J; Sun, C; Faruque, O; Ye, GM; Li, J; Liang, QR; Chang, ZJ; Yang, WNA; Han, X; Shi, YG				Nie, Jia; Sun, Chao; Faruque, Omar; Ye, Guangming; Li, Jia; Liang, Qiangrong; Chang, Zhijie; Yang, Wannian; Han, Xiao; Shi, Yuguang			Synapses of Amphids Defective (SAD-A) Kinase Promotes Glucose-stimulated Insulin Secretion through Activation of p21-activated Kinase (PAK1) in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL POLARIZATION; LKB1 DELETION; IN-VIVO; PROTEINS; CDC42; MECHANISMS; PHOSPHORYLATION; EXOCYTOSIS; POLARITY; PATHWAY	The p21-activated kinase-1 (PAK1) is implicated in regulation of insulin exocytosis as an effector of Rho GTPases. PAK1 is activated by the onset of glucose-stimulated insulin secretion (GSIS) through phosphorylation of Thr-423, a major activation site by Cdc42 and Rac1. However, the kinase(s) that phosphorylates PAK1 at Thr-423 in islet beta-cells remains elusive. The present studies identified SAD-A (synapses of amphids defective), a member of AMP-activated protein kinase-related kinases exclusively expressed in brain and pancreas, as a key regulator of GSIS through activation of PAK1. We show that SAD-A directly binds to PAK1 through its kinase domain. The interaction is mediated by the p21-binding domain (PBD) of PAK1 and requires both kinases in an active conformation. The binding leads to direct phosphorylation of PAK1 at Thr-423 by SAD-A, triggering the onset of GSIS from islet beta-cells. Consequently, ablation of PAK1 kinase activity or depletion of PAK1 expression completely abolishes the potentiating effect of SAD-A on GSIS. Consistent with its role in regulating GSIS, overexpression of SAD-A in MIN6 islet beta-cells significantly stimulated cytoskeletal remodeling, which is required for insulin exocytosis. Together, the present studies identified a critical role of SAD-A in the activation of PAK1 during the onset of insulin exocytosis.	[Nie, Jia; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China; [Nie, Jia; Sun, Chao; Faruque, Omar; Ye, Guangming; Li, Jia; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Sun, Chao] NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Liang, Qiangrong] Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Chang, Zhijie] Tsinghua Univ, Sch Med, Inst Biomed, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yang, Wannian] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwest A&F University - China; Sanford Health; University of South Dakota; Tsinghua University	Han, X (corresponding author), Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China.	hanxiao@njmu.edu.cn; yus11@psu.edu	Chang, Zhijie/AAH-8109-2019; nie, jia/AAE-8355-2019	nie, jia/0000-0001-9085-7224; Chang, Zhijie/0000-0003-1567-3227	National Institutes of Health [DK076685]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076685, R56DK076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Asahara SI, 2008, DIABETES, V57, pA55; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Fujimoto T, 2008, BIOCHEMISTRY-US, V47, P4151, DOI 10.1021/bi702528r; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Mountjoy PD, 2007, EXP PHYSIOL, V92, P311, DOI 10.1113/expphysiol.2006.036004; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi YG, 1999, J BIOL CHEM, V274, P5723, DOI 10.1074/jbc.274.9.5723; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	45	27	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26435	26444		10.1074/jbc.M112.378372	http://dx.doi.org/10.1074/jbc.M112.378372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669945	Green Published, hybrid			2022-12-25	WOS:000306916300068
J	Sato, Y; Yamagata, A; Goto-Ito, S; Kubota, K; Miyamoto, R; Nakada, S; Fukai, S				Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Kubota, Keiko; Miyamoto, Rikako; Nakada, Shinichiro; Fukai, Shuya			Molecular Basis of Lys-63-linked Polyubiquitination Inhibition by the Interaction between Human Deubiquitinating Enzyme OTUB1 and Ubiquitin-conjugating Enzyme UBC13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; STRUCTURAL BASIS; DNA; RAP80; RNF8; RECOGNITION; CHAINS; BRCA1	UBC13 is the only known E2 ubiquitin (Ub)-conjugating enzyme that produces Lys-63-linked Ub chain with its cofactor E2 variant UEV1a or MMS2. Lys-63-linked ubiquitination is crucial for recruitment of DNA repair and damage response molecules to sites of DNA double-strand breaks (DSBs). A deubiquitinating enzyme OTUB1 suppresses Lys-63-linked ubiquitination of chromatin surrounding DSBs by binding UBC13 to inhibit its E2 activity independently of the isopeptidase activity. OTUB1 strongly suppresses UBC13-dependent Lys-63-linked tri-Ub production, whereas it allows di-Ub production in vitro. The mechanism of this non-canonical OTUB1-mediated inhibition of ubiquitination remains to be elucidated. Furthermore, the atomic level information of the interaction between human OTUB1 and UBC13 has not been reported. Here, we determined the crystal structure of human OTUB1 in complex with human UBC13 and MMS2 at 3.15 angstrom resolution. The presented atomic-level interactions were confirmed by surface-plasmon resonance spectroscopy with structure-based mutagenesis. The designed OTUB1 mutants cannot inhibit Lys-63-linked Ub chain formation in vitro and histone ubiquitination and 53BP1 assembly around DSB sites in vivo. Finally, we propose a model for how capping of di-Ub by the OTUB1-UBC13-MMS2/UEV1a complex efficiently inhibits Lys-63-linked tri-Ub formation.	[Nakada, Shinichiro] Osaka Univ, Dept Bioregulat & Cellular Response, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Kubota, Keiko; Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Kubota, Keiko; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Sato, Yusuke; Yamagata, Atsushi; Fukai, Shuya] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba 2778501, Japan; [Miyamoto, Rikako; Nakada, Shinichiro] Keio Univ, Ctr Integrated Med Res, Sch Med, Tokyo 1608582, Japan	Osaka University; University of Tokyo; University of Tokyo; University of Tokyo; Keio University	Nakada, S (corresponding author), Osaka Univ, Dept Bioregulat & Cellular Response, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	snakada.res@gmail.com; fukai@iam.u-tokyo.ac.jp	Sato, Yusuke/GPW-9280-2022; Fukai, Shuya/X-4838-2018; OsakaU/AAY-3661-2020	Sato, Yusuke/0000-0001-8495-8950; Fukai, Shuya/0000-0002-1241-1443; Nakada, Shinichiro/0000-0001-9297-1565	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan; MEXT; Takeda Science Foundation; Kato Memorial Bioscience Foundation; Nakajima Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Bioscience Foundation; Nakajima Foundation	This work was supported by KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan (to S. F., Y. S., and S. N.), the Promotion of Environmental Improvement for Independence of Young Researchers "Kanrinmaru Project" from MEXT (to S. N.), and grants from Takeda Science Foundation (to S. N.), Kato Memorial Bioscience Foundation (to S. N.), and The Nakajima Foundation (to S. F.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046	29	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25860	25868		10.1074/jbc.M112.364752	http://dx.doi.org/10.1074/jbc.M112.364752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679021	hybrid, Green Published			2022-12-25	WOS:000306916300015
J	Schumacher, MA; Ye, QZ; Barge, MT; Zampini, M; Barilla, D; Hayes, F				Schumacher, Maria A.; Ye, Qiaozhen; Barge, Madhuri T.; Zampini, Massimiliano; Barilla, Daniela; Hayes, Finbarr			Structural Mechanism of ATP-induced Polymerization of the Partition Factor ParF IMPLICATIONS FOR DNA SEGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC ACTIN HOMOLOG; PLASMID PARTITION; BACTERIAL SEGROSOME; DYNAMIC INSTABILITY; PROTEIN; BINDING; COMPLEX; MIND; TUBZ; CENTROMERE	Segregation of the bacterial multidrug resistance plasmid TP228 requires the centromere-binding protein ParG, the parH centromere, and the Walker box ATPase ParF. The cycling of ParF between ADP-and ATP-bound states drives TP228 partition; ATP binding stimulates ParF polymerization, which is essential for segregation, whereas ADP binding antagonizes polymerization and inhibits DNA partition. The molecular mechanism involved in this adenine nucleotide switch is unclear. Moreover, it is unknown how any Walker box protein polymerizes in an ATP-dependent manner. Here, we describe multiple ParF structures in ADP- and phosphomethylphosphonic acid adenylate ester (AMPPCP)-bound states. ParF-ADP is monomeric but dimerizes when complexed with AMPPCP. Strikingly, in ParF-AMPPCP structures, the dimers interact to create dimer-of-dimer "units" that generate a specific linear filament. Mutation of interface residues prevents both polymerization and DNA segregation in vivo. Thus, these data provide insight into a unique mechanism by which a Walker box protein forms polymers that involves the generation of ATP-induced dimer-of-dimer building blocks.	[Schumacher, Maria A.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Ye, Qiaozhen] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Barge, Madhuri T.; Barilla, Daniela] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Zampini, Massimiliano; Hayes, Finbarr] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Zampini, Massimiliano; Hayes, Finbarr] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	Duke University; University of Texas System; UTMD Anderson Cancer Center; University of York - UK; University of Manchester; University of Manchester	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, 255 Nanaline H Duke,POB 3711, Durham, NC 27710 USA.	maria.schumacher@duke.edu; daniela.barilla@york.ac.uk; finbarr.hayes@manchester.ac.uk		Barilla, Daniela/0000-0002-3486-7492; Ye, Qiaozhen/0000-0002-3942-4121	National Institutes of Health [GM074815]; MD Anderson Trust; Burroughs Wellcome career development award; Biotechnology and Biological Sciences Research Council [G003114]; Medical Research Council [G0801162]; BBSRC [BB/G003114/1] Funding Source: UKRI; MRC [G0801162] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003114/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Trust; Burroughs Wellcome career development award(Burroughs Wellcome Fund); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074815 (to M. A. S.). This work was also supported by an MD Anderson Trust fellowship and a Burroughs Wellcome career development award (to M. A. S.). Work in the laboratory of F. H. was supported by the Biotechnology and Biological Sciences Research Council, Grant G003114. Work in the laboratory of D. B. was supported by Medical Research Council Grant G0801162.	Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delano W. L., 2001, PYMOL MOL GRAPHICS S; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Hayes F, 2006, TRENDS BIOCHEM SCI, V31, P247, DOI 10.1016/j.tibs.2006.03.002; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; MOODIE SL, 1993, NUCLEIC ACIDS RES, V21, P1369, DOI 10.1093/nar/21.6.1369; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Sakai N, 2001, STRUCTURE, V9, P817, DOI 10.1016/S0969-2126(01)00638-4; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Surtees JA, 2001, J BIOL CHEM, V276, P12385, DOI 10.1074/jbc.M009370200; Wu MY, 2011, NUCLEIC ACIDS RES, V39, P5082, DOI 10.1093/nar/gkr115; Zampini M, 2009, J BACTERIOL, V191, P3832, DOI 10.1128/JB.01630-08	37	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26146	26154		10.1074/jbc.M112.373696	http://dx.doi.org/10.1074/jbc.M112.373696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22674577	Green Published, hybrid			2022-12-25	WOS:000306916300042
J	Lohse, S; Brunke, C; Derer, S; Peipp, M; Boross, P; Kellner, C; Beyer, T; Dechant, M; van der Winkel, JGJ; Leusen, JHW; Valerius, T				Lohse, Stefan; Brunke, Christina; Derer, Stefanie; Peipp, Matthias; Boross, Peter; Kellner, Christian; Beyer, Thomas; Dechant, Michael; van der Winkel, Jan G. J.; Leusen, Jeanette H. W.; Valerius, Thomas			Characterization of a Mutated IgA2 Antibody of the m(1) Allotype against the Epidermal Growth Factor Receptor for the Recruitment of Monocytes and Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-ALPHA-RI; TUMOR-ASSOCIATED MACROPHAGES; FAB-ARM EXCHANGE; EFFECTOR MECHANISMS; IMMUNOGLOBULIN-A; IGG4 ANTIBODIES; NEUTROPHILS; CELLS; CD89; THERAPEUTICS	IgA antibodies constitute an important part of the mucosal immune system, but their immunotherapeutic potential remains rather unexplored, in part due to biotechnological issues. For example, the IgA2m(1) allotype carries an unusual heavy and light chain pairing, which may confer production and stability concerns. Here, we report the generation and the biochemical and functional characterization of a P221R-mutated IgA2m(1) antibody against the epidermal growth factor receptor (EGFR). Compared with wild type, the mutated antibody demonstrated heavy chains covalently linked to light chains in monomeric as well as in joining (J)-chain containing dimeric IgA. Functional studies with wild type and mutated IgA2m(1) revealed similar binding to EGFR and direct effector functions such as EGFR down-modulation and growth inhibition. Furthermore, both IgA molecules triggered similar levels of indirect tumor cell killing such as antibody-dependent cell-mediated cytotoxicity (ADCC) by isolated monocytes, activated polymorphonuclear cells, and human whole blood. Interestingly, the dimeric IgA antibodies demonstrated higher efficiency in direct as well as in indirect effector mechanisms compared with their respective monomeric forms. Both wild type and mutated antibody triggered effective Fc alpha RI-mediated tumor cell killing by macrophages already at low effector to target cell ratios. Interestingly, also polarized macrophages mediated significant IgA2-mediated ADCC. M2 macrophages, which have been described as promoting tumor growth and progression, may convert to ADCC-mediating effector cells in the presence of EGFR-directed antibodies. In conclusion, these results provide further insight into the immunotherapeutic potential of recombinant IgA antibodies for tumor immunotherapy and suggest macrophages as an additional effector cell population.	[Lohse, Stefan; Brunke, Christina; Derer, Stefanie; Peipp, Matthias; Kellner, Christian; Valerius, Thomas] Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Internal Med 2, D-24105 Kiel, Germany; [Beyer, Thomas; Dechant, Michael] Univ Kiel, Dept Internal Med Nephrol & Hypertens 4, D-24105 Kiel, Germany; [Boross, Peter; van der Winkel, Jan G. J.; Leusen, Jeanette H. W.] Univ Med Ctr Utrecht, Dept Immunol, Lab Immunotherapy, NL-3584 EA Utrecht, Netherlands; [van der Winkel, Jan G. J.] Genmab BV, NL-3584 EA Utrecht, Netherlands	University of Kiel; University of Kiel; Utrecht University; Utrecht University Medical Center; Genmab	Valerius, T (corresponding author), Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Internal Med 2, Schittenhelmstr 12, D-24105 Kiel, Germany.	t.valerius@med2.uni-kiel.de	, Jeanette/AAG-3736-2019; beyer, thomas/AAN-1789-2020; Leusen, Jeanette/I-9010-2014; Kellner, Christian/G-4238-2015; Valerius, Thomas/A-3086-2011; Lohse, Stefan/P-6627-2016; Derer, Stefanie/B-9963-2014; Derer, Stefanie/B-9300-2017; Boross, Peter/AAD-8928-2022; Peipp, Matthias/A-8775-2013	Kellner, Christian/0000-0002-2562-6902; Lohse, Stefan/0000-0003-2529-1900; Leusen, Jeanette/0000-0003-4982-6914; Beyer, Thomas/0000-0002-8308-3918; Peipp, Matthias/0000-0002-5088-3804	German Research Organization (Deutsche Forschungsgemeinschaft) [Va 124/7-1, De 1478/1-1, Lo 1853/1-1]; Wilhelm Sander Foundation [2009.098.1]	German Research Organization (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Wilhelm Sander Foundation	This work was supported by the German Research Organization (Deutsche Forschungsgemeinschaft, Va 124/7-1, De 1478/1-1, and Lo 1853/1-1) and the Wilhelm Sander Foundation (2009.098.1).	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Bakema JE, 2008, J IMMUNOL, V181, P4080, DOI 10.4049/jimmunol.181.6.4080; Beyer T, 2009, J IMMUNOL METHODS, V346, P26, DOI 10.1016/j.jim.2009.05.002; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chintalacharuvu KR, 2002, J IMMUNOL, V169, P5072, DOI 10.4049/jimmunol.169.9.5072; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dechant M, 2002, BLOOD, V100, P4574, DOI 10.1182/blood-2002-03-0687; Dechant M, 2007, J IMMUNOL, V179, P2936, DOI 10.4049/jimmunol.179.5.2936; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Huls G, 1999, CANCER RES, V59, P5778; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lohse S, 2011, J IMMUNOL, V186, P3770, DOI 10.4049/jimmunol.1003082; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Maruoka T, 2004, IMMUNOGENETICS, V55, P712, DOI 10.1007/s00251-003-0626-1; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Oortwijn BD, 2006, J AM SOC NEPHROL, V17, P3529, DOI 10.1681/ASN.2006040388; Otten MA, 2007, J IMMUNOL, V179, P2918, DOI 10.4049/jimmunol.179.5.2918; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Peipp M, 2008, CURR OPIN IMMUNOL, V20, P436, DOI 10.1016/j.coi.2008.05.012; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Pleass RJ, 1996, BIOCHEM J, V318, P771, DOI 10.1042/bj3180771; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Senior BW, 2005, J IMMUNOL, V174, P7792, DOI 10.4049/jimmunol.174.12.7792; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; STOPPACCIARO A, 1993, J EXP MED, V178, P151, DOI 10.1084/jem.178.1.151; Togo S, 2003, FEBS LETT, V535, P205, DOI 10.1016/S0014-5793(02)03891-7; TSUZUKIDA Y, 1979, P NATL ACAD SCI USA, V76, P1104, DOI 10.1073/pnas.76.3.1104; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; Wang AC, 1973, J IMMUNOGENET, V1, P31; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yin N, 2007, J LEUKOCYTE BIOL, V82, P551, DOI 10.1189/jlb.0207112; Yoo EM, 2011, MOL IMMUNOL, V48, P1818, DOI 10.1016/j.molimm.2011.05.011	49	28	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25139	25150		10.1074/jbc.M112.353060	http://dx.doi.org/10.1074/jbc.M112.353060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679018	Green Published, hybrid			2022-12-25	WOS:000306651700025
J	Milano, SK; Kwon, W; Pereira, R; Antonyak, MA; Cerione, RA				Milano, Shawn K.; Kwon, Woojin; Pereira, Ryan; Antonyak, Marc A.; Cerione, Richard A.			Characterization of a Novel Activated Ran GTPase Mutant and Its Ability to Induce Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN IMPORT; GROWTH-FACTOR; TRIPHOSPHATE CONFORMATION; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; BINDING PROTEIN; DNA-SYNTHESIS; EXPRESSION; SMOC-2; TRANSPORT	Ran (Ras-related nuclear) protein, a member of the Ras superfamily of GTPases, is best known for its roles in nucleocytoplasmic transport, mitotic spindle fiber assembly, and nuclear envelope formation. Recently, we have shown that the overexpression of Ran in fibroblasts induces cellular transformation and tumor formation in mice (Ly, T. K., Wang, J., Pereira, R., Rojas, K. S., Peng, X., Feng, Q., Cerione, R. A., and Wilson, K. F. (2010) J. Biol. Chem. 285, 5815-5826). Here, we describe a novel activated Ran mutant, Ran(K152A), which is capable of an increased rate of GDP-GTP exchange and an accelerated GTP binding/GTP hydrolytic cycle compared with wild-type Ran. We show that its expression in NIH-3T3 fibroblasts induces anchorage-independent growth and stimulates cell invasion, as well as activates signaling pathways that lead to extracellular regulated kinase (ERK) activity. Furthermore, Ran(K152A) expression in the human mammary SKBR3 adenocarcinoma cell line gives rise to an enhanced transformed phenotype and causes a robust stimulation of both ERK and the N-terminal c-Jun kinase (JNK). Microarray analysis reveals that the expression of the gene encoding SMOC-2 (secreted modular calcium-binding protein-2), which has been shown to synergize with different growth factors, is increased by at least 50-fold in cells stably expressing Ran(K152A) compared with cells expressing control vector. Knocking down SMOC-2 expression greatly reduces the ability of Ran(K152A) to stimulate anchorage-independent growth in NIH-3T3 cells and in SKBR3 cells and also inhibits cell invasion in fibroblasts. Collectively, our findings highlight a novel connection between the hyper-activation of the small GTPase Ran and the matricellular protein SMOC-2 that has important consequences for oncogenic transformation.	[Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM040654] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; CLARKE PR, 1995, J CELL SCI, V108, P1217; Cool RH, 1999, MOL CELL BIOL, V19, P6297; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Joseph J, 2006, J CELL SCI, V119, P3481, DOI 10.1242/jcs.03071; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Ly TK, 2010, J BIOL CHEM, V285, P5815, DOI 10.1074/jbc.M109.071886; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; REN MD, 1994, MOL CELL BIOL, V14, P4216, DOI 10.1128/MCB.14.6.4216; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sato M, 2010, NUCLEUS-PHILA, V1, P231, DOI 10.1038/embor.2009.158; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200	41	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24955	24966		10.1074/jbc.M111.306514	http://dx.doi.org/10.1074/jbc.M111.306514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679017	hybrid, Green Published			2022-12-25	WOS:000306651700009
J	Nyarko, A; Song, YJ; Barbar, E				Nyarko, Afua; Song, Yujuan; Barbar, Elisar			Intrinsic Disorder in Dynein Intermediate Chain Modulates Its Interactions with NudE and Dynactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; MULTIPLE-MODES; LIGHT-CHAINS; PROTEIN; COMPLEX; KINETOCHORE; TRANSPORT; BINDING; MOTOR	The functional diversity of cytoplasmic dynein is in part attributed to multiple interactions between noncatalytic dynein subunits and an array of regulatory proteins. This study focuses on the interaction between the dynein intermediate chain subunit (IC) and a dynein regulator protein (NudE). We use isothermal titration calorimetry and NMR spectroscopy to map their interacting sections to their respective N-terminal domains, which are predicted to form dimeric coiled-coils. Interestingly, the specific residues within IC that interact with NudE are a subset of the bi-segmental binding region reported for p150(Glued), a subunit of the dynein activator protein dynactin. Although the IC binding domains of both NudE and p150(Glued) form dimeric coiled-coils and bind IC at a common site, we observe distinct binding modes for each regulatory protein: 1) NudE binds region 1 of the bi-segmental binding footprint of p150(Glued), whereas p150(Glued) requires regions 1 and 2 to match the binding affinity of NudE with region 1 alone. 2) Compared with unbound IC, NudE-bound IC shows a slight increase in flexibility in region 2, in contrast to the increase in ordered structure observed for p150(Glued)-bound IC (Morgan, J. L., Song, Y., and Barbar, E. (2011) J. Biol. Chem. 286, 39349-39359). 3) Although NudE has a higher affinity for the common binding segment on IC, when all three proteins are in solution, IC preferentially binds p150(Glued). These results underscore the importance of a bi-segmental binding region of IC and disorder in region 2 and flanking linkers in selecting which regulatory protein binds IC.	[Nyarko, Afua; Song, Yujuan; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Nyarko, Afua/R-9872-2019	Barbar, Elisar/0000-0003-4892-5259	National Science Foundation [0818896];  [00210]	National Science Foundation(National Science Foundation (NSF)); 	This work was supported by National Science Foundation Grant 0818896.; We acknowledge the support of the nucleic acid and protein core and the mass spectrometry facilities and services core in the OSU Environmental Health Sciences Center supported by National Institutes of Health NIEHS Grant 00210. We also thank Prof. Clare Woodward for valuable discussions.	Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Boylan KLM, 2002, GENETICS, V162, P1211; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Goddard T.D., SPARKY 3; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 2002, MOL BIOL CELL, V13, P1722, DOI 10.1091/mbc.02-02-0011; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Schaar BT, 2004, NEURON, V44, P213, DOI 10.1016/j.neuron.2004.10.002; SCHROER TA, 1994, CURR OPIN CELL BIOL, V6, P69, DOI 10.1016/0955-0674(94)90118-X; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wainman A, 2009, J CELL SCI, V122, P1747, DOI 10.1242/jcs.041798; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	50	27	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24884	24893		10.1074/jbc.M112.376038	http://dx.doi.org/10.1074/jbc.M112.376038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669947	Green Published, hybrid			2022-12-25	WOS:000306651700003
J	Hamacher, K; Greiner, T; Ogata, H; Van Etten, JL; Gebhardt, M; Villarreal, LP; Cosentino, C; Moroni, A; Thiel, G				Hamacher, Kay; Greiner, Timo; Ogata, Hiroyuki; Van Etten, James L.; Gebhardt, Manuela; Villarreal, Luis P.; Cosentino, Cristian; Moroni, Anna; Thiel, Gerhard			Phycodnavirus Potassium Ion Channel Proteins Question the Virus Molecular Piracy Hypothesis	PLOS ONE			English	Article							ECTOCARPUS-SILICULOSUS VIRUS; MULTIPLE SEQUENCE ALIGNMENT; VIRAL K+ CHANNELS; CHLORELLA VIRUSES; HOST-CELLS; KCV; INFECTION; GENOME; NC64A; EUKARYOTES	Phycodnaviruses are large dsDNA, algal-infecting viruses that encode many genes with homologs in prokaryotes and eukaryotes. Among the viral gene products are the smallest proteins known to form functional K+ channels. To determine if these viral K+ channels are the product of molecular piracy from their hosts, we compared the sequences of the K+ channel pore modules from seven phycodnaviruses to the K+ channels from Chlorella variabilis and Ectocarpus siliculosus, whose genomes have recently been sequenced. C. variabilis is the host for two of the viruses PBCV-1 and NY-2A and E. siliculosus is the host for the virus EsV-1. Systematic phylogenetic analyses consistently indicate that the viral K+ channels are not related to any lineage of the host channel homologs and that they are more closely related to each other than to their host homologs. A consensus sequence of the viral channels resembles a protein of unknown function from a proteobacterium. However, the bacterial protein lacks the consensus motif of all K+ channels and it does not form a functional channel in yeast, suggesting that the viral channels did not come from a proteobacterium. Collectively, our results indicate that the viruses did not acquire their K+ channel-encoding genes from their current algal hosts by gene transfer; thus alternative explanations are required. One possibility is that the viral genes arose from ancient organisms, which served as their hosts before the viruses developed their current host specificity. Alternatively the viral proteins could be the origin of K+ channels in algae and perhaps even all cellular organisms.	[Hamacher, Kay] Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany; [Greiner, Timo; Gebhardt, Manuela; Thiel, Gerhard] Tech Univ Darmstadt, Membrane Biophys Grp, Darmstadt, Germany; [Ogata, Hiroyuki] Aix Marseille Univ, Struct & Genom Informat Lab, Marseille, France; [Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Villarreal, Luis P.] Univ Calif Irvine, Ctr Virus Res, Irvine, CA USA; [Cosentino, Cristian; Moroni, Anna] Univ Milan, Dept Biol, Milan, Italy	Technical University of Darmstadt; Technical University of Darmstadt; UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Irvine; University of Milan	Hamacher, K (corresponding author), Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	moroni, anna/H-2097-2014; Greiner, Timo/Y-1900-2019; Cosentino, Cristian/F-2604-2010	moroni, anna/0000-0002-1860-406X; Greiner, Timo/0000-0002-0909-570X; Cosentino, Cristian/0000-0002-2784-0048; Hamacher, Kay/0000-0002-6921-8345; Thiel, Gerhard/0000-0002-2335-1351	Deutsche Forschungsgemeinschaft [DFG GrK-1657]; Public Health Service Grant [GM32441]; Fonds der Chemischen Industrie; National Institutes of Health grant from the COBRE program of the National Center for Research Resources [P20RR15635]; European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 [201924]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); National Institutes of Health grant from the COBRE program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Drug Initiative on Channels and Transporters (EDICT) project EU FP7; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Study was supported by: 1) Deutsche Forschungsgemeinschaft (DFG GrK-1657: GT, and KH), 2) Public Health Service Grant GM32441 (JLVE), 3) Fonds der Chemischen Industrie (KH), 4) National Institutes of Health grant P20RR15635 from the COBRE program of the National Center for Research Resources (JLVE) 5) European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 (201924) (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balss J, 2008, P NATL ACAD SCI USA, V105, P12313, DOI 10.1073/pnas.0805709105; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Chen J, 2005, BIOCHEM BIOPH RES CO, V326, P887, DOI 10.1016/j.bbrc.2004.11.125; Ciampor F., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P433, DOI 10.1556/AMicr.50.2003.4.9; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Delaroque N, 1999, J GEN VIROL, V80, P1367, DOI 10.1099/0022-1317-80-6-1367; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; Frohns F, 2006, J VIROL, V80, P2437, DOI 10.1128/JVI.80.5.2437-2444.2006; Gazzarrini S, 2006, P NATL ACAD SCI USA, V103, P5355, DOI 10.1073/pnas.0600848103; Gazzarrini S, 2004, J BIOL CHEM, V279, P28443, DOI 10.1074/jbc.M401184200; Gazzarrini S, 2003, FEBS LETT, V552, P12, DOI 10.1016/S0014-5793(03)00777-4; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Greiner T, 2011, PLANT J, V68, P977, DOI 10.1111/j.1365-313X.2011.04748.x; Greiner T, 2009, J GEN VIROL, V90, P2033, DOI 10.1099/vir.0.010629-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Neupartl M, 2008, VIROLOGY, V372, P340, DOI 10.1016/j.virol.2007.10.024; Ogata H, 2007, GENOME RES, V17, P1353, DOI 10.1101/gr.6358607; Ogata H, 2011, ISME J, V5, P1143, DOI 10.1038/ismej.2010.210; Pagliuca C, 2007, BIOCHEMISTRY-US, V46, P1079, DOI 10.1021/bi061530w; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shim JW, 2007, FEBS LETT, V581, P1027, DOI 10.1016/j.febslet.2007.02.005; Tayefeh S, 2009, BIOPHYS J, V96, P485, DOI 10.1016/j.bpj.2008.09.050; Thiel G, 2011, BBA-BIOMEMBRANES, V1808, P580, DOI 10.1016/j.bbamem.2010.04.008; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Van Etten JL, TRENDS PL SCI, V17, P1; Villarreal LP, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P477, DOI 10.1016/B978-0-12-374153-0.00021-7; Wang K., 2010, BIOCHIM BIOPHYS ACTA, V29, P2059; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Yin YB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-24; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoshida T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-427	50	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38826	10.1371/journal.pone.0038826	http://dx.doi.org/10.1371/journal.pone.0038826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685610	Green Published, gold			2022-12-25	WOS:000305351700074
J	Lindgren, D; Sjodahl, G; Lauss, M; Staaf, J; Chebil, G; Lovgren, K; Gudjonsson, S; Liedberg, F; Patschan, O; Mansson, W; Ferno, M; Hoglund, M				Lindgren, David; Sjodahl, Gottfrid; Lauss, Martin; Staaf, Johan; Chebil, Gunilla; Lovgren, Kristina; Gudjonsson, Sigurdur; Liedberg, Fredrik; Patschan, Oliver; Mansson, Wiking; Ferno, Marten; Hoglund, Mattias			Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; COPY NUMBER; ARRAY-CGH; HYBRIDIZATION; TUMORS; INACTIVATION; IMBALANCES; SIGNATURES; MUTATIONS	Similar to other malignancies, urothelial carcinoma (UC) is characterized by specific recurrent chromosomal aberrations and gene mutations. However, the interconnection between specific genomic alterations, and how patterns of chromosomal alterations adhere to different molecular subgroups of UC, is less clear. We applied tiling resolution array CGH to 146 cases of UC and identified a number of regions harboring recurrent focal genomic amplifications and deletions. Several potential oncogenes were included in the amplified regions, including known oncogenes like E2F3, CCND1, and CCNE1, as well as new candidate genes, such as SETDB1 (1q21), and BCL2L1 (20q11). We next combined genome profiling with global gene expression, gene mutation, and protein expression data and identified two major genomic circuits operating in urothelial carcinoma. The first circuit was characterized by FGFR3 alterations, overexpression of CCND1, and 9q and CDKN2A deletions. The second circuit was defined by E3F3 amplifications and RB1 deletions, as well as gains of 5p, deletions at PTEN and 2q36, 16q, 20q, and elevated CDKN2A levels. TP53/MDM2 alterations were common for advanced tumors within the two circuits. Our data also suggest a possible RAS/RAF circuit. The tumors with worst prognosis showed a gene expression profile that indicated a keratinized phenotype. Taken together, our integrative approach revealed at least two separate networks of genomic alterations linked to the molecular diversity seen in UC, and that these circuits may reflect distinct pathways of tumor development.	[Lindgren, David] Lund Univ, Dept Mol Pathol, Malmo, Sweden; [Sjodahl, Gottfrid; Lauss, Martin; Staaf, Johan; Hoglund, Mattias] Lund Univ, Dept Oncol, Canc Branch, Lund, Sweden; [Chebil, Gunilla; Lovgren, Kristina; Ferno, Marten] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Gudjonsson, Sigurdur; Liedberg, Fredrik; Patschan, Oliver; Mansson, Wiking] Skane Univ Hosp, Dept Urol, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Lindgren, D (corresponding author), Lund Univ, Dept Mol Pathol, Malmo, Sweden.	mattias.hoglund@med.lu.se	Gudjonsson, S./K-6878-2015	Gudjonsson, S./0000-0002-5147-595X; Sjodahl, Gottfrid/0000-0002-7869-0473; Hoglund, Mattias/0000-0001-9283-4421; Patschan, Oliver/0000-0001-5788-794X	Swedish Cancer Society [10 0517]; Swedish Research Council [2011-17816-83790-87]; Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	This work was supported by the Swedish Cancer Society (http://www.vr.se) (grant number 10 0517), the Swedish Research Council (www.cancerfonden.se/) (grant number 2011-17816-83790-87), the Crafoord Foundation (http://www.crafoord.se/vetenskaplig_forskning.asp), the Gunnar Nilsson Foundation (http://www.cancerstiftelsen.com/), the Medical Faculty of Lund University Hospital (http://www.med.lu.se/), and the Swedish Society for Medical Research (http://www.ssmf.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Fadl-Elmula Imad, 2005, Cell Chromosome, V4, P1, DOI 10.1186/1475-9268-4-1; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Haigis KM, 2011, NAT GENET, V43, P177, DOI 10.1038/ng0311-177; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hoglund M, 2001, CANCER RES, V61, P8241; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Majewski T, 2008, LAB INVEST, V88, P694, DOI 10.1038/labinvest.2008.27; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Richter J, 1998, AM J PATHOL, V153, P1615, DOI 10.1016/S0002-9440(10)65750-1; Richter J, 1997, CANCER RES, V57, P2860; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Staaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-382; Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330; Veltman JA, 2003, CANCER RES, V63, P2872; Williams SV, 2002, GENE CHROMOSOME CANC, V34, P86, DOI 10.1002/gcc.10050; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697	25	150	152	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38863	10.1371/journal.pone.0038863	http://dx.doi.org/10.1371/journal.pone.0038863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685613	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700077
J	Gilardi, JD; Toft, CA				Gilardi, James D.; Toft, Catherine A.			Parrots Eat Nutritious Foods despite Toxins	PLOS ONE			English	Article							YELLOW-CHEVRONED PARAKEET; DISPERSAL SEED PREDATION; LILAC-CROWNED PARROT; ARTEMIA-SALINA; DRY FOREST; SOIL CHARACTERISTICS; TOXICITY ASSESSMENT; SCARLET MACAW; BRINE SHRIMP; RAIN-FOREST	Background: Generalist herbivores are challenged not only by the low nitrogen and high indigestibility of their plant foods, but also by physical and chemical defenses of plants. This study investigated the foods of wild parrots in the Peruvian Amazon and asked whether these foods contain dietary components that are limiting for generalist herbivores (protein, lipids, minerals) and in what quantity; whether parrots chose foods based on nutrient content; and whether parrots avoid plants that are chemically defended. Methodology/Principal Findings: We made 224 field observations of free-ranging parrots of 17 species in 8 genera foraging on 102 species of trees in an undisturbed tropical rainforest, in two dry seasons (July-August 1992-1993) and one wet season (January-February 1994). We performed laboratory analyses of parts of plants eaten and not eaten by parrots and brine shrimp assays of toxicity as a proxy for vertebrates. Parrots ate seeds, fruits, flowers, leaves, bark, and insect larvae, but up to 70% of their diet comprised seeds of many species of tropical trees, in various stages of ripeness. Plant parts eaten by parrots were rich in protein, lipid, and essential minerals, as well as potentially toxic chemicals. Seeds were higher than other plant materials in protein and lipid and lower in fiber. Large macaws of three species ate foods higher in protein and lipids and lower in fiber compared to plant parts available but not eaten. Macaws ate foods that were lower in phenolic compounds than foods they avoided. Nevertheless, foods eaten by macaws contained measurable levels of toxicity. Macaws did not appear to make dietary selections based on mineral content. Conclusions/Significance: Parrots represent a remarkable example of a generalist herbivore that consumes seeds destructively despite plant chemical defenses. With the ability to eat toxic foods, rainforest-dwelling parrots exploited a diversity of nutritious foods, even in the dry season when food was scarce for other frugivores and granivores.	[Gilardi, James D.; Toft, Catherine A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Gilardi, JD (corresponding author), World Parrot Trust, Lake Alfred, FL USA.	gilardi@worldparrottrust.org			Wildlife Conservation Society	Wildlife Conservation Society	Funding was provided primarily by intramural graduate fellowships for salary support for JDG and intramural small grants for research supplies (UC Davis Graduate Division, Center for Population Biology) and one small extramural award for research supplies from the Wildlife Conservation Society, a scholarly society that mentors graduate students. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo V, 1992, AFA WATCHBIRD, V19, P31; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Banko PC, 2002, J CHEM ECOL, V28, P1393, DOI 10.1023/A:1016248502927; Berg KS, 2007, J FIELD ORNITHOL, V78, P1, DOI 10.1111/j.1557-9263.2006.00080.x; Blohm H, 1962, POISONOUS PLANTS VEN; Bonadie WA, 2000, BIOL CONSERV, V95, P1, DOI 10.1016/S0006-3207(00)00018-5; Bosque C, 2003, COMP BIOCHEM PHYS A, V135, P321, DOI 10.1016/S1095-6433(03)00080-1; Boyes RS, 2010, AFR J ECOL, V48, P769, DOI 10.1111/j.1365-2028.2009.01177.x; Brightsmith DJ, 2004, BIOTROPICA, V36, P534, DOI 10.1646/1602; Brightsmith DJ, 2008, BIOTROPICA, V40, P766, DOI 10.1111/j.1744-7429.2008.00429.x; Brightsmith DJ, 2010, J AVIAN MED SURG, V24, P9, DOI 10.1647/1082-6742-24.1.9; Cano A, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P271; COATESESTRADA R, 1993, J TROP ECOL, V9, P121, DOI 10.1017/S0266467400007070; da Silva PA, 2007, REV BRAS ORNITOL, V15, P127; Favilla M, 2006, FOOD CHEM TOXICOL, V44, P1922, DOI 10.1016/j.fct.2006.06.024; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOSTER R., 1994, RAP WORKING PAPERS, V6; Francisco MR, 2008, ACTA OECOL, V33, P240, DOI 10.1016/j.actao.2007.11.002; Francisco MR, 2002, BIOTROPICA, V34, P613, DOI 10.1111/j.1744-7429.2002.tb00582.x; FREELAND WJ, 1989, BIOCHEM SYST ECOL, V17, P493, DOI 10.1016/0305-1978(89)90029-X; GALETTI M, 1992, BIOTROPICA, V24, P222, DOI 10.2307/2388679; Galetti Mauro, 1997, Ararajuba, V5, P115; Herrera LG, 2006, BIOTROPICA, V38, P735, DOI 10.1111/j.1744-7429.2006.00201.x; Gilardi JD, 1998, CONDOR, V100, P641, DOI 10.2307/1369745; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; Gilardi JD, 1996, THESIS UC DAVIS DAVI; Goering H. K, 1970, FORAGE FIBER ANALYSE, V379; Green AK, 2004, COMP BIOCHEM PHYS A, V139, P325, DOI 10.1016/j.cbpb.2004.09.017; Hartl M, 2000, FOOD CHEM TOXICOL, V38, P1097, DOI 10.1016/S0278-6915(00)00112-5; Haugaasen T, 2008, ORNITOL NEOTROP, V19, P321; Herrerias-Diego Y, 2008, BIOL CONSERV, V141, P241, DOI 10.1016/j.biocon.2007.09.017; Homberger D.G., 1980, Bonner Zoologische Monographien, P1; Horgen FD, 2001, PHYTOMEDICINE, V8, P71, DOI 10.1078/0944-7113-00019; Houston D, 2007, BIOL CONSERV, V138, P248, DOI 10.1016/j.biocon.2007.04.023; Villasenor-Sanchez EI, 2010, J TROP ECOL, V26, P227, DOI 10.1017/S0266467409990447; JAKUBAS WJ, 1995, CAN J ZOOL, V73, P1106, DOI 10.1139/z95-132; JANZEN DH, 1990, BIOTROPICA, V22, P272, DOI 10.2307/2388538; JANZEN DH, 1981, AUK, V98, P841; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Krishnaraju AV, 2005, INT J APPL SCI ENG, V3, P125, DOI [10.6703/IJASE.2005.3(2).125, DOI 10.6703/IJASE.2005.3(2).125]; Mangione AM, 2004, J CHEM ECOL, V30, P1409, DOI 10.1023/B:JOEC.0000037748.19927.a1; Masello JF, 2006, EMU, V106, P69, DOI 10.1071/MU04047; Matuzak GD, 2008, WILSON J ORNITHOL, V120, P353, DOI 10.1676/07-038.1; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Milton K., 1980, FORAGING STRATEGIES; Moegenburg SM, 2003, ECOLOGY, V84, P2600, DOI 10.1890/02-0063; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Norconk MA, 2004, INT J PRIMATOL, V25, P1, DOI 10.1023/B:IJOP.0000014642.68751.ed; Norconk MA, 1997, PRIMATES, V38, P177, DOI 10.1007/BF02382007; Norconk MA, 1998, AM J PRIMATOL, V45, P103, DOI 10.1002/(SICI)1098-2345(1998)45:1<103::AID-AJP8>3.0.CO;2-#; Paranhos SJ, 2007, REV BRAS ORNITOL, V15, P95; Powell LL, 2009, BIOTROPICA, V41, P279, DOI 10.1111/j.1744-7429.2009.00514.x; Pryor GS, 2001, AUK, V118, P1080, DOI 10.1642/0004-8038(2001)118[1080:PROASF]2.0.CO;2; Ragusa-Netto J, 2008, STUD NEOTROP FAUNA E, V43, P99, DOI 10.1080/01650520701510859; Ragusa-Netto J, 2007, STUD NEOTROP FAUNA E, V42, P93, DOI 10.1080/01650520600979643; Renton K, 2006, BIOTROPICA, V38, P280, DOI 10.1111/j.1744-7429.2006.00123.x; Renton K, 2001, CONDOR, V103, P62, DOI 10.1650/0010-5422(2001)103[0062:LCPDAF]2.0.CO;2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robbins C.S., 1981, Studies in Avian Biology, P275; Rodriguez-Ferraro A, 2007, WILSON J ORNITHOL, V119, P602, DOI 10.1676/06-028.1; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; Schaefer HM, 2003, ANIM BEHAV, V65, P531, DOI 10.1006/anbe.2003.2089; SEIBERT R. J., 1948, ANN MISSOURI BOT GARD, V35, P117, DOI 10.2307/2394388; Selman RG, 2002, OSTRICH, V73, P127, DOI 10.1080/00306525.2002.11446741; Shepherd JD, 2008, REV CHIL HIST NAT, V81, P395; Silva da, 2005, REV BRAS ORNITOL, V13, P183; SILVIUS KM, 1995, BIOTROPICA, V27, P96, DOI 10.2307/2388907; SOLIS PN, 1993, PLANTA MED, V59, P250, DOI 10.1055/s-2006-959661; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; SWEENEY RA, 1989, J ASSOC OFF ANA CHEM, V72, P770; Symes CT, 2007, EMU, V107, P115, DOI 10.1071/MU06041; Symes CT, 2003, TROP ZOOL, V16, P47, DOI 10.1080/03946975.2003.10531183; Taylor S, 2006, OSTRICH, V77, P179, DOI 10.2989/00306520609485531; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; Trivedi MR, 2004, BIOTROPICA, V36, P118, DOI 10.1111/j.1744-7429.2004.tb00302.x; Tsahar E, 2006, AUK, V123, P1004, DOI 10.1642/0004-8038(2006)123[1004:DNAFBH]2.0.CO;2; Undersander D., 1993, FORAGE ANALYSES PROC, DOI DOI 10.1093/JAOAC/81.3.620; Vaughan C, 2006, REV BIOL TROP, V54, P919; Vilialba JJ, 2007, ANIMAL, V1, P1360, DOI 10.1017/S1751731107000134; Waterman P., 1994, ANAL PLANT PHENOLIC; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wolf P, 2007, J ANIM PHYSIOL AN N, V91, P282, DOI 10.1111/j.1439-0396.2007.00706.x; Wright TF, 2008, ANIM BEHAV, V76, P1017, DOI 10.1016/j.anbehav.2008.03.025	84	34	35	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38293	10.1371/journal.pone.0038293	http://dx.doi.org/10.1371/journal.pone.0038293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679496	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900026
J	Estruch, SB; Buzon, V; Carbo, LR; Schorova, L; Luders, J; Estebanez-Perpina, E				Estruch, Sara B.; Buzon, Victor; Carbo, Laia R.; Schorova, Lenka; Lueders, Jens; Estebanez-Perpina, Eva			The Oncoprotein BCL11A Binds to Orphan Nuclear Receptor TLX and Potentiates its Transrepressive Function	PLOS ONE			English	Article							NEURAL STEM-CELLS; ANDROGEN-RECEPTOR; TAILLESS; TRANSCRIPTION; EXPRESSION; NEUROGENESIS; COREPRESSOR; PROTEINS; RECRUITS; HOMOLOG	Nuclear orphan receptor TLX (NR2E1) functions primarily as a transcriptional repressor and its pivotal role in brain development, glioblastoma, mental retardation and retinopathologies make it an attractive drug target. TLX is expressed in the neural stem cells (NSCs) of the subventricular zone and the hippocampus subgranular zone, regions with persistent neurogenesis in the adult brain, and functions as an essential regulator of NSCs maintenance and self-renewal. Little is known about the TLX social network of interactors and only few TLX coregulators are described. To identify and characterize novel TLX-binders and possible coregulators, we performed yeast-two-hybrid (Y2H) screens of a human adult brain cDNA library using different TLX constructs as baits. Our screens identified multiple clones of Atrophin-1 (ATN1), a previously described TLX interactor. In addition, we identified an interaction with the oncoprotein and zinc finger transcription factor BCL11A (CTIP1/Evi9), a key player in the hematopoietic system and in major blood-related malignancies. This interaction was validated by expression and coimmunoprecipitation in human cells. BCL11A potentiated the transrepressive function of TLX in an in vitro reporter gene assay. Our work suggests that BCL11A is a novel TLX coregulator that might be involved in TLX-dependent gene regulation in the brain.	[Estruch, Sara B.; Buzon, Victor; Carbo, Laia R.; Schorova, Lenka; Estebanez-Perpina, Eva] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Estruch, Sara B.; Buzon, Victor; Carbo, Laia R.; Schorova, Lenka; Estebanez-Perpina, Eva] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Lueders, Jens] Inst Res Biomed, Cell & Dev Biol Programme, Barcelona, Spain	University of Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Estruch, SB (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain.	evaestebanez@ub.edu	Lüders, Jens/H-2812-2015; Estebanez-Perpina, Eva/L-4021-2014	Lüders, Jens/0000-0002-9018-7977; Estebanez-Perpina, Eva/0000-0003-2687-5801	RyC fellowship; Ministerio de Ciencia e Innovacion (Gobierno de Espana) [SAF-2008-03562, SAF-2011- 29681]; Marie-Curie International Reintegration Grant [224812]; Marato de TV3 Grant-Malalties Rares; Asociacion Espanola Contra el Cancer	RyC fellowship; Ministerio de Ciencia e Innovacion (Gobierno de Espana)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie-Curie International Reintegration Grant(European Commission); Marato de TV3 Grant-Malalties Rares; Asociacion Espanola Contra el Cancer	EEP is supported by a RyC-2007 fellowship, SAF-2008-03562 and SAF-2011- 29681 projects from the Ministerio de Ciencia e Innovacion (Gobierno de Espana), a Marie-Curie International Reintegration Grant (IRG-code 224812) and the Marato de TV3 Grant-Malalties Rares (2010). SBE is recipient of a PPL Grant from the Asociacion Espanola Contra el Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Gui HX, 2011, DEV NEUROSCI-BASEL, V33, P1, DOI 10.1159/000321585; Gunnersen JM, 2002, MOL CELL NEUROSCI, V19, P560, DOI 10.1006/mcne.2001.1098; Ingraham HA, 2005, CURR OPIN STRUC BIOL, V15, P708, DOI 10.1016/j.sbi.2005.10.009; Jackson A, 1998, GENOMICS, V50, P34, DOI 10.1006/geno.1998.5270; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Kuo TY, 2007, J NEUROSCI RES, V85, P1628, DOI 10.1002/jnr.21300; Kuo TY, 2010, J NEUROSCI RES, V88, P2364, DOI 10.1002/jnr.22407; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Sankaran VG, 2010, ANN NY ACAD SCI, V1202, P64, DOI 10.1111/j.1749-6632.2010.05574.x; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Suzuki Y, 2011, INT J CLIN EXP PATHO, V4, P378; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wang L, 2008, NUCL RECEPT SIGNAL, P6; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Young KA, 2002, BEHAV BRAIN RES, V132, P145, DOI 10.1016/S0166-4328(01)00413-2; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4	41	22	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37963	10.1371/journal.pone.0037963	http://dx.doi.org/10.1371/journal.pone.0037963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675500	Green Published, gold			2022-12-25	WOS:000305341700029
J	Abdelmagid, SM; Barr, AE; Rico, M; Amin, M; Litvin, J; Popoff, SN; Safadi, FF; Barbe, MF				Abdelmagid, Samir M.; Barr, Ann E.; Rico, Mario; Amin, Mamta; Litvin, Judith; Popoff, Steven N.; Safadi, Fayez F.; Barbe, Mary F.			Performance of Repetitive Tasks Induces Decreased Grip Strength and Increased Fibrogenic Proteins in Skeletal Muscle: Role of Force and Inflammation	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; CARPAL-TUNNEL-SYNDROME; FACTOR GENE-EXPRESSION; FLEXOR TENDON CELLS; TNF-ALPHA; RAT MODEL; IN-VIVO; STRAIN INJURY; LENGTHENING CONTRACTIONS	Background: This study elucidates exposure-response relationships between performance of repetitive tasks, grip strength declines, and fibrogenic-related protein changes in muscles, and their link to inflammation. Specifically, we examined forearm flexor digitorum muscles for changes in connective tissue growth factor (CTGF; a matrix protein associated with fibrosis), collagen type I (Col1; a matrix component), and transforming growth factor beta 1 (TGFB1; an upstream modulator of CTGF and collagen), in rats performing one of two repetitive tasks, with or without anti-inflammatory drugs. Methodology/Results: To examine the roles of force versus repetition, rats performed either a high repetition negligible force food retrieval task (HRNF), or a high repetition high force handle-pulling task (HRHF), for up to 9 weeks, with results compared to trained only (TR-NF or TR-HF) and normal control rats. Grip strength declined with both tasks, with the greatest declines in 9-week HRHF rats. Quantitative PCR (qPCR) analyses of HRNF muscles showed increased expression of Col1 in weeks 3-9, and CTGF in weeks 6 and 9. Immunohistochemistry confirmed PCR results, and also showed greater increases of CTGF and collagen matrix in 9-week HRHF rats than 9-week HRNF rats. ELISA, and immunohistochemistry revealed greater increases of TGFB1 in TR-HF and 6-week HRHF, compared to 6-week HRNF rats. To examine the role of inflammation, results from 6-week HRHF rats were compared to rats receiving ibuprofen or anti-TNF-alpha treatment in HRHF weeks 4-6. Both treatments attenuated HRHF-induced increases in CTGF and fibrosis by 6 weeks of task performance. Ibuprofen attenuated TGFB1 increases and grip strength declines, matching our prior results with anti-TNF alpha. Conclusions/Significance: Performance of highly repetitive tasks was associated with force-dependent declines in grip strength and increased fibrogenic-related proteins in flexor digitorum muscles. These changes were attenuated, at least short-term, by anti-inflammatory treatments.	[Abdelmagid, Samir M.] Childrens Hosp Philadelphia, Dept Surg, Plast & Reconstruct Div, Philadelphia, PA 19104 USA; [Barr, Ann E.] Univ Pacific, Coll Hlth Profess, Hillsboro, OR USA; [Rico, Mario] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Amin, Mamta; Litvin, Judith; Popoff, Steven N.; Barbe, Mary F.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Litvin, Judith; Popoff, Steven N.; Safadi, Fayez F.; Barbe, Mary F.] Temple Univ, Sch Med, Musculoskeletal Res Grp, Philadelphia, PA 19122 USA; [Safadi, Fayez F.] NE Ohio Med Univ NEOMED, Dept Anat & Neurobiol, Rootstown, OH USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of the Pacific; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Northeast Ohio Medical University (NEOMED)	Abdelmagid, SM (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Plast & Reconstruct Div, Philadelphia, PA 19104 USA.	mary.barbe@temple.edu	Safadi, Fayez/AAU-8699-2021	Barbe, Mary/0000-0002-5235-9803; Rico, Mario/0000-0002-1356-0416	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) [AR056019, AR051212]; National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) [OH-8599]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U01OH008599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051212, R01AR056019] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by Grant Numbers AR056019 to MFB and AR051212 AEB from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH), and by Grant Number OH-8599 to MFB from the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Al-Shatti T, 2005, J NEUROIMMUNOL, V167, P13, DOI 10.1016/j.jneuroim.2005.06.013; Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Baker BA, 2007, MED SCI SPORT EXER, V39, P1275, DOI 10.1249/mss.0b013e3180686dc7; Banes AJ, 1999, OSTEOARTHR CARTILAGE, V7, P141, DOI 10.1053/joca.1998.0169; Barbe MF, 2008, J ORTHOP RES, V26, P1320, DOI 10.1002/jor.20674; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Barr AE, 2003, J BONE MINER RES, V18, P2023, DOI 10.1359/jbmr.2003.18.11.2023; Beddy D, 2006, BRIT J SURG, V93, P1290, DOI 10.1002/bjs.5431; Bosetti M, 2012, J TISSUE ENG REGEN M, V6, P205, DOI [10.1002/term.416, 10.1002/term.1526]; Bureau of Labor Statistics, 2010, BUR LAB STAT PUBL; Byl NN, 2007, ILAR J, V48, P411, DOI 10.1093/ilar.48.4.411; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Clark BD, 2003, J NEUROTRAUM, V20, P681, DOI 10.1089/089771503322144590; Clarke MSF, 1996, FASEB J, V10, P502, DOI 10.1096/fasebj.10.4.8647349; Coq JO, 2009, EXP NEUROL, V220, P234, DOI 10.1016/j.expneurol.2009.08.008; Cutlip RG, 2006, APPL PHYSIOL NUTR ME, V31, P573, DOI 10.1139/H06-033; Czarkowska-Paczek B, 2009, J PHYSIOL PHARMACOL, V60, P157; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Driban JB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/691412; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Elliott MB, 2009, NEUROSCI LETT, V454, P34, DOI 10.1016/j.neulet.2009.01.037; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; FEIT H, 1989, MUSCLE NERVE, V12, P486, DOI 10.1002/mus.880120609; FibroGen, 2012, ANTICTGF MON ANT; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Harwood FL, 1999, WOUND REPAIR REGEN, V7, P381, DOI 10.1046/j.1524-475X.1999.00381.x; HARWOOD R, 1976, BIOCHEM J, V156, P81, DOI 10.1042/bj1560081; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Iwasaki T, 2005, AM J PHYSIOL-ENDOC M, V288, pE1222, DOI 10.1152/ajpendo.00370.2004; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Krentz JR, 2008, APPL PHYSIOL NUTR ME, V33, P470, DOI 10.1139/H08-019; Lapointe BM, 2002, AM J PHYSIOL-REG I, V282, pR323, DOI 10.1152/ajpregu.00339.2001; LARSSON B, 1992, ACTA ORTHOP SCAND, V63, P203, DOI 10.3109/17453679209154824; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Machida M, 2010, J PHYSIOL PHARMACOL, V61, P559; Martinez-Salgado C, 2006, EXP CELL RES, V312, P2093, DOI 10.1016/j.yexcr.2006.03.008; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; NIOSH, 2011, NAT MAN AG JUN 2010; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Rani S, 2009, J HISTOCHEM CYTOCHEM, V57, P1061, DOI 10.1369/jhc.2009.954081; Rani S, 2009, BONE, V44, P502, DOI 10.1016/j.bone.2008.11.012; Rice TL, 2008, BRIT J SPORT MED, V42, P758, DOI 10.1136/bjsm.2007.038067; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Schafers M, 2003, PAIN, V104, P579, DOI 10.1016/S0304-3959(03)00115-5; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; Sommerich CM, 2007, J ORTHOP RES, V25, P713, DOI 10.1002/jor.20363; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Stauber WT, 1996, MUSCLE NERVE, V19, P423, DOI 10.1002/mus.880190402; STAUBER WT, 1990, J APPL PHYSIOL, V69, P868, DOI 10.1152/jappl.1990.69.3.868; Stauber WT, 2000, MUSCLE NERVE, V23, P1819, DOI 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2; Topp KS, 1999, MOVEMENT DISORD, V14, P295, DOI 10.1002/1531-8257(199903)14:2<295::AID-MDS1015>3.0.CO;2-J; Trappe TA, 2011, AM J PHYSIOL-REG I, V300, pR655, DOI 10.1152/ajpregu.00611.2010; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Willems MET, 2010, J PHYSIOL SCI, V60, P143, DOI 10.1007/s12576-009-0078-y; Williams RO, 2000, J IMMUNOL, V165, P7240, DOI 10.4049/jimmunol.165.12.7240; Yu F, 2009, CELL SIGNAL, V21, P867, DOI 10.1016/j.cellsig.2009.01.030; Ziltener J. -L., 2010, Annals of Physical and Rehabilitation Medicine, V53, P278, DOI 10.1016/j.rehab.2010.03.001	71	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38359	10.1371/journal.pone.0038359	http://dx.doi.org/10.1371/journal.pone.0038359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675458	gold, Green Published			2022-12-25	WOS:000305338500139
J	Hao, J; Meng, LQ; Xu, PC; Chen, M; Zhao, MH				Hao, Jian; Meng, Li-Qiang; Xu, Peng-Cheng; Chen, Min; Zhao, Ming-Hui			p38MAPK, ERK and PI3K Signaling Pathways Are Involved in C5a-Primed Neutrophils for ANCA-Mediated Activation	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; PROTEIN-KINASE; ANTIMYELOPEROXIDASE ANTIBODIES; MOLECULAR-STRUCTURE; REGULATED KINASE; GLOMERULONEPHRITIS; MYELOPEROXIDASE; AUTOANTIBODIES; INHIBITION; VASCULITIS	Background: The complement system is one of the important contributing factors in the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). C5a and the neutrophil C5a receptor play a central role in antineutrophil cytoplasmic antibody (ANCA)-mediated neutrophil recruitment and activation. The current study further investigated the signaling pathways of C5a-mediated priming of human neutrophils for ANCA-induced neutrophil activation. Methodology/Principal Findings: The effects of the p38 mitogen-activated protein kinase (p38MAPK) inhibitor (SB202190), extracellular signal-regulated kinase (ERK) inhibitor (PD98059), c-Jun N-terminal kinase (JNK) inhibitor (6o) and phosphoinositol 3-kinase (PI3K) inhibitor (LY294002) were tested on respiratory burst and degranulation of C5a-primed neutrophils activated with ANCA, as well as on C5a-induced increase in expression of membrane-bound PR3 (mPR3) on neutrophils. For C5a-primed neutrophils for MPO-ANCA-induced respiratory burst, the mean fluorescence intensity (MFI) value was 254.8 +/- 67.1, which decreased to 203.6 +/- 60.3, 204.4 +/- 36.7, 202.4 +/- 49.9 and 188 +/- 47.9 upon pre-incubation with SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without inhibitors, P<0.01, P<0.05, P<0.01 and P<0.05), respectively. For PR3-ANCA-positive IgG, the MFI value increased in C5a-primed neutrophils, which decreased upon pre-incubation with above-mentioned inhibitors. The lactoferrin concentration increased in C5a-primed neutrophils induced by MPO or PR3-ANCA-positive IgG supernatant and decreased upon preincubation with above-mentioned three inhibitors. mPR3 expression increased from 923.3 +/- 182.4 in untreated cells to 1278.3 +/- 299.3 after C5a treatment and decreased to 1069.9 +/- 188.9, 1100 +/- 238.2, 1092.3 +/- 231.8 and 1053.9 +/- 200.3 by SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without inhibitors, P<0.01, P<0.05, P<0.01 and P<0.01), respectively. Conclusions/Significance: Activation of p38MAPK, ERK and PI3K are important steps in the translocation of ANCA antigens and C5a-induced activation of neutrophils by ANCA.	[Hao, Jian; Meng, Li-Qiang; Xu, Peng-Cheng; Chen, Min; Zhao, Ming-Hui] Peking Univ, Minist Hlth China, Key Lab Renal Dis, Renal Div,Dept Med,Inst Nephrol,Hosp 1, Beijing 100871, Peoples R China; [Hao, Jian] Inner Mongolia Med Coll, Affiliated Hosp, Dept Med, Div Renal, Hohhot, Inner Mongolia, Peoples R China	Peking University; Inner Mongolia Medical University	Hao, J (corresponding author), Peking Univ, Minist Hlth China, Key Lab Renal Dis, Renal Div,Dept Med,Inst Nephrol,Hosp 1, Beijing 100871, Peoples R China.	leimeng@public3.bta.net.cn	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Chinese 973 project [2012CB517702]; National Natural Science Fund [30972733, 81021004]	Chinese 973 project(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study is supported by a grant of Chinese 973 project (No. 2012CB517702) and two grants from the National Natural Science Fund (No. 30972733 and No. 81021004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Choi M, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.2003.00718.x; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Franssen CFM, 1999, J AM SOC NEPHROL, V10, P1506; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hess C, 2000, BLOOD, V96, P2822; Hewins P, 2006, KIDNEY INT, V69, P605, DOI 10.1038/sj.ki.5000167; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kauskot A, 2007, J BIOL CHEM, V282, P31990, DOI 10.1074/jbc.M701596200; KEOGAN MT, 1992, CLIN EXP IMMUNOL, V90, P228; Kettritz R, 2001, J AM SOC NEPHROL, V12, P37, DOI 10.1681/ASN.V12137; Kettritz R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019411.36000.06; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; MULDER AHL, 1994, CLIN EXP IMMUNOL, V98, P270; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; PORGES AJ, 1994, J IMMUNOL, V153, P1271; REUMAUX D, 1995, BLOOD, V86, P3189; Rodriguez-Franco Dora Alicia, 2005, Rev Latinoam Microbiol, V47, P102; Runden E, 1998, J NEUROSCI, V18, P7296; Schaeffer V, 2007, SHOCK, V27, P623, DOI 10.1097/SHK.0b013e31802fa0bd; Schreiber A, 2010, KIDNEY INT, V77, P118, DOI 10.1038/ki.2009.420; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; van der Veen BS, 2011, ANN RHEUM DIS, V70, P356, DOI 10.1136/ard.2010.129106; Veeranna, 1998, J NEUROSCI, V18, P4008; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946	37	60	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38317	10.1371/journal.pone.0038317	http://dx.doi.org/10.1371/journal.pone.0038317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675451	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500129
J	Rana, S; Nissen, F; Marr, A; Markert, A; Altmann, A; Mier, W; Debus, J; Haberkorn, U; Askoxylakis, V				Rana, Shoaib; Nissen, Felix; Marr, Annabell; Markert, Annette; Altmann, Annette; Mier, Walter; Debus, Juergen; Haberkorn, Uwe; Askoxylakis, Vasileios			Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CANCER-THERAPY; EXPRESSION; HYPOXIA; MARKER; ANTIGEN; MATU	Background: Carbonic anhydrase IX (CA IX) is a hypoxia-regulated transmembrane protein over-expressed in various types of human cancer. Recently, a new peptide with affinity for human carbonic anhydrase IX (CaIX-P1) was identified using the phage display technology. Aim of the present study is to characterize the binding site in the sequence of CaIX-P1, in order to optimize the binding and metabolic properties and use it for targeting purposes. Methodology/Principal Findings: Various fragments of CaIX-P1 were synthesized on solid support using Fmoc chemistry. Alanine scanning was performed for identification of the amino acids crucial for target binding. Derivatives with increased binding affinity were radiolabeled and in vitro studies were carried out on the CA IX positive human renal cell carcinoma cell line SKRC 52 and the CA IX negative human pancreatic carcinoma cell line BxPC3. Metabolic stability was investigated in cell culture medium and human serum. Organ distribution and planar scintigraphy studies were performed in Balb/c nu/nu mice carrying subcutaneously transplanted SKRC 52 tumors. The results of our studies clearly identified amino acids that are important for target binding. Among various fragments and derivatives the ligand CaIX-P1-4-10 (NHVPLSPy) was found to possess increased binding potential in SKRC 52 cells, whereas no binding capacity for BxPC3 cells was observed. Binding of radiolabeled CaIX-P1-4-10 on CA IX positive cells could be inhibited by both the unlabeled and the native CaIX-P1 peptide but not by control peptides. Stability experiments indicated the degradation site in the sequence of CaIX-P1-4-10. Biodistribution studies showed a higher in vivo accumulation in the tumor than in most healthy tissues. Conclusions: Our data reveal modifications in the sequence of the CA IX affine ligand CaIX-P1 that might be favorable for improvement of target affinity and metabolic stability, which are necessary prior to the use of the ligand in clinical approaches.	[Rana, Shoaib; Debus, Juergen; Askoxylakis, Vasileios] Univ Heidelberg, Dept Radiat Oncol, Heidelberg, Germany; [Rana, Shoaib; Marr, Annabell; Markert, Annette; Altmann, Annette; Haberkorn, Uwe; Askoxylakis, Vasileios] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany; [Nissen, Felix; Marr, Annabell; Markert, Annette; Altmann, Annette; Mier, Walter; Haberkorn, Uwe] Univ Heidelberg, Dept Nucl Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Rana, S (corresponding author), Univ Heidelberg, Dept Radiat Oncol, Heidelberg, Germany.	v.askoxylakis@dkfz.de			Tumorzentrum Heidelberg/Mannheim; Postdoc Program of the Medical Faculty of the University of Heidelberg	Tumorzentrum Heidelberg/Mannheim; Postdoc Program of the Medical Faculty of the University of Heidelberg	This project has been financially supported by the Tumorzentrum Heidelberg/Mannheim. VA received financial support from the Postdoc Program of the Medical Faculty of the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askoxylakis V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015962; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; Choschzick M, 2011, VIRCHOWS ARCH, V459, P193, DOI 10.1007/s00428-011-1105-y; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Li G, 2010, UROL ONCOL; Li GR, 2001, CLIN CANCER RES, V7, P89; Li GR, 2007, CLIN EXP METASTAS, V24, P149, DOI 10.1007/s10585-007-9064-z; Li Peng, 2002, Current Topics in Medicinal Chemistry, V2, P325, DOI 10.2174/1568026023394209; LIAO SY, 1994, AM J PATHOL, V145, P598; Marr A, 2011, METHODS, V55, P215, DOI 10.1016/j.ymeth.2011.05.002; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Saarnio J, 1998, AM J PATHOL, V153, P279, DOI 10.1016/S0002-9440(10)65569-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siebels M, 2011, WORLD J UROL, V29, P121, DOI 10.1007/s00345-010-0570-2; Supuran C.T., 2009, DRUG DESIGN ZINC ENZ, DOI [10.1002/9780470508169.ch22, DOI 10.1002/9780470508169]; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Tran L, 2011, J PHARMACEUT BIOMED, V56, P609, DOI 10.1016/j.jpba.2011.05.026; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wykoff CC, 2000, CANCER RES, V60, P7075; ZAVADA J, 1993, INT J CANCER, V54, P268, DOI 10.1002/ijc.2910540218	25	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38279	10.1371/journal.pone.0038279	http://dx.doi.org/10.1371/journal.pone.0038279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693612	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500123
J	Reynolds, PL; Bruno, JF				Reynolds, Pamela L.; Bruno, John F.			Effects of Trophic Skewing of Species Richness on Ecosystem Functioning in a Diverse Marine Community	PLOS ONE			English	Article							FOOD-CHAIN LENGTH; PREDATOR DIVERSITY; PLANT DIVERSITY; TOP-DOWN; BIODIVERSITY; HERBIVORE; SEAGRASS; AMPHIPOD; PRODUCTIVITY; CONSEQUENCES	Widespread overharvesting of top consumers of the world's ecosystems has "skewed" food webs, in terms of biomass and species richness, towards a generally greater domination at lower trophic levels. This skewing is exacerbated in locations where exotic species are predominantly low-trophic level consumers such as benthic macrophytes, detritivores, and filter feeders. However, in some systems where numerous exotic predators have been added, sometimes purposefully as in many freshwater systems, food webs are skewed in the opposite direction toward consumer dominance. Little is known about how such modifications to food web topology, e.g., changes in the ratio of predator to prey species richness, affect ecosystem functioning. We experimentally measured the effects of trophic skew on production in an estuarine food web by manipulating ratios of species richness across three trophic levels in experimental mesocosms. After 24 days, increasing macroalgal richness promoted both plant biomass and grazer abundance, although the positive effect on plant biomass disappeared in the presence of grazers. The strongest trophic cascade on the experimentally stocked macroalgae emerged in communities with a greater ratio of prey to predator richness (bottom-rich food webs), while stronger cascades on the accumulation of naturally colonizing algae (primarily microalgae with some early successional macroalgae that recruited and grew in the mesocosms) generally emerged in communities with greater predator to prey richness (the more top-rich food webs). These results suggest that trophic skewing of species richness and overall changes in food web topology can influence marine community structure and food web dynamics in complex ways, emphasizing the need for multitrophic approaches to understand the consequences of marine extinctions and invasions.	[Reynolds, Pamela L.; Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Reynolds, Pamela L.] Coll William & Mary, Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA USA	University of North Carolina; University of North Carolina Chapel Hill; William & Mary; Virginia Institute of Marine Science	Reynolds, PL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	reynolds@vims.edu		Reynolds, Pamela/0000-0002-0177-3537	University of North Carolina's Institute of Marine Sciences; National Science Foundation [OCE-30623736]; University of North Carolina Wilson Award	University of North Carolina's Institute of Marine Sciences; National Science Foundation(National Science Foundation (NSF)); University of North Carolina Wilson Award	Funding support came from University of North Carolina's Institute of Marine Sciences, National Science Foundation grant OCE-30623736 to Bruno, and a University of North Carolina Wilson Award to Reynolds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Byrnes JE, 2009, ECOLOGY, V90, P2879, DOI 10.1890/08-1073.1; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardinale Bradley, 2009, P105; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Cruz-Rivera E, 2003, ECOL MONOGR, V73, P483, DOI 10.1890/0012-9615(2003)073[0483:PNQIWC]2.0.CO;2; Cruz-Rivera E, 2001, MAR ECOL PROG SER, V218, P249, DOI 10.3354/meps218249; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Douglass JG, 2008, ECOL LETT, V11, P598, DOI 10.1111/j.1461-0248.2008.01175.x; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Duffy JE, 2003, ECOL LETT, V6, P637; DUFFY JE, 1994, ECOLOGY, V75, P1304, DOI 10.2307/1937456; Duffy JE, 2000, ECOL MONOGR, V70, P237, DOI 10.1890/0012-9615(2000)070[0237:SIOGAO]2.0.CO;2; Duffy JE, 1989, ECOLOGY EVOLUTION HE; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Eby LA, 2006, TRENDS ECOL EVOL, V21, P576, DOI 10.1016/j.tree.2006.06.016; EDGAR GJ, 1992, J EXP MAR BIOL ECOL, V157, P225, DOI 10.1016/0022-0981(92)90164-6; Edwards KF, 2010, ECOL LETT, V13, P194, DOI 10.1111/j.1461-0248.2009.01417.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Ferriter A., 2004, 2004 EV CONS REP, P11; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Fox JW, 2004, ECOLOGY, V85, P549, DOI 10.1890/03-0095; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hairston NG, 1960, AM NAT, V94, P425; Halpern BS, 2005, ECOL LETT, V8, P189, DOI 10.1111/j.1461-0248.2004.00712.x; Hay ME, 1988, ECOLOGY RUBBLE STRUC; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; HOLMLUND MB, 1990, J EXP MAR BIOL ECOL, V139, P65, DOI 10.1016/0022-0981(90)90039-F; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hunter MD, 1992, ECOLOGY, V73; Jernakoff P, 1996, OCEANOGR MAR BIOL, V34, P109; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Krysko KL, 2011, ZOOTAXA, P1; Lee SC, 2009, P NATL ACAD SCI USA, V106, P7052, DOI 10.1073/pnas.0809284106; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Long ZT, 2007, ECOLOGY, V88, P2821, DOI 10.1890/06-1977.1; Long ZT, 2011, J ANIM ECOL, V80, P586, DOI 10.1111/j.1365-2656.2010.01800.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; MA, 2005, ECOSYSTEMS HUMAN WEL; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Moran ER, 2010, MAR ECOL PROG SER, V400, P277, DOI 10.3354/meps08406; Mulder CPH, 1999, ECOL LETT, V2, P237; Muncy RJ, 1984, ER827 US ARM CORPS E; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NELSON WG, 1979, J EXP MAR BIOL ECOL, V39, P231, DOI 10.1016/0022-0981(79)90129-1; NELSON WG, 1979, J EXP MAR BIOL ECOL, V38, P225, DOI 10.1016/0022-0981(79)90069-8; O'Connor MI, 2009, J ANIM ECOL, V78, P732, DOI 10.1111/j.1365-2656.2009.01533.x; Oksanen J., 2016, R PACKAG; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Pitt William C., 2007, P265, DOI 10.1007/978-3-540-46046-6_12; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Powers SP, 2002, J EXP MAR BIOL ECOL, V273, P171, DOI 10.1016/S0022-0981(02)00162-4; Ray J. C., 2005, LARGE CARNIVORES CON; Reynolds PL, 2011, J ECOL, V99, P1272, DOI 10.1111/j.1365-2745.2011.01837.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Ruzycki JR, 2003, ECOL APPL, V13, P23, DOI 10.1890/1051-0761(2003)013[0023:EOILTO]2.0.CO;2; Sax D. F., 2005, SPECIES INVASIONS IN; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; Schmid Bernhard, 2009, P14; Searle S., 1992, VARIANCE COMPONENTS; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Simberloff D, 2011, ENCY BIOL INVASIONS; Sotka EE, 2011, EVOL ECOL, V25, P1335, DOI 10.1007/s10682-011-9473-y; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; STONER AW, 1979, MAR BIOL, V55, P201, DOI 10.1007/BF00396819; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thebault E, 2006, ECOL RES, V21, P17, DOI 10.1007/s11284-005-0127-9; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TRACY CR, 1992, AM NAT, V139, P102, DOI 10.1086/285315; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; VIRNSTEIN RW, 1986, MAR ECOL PROG SER, V29, P279, DOI 10.3354/meps029279; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479	109	12	13	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36196	10.1371/journal.pone.0036196	http://dx.doi.org/10.1371/journal.pone.0036196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693549	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500010
J	Schellenberger, MT; Grova, N; Farinelle, S; Willieme, S; Revets, D; Muller, CP				Schellenberger, Mario T.; Grova, Nathalie; Farinelle, Sophie; Willieme, Stephanie; Revets, Dominique; Muller, Claude P.			Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; IMMUNE-COMPLEXES; LUNG-CANCER; DNA-DAMAGE; IN-VITRO; RESPONSES; MEASLES; CARRIER; CARCINOGENICITY; BENZO(A)PYRENE	The prototype polycyclic aromatic hydrocarbon benzo[a] pyrene (B[a] P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a] P-protein conjugate vaccine to induce B[a] P specific antibodies (Grova et al., Vaccine. 2009; 27: 4142-51). Here, we investigated in mice the efficacy of B[a] P-peptide conjugates based on promiscuous T cell epitopes (TCE) into further improve this approach. We showed that B[a] P-peptide conjugates induced very different levels of hapten-specific antibodies with variable functional efficacy, depending on the carrier. In some cases peptide carriers induced a more efficient antibody response against B[a] P than tetanus toxoid as a protein carrier, with the capacity to sequester more B[a] P in the blood. Reducing the carrier size to a single TCE can dramatically shift the antibody bias from the carrier to the B[a] P. Conjugates based on the TCE FIGITEL induced the best anti-hapten response and no antibodies against the carrier peptide. Some peptide conjugates increased the selectivity of the antibodies for the activated metabolite 7,8-diol-B[a] P and B[a] P by one or two orders of magnitude. The antibody efficacy was also demonstrated in their ability to sequester B[a] P in the blood and modulate its faecal excretion (15-56%). We further showed that pre-existing immunity to the carrier from which the TCE was derived did not reduce the immunogenicity of the peptide conjugate. In conclusion, we showed that a vaccination against B[a] P using promiscuous TCEs of tetanus toxin as carriers is feasible even in case of a preexisting immunity to the toxoid and that some TCE epitopes dramatically redirect the antibody response to the hapten. Further studies to demonstrate a long-term protection of an immunoprophylactic immunisation against B[a] P are warranted.	[Schellenberger, Mario T.; Grova, Nathalie; Farinelle, Sophie; Willieme, Stephanie; Revets, Dominique; Muller, Claude P.] Ctr Rech Publ Sante, Inst Immunol, Natl Publ Hlth Lab, Luxembourg, Luxembourg	Luxembourg Institute of Health	Schellenberger, MT (corresponding author), Ctr Rech Publ Sante, Inst Immunol, Natl Publ Hlth Lab, Luxembourg, Luxembourg.	claude.muller@.crp-sante.lu		Grova, Nathalie/0000-0002-7042-164X	Fond National de la Recherche Luxembourg [FNR: 01/04/11]; BFR fellowship from Ministry of Health of Luxembourg [BFR06-081]; AFR fellowship [TR-PHD BFR06-081]; Fond National de la Recherche	Fond National de la Recherche Luxembourg(Luxembourg National Research Fund); BFR fellowship from Ministry of Health of Luxembourg; AFR fellowship; Fond National de la Recherche	The authors acknowledge the support of the Fond National de la Recherche Luxembourg (www.fnr.lu, Tobavac project, FNR: 01/04/11). MT Schellenberger was funded by a BFR fellowship (BFR06-081) from the Ministry of Health of Luxembourg and a AFR fellowship (TR-PHD BFR06-081) funded by the Fond National de la Recherche. The authors acknowledge the CRP-Sante (www.crp-sante.lu) and the Ministry of Health of Luxembourg for their continued support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARINGTON T, 1994, INFECT IMMUN, V62, P9, DOI 10.1128/IAI.62.1.9-14.1994; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bouche FB, 2005, VACCINE, V23, P2074, DOI 10.1016/j.vaccine.2005.01.011; Boysen G, 2003, MUTAT RES-REV MUTAT, V543, P17, DOI 10.1016/S1383-5742(02)00068-6; Carlson EA, 2004, MAR ENVIRON RES, V58, P731, DOI 10.1016/j.marenvres.2004.03.023; CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173; De Buck SS, 2005, VACCINE, V23, P2403, DOI 10.1016/j.vaccine.2005.01.020; De Buck SS, 2005, J PHARMACOL EXP THER, V313, P640, DOI 10.1124/jpet.104.081034; De Buck SS, 2005, CARCINOGENESIS, V26, P835, DOI 10.1093/carcin/bgi010; De Buck SS, 2009, INT J CANCER; DEMOTZ S, 1989, J IMMUNOL, V142, P394; Deng SX, 2002, J IMMUNOL METHODS, V269, P299, DOI 10.1016/S0022-1759(02)00237-5; Food SCo, 2002, POL AR HYDR OCC FOOD; GRANOFF DM, 1994, JAMA-J AM MED ASSOC, V272, P1116, DOI 10.1001/jama.272.14.1116; Grova N, 2002, INT DAIRY J, V12, P1025, DOI 10.1016/S0958-6946(02)00126-7; Grova N, 2008, CHEMOSPHERE, V73, pS295, DOI 10.1016/j.chemosphere.2007.12.037; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; Grova N, 2009, VACCINE, V27, P4142, DOI 10.1016/j.vaccine.2009.04.052; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Haney M, 2010, BIOL PSYCHIAT, V67, P59, DOI 10.1016/j.biopsych.2009.08.031; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; Hecht S S, 2001, IARC Sci Publ, V154, P245; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 1996, ADV EXP MED BIOL, V401, P1; Hecht SS, 1996, PREV MED, V25, P7, DOI 10.1006/pmed.1996.0004; HERZENBERG LA, 1980, NATURE, V285, P664, DOI 10.1038/285664a0; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hojrup P, 2003, PROTEOLYTIC PEPTIDE, P227; James EA, 2007, INT IMMUNOL, V19, P1291, DOI 10.1093/intimm/dxm099; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; Kurikka S, 1996, VACCINE, V14, P1239, DOI 10.1016/S0264-410X(96)00025-4; LIKHACHEV AJ, 1992, PROG CLIN BIOL RES, V374, P435; LISE LD, 1987, INFECT IMMUN, V55, P2658, DOI 10.1128/IAI.55.11.2658-2661.1987; MCLEMORE TL, 1978, CANCER RES, V38, P3805; Muller CP, PEPTIDE VACCINES; Niu QA, 2010, OCCUP ENVIRON MED, V67, P444, DOI 10.1136/oem.2009.047969; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; PERERA F, 1981, ENVIRON HEALTH PERSP, V42, P163, DOI 10.2307/3429207; Polonelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026777; Prodhomme EJF, 2010, J PROTEOME RES, V9, P5598, DOI 10.1021/pr100407w; PROUGH RA, 1977, LIFE SCI, V21, P1629, DOI 10.1016/0024-3205(77)90241-7; Putz MM, 2004, VACCINE, V22, P4173, DOI 10.1016/j.vaccine.2004.06.013; ROSS JA, 1995, CANCER RES, V55, P1039; Schellenberger MT, 2011, HUM VACCINES, V7, P166, DOI 10.4161/hv.7.0.14579; Schellenberger MT, 2009, TOXICOL APPL PHARM; Silbart LK, 1997, VET HUM TOXICOL, V39, P37; Sipinen V, 2010, MUTAGENESIS, V25, P417, DOI 10.1093/mutage/geq024; SKOGH T, 1985, IMMUNOLOGY, V55, P585; SKOGH T, 1988, J CLIN LAB IMMUNOL, V27, P13; THYSSEN J, 1981, J NATL CANCER I, V66, P575; WOLTERBEEK APM, 1995, CANCER LETT, V89, P107, DOI 10.1016/0304-3835(95)90165-5; Younglai EV, 2007, CURR PHARM DESIGN, V13, P3005, DOI 10.2174/138161207782110499	55	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38329	10.1371/journal.pone.0038329	http://dx.doi.org/10.1371/journal.pone.0038329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666501	gold, Green Submitted, Green Published			2022-12-25	WOS:000305353400112
J	Vitolo, MI; Boggs, AE; Whipple, RA; Yoon, JR; Thompson, K; Matrone, MA; Cho, EH; Balzer, EM; Martin, SS				Vitolo, M. I.; Boggs, A. E.; Whipple, R. A.; Yoon, J. R.; Thompson, K.; Matrone, M. A.; Cho, E. H.; Balzer, E. M.; Martin, S. S.			Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin	ONCOGENE			English	Article						PTEN; microtentacle; actin; contractility; cofilin; metastasis	CIRCULATING TUMOR-CELLS; NONMUSCLE MYOSIN-II; LIGHT-CHAIN KINASE; BREAST-CANCER; LIM-KINASE; F-ACTIN; PHOSPHOINOSITIDE-BINDING; PHOSPHATASE SLINGSHOT; INHIBITION; EXPRESSION	Loss of PTEN tumor suppressor enhances metastatic risk in breast cancer, although the underlying mechanisms are poorly defined. We report that homozygous deletion of PTEN in mammary epithelial cells induces tubulin-based microtentacles (McTNs) that facilitate cell reattachment and homotypic aggregation. Treatment with contractility-modulating drugs showed that McTNs in PTEN-/- cells are suppressible by controlling the actin cytoskeleton. Because outward microtubule extension is counteracted by actin cortical contraction, increased activity of actin-severing proteins could release constraints on McTN formation in PTEN-/- cells. One such actin-severing protein, cofilin, is activated in detached PTEN-/- cells that could weaken the actin cortex to promote McTNs. Expression of wild-type cofilin, an activated mutant (S3A), and an inactive mutant (S3E) demonstrated that altering cofilin phosphorylation directly affects McTNs formation. Chemical inhibition of PI3K did not reduce McTNs or inactivate cofilin in PTEN-/- cells. Additionally, knock-in expression of the two most common PI3K-activating mutations observed in human cancer patients did not increase McTNs or activate cofilin. PTEN loss and PI3K activation also caused differential activation of the cofilin regulators, LIM-kinase1 (LIMK) and Slingshot-1L (SSH). Furthermore, McTNs were suppressed and cofilin was inactivated by restoration of PTEN in the PTEN-/- cells, indicating that both the elevation of McTNs and the activation of cofilin are specific results arising from PTEN loss. These data identify a novel mechanism by which PTEN loss could remodel the cortical actin network to facilitate McTNs that promote tumor cell reattachment and aggregation. Using isogenic MCF-10A PTEN-/- and PIK3CA mutants, we have further demonstrated that there are clear differences in activation of cofilin, LIMK and SSH between PTEN loss and PI3K activation, providing a new evidence that these mutations yield distinct cytoskeletal phenotypes, which could have an impact on tumor biology. Oncogene (2013) 32, 2200-2210; doi:10.1038/onc.2012.234; published online 11 June 2012	[Vitolo, M. I.; Boggs, A. E.; Whipple, R. A.; Yoon, J. R.; Thompson, K.; Martin, S. S.] Univ Maryland, Marlene & Stewart Greenebaum NCI Canc Ctr, Baltimore, MD 21201 USA; [Boggs, A. E.; Yoon, J. R.; Martin, S. S.] Univ Maryland, Grad Program Life Sci, Program Mol Med, Baltimore, MD 21201 USA; [Matrone, M. A.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Cho, E. H.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balzer, E. M.] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Martin, S. S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Scripps Research Institute; Scripps Research Institute; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Martin, SS (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Room 10-29,Bressler Bldg,655 West Baltimore St, Baltimore, MD 21201 USA.	ssmartin@som.umaryland.edu	Cho, Edward/B-3727-2012	Cho, Edward/0000-0002-0278-334X; Vitolo, Michele/0000-0001-8055-9645	Ruth L Kirschstein-National Service Research Award [T32-HL07698]; National Cancer Institute [R01-CA124704]; Susan G Komen Foundation [KG100240]; Era of Hope Scholar award from the Department of Defense [BC100675]; NATIONAL CANCER INSTITUTE [P30CA134274, R01CA154624, R01CA124704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698] Funding Source: NIH RePORTER	Ruth L Kirschstein-National Service Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); Era of Hope Scholar award from the Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Ruth L Kirschstein-National Service Research Award, T32-HL07698 (MIV), National Cancer Institute, R01-CA124704 (SSM), Susan G Komen Foundation, KG100240 (SSM) and an Era of Hope Scholar award from the Department of Defense, BC100675 (SSM).	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Asch HL, 1996, CANCER RES, V56, P4841; Balzer EM, 2010, BREAST CANCER RES TR, V121, P65, DOI 10.1007/s10549-009-0457-3; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doreian BW, 2009, MOL BIOL CELL, V20, P3142, DOI 10.1091/mbc.E09-03-0197; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Glinsky VV, 2003, CANCER RES, V63, P3805; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Janssen EAM, 2007, CELL ONCOL, V29, P25; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; Kusano K, 1999, MOL CELL BIOCHEM, V190, P133, DOI 10.1023/A:1006962210692; Liu CR, 2004, CHINESE MED J-PEKING, V117, P213; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Matrone MA, 2010, ONCOGENE, V29, P3217, DOI 10.1038/onc.2010.68; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Naumov GN, 2002, CANCER RES, V62, P2162; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Okagaki T, 1999, J BIOCHEM-TOKYO, V125, P619, DOI 10.1093/oxfordjournals.jbchem.a022328; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shin DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007451; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Whipple RA, 2007, EXP CELL RES, V313, P1326, DOI 10.1016/j.yexcr.2007.02.001; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Zschiesche W, 1997, ANTICANCER RES, V17, P561	58	32	33	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 25	2013	32	17					2200	2210		10.1038/onc.2012.234	http://dx.doi.org/10.1038/onc.2012.234			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22689060	Green Accepted			2022-12-25	WOS:000318062800009
J	Whale, AD; Dart, A; Holt, M; Jones, GE; Wells, CM				Whale, A. D.; Dart, A.; Holt, M.; Jones, G. E.; Wells, C. M.			PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity	ONCOGENE			English	Article						prostate; cancer; motility	CHRONIC MYELOID-LEUKEMIA; SIGNALING PATHWAY; LIM KINASE; CANCER; MIGRATION; INVASION; LOOP; RESISTANCE; IMATINIB; COFILIN	Hepatocyte growth factor (HGF) and its receptor (c-Met) are associated with cancer cell motility and invasiveness. p21-activated kinase 4 (PAK4), a potential therapeutic target, is recruited to and activated by c-Met. In response, PAK4 phosphorylates LIM kinase 1 (LIMK1) in an HGF-dependent manner in metastatic prostate carcinoma cells. PAK4 overexpression is known to induce increased cell migration speed but the requirement for kinase activity has not been established. We have used a panel of PAK4 truncations and mutations in a combination of overexpression and RNAi rescue experiments to determine the requirement for PAK4 kinase activity during carcinoma cell motility downstream of HGF. We find that neither the kinase domain alone nor a PAK4 mutant unable to bind Cdc42 is able to fully rescue cell motility in a PAK4-deficient background. Nevertheless, we find that PAK4 kinase activity and associated LIMK1 activity are essential for carcinoma cell motility, highlighting PAK4 as a potential anti-metastatic therapeutic target. We also show here that overexpression of PAK4 harbouring a somatic mutation, E329K, increased the HGF-driven motility of metastatic prostate carcinoma cells. E329 lies within the glycine-rich loop region of the kinase. Our data suggest that E329K mutation leads to a modest increase in kinase activity, conferring resistance to competitive ATP inhibitors in addition to promoting cell migration. The existence of such a mutation may have implications for the development of PAK4-specific competitive ATP inhibitors should PAK4 be further explored for clinical inhibition. Oncogene (2013) 32, 2114-2120; doi:10.1038/onc.2012.233; published online 11 June 2012	[Whale, A. D.; Holt, M.; Jones, G. E.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Whale, A. D.; Dart, A.; Wells, C. M.] Kings Coll London, Div Canc Studies, London SE1 1UL, England	University of London; King's College London; University of London; King's College London	Wells, CM (corresponding author), Kings Coll London, Div Canc Studies, New Hunts House,Guys Campus, London SE1 1UL, England.	claire.wells@kcl.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048; Dart, Anna/0000-0002-2412-3502; Holt, Mark/0000-0001-7775-8539	Cancer Research UK; Breast Cancer Campaign	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign	ADW and work in the laboratories of GEJ and CMW is supported by a grant from the Cancer Research UK. AD is supported by a grant from Breast Cancer Campaign. We would like to thank Matthias Krause for gateway destination and pGIPZ-control shRNA vectors. We also thank Mary Holdom for helpful discussion and advice with protein structure analysis and Mike Olsen for practical advice with using LIMKi.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Baldassa S, 2010, J CELL PHYSIOL, V224, P722, DOI 10.1002/jcp.22172; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Grant BD, 1998, BIOCHEMISTRY-US, V37, P7708, DOI 10.1021/bi972987w; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Li ZL, 2010, MOL BIOL CELL, V21, P3317, DOI 10.1091/mbc.E10-03-0245; Li ZL, 2010, J BIOL CHEM, V285, P23699, DOI 10.1074/jbc.M110.123497; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pavlovsky C, 2009, AM J HEMATOL, V84, P287, DOI 10.1002/ajh.21380; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Yamamoto M, 2004, BIOCHEM BIOPH RES CO, V319, P1272, DOI 10.1016/j.bbrc.2004.05.113; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Zhao Zhuo-Shen, 2010, F1000 Biol Rep, V2, P70, DOI 10.3410/B2-70; Zicha D, 1997, Methods Mol Biol, V75, P449	37	40	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2114	2120		10.1038/onc.2012.233	http://dx.doi.org/10.1038/onc.2012.233			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22689056	Green Accepted			2022-12-25	WOS:000317919900013
J	Sabourin, J; Antigny, F; Robin, E; Frieden, M; Raddatz, E				Sabourin, Jessica; Antigny, Fabrice; Robin, Elodie; Frieden, Maud; Raddatz, Eric			Activation of Transient Receptor Potential Canonical 3 (TRPC3)-mediated Ca2+ Entry by A(1) Adenosine Receptor in Cardiomyocytes Disturbs Atrioventricular Conduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RABBIT PORTAL-VEIN; ANOXIA-REOXYGENATION; TRPC CHANNELS; SARCOPLASMIC-RETICULUM; DIRECT INHIBITION; DEVELOPING HEART; CATION CHANNELS; PHORBOL ESTERS; CRAC CHANNEL	Although the activation of the A(1)-subtype of the adenosine receptors (A(1)AR) is arrhythmogenic in the developing heart, little is known about the underlying downstream mechanisms. The aim of this study was to determine to what extent the transient receptor potential canonical (TRPC) channel 3, functioning as receptor-operated channel (ROC), contributes to the A(1)AR-induced conduction disturbances. Using embryonic atrial and ventricular myocytes obtained from 4-day-old chick embryos, we found that the specific activation of A(1)AR by CCPA induced sarcolemmal Ca2+ entry. However, A1AR stimulation did not induce Ca2+ release from the sarcoplasmic reticulum. Specific blockade of TRPC3 activity by Pyr3, by a dominant negative of TRPC3 construct, or inhibition of phospholipase Cs and PKCs strongly inhibited the A(1)AR-enhanced Ca2+ entry. Ca2+ entry through TRPC3 was activated by the 1,2-diacylglycerol (DAG) analog OAG via PKC-independent and -dependent mechanisms in atrial and ventricular myocytes, respectively. In parallel, inhibition of the atypical PKC zeta by myristoylated PKC zeta pseudosubstrate inhibitor significantly decreased the A(1)AR-enhanced Ca2+ entry in both types of myocytes. Additionally, electrocardiography showed that inhibition of TRPC3 channel suppressed transient A(1)AR-induced conduction disturbances in the embryonic heart. Our data showing that A(1)AR activation subtly mediates a proarrhythmic Ca2+ entry through TRPC3-encoded ROC by stimulating the phospholipase C/DAG/PKC cascade provide evidence for a novel pathway whereby Ca2+ entry and cardiac function are altered. Thus, the A(1)AR-TRPC3 axis may represent a potential therapeutic target.	[Sabourin, Jessica; Robin, Elodie; Raddatz, Eric] Univ Lausanne, Dept Physiol, Fac Biol & Med, CH-1005 Lausanne, Switzerland; [Antigny, Fabrice] Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; [Frieden, Maud] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Lausanne; University of Geneva; University of Geneva	Raddatz, E (corresponding author), Univ Lausanne, Dept Physiol, Fac Biol & Med, 7 Rue Bugnon, CH-1005 Lausanne, Switzerland.	eric.raddatz@unil.ch	Antigny, Fabrice/Q-3999-2018	Antigny, Fabrice/0000-0002-9515-6571; Frieden, Maud/0000-0001-7135-0874; Sabourin, Jessica/0000-0002-2980-8455	Swiss National Science Foundation [310030-127633]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 310030-127633.	Albert AP, 2002, J PHYSIOL-LONDON, V544, P113, DOI 10.1113/jphysiol.2002.022574; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Alvarez J, 2008, AM J PHYSIOL-HEART C, V295, pH21, DOI 10.1152/ajpheart.00135.2008; Ambudkar IS, 2006, CELL CALCIUM, V40, P495, DOI 10.1016/j.ceca.2006.08.011; AMOROSO S, 1995, BBA-BIOMEMBRANES, V1239, P67, DOI 10.1016/0005-2736(95)00143-Q; Ansari HR, 2009, AM J PHYSIOL-HEART C, V297, pH1032, DOI 10.1152/ajpheart.00374.2009; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Basheer R, 2002, J NEUROSCI, V22, P7680; BOGOYEVITCH MA, 1993, CIRC RES, V72, P757, DOI 10.1161/01.RES.72.4.757; Brenner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000802; Bruchez P, 2008, J CARDIOVASC ELECTR, V19, P1196, DOI 10.1111/j.1540-8167.2008.01218.x; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cerniway RJ, 2002, BASIC RES CARDIOL, V97, P232, DOI 10.1007/s003950200016; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Eder Petra, 2007, P331; Ethier MF, 2006, AM J RESP CELL MOL, V35, P496, DOI 10.1165/rcmb.2005-0290OC; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; Fredholm BB, 2003, CELL MOL NEUROBIOL, V23, P379, DOI 10.1023/A:1023644822539; Freichel M, 1999, CELL PHYSIOL BIOCHEM, V9, P270, DOI 10.1159/000016321; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Gardner AM, 2003, J BIOL CHEM, V278, P15421, DOI 10.1074/jbc.M208366200; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Gorlach A, 2005, CIRC RES, V97, P1, DOI 10.1161/01.RES.0000174112.36064.77; Gundlfinger A, 2007, J PHYSIOL-LONDON, V582, P263, DOI 10.1113/jphysiol.2007.132613; Helliwell RM, 1997, J PHYSIOL-LONDON, V499, P417, DOI 10.1113/jphysiol.1997.sp021938; Henry P, 1996, CIRC RES, V78, P161, DOI 10.1161/01.RES.78.1.161; Hioki M, 2012, HEART VESSELS, V27, P221, DOI 10.1007/s00380-011-0159-8; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hleihel W, 2006, EXP PHYSIOL, V91, P681, DOI 10.1113/expphysiol.2006.033175; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Ju Yue-kun, 2007, Heart Lung Circ, V16, P349, DOI 10.1016/j.hlc.2007.07.004; Juranek I., 2004, Central European Journal of Public Health, V12, pS33; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Lof C, 2011, ADV EXP MED BIOL, V704, P125, DOI 10.1007/978-94-007-0265-3_6; Mori Y, 2001, JPN J PHARMACOL, V87, P245, DOI 10.1254/jjp.87.245; Morrison RR, 2006, AM J PHYSIOL-HEART C, V291, pH1875, DOI 10.1152/ajpheart.00158.2005; Nishida M, 2010, YAKUGAKU ZASSHI, V130, P295, DOI 10.1248/yakushi.130.295; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Parsons M, 2000, FASEB J, V14, P1423, DOI 10.1096/fj.14.10.1423; Peart J, 2000, AM J PHYSIOL-HEART C, V279, pH2166, DOI 10.1152/ajpheart.2000.279.5.H2166; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Priviero F, 2004, CLIN EXP PHARMACOL P, V31, P741, DOI 10.1111/j.1440-1681.2004.04064.x; Putney J W Jr, 2001, Mol Interv, V1, P84; Robin E, 2011, J MOL CELL CARDIOL, V51, P945, DOI 10.1016/j.yjmcc.2011.08.023; Rogel A, 2006, NUCLEOS NUCLEOT NUCL, V25, P1283, DOI 10.1080/15257770600890939; Roscoe AK, 2000, ANESTHESIOLOGY, V92, P1692, DOI 10.1097/00000542-200006000-00029; Rose'Meyer RB, 2010, CLIN EXP PHARMACOL P, V37, P46, DOI 10.1111/j.1440-1681.2009.05228.x; Rybin VO, 1997, AM J PHYSIOL-HEART C, V272, pH1636, DOI 10.1152/ajpheart.1997.272.4.H1636; Sabourin J, 2011, CARDIOVASC RES, V92, P226, DOI 10.1093/cvr/cvr167; Sabourin J, 2009, J BIOL CHEM, V284, P36248, DOI 10.1074/jbc.M109.012872; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Sarre A, 2006, J CARDIOVASC ELECTR, V17, P1350, DOI 10.1111/j.1540-8167.2006.00637.x; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Steinckwich N, 2007, J LEUKOCYTE BIOL, V81, P1054, DOI 10.1189/jlb.0406248; Takahashi T, 2010, BRIT J PHARMACOL, V161, P1806, DOI 10.1111/j.1476-5381.2010.01002.x; Tenthorey D, 1998, J CARDIOVASC PHARM, V31, P195, DOI 10.1097/00005344-199802000-00004; Vassort G, 2009, CAN J PHYSIOL PHARM, V87, P100, DOI 10.1139/Y08-112; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yang ZG, 2009, BBA-MOL CELL RES, V1793, P1868, DOI 10.1016/j.bbamcr.2009.10.007; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshida J, 2005, EUR J PHARMACOL, V510, P217, DOI 10.1016/j.ejphar.2005.01.029; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	73	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26688	26701		10.1074/jbc.M112.378588	http://dx.doi.org/10.1074/jbc.M112.378588			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692208	Green Published, hybrid			2022-12-25	WOS:000307386000020
J	Busch, F; Mobasheri, A; Shayan, P; Stahlmann, R; Shakibaei, M				Busch, Franziska; Mobasheri, Ali; Shayan, Parviz; Stahlmann, Ralf; Shakibaei, Mehdi			Sirt-1 Is Required for the Inhibition of Apoptosis and Inflammatory Responses in Human Tenocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; TUMOR-SUPPRESSOR PROTEIN; HUMAN TENDON CELLS; CALORIE RESTRICTION; IN-VITRO; DEPENDENT TRANSCRIPTION; RESVERATROL; ACTIVATION; P53	Tendon overuse injuries and tendinitis are accompanied by catabolic processes and apoptosis of tenocytes. However, the precise molecular mechanisms of the destructive processes in tendon are not fully understood. Sirt-1, a nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase, has been linked to transcriptional silencing and appears to play a key role in inflammation. The purpose of this study was to examine whether down-regulation of Sirt-1 using antisense oligonucleotides (ASO) affects inflammatory and apoptotic signaling in tenocytes. Transient transfection of tenocytes with ASO against Sirt-1 induced expression of Bax and other proteins involved in apoptosis (cleaved caspase-3 and poly(ADP-ribose) polymerase), acetylation of tumor suppressor p53, and mitochondrial degradation. Interestingly, Sirt-1 was found to interact directly with p53. In contrast, Sirt-1 activator resveratrol inhibited interleukin-1 beta (IL-1 beta)- and nicotinamide-induced NF-kappa B activation and p65 acetylation and suppressed the activation of I kappa B-alpha kinase. Resveratrol also reversed the IL-1 beta- or nicotinamide-induced up-regulation of various gene products that mediate inflammation (cyclooxygenase-2) and matrix degradation (matrix metalloproteinase-9) that are known to be regulated by NF-kappa B. Knockdown of Sirt-1 by using ASO abolished the inhibitory effects of resveratrol on inflammatory and apoptotic signaling including Akt activation and SCAX suppression. Down-regulation of histone deacetylase Sirt-1 by mRNA interference abrogated the effect of resveratrol on NF-kappa B suppression, thus highlighting the crucial homeostatic role of this enzyme. Overall, these results suggest for the first time that Sirt-1 can regulate p53 and NF-kappa B signaling via deacetylation, demonstrating a novel role for resveratrol in the treatment of tendinitis/tendinopathy.	[Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough LE12 5RD, Leics, England; [Shayan, Parviz] Invest Inst Mol Biol Syst Transfer, Tehran 1417863171, Iran; [Stahlmann, Ralf] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany	University of Munich; University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506				Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; BORING CC, 1991, CA-CANCER J CLIN, V41, P19, DOI 10.3322/canjclin.41.1.19; Cao ZX, 2004, EUR J PHARMACOL, V489, P39, DOI 10.1016/j.ejphar.2004.02.031; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lian OB, 2005, AM J SPORT MED, V33, P561, DOI 10.1177/0363546504270454; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870; Pan WH, 2006, J CELL BIOCHEM, V98, P14, DOI 10.1002/jcb.20790; Pirollo KF, 2003, PHARMACOL THERAPEUT, V99, P55, DOI 10.1016/S0163-7258(03)00053-6; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Savouret JF, 2002, BIOMED PHARMACOTHER, V56, P84, DOI 10.1016/S0753-3322(01)00158-5; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Scott A, 2005, J ORTHOP RES, V23, P1219, DOI 10.1016/j.orthres.2004.12.011; Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tang JB, 2004, PLAST RECONSTR SURG, V113, P1703, DOI 10.1097/01.PRS.0000117365.48381.42; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	54	65	67	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25770	25781		10.1074/jbc.M112.355420	http://dx.doi.org/10.1074/jbc.M112.355420			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689577	hybrid, Green Published			2022-12-25	WOS:000306916300008
J	McDaniel, BK; Binder, BM				McDaniel, Brittany K.; Binder, Brad M.			Ethylene Receptor 1 (ETR1) Is Sufficient and Has the Predominant Role in Mediating Inhibition of Ethylene Responses by Silver in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE-ACTIVITY; GOLD(I) COMPLEXES; GENE FAMILY; BINDING; GROWTH; MUTATIONS; DOMAIN; PATHWAY; MUTANT; COPPER	Ethylene influences many processes in Arabidopsis thaliana through the action of five receptor isoforms. All five isoforms use copper as a cofactor for binding ethylene. Previous research showed that silver can substitute for copper as a cofactor for ethylene binding activity in the ETR1 ethylene receptor yet also inhibit ethylene responses in plants. End-point and rapid kinetic analyses of dark-grown seedling growth revealed that the effects of silver are mostly dependent upon ETR1, and ETR1 alone is sufficient for the effects of silver. Ethylene responses in etr1-6 etr2-3 ein4-4 triple mutants were not blocked by silver. Transformation of these triple mutants with cDNA for each receptor isoform under the promoter control of ETR1 revealed that the cETR1 transgene completely rescued responses to silver while the cETR2 transgene failed to rescue these responses. The other three isoforms partially rescued responses to silver. Ethylene binding assays on the binding domains of the five receptor isoforms expressed in yeast showed that silver supports ethylene binding to ETR1 and ERS1 but not the other isoforms. Thus, silver may have an effect on ethylene signaling outside of the ethylene binding pocket of the receptors. Ethylene binding to ETR1 with silver was similar to 30% of binding with copper. However, alterations in the K-d for ethylene binding to ETR1 and the half-time of ethylene dissociation from ETR1 do not underlie this lower binding. Thus, it is likely that the lower ethylene binding activity of ETR1 with silver is due to fewer ethylene binding sites generated with silver versus copper.	[McDaniel, Brittany K.; Binder, Brad M.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Binder, BM (corresponding author), M407 Walters Life Sci Bldg,1414 Cumberland Ave, Knoxville, TN 37996 USA.	bbinder@utk.edu		Binder, Brad/0000-0002-8172-2034	NSF [MCB0918430]; BCMB Dept. Hunsicker Research Incentive Award; Direct For Biological Sciences [0918430] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); BCMB Dept. Hunsicker Research Incentive Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an NSF Grant (MCB0918430) and a BCMB Dept. Hunsicker Research Incentive Award (to B. M. B.).	Abeles F, 1992, ETHYLENE PLANT BIOL; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Binder B. M., 2012, ANN PLANT REV PLANT, P117; Binder BM, 2003, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2003.628.21; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2007, FEBS LETT, V581, P5105, DOI 10.1016/j.febslet.2007.09.057; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Binder BM, 2006, PLANT PHYSIOL, V142, P1690, DOI 10.1104/pp.106.087858; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; BLANKENSHIP SM, 1993, J AM SOC HORTIC SCI, V118, P609, DOI 10.21273/JASHS.118.5.609; BURG SP, 1967, PLANT PHYSIOL, V42, P144, DOI 10.1104/pp.42.1.144; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2009, PLANT SIGNAL BEHAV, V4, P1152, DOI 10.4161/psb.4.12.9943; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; GUO BC, 1991, CHEM PHYS LETT, V181, P16, DOI 10.1016/0009-2614(91)90214-T; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hertwig RH, 1996, J PHYS CHEM-US, V100, P12253, DOI 10.1021/jp953064i; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Kim H, 2011, PLANT PHYSIOL, V156, P417, DOI 10.1104/pp.110.170621; Liu Q, 2012, PLANT PHYSIOL, V158, P1193, DOI 10.1104/pp.111.187757; Liu Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-60; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Parks BM, 1999, P NATL ACAD SCI USA, V96, P14142, DOI 10.1073/pnas.96.24.14142; Plett JM, 2009, PHYSIOL MOL PLANT P, V74, P18, DOI 10.1016/j.pmpp.2009.08.004; Plett JM, 2009, J EXP BOT, V60, P3923, DOI 10.1093/jxb/erp228; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rivarola M, 2009, PLANT PHYSIOL, V150, P547, DOI 10.1104/pp.109.138461; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Roithova J, 2009, COORDIN CHEM REV, V253, P666, DOI 10.1016/j.ccr.2008.06.007; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; SANDERS IO, 1991, ANN BOT-LONDON, V68, P97, DOI 10.1093/oxfordjournals.aob.a088242; Schaller GE, 2007, METHOD ENZYMOL, V422, P270, DOI 10.1016/S0076-6879(06)22013-5; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schroder D, 1998, INORG CHEM, V37, P624, DOI 10.1021/ic970986m; SCHRODER D, 1995, ORGANOMETALLICS, V14, P312, DOI 10.1021/om00001a045; Seifert GJ, 2004, PLANT CELL, V16, P723, DOI 10.1105/tpc.019661; Sievers MR, 1998, J AM CHEM SOC, V120, P1891, DOI 10.1021/ja973834z; SISLER E C, 1977, Tobacco Science, V21, P43; Sisler EC, 1999, BOT BULL ACAD SINICA, V40, P1; Sisler EC, 1996, PLANT GROWTH REGUL, V18, P169, DOI 10.1007/BF00024378; SISLER EC, 1979, PLANT PHYSIOL, V64, P538, DOI 10.1104/pp.64.4.538; Sisler EC, 1996, PLANT GROWTH REGUL, V18, P79, DOI 10.1007/BF00028491; SISLER EC, 1991, PLANT HORMONE ETHYLE, P81; Strader LC, 2009, PLANT CELL, V21, P3585, DOI 10.1105/tpc.108.065185; THOMPSON JS, 1983, J AM CHEM SOC, V105, P3522, DOI 10.1021/ja00349a026; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	72	76	82	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26094	26103		10.1074/jbc.M112.383034	http://dx.doi.org/10.1074/jbc.M112.383034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692214	Green Published, hybrid			2022-12-25	WOS:000306916300037
J	Sanchez-Mir, L; Franco, A; Madrid, M; Vicente-Soler, J; Villar-Tajadura, MA; Soto, T; Perez, P; Gacto, M; Cansado, J				Sanchez-Mir, Laura; Franco, Alejandro; Madrid, Marisa; Vicente-Soler, Jero; Antonia Villar-Tajadura, M.; Soto, Teresa; Perez, Pilar; Gacto, Mariano; Cansado, Jose			Biological Significance of Nuclear Localization of Mitogen-activated Protein Kinase Pmk1 in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; RNA-BINDING PROTEIN; SCHIZOSACCHAROMYCES-POMBE; MAP KINASE; GENE-EXPRESSION; STRESS; SIGNAL; MORPHOGENESIS; PHOSPHATASES; ENCODES	Mitogen-activated protein kinase (MAPK) signaling pathways play a fundamental role in the response of eukaryotic cells to environmental changes. Also, much evidence shows that the stimulus-dependent nuclear targeting of this class of regulatory kinases is crucial for adequate regulation of distinct cellular events. In the fission yeast Schizosaccharomyces pombe, the cell integrity MAPK pathway, whose central element is the MAPK Pmk1, regulates multiple processes such as cell wall integrity, vacuole fusion, cytokinesis, and ionic homeostasis. In non-stressed cells Pmk1 is constitutively localized in both cytoplasm and nucleus, and its localization pattern appears unaffected by its activation status or in response to stress, thus questioning the biological significance of the presence of this MAPK into the nucleus. We have addressed this issue by characterizing mutants expressing Pmk1 versions excluded from the cell nucleus and anchored to the plasma membrane in different genetic backgrounds. Although nuclear Pmk1 partially regulates cell wall integrity at a transcriptional level, membrane-tethered Pmk1 performs many of the biological functions assigned to wild type MAPK like regulation of chloride homeostasis, vacuole fusion, and cellular separation. However, we found that down-regulation of nuclear Pmk1 by MAPK phosphatases induced by the stress activated protein kinase pathway is important for the fine modulation of extranuclear Pmk1 activity. These results highlight the importance of the control of MAPK activity at subcellular level.	[Sanchez-Mir, Laura; Franco, Alejandro; Madrid, Marisa; Vicente-Soler, Jero; Soto, Teresa; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain; [Antonia Villar-Tajadura, M.; Perez, Pilar] Univ Salamanca, Inst Biol Func & Genom, Consejo Super Invest Cient, Dept Microbiol & Genet, Salamanca 37007, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Cansado, J (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, Campus Univ Espinardo, E-30071 Murcia, Spain.	jcansado@um.es	Madrid, Marisa/AAV-2154-2020; Perez, Pilar/B-4948-2010; Madrid, Marisa/K-7755-2014; Cansado, Jose/ABC-6872-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Cansado, Jose/K-5212-2014; Mir, Laura Sanchez/H-5409-2015; Franco, Alejandro/ABG-6823-2020; Pino, Teresa Soto/AAC-6096-2020	Madrid, Marisa/0000-0002-7970-2587; Perez, Pilar/0000-0003-3557-2247; Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152; Vicente-Soler, Jerónima/0000-0001-8759-6545; Mir, Laura Sanchez/0000-0002-3898-5840; Franco, Alejandro/0000-0001-7461-3414; Pino, Teresa Soto/0000-0003-2965-318X	Ministerio de Educacion, Cultura y Deporte [BFU2011-22517, BFU2010-15641]; Fundacion Seneca, Spain [15280/PI/10]	Ministerio de Educacion, Cultura y Deporte; Fundacion Seneca, Spain(Fundacion Seneca)	This work was supported in part by Ministerio de Educacion, Cultura y Deporte Grants BFU2011-22517 (to J. C.) and BFU2010-15641 (to P. P.) and 15280/PI/10 from Fundacion Seneca, Spain.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Alfa C., 1993, EXPT FISSION YEAST, P16; Arellano M, 1997, J CELL SCI, V110, P2547; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Hirata D, 1998, J CELL SCI, V111, P149; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; KRISAK L, 1994, GENE DEV, V8, P2151, DOI 10.1101/gad.8.18.2151; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martinez-Bono B, 2010, FEMS YEAST RES, V10, P28, DOI 10.1111/j.1567-1364.2009.00591.x; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nguyen AN, 2002, MOL BIOL CELL, V13, P2651, DOI 10.1091/mbc.02-03-0043; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489; Papadopoulou K, 2010, J CELL SCI, V123, P4374, DOI 10.1242/jcs.073056; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Satoh R, 2009, MOL BIOL CELL, V20, P2473, DOI 10.1091/mbc.E08-09-0893; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Sugiura R, 2003, NATURE, V424, P961, DOI 10.1038/nature01907; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Toda T, 1996, MOL CELL BIOL, V16, P6752; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	40	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26038	26051		10.1074/jbc.M112.345611	http://dx.doi.org/10.1074/jbc.M112.345611			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685296	hybrid, Green Published			2022-12-25	WOS:000306916300031
J	Mottillo, EP; Bloch, AE; Leff, T; Granneman, JG				Mottillo, Emilio P.; Bloch, Ainsley E.; Leff, Todd; Granneman, James G.			Lipolytic Products Activate Peroxisome Proliferator-activated Receptor (PPAR) alpha and delta in Brown Adipocytes to Match Fatty Acid Oxidation with Supply	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; WHITE ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1 GENE; DIET-INDUCED OBESITY; MITOCHONDRIAL-FUNCTION; ADAPTIVE THERMOGENESIS; CELLULAR PLASTICITY; METABOLIC DISEASES; UPSTREAM ENHANCER; LIPID-METABOLISM	beta-adrenergic receptors (beta-ARs) promote brown adipose tissue (BAT) thermogenesis by mobilizing fatty acids and inducing the expression of oxidative genes. beta-AR activation increases the expression of oxidative genes by elevating cAMP, but whether lipolytic products can modulate gene expression is not known. This study examined the role that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) plays in the induction of gene expression. Activation of brown adipocytes by beta-AR agonism or 8-bromo-cyclic AMP increased the expression of PGC1 alpha, PDK4, PPAR alpha, uncoupling protein 1 (UCP1), and neuron-derived orphan receptor-1 (NOR-1), and concurrent inhibition of HSL reduced the induction of PGC1 alpha, PDK4, PPAR alpha, and UCP1 but not NOR-1. Similar results were observed in the BAT of mice following pharmacological or genetic inhibition of HSL and in brown adipocytes with stable knockdown of ATGL. Conversely, treatments that increase endogenous fatty acids elevated the expression of oxidative genes. Pharmacological antagonism and siRNA knockdown indicate that PPAR alpha and PPAR delta modulate the induction of oxidative genes by beta-AR agonism. Using a live cell fluorescent reporter assay of PPAR activation, we demonstrated that ligands for PPAR alpha and -delta, but not PPAR gamma, were rapidly generated at the lipid droplet surface and could transcriptionally activate PPAR alpha and -delta. Knockdown of ATGL reduced cAMP-mediated induction of genes involved in fatty acid oxidation and oxidative phosphorylation. Consequently, ATGL knockdown reduced maximal oxidation of fatty acids, but not pyruvate, in response to cAMP stimulation. Overall, the results indicate that lipolytic products can activate PPAR alpha and PPAR delta in brown adipocytes, thereby expanding the oxidative capacity to match enhanced fatty acid supply.	[Mottillo, Emilio P.; Bloch, Ainsley E.; Leff, Todd; Granneman, James G.] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, Detroit, MI 48201 USA; [Leff, Todd] Wayne State Univ, Cardiovasc Res Inst, Sch Med, Detroit, MI 48201 USA; [Mottillo, Emilio P.; Leff, Todd; Granneman, James G.] Wayne State Univ, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Granneman, James G.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48201 USA; [Granneman, James G.] John D Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu	Leff, Todd/U-9084-2018	Leff, Todd/0000-0001-6923-3900	National Institutes of Health [DK092741, DK076229, DK062292]; Department of Veterans Affairs; Canadian Institutes of Health Research (CIHR) [MDR-214349]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062292, P30DK020572, R01DK062292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK092741, DK076229, and DK062292. This work also was supported by the Department of Veterans Affairs.; Supported by Doctoral Research Award MDR-214349 from the Canadian Institutes of Health Research (CIHR).	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Jonckheere AI, 2010, CLIN CHEM, V56, P424, DOI 10.1373/clinchem.2009.131441; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Karamitri A, 2009, J BIOL CHEM, V284, P20738, DOI 10.1074/jbc.M109.021766; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Muzik Otto, 2012, Front Endocrinol (Lausanne), V3, P15, DOI 10.3389/fendo.2012.00015; NECHAD M, 1987, AM J PHYSIOL, V253, pC889, DOI 10.1152/ajpcell.1987.253.6.C889; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Spiegelman BM, 2007, NOVART FDN SYMP, V287, P60; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351	55	150	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25038	25048		10.1074/jbc.M112.374041	http://dx.doi.org/10.1074/jbc.M112.374041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22685301	Green Published, hybrid			2022-12-25	WOS:000306651700017
J	Emami, K; Askari, V; Ullrich, M; Mohinudeen, K; Anil, AC; Khandeparker, L; Burgess, JG; Mesbahi, E				Emami, Kaveh; Askari, Vahid; Ullrich, Matthias; Mohinudeen, Khwajah; Anil, Arga Chandrashekar; Khandeparker, Lidita; Burgess, J. Grant; Mesbahi, Ehsan			Characterization of Bacteria in Ballast Water Using MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							ASSISTED LASER DESORPTION/IONISATION; DESORPTION IONIZATION-TIME; MICROORGANISM IDENTIFICATION; RAPID IDENTIFICATION; ESCHERICHIA-COLI; FRESH-WATERS; SHIPS; CLASSIFICATION; PROTEOMICS; SEDIMENTS	To evaluate a rapid and cost-effective method for monitoring bacteria in ballast water, several marine bacterial isolates were characterized by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Since International Maritime Organization (IMO) regulations are concerned with the unintended transportation of pathogenic bacteria through ballast water, emphasis was placed on detecting species of Vibrio, enterococci and coliforms. Seawater samples collected from the North Sea were incubated in steel ballast tanks and the presence of potentially harmful species of Pseudomonas was also investigated. At the genus-level, the identification of thirty six isolates using MALDI-TOF MS produced similar results to those obtained by 16S rRNA gene sequencing. No pathogenic species were detected either by 16S rRNA gene analysis or by MALDI-TOF MS except for the opportunistically pathogenic bacterium Pseudomonas aeruginosa. In addition, in house software that calculated the correlation coefficient values (CCV) of the mass spectral raw data and their variation was developed and used to allow the rapid and efficient identification of marine bacteria in ballast water for the first time.	[Emami, Kaveh] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Askari, Vahid] Univ Teesside, Sch Sci & Engn, Middlesbrough, Tees Valley, England; [Ullrich, Matthias] Jacobs Univ Bremen, Mol Life Sci Res Ctr, D-28359 Bremen, Germany; [Mohinudeen, Khwajah] Newcastle Univ, NEPAF Proteome Anal Facil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Anil, Arga Chandrashekar; Khandeparker, Lidita] Natl Inst Oceanog, Panaji, India; [Burgess, J. Grant; Mesbahi, Ehsan] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University of Teesside; Jacobs University; Newcastle University - UK; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Newcastle University - UK	Emami, K (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	kaveh.emami@ncl.ac.uk		Emami, Kaveh/0000-0003-0182-0070; Ismail Abdul Hameed, Khwajah Mohinudeen/0000-0002-1944-378X	European Union; NERC; UKIERI (UK India Education and Research Initiative); British Council; UK Department for Education and Skills (DfES), Office of Science and Innovation; FCO, Scotland, Northern Ireland, Wales; GSK; BP; Shell; BAE	European Union(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UKIERI (UK India Education and Research Initiative); British Council(The British Council in India); UK Department for Education and Skills (DfES), Office of Science and Innovation; FCO, Scotland, Northern Ireland, Wales; GSK(GlaxoSmithKline); BP; Shell(Royal Dutch Shell); BAE	This document is an output from the North Sea Ballast Water Opportunity project, co-financed by the European Union through the North Sea Region Programme 2007-2013 "Investing in the future by working together for a sustainable and competitive region". The authors also acknowledge support and funding from NERC and the UKIERI (UK India Education and Research Initiative) project funded by the British Council, the UK Department for Education and Skills (DfES), Office of Science and Innovation, the FCO, Scotland, Northern Ireland, Wales, GSK, BP, Shell and BAE for the benefit of the India Higher Education Sector and the UK Higher Education Sector. The views expressed are not necessarily those of the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by GSK, BP, Shell and BAE for the benefit of the India Higher Education Sector and the UK Higher Education Sector. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDREWS WH, 1972, APPL MICROBIOL, V23, P521, DOI 10.1128/AEM.23.3.521-523.1972; ANHALT JP, 1975, ANAL CHEM, V47, P219, DOI 10.1021/ac60352a007; Anil AC, 2002, CURR SCI INDIA, V83, P214; Bohme K, 2010, ANAL METHODS-UK, V2, P1941, DOI 10.1039/c0ay00457j; Bohme K, 2010, J PROTEOME RES, V9, P3169, DOI 10.1021/pr100047q; BUCK JD, 1963, J BACTERIOL, V86, P1125, DOI 10.1128/JB.86.5.1125-1126.1963; CHESTER B, 1980, J CLIN MICROBIOL, V11, P537, DOI 10.1128/JCM.11.5.537-539.1980; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Demirev PA, 2004, J HOPKINS APL TECH D, V25, P27; Demirev PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/annurev.anchem.1.031207.112838; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Dieckmann R, 2010, J APPL MICROBIOL, V109, P199, DOI 10.1111/j.1365-2672.2009.04647.x; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Dworzanski JP, 2005, EXPERT REV PROTEOMIC, V2, P863, DOI 10.1586/14789450.2.6.863; Dworzanski JP, 2010, ANAL CHEM, V82, P145, DOI 10.1021/ac9015648; Dworzanski JP, 2004, ANAL CHEM, V76, P2355, DOI 10.1021/ac0349781; Eddabra R, 2012, MICROBIOL RES, V167, P226, DOI 10.1016/j.micres.2011.09.002; Everley RA, 2008, J AM SOC MASS SPECTR, V19, P1621, DOI 10.1016/j.jasms.2008.07.003; Fagerquist CK, 2009, APPL ENVIRON MICROB, V75, P4341, DOI 10.1128/AEM.00079-09; Fernandez-No IC, 2010, ELECTROPHORESIS, V31, P1116, DOI 10.1002/elps.200900591; Ferranti P, 2011, RAPID COMMUN MASS SP, V25, P1173, DOI 10.1002/rcm.4973; Ferranti P, 2009, RAPID COMMUN MASS SP, V23, P1328, DOI 10.1002/rcm.4006; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Gallo P, 2009, RAPID COMMUN MASS SP, V23, P3279, DOI 10.1002/rcm.4243; GAUTHIER YP, 1995, BIOL TRACE ELEM RES, V47, P37, DOI 10.1007/BF02790099; Gollasch S, 2007, HARMFUL ALGAE, V6, P585, DOI 10.1016/j.hal.2006.12.009; Hazen TH, 2009, APPL ENVIRON MICROB, V75, P6745, DOI 10.1128/AEM.01171-09; Holland RD, 1999, ANAL CHEM, V71, P3226, DOI 10.1021/ac990175v; KING EO, 1954, J LAB CLIN MED, V44, P301; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Mimura H, 2005, MAR POLLUT BULL, V50, P751, DOI 10.1016/j.marpolbul.2005.02.006; Oberbeckmann S, 2011, FEMS MICROBIOL ECOL, V75, P145, DOI 10.1111/j.1574-6941.2010.00998.x; Palmblad M, 2007, J AM SOC MASS SPECTR, V18, P693, DOI 10.1016/j.jasms.2006.11.013; Pennanec X, 2010, RAPID COMMUN MASS SP, V24, P384, DOI 10.1002/rcm.4404; Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766; Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; RYAN WJ, 1976, J CLIN PATHOL, V29, P1014, DOI 10.1136/jcp.29.11.1014; SLANETZ LW, 1957, J BACTERIOL, V74, P591, DOI 10.1128/JB.74.5.591-595.1957; Takahashi CK, 2008, J VENOM ANIM TOXINS, V14, P393, DOI 10.1590/S1678-91992008000300002; Tamelander J., 2010, GLOBALLAST MONOGRAPH; Taylor CE, 2006, PROTEOMICS, P39, DOI 10.1002/pmic.200600549; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005	48	65	74	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38515	10.1371/journal.pone.0038515	http://dx.doi.org/10.1371/journal.pone.0038515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685576	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700039
J	Lustig, A; Ketter-Katz, H; Katzir, G				Lustig, Avichai; Ketter-Katz, Hadas; Katzir, Gadi			Visually Guided Avoidance in the Chameleon (Chamaeleo chameleon): Response Patterns and Lateralization	PLOS ONE			English	Article							ASYMMETRICAL HATCHING BEHAVIORS; BRAIN LATERALIZATION; SMOOTH-PURSUIT; TELEOST FISH; LEFT-HANDERS; GUARD BEES; EYE USE; AGGRESSION; ADVANTAGES; LIZARDS	The common chameleon, Chamaeleo chameleon, is an arboreal lizard with highly independent, large-amplitude eye movements. In response to a moving threat, a chameleon on a perch responds with distinct avoidance movements that are expressed in its continuous positioning on the side of the perch distal to the threat. We analyzed body-exposure patterns during threat avoidance for evidence of lateralization, that is, asymmetry at the functional/behavioral levels. Chameleons were exposed to a threat approaching horizontally from the left or right, as they held onto a vertical pole that was either wider or narrower than the width of their head, providing, respectively, monocular or binocular viewing of the threat. We found two equal-sized sub-groups, each displaying lateralization of motor responses to a given direction of stimulus approach. Such an anti-symmetrical distribution of lateralization in a population may be indicative of situations in which organisms are regularly exposed to crucial stimuli from all spatial directions. This is because a bimodal distribution of responses to threat in a natural population will reduce the spatial advantage of predators.	[Lustig, Avichai; Ketter-Katz, Hadas] Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Environm & Evolutionary Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Marine Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa; University of Haifa	Lustig, A (corresponding author), Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel.	Lustigavi@gmail.com			Israel Academy of Sciences and Humanities - Israel Science Foundation [20978009]	Israel Academy of Sciences and Humanities - Israel Science Foundation	The research was funded by the Israel Academy of Sciences and Humanities - Israel Science Foundation (#20978009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bisazza A, 2003, BEHAV BRAIN RES, V141, P131, DOI 10.1016/S0166-4328(02)00344-3; Bisazza A, 1997, Laterality, V2, P49, DOI 10.1080/713754252; Bisazza A, 1997, PHYSIOL BEHAV, V62, P1405, DOI 10.1016/S0031-9384(97)00230-8; Boeddeker N, 2003, P ROY SOC B-BIOL SCI, V270, P393, DOI 10.1098/rspb.2002.2240; Bonati B, 2008, BEHAV PROCESS, V79, P171, DOI 10.1016/j.beproc.2008.07.007; Bonati B, 2010, BEHAV BRAIN RES, V207, P1, DOI 10.1016/j.bbr.2009.09.002; Byrne RA, 2002, ANIM BEHAV, V64, P461, DOI 10.1006/anbe.2002.3089; Cantalupo C, 1995, NEUROPSYCHOLOGIA, V33, P1637, DOI 10.1016/0028-3932(95)00043-7; Casey MB, 2005, DEV PSYCHOBIOL, V47, P123, DOI 10.1002/dev.20078; Casey MB, 2000, DEV PSYCHOBIOL, V37, P13, DOI 10.1002/1098-2302(200007)37:1<13::AID-DEV3>3.0.CO;2-M; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Cuadrado M, 2001, BIOL J LINN SOC, V72, P547, DOI 10.1111/j.1095-8312.2001.tb01337.x; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; Dimond Stuart, 1972, DOUBLE BRAIN; Hassenstein B, 1999, J EXP BIOL, V202, P1701; HEATWOLE H, 1968, COPEIA, P109, DOI 10.2307/1441557; Hews DK, 2004, ANIM BEHAV, V68, P1201, DOI 10.1016/j.anbehav.2003.11.024; Hews DK, 2001, BRAIN BEHAV EVOLUT, V58, P356, DOI 10.1159/000057576; Hoffmann ER, 1997, INT J IND ERGONOM, V19, P49, DOI 10.1016/0169-8141(95)00092-5; Izawa EI, 2005, BEHAV PROCESS, V69, P357, DOI 10.1016/j.beproc.2005.02.001; JUNGER W, 1991, J COMP PHYSIOL A, V169, P633; KELBER A, 1990, J COMP PHYSIOL A, V167, P569; Keter-Katz H, 2012, ANIM COGN IN PRESS; KILSHAW D, 1983, BRIT J PSYCHOL, V74, P253, DOI 10.1111/j.2044-8295.1983.tb01861.x; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Malashichev YB, 2004, BIOESSAYS, V26, P512, DOI 10.1002/bies.20036; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Pearson L, 1976, VERTEBRATE BRAIN, P513; Robins A, 2005, NEUROREPORT, V16, P849, DOI 10.1097/00001756-200505310-00014; Robins A, 1998, ANIM BEHAV, V56, P875, DOI 10.1006/anbe.1998.0877; Robins A, 2006, ANIM BEHAV, V72, P843, DOI 10.1016/j.anbehav.2006.01.022; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; Rogers L. J., 2002, COMP VERTEBRATE LATE, P94; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Tommasi L, 1999, Laterality, V4, P89, DOI 10.1080/713754325; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 1998, NEUROREPORT, V9, P3341, DOI 10.1097/00001756-199810050-00035; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Yoshioka JG, 1930, PEDAGOG SEMIN J GEN, V38, P471; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; ZEIL J, 1989, J COMP PHYSIOL A, V165, P711, DOI 10.1007/BF00611002; ZEIL J, 1986, BEHAV ECOL SOCIOBIOL, V19, P213	48	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37875	10.1371/journal.pone.0037875	http://dx.doi.org/10.1371/journal.pone.0037875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685546	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700009
J	Meyer, S; Fuchs, TJ; Bosserhoff, AK; Hofstadter, F; Pauer, A; Roth, V; Buhmann, JM; Moll, I; Anagnostou, N; Brandner, JM; Ikenberg, K; Moch, H; Landthaler, M; Vogt, T; Wild, PJ				Meyer, Stefanie; Fuchs, Thomas J.; Bosserhoff, Anja K.; Hofstaedter, Ferdinand; Pauer, Armin; Roth, Volker; Buhmann, Joachim M.; Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M.; Ikenberg, Kristian; Moch, Holger; Landthaler, Michael; Vogt, Thomas; Wild, Peter J.			A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts	PLOS ONE			English	Article							BETA-CATENIN; PROGNOSTIC-FACTOR; EXPRESSION; SURVIVAL; GENE; THERAPY; MARKER; BIOMARKERS; EVENT; CELLS	Background: Current staging methods such as tumor thickness, ulceration and invasion of the sentinel node are known to be prognostic parameters in patients with malignant melanoma (MM). However, predictive molecular marker profiles for risk stratification and therapy optimization are not yet available for routine clinical assessment. Methods and Findings: Using tissue microarrays, we retrospectively analyzed samples from 364 patients with primary MM. We investigated a panel of 70 immunohistochemical (IHC) antibodies for cell cycle, apoptosis, DNA mismatch repair, differentiation, proliferation, cell adhesion, signaling and metabolism. A marker selection procedure based on univariate Cox regression and multiple testing correction was employed to correlate the IHC expression data with the clinical follow-up (overall and recurrence-free survival). The model was thoroughly evaluated with two different cross validation experiments, a permutation test and a multivariate Cox regression analysis. In addition, the predictive power of the identified marker signature was validated on a second independent external test cohort (n = 225). A signature of seven biomarkers (Bax, Bcl-X, PTEN, COX-2, loss of beta-Catenin, loss of MTAP, and presence of CD20 positive B-lymphocytes) was found to be an independent negative predictor for overall and recurrence-free survival in patients with MM. The seven-marker signature could also predict a high risk of disease recurrence in patients with localized primary MM stage pT1-2 (tumor thickness <= 2.00 mm). In particular, three of these markers (MTAP, COX-2, Bcl-X) were shown to offer direct therapeutic implications. Conclusions: The seven-marker signature might serve as a prognostic tool enabling physicians to selectively triage, at the time of diagnosis, the subset of high recurrence risk stage I-II patients for adjuvant therapy. Selective treatment of those patients that are more likely to develop distant metastatic disease could potentially lower the burden of untreatable metastatic melanoma and revolutionize the therapeutic management of MM.	[Meyer, Stefanie; Landthaler, Michael] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Fuchs, Thomas J.; Buhmann, Joachim M.] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Bosserhoff, Anja K.; Hofstaedter, Ferdinand] Univ Hosp Regensburg, Inst Pathol, Regensburg, Germany; [Pauer, Armin] Cent Tumor Registry Regensburg, Regensburg, Germany; [Roth, Volker] Univ Basel, Dept Comp Sci, Basel, Switzerland; [Fuchs, Thomas J.; Buhmann, Joachim M.] ETH, Inst Cell Biol, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol, Hamburg, Germany; [Ikenberg, Kristian; Moch, Holger; Wild, Peter J.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Vogt, Thomas] Saarland Univ Hosp, Dept Dermatol, Homburg, Germany	University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Regensburg; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; Universitatsklinikum des Saarlandes	Meyer, S (corresponding author), Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany.	peter.wild@usz.ch	Bosserhoff, Anja/GNH-4801-2022; Roth, Volker/Q-4025-2017; Buhmann, Joachim/AAU-4760-2020	Roth, Volker/0000-0003-0991-0273; Wild, Peter Johannes/0000-0002-1017-3744; Bosserhoff, Anja/0000-0001-8147-394X	German Cancer Aid (Deutsche Krebshilfe e.V.) [108134]	German Cancer Aid (Deutsche Krebshilfe e.V.)(Deutsche Krebshilfe)	This work was funded by the German Cancer Aid (Deutsche Krebshilfe e.V.), grant 108134. The funding source had no involvement in the study design, the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the paper for publication.	Alonso SR, 2004, AM J PATHOL, V164, P193, DOI 10.1016/S0002-9440(10)63110-0; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Avivi I, 2003, BRIT J CANCER, V89, P1389, DOI 10.1038/sj.bjc.6601187; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; COX DR, 1972, J R STAT SOC B, V34, P187; Denkert C, 2002, AM J PATHOL, V160, P893, DOI 10.1016/S0002-9440(10)64912-7; Fukushima H, 2001, J EXP CLIN CANC RES, V20, P553; Guldberg P, 1997, CANCER RES, V57, P3660; Heere-Ress E, 2002, INT J CANCER, V99, P29, DOI 10.1002/ijc.10248; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Ishwaran H, 2010, STAT PROBABIL LETT, V80, P1056, DOI 10.1016/j.spl.2010.02.020; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Koesters R, 1999, CANCER RES, V59, P3880; Kuphal S, 2011, INT J ONCOL, V39, P235, DOI 10.3892/ijo.2011.1028; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Meyer S, 2010, PPAR RES, V2010, DOI 10.1155/2010/848645; Meyer S, 2010, EXP DERMATOL, V19, pE251, DOI 10.1111/j.1600-0625.2010.01072.x; Mikhail M, 2005, CLIN CANCER RES, V11, P5153, DOI 10.1158/1078-0432.CCR-05-0397; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Reichle A, 2007, MELANOMA RES, V17, P360, DOI 10.1097/CMR.0b013e3282f1d2c8; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rothberg BEG, 2010, J INVEST DERMATOL, V130, P1971, DOI 10.1038/jid.2010.149; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sarpa HG, 2006, AM J SURG PATHOL, V30, P1396, DOI 10.1097/01.pas.0000213262.61855.7d; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Weinlich G, 2006, BRIT J CANCER, V94, P835, DOI 10.1038/sj.bjc.6603028; Wild PJ, 2006, ARCH DERMATOL, V142, P471, DOI 10.1001/archderm.142.4.471; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	40	62	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38222	10.1371/journal.pone.0038222	http://dx.doi.org/10.1371/journal.pone.0038222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685558	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305351700021
J	Sukhwinder-Singh; Hernandez, MV; Crossa, J; Singh, PK; Bains, NS; Singh, K; Sharma, I				Sukhwinder-Singh; Hernandez, Mateo V.; Crossa, Jose; Singh, Pawan K.; Bains, Navtej S.; Singh, Kuldeep; Sharma, Indu			Multi-Trait and Multi-Environment QTL Analyses for Resistance to Wheat Diseases	PLOS ONE			English	Article							PYRENOPHORA-TRITICI-REPENTIS; FUSARIUM HEAD BLIGHT; CHROMOSOMAL LOCATION; QUANTITATIVE TRAITS; CONFERS RESISTANCE; DURABLE RESISTANCE; HIGH-RESOLUTION; STRIPE RUST; AESTIVUM L.; MIXED-MODEL	Background: Stripe rust, leaf rust, tan spot, and Karnal bunt are economically significant diseases impacting wheat production. The objectives of this study were to identify quantitative trait loci for resistance to these diseases in a recombinant inbred line (RIL) from a cross HD29/WH542, and to evaluate the evidence for the presence loci on chromosome region conferring multiple disease resistance. Methodology/Principal Findings: The RIL population was evaluated for four diseases and genotyped with DNA markers. Multi-trait (MT) analysis revealed thirteen QTLs on nine chromosomes, significantly associated with resistance. Phenotypic variation explained by all significant QTLs for KB, TS, Yr, Lr diseases were 57%, 55%, 38% and 22%, respectively. Marginal trait analysis identified the most significant QTLs for resistance to KB on chromosomes 1BS, 2DS, 3BS, 4BL, 5BL, and 5DL. Chromosomes 3AS and 4BL showed significant association with TS resistance. Significant QTLs for Yr resistance were identified on chromosomes 2AS, 4BL and 5BL, while Lr was significant on 6DS. MT analysis revealed that all the QTLs except 3BL significantly reduce KB and was contributed from parent HD29 while all resistant QTLs for TS except on chromosomes 2DS. 1, 2DS. 2 and 3BL came from WH542. Five resistant QTLs for Yr and six for Lr were contributed from parents WH542 and HD29 respectively. Chromosome region on 4BL showed significant association to KB, TS, and Yr in the population. The multi environment analysis for KB identified three putative QTLs of which two new QTLs, mapped on chromosomes 3BS and 5DL explained 10 and 20% of the phenotypic variation, respectively. Conclusions/Significance: This study revealed that MT analysis is an effective tool for detection of multi-trait QTLs for disease resistance. This approach is a more effective and practical than individual QTL mapping analyses. MT analysis identified RILs that combine resistance to multiple diseases from parents WH542 and/or HD29.	[Sukhwinder-Singh; Hernandez, Mateo V.; Crossa, Jose; Singh, Pawan K.] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Hernandez, Mateo V.] Univ Autonoma Chapingo, Chapingo, Mexico; [Bains, Navtej S.; Singh, Kuldeep; Sharma, Indu] Punjab Agr Univ, Dept Plant Breeding Genet & Biotechnol, Ludhiana 141004, Punjab, India	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Punjab Agricultural University	Sukhwinder-Singh (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico.	suk.singh@cgiar.org	Vargas Hernandez, Mateo/AIE-0949-2022; Crossa, Jose/AAE-7898-2019	Vargas Hernandez, Mateo/0000-0002-0735-3242; Crossa, Jose/0000-0001-9429-5855; Singh, Kuldeep/0000-0001-5239-6586; Singh, Pawan/0000-0003-4610-3120	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This research was funded by Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GENSTAT REL 13; BASTEN CJ, 2004, QTL CARTOGRAPHER VER; Bonin CM, 2009, CROP SCI, V49, P1304, DOI 10.2135/cropsci2008.08.0459; Boshoff W. H. P., 1999, Plant Disease, V83, P591, DOI 10.1094/PDIS.1999.83.6.591C; Bozkurt TO, 2010, MOL PLANT PATHOL, V11, P625, DOI [10.1111/J.1364-3703.2010.00633.X, 10.1111/j.1364-3703.2010.00633.x]; BRENNAN JP, 1990, 9002 CIMMYT; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; CHURCHILL GA, 1994, GENETICS, V138, P963; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Effertz RJ, 2002, PHYTOPATHOLOGY, V92, P527, DOI 10.1094/PHYTO.2002.92.5.527; ELIAS E, 1989, CROP SCI, V29, P299, DOI 10.2135/cropsci1989.0011183X002900020013x; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Faris JD, 2005, THEOR APPL GENET, V111, P386, DOI 10.1007/s00122-005-2033-5; Faris JD, 1996, PHYTOPATHOLOGY, V86, P459, DOI 10.1094/Phyto-86-459; Faris JD, 1997, THEOR APPL GENET, V94, P98, DOI 10.1007/s001220050387; Genstat 5 Committee, 2005, GENST WIND REL 12 0; Haen KM, 2004, CROP SCI, V44, P951, DOI 10.2135/cropsci2004.0951; JANSEN RC, 1994, GENETICS, V136, P1447; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin F, 2009, THEOR APPL GENET, V118, P631, DOI 10.1007/s00122-008-0894-0; Luo PG, 2009, PROG NAT SCI-MATER, V19, P9, DOI 10.1016/j.pnsc.2008.02.017; Mago R, 2004, GENOME, V47, P112, DOI 10.1139/G03-096; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Malosetti M., 2015, P 8 WORLD C GEN APPL; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Miedaner T, 2012, MOL BREEDING, V29, P731, DOI 10.1007/s11032-011-9586-6; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Piepho HP, 2000, GENETICS, V156, P2043; Risser P, 2011, PHYTOPATHOLOGY, V101, P1209, DOI 10.1094/PHYTO-08-10-0203; Rush CM, 2005, PLANT DIS, V89, P212, DOI 10.1094/PD-89-0212; Seah S, 2000, MOL PLANT MICROBE IN, V13, P334, DOI 10.1094/MPMI.2000.13.3.334; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; SINGH RP, 1984, CAN J GENET CYTOL, V26, P723, DOI 10.1139/g84-115; Singh S, 2008, PLANT DIS, V92, P91, DOI 10.1094/PDIS-92-1-0091; Singh S, 2007, THEOR APPL GENET, V116, P147, DOI 10.1007/s00122-007-0654-6; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; William HM, 2007, EUPHYTICA, V157, P307, DOI 10.1007/s10681-007-9405-7; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Zwonitzer JC, 2010, PHYTOPATHOLOGY, V100, P72, DOI 10.1094/PHYTO-100-1-0072	53	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38008	10.1371/journal.pone.0038008	http://dx.doi.org/10.1371/journal.pone.0038008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679489	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900016
J	Cui, Y; Lee, MY; Huo, NX; Bragg, J; Yan, LJ; Yuan, C; Li, C; Holditch, SJ; Xie, JZ; Luo, MC; Li, DW; Yu, JL; Martin, J; Schackwitz, W; Gu, YQ; Vogel, JP; Jackson, AO; Liu, ZY; Garvin, DF				Cui, Yu; Lee, Mi Yeon; Huo, Naxin; Bragg, Jennifer; Yan, Lijie; Yuan, Cheng; Li, Cui; Holditch, Sara J.; Xie, Jingzhong; Luo, Ming-Cheng; Li, Dawei; Yu, Jialin; Martin, Joel; Schackwitz, Wendy; Gu, Yong Qiang; Vogel, John P.; Jackson, Andrew O.; Liu, Zhiyong; Garvin, David F.			Fine Mapping of the Bsr1 Barley Stripe Mosaic Virus Resistance Gene in the Model Grass Brachypodium distachyon	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; LINKAGE MAP; GENOME; RICE; PATHOGENICITY; SYSTEM; DETERMINANTS; MOVEMENT; ALPHA	The ND18 strain of Barley stripe mosaic virus (BSMV) infects several lines of Brachypodium distachyon, a recently developed model system for genomics research in cereals. Among the inbred lines tested, Bd3-1 is highly resistant at 20 to 25 degrees C, whereas Bd21 is susceptible and infection results in an intense mosaic phenotype accompanied by high levels of replicating virus. We generated an F-6:7 recombinant inbred line (RIL) population from a cross between Bd3-1 and Bd21 and used the RILs, and an F-2 population of a second Bd21 X Bd3-1 cross to evaluate the inheritance of resistance. The results indicate that resistance segregates as expected for a single dominant gene, which we have designated Barley stripe mosaic virus resistance 1 (Bsr1). We constructed a genetic linkage map of the RIL population using SNP markers to map this gene to within 705 Kb of the distal end of the top of chromosome 3. Additional CAPS and Indel markers were used to fine map Bsr1 to a 23 Kb interval containing five putative genes. Our study demonstrates the power of using RILs to rapidly map the genetic determinants of BSMV resistance in Brachypodium. Moreover, the RILs and their associated genetic map, when combined with the complete genomic sequence of Brachypodium, provide new resources for genetic analyses of many other traits.	[Cui, Yu; Yan, Lijie; Yuan, Cheng; Li, Cui; Xie, Jingzhong; Li, Dawei; Yu, Jialin; Liu, Zhiyong] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cui, Yu; Lee, Mi Yeon; Holditch, Sara J.; Jackson, Andrew O.] Univ Calif Berkeley, Dept Plant & Microbiol, Berkeley, CA 94720 USA; [Huo, Naxin; Bragg, Jennifer; Gu, Yong Qiang; Vogel, John P.] USDA ARS Western Reg Res Ctr, Albany, CA USA; [Luo, Ming-Cheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Martin, Joel; Schackwitz, Wendy] US DOE Joint Genome Inst, Walnut Creek, CA USA; [Garvin, David F.] Univ Minnesota, USDA ARS Plant Sci Res Unit, St Paul, MN 55108 USA; [Garvin, David F.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	China Agricultural University; University of California System; University of California Berkeley; University of California System; University of California Davis; United States Department of Energy (DOE); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cui, Y (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	andyoj@berkeley.edu; zhiyongliu@cau.edu.cn	Schackwitz, Wendy/GXH-9536-2022; Luo, Ming-Cheng/C-5600-2011; Li, Dawei/I-8751-2016; Xie, Jingzhong/AAF-5899-2020	Luo, Ming-Cheng/0000-0002-9744-5887; Li, Dawei/0000-0003-4133-1263; Schackwitz, Wendy/0000-0002-3013-9180; Martin, Joel/0000-0001-9511-6441; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Yuan, Cheng/0000-0003-2582-4041; Vogel, John/0000-0003-1786-2689	China Scholarship Council; National Natural Science Foundation of China [30971780, 31030056]; 863 project [2011AA100104]; MOA [2009ZX08009-048B]; Program of Introducing Talents of Discipline to Universities [111-2-03]; United States Department of Agriculture [3640-21000-021-00D]; Office of Science (BER), U.S. Department of Energy [DE-AI02-07ER64452, DE-SC0001526]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231];  [2012SKLAB01-7];  [CSREES-2008-35319-19225]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 project(National High Technology Research and Development Program of China); MOA; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); United States Department of Agriculture(United States Department of Agriculture (USDA)); Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); ; 	This work was supported by a China Scholarship Council Award to YC, by the National Natural Science Foundation of China (30971780, 31030056), 2012SKLAB01-7, 863 project 2011AA100104, MOA projects 2009ZX08009-048B, and the Program of Introducing Talents of Discipline to Universities (111-2-03) to ZL, by the United States Department of Agriculture (CRIS project no. 3640-21000-021-00D), and Competitive Grant CSREES-2008-35319-19225 to AOJ, and by the Office of Science (BER), U.S. Department of Energy (Interagency Agreement nos. DE-AI02-07ER64452 and DE-SC0001526). Work conducted by the U.S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Bragg JN, 2008, ENCY VIROLOGY, P459; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Carroll T. W., 1980, Plant Disease (formerly Plant Disease Reporter), V64, P136; Carroll TW, 1986, PLANT VIRUSES RODSHA, P373; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Edwards MC, 1996, PHYTOPATHOLOGY, V86, P184, DOI 10.1094/Phyto-86-184; Edwards MC, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P465, DOI 10.1007/1-4020-3780-5_22; ESLICH R. F., 1953, PLANT DIS REPORTER, V37, P290; Faris JD, 2008, FUNCT INTEGR GENOMIC, V8, P149, DOI 10.1007/s10142-008-0073-z; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/g09-062, 10.1139/G09-062]; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2007, J SCI FOOD AGR, V87, P1177, DOI 10.1002/jsfa.2868; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Huo NX, 2008, FUNCT INTEGR GENOMIC, V8, P135, DOI 10.1007/s10142-007-0062-7; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jackson A. O., 1991, Seminars in Virology, V2, P107; Jackson AO, 2009, ANNU REV PHYTOPATHOL, V47, P385, DOI 10.1146/annurev-phyto-080508-081733; JACKSON AO, 1991, CAN J PLANT PATHOL, V13, P163, DOI 10.1080/07060669109500952; JACKSON AO, 1989, ANNU REV PHYTOPATHOL, V27, P95; Jackson AO, 1981, HDB PLANT VIRUS INFE, P565; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Lawrence DM, 1998, METH MOL B, V81, P99; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; McKinney HH, 1965, BIOL CHARACTERISTICS; Moffett P, 2009, ADV VIRUS RES, V75, P1, DOI 10.1016/S0065-3527(09)07501-0; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Ozdemir BS, 2008, INT J PLANT GENOMICS; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; PETTY ITD, 1994, VIROLOGY, V198, P218, DOI 10.1006/viro.1994.1024; Routledge APM, 2004, MOL PLANT PATHOL, V5, P253, DOI 10.1111/j.1364-3703.2004.00224.x; SISLER W. W., 1956, Plant Disease Reporter, V40, P1106; Timian R. G., 1987, Barley Genetics Newsletter, V17, P79; TIMIAN R. G., 1955, PLANT DIS REPORTER, V39, P550; TIMIAN RG, 1975, PLANT DIS REP, V59, P984; TIMIAN RG, 1974, PHYTOPATHOLOGY, V64, P342, DOI 10.1094/Phyto-64-342; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; VAZQUEZ G, 1974, CROP SCI, V14, P429, DOI 10.2135/cropsci1974.0011183X001400030027x; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Vogel J, 2006, PLANT CELL TISSUE OR, V84; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel J, 2009, PLANT GENET GENOMICS, V7, P427, DOI 10.1007/978-0-387-77489-3_16; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Weiland JJ, 1996, MOL PLANT MICROBE IN, V9, P62, DOI 10.1094/MPMI-9-0062; WEILAND JJ, 1994, VIROLOGY, V201, P116, DOI 10.1006/viro.1994.1271; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; ZHENG Y, 1990, J GEN VIROL, V71, P1865, DOI 10.1099/0022-1317-71-8-1865; [No title captured]	56	39	42	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38333	10.1371/journal.pone.0038333	http://dx.doi.org/10.1371/journal.pone.0038333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675544	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700059
J	Liu, B; Tikunova, SB; Kline, KP; Siddiqui, JK; Davis, JP				Liu, Bin; Tikunova, Svetlana B.; Kline, Kristopher P.; Siddiqui, Jalal K.; Davis, Jonathan P.			Disease-Related Cardiac Troponins Alter Thin Filament Ca2+ Association and Dissociation Rates	PLOS ONE			English	Article							CALCIUM-SENSITIZING MUTATIONS; DILATED CARDIOMYOPATHY; MOUSE MODEL; COOPERATIVE ACTIVATION; ALPHA-TROPOMYOSIN; HEART-FAILURE; EXCHANGE; KINETICS; BINDING; CONTRACTION	The contractile response of the heart can be altered by disease-related protein modifications to numerous contractile proteins. By utilizing an IAANS labeled fluorescent troponin C, TnC(IAANS)(T53C), we examined the effects of ten disease-related troponin modifications on the Ca2+ binding properties of the troponin complex and the reconstituted thin filament. The selected modifications are associated with a broad range of cardiac diseases: three subtypes of familial cardiomyopathies (dilated, hypertrophic and restrictive) and ischemia-reperfusion injury. Consistent with previous studies, the majority of the protein modifications had no effect on the Ca2+ binding properties of the isolated troponin complex. However, when incorporated into the thin filament, dilated cardiomyopathy mutations desensitized (up to 3.3-fold), while hypertrophic and restrictive cardiomyopathy mutations, and ischemia-induced truncation of troponin I, sensitized the thin filament to Ca2+ (up to 6.3-fold). Kinetically, the dilated cardiomyopathy mutations increased the rate of Ca2+ dissociation from the thin filament (up to 2.5-fold), while the hypertrophic and restrictive cardiomyopathy mutations, and the ischemia-induced truncation of troponin I decreased the rate (up to 2-fold). The protein modifications also increased (up to 5.4-fold) or decreased (up to 2.5-fold) the apparent rate of Ca2+ association to the thin filament. Thus, the disease-related protein modifications alter Ca2+ binding by influencing both the association and dissociation rates of thin filament Ca2+ exchange. These alterations in Ca2+ exchange kinetics influenced the response of the thin filament to artificial Ca2+ transients generated in a stopped-flow apparatus. Troponin C may act as a hub, sensing physiological and pathological stimuli to modulate the Ca2+-binding properties of the thin filament and influence the contractile performance of the heart.	[Liu, Bin; Kline, Kristopher P.; Siddiqui, Jalal K.; Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Tikunova, Svetlana B.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA	University System of Ohio; Ohio State University; University of Houston System; University of Houston	Liu, B (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	davis.812@osu.edu			American Heart Association; National Institues of Health [HL091986, HL087462]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091986] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Heart Association (to BL and JPD), National Institues of Health grants HL091986 (to JPD) and HL087462 (to SBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 1999, BIOCHEMISTRY-US, V38, P4235, DOI 10.1021/bi982495z; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Iorga B, 2008, CARDIOVASC RES, V77, P676, DOI 10.1093/cvr/cvm113; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1741, DOI 10.1152/ajpheart.00759.2010; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; KASTURI R, 1993, J BIOL CHEM, V268, P7958; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Kushwaha SS, 1997, NEW ENGL J MED, V336, P267, DOI 10.1056/NEJM199701233360407; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Murphy AM, 2000, MOL MED TODAY, V6, P330, DOI 10.1016/S1357-4310(00)01732-9; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031	40	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38259	10.1371/journal.pone.0038259	http://dx.doi.org/10.1371/journal.pone.0038259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675533	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700052
J	Gabizon, R; Brandt, T; Sukenik, S; Lahav, N; Lebendiker, M; Shalev, DE; Veprintsev, D; Friedler, A				Gabizon, Ronen; Brandt, Tobias; Sukenik, Shahar; Lahav, Noa; Lebendiker, Mario; Shalev, Deborah E.; Veprintsev, Dmitry; Friedler, Assaf			Specific Recognition of p53 Tetramers by Peptides Derived from p53 Interacting Proteins	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; HIV-1 INTEGRASE; BINDING DOMAIN; S100 FAMILY; DNA-BINDING; KINASE-C; THERMODYNAMIC ANALYSIS; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; OLIGOMERIZATION	Oligomerization plays a major role in regulating the activity of many proteins, and in modulating their interactions. p53 is a homotetrameric transcription factor that has a pivotal role in tumor suppression. Its tetramerization domain is contained within its C-terminal domain, which is a site for numerous protein-protein interactions. Those can either depend on or regulate p53 oligomerization. Here we screened an array of peptides derived from proteins known to bind the tetrameric p53 C-terminal domain (p53CTD) and identified ten binding peptides. We quantitatively characterized their binding to p53CTD using fluorescence anisotropy. The peptides bound tetrameric p53CTD with micromolar affinities. Despite the high charge of the binding peptides, electrostatics contributed only mildly to the interactions. NMR studies indicated that the peptides bound p53CTD at defined sites. The most significant chemical shift deviations were observed for the peptides WS100B(81-92), which bound directly to the p53 tetramerization domain, and PKC alpha(281-295), which stabilized p53CTD in circular dichroism thermal denaturation studies. Using analytical ultracentrifugation, we found that several of the peptides bound preferentially to p53 tetramers. Our results indicate that the protein-protein interactions of p53 are dependent on the oligomerization state of p53. We conclude that peptides may be used to regulate the oligomerization of p53.	[Gabizon, Ronen; Sukenik, Shahar; Lahav, Noa; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Brandt, Tobias; Veprintsev, Dmitry] MRC Lab Mol Biol, Cambridge, England; [Lebendiker, Mario; Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel; [Veprintsev, Dmitry] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Veprintsev, Dmitry] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	Hebrew University of Jerusalem; MRC Laboratory Molecular Biology; Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gabizon, R (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	dmitry.veprintsev@psi.ch; assaf.friedler@mail.huji.ac.il	Shalev, Deborah E/AAY-2873-2021; Veprintsev, Dmitry B/H-2228-2012; Sukenik, Shahar/J-4438-2013	Veprintsev, Dmitry B/0000-0002-3583-5409; Sukenik, Shahar/0000-0003-3855-9574; Gabizon, Ronen/0000-0002-3626-5073	European Research Council under the European Community's Seventh Framework Programme [203413]; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Cambridge European Trust; Medical Research Council	European Research Council under the European Community's Seventh Framework Programme(European Commission); Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Cambridge European Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. RG is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. TB is supported by the Cambridge European Trust and the Medical Research Council. This research was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Dehner A, 2005, ANGEW CHEM INT EDIT, V44, P5247, DOI 10.1002/anie.200501887; Delphin C, 1997, EUR J BIOCHEM, V245, P684, DOI 10.1111/j.1432-1033.1997.t01-1-00684.x; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Friedler A, 2005, J BIOL CHEM, V280, P8051, DOI 10.1074/jbc.M411176200; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Gabizon R, 2008, BIOPOLYMERS, V90, P105, DOI 10.1002/bip.20919; Gordo S, 2008, P NATL ACAD SCI USA, V105, P16426, DOI 10.1073/pnas.0805658105; Gotz C, 1999, MOL CELL BIOCHEM, V191, P111, DOI 10.1023/A:1006886727248; Hayouka Z, 2008, BIOPOLYMERS, V90, P481, DOI 10.1002/bip.20930; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hayouka Z, 2010, BIOORGAN MED CHEM, V18, P8388, DOI 10.1016/j.bmc.2010.09.046; Hayouka Z, 2010, BIOCHEM BIOPH RES CO, V394, P260, DOI 10.1016/j.bbrc.2010.02.100; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maes M, 2009, BIOORGAN MED CHEM, V17, P7635, DOI 10.1016/j.bmc.2009.09.053; Martinell M, 2006, CHEMBIOCHEM, V7, P1105, DOI 10.1002/cbic.200500555; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Natan E, 2009, P NATL ACAD SCI USA, V106, P14327, DOI 10.1073/pnas.0907840106; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Politi Laura, 2009, Archaea, V2, P221, DOI 10.1155/2009/280317; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Robinson R. A., 1970, ELECTROLYTE SOLUTION, V2nd; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Schneider-Merck T, 2006, J BIOL CHEM, V281, P269, DOI 10.1074/jbc.M503459200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Takahasi K, 2010, GENES CELLS, V15, P901, DOI 10.1111/j.1365-2443.2010.01427.x; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wagner P, 1998, ONCOGENE, V16, P105, DOI 10.1038/sj.onc.1201510; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	56	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38060	10.1371/journal.pone.0038060	http://dx.doi.org/10.1371/journal.pone.0038060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693587	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500083
J	Simoes, SD; da Cunha, SS; Cruz, AA; Dias, KC; Alcantara-Neves, NM; Amorim, LD; Rodrigues, LC; Barreto, ML				Simoes, Silvia de Magalhaes; da Cunha, Sergio S.; Cruz, Alvaro A.; Dias, Karen Conceicao; Alcantara-Neves, Neuza M.; Amorim, Leila D.; Rodrigues, Laura C.; Barreto, Mauricio L.			A Community Study of Factors Related to Poorly Controlled Asthma among Brazilian Urban Children	PLOS ONE			English	Article							ALLERGIC RHINITIS; MEDICATION USE; SEVERITY; HEALTH; SYMPTOMS; INSIGHTS; EXPOSURE; REALITY; FUNGI	Background: Asthma constitutes a serious public health problem in many regions of the world, including the city of Salvador, State of Bahia - Brazil. The purpose of this study was to analyse the factors associated with poor asthma control. Methodology/Principal Findings: Two definitions were used for asthma: 1) wheezing in the last 12 months; 2) wheezing in the last 12 months plus other asthma symptoms or asthma diagnosis ever. The definition of poorly controlled asthma was: at least one reported hospitalisation due to asthma and/or high frequency of symptoms, in the last year. Children with poorly controlled asthma (N = 187/374) were compared with wheezing children with controlled asthma regarding age, gender, atopy, parental asthma, rhinitis, eczema, exposure to second hand tobacco smoke, presence of moulds, pets and pests in the house, helminth infections and body mass index. Crude and logistic regression adjusted odds ratios were used as measures of association. There was a higher proportion of poorly controlled asthma among children with eczema (OR = 1.55; 95% CI 1.02; 2.37). The strength of the association was greater among children with eczema and rhinitis (42.6%, 53.4% and 57.7%, respectively, in children who had no rhinitis nor eczema, had only one of those, and had both (p = 0.02 for trend test). The presence of mould in the houses was inversely associated with poorly controlled asthma (OR = 0.54; 95% CI 0.34; 0.87). Conclusions/Significance: Our results indicate an association between eczema and poor asthma control in this environment, but emphasize the role of various other individual and environmental factors as determinants of poor control.	[Simoes, Silvia de Magalhaes] Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Aracaju, Brazil; [Simoes, Silvia de Magalhaes; da Cunha, Sergio S.; Cruz, Alvaro A.; Dias, Karen Conceicao; Alcantara-Neves, Neuza M.; Amorim, Leila D.; Rodrigues, Laura C.; Barreto, Mauricio L.] SCAALA Social Change Asthma & Allergy Latin Amer, Recife, PE, Brazil; [da Cunha, Sergio S.] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil; [Cruz, Alvaro A.] Univ Fed Bahia, ProAR Nucleo Excelencia Asma, PRONEX CNPq FAPESB, Salvador, BA, Brazil; [Dias, Karen Conceicao; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Alcantara-Neves, Neuza M.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil; [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London WC1, England; [Amorim, Leila D.] Univ Fed Bahia, Inst Matemat, Salvador, BA, Brazil	Universidade Federal de Sergipe; Universidade Federal de Pernambuco; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia	Simoes, SD (corresponding author), Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Aracaju, Brazil.	silvia@alergia.org	Amorim, Leila/ABG-9480-2021; Cruz, Alvaro A/I-1676-2012; Amorim, Leila/B-4508-2015; Barreto, Mauricio L/B-1752-2008; RODRIGUES, LAURA CUNHA/AAO-4130-2021	Amorim, Leila/0000-0002-1112-2332; Cruz, Alvaro A/0000-0002-7403-3871; Amorim, Leila/0000-0002-1112-2332; Barreto, Mauricio L/0000-0002-0215-4930; Souza da Cunha, Sergio/0000-0002-4926-3827	Welcome Trust UK [072405/Z/03/Z]; Foundation for Research of the State of Bahia (FAPESB) [1941/2006, SUS0028/2009]; Brazilian Council for Development of Science and Technology (CNPq)	Welcome Trust UK(Wellcome Trust); Foundation for Research of the State of Bahia (FAPESB); Brazilian Council for Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is part of the SCAALA programme (Social Change, Asthma and Allergy in Latin America), which is funded by The Welcome Trust UK, Ref 072405/Z/03/Z. SMS was supported by a scholarship of the Foundation for Research of the State of Bahia (FAPESB) grant 1941/2006. AAC has scientist award of the Brazilian Council for Development of Science and Technology (CNPq), and a grant from FAPESB (SUS0028/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MI, 2000, INT ARCH ALLERGY IMM, V123, P145, DOI 10.1159/000024433; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barreto ML, 2006, BMC PULM MED; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Cassol VE, 2006, J ASTHMA, V43, P57, DOI 10.1080/02770900500448597; Crane J, 2003, EUR RESPIR J, V21, P455, DOI 10.1183/09031936.03.00041403; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Downs SH, 2001, AM J RESP CRIT CARE, V164, P455, DOI 10.1164/ajrccm.164.3.2008042; Gent JF, 2009, ENVIRON RES, V109, P768, DOI 10.1016/j.envres.2009.04.010; Halpern MT, 2004, J ASTHMA, V41, P117, DOI 10.1081/JAS-120026069; Heinrich J, 2003, J EXPO ANAL ENV EPID, V13, P152, DOI 10.1038/sj.jea.7500267; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Hoffman W. A., 1934, PUERTO RICO J PUBLIC, V9, P281, DOI DOI 10.1590/S0037-86822012000300024; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kyllonen H, 2006, CLIN EXP ALLERGY, V36, P192, DOI 10.1111/j.1365-2222.2006.02419.x; Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409; Medeiros M, 2003, J ALLERGY CLIN IMMUN, V111, P947, DOI 10.1067/mai.2003.1381; Neffen H, 2005, REV PANAM SALUD PUBL, V17, P191, DOI 10.1590/S1020-49892005000300007; O'Driscoll BR, BMC PULM MED; Ponte EV, 2008, ALLERGY, V63, P564, DOI 10.1111/j.1398-9995.2007.01624.x; Ponte EV, 2006, ANN ALLERG ASTHMA IM, V96, P713, DOI 10.1016/S1081-1206(10)61070-8; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Santos DB, 2012, EUR J CLIN PHARMACOL, V68, P73, DOI 10.1007/s00228-011-1092-6; Simons FER, 1999, J ALLERGY CLIN IMMUN, V104, P534, DOI 10.1016/S0091-6749(99)70320-9; Sole D, 2005, PEDIAT ALLERG IMM-UK, V16, P121, DOI 10.1111/j.1399-3038.2005.00227.x; STRACHAN DP, 1995, BRIT MED J, V311, P1053, DOI 10.1136/bmj.311.7012.1053; Weissman DN, 2002, CHEST, V121, P6, DOI 10.1378/chest.121.1.6; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37050	10.1371/journal.pone.0037050	http://dx.doi.org/10.1371/journal.pone.0037050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693565	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305338500027
J	Yan, P; Shen, WT; Gao, XZ; Li, XY; Zhou, P; Duan, J				Yan, Pu; Shen, Wentao; Gao, XinZheng; Li, Xiaoying; Zhou, Peng; Duan, Jun			High-Throughput Construction of Intron-Containing Hairpin RNA Vectors for RNAi in Plants	PLOS ONE			English	Article							TRANSIENT EXPRESSION SYSTEM; ONE-STEP; ONE-POT; DNA; CLONING; EFFICIENT; SEQUENCE; INTERFERENCE; PROTEINS; DESIGN	With the wide use of double-stranded RNA interference (RNAi) for the analysis of gene function in plants, a high-throughput system for making hairpin RNA (hpRNA) constructs is in great demand. Here, we describe a novel restriction-ligation approach that provides a simple but efficient construction of intron-containing hpRNA (ihpRNA) vectors. The system takes advantage of the type IIs restriction enzyme BsaI and our new plant RNAi vector pRNAi-GG based on the Golden Gate (GG) cloning. This method requires only a single PCR product of the gene of interest flanked with BsaI recognition sequence, which can then be cloned into pRNAi-GG at both sense and antisense orientations simultaneously to form ihpRNA construct. The process, completed in one tube with one restriction-ligation step, produced a recombinant ihpRNA with high efficiency and zero background. We demonstrate the utility of the ihpRNA constructs generated with pRNAi-GG vector for the effective silencing of various individual endogenous and exogenous marker genes as well as two genes simultaneously. This method provides a novel and high-throughput platform for large-scale analysis of plant functional genomics.	[Yan, Pu; Duan, Jun] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Yan, Pu; Shen, Wentao; Li, Xiaoying; Zhou, Peng] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Gao, XinZheng] Hainan Med Coll, Dept Basic Med Sci, Haikou, Peoples R China; [Yan, Pu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Tropical Agricultural Sciences; Hainan Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yan, P (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	zhp6301@126.com; duanj@scib.ac.cn			National Natural Science Foundation of China [30960218]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB110212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nonprofit Institute Research Grant of CATAS-ITBB	This work is supported by the National Natural Science Foundation of China (Grant no. 30960218) and the National Nonprofit Institute Research Grant of CATAS-ITBB (ITBB110212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Eamens AL, 2011, METHODS MOL BIOL, V701, P179, DOI 10.1007/978-1-61737-957-4_10; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gunsalus KC, 2005, CURR OPIN CELL BIOL, V17, P3, DOI 10.1016/j.ceb.2004.12.008; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Himmelbach A, 2007, PLANT PHYSIOL, V145, P1192, DOI 10.1104/pp.107.111575; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kusaba M, 2004, CURR OPIN BIOTECH, V15, P139, DOI 10.1016/j.copbio.2004.02.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Santos-Rosa M, 2008, PLANT CELL REP, V27, P1053, DOI 10.1007/s00299-008-0531-z; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xiao YH, 2006, BIOTECHNIQUES, V41, P548, DOI 10.2144/000112295; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Yan P, 2009, BIOCHEM BIOPH RES CO, V383, P464, DOI 10.1016/j.bbrc.2009.04.036; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	30	42	53	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38186	10.1371/journal.pone.0038186	http://dx.doi.org/10.1371/journal.pone.0038186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675447	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500104
J	Du, YM; Kong, GY; You, XN; Zhang, S; Zhang, T; Gao, Y; Ye, LH; Zhang, XD				Du, Yumei; Kong, Guangyao; You, Xiaona; Zhang, Shuai; Zhang, Tao; Gao, Yuen; Ye, Lihong; Zhang, Xiaodong			Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG NONCODING RNA; HEPATOCELLULAR-CARCINOMA; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; TILING ARRAYS; BREAST-CANCER; TUMOR-GROWTH; GENE; EXPRESSION; GENOME	Long noncoding RNAs (lncRNAs) play crucial roles in human cancers. It has been reported that lncRNA highly up-regulated in liver cancer (HULC) is dramatically up-regulated in hepatocellular carcinoma (HCC). Hepatitis B virus X protein (HBx) contributes importantly to the development of HCC. However, the function of HULC in HCC mediated by HBx remains unclear. Here, we report that HULC is involved in HBx-mediated hepatocarcinogenesis. We found that the expression levels of HULC were positively correlated with those of HBx in clinical HCC tissues. Moreover, we revealed that HBx up-regulated HULC in human immortalized normal liver L-O2 cells and hepatoma HepG2 cells. Luciferase reporter gene assay and chromatin immunoprecipitation (ChIP) assay showed that HBx activated the HULC promoter via cAMP-responsive element-binding protein. We further demonstrated that HULC promoted cell proliferation by methyl thiazolyl tetrazolium, 5-ethynyl-2'-de-oxyuridine, colony formation assay, and tumorigenicity assay. Next, we hypothesized that HULC might function through regulating a tumor suppressor gene p18 located near HULC in the same chromosome. We found that the mRNA levels of p18 were inversely correlated with those of HULC in the above clinical HCC specimens. Then, we validated that HULC down-regulated p18, which was involved in the HULC-enhanced cell proliferation in vitro and in vivo. Furthermore, we observed that knockdown of HULC could abolish the HBx-enhanced cell proliferation through up-regulating p18. Thus, we conclude that the up-regulated HULC by HBx promotes proliferation of hepatoma cells through suppressing p18. This finding provides new insight into the roles of lncRNAs in HBx-related hepatocarcinogenesis.	[Ye, Lihong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China; [Du, Yumei; Kong, Guangyao; You, Xiaona; Zhang, Shuai; Zhang, Tao; Gao, Yuen; Zhang, Xiaodong] Nankai Univ, Inst Mol Biol, Minist Educ, Dept Canc Res,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Ye, LH (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Zhang, Tao/F-4366-2018; Ibrahim, Essam Hassan/G-1960-2018; Gao, Yuen/AAM-7541-2021; Kong, Guangyao/L-2162-2013	Zhang, Tao/0000-0002-4749-6774; Ibrahim, Essam Hassan/0000-0003-0130-2257; Gao, Yuen/0000-0002-2807-2976; You, Xiaona/0000-0001-9996-1466; Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China (973 Program) [2009CB521702, 2011CB512113]; Natural Scientific Foundation of China [81071624, 81071623]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program, Grants 2009CB521702 and 2011CB512113) and the Natural Scientific Foundation of China (Grants 81071624 and 81071623).	Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kew MC, 1997, HEPATOLOGY, V25, P1037, DOI 10.1002/hep.510250442; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kwak YT, 2011, MOL CANCER RES, V9, P341, DOI 10.1158/1541-7786.MCR-10-0248; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Liu QY, 2011, J BIOL CHEM, V286, P17168, DOI 10.1074/jbc.M110.167783; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Waris G, 2003, J BIOSCIENCES, V28, P311, DOI 10.1007/BF02970150; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466	47	294	331	0	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26302	26311		10.1074/jbc.M112.342113	http://dx.doi.org/10.1074/jbc.M112.342113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685290	hybrid, Green Published			2022-12-25	WOS:000306916300056
J	Javadi, M; Hofstatter, E; Stickle, N; Beattie, BK; Jaster, R; Carter-Su, C; Barber, DL				Javadi, Mojib; Hofstaetter, Edda; Stickle, Natalie; Beattie, Bryan K.; Jaster, Robert; Carter-Su, Christin; Barber, Dwayne L.			The SH2B1 Adaptor Protein Associates with a Proximal Region of the Erythropoietin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EPO RECEPTOR; STAT5A(-/-)5B(-/-) MICE; ERYTHROID PROGENITORS; LYMPHOID DEVELOPMENT; GROWTH-FACTOR; IN-VIVO; ACTIVATION; JAK2; DOMAIN	Gene targeting experiments have shown that the cytokine erythropoietin (EPO), its cognate erythropoietin receptor (EPO-R), and associated Janus tyrosine kinase, JAK2, are all essential for erythropoiesis. Structural-functional and murine knock-in experiments have suggested that EPO-R Tyr-343 is important in EPO-mediated mitogenesis. Although Stat5 binds to EPO-R phosphotyrosine 343, the initial Stat5-deficient mice did not have profound erythroid abnormalities suggesting that additional Src homology 2 (SH2) domain-containing effectors may bind to EPO-R Tyr-343 and couple to downstream signaling pathways. We have utilized cloning of ligand target (COLT) screening to demonstrate that EPO-R Tyr(P)-343 and Tyr(P)-401 bind to the SH2 domain-containing adaptor protein SH2B1 beta. Immunoprecipitation and in vitro mixing experiments reveal that EPO-R binds to SH2B1 in an SH2 domain-dependent manner and that the sequence that confers SH2B1 binding to the EPO-R is pYXXL. Previous studies have shown that SH2B1 binds directly to JAK2, but we show that in hematopoietic cells, SH2B1 beta preferentially associates with the EPO-R. SH2B1 is capable of constitutive association with EPO-R, which is necessary for its optimal SH2-dependent recruitment to EPO-R-Tyr(P)-343/Tyr(P)-401. We also demonstrate that SH2B1 is responsive to EPO stimulation and becomes phosphorylated, most likely on serines/threonines, in an EPO dose-and time-dependent manner. In the absence of SH2B1, we observe enhanced activation of signaling pathways downstream of the EPO-R, indicating that SH2B1 is a negative regulator of EPO signaling.	[Javadi, Mojib; Hofstaetter, Edda; Stickle, Natalie; Beattie, Bryan K.; Barber, Dwayne L.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2M9, Canada; [Barber, Dwayne L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Barber, Dwayne L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Jaster, Robert] Univ Rostock, Dept Gastroenterol, D-18057 Rostock, Germany; [Carter-Su, Christin] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Rostock; University of Michigan System; University of Michigan	Barber, DL (corresponding author), Ontario Canc Inst, Campbell Family Canc Res Inst, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	dbarber@uhnres.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150	National Institutes of Health [RO1-DK54222]; Canadian Institutes of Health Research [MOP-13612]; Rotary International scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rotary International scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK54222 (to C. C. S.). This work was also supported by Grant MOP-13612 (to D. L. B.) from Canadian Institutes of Health Research.; Supported by a Rotary International scholarship.	BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Barber DL, 2001, BLOOD, V97, P2230, DOI 10.1182/blood.V97.8.2230; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Halupa A, 2005, EXP CELL RES, V309, P1, DOI 10.1016/j.yexcr.2005.04.030; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Haq R, 2002, J BIOL CHEM, V277, P17359, DOI 10.1074/jbc.M201842200; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Kurzer JH, 2006, MOL CELL BIOL, V26, P6381, DOI 10.1128/MCB.00570-06; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Li K, 2003, BLOOD, V102, P3147, DOI 10.1182/blood-2003-01-0078; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Mason JM, 2000, J BIOL CHEM, V275, P4398, DOI 10.1074/jbc.275.6.4398; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Maures TJ, 2011, J CELL SCI, V124, P1542, DOI 10.1242/jcs.078949; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Miller CP, 2002, BLOOD, V99, P898, DOI 10.1182/blood.V99.3.898; MIURA O, 1994, BLOOD, V84, P1501; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nishi M, 2005, MOL CELL BIOL, V25, P2607, DOI 10.1128/MCB.25.7.2607-2621.2005; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rui LY, 2000, MOL CELL BIOL, V20, P3168, DOI 10.1128/MCB.20.9.3168-3177.2000; Rui LY, 1999, J BIOL CHEM, V274, P26485, DOI 10.1074/jbc.274.37.26485; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 1997, J BIOL CHEM, V272, P14009, DOI 10.1074/jbc.272.22.14009; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; von Lindern M, 2000, J BIOL CHEM, V275, P34719, DOI 10.1074/jbc.M007042200; Wakioka T, 1999, LEUKEMIA, V13, P760, DOI 10.1038/sj.leu.2401397; Walters DK, 2005, BLOOD, V105, P2952, DOI 10.1182/blood-2004-07-2758; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156; Zhang MC, 2008, J CELL BIOCHEM, V103, P162, DOI 10.1002/jcb.21397; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	54	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26223	26234		10.1074/jbc.M112.382721	http://dx.doi.org/10.1074/jbc.M112.382721			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669948	Green Published, hybrid			2022-12-25	WOS:000306916300049
J	Bade, VN; Nickels, J; Keusekotten, K; Praefcke, GJK				Bade, Veronika N.; Nickels, Jochen; Keusekotten, Kirstin; Praefcke, Gerrit J. K.			Covalent Protein Modification with ISG15 via a Conserved Cysteine in the Hinge Region	PLOS ONE			English	Article							POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; 15-KDA PROTEIN; PML/RAR-ALPHA; NS1 PROTEIN; HUMAN-CELLS; DNA-REPAIR; UBIQUITIN; ISGYLATION; INFLUENZA	The ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) is strongly induced by type I interferons and displays antiviral activity. As other ubiquitin-like proteins (Ubls), ISG15 is post-translationally conjugated to substrate proteins by an isopeptide bond between the C-terminal glycine of ISG15 and the side chains of lysine residues in the substrates (ISGylation). ISG15 consists of two ubiquitin-like domains that are separated by a hinge region. In many orthologs, this region contains a single highly reactive cysteine residue. Several hundred potential substrates for ISGylation have been identified but only a few of them have been rigorously verified. In order to investigate the modification of several ISG15 substrates, we have purified ISG15 conjugates from cell extracts by metal-chelate affinity purification and immunoprecipitations. We found that the levels of proteins modified by human ISG15 can be decreased by the addition of reducing agents. With the help of thiol blocking reagents, a mutational analysis and miRNA mediated knock-down of ISG15 expression, we revealed that this modification occurs in living cells via a disulphide bridge between the substrates and Cys78 in the hinge region of ISG15. While the ISG15 activating enzyme UBE1L is conjugated by ISG15 in the classical way, we show that the ubiquitin conjugating enzyme Ubc13 can either be classically conjugated by ISG15 or can form a disulphide bridge with ISG15 at the active site cysteine 87. The latter modification would interfere with its function as ubiquitin conjugating enzyme. However, we found no evidence for an ISG15 modification of the dynamin-like GTPases MxA and hGBP1. These findings indicate that the analysis of potential substrates for ISG15 conjugation must be performed with great care to distinguish between the two types of modification since many assays such as immunoprecipitation or metal-chelate affinity purification are performed with little or no reducing agent present.	[Bade, Veronika N.; Nickels, Jochen; Keusekotten, Kirstin; Praefcke, Gerrit J. K.] Univ Cologne, Inst Genet, CMMC, Cologne, Germany	University of Cologne	Bade, VN (corresponding author), Univ Cologne, Inst Genet, CMMC, Weyertal 121, Cologne, Germany.	gpraefck@uni-koeln.de		Praefcke, Gerrit/0000-0001-8818-1499; bade, Veronika/0000-0002-9877-5220	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB635]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This research was supported by a grant of the Deutsche Forschungsgemeinschaft (German Research Foundation) (SFB635). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, J IMMUNOL, V157, P4100; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; GREGORY JD, 1955, J AM CHEM SOC, V77, P3922, DOI 10.1021/ja01619a073; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Guo YL, 2010, CANCER RES, V70, P9875, DOI 10.1158/0008-5472.CAN-10-1100; HAAS AL, 1987, J BIOL CHEM, V262, P11315; HERSH LB, 1979, J BIOL CHEM, V254, P1988; Hochrainer K, 2008, CELL MOL LIFE SCI, V65, P2105, DOI 10.1007/s00018-008-8148-5; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; KNIGHT E, 1991, J IMMUNOL, V146, P2280; Knobeloch KP, 2005, MOL CELL BIOL, V25, P11030, DOI 10.1128/MCB.25.24.11030-11034.2005; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Nyman TA, 2000, EUR J BIOCHEM, V267, P4011, DOI 10.1046/j.1432-1327.2000.01433.x; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Okumura F, 2008, J BIOL CHEM, V283, P24484, DOI 10.1074/jbc.M803795200; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Padovan E, 2002, CANCER RES, V62, P3453; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Schnellhardt M, 2012, METHODS MOL BIOL, V832, P81, DOI 10.1007/978-1-61779-474-2_4; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shah SJ, 2008, MOL CANCER THER, V7, P905, DOI 10.1158/1535-7163.MCT-07-0515; Sorensen CM, 2007, BIOCHEMISTRY-US, V46, P772, DOI 10.1021/bi061408x; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	52	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38294	10.1371/journal.pone.0038294	http://dx.doi.org/10.1371/journal.pone.0038294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693631	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343900027
J	Jung, CH; Wong, CE; Singh, MB; Bhalla, PL				Jung, Chol-Hee; Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.			Comparative Genomic Analysis of Soybean Flowering Genes	PLOS ONE			English	Article							MADS-BOX GENE; ARABIDOPSIS-THALIANA; FINGER PROTEIN; GLYCINE-MAX; LOCUS-T; SHOOT; TIME; VERNALIZATION; ACTS; SEQUENCE	Flowering is an important agronomic trait that determines crop yield. Soybean is a major oilseed legume crop used for human and animal feed. Legumes have unique vegetative and floral complexities. Our understanding of the molecular basis of flower initiation and development in legumes is limited. Here, we address this by using a computational approach to examine flowering regulatory genes in the soybean genome in comparison to the most studied model plant, Arabidopsis. For this comparison, a genome-wide analysis of orthologue groups was performed, followed by an in silico gene expression analysis of the identified soybean flowering genes. Phylogenetic analyses of the gene families highlighted the evolutionary relationships among these candidates. Our study identified key flowering genes in soybean and indicates that the vernalisation and the ambient-temperature pathways seem to be the most variant in soybean. A comparison of the orthologue groups containing flowering genes indicated that, on average, each Arabidopsis flowering gene has 2-3 orthologous copies in soybean. Our analysis highlighted that the CDF3, VRN1, SVP, AP3 and PIF3 genes are paralogue-rich genes in soybean. Furthermore, the genome mapping of the soybean flowering genes showed that these genes are scattered randomly across the genome. A paralogue comparison indicated that the soybean genes comprising the largest orthologue group are clustered in a 1.4 Mb region on chromosome 16 of soybean. Furthermore, a comparison with the undomesticated soybean (Glycine soja) revealed that there are hundreds of SNPs that are associated with putative soybean flowering genes and that there are structural variants that may affect the genes of the light-signalling and ambient-temperature pathways in soybean. Our study provides a framework for the soybean flowering pathway and insights into the relationship and evolution of flowering genes between a short-day soybean and the long-day plant, Arabidopsis.	[Jung, Chol-Hee; Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.] Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia	University of Melbourne	Jung, CH (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	premlb@unimelb.edu.au	Jung, Cholhee/S-8670-2019	Bhalla, Prem/0000-0002-2910-0393; Singh, Mohan/0000-0001-9427-8975	Australian Research Council [CE0348212]	Australian Research Council(Australian Research Council)	Funding for this research was provided by the Australian Research Council (http://www.arc.gov.au) in form of the ARC Centre of Excellence grant (CE0348212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; BARTON MK, 1993, DEVELOPMENT, V119, P823; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen MJ, 2006, PLANT J, V46, P823, DOI 10.1111/j.1365-313X.2006.02740.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Ferl RJ, 2002, GENOME BIOL, V3; Fornara Fabio, 2010, Cell, V141, DOI 10.1016/j.cell.2010.04.024; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Gu Q, 1998, DEVELOPMENT, V125, P1509; Han P, 2008, PLANT J, V55, P253, DOI 10.1111/j.1365-313X.2008.03499.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laux T, 1996, DEVELOPMENT, V122, P87; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liscum E, 2003, PLANT PHYSIOL, V133, P1429, DOI 10.1104/pp.103.030601; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Nakaminami K, 2009, J EXP BOT, V60, P1047, DOI 10.1093/jxb/ern351; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Robles P, 2005, INT J DEV BIOL, V49, P633, DOI 10.1387/ijdb.052020pr; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Summerfield RJ, 1985, GLYCINE MAX, P139; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tucker SC, 2003, PLANT PHYSIOL, V131, P911, DOI 10.1104/pp.102.017459; Veley KM, 2008, PLANT PHYSIOL, V147, P682, DOI 10.1104/pp.108.118927; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Washburn CF, 2000, AM J BOT, V87, P1425, DOI 10.2307/2656869; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yu H, 2002, P NATL ACAD SCI USA, V99, P16336, DOI 10.1073/pnas.212624599; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105	56	74	76	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38250	10.1371/journal.pone.0038250	http://dx.doi.org/10.1371/journal.pone.0038250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679494	Green Published, gold			2022-12-25	WOS:000305343900024
J	Macdonald, SHF; Woodward, E; Coleman, MM; Dorris, ER; Nadarajan, P; Chew, WM; McLaughlin, AM; Keane, J				Macdonald, Stephen H. -F.; Woodward, Elliott; Coleman, Michelle M.; Dorris, Emma R.; Nadarajan, Parthiban; Chew, Wui-Mei; McLaughlin, Anne-Marie; Keane, Joseph			Networked T Cell Death following Macrophage Infection by Mycobacterium tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIGEN PRESENTATION; EXPRESSION ANALYSIS; APOPTOSIS; SECRETION; MODULATION; MECHANISMS; RESPONSES; EVASION; PROTEIN	Background: Depletion of T cells following infection by Mycobacterium tuberculosis (Mtb) impairs disease resolution, and interferes with clinical test performance that relies on cell-mediated immunity. A number of mechanisms contribute to this T cell suppression, such as activation-induced death and trafficking of T cells out of the peripheral circulation and into the diseased lungs. The extent to which Mtb infection of human macrophages affects T cell viability however, is not well characterised. Methodology/Principal Findings: We found that lymphopenia (<1.5x10(9) cells/l) was prevalent among culture-positive tuberculosis patients, and lymphocyte counts significantly improved post-therapy. We previously reported that Mtb-infected human macrophages resulted in death of infected and uninfected bystander macrophages. In the current study, we sought to examine the influence of infected human alveolar macrophages on T cells. We infected primary human alveolar macrophages (the primary host cell for Mtb) or PMA-differentiated THP-1 cells with Mtb H37Ra, then prepared cell-free supernatants. The supernatants of Mtb-infected macrophages caused dose-dependent, caspase-dependent, T cell apoptosis. This toxic effect of infected macrophage secreted factors did not require TNF-alpha or Fas. The supernatant cytotoxic signal(s) were heat-labile and greater than 50 kDa in molecular size. Although ESAT-6 was toxic to T cells, other Mtb-secreted factors tested did not influence T cell viability; nor did macrophage-free Mtb bacilli or broth from Mtb cultures. Furthermore, supernatants from Mycobacterium bovis Bacille de Calmette et Guerin (BCG)-infected macrophages also elicited T cell death suggesting that ESAT-6 itself, although cytotoxic, was not the principal mediator of T cell death in our system. Conclusions: Mtb-Infected macrophages secrete heat-labile factors that are toxic to T cells, and may contribute to the immunosuppression seen in tuberculosis as well as interfere with microbial eradication in the granuloma.	[Macdonald, Stephen H. -F.; Woodward, Elliott; Coleman, Michelle M.; Dorris, Emma R.; Nadarajan, Parthiban; Chew, Wui-Mei; McLaughlin, Anne-Marie; Keane, Joseph] St James Hosp, Trinity Inst Mol Med, Dept Clin Med, Dublin, Ireland	Trinity College Dublin	Macdonald, SHF (corresponding author), St James Hosp, Trinity Inst Mol Med, Dept Clin Med, Dublin, Ireland.	macdonaldez@gmail.com	Keane, Joseph/AAX-6658-2021; Dorris, Emma/AAJ-6563-2020	Keane, Joseph/0000-0001-5313-385X; Dorris, Emma/0000-0003-2014-934X; Nadarajan, Parthiban/0000-0002-1685-1876; Coleman, Michelle/0000-0002-6752-3266; Macdonald, Stephen/0000-0001-6306-8035	Science Foundation Ireland (SFI); Health Research Board (HRB); SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster [07/SRC/B1144, E02209420]; HRB's PhD Scholars' Program	Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB); SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster(Science Foundation Ireland); HRB's PhD Scholars' Program	This work was funded by the Science Foundation Ireland (SFI; www.sfi.ie) and the Health Research Board (HRB; www.hrb.ie). JK, SHFM and MMC were supported by SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster grant (07/SRC/B1144 Cluster Grant E02209420). ERD was funded by the HRB's PhD Scholars' Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Blanchette J, 2003, IMMUNOLOGY, V108, P513, DOI 10.1046/j.1365-2567.2003.01620.x; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Davoudi S, 2008, BRAZ J INFECT DIS, V12, P483, DOI 10.1590/S1413-86702008000600008; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gilbertson B, 1999, J IMMUNOL, V163, P2073; Green JA, 2010, J IMMUNOL, V184, P6492, DOI 10.4049/jimmunol.0903811; Gupta RK, 2010, MICROBIOL-SGM, V156, P2714, DOI 10.1099/mic.0.037622-0; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hirsch CS, 2005, J CLIN IMMUNOL, V25, P353, DOI 10.1007/s10875-005-4841-4; Jendro MC, 2004, MED MICROBIOL IMMUN, V193, P45, DOI 10.1007/s00430-003-0182-1; Jones BE, 1997, CLIN INFECT DIS, V24, P988, DOI 10.1093/clinids/24.5.988; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kelly DM, 2008, INFECT IMMUN, V76, P351, DOI 10.1128/IAI.00614-07; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; Mariani F, 2000, GENE, V253, P281, DOI 10.1016/S0378-1119(00)00249-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Mustafa T, 2006, IMMUNOLOGY, V117, P454, DOI 10.1111/j.1365-2567.2005.02318.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; O'Leary S, 2010, AM J RESP CELL MOL B; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Ryan RCM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-237; Samten B, 2009, TUBERCULOSIS, V89, pS74, DOI 10.1016/S1472-9792(09)70017-4; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Sharma S, 2009, IMMUNOL CELL BIOL, V87, P226, DOI 10.1038/icb.2008.97; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631; Wojtas B, 2011, MICROB PATHOGENESIS, V51, P9, DOI 10.1016/j.micpath.2011.03.004; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Zhong J, 2003, IMMUNOL CELL BIOL, V81, P480, DOI 10.1046/j.1440-1711.2003.01193.x	45	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38488	10.1371/journal.pone.0038488	http://dx.doi.org/10.1371/journal.pone.0038488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675566	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700078
J	Innocenti, A; De Stefani, E; Bernardi, NF; Campione, GC; Gentilucci, M				Innocenti, Alessandro; De Stefani, Elisa; Bernardi, Nicolo Francesco; Campione, Giovanna Cristina; Gentilucci, Maurizio			Gaze Direction and Request Gesture in Social Interactions	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; VISUAL CUES; MECHANISMS; PERCEPTION; PREHENSION; ATTENTION; MOVEMENTS; BEHAVIOR; OTHERS; GRASP	One of the most important faculties of humans is to understand the behaviour of other conspecifics. The present study aimed at determining whether, in a social context, request gesture and gaze direction of an individual are enough to infer his/her intention to communicate, by searching for their effects on the kinematics of another individual's arm action. In four experiments participants reached, grasped and lifted a bottle filled of orange juice in presence of an empty glass. In experiment 1, the further presence of a conspecific not producing any request with a hand and gaze did not modify the kinematics of the sequence. Conversely, experiments 2 and 3 showed that the presence of a conspecific producing only a request of pouring by holding the glass with his/her right hand, or only a request of comunicating with the conspecific, by using his/her gaze, affected lifting and grasping of the sequence, respectively. Experiment 4 showed that hand gesture and eye contact simultaneously produced affected the entire sequence. The results suggest that the presence of both request gesture and direct gaze produced by an individual changes the control of a motor sequence executed by another individual. We propose that a social request activates a social affordance that interferes with the control of whatever sequence and that the gaze of the potential receiver who held the glass with her hand modulates the effectiveness of the manual gesture. This paradigm if applied to individuals affected by autism disorder can give new insight on the nature of their impairment in social interaction and communication.	[Innocenti, Alessandro; De Stefani, Elisa; Bernardi, Nicolo Francesco; Campione, Giovanna Cristina; Gentilucci, Maurizio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] Ist Italiano Tecnol, Parma, Italy; [Bernardi, Nicolo Francesco] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; University of Milano-Bicocca	Innocenti, A (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	maurizio.gentilucci@unipr.it	De Stefani, Elisa/C-3154-2018	De Stefani, Elisa/0000-0003-4492-3926; Bernardi, Nicolo Francesco/0000-0002-1250-1916; Campione, Giovanna Cristina/0000-0003-0410-5400	Ministero dell'Istruzione; dell'Universita e della Ricerca; Istituto Italiano della Tecnologia	Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Italiano della Tecnologia	The work was supported by grants Ministero dell'Istruzione, dell'Universita e della Ricerca and Istituto Italiano della Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Barten S., 1979, SYMBOLIC FUNCTIONING, P126; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015855; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gangitano M, 1998, EXP BRAIN RES, V122, P441, DOI 10.1007/s002210050532; Gentilucci M, 1997, PARIETAL LOBE CONTRI, P339; Gentilucci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019793; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Greene DJ, 2011, NEUROIMAGE, V56, P354, DOI 10.1016/j.neuroimage.2011.02.031; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Kampe KKW, 2001, NATURE, P413; KANNER L, 1971, J AUTISM CHILD SCHIZ, V1, P119, DOI 10.1007/BF01537953; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; Mon-Williams M, 2000, EXP BRAIN RES, V134, P268, DOI 10.1007/s002210000479; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelphrey KA, 2006, CURR DIR PSYCHOL SCI, V15, P136, DOI 10.1111/j.0963-7214.2006.00423.x; Pierno AC, 2008, SOC NEUROSCI-UK, V3, P51, DOI 10.1080/17470910701563269; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schilbach L, 2011, AUTISM IN PRESS; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; TIPPER SP, 1991, BRIT J PSYCHOL, V82, P507, DOI 10.1111/j.2044-8295.1991.tb02416.x; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Vivanti G, 2011, DEV PSYCHOL, V47, P841, DOI 10.1037/a0023105; Vlainic E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00208	38	36	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36390	10.1371/journal.pone.0036390	http://dx.doi.org/10.1371/journal.pone.0036390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22693550	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500011
J	Litchfield, LM; Riggs, KA; Hockenberry, AM; Oliver, LD; Barnhart, KG; Cai, J; Pierce, WM; Ivanova, MM; Bates, PJ; Appana, SN; Datta, S; Kulesza, P; McBryan, J; Young, LS; Klinge, CM				Litchfield, Lacey M.; Riggs, Krista A.; Hockenberry, Alyson M.; Oliver, Laura D.; Barnhart, Katelyn G.; Cai, Jian; Pierce, William M., Jr.; Ivanova, Margarita M.; Bates, Paula J.; Appana, Savitri N.; Datta, Susmita; Kulesza, Piotr; McBryan, Jean; Young, Leonie S.; Klinge, Carolyn M.			Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor beta Transcription in Breast Cancer Cells	PLOS ONE			English	Article							HUMAN MICROGLIAL CELLS; BCL-2 MESSENGER-RNA; ESTROGEN-RECEPTOR; GENE-EXPRESSION; FACTOR-I; GLUCOCORTICOID-RECEPTOR; HORMONE-RECEPTOR; FACTOR INTERACTS; PROMOTER; PROTEIN	Introduction: The orphan nuclear receptor COUP-TFII plays an undefined role in breast cancer. Previously we reported lower COUP-TFII expression in tamoxifen/endocrine-resistant versus sensitive breast cancer cell lines. The identification of COUP-TFII-interacting proteins will help to elucidate its mechanism of action as a transcriptional regulator in breast cancer. Results: FLAG-affinity purification and multidimensional protein identification technology (MudPIT) identified nucleolin among the proteins interacting with COUP-TFII in MCF-7 tamoxifen-sensitive breast cancer cells. Interaction of COUP-TFII and nucleolin was confirmed by coimmunoprecipitation of endogenous proteins in MCF-7 and T47D breast cancer cells. In vitro studies revealed that COUP-TFII interacts with the C-terminal arginine-glycine repeat (RGG) domain of nucleolin. Functional interaction between COUP-TFII and nucleolin was indicated by studies showing that siRNA knockdown of nucleolin and an oligonucleotide aptamer that targets nucleolin, AS1411, inhibited endogenous COUP-TFII-stimulated RARB2 expression in MCF-7 and T47D cells. Chromatin immunoprecipitation revealed COUP-TFII occupancy of the RARB2 promoter was increased by all-trans retinoic acid (atRA). RAR beta 2 regulated gene RRIG1 was increased by atRA and COUP-TFII transfection and inhibited by siCOUP-TFII. Immunohistochemical staining of breast tumor microarrays showed nuclear COUP-TFII and nucleolin staining was correlated in invasive ductal carcinomas. COUP-TFII staining correlated with ER alpha, SRC1, AIB1, Pea3, MMP2, and phospho-Src and was reduced with increased tumor grade. Conclusions: Our data indicate that nucleolin plays a coregulatory role in transcriptional regulation of the tumor suppressor RARB2 by COUP-TFII.	[Litchfield, Lacey M.; Riggs, Krista A.; Hockenberry, Alyson M.; Oliver, Laura D.; Barnhart, Katelyn G.; Ivanova, Margarita M.; Klinge, Carolyn M.] Dept Biochem & Mol Biol, Louisville, KY USA; [Litchfield, Lacey M.; Riggs, Krista A.; Hockenberry, Alyson M.; Oliver, Laura D.; Barnhart, Katelyn G.; Ivanova, Margarita M.; Klinge, Carolyn M.] Ctr Genet & Mol Med, Louisville, KY USA; [Cai, Jian; Pierce, William M., Jr.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Bates, Paula J.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Appana, Savitri N.; Datta, Susmita] Univ Louisville, Dept Bioinformat & Biostat, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA; [Kulesza, Piotr] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [McBryan, Jean; Young, Leonie S.] Royal Coll Surgeons Ireland, Dept Surg, Endocrine Oncol Res Grp, Dublin 2, Ireland	University of Louisville; University of Louisville; University of Louisville; Northwestern University; Feinberg School of Medicine; Royal College of Surgeons - Ireland	Litchfield, LM (corresponding author), Dept Biochem & Mol Biol, Louisville, KY USA.	carolyn.klinge@louisville.edu	Ivanova, Margarita/AAM-4510-2021	Klinge, Carolyn/0000-0002-3358-4378; McBryan, Jean/0000-0002-7568-2208; Bates, Paula/0000-0002-4622-4152; Ivanova, Margarita/0000-0002-6197-8606; Hockenberry, Alyson/0000-0003-0828-1428; Young, Leonie/0000-0002-4904-0367	Komen for the Cure [KG080365]; NIEHS [T32 ES011564]; Health Research Board; Science Foundation Ireland; Breast Cancer Ireland; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES011564] Funding Source: NIH RePORTER	Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Breast Cancer Ireland; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Komen for the Cure grant KG080365 to C. M. K. L. M. L. and K. A. R. were supported by NIEHS T32 ES011564. J.M. and L.S.Y. were supported by grants from the Health Research Board, Science Foundation Ireland, and Breast Cancer Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2011, CLIN TRANSL ONCOL, V13, P767, DOI 10.1007/s12094-011-0731-9; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Berns EMJJ, 1998, BREAST CANCER RES TR, V48, P87, DOI 10.1023/A:1005903226483; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; De Martino MU, 2004, ANN NY ACAD SCI, V1024, P72, DOI 10.1196/annals.1321.006; De Martino MU, 2004, MOL ENDOCRINOL, V18, P820, DOI 10.1210/me.2003-0341; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Hanakahi LA, 2000, BIOCHEMISTRY-US, V39, P15493, DOI 10.1021/bi001683y; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jensen EV, 2001, P NATL ACAD SCI USA, V98, P15197, DOI 10.1073/pnas.211556298; JORDAN VC, 2011, BREAST S1, V20, pS1; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Keen JC, 2003, CANCER-AM CANCER SOC, V97, P825, DOI 10.1002/cncr.11126; Klinge CM, 1999, J STEROID BIOCHEM, V71, P1, DOI 10.1016/S0960-0760(99)00124-7; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; Klinge CM, 2000, ARCH BIOCHEM BIOPHYS, V373, P163, DOI 10.1006/abbi.1999.1552; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Liang ZD, 2006, CANCER RES, V66, P7111, DOI 10.1158/0008-5472.CAN-06-0812; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Malanga M, 2008, J BIOL CHEM, V283, P19991, DOI 10.1074/jbc.M709495200; Marcus SL, 1996, J BIOL CHEM, V271, P27197, DOI 10.1074/jbc.271.44.27197; Masiuk M, 2004, ANTICANCER RES, V24, P963; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; More E, 2003, J ENDOCRINOL, V176, P83, DOI 10.1677/joe.0.1760083; Nagasaki S, 2009, CANCER SCI, V13, P13; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Navab R, 2004, CANCER RES, V64, P5097, DOI 10.1158/0008-5472.CAN-03-1185; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Petit FG, 2004, MECH AGEING DEV, V125, P719, DOI 10.1016/j.mad.2004.03.009; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; QIU Y, 1995, GENOMICS, V29, P240, DOI 10.1006/geno.1995.1237; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Redmond AM, 2009, CLIN CANCER RES, V15, P2098, DOI 10.1158/1078-0432.CCR-08-1649; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Riggs KA, 2006, CANCER RES, V66, P10188, DOI 10.1158/0008-5472.CAN-05-3937; Rohr O, 2000, J BIOL CHEM, V275, P2654, DOI 10.1074/jbc.275.4.2654; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Rousseau C, 2003, J STEROID BIOCHEM, V86, P1, DOI 10.1016/S0960-0760(03)00255-3; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Shibata H, 2004, ENDOCR RES, V30, P795, DOI 10.1081/ERC-200044042; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Tamimi RM, 2009, CANCER RES, V69, P9323, DOI 10.1158/0008-5472.CAN-09-1018; Tediose T, 2010, NUCLEIC ACIDS RES, V38, P2799, DOI 10.1093/nar/gkq013; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; TH-M Huang, 2010, COLD SPRING HARBOR P, P2; THEODOSIOU M, 2010, CELL MOL LIFE SCI; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tsou JH, 2008, NUCLEIC ACIDS RES, V36, P217, DOI 10.1093/nar/gkm1027; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Xie X, 2011, P NATL ACAD SCI USA, V108, P14843, DOI 10.1073/pnas.1110236108; Xu XC, 2007, CANCER LETT, V253, P14, DOI 10.1016/j.canlet.2006.11.019; Yang QF, 2002, BREAST CANCER RES TR, V76, P167, DOI 10.1023/A:1020576606004; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200	72	33	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38278	10.1371/journal.pone.0038278	http://dx.doi.org/10.1371/journal.pone.0038278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693611	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500122
J	Lis, R; Touboul, C; Raynaud, CM; Malek, JA; Suhre, K; Mirshahi, M; Rafii, A				Lis, Raphael; Touboul, Cyril; Raynaud, Christophe M.; Malek, Joel A.; Suhre, Karsten; Mirshahi, Massoud; Rafii, Arash			Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties	PLOS ONE			English	Article							STEM-CELLS; AIRWAY EPITHELIUM; TUMOR PROGRESSION; GENE-EXPRESSION; STROMAL CELLS; FIBROBLASTS; RECRUITMENT; CARCINOMA; SMOKERS; NICHE	Tumor microenvironement is an important actor of ovarian cancer progression but the relations between mesenchymal cells and ovarian cancer cells remain unclear. The objective of this study was to determine the ovarian cancer cells' biological modifications induced by mesenchymal cells. To address this issue, we used two different ovarian cancer cell lines (NIH: OVCAR3 and SKOV3) and co-cultured them with mesenchymal cells. Upon co-culture the different cell populations were sorted to study their transcriptome and biological properties. Transcriptomic analysis revealed three biologicalfunction gene clusters were enriched upon contact with mesenchymal cells. These were related to the increase of metastatic abilities (adhesion, migration and invasion), proliferation and chemoresistance in vitro. Therefore, contact with the mesenchymal cell niche could increase metastatic initiation and expansion through modification of cancer cells. Taken together these findings suggest that pathways involved in hetero-cellular interaction may be targeted to disrupt the acquired pro-metastatic profile.	[Lis, Raphael; Touboul, Cyril; Raynaud, Christophe M.; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Lis, Raphael; Touboul, Cyril; Mirshahi, Massoud] Univ Paris 06, INSERM, UMRS 872, Ctr Rech Cordeliers,Equipe 18, Paris, France; [Suhre, Karsten] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Lis, Raphael; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Cornell University; Cornell University	Lis, R (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu	Raynaud, Christophe/AAQ-9426-2020; Suhre, Karsten/AAF-1778-2020; Rafii, Arash/E-4106-2013	Raynaud, Christophe/0000-0003-1551-8075; Suhre, Karsten/0000-0001-9638-3912; 	Qatar National Research Fund under National Priorities Research Program [NPRP 09-1174-3-291, NPRP 4-640-1-096.]	Qatar National Research Fund under National Priorities Research Program(Qatar National Research Fund (QNRF))	This publication was made possible by a grant from the Qatar National Research Fund under its National Priorities Research Program award number NPRP 09-1174-3-291 and NPRP 4-640-1-096. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V474, P609; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carolan BJ, 2008, J IMMUNOL, V181, P5760, DOI 10.4049/jimmunol.181.8.5760; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kenny HA, 2011, CANCER DISCOV, V1, P100, DOI 10.1158/2159-8290.CD-11-0117; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Martinet L, 2010, INT J CANCER, V126, P2143, DOI 10.1002/ijc.24881; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pasquet M, 2010, INT J CANCER, V126, P2090, DOI 10.1002/ijc.24886; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Zhang SM, 2009, CLIN EXP METASTAS, V26, P993, DOI 10.1007/s10585-009-9289-0	24	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38340	10.1371/journal.pone.0038340	http://dx.doi.org/10.1371/journal.pone.0038340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666502	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400113
J	Tsai, WC; Hsu, CC; Pang, JHS; Lin, MS; Chen, YH; Liang, FC				Tsai, Wen-Chung; Hsu, Chih-Chin; Pang, Jong-Hwei S.; Lin, Miao-Sui; Chen, Ying-Hsun; Liang, Fang-Chen			Low-Level Laser Irradiation Stimulates Tenocyte Migration with Up-Regulation of Dynamin II Expression	PLOS ONE			English	Article							LIGHT-EMITTING DIODE; NEAR-INFRARED LIGHT; CELL-MIGRATION; IN-VITRO; ACHILLES-TENDON; NITRIC-OXIDE; IR RADIATION; THERAPY; TENDINOPATHY; NM	Low-level laser therapy (LLLT) is commonly used to treat sports-related tendinopathy or tendon injury. Tendon healing requires tenocyte migration to the repair site, followed by proliferation and synthesis of the extracellular matrix. This study was designed to determine the effect of laser on tenocyte migration. Furthermore, the correlation between this effect and expression of dynamin 2, a positive regulator of cell motility, was also investigated. Tenocytes intrinsic to rat Achilles tendon were treated with low-level laser (660 nm with energy density at 1.0, 1.5, and 2.0 J/cm(2)). Tenocyte migration was evaluated by an in vitro wound healing model and by transwell filter migration assay. The messenger RNA (mRNA) and protein expressions of dynamin 2 were determined by reverse transcription/real-time polymerase chain reaction (real-time PCR) and Western blot analysis respectively. Immunofluorescence staining was used to evaluate the dynamin 2 expression in tenocytes. Tenocytes with or without laser irradiation was treated with dynasore, a dynamin competitor and then underwent transwell filter migration assay. In vitro wound model revealed that more tenocytes with laser irradiation migrated across the wound border to the cell-free zone. Transwell filter migration assay confirmed that tenocyte migration was enhanced dose-dependently by laser. Real-time PCR and Western-blot analysis demonstrated that mRNA and protein expressions of dynamin 2 were up-regulated by laser irradiation dose-dependently. Confocal microscopy showed that laser enhanced the expression of dynamin 2 in cytoplasm of tenocytes. The stimulation effect of laser on tenocytes migration was suppressed by dynasore. In conclusion, low-level laser irradiation stimulates tenocyte migration in a process that is mediated by up-regulation of dynamin 2, which can be suppressed by dynasore.	[Tsai, Wen-Chung; Hsu, Chih-Chin; Lin, Miao-Sui; Chen, Ying-Hsun; Liang, Fang-Chen] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taoyuan County, Taiwan; [Tsai, Wen-Chung; Hsu, Chih-Chin; Lin, Miao-Sui] Chang Gung Univ, Coll Med, Guishan, Taoyuan County, Taiwan; [Pang, Jong-Hwei S.] Chang Gung Univ, Grad Inst Clin Med Sci, Guishan, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Tsai, WC (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taoyuan County, Taiwan.	jonghwei@mail.cgu.edu.tw		PANG, JONG-HWEI/0000-0003-3432-0208	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study received financial support for National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anders JJ, 2008, IEEE J SEL TOP QUANT, V14, P118, DOI 10.1109/JSTQE.2008.916181; Baxter GD, 2010, DELISAS PHYS MED REH, P1706; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Bjordal JM., 2001, PHYS THER REV, V6, P91, DOI [10.1179/ptr.2001.6.2.91, DOI 10.1179/PTR.2001.6.2.91]; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Casalechi HL, 2009, LASER MED SCI, V24, P659, DOI 10.1007/s10103-008-0607-6; Chao PHG, 2007, CONNECT TISSUE RES, V48, P188, DOI 10.1080/03008200701424451; Chen CH, 2009, J ORTHOP RES, V27, P646, DOI 10.1002/jor.20800; Crespi R, 2006, J PERIODONTOL, V77, P1217, DOI 10.1902/jop.2006.050416; Dominik M, 2005, CELL MOTIL CYTOSKEL, V61, P172, DOI 10.1002/cm.20075; Eppinga RD, 2011, ONCOGENE; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fillipin LI, 2005, LASER SURG MED, V37, P293, DOI 10.1002/lsm.20225; Goldman JA, 1981, BIOMEDICAL LASER TEC, P293; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kipshidze N, 2000, PHOTOCHEM PHOTOBIOL, V72, P579, DOI 10.1562/0031-8655(2000)072<0579:POVIAE>2.0.CO;2; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Kujawa J, 2004, J CLIN LASER MED SUR, V22, P111, DOI 10.1089/104454704774076163; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; LEADBETTER WB, 1992, CLIN SPORT MED, V11, P533; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Lubart R, 2006, PHOTOMED LASER SURG, V24, P179, DOI 10.1089/pho.2006.24.179; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; OBRIEN M, 1992, CLIN SPORT MED, V11, P505; Oliveira FS, 2009, LASER SURG MED, V41, P271, DOI 10.1002/lsm.20760; Rochkind S, 2009, LASER SURG MED, V41, P277, DOI 10.1002/lsm.20757; Samoilova KA, 2008, PHOTOMED LASER SURG, V26, P443, DOI 10.1089/pho.2007.2205; Saunders L., 2003, PHYSIOTHERAPY, V89, P365; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Stergioulas A, 2008, AM J SPORT MED, V36, P881, DOI 10.1177/0363546507312165; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tsai WC, 2008, CONNECT TISSUE RES, V49, P367, DOI 10.1080/03008200802325359; Tumilty S, 2010, PHOTOMED LASER SURG, V28, P3, DOI 10.1089/pho.2008.2470; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xie ZG, 2004, CELL CYCLE, V3, P108; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Zhang JT, 2008, J CELL PHYSIOL, V217, P518, DOI 10.1002/jcp.21529; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707	46	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38235	10.1371/journal.pone.0038235	http://dx.doi.org/10.1371/journal.pone.0038235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666495	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400108
J	Losfeld, ME; Soncin, F; Ng, BG; Singec, I; Freeze, HH				Losfeld, Marie-Estelle; Soncin, Francesca; Ng, Bobby G.; Singec, Ilyas; Freeze, Hudson H.			A sensitive green fluorescent protein biomarker of N-glycosylation site occupancy	FASEB JOURNAL			English	Article						congenital disorders of glycosylation; stem cells; genetic disease	PLURIPOTENT STEM-CELLS; CONGENITAL DISORDERS; LINKED GLYCOSYLATION; SERUM TRANSFERRIN; GFP	N-glycosylation mediates many biological functions. Genetic defects in the N-glycosylation pathway cause > 35 inherited human disorders called congenital disorders of glycosylation (CDGs). As a result, some N-glycosylation sites are unoccupied. Serum transferrin is a diagnostic marker for these patients, but there are no corresponding cellular markers to assess glycosylation competence. Therefore, we engineered a green fluorescent protein (GFP) construct to measure N-glycosylation site occupancy. We designed an endoplasmic reticulum-retained GFP biomarker whose fluorescence is lost when it is N-glycosylated due to steric hindrance by the glycan. This marker is a highly sensitive indicator of N-glycosylation site occupancy. In CDG cells carrying the GFP construct, a 25% decrease of glycosylation efficiency induces a 5-fold increase in fluorescence, while cDNA complementation of the genetic defect results in a 5-fold decrease in fluorescence. This engineered GFP detects impaired N-glycosylation in multiple cell lines, including CHO cells, HeLa cells, normal and patient fibroblasts, induced pluripotent stem cells (iPSCs), and human embryonic stem cells (hESCs). This marker is a highly sensitive tool to study N-glycosylation site occupancy. It can be used to screen for compounds that reverse poor N-glycosylation site occupancy.-Losfeld, M.-E., Soncin, F., Ng, B. G., Singec, I., Freeze, H. H. A sensitive green fluorescent protein biomarker of N-glycosylation site occupancy. FASEB J. 26, 4210-4217 (2012). www.fasebj.org	[Losfeld, Marie-Estelle; Soncin, Francesca; Ng, Bobby G.; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Singec, Ilyas] Sanford Burnham Med Res Inst, Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org	Soncin, Francesca/AAB-6143-2021	SINGEC, ILYAS/0000-0003-3941-1838; Freeze, Hudson/0000-0001-6316-0501	U.S. National Institutes of Health grant [R01DK 55615]; The Rocket Fund; Mason's Hope; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	U.S. National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Rocket Fund; Mason's Hope; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grant R01DK 55615, The Rocket Fund, and Mason's Hope. The authors greatly appreciate the help of Dr. J. R. Bishop for bioinformatics approach. The authors thank Brandon Nelson, Shira Geller, and the Sanford-Burnham Medical Research Institute (SBMRI) Stem Cell Core Facility for technical and material support on the hESC/iPSC work. The authors thank Dr. Anne Bang of the Conrad Prebys Center for Chemical Genomics/ Screening Center (SBMRI) for guidance on the iPSC work. The authors thank Drs. Geetha Srikrishna and Ping He for providing constructive comments on the manuscript.	CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; Eklund Erik A, 2006, NeuroRx, V3, P254; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Goh YY, 2002, PROTEIN ENG, V15, P493, DOI 10.1093/protein/15.6.493; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hendriksz CJ, 2001, ARCH DIS CHILD, V85, P339, DOI 10.1136/adc.85.4.339; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; Nishikawa A, 2001, BIOCHEM J, V355, P245, DOI 10.1042/0264-6021:3550245; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Peanne R, 2011, GLYCOBIOLOGY, V21, P864, DOI 10.1093/glycob/cwq176; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; STIBLER H, 1990, ARCH DIS CHILD, V65, P107, DOI 10.1136/adc.65.1.107; Sun LW, 2005, AM J MED GENET A, V137A, P22, DOI 10.1002/ajmg.a.30831; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6; Wolff M, 2008, COMB CHEM HIGH T SCR, V11, P602, DOI 10.2174/138620708785739880; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	28	22	24	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4210	4217		10.1096/fj.12-211656	http://dx.doi.org/10.1096/fj.12-211656			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22691915	Green Published			2022-12-25	WOS:000309704000026
J	Schuler, B; Vogel, J; Grenacher, B; Jacobs, RA; Arras, M; Gassmann, M				Schuler, Beat; Vogel, Johannes; Grenacher, Beat; Jacobs, Robert A.; Arras, Margarete; Gassmann, Max			Acute and chronic elevation of erythropoietin in the brain improves exercise performance in mice without inducing erythropoiesis	FASEB JOURNAL			English	Article						Epo; cerebral; doping; neurotrophic effect; motivation	MAXIMAL OXYGEN-UPTAKE; OVEREXPRESSING ERYTHROPOIETIN; EXCESSIVE ERYTHROCYTOSIS; HIPPOCAMPAL RESPONSE; HYPOXIC VENTILATION; MEMORY RETRIEVAL; GENE-EXPRESSION; TRANSGENIC MICE; NERVOUS-SYSTEM; MOUSE	Application of recombinant human erythropoietin (rhEpo) improves exercise capacity by stimulating red blood cell production that, in turn, enhances oxygen delivery and utilization. Apart from this, when applied at high doses, rhEpo crosses the blood-brain barrier, triggering protective neuronal effects. Here we show a fundamental new role by which the presence of Epo in the brain augments exercise performance without altering red blood cell production. Two different animal models, the transgenic mouse line Tg21, which constitutively overexpresses human Epo exclusively in the brain without affecting erythropoiesis, and wild-type mice treated with a single high dose of rhEpo, demonstrate an unexpected improvement in maximal exercise performance independent of changes in total hemoglobin mass, as well as in whole blood volume and cardiovascular parameters. This novel finding builds a more complete understanding regarding the central effects of endogenously produced and exogenously applied Epo on exercise performance.-Schuler, B., Vogel, J., Grenacher, B., Jacobs, R. A., Arras, M., Gassmann, M. Acute and chronic elevation of erythropoietin in the brain improves exercise performance in mice without inducing erythropoiesis. FASEB J. 26, 3884-3890 (2012). www.fasebj.org	[Gassmann, Max] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, DVM, CH-8057 Zurich, Switzerland; [Schuler, Beat; Vogel, Johannes; Grenacher, Beat; Jacobs, Robert A.; Gassmann, Max] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Arras, Margarete] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Arras, Margarete] Univ Zurich Hosp, Div Surg Res, CH-8091 Zurich, Switzerland; [Gassmann, Max] Univ Peruana Cayetano Heredia, Lima, Peru	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Zurich; University Zurich Hospital; Universidad Peruana Cayetano Heredia	Gassmann, M (corresponding author), Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, DVM, Winterthurerstr 260, CH-8057 Zurich, Switzerland.	maxg@access.uzh.ch	Jacobs, Robert A/G-8439-2015	Jacobs, Robert A/0000-0003-0180-8266; Gassmann, Max/0000-0003-2750-8878; Vogel, Johannes/0000-0003-4181-4521; Arras, Margarete/0000-0003-3864-9879	Nachwuchsforderungskredit (University of Zurich); Zurich Center for Integrative Human Physiology (ZIHP); Swiss National Science Foundation; Roche Foundation for Anemic Research (RoFAR)	Nachwuchsforderungskredit (University of Zurich); Zurich Center for Integrative Human Physiology (ZIHP); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Foundation for Anemic Research (RoFAR)	The authors thank Mar a Alvarez Sanchez, Cornelia Albrecht, and Mirzet Delic, as well as Prof. Kurt Burki and Prof. Carsten Lundby, for technical assistance and discussion, respectively. This work was supported by the Nachwuchsforderungskredit (University of Zurich), the Zurich Center for Integrative Human Physiology (ZIHP), including the help of the Zurich Integrative Rodent Physiology (ZIRP) facility, the Swiss National Science Foundation, and the Roche Foundation for Anemic Research (RoFAR).	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Astorino TA, 2005, BRIT J SPORT MED, V39, P655, DOI 10.1136/bjsm.2004.016550; Bassett DR, 1997, MED SCI SPORT EXER, V29, P591, DOI 10.1097/00005768-199705000-00002; BERGLUND B, 1991, J INTERN MED, V229, P125, DOI 10.1111/j.1365-2796.1991.tb00319.x; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Crisafulli A, 2007, PHYSIOL MEAS, V28, P1201, DOI 10.1088/0967-3334/28/10/006; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Duncan GE, 1997, MED SCI SPORT EXER, V29, P273, DOI 10.1097/00005768-199702000-00017; Ehrenreich H, 2004, METAB BRAIN DIS, V19, P195, DOI 10.1023/B:MEBR.0000043969.96895.3c; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; El-Kordi A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-37; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; FOLINSBEE LJ, 1983, MED SCI SPORT EXER, V15, P503; Frietsch T, 2007, J CEREBR BLOOD F MET, V27, P469, DOI 10.1038/sj.jcbfm.9600360; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Gassmann M, 2003, ADV EXP MED BIOL, V543, P323; Glaus TM, 2004, COMP BIOCHEM PHYS A, V138, P355, DOI 10.1016/j.cbpb.2004.05.008; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Hale T, 2008, J SPORT SCI, V26, P365, DOI 10.1080/02640410701701016; Heinicke K, 2006, AM J PHYSIOL-REG I, V291, pR947, DOI 10.1152/ajpregu.00152.2006; Jelkmann W, 2007, METHOD ENZYMOL, V435, P179, DOI 10.1016/S0076-6879(07)35010-6; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; Kayser B, 2003, EUR J APPL PHYSIOL, V90, P411, DOI 10.1007/s00421-003-0902-7; Leite LHR, 2010, MED SCI SPORT EXER, V42, P1469, DOI 10.1249/MSS.0b013e3181d03d36; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Meeusen R, 2007, APPL PHYSIOL NUTR ME, V32, P857, DOI 10.1139/H07-080; Miskowiak K, 2008, NEUROPSYCHOPHARMACOL, V33, P611, DOI 10.1038/sj.npp.1301439; Miskowiak K, 2007, PSYCHOPHARMACOLOGY, V195, P451, DOI 10.1007/s00213-007-0907-8; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Ninot G, 2006, J SPORT SCI, V24, P383, DOI 10.1080/02640410500131340; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rasmussen P, 2010, J APPL PHYSIOL, V109, P476, DOI 10.1152/japplphysiol.00234.2010; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1998, AM J PHYSIOL-HEART C, V274, pH1184, DOI 10.1152/ajpheart.1998.274.4.H1184; Ruschitzka FT, 2000, P NATL ACAD SCI USA, V97, P11609, DOI 10.1073/pnas.97.21.11609; Schuler B, 2010, P NATL ACAD SCI USA, V107, P419, DOI 10.1073/pnas.0912924107; Schuler B, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-28; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Soliz J, 2005, J PHYSIOL-LONDON, V568, P559, DOI 10.1113/jphysiol.2005.093328; Soliz J, 2009, AM J PHYSIOL-REG I, V296, pR1837, DOI 10.1152/ajpregu.90967.2008; Taylor JL, 2000, J APPL PHYSIOL, V89, P305, DOI 10.1152/jappl.2000.89.1.305; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Vogel J, 2003, BLOOD, V102, P2278, DOI 10.1182/blood-2003-01-0283; Vogel J, 2011, J PHYSIOL-LONDON, V589, P1259, DOI 10.1113/jphysiol.2010.196147; Wenger RH, 2011, COMPR PHYSIOL, V1, P1759, DOI 10.1002/cphy.c100075; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Wustenberg T, 2011, MOL PSYCHIATR, V16, P26, DOI 10.1038/mp.2010.51	49	24	25	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3884	3890		10.1096/fj.11-191197	http://dx.doi.org/10.1096/fj.11-191197			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22683849	Green Accepted			2022-12-25	WOS:000308391600028
J	Benevides, RG; Ganne, G; Simoes, RD; Schubert, V; Niemietz, M; Unverzagt, C; Chazalet, V; Breton, C; Varrot, A; Cavada, BS; Imberty, A				Benevides, Raquel Guimaraes; Ganne, Geraldine; Simoes, Rafael da Conceicao; Schubert, Volker; Niemietz, Mathaeus; Unverzagt, Carlo; Chazalet, Valerie; Breton, Christelle; Varrot, Annabelle; Cavada, Benildo Sousa; Imberty, Anne			A Lectin from Platypodium elegans with Unusual Specificity and Affinity for Asymmetric Complex N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEROCARPUS-ANGOLENSIS LECTIN; CONCANAVALIN-A; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LEGUME LECTINS; BIANTENNARY OLIGOSACCHARIDES; CARBOHYDRATE-BINDING; CORE TRIMANNOSIDE; RECOGNITION; PROTEINS	Lectin activity with specificity for mannose and glucose has been detected in the seed of Platypodium elegans, a legume plant from the Dalbergieae tribe. The gene of Platypodium eleganslectin A has been cloned, and the resulting 261-amino acid protein belongs to the legume lectin family with similarity with Pterocarpus angolensis agglutinin from the same tribe. The recombinant lectin has been expressed in Escherichia coli and refolded from inclusion bodies. Analysis of specificity by glycan array evidenced a very unusual preference for complex type N-glycans with asymmetrical branches. A short branch consisting of one mannose residue is preferred on the 6-arm of the N-glycan, whereas extensions by GlcNAc, Gal, and NeuAc are favorable on the 3-arm. Affinities have been obtained by microcalorimetry using symmetrical and asymmetrical Asn-linked heptasaccharides prepared by the semisynthetic method. Strong affinity with K-d of 4.5 mu M was obtained for both ligands. Crystal structures of Platypodium elegans lectin A complexed with branched trimannose and symmetrical complex-type Asn-linked heptasaccharide have been solved at 2.1 and 1.65 angstrom resolution, respectively. The lectin adopts the canonical dimeric organization of legume lectins. The trimannose bridges the binding sites of two neighboring dimers, resulting in the formation of infinite chains in the crystal. The Asn-linked heptasaccharide binds with the 6-arm in the primary binding site with extensive additional contacts on both arms. The GlcNAc on the 6-arm is bound in a constrained conformation that may rationalize the higher affinity observed on the glycan array for N-glycans with only a mannose on the 6-arm.	[Benevides, Raquel Guimaraes; Ganne, Geraldine; Chazalet, Valerie; Breton, Christelle; Varrot, Annabelle; Cavada, Benildo Sousa; Imberty, Anne] Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; [Benevides, Raquel Guimaraes; Ganne, Geraldine; Chazalet, Valerie; Breton, Christelle; Varrot, Annabelle; Cavada, Benildo Sousa; Imberty, Anne] Inst Chim Mol Grenoble, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; [Benevides, Raquel Guimaraes; Simoes, Rafael da Conceicao] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60440970 Fortaleza, Ceara, Brazil; [Schubert, Volker; Niemietz, Mathaeus; Unverzagt, Carlo] Univ Bayreuth, D-95440 Bayreuth, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade Federal do Ceara; University of Bayreuth	Cavada, BS (corresponding author), Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France.	bscavada@ufc.br; imberty@cermav.cnrs.fr	Cavada, Benildo/CEA-4997-2022; Imberty, Anne/P-6451-2018	Cavada, Benildo/0000-0002-5791-6170; Guimaraes Benevides, Raquel/0000-0002-5410-6973; Imberty, Anne/0000-0001-6825-9527; Varrot, Annabelle/0000-0001-6667-8162	CNRS; French Ministry of Research; German Research Foundation (DFG); National Institutes of Health from NIGMS [GM62116]; CAPES; CNPq; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by CNRS and the French Ministry of Research and the German Research Foundation (DFG).; The glycan microarray analysis was provided by the Consortium for Functional Glycomics funded by National Institutes of Health Grant GM62116 from NIGMS. We acknowledge the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities, and we are grateful for the assistance in using beamline BM30A.; Recipient of CAPES and CNPq grants from the Brazilian government.	Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g; Buts L, 2006, FEBS J, V273, P2407, DOI 10.1111/j.1742-4658.2006.05248.x; Cavada B. S., 1993, Revista Brasileira de Fisiologia Vegetal, V5, P193; Dam TK, 1998, J BIOL CHEM, V273, P32812, DOI 10.1074/jbc.273.49.32812; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Delatorre P, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-52; DEREWENDA Z, 1989, EMBO J, V8, P2189, DOI 10.1002/j.1460-2075.1989.tb08341.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Pino A, 2007, PLANT PHYSIOL, V144, P1733, DOI 10.1104/pp.107.100867; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gourdine JP, 2008, J BIOL CHEM, V283, P30112, DOI 10.1074/jbc.M804353200; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; IMBERTY A, 1991, GLYCOCONJUGATE J, V8, P456, DOI 10.1007/BF00769847; Kajihara Y, 2004, CHEM-EUR J, V10, P971, DOI 10.1002/chem.200305115; Lameignere E, 2010, GLYCOBIOLOGY, V20, P87, DOI 10.1093/glycob/cwp151; Lorenzi H, 1998, ARVORES BRASILEIRAS; Loris R, 2004, J MOL BIOL, V335, P1227, DOI 10.1016/j.jmb.2003.11.043; Loris R, 2003, J BIOL CHEM, V278, P16297, DOI 10.1074/jbc.M211148200; Loris R, 1996, J BIOL CHEM, V271, P30614, DOI 10.1074/jbc.271.48.30614; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mezzato S, 2010, CARBOHYD RES, V345, P1306, DOI 10.1016/j.carres.2010.02.022; Moothoo DN, 1998, GLYCOBIOLOGY, V8, P173, DOI 10.1093/glycob/8.2.173; Moreira A., 1977, PLANT PHYSIOL, V59, P783; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen LR, 1997, BIOCHEMISTRY-US, V36, P15073, DOI 10.1021/bi971828+; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Rozwarski DA, 1998, J BIOL CHEM, V273, P32818, DOI 10.1074/jbc.273.49.32818; Rudiger H, 1998, ACTA ANAT, V161, P130; Rudiger H, 2000, CURR MED CHEM, V7, P389, DOI 10.2174/0929867003375164; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Srinivas VR, 2001, BBA-GEN SUBJECTS, V1527, P102, DOI 10.1016/S0304-4165(01)00153-2; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILLIAMS BA, 1992, J BIOL CHEM, V267, P22907; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wright CS, 1996, STRUCTURE, V4, P1339, DOI 10.1016/S0969-2126(96)00141-4; YOUNG NM, 1992, J MOL BIOL, V228, P924, DOI 10.1016/0022-2836(92)90875-K	40	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26352	26364		10.1074/jbc.M112.375816	http://dx.doi.org/10.1074/jbc.M112.375816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692206	hybrid, Green Published			2022-12-25	WOS:000306916300061
J	Shen, M; Lin, F; Zhang, JQ; Tang, YT; Chen, WK; Liu, HL				Shen, Ming; Lin, Fei; Zhang, Jiaqing; Tang, Yiting; Chen, Wei-Kang; Liu, Honglin			Involvement of the Up-regulated FoxO1 Expression in Follicular Granulosa Cell Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; 3-NITROPROPIONIC ACID; RAT-LIVER; GENE-EXPRESSION; MITOCHONDRIAL TOXIN; HYDROGEN-PEROXIDE; OVARIAN-FOLLICLES; MOUSE STRIATUM; ATRESIA; CYCLE	Follicular atresia is common in female mammalian ovaries, where most follicles undergo degeneration at any stage of growth and development. Oxidative stress gives rise to triggering granulosa cell apoptosis, which has been suggested as a major cause of follicular atresia. However, the underlying mechanism by which the oxidative stress induces follicular atresia remains unclear. FoxO transcription factors are known as critical mediators in the regulation of oxidative stress and apoptosis. In this study, the involvement of FoxO1 in oxidative stress-induced apoptosis of mouse follicular granulosa cells (MGCs) was investigated in vivo and in vitro. It was observed that increased apoptotic signals correlated with elevated expression of FoxO1 in MGCs when mice were treated with the oxidant. Correspondingly, the expressions of FoxO1 target genes, such as proapoptotic genes and antioxidative genes, were also up-regulated. In primary cultured MGCs, treatment with H2O2 led to FoxO1 nuclear translocation. Further studies with overexpression and knockdown of FoxO1 demonstrated the critical role of FoxO1 in the induction of MGC apoptosis by oxidative stress. Finally, inactivation of FoxO1 by insulin treatment confirmed that FoxO1 induced by oxidative stress played a pivotal role in up-regulating the expression of downstream apoptosis-related genes in MGCs. Our results suggest that up-regulation of FoxO1 by oxidative stress leads to apoptosis of granulosa cells, which eventually results in follicular atresia in mice.	[Shen, Ming; Lin, Fei; Zhang, Jiaqing; Tang, Yiting; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China; [Chen, Wei-Kang] K&R BioPharmaceut, Nanjing 210009, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China.	chen.50@osu.edu; liuhonglin@njau.edu.cn	Lin, Fei/AEI-9957-2022; liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	key project of the Chinese National Programs for Fundamental Research and Development (973 Program) [2007CB947403]	key project of the Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China)	This work was supported by a grant from a key project of the Chinese National Programs for Fundamental Research and Development (973 Program 2007CB947403).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Asselin E, 2000, BIOL SIGNAL RECEPT, V9, P87; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buczynska Alina, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P331; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; CLOPTON DA, 1995, BIOCHEM BIOPH RES CO, V210, P189, DOI 10.1006/bbrc.1995.1645; Cui M, 2009, ADV EXP MED BIOL, V665, P143; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dlamini Z, 2004, PHARMACOL THERAPEUT, V101, P1, DOI 10.1016/j.pharmthera.2003.08.005; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Farombi EO, 2004, CELL BIOL TOXICOL, V20, P71, DOI 10.1023/B:CBTO.0000027916.61347.bc; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Fontaine M A, 2000, J Neurochem, V75, P1709, DOI 10.1046/j.1471-4159.2000.0751709.x; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; GILLE JJP, 1992, MUTAT RES, V275, P405, DOI 10.1016/0921-8734(92)90043-O; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grotowski W, 1997, Ginekol Pol, V68, P317; Gupta RK, 2009, TOXICOL APPL PHARM, V240, P1, DOI 10.1016/j.taap.2009.07.007; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Hoyer PB, 2007, BIRTH DEFECTS RES B, V80, P113, DOI 10.1002/bdrb.20103; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Inoue N, 2006, J REPROD DEVELOP, V52, P723, DOI 10.1262/jrd.18043; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Kaczara P, 2010, FREE RADICAL BIO MED, V48, P1064, DOI 10.1016/j.freeradbiomed.2010.01.022; Kajihara T, 2009, MED MOL MORPHOL, V42, P216, DOI 10.1007/s00795-009-0466-7; Kim GW, 2001, NEUROBIOL DIS, V8, P114, DOI 10.1006/nbdi.2000.0327; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kumar M, 2010, ARCH GYNECOL OBSTET, V282, P695, DOI 10.1007/s00404-010-1623-x; Kumar P, 2011, J PSYCHOPHARMACOL, V25, P1399, DOI 10.1177/0269881110364269; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Melov S, 2002, INT J BIOCHEM CELL B, V34, P1395, DOI 10.1016/S1357-2725(02)00086-9; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Montilla P, 2004, EUR J PHARMACOL, V488, P19, DOI 10.1016/j.ejphar.2004.02.004; Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008; Mujahid A, 2007, POULTRY SCI, V86, P364, DOI 10.1093/ps/86.2.364; Murdoch WJ, 1998, J REPROD FERTIL, V114, P127, DOI 10.1530/jrf.0.1140127; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Ortega-Camarillo C, 2009, REPRODUCTION, V137, P979, DOI 10.1530/REP-08-0463; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; SCHIAFFONATI L, 1990, J CELL PHYSIOL, V143, P79, DOI 10.1002/jcp.1041430110; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Sener G, 2005, PHARMACOLOGY, V74, P37, DOI 10.1159/000083245; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Valdez KE, 2005, REPRODUCTION, V130, P71, DOI 10.1530/rep.1.00430; Venditti P, 2006, J EXP BIOL, V209, P817, DOI 10.1242/jeb.02045; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zafir A, 2009, INDIAN J BIOCHEM BIO, V46, P53	83	112	127	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25727	25740		10.1074/jbc.M112.349902	http://dx.doi.org/10.1074/jbc.M112.349902			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669940	Green Published, hybrid			2022-12-25	WOS:000306916300004
J	Xu, YQ; Parmar, A; Roux, E; Balbis, A; Dumas, V; Chevalier, S; Posner, BI				Xu, Yanqing; Parmar, Amanda; Roux, Emmanuelle; Balbis, Alejandro; Dumas, Victor; Chevalier, Stephanie; Posner, Barry I.			Epidermal Growth Factor-induced Vacuolar (H+)-ATPase Assembly A ROLE IN SIGNALING VIA mTORC1 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; INDUCED DNA-SYNTHESIS; YEAST V-ATPASE; H+-ATPASE; FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN TARGET; CELL-GROWTH; RAG GTPASES; INSULIN	Using proteomics and immunofluorescence, we demonstrated epidermal growth factor (EGF) induced recruitment of extrinsic V-1 subunits of the vacuolar (H+)-ATPase (V-ATPase) to rat liver endosomes. This was accompanied by reduced vacuolar pH. Bafilomycin, an inhibitor of V-ATPase, inhibited EGF-stimulated DNA synthesis and mammalian target of rapamycin complex 1 (mTORC1) activation as indicated by a decrease in eukaryotic initiation factor 4E-binding 1 (4E-BP1) phosphorylation and p70 ribosomal S6 protein kinase (p70S6K) phosphorylation and kinase activity. There was no corresponding inhibition of EGF-induced Akt and extracellular signal-regulated kinase (Erk) activation. Chloroquine, a neutralizer of vacuolar pH, mimicked bafilomycin effects. Bafilomycin did not inhibit the association of mTORC1 with Raptor nor did it affect AMP-activated protein kinase activity. Rather, the intracellular concentrations of essential but not non-essential amino acids were decreased by bafilomycin in EGF-treated primary rat hepatocytes. Cycloheximide, a translation elongation inhibitor known to augment intracellular amino acid levels, prevented the effect of bafilomycin on amino acids levels and completely reversed its inhibition of EGF-induced mTORC1 activation. In vivo administration of EGF stimulated the recruitment of Ras homologue enriched in brain (Rheb) but not mammalian target of rapamycin (mTOR) to endosomes and lysosomes. This was inhibited by chloroquine treatment. Our results suggest a role for vacuolar acidification in EGF signaling to mTORC1.	[Posner, Barry I.] McGill Univ, Fac Med, Polypeptide Hormone Lab, Montreal, PQ H3A 2B2, Canada; [Chevalier, Stephanie] McGill Univ, Ctr Hlth, McGill Nutr & Food Sci Ctr, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; Royal Victoria Hospital	Posner, BI (corresponding author), McGill Univ, Fac Med, Polypeptide Hormone Lab, 3640 Univ St,Suite W315, Montreal, PQ H3A 2B2, Canada.	barry.posner@mcgill.ca	Chevalier, Stephanie/AAA-5386-2021		Canadian Institutes for Health Research (CIHR); Genome Canada and Genome Quebec	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada and Genome Quebec	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and both Genome Canada and Genome Quebec. Part of this work was presented at ENDO 2010, The 92nd Annual Meeting and Expo, June 23-26, 2010, San Diego, CA.	AbdelNabi R, 1996, ALCOHOL, V13, P171, DOI 10.1016/0741-8329(95)02031-4; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041; Balbis A, 2004, J BIOL CHEM, V279, P39348, DOI 10.1074/jbc.M404280200; Balbis A, 2004, J BIOL CHEM, V279, P12777, DOI 10.1074/jbc.M311493200; Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Band CJ, 1999, ENDOCRINOLOGY, V140, P5626, DOI 10.1210/en.140.12.5626; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bevan AP, 1996, TRENDS ENDOCRIN MET, V7, P13, DOI 10.1016/1043-2760(95)00179-4; BEVAN AP, 1995, J BIOL CHEM, V270, P10784, DOI 10.1074/jbc.270.18.10784; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Croce AC, 2004, PHOTOCH PHOTOBIO SCI, V3, P920, DOI 10.1039/b407358d; Dadmarz M, 1998, LIFE SCI, V63, P1485, DOI 10.1016/S0024-3205(98)00415-9; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Drose S, 1997, J EXP BIOL, V200, P1; FAURE R, 1992, J BIOL CHEM, V267, P11215; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; KANE PM, 1995, J BIOL CHEM, V270, P17025; KAY DG, 1986, J BIOL CHEM, V261, P8473; KHAN MN, 1986, J BIOL CHEM, V261, P8462; KHAN MN, 1981, P NATL ACAD SCI-BIOL, V78, P4980, DOI 10.1073/pnas.78.8.4980; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Kong M, 2003, J BIOL CHEM, V278, P5837, DOI 10.1074/jbc.M208286200; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; Lim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lusa S, 2001, J CELL SCI, V114, P1893; MANABE T, 1993, J CELL PHYSIOL, V157, P445, DOI 10.1002/jcp.1041570303; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McConahey P J, 1980, Methods Enzymol, V70, P210; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mineo C, 1996, EXP CELL RES, V224, P237, DOI 10.1006/excr.1996.0133; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saurin AJ, 1996, BIOCHEM J, V313, P65, DOI 10.1042/bj3130065; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Valovka T, 2003, MOL CELL BIOL, V23, P852, DOI 10.1128/MCB.23.3.852-863.2003; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wang Y, 2009, J CELL BIOCHEM, V107, P96, DOI 10.1002/jcb.22105; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	85	38	38	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26409	26422		10.1074/jbc.M112.352229	http://dx.doi.org/10.1074/jbc.M112.352229			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689575	hybrid, Green Published			2022-12-25	WOS:000306916300066
J	Tiberia, E; Turnbull, J; Wang, T; Ruggieri, A; Zhao, XC; Pencea, N; Israelian, J; Wang, Y; Ackerley, CA; Wang, PX; Liu, Y; Minassian, BA				Tiberia, Erica; Turnbull, Julie; Wang, Tony; Ruggieri, Alessandra; Zhao, Xiao-Chu; Pencea, Nela; Israelian, Johan; Wang, Yin; Ackerley, Cameron A.; Wang, Peixiang; Liu, Yan; Minassian, Berge A.			Increased Laforin and Laforin Binding to Glycogen Underlie Lafora Body Formation in Malin-deficient Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; SPECIFICITY PROTEIN PHOSPHATASE; E3 UBIQUITIN LIGASE; POLYGLUCOSAN BODIES; EPM2A GENE; ACCUMULATION; MUTATIONS; MICE; NEURODEGENERATION; DEGRADATION	The solubility of glycogen, essential to its metabolism, is a property of its shape, a sphere generated through extensive branching during synthesis. Lafora disease (LD) is a severe teenage-onset neurodegenerative epilepsy and results from multiorgan accumulations, termed Lafora bodies (LB), of abnormally structured aggregation-prone and digestion-resistant glycogen. LD is caused by loss-of-function mutations in the EPM2A or EPM2B gene, encoding the interacting laforin phosphatase and malin E3 ubiquitin ligase enzymes, respectively. The substrate and function of malin are unknown; an early counterintuitive observation in cell culture experiments that it targets laforin to proteasomal degradation was not pursued until now. The substrate and function of laforin have recently been elucidated. Laforin dephosphorylates glycogen during synthesis, without which phosphate ions interfere with and distort glycogen construction, leading to LB. We hypothesized that laforin in excess or not removed following its action on glycogen also interferes with glycogen formation. We show in malin-deficient mice that the absence of malin results in massively increased laforin preceding the appearance of LB and that laforin gradually accumulates in glycogen, which corresponds to progressive LB generation. We show that increasing the amounts of laforin in cell culture causes LB formation and that this occurs only with glycogen binding-competent laforin. In summary, malin deficiency causes increased laforin, increased laforin binding to glycogen, and LB formation. Furthermore, increased levels of laforin, when it can bind glycogen, causes LB. We conclude that malin functions to regulate laforin and that malin deficiency at least in part causes LB and LD through increased laforin binding to glycogen.	[Tiberia, Erica; Turnbull, Julie; Wang, Tony; Ruggieri, Alessandra; Zhao, Xiao-Chu; Pencea, Nela; Israelian, Johan; Wang, Peixiang; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Pencea, Nela; Ackerley, Cameron A.] Hosp Sick Children, Div Pathol, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Div Neurol, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Turnbull, Julie] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Minassian, Berge A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Wang, Yin; Liu, Yan] Univ Michigan, Dept Surg, Div Immunotherapy, Sect Gen Surg, Ann Arbor, MI 48109 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Michigan System; University of Michigan	Turnbull, J (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.	jturnbull@sickkids.ca; berge.minassian@sickkids.ca	Ruggieri, Alessandra/J-2881-2018	Ruggieri, Alessandra/0000-0002-2777-6226	National Institutes of Health Grant [1R21NS062391]; Canadian Institutes of Health Research Grant [MOP14667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062391] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21NS062391 (to Y. L.). This work was also supported by Canadian Institutes of Health Research Grant MOP14667 (to B. A. M.).	ANDERSEN DH, 1956, LAB INVEST, V5, P11; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Bao Y, 1996, J CLIN INVEST, V97, P941, DOI 10.1172/JCI118517; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Couarch P, 2011, J MOL MED, V89, P915, DOI 10.1007/s00109-011-0758-y; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Girard JM, 2006, BIOCHIMIE, V88, P1961, DOI 10.1016/j.biochi.2006.08.002; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROBITAILLE Y, 1980, BRAIN, V103, P315, DOI 10.1093/brain/103.2.315; SCHOCHET SS, 1970, ARCH PATHOL, V90, P354; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Van Heycop Ten Ham M., 1975, LAFORA DIS FORM PROG; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	40	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25650	25659		10.1074/jbc.M111.331611	http://dx.doi.org/10.1074/jbc.M111.331611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669944	Green Published, hybrid			2022-12-25	WOS:000306651700072
J	Threlfall, CG; Law, B; Banks, PB				Threlfall, Caragh G.; Law, Bradley; Banks, Peter B.			Influence of Landscape Structure and Human Modifications on Insect Biomass and Bat Foraging Activity in an Urban Landscape	PLOS ONE			English	Article							AERIAL INSECTIVOROUS BATS; NET PRIMARY PRODUCTIVITY; NEW-SOUTH-WALES; SPECIES RICHNESS; FOREST; HABITAT; URBANIZATION; COMMUNITY; VEGETATION; ABUNDANCE	Urban landscapes are often located in biologically diverse, productive regions. As such, urbanization may have dramatic consequences for this diversity, largely due to changes in the structure and function of urban communities. We examined the influence of landscape productivity (indexed by geology), housing density and vegetation clearing on the spatial distribution of nocturnal insect biomass and the foraging activity of insectivorous bats in the urban landscape of Sydney, Australia. Nocturnal insect biomass (g) and bat foraging activity were sampled from 113 sites representing backyard, open space, bushland and riparian landscape elements, across urban, suburban and vegetated landscapes within 60 km of Sydney's Central Business District. We found that insect biomass was at least an order of magnitude greater within suburban landscapes in bushland and backyard elements located on the most fertile shale influenced geologies (both p<0.001) compared to nutrient poor sandstone landscapes. Similarly, the feeding activity of bats was greatest in bushland, and riparian elements within suburbs on fertile geologies (p = 0.039). Regression tree analysis indicated that the same three variables explained the major proportion of the variation in insect biomass and bat foraging activity. These were ambient temperature (positive), housing density (negative) and the percent of fertile shale geologies (positive) in the landscape; however variation in insect biomass did not directly explain bat foraging activity. We suggest that prey may be unavailable to bats in highly urbanized areas if these areas are avoided by many species, suggesting that reduced feeding activity may reflect under-use of urban habitats by bats. Restoration activities to improve ecological function and maintain the activity of a diversity of bat species should focus on maintaining and restoring bushland and riparian habitat, particularly in areas with fertile geology as these were key bat foraging habitats.	[Threlfall, Caragh G.; Banks, Peter B.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Law, Bradley] NSW Primary Ind, Forest Sci Ctr, Beecroft, NSW, Australia; [Banks, Peter B.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; NSW Department of Primary Industries; University of Sydney	Threlfall, CG (corresponding author), Univ Melbourne, Dept Resource Management & Geog, Melbourne, Vic 3010, Australia.	caragh.threlfall@unimelb.edu.au	Threlfall, Caragh G/Y-2292-2018; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Threlfall, Caragh G/0000-0002-4197-8588; Banks, Peter/0000-0002-4340-6495; Law, Bradley/0000-0002-3991-3865	student grants by the Royal Zoological Society of NSW; Ecological Society of Australia	student grants by the Royal Zoological Society of NSW; Ecological Society of Australia	This research was supported by student grants to C. T. provided by the Royal Zoological Society of NSW and the Ecological Society of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IM, 2009, BIOL CONSERV, V142, P2904, DOI 10.1016/j.biocon.2009.07.012; ADAMS M, 1988, AUST J BIOL SCI, V41, P315, DOI 10.1071/BI9880315; Adams MD, 2010, ACTA CHIROPTEROL, V12, P231, DOI 10.3161/150811010X504725; Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; Adams MD, 2005, WILDLIFE RES, V32, P173, DOI 10.1071/WR04060; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Basham R, 2011, AUSTRAL ECOL, V36, P663, DOI 10.1111/j.1442-9993.2010.02202.x; Benson D, 1996, MOUNTAIN DEVIL MANGR; Benson D. H., 1995, TAKEN GRANTED BUSHLA; BRAITHWAITE LW, 1984, AUST WILDLIFE RES, V11, P41; BRAITHWAITE LW, 1989, BIOL CONSERV, V50, P33, DOI 10.1016/0006-3207(89)90004-9; Christie Fiona J., 2010, Urban Ecosystems, V13, P169, DOI 10.1007/s11252-009-0115-x; Churchill S, 2008, AUSTR BATS, V2nd; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Corben C, 2010, AUSTRALASIAN BAT SOC, V35, P40; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Erkert H.G., 1982, P201; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; GEGGIE JF, 1985, CAN J ZOOL, V63, P263, DOI 10.1139/z85-040; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haberl H, 2004, LAND USE POLICY, V21, P279, DOI 10.1016/j.landusepol.2003.10.008; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Hecker KR, 1999, J MAMMAL, V80, P1196, DOI 10.2307/1383170; Hourigan C. L., 2006, Urban Ecosystems, V9, P67, DOI 10.1007/s11252-006-7902-4; Hoye Glenn, 2004, P138; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Imhoff ML, 2004, REMOTE SENS ENVIRON, V89, P434, DOI 10.1016/j.rse.2003.10.015; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Jung K, 2010, J MAMMAL, V91, P144, DOI [10.1644/08-MAMM-A-313R.1, 10.1644/08-MAMM-A-313R.1.]; Kalcounis-Rueppell MC, 2007, BIOL CONSERV, V138, P120, DOI 10.1016/j.biocon.2007.04.009; KAVANAGH RP, 1990, AUST WILDLIFE RES, V17, P285; Kunz TH, 2003, BAT ECOLOGY, P3; LANDSBERG J, 1995, AUST J ECOL, V20, P299, DOI 10.1111/j.1442-9993.1995.tb00542.x; Lassau SA, 2005, AUSTRAL ECOL, V30, P179, DOI 10.1111/j.1442-9993.2005.01435.x; Lassau SA, 2007, AUSTRAL ECOL, V32, P656, DOI 10.1111/j.1442-9993.2007.01751.x; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; Law Bradley, 1998, Australian Zoologist, V30, P467; Law BS, 2011, WILDLIFE RES, V38, P173, DOI 10.1071/WR10204; Law BS, 1999, BIOL CONSERV, V88, P333, DOI 10.1016/S0006-3207(98)00118-9; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Lesinski G, 2000, Z SAUGETIERKD, V65, P129; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; Mittelbach GG, 2010, ECOLOGY, V91, P2540, DOI 10.1890/09-1029.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Ober HK, 2008, FOREST ECOL MANAG, V256, P1124, DOI 10.1016/j.foreco.2008.06.010; ONEILL MG, 1989, AUST J ECOL, V14, P19; Pyke G.H., 1985, P65; R Development Core Team, 2007, R LANG ENV STAT COMP; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Recher H.F., 1985, P283; Recher HF, 1996, FOREST ECOL MANAG, V85, P177, DOI 10.1016/S0378-1127(96)03758-9; Ripley B R-Project Website, TREE CLASS REGR TREE; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Smith DA, 2010, RESTOR ECOL, V18, P914, DOI 10.1111/j.1526-100X.2009.00538.x; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker PH, 1960, SOIL SURVEY COUNTY C; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283; Zoborowski P, 2003, FIELD GUIDE INSECTS; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918	77	42	48	0	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38800	10.1371/journal.pone.0038800	http://dx.doi.org/10.1371/journal.pone.0038800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685608	gold, Green Published			2022-12-25	WOS:000305351700072
J	Izzi, B; Francois, I; Labarque, V; Thys, C; Wittevrongel, C; Devriendt, K; Legius, E; Van den Bruel, A; D'Hooghe, M; Lambrechts, D; de Zegher, F; Van Geet, C; Freson, K				Izzi, Benedetta; Francois, Inge; Labarque, Veerle; Thys, Chantal; Wittevrongel, Christine; Devriendt, Koen; Legius, Eric; Van den Bruel, Annick; D'Hooghe, Marc; Lambrechts, Diether; de Zegher, Francis; Van Geet, Chris; Freson, Kathleen			Methylation Defect in Imprinted Genes Detected in Patients with an Albright's Hereditary Osteodystrophy Like Phenotype and Platelet Gs Hypofunction	PLOS ONE			English	Article							PSEUDOHYPOPARATHYROIDISM TYPE-IB; STIMULATORY G-PROTEIN; XL-ALPHA-S; AUTOSOMAL-DOMINANT; EPIGENETIC DEFECTS; GNAS1 GENE; HORMONE RESISTANCE; MOLECULAR ANALYSIS; ADENYLATE-CYCLASE; CONTROL ELEMENT	Background: Pseudohypoparathyroidism (PHP) indicates a group of heterogeneous disorders whose common feature is represented by impaired signaling of hormones that activate Gsalpha, encoded by the imprinted GNAS gene. PHP-Ib patients have isolated Parathormone (PTH) resistance and GNAS epigenetic defects while PHP-Ia cases present with hormone resistance and characteristic features jointly termed as Albright's Hereditary Osteodystrophy (AHO) due to maternally inherited GNAS mutations or similar epigenetic defects as found for PHP-Ib. Pseudopseudohypoparathyroidism (PPHP) patients with an AHO phenotype and no hormone resistance and progressive osseous heteroplasia (POH) cases have inactivating paternally inherited GNAS mutations. Methodology/Principal Findings: We here describe 17 subjects with an AHO-like phenotype that could be compatible with having PPHP but none of them carried Gsalpha mutations. Functional platelet studies however showed an obvious Gs hypofunction in the 13 patients that were available for testing. Methylation for the three differentially methylated GNAS regions was quantified via the Sequenom EpiTYPER. Patients showed significant hypermethylation of the XL amplicon compared to controls (36 +/- 3 vs. 29 +/- 3%; p<0.001); a pattern that is reversed to XL hypomethylation found in PHPIb. Interestingly, XL hypermethylation was associated with reduced XLalphaS protein levels in the patients' platelets. Methylation for NESP and ExonA/B was significantly different for some but not all patients, though most patients have site-specific CpG methylation abnormalities in these amplicons. Since some AHO features are present in other imprinting disorders, the methylation of IGF2, H19, SNURF and GRB10 was quantified. Surprisingly, significant IGF2 hypermethylation (20 +/- 10 vs. 14 +/- 7%; p<0.05) and SNURF hypomethylation (23 +/- 6 vs. 32 +/- 6%; p<0.001) was found in patients vs. controls, while H19 and GRB10 methylation was normal. Conclusion/Significance: In conclusion, this is the first report of methylation defects including GNAS in patients with an AHO-like phenotype without endocrinological abnormalities. Additional studies are still needed to correlate the methylation defect with the clinical phenotype.	[Izzi, Benedetta; Thys, Chantal; Wittevrongel, Christine; Van Geet, Chris; Freson, Kathleen] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Francois, Inge; Labarque, Veerle; de Zegher, Francis; Van Geet, Chris] Univ Leuven, Dept Pediat, Louvain, Belgium; [Devriendt, Koen; Legius, Eric] Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Van den Bruel, Annick; D'Hooghe, Marc] Gen Hosp Sint Jan Brugge, Brugge, Belgium; [Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Lambrechts, Diether] VIB, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB)	Izzi, B (corresponding author), Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium.	kathleen.freson@med.kuleuven.be	Izzi, Benedetta/B-4563-2016; Lambrechts, Diether/AAJ-3167-2020; Verdrengh, Evelien/H-4571-2012	Izzi, Benedetta/0000-0002-3649-7931; Lambrechts, Diether/0000-0002-3429-302X; freson, kathleen/0000-0002-4381-2442	Excellentie financiering KULeuven [EF/05/013]; Fund for Scientific Research - Flanders (FWO-Vlaanderen, Belgium) [G.0490.10N, G.0743.09]; Research Council of the University of Leuven (Onderzoeksraad KULeuven, Belgium) [GOA/2009/13]	Excellentie financiering KULeuven(KU Leuven); Fund for Scientific Research - Flanders (FWO-Vlaanderen, Belgium)(FWO); Research Council of the University of Leuven (Onderzoeksraad KULeuven, Belgium)(KU Leuven)	This work was supported by the 'Excellentie financiering KULeuven' (EF/05/013), by research grants G.0490.10N and G.0743.09 from the Fund for Scientific Research - Flanders (FWO-Vlaanderen, Belgium), GOA/2009/13 from the Research Council of the University of Leuven (Onderzoeksraad KULeuven, Belgium). C. V. G. is holder of a clinical-fundamental research mandate of the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium and of the Bayer and Norbert Heimburger (CSL Behring) Chairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Ahrens W, 2001, J CLIN ENDOCR METAB, V86, P4630, DOI 10.1210/jc.86.10.4630; Ahrens W, 2006, J PEDIATR ENDOCR MET, V19, P647; Aldred MA, 2002, AM J MED GENET, V113, P167, DOI 10.1002/ajmg.10751; Ammerpohl O, 2009, BBA-GEN SUBJECTS, V1790, P847, DOI 10.1016/j.bbagen.2009.02.001; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Baple EL, 2011, EUR J HUM GENET, V19, P360, DOI 10.1038/ejhg.2010.218; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2001, HUM MOL GENET, V10, P1231, DOI 10.1093/hmg/10.12.1231; Bliek J, 2009, EUR J HUM GENET, V17, P611, DOI 10.1038/ejhg.2008.233; Bruce S, 2009, J CLIN ENDOCR METAB, V94, P579, DOI 10.1210/jc.2008-1805; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cavaco BM, 2010, ENDOCRINE, V37, P408, DOI 10.1007/s12020-010-9321-9; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; de Beur SJ, 2003, AM J HUM GENET, V73, P314, DOI 10.1086/377136; de Nanclares GP, 2007, J CLIN ENDOCR METAB, V92, P2370, DOI 10.1210/jc.2006-2287; de Sanctis L, 2003, PEDIATR RES, V53, P749, DOI 10.1203/01.PDR.0000059752.07086.A2; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Fernandez-Rebollo E, 2011, J BONE MINER RES, V26, P1854, DOI 10.1002/jbmr.408; Freson K, 2004, J CLIN INVEST, V113, P905, DOI 10.1172/JCI200419252; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Freson K, 2002, HUM MOL GENET, V11, P2741, DOI 10.1093/hmg/11.22.2741; Freson K, 2001, THROMB HAEMOSTASIS, V86, P733, DOI 10.1055/s-0037-1616126; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Freson K, 2008, J CLIN ENDOCR METAB, V93, P4851, DOI 10.1210/jc.2008-0883; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Genevieve D, 2005, EUR J HUM GENET, V13, P1033, DOI 10.1038/sj.ejhg.5201448; Germain-Lee EL, 2003, J CLIN ENDOCR METAB, V88, P4059, DOI 10.1210/jc.2003-030028; Izzi B, 2012, J HUM GENET, V57, P277, DOI 10.1038/jhg.2012.1; Izzi B, 2010, CLIN CHIM ACTA, V411, P2033, DOI 10.1016/j.cca.2010.08.034; Krechowec SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029753; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Levine MA, 2002, PRINCIPLES BONE BIOL, P1137, DOI [10.1016/b978-012098652-1/50166-9, DOI 10.1016/B978-012098652-1/50166-9]; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Linglart A, 2007, CLIN ENDOCRINOL, V67, P822, DOI 10.1111/j.1365-2265.2007.02969.x; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; Liu Z, 2011, J BIOL CHEM, V286, P38558, DOI 10.1074/jbc.M111.240150; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Mantovani G, 2003, J CLIN ENDOCR METAB, V88, P4070, DOI 10.1210/jc.2002-022028; Mantovani G, 2000, J CLIN ENDOCR METAB, V85, P4243, DOI 10.1210/jc.85.11.4243; Mantovani G, 2010, J CLIN ENDOCR METAB, V95, P651, DOI 10.1210/jc.2009-0176; Mariot V, 2008, J CLIN ENDOCR METAB, V93, P661, DOI 10.1210/jc.2007-0927; Mariot V, 2011, BONE, V48, P312, DOI 10.1016/j.bone.2010.09.032; Maupetit-Mehouas S, 2011, J MED GENET, V48, P55, DOI 10.1136/jmg.2010.081356; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Poole RL, 2010, AM J MED GENET A, V152A, P1990, DOI 10.1002/ajmg.a.33530; Richard N, 2012, J CLIN ENDOCR METAB, V97, pE863, DOI 10.1210/jc.2011-2804; Shirohzu H, 2002, AM J MED GENET, V112, P31, DOI 10.1002/ajmg.10658; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Turner CLS, 2010, EUR J HUM GENET, V18, P648, DOI 10.1038/ejhg.2009.246; Unluturk U, 2008, AM J MED SCI, V336, P84, DOI 10.1097/MAJ.0b013e31815b218f; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WILSON LC, 1994, J MED GENET, V31, P779, DOI 10.1136/jmg.31.10.779; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zazo C, 2011, J BONE MINER RES, V26, P1864, DOI 10.1002/jbmr.369	68	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38579	10.1371/journal.pone.0038579	http://dx.doi.org/10.1371/journal.pone.0038579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679513	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900060
J	Wu, YB; Punta, M; Xiao, R; Acton, TB; Sathyamoorthy, B; Dey, F; Fischer, M; Skerra, A; Rost, B; Montelione, GT; Szyperski, T				Wu, Yibing; Punta, Marco; Xiao, Rong; Acton, Thomas B.; Sathyamoorthy, Bharathwaj; Dey, Fabian; Fischer, Markus; Skerra, Arne; Rost, Burkhard; Montelione, Gaetano T.; Szyperski, Thomas			NMR Structure of Lipoprotein YxeF from Bacillus subtilis Reveals a Calycin Fold and Distant Homology with the Lipocalin Blc from Escherichia coli	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; PRODUCTION PLATFORM; BINDING PROTEINS; DATABASE; ASSIGNMENTS; PROGRAM; FAMILY; RECOGNITION; STABILITY; ALGORITHM	The soluble monomeric domain of lipoprotein YxeF from the Gram positive bacterium B. subtilis was selected by the Northeast Structural Genomics Consortium (NESG) as a target of a biomedical theme project focusing on the structure determination of the soluble domains of bacterial lipoproteins. The solution NMR structure of YxeF reveals a calycin fold and distant homology with the lipocalin Blc from the Gram-negative bacterium E. coli. In particular, the characteristic beta-barrel, which is open to the solvent at one end, is extremely well conserved in YxeF with respect to Blc. The identification of YxeF as the first lipocalin homologue occurring in a Gram-positive bacterium suggests that lipocalins emerged before the evolutionary divergence of Gram positive and Gram negative bacteria. Since YxeF is devoid of the alpha-helix that packs in all lipocalins with known structure against the beta-barrel to form a second hydrophobic core, we propose to introduce a new lipocalin sub-family named 'slim lipocalins', with YxeF and the other members of Pfam family PF11631 to which YxeF belongs constituting the first representatives. The results presented here exemplify the impact of structural genomics to enhance our understanding of biology and to generate new biological hypotheses.	[Wu, Yibing; Sathyamoorthy, Bharathwaj; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, Munich, Germany; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] State Univ New Jersey, Robert Wood Johnson Med Sch, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Dey, Fabian; Fischer, Markus] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Skerra, Arne] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Freising Weihenstephan, Germany; [Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, Freising Weihenstephan, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Technical University of Munich; Technical University of Munich; Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; Howard Hughes Medical Institute; Technical University of Munich; Technical University of Munich	Wu, YB (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	szypersk@buffalo.edu	Punta, Marco/ABH-4698-2020; Rost, Burkhard/A-1908-2016; Sathyamoorthy, Bharathwaj/ABG-2715-2020; Skerra, Arne/A-2269-2013	Punta, Marco/0000-0002-0050-0676; Rost, Burkhard/0000-0003-0179-8424; Sathyamoorthy, Bharathwaj/0000-0002-1568-2599; Montelione, Gaetano/0000-0002-9440-3059; Skerra, Arne/0000-0002-5717-498X	National Institutes of Health [U54 GM094597]; National Science Foundation [MCB 0817857]; Technische Universitat Munchen, Institute for Advanced Study; German Excellence Initiative; University at Buffalo's Center for Computational Research; Div Of Molecular and Cellular Bioscience [0817857] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Technische Universitat Munchen, Institute for Advanced Study; German Excellence Initiative; University at Buffalo's Center for Computational Research; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (U54 GM094597 to TS and GTM), the National Science Foundation (MCB 0817857 to TS) and the Technische Universitat Munchen, Institute for Advanced Study, funded by the German Excellence Initiative (to BR and MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank R. Shastry, C. Ciccosanti, H. Janjua, and G.V.T. Swapna for contributions in sample preparation, and Dr. Masayori Inouye, Rutgers University, for advice regarding the biology and biochemistry of bacterial lipoproteins. Support was also obtained from the University at Buffalo's Center for Computational Research.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atreya HS, 2004, P NATL ACAD SCI USA, V101, P9642, DOI 10.1073/pnas.0403529101; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beste G, 1999, P NATL ACAD SCI USA, V96, P1898, DOI 10.1073/pnas.96.5.1898; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bishop R, 2000, BACTERIAL LIPOCALINS; Bishop RE, 2000, BBA-PROTEIN STRUCT M, V1482, P73, DOI 10.1016/S0167-4838(00)00138-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campanacci V, 2006, FEBS LETT, V580, P4877, DOI 10.1016/j.febslet.2006.07.086; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delfosse V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004712; du Penhoat Catherine Herve, 2005, Journal of Structural and Functional Genomics, V6, P51, DOI 10.1007/s10969-005-5277-z; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Greene LH, 2001, PROTEIN SCI, V10, P2301, DOI 10.1110/ps.22901; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Jansson M, 1996, J BIOMOL NMR, V7, P131; KATAKURA Y, 1994, BBA-PROTEIN STRUCT M, V1207, P58, DOI 10.1016/0167-4838(94)90051-5; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kim HJ, 2009, J AM CHEM SOC, V131, P3565, DOI 10.1021/ja806857r; Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu GH, 2005, P NATL ACAD SCI USA, V102, P10487, DOI 10.1073/pnas.0504338102; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mills JL, 2009, BIOCHEMISTRY-US, V48, P7411, DOI 10.1021/bi900535j; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; Rzychon M, 2003, PROTEIN SCI, V12, P2252, DOI 10.1110/ps.03247703; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Schiefner A, 2010, ACTA CRYSTALLOGR D, V66, P1308, DOI 10.1107/S0907444910039375; Schlehuber S, 2002, BIOPHYS CHEM, V96, P213, DOI 10.1016/S0301-4622(02)00026-1; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Shen Y, 2005, J AM CHEM SOC, V127, P9085, DOI 10.1021/ja0501870; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	64	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37404	10.1371/journal.pone.0037404	http://dx.doi.org/10.1371/journal.pone.0037404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693626	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900007
J	Indig, FE; Rybanska, I; Karmakar, P; Devulapalli, C; Fu, HQ; Carrier, F; Bohr, VA				Indig, Fred E.; Rybanska, Ivana; Karmakar, Parimal; Devulapalli, Chakravarty; Fu, Haiqing; Carrier, France; Bohr, Vilhelm A.			Nucleolin Inhibits G4 Oligonucleotide Unwinding by Werner Helicase	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DNA TOPOISOMERASE-I; PROTEOMIC ANALYSIS; COMPLEX-FORMATION; BINDING-PROTEIN; SYNDROME GENE; WRN HELICASE; CELL-LINES; CAMPTOTHECIN; LOCALIZATION	Background: The Werner protein (WRNp), a member of the RecQ helicase family, is strongly associated with the nucleolus, as is nucleolin (NCL), an important nucleolar constituent protein. Both WRNp and NCL respond to the effects of DNA damaging agents. Therefore, we have investigated if these nuclear proteins interact and if this interaction has a possible functional significance in DNA damage repair. Methodology/Principal Findings: Here we report that WRNp interacts with the RNA-binding protein, NCL, based on immunoprecipitation, immunofluorescent co-localization in live and fixed cells, and direct binding of purified WRNp to nucleolin. We also map the binding region to the C-terminal domains of both proteins. Furthermore, treatment of U2OS cells with 15 mu M of the Topoisomerase I inhibitor, camptothecin, causes the dissociation of the nucleolin-Werner complex in the nucleolus, followed by partial re-association in the nucleoplasm. Other DNA damaging agents, such as hydroxyurea, Mitomycin C, and aphidicolin do not have these effects. Nucleolin or its C-terminal fragment affected the helicase, but not the exonuclease activity of WRNp, by inhibiting WRN unwinding of G4 tetraplex DNA structures, as seen in activity assays and electrophoretic mobility shift assays (EMSA). Conclusions/Significance: These data suggest that nucleolin may regulate G4 DNA unwinding by WRNp, possibly in response to certain DNA damaging agents. We postulate that the NCL-WRNp complex may contain an inactive form of WRNp, which is released from the nucleolus upon DNA damage. Then, when required, WRNp is released from inhibition and can participate in the DNA repair processes.	[Indig, Fred E.] NIA, Clin Invest Lab, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Rybanska, Ivana; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Karmakar, Parimal] Jadavpur Univ, Dept Life Sci & Biotechnol, Kolkata, India; [Devulapalli, Chakravarty; Carrier, France] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Fu, Haiqing] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Jadavpur University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Indig, FE (corresponding author), NIA, Clin Invest Lab, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA.	indigf@mail.nih.gov	Bohr, Vilhelm/AAP-5931-2020	Carrier, France/0000-0002-5517-5284	National Institutes of Health (NIH), National Institute on Aging; NIH/National Cancer Institute (NCI) [RO1 1CA116491-01]; NIH/National Insitute of General Medical Sciences (NIGMS) [RO1 GM57827]; National Kidney Foundation; NATIONAL CANCER INSTITUTE [R01CA116491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000721, ZICAG000615] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Insitute of General Medical Sciences (NIGMS); National Kidney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging; by grants NIH/National Cancer Institute (NCI) RO1 1CA116491-01 and NIH/National Insitute of General Medical Sciences (NIGMS) RO1 GM57827 to FC; and a National Kidney Foundation post-doctoral fellowship to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bjergbaek L, 2002, SWISS MED WKLY, V132, P433; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Danks MK, 1996, CANCER RES, V56, P1664; De AY, 2006, BIOCHEM BIOPH RES CO, V344, P206, DOI 10.1016/j.bbrc.2006.03.113; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gerbi SA, 2003, CURR OPIN CELL BIOL, V15, P318, DOI 10.1016/S0955-0674(03)00049-8; Ginisty H, 1999, J CELL SCI, V112, P761; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Harrigan JA, 2003, J BIOL CHEM, V278, P22686, DOI 10.1074/jbc.M213103200; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Indig FE, 1997, BIOCHEM J, V327, P291, DOI 10.1042/bj3270291; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Laine JP, 2003, CANCER RES, V63, P7136; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Linke SP, 2003, CANCER RES, V63, P2596; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; MI ZH, 1994, BIOCHEMISTRY-US, V33, P10325, DOI 10.1021/bi00200a013; Nalabothula Narasimharao, 2010, Mol Cell Pharmacol, V2, P203; OCHS R, 1983, EXP CELL RES, V146, P139, DOI 10.1016/0014-4827(83)90332-4; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Otterlei M, 2006, J CELL SCI, V119, P5137, DOI 10.1242/jcs.03291; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Pichierri P, 2000, MUTAT RES-FUND MOL M, V456, P45, DOI 10.1016/S0027-5107(00)00109-3; Pollice A, 2000, BIOCHEM BIOPH RES CO, V268, P909, DOI 10.1006/bbrc.2000.2237; Pommier Y, 1998, BIOCHEMISTRY-US, V37, P3818, DOI 10.1021/bi972067d; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; POOT M, 1992, MUTAT RES, V270, P185, DOI 10.1016/0027-5107(92)90129-P; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SCHULTE RJ, 1994, J IMMUNOL, V153, P5465; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; SEN D, 1992, METHOD ENZYMOL, V211, P191; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Shen JC, 2001, MECH AGEING DEV, V122, P921, DOI 10.1016/S0047-6374(01)00248-2; Shiratori M, 2002, ONCOGENE, V21, P2447, DOI 10.1038/sj.onc.1205334; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Suzuki N, 1999, NUCLEIC ACIDS RES, V27, P2361, DOI 10.1093/nar/27.11.2361; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; Suzuki T, 2001, ONCOGENE, V20, P2551, DOI 10.1038/sj.onc.1204344; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang Chonglin, 2009, Mol Cell Pharmacol, V1, P130; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhang SS, 2004, EXP CELL RES, V293, P248, DOI 10.1016/j.yexcr.2003.10.018	67	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e35229	10.1371/journal.pone.0035229	http://dx.doi.org/10.1371/journal.pone.0035229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675465	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700002
J	Manning, CF; Bundros, AM; Trimmer, JS				Manning, Colleen F.; Bundros, Angeliki M.; Trimmer, James S.			Benefits and Pitfalls of Secondary Antibodies: Why Choosing the Right Secondary Is of Primary Importance	PLOS ONE			English	Article							K+ CHANNELS; POTASSIUM CHANNELS; MAMMALIAN BRAIN; SURFACE EXPRESSION; ALPHA-SUBUNITS; LOCALIZATION; CELLS; PHOSPHORYLATION; NEURONS; PSD-95	Simultaneous labeling of multiple targets in a single sample, or multiplexing, is a powerful approach to directly compare the amount, localization and/or molecular properties of different targets in the same sample. Here we highlight the robust reliability of the simultaneous use of multiple mouse monoclonal antibodies (mAbs) of different immunoglobulin G (IgG) subclasses in a wide variety of multiplexing applications employing anti-mouse IgG subclass-specific secondary antibodies (2 degrees Abs). We also describe the unexpected finding that IgG subclass-specific 2 degrees Abs are superior to general anti-mouse IgG 2 degrees Abs in every tested application in which mouse mAbs were used. This was due to a detection bias of general anti-mouse IgG-specific 2 degrees Abs against mAbs of the most common mouse IgG subclass, IgG1, and to a lesser extent IgG2b mAbs. Thus, when using any of numerous mouse mAbs available through commercial and non-profit sources, for cleaner and more robust results each mAb should be detected with its respective IgG subclass-specific 2 degrees Ab and not a general anti-mouse IgG-specific 2 degrees Ab.	[Manning, Colleen F.; Bundros, Angeliki M.; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Manning, CF (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu			National Institutes of Health [NS34383, NS42225, NS50606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225, U24NS050606, R37NS034383, R01NS034383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS34383, NS42225, and NS50606) to J.S.T. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Brouns I, 2002, J HISTOCHEM CYTOCHEM, V50, P575, DOI 10.1177/002215540205000415; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Couchman JR, 2009, J HISTOCHEM CYTOCHEM, V57, P7, DOI 10.1369/jhc.2008.952820; Daneshtalab N, 2010, J PHARMACOL TOXICOL, V61, P127, DOI 10.1016/j.vascn.2009.12.002; Frisch J, 2011, METHODS MOL BIOL, V717, P233, DOI 10.1007/978-1-61779-024-9_13; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Kaufmann WA, 2009, J COMP NEUROL, V515, P215, DOI 10.1002/cne.22066; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; NATSUUMESAKAI S, 1977, IMMUNOLOGY, V32, P861; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; Rasband MN, 2002, J CELL BIOL, V159, P663, DOI 10.1083/jcb.200206024; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; SHI GY, 1994, J BIOL CHEM, V269, P23204; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhu W, 2009, THERAPEUTIC MONOCLON, P151	29	34	34	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38313	10.1371/journal.pone.0038313	http://dx.doi.org/10.1371/journal.pone.0038313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675541	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900023
J	Meyer, P; Landgraf, K; Hogel, B; Eiermann, W; Ataseven, B				Meyer, Peter; Landgraf, Katharina; Hoegel, Bernhard; Eiermann, Wolfgang; Ataseven, Beyhan			BRCA2 Mutations and Triple-Negative Breast Cancer	PLOS ONE			English	Article							PREVALENCE; CARRIERS	Recently, BRCA1 germline mutations were found in a high proportion (14-34%) of patients with triple-negative breast cancer (TNBC). BRCA2 was either not analyzed or showed much lower mutation frequencies. Therefore, we screened a group of TNBC patients (n = 30) of white European descent for mutations in BRCA2 as well as in BRCA1. Cases were unselected for age of disease-onset (median age at breast cancer diagnosis was 58 years, ranging from 37 to 74 years), family history of cancer and BRCA1 and BRCA2 mutation status. Half of the patients (15/30) showed a family history of breast and/or ovarian cancer. A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%), and only one case showed a BRCA1 mutation (3.3%). Although the study group was small, these results point to BRCA2 mutations being important in TNBC.	[Meyer, Peter; Landgraf, Katharina] Univ Hosp, Inst Med Genet, Rostock, Germany; [Hoegel, Bernhard] Red Cross Hosp, Inst Pathol, Munich, Germany; [Eiermann, Wolfgang; Ataseven, Beyhan] Frauenklin Roten Kreuz, Munich, Germany	University of Rostock	Meyer, P (corresponding author), Univ Hosp, Inst Med Genet, Rostock, Germany.	pm@uni.de			Human Genetics Foundation Munich (Germany)	Human Genetics Foundation Munich (Germany)	This study was supported by the Human Genetics Foundation Munich (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Bauerfeind I, 2011, MAMMAKARZINOME DIAGN, VXII; Borg A, 2010, HUM MUTAT, V31, pE1200, DOI 10.1002/humu.21202; Comen E, 2011, BREAST CANCER RES TR, V129, P185, DOI 10.1007/s10549-011-1433-2; Evans DG, 2011, J MED GENET, V48, P520, DOI 10.1136/jmedgenet-2011-100006; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gadzicki D, 2011, J COMMUN GENET, V2, P53, DOI 10.1007/s12687-011-0042-4; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Krupa R., 2009, Experimental Oncology, V31, P250; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meyer P, 2003, HUM MUTAT, V22; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Young SR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-86	15	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38361	10.1371/journal.pone.0038361	http://dx.doi.org/10.1371/journal.pone.0038361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666503	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400114
J	Flori, L; Gonzatti, MI; Thevenon, S; Chantal, I; Pinto, J; Berthier, D; Aso, PM; Gautier, M				Flori, Laurence; Gonzatti, Mary Isabel; Thevenon, Sophie; Chantal, Isabelle; Pinto, Joar; Berthier, David; Aso, Pedro M.; Gautier, Mathieu			A Quasi-Exclusive European Ancestry in the Senepol Tropical Cattle Breed Highlights the Importance of the slick Locus in Tropical Adaptation	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; BOS-TAURUS; HEAT TOLERANCE; ARTIFICIAL SELECTION; POLLED LOCUS; R-PACKAGE; GENOME; SIGNATURES; DIVERSITY; ADMIXTURE	Background: The Senepol cattle breed (SEN) was created in the early XXth century from a presumed cross between a European (EUT) breed (Red Poll) and a West African taurine (AFT) breed (N'Dama). Well adapted to tropical conditions, it is also believed trypanotolerant according to its putative AFT ancestry. However, such origins needed to be verified to define relevant husbandry practices and the genetic background underlying such adaptation needed to be characterized. Methodology/Principal Findings: We genotyped 153 SEN individuals on 47,365 SNPs and combined the resulting data with those available on 18 other populations representative of EUT, AFT and Zebu (ZEB) cattle. We found on average 89% EUT, 10.4% ZEB and 0.6% AFT ancestries in the SEN genome. We further looked for footprints of recent selection using standard tests based on the extent of haplotype homozygosity. We underlined i) three footprints on chromosome (BTA) 01, two of which are within or close to the polled locus underlying the absence of horns and ii) one footprint on BTA20 within the slick hair coat locus, involved in thermotolerance. Annotation of these regions allowed us to propose three candidate genes to explain the observed signals (TIAM1, GRIK1 and RAI14). Conclusions/Significance: Our results do not support the accepted concept about the AFT origin of SEN breed. Initial AFT ancestry (if any) might have been counter-selected in early generations due to breeding objectives oriented in particular toward meat production and hornless phenotype. Therefore, SEN animals are likely susceptible to African trypanosomes which questions the importation of SEN within the West African tsetse belt, as promoted by some breeding societies. Besides, our results revealed that SEN breed is predominantly a EUT breed well adapted to tropical conditions and confirmed the importance in thermotolerance of the slick locus.	[Flori, Laurence] INRA, UMR GABI 1313, F-78350 Jouy En Josas, France; [Flori, Laurence; Thevenon, Sophie; Chantal, Isabelle; Berthier, David] CIRAD, UMR INTERTRYP, Montpellier, France; [Gonzatti, Mary Isabel; Pinto, Joar; Aso, Pedro M.] Univ Simon Bolivar, Dept Biol Celular, Caracas, Venezuela; [Gautier, Mathieu] INRA, UMR CBGP, Montferrier Sur Lez, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CIRAD; Simon Bolivar University; INRAE; Institut de Recherche pour le Developpement (IRD)	Flori, L (corresponding author), INRA, UMR GABI 1313, F-78350 Jouy En Josas, France.	laurence.flori@jouy.inra.fr	gautier, mathieu/AAU-8789-2020; Flori, Laurence/H-3683-2013; gautier, mathieu/F-7429-2010	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; David, BERTHIER/0000-0002-3283-6588; Thevenon, Sophie/0000-0001-6059-5884; Isabelle, CHANTAL/0000-0002-3429-484X; Gonzatti, Mary Isabel/0000-0003-4266-2988	INRA (Institut National de la Recherche Agronomique)-Animal Genetics Department; ECOS (Evaluation-orientation de la COoperation Scientifique) [PI-2008002104]; FONACIT (FOnds NAtional pour les Sciences, les Technologies et l'Innovation) [G98-3462, 2007-1425]; Agence Nationale de la Recherche [EMILE 09-BLAN-0145-01]	INRA (Institut National de la Recherche Agronomique)-Animal Genetics Department; ECOS (Evaluation-orientation de la COoperation Scientifique); FONACIT (FOnds NAtional pour les Sciences, les Technologies et l'Innovation); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an INRA (Institut National de la Recherche Agronomique)-Animal Genetics Department Grant (TROPSENEPOL project), an ECOS (Evaluation-orientation de la COoperation Scientifique) Nord No. PI-2008002104 grant and by FONACIT (FOnds NAtional pour les Sciences, les Technologies et l'Innovation) projects G98-3462 and 2007-1425. MG acknowledges partial funding by the Agence Nationale de la Recherche programme BLANC EMILE 09-BLAN-0145-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; BENNETT JW, 1964, P AUST SOC ANIM PROD, V5, P160; Bergfeld WF, 1998, J AM ACAD DERMATOL, V39, pS86, DOI 10.1016/S0190-9622(98)70452-9; Berman A, 2004, J DAIRY SCI, V87, P1400, DOI 10.3168/jds.S0022-0302(04)73289-0; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; d'Ieteren GDM, 1998, REV SCI TECH OIE, V17, P154, DOI 10.20506/rst.17.1.1088; Dayo GK, 2009, MOL ECOL, V18, P1801, DOI 10.1111/j.1365-294X.2009.04141.x; De Alba J, 1987, ANIMAL GENETIC RESOU, P17; Dikmen S, 2008, J DAIRY SCI, V91, P3395, DOI 10.3168/jds.2008-1072; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Felius M., 2011, Diversity, V3, P660, DOI 10.3390/d3040660; Fleming CB, 1999, INT SEN RES S ST CRO; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Freeman AR, 2006, ANIM GENET, V37, P1, DOI 10.1111/j.1365-2052.2005.01363.x; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Godfrey RW, 1999, INT SEN RES S ST CRO; Goto H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-224; Hammond AC, 1998, J ANIM SCI, V76, P1568; Hammond AC, 1996, J ANIM SCI, V74, P295; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Mariasegaram M, 2007, ANIM GENET, V38, P54, DOI 10.1111/j.1365-2052.2007.01560.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MURRAY M, 1984, J INFECT DIS, V149, P311, DOI 10.1093/infdis/149.3.311; Neto LRP, 2011, VET PARASITOL, V180, P165, DOI 10.1016/j.vetpar.2011.05.048; Olson TA, 2003, J ANIM SCI, V81, P80; Padda DS, 1999, P INT SEN RES S KING; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Payne W.J.A., 1997, TROPICAL CATTLE ORIG; Petit J P, 1973, Rev Elev Med Vet Pays Trop, V26, P97; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Queval R, 1971, Rev Elev Med Vet Pays Trop, V24, P667; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seidlitz EP, 2010, CAN J PHYSIOL PHARM, V88, P929, DOI [10.1139/Y10-070, 10.1139/y10-070]; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Souvenir Zafindrajaona P., 1999, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V52, P155; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teasdale M. D., 2012, BOVINE GENOMICS, P1; Toll-Riera M, 2011, MOL BIOL EVOL, V28, P383, DOI 10.1093/molbev/msq206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wunderlich KR, 2006, ANIM GENET, V37, P592, DOI 10.1111/j.1365-2052.2006.01538.x	64	38	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36133	10.1371/journal.pone.0036133	http://dx.doi.org/10.1371/journal.pone.0036133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22675421	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336100018
J	Guo, YY; Luo, YB; Liu, ZJ; Wang, XQ				Guo, Yan-Yan; Luo, Yi-Bo; Liu, Zhong-Jian; Wang, Xiao-Quan			Evolution and Biogeography of the Slipper Orchids: Eocene Vicariance of the Conduplicate Genera in the Old and New World Tropics	PLOS ONE			English	Article							ESTIMATING DIVERGENCE TIMES; QINGHAI-TIBETAN PLATEAU; CHLOROPLAST GENOME; MOLECULAR PHYLOGENY; NORTHERN-HEMISPHERE; HISTORICAL BIOGEOGRAPHY; ECOLOGICAL SPECIATION; PLANT DISJUNCTIONS; GENETIC DIVERSITY; GONDWANA BREAKUP	Intercontinental disjunctions between tropical regions, which harbor two-thirds of the flowering plants, have drawn great interest from biologists and biogeographers. Most previous studies on these distribution patterns focused on woody plants, and paid little attention to herbs. The Orchidaceae is one of the largest families of angiosperms, with a herbaceous habit and a high species diversity in the Tropics. Here we investigate the evolutionary and biogeographical history of the slipper orchids, which represents a monophyletic subfamily (Cypripedioideae) of the orchid family and comprises five genera that are disjunctly distributed in tropical to temperate regions. A relatively well-resolved and highly supported phylogeny of slipper orchids was reconstructed based on sequence analyses of six maternally inherited chloroplast and two low-copy nuclear genes (LFY and ACO). We found that the genus Cypripedium with a wide distribution in the northern temperate and subtropical zones diverged first, followed by Selenipedium endemic to South America, and finally conduplicate-leaved genera in the Tropics. Mexipedium and Phragmipedium from the neotropics are most closely related, and form a clade sister to Paphiopedilum from tropical Asia. According to molecular clock estimates, the genus Selenipedium originated in Palaeocene, while the most recent common ancestor of conduplicate-leaved slipper orchids could be dated back to the Eocene. Ancestral area reconstruction indicates that vicariance is responsible for the disjunct distribution of conduplicate slipper orchids in palaeotropical and neotropical regions. Our study sheds some light on mechanisms underlying generic and species diversification in the orchid family and tropical disjunctions of herbaceous plant groups. In addition, we suggest that the biogeographical study should sample both regional endemics and their widespread relatives.	[Guo, Yan-Yan; Luo, Yi-Bo; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Guo, Yan-Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guo, YY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828; Luo, Yi-bo/0000-0002-2824-8011; Liu, Zhong-Jian/0000-0003-4390-3878	National Natural Science Foundation of China [30730010]; Chinese Academy of Sciences (the 100-Talent Project)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (the 100-Talent Project)	This work was supported by the National Natural Science Foundation of China (Grant No. 30730010), and the Chinese Academy of Sciences (the 100-Talent Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Albert Victor A., 1994, Lindleyana, V9, P115; Albert Victor A., 1992, Lindleyana, V7, P172; Antonelli A, 2010, BIOL J LINN SOC, V100, P597, DOI 10.1111/j.1095-8312.2010.01438.x; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; Atwood J.T., 1984, SELBYANA, V7, P129; Averyanov L, 2003, SLIPPER ORCHIDS VIET; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Azuma H, 2001, AM J BOT, V88, P2275, DOI 10.2307/3558389; Bittkau C, 2009, J BIOGEOGR, V36, P1346, DOI 10.1111/j.1365-2699.2008.02003.x; Bouetard A, 2010, MOL PHYLOGENET EVOL, V55, P621, DOI 10.1016/j.ympev.2010.01.021; Bream GJ, 1988, PAPHIOPEDILUM; Cameron Kenneth M., 2006, Aliso, V22, P447; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Cameron KM, 2000, MONOCOTS SYSTEMATICS, P457; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; Cox AV, 1997, PLANT SYST EVOL, V208, P197, DOI 10.1007/BF00985442; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Cribb P., 2009, Curtis's Botanical Magazine, V26, P5, DOI 10.1111/j.1467-8748.2009.01632.x; Cribb P, 1997, GENUS CYPRIPEDIUM; Cribb PJ, 1998, GENUS PAPHIOPEDILUM; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cuenca A, 2008, MOL PHYLOGENET EVOL, V46, P760, DOI 10.1016/j.ympev.2007.10.010; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Ducousso M, 2004, MOL ECOL, V13, P231, DOI 10.1046/j.1365-294X.2003.02032.x; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng CM, 2009, MOL PHYLOGENET EVOL, V51, P201, DOI 10.1016/j.ympev.2009.01.017; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Freudenstein JV, 2001, SYST BOT, V26, P643; Freudenstein JV, 2000, MONOCOTS SYSTEMATICS, P421; Freudensteinia JV, 2008, AM J BOT, V95, P498, DOI 10.3732/ajb.95.4.498; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Givnish TJ, 2004, INT J PLANT SCI, V165, pS1, DOI 10.1086/424022; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Grob GBJ, 2004, MOL PHYLOGENET EVOL, V30, P13, DOI 10.1016/S1055-7903(03)00183-0; Guan ZJ, 2011, J PLANT RES, V124, P289, DOI 10.1007/s10265-010-0372-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hallam A, 1995, OUTLINE PHANEROZOIC; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HEANEY LR, 1991, CLIMATIC CHANGE, V19, P53, DOI 10.1007/BF00142213; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huang JL, 2010, J SYST EVOL, V48, P240, DOI 10.1111/j.1759-6831.2010.00080.x; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ickert-Bond SM, 2006, MOL PHYLOGENET EVOL, V39, P512, DOI 10.1016/j.ympev.2005.12.003; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; John P, 1997, PHYSIOL PLANTARUM, V100, P583, DOI 10.1034/j.1399-3054.1997.1000321.x; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Karasawa K, 2005, B HIROSHIMA BOT GARD, V22/ 23, P1; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Koopowitz H, 2008, TROPICAL SLIPPER ORC; Kores P.J., 2000, MONOCOTS SYSTEMATIC; Lan TY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-126; LAVIN M, 1993, AM J BOT, V80, P1, DOI 10.2307/2445114; Li JH, 2011, MOL PHYLOGENET EVOL, V61, P308, DOI 10.1016/j.ympev.2011.06.006; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIDGARD S, 1990, PALEOBIOLOGY, V16, P77, DOI 10.1017/S009483730000974X; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lindley J, 1840, GENERA SPECIES ORCHI; Liu ZJ, 2009, GENUS PAPHIOPEDILUM; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; McKenna M.C., 1983, STRUCTURE DEV GREENL, P351, DOI [10.1007/978-1-4613-3485-9_19, DOI 10.1007/978-1-4613-3485-9_19]; MCKENNA MC, 1983, ANN MO BOT GARD, V70, P459, DOI 10.2307/2992083; Merckx V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-178; Michalak I, 2010, J BIOGEOGR, V37, P1214, DOI 10.1111/j.1365-2699.2010.02306.x; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Milne RI, 2006, ANN BOT-LONDON, V98, P465, DOI 10.1093/aob/mcl148; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Molvary M, 1999, GENERA ORCHIDACEARUM, P59; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Neubig KM, 2010, AM J BOT, V97, pE52, DOI 10.3732/ajb.1000128; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Nie ZL, 2008, MOL PHYLOGENET EVOL, V48, P1027, DOI 10.1016/j.ympev.2008.06.004; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nilsson O, 1998, GENETICS, V150, P403; Nylander J. A. A., 2004, MRMODELTEST V2; Oh SH, 2005, AM J BOT, V92, P179, DOI 10.3732/ajb.92.1.179; Oh SH, 2003, MOL PHYLOGENET EVOL, V29, P203, DOI 10.1016/S1055-7903(03)00093-9; Otero JT, 2006, TRENDS ECOL EVOL, V21, P64, DOI 10.1016/j.tree.2005.11.016; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Peng D, 2008, MOL PHYLOGENET EVOL, V47, P1190, DOI 10.1016/j.ympev.2008.02.001; Pennington RT, 2004, PHILOS T R SOC B, V359, P1611, DOI 10.1098/rstb.2004.1532; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfitzer EHH, 1903, PFLANZENREICH, P1; Phillips RD, 2009, AUST J BOT, V57, P259, DOI 10.1071/BT08157; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRANCE GT, 1977, ANN MO BOT GARD, V64, P659, DOI 10.2307/2395293; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; RAVEN PH, 1988, TAXON, V37, P549, DOI 10.2307/1221098; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Repetur CP, 1997, SYST BOT, V22, P465, DOI 10.2307/2419821; Roberts DL, 2008, CURR BIOL, V18, pR325, DOI 10.1016/j.cub.2008.02.026; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Russell A, 2010, TAXON, V59, P389, DOI 10.1002/tax.592005; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Sapir Y, 2007, MOL ECOL, V16, P5017, DOI 10.1111/j.1365-294X.2007.03557.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Smedmark JEE, 2010, J BIOGEOGR, V37, P2260, DOI 10.1111/j.1365-2699.2010.02366.x; Sorhannus U, 1999, MOL BIOL EVOL, V16, P849, DOI 10.1093/oxfordjournals.molbev.a026169; Soto MA, 1990, ORQUIDEA MEX, V12, P1; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Thorne R, 2004, INT J PLANT SCI, V165, pS137, DOI 10.1086/424023; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Trejo-Torres JC, 2001, J BIOGEOGR, V28, P775, DOI 10.1046/j.1365-2699.2001.00576.x; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Valiente-Banuet A, 2006, P NATL ACAD SCI USA, V103, P16812, DOI 10.1073/pnas.0604933103; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wei XX, 2010, MOL PHYLOGENET EVOL, V55, P776, DOI 10.1016/j.ympev.2010.03.007; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; WING SL, 1987, ANN MO BOT GARD, V74, P748, DOI 10.2307/2399449; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Yu Y, S DIVA STAT DISPERSA; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	164	52	58	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38788	10.1371/journal.pone.0038788	http://dx.doi.org/10.1371/journal.pone.0038788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685605	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700069
J	Lefebvre, JF; Vello, E; Ge, B; Montgomery, SB; Dermitzakis, ET; Pastinen, T; Labuda, D				Lefebvre, Jean Francois; Vello, Emilio; Ge, Bing; Montgomery, Stephen B.; Dermitzakis, Emmanouil T.; Pastinen, Tomi; Labuda, Damian			Genotype-Based Test in Mapping Cis-Regulatory Variants from Allele-Specific Expression Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION; COMMON; LOCUS; MODEL; RISK	Identifying and understanding the impact of gene regulatory variation is of considerable importance in evolutionary and medical genetics; such variants are thought to be responsible for human-specific adaptation [1] and to have an important role in genetic disease. Regulatory variation in cis is readily detected in individuals showing uneven expression of a transcript from its two allelic copies, an observation referred to as allelic imbalance (AI). Identifying individuals exhibiting AI allows mapping of regulatory DNA regions and the potential to identify the underlying causal genetic variant(s). However, existing mapping methods require knowledge of the haplotypes, which make them sensitive to phasing errors. In this study, we introduce a genotype-based mapping test that does not require haplotype-phase inference to locate regulatory regions. The test relies on partitioning genotypes of individuals exhibiting AI and those not expressing AI in a 2x3 contingency table. The performance of this test to detect linkage disequilibrium (LD) between a potential regulatory site and a SNP located in this region was examined by analyzing the simulated and the empirical AI datasets. In simulation experiments, the genotype-based test outperforms the haplotype-based tests with the increasing distance separating the regulatory region from its regulated transcript. The genotype-based test performed equally well with the experimental AI datasets, either from genome-wide cDNA hybridization arrays or from RNA sequencing. By avoiding the need of haplotype inference, the genotype-based test will suit AI analyses in population samples of unknown haplotype structure and will additionally facilitate the identification of cis-regulatory variants that are located far away from the regulated transcript.	[Lefebvre, Jean Francois; Vello, Emilio; Labuda, Damian] Univ Montreal, Ctr Rech, CHU Sainte Justine, Montreal, PQ H3C 3J7, Canada; [Ge, Bing; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Wellcome Trust Sanger Inst, Cambridge, England; [Pastinen, Tomi] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Pastinen, Tomi] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Geneva; Wellcome Trust Sanger Institute; McGill University; McGill University; Universite de Montreal	Lefebvre, JF (corresponding author), Univ Montreal, Ctr Rech, CHU Sainte Justine, Montreal, PQ H3C 3J7, Canada.	damian.labuda@umontreal.ca	Dermitzakis, Emmanouil/B-7687-2013	Montgomery, Stephen/0000-0002-5200-3903	GenomeQuebec/GenomeCanada; Canada Research Chairs; Canadian Institutes of Health Research; Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec	GenomeQuebec/GenomeCanada(Genome Canada); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec	Financial support from GenomeQuebec/GenomeCanada, from Canada Research Chairs (TP), the Canadian Institutes of Health Research and the Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freilinger T, 2009, STROKE, V40, P970, DOI 10.1161/STROKEAHA.107.510800; Gao L, 2009, EUR J CANCER, V45, P428, DOI 10.1016/j.ejca.2008.09.019; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lefebvre JF, 2008, GENETICS, V178, P2069, DOI 10.1534/genetics.107.082255; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; LEWONTIN RC, 1988, GENETICS, V120, P849; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morcos L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r25; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wagner JR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000849; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38667	10.1371/journal.pone.0038667	http://dx.doi.org/10.1371/journal.pone.0038667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685595	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700058
J	Zhu, JQ; Liu, SM; Ma, Y; Zhang, JQ; Qi, HS; Wei, ZJ; Yao, Q; Zhang, WQ; Li, S				Zhu, Jin-Qi; Liu, Shumin; Ma, Yao; Zhang, Jia-Qi; Qi, Hai-Sheng; Wei, Zhao-Jun; Yao, Qiong; Zhang, Wen-Qing; Li, Sheng			Improvement of Pest Resistance in Transgenic Tobacco Plants Expressing dsRNA of an Insect-Associated Gene EcR	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; JUVENILE-HORMONE; COTTON BOLLWORM; MULTIPLE CROPS; INTERFERENCE; 20-HYDROXYECDYSONE; SUPPRESSION; INGESTION; POTENT	The adoption of pest-resistant transgenic plants to reduce yield loss and pesticide utilization has been successful in the past three decades. Recently, transgenic plant expressing double-stranded RNA (dsRNA) targeting pest genes emerges as a promising strategy for improving pest resistance in crops. The steroid hormone, 20-hydroxyecdysone (20E), predominately controls insect molting via its nuclear receptor complex, EcR-USP. Here we report that pest resistance is improved in transgenic tobacco plants expressing dsRNA of EcR from the cotton bollworm, Helicoverpa armigera, a serious lepidopteran pest for a variety of crops. When H. armigera larvae were fed with the whole transgenic tobacco plants expressing EcR dsRNA, resistance to H. armigera was significantly improved in transgenic plants. Meanwhile, when H. armigera larvae were fed with leaves of transgenic tobacco plants expressing EcR dsRNA, its EcR mRNA level was dramatically decreased causing molting defects and larval lethality. In addition, the transgenic tobacco plants expressing H. armigera EcR dsRNA were also resistant to another lepidopteran pest, the beet armyworm, Spodoptera exigua, due to the high similarity in the nucleotide sequences of their EcR genes. This study provides additional evidence that transgenic plant expressing dsRNA targeting insect-associated genes is able to improve pest resistance.	[Zhu, Jin-Qi; Liu, Shumin; Ma, Yao; Zhang, Jia-Qi; Qi, Hai-Sheng; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Zhang, Jia-Qi; Qi, Hai-Sheng; Wei, Zhao-Jun] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Yao, Qiong; Zhang, Wen-Qing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Qiong; Zhang, Wen-Qing] Sun Yat Sen Univ, Sch Life Sci, Inst Entomol, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Hefei University of Technology; Sun Yat Sen University; Sun Yat Sen University	Zhu, JQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.	shengli@sippe.ac.cn	zhang, wenqing/GYA-0786-2022; Wei, Zhaojun/H-5341-2017	Wei, Zhaojun/0000-0003-1729-209X	Shanghai Natural Science Foundation [11ZR1443300]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2010KIP308]; Chinese Academy of Sciences [SKLBC08K01]; State Key Laboratory of Biocontrol, Sun Yat-sen University [KSCX2-EW-J-12]; Outstanding Youth Investigator award [31125025]; SA-SIBS	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Biocontrol, Sun Yat-sen University; Outstanding Youth Investigator award; SA-SIBS	This work was supported by Shanghai Natural Science Foundation (11ZR1443300) and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2010KIP308) to JZ, Chinese Academy of Sciences (SKLBC08K01) to SL, and the State Key Laboratory of Biocontrol, Sun Yat-sen University (KSCX2-EW-J-12) to SL and WZ. SL received the Outstanding Youth Investigator award (31125025) and the SA-SIBS award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista L, 2009, CIRC RES, V104, P1364, DOI 10.1161/CIRCRESAHA.108.190645; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gordon KHJ, 2006, ADV VIRUS RES, V68, P459, DOI 10.1016/S0065-3527(06)68013-5; Graham LD, 2010, MOL BIOCHEM PARASIT, V171, P104, DOI 10.1016/j.molbiopara.2010.03.003; Hall BL, 1998, DEVELOPMENT, V125, P4709; He HJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-1; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Parihar M, 2010, GEN COMP ENDOCR, V167, P11, DOI 10.1016/j.ygcen.2010.02.005; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Poethig RS, 2006, COLD SPRING HARB SYM, V71, P165, DOI 10.1101/sqb.2006.71.030; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Sharma HC, 2004, CRIT REV PLANT SCI, V23, P47, DOI 10.1080/07352680490273400; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Tzertzinis G, 2010, PLOS NEGLECT TROP D, V4, pe65; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu JJ, 2010, J INSECT PHYSIOL, V56, P1471, DOI 10.1016/j.jinsphys.2010.04.004; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	45	115	128	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38572	10.1371/journal.pone.0038572	http://dx.doi.org/10.1371/journal.pone.0038572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685585	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700048
J	Klinth, JE; Castelain, M; Uhlin, BE; Axner, O				Klinth, Jeanna E.; Castelain, Mickael; Uhlin, Bernt Eric; Axner, Ove			The Influence of pH on the Specific Adhesion of P Piliated Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; SURFACE-PLASMON RESONANCE; OPTICAL TWEEZERS; PHYSICAL-PROPERTIES; PILUS BIOGENESIS; CRANBERRY JUICE; HUMAN-CELLS; ANTIBACTERIAL ACTIVITY; GALABIOSE DERIVATIVES; BINDING INTERACTIONS	Adhesion to host tissues is an initiating step in a majority of bacterial infections. In the case of Gram-negative bacteria this adhesion is often mediated by a specific interaction between an adhesin, positioned at the distal end of bacterial pili, and its receptor on the surface of the host tissue. Furthermore, the rod of the pilus, and particularly its biomechanical properties, is believed to be crucial for the ability of bacteria to withstand external forces caused by, for example, (in the case of urinary tract infections) urinary rinsing flows by redistributing the force to several pili. In this work, the adhesion properties of P-piliated E. coli and their dependence of pH have been investigated in a broad pH range by both the surface plasmon resonance technique and force measuring optical tweezers. We demonstrate that P piliated bacteria have an adhesion ability throughout the entire physiologically relevant pH range (pH 4.5 - 8). We also show that pH has a higher impact on the binding rate than on the binding stability or the biomechanical properties of pili; the binding rate was found to have a maximum around pH 5 while the binding stability was found to have a broader distribution over pH and be significant over the entire physiologically relevant pH range. Force measurements on a single organelle level show that the biomechanical properties of P pili are not significantly affected by pH.	[Klinth, Jeanna E.; Castelain, Mickael; Axner, Ove] Umea Univ, Dept Phys, Umea, Sweden; [Klinth, Jeanna E.; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, Umea, Sweden; [Klinth, Jeanna E.; Uhlin, Bernt Eric; Axner, Ove] Umea Univ, UCMR, Umea, Sweden; [Klinth, Jeanna E.; Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Klinth, JE (corresponding author), Umea Univ, Dept Phys, Umea, Sweden.	jeanna.klinth@physics.umu.se	Klinth, Jeanna/E-3662-2013; Castelain, Mickaël/A-9647-2011; Uhlin, Bernt Eric/AAO-6292-2021	Klinth, Jeanna/0000-0002-5977-847X; Castelain, Mickaël/0000-0002-0256-7663; Uhlin, Bernt Eric/0000-0002-2991-8072; Axner, Ove/0000-0002-8580-9700	Swedish Research Council [349-2007-8673, 621-2008-3280, 621-2009-5720, VR-MH 2010-3031]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Grants from Swedish Research Council numbers: 349-2007-8673, 621-2008-3280; 621-2009-5720 and VR-MH 2010-3031 (URL: http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg V, 2007, ORG BIOMOL CHEM, V5, P1827, DOI 10.1039/b702397a; Andersson M, 2008, CHEMPHYSCHEM, V9, P221, DOI 10.1002/cphc.200700389; Andersson M, 2007, BIOPHYS J, V93, P3008, DOI 10.1529/biophysj.107.110643; Andersson M, 2006, BIOPHYS J, V91, P2717, DOI 10.1529/biophysj.106.087429; Andersson M, 2006, PROC SPIE, V6088, DOI 10.1117/12.642266; ASSCHER AW, 1966, LANCET, V2, P1037; Axner O, 2010, SPRINGER SER CHEM PH, V96, P337, DOI 10.1007/978-3-642-02597-6_18; BAGA M, 1987, CELL, V49, P241, DOI 10.1016/0092-8674(87)90565-4; Balsalobre C, 2003, J BACTERIOL, V185, P620, DOI 10.1128/JB.185.2.620-629.2003; Bjarnsholt Thomas, 2008, Curr Infect Dis Rep, V10, P22, DOI 10.1007/s11908-008-0006-y; Bjornham O, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148027; Bjornham O, 2008, EUR BIOPHYS J BIOPHY, V37, P381, DOI 10.1007/s00249-007-0223-6; Bjornham O, 2009, EUR BIOPHYS J BIOPHY, V38, P245, DOI 10.1007/s00249-008-0376-y; Blatherwick NR, 1923, J BIOL CHEM, V57, P815; BODEL PT, 1959, J LAB CLIN MED, V54, P881; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Chorell E, 2010, J MED CHEM, V53, P5690, DOI 10.1021/jm100470t; Davenport K, 2007, UROL RES, V35, P207, DOI 10.1007/s00240-007-0100-x; Dessi A, 2011, REV BRAS FARMACOGN, V21, P807, DOI 10.1590/S0102-695X2011005000126; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Emtenas H, 2002, J COMB CHEM, V4, P630, DOI 10.1021/cc020032d; Fallman E, 2004, BIOSENS BIOELECTRON, V19, P1429, DOI 10.1016/j.bios.2003.12.029; Fallman E, 2005, EMBO REP, V6, P52, DOI 10.1038/sj.embor.7400310; GONG MF, 1992, J MOL BIOL, V228, P735, DOI 10.1016/0022-2836(92)90860-M; HOSCHUTZKY H, 1989, INFECT IMMUN, V57, P76; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; Jimenez-Lozano J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041901; KAYE D, 1968, J CLIN INVEST, V47, P2374, DOI 10.1172/JCI105921; Kim SH, 2011, J INFECT CHEMOTHER, V17, P322, DOI 10.1007/s10156-010-0170-5; Klinth JE, 2012, EUR BIOPHYS J BIOPHY, V41, P285, DOI 10.1007/s00249-011-0784-2; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Larsson A, 2003, BIOORGAN MED CHEM, V11, P2255, DOI 10.1016/S0968-0896(03)00114-7; LINDBERG F, 1987, NATURE, V328, P84, DOI 10.1038/328084a0; LINDBERG FP, 1984, EMBO J, V3, P1167, DOI 10.1002/j.1460-2075.1984.tb01946.x; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; MARQUARDT H, 1973, UROLOGE A, V12, P173; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MOU TW, 1962, J UROLOGY, V87, P978, DOI 10.1016/S0022-5347(17)65077-8; Nilsson U, 1996, BIOORGAN MED CHEM, V4, P1809, DOI 10.1016/S0968-0896(96)00163-0; NORGREN M, 1984, EMBO J, V3, P1159, DOI 10.1002/j.1460-2075.1984.tb01945.x; O'Grady F, 1966, Br J Urol, V38, P149, DOI 10.1111/j.1464-410X.1966.tb09693.x; Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1; Ohlsson J, 2002, CHEMBIOCHEM, V3, P772, DOI 10.1002/1439-7633(20020802)3:8<772::AID-CBIC772>3.0.CO;2-8; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Pourshafie MR, 2004, J MICROBIOL METH, V58, P313, DOI 10.1016/j.mimet.2004.04.009; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Rossi R, 2010, J CLIN GASTROENTEROL, V44, pS61, DOI 10.1097/MCG.0b013e3181d2dc8e; SAEKI H, 1986, UROL INT, V41, P174, DOI 10.1159/000281192; Salminen A, 2007, J ANTIMICROB CHEMOTH, V60, P495, DOI 10.1093/jac/dkm251; Salo J, 2012, CLIN INFECT DIS, V54, P340, DOI 10.1093/cid/cir801; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SOKURENKO EV, 1992, INFECT IMMUN, V60, P4709, DOI 10.1128/IAI.60.11.4709-4719.1992; SOMMERKA.H, 1971, UROLOGE, V10, P145; Stapleton AE, 2012, MAYO CLIN PROC, V87, P143, DOI 10.1016/j.mayocp.2011.10.006; UHLIN BE, 1985, P NATL ACAD SCI USA, V82, P1800, DOI 10.1073/pnas.82.6.1800; Ulett GC, 2007, MICROBIOL-SGM, V153, P2321, DOI 10.1099/mic.0.2006/004648-0; Vahidi B, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003316; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Vogel A, 2004, CR MECANIQUE, V332, P737, DOI 10.1016/j.crme.2004.03.017; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; WATERS WE, 1967, BRIT J PREV SOC MED, V21, P129; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x	62	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38548	10.1371/journal.pone.0038548	http://dx.doi.org/10.1371/journal.pone.0038548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679512	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900057
J	Dey, N; Das, F; Ghosh-Choudhury, N; Mandal, CC; Parekh, DJ; Block, K; Kasinath, BS; Abboud, HE; Choudhury, GG				Dey, Nirmalya; Das, Falguni; Ghosh-Choudhury, Nandini; Mandal, Chandi Charan; Parekh, Dipen J.; Block, Karen; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HIPPEL-LINDAU GENE; NF-KAPPA-B; KIDNEY CANCER; HIGH GLUCOSE; MAMMALIAN TARGET; BINDING PARTNER; DOWN-REGULATION; PTEN LOSS; EXPRESSION	Metastatic renal cancer manifests multiple signatures of gene expression. Deviation in expression of mature miRNAs has been linked to human cancers. Importance of miR-21 in renal cell carcinomas is proposed from profiling studies using tumor tissue samples. However, the role of miR-21 function in causing renal cancer cell proliferation and invasion has not yet been shown. Using cultured renal carcinoma cells, we demonstrate enhanced expression of mature miR-21 along with pre-and pri-miR-21 by increased transcription compared to normal proximal tubular epithelial cells. Overexpression of miR-21 Sponge to quench endogenous miR-21 levels inhibited proliferation, migration and invasion of renal cancer cells. In the absence of mutation in the PTEN tumor suppressor gene, PTEN protein levels are frequently downregulated in renal cancer. We show that miR-21 targets PTEN mRNA 3'untranslated region to decrease PTEN protein expression and augments Akt phosphorylation in renal cancer cells. Downregulation of PTEN as well as overexpression of constitutively active Akt kinase prevented miR-21 Sponge-induced inhibition of renal cancer cell proliferation and migration. Moreover, we show that miR-21 Sponge inhibited the inactivating phosphorylation of the tumor suppressor protein tuberin and attenuated TORC1 activation. Finally, we demonstrate that expression of constitutively active TORC1 attenuated miR-21 Sponge-mediated suppression of proliferation and migration of renal cancer cells. Our results uncover a layer of post-transcriptional regulation of PTEN by transcriptional activation of miR-21 to force the canonical oncogenic Akt/TORC1 signaling conduit to drive renal cancer cell proliferation and invasion.	[Dey, Nirmalya; Das, Falguni; Block, Karen; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Block, Karen; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Adm Res, San Antonio, TX USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi Charan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Parekh, Dipen J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Dey, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	United States National Institutes of Health (NIH) [RO1 DK50190]; VA Research Service Merit Review; Juvenile Diabetes Research Foundation [1-2008-185]; VA Senior Research Career Scientist Award; VA Merit Review, NIH [RO1 AR 52425]; Cancer Therapy and Research Center, San Antonio, Texas; VA Research Service Career Scientist Award; Merit Review Awards;  [NIH RO1 CA 131272];  [NIH RO1 DK 077295];  [NIH RO1 DK078971];  [NIH RC2A 036613]; NATIONAL CANCER INSTITUTE [R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R01DK050190, R01DK078971] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Research Service Merit Review(US Department of Veterans Affairs); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Senior Research Career Scientist Award; VA Merit Review, NIH; Cancer Therapy and Research Center, San Antonio, Texas; VA Research Service Career Scientist Award; Merit Review Awards; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A United States National Institutes of Health (NIH) RO1 DK50190 grant to GGC supported this work. Part of this work was also supported by VA Research Service Merit Review grant to GGC. GGC is also supported by Juvenile Diabetes Research Foundation 1-2008-185 grants and is recipient of VA Senior Research Career Scientist Award. NGC is supported by VA Merit Review, NIH RO1 AR 52425 grants and Ronald P. Williams Orthopedic Oncology Developmental Research Award from Cancer Therapy and Research Center, San Antonio, Texas. KB, BSK and HEA are supported by grants, NIH RO1 CA 131272 (KB), NIH RO1 DK 077295 (BSK), NIH RO1 DK078971 (HEA), NIH RC2A 036613 (BSK) and VA Research Service Career Scientist Award (KB) and Merit Review Awards (KB, BSK and HEA).	Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett KL, 2011, GENE CHROMOSOME CANC, V50, P654, DOI 10.1002/gcc.20887; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dahinden C, 2010, CLIN CANCER RES, V16, P88, DOI 10.1158/1078-0432.CCR-09-0260; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fahmy MA, 2010, CANCER, V117, P290; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146pe39; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee JS, 2003, J SURG ONCOL, V84, P166, DOI 10.1002/jso.10302; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Milowsky MI, 2003, UROL CLIN N AM, V30, P601, DOI 10.1016/S0094-0143(03)00031-4; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Novick AC, 2007, UROL ONCOL-SEMIN ORI, V25, P188, DOI 10.1016/j.urolonc.2007.03.006; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Oya M, 2003, CARCINOGENESIS, V24, P377, DOI 10.1093/carcin/24.3.377; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pasquinelli AE, 2010, SCIENCE, V328, P1494, DOI 10.1126/science.1191531; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Poon JS, 2010, CELL CYCLE, V9, P4450, DOI 10.4161/cc.9.22.13936; Powers MP, 2011, DIAGN MOL PATHOL, V20, P63, DOI 10.1097/PDM.0b013e3181efe2a9; Rouviere O, 2006, NAT CLIN PRACT ONCOL, V3, P200, DOI 10.1038/ncponc0479; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smits KM, 2008, CLIN CANCER RES, V14, P782, DOI 10.1158/1078-0432.CCR-07-1753; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Traynor K, 2009, AM J HEALTH-SYST PH, V66, P788, DOI 10.2146/news090037; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Weber K, 2007, CANCER METAST REV, V26, P691, DOI 10.1007/s10555-007-9090-y; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yi Z, 2011, J CANCER RES CLIN, V136, P855; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	118	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37366	10.1371/journal.pone.0037366	http://dx.doi.org/10.1371/journal.pone.0037366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22685542	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700013
J	Moser, MJ; DiFrancesco, RA; Gowda, K; Klingele, AJ; Sugar, DR; Stocki, S; Mead, DA; Schoenfeld, TW				Moser, Michael J.; DiFrancesco, Robert A.; Gowda, Krishne; Klingele, Audrey J.; Sugar, Darby R.; Stocki, Stacy; Mead, David A.; Schoenfeld, Thomas W.			Thermostable DNA Polymerase from a Viral Metagenome Is a Potent RT-PCR Enzyme	PLOS ONE			English	Article							VIRUS REVERSE-TRANSCRIPTASE; STRUCTURAL DETERMINANTS; AMPLIFICATION; EXPRESSION; FIDELITY; REPLICATION; PROTEIN; ASSAY; GENE; BACTERIOPHAGE-MS2	Viral metagenomic libraries are a promising but previously untapped source of new reagent enzymes. Deep sequencing and functional screening of viral metagenomic DNA from a near-boiling thermal pool identified clones expressing thermostable DNA polymerase (Pol) activity. Among these, 3173 Pol demonstrated both high thermostability and innate reverse transcriptase (RT) activity. We describe the biochemistry of 3173 Pol and report its use in single-enzyme reverse transcription PCR (RT-PCR). Wild-type 3173 Pol contains a proofreading 3'-5' exonuclease domain that confers high fidelity in PCR. An easier-to-use exonuclease-deficient derivative was incorporated into a PyroScript RT-PCR master mix and compared to one-enzyme (Tth) and two-enzyme (MMLV RT/Taq) RT-PCR systems for quantitative detection of MS2 RNA, influenza A RNA, and mRNA targets. Specificity and sensitivity of 3173 Pol-based RT-PCR were higher than Tth Pol and comparable to three common two-enzyme systems. The performance and simplified set-up make this enzyme a potential alternative for research and molecular diagnostics.	[Moser, Michael J.; DiFrancesco, Robert A.; Gowda, Krishne; Klingele, Audrey J.; Sugar, Darby R.; Stocki, Stacy; Mead, David A.; Schoenfeld, Thomas W.] Lucigen Corp, Middleton, WI USA		Moser, MJ (corresponding author), Lucigen Corp, Middleton, WI USA.	tschoenfeld@lucigen.com		MEAD, David/0000-0003-1982-9356	National Science Foundation [0109756, 0215988, 0839404]; National Institutes of Health [1 R43 HG002714-01, 2 R44 HG002714-02A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG002714, R43HG002714] Funding Source: NIH RePORTER; Directorate For Engineering [1058238] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (grant numbers 0109756, 0215988, and 0839404) and the National Institutes of Health (grant numbers 1 R43 HG002714-01 and 2 R44 HG002714-02A1) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando T, 1997, J CLIN MICROBIOL, V35, P570, DOI 10.1128/JCM.35.3.570-577.1997; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bolufer P, 2001, HAEMATOLOGICA, V86, P570; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brincat JL, 2002, J VIROL, V76, P88, DOI 10.1128/JVI.76.1.88-95.2002; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; Chandler DP, 1998, APPL ENVIRON MICROB, V64, P669; CHUMAKOV KM, 1994, PCR METH APPL, V4, P62; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; CREIGHTON S, 1992, J BIOL CHEM, V267, P2633; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Desombere I, 2005, J CLIN MICROBIOL, V43, P2590, DOI 10.1128/JCM.43.6.2590-2597.2005; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; FEHLMANN C, 1993, CLIN CHEM, V39, P368; FIERS W, 1975, NATURE, V256, P273, DOI 10.1038/256273a0; Gerard GF, 1997, MOL BIOTECHNOL, V8, P61, DOI 10.1007/BF02762340; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; Halvas EK, 2000, J VIROL, V74, P312, DOI 10.1128/JVI.74.1.312-319.2000; Hogrefe HH, 2001, METHOD ENZYMOL, V334, P91; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Konnick EQ, 2005, J CLIN MICROBIOL, V43, P2133, DOI 10.1128/JCM.43.5.2133-2140.2005; Konnick EQ, 2005, J CLIN MICROBIOL, V43, P596, DOI 10.1128/JCM.43.2.596-603.2005; KOTEWICZ ML, 1988, NUCLEIC ACIDS RES, V16, P265, DOI 10.1093/nar/16.1.265; Kurihara Y, 2002, BIOL PHARM BULL, V25, P1272, DOI 10.1248/bpb.25.1272; Lawyer F C, 1993, PCR Methods Appl, V2, P275; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Li H, 2007, J CLIN ENDOCR METAB, V92, P4046, DOI 10.1210/jc.2006-2358; Lima SMB, 2006, FEBS J, V273, P1463, DOI 10.1111/j.1742-4658.2006.05167.x; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-77; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lotti LV, 2007, J CELL PHYSIOL, V212, P633, DOI 10.1002/jcp.21056; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Mbisa JL, 2005, J VIROL, V79, P419, DOI 10.1128/JVI.79.1.419-427.2005; MEAD DA, 1991, BIOTECHNIQUES, V11, P76; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Connell KP, 2006, APPL ENVIRON MICROB, V72, P478, DOI 10.1128/AEM.72.1.478-483.2006; Perler FB, 1996, ADV PROTEIN CHEM, V48, P377; RICCHETTI M, 1990, EMBO J, V9, P1583, DOI 10.1002/j.1460-2075.1990.tb08278.x; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; Sambrook J, 2001, MOL CLONING LAB MANU; Sauter KBM, 2006, ANGEW CHEM INT EDIT, V45, P7633, DOI 10.1002/anie.200602772; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schoenfeld T, 2010, TRENDS MICROBIOL, V18, P20, DOI 10.1016/j.tim.2009.10.001; Schonbrunner NJ, 2006, BIOCHEMISTRY-US, V45, P12786, DOI 10.1021/bi0609117; SELLMANN E, 1992, J BACTERIOL, V174, P4350, DOI 10.1128/JB.174.13.4350-4355.1992; SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487; SKERRA A, 1992, NUCLEIC ACIDS RES, V20, P3551, DOI 10.1093/nar/20.14.3551; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; TABOR S, 1987, J BIOL CHEM, V262, P16212; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514	62	32	39	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38371	10.1371/journal.pone.0038371	http://dx.doi.org/10.1371/journal.pone.0038371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675552	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700066
J	Schaette, R; Turtle, C; Munro, KJ				Schaette, Roland; Turtle, Charlotte; Munro, Kevin J.			Reversible Induction of Phantom Auditory Sensations through Simulated Unilateral Hearing Loss	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; COMPUTATIONAL MODEL; HOMEOSTATIC PLASTICITY; NEURONAL HYPERACTIVITY; TINNITUS PITCH; DEPRIVATION; MECHANISMS; LISTENERS; AMPLITUDE	Tinnitus, a phantom auditory sensation, is associated with hearing loss in most cases, but it is unclear if hearing loss causes tinnitus. Phantom auditory sensations can be induced in normal hearing listeners when they experience severe auditory deprivation such as confinement in an anechoic chamber, which can be regarded as somewhat analogous to a profound bilateral hearing loss. As this condition is relatively uncommon among tinnitus patients, induction of phantom sounds by a lesser degree of auditory deprivation could advance our understanding of the mechanisms of tinnitus. In this study, we therefore investigated the reporting of phantom sounds after continuous use of an earplug. 18 healthy volunteers with normal hearing wore a silicone earplug continuously in one ear for 7 days. The attenuation provided by the earplugs simulated a mild high-frequency hearing loss, mean attenuation increased from,10 dB at 0.25 kHz to >30 dB at 3 and 4 kHz. 14 out of 18 participants reported phantom sounds during earplug use. 11 participants presented with stable phantom sounds on day 7 and underwent tinnitus spectrum characterization with the earplug still in place. The spectra showed that the phantom sounds were perceived predominantly as high-pitched, corresponding to the frequency range most affected by the earplug. In all cases, the auditory phantom disappeared when the earplug was removed, indicating a causal relation between auditory deprivation and phantom sounds. This relation matches the predictions of our computational model of tinnitus development, which proposes a possible mechanism by which a stabilization of neuronal activity through homeostatic plasticity in the central auditory system could lead to the development of a neuronal correlate of tinnitus when auditory nerve activity is reduced due to the earplug.	[Schaette, Roland] UCL, Ear Inst, London, England; [Turtle, Charlotte; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of London; University College London; University of Manchester	Schaette, R (corresponding author), UCL, Ear Inst, London, England.	r.schaette@ucl.ac.uk	munro, kevin j/A-2899-2015	munro, kevin j/0000-0001-6543-9098	British Tinnitus Association	British Tinnitus Association	This study was supported by the British Tinnitus Association (www.tinnitus.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Chrostowski M, 2011, J COMPUT NEUROSCI, V30, P279, DOI 10.1007/s10827-010-0256-1; Del Bo L, 2008, OTOLARYNG HEAD NECK, V139, P391, DOI 10.1016/j.otohns.2008.06.019; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Lecluyse W, 2009, J ACOUST SOC AM, V126, P2570, DOI 10.1121/1.3238248; Moore BCJ, 2004, EAR HEARING, V25, P98, DOI 10.1097/01.AUD.0000120359.49711.D7; Munro KJ, 2009, J ACOUST SOC AM, V126, P568, DOI 10.1121/1.3161829; Nicolas-Puel Cecile, 2002, Int Tinnitus J, V8, P37; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Parra LC, 2007, J ACOUST SOC AM, V121, P1632, DOI 10.1121/1.2431346; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Schaette R, 2008, HEARING RES, V240, P57, DOI 10.1016/j.heares.2008.02.006; Schaette R, 2006, EUR J NEUROSCI, V23, P3124, DOI 10.1111/j.1460-9568.2006.04774.x; Schaette R, 2010, HEARING RES, V269, P95, DOI 10.1016/j.heares.2010.06.022; Schaette R, 2009, J NEUROPHYSIOL, V101, P3042, DOI 10.1152/jn.91256.2008; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Whiting B, 2009, NEUROSCIENCE, V163, P1264, DOI 10.1016/j.neuroscience.2009.07.049; YOUNG ED, 2002, INTEGRATIVE FUNCTION, P121	26	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e35238	10.1371/journal.pone.0035238	http://dx.doi.org/10.1371/journal.pone.0035238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675466	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700003
J	Domenech, E; Gomez-Lopez, G; Gzlez-Pena, D; Lopez, M; Herreros, B; Menezes, J; Gomez-Lozano, N; Carro, A; Grana, O; Pisano, DG; Dominguez, O; Garcia-Marco, JA; Piris, MA; Sanchez-Beato, M				Domenech, Elena; Gomez-Lopez, Gonzalo; Gzlez-Pena, Daniel; Lopez, Mar; Herreros, Beatriz; Menezes, Juliane; Gomez-Lozano, Natalia; Carro, Angel; Grana, Osvaldo; Pisano, David G.; Dominguez, Orlando; Garcia-Marco, Jose A.; Piris, Miguel A.; Sanchez-Beato, Margarita			New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing	PLOS ONE			English	Article							NF-KAPPA-B; CELL LYMPHOMA; TYROSINE KINASE; RECEPTOR; CANCER; ARID1A; GENES; ACTIVATION; EXPRESSION; COMPLEXES	Chronic lymphocytic leukemia (CLL) is a heterogeneous disease without a well-defined genetic alteration responsible for the onset of the disease. Several lines of evidence coincide in identifying stimulatory and growth signals delivered by B-cell receptor (BCR), and co-receptors together with NFkB pathway, as being the driving force in B-cell survival in CLL. However, the molecular mechanism responsible for this activation has not been identified. Based on the hypothesis that BCR activation may depend on somatic mutations of the BCR and related pathways we have performed a complete mutational screening of 301 selected genes associated with BCR signaling and related pathways using massive parallel sequencing technology in 10 CLL cases. Four mutated genes in coding regions (KRAS, SMARCA2, NFKBIE and PRKD3) have been confirmed by capillary sequencing. In conclusion, this study identifies new genes mutated in CLL, all of them in cases with progressive disease, and demonstrates that next-generation sequencing technologies applied to selected genes or pathways of interest are powerful tools for identifying novel mutational changes.	[Domenech, Elena; Lopez, Mar; Herreros, Beatriz; Menezes, Juliane; Piris, Miguel A.; Sanchez-Beato, Margarita] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain; [Gomez-Lopez, Gonzalo; Gzlez-Pena, Daniel; Carro, Angel; Grana, Osvaldo; Pisano, David G.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain; [Gzlez-Pena, Daniel] Univ Vigo, Pontevedra, Spain; [Gomez-Lozano, Natalia; Garcia-Marco, Jose A.; Sanchez-Beato, Margarita] Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr CNIO, Biotechnol Programme, Madrid, Spain; [Piris, Miguel A.] Fdn Marques Valdecilla, IFIMAV, Santander, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Universidade de Vigo; Hospital Puerta de Hierro-Majadahonda; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario Marques de Valdecilla (HUMV)	Domenech, E (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain.	msbeato@idiphim.org	Sanchez-Beato, Margarita/G-8753-2012; Piris, Miguel A/B-7067-2008; Gomez-Lopez, Gonzalo/D-9123-2016; Piris, Miguel A/AAP-1445-2020; Garcia Marco, Jose/H-2554-2015; Pisano, David/N-5817-2014; Dominguez, Orlando/M-7515-2018; Gomez-Lozano, Natalia/K-6488-2014; Glez-Pena, Daniel/D-5922-2014	Sanchez-Beato, Margarita/0000-0002-0058-7599; Piris, Miguel A/0000-0001-5839-3634; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Piris, Miguel A/0000-0001-5839-3634; Garcia Marco, Jose/0000-0002-8993-5982; Pisano, David/0000-0002-4895-4124; Gomez-Lozano, Natalia/0000-0003-3959-9519; Menezes, Juliane/0000-0003-3727-2096; Glez-Pena, Daniel/0000-0002-6129-7245; Grana-Castro, Osvaldo/0000-0003-1615-4242	Ministerio de Educacion y Ciencia, Spain [SAF2008-03871]; Fondo de Investigaciones Sanitarias (FIS), Spain [PI10/00621, RTICC RD06/0020/0107, CP11/00018]; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Spain; FIS, Spain; "Angeles Alvarino" fellowship; Xunta de Galicia, Spain; Ministerio de Educacion y Ciencia, Spain; la Fundacion La Caixa, Spain; Contracts Miguel Servet from FIS	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fondo de Investigaciones Sanitarias (FIS), Spain(Instituto de Salud Carlos III); Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Spain; FIS, Spain(Instituto de Salud Carlos III); "Angeles Alvarino" fellowship; Xunta de Galicia, Spain(Xunta de Galicia); Ministerio de Educacion y Ciencia, Spain(Spanish Government); la Fundacion La Caixa, Spain; Contracts Miguel Servet from FIS	This work was supported by grants from the Ministerio de Educacion y Ciencia, Spain (SAF2008-03871), Fondo de Investigaciones Sanitarias (FIS), Spain (PI10/00621, RTICC RD06/0020/0107, CP11/00018), and Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Spain. ED is supported by a fellowship from FIS, Spain; DG-P by a "Angeles Alvarino" fellowship and a visiting scholar grant from Xunta de Galicia, Spain; BH by a contract from Ministerio de Educacion y Ciencia, Spain; JM by a fellowship from la Fundacion La Caixa, Spain; and NGL and MS-B are supported by Contracts Miguel Servet from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, LEUKEMIA LYMPHOMA, V50, P1699, DOI 10.1080/10428190903189035; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Dal-Bo M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-76; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Emmerich F, 2003, J PATHOL, V201, P413, DOI 10.1002/path.1454; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gougopoulou DM, 1996, STEM CELLS, V14, P725, DOI 10.1002/stem.140725; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; Herreros B, 2010, LEUKEMIA, V24, P872, DOI 10.1038/leu.2009.285; Hirano M, 2004, INT IMMUNOL, V16, P747, DOI 10.1093/intimm/dxh076; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Juszczynski P, 2009, BLOOD, V114, P5315, DOI 10.1182/blood-2009-02-204362; Ke JY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-132; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nedergaard T, 1997, INT J CANCER, V71, P364, DOI 10.1002/(SICI)1097-0215(19970502)71:3<364::AID-IJC10>3.0.CO;2-G; Pracht C, 2007, CELL SIGNAL, V19, P715, DOI 10.1016/j.cellsig.2006.07.023; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rodriguez A, 2007, LEUKEMIA, V21, P1984, DOI 10.1038/sj.leu.2404831; Rodriguez A, 2004, CLIN CANCER RES, V10, P6796, DOI 10.1158/1078-0432.CCR-04-0753; Rodriguez-Nieto S, 2010, HUMAN MUTATION; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Thorselius M, 2006, BLOOD, V107, P2889, DOI 10.1182/blood-2005-06-2227; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433	35	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38158	10.1371/journal.pone.0038158	http://dx.doi.org/10.1371/journal.pone.0038158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675518	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339900015
J	Hagemann, TL; Jobe, EM; Messing, A				Hagemann, Tracy L.; Jobe, Emily M.; Messing, Albee			Genetic Ablation of Nrf2/Antioxidant Response Pathway in Alexander Disease Mice Reduces Hippocampal Gliosis but Does Not Impact Survival	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRANSCRIPTION FACTOR NRF2; COMPLEX-II INHIBITION; ALPHA-B-CRYSTALLIN; OXIDATIVE STRESS; IN-VIVO; PROTEASOME PATHWAY; GFAP ACCUMULATION; ACTIVATION; AUTOPHAGY	In Alexander disease (AxD) the presence of mutant glial fibrillary acidic protein (GFAP), the major intermediate filament of astrocytes, triggers protein aggregation, with marked induction of a stress response mediated by the transcription factor, Nrf2. To clarify the role of Nrf2 in AxD, we have crossed Gfap mutant and transgenic mouse models into an Nrf2 null background. Deletion of Nrf2 eliminates the phase II stress response normally present in mouse models of AxD, but causes no change in body weight or lifespan, even in a severe lethal model. AxD astrocytes without Nrf2 retain features of reactivity, such as expression of the endothelin-B receptor, but have lower Gfap levels, a decrease in p62 protein and reduced iron accumulation, particularly in hippocampus. Microglial activation, indicated by Iba1 expression, is also diminished. Although the Nrf2 response is generally considered beneficial, these results show that in the context of AxD, loss of the antioxidant pathway has no obvious negative effects, while actually decreasing Gfap accumulation and pathology. Given the attention Nrf2 is receiving as a potential therapeutic target in AxD and other neurodegenerative diseases, it will be interesting to see whether induction of Nrf2, beyond the endogenous response, is beneficial or not in these same models.	[Hagemann, Tracy L.; Jobe, Emily M.; Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Jobe, Emily M.] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hagemann, TL (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	hagemann@waisman.wisc.edu		Jobe, Emily/0000-0001-8712-4767	National Institutes of Health [R01-NS060120, P30-HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803, R01NS060120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health: R01-NS060120 (AM) and P30-HD03352 (Waisman Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2011, ARCH NEUROL; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Shiihara T, 2004, J NEUROL SCI, V225, P125, DOI 10.1016/j.jns.2004.07.008; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Stumpf E, 2003, ARCH NEUROL-CHICAGO, V60, P1307, DOI 10.1001/archneur.60.9.1307; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang LQ, 2011, J NEUROSCI, V31, P2868, DOI 10.1523/JNEUROSCI.3410-10.2011; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	59	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37304	10.1371/journal.pone.0037304	http://dx.doi.org/10.1371/journal.pone.0037304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693571	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500034
J	Salvaing, J; Aguirre-Lavin, T; Boulesteix, C; Lehmann, G; Debey, P; Beaujean, N				Salvaing, Juliette; Aguirre-Lavin, Tiphaine; Boulesteix, Claire; Lehmann, Gaetan; Debey, Pascale; Beaujean, Nathalie			5-Methylcytosine and 5-Hydroxymethylcytosine Spatiotemporal Profiles in the Mouse Zygote	PLOS ONE			English	Article							DNA METHYLATION; PATERNAL GENOME; TRANSCRIPTIONAL ACTIVITY; ACTIVE DEMETHYLATION; TET PROTEINS; EMBRYOS; REPLICATION; MAINTENANCE; PATTERNS; FERTILIZATION	Background: In the mouse zygote, DNA methylation patterns are heavily modified, and differ between the maternal and paternal pronucleus. Demethylation of the paternal genome has been described as an active and replication-independent process, although the mechanisms responsible for it remain elusive. Recently, 5-hydroxymethylcytosine has been suggested as an intermediate in this demethylation. Methodology/Principal Findings: In this study, we quantified DNA methylation and hydroxymethylation in both pronuclei of the mouse zygote during the replication period and we examined their patterns on the pericentric heterochromatin using 3D immuno-FISH. Our results demonstrate that 5-methylcytosine and 5-hydroxymethylcytosine localizations on the pericentric sequences are not complementary; indeed we observe no enrichment of either marks on some regions and an enrichment of both on others. In addition, we show that DNA demethylation continues during DNA replication, and is inhibited by aphidicolin. Finally, we observe notable differences in the kinetics of demethylation and hydroxymethylation; in particular, a peak of 5-hydroxymethylcytosine, unrelated to any change in 5-methylcytosine level, is observed after completion of replication. Conclusions/Significance: Together our results support the already proposed hypothesis that 5-hydroxymethylcytosine is not a simple intermediate in an active demethylation process and could play a role of its own during early development.	[Salvaing, Juliette; Aguirre-Lavin, Tiphaine; Boulesteix, Claire; Lehmann, Gaetan; Debey, Pascale; Beaujean, Nathalie] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Salvaing, Juliette; Aguirre-Lavin, Tiphaine; Boulesteix, Claire; Lehmann, Gaetan; Debey, Pascale; Beaujean, Nathalie] ENVA, Maisons Alfort, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA)	Salvaing, J (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	juliette.salvaing@jouy.inra.fr	Beaujean, Nathalie/C-9883-2011	Beaujean, Nathalie/0000-0003-0188-9190	INRA (Institut National de la Recherche Agronomique) "Young Team" research grant; Region Ile-de-France	INRA (Institut National de la Recherche Agronomique) "Young Team" research grant; Region Ile-de-France(Region Ile-de-France)	This work was supported by an INRA (Institut National de la Recherche Agronomique) "Young Team" research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to members of Unite Experimentale d'Infectiologie Experimentale des Rongeurs et Poissons (UEIERP) in charge of the mice. The authors wish to thank Justine Auge and Anne Jeandin for their help in initiating this study. They also thank the MIMA2 facility for access to confocal and ApoTome microscopes and the Region Ile-de-France for funding this last system.	Adenot P, 2011, EPIGENETICS OFFICIAL, V6, P1; Adenot PG, 1997, DEVELOPMENT, V124, P4615; [Anonymous], 2010, R LANG ENV STAT COMP; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; Corry GN, 2009, BIRTH DEFECTS RES C, V87, P297, DOI 10.1002/bdrc.20165; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jeanblanc M, 2008, GYNECOL OBSTET FERTI, V36, P1126, DOI 10.1016/j.gyobfe.2008.07.015; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maalouf WE, 2010, METHODS MOL BIOL, V659, P401, DOI 10.1007/978-1-60761-789-1_31; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Nestor CE, 2011, GENOME RES; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Park JS, 2007, DEV DYNAM, V236, P2523, DOI 10.1002/dvdy.21278; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Romanova L, 2006, BIOL REPROD, V74, P807, DOI 10.1095/biolreprod.105.047340; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046; Zaitseva I, 2007, MOL REPROD DEV, V74, P1255, DOI 10.1002/mrd.20704	49	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38156	10.1371/journal.pone.0038156	http://dx.doi.org/10.1371/journal.pone.0038156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693592	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500096
J	Turpin, W; Humblot, C; Noordine, ML; Thomas, M; Guyot, JP				Turpin, Williams; Humblot, Christele; Noordine, Marie-Louise; Thomas, Muriel; Guyot, Jean-Pierre			Lactobacillaceae and Cell Adhesion: Genomic and Functional Screening	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; INTESTINAL EPITHELIAL-CELLS; ESCHERICHIA-COLI; GENE-EXPRESSION; IN-VITRO; STRESS TOLERANCE; MUC2 MUCIN; PROTEINS; PLANTARUM; SURFACE	The analysis of collections of lactic acid bacteria (LAB) from traditional fermented plant foods in tropical countries may enable the detection of LAB with interesting properties. Binding capacity is often the main criterion used to investigate the probiotic characteristics of bacteria. In this study, we focused on a collection of 163 Lactobacillaceace comprising 156 bacteria isolated from traditional amylaceous fermented foods and seven strains taken from a collection and used as controls. The collection had a series of analyses to assess binding potential for the selection of new probiotic candidates. The presence/absence of 14 genes involved in binding to the gastrointestinal tract was assessed. This enabled the detection of all the housekeeping genes (ef-Tu, eno, gap, groEl and srtA) in the entire collection, of some of the other genes (apf, cnb, fpbA, mapA, mub) in 86% to 100% of LAB, and of the other genes (cbsA, gtf, msa, slpA) in 0% to 8% of LAB. Most of the bacteria isolated from traditional fermented foods exhibited a genetic profile favorable for their binding to the gastrointestinal tract. We selected 30 strains with different genetic profiles to test their binding ability to non-mucus (HT29) and mucus secreting (HT29-MTX) cell lines as well as their ability to degrade mucus. Assays on both lines revealed high variability in binding properties among the LAB, depending on the cell model used. Finally, we investigated if their binding ability was linked to tighter cross-talk between bacteria and eukaryotic cells by measuring the expression of bacterial genes and of the eukaryotic MUC2 gene. Results showed that wild LAB from tropical amylaceous fermented food had a much higher binding capacity than the two LAB currently known to be probiotics. However their adhesion was not linked to any particular genetic equipment.	[Turpin, Williams; Humblot, Christele; Guyot, Jean-Pierre] IRD, UMR Nutripass, IRD Montpellier2 Montpellier1, Montpellier, France; [Noordine, Marie-Louise; Thomas, Muriel] INRA, Commensal & Probiot Host Interact Team, UMR1319, Jouy En Josas, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Turpin, W (corresponding author), IRD, UMR Nutripass, IRD Montpellier2 Montpellier1, Montpellier, France.	Christele.Humblot@ird.fr	Humblot, Christèle/A-7932-2008; Williams, Turpin/H-3255-2019; thomas, muriel/HDO-3887-2022	Humblot, Christèle/0000-0002-9797-1625; Williams, Turpin/0000-0001-9364-5868; 	French Ministry of Education and Research	French Ministry of Education and Research	Williams Turpin acknowledges a PhD grant from the French Ministry of Education and Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati V, 1998, J APPL MICROBIOL, V85, P512, DOI 10.1046/j.1365-2672.1998.853527.x; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Castaldo C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-14; Chagnaud P, 2001, J MICROBIOL METH, V44, P139, DOI 10.1016/S0167-7012(00)00244-X; Champomier-Verges MC, 2001, RES MICROBIOL, V152, P839, DOI 10.1016/S0923-2508(01)01267-0; Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Fakhry S, 2009, RES MICROBIOL, V160, P817, DOI 10.1016/j.resmic.2009.09.009; de Palencia PF, 2009, APPL ENVIRON MICROB, V75, P4887, DOI 10.1128/AEM.00394-09; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Giraud E, 1991, APPL MICROBIOL BIOTE, P36; Goh YJ, 2010, APPL ENVIRON MICROB, V76, P5005, DOI 10.1128/AEM.00030-10; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Hinton JCD, 2004, CURR OPIN MICROBIOL, V7, P277, DOI 10.1016/j.mib.2004.04.009; Hufner E, 2008, SYST APPL MICROBIOL, V31, P323, DOI 10.1016/j.syapm.2008.06.005; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Izquierdo E, 2009, ELECTROPHORESIS, V30, P949, DOI 10.1002/elps.200800399; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; KERNEIS S, 1994, GUT, V35, P1449, DOI 10.1136/gut.35.10.1449; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; Kim Y, 2009, INT J FOOD MICROBIOL, V131, P224, DOI 10.1016/j.ijfoodmicro.2009.03.002; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kravtsov EG, 2008, B EXP BIOL MED+, V145, P232, DOI 10.1007/s10517-008-0058-x; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13665, DOI 10.1074/jbc.270.23.13665; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Ljungh A, 2009, LACTOBACILLUS MOL BI; Luquet FM, 2005, BACTERIES LACTIQUES; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Michail S, 2002, J PEDIATR GASTR NUTR, V35, P350, DOI 10.1097/00005176-200209000-00021; Miyoshi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1622, DOI 10.1271/bbb.50688; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Morlon-Guyot J, 1998, INT J SYST BACTERIOL, V48, P1101, DOI 10.1099/00207713-48-4-1101; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; O'Flaherty SJ, 2010, MICROBIOL-SGM, V156, P3360, DOI 10.1099/mic.0.043158-0; Pfeiler EA, 2009, APPL ENVIRON MICROB, V75, P6013, DOI 10.1128/AEM.00495-09; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Rozen S, 2000, Methods Mol Biol, V132, P365; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez B, 2011, APPL ENVIRON MICROB, V77, P1123, DOI 10.1128/AEM.02080-10; Sanchez B, 2010, J MICROBIOL BIOTECHN, V20, P978, DOI 10.4014/jmb.0911.11007; Smeianov VV, 2007, APPL ENVIRON MICROB, V73, P2661, DOI 10.1128/AEM.00005-07; Subramani DB, 2010, BENEF MICROBES, V1, P343, DOI 10.3920/BM2010.0039; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOBA T, 1995, APPL ENVIRON MICROB, V61, P2467, DOI 10.1128/AEM.61.7.2467-2471.1995; Turpin W, 2011, APPL ENVIRON MICROB, V77, P8722, DOI 10.1128/AEM.05988-11; Turpin W, 2010, INT J FOOD MICROBIOL, V143, P87, DOI 10.1016/j.ijfoodmicro.2010.07.032; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; VANKLINKEN BJW, 1995, AM J PHYSIOL-GASTR L, V269, pG613, DOI 10.1152/ajpgi.1995.269.5.G613; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; Vieira MAM, 2010, INFECT IMMUN, V78, P927, DOI 10.1128/IAI.01115-09; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Watanabe M, 2010, J APPL MICROBIOL, V109, P927, DOI 10.1111/j.1365-2672.2010.04719.x; Yasuda E, 2011, APPL ENVIRON MICROB, V77, P4539, DOI 10.1128/AEM.00240-11; Zago M, 2011, FOOD MICROBIOL, V28, P1033, DOI 10.1016/j.fm.2011.02.009; Zhou JS, 2001, INT J FOOD MICROBIOL, V63, P81, DOI 10.1016/S0168-1605(00)00398-6	76	71	72	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38034	10.1371/journal.pone.0038034	http://dx.doi.org/10.1371/journal.pone.0038034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675431	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500078
J	Quinlan, CL; Orr, AL; Perevoshchikova, IV; Treberg, JR; Ackrell, BA; Brand, MD				Quinlan, Casey L.; Orr, Adam L.; Perevoshchikova, Irina V.; Treberg, Jason R.; Ackrell, Brian A.; Brand, Martin D.			Mitochondrial Complex II Can Generate Reactive Oxygen Species at High Rates in Both the Forward and Reverse Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE PRODUCTION; SUCCINATE-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; ELECTRON-TRANSPORT CHAIN; SUPEROXIDE-PRODUCTION; ESCHERICHIA-COLI; DROSOPHILA MITOCHONDRIA; FUMARATE REDUCTASE; RESPIRATORY-CHAIN; INNER MEMBRANE	Respiratory complex II oxidizes succinate to fumarate as part of the Krebs cycle and reduces ubiquinone in the electron transport chain. Previous experimental evidence suggested that complex II is not a significant contributor to the production of reactive oxygen species (ROS) in isolated mitochondria or intact cells unless mutated. However, we find that when complex I and complex III are inhibited and succinate concentration is low, complex II in rat skeletal muscle mitochondria can generate superoxide or H2O2 at high rates. These rates approach or exceed the maximum rates achieved by complex I or complex III. Complex II generates these ROS in both the forward reaction, with electrons supplied by succinate, and the reverse reaction, with electrons supplied from the reduced ubiquinone pool. ROS production in the reverse reaction is prevented by inhibition of complex II at either the ubiquinone-binding site (by atpenin A5) or the flavin (by malonate), whereas ROS production in the forward reaction is prevented by malonate but not by atpenin A5, showing that the ROS from complex II arises only from the flavin site (site IIF). We propose a mechanism for ROS production by complex II that relies upon the occupancy of the substrate oxidation site and the reduction state of the enzyme. We suggest that complex II may be an important contributor to physiological and pathological ROS production.	[Quinlan, Casey L.; Orr, Adam L.; Perevoshchikova, Irina V.; Ackrell, Brian A.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA; [Treberg, Jason R.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada; [Treberg, Jason R.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB R3T 2N2, Canada	Buck Institute for Research on Aging; University of Manitoba; University of Manitoba	Quinlan, CL (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	cquinlan@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [R01 AG033542, P01 AG025901, PL1 AG032118, TL1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; Canada Research Chairs Program; NATIONAL INSTITUTE ON AGING [R01AG033542, PL1AG032118, TL1AG032116, P01AG025901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Canada Research Chairs Program(Canada Research Chairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG033542, P01 AG025901, PL1 AG032118, and TL1 AG032116 and by The Ellison Medical Foundation, Grant AG-SS-2288-09.; Supported by the Canada Research Chairs Program.	Ackrell B A, 1978, Methods Enzymol, V53, P466; ACKRELL BAC, 1975, J BIOL CHEM, V250, P7114; Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; BELIKOVA YO, 1988, BIOCHIM BIOPHYS ACTA, V936, P1, DOI 10.1016/0005-2728(88)90245-9; BONOMI F, 1983, EUR J BIOCHEM, V134, P439, DOI 10.1111/j.1432-1033.1983.tb07586.x; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bunik VI, 2002, EUR J BIOCHEM, V269, P5004, DOI 10.1046/j.1432-1033.2002.03204.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Drahota Z, 2002, J BIOENERG BIOMEMBR, V34, P105, DOI 10.1023/A:1015123908918; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; GUTMAN, 1971, BIOCHEMISTRY-US, V10, P4763, DOI 10.1021/bi00801a025; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hirst J, 1996, J AM CHEM SOC, V118, P5031, DOI 10.1021/ja9534361; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Ishii T, 2005, CANCER RES, V65, P203; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MERLI A, 1979, BIOCHEMISTRY-US, V18, P1393, DOI 10.1021/bi00575a001; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MOWERY PC, 1977, ARCH BIOCHEM BIOPHYS, V178, P495, DOI 10.1016/0003-9861(77)90220-X; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; Paranagama MP, 2010, MITOCHONDRION, V10, P158, DOI 10.1016/j.mito.2009.12.145; Quinlan C. L., 2011, HDB BIOL AGING, P45; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; RAMSAY RR, 1981, P NATL ACAD SCI-BIOL, V78, P825, DOI 10.1073/pnas.78.2.825; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; YU L, 1987, J BIOL CHEM, V262, P1137; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhao ZW, 2006, BIOCHEM CELL BIOL, V84, P1013, DOI 10.1139/O06-188	51	436	446	16	131	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27255	27264		10.1074/jbc.M112.374629	http://dx.doi.org/10.1074/jbc.M112.374629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689576	hybrid, Green Published			2022-12-25	WOS:000307386000077
J	Sengerova, B; Allerston, CK; Abu, M; Lee, SY; Hartley, J; Kiakos, K; Schofield, CJ; Hartley, JA; Gileadi, O; McHugh, PJ				Sengerova, Blanka; Allerston, Charles K.; Abu, Mika; Lee, Sook Y.; Hartley, Janet; Kiakos, Konstantinos; Schofield, Christopher J.; Hartley, John A.; Gileadi, Opher; McHugh, Peter J.			Characterization of the Human SNM1A and SNM1B/Apollo DNA Repair Exonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; FANCONI-ANEMIA PATHWAY; STRUCTURE-SPECIFIC ENDONUCLEASE; STRUCTURE-SPECIFIC NUCLEASES; IONIZING-RADIATION; S-PHASE; REPLICATION; PROTEIN; POLYMERASE; TELOMERES	Human SNM1A and SNM1B/Apollo have both been implicated in the repair of DNA interstrand cross-links (ICLs) by cellular studies, and SNM1B is also required for telomere protection. Here, we describe studies on the biochemical characterization of the SNM1A and SNM1B proteins. The results reveal some fundamental differences in the mechanisms of the two proteins. Both SNM1A and SNM1B digest double-stranded and single-stranded DNA with a 5'-to-3' directionality in a reaction that is stimulated by divalent cations, and both nucleases are inhibited by the zinc chelator o-phenanthroline. We find that SNM1A has greater affinity for single-stranded DNA over double-stranded DNA that is not observed with SNM1B. Although both proteins demonstrate a low level of processivity on low molecular weight DNA oligonucleotide substrates, when presented with high molecular weight DNA, SNM1A alone is rendered much more active, being capable of digesting kilobase-long stretches of DNA. Both proteins can digest past ICLs induced by the non-distorting minor groove cross-linking agent SJG-136, albeit with SNM1A showing a greater capacity to achieve this. This is consistent with the proposal that SNM1A and SNM1B might exhibit some redundancy in ICL repair. Together, our work establishes differences in the substrate selectivities of SNM1A and SNM1B that are likely to be relevant to their in vivo roles and which might be exploited in the development of selective inhibitors.	[Sengerova, Blanka; Abu, Mika; Lee, Sook Y.; McHugh, Peter J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England; [Allerston, Charles K.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Hartley, Janet; Kiakos, Konstantinos; Hartley, John A.] UCL, UCL Canc Inst, Canc Res UK Drug DNA Interact Res Grp, London WC1E 6BT, England; [Lee, Sook Y.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford; University of Oxford; Cancer Research UK; University of London; University College London; University of Oxford	McHugh, PJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England.	peter.mchugh@imm.ox.ac.uk	Hartley, John/GRY-6691-2022; Collis, Blanka/ABB-6858-2020; Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X; Schofield, Christopher/0000-0002-0290-6565; McHugh, Peter/0000-0002-8679-4627	Cancer Research UK Programme Grant; National Science Scholarship (Ph.D.) from Singaporean Agency for Science, Technology, and Research (A*STAR); Cancer Research UK [9994] Funding Source: researchfish	Cancer Research UK Programme Grant(Cancer Research UK); National Science Scholarship (Ph.D.) from Singaporean Agency for Science, Technology, and Research (A*STAR); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK Programme Grant to PMcH.; Funded by a National Science Scholarship (Ph.D.) from the Singaporean Agency for Science, Technology, and Research (A*STAR).	Akhter S, 2010, AGING CELL, V9, P1047, DOI 10.1111/j.1474-9726.2010.00631.x; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Biggins John B., 2006, V335, P83; Bonatto D, 2005, PROTEIN J, V24, P399, DOI 10.1007/s10930-005-7594-2; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; de Villartay JP, 2009, DNA REPAIR, V8, P202, DOI 10.1016/j.dnarep.2008.10.010; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Dorjsuren D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1082; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Elisseeva E, 1999, J BIOL CHEM, V274, P25151, DOI 10.1074/jbc.274.35.25151; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Freibaum BD, 2006, J BIOL CHEM, V281, P15033, DOI 10.1074/jbc.C600038200; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; HENRIQUES JAP, 1980, GENETICS, V95, P273; Herbette Stephane, 2010, Plant Physiol, V153, P1932, DOI 10.1104/pp.110.155200; Hutton RD, 2010, NUCLEIC ACIDS RES, V38, P1664, DOI 10.1093/nar/gkp1104; Hutton RD, 2008, NUCLEIC ACIDS RES, V36, P6720, DOI 10.1093/nar/gkn745; Jose TJ, 1999, J BIOL INORG CHEM, V4, P814, DOI 10.1007/s007750050355; Kiakos K, 2010, METHODS MOL BIOL, V613, P283, DOI 10.1007/978-1-60327-418-0_18; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kumari A, 2008, J BIOL CHEM, V283, P27433, DOI 10.1074/jbc.M801237200; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee G, 2011, NAT CHEM BIOL, V7, P367, DOI [10.1038/NCHEMBIO.561, 10.1038/nchembio.561]; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Li XR, 2005, DNA REPAIR, V4, P163, DOI 10.1016/j.dnarep.2004.08.012; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Mason JM, 2011, HUM MOL GENET, V20, P2549, DOI 10.1093/hmg/ddr153; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; RUHLAND A, 1981, MUTAT RES, V91, P457, DOI 10.1016/0165-7992(81)90052-X; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; SLATER JP, 1971, BIOCHEM BIOPH RES CO, V44, P37, DOI 10.1016/S0006-291X(71)80155-9; Spanswick VJ, 2002, BLOOD, V100, P224, DOI 10.1182/blood.V100.1.224; Ho TV, 2011, NUCLEIC ACIDS RES, V39, P7455, DOI 10.1093/nar/gkr448; Tiefenbach T, 2012, NUCLEIC ACIDS RES, V40, P2131, DOI 10.1093/nar/gkr1059; Touzot F, 2010, P NATL ACAD SCI USA, V107, P10097, DOI 10.1073/pnas.0914918107; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; WILLIAMS RO, 1973, J CELL BIOL, V58, P594, DOI 10.1083/jcb.58.3.594; Wu P, 2010, MOL CELL, V39, P606, DOI 10.1016/j.molcel.2010.06.031; Yang Chaoyong James, 2006, V335, P71; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032	62	32	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26254	26267		10.1074/jbc.M112.367243	http://dx.doi.org/10.1074/jbc.M112.367243			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692201	Green Published, hybrid			2022-12-25	WOS:000306916300052
J	Hacker, K; Choi, YS; Trebino, L; Hicks, L; Friedman, E; Blanchfield, B; Gazelle, GS				Hacker, Karen; Choi, Yoon Susan; Trebino, Lisa; Hicks, LeRoi; Friedman, Elisa; Blanchfield, Bonnie; Gazelle, G. Scott			Exploring the Impact of Language Services on Utilization and Clinical Outcomes for Diabetics	PLOS ONE			English	Article							LIMITED ENGLISH PROFICIENCY; HEALTH-CARE QUALITY; MEDICAL INTERPRETATION; INTERPRETER SERVICES; CONCORDANCE; SPEAKING; SATISFACTION; DISPARITIES; MANAGEMENT; BARRIERS	Background: Significant health disparities exist between limited English proficient and English-proficient patients. Little is known about the impact of language services on chronic disease outcomes such as for diabetes. Methods/Principal Findings: To determine whether the amount and type of language services received during primary care visits had an impact on diabetes-related outcomes (hospitalization, emergency room utilization, glycemic control) in limited English proficient patients, a retrospective cohort design was utilized. Hospital and medical record data was examined for 1425 limited English proficient patients in the Cambridge Health Alliance diabetes registry. We categorized patients receiving usual care into 7 groups based on the amount and combination of language services (language concordant providers, formal interpretation and nothing) received at primary care visits during a 9 month period. Bivariate analyses and multiple logistic regression were used to determine relationships between language service categories and outcomes in the subsequent 6 months. Thirty-one percent of patients (445) had no documentation of interpreter use or seeing a language concordant provider in any visits. Patients who received 100% of their primary care visits with language concordant providers were least likely to have diabetes-related emergency department visits compared to other groups (p<0001) in the following 6 months. Patients with higher numbers of co-morbidities were more likely to receive formal interpretation. Conclusions/Significance: Language concordant providers may help reduce health care utilization for limited English proficient patients with diabetes. However, given the lack of such providers in sufficient numbers to meet patients' communication needs, strategies are needed to both increase their numbers and ensure that the highest risk patients receive the most appropriate language services. In addition, systems serving diverse populations must clarify why some limited English proficient patients do not receive language services at some or all of their visits and whether this has an impact on quality of care.	[Hacker, Karen; Choi, Yoon Susan; Trebino, Lisa; Friedman, Elisa] Cambridge Hlth Alliance, Inst Community Hlth, Cambridge, MA USA; [Hacker, Karen; Gazelle, G. Scott] Harvard Univ, Sch Med, Boston, MA USA; [Hicks, LeRoi] Univ Massachusetts, Sch Med, Umass Mem Hlth Care, Worcester, MA USA; [Blanchfield, Bonnie; Gazelle, G. Scott] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital	Hacker, K (corresponding author), Cambridge Hlth Alliance, Inst Community Hlth, Cambridge, MA USA.	Khacker@challiance.org			Robert Wood Johnson Foundation [55881]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was funded in part by a grant from the Robert Wood Johnson Foundation Grant #55881 Cost Effectiveness of Language Services. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality (AHRQ), 2005, REC START SET AMB CA; Association IMI, 2007, MED INT STAND PRACT; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Bernstein Judith, 2002, J Immigr Health, V4, P171, DOI 10.1023/A:1020125425820; Carrasquillo O, 1999, J GEN INTERN MED, V14, P82, DOI 10.1046/j.1525-1497.1999.00293.x; CHA, 2009, PAT DEM REP; Crossman KL, 2010, PEDIATRICS, V125, pE631, DOI 10.1542/peds.2009-0769; Dang J, 2010, J CANCER EDUC, V25, P253, DOI 10.1007/s13187-010-0074-1; DuBard CA, 2008, AM J PUBLIC HEALTH, V98, P2021, DOI 10.2105/AJPH.2007.119008; Eamranond PP, 2009, J IMMIGR MINOR HEALT, V11, P494, DOI 10.1007/s10903-008-9222-7; Egede LE, 2004, DIABETES CARE, V27, P1748, DOI 10.2337/diacare.27.7.1748; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ferguson WJ, 2008, HEALTH AFFAIR, V27, P1695, DOI 10.1377/hlthaff.27.6.1695; Fernandez A, 2011, J GEN INTERN MED, V26, P170, DOI 10.1007/s11606-010-1507-6; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Flores G, 2003, PEDIATRICS, V111, P6, DOI 10.1542/peds.111.1.6; Flores G, 2003, ERRORS MED INTERPRET; Gany F, 2007, J GEN INTERN MED, V22, P319, DOI 10.1007/s11606-007-0361-7; Gentile NT, 2008, ETHNIC DIS, V18, P330; Gonzalez HM, 2010, J AM BOARD FAM MED, V23, P745, DOI 10.3122/jabfm.2010.06.090264; Green AR, 2005, J GEN INTERN MED, V20, P1050, DOI 10.1111/j.1525-1497.2005.0223.x; Hampers LC, 1999, PEDIATRICS, V103, P1253, DOI 10.1542/peds.103.6.1253; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Jacobs E, 2006, MILBANK Q, V84, P111, DOI 10.1111/j.1468-0009.2006.00440.x; Jacobs EA, 2005, AM J PUBLIC HEALTH, V95, P1410, DOI 10.2105/AJPH.2004.041418; Jacobs EA, 2001, J GEN INTERN MED, V16, P468, DOI 10.1046/j.1525-1497.2001.016007468.x; John-Baptiste A, 2004, J GEN INTERN MED, V19, P221, DOI 10.1111/j.1525-1497.2004.21205.x; Karliner LS, 2008, J GEN INTERN MED, V23, P1555, DOI 10.1007/s11606-008-0693-y; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Lasater LM, 2001, ARCH INTERN MED, V161, P77, DOI 10.1001/archinte.161.1.77; Lerman I, 2004, BIOMED PHARMACOTHER, V58, P566, DOI 10.1016/j.biopha.2004.09.003; Lopez-Quintero C, 2010, J AM DIET ASSOC, V110, pS62, DOI 10.1016/j.jada.2010.03.009; MANSON A, 1988, MED CARE, V26, P1119, DOI 10.1097/00005650-198812000-00003; Moreno G, 2010, J GEN INTERN MED, V25, P1282, DOI 10.1007/s11606-010-1467-x; Nam S, 2011, DIABETES RES CLIN PR; Ngo-Metzger Q, 2007, J GEN INTERN MED, V22, P324, DOI 10.1007/s11606-007-0340-z; Parchman ML, 2009, PATIENT EDUC COUNS, V77, P55, DOI 10.1016/j.pec.2009.03.006; Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005; Pippins JR, 2007, MED CARE, V45, P1020, DOI 10.1097/MLR.0b013e31814847be; Robinson S, 2009, POPUL HEALTH MANAG, V12, P139, DOI 10.1089/pop.2008.0026; Rogers AJ, 2004, AM J EMERG MED, V22, P534, DOI 10.1016/j.ajem.2004.08.012; Schenker Y, 2010, PATIENT EDUC COUNS, V81, P222, DOI 10.1016/j.pec.2010.02.005; Sequist TD, 2008, J GEN INTERN MED, V23, P678, DOI 10.1007/s11606-008-0510-7; Tocher TM, 1998, WESTERN J MED, V168, P504; Tomlin AM, 2006, DIABETES RES CLIN PR, V73, P260, DOI 10.1016/j.diabres.2006.01.008; Traylor AH, 2010, J GEN INTERN MED, V25, P1172, DOI 10.1007/s11606-010-1424-8; Vargas RB, 2004, J HEALTH CARE POOR U, V15, P562, DOI 10.1353/hpu.2004.0074; Wilson E, 2005, J GEN INTERN MED, V20, P800, DOI 10.1111/j.1525-1497.2005.0174.x; Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155	49	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38507	10.1371/journal.pone.0038507	http://dx.doi.org/10.1371/journal.pone.0038507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675571	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700083
J	Lahey, T; Ghosh, M; Fahey, JV; Shen, Z; Mukura, LR; Song, Y; Cu-Uvin, S; Mayer, KH; Wright, PF; Kappes, JC; Ochsenbauer, C; Wira, CR				Lahey, Timothy; Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Mukura, Lucy R.; Song, Yan; Cu-Uvin, Susan; Mayer, Kenneth H.; Wright, Peter F.; Kappes, John C.; Ochsenbauer, Christina; Wira, Charles R.			Selective Impact of HIV Disease Progression on the Innate Immune System in the Human Female Reproductive Tract	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LEUKOCYTE PROTEASE INHIBITOR; UTERINE EPITHELIAL-CELLS; HETEROSEXUAL TRANSMISSION; ACTIVATION MARKERS; T-CELLS; IDENTIFICATION; ELAFIN; SUSCEPTIBILITY; PROTECTION	Background: We have previously demonstrated intrinsic anti-HIV activity in cervicovaginal lavage (CVL) from HIV-infected women with high CD4 counts and not on antiretroviral therapy. However, the impact of HIV disease progression on CVL innate immune responses has not been delineated. Methods: CVL from 57 HIV-infected women not on antiretroviral therapy were collected by washing the cervicovaginal area with 10 mu l of sterile normal saline. We characterized subject HIV disease progression by CD4 count strata: >500 cells/mu l, 200-500 cells/mu l, or <200 cells/mu l of blood. To assess CVL anti-HIV activity, we incubated TZM-bl cells with HIV plus or minus CVL. Antimicrobials, cytokines, chemokines and anti-gp160 HIV IgG antibodies were measured by ELISA and Luminex. Results: CVL exhibited broad anti-HIV activity against multiple laboratory-adapted and transmitted/founder (T/F) viruses, with anti-HIV activity ranging from 0 to 100% showing wide variation between viral strains. Although there was broad CVL inhibition of most both laboratory-adapted and T/F virus strains, there was practically no inhibition of T/F strain RHPA.c, which was isolated from a woman newly infected via heterosexual intercourse. HIV disease progression, measured by declining CD4 T cell counts, resulted in a selective reduction in intrinsic anti-HIV activity in CVL that paralleled CVL decreases in human beta-defensin 2 and increases in Elafin and secretory leukocyte protease inhibitor. HIV disease progress predicted decreased CVL anti-HIV activity against both laboratory-adapted and T/F strains of HIV. Anti-HIV activity exhibited close associations with CVL levels of fourteen cytokines and chemokines. Conclusions: Amid a multifaceted immune defense against HIV-1 and other sexually transmitted pathogens, HIV disease progression is associated with selective disturbances in both CVL anti-HIV activity and specific innate immune defenses in the human female reproductive tract (FRT). Overall, these studies indicate that innate immune protection in the FRT is compromised as women progress to AIDS.	[Lahey, Timothy] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Mukura, Lucy R.; Song, Yan; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [Cu-Uvin, Susan; Mayer, Kenneth H.] Brown Univ, Dept Obstet & Gynecol & Med, Alpert Sch Med, Providence, RI 02912 USA; [Wright, Peter F.] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA; [Kappes, John C.; Ochsenbauer, Christina] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Dartmouth College; Dartmouth College; Brown University; Dartmouth College; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lahey, T (corresponding author), Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA.	Timothy.Lahey@Dartmouth.edu			National Institutes of Health (NIH) Grants Allergy and Infectious Diseases [AI51877, AI13541, AI40350, AI066884]; NIH Center for HIV/AIDS Vaccine Immunology [U01-AI067854]; Lifespan/Tufts/Brown Centers for AIDS Research (CFAR) [P30AI42853]; Centers for Disease Control [106795]; Virology and Nucleotide Sequencing Cores of the University of Alabama at Birmingham CFAR, NIH [P30-AI27767]; National Center for Research Resources, Centers for Biomedical Research Excellence [5P20RR016437-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040350, K24AI066884, R01AI102838, R01AI013541, U01AI067854, P30AI027767, R37AI013541, P30AI042853, R55AI013541, R21AI040350] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grants Allergy and Infectious Diseases; NIH Center for HIV/AIDS Vaccine Immunology; Lifespan/Tufts/Brown Centers for AIDS Research (CFAR); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Virology and Nucleotide Sequencing Cores of the University of Alabama at Birmingham CFAR, NIH; National Center for Research Resources, Centers for Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants Allergy and Infectious Diseases AI51877 and AI13541 (CRW), AI40350 and AI066884, (SCU), NIH Center for HIV/AIDS Vaccine Immunology U01-AI067854 (JCK and CO); Lifespan/Tufts/Brown Centers for AIDS Research (CFAR) P30AI42853, Centers for Disease Control 106795 (SCU and KHM) and the Virology and Nucleotide Sequencing Cores of the University of Alabama at Birmingham CFAR (P30-AI27767) NIH, National Center for Research Resources, Centers for Biomedical Research Excellence 5P20RR016437-08 (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Blaak H, 1998, J VIROL, V72, P218, DOI 10.1128/JVI.72.1.218-224.1998; Cohen MS, N ENGL J MED, V365, P493; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; FUCHS D, 1990, IMMUNOL LETT, V26, P75, DOI 10.1016/0165-2478(90)90178-S; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Ishikawa C, 2010, J INNATE IMMUN, V2, P66, DOI 10.1159/000242114; Joint United Nations Program on HIV/AIDS (UNAIDS) and World Health Organization (WHO), 2007, AIDS EP UPD; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; King AE, 2003, BIOCHEM BIOPH RES CO, V310, P594, DOI 10.1016/j.bbrc.2003.08.151; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; King Anne E, 2003, Reprod Biol Endocrinol, V1, P116, DOI 10.1186/1477-7827-1-116; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montefiori DC, 2010, PROTOCOL NEUTRALIZIN; Ochsenbauer C, 2011, J VIROL; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; PITCHENIK AE, 1983, ANN INTERN MED, V98, P277, DOI 10.7326/0003-4819-98-3-277; Pitt J, 1998, J ACQ IMMUN DEF SYND, V19, P462, DOI 10.1097/00042560-199812150-00004; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Seth N, 2005, J IMMUNOL, V175, P6948, DOI 10.4049/jimmunol.175.10.6948; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Tuomala RE, 2003, J INFECT DIS, V187, P375, DOI 10.1086/367706; Uvin SC, 1997, OBSTET GYNECOL, V90, P739, DOI 10.1016/S0029-7844(97)00411-0; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yeaman GR, 1998, AIDS RES HUM RETROV, V14, pS57	47	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38100	10.1371/journal.pone.0038100	http://dx.doi.org/10.1371/journal.pone.0038100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675510	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341700037
J	Parnell, SC; Puri, S; Wallace, DP; Calvet, JP				Parnell, Stephen C.; Puri, Sanjeev; Wallace, Darren P.; Calvet, James P.			Protein Phosphatase-1 alpha Interacts with and Dephosphorylates Polycystin-1	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; KIDNEY-DISEASE; STRUCTURAL BASIS; PKD1 GENE; IN-VITRO; 3' REGION; PHOSPHORYLATION; MUTATIONS; KINASE; DOMAIN	Polycystin signaling is likely to be regulated by phosphorylation. While a number of potential protein kinases and their target phosphorylation sites on polycystin-1 have been identified, the corresponding phosphatases have not been extensively studied. We have now determined that polycystin-1 is a regulatory subunit for protein phosphatase-1 alpha (PP1 alpha). Sequence analysis has revealed the presence of a highly conserved PP1-interaction motif in the cytosolic, C-terminal tail of polycystin-1; and we have shown that transfected PP1 alpha specifically co-immunoprecipitates with a polycystin-1 C-tail construct. To determine whether PP1 alpha dephosphorylates polycystin-1, a PKA-phosphorylated GST-polycystin-1 fusion protein was shown to be dephosphorylated by PP1 alpha but not by PP2B (calcineurin). Mutations within the PP1-binding motif of polycystin-1, including an autosomal dominant polycystic kidney disease (ADPKD)-associated mutation, significantly reduced PP1 alpha-mediated dephosphorylation of polycystin-1. The results suggest that polycystin-1 forms a holoenzyme complex with PP1 alpha via a conserved PP1-binding motif within the polycystin-1 C-tail, and that PKA-phosphorylated polycystin-1 serves as a substrate for the holoenzyme.	[Parnell, Stephen C.; Calvet, James P.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [Parnell, Stephen C.; Wallace, Darren P.; Calvet, James P.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Dept Biotechnol, Chandigarh 160014, India; [Wallace, Darren P.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Panjab University; University of Kansas; University of Kansas Medical Center	Parnell, SC (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	sparnell@kumc.edu; jcalvet@kumc.edu		Puri, Sanjeev/0000-0002-3967-987X; Puri, Sanjeev/0000-0002-4314-9871; Wallace, Darren/0000-0003-4616-7669	PKD Foundation [131a2f]; National Institutes of Health [P50 DK057301]; Pilot & Feasibility award [P50]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301] Funding Source: NIH RePORTER	PKD Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot & Feasibility award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by PKD Foundation (www.pkdcure.org) fellowship award 131a2f to Stephen Parnell, and by National Institutes of Health (www.nih.gov) Grant P50 DK057301 to James Calvet and a P50 Pilot & Feasibility award (SCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 1999, HUM GENET, V105, P648, DOI 10.1007/s004390051157; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Badenas C, 1999, KIDNEY INT, V55, P1225, DOI 10.1046/j.1523-1755.1999.00368.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Beullens M, 2002, J BIOL CHEM, V277, P19855, DOI 10.1074/jbc.M200847200; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E., 2012, FEBS J; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Li HP, 1999, BIOCHEM BIOPH RES CO, V259, P356, DOI 10.1006/bbrc.1999.0780; Liu J, 2000, J BIOL CHEM, V275, P26074, DOI 10.1074/jbc.M003843200; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Parnell SC, 1999, BIOCHEM BIOPH RES CO, V259, P539, DOI 10.1006/bbrc.1999.0810; Perrichot RA, 1999, HUM GENET, V105, P231, DOI 10.1007/s004390051094; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Reed B, 2008, AM J KIDNEY DIS, V52, P1042, DOI 10.1053/j.ajkd.2008.05.015; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Sutters M, 2001, KIDNEY INT, V60, P484, DOI 10.1046/j.1523-1755.2001.060002484.x; Tan YC, 2009, HUM MUTAT, V30, P264, DOI 10.1002/humu.20842; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200	50	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36798	10.1371/journal.pone.0036798	http://dx.doi.org/10.1371/journal.pone.0036798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675472	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700006
J	Wenzel, EM; Morton, A; Ebert, K; Welzel, O; Kornhuber, J; Cousin, MA; Groemer, TW				Wenzel, Eva M.; Morton, Andrew; Ebert, Katrin; Welzel, Oliver; Kornhuber, Johannes; Cousin, Michael A.; Groemer, Teja W.			Key Physiological Parameters Dictate Triggering of Activity-Dependent Bulk Endocytosis in Hippocampal Synapses	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; NERVE-TERMINALS; CHROMAFFIN CELLS; CLATHRIN; RELEASE; DYNAMIN; RETRIEVAL; MEMBRANE; POOLS; PHOSPHORYLATION	To maintain neurotransmission in central neurons, several mechanisms are employed to retrieve synaptically exocytosed membrane. The two major modes of synaptic vesicle (SV) retrieval are clathrin-mediated endocytosis and activity-dependent bulk endocytosis (ADBE). ADBE is the dominant SV retrieval mode during intense stimulation, however the precise physiological conditions that trigger this mode are not resolved. To determine these parameters we manipulated rat hippocampal neurons using a wide spectrum of stimuli by varying both the pattern and duration of stimulation. Using live-cell fluorescence imaging and electron microscopy approaches, we established that stimulation frequency, rather than the stimulation load, was critical in the triggering of ADBE. Thus two hundred action potentials, when delivered at high frequency, were sufficient to induce near maximal bulk formation. Furthermore we observed a strong correlation between SV pool size and ability to perform ADBE. We also identified that inhibitory nerve terminals were more likely to utilize ADBE and had a larger SV recycling pool. Thus ADBE in hippocampal synaptic terminals is tightly coupled to stimulation frequency and is more likely to occur in terminals with large SV pools. These results implicate ADBE as a key modulator of both hippocampal neurotransmission and plasticity.	[Wenzel, Eva M.; Ebert, Katrin; Welzel, Oliver; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Morton, Andrew; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Wenzel, Eva M.] Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway	University of Erlangen Nuremberg; University of Edinburgh; University of Oslo	Wenzel, EM (corresponding author), Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Norwegian Radium Hosp, Montebello, Norway.	eva.wenzel@rr-research.no	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Morton, Andrew/0000-0002-8180-542X; Cousin, Michael/0000-0002-1762-160X; Groemer, Teja/0000-0003-3854-716X; Wenzel, Eva Maria/0000-0002-5561-3344	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen [J5, E10]; Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN; Biotechnology and Biology Sciences Research Council; Wellcome Trust [084277]	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen; Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN; Biotechnology and Biology Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	TWG is supported by the Interdisciplinary Center of Clinical Research (IZKF) in Erlangen (Project J5 and E10). EMW was supported by a stipend from the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN. AM is supported by a Biotechnology and Biology Sciences Research Council studentship and work was supported by a Wellcome Trust award to MAC (084277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Cheung G, 2010, J NEUROSCI, V30, P8151, DOI 10.1523/JNEUROSCI.0293-10.2010; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Henkel AW, 2001, J CELL SCI, V114, P4613; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; LENCER WI, 1990, AM J PHYSIOL, V258, pC309, DOI 10.1152/ajpcell.1990.258.2.C309; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Paillart C, 2003, J NEUROSCI, V23, P4092; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Stroebel A, 2010, MICROSC RES TECHNIQ, V73, P1115, DOI 10.1002/jemt.20858; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Welzel O, 2011, BIOPHYS J, V100, P593, DOI 10.1016/j.bpj.2010.12.3706; Welzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013514; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005	43	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38188	10.1371/journal.pone.0038188	http://dx.doi.org/10.1371/journal.pone.0038188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675521	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700044
J	Corver, WE; Ruano, D; Weijers, K; den Hartog, WCE; van Nieuwenhuizen, MP; de Miranda, N; van Eijk, R; Middeldorp, A; Jordanova, ES; Oosting, J; Kapiteijn, E; Hovens, G; Smit, J; van Wezel, T; Morreau, H				Corver, Willem E.; Ruano, Dina; Weijers, Karin; den Hartog, Wietske C. E.; van Nieuwenhuizen, Merlijn P.; de Miranda, Noel; van Eijk, Ronald; Middeldorp, Anneke; Jordanova, Ekaterina S.; Oosting, Jan; Kapiteijn, Ellen; Hovens, Guido; Smit, Jan; van Wezel, Tom; Morreau, Hans			Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; RENAL-CELL CARCINOMAS; COMPLEX-I; PLOIDY ANALYSIS; FLOW-CYTOMETRY; COPY NUMBER; TUMORS; CANCER; BRAF; HYBRIDIZATION	Background: Recurrent non-medullary thyroid carcinoma (NMTC) is a rare disease. We initially characterized 27 recurrent NMTC: 13 papillary thyroid cancers (PTC), 10 oncocytic follicular carcinomas (FTC-OV), and 4 non-oncocytic follicular carcinomas (FTC). A validation cohort composed of benign and malignant (both recurrent and non-recurrent) thyroid tumours was subsequently analysed (n = 20). Methods: Data from genome-wide SNP arrays and flow cytometry were combined to determine the chromosomal dosage (allelic state) in these tumours, including mutation analysis of components of PIK3CA/AKT and MAPK pathways. Results: All FTC-OVs showed a very distinct pattern of genomic alterations. Ten out of 10 FTC-OV cases showed near-haploidisation with or without subsequent genome endoreduplication. Near-haploidisation was seen in 5/10 as extensive chromosome-wide monosomy (allelic state [A]) with near-haploid DNA indices and retention of especially chromosome 7 (seen as a heterozygous allelic state [AB]). In the remaining 5/10 chromosomal allelic states AA with near diploid DNA indices were seen with allelic state AABB of chromosome 7, suggesting endoreduplication after preceding haploidisation. The latter was supported by the presence of both near-haploid and endoreduplicated tumour fractions in some of the cases. Results were confirmed using FISH analysis. Relatively to FTC-OV limited numbers of genomic alterations were identified in other types of recurrent NMTC studied, except for chromosome 22q which showed alterations in 6 of 13 PTCs. Only two HRAS, but no mutations of EGFR or BRAF were found in FTC-OV. The validation cohort showed two additional tumours with the distinct pattern of genomic alterations (both with oncocytic features and recurrent). Conclusions: We demonstrate that recurrent FTC-OV is frequently characterised by genome-wide DNA haploidisation, heterozygous retention of chromosome 7, and endoreduplication of a near-haploid genome. Whether normal gene dosage on especially chromosome 7 (containing EGFR, BRAF, cMET) is crucial for FTC-OV tumour survival is an important topic for future research. Microarrays: Data are made available at GEO (GSE31828).	[Corver, Willem E.; Ruano, Dina; Weijers, Karin; den Hartog, Wietske C. E.; van Nieuwenhuizen, Merlijn P.; de Miranda, Noel; van Eijk, Ronald; Middeldorp, Anneke; Jordanova, Ekaterina S.; Oosting, Jan; van Wezel, Tom; Morreau, Hans] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Kapiteijn, Ellen] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Hovens, Guido; Smit, Jan] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Corver, WE (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	w.e.corver@lumc.nl; j.morreau@lumc.nl	van Wezel, Tom/Z-3092-2019; de Miranda, NFCC/I-2520-2015; Smit, J.W.A./H-8091-2014; Kapiteijn, Ellen/AAK-6065-2020; van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/A-9599-2008; Corver, Willem/T-6576-2018; de Miranda, Noel/F-4518-2010	van Wezel, Tom/0000-0001-5773-7730; de Miranda, NFCC/0000-0001-6122-1024; Smit, J.W.A./0000-0003-1052-9314; Kapiteijn, Ellen/0000-0002-4814-6426; van Wezel, Tom/0000-0001-5773-7730; de Miranda, Noel/0000-0001-6122-1024; Corver, Willem/0000-0001-8313-3658; Jordanova, Ekaterina S./0000-0002-8121-1322; van Eijk, Ronald/0000-0001-7955-6295; Jordanova, Ekaterina/0000-0003-3890-7102				Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Bovee JVMG, 2000, AM J PATHOL, V157, P1587, DOI 10.1016/S0002-9440(10)64796-7; Corver WE, 2005, J PATHOL, V206, P233, DOI 10.1002/path.1765; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Dettori T, 2003, GENE CHROMOSOME CANC, V38, P22, DOI 10.1002/gcc.10238; ELNAGGAR AK, 1988, ARCH OTOLARYNGOL, V114, P520; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Frisk T, 1999, GENE CHROMOSOME CANC, V25, P349, DOI 10.1002/(SICI)1098-2264(199908)25:4<349::AID-GCC6>3.3.CO;2-4; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gasparre G, 2010, MOL CELL ENDOCRINOL, V321, P67, DOI 10.1016/j.mce.2010.02.022; GregoriRomero MA, 1996, CANCER GENET CYTOGEN, V92, P28, DOI 10.1016/S0165-4608(96)00026-X; Gupta-Abramson V, 2008, J CLIN ONCOL, V26, P4714, DOI 10.1200/JCO.2008.16.3279; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; Hoftijzer H, 2009, EUR J ENDOCRINOL, V161, P923, DOI 10.1530/EJE-09-0702; Hogan Thomas, 2009, J Oncol Pharm Pract, V15, P111, DOI 10.1177/1078155208101212; Kapiteijn E, 2012, ANN ONCOL, V23, P10, DOI 10.1093/annonc/mdr117; Kim HJ, 2009, AM J SURG PATHOL, V33, P1276, DOI 10.1097/PAS.0b013e3181a2aa36; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Masago K, 2009, INT J CANCER, V124, P2744, DOI 10.1002/ijc.24250; Mayr JA, 2008, CLIN CANCER RES, V14, P2270, DOI 10.1158/1078-0432.CCR-07-4131; MCLEOD MK, 1988, ARCH SURG-CHICAGO, V123, P849; Nagy A, 2002, GENE CHROMOSOME CANC, V35, P256, DOI 10.1002/gcc.10118; Nikiforov YE, 2011, ARCH PATHOL LAB MED, V135, P569, DOI 10.1043/2010-0664-RAIR.1; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107; Ribeiro FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-371; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Rivera M, 2010, MODERN PATHOL, V23, P1191, DOI 10.1038/modpathol.2010.112; RIZZONI M, 1974, CHROMOSOMA, V45, P151, DOI 10.1007/BF00362308; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Savagner F, 2001, THYROID, V11, P327, DOI 10.1089/10507250152039055; SCHULTZ DS, 1992, AM J CLIN PATHOL, V98, P291, DOI 10.1093/ajcp/98.3.291; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; SPEICHER MR, 1994, AM J PATHOL, V145, P356; Stankov K, 2004, INT J CANCER, V111, P463, DOI 10.1002/ijc.20259; Stankov K, 2006, THYROID, V16, P325, DOI 10.1089/thy.2006.16.325; Tallini G, 1999, LAB INVEST, V79, P547; Tan MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-196; Tung WS, 1997, GENE CHROMOSOME CANC, V19, P43, DOI 10.1002/(SICI)1098-2264(199705)19:1<43::AID-GCC7>3.0.CO;2-0; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Wada N, 2002, J CLIN ENDOCR METAB, V87, P4595, DOI 10.1210/jc.2002-020339; Xu XL, 2003, CANCER RES, V63, P4561; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; ZEDENIUS J, 1995, HUM GENET, V96, P27, DOI 10.1007/BF00214182; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475; Zimmermann Franz A, 2011, Front Biosci (Elite Ed), V3, P315	49	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38287	10.1371/journal.pone.0038287	http://dx.doi.org/10.1371/journal.pone.0038287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675538	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900021
J	Low, C; Jegerschold, C; Kovermann, M; Moberg, P; Nordlund, P				Low, Christian; Jegerschold, Caroline; Kovermann, Michael; Moberg, Per; Nordlund, Par			Optimisation of Over-Expression in E. coli and Biophysical Characterisation of Human Membrane Protein Synaptogyrin 1	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; BACTERIOPHAGE-T7 RNA-POLYMERASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; SCAMP1 FUNCTION; SYNAPTOPHYSIN; GENE; OVEREXPRESSION; SCHIZOPHRENIA; ENDOCYTOSIS	Progress in functional and structural studies of integral membrane proteins (IMPs) is lacking behind their soluble counterparts due to the great challenge in producing stable and homogeneous IMPs. Low natural abundance, toxicity when over-expressed and potential lipid requirements of IMPs are only a few reasons for the limited progress. Here, we describe an optimised workflow for the recombinant over-expression of the human tetraspan vesicle protein (TVP) synaptogyrin in Escherichia coli and its biophysical characterisation. TVPs are ubiquitous and abundant components of vesicles. They are believed to be involved in various aspects of the synaptic vesicle cycle, including vesicle biogenesis, exocytosis and endocytotic recycling. Even though TVPs are found in most cell types, high-resolution structural information for this class of membrane proteins is still missing. The optimisation of the N-terminal sequence of the gene together with the usage of the recently developed Lemo21(DE3) strain which allows the balancing of the translation with the membrane insertion rate led to a 50-fold increased expression rate compared to the classical BL21(DE3) strain. The protein was soluble and stable in a variety of mild detergents and multiple biophysical methods confirmed the folded state of the protein. Crosslinking experiments suggest an oligomeric architecture of at least four subunits. The protein stability is significantly improved in the presence of cholesteryl hemisuccinate as judged by differential light scattering. The approach described here can easily be adapted to other eukaryotic IMPs.	[Low, Christian; Moberg, Per; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Jegerschold, Caroline] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Kovermann, Michael] Univ Halle Wittenberg, Inst Phys, Saale, Germany; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Karolinska Institutet; Karolinska Institutet; Martin Luther University Halle Wittenberg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Low, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	christian.low@ki.se; par.nordlund@ki.se		Jegerschold, Caroline/0000-0003-2419-6354; Loew, Christian/0000-0003-0764-7483	EMBO (European Molecular Biology Organization) postdoctoral fellowship; Swedish Research council; Swedish Cancer Society; integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant	EMBO (European Molecular Biology Organization) postdoctoral fellowship; Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant(National Research Foundation, Singapore)	CL was supported by an EMBO (European Molecular Biology Organization) postdoctoral fellowship. This research was supported by grants from the Swedish Research council, Swedish Cancer Society and the integrated EU project EDICT (European drug initiative on channels and transporters), as well as Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abraham C, 2006, P NATL ACAD SCI USA, V103, P8227, DOI 10.1073/pnas.0509400103; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Casagrande F, 2009, J MOL BIOL, V394, P708, DOI 10.1016/j.jmb.2009.09.048; Chen R, 2011, BIOTECHNOL ADV; Cheng MC, 2007, J PSYCHIATR RES, V41, P1027, DOI 10.1016/j.jpsychires.2006.08.010; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Felkl M, 2008, NEUROSCIENCE, V156, P344, DOI 10.1016/j.neuroscience.2008.07.033; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Hubner K, 2002, INT REV CYTOL, V214, P103; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Iatropoulos P, 2009, PSYCHIAT GENET, V19, P237, DOI 10.1097/YPG.0b013e32832cebf7; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; Klepsch MM, 2011, J MOL BIOL, V407, P532, DOI 10.1016/j.jmb.2011.02.007; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nguyen TA, 2010, J MOL MICROB BIOTECH, V18, P85, DOI 10.1159/000283512; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; Senisterra GA, 2010, J BIOMOL SCREEN, V15, P314, DOI 10.1177/1087057109357117; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Stenius K, 1995, J CELL BIOL, V131, P1801, DOI 10.1083/jcb.131.6.1801; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Verma R, 2005, J HUM GENET, V50, P635, DOI 10.1007/s10038-005-0307-z; Verma R, 2004, BIOL PSYCHIAT, V55, P196, DOI 10.1016/j.biopsych.2003.10.012; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Welch M, 2011, METHOD ENZYMOL, V498, P43, DOI 10.1016/B978-0-12-385120-8.00003-6; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Zhao HJ, 2001, MOL BIOL CELL, V12, P2275, DOI 10.1091/mbc.12.8.2275	53	20	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38244	10.1371/journal.pone.0038244	http://dx.doi.org/10.1371/journal.pone.0038244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675529	gold, Green Published			2022-12-25	WOS:000305339900019
J	Basmaci, R; Yagupsky, P; Ilharreborde, B; Guyot, K; Porat, N; Chomton, M; Thiberge, JM; Mazda, K; Bingen, E; Bonacorsi, P; Bidet, P				Basmaci, Romain; Yagupsky, Pablo; Ilharreborde, Brice; Guyot, Kathleen; Porat, Nurith; Chomton, Marilyn; Thiberge, Jean-Michel; Mazda, Keyvan; Bingen, Edouard; Bonacorsi, Stephane; Bidet, Philippe			Multilocus Sequence Typing and rtxA Toxin Gene Sequencing Analysis of Kingella kingae Isolates Demonstrates Genetic Diversity and International Clones	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; OSTEOARTICULAR INFECTIONS; YOUNG-CHILDREN; SEPTIC ARTHRITIS; DIAGNOSIS; ENDOCARDITIS; PATHOGEN	Background: Kingella kingae, a normal component of the upper respiratory flora, is being increasingly recognized as an important invasive pathogen in young children. Genetic diversity of this species has not been studied. Methods: We analyzed 103 strains from different countries and clinical origins by a new multilocus sequence-typing (MLST) schema. Putative virulence gene rtxA, encoding an RTX toxin, was also sequenced, and experimental virulence of representative strains was assessed in a juvenile-rat model. Results: Thirty-six sequence-types (ST) and nine ST-complexes (STc) were detected. The main STc 6, 14 and 23 comprised 23, 17 and 20 strains respectively, and were internationally distributed. rtxA sequencing results were mostly congruent with MLST, and showed horizontal transfer events. Of interest, all members of the distantly related ST-6 (n = 22) and ST-5 (n = 4) harboured a 33 bp duplication or triplication in their rtxA sequence, suggesting that this genetic trait arose through selective advantage. The animal model revealed significant differences in virulence among strains of the species. Conclusion: MLST analysis reveals international spread of ST-complexes and will help to decipher acquisition and evolution of virulence traits and diversity of pathogenicity among K. kingae strains, for which an experimental animal model is now available.	[Basmaci, Romain; Guyot, Kathleen; Chomton, Marilyn; Bingen, Edouard; Bonacorsi, Stephane; Bidet, Philippe] Univ Paris Diderot, EA 3105, Paris, France; [Basmaci, Romain; Chomton, Marilyn; Bingen, Edouard; Bonacorsi, Stephane; Bidet, Philippe] Hop Robert Debre, AP HP, Microbiol Lab, F-75019 Paris, France; [Yagupsky, Pablo] Ben Gurion Univ Negev, Clin Microbiol Lab, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Ilharreborde, Brice; Mazda, Keyvan] Hop Robert Debre, AP HP, Serv Chirurg Orthoped, F-75019 Paris, France; [Porat, Nurith] Ben Gurion Univ Negev, Pediat Infect Dis Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Thiberge, Jean-Michel] Inst Pasteur, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Ben Gurion University; Soroka Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Ben Gurion University; Soroka Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Basmaci, R (corresponding author), Univ Paris Diderot, EA 3105, Paris, France.	stephane.bonacorsi@rdb.aphp.fr			Academie Nationale de Medecine	Academie Nationale de Medecine	This work was supported in part by the "Academie Nationale de Medecine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Basmaci R, 2011, PEDIATR INFECT DIS J, V30, P902, DOI 10.1097/INF.0b013e31821fe0f7; Bofinger JJ, 2007, J CLIN MICROBIOL, V45, P3118, DOI 10.1128/JCM.00878-07; Ceroni D, 2010, J PEDIATR ORTHOPED, V30, P301, DOI 10.1097/BPO.0b013e3181d4732f; Cherkaoui A, 2009, Rev Med Suisse, V5, P2235; Chometon S, 2007, PEDIATR INFECT DIS J, V26, P377, DOI 10.1097/01.inf.0000259954.88139.f4; Dubnov-Raz G, 2010, PEDIATR INFECT DIS J, V29, P639, DOI 10.1097/INF.0b013e3181d57a6c; Hay F, 2002, ARCH PEDIATRIE, V9, P37, DOI 10.1016/S0929-693X(01)00692-3; Holmes AA, 2011, ANN PEDIAT CARDIOL, V4, P210, DOI 10.4103/0974-2069.84664; Ilharreborde B, 2009, J CLIN MICROBIOL, V47, P1837, DOI 10.1128/JCM.00144-09; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lehours P, 2011, J CLIN MICROBIOL, V49, P1245, DOI 10.1128/JCM.01657-10; Rosey AL, 2007, J MICROBIOL METH, V68, P88, DOI 10.1016/j.mimet.2006.06.010; Sena AC, 2010, PEDIATR INFECT DIS J, V29, P86, DOI 10.1097/INF.0b013e3181b48cc3; Stahelin J, 1998, CLIN INFECT DIS, V27, P1328, DOI 10.1093/clinids/27.5.1328; TOSHNIWAL R, 1986, DIAGN MICR INFEC DIS, V5, P81, DOI 10.1016/0732-8893(86)90095-7; Verdier I, 2005, PEDIATR INFECT DIS J, V24, P692, DOI 10.1097/01.inf.0000172153.10569.dc; YAGUPSKY P, 1992, J CLIN MICROBIOL, V30, P1278, DOI 10.1128/JCM.30.5.1278-1281.1992; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867; Yagupsky P, 2009, PEDIATR INFECT DIS J, V28, P707, DOI 10.1097/INF.0b013e31819f1f36; Yagupsky PQ, 2004, LANCET INFECT DIS, V4, P358, DOI 10.1016/S1473-3099(04)01046-1; Youssef D, 2010, CARDIOL YOUNG, V20, P448, DOI 10.1017/S1047951110000351	21	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38078	10.1371/journal.pone.0038078	http://dx.doi.org/10.1371/journal.pone.0038078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693588	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500086
J	McElroy, SJ; Hobbs, S; Kallen, M; Tejera, N; Rosen, MJ; Grishin, A; Matta, P; Schneider, C; Upperman, J; Ford, H; Polk, DB; Weitkamp, JH				McElroy, Steven J.; Hobbs, Stuart; Kallen, Michael; Tejera, Noemi; Rosen, Michael J.; Grishin, Anatoly; Matta, Poojitha; Schneider, Claus; Upperman, Jeffrey; Ford, Henri; Polk, D. Brent; Weitkamp, Joern-Hendrik			Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXPERIMENTAL NECROTIZING ENTEROCOLITIS; INTESTINAL EPITHELIUM; PRETERM INFANTS; COLONIC INJURY; TLR4; RAT; PATHOGENESIS; RECEPTOR; CYCLOOXYGENASE-2	Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal morbidity and mortality in preterm infants. NEC is characterized by an exaggerated inflammatory response to bacterial flora leading to bowel necrosis. Bacterial lipopolysaccharide (LPS) mediates inflammation through TLR4 activation and is a key molecule in the pathogenesis of NEC. However, LPS also induces cyclooxygenase-2 (COX-2), which promotes intestinal barrier restitution through stimulation of intestinal cell survival, proliferation, and migration. Epidermal growth factor receptor (EGFR) activation prevents experimental NEC and may play a critical role in LPS-stimulated COX-2 production. We hypothesized that EGFR is required for LPS induction of COX-2 expression. Our data show that inhibiting EGFR kinase activity blocks LPS-induced COX-2 expression in small intestinal epithelial cells. LPS induction of COX-2 requires Src-family kinase signaling while LPS transactivation of EGFR requires matrix metalloprotease (MMP) activity. EGFR tyrosine kinase inhibitors block LPS stimulation of mitogen-activated protein kinase ERK, suggesting an important role of the MAPK/ERK pathway in EGFR-mediated COX-2 expression. LPS stimulates proliferation of IEC-6 cells, but this stimulation is inhibited with either the EGFR kinase inhibitor AG1478, or the selective COX-2 inhibitor Celecoxib. Taken together, these data show that EGFR plays an important role in LPS-induction of COX-2 expression in enterocytes, which may be one mechanism for EGF in inhibition of NEC.	[McElroy, Steven J.; Rosen, Michael J.; Matta, Poojitha; Weitkamp, Joern-Hendrik] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Hobbs, Stuart] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Grishin, Anatoly; Upperman, Jeffrey; Ford, Henri] Childrens Hosp Los Angeles, Saban Res Inst, Div Pediat Surg, Los Angeles, CA 90027 USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Children's Hospital Los Angeles; University of Southern California; University of Southern California	McElroy, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	hendrik.weitkamp@vanderbilt.edu	Tejera, Noemi/O-1558-2016; McElroy, Steven/AGR-6835-2022; McElroy, Steven/AAC-7204-2019; Weitkamp, Joern-Hendrik/AAZ-8272-2020	McElroy, Steven/0000-0002-4321-723X; McElroy, Steven/0000-0002-4321-723X; Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Tejera, Noemi/0000-0001-8100-6022; Rosen, Michael/0000-0002-5149-718X	National Institutes of Health (NIH) [K08DK083677, R21AI083612, R01GM076592, R01AI014032, R01DK54993, R01DK56008, K08HD061607]; Vanderbilt Physician Scientist Development Award; Vanderbilt Digestive Diseases Research Center [NIH P30DK058404]; Center's Pilot and Feasibility Program, Flow Cytometry and Cellular and Animal Modeling Shared Resources and the National Institutes of Health funded Vanderbilt Summer Research and Training Program [1T35 ES016534-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083612, R01AI014032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083677, R01DK056008, P30DK058404, R01DK054993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T35ES016534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Award; Vanderbilt Digestive Diseases Research Center; Center's Pilot and Feasibility Program, Flow Cytometry and Cellular and Animal Modeling Shared Resources and the National Institutes of Health funded Vanderbilt Summer Research and Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (NIH) Grants: K08DK083677 (to SJM); R21AI083612 (to AG); R01GM076592 (to CS); R01AI014032 (to HRF); R01DK54993 and R01DK56008 (to DBP); and K08HD061607 (to JHW). It was also supported in part by a Vanderbilt Physician Scientist Development Award (to JHW), and the Vanderbilt Digestive Diseases Research Center (NIH P30DK058404) including the Center's Pilot and Feasibility Program, Flow Cytometry and Cellular and Animal Modeling Shared Resources and the National Institutes of Health funded Vanderbilt Summer Research and Training Program 1T35 ES016534-01 (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chailler Pierre, 1999, Frontiers in Bioscience, V4, pD87, DOI 10.2741/Chailler; Chung DH, 2001, ANN SURG, V233, P835, DOI 10.1097/00000658-200106000-00014; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Crow JD, 2000, J PEDIATR SURG, V35, P177; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Fagbemi AO, 2001, EARLY HUM DEV, V65, P1, DOI 10.1016/S0378-3782(01)00164-5; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Grishin A, 2004, SURGERY, V136, P329, DOI 10.1016/j.surg.2004.05.008; Grishin AV, 2006, J IMMUNOL, V176, P580, DOI 10.4049/jimmunol.176.1.580; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lugo B, 2007, J PEDIATR SURG, V42, P1165, DOI 10.1016/j.jpedsurg.2007.02.006; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Nair RR, 2008, SEMIN PERINATOL, V32, P107, DOI 10.1053/j.semperi.2008.01.007; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Shin CE, 2000, J PEDIATR SURG, V35, P173, DOI 10.1016/S0022-3468(00)90005-8; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Warner BB, 2007, J PEDIATR-US, V150, P358, DOI 10.1016/j.jpeds.2006.11.059; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105	34	46	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38373	10.1371/journal.pone.0038373	http://dx.doi.org/10.1371/journal.pone.0038373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675459	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000305338500140
J	Sahu, SN; Lewis, J; Patel, I; Bozdag, S; Lee, JH; LeClerc, JE; Cinar, HN				Sahu, Surasri N.; Lewis, Jada; Patel, Isha; Bozdag, Serdar; Lee, Jeong H.; LeClerc, Joseph E.; Cinar, Hediye Nese			Genomic Analysis of Immune Response against Vibrio cholerae Hemolysin in Caenorhabditis elegans	PLOS ONE			English	Article							EL-TOR HEMOLYSIN; INNATE IMMUNITY; VIRULENCE FACTORS; CELL VACUOLATION; RECEPTOR; GENES; EXPRESSION; SURVIVAL; PATHWAY; TOXIN	Vibrio cholerae cytolysin (VCC) is among the accessory V. cholerae virulence factors that may contribute to disease pathogenesis in humans. VCC, encoded by hlyA gene, belongs to the most common class of bacterial toxins, known as pore-forming toxins (PFTs). V. cholerae infects and kills Caenorhabditis elegans via cholerae toxin independent manner. VCC is required for the lethality, growth retardation and intestinal cell vacuolation during the infection. However, little is known about the host gene expression responses against VCC. To address this question we performed a microarray study in C. elegans exposed to V. cholerae strains with intact and deleted hlyA genes. Many of the VCC regulated genes identified, including C-type lectins, Prion-like (glutamine [Q]/asparagine [N]-rich)-domain containing genes, genes regulated by insulin/IGF-1-mediated signaling (IIS) pathway, were previously reported as mediators of innate immune response against other bacteria in C. elegans. Protective function of the subset of the genes up-regulated by VCC was confirmed using RNAi. By means of a machine learning algorithm called FastMEDUSA, we identified several putative VCC induced immune regulatory transcriptional factors and transcription factor binding motifs. Our results suggest that VCC is a major virulence factor, which induces a wide variety of immune response-related genes during V. cholerae infection in C. elegans.	[Sahu, Surasri N.; Lee, Jeong H.; Cinar, Hediye Nese] US FDA, Div Virulence Assessment, Laurel, MD USA; [Lewis, Jada; Patel, Isha; LeClerc, Joseph E.] US FDA, Div Mol Biol, Laurel, MD USA; [Bozdag, Serdar] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA; [Sahu, Surasri N.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Lee, Jeong H.] Kyungpook Natl Univ, Taegu, South Korea	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kyungpook National University	Sahu, SN (corresponding author), US FDA, Div Virulence Assessment, Laurel, MD USA.	hediye.cinar@fda.hhs.gov						Abdillahi SM, 2012, J INNATE IMMUN, V4, P371, DOI 10.1159/000335239; ALM RA, 1991, VACCINE, V9, P588, DOI 10.1016/0264-410X(91)90247-4; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Antebi Adam, 2006, WormBook, P1; Barrasa MI, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-21; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Cinar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011558; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; FEELEY JC, 1963, B WORLD HEALTH ORGAN, V28, P347; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Huffman DL, 2004, INT J MED MICROBIOL, V293, P599, DOI 10.1078/1438-4221-00303; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Kundaje A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000224; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Maglich JM, 2001, GENOME BIOL, V2; Marroquin LD, 2000, GENETICS, V155, P1693; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MICHALSKI J, 1993, INFECT IMMUN, V61, P4462, DOI 10.1128/IAI.61.10.4462-4468.1993; Mitra R, 2000, INFECT IMMUN, V68, P1928, DOI 10.1128/IAI.68.4.1928-1933.2000; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2003, PROTEIN SCI, V12, P379, DOI 10.1110/ps.0231703; PARSOT C, 1990, P NATL ACAD SCI USA, V87, P9898, DOI 10.1073/pnas.87.24.9898; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reddy KC, 2011, P NATL ACAD SCI USA, V108, P12887, DOI 10.1073/pnas.1108265108; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; Sluder AE, 1999, GENOME RES, V9, P103; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Van Gilst M, 2002, CRIT REV EUKAR GENE, V12, P65; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x	66	35	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38200	10.1371/journal.pone.0038200	http://dx.doi.org/10.1371/journal.pone.0038200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675448	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500108
J	Jin, C; Rajabi, H; Rodrigo, CM; Porco, JA; Kufe, D				Jin, C.; Rajabi, H.; Rodrigo, C. M.; Porco, J. A., Jr.; Kufe, D.			Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein	ONCOGENE			English	Article						MUC1-C; translation; AKT; mTOR; PDCD4; silvestrol	GROWTH-FACTOR RECEPTOR; MOLECULAR-MECHANISMS; CARCINOMA ANTIGEN; ACTIVATION; SURVIVAL; DEGRADATION; SILVESTROL; EXPRESSION; INHIBITORS; INITIATION	The oncogenic MUC1 C-terminal subunit (MUC1-C) subunit is aberrantly overexpressed in most human breast cancers by mechanisms that are not well understood. The present studies demonstrate that stimulation of non-malignant MCF-10A cells with epidermal growth factor (EGF) or heregulin (HRG) results in marked upregulation of MUC1-C translation. Growth factor-induced MUC1-C translation was found to be mediated by PI3K -> AKT, and not by MEK -> ERK1/2, signaling. We also show that activation of the mammalian target of rapamycin complex 1 (mTORC1)-> ribosomal protein S6 kinase 1 (S6K1) pathway decreases tumor suppressor programmed cell death protein 4 (PDCD4), an inhibitor of the eIF4A RNA helicase, and contributes to the induction of MUC1-C translation. In concert with these results, treatment of growth factor-stimulated MCF-10A cells with the eIF4A RNA helicase inhibitors, silvestrol and CR-1-31-B, blocked increases in MUC1-C abundance. The functional significance of the increase in MUC1-C translation is supported by the demonstration that MUC1-C, in turn, forms complexes with EGF receptor (EGFR) and promotes EGFR-mediated activation of the PI3K -> AKT pathway and the induction of growth. Compared with MCF-10A cells, constitutive overexpression of MUC1-C in breast cancer cells was unaffected by EGF stimulation, but was blocked by inhibiting PI3K -> AKT signaling. The overexpression of MUC1-C in breast cancer cells was also inhibited by blocking eIF4A RNA helicase activity with silvestrol and CR-1-31-B. These findings indicate that EGF-induced MUC1-C expression is mediated by the PI3K -> AKT pathway and the eIF4A RNA helicase, and that this response promotes EGFR signaling in an autoinductive loop. The findings also indicate that targeting the eIF4A RNA helicase is a novel approach for blocking MUC1-C overexpression in breast cancer cells. Oncogene (2013) 32, 2179-2188; doi:10.1038/onc.2012.236; published online 11 June 2012	[Jin, C.; Rajabi, H.; Kufe, D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Rodrigo, C. M.; Porco, J. A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 450 Brookline Ave,Dana 830, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu			National Cancer Institute [CA97098, CA42802, CA100707]; National Institutes of Health Grant [GM-073855]; American Cancer Society [PF-11-077-01-CDD]; NATIONAL CANCER INSTITUTE [R01CA166480, R01CA097098, P50CA100707, R01CA042802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073855] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute Grants CA97098, CA42802 and CA100707; the National Institutes of Health Grant GM-073855 (JAP), and a postdoctoral fellowship from the American Cancer Society PF-11-077-01-CDD (CMR).	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Gerard B, 2007, ANGEW CHEM INT EDIT, V46, P7831, DOI 10.1002/anie.200702707; Hsieh AC, 2011, BRIT J CANCER, V105, P329, DOI 10.1038/bjc.2011.241; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Hwang BY, 2004, J ORG CHEM, V69, P3350, DOI 10.1021/jo040120f; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Joshi MD, 2009, MOL CANCER THER, V8, P3056, DOI 10.1158/1535-7163.MCT-09-0646; Kong D, 2009, CURR MED CHEM, V16, P2839, DOI 10.2174/092986709788803222; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Rodrigo CM, 2012, J MED CHEM, V55, P558, DOI 10.1021/jm201263k; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wedeken L, 2011, J BIOL CHEM, V286, P42855, DOI 10.1074/jbc.M111.269456; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Zhou YC, 2011, MOL PHARMACOL, V79, P886, DOI 10.1124/mol.110.070797	44	29	32	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2179	2188		10.1038/onc.2012.236	http://dx.doi.org/10.1038/onc.2012.236			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22689062	Green Accepted			2022-12-25	WOS:000318062800007
J	Ramos, TN; Darley, MM; Weckbach, S; Stahel, PF; Tomlinson, S; Barnum, SR				Ramos, Theresa N.; Darley, Meghan M.; Weckbach, Sebastian; Stahel, Philip F.; Tomlinson, Stephen; Barnum, Scott R.			The C5 Convertase Is Not Required for Activation of the Terminal Complement Pathway in Murine Experimental Cerebral Malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL SIMIAN MALARIA; C6 DEFICIENCY; TARGETED EXPRESSION; PLASMINOGEN-BINDING; FACTOR-B; MICE; COAGULATION; COMPONENT; C3; SUSCEPTIBILITY	Cerebral malaria (CM) is the most severe manifestation of clinical malaria syndromes and has a high fatality rate especially in the developing world. Recent studies demonstrated that C5(-/-) mice are resistant to experimental CM (ECM) and that protection was due to the inability to form the membrane attack complex. Unexpectedly, we observed that C4(-/-) and factor B-/- mice were fully susceptible to disease, indicating that activation of the classical or alternative pathways is not required for ECM. C3(-/-) mice were also susceptible to ECM, indicating that the canonical C5 convertases are not required for ECM development and progression. Abrogation of ECM by treatment with anti-C9 antibody and detection of C5a in serum of C3(-/-) mice confirmed that C5 activation occurs in ECM independent of C5 convertases. Our data indicate that activation of C5 in ECM likely occurs via coagulation enzymes of the extrinsic protease pathway.	[Ramos, Theresa N.; Darley, Meghan M.; Barnum, Scott R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Ramos, Theresa N.; Darley, Meghan M.; Barnum, Scott R.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Weckbach, Sebastian; Stahel, Philip F.] Univ Colorado, Dept Orthoped Surg, Denver, CO 80204 USA; [Weckbach, Sebastian; Stahel, Philip F.] Univ Colorado, Dept Neurosurg, Denver, CO 80204 USA; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Tomlinson, Stephen] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Barnum, SR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB-842, Birmingham, AL 35294 USA.	sbarnum@uab.edu			National Institutes of Health [T32 AI07051, NS077811, AI08382, HL82485]; Veterans Affairs Grant [NURC-051-10F]; German Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Grant(US Department of Veterans Affairs); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AI07051 and NS077811 (to T. N. R.), AI08382 (to S. R. B.), and HL82485 (to S. T.). This work was also supported by Veterans Affairs Grant NURC-051-10F (to S. T.) and a research fellowship from the German Research Foundation (to S. W.).	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; ATKINSON JP, 1975, J INFECT DIS, V131, P26, DOI 10.1093/infdis/131.1.26; Barnum SR, 2006, BRAIN RES REV, V52, P58, DOI 10.1016/j.brainresrev.2005.12.002; Christiansen VJ, 1997, ARTERIOSCL THROM VAS, V17, P164, DOI 10.1161/01.ATV.17.1.164; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Dasari P, 2012, BLOOD, V119, P4301, DOI 10.1182/blood-2011-11-392134; Davoust N, 1999, J IMMUNOL, V163, P6551; Delahaye NF, 2006, J INFECT DIS, V193, P312, DOI 10.1086/498579; GABRIEL J, 1983, CLIN EXP IMMUNOL, V52, P129; Ghosh K, 2008, PARASITOL RES, V102, P571, DOI 10.1007/s00436-007-0832-0; GLEW RH, 1975, J INFECT DIS, V131, P17, DOI 10.1093/infdis/131.1.17; Grau GER, 2012, FUTURE MICROBIOL, V7, P291, DOI [10.2217/FMB.11.155, 10.2217/fmb.11.155]; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Hobart MJ, 1998, HUM GENET, V103, P506, DOI 10.1007/s004390050858; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Malowany JI, 2012, SEMIN DIAGN PATHOL, V29, P49, DOI 10.1053/j.semdp.2011.07.005; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Pang XL, 1998, VACCINE, V16, P1299, DOI 10.1016/S0264-410X(98)00057-7; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Ramos TN, 2011, J IMMUNOL, V186, P6657, DOI 10.4049/jimmunol.1100603; Ramos TN, 2009, NEUROSCI LETT, V467, P234, DOI 10.1016/j.neulet.2009.10.045; Read RW, 2006, EXP EYE RES, V82, P389, DOI 10.1016/j.exer.2005.07.011; REINARTZ J, 1995, J IMMUNOL, V154, P844; Silver KL, 2010, CELL MICROBIOL, V12, P1036, DOI 10.1111/j.1462-5822.2010.01492.x; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; WARD PA, 1981, J IMMUNOL, V126, P1826; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WETSEL RA, 1983, J EXP MED, V157, P2029, DOI 10.1084/jem.157.6.2029; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; Wurzner R, 2003, CLIN EXP IMMUNOL, V133, P156, DOI 10.1046/j.1365-2249.2003.02230.x; Zhu ZB, 2000, CLIN EXP IMMUNOL, V119, P305	44	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24734	24738		10.1074/jbc.C112.378364	http://dx.doi.org/10.1074/jbc.C112.378364			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22689574	Green Published, hybrid			2022-12-25	WOS:000306651100066
J	Jakobi, AJ; Huizinga, EG				Jakobi, Arjen J.; Huizinga, Eric G.			A Rapid Cloning Method Employing Orthogonal End Protection	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; VON-WILLEBRAND-FACTOR; PROTEIN; CONSTRUCTION; DOMAIN; FIBRONECTIN; FRAGMENTS; STRATEGY; SYSTEM; PCR	We describe a novel in vitro cloning strategy that combines standard tools in molecular biology with a basic protecting group concept to create a versatile framework for the rapid and seamless assembly of modular DNA building blocks into functional open reading frames. Analogous to chemical synthesis strategies, our assembly design yields idempotent composite synthons amenable to iterative and recursive split-and-pool reaction cycles. As an example, we illustrate the simplicity, versatility and efficiency of the approach by constructing an open reading frame composed of tandem arrays of a human fibronectin type III (FNIII) domain and the von Willebrand Factor A2 domain (VWFA2), as well as chimeric (FNIII)(n)-VWFA2-(FNIII)(n) constructs. Although we primarily designed this strategy to accelerate assembly of repetitive constructs for single-molecule force spectroscopy, we anticipate that this approach is equally applicable to the reconstitution and modification of complex modular sequences including structural and functional analysis of multi-domain proteins, synthetic biology or the modular construction of episomal vectors.	[Jakobi, Arjen J.; Huizinga, Eric G.] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Jakobi, AJ (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	e.g.huizinga@uu.nl		Jakobi, Arjen/0000-0002-7761-2027	Council of Chemical Sciences of the Netherlands Organization for Scientific Research (NWO) [700.55.012]	Council of Chemical Sciences of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by ECHO (Excellent CHemisch Onderzoek (Excellent Chemical Research)) grant 700.55.012 from the Council of Chemical Sciences of the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/) to EGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; Bornschlogl T, 2011, METHODS MOL BIOL, V783, P233, DOI 10.1007/978-1-61779-282-3_13; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fernandes S, 2009, ANAL BIOCHEM, V385, P171, DOI 10.1016/j.ab.2008.10.008; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Mcintyre GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003827; NOVOKHATNY V, 1992, J MOL BIOL, V227, P1182, DOI 10.1016/0022-2836(92)90530-W; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	25	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37617	10.1371/journal.pone.0037617	http://dx.doi.org/10.1371/journal.pone.0037617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685543	gold, Green Published			2022-12-25	WOS:000305351700007
J	Maire, V; Martre, P; Kattge, J; Gastal, F; Esser, G; Fontaine, S; Soussana, JF				Maire, Vincent; Martre, Pierre; Kattge, Jens; Gastal, Francois; Esser, Gerd; Fontaine, Sebastien; Soussana, Jean-Francois			The Coordination of Leaf Photosynthesis Links C and N Fluxes in C-3 Plant Species	PLOS ONE			English	Article							MESOPHYLL DIFFUSION CONDUCTANCE; NITROGEN DISTRIBUTION; CARBON GAIN; STOMATAL CONDUCTANCE; GAS-EXCHANGE; CANOPY PHOTOSYNTHESIS; TEMPERATURE RESPONSE; BIOCHEMICAL-MODEL; USE EFFICIENCY; CELL-WALLS	Photosynthetic capacity is one of the most sensitive parameters in vegetation models and its relationship to leaf nitrogen content links the carbon and nitrogen cycles. Process understanding for reliably predicting photosynthetic capacity is still missing. To advance this understanding we have tested across C-3 plant species the coordination hypothesis, which assumes nitrogen allocation to photosynthetic processes such that photosynthesis tends to be co-limited by ribulose-1,5-bisphosphate (RuBP) carboxylation and regeneration. The coordination hypothesis yields an analytical solution to predict photosynthetic capacity and calculate area-based leaf nitrogen content (N-a). The resulting model linking leaf photosynthesis, stomata conductance and nitrogen investment provides testable hypotheses about the physiological regulation of these processes. Based on a dataset of 293 observations for 31 species grown under a range of environmental conditions, we confirm the coordination hypothesis: under mean environmental conditions experienced by leaves during the preceding month, RuBP carboxylation equals RuBP regeneration. We identify three key parameters for photosynthetic coordination: specific leaf area and two photosynthetic traits (k(3), which modulates N investment and is the ratio of RuBP carboxylation/oxygenation capacity (V-Cmax) to leaf photosynthetic N content (N-pa); and J(fac), which modulates photosynthesis for a given k(3) and is the ratio of RuBP regeneration capacity (J(max)) to V-Cmax). With species-specific parameter values of SLA, k(3) and J(fac), our leaf photosynthesis coordination model accounts for 93% of the total variance in N-a across species and environmental conditions. A calibration by plant functional type of k(3) and J(fac) still leads to accurate model prediction of N-a, while SLA calibration is essentially required at species level. Observed variations in k(3) and J(fac) are partly explained by environmental and phylogenetic constraints, while SLA variation is partly explained by phylogeny. These results open a new avenue for predicting photosynthetic capacity and leaf nitrogen content in vegetation models.	[Maire, Vincent; Fontaine, Sebastien; Soussana, Jean-Francois] INRA, UREP, UR874, Clermont Ferrand, France; [Martre, Pierre] INRA, UMR1095, GDEC, Clermont Ferrand, France; [Martre, Pierre] Blaise Pascal Univ, UMR1095, GDEC, Aubiere, France; [Kattge, Jens] Max Planck Inst Biogeochem, Jena, Germany; [Gastal, Francois] INRA, UR4 P3F, Lusignan, France; [Esser, Gerd] Univ Giessen, Inst Plant Ecol, Giessen, Germany	INRAE; INRAE; Universite Clermont Auvergne (UCA); Max Planck Society; INRAE; Justus Liebig University Giessen	Maire, V (corresponding author), INRA, UREP, UR874, Clermont Ferrand, France.	vmaire24@gmail.com; jfsoussana@clermont.inra.fr	Soussana, Jean-Francois/M-2814-2017; Martre, Pierre/G-5399-2013; Martre, Pierre/AAB-5118-2019; Soussana, Jean-Francois/P-2094-2016; Kattge, Jens/J-8283-2016; Soussana, Jean-Francois/E-2543-2012; Martre, Pierre/M-5282-2013	Martre, Pierre/0000-0002-7419-6558; Martre, Pierre/0000-0002-7419-6558; Soussana, Jean-Francois/0000-0002-1932-6583; Kattge, Jens/0000-0002-1022-8469; Martre, Pierre/0000-0002-7419-6558; Gastal, Francois/0000-0001-9191-5916; Maire, Vincent/0000-0002-3245-2568	French research ministry (MENRT); French ANR DISCOVER project [ANR-05-BDIV-010-01]	French research ministry (MENRT)(Ministry of Research, France); French ANR DISCOVER project(French National Research Agency (ANR))	This study contributes to the French ANR DISCOVER project (ANR-05-BDIV-010-01). VM was funded by a PhD grant of the French research ministry (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; BALDOCCHI D, 1994, TREE PHYSIOL, V14, P1069, DOI 10.1093/treephys/14.7-8-9.1069; Bernacchi CJ, 2003, PLANT CELL ENVIRON, V26, P1419, DOI 10.1046/j.0016-8025.2003.01050.x; Bertheloot J, 2008, PLANT PHYSIOL, V148, P1707, DOI 10.1104/pp.108.124156; CHEN JL, 1993, OECOLOGIA, V93, P63, DOI 10.1007/BF00321192; Damour G, 2010, PLANT CELL ENVIRON, V33, P1419, DOI 10.1111/j.1365-3040.2010.02181.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dreccer M. F., 1998, Journal of Crop Production, V1, P47; Dreccer MF, 2000, ANN BOT-LONDON, V86, P821, DOI 10.1006/anbo.2000.1244; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Evans J.R., 1989, PHOTOSYNTHESIS, P183; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Falge E, 1996, TREES-STRUCT FUNCT, V10, P277; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Farquhar GD, 2002, SILVA FENN, V36, P625, DOI 10.14214/sf.530; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; Field C. H., 1986, EC FORM FUNCTION, P25; Flexas J, 2009, J EXP BOT, V60, P2215, DOI 10.1093/jxb/erp150; Harrison MT, 2009, PLANT CELL ENVIRON, V32, P259, DOI 10.1111/j.1365-3040.2008.01918.x; Haxeltine A, 1996, FUNCT ECOL, V10, P551, DOI 10.2307/2390165; HIKOSAKA K, 1994, OECOLOGIA, V97, P451, DOI 10.1007/BF00325881; Hikosaka K, 1996, PLANTA, V198, P144, DOI 10.1007/BF00197597; HIROSE T, 1989, ECOLOGY, V70, P1610, DOI 10.2307/1938094; HIROSE T, 1988, OECOLOGIA, V77, P145, DOI 10.1007/BF00379180; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; Irving LJ, 2006, NEW PHYTOL, V169, P493, DOI 10.1111/j.1469-8137.2005.01584.x; Johnson IR, 2010, ANN BOT-LONDON, V106, P735, DOI 10.1093/aob/mcq183; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; Kattge J, 2009, GLOBAL CHANGE BIOL, V15, P976, DOI 10.1111/j.1365-2486.2008.01744.x; Kull O, 2002, OECOLOGIA, V133, P267, DOI 10.1007/s00442-002-1042-1; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Lotscher M, 2003, ANN BOT-LONDON, V92, P679, DOI 10.1093/aob/mcg188; MAIRE V, 2009, THESIS B PASCAL U CL; Maire V, 2012, ECOL MODEL IN PRESS, P231; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Medlyn BE, 1996, AUST J PLANT PHYSIOL, V23, P593, DOI 10.1071/PP9960593; Misson L, 2006, TREE PHYSIOL, V26, P729, DOI 10.1093/treephys/26.6.729; MOONEY HA, 1978, OECOLOGIA, V36, P103, DOI 10.1007/BF00344575; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; Niinemets U, 2009, J EXP BOT, V60, P2271, DOI 10.1093/jxb/erp063; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Onoda Y, 2005, J EXP BOT, V56, P755, DOI 10.1093/jxb/eri052; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Press W.H., 1992, NUMERICAL RECIPES, Vsecond; Reynolds JF, 1996, PLANT SOIL, V185, P65, DOI 10.1007/BF02257565; Rousseaux MC, 1999, CROP SCI, V39, P1093, DOI 10.2135/cropsci1999.0011183X003900040023x; Schieving F, 1999, NEW PHYTOL, V143, P201, DOI 10.1046/j.1469-8137.1999.00431.x; SCHIEVING F, 1992, PLANT SOIL, V142, P9, DOI 10.1007/BF00010170; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Soussana JF, 2012, ECOL MODEL, V231, P134, DOI 10.1016/j.ecolmodel.2012.02.002; Suzuki Y, 2001, PLANT CELL ENVIRON, V24, P1353, DOI 10.1046/j.0016-8025.2001.00789.x; Terashima I, 2005, ANN BOT-LONDON, V95, P507, DOI 10.1093/aob/mci049; THOMPSON WA, 1992, AUST J PLANT PHYSIOL, V19, P19; VONCAEMMERER S, 1984, PLANTA, V160, P320, DOI 10.1007/BF00393413; WERGER MJA, 1991, VEGETATIO, V97, P11; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Wohlfahrt G, 1999, PLANT CELL ENVIRON, V22, P1281, DOI 10.1046/j.1365-3040.1999.00479.x; Wohlfahrt G, 1998, ECOL MODEL, V113, P179, DOI 10.1016/S0304-3800(98)00143-4; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395	67	86	88	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38345	10.1371/journal.pone.0038345	http://dx.doi.org/10.1371/journal.pone.0038345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685562	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700025
J	Moss, WN; Dela-Moss, LI; Kierzek, E; Kierzek, R; Priore, SF; Turner, DH				Moss, Walter N.; Dela-Moss, Lumbini I.; Kierzek, Elzbieta; Kierzek, Ryszard; Priore, Salvatore F.; Turner, Douglas H.			The 3 ' Splice Site of Influenza A Segment 7 mRNA Can Exist in Two Conformations: A Pseudoknot and a Hairpin	PLOS ONE			English	Article							PHYLOGENETIC-COMPARATIVE-ANALYSIS; SELECTIVE 2'-HYDROXYL ACYLATION; NEAREST-NEIGHBOR MODEL; METAL-ION BINDING; SECONDARY STRUCTURE; INTERNAL LOOP; BASE-PAIRS; THERMODYNAMIC PROPERTIES; COUNTERION CONDENSATION; TETRAHYMENA RIBOZYME	The 3' splice site of influenza A segment 7 is used to produce mRNA for the M2 ion-channel protein, which is critical to the formation of viable influenza virions. Native gel analysis, enzymatic/chemical structure probing, and oligonucleotide binding studies of a 63 nt fragment, containing the 3' splice site, key residues of an SF2/ASF splicing factor binding site, and a polypyrimidine tract, provide evidence for an equilibrium between pseudoknot and hairpin structures. This equilibrium is sensitive to multivalent cations, and can be forced towards the pseudoknot by addition of 5 mM cobalt hexammine. In the two conformations, the splice site and other functional elements exist in very different structural environments. In particular, the splice site is sequestered in the middle of a double helix in the pseudoknot conformation, while in the hairpin it resides in a two-by-two nucleotide internal loop. The results suggest that segment 7 mRNA splicing can be controlled by a conformational switch that exposes or hides the splice site.	[Moss, Walter N.; Dela-Moss, Lumbini I.; Priore, Salvatore F.; Turner, Douglas H.] Univ Rochester, Ctr RNA Biol, Dept Chem, Rochester, NY 14627 USA; [Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Noskowskiego, Poland	University of Rochester; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Moss, WN (corresponding author), Univ Rochester, Ctr RNA Biol, Dept Chem, Rochester, NY 14627 USA.	turner@chem.rochester.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570; Kierzek, Ryszard/0000-0002-7644-0016; Kierzek, Elzbieta/0000-0002-5563-003X	National Institutes of Health (NIH) [R01 GM22939]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01 GM22939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Almakarem AS, 2012, NUCLEIC ACIDS RES, V40, P1407, DOI 10.1093/nar/gkr810; Aggarwal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010372; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barik S, 2010, VIRUSES-BASEL, V2, P1448, DOI 10.3390/v2071448; BROWN RS, 1985, BIOCHEMISTRY-US, V24, P4785, DOI 10.1021/bi00339a012; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cao S, 2010, RNA, V16, P538, DOI 10.1261/rna.1800210; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chen C, 2010, MOL CELL BIOL, V30, P4108, DOI 10.1128/MCB.00531-10; Chen JL, 2012, BIOCHEMISTRY-US, V51, P3508, DOI 10.1021/bi3002709; Childs JL, 2002, P NATL ACAD SCI USA, V99, P11091, DOI 10.1073/pnas.172391199; Ciesiolka J, 1998, J MOL BIOL, V275, P211, DOI 10.1006/jmbi.1997.1462; Cornish PV, 2006, BIOCHEMISTRY-US, V45, P11162, DOI 10.1021/bi060430n; Dallas A, 1997, STRUCTURE, V5, P1639, DOI 10.1016/S0969-2126(97)00311-0; DESHLER JO, 1991, GENE DEV, V5, P1252, DOI 10.1101/gad.5.7.1252; Disney MD, 2008, J AM CHEM SOC, V130, P11185, DOI 10.1021/ja803234t; Disney MD, 2004, BIOPOLYMERS, V73, P151, DOI 10.1002/bip.10520; Disney MD, 2001, BIOCHEMISTRY-US, V40, P6507, DOI 10.1021/bi002008r; DOMENJOUD L, 1991, MOL CELL BIOL, V11, P4581, DOI 10.1128/MCB.11.9.4581; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009388; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Fouchier RAM, 2012, NATURE, V481, P443, DOI 10.1038/481443a; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; Frugier M, 1997, P NATL ACAD SCI USA, V94, P11291, DOI 10.1073/pnas.94.21.11291; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Girish V, 2004, Indian J Cancer, V41, P47; Gonzalez RL, 1999, J MOL BIOL, V289, P1267, DOI 10.1006/jmbi.1999.2841; Gultyaev AP, 2007, BIOINFORMATICS, V23, P272, DOI 10.1093/bioinformatics/btl559; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Heilman-Miller SL, 2001, J MOL BIOL, V306, P1157, DOI 10.1006/jmbi.2001.4437; Heilman-Miller SL, 2001, J MOL BIOL, V309, P57, DOI 10.1006/jmbi.2001.4660; Hermann T, 1999, CHEM BIOL, V6, pR335, DOI 10.1016/S1074-5521(00)80003-4; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Holland JA, 1999, RNA, V5, P257, DOI 10.1017/S1355838299981360; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Hung LW, 2000, P NATL ACAD SCI USA, V97, P5107, DOI 10.1073/pnas.090588197; Jacquenet S, 2001, NUCLEIC ACIDS RES, V29, P464, DOI 10.1093/nar/29.2.464; Jaeger L, 1996, BIOCHIMIE, V78, P466, DOI 10.1016/0300-9084(96)84753-5; Jang SB, 1998, BIOCHEMISTRY-US, V37, P11726, DOI 10.1021/bi980758j; Jenkins JL, 2008, J BIOL CHEM, V283, P33641, DOI 10.1074/jbc.M806297200; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kirsebom L.A., 2005, HDB RNA BIOCH, P214; Krug RM, 2003, ANTIVIR RES, V57, P147, DOI 10.1016/S0166-3542(02)00207-3; Labuda LP, 2009, ACS CHEM BIOL, V4, P299, DOI 10.1021/cb800313m; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerman YV, 2011, RNA, V17, P1664, DOI 10.1261/rna.2641911; Liang RT, 2010, BIOCHEMISTRY-US, V49, P8155, DOI 10.1021/bi100286n; Loeb DD, 2002, J VIROL, V76, P10195, DOI 10.1128/JVI.76.20.10195-10202.2002; Madjid M, 2003, J ROY SOC MED, V96, P345, DOI 10.1258/jrsm.96.7.345; Massin P, 2010, VET MICROBIOL, V142, P232, DOI 10.1016/j.vetmic.2009.10.012; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mei HY, 1998, BIOCHEMISTRY-US, V37, P14204, DOI 10.1021/bi981308u; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Nagaswamy U, 2000, NUCLEIC ACIDS RES, V28, P375, DOI 10.1093/nar/28.1.375; Nixon PL, 1999, BIOPOLYMERS, V50, P443, DOI 10.1002/(SICI)1097-0282(19991005)50:4<443::AID-BIP9>3.3.CO;2-3; PACE NR, 1989, GENE, V82, P65, DOI 10.1016/0378-1119(89)90031-0; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pasternak A, 2008, BIOCHEMISTRY-US, V47, P1249, DOI 10.1021/bi701758z; Pasternak A, 2007, NUCLEIC ACIDS RES, V35, P4055, DOI 10.1093/nar/gkm421; Priore SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035989; Robb NC, 2012, J GEN VIROL, V93, P113, DOI 10.1099/vir.0.035485-0; Rudisser S, 2000, J MOL BIOL, V295, P1211, DOI 10.1006/jmbi.1999.3421; SHIH SR, 1995, P NATL ACAD SCI USA, V92, P6324, DOI 10.1073/pnas.92.14.6324; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Stiver G, 2003, CAN MED ASSOC J, V168, P49; STREICHER B, 1993, NUCLEIC ACIDS RES, V21, P311; Sucheck SJ, 2000, CURR OPIN CHEM BIOL, V4, P678, DOI 10.1016/S1367-5931(00)00142-3; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Theimer CA, 1998, J MOL BIOL, V279, P545, DOI 10.1006/jmbi.1998.1812; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Ulyanov NB, 2007, NUCLEIC ACIDS RES, V35, P6150, DOI 10.1093/nar/gkm660; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; WATAKABE A, 1989, NUCLEIC ACIDS RES, V17, P8159, DOI 10.1093/nar/17.20.8159; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson WD, 2000, CURR MED CHEM, V7, P73, DOI 10.2174/0929867003375434; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Woodson SA, 2001, CURR PROTOC NUCL ACI, DOI [10.1002/0471142700.nc1106s06, DOI 10.1002/047114270.NC1104S02]; World Health Organization, 2009, INFL SEAS FACT SHEET; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Ziehler W A, 2001, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0601s00	98	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38323	10.1371/journal.pone.0038323	http://dx.doi.org/10.1371/journal.pone.0038323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685560	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700023
J	Silvente, S; Sobolev, AP; Lara, M				Silvente, Sonia; Sobolev, Anatoly P.; Lara, Miguel			Metabolite Adjustments in Drought Tolerant and Sensitive Soybean Genotypes in Response to Water Stress	PLOS ONE			English	Article							SYMBIOTIC N-2 FIXATION; PROLINE ACCUMULATION; MOLECULAR ANALYSIS; NITROGEN-FIXATION; GRAIN LEGUMES; CULTIVARS; NODULES; NMR; L.; CARBON	Soybean (Glycine max L.) is an important source of protein for human and animal nutrition, as well as a major source of vegetable oil. The soybean crop requires adequate water all through its growth period to attain its yield potential, and the lack of soil moisture at critical stages of growth profoundly impacts the productivity. In this study, utilizing H-1 NMR-based metabolite analysis combined with the physiological studies we assessed the effects of short-term water stress on overall growth, nitrogen fixation, ureide and proline dynamics, as well as metabolic changes in drought tolerant (NA5009RG) and sensitive (DM50048) genotypes of soybean in order to elucidate metabolite adjustments in relation to the physiological responses in the nitrogen-fixing plants towards water limitation. The results of our analysis demonstrated critical differences in physiological responses between these two genotypes, and identified the metabolic pathways that are affected by short-term water limitation in soybean plants. Metabolic changes in response to drought conditions highlighted pools of metabolites that play a role in the adjustment of metabolism and physiology of the soybean varieties to meet drought effects.	[Silvente, Sonia; Lara, Miguel] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico; [Sobolev, Anatoly P.] CNR, Ist Metodol Chimiche, Lab Risonanza Magnet Annalaura Segre, Rome, Italy	Universidad Nacional Autonoma de Mexico; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR)	Silvente, S (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	silvente@ccg.unam.mx	Sobolev, Anatoly/AAX-1170-2020	Sobolev, Anatoly/0000-0001-8709-7666	Direccion General de Asuntos del Personal Academico/UNAM, Mexico [PAPIIT: IN212110]	Direccion General de Asuntos del Personal Academico/UNAM, Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Direccion General de Asuntos del Personal Academico/UNAM, Mexico (grant no. PAPIIT: IN212110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamillo JM, 2010, PLANT CELL ENVIRON, V33, P1828, DOI 10.1111/j.1365-3040.2010.02187.x; Alia, 2001, AMINO ACIDS, V21, P195; Angra S., 2010, International Journal of Agricultural Research, V5, P328, DOI 10.3923/ijar.2010.328.345; Arrese-Igor C, 1999, SYMBIOSIS, V27, P189; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bligny R, 2001, CURR OPIN PLANT BIOL, V4, P191, DOI 10.1016/S1369-5266(00)00160-6; Charlton AJ, 2008, METABOLOMICS, V4, P312, DOI 10.1007/s11306-008-0128-0; Colquhoun IJ, 2007, J PESTIC SCI, V32, P200, DOI 10.1584/jpestics.R07-03; CONROY MJ, 1988, J WILDLIFE MANAGE, V52, P694, DOI 10.2307/3800933; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; FORD CW, 1984, PHYTOCHEMISTRY, V23, P1007, DOI 10.1016/S0031-9422(00)82601-1; FUKUTOKU Y, 1981, PLANT CELL PHYSIOL, V22, P1397, DOI 10.1093/oxfordjournals.pcp.a076292; Galvez L, 2005, J EXP BOT, V56, P2551, DOI 10.1093/jxb/eri249; Gonzalez EM, 1998, J EXP BOT, V49, P1705, DOI 10.1093/jexbot/49.327.1705; Goodacre R, 2000, ANAL CHEM, V72, P119, DOI 10.1021/ac990661i; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hien DT, 2003, PLANT SCI, V165, P1059, DOI 10.1016/S0168-9452(03)00301-7; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; KELLER F, 1993, J EXP BOT, V44, P1351, DOI 10.1093/jxb/44.8.1351; King CA, 2005, PLANT PHYSIOL, V137, P1389, DOI 10.1104/pp.104.056317; Lazcano-Ferrat I, 1999, CROP SCI, V39, P467, DOI 10.2135/cropsci1999.0011183X0039000200028x; Marino D, 2007, PLANT PHYSIOL, V143, P1968, DOI 10.1104/pp.106.097139; Masoumi H, 2011, AUST J CROP SCI, V5, P544; McManus MT, 2000, ENVIRON EXP BOT, V43, P11, DOI 10.1016/S0098-8472(99)00041-6; Mohsenzadeh S, 2006, ENVIRON EXP BOT, V56, P314, DOI 10.1016/j.envexpbot.2005.03.008; Neo HH, 1997, PLANT PHYSIOL, V113, P259, DOI 10.1104/pp.113.1.259; PANDEY RK, 1984, AGRON J, V76, P557, DOI 10.2134/agronj1984.00021962007600040011x; Pimentel D., 2008, BIOFUELS SOLAR WIND, P373; Pinheiro C, 2004, J PLANT PHYSIOL, V161, P1203, DOI 10.1016/j.jplph.2004.01.016; Premachandra GS, 1995, J EXP BOT, V46, P1833, DOI 10.1093/jxb/46.12.1833; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Ronde J. A. de, 2000, African Crop Science Journal, V8, P85; Samarah N, 2004, J PLANT NUTR, V27, P815, DOI 10.1081/PLN-120030673; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Sassi S, 2010, AFR J BIOTECHNOL, V9, P6061; Serraj R, 1999, J EXP BOT, V50, P143, DOI 10.1093/jexbot/50.331.143; Serraj R, 2001, AGRONOMIE, V21, P621, DOI 10.1051/agro:2001153; Sobolev AP, 2003, MAGN RESON CHEM, V41, P237, DOI 10.1002/mrc.1176; SPRENT JI, 1972, NEW PHYTOL, V71, P603, DOI 10.1111/j.1469-8137.1972.tb01270.x; SUMMERFIELD RJ, 1977, EXP AGR, V13, P81, DOI 10.1017/S0014479700007638; SUNDARESAN S, 1995, PHYSIOL PLANTARUM, V94, P635, DOI 10.1111/j.1399-3054.1995.tb00978.x; VOGELS GD, 1970, ANAL BIOCHEM, V33, P143, DOI 10.1016/0003-2697(70)90448-3	47	174	177	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38554	10.1371/journal.pone.0038554	http://dx.doi.org/10.1371/journal.pone.0038554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685583	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700046
J	Guo, QS; Xia, B; Zhang, F; Richardson, MM; Li, MH; Zhang, JS; Chen, F; Zhang, XA				Guo, Qiusha; Xia, Bing; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Chen, Feng; Zhang, Xin A.			Tetraspanin CO-029 Inhibits Colorectal Cancer Cell Movement by Deregulating Cell-Matrix and Cell-Cell Adhesions	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; STEM-CELLS; E-CADHERIN; INTRAHEPATIC METASTASIS; TUMOR INVASION; GROWTH-FACTOR; ASSOCIATION; EXPRESSION; MOTILITY; MIGRATION	Alterations in tetraspanin CO-029 expression are associated with the progression and metastasis of cancers in the digestive system. However, how CO-029 promotes cancer metastasis is still poorly understood. To determine the mechanism, we silenced CO-029 expression in HT29 colon cancer cells and found that the CO-029 knockdown significantly reduced cell migratory ability. The diminished cell migration was accompanied by the upregulation of both integrin-dependent cell-matrix adhesion on laminin and calcium-dependent cell-cell adhesion. The cell surface levels of laminin-binding integrin alpha 3 beta 1 and fibronectin-integrin alpha 5 beta 1 were increased while the level of CD44 was decreased upon CO-029 silencing. These changes contribute to the altered cell-matrix adhesion. The deregulated cell-cell adhesion results, at least partially, from increased activity of cadherins and reduced level of MelCAM. In conclusion, CO-029 functions as a regulator of both cell-matrix and cell-cell adhesion. During colon cancer progression, CO-029 promotes cancer cell movement by deregulating cell adhesions.	[Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Memphis, TN 38163 USA; [Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc, Memphis, TN 38163 USA; [Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Guo, Qiusha; Xia, Bing] Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Guo, Qiusha; Chen, Feng] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Wuhan University; Washington University (WUSTL)	Guo, QS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Memphis, TN 38163 USA.	bingxiawh@gmail.com; xin-zhang-1@ouhsc.edu	Zhang, Feng/B-6691-2012	Zhang, Feng/0000-0002-6103-1498	National Institutes of Health [CA096991]; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health CA096991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Boucheix C, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002381; BOUCHEIX C, 1983, FEBS LETT, V161, P289, DOI 10.1016/0014-5793(83)81027-8; Claas C, 1998, J CELL BIOL, V141, P267, DOI 10.1083/jcb.141.1.267; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; de Both NJ, 1999, BRIT J CANCER, V81, P934, DOI 10.1038/sj.bjc.6690790; DELWEL GO, 1993, J BIOL CHEM, V268, P25865; FIDLER IJ, 1987, BREAST CANCER RES TR, V9, P17, DOI 10.1007/BF01806690; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Glinsky GV, 1996, CANCER LETT, V101, P43, DOI 10.1016/0304-3835(96)04112-2; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Herlevsen M, 2003, J CELL SCI, V116, P4373, DOI 10.1242/jcs.00760; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huerta S, 2003, INT J ONCOL, V22, P663; Inoue G, 2001, INT J MOL MED, V7, P67; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones PH, 1996, CELL ADHES COMMUN, V4, P297, DOI 10.3109/15419069609010773; Kanetaka K, 2003, J GASTROEN HEPATOL, V18, P1309, DOI 10.1046/j.1440-1746.2003.03182.x; Kanetaka K, 2001, J HEPATOL, V35, P637, DOI 10.1016/S0168-8278(01)00183-0; Koyama Y, 1998, BIOCHEM BIOPH RES CO, V246, P841, DOI 10.1006/bbrc.1998.8725; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Marhaba R, 2004, J MOL HISTOL, V35, P211; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Nakazawa Y, 2008, BLOOD; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Ovalle S, 2007, INT J CANCER, V121, P2140, DOI 10.1002/ijc.22902; PAGET S, 1989, CANCER METAST REV, V8, P98; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Sales KM, 2007, STEM CELL REV, V3, P249, DOI 10.1007/s12015-007-9002-0; SELA BA, 1989, HYBRIDOMA, V8, P481, DOI 10.1089/hyb.1989.8.481; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sho M, 1998, INT J CANCER, V79, P509, DOI 10.1002/(SICI)1097-0215(19981023)79:5<509::AID-IJC11>3.0.CO;2-X; Stutzmann J, 2000, MICROSC RES TECHNIQ, V51, P179, DOI 10.1002/1097-0029(20001015)51:2<179::AID-JEMT9>3.0.CO;2-4; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; Szollosi J, 1996, J IMMUNOL, V157, P2939; TAICHMAN DB, 1991, CELL REGUL, V2, P347, DOI 10.1091/mbc.2.5.347; Tanaka F, 2002, J BIOCHEM, V131, P39, DOI 10.1093/oxfordjournals.jbchem.a003075; Testa JE, 1999, CANCER RES, V59, P3812; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Weinberg, 2007, BIOL CANC, P587; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200; Yu Q, 2000, GENE DEV, V14, P163; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Zou GM, 2007, J CELL PHYSIOL, V213, P440, DOI 10.1002/jcp.21140	66	17	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38464	10.1371/journal.pone.0038464	http://dx.doi.org/10.1371/journal.pone.0038464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679508	Green Published, gold			2022-12-25	WOS:000305343900046
J	Zhang, Q; Tan, DM; Luo, WP; Lu, JJ; Tan, Y				Zhang, Qian; Tan, Dongmei; Luo, Wenping; Lu, Junjie; Tan, Yi			Expression of CD82 in Human Trophoblast and Its Role in Trophoblast Invasion	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; MATERNAL-FETAL INTERFACE; EPITHELIAL-MESENCHYMAL TRANSITION; EMBRYO IMPLANTATION; TUMOR INVASION; CELLS; KAI1; CANCER; DIFFERENTIATION; INVASIVENESS	Background: Well-controlled trophoblast invasion at maternal-fetal interface is a critical event for the normal development of placenta. CD82 is a member of transmembrane 4 superfamily, which showed important role in inhibiting tumor cell invasion and migration. We surmised that CD82 are participates in trophoblast differentiation during placenta development. Methodology/Principal Findings: CD82 was found to be strongly expressed in human first trimester placental villous and extravillous trophoblast cells as well as in trophoblast cell lines. To investigate whether CD82 plays a role in trophoblast invasion and migration, we further utilized human villous explants culture model on matrigel and invasion/migration assay of trophoblast cell line HTR8/SVneo. CD82 siRNA significantly promoted outgrowth of villous explants in vitro (P<0.01), as well as invasion and migration of HTR8/SVneo cells (P<0.05), whereas the trophoblast proliferation was not affected. The enhanced effect of CD82 siRNA on invasion and migration of trophoblast cells was found associated with increased gelatinolytic activities of matrix metalloproteinase MMP9 while over-expression of CD82 markedly decreased trphoblast cell invasion and migration as well as MMP9 activities. Conclusions/Significance: These findings suggest that CD82 is an important negative regulator at maternal-fetal interface during early pregnancy, inhibiting human trophoblast invasion and migration.	[Zhang, Qian; Tan, Dongmei; Luo, Wenping; Lu, Junjie; Tan, Yi] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Chongqing Medical University	Zhang, Q (corresponding author), Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China.	tanyee66@hotmail.com			Chongqing National Natural Science Foundation [CSTC2009BB5409]; Research Fund for the Doctoral Program of Department of Education of China [20095503110006]	Chongqing National Natural Science Foundation; Research Fund for the Doctoral Program of Department of Education of China	This study was supported by Chongqing National Natural Science Foundation (CSTC2009BB5409), and the Research Fund for the Doctoral Program of Department of Education of China (20095503110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee DNT, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000019120.48685.02; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Bischof P, 1995, Early Pregnancy, V1, P263; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dong JT, 1996, CANCER RES, V56, P4387; Drake PM, 2004, DEV DYNAM, V229, P877, DOI 10.1002/dvdy.10477; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; Friess H, 1998, INT J CANCER, V79, P349, DOI 10.1002/(SICI)1097-0215(19980821)79:4<349::AID-IJC7>3.0.CO;2-V; Fu JJ, 2010, J BIOL CHEM, V285, P10870, DOI 10.1074/jbc.M109.004200; Gellersen B, 2007, AM J PATHOL, V170, P126, DOI 10.2353/ajpath.2007.060175; Guo XZ, 1998, HEPATOLOGY, V28, P1481, DOI 10.1002/hep.510280606; Hannan NJ, 2007, CURR OPIN OBSTET GYN, V19, P266, DOI 10.1097/GCO.0b013e328133885f; Jee BK, 2006, BIOCHEM BIOPH RES CO, V342, P655, DOI 10.1016/j.bbrc.2006.01.153; Kilani RT, 2007, REPRODUCTION, V133, P257, DOI 10.1530/REP-06-0080; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lee JH, 2003, CANCER RES, V63, P7247; Li MQ, 2011, J MOL ENDOCRINOL, V47, P195, DOI 10.1530/JME-10-0165; Li MQ, 2011, INT J CLIN EXP PATHO, V4, P276; Li MQ, 2010, BIOL REPROD, V82, P968, DOI 10.1095/biolreprod.109.080739; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mannion BA, 1996, J IMMUNOL, V157, P2039; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Ren L, 2011, HUM REPROD; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Vicovac L, 1996, ACTA ANAT, V156, P202; Wu X, 2004, BIOL REPROD, V70, P1877, DOI 10.1095/biolreprod.103.024729; Yang XH, 1997, CANCER LETT, V119, P149, DOI 10.1016/S0304-3835(97)00273-5; Zhou Z, 2009, PLACENTA, V30, P929, DOI 10.1016/j.placenta.2009.09.003	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38487	10.1371/journal.pone.0038487	http://dx.doi.org/10.1371/journal.pone.0038487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679510	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900048
J	Favaro, LCD; Sebastianes, FLD; Araujo, WL				de Lima Favaro, Leia Cecilia; de Souza Sebastianes, Fernanda Luiza; Araujo, Welington Luiz			Epicoccum nigrum P16, a Sugarcane Endophyte, Produces Antifungal Compounds and Induces Root Growth	PLOS ONE			English	Article							POSTHARVEST BROWN-ROT; FUNGAL ENDOPHYTES; BIOLOGICAL-CONTROL; RHIZOCTONIA-SOLANI; NITROGEN-FIXATION; MONILINIA-LAXA; PURPURASCENS; DIVERSITY; BIOCONTROL; PATHOGENS	Background: Sugarcane is one of the most important crops in Brazil, mainly because of its use in biofuel production. Recent studies have sought to determine the role of sugarcane endophytic microbial diversity in microorganism-plant interactions, and their biotechnological potential. Epicoccum nigrum is an important sugarcane endophytic fungus that has been associated with the biological control of phytopathogens, and the production of secondary metabolites. In spite of several studies carried out to define the better conditions to use E. nigrum in different crops, little is known about the establishment of an endophytic interaction, and its potential effects on plant physiology. Methodology/Principal Findings: We report an approach based on inoculation followed by re-isolation, molecular monitoring, microscopic analysis, plant growth responses to fungal colonization, and antimicrobial activity tests to study the basic aspects of the E. nigrum endophytic interaction with sugarcane, and the effects of colonization on plant physiology. The results indicate that E. nigrum was capable of increasing the root system biomass and producing compounds that inhibit the in vitro growth of sugarcane pathogens Fusarium verticillioides, Colletotrichum falcatum, Ceratocystis paradoxa, and Xanthomomas albilineans. In addition, E. nigrum preferentially colonizes the sugarcane surface and, occasionally, the endophytic environment. Conclusions/Significance: Our work demonstrates that E. nigrum has great potential for sugarcane crop application because it is capable of increasing the root system biomass and controlling pathogens. The study of the basic aspects of the interaction of E. nigrum with sugarcane demonstrated the facultative endophytism of E. nigrum and its preference for the phylloplane environment, which should be considered in future studies of biocontrol using this species. In addition, this work contributes to the knowledge of the interaction of this ubiquitous endophyte with the host plant, and also to a better use of microbial endophytes in agriculture.	[de Lima Favaro, Leia Cecilia] Brazilian Agr Res Corp, Embrapa Agroenergia, Brasilia, DF, Brazil; [de Souza Sebastianes, Fernanda Luiza] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Sao Paulo, Brazil; [Araujo, Welington Luiz] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade de Sao Paulo	Favaro, LCD (corresponding author), Brazilian Agr Res Corp, Embrapa Agroenergia, Brasilia, DF, Brazil.	leia.favaro@embrapa.br	DE LIMA FAVARO, LEIA CECILIA/F-7350-2012; Araújo, Welington/G-4905-2012	DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Araújo, Welington/0000-0002-2120-8172	FAPESP (State of Sao Paulo Research Foundation) [02/14143-3, 10/08286-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	FAPESP (State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by FAPESP (State of Sao Paulo Research Foundation) (Grants 02/14143-3 and 10/08286-2). The authors also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a doctoral fellowship to LCLF (Graduate Program in Plant Genetics and Breeding, "Luiz de Queiroz" College of Agriculture, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2007, J INVERTEBR PATHOL, V96, P34, DOI 10.1016/j.jip.2007.02.004; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; [Anonymous], 1994, BIOTECHNOLOGY ENDOPH; Araujo FDS, 2012, ZIANG NAT PROD C LAN; Arnold AE, 2007, J TROP ECOL, V23, P369, DOI 10.1017/S0266467407004038; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Azevedo JL, 2007, FUNGI MULTIFACETED M, P189; Backman PA, 2008, BIOL CONTROL, V46, P1, DOI 10.1016/j.biocontrol.2008.03.009; Baldani JI, 2002, FUNCT PLANT BIOL, V29, P417, DOI 10.1071/PP01083; BAMFORD PHILIP C., 1961, TRANS BRIT MYCOL SOC, V44, P354; BAUTE MA, 1978, J ANTIBIOT, V31, P1099, DOI 10.7164/antibiotics.31.1099; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Boddey RM, 2003, PLANT SOIL, V252, P139, DOI 10.1023/A:1024152126541; BROWN AE, 1987, SOIL BIOL BIOCHEM, V19, P657, DOI 10.1016/0038-0717(87)90044-7; Camatti-Sartori V, 2005, J BASIC MICROB, V45, P397, DOI 10.1002/jobm.200410547; Campanile G, 2007, EUR J PLANT PATHOL, V117, P237, DOI 10.1007/s10658-006-9089-1; CHAND T, 1984, T BRIT MYCOL SOC, V83, P107, DOI 10.1016/S0007-1536(84)80250-8; de Almeida CV, 2005, PESQUI AGROPECU BRAS, V40, P467, DOI 10.1590/S0100-204X2005000500007; de Azeredo L A, 1998, Int Microbiol, V1, P205; De Cal A, 2009, J APPL MICROBIOL, V106, P592, DOI 10.1111/j.1365-2672.2008.04030.x; Favaro LCD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014828; Dini-Andreote F, 2010, PLANT SOIL, V336, P337, DOI 10.1007/s11104-010-0486-z; Elmer PAG, 2001, P 13 BIENN C AUSTR P, P339; Favaro LCL, 2007, RES 5 C BRAS MIC, P199; FISHER PJ, 1992, NEW PHYTOL, V120, P137, DOI 10.1111/j.1469-8137.1992.tb01066.x; Fowler S. R., 1999, Proceedings of the Fifty Second New Zealand Plant Protection Conference, Auckland Airport Centra, Auckland, New Zealand, 10-12 August, 1999, P141; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; GRATTAPAGLIA D, 1990, TECNICAS APLICACOES, P99; Hashem M., 2004, Archives of Phytopathology and Plant Protection, V37, P283, DOI 10.1080/03235400310001612955; ICHIKAWA T, 1971, FOLIA MICROBIOL, V16, P218, DOI 10.1007/BF02884210; IKAWA M, 1978, J ANTIBIOT, V31, P159, DOI 10.7164/antibiotics.31.159; Wangun HVK, 2007, ORG BIOMOL CHEM, V5, P1702, DOI 10.1039/b702378b; Kortekamp A, 1997, VITIS, V36, P215; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Lahlali R, 2010, FEMS MICROBIOL LETT, V311, P152, DOI 10.1111/j.1574-6968.2010.02084.x; Larena I, 2005, BIOL CONTROL, V32, P305, DOI 10.1016/j.biocontrol.2004.10.010; Larena I, 2009, POSTHARVEST BIOL TEC, V54, P63, DOI 10.1016/j.postharvbio.2009.05.007; Larran S, 2007, WORLD J MICROB BIOT, V23, P565, DOI 10.1007/s11274-006-9266-6; Luvizotto DM, 2010, WORLD J MICROB BIOT, V26, P1829, DOI 10.1007/s11274-010-0364-0; MADRIGAL C, 1991, MYCOL RES, V95, P1375, DOI 10.1016/S0953-7562(09)80388-2; MADRIGAL C, 1995, CAN J BOT, V73, P425, DOI 10.1139/b95-043; Mari M, 2007, J SCI FOOD AGR, V87, P1271, DOI 10.1002/jsfa.2839; Martini M, 2009, PLANT DIS, V93, P993, DOI 10.1094/PDIS-93-10-0993; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Mielnichuk N, 2007, FOREST PATHOL, V37, P236, DOI 10.1111/j.1439-0329.2007.00496.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musetti R, 2011, J APPL MICROBIOL, V110, P746, DOI 10.1111/j.1365-2672.2011.04937.x; Nasim G, 2008, PAK J BOT, V40, P2587; Newcombe George, 2009, Commun Integr Biol, V2, P29; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pallu APS, 2009, 3 INT C ENV IND APPL, P130; Pieckenstain FL, 2001, MYCOL RES, V105, P77, DOI 10.1017/S0953756200003129; Pinto LSRC, 2000, NEW PHYTOL, V147, P609, DOI 10.1046/j.1469-8137.2000.00722.x; Quecine MC, 2008, RES 54 C BRAS GEN, P133; Rojas JD, 2012, MICROB ECOL, V63, P565, DOI 10.1007/s00248-011-9938-0; Romao AS, 2007, MICOLOGIA AVANCOS CO, P150; Romao AS, 2010, THESIS U SAO PAULO L; ROYSE DJ, 1978, PHYTOPATHOLOGY, V68, P603, DOI 10.1094/Phyto-68-603; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; SPELHAUG SR, 1989, J FOOD PROTECT, V52, P856, DOI 10.4315/0362-028X-52.12.856; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Suryanarayanan T., 2011, FOR SCI, V80, P67, DOI DOI 10.1007/978-94-007-1599-8_4; Suryanarayanan T. S., 2009, Fungal Biology Reviews, V23, P9, DOI 10.1016/j.fbr.2009.07.001; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; WEBBER JF, 1986, T BRIT MYCOL SOC, V86, P93, DOI 10.1016/S0007-1536(86)80120-6; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Zhang YG, 2007, J NAT PROD, V70, P1522, DOI 10.1021/np070239u; ZHOU T, 1991, PHYTOPATHOLOGY, V81, P774, DOI 10.1094/Phyto-81-774; ZHOU T, 1991, CAN J BOT, V69, P2503, DOI 10.1139/b91-311	75	80	108	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36826	10.1371/journal.pone.0036826	http://dx.doi.org/10.1371/journal.pone.0036826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675473	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700007
J	Kurouski, D; Washington, J; Ozbil, M; Prabhakar, R; Shekhtman, A; Lednev, IK				Kurouski, Dmitry; Washington, Jacqueline; Ozbil, Mehmet; Prabhakar, Rajeev; Shekhtman, Alexander; Lednev, Igor K.			Disulfide Bridges Remain Intact while Native Insulin Converts into Amyloid Fibrils	PLOS ONE			English	Article							SECONDARY STRUCTURE; MOLECULAR-DYNAMICS; PROTEIN; BETA(2)-MICROGLOBULIN; FIBRILLATION; BONDS; NMR; SPECTROSCOPY; MECHANISM; EVOLUTION	Amyloid fibrils are beta-sheet-rich protein aggregates commonly found in the organs and tissues of patients with various amyloid-associated diseases. Understanding the structural organization of amyloid fibrils can be beneficial for the search of drugs to successfully treat diseases associated with protein misfolding. The structure of insulin fibrils was characterized by deep ultraviolet resonance Raman (DUVRR) and Nuclear Magnetic Resonance (NMR) spectroscopy combined with hydrogen-deuterium exchange. The compositions of the fibril core and unordered parts were determined at single amino acid residue resolution. All three disulfide bonds of native insulin remained intact during the aggregation process, withstanding scrambling. Three out of four tyrosine residues were packed into the fibril core, and another aromatic amino acid, phenylalanine, was located in the unordered parts of insulin fibrils. In addition, using all-atom MD simulations, the disulfide bonds were confirmed to remain intact in the insulin dimer, which mimics the fibrillar form of insulin.	[Kurouski, Dmitry; Washington, Jacqueline; Shekhtman, Alexander; Lednev, Igor K.] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Ozbil, Mehmet; Prabhakar, Rajeev] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Miami	Kurouski, D (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ilednev@albany.edu	Özbil, Mehmet/ABH-2905-2020; Lednev, Igor K/J-8387-2017; Ozbil, Mehmet/AAI-1882-2019	Özbil, Mehmet/0000-0002-1465-7674; Lednev, Igor K/0000-0002-6504-531X; Cobbert, Jacqueline/0000-0001-7782-0953; Prabhakar, Rajeev/0000-0003-1137-1272; Shekhtman, Alexander/0000-0003-2649-2675; Kurouski, Dmitry/0000-0002-6040-4213	National Institutes of Health [R01 GM085006-01A2]; National Institute on Aging of the National Institutes of Health [R01AG033719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R01 GM085006-01A2 from National Institutes of Health (AS) and award R01AG033719 from the National Institute on Aging of the National Institutes of Health (IKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chang SG, 2003, MOL CELLS, V16, P323; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jaimohan SM, 2009, ACTA CRYSTALLOGR F, V65, P1027, DOI 10.1107/S1744309109034071; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Kim T, 2006, J AM CHEM SOC, V128, P5330, DOI 10.1021/ja0607382; KLINE AD, 1990, BIOCHEMISTRY-US, V29, P2906, DOI 10.1021/bi00464a003; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Kurouski Dmitry, 2011, Int J Biomed Nanosci Nanotechnol, V2, P167, DOI 10.1504/IJBNN.2011.041000; Kurouski D, 2010, CHEM COMMUN, V46, P7154, DOI 10.1039/c0cc02423f; Lednev I. K., 2007, PROTEIN STRUCTURES M, P1; Lednev IK, 2005, ANAL BIOANAL CHEM, V381, P431, DOI 10.1007/s00216-004-2991-5; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Masse JE, 2006, J MAGN RESON, V181, P45, DOI 10.1016/j.jmr.2006.03.012; Mikhonin AV, 2006, J PHYS CHEM B, V110, P1928, DOI 10.1021/jp054593h; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Nayak A, 2009, PROTEINS, V74, P556, DOI 10.1002/prot.22169; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schoneich C, 2002, ARCH BIOCHEM BIOPHYS, V397, P370, DOI 10.1006/abbi.2001.2621; Shashilov VA, 2010, CHEM REV, V110, P5692, DOI 10.1021/cr900152h; Shashilov VA, 2010, METHODS, V52, P23, DOI 10.1016/j.ymeth.2010.05.004; Tu A.T., 1982, RAMAN SPECTROSCOPY B; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu M, 2007, J AM CHEM SOC, V129, P11002, DOI 10.1021/ja073798w; Xu M, 2007, PROTEIN SCI, V16, P815, DOI 10.1110/ps.062639307; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	51	64	65	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36989	10.1371/journal.pone.0036989	http://dx.doi.org/10.1371/journal.pone.0036989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675475	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900004
J	Adam, C; Picard, M; Dequard-Chablat, M; Sellem, CH; Hermann-Le Denmat, S; Contamine, V				Adam, Celine; Picard, Marguerite; Dequard-Chablat, Michelle; Sellem, Carole H.; Hermann-Le Denmat, Sylvie; Contamine, Veronique			Biological Roles of the Podospora anserina Mitochondrial Lon Protease and the Importance of Its N-Domain	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; REAL-TIME PCR; NUCLEAR MUTATIONS; CELLS; MAINTENANCE; PROTEOLYSIS; EXPRESSION; SEQUENCE; DNA; BACTERIAL	Mitochondria have their own ATP-dependent proteases that maintain the functional state of the organelle. All multicellular eukaryotes, including filamentous fungi, possess the same set of mitochondrial proteases, unlike in unicellular yeasts, where ClpXP, one of the two matricial proteases, is absent. Despite the presence of ClpXP in the filamentous fungus Podospora anserina, deletion of the gene encoding the other matricial protease, PaLon1, leads to lethality at high and low temperatures, indicating that PaLON1 plays a main role in protein quality control. Under normal physiological conditions, the PaLon1 deletion is viable but decreases life span. PaLon1 deletion also leads to defects in two steps during development, ascospore germination and sexual reproduction, which suggests that PaLON1 ensures important regulatory functions during fungal development. Mitochondrial Lon proteases are composed of a central ATPase domain flanked by a large non-catalytic N-domain and a C-terminal protease domain. We found that three mutations in the N-domain of PaLON1 affected fungal life cycle, PaLON1 protein expression and mitochondrial proteolytic activity, which reveals the functional importance of the N-domain of the mitochondrial Lon protease. All PaLon1 mutations affected the C-terminal part of the N-domain. Considering that the C-terminal part is predicted to have an alpha helical arrangement in which the number, length and position of the helices are conserved with the solved structure of its bacterial homologs, we propose that this all-helical structure participates in Lon substrate interaction.	[Adam, Celine; Picard, Marguerite; Dequard-Chablat, Michelle; Hermann-Le Denmat, Sylvie; Contamine, Veronique] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Adam, Celine; Picard, Marguerite; Dequard-Chablat, Michelle; Hermann-Le Denmat, Sylvie; Contamine, Veronique] CNRS, F-91405 Orsay, France; [Sellem, Carole H.] CNRS, Ctr Genet Mol, UPR 3404, Gif Sur Yvette, France; [Hermann-Le Denmat, Sylvie] Ecole Normale Super, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Adam, C (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France.	sylvie.hermann-ledenmat@igmors.u-psud.fr; veronique.contamine@igmors.u-psud.fr			Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by research projects granted by the Association Francaise contre les Myopathies [http://www.afm-telethon.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 2002, CURR GENET, V40, P365, DOI 10.1007/s00294-002-0275-1; Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chir JL, 2009, BIOCHEM BIOPH RES CO, V382, P762, DOI 10.1016/j.bbrc.2009.03.109; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Contamine V, 1998, FUNGAL GENET BIOL, V23, P223, DOI 10.1006/fgbi.1998.1040; Contamine W, 2004, GENETICS, V166, P135, DOI 10.1534/genetics.166.1.135; Dequard-Chablat M, 2011, MOL BIOL EVOL, V28, P2063, DOI 10.1093/molbev/msr025; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Ebel W, 1999, J BACTERIOL, V181, P2236, DOI 10.1128/JB.181.7.2236-2243.1999; El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3; El-Khoury R, 2009, GENETICS, V183, P861, DOI 10.1534/genetics.109.107813; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Guha S, 2011, J MOL BIOL, V408, P222, DOI 10.1016/j.jmb.2011.02.044; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; HAFFTER P, 1992, GENETICS, V131, P255; Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Li M, 2010, ACTA CRYSTALLOGR D, V66, P865, DOI 10.1107/S0907444910019554; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Melnikov EE, 2008, ACTA BIOCHIM POL, V55, P281, DOI 10.18388/abp.2008_3075; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Rigas S, 2009, NEW PHYTOL, V181, P588, DOI 10.1111/j.1469-8137.2008.02701.x; Roudiak SG, 1998, BIOCHEMISTRY-US, V37, P11255, DOI 10.1021/bi980945h; Sellem CH, 2005, GENETICS, V169, P1379, DOI 10.1534/genetics.104.033837; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	41	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38138	10.1371/journal.pone.0038138	http://dx.doi.org/10.1371/journal.pone.0038138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693589	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500092
J	Garcia-Fraile, P; Carro, L; Robledo, M; Ramirez-Bahena, MH; Flores-Felix, JD; Fernandez, MT; Mateos, PF; Rivas, R; Igual, JM; Martinez-Molina, E; Peix, A; Velazquez, E				Garcia-Fraile, Paula; Carro, Lorena; Robledo, Marta; Ramirez-Bahena, Martha-Helena; Flores-Felix, Jose-David; Teresa Fernandez, Maria; Mateos, Pedro F.; Rivas, Raul; Mariano Igual, Jose; Martinez-Molina, Eustoquio; Peix, Alvaro; Velazquez, Encarna			Rhizobium Promotes Non-Legumes Growth and Quality in Several Production Steps: Towards a Biofertilization of Edible Raw Vegetables Healthy for Humans	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA; ESCHERICHIA-COLI; IMPROVING GROWTH; ACC-DEAMINASE; PLANT; LEGUMINOSARUM; RHIZOSPHERE; INDUCTION; LETTUCE; STRAIN	The biofertilization of crops with plant-growth-promoting microorganisms is currently considered as a healthy alternative to chemical fertilization. However, only microorganisms safe for humans can be used as biofertilizers, particularly in vegetables that are raw consumed, in order to avoid sanitary problems derived from the presence of pathogenic bacteria in the final products. In the present work we showed that Rhizobium strains colonize the roots of tomato and pepper plants promoting their growth in different production stages increasing yield and quality of seedlings and fruits. Our results confirmed those obtained in cereals and alimentary oil producing plants extending the number of non-legumes susceptible to be biofertilized with rhizobia to those whose fruits are raw consumed. This is a relevant conclusion since safety of rhizobia for human health has been demonstrated after several decades of legume inoculation ensuring that they are optimal bacteria for biofertilization.	[Garcia-Fraile, Paula; Carro, Lorena; Robledo, Marta; Flores-Felix, Jose-David; Teresa Fernandez, Maria; Mateos, Pedro F.; Rivas, Raul; Martinez-Molina, Eustoquio; Velazquez, Encarna] Univ Salamanca, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Robledo, Marta; Mateos, Pedro F.; Martinez-Molina, Eustoquio] Ctr Hispanoluso Invest Agr, Salamanca, Spain; [Ramirez-Bahena, Martha-Helena; Mariano Igual, Jose; Peix, Alvaro] CSIC, Inst Recursos Nat & Agrobiol, Salamanca, Spain; [Ramirez-Bahena, Martha-Helena; Mateos, Pedro F.; Rivas, Raul; Mariano Igual, Jose; Martinez-Molina, Eustoquio; Peix, Alvaro; Velazquez, Encarna] Univ Salamanca, Unidad Asociada, Grupo Interacc Planta Microorganismo, Consejo Super Invest Cient, E-37008 Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca	Garcia-Fraile, P (corresponding author), John Innes Ctr, Norwich Res Pk Colney, Norwich, Norfolk, England.	evp@usal.es	Robledo, Marta/F-4879-2016; Igual, José M/B-6993-2015; Robledo, Marta/P-9938-2019; Ramírez-Bahena, Martha Helena/ABB-3717-2021; Mateos, Pedro/L-6001-2014; Flores-Félix, Jose David/B-2082-2017; Rivas, Raúl/B-1869-2017; Carro, Lorena/G-3126-2016; Ramirez-Bahena, Martha Helena/B-8564-2017; Peix, Alvaro/A-7196-2010; Velázquez, Encarna/B-3669-2017; Fraile, Paula Garcia/N-8193-2014	Robledo, Marta/0000-0002-4049-7635; Igual, José M/0000-0002-5080-0378; Robledo, Marta/0000-0002-4049-7635; Mateos, Pedro/0000-0003-1628-598X; Flores-Félix, Jose David/0000-0003-2200-4400; Rivas, Raúl/0000-0003-2202-1470; Carro, Lorena/0000-0001-8833-642X; Ramirez-Bahena, Martha Helena/0000-0002-0744-8313; Peix, Alvaro/0000-0001-5084-1586; Velázquez, Encarna/0000-0002-5946-7241; Fraile, Paula Garcia/0000-0002-9576-2184; Martinez-Molina, Eustoquio/0000-0002-0983-9780	Ministerio de Ciencia e Innovacion (Ministry of Science and Innovation, Spanish Central Government) [AGL2010-17380, AGL2011-29227]; Regional Development Funds; Junta de Castilla y Leon (Castilla and Leon Council, Spanish Regional Government) [SA183A11-2]; JAE-DOC from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council); Spanish International Cooperation Agency (Spanish Central Government)	Ministerio de Ciencia e Innovacion (Ministry of Science and Innovation, Spanish Central Government)(Ministry of Science and Innovation, Spain (MICINN)); Regional Development Funds; Junta de Castilla y Leon (Castilla and Leon Council, Spanish Regional Government); JAE-DOC from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council); Spanish International Cooperation Agency (Spanish Central Government)	This work was supported by Ministerio de Ciencia e Innovacion (Ministry of Science and Innovation, Spanish Central Government, Grant AGL2010-17380, that includes co-financial support of Regional Development Funds, and Grant AGL2011-29227) and Junta de Castilla y Leon (Castilla and Leon Council, Spanish Regional Government, Grant SA183A11-2). Martha Helena Ramirez-Bahena is recipient of a postdoctoral researcher contract JAE-DOC from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council). Maria Teresa Fernandez was supported by a fellowship of Spanish International Cooperation Agency (Spanish Central Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Antoun H, 1998, PLANT SOIL, V204, P57, DOI 10.1023/A:1004326910584; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; Berg G, 2005, ENVIRON MICROBIOL, V84, P11; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bhattacharjee RB, 2008, APPL MICROBIOL BIOT, V80, P199, DOI 10.1007/s00253-008-1567-2; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Chabot R, 1996, APPL ENVIRON MICROB, V62, P2767, DOI 10.1128/AEM.62.8.2767-2772.1996; Chabot R, 1996, PLANT SOIL, V184, P311, DOI 10.1007/BF00010460; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; DAZZO FB, 1984, APPL ENVIRON MICROB, V48, P1140, DOI 10.1128/AEM.48.6.1140-1150.1984; Dinu LD, 2011, APPL ENVIRON MICROB, V77, P8295, DOI 10.1128/AEM.05020-11; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Garcia-Fraile P, 2009, 1 IB C BEN MICR PLAN; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Gulati A, 2010, ARCH MICROBIOL, V192, P975, DOI 10.1007/s00203-010-0615-3; Gutierrez-Zamora ML, 2001, J BIOTECHNOL, V91, P117, DOI 10.1016/S0168-1656(01)00332-7; Ingram DT, 2007, J FOOD PROTECT, V70, P828, DOI 10.4315/0362-028X-70.4.828; Kang SH, 2007, J MICROBIOL BIOTECHN, V17, P96; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; Kim J, 2009, J FOOD PROTECT, V72, P1576, DOI 10.4315/0362-028X-72.7.1576; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kone SB, 2010, BIOL CONTROL, V52, P167, DOI 10.1016/j.biocontrol.2009.10.018; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Liu Y, 2011, CURR MICROBIOL, V62, P1113, DOI 10.1007/s00284-010-9835-7; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Mishra RPN, 2006, CURR MICROBIOL, V52, P383, DOI 10.1007/s00284-005-0296-3; Noel TC, 1996, CAN J MICROBIOL, V42, P279, DOI 10.1139/m96-040; OGARA F, 1976, BIOCHIM BIOPHYS ACTA, V451, P342, DOI 10.1016/0304-4165(76)90129-X; OHARA GW, 1989, APPL ENVIRON MICROB, V55, P1870, DOI 10.1128/AEM.55.8.1870-1876.1989; Peix A, 2001, SOIL BIOL BIOCHEM, V33, P103, DOI 10.1016/S0038-0717(00)00120-6; Peix A, 2009, SYST APPL MICROBIOL, V32, P334, DOI 10.1016/j.syapm.2009.03.004; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Ramirez-Bahena MH, 2009, CAN J MICROBIOL, V55, P1207, DOI [10.1139/W09-074, 10.1139/w09-074]; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Rokhbakhsh-Zamin F, 2011, J MICROBIOL BIOTECHN, V21, P556, DOI 10.4014/jmb.1012.12006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang MK, 2010, PHYTOPATHOLOGY, V100, P774, DOI 10.1094/PHYTO-100-8-0774; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Volksch B, 2009, INFECT GENET EVOL, V9, P1381, DOI 10.1016/j.meegid.2009.09.016; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069; Zahir ZA, 2009, ARCH MICROBIOL, V191, P415, DOI 10.1007/s00203-009-0466-y	53	92	108	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38122	10.1371/journal.pone.0038122	http://dx.doi.org/10.1371/journal.pone.0038122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675441	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500090
J	Manoli, DS; Subramanyam, D; Carey, C; Sudin, E; Van Westerhuyzen, JA; Bales, KL; Blelloch, R; Shah, NM				Manoli, Devanand S.; Subramanyam, Deepa; Carey, Catriona; Sudin, Erik; Van Westerhuyzen, Julie A.; Bales, Karen L.; Blelloch, Robert; Shah, Nirao M.			Generation of Induced Pluripotent Stem Cells from the Prairie Vole	PLOS ONE			English	Article							MICROTUS-OCHROGASTER; HUMAN FIBROBLASTS; VASOPRESSIN; MOUSE; INDUCTION; OXYTOCIN; NEUROBIOLOGY; MONOGAMY; PATTERNS; BEHAVIOR	The vast majority of animals mate more or less promiscuously. A few mammals, including humans, utilize more restrained mating strategies that entail a longer term affiliation with a single mating partner. Such pair bonding mating strategies have been resistant to genetic analysis because of a lack of suitable model organisms. Prairie voles are small mouse-like rodents that form enduring pair bonds in the wild as well as in the laboratory, and consequently they have been used widely to study social bonding behavior. The lack of targeted genetic approaches in this species however has restricted the study of the molecular and neural circuit basis of pair bonds. As a first step in rendering the prairie vole amenable to reverse genetics, we have generated induced pluripotent stem cell (IPSC) lines from prairie vole fibroblasts using retroviral transduction of reprogramming factors. These IPSC lines display the cellular and molecular hallmarks of IPSC cells from other organisms, including mice and humans. Moreover, the prairie vole IPSC lines have pluripotent differentiation potential since they can give rise to all three germ layers in tissue culture and in vivo. These IPSC lines can now be used to develop conditions that facilitate homologous recombination and eventually the generation of prairie voles bearing targeted genetic modifications to study the molecular and neural basis of pair bond formation.	[Manoli, Devanand S.; Carey, Catriona; Sudin, Erik; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Manoli, Devanand S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Subramanyam, Deepa; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Blelloch, Robert; Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Van Westerhuyzen, Julie A.; Bales, Karen L.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Manoli, DS (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	nms@ucsf.edu		Manoli, Devanand/0000-0002-7238-2330; Subramanyam, Deepa/0000-0002-1650-5690	University of California, San Francisco Program for Breakthrough Biomedical Research; National Institute of Health Director's Pioneer Award [DP1OD006425]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006425] Funding Source: NIH RePORTER	University of California, San Francisco Program for Breakthrough Biomedical Research(University of California System); National Institute of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds to Nirao Shah from the University of California, San Francisco Program for Breakthrough Biomedical Research and an National Institute of Health Director's Pioneer Award (DP1OD006425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Berry K, 2008, BEHAV RES THER, V46, P1275, DOI 10.1016/j.brat.2008.08.009; Bora E, 2009, CURR OPIN PSYCHIATR, V22, P320, DOI 10.1097/YCO.0b013e328329e970; Bosch OJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1406, DOI 10.1038/npp.2008.154; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CARTER CS, 1993, SCI AM, V268, P100, DOI 10.1038/scientificamerican0693-100; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donaldson ZR, 2009, BIOL REPROD, V81, P1189, DOI 10.1095/biolreprod.109.077529; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; HARTKE GT, 1974, J HERED, V65, P301, DOI 10.1093/oxfordjournals.jhered.a108533; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; INSEL TR, 1994, J NEUROSCI, V14, P5381; Insel TR, 1997, AM J PSYCHIAT, V154, P726; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Li XY, 2007, CELL TISSUE RES, V327, P607, DOI 10.1007/s00441-006-0354-6; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; McGraw LA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-70; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2010, EXP CELL RES, V316, P2565, DOI 10.1016/j.yexcr.2010.04.023; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Rebuzzini P, 2008, CYTOTECHNOLOGY, V58, P17, DOI 10.1007/s10616-008-9164-x; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suwinska A, 2010, INT J DEV BIOL, V54, P113, DOI 10.1387/ijdb.082704as; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, PHILOS T R SOC B, V366, P2222, DOI 10.1098/rstb.2011.0003; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson E.O., 1975, P1; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; You Y, 1997, NAT GENET, V15, P285, DOI 10.1038/ng0397-285; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zhou HY, 2010, CURR OPIN HEMATOL, V17, P276, DOI 10.1097/MOH.0b013e328339f2ee	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38119	10.1371/journal.pone.0038119	http://dx.doi.org/10.1371/journal.pone.0038119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675440	gold, Green Published			2022-12-25	WOS:000305338500089
J	Macauley, MS; Chan, J; Zandberg, WF; He, Y; Whitworth, GE; Stubbs, KA; Yuzwa, SA; Bennet, AJ; Varki, A; Davies, GJ; Vocadlo, DJ				Macauley, Matthew S.; Chan, Jefferson; Zandberg, Wesley F.; He, Yuan; Whitworth, Garrett E.; Stubbs, Keith A.; Yuzwa, Scott A.; Bennet, Andrew J.; Varki, Ajit; Davies, Gideon J.; Vocadlo, David J.			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups INTRACELLULAR beta-O-LINKED N-GLYCOLYLGLUCOSAMINE (GlcNGc), UDP-GlcNGc, AND THE BIOCHEMICAL AND STRUCTURAL RATIONALE FOR THE SUBSTRATE TOLERANCE OF beta-O-LINKED beta-N-ACETYLGLUCOSAMINIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC ACIDS; CAPILLARY-ELECTROPHORESIS; TETRATRICOPEPTIDE REPEATS; ASSISTED CATALYSIS; NUCLEOTIDE SUGARS; GLCNACASE; MECHANISM; PROTEIN; CELLS; GLYCOSYLATION	The O-GlcNAc modification involves the attachment of single beta-O-linked N-acetylglucosamine residues to serine and threonine residues of nucleocytoplasmic proteins. Interestingly, previous biochemical and structural studies have shown that O-GlcNAcase (OGA), the enzyme that removes O-GlcNAc from proteins, has an active site pocket that tolerates various N-acyl groups in addition to the N-acetyl group of GlcNAc. The remarkable sequence and structural conservation of residues comprising this pocket suggest functional importance. We hypothesized this pocket enables processing of metabolic variants of O-GlcNAc that could be formed due to inaccuracy within the metabolic machinery of the hexosamine biosynthetic pathway. In the accompanying paper (Bergfeld, A. K., Pearce, O. M., Diaz, S. L., Pham, T., and Varki, A. (2012) J. Biol. Chem. 287, 28865-28881), N-glycolylglucosamine (GlcNGc) was shown to be a catabolite of NeuNGc. Here, we show that the hexosamine salvage pathway can convert GlcNGc to UDP-GlcNGc, which is then used to modify proteins with O-GlcNGc. The kinetics of incorporation and removal of O-GlcNGc in cells occur in a dynamic manner on a time frame similar to that of O-GlcNAc. Enzymatic activity of O-GlcNAcase (OGA) toward a GlcNGc glycoside reveals OGA can process glycolyl-containing substrates fairly efficiently. A bacterial homolog (BtGH84) of OGA, from a human gut symbiont, also processes O-GlcNGc substrates, and the structure of this enzyme bound to a GlcNGc-derived species reveals the molecular basis for tolerance and binding of GlcNGc. Together, these results demonstrate that analogs of GlcNAc, such as GlcNGc, are metabolically viable species and that the conserved active site pocket of OGA likely evolved to enable processing of mis-incorporated analogs of O-GlcNAc and thereby prevent their accumulation. Such plasticity in carbohydrate processing enzymes may be a general feature arising from inaccuracy in hexosamine metabolic pathways.	[Macauley, Matthew S.; Chan, Jefferson; Zandberg, Wesley F.; Whitworth, Garrett E.; Bennet, Andrew J.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Yuzwa, Scott A.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [He, Yuan; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Stubbs, Keith A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Simon Fraser University; Simon Fraser University; University of York - UK; University of Western Australia; University of California System; University of California San Diego; University of California System; University of California San Diego	Vocadlo, DJ (corresponding author), 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Davies, Gideon J/A-9042-2011; Stubbs, Keith/H-5909-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Davies, Gideon J/0000-0002-7343-776X; He, Yuan/0000-0002-1712-0776; Macauley, Matthew/0000-0003-4579-1048; Chan, Jefferson/0000-0003-4139-4379; Stubbs, Keith/0000-0001-6899-402X	National Institutes of Health [R01GM32373]; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; University of York; Australian Research Council; Biotechnology and Biological Sciences Research Council; Royal Society/Wolfson Research Merit Award; BBSRC [BB/F007124/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007124/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of York(European Commission); Australian Research Council(Australian Research Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society/Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM32373 (to A. V.). This work was also supported by the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council of Canada (to D. J. V.).; Recipient of a senior scholarship from the Michael Smith Foundation for Health Research and Natural Sciences and Engineering Research Council of Canada.; Recipient of Ph.D. support from the Wild Fund of the University of York.; Recipient of support from the Australian Research Council.; Royal Society/Wolfson Research Merit Award recipient and supported by the Biotechnology and Biological Sciences Research Council.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUMANN W, 1989, BIOL CHEM H-S, V370, P141, DOI 10.1515/bchm3.1989.370.1.141; Bergfeld AK, 2012, J BIOL CHEM, V287, P28865, DOI 10.1074/jbc.M112.363549; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boomkamp Stephanie D., 2008, V49, P441, DOI 10.1007/978-1-4020-8831-5_17; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; CHOU CF, 1992, J BIOL CHEM, V267, P3901; Cunha AC, 1999, J CHEM EDUC, V76, P79, DOI 10.1021/ed076p79; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DIAZ S, 1985, ANAL BIOCHEM, V150, P32, DOI 10.1016/0003-2697(85)90438-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng HT, 2008, J CHROMATOGR B, V870, P131, DOI 10.1016/j.jchromb.2008.05.038; FERNANDE.A, 1971, J BIOL CHEM, V246, P3485; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Greig IR, 2009, J AM CHEM SOC, V131, P13415, DOI 10.1021/ja904506u; Hart G., 2008, ESSENTIALS GLYCOBIOL; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He Y, 2010, J AM CHEM SOC, V132, P1807, DOI 10.1021/ja9086769; KENT PW, 1968, BIOCHEM J, V106, P645, DOI 10.1042/bj1060645; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Lagarrigue M, 2008, J CHROMATOGR A, V1178, P239, DOI 10.1016/j.chroma.2007.11.024; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Martinez-Fleites C, 2010, BBA-GEN SUBJECTS, V1800, P122, DOI 10.1016/j.bbagen.2009.07.019; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Schauer R, 1996, BIOL CHEM H-S, V377, P293, DOI 10.1515/bchm3.1996.377.5.293; SINAY P, 1971, CARBOHYD RES, V16, P113, DOI 10.1016/S0008-6215(00)86104-2; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; VAMECQ J, 1990, BIOCHEM CELL BIOL, V68, P846, DOI 10.1139/o90-125; Varki A, 1996, GLYCOBIOLOGY, V6, P707, DOI 10.1093/glycob/6.7.707; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	57	16	16	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28882	28897		10.1074/jbc.M112.363721	http://dx.doi.org/10.1074/jbc.M112.363721			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692202	Green Published, hybrid			2022-12-25	WOS:000308074600059
J	Yin, KJ; Olsen, K; Hamblin, M; Zhang, JF; Schwendeman, SP; Chen, YE				Yin, Ke-Jie; Olsen, Karl; Hamblin, Milton; Zhang, Jifeng; Schwendeman, Steven P.; Chen, Y. Eugene			Vascular Endothelial Cell-specific MicroRNA-15a Inhibits Angiogenesis in Hindlimb Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PROSTATE-CANCER; IN-VITRO; VEGF; EXPRESSION; MIR-15A; DISEASE; TUMOR; TRANSLATION; MECHANISM	The effects and potential mechanisms of the vascular endothelial cell (EC)-enriched microRNA-15a (miR-15a) on angiogenesis remain unclear. Here, we show a novel finding that EC-selective miR-15a transgenic overexpression leads to reduced blood vessel formation and local blood flow perfusion in mouse hindlimbs at 1-3 weeks after hindlimb ischemia. Mechanistically, gain- or loss-of-miR-15a function by lentiviral infection in ECs significantly reduces or increases tube formation, cell migration, and cell differentiation, respectively. By FGF2 and VEGF 3'-UTR luciferase reporter assays, Real-time PCR, and immunoassays, we further identified that the miR-15a directly targets FGF2 and VEGF to facilitate its anti-angiogenic effects. Our data suggest that the miR-15a in ECs can significantly suppress cell-autonomous angiogenesis through direct inhibition of endogenous endothelial FGF2 and VEGF activities. Pharmacological modulation of miR-15a function may provide a new therapeutic strategy to intervene against angiogenesis in a variety of pathological conditions.	[Yin, Ke-Jie; Hamblin, Milton; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Olsen, Karl; Schwendeman, Steven P.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yin, KJ (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	kejie@umich.edu; echenum@umich.edu		Yin, Ke-Jie/0000-0002-7169-3858	National Institutes of Health [NS066652, HL089544, HL68345, T32 HL007853]; American Heart Association [0630209N, 0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853, R01HL089544, R01HL068345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS066652, HL089544 (to Y. E. C.), and HL68345 (to S. P. S.) and T32 HL007853 (to M. H.). This work was also supported by American Heart Association Grants 0630209N (to K.-J. Y.), 0835237N (to J. Z.), and 0840025N (to Y. E. C.).	Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Duan J, 2000, CIRCULATION, V102, P370; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hayashi T, 2006, CURR NEUROVASC RES, V3, P119, DOI 10.2174/156720206776875902; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Karaa ZS, 2009, RNA, V15, P249, DOI 10.1261/rna.1301109; Krupinski Jerzy, 1993, Patologia Polska, V44, P203; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shiba Y, 2008, CURR PHARM DESIGN, V14, P371, DOI 10.2174/138161208783497741; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; Yin KJ, 2011, ARTERIOSCL THROM VAS, V31, P574, DOI 10.1161/ATVBAHA.110.221267; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yin KJ, 2002, STROKE, V33, P2471, DOI 10.1161/01.STR.0000030316.79601.03; Zhang CX, 2010, J CARDIOVASC TRANSL, V3, P235, DOI 10.1007/s12265-010-9164-z; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	47	107	111	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27055	27064		10.1074/jbc.M112.364414	http://dx.doi.org/10.1074/jbc.M112.364414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692216	hybrid, Green Published			2022-12-25	WOS:000307386000058
J	Nystrom, S; Mishra, R; Hornemann, S; Aguzzi, A; Nilsson, KPR; Hammarstrom, P				Nystrom, Sofie; Mishra, Rajesh; Hornemann, Simone; Aguzzi, Adriano; Nilsson, K. Peter R.; Hammarstrom, Per			Multiple Substitutions of Methionine 129 in Human Prion Protein Reveal Its Importance in the Amyloid Fibrillation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; THERMODYNAMIC STABILITY; DNA POLYMORPHISM; GENE; VARIANT; AGGREGATION; CONVERSION; GENOTYPE; KINETICS	The role of the polymorphism Met or Val in position 129 in the human prion protein is well documented regarding disease susceptibility and clinical manifestations. However, little is known about the molecular background to this phenomenon. We investigated herein the conformational stability, amyloid fibrillation kinetics, and seeding propensity of different 129 mutants, located in beta-strand 1 of PrP (Met(129) (WT), M129A, M129V, M129L, M129W, M129P, M129E, M129K, and M129C) in HuPrP(90-231). The mutations M129V, M129L, M129K, and M129C did not affect stability (midpoints of thermal denaturation, T-m = 65-66 degrees C), whereas the mutants M129A and M129E and the largest side chain M129W were destabilized by 3-4 degrees C. The most destabilizing substitution was M129P, which lowered the T-m by 7.2 degrees C. All mutants, except for M129C, formed amyloid-like fibrils within hours during fibril formation under near physiological conditions. Fibril-forming mutants showed a sigmoidal kinetic profile and showed shorter lag times during seeding with preformed amyloid fibrils implicating a nucleated polymerization reaction. In the spontaneous reactions, the lag time of fibril formation was rather uniform for the mutants M129A, M129V, and M129L resembling the wild type. When the substituted amino acid had a distinct feature discriminating it from the wild type, such as size (M129W), charge (M129E, M129K), or rotational constraint (M129P), the fibrillation was impeded. M129C did not form ThT/Congo red-positive fibrils, and non-reducing SDS-PAGE of M129C during fibrillation conditions at different time points revealed covalent dimer formation already 15 min after fibrillation reaction initiation. Position 129 appears to be a key site for dictating PrP receptiveness toward recruitment into the amyloid state.	[Nystrom, Sofie; Mishra, Rajesh; Nilsson, K. Peter R.; Hammarstrom, Per] Linkoping Univ, IFM Dept Chem, S-58183 Linkoping, Sweden; [Hornemann, Simone; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	Linkoping University; University of Zurich; University Zurich Hospital	Hammarstrom, P (corresponding author), Linkoping Univ, IFM Dept Chem, S-58183 Linkoping, Sweden.	perha@ifm.liu.se	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708; Nystrom, Sofie/0000-0002-4303-4783	EU-FP7 Health Programme Project LUPAS; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Linkoping University Center for Neuroscience	EU-FP7 Health Programme Project LUPAS; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Linkoping University Center for Neuroscience	This work was supported by the EU-FP7 Health Programme Project LUPAS (to A. A., P. H., P. R. N., S. H., and S. N.), the Swedish Research Council (to P. H.), Knut and Alice Wallenberg Foundation (to P. H. and P. N.), The Swedish Foundation for Strategic Research (to P. H. and P. N.), and the Linkoping University Center for Neuroscience (to R. M.).	Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; DLOUHY SR, 1992, NAT GENET, V1, P64, DOI 10.1038/ng0492-64; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Gerber R, 2008, J MOL BIOL, V381, P212, DOI 10.1016/j.jmb.2008.05.057; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hainfellner JA, 1999, ANN NEUROL, V45, P812; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hosszu LLP, 2010, BIOCHEMISTRY-US, V49, P8729, DOI 10.1021/bi100572j; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Koh E, 2006, BIOINFORMATICS, V22, P297, DOI 10.1093/bioinformatics/bti775; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Lewis PA, 2006, J GEN VIROL, V87, P2443, DOI 10.1099/vir.0.81630-0; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Margalith I, 2012, J BIOL CHEM, V287, P18872, DOI 10.1074/jbc.M112.355958; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; OWEN F, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Petraroli R, 1996, AM J HUM GENET, V58, P888; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1	61	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25975	25984		10.1074/jbc.M112.372136	http://dx.doi.org/10.1074/jbc.M112.372136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669942	Green Published, hybrid			2022-12-25	WOS:000306916300025
J	Yoshida, T; Yamashita, M; Hayashi, M				Yoshida, Tadashi; Yamashita, Maho; Hayashi, Matsuhiko			Kruppel-like Factor 4 Contributes to High Phosphate-induced Phenotypic Switching of Vascular Smooth Muscle Cells into Osteogenic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; GENE-EXPRESSION; IN-VIVO; OXIDIZED PHOSPHOLIPIDS; DIFFERENTIATION MARKERS; TRANSCRIPTION FACTORS; HISTONE DEACETYLASES; MEDIA CALCIFICATION; DOWN-REGULATION; MYOCARDIN	Hyperphosphatemia in chronic kidney disease is highly associated with vascular calcification. Previous studies have shown that high phosphate-induced phenotypic switching of vascular smooth muscle cells (SMCs) into osteogenic cells plays an important role in the calcification process. In the present study, we determined whether Kruppel-like factor 4 (Klf4) and phosphorylated Elk-1, transcriptional repressors of SMC differentiation marker genes activated by intimal atherogenic stimuli, contributed to this process. Rat aortic SMCs were cultured in the medium with normal (0.9 mmol/liter) or high (4.5 mmol/liter) phosphate concentration. Results showed that high phosphate concentration induced SMC calcification. Moreover, high phosphate decreased expression of SMC differentiation marker genes including smooth muscle alpha-actin and SM22 alpha, whereas it increased expression of osteogenic genes, such as Runx2 and osteopontin. High phosphate also induced Klf4 expression, although it did not phosphorylate Elk-1. In response to high phosphate, Klf4 selectively bound to the promoter regions of SMC differentiation marker genes. Of importance, siRNA-mediated knockdown of Klf4 blunted high phosphate-induced suppression of SMC differentiation marker genes, as well as increases in expression of osteogenic genes and calcium deposition. Klf4 was also induced markedly in the calcified aorta of adenine-induced uremic rats. Results provide novel evidence that Klf4 mediates high phosphate-induced conversion of SMCs into osteogenic cells.	[Yoshida, Tadashi] Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Yoshida, T (corresponding author), Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tayoshida-npr@umin.ac.jp	Hayashi, Matsuhiko/J-4748-2013		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Ministry of Health Labour and Welfare; Takeda Science Foundation; Keio Gijuku Academic Development Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Keio Gijuku Academic Development Fund	This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. H.), a grant for Research on Measures for Intractable Diseases from Japanese Ministry of Health Labour and Welfare (to M. H.), Takeda Science Foundation (to T. Y.), and Keio Gijuku Academic Development Fund (to T. Y.).	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Moe SM, 2002, KIDNEY INT, V61, P638, DOI 10.1046/j.1523-1755.2002.00170.x; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Oyama Y, 2002, CIRC RES, V90, P348, DOI 10.1161/hh0302.105098; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2010, J BIOL CHEM, V285, P21175, DOI 10.1074/jbc.M110.112482; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	29	50	52	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25706	25714		10.1074/jbc.M112.361360	http://dx.doi.org/10.1074/jbc.M112.361360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679022	Green Published, hybrid			2022-12-25	WOS:000306916300002
J	Gupta, PK; Prabhakar, S; Sharma, NK; Anand, A				Gupta, Pawan K.; Prabhakar, Sudesh; Sharma, Neel K.; Anand, Akshay			Possible Association between Expression of Chemokine Receptor-2 (CCR2) and Amyotrophic Lateral Sclerosis (ALS) Patients of North India	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SPINAL CORD BARRIER; CEREBROSPINAL-FLUID; BLOOD-BRAIN; MOUSE MODEL; FACTOR-A; MCP-1; MICE	Background and Objectives: We earlier reported elevated chemokine ligand-2 (CCL2) in Indian amyotrophic lateral sclerosis (ALS) patients. We now analysed chemokine receptor-2 (CCR2), the receptor of CCL2, in these ALS patients. Methods: Indian sporadic ALS patients (n = 50) were included on the basis of El Escorial criteria. Percentage (%) of CCR2 expressing peripheral blood mononuclear cells (PBMCs) was evaluated using Flow Cytometry. Real Time Polymerase Chain Reaction (PCR) was used to quantitate CCR2 mRNA expression in PBMCs. Normal controls (n = 40) were also included for comparison. Results: Flow Cytometry revealed significantly reduced CCR2 expressing PBMCs in the ALS patients. We also found a significant decline in number of CCR2 expressing PBMCs in limb onset ALS when compared to bulbar onset ALS. PBMCs from ALS patients showed substantial down-regulation of CCR2 mRNA. CCR2 mRNA expression was found to be decreased among limb ALS patients as compared to bulbar onset ALS. Further, the count of CCR2+ PBMCs and CCR2 mRNA transcript in PBMCs was significantly lower in severe and moderate ALS as compared to ALS patients with mild impairments. Conclusions: Downregulation of PBMCs CCR2 may indicate its etio-pathological relevance in ALS pathogenesis. Reduced PBMCs CCR2 may result in decreased infiltration of leukocytes at the site of degeneration as a compensatory response to ALS. CCR2 levels measurements in hematopoietic stem cells and estimation of comparative PBMCs count among ALS, disease controls and normal controls can unveil its direct neuroprotective role. However, the conclusions are restricted by the absence of neurological/non-neurological disease controls in the study.	[Gupta, Pawan K.; Prabhakar, Sudesh; Sharma, Neel K.; Anand, Akshay] PGIMER, Dept Neurol, Neurosci Res Lab, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, PK (corresponding author), PGIMER, Dept Neurol, Neurosci Res Lab, Chandigarh, India.	akshay1anand@rediffmail.com			ICMR (Indian Council of Medical Research) [5/4-5/10/Neuro/2005- NCD - I]	ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR))	Funding agency: ICMR (Indian Council of Medical Research) Grant No. 5/4-5/10/Neuro/2005- NCD - I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock AA, 2003, J NEUROSCI, V23, P7922; Baron P, 2005, MUSCLE NERVE, V32, P541, DOI 10.1002/mus.20376; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-114; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-47; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Ilzecka J, 2004, CLIN NEUROL NEUROSUR, V106, P289, DOI 10.1016/j.clineuro.2003.12.007; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Kyrkanides S, 2008, J NEUROIMMUNOL, V203, P50, DOI 10.1016/j.jneuroim.2008.06.024; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Nagata T, 2007, NEUROL RES, V29, P772, DOI 10.1179/016164107X229795; Nalini A, 2008, J NEUROL SCI, V272, P60, DOI 10.1016/j.jns.2008.04.034; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Verstraete E, 2010, AMYOTROPH LATERAL SC, V11, P555, DOI 10.3109/17482968.2010.513053; Wilms H, 2003, J NEUROIMMUNOL, V144, P139, DOI 10.1016/j.jneuroim.2003.08.042; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38382	10.1371/journal.pone.0038382	http://dx.doi.org/10.1371/journal.pone.0038382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685564	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700027
J	Abd-Alla, AMM; Adun, H; Parker, AG; Vreysen, MJB; Bergoin, M				Abd-Alla, Adly M. M.; Adun, Henry; Parker, Andrew G.; Vreysen, Marc J. B.; Bergoin, Max			The Antiviral Drug Valacyclovir Successfully Suppresses Salivary Gland Hypertrophy Virus (SGHV) in Laboratory Colonies of Glossina pallidipes	PLOS ONE			English	Article							DNA VIRUS; TSETSE-FLIES; DIPTERA; HYPERPLASIA; BREVIPALPIS; LESIONS; KENYA	Many species of tsetse flies are infected with a virus that causes salivary gland hypertrophy (SGH) symptoms associated with a reduced fecundity and fertility. A high prevalence of SGH has been correlated with the collapse of two laboratory colonies of Glossina pallidipes and colony maintenance problems in a mass rearing facility in Ethiopia. Mass-production of G. pallidipes is crucial for programs of tsetse control including the sterile insect technique (SIT), and therefore requires a management strategy for this virus. Based on the homology of DNA polymerase between salivary gland hypertrophy virus and herpes viruses at the amino acid level, two antiviral drugs, valacyclovir and acyclovir, classically used against herpes viruses were selected and tested for their toxicity on tsetse flies and their impact on virus replication. While long term per os administration of acyclovir resulted in a significant reduction of productivity of the colonies, no negative effect was observed in colonies fed with valacyclovir-treated blood. Furthermore, treatment of a tsetse colony with valacyclovir for 83 weeks resulted in a significant reduction of viral loads and consequently suppression of SGH symptoms. The combination of initial selection of SGHV-negative flies by non-destructive PCR, a clean feeding system, and valacyclovir treatment resulted in a colony that was free of SGH syndromes in 33 weeks. This is the first report of the use of a drug to control a viral infection in an insect and of the demonstration that valacyclovir can be used to suppress SGH in colonies of G. pallidipes.	[Abd-Alla, Adly M. M.; Adun, Henry; Parker, Andrew G.; Vreysen, Marc J. B.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Bergoin, Max] Univ Montpellier, Lab Pathol Comparee, F-34059 Montpellier, France	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Universite de Montpellier	Abd-Alla, AMM (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org		Parker, Andrew Gordon/0000-0001-8187-1278; ABD-ALLA, Adly/0000-0001-7540-4462				Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Abd-Alla AMM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001220; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; [Anonymous], 2010, R LANG ENV STAT COMP; Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; Bras A P, 2001, Can J Clin Pharmacol, V8, P207; De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P941, DOI 10.1038/nrd2485; ELLIS DS, 1987, ENTOMOL EXP APPL, V45, P167, DOI 10.1007/BF00305643; Enserink M, 2007, SCIENCE, V317, P310, DOI 10.1126/science.317.5836.310; Feldmann U, 1994, TECHNIQUES INSECT RE, P13; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Geerts S., 1998, DRUG MANAGEMENT PARA; JAENSON TGT, 1978, T ROY SOC TROP MED H, V72, P234, DOI 10.1016/0035-9203(78)90200-6; Jordan A, 1986, TRYPANOSOMIASIS CONT; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; JURA WGZO, 1988, J INVERTEBR PATHOL, V52, P1, DOI 10.1016/0022-2011(88)90095-X; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; Lietze VU, 2011, ANNU REV ENTOMOL, V56, P63, DOI 10.1146/annurev-ento-120709-144841; MINTERGOEDBLOED E, 1989, T ROY SOC TROP MED H, V83, P640, DOI 10.1016/0035-9203(89)90380-5; ODINDO MO, 1982, INSECT SCI APPL, V3, P65, DOI 10.1017/S1742758400001922; OTIENO LH, 1980, J INVERTEBR PATHOL, V36, P113, DOI 10.1016/0022-2011(80)90142-1; Sasanya JJ, 2010, J CHROMATOGR B, V878, P2384, DOI 10.1016/j.jchromb.2010.07.008; SHAW MK, 1993, J INVERTEBR PATHOL, V61, P162, DOI 10.1006/jipa.1993.1029; Sokal R. R, 1981, BIOMETRY; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38417	10.1371/journal.pone.0038417	http://dx.doi.org/10.1371/journal.pone.0038417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679503	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900039
J	Keary, N; Bischof, HJ				Keary, Nina; Bischof, Hans-Joachim			Activation Changes in Zebra Finch (Taeniopygia guttata) Brain Areas Evoked by Alterations of the Earth Magnetic Field	PLOS ONE			English	Article							COMPASS ORIENTATION; HIPPOCAMPAL-FORMATION; GEOMAGNETIC-FIELD; HOMING PIGEONS; VISUAL WULST; CLUSTER-N; BEAK; BEHAVIOR; MAGNETORECEPTION; RESPONSES	Many animals are able to perceive the earth magnetic field and to use it for orientation and navigation within the environment. The mechanisms underlying the perception and processing of magnetic field information within the brain have been thoroughly studied, especially in birds, but are still obscure. Three hypotheses are currently discussed, dealing with ferromagnetic particles in the beak of birds, with the same sort of particles within the lagena organs, or describing magnetically influenced radical-pair processes within retinal photopigments. Each hypothesis is related to a well-known sensory organ and claims parallel processing of magnetic field information with somatosensory, vestibular and visual input, respectively. Changes in activation within nuclei of the respective sensory systems have been shown previously. Most of these previous experiments employed intensity enhanced magnetic stimuli or lesions. We here exposed unrestrained zebra finches to either a stationary or a rotating magnetic field of the local intensity and inclination. C-Fos was used as an activity marker to examine whether the two treatments led to differences in fourteen brain areas including nuclei of the somatosensory, vestibular and visual system. An ANOVA revealed an overall effect of treatment, indicating that the magnetic field change was perceived by the birds. While the differences were too small to be significant in most areas, a significant enhancement of activation by the rotating stimulus was found in a hippocampal subdivision. Part of the hyperpallium showed a strong, nearly significant, increase. Our results are compatible with previous studies demonstrating an involvement of at least three different sensory systems in earth magnetic field perception and suggest that these systems, probably less elaborated, may also be found in nonmigrating birds.	[Keary, Nina; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, D-33615 Bielefeld, Germany	University of Bielefeld	Keary, N (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, Morgenbreede 45, D-33615 Bielefeld, Germany.	nina.keary@uni-bielefeld.de			Deutsche Forschungsgemeinschaft [Bi 245/18-2]; University of Bielefeld	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Bielefeld	Funding was provided by a grant of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to H-JB and Wolfgang Wiltschko, grant number Bi 245/18-2 and a scholarship of the University of Bielefeld to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atoji Y, 2004, J COMP NEUROL, V475, P426, DOI 10.1002/cne.20186; BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; Bingman VP, 2003, BRAIN BEHAV EVOLUT, V62, P117, DOI 10.1159/000072442; BINGMAN VP, 1990, BEHAV BRAIN RES, V40, P227, DOI 10.1016/0166-4328(90)90079-T; Bischof Hans-Joachim, 2011, Communicative & Integrative Biology, V4, P713; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; CLAYTON NS, 1995, J NEUROSCI, V15, P2796; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Falkenberg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009231; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Harada Y, 2002, ACTA OTO-LARYNGOL, V122, P132, DOI 10.1080/00016480252814126; Harada Y, 2001, ACTA OTO-LARYNGOL, V121, P590, DOI 10.1080/000164801316878872; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Kahn MC, 2003, J COMP NEUROL, V459, P127, DOI 10.1002/cne.10601; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; LOHMANN KJ, 1991, J EXP BIOL, V155, P37; Mayer U, 2012, J EXP BIOL IN PRESS; Mayer U, 2010, NEUROBIOL LEARN MEM, V93, P322, DOI 10.1016/j.nlm.2009.11.006; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; PRESTI D, 1980, NATURE, V285, P99, DOI 10.1038/285099a0; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Schulten K., 1986, P PHYS, P99, DOI 10.1007/978-3-642-71526-6_16; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; Shcherbakov VP, 1999, EUR BIOPHYS J BIOPHY, V28, P380, DOI 10.1007/s002490050222; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SINSCH U, 1987, J COMP PHYSIOL A, V161, P715, DOI 10.1007/BF00605013; Sinsch U., 1990, Progress in Zoology, V38, P75; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Vargas JP, 2006, BRAIN RES BULL, V70, P158, DOI 10.1016/j.brainresbull.2006.03.018; Voss J, 2007, NEUROREPORT, V18, P1053, DOI 10.1097/WNR.0b013e32818b2a21; Watanabe S, 2004, BEHAV BRAIN RES, V155, P147, DOI 10.1016/j.bbr.2004.04.007; Watanabe S, 2006, REV NEUROSCI, V17, P1; Watanabe S, 2011, BEHAV BRAIN RES, V222, P51, DOI 10.1016/j.bbr.2011.03.035; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; Wiltscbko W., 1968, Zeitschrift fuer Tierpsychologie, V25, P537; Wiltschko R, 1998, NATURWISSENSCHAFTEN, V85, P164, DOI 10.1007/s001140050476; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko W, 1996, J EXP BIOL, V199, P29; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WILTSCHKO W, 1981, NATURE, V291, P433, DOI 10.1038/291433a0; Wiltschko W., 1966, Zoologischer Anzeiger Suppl, V29, P362; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	63	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38697	10.1371/journal.pone.0038697	http://dx.doi.org/10.1371/journal.pone.0038697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679515	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900063
J	Muller, II; Muller, KAL; Schonleber, H; Karathanos, A; Schneider, M; Jorbenadze, R; Bigalke, B; Gawaz, M; Geisler, T				Mueller, Iris I.; Mueller, Karin A. L.; Schoenleber, Heiko; Karathanos, Athanasios; Schneider, Martina; Jorbenadze, Rezo; Bigalke, Boris; Gawaz, Meinrad; Geisler, Tobias			Macrophage Migration Inhibitory Factor Is Enhanced in Acute Coronary Syndromes and Is Associated with the Inflammatory Response	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUES; PLATELET INHIBITION; FACTOR MIF; MECHANISMS; DISEASE; ATHEROGENESIS; EXPRESSION	Background: Chronic inflammation promotes atherosclerosis in cardiovascular disease and is a major prognostic factor for patients undergoing percutaneous coronary intervention (PCI). Macrophage migration inhibitory factor (MIF) is involved in the progress of atherosclerosis and plaque destabilization and plays a pivotal role in the development of acute coronary syndromes (ACS). Little is known to date about the clinical impact of MIF in patients with symptomatic coronary artery disease (CAD). Methods and Results: In a pilot study, 286 patients with symptomatic CAD (n = 119 ACS, n = 167 stable CAD) undergoing PCI were consecutively evaluated. 25 healthy volunteers served as control. Expression of MIF was consecutively measured in patients at the time of PCI. Baseline levels of interleukin 6 (IL-6), "regulated upon activation, normal T-cell expressed, and secreted" (RANTES) and monocyte chemoattractant protein-1 (MCP-1) were measured by Bio-Plex Cytokine assay. C-reactive protein (CRP) was determined by Immunoassay. Patients with ACS showed higher plasma levels of MIF compared to patients with stable CAD and control subjects (median 2.85 ng/mL, interquartile range (IQR) 3.52 versus median 1.22 ng/mL, IQR 2.99, versus median 0.1, IQR 0.09, p<0.001). Increased MIF levels were associated with CRP and IL-6 levels and correlated with troponin I (TnI) release (spearman rank coefficient: 0.31, p<0.001). Patients with ACS due to plaque rupture showed significantly higher plasma levels of MIF than patients with flow limiting stenotic lesions (p = 0.002). Conclusion: To our knowledge this is the first study, demonstrating enhanced expression of MIF in ACS. It is associated with established inflammatory markers, correlates with the extent of cardiac necrosis marker release after PCI and is significantly increased in ACS patients with "culprit" lesions. Further attempts should be undertaken to characterize the role of MIF for risk assessment in the setting of ACS.	[Mueller, Iris I.; Mueller, Karin A. L.; Schoenleber, Heiko; Karathanos, Athanasios; Schneider, Martina; Jorbenadze, Rezo; Bigalke, Boris; Gawaz, Meinrad; Geisler, Tobias] Univ Tubingen, Med Klin 3, Tubingen, Germany	Eberhard Karls University of Tubingen	Muller, II (corresponding author), Univ Tubingen, Med Klin 3, Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de; tobias.geisler@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020; Mondy, William L/G-4883-2012		Deutsche Forschungsgemeinschaft [Transregio-SFB19]; Klinische Forschergruppe: Platelets-Molecular Mechanisms and Translational Implications [KFO 274]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe: Platelets-Molecular Mechanisms and Translational Implications	Material for platelet aggregation studies with the Multiplate device was kindly provided free of charge by Dynabyte (Munich, Germany). The company had no influence on design, conduct of the study, interpretation of the data and the whole manuscript process. The study was in part funded by the Deutsche Forschungsgemeinschaft (Transregio-SFB19), and the Klinische Forschergruppe (KFO 274): Platelets-Molecular Mechanisms and Translational Implications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Geisler T, 2004, MED SCI MONITOR, V10, pRA308; Gresele P, 2011, EUR HEART J, V32, P316, DOI 10.1093/eurheartj/ehq390; Lin SG, 2000, CIRC RES, V87, P1202, DOI 10.1161/01.RES.87.12.1202; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; Muller K, 2010, ATHEROSCLEROSIS, V213, P256, DOI 10.1016/j.atherosclerosis.2010.07.023; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saltzman AJ, 2010, J INVASIVE CARDIOL, V22, P2; Schmeisser A, 2005, ATHEROSCLEROSIS, V178, P83, DOI 10.1016/j.atherosclerosis.2004.08.038; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Yang Li-xia, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P912; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	19	49	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38376	10.1371/journal.pone.0038376	http://dx.doi.org/10.1371/journal.pone.0038376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693633	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900031
J	Dabrowski, PW; Nitsche, A				Dabrowski, Piotr Wojtek; Nitsche, Andreas			mPSQed: A Software for the Design of Multiplex Pyrosequencing Assays	PLOS ONE			English	Article								Molecular-based diagnostic assays are the gold standard for infectious diseases today, since they allow a rapid and sensitive identification and typing of various pathogens. While PCR can be designed to be specific for a certain pathogen, a subsequent sequence analysis is frequently required for confirmation or typing. The design of appropriate PCR-based assays is a complex task, especially when conserved discriminating polymorphisms are rare or if the number of types which need to be differentiated is high. One extremely useful but underused method for this purpose is the multiplex pyrosequencing technique. Unfortunately there is no software available to aid researchers in designing multiplex pyrosequencing assays. Here, we present mPSQed (Multiplex PyroSeQuencing EDitor), a program targeted at closing this gap. We also present the design of an exemplarily theoretical assay for the differentiation of human adenovirus types A-F using two pyrosequencing primers on two distinct PCR products, designed quickly and easily using our software.	[Dabrowski, Piotr Wojtek] Robert Koch Inst, Cent Adm IT 4, Berlin, Germany; [Dabrowski, Piotr Wojtek; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Secur 1, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Dabrowski, PW (corresponding author), Robert Koch Inst, Cent Adm IT 4, Berlin, Germany.	DabrowskiW@rki.de	Dabrowski, Piotr Wojtek/L-1423-2015	Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Nitsche, Andreas/0000-0001-8185-3176	Robert Koch Institute	Robert Koch Institute	Both authors are directly employed by the Robert Koch Institute, and as such no third party funding was used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bio C, 2011, CLC WORKB; DNASTAR, 2011, LAS; DRUMMOND AJ, 2010, GENEIOUS V5 5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Hillbrecht D, 2003, HELPSETMAKER TOOL PR; Katoh M, NUCL ACIDS RES; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Patel Pritesh, 2007, V373, P75; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rozen S, 2000, Methods Mol Biol, V132, P365; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38140	10.1371/journal.pone.0038140	http://dx.doi.org/10.1371/journal.pone.0038140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675516	Green Published, gold			2022-12-25	WOS:000305341700041
J	Jerng, HH; Pfaffinger, PJ				Jerng, Henry H.; Pfaffinger, Paul J.			Incorporation of DPP6a and DPP6K Variants in Ternary Kv4 Channel Complex Reconstitutes Properties of A-type K Current in Rat Cerebellar Granule Cells	PLOS ONE			English	Article							DIFFERENTIAL DISTRIBUTION; INACTIVATION PROPERTIES; VOLTAGE-CLAMP; PROTEIN DPPX; T-TYPE; EXPRESSION; SUBUNITS; MODULATION; KCHIPS; TRAFFICKING	Dipeptidyl peptidase-like protein 6 (DPP6) proteins co-assemble with Kv4 channel alpha-subunits and Kv channel-interacting proteins (KChIPs) to form channel protein complexes underlying neuronal somatodendritic A-type potassium current (I-SA). DPP6 proteins are expressed as N-terminal variants (DPP6a, DPP6K, DPP6S, DPP6L) that result from alternative mRNA initiation and exhibit overlapping expression patterns. Here, we study the role DPP6 variants play in shaping the functional properties of I-SA found in cerebellar granule (CG) cells using quantitative RT-PCR and voltage-clamp recordings of whole-cell currents from reconstituted channel complexes and native I-SA channels. Differential expression of DPP6 variants was detected in rat CG cells, with DPP6K (41 +/- 3%)>DPP6a (33 +/- 3%)>>DPP6S (18 +/- 2%)>DPP6L (8 +/- 3%). To better understand how DPP6 variants shape native neuronal I-SA, we focused on studying interactions between the two dominant variants, DPP6K and DPP6a. Although previous studies did not identify unique functional effects of DPP6K, we find that the unique N-terminus of DPP6K modulates the effects of KChIP proteins, slowing recovery and producing a negative shift in the steady-state inactivation curve. By contrast, DPP6a uses its distinct N-terminus to directly confer rapid N-type inactivation independently of KChIP3a. When DPP6a and DPP6K are co-expressed in ratios similar to those found in CG cells, their distinct effects compete in modulating channel function. The more rapid inactivation from DPP6a dominates during strong depolarization; however, DPP6K produces a negative shift in the steady-state inactivation curve and introduces a slow phase of recovery from inactivation. A direct comparison to the native CG cell I-SA shows that these mixed effects are present in the native channels. Our results support the hypothesis that the precise expression and co-assembly of different auxiliary subunit variants are important factors in shaping the I-SA functional properties in specific neuronal populations.	[Jerng, Henry H.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Jerng, HH (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hjerng@cns.bcm.edu			National Institutes of Health [R01 NS37444, R01 GM090029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 NS37444 and R01 GM090029 (located at http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; Anderson D, 2010, CHANNELS, V4, P163, DOI 10.4161/chan.4.3.11955; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; BARDONI R, 1993, J NEUROPHYSIOL, V69, P2222, DOI 10.1152/jn.1993.69.6.2222; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Dougherty K, 2009, CHANNELS, V3, P122, DOI 10.4161/chan.3.2.8333; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Jerng H. H., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; LACERDA AE, 1994, BIOPHYS J, V66, P1833, DOI 10.1016/S0006-3495(94)80977-4; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; ROBELLO M, 1989, BIOSCIENCE REP, V9, P451, DOI 10.1007/BF01117047; ROSSI P, 1994, PFLUG ARCH EUR J PHY, V429, P107, DOI 10.1007/BF02584036; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Soh H, 2008, J BIOL CHEM, V283, P15072, DOI 10.1074/jbc.M706964200; STEFANI A, 1992, NEUROSCI LETT, V144, P4, DOI 10.1016/0304-3940(92)90703-A; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Takimoto K, 2006, BIOCHEM BIOPH RES CO, V348, P1094, DOI 10.1016/j.bbrc.2006.07.157; Talley EM, 1999, J NEUROSCI, V19, P1895; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang X, 2005, J NEUROSCI RES, V81, P530, DOI 10.1002/jnr.20576; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xiong H, 2004, MOL BRAIN RES, V128, P103, DOI 10.1016/j.molbrainres.2004.06.024; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; ZEGARRAMORAN O, 1994, EXP BRAIN RES, V98, P298	57	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38205	10.1371/journal.pone.0038205	http://dx.doi.org/10.1371/journal.pone.0038205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675523	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700046
J	Killaspy, H; White, S; Wright, C; Taylor, TL; Turton, P; Kallert, T; Schuster, M; Cervilla, JA; Brangier, P; Raboch, J; Kalisova, L; Onchev, G; Alexiev, S; Mezzina, R; Ridente, P; Wiersma, D; Visser, E; Kiejna, A; Piotrowski, P; Ploumpidis, D; Gonidakis, F; Caldas-de-Almeida, JM; Cardoso, G; King, M				Killaspy, Helen; White, Sarah; Wright, Christine; Taylor, Tatiana L.; Turton, Penny; Kallert, Thomas; Schuster, Mirjam; Cervilla, Jorge A.; Brangier, Paulette; Raboch, Jiri; Kalisova, Lucie; Onchev, Georgi; Alexiev, Spiridon; Mezzina, Roberto; Ridente, Pina; Wiersma, Durk; Visser, Ellen; Kiejna, Andrzej; Piotrowski, Patryk; Ploumpidis, Dimitris; Gonidakis, Fragiskos; Caldas-de-Almeida, Jose Miguel; Cardoso, Graca; King, Michael			Quality of Longer Term Mental Health Facilities in Europe: Validation of the Quality Indicator for Rehabilitative Care against Service Users' Views	PLOS ONE			English	Article							INSTITUTIONAL CARE; COMMUNITY; CONSEQUENCES; PEOPLE; SCALE	Background: The Quality Indicator for Rehabilitative Care (QuIRC) is a staff rated, international toolkit that assesses care in longer term hospital and community based mental health facilities. The QuIRC was developed from review of the international literature, an international Delphi exercise with over 400 service users, practitioners, carers and advocates from ten European countries at different stages of deinstitutionalisation, and review of the care standards in these countries. It can be completed in under an hour by the facility manager and has robust content validity, acceptability and inter-rater reliability. In this study, we investigated the internal validity of the QuIRC. Our aim was to identify the QuIRC domains of care that independently predicted better service user experiences of care. Method: At least 20 units providing longer term care for adults with severe mental illness were recruited in each of ten European countries. Service users completed standardised measures of their experiences of care, quality of life, autonomy and the unit's therapeutic milieu. Unit managers completed the QuIRC. Multilevel modelling allowed analysis of associations between service user ratings as dependent variables with unit QuIRC domain ratings as independent variables. Results: 1750/2495 (70%) users and the managers of 213 units from across ten European countries participated. QuIRC ratings were positively associated with service users' autonomy and experiences of care. Associations between QuIRC ratings and service users' ratings of their quality of life and the unit's therapeutic milieu were explained by service user characteristics (age, diagnosis and functioning). A hypothetical 10% increase in QuIRC rating resulted in a clinically meaningful improvement in autonomy. Conclusions: Ratings of the quality of longer term mental health facilities made by service managers were positively associated with service users' autonomy and experiences of care. Interventions that improve quality of care in these settings may promote service users' autonomy.	[Killaspy, Helen; Taylor, Tatiana L.; King, Michael] UCL, Mental Hlth Sci Unit, London, England; [White, Sarah; Wright, Christine; Turton, Penny] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Kallert, Thomas] Pk Hosp Leipzig, Dept Psychiat Psychosomat Med & Psychotherapy, Leipzig, Germany; [Schuster, Mirjam] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Hosp, Dresden, Germany; [Cervilla, Jorge A.] Univ Granada, San Cecilio Univ Hosp, Mental Hlth Unit, Granada, Spain; [Brangier, Paulette] Univ Granada, Biomed Res Ctr, Mental Hlth Network, Granada, Spain; [Raboch, Jiri; Kalisova, Lucie] Charles Univ Prague, Dept Psychiat, Prague, Czech Republic; [Onchev, Georgi; Alexiev, Spiridon] Med Univ Sofia, Dept Psychiat, Sofia, Bulgaria; [Mezzina, Roberto; Ridente, Pina] Trieste Healthcare Agcy, Dept Mental Hlth, Trieste, Italy; [Wiersma, Durk; Visser, Ellen] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Kiejna, Andrzej; Piotrowski, Patryk] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland; [Ploumpidis, Dimitris; Gonidakis, Fragiskos] Univ Mental Hlth Res Inst, Athens, Greece; [Caldas-de-Almeida, Jose Miguel; Cardoso, Graca] Univ Nova Lisboa, Fac Med Sci, Lisbon, Portugal	University of London; University College London; St Georges University London; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hospital Universitario San Cecilio; University of Granada; University of Granada; Charles University Prague; Medical University Sofia; University of Groningen; Wroclaw Medical University; Universidade Nova de Lisboa	Killaspy, H (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	h.killaspy@ucl.ac.uk	Cervilla, Jorge A/O-2106-2016; raboch, jiri/N-7445-2017; King, Michael B/D-7477-2011; Salisbury, Tatiana/CAF-8877-2022; Piotrowski, Patryk/ABD-4063-2021; Kališová, Lucie/N-1373-2017; gonidakis, fragiskos/AAC-5296-2020	Cervilla, Jorge A/0000-0001-6891-1992; raboch, jiri/0000-0001-6667-1497; King, Michael B/0000-0003-4715-7171; Piotrowski, Patryk/0000-0001-7208-0562; Kališová, Lucie/0000-0003-0695-2048; Onchev, Georgi/0000-0002-5139-5917; Cardoso, Graca/0000-0003-1756-0197; Taylor Salisbury, Tatiana/0000-0002-8249-3886; Killaspy, Helen/0000-0003-2481-4802; Urban, Mirjam/0000-0003-1714-4847; White, Sarah/0000-0003-2468-6193; caldas de almeida, jose miguel/0000-0003-1902-6772	European Commission [SP5A-CT-2007-044088]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by a three-year grant from the European Commission's 6th Framework (SP5A-CT-2007-044088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cullen D, 1997, IRISH J PSYCHOL MED, V14, P92; Dunlap WP, 2004, BEHAV RES METH INS C, V36, P695, DOI 10.3758/BF03206551; European Commission, 2005, GREEN PAP IMPR MENT; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hatton C, 2004, J INTELL DISABIL RES, V48, P103, DOI 10.1111/j.1365-2788.2004.00499.x; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Killaspy H, 2010, BMC PSYCHIATRY, V11, P35; Killaspy H, 2008, J MENT HEALTH, V17, P207, DOI 10.1080/09638230701506275; Killaspy H, 2010, PSYCHIATR BULL, V34, P265, DOI 10.1192/pb.bp.109.028530; Killaspy H, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-36; Knapp M, 2011, HEALTH SOC CARE COMM, V19, P113, DOI 10.1111/j.1365-2524.2010.00969.x; Liegeois A, 2005, J MED ETHICS, V31, P452, DOI 10.1136/jme.2003.006999; Meltzer HY, 1997, CURR MED RES OPIN, V14, P1, DOI 10.1185/03007999709113338; Mueser K.T., 1998, HDB SOCIAL FUNCTIONI; Muijen M, 2008, PSYCHIAT SERV, V59, P479, DOI 10.1176/ps.2008.59.5.479; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Rehabilitation Social Faculty, 2009, FRRS04 ROYAL COLL PS; Rossberg JI, 2003, ACTA PSYCHIAT SCAND, V108, P374, DOI 10.1034/j.1600-0447.2003.00191.x; Taylor TL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-55; Trauer T, 2001, SOC PSYCH PSYCH EPID, V36, P416, DOI 10.1007/s001270170032; Trieman N, 2002, BRIT J PSYCHIAT, V181, P428, DOI 10.1192/bjp.181.5.428; Turton P, 2010, PSYCHIAT SERV, V61, P293, DOI 10.1176/ps.2010.61.3.293; Webb Y, 2000, Int J Health Care Qual Assur Inc Leadersh Health Serv, V13, P273, DOI 10.1108/09526860010373253; World Health Organization (WHO), 2005, MENT HLTH ATL	25	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38070	10.1371/journal.pone.0038070	http://dx.doi.org/10.1371/journal.pone.0038070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675508	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000305341700036
J	Seeger, MA; Mittal, A; Velamakanni, S; Hohl, M; Schauer, S; Salaa, I; Grutter, MG; van Veen, HW				Seeger, Markus A.; Mittal, Anshumali; Velamakanni, Saroj; Hohl, Michael; Schauer, Stefan; Salaa, Ihsene; Gruetter, Markus G.; van Veen, Hendrik W.			Tuning the Drug Efflux Activity of an ABC Transporter in vivo by in vitro Selected DARPin Binders	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; LACTOCOCCUS-LACTIS; ATP-BINDING; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; RIBOSOME DISPLAY; REPEAT PROTEINS; FUNCTIONAL-ROLE; PHAGE DISPLAY; ANTIBODY	ABC transporters use the energy from binding and hydrolysis of ATP to import or extrude substrates across the membrane. Using ribosome display, we raised designed ankyrin repeat proteins (DARPins) against detergent solubilized LmrCD, a heterodimeric multidrug ABC exporter from Lactococcus lactis. Several target-specific DARPin binders were identified that bind to at least three distinct, partially overlapping epitopes on LmrD in detergent solution as well as in native membranes. Remarkably, functional screening of the LmrCD-specific DARPin pools in L. lactis revealed three homologous DARPins which, when generated in LmrCD-expressing cells, strongly activated LmrCD-mediated drug transport. As LmrCD expression in the cell membrane was unaltered upon the co-expression of activator DARPins, the activation is suggested to occur at the level of LmrCD activity. Consistent with this, purified activator DARPins were found to stimulate the ATPase activity of LmrCD in vitro when reconstituted in proteoliposomes. This study suggests that membrane transporters are tunable in vivo by in vitro selected binding proteins. Our approach could be of biopharmaceutical importance and might facilitate studies on molecular mechanisms of ABC transporters.	[Seeger, Markus A.; Velamakanni, Saroj; Salaa, Ihsene; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Seeger, Markus A.; Mittal, Anshumali; Hohl, Michael; Gruetter, Markus G.] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Schauer, Stefan] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Cambridge; University of Zurich; University of Zurich	Seeger, MA (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	m.seeger@bioc.uzh.ch; hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008; Mittal, Anshumali/G-9685-2012	van Veen, Hendrik W./0000-0002-9658-8077; Seeger, Markus/0000-0003-1761-8571; Mittal, Anshumali/0000-0002-0478-2682	Swiss National Science Foundation Prospective Researcher; European Molecular Biology Organization; Novartis Foundation; Swiss National Science Foundation; Ambizione Fellowship; Research Credit (Forschungskredit) of the University of Zurich; British Society for Antimicrobial Chemotherapy; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I002383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish	Swiss National Science Foundation Prospective Researcher; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Novartis Foundation(Novartis); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ambizione Fellowship; Research Credit (Forschungskredit) of the University of Zurich; British Society for Antimicrobial Chemotherapy; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by the Swiss National Science Foundation Prospective Researcher (to MAS), European Molecular Biology Organization Long Term fellowship (to MAS), Novartis Foundation (to MAS), Swiss National Science Foundation, Ambizione Fellowship (to MAS), Research Credit (Forschungskredit) of the University of Zurich (to MAS), British Society for Antimicrobial Chemotherapy (to HWvV), and Biotechnology and Biological Sciences Research Council (to HWvV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustiandari H, 2008, J BACTERIOL, V190, P759, DOI 10.1128/JB.01151-07; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; BALL WJ, 1986, BIOCHEMISTRY-US, V25, P7155, DOI 10.1021/bi00370a058; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boersma YL, 2011, J BIOL CHEM, V286, P41273, DOI 10.1074/jbc.M111.293266; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEBIEC H, 1993, J BIOL CHEM, V268, P13356; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hotzel I, 2011, PROTEIN ENG DES SEL, V24, P679, DOI 10.1093/protein/gzr039; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Huber T, 2007, J STRUCT BIOL; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kim J, 2011, METHODS; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; LEENHOUTS KJ, 1991, J BACTERIOL, V173, P4794, DOI 10.1128/jb.173.15.4794-4798.1991; LEPPERT G, 1990, GENETICS, V125, P13; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Merz T, 2008, J MOL BIOL, V376, P232, DOI 10.1016/j.jmb.2007.11.047; Milovnik P, 2009, PROTEIN ENG DES SEL, V22, P357, DOI 10.1093/protein/gzp011; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Padan E, 1998, FEBS LETT, V441, P53, DOI 10.1016/S0014-5793(98)01524-5; Pajic M, 2009, CANCER RES, V69, P6396, DOI 10.1158/0008-5472.CAN-09-0041; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; Rubinstein JL, 2003, ANAL BIOCHEM, V314, P294, DOI 10.1016/S0003-2697(02)00649-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Stefan N, 2011, J MOL BIOL, V413, P826, DOI 10.1016/j.jmb.2011.09.016; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Venter H, 2005, BIOCHEM SOC T, V33, P1008, DOI 10.1042/BST20051008; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	76	14	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37845	10.1371/journal.pone.0037845	http://dx.doi.org/10.1371/journal.pone.0037845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675494	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700024
J	Sato, A; Koda, H; Lemasson, A; Nagumo, S; Masataka, N				Sato, Anna; Koda, Hiroki; Lemasson, Alban; Nagumo, Sumiharu; Masataka, Nobuo			Visual Recognition of Age Class and Preference for Infantile Features: Implications for Species-Specific vs Universal Cognitive Traits in Primates	PLOS ONE			English	Article							ANTHROPOID PRIMATES; FACE RECOGNITION; BABY SCHEMA; FACIAL FEATURES; HOMO-SAPIENS; HEAD SHAPE; EVOLUTION; MACAQUES; CUTENESS; MONKEYS	Despite not knowing the exact age of individuals, humans can estimate their rough age using age-related physical features. Nonhuman primates show some age-related physical features; however, the cognitive traits underlying their recognition of age class have not been revealed. Here, we tested the ability of two species of Old World monkey, Japanese macaques (JM) and Campbell's monkeys (CM), to spontaneously discriminate age classes using visual paired comparison (VPC) tasks based on the two distinct categories of infant and adult images. First, VPCs were conducted in JM subjects using conspecific JM stimuli. When analyzing the side of the first look, JM subjects significantly looked more often at novel images. Based on analyses of total looking durations, JM subjects looked at a novel infant image longer than they looked at a familiar adult image, suggesting the ability to spontaneously discriminate between the two age classes and a preference for infant over adult images. Next, VPCs were tested in CM subjects using heterospecific JM stimuli. CM subjects showed no difference in the side of their first look, but looked at infant JM images longer than they looked at adult images; the fact that CMs were totally naive to JMs suggested that the attractiveness of infant images transcends species differences. This is the first report of visual age class recognition and a preference for infant over adult images in nonhuman primates. Our results suggest not only species-specific processing for age class recognition but also the evolutionary origins of the instinctive human perception of baby cuteness schema, proposed by the ethologist Konrad Lorenz.	[Sato, Anna; Koda, Hiroki; Nagumo, Sumiharu; Masataka, Nobuo] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Lemasson, Alban] Univ Rennes 1, Stn Biol, EthoS Ethol Anim & Humaine CNRS UMR6552, Paimpont, France; [Lemasson, Alban] Inst Univ France, Paris, France	Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut Universitaire de France	Sato, A (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	koda.hiroki.7a@kyoto-u.ac.jp			JSPS [22330200]; Primate Research Institute, Kyoto University; Program for International Collaboration of Science-Centre National de Recherche Scientifique; JSPS Research Fellowship for Young Scientists; Grants-in-Aid for Scientific Research [23653316] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Primate Research Institute, Kyoto University; Program for International Collaboration of Science-Centre National de Recherche Scientifique; JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported in part by a JSPS Grant-in-Aid for Scientific Research (B, #22330200) to HK, under the Young Researcher Overseas Visits Program for the Vitalizing Brain Circulation from the Primate Research Institute, Kyoto University; by a grant from the Program for International Collaboration of Science-Centre National de Recherche Scientifique to AL; and by a JSPS Research Fellowship for Young Scientists to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; ALBERT EM, 1964, AM ANTHROPOL, V66, P35, DOI 10.1525/aa.1964.66.suppl_3.02a00020; ALLEY TR, 1983, MERRILL PALMER QUART, V29, P411; ALLEY TR, 1983, CHILD DEV, V54, P241, DOI 10.2307/1129882; ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Bascom WR, 1942, AM ANTHROPOL, V44, P37, DOI 10.1525/aa.1942.44.1.02a00050; Brosch T, 2007, BABY CAUGHT MY EYE A; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; DEWAAL F, 1982, CHIMPANZEE POLITICS; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Dufour V, 2010, J ETHOL, V28, P231, DOI 10.1007/s10164-009-0174-8; Dunbar R. I., 1998, BRAIN, V9, P10; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; FAGAN JF, 1973, J EXP CHILD PSYCHOL, V16, P424, DOI 10.1016/0022-0965(73)90005-2; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Gittleman J.L., 1985, EVOLUTION ESSAYS HON, P187; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; GOULD SJ, 1979, NAT HIST, V88, P30; HINDE RA, 1985, ANIM BEHAV, V33, P1371, DOI 10.1016/S0003-3472(85)80205-0; Hodsoll J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012509; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Koba R, 2008, BEHAV PROCESS, V79, P70, DOI 10.1016/j.beproc.2008.04.005; Lemasson A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1027, DOI 10.1007/s00265-007-0530-z; Lemasson A, 2010, BIOL LETTERS, V6, P325, DOI 10.1098/rsbl.2009.0875; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Luo LZ, 2011, J EXP CHILD PSYCHOL, V110, P115, DOI 10.1016/j.jecp.2011.04.002; Mareschal D, 2002, COGNITIVE SCI, V26, P377, DOI 10.1207/s15516709cog2603_8; Masataka N., 2003, ONSET LANGUAGE; Mitani JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P213, DOI 10.1007/s002650050335; Murai C, 2005, DEVELOPMENTAL SCI, V8, P240, DOI 10.1111/j.1467-7687.2005.00413.x; Murai C, 2004, PRIMATES, V45, P1, DOI 10.1007/s10329-003-0053-9; Noe Ronald, 2001, P93, DOI 10.1017/CBO9780511752421.008; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Quinn PC, 2008, DEVELOPMENTAL SCI, V11, P76, DOI 10.1111/j.1467-7687.2007.00647.x; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; Sanefuji W, 2007, J ETHOL, V25, P249, DOI 10.1007/s10164-006-0018-8; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318	54	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38387	10.1371/journal.pone.0038387	http://dx.doi.org/10.1371/journal.pone.0038387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22685529	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500142
J	Xu, P; Chen, JC; Chen, Z; Zhou, SY; Hu, P; Chen, XY; Huang, MD				Xu, Peng; Chen, Jincan; Chen, Zhuo; Zhou, Shanyong; Hu, Ping; Chen, Xueyuan; Huang, Mingdong			Receptor-Targeting Phthalocyanine Photosensitizer for Improving Antitumor Photocytotoxicity	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PHOTODYNAMIC ACTIVITY; IN-VITRO; PHOTOCHEMICAL PROPERTIES; BASIC PRINCIPLES; CANCER-CELLS; THERAPY; BREAST; ANALOGS; ZINC	Photodynamic therapy (PDT) is a promising therapeutic modality which uses a photosensitizer to capture visible light resulting in phototoxicity in the irradiated region. PDT has been used in a number of pathological indications, including tumor. A key desirable feature of the photosensitizer is the high phototoxicity on tumor cells but not on normal cells. In this study, we conjugate a gonadotropin-releasing hormone (GnRH) to a photosensitizer, Zinc phthalocyanine (ZnPc), in order to enhance its specificity to breast cancer, which over-expresses GnRH receptor. ZnPc has unique advantages over other photosensitizers, but is difficult to derivatize and purify as a single isomer. We previously developed a straight-forward way to synthesize mono-substituted beta-carboxy-phthalocyanine zinc (ZnPc-COOH). Photophysical and photochemical parameters of this ZnPc-GnRH conjugate including fluorescence quantum yield (Phi(f)), fluorescence decay time (tau(s)) and singlet oxygen quantum yield (Phi(Delta)) were evaluated and found comparable with that of ZnPc, indicating that addition of a GnRH peptide does not significantly alter the generation of singlet oxygen from ZnPc. Cellular uptakes and phototoxicities of this conjugate were tested and found significantly enhanced on human breast cancer cell lines overexpressing GnRH receptors (MDA-MB-231 and MCF-7 cells) compared to cells with low levels of GnRH receptors, such as human embryonic lung fibroblast (HELF) and human liver carcinoma (HepG2) cells. In addition, the cellular uptake of this conjugate toward MCF-7 cells were found clearly alleviated by a GnRH receptor blocker Cetrorelix, suggesting that the cellular uptake of this conjugate was GnRH receptor-mediated. Put together, these findings revealed that coupling ZnPc with GnRH analogue was an effective way to improve the selectivity of ZnPc towards tumors with over-expressed GnRH receptors.	[Xu, Peng; Chen, Jincan; Chen, Zhuo; Zhou, Shanyong; Hu, Ping; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China; [Xu, Peng; Chen, Jincan; Chen, Zhuo; Chen, Xueyuan; Huang, Mingdong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Xueyuan] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Xu, P (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China.	zchen@fjirsm.ac.cn; mhuang@fjirsm.ac.cn	Chen, Zhuo/O-2928-2019; Chen, Zhuo/A-6144-2011; Chen, Xueyuan/C-5613-2012; Xu, Peng/GXF-8681-2022; Huang, Mingdong/J-4278-2017	Chen, Zhuo/0000-0002-6351-8689; Chen, Zhuo/0000-0002-6351-8689; Chen, Xueyuan/0000-0003-0493-839X; Xu, Peng/0000-0003-3968-7279; Huang, Mingdong/0000-0003-0085-9141	Fujian Province Natural Science Foundation [2009I0029]; National Natural Science Foundation [30973567, 30811130467]; Chinese Ministry of Science and Technology [2006AA02A313]	Fujian Province Natural Science Foundation(Natural Science Foundation of Fujian Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by Fujian Province Natural Science Foundation (2009I0029), National Natural Science Foundation (30973567 and 30811130467) and the Chinese Ministry of Science and Technology (2006AA02A313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CM, 2001, J PORPHYR PHTHALOCYA, V5, P161, DOI 10.1002/jpp.324; Allen Cynthia M., 2002, P329; Avetisov S E, 2007, Vestn Oftalmol, V123, P3; Bai M, 2011, ORG BIOMOL CHEM, V9, P7028, DOI 10.1039/c1ob05955f; BAJUSZ S, 1989, P NATL ACAD SCI USA, V86, P6318, DOI 10.1073/pnas.86.16.6318; Biyiklioglu Z, 2010, J PHOTOCH PHOTOBIO A, V211, P32, DOI 10.1016/j.jphotochem.2010.01.018; Brasseur N, 1999, PHOTOCHEM PHOTOBIOL, V69, P345, DOI 10.1562/0031-8655(1999)069<0345:RMTOPT>2.3.CO;2; Carcenac M, 1999, PHOTOCHEM PHOTOBIOL, V70, P930, DOI 10.1111/j.1751-1097.1999.tb08304.x; Chen JC, 2008, CHEM J CHINESE U, V29, P2131; Chen JC, 2006, INORG CHEM COMMUN, V9, P313, DOI 10.1016/j.inoche.2005.12.002; Chen JC, 2011, J PORPHYR PHTHALOCYA, V15, P293, DOI 10.1142/S1088424611003276; Chen Z, 2010, CHEMMEDCHEM, V5, P890, DOI 10.1002/cmdc.201000042; Choi Y, 2006, CHEMMEDCHEM, V1, P458, DOI 10.1002/cmdc.200500036; DOUGHERTY TJ, 1993, PHOTOCHEM PHOTOBIOL, V58, P895, DOI 10.1111/j.1751-1097.1993.tb04990.x; EIDNE KA, 1987, J CLIN ENDOCR METAB, V64, P425, DOI 10.1210/jcem-64-3-425; Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b; Harrison GS, 2004, ENDOCR-RELAT CANCER, V11, P725, DOI 10.1677/erc.1.00777; Huang D, 2000, SPECTROSC SPECT ANAL, V20, P95; JANAKY T, 1992, P NATL ACAD SCI USA, V89, P972, DOI 10.1073/pnas.89.3.972; Kakar SS, 2008, ADV EXP MED BIOL, V614, P285, DOI 10.1007/978-0-387-74911-2_32; Kakar SS, 2004, VITAM HORM, V69, P151, DOI 10.1016/S0083-6729(04)69006-6; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; Keller G, 2005, CANCER RES, V65, P5857, DOI 10.1158/0008-5472.CAN-04-3816; Kovacs M, 1997, P NATL ACAD SCI USA, V94, P1420, DOI 10.1073/pnas.94.4.1420; Kuznetsova NA, 2000, RUSS J GEN CHEM, V70, P133; Leuschner C, 2003, BREAST CANCER RES TR, V78, P17, DOI 10.1023/A:1022169525521; Leuschner C, 2006, BREAST CANCER RES TR, V99, P163, DOI 10.1007/s10549-006-9199-7; Liu JY, 2009, ORG BIOMOL CHEM, V7, P1583, DOI 10.1039/b822128f; Lo PC, 2007, BIOORG MED CHEM LETT, V17, P1073, DOI 10.1016/j.bmcl.2006.11.017; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Nagy A, 2005, BIOL REPROD, V73, P851, DOI 10.1095/biolreprod.105.043489; Nagy A, 1996, P NATL ACAD SCI USA, V93, P7269, DOI 10.1073/pnas.93.14.7269; Nyk M, 2010, J LUMIN, V130, P2487, DOI 10.1016/j.jlumin.2010.08.017; Ogunsipe A, 2004, NEW J CHEM, V28, P822, DOI 10.1039/b315319c; Rahimipour S, 2003, J MED CHEM, V46, P3965, DOI 10.1021/jm020535y; Sharman WM, 2005, BIOCONJUGATE CHEM, V16, P1166, DOI 10.1021/bc0500241; Sharman WM, 2004, ADV DRUG DELIVER REV, V56, P53, DOI 10.1016/j.addr.2003.08.015; Sharman WM, 1999, DRUG DISCOV TODAY, V4, P507, DOI 10.1016/S1359-6446(99)01412-9; Smirnova Z. S., 2005, Khimiko-Farmatsevticheskii Zhurnal, V39, P3; Stefflova K, 2006, J MED CHEM, V49, P3850, DOI 10.1021/jm060146u; Taquet JP, 2007, CURR MED CHEM, V14, P1673, DOI 10.2174/092986707780830970; Tirand L, 2006, J CONTROL RELEASE, V111, P153, DOI 10.1016/j.jconrel.2005.11.017; Vrouenraets MB, 2003, ANTICANCER RES, V23, P505; World Health Organization, 2011, FACT SHEET 297; Xu CJ, 2009, J AM CHEM SOC, V131, P15346, DOI 10.1021/ja905938a	45	27	27	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37051	10.1371/journal.pone.0037051	http://dx.doi.org/10.1371/journal.pone.0037051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693566	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500028
J	Asada, K; Ando, T; Niwa, T; Nanjo, S; Watanabe, N; Okochi-Takada, E; Yoshida, T; Miyamoto, K; Enomoto, S; Ichinose, M; Tsukamoto, T; Ito, S; Tatematsu, M; Sugiyama, T; Ushijima, T				Asada, K.; Ando, T.; Niwa, T.; Nanjo, S.; Watanabe, N.; Okochi-Takada, E.; Yoshida, T.; Miyamoto, K.; Enomoto, S.; Ichinose, M.; Tsukamoto, T.; Ito, S.; Tatematsu, M.; Sugiyama, T.; Ushijima, T.			FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect	ONCOGENE			English	Article						field for cancerization; chromosome X; DNA methylation; gastrointestinal cancer; Helicobacter pylori	ABERRANT DNA METHYLATION; SQUAMOUS-CELL CARCINOMA; GASTRIC MUCOSAE; HELICOBACTER-PYLORI; SILENCED GENES; CANCER; HYPERMETHYLATION; EXPRESSION; BREAST; RISK	Tumor-suppressor genes on chromosome X can be inactivated by a single hit, any of the point mutations, chromosomal loss and aberrant DNA methylation. As aberrant DNA methylation can be induced frequently, we here aimed to identify a tumor-suppressor gene on chromosome X inactivated by promoter DNA methylation. Of 69 genes on chromosome X upregulated by treatment of a gastric cancer cell line with a DNA-demethylating agent, 5-aza-2'-deoxycytidine, 11 genes had low or no expression in the cell line and abundant expression in normal gastric mucosae. Among them, FHL1 was frequently methylation-silenced in gastric and colon cancer cell lines, and methylated in primary gastric (21/80) and colon (5/50) cancers. Knockdown of the endogenous FHL1 in two cell lines by two kinds of shRNAs significantly increased cell growth in vitro and sizes of xenografts in nude mice. Expression of exogenous FHL1 in a non-expressing cell line significantly reduced its migration, invasion and growth. Notably, a somatic mutation (G642T; Lys214Asn) was identified in one of 144 colon cancer specimens, and the mutant FHL1 was shown to lack its inhibitory effects on migration, invasion and growth. FHL1 methylation was associated with Helicobacter pylori infection and accumulated in normal-appearing gastric mucosae of gastric cancer patients. These data showed that FHL1 is a methylation-silenced tumor-suppressor gene on chromosome X in gastrointestinal cancers, and that its silencing contributes to the formation of an epigenetic field for cancerization. Oncogene (2013) 32, 2140-2149; doi:10.1038/onc.2012.228; published online 11 June 2012	[Asada, K.; Ando, T.; Niwa, T.; Nanjo, S.; Watanabe, N.; Okochi-Takada, E.; Yoshida, T.; Ushijima, T.] Natl Canc Ctr, Div Epigen, Tokyo 1040045, Japan; [Ando, T.; Sugiyama, T.] Toyama Univ, Dept Internal Med 3, Toyama 930, Japan; [Miyamoto, K.] Chugoku Canc Ctr, Natl Hosp Org Kure Med Ctr, Inst Clin Res, Hiroshima, Japan; [Miyamoto, K.] Chugoku Canc Ctr, Natl Hosp Org Kure Med Ctr, Dept Surg, Hiroshima, Japan; [Enomoto, S.; Ichinose, M.] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan; [Tsukamoto, T.; Tatematsu, M.] Aichi Canc Ctr Res Inst, Div Oncol Pathol, Nagoya, Aichi, Japan; [Ito, S.] Aichi Canc Ctr Hosp, Dept Gastroenterol Surg, Nagoya, Aichi 464, Japan	National Cancer Center - Japan; University of Toyama; Wakayama Medical University; Aichi Cancer Center; Aichi Cancer Center	Ushijima, T (corresponding author), Natl Canc Ctr, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp	Ichinose, Masao/HAB-1645-2022; Tsukamoto, Tetsuya/ABD-4397-2020; Asada, Kiyoshi/GPW-7758-2022; Asada, Kiyoshi/AFL-8696-2022; Ushijima, Toshikazu/AAP-5742-2021	Tsukamoto, Tetsuya/0000-0002-7502-8724; Asada, Kiyoshi/0000-0002-4515-6047; Ushijima, Toshikazu/0000-0003-3405-7817	Ministry of Health, Labour and Welfare, Japan; National Cancer Center Research and Development Fund; Foundation for Promotion of Cancer Research	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Foundation for Promotion of Cancer Research	We thank Dr Yanagihara and Dr Yasui for their kind gift of cell lines. This study was supported by a Grant-in-Aid for the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan, and by the National Cancer Center Research and Development Fund. TA is a recipient of the Research Resident Fellowship from the Foundation for Promotion of Cancer Research.	Achyut BR, 2011, GASTROENTEROLOGY, V141, P1167, DOI 10.1053/j.gastro.2011.07.048; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; CHENG H, 1984, GASTROENTEROLOGY, V86, P78; Ding LH, 2011, J CELL MOL MED, V15, P72, DOI 10.1111/j.1582-4934.2009.00938.x; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Enomoto S, 2007, CANCER SCI, V98, P1853, DOI 10.1111/j.1349-7006.2007.00625.x; FUKAYAMA M, 1994, LAB INVEST, V71, P73; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hosoya K, 2009, CANCER LETT, V285, P182, DOI 10.1016/j.canlet.2009.05.016; Ishii T, 2007, GUT, V56, P13, DOI 10.1136/gut.2005.089813; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaneda A, 2004, CANCER LETT, V212, P203, DOI 10.1016/j.canlet.2004.03.020; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee YC, 2011, CANCER PREV RES, V4, P1982, DOI 10.1158/1940-6207.CAPR-11-0096; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Matsumoto M, 2010, INT J MOL MED, V26, P241, DOI 10.3892/ijmm_00000458; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Moriguchi K, 2007, CANCER LETT, V249, P178, DOI 10.1016/j.canlet.2006.08.014; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Niu C, 2012, INT J CANCER, V130, P2549, DOI 10.1002/ijc.26259; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Ota N, 2006, ANTICANCER RES, V26, P3729; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Sakashita K, 2008, ANN SURG ONCOL, V15, P2293, DOI 10.1245/s10434-008-9904-3; Shathasivam T, 2010, J CELL MOL MED, V14, P2702, DOI 10.1111/j.1582-4934.2010.01176.x; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Ushijima T, 2005, CANCER RES, V65, P11; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	43	34	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2140	2149		10.1038/onc.2012.228	http://dx.doi.org/10.1038/onc.2012.228			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22689052				2022-12-25	WOS:000318062800003
J	Mansfield, C; West, TG; Curtin, NA; Ferenczi, MA				Mansfield, Catherine; West, Tim G.; Curtin, Nancy A.; Ferenczi, Michael A.			Stretch of Contracting Cardiac Muscle Abruptly Decreases the Rate of Phosphate Release at High and Low Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBERS; MYOSIN; FORCE; TITIN; FILAMENT; RABBIT; HEART	The contractile performance of the heart is linked to the energy that is available to it. Yet, the heart needs to respond quickly to changing demands. During diastole, the heart fills with blood and the heart chambers expand. Upon activation, contraction of cardiac muscle expels blood into the circulation. Early in systole, parts of the left ventricle are being stretched by incoming blood, before contraction causes shrinking of the ventricle. We explore here the effect of stretch of contracting permeabilized cardiac trabeculae of the rat on the rate of inorganic phosphate (P-i) release resulting from ATP hydrolysis, using a fluorescent sensor for P-i with millisecond time resolution. Stretch immediately reduces the rate of P-i release, an effect observed both at full calcium activation (32 mu mol/liter of Ca2+), and at a physiological activation level of 1 mu mol/liter of Ca2+. The results suggest that stretch redistributes the actomyosin cross-bridges toward their P-i-containing state. The redistribution means that a greater fraction of cross-bridges will be poised to rapidly produce a force-generating transition and movement, compared with cross-bridges that have not been subjected to stretch. At the same time stretch modifies the Pi balance in the cytoplasm, which may act as a cytoplasmic signal for energy turnover.	[Mansfield, Catherine; Curtin, Nancy A.; Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England; [West, Tim G.] Univ London, Royal Vet Coll, London AL9 7TA, Herts, England	Imperial College London; University of London; University of London Royal Veterinary College	Ferenczi, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England.	m.ferenczi@imperial.ac.uk	Ferenczi, Michael/F-9510-2015	Ferenczi, Michael/0000-0002-0349-331X; Mansfield, Catherine/0000-0002-5063-5181	British Heart Foundation [RG/11/20/29266] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Ashikaga H, 2009, JACC-CARDIOVASC IMAG, V2, P202, DOI 10.1016/j.jcmg.2008.11.009; Bickham DC, 2011, BIOPHYS J, V101, P2445, DOI 10.1016/j.bpj.2011.10.007; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; Calaghan SC, 1999, PROG BIOPHYS MOL BIO, V71, P59, DOI 10.1016/S0079-6107(98)00037-6; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Choi HS, 2000, J PHYSIOL-LONDON, V529, P661, DOI 10.1111/j.1469-7793.2000.00661.x; Curtin N A, 1975, J Mechanochem Cell Motil, V3, P147; Curtin NA, 2003, ADV EXP MED BIOL, V538, P613; CURTIN NA, 1973, COLD SPRING HARB SYM, V37, P619, DOI 10.1101/SQB.1973.037.01.074; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Ferenczi M. A., 1985, J PHYSL, V369, P72; FERENCZI MA, 1984, J PHYSIOL-LONDON, V350, P519, DOI 10.1113/jphysiol.1984.sp015216; Fujita H, 2004, AM J PHYSIOL-HEART C, V287, pH2528, DOI 10.1152/ajpheart.00553.2004; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P577, DOI 10.1113/jphysiol.1984.sp015394; He ZH, 2000, BIOPHYS J, V79, P945, DOI 10.1016/S0006-3495(00)76349-1; He ZH, 1998, ADV EXP MED BIOL, V453, P331; He ZH, 1997, J PHYSIOL-LONDON, V501, P125, DOI 10.1111/j.1469-7793.1997.125bo.x; Herzog W, 2003, J EXP BIOL, V206, P3635, DOI 10.1242/jeb.00645; Lee EJ, 2010, J MOL CELL CARDIOL, V49, P449, DOI 10.1016/j.yjmcc.2010.05.006; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC1398, DOI 10.1152/ajpcell.00222.2010; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; Linari M, 2003, J PHYSIOL-LONDON, V548, P461, DOI 10.1113/jphysiol.2002.032185; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; MCCRAY JA, 1980, P NATL ACAD SCI-BIOL, V77, P7237, DOI 10.1073/pnas.77.12.7237; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; MOISESCU DG, 1978, J PHYSIOL-LONDON, V275, P241, DOI 10.1113/jphysiol.1978.sp012188; Muhlfeld C, 2005, COMP BIOCHEM PHYS A, V141, P310, DOI 10.1016/j.cbpb.2005.06.001; MULIERI LA, 1989, CIRC RES, V65, P1441, DOI 10.1161/01.RES.65.5.1441; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; Schmitz JPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034118; Stevens C, 2003, PROG BIOPHYS MOL BIO, V82, P229, DOI 10.1016/S0079-6107(03)00023-3; van der Velden J, 1998, J PHYSIOL-LONDON, V507, P497, DOI 10.1111/j.1469-7793.1998.497bt.x; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732	35	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25696	25705		10.1074/jbc.M112.373498	http://dx.doi.org/10.1074/jbc.M112.373498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692210	hybrid, Green Published			2022-12-25	WOS:000306916300001
J	Chen, YT; Collins, TRL; Guan, ZQ; Chen, VB; Hsieh, TS				Chen, Yu-Tsung; Collins, Tammy R. L.; Guan, Ziqiang; Chen, Vincent B.; Hsieh, Tao-Shih			Probing Conformational Changes in Human DNA Topoisomerase II alpha by Pulsed Alkylation Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DROSOPHILA-MELANOGASTER; CHEMICAL-MODIFICATION; ARGININE RESIDUES; PROTEIN CLAMP; ATPASE DOMAIN; CLEAVAGE; YEAST; INHIBITION; MECHANISM	Type II topoisomerases are essential enzymes for solving DNA topological problems by passing one segment of DNA duplex through a transient double-strand break in a second segment. The reaction requires the enzyme to precisely control DNA cleavage and gate opening coupled with ATP hydrolysis. Using pulsed alkylation mass spectrometry, we were able to monitor the solvent accessibilities around 13 cysteines distributed throughout human topoisomerase II alpha by measuring the thiol reactivities with monobromobimane. Most of the measured reactivities are in accordance with the predicted ones based on a homology structural model generated from available crystal structures. However, these results reveal new information for both the residues not covered in the structural model and potential differences between the modeled and solution holoenzyme structures. Furthermore, on the basis of the reactivity changes of several cysteines located at the N-gate and DNA gate, we could monitor the movement of topoisomerase II in the presence of cofactors and detect differences in the DNA gate between two closed clamp enzyme conformations locked by either 5'-adenylyl beta,gamma-imidodiphosphate or the anticancer drug ICRF-193.	[Chen, Yu-Tsung; Collins, Tammy R. L.; Guan, Ziqiang; Chen, Vincent B.; Hsieh, Tao-Shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Hsieh, Tao-Shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Duke University; Academia Sinica - Taiwan	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	thsieh@duke.edu	Hsieh, Tao-shih/G-9305-2012; Wu, Wan-lin/G-8937-2012; Guan, Ziqiang/AAE-5110-2019	Collins, Tammy/0000-0002-8023-256X; Chen, Vincent/0000-0003-2492-979X	National Institutes of Health [GM29006]; Academia Sinica; United States Department of Defense Breast Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica(Academia Sinica - Taiwan); United States Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institutes of Health (GM29006) and an intramural grant from Academia Sinica.; Supported in part by a grant from the United States Department of Defense Breast Cancer Research Program. Present address: Lab. of Molecular Genetics, NIEHS, NIH, Research Triangle Park, NC 27709.	Apuy JL, 2001, BIOCHEMISTRY-US, V40, P15153, DOI 10.1021/bi0112199; ATASSI MZ, 1972, IMMUNOCHEMISTRY, V9, P907, DOI 10.1016/0019-2791(72)90164-4; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Bender RP, 2006, BIOCHEMISTRY-US, V45, P10140, DOI 10.1021/bi0524666; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21335; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Fass D, 1999, NAT STRUCT BIOL, V6, P322; HABEEB AFS, 1972, BIOCHIM BIOPHYS ACTA, V263, P339, DOI 10.1016/0005-2795(72)90087-6; HANAI R, 1994, P NATL ACAD SCI USA, V91, P11904, DOI 10.1073/pnas.91.25.11904; HSIEH TS, 1983, METHOD ENZYMOL, V100, P161; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Jensen LH, 2005, CANCER RES, V65, P7470, DOI 10.1158/0008-5472.CAN-05-0707; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim YJ, 2004, ANAL BIOCHEM, V332, P376, DOI 10.1016/j.ab.2004.06.033; KOSOWER EM, 1980, J AM CHEM SOC, V102, P4983, DOI 10.1021/ja00535a028; LEE MP, 1994, J MOL BIOL, V235, P436, DOI 10.1006/jmbi.1994.1004; Li W, 1997, J BIOL CHEM, V272, P31190, DOI 10.1074/jbc.272.49.31190; Lin RK, 2011, J BIOL CHEM, V286, P33591, DOI 10.1074/jbc.M111.258137; LIU LF, 1983, J BIOL CHEM, V258, P5365; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; MORRISON A, 1979, CELL, V17, P175, DOI 10.1016/0092-8674(79)90305-2; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANDER M, 1983, J BIOL CHEM, V258, P8421; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Tu BP, 1999, P NATL ACAD SCI USA, V96, P4862, DOI 10.1073/pnas.96.9.4862; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WASSERMAN RA, 1993, CANCER RES, V53, P3591; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; Wood TD, 1998, P NATL ACAD SCI USA, V95, P3362, DOI 10.1073/pnas.95.7.3362; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wu X, 2008, CHEM RES TOXICOL, V21, P483, DOI 10.1021/tx700341n; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	42	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25660	25668		10.1074/jbc.M112.377606	http://dx.doi.org/10.1074/jbc.M112.377606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679013	Green Published, hybrid			2022-12-25	WOS:000306651700073
J	Bordeleau, F; Lapierre, MEM; Sheng, YL; Marceau, N				Bordeleau, Francois; Lapierre, Marie-Eve Myrand; Sheng, Yunlong; Marceau, Normand			Keratin 8/18 Regulation of Cell Stiffness-Extracellular Matrix Interplay through Modulation of Rho-Mediated Actin Cytoskeleton Dynamics	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MECHANICAL-STRESS; EPITHELIAL-CELLS; FOCAL ADHESIONS; PROGRESSION; SUBSTRATE; KINASE; ELASTICITY; INTEGRINS; APOPTOSIS	Cell mechanical activity generated from the interplay between the extracellular matrix (ECM) and the actin cytoskeleton is essential for the regulation of cell adhesion, spreading and migration during normal and cancer development. Keratins are the intermediate filament (IF) proteins of epithelial cells, expressed as pairs in a lineage/differentiation manner. Hepatic epithelial cell IFs are made solely of keratins 8/18 (K8/K18), hallmarks of all simple epithelia. Notably, our recent work on these epithelial cells has revealed a key regulatory function for K8/K18 IFs in adhesion/migration, through modulation of integrin interactions with ECM, actin adaptors and signaling molecules at focal adhesions. Here, using K8-knockdown rat H4 hepatoma cells and their K8/K18-containing counterparts seeded on fibronectin-coated substrata of different rigidities, we show that the K8/K18 IF-lacking cells lose their ability to spread and exhibit an altered actin fiber organization, upon seeding on a low-rigidity substratum. We also demonstrate a concomitant reduction in local cell stiffness at focal adhesions generated by fibronectin-coated microbeads attached to the dorsal cell surface. In addition, we find that this K8/K18 IF modulation of cell stiffness and actin fiber organization occurs through RhoA-ROCK signaling. Together, the results uncover a K8/K18 IF contribution to the cell stiffness-ECM rigidity interplay through a modulation of Rho-dependent actin organization and dynamics in simple epithelial cells.	[Bordeleau, Francois; Lapierre, Marie-Eve Myrand; Marceau, Normand] Ctr hosp Quebec, Ctr Rech Cancerol, Quebec City, PQ, Canada; [Bordeleau, Francois; Lapierre, Marie-Eve Myrand; Marceau, Normand] Ctr Hosp Quebec, Ctr Rech, Quebec City, PQ, Canada; [Bordeleau, Francois; Sheng, Yunlong] Univ Laval, Ctr Opt Photon & Laser, Quebec City, PQ G1K 7P4, Canada	Laval University	Bordeleau, F (corresponding author), Ctr hosp Quebec, Ctr Rech Cancerol, Quebec City, PQ, Canada.	Normand.Marceau@crhdq.ulaval.ca			grants from the National Sciences and Engineering Council of Canada [312270]; Canadian Institutes of Health Research [MOP15529]	grants from the National Sciences and Engineering Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the National Sciences and Engineering Council of Canada (312270) and the Canadian Institutes of Health Research (MOP15529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Barnes SL, 2007, MED PHYS, V34, P4439, DOI 10.1118/1.2795665; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; BLOUIN R, 1992, DIFFERENTIATION, V52, P45, DOI 10.1111/j.1432-0436.1992.tb00498.x; Bordeleau F, 2008, BIOCHEM CELL BIOL, V86, P352, DOI [10.1139/O08-076, 10.1139/o08-076]; Bordeleau F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3626864; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chen EJ, 1996, IEEE T ULTRASON FERR, V43, P191, DOI 10.1109/58.484478; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Fereol S, 2009, BIOPHYS J, V96, P2009, DOI 10.1016/j.bpj.2008.10.072; Fung Y.C., 1993, BIOMECHANICS MECH PR; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Kuo YH, 2010, HEPATOL INT, V4, P700, DOI 10.1007/s12072-010-9223-1; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Marceau N, 2001, BIOCHEM CELL BIOL, V79, P543, DOI 10.1139/bcb-79-5-543; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 1997, HEPATOLOGY, V25, P1043, DOI 10.1002/hep.510250537; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Steinbock FA, 1999, BIOL CHEM, V380, P151, DOI 10.1515/BC.1999.023; Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wei WC, 2008, AM J PHYSIOL-CELL PH, V295, pC1579, DOI 10.1152/ajpcell.00223.2008; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	56	50	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38780	10.1371/journal.pone.0038780	http://dx.doi.org/10.1371/journal.pone.0038780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685604	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700068
J	Ma, Y; Wang, SQ; Xu, WR; Wang, RL; Chou, KC				Ma, Ying; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Chou, Kuo-Chen			Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach	PLOS ONE			English	Article							FREQUENCY VIBRATIONS PHONONS; PROTEASE CLEAVAGE SITES; LIGAND-BINDING DOMAIN; BIOLOGICAL FUNCTIONS; PPAR-GAMMA; ALLOSTERIC TRANSITION; MOLECULAR-DYNAMICS; COLLECTIVE MOTION; 3D STRUCTURE; FATTY-ACIDS	Owing to their unique functions in regulating glucose, lipid and cholesterol metabolism, PPARs (peroxisome proliferator-activated receptors) have drawn special attention for developing drugs to treat type-2 diabetes. By combining the lipid benefit of PPAR-alpha agonists (such as fibrates) with the glycemic advantages of the PPAR-gamma agonists (such as thiazolidinediones), the dual PPAR agonists approach can both improve the metabolic effects and minimize the side effects caused by either agent alone, and hence has become a promising strategy for designing effective drugs against type-2 diabetes. In this study, by means of the powerful "core hopping" and "glide docking" techniques, a novel class of PPAR dual agonists was discovered based on the compound GW409544, a well-known dual agonist for both PPAR-alpha and PPAR-gamma modified from the farglitazar structure. It was observed by molecular dynamics simulations that these novel agonists not only possessed the same function as GW409544 did in activating PPAR-alpha and PPAR-gamma, but also had more favorable conformation for binding to the two receptors. It was further validated by the outcomes of their ADME (absorption, distribution, metabolism, and excretion) predictions that the new agonists hold high potential to become drug candidates. Or at the very least, the findings reported here may stimulate new strategy or provide useful insights for discovering more effective dual agonists for treating type-2 diabetes. Since the "core hopping" technique allows for rapidly screening novel cores to help overcome unwanted properties by generating new lead compounds with improved core properties, it has not escaped our notice that the current strategy along with the corresponding computational procedures can also be utilized to find novel and more effective drugs for treating other illnesses.	[Ma, Ying; Wang, Shu-Qing; Wang, Run-Ling] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China; [Xu, Wei-Ren] TIPR, Tianjin, Peoples R China; [Wang, Shu-Qing; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Tianjin Medical University	Ma, Y (corresponding author), Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China.	sqwang@gordonlifescience.org; wangrunling@tijmu.edu.cn	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [20972112, 21102103]; Doctoral Program of Higher Education of China [20091202110010]; China Postdoctoral Science Foundation [2011M500532]; Tianjin Municipal Natural Science Foundation [09JCZDJC21600]; Tianjin medical university [2011KY43]; Tianjin Institute of Pharmaceutical Research (TIPR)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin); Tianjin medical university; Tianjin Institute of Pharmaceutical Research (TIPR)	This study was supported by grants (20972112 and 21102103) from the National Natural Science Foundation of China; a grant (20091202110010) from the Doctoral Program of Higher Education of China; a grant (2011M500532) from the China Postdoctoral Science Foundation; a grant (09JCZDJC21600) from the Key Program of Tianjin Municipal Natural Science Foundation; a grant (2011KY43) from the Tianjin medical university, as well as Tianjin Institute of Pharmaceutical Research (TIPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LIGPRE2 3; [Anonymous], 2009, QIKPROP3 2; [Anonymous], 2009, PRIME2 1 GLIDE5 5; [Anonymous], 2009, COMBIGLIDE2 5; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BLASCHKE F, 2006, ENDOCRIN METAB CLIN, V35, pR9; Blaschke F, 2006, ENDOCRIN METAB CLIN, V35, P561, DOI 10.1016/j.ecl.2006.06.001; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Cai L, 2011, MED CHEM, V7, P121, DOI 10.2174/157340611794859343; Carpino PA, 2010, EXPERT OPIN THER PAT, V20, P1627, DOI 10.1517/13543776.2010.533171; CHOU KC, 1984, BIOPHYS CHEM, V20, P61, DOI 10.1016/0301-4622(84)80005-8; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; CHOU KC, 1987, BIOPOLYMERS, V26, P285, DOI 10.1002/bip.360260209; Chou KC, 2004, J PROTEOME RES, V3, P1284, DOI 10.1021/pr049849v; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 1999, BIOCHEM BIOPH RES CO, V259, P420, DOI 10.1006/bbrc.1999.0792; CHOU KC, 1988, BIOPOLYMERS, V27, P1795, DOI 10.1002/bip.360271109; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1984, BIOPHYS J, V45, P881, DOI 10.1016/S0006-3495(84)84234-4; CHOU KC, 1994, BIOPOLYMERS, V34, P143, DOI 10.1002/bip.360340114; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Concu R, 2009, J PROTEOME RES, V8, P4372, DOI 10.1021/pr9003163; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023; Du QS, 2009, J COMPUT CHEM, V30, P295, DOI 10.1002/jcc.21056; Ebdrup S, 2003, J MED CHEM, V46, P1306, DOI 10.1021/jm021027r; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Gangloff M, 2001, J BIOL CHEM, V276, P15059, DOI 10.1074/jbc.M009870200; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou XB, 2011, PROTEIN PEPTIDE LETT, V18, P440, DOI 10.2174/092986611794927992; Housaindokht MR, 2008, J THEOR BIOL, V254, P294, DOI 10.1016/j.jtbi.2008.04.036; Husslein T, 1998, FARADAY DISCUSS, V111, P201; HUSSLEIN T, 1998, FARADAY DISCUSS, P225; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Javangula KC, 2006, ANN THORAC SURG, V81, P1913, DOI 10.1016/j.athoracsur.2005.03.045; Ji CG, 2008, J AM CHEM SOC, V130, P17129, DOI 10.1021/ja807374x; Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; Lewis SN, 2010, PPAR RES, V2010, DOI 10.1155/2010/861238; Li XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028111; Liao QH, 2011, MED CHEM, V7, P24, DOI 10.2174/157340611794072698; Liu G, 2003, J MED CHEM, V46, P4232, DOI 10.1021/jm034122o; Liu XY, 2011, PROTEIN PEPT LETT; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Michalik L, 2007, J BIOL CHEM, V282, P9666, DOI 10.1074/jbc.M610523200; Mochizuki K, 2001, BBA-MOL CELL BIOL L, V1531, P68, DOI 10.1016/S0167-4889(01)00071-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Prado-Prado FJ, 2008, BIOORGAN MED CHEM, V16, P5871, DOI 10.1016/j.bmc.2008.04.068; Prado-Prado FJ, 2009, BIOORGAN MED CHEM, V17, P569, DOI 10.1016/j.bmc.2008.11.075; PRADOPRADO FJ, 2009, BIOORG MED IN PRESS; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schrodinger, 2009, COR HOPP; Shearer BG, 2007, BBA-MOL CELL BIOL L, V1771, P1082, DOI 10.1016/j.bbalip.2007.05.005; Shen HB, 2008, ANAL BIOCHEM, V375, P388, DOI 10.1016/j.ab.2008.01.012; Singh KD, 2011, J MOL MODEL; Sirois S, 2004, J CHEM INF COMP SCI, V44, P1111, DOI 10.1021/ci034270n; Song ZY, 2000, BIOPHYS J, V79, P767, DOI 10.1016/S0006-3495(00)76334-X; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yue LD, 2005, BIOCHIMIE, V87, P539, DOI 10.1016/j.biochi.2005.02.002; Zhang JW, 2002, PROTEINS, V48, P447, DOI 10.1002/prot.10173	80	107	108	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38546	10.1371/journal.pone.0038546	http://dx.doi.org/10.1371/journal.pone.0038546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685582	Green Published, gold			2022-12-25	WOS:000305351700045
J	Otero, JE; Chen, T; Zhang, KH; Abu-Amer, Y				Otero, Jesse E.; Chen, Tim; Zhang, Kaihua; Abu-Amer, Yousef			Constitutively Active Canonical NF-kappa B Pathway Induces Severe Bone Loss in Mice	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; ACTIVATION	Physiologic osteoclastogenesis entails activation of multiple signal transduction pathways distal to the cell membrane receptor RANK. However, atypical osteoclastogenesis driven by pro-inflammatory stimuli has been described. We have reported recently a novel mechanism whereby endogenous mutational activation of the classical NF-kappa B pathway is sufficient to induce RANKL/RANK-independent osteoclastogenesis. Here we investigate the physiologic relevance of this phenomenon in vivo. Using a knock-in approach, the active form of IKK2, namely IKK2SSEE, was introduced into the myeloid lineage with the aid of CD11b-cre mice. Phenotypic assessment revealed that expression of IKK2SSEE in the myeloid compartment induced significant bone loss in vivo. This observation was supported by a dramatic increase in the number and size of osteoclasts in trabecular regions, elevated levels of circulating TRACP-5b, and reduced bone volume. Mechanistically, we observed that IKK2SSEE induced high expression of not only p65 but also p52 and RelB; the latter two molecules are considered exclusive members of the alternative NF-kB pathway. Intriguingly, RelB and P52 were both required to mediate the osteoclastogenic effect of IKK2SSEE and co-expression of these two proteins was sufficient to recapitulate osteoclastogenesis in the absence of RANKL or IKK2SSEE. Furthermore, we found that NF-kB2/p100 is a potent inhibitor of IKK2SSEE-induced osteoclastogenesis. Deletion of p52 enabled more robust osteoclast formation by the active kinase. In summary, molecular activation of IKK2 may play a role in conditions of pathologic bone destruction, which may be refractory to therapeutic interventions targeting the proximal RANKL/RANK signal.	[Otero, Jesse E.] Univ Iowa Hosp & Clin, Dept Orthoped Surg, Iowa City, IA 52242 USA; [Chen, Tim; Zhang, Kaihua; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped Surg & Cell Biol & Physiol, St Louis, MO USA	University of Iowa; Washington University (WUSTL)	Otero, JE (corresponding author), Univ Iowa Hosp & Clin, Dept Orthoped Surg, Iowa City, IA 52242 USA.	abuamery@wustl.edu			National Institutes of Health [R01-AR049192, R01-AR054326, P30-AR057235]; Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049192, P30AR057235, R01AR054326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the National Institutes of Health (grants R01-AR049192, R01-AR054326, and P30-AR057235) and a grant from the Shriners Hospital for Children. www.nih.gov/.www.shrinershq.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Abu-Amer Yousef, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P347, DOI 10.2174/1568008054863808; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Darwech I, 2009, J CELL BIOCHEM, V108, P1337, DOI 10.1002/jcb.22364; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Hunter DJ, 2000, ARTHRITIS RES, V2, P441, DOI 10.1186/ar125; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim HB, 2010, BIOSYSTEMS, V99, P140, DOI 10.1016/j.biosystems.2009.10.009; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Madge LA, 2010, J BIOL CHEM, V285, P38069, DOI 10.1074/jbc.M110.147207; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Otero JE, 2008, J BIOL CHEM, V283, P24546, DOI 10.1074/jbc.M800434200; Ruocco MG, 2007, ADV EXP MED BIOL, V602, P125; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716	24	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38694	10.1371/journal.pone.0038694	http://dx.doi.org/10.1371/journal.pone.0038694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685599	Green Submitted, gold, Green Published			2022-12-25	WOS:000305351700062
J	Cai, H; Jiang, J; Yang, Q; Chen, QM; Deng, YQ				Cai, Hua; Jiang, Jun; Yang, Qi; Chen, Qingmei; Deng, Yiqun			Functional Characterization of a First Avian Cytochrome P450 of the CYP2D Subfamily (CYP2D49)	PLOS ONE			English	Article							TESTOSTERONE 16-ALPHA-HYDROXYLASE C-P-45016-ALPHA; CHICKEN XENOBIOTIC RECEPTOR; DOG LIVER-MICROSOMES; DRUG OXIDATION; TRANSCRIPTIONAL ACTIVATION; DEBRISOQUINE 4-HYDROXYLASE; CATALYTIC SPECIFICITY; CIRCULAR-DICHROISM; MOLECULAR-CLONING; ACTIVE-SITE	The CYP2D family members are instrumental in the metabolism of 20-25% of commonly prescribed drugs. Although many CYP2D isoforms have been well characterized in other animal models, research concerning the chicken CYP2Ds is limited. In this study, a cDNA encoding a novel CYP2D enzyme (CYP2D49) was cloned from the chicken liver for the first time. The CYP2D49 cDNA contained an open reading frame of 502 amino acids that shared 52%-57% identities with other CYP2Ds. The gene structure and neighboring genes of CYP2D49 are conserved and similar to those of human CYP2D6. Additionally, similar to human CYP2D6, CYP2D49 is un-inducible in the liver and expressed predominantly in the liver, kidney and small intestine, with detectable levels in several other tissues. Metabolic assays of the CYP2D49 protein heterologously expressed in E. coli and Hela cells indicated that CYP2D49 metabolized the human CYP2D6 substrate, bufuralol, but not debrisoquine. Moreover, quinidine, a potent inhibitor of human CYP2D6, only inhibited the bufuralol 1'-hydroxylation activity of CYP2D49 to a negligible degree. All these results indicated that CYP2D49 had functional characteristics similar to those of human CYP2D6 but measurably differed in the debrisoquine 4'-hydroxylation and quinidine inhibitory profile. Further structure-function investigations that employed site-directed mutagenesis and circular dichroism spectroscopy identified the importance of Val-126, Glu-222, Asp-306, Phe-486 and Phe-488 in keeping the enzymatic activity of CYP2D49 toward bufuralol as well as the importance of Asp-306, Phe-486 and Phe-488 in maintaining the conformation of CYP2D49 protein. The current study is only the first step in characterizing the metabolic mechanism of CYP2D49; further studies are still required.	[Cai, Hua; Jiang, Jun; Yang, Qi; Chen, Qingmei; Deng, Yiqun] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Deng, YQ (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	yqdeng@scau.edu.cn	Deng, Yiqun/K-7709-2013	Deng, Yiqun/0000-0002-6838-3779	National Basic Research Program of China (973 program) [2009CB118802]; National Natural Science Foundation of China [31172087]; Guangdong Province Universities and Colleges Special Funds for Talents; China Postdoctoral Science Foundation [201104362]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Special Funds for Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Basic Research Program of China (973 program, 2009CB118802), the National Natural Science Foundation of China grant (31172087), Guangdong Province Universities and Colleges Special Funds for Talents (2010), and the Special Financial Grant from the China Postdoctoral Science Foundation (201104362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABBAGH SG, 1981, J PHARM PHARMACOL, V33, P161, DOI 10.1111/j.2042-7158.1981.tb13740.x; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131, DOI 10.1080/00498250010021684; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Daly AK, 1996, PHARMACOGENETICS, V6, P319, DOI 10.1097/00008571-199608000-00005; de Graaf C, 2007, CURR DRUG METAB, V8, P59, DOI 10.2174/138920007779315062; ELLIS SW, 1995, J BIOL CHEM, V270, P29055, DOI 10.1074/jbc.270.49.29055; Flanagan JU, 2004, BIOCHEM J, V380, P353, DOI 10.1042/BJ20040062; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; GONZALEZ FJ, 1987, DNA-J MOLEC CELL BIO, V6, P149, DOI 10.1089/dna.1987.6.149; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GUT J, 1986, J BIOL CHEM, V261, P1734; Hadidi S, 2001, IMMUNOL LETT, V77, P97, DOI 10.1016/S0165-2478(01)00208-5; Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362; Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571; Hayhurst GP, 2001, BIOCHEM J, V355, P373, DOI 10.1042/0264-6021:3550373; Hichiya H, 2004, BIOCHEM PHARMACOL, V68, P165, DOI 10.1016/j.bcp.2004.03.018; Hichiya H, 2002, BIOCHEM PHARMACOL, V64, P1101, DOI 10.1016/S0006-2952(02)01287-X; Hiroi T, 2002, DRUG METAB DISPOS, V30, P970, DOI 10.1124/dmd.30.9.970; JIANG QS, 1995, BIOCHEM BIOPH RES CO, V209, P1149, DOI 10.1006/bbrc.1995.1617; Keizers PHJ, 2004, BIOCHEM PHARMACOL, V68, P2263, DOI 10.1016/j.bcp.2004.08.013; Khalil WF, 2001, J VET PHARMACOL THER, V24, P343, DOI 10.1046/j.1365-2885.2001.00349.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; MATSUNAGA E, 1990, J MOL EVOL, V30, P155, DOI 10.1007/BF02099942; Michael PP, 2005, CYTOCHROME P450 PROT, P19; MURA C, 1991, NUCLEIC ACIDS RES, V19, P1162, DOI 10.1093/nar/19.5.1162; Narimatsu S, 2009, BIOCHEM PHARMACOL, V77, P920, DOI 10.1016/j.bcp.2008.11.006; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Niwa T, 2011, CURR DRUG METAB, V12, P412, DOI 10.2174/138920011795495286; Okey AB, 1992, PHARMACOGENETICS DRU, P594; Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566; Paine MJI, 2003, J BIOL CHEM, V278, P4021, DOI 10.1074/jbc.M209519200; Perrins, 2003, ENCY BRITANNICA FIRE; Roussel F, 1998, ARCH BIOCHEM BIOPHYS, V357, P27, DOI 10.1006/abbi.1998.0801; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; SAKAMOTO K, 1995, ARCH BIOCHEM BIOPHYS, V319, P372, DOI 10.1006/abbi.1995.1307; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; SUZUKI T, 1992, DRUG METAB DISPOS, V20, P367; Tasaki T, 1998, J BIOCHEM, V123, P747; TSUNEOKA Y, 1992, EUR J BIOCHEM, V208, P739, DOI 10.1111/j.1432-1033.1992.tb17242.x; Wan J, 1997, ARCH BIOCHEM BIOPHYS, V348, P383, DOI 10.1006/abbi.1997.0402; WONG G, 1989, J BIOL CHEM, V264, P2920; WONG G, 1987, BIOCHEMISTRY-US, V26, P8683, DOI 10.1021/bi00400a029; WOOLHOUSE NM, 1979, CLIN PHARMACOL THER, V26, P586; Yamamoto Y, 1998, J BIOCHEM-TOKYO, V124, P503, DOI 10.1093/oxfordjournals.jbchem.a022141; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000; Zuber R, 2002, J CELL MOL MED, V6, P189, DOI 10.1111/j.1582-4934.2002.tb00186.x	53	8	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38395	10.1371/journal.pone.0038395	http://dx.doi.org/10.1371/journal.pone.0038395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675558	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700070
J	Ryu, YU; Buchanan, JJ				Ryu, Young U.; Buchanan, John J.			Accuracy, Stability, and Corrective Behavior in a Visuomotor Tracking Task: A Preliminary Study	PLOS ONE			English	Article							NONEQUILIBRIUM PHASE-TRANSITIONS; RHYTHMIC MOVEMENT COORDINATION; VISUAL-PERCEPTION; RELATIVE PHASE; DYNAMICS; SYNCHRONIZATION; FEEDBACK; MODEL	Visuomotor tracking tasks have been used to elucidate the underlying mechanisms that allow for the coordination of a movement to an environmental event. The main purpose of the present study was to examine the relationship between accuracy and stability of tracking performance and the amount of corrective movements that emerge for various coordination patterns in a unimanual visuomotor tracking task. Participants (N = 6) produced rhythmic elbow flexion-extension motions and were required to track an external sinusoidal signal at five different relative phases, 0 degrees, 45 degrees, 90 degrees, 135 degrees, and 180 degrees. Differential accuracy and stability were found among the five tracking patterns with the 0 degrees relative phase pattern being the most accurate and stable pattern. Corrective movements were correlated with changes in accuracy only for the 0 degrees relative phase pattern, with more corrections emerging for less accurate performance. The amount of corrective movements decreased as the stability of tracking performance increased for the 0 degrees, 45 degrees, and 135 degrees patterns. For the 90 degrees and 180 degrees tracking patterns, the amount of corrective movements was not correlated with pattern accuracy or pattern stability. The results demonstrate that corrective behaviors are an important motor process in maintaining the stability of stable perceptionaction coordination patterns, while offering little benefit for unstable perception-action patterns.	[Ryu, Young U.] Catholic Univ Daegu, Dept Phys Therapy, Gyongsan, South Korea; [Buchanan, John J.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Catholic University of Daegu; Texas A&M University System; Texas A&M University College Station	Ryu, YU (corresponding author), Catholic Univ Daegu, Dept Phys Therapy, Gyongsan, South Korea.	ryuyounguk@gmail.com		Ryu, Young Uk/0000-0003-1601-4477	National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0006539]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0006539) awarded to YUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; Buekers MJ, 2000, NEUROSCI LETT, V290, P181, DOI 10.1016/S0304-3940(00)01350-1; BURGESSLIMERICK R, 1991, J MOTOR BEHAV, V23, P301, DOI 10.1080/00222895.1991.9942041; Ceux T, 2003, NEUROSCI LETT, V349, P103, DOI 10.1016/S0304-3940(03)00799-7; Craik KJW, 1947, B J PSYCHOL-GEN SECT, V38, P56, DOI 10.1111/j.2044-8295.1947.tb01141.x; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Mardia KV, 1972, FUNDAMENTALS EXPT DE; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; NOBLE M, 1955, J EXP PSYCHOL, V49, P249, DOI 10.1037/h0047910; Peper CLE, 1998, BIOL CYBERN, V79, P291, DOI 10.1007/s004220050479; Russell DM, 2001, J MOTOR BEHAV, V33, P329, DOI 10.1080/00222890109601918; Ryu YU, 2009, EXP BRAIN RES, V196, P279, DOI 10.1007/s00221-009-1847-9; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; SCHONER G, 1992, J MOTOR BEHAV, V24, P29, DOI 10.1080/00222895.1992.9941599; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Tallet J, 2008, J MOTOR BEHAV, V40, P103, DOI 10.3200/JMBR.40.2.103-116; Wickens CD, 1995, HUM FACTORS, V37, P474; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Zaal FTJM, 2000, J EXP PSYCHOL HUMAN, V26, P1209, DOI 10.1037//0096-1523.26.3.1209; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38537	10.1371/journal.pone.0038537	http://dx.doi.org/10.1371/journal.pone.0038537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675574	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341700086
J	Adams, AC; Coskun, T; Rovira, ARI; Schneider, MA; Raches, DW; Micanovic, R; Bina, HA; Dunbar, JD; Kharitonenkov, A				Adams, Andrew C.; Coskun, Tamer; Rovira, Armando R. Irizarry; Schneider, Michael A.; Raches, David W.; Micanovic, Radmila; Bina, Holly A.; Dunbar, James D.; Kharitonenkov, Alexei			Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; KLOTHO GENE FAMILY; FACTOR RECEPTOR 4; BETA-KLOTHO; INSULIN-RESISTANCE; METABOLIC-ACTIVITY; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; OBESITY; MICE	Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of energy metabolism. Several studies have been conducted to understand the mechanism of FGF19 and FGF21 action, however, the data presented has often been inconsistent and at times contradictory. Here in a single study we compare the mechanisms mediating FGF19/FGF21 actions, and how similarities/differences in actions at the cellular level between these two factors translate to common/divergent physiological outputs. Firstly, we show that in cell culture FGF19/FGF21 are very similar, however, key differences are still observed differentiating the two. In vitro we found that both FGF's activate FGFRs in the context of beta Klotho (KLB) expression. Furthermore, both factors alter ERK phosphorylation and glucose uptake with comparable potency. Combination treatment of cells with both factors did not have additive effects and treatment with a competitive inhibitor, the FGF21 delta N17 mutant, also blocked FGF19' s effects, suggestive of a shared receptor activation mechanism. The key differences between FGF21/FGF19 were noted at the receptor interaction level, specifically the unique ability of FGF19 to bind/signal directly via FGFR4. To determine if differential effects on energy homeostasis and hepatic mitogenicity exist we treated DIO and ob/ob mice with FGF19/FGF21. We find comparable efficacy of the two proteins to correct body weight and serum glucose in both DIO and ob/ob mice. Nevertheless, FGF21 and FGF19 had distinctly different effects on proliferation in the liver. Interestingly, in vivo blockade of FGF21 signaling in mice using Delta N17 caused profound changes in glycemia indicative of the critical role KLB and FGF21 play in the regulation of glucose homeostasis. Overall, our data demonstrate that while subtle differences exist in vitro the metabolic effects in vivo of FGF19/FGF21 are indistinguishable, supporting a shared mechanism of action for these two hormones in the regulation of energy balance.	[Adams, Andrew C.; Coskun, Tamer; Rovira, Armando R. Irizarry; Schneider, Michael A.; Raches, David W.; Micanovic, Radmila; Bina, Holly A.; Dunbar, James D.; Kharitonenkov, Alexei] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Adams, AC (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	Kharitonenkov_Alexei@lilly.com	Coskun, Tamer/AAR-8422-2021	Adams, Andrew/0000-0002-7465-1856				Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSL ENDOCRINO; Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Crissman JW, 2004, TOXICOL PATHOL, V32, P126, DOI 10.1080/01926230490268756; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2012, MOL CELL BIOL; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2008, CURR OPIN NEPHROL HY, V17, P368, DOI 10.1097/MNH.0b013e3282ffd994; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Long YC, 2011, BBA-MOL BASIS DIS, V1812, P791, DOI 10.1016/j.bbadis.2011.04.002; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Motoda N, 2011, INT J ONCOL, V38, P133, DOI 10.3892/ijo_00000832; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Wu XL, 2012, J MOL BIOL, V418, P82, DOI 10.1016/j.jmb.2012.02.027; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yeoh JSG, 2007, MECH AGEING DEV, V128, P17, DOI 10.1016/j.mad.2006.11.005	42	85	88	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38438	10.1371/journal.pone.0038438	http://dx.doi.org/10.1371/journal.pone.0038438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675463	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500147
J	Amraoui, F; Krida, G; Bouattour, A; Rhim, A; Daaboub, J; Harrat, Z; Boubidi, SC; Tijane, M; Sarih, M; Failloux, AB				Amraoui, Fadila; Krida, Ghazi; Bouattour, Ali; Rhim, Adel; Daaboub, Jabeur; Harrat, Zoubir; Boubidi, Said-Chawki; Tijane, Mhamed; Sarih, Mhammed; Failloux, Anna-Bella			Culex pipiens, an Experimental Efficient Vector of West Nile and Rift Valley Fever Viruses in the Maghreb Region	PLOS ONE			English	Article							ATTENUATED AVIRULENT ISOLATE; MOSQUITOS; COMPETENCE; CULICIDAE; DIPTERA; AFRICA; AEDES; TRANSCRIPTION; EPIDEMIOLOGY; REPLICATION	West Nile fever (WNF) and Rift Valley fever (RVF) are emerging diseases causing epidemics outside their natural range of distribution. West Nile virus (WNV) circulates widely and harmlessly in the old world among birds as amplifying hosts, and horses and humans as accidental dead-end hosts. Rift Valley fever virus (RVFV) re-emerges periodically in Africa causing massive outbreaks. In the Maghreb, eco-climatic and entomologic conditions are favourable for WNV and RVFV emergence. Both viruses are transmitted by mosquitoes belonging to the Culex pipiens complex. We evaluated the ability of different populations of Cx. pipiens from North Africa to transmit WNV and the avirulent RVFV Clone 13 strain. Mosquitoes collected in Algeria, Morocco, and Tunisia during the summer 2010 were experimentally infected with WNV and RVFV Clone 13 strain at titers of 10(7.8) and 10(8.5) plaque forming units/mL, respectively. Disseminated infection and transmission rates were estimated 14-21 days following the exposure to the infectious blood-meal. We show that 14 days after exposure to WNV, all mosquito st developed a high disseminated infection and were able to excrete infectious saliva. However, only 69.2% of mosquito strains developed a disseminated infection with RVFV Clone 13 strain, and among them, 77.8% were able to deliver virus through saliva. Thus, Cx. pipiens from the Maghreb are efficient experimental vectors to transmit WNV and to a lesser extent, RVFV Clone 13 strain. The epidemiologic importance of our findings should be considered in the light of other parameters related to mosquito ecology and biology.	[Amraoui, Fadila; Sarih, Mhammed] Inst Pasteur Maroc, Lab Malad Vectorielles, Casablanca, Morocco; [Krida, Ghazi; Bouattour, Ali; Rhim, Adel] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Epidemiol & Microbiol Vet, Serv Entomol Med, Tunis, Tunisia; [Krida, Ghazi] Univ Carthage, Inst Natl Agron Tunisie, Tunis, Tunisia; [Daaboub, Jabeur] Minist Sante Publ Tunisie, Direct Hyg Milieu & Protect Environm, Tunis, Tunisia; [Harrat, Zoubir; Boubidi, Said-Chawki] Inst Pasteur Alger, Unite Entomol Med, Serv Ecoepidemiol Parasitaire & Genet Populat, Algiers, Algeria; [Amraoui, Fadila; Tijane, Mhamed] Fac Sci Rabat, Lab Biochim & Immunol, Rabat, Morocco; [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; Mohammed V University in Rabat; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Amraoui, F (corresponding author), Inst Pasteur Maroc, Lab Malad Vectorielles, Casablanca, Morocco.	anna-bella.failloux@pasteur.fr			Institut Pasteur (ACIP) [A-08-2009]; European Commission [228421]; "Division International" of the Institut Pasteur	Institut Pasteur (ACIP); European Commission(European CommissionEuropean Commission Joint Research Centre); "Division International" of the Institut Pasteur	This work was funded by the Institut Pasteur (ACIP grant A-08-2009) and the European Commission Framework Program Seven Award "InfraVec" (n 228421). FA was supported by the "Division International" of the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rahim IHA, 1999, REV SCI TECH OIE, V18, P741, DOI 10.20506/rst.18.3.1195; Ahmad K, 2000, LANCET, V356, P1422, DOI 10.1016/S0140-6736(05)74068-X; Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P103, DOI 10.2987/09-5926.1; Ben Hassine T, 2011, Bull Soc Pathol Exot, V104, P266, DOI 10.1007/s13149-011-0173-1; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Bouloy MB, 1998, LANCET, V352, P1596, DOI 10.1016/S0140-6736(05)61043-4; Dancesco P, 1975, Bull Soc Pathol Exot Filiales, V68, P503; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; El-Harrak M., 1997, VIROLOGIE, V1, P248; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206; FARAN ME, 1987, AM J TROP MED HYG, V37, P403, DOI 10.4269/ajtmh.1987.37.403; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; FONTENILLE D, 1995, AM J TROP MED HYG, V52, P403, DOI 10.4269/ajtmh.1995.52.403; Garbouj M., 2003, B EPIDEMIOLOGIQUE, V3, P4; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0; Krida G, 2012, ANN SOC ENT IN PRESS; Krida Ghazi, 1997, Bulletin de la Societe Entomologique de France, V102, P143; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533, DOI 10.4269/ajtmh.1977.26.533; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; LeGuenno B, 1996, LANCET, V348, P1315, DOI 10.1016/S0140-6736(05)65799-6; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Moutailler S, 2010, VECTOR-BORNE ZOONOT, V10, P681, DOI 10.1089/vbz.2009.0246; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Murgue B, 2001, EMERG INFECT DIS, V7, P692; OIE, 9515 OIE; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; RIOUX J.-A., 1965, ARCH INST PASTEUR TUNIS, V42, P1; Rioux J. A., 1958, CULICIDES MIDI MEDIT; Roubaud E., 1939, B SOC PATHOL EXOT, V36, P172; Roubaud E, 1933, ANN SCI NAT ZOOL, V16, P5; Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817; Senevet G., 1958, Arch Inst Pasteur Alger Algiers, V36, P70; Senevet G, 1959, ORTHOPODOMYIA MANSON; SENEVET GEORGES, 1963, ARCH INST PASTEUR ALGERIE, V41, P115; Smithburn KC., 1940, AM J TROP MED HYG, V1, P471, DOI 10.4269/ajtmh.1940.s1-20.471; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; Triki H, 2001, Med Trop (Mars), V61, P487; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; VERMEIL C., 1954, BULL SOC PATHOL EXOT, V47, P841; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265	52	74	81	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36757	10.1371/journal.pone.0036757	http://dx.doi.org/10.1371/journal.pone.0036757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693557	Green Published, gold			2022-12-25	WOS:000305338500018
J	Duffield, GE; Mikkelsen, JD; Ebling, FJP				Duffield, Giles E.; Mikkelsen, Jens D.; Ebling, Francis J. P.			Conserved Expression of the Glutamate NMDA Receptor 1 Subunit Splice Variants during the Development of the Siberian Hamster Suprachiasmatic Nucleus	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; CIRCADIAN SYSTEM; GENE-EXPRESSION; PHOTIC REGULATION; NURSING MOTHERS; NERVOUS-SYSTEM; PHASE-SHIFTS; CLOCK GENES; RAT-BRAIN	Glutamate neurotransmission and the N-methyl-D-aspartate receptor (NMDAR) are central to photic signaling to the master circadian pacemaker located in the hypothalamic suprachiasmatic nucleus (SCN). NMDARs also play important roles in brain development including visual input circuits. The functional NMDAR is comprised of multiple subunits, but each requiring the NR1 subunit for normal activity. The NR1 can be alternatively spliced to produce isoforms that confer different functional properties on the NMDAR. The SCN undergoes extensive developmental changes during postnatal life, including synaptogenesis and acquisition of photic signaling. These changes are especially important in the highly photoperiodic Siberian hamster, in which development of sensitivity to photic cues within the SCN could impact early physiological programming. In this study we examined the expression of NR1 isoforms in the hamster at different developmental ages. Gene expression in the forebrain was quantified by in situ hybridization using oligonucleotide probes specific to alternatively spliced regions of the NR1 heteronuclear mRNA, including examination of anterior hypothalamus, piriform cortex, caudate-putamen, thalamus and hippocampus. Gene expression analysis within the SCN revealed the absence of the N1 cassette, the presence of the C2 cassette alone and the combined absence of C1 and C2 cassettes, indicating that the dominant splice variants are NR1-2a and NR1-4a. Whilst we observe changes at different developmental ages in levels of NR1 isoform probe hybridization in various forebrain structures, we find no significant changes within the SCN. This suggests that a switch in NR1 isoform does not underlie or is not produced by developmental changes within the hamster SCN. Consistency of the NR1 isoforms would ensure that the response of the SCN cells to photic signals remains stable throughout life, an important aspect of the function of the SCN as a responder to environmental changes in quality/quantity of light over the circadian day and annual cycle.	[Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Mikkelsen, Jens D.] Univ Copenhagen Hosp, Neurobiol Res Unit, Rigshosp, DK-2100 Copenhagen, Denmark; [Ebling, Francis J. P.] Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham, England	University of Notre Dame; Rigshospitalet; University of Copenhagen; University of Nottingham	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	Ebling, Francis/A-1900-2013; Ebling, Francis/Q-6193-2019	Ebling, Francis/0000-0002-7316-9582; Ebling, Francis/0000-0002-7316-9582	Medical Research Council; Lundbeck Foundation; NovoNordisk Foundation; University of Notre Dame; American Heart Association [10SDG4030011]; National Institute of General Medical Sciences [R01-GM087508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Notre Dame; American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the Medical Research Council (Postgraduate studentship to GED), the Lundbeck Foundation (to JDM), the NovoNordisk Foundation (to JDM), the University of Notre Dame (to GED), the American Heart Association (10SDG4030011 to GED) and the National Institute of General Medical Sciences (R01-GM087508 to GED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendova Z, 2009, NEUROSCIENCE, V159, P599, DOI 10.1016/j.neuroscience.2009.01.016; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Campusano JM, 2005, NEUROCHEM RES, V30, P567, DOI 10.1007/s11064-005-2691-3; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Colonnese MT, 2006, J COMP NEUROL, V494, P738, DOI 10.1002/cne.20841; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cramer KS, 1996, PROG BRAIN RES, V108, P235, DOI 10.1016/S0079-6123(08)62543-1; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Duffield GE, 1998, J NEUROENDOCRINOL, V10, P871; DUFFIELD GE, 1995, EUR J NEUROSCI, V7, P1089, DOI 10.1111/j.1460-9568.1995.tb01096.x; Duffield GE, 1998, J BIOL RHYTHM, V13, P315, DOI 10.1177/074873098129000156; Duffield GE, 1999, J COMP NEUROL, V408, P73; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; EBLING FJP, 1994, GEN COMP ENDOCR, V95, P475, DOI 10.1006/gcen.1994.1147; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; EBLING FJP, 1995, J NEUROENDOCRINOL, V7, P555, DOI 10.1111/j.1365-2826.1995.tb00792.x; Ebling FJP, 2010, MOL CELL ENDOCRINOL, V324, P95, DOI 10.1016/j.mce.2010.03.018; El-Hennamy R, 2008, J BIOL RHYTHM, V23, P435, DOI 10.1177/0748730408322635; GANNON RL, 1994, MOL BRAIN RES, V23, P338, DOI 10.1016/0169-328X(94)90244-5; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; Grosse J, 1999, BRAIN RES BULL, V48, P185, DOI 10.1016/S0361-9230(98)00162-2; HARTGRAVES MD, 1994, BRAIN RES, V640, P113, DOI 10.1016/0006-8993(94)91863-5; Hastings MH, 1998, CHRONOBIOL INT, V15, P425, DOI 10.3109/07420529808998700; HOFER M, 1994, PROG BRAIN RES, V102, P277; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; HORTON TH, 1990, BIOL REPROD, V42, P441, DOI 10.1095/biolreprod42.3.441; ISHIDA N, 1994, NEUROSCI LETT, V166, P211, DOI 10.1016/0304-3940(94)90488-X; IVELL R, 1984, P NATL ACAD SCI-BIOL, V81, P2006, DOI 10.1073/pnas.81.7.2006; JENSEN AM, 1993, J NEUROSCI, V13, P1664; KAUFMAN CM, 1994, BRAIN RES, V633, P162, DOI 10.1016/0006-8993(94)91535-0; Kennaway DJ, 2002, TRENDS ENDOCRIN MET, V13, P398, DOI 10.1016/S1043-2760(02)00692-6; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; KUS L, 1995, MOL BRAIN RES, V28, P55, DOI 10.1016/0169-328X(94)00179-I; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LEE TM, 1989, BIOL REPROD, V40, P495, DOI 10.1095/biolreprod40.3.495; Llansola M, 2004, J NEUROCHEM, V91, P591, DOI 10.1111/j.1471-4159.2004.02730.x; Manta G, 2011, NEUROCHEM RES, V36, P1417, DOI 10.1007/s11064-011-0467-5; Mateju K, 2009, EUR J NEUROSCI, V29, P490, DOI 10.1111/j.1460-9568.2009.06609.x; McNulty S, 1998, EUR J NEUROSCI, V10, P1063, DOI 10.1046/j.1460-9568.1998.00114.x; MIKKELSEN JD, 1993, BRAIN RES, V632, P329, DOI 10.1016/0006-8993(93)91171-N; MIKKELSEN JD, 1995, NEUROCHEM INT, V27, P263, DOI 10.1016/0197-0186(95)00039-B; Miskevich F, 2006, J NEUROSCI METH, V152, P65, DOI 10.1016/j.jneumeth.2005.08.010; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOORE RY, 1989, RES PERINATAL MED, V9, P1; MORIN LP, 1994, BRAIN RES REV, V19, P102, DOI 10.1016/0165-0173(94)90005-1; Moriya T, 2000, MOL PHARMACOL, V58, P1554, DOI 10.1124/mol.58.6.1554; Muller C, 1998, DEV BRAIN RES, V110, P203, DOI 10.1016/S0165-3806(98)00108-4; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; NISHIZAWA M, 1985, FEBS LETT, V183, P55, DOI 10.1016/0014-5793(85)80953-4; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Okabe S, 1999, J NEUROSCI, V19, P7781; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; SATO K, 1995, NEUROSCIENCE, V64, P459, DOI 10.1016/0306-4522(94)00335-3; Schurov IL, 1999, J NEUROENDOCRINOL, V11, P43; Smolen AJ, 1990, IN SITU HYBRIDIZATIO, P175; SPEH JC, 1993, DEV BRAIN RES, V76, P171, DOI 10.1016/0165-3806(93)90205-O; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; Sumova A, 2006, FEBS LETT, V580, P2836, DOI 10.1016/j.febslet.2006.03.023; THOMAS KL, 1994, NEUROREPORT, V6, P119, DOI 10.1097/00001756-199412300-00031; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; VANDENPOL AN, 1994, J COMP NEUROL, V343, P428, DOI 10.1002/cne.903430307; VANDENPOL AN, 1994, J NEUROSCI, V14, P3816; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WEAVER DR, 1995, MOL BRAIN RES, V33, P136, DOI 10.1016/0169-328X(95)00117-B; Weaver DR, 1989, RES PERINATAL MED, P209; Weiss SW, 1998, J NEUROSCI, V18, P1725; Young III WS, 1986, IN SITU HYBRIDIZATIO, P243; Zhao JP, 2006, J NEUROSCI, V26, P12647, DOI 10.1523/JNEUROSCI.3678-06.2006; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	81	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37496	10.1371/journal.pone.0037496	http://dx.doi.org/10.1371/journal.pone.0037496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675426	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500039
J	Iwamaru, Y; Takenouchi, T; Murayama, Y; Okada, H; Imamura, M; Shimizu, Y; Hashimoto, M; Mohri, S; Yokoyama, T; Kitani, H				Iwamaru, Yoshifumi; Takenouchi, Takato; Murayama, Yuichi; Okada, Hiroyuki; Imamura, Morikazu; Shimizu, Yoshihisa; Hashimoto, Makoto; Mohri, Shirou; Yokoyama, Takashi; Kitani, Hiroshi			Anti-Prion Activity of Brilliant Blue G	PLOS ONE			English	Article							PURINERGIC P2X(7) RECEPTOR; CREUTZFELDT-JAKOB-DISEASE; MICROGLIAL CELL-LINE; PROTEIN ACCUMULATION; CULTURED-CELLS; IN-VITRO; 2-ARACHIDONOYLGLYCEROL PRODUCTION; CHRONIC NEURODEGENERATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE	Background: Prion diseases are fatal neurodegenerative disorders with no effective therapy currently available. Accumulating evidence has implicated over-activation of P2X7 ionotropic purinergic receptor (P2X7R) in the progression of neuronal loss in several neurodegenerative diseases. This has led to the speculation that simultaneous blockade of this receptor and prion replication can be an effective therapeutic strategy for prion diseases. We have focused on Brilliant Blue G (BBG), a well-known P2X7R antagonist, possessing a chemical structure expected to confer anti-prion activity and examined its inhibitory effect on the accumulation of pathogenic isoforms of prion protein (PrPres) in a cellular and a mouse model of prion disease in order to determine its therapeutic potential. Principal Findings: BBG prevented PrPres accumulation in infected MG20 microglial and N2a neural cells at 50% inhibitory concentrations of 14.6 and 3.2 mu M, respectively. Administration of BBG in vivo also reduced PrPres accumulation in the brains of mice with prion disease. However, it did not appear to alleviate the disease progression compared to the vehicle-treated controls, implying a complex role of P2X7R on the neuronal degeneration in prion diseases. Significance: These results provide novel insights into the pathophysiology of prion diseases and have important implications for the treatment.	[Iwamaru, Yoshifumi; Murayama, Yuichi; Okada, Hiroyuki; Imamura, Morikazu; Shimizu, Yoshihisa; Mohri, Shirou; Yokoyama, Takashi] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan; [Hashimoto, Makoto] Tokyo Metropolitan Inst Med Sci, Div Sensory & Motor Syst, Setagaya Ku, Tokyo 113, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Agrobiological Sciences - Japan; Tokyo Metropolitan Institute of Medical Science	Iwamaru, Y (corresponding author), Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	kitani@affrc.go.jp	Mohri, Shirou/AAK-1281-2020		BSE; Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [23780313, 22580389]	BSE; Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the BSE and other Prion 20 Disease Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan and by a Grant-in-Aid for Young Scientists (Category B: Grant# 23780313) and Scientific Research (Category C: Grant# 22580389) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini P, 1996, NEUROREPORT, V7, P2533, DOI 10.1097/00001756-199611040-00026; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Bolognesi ML, 2010, CHEMMEDCHEM, V5, P1324, DOI 10.1002/cmdc.201000133; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Brown AR, 2003, J GEN VIROL, V84, P2605, DOI 10.1099/vir.0.19137-0; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Cabral GA, 2001, ADV EXP MED BIOL, V493, P207; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Daude N, 2003, J CELL SCI, V116, P2775, DOI 10.1242/jcs.00494; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hracsko Z, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-28; Iriyama A, 2012, RETINA-J RET VIT DIS, V32, P613, DOI 10.1097/IAE.0b013e31822091df; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Khaspekov LG, 2004, EUR J NEUROSCI, V19, P1691, DOI 10.1111/j.1460-9568.2004.03285.x; Kordek R, 1999, ACTA NEUROPATHOL, V98, P597, DOI 10.1007/s004010051124; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Nagaoka K, 2010, BIOCHEM BIOPH RES CO, V397, P626, DOI 10.1016/j.bbrc.2010.06.013; Ortega F, 2011, NEUROPHARMACOLOGY; Papp L, 2004, NEUROREPORT, V15, P2387, DOI 10.1097/00001756-200410250-00017; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Skaper SD, 2006, GLIA, V54, P234, DOI 10.1002/glia.20379; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Takenouchi T, 2007, FEBS LETT, V581, P3019, DOI 10.1016/j.febslet.2007.05.057; Takenouchi T, 2010, ARCH IMMUNOL THER EX, V58, P91, DOI 10.1007/s00005-010-0069-y; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Tribouillard-Tanvier D, 2009, J VIROL, V83, P11244, DOI 10.1128/JVI.01413-09; Walsh DT, 2001, J NEUROPATH EXP NEUR, V60, P173, DOI 10.1093/jnen/60.2.173; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12	63	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37896	10.1371/journal.pone.0037896	http://dx.doi.org/10.1371/journal.pone.0037896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693582	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500063
J	Lebon, F; Lotze, M; Stinear, CM; Byblow, WD				Lebon, Florent; Lotze, Martin; Stinear, Cathy M.; Byblow, Winston D.			Task-Dependent Interaction between Parietal and Contralateral Primary Motor Cortex during Explicit versus Implicit Motor Imagery	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MENTAL ROTATION; CORTICOSPINAL EXCITABILITY; HAND MOVEMENTS; INVOLVEMENT; TMS; SYSTEM; BRAIN; FMRI; REPRESENTATIONS	Both mental rotation (MR) and motor imagery (MI) involve an internalization of movement within motor and parietal cortex. Transcranial magnetic stimulation (TMS) techniques allow for a task-dependent investigation of the interhemispheric interaction between these areas. We used image-guided dual-coil TMS to investigate interactions between right inferior parietal lobe (rIPL) and left primary motor cortex (M1) in 11 healthy participants. They performed MI (right index-thumb pinching in time with a 1 Hz metronome) or hand MR tasks, while motor evoked potentials (MEPs) were recorded from right first dorsal interosseous. At rest, rIPL conditioning 6 ms prior to M1 stimulation facilitated MEPs in all participants, whereas this facilitation was abolished during MR. While rIPL conditioning 12 ms prior to M1 stimulation had no effect on MEPs at rest, it suppressed corticomotor excitability during MI. These results support the idea that rIPL forms part of a distinct inhibitory network that may prevent unwanted movement during imagery tasks.	[Lebon, Florent; Stinear, Cathy M.] Univ Auckland, Dept Med, Neurol Res Grp, Auckland, New Zealand; [Lebon, Florent; Stinear, Cathy M.] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Stinear, Cathy M.; Byblow, Winston D.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Byblow, Winston D.] Univ Auckland, Movement Neurosci Lab, Dept Sport & Exercise Sci, Auckland 1, New Zealand	University of Auckland; Ernst Moritz Arndt Universitat Greifswald; University of Auckland; University of Auckland	Lebon, F (corresponding author), Univ Auckland, Dept Med, Neurol Res Grp, Auckland, New Zealand.	w.byblow@auckland.ac.nz	Lebon, Florent/W-4065-2017; Lotze, Martin/D-2964-2012; Byblow, Winston/D-3579-2009	Lebon, Florent/0000-0003-0096-9762; Lotze, Martin/0000-0003-4519-4956; Byblow, Winston/0000-0001-8347-6730; Stinear, Cathy/0000-0002-9404-1959	Federal Ministry of Education and Research Germany (BMBF); Royal Society of New Zealand International Mobility Fund	Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Royal Society of New Zealand International Mobility Fund(Royal Society of New Zealand)	ML was supported by the Federal Ministry of Education and Research Germany (BMBF). WDB was supported by the Royal Society of New Zealand International Mobility Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkofski F, 2000, HUM BRAIN MAPP, V11, P273, DOI 10.1002/1097-0193(200012)11:4<273::AID-HBM40>3.0.CO;2-0; Bode S, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-38; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Danckert J, 2002, NEUROCASE, V8, P194, DOI 10.1076/neur.8.2.194.16204; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; Deftereos SN, 2008, FUNCT NEUROL, V23, P137; Eisenegger C, 2007, EUR J NEUROSCI, V25, P1240, DOI 10.1111/j.1460-9568.2007.05354.x; Fleming MK, 2010, EXP BRAIN RES, V201, P499, DOI 10.1007/s00221-009-2062-4; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gogos A, 2010, NEUROPSYCHOLOGIA, V48, P529, DOI 10.1016/j.neuropsychologia.2009.10.013; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2009, J PHYSIOL-LONDON, V587, P4281, DOI 10.1113/jphysiol.2009.174086; Kosslyn S.M., 2010, NEUROPHYSIOLOGICAL F, P3, DOI [DOI 10.1093/ACPR0F:0S0/9780199546251.003.0001, DOI 10.1093/ACPROF:OSO/9780199546251.003.0001]; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lebon F, 2012, EUR J NEUROSCI, V35, P323, DOI 10.1111/j.1460-9568.2011.07938.x; Lotze M, 2010, RESTOR NEUROL NEUROS, V28, P469, DOI 10.3233/RNN-2010-0563; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sauner D, 2006, EUR J NEUROSCI, V23, P2215, DOI 10.1111/j.1460-9568.2006.04731.x; Schwoebel J, 2002, BRAIN COGNITION, V50, P1, DOI 10.1016/S0278-2626(02)00005-2; Seurinck R, 2011, J COGNITIVE NEUROSCI, V23, P1395, DOI 10.1162/jocn.2010.21525; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Stinear CM, 2004, EXP BRAIN RES, V157, P351, DOI 10.1007/s00221-004-1851-z; Stinear CM, 2003, CLIN NEUROPHYSIOL, V114, P909, DOI 10.1016/S1388-2457(02)00373-5; Stinear CM, 2010, NEUROPHYSIOLOGICAL F; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wraga M, 2003, BRAIN COGNITION, V52, P135, DOI 10.1016/S0278-2626(03)00033-2; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	46	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37850	10.1371/journal.pone.0037850	http://dx.doi.org/10.1371/journal.pone.0037850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693579	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500060
J	Mokhonov, VV; Theendakara, VP; Gribanova, YE; Ahmedli, NB; Farber, DB				Mokhonov, Vladislav V.; Theendakara, Veena P.; Gribanova, Yekaterina E.; Ahmedli, Novruz B.; Farber, Debora B.			Sequence-Specific Binding of Recombinant Zbed4 to DNA: Insights into Zbed4 Participation in Gene Transcription and Its Association with Other Proteins	PLOS ONE			English	Article							ZINC-FINGER; SECONDARY STRUCTURE; GC-BOX; ELEMENT; IDENTIFICATION; EXPRESSION; INTERACTS; DOMAIN; VISUALIZATION; LYSOZYME	Zbed4, a member of the BED subclass of Zinc-finger proteins, is expressed in cone photoreceptors and glial Muller cells of human retina whereas it is only present in Muller cells of mouse retina. To characterize structural and functional properties of Zbed4, enough amounts of purified protein were needed. Thus, recombinant Zbed4 was expressed in E. coli and its refolding conditions optimized for the production of homogenous and functionally active protein. Zbed4's secondary structure, determined by circular dichroism spectroscopy, showed that this protein contains 32% alpha-helices, 18% beta-sheets, 20% turns and 30% unordered structures. CASTing was used to identify the target sites of Zbed4 in DNA. The majority of the DNA fragments obtained contained poly-Gs and some of them had, in addition, the core signature of GC boxes; a few clones had only GC-boxes. With electrophoretic mobility shift assays we demonstrated that Zbed4 binds both not only to DNA and but also to RNA oligonucleotides with very high affinity, interacting with poly-G tracts that have a minimum of 5 Gs; its binding to and GC-box consensus sequences. However, the latter binding depends on the GC-box flanking nucleotides. We also found that Zbed4 interacts in Y79 retinoblastoma cells with nuclear and cytoplasmic proteins Scaffold Attachment Factor B1 (SAFB1), estrogen receptor alpha (ER alpha), and cellular myosin 9 (MYH9), as shown with immunoprecipitation and mass spectrometry studies as well as gel overlay assays. In addition, immunostaining corroborated the co-localization of Zbed4 with these proteins. Most importantly, in vitro experiments using constructs containing promoters of genes directing expression of the luciferase gene, showed that Zbed4 transactivates the transcription of those promoters with poly-G tracts.	[Mokhonov, Vladislav V.; Theendakara, Veena P.; Gribanova, Yekaterina E.; Ahmedli, Novruz B.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Mokhonov, Vladislav V.; Theendakara, Veena P.; Gribanova, Yekaterina E.; Ahmedli, Novruz B.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mokhonov, VV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	Akhmedov@jsei.ucla.edu; farber@jsei.ucla.edu	Mokhonov, Vladislav/K-2006-2015; Mokhonov, Vladislav/E-9186-2017	Farber, Debora/0000-0002-3207-697X; Mokhonov, Vladislav/0000-0002-8542-5723	National Institutes of Health [EY008285]; Hope for Vision; NATIONAL EYE INSTITUTE [R01EY008285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (EY008285) and Hope for Vision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen T, 2009, J BIOL CHEM, V284, P6683, DOI 10.1074/jbc.M807753200; CLARK DV, 1995, MOL GEN GENET, V247, P367, DOI 10.1007/BF00293205; Clark ED, 1999, METHOD ENZYMOL, V309, P217; Coupe SA, 1997, PLANT J, V11, P1207, DOI 10.1046/j.1365-313X.1997.11061207.x; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gu ZY, 2002, PROTEIN EXPRES PURIF, V25, P174, DOI 10.1006/prep.2002.1624; Gu ZY, 2001, J CHROMATOGR A, V918, P311, DOI 10.1016/S0021-9673(01)00766-X; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Iuchi S, 2005, MOL B INT U, P7; JANKOWSKI JM, 1987, BIOSCIENCE REP, V7, P955, DOI 10.1007/BF01122129; Jiang L, 2009, MOL CELL BIOCHEM, V328, P137, DOI 10.1007/s11010-009-0083-8; Kallenbach N. R., 1996, CIRCULAR DICHROISM C, P201; Katoh S, 2000, PROCESS BIOCHEM, V35, P1119, DOI 10.1016/S0032-9592(00)00145-X; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kushner PJ, 2003, PURE APPL CHEM, V75, P1757, DOI 10.1351/pac200375111757; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; LAM E, 1990, PLANT CELL, V2, P857, DOI 10.1105/tpc.2.9.857; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Lerner LE, 2000, METHOD ENZYMOL, V315, P617; Li WF, 2008, J AM CHEM SOC, V130, P892, DOI 10.1021/ja075302g; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Novy R., 2001, INNOVATIONS, V12, P1; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saghizadeh M, 2011, MOL VIS, V17, P2011; Saghizadeh M, 2009, INVEST OPHTH VIS SCI, V50, P3580, DOI 10.1167/iovs.08-2751; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Ullman CG, 1996, BIOCHEM J, V319, P229, DOI 10.1042/bj3190229; Vallejo LF, 2004, BIOTECHNOL BIOENG, V85, P601, DOI 10.1002/bit.10906; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Wu WJ, 2007, FEBS J, V274, P390, DOI 10.1111/j.1742-4658.2006.05587.x	52	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e35317	10.1371/journal.pone.0035317	http://dx.doi.org/10.1371/journal.pone.0035317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693546	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500007
J	Schartl, M; Kneitz, S; Wilde, B; Wagner, T; Henkel, CV; Spaink, HP; Meierjohann, S				Schartl, Manfred; Kneitz, Susanne; Wilde, Brigitta; Wagner, Toni; Henkel, Christiaan V.; Spaink, Herman P.; Meierjohann, Svenja			Conserved Expression Signatures between Medaka and Human Pigment Cell Tumors	PLOS ONE			English	Article							GENE-EXPRESSION; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; REACTIVE OXYGEN; PROLIFERATION; XIPHOPHORUS; ZEBRAFISH; PHENOTYPE; ONCOGENE; MODEL	Aberrations in gene expression are a hallmark of cancer cells. Differential tumor-specific transcript levels of single genes or whole sets of genes may be critical for the neoplastic phenotype and important for therapeutic considerations or useful as biomarkers. As an approach to filter out such relevant expression differences from the plethora of changes noted in global expression profiling studies, we searched for changes of gene expression levels that are conserved. Transcriptomes from massive parallel sequencing of different types of melanoma from medaka were generated and compared to microarray datasets from zebrafish and human melanoma. This revealed molecular conservation at various levels between fish models and human tumors providing a useful strategy for identifying expression signatures strongly associated with disease phenotypes and uncovering new melanoma molecules.	[Schartl, Manfred; Kneitz, Susanne; Wilde, Brigitta; Wagner, Toni; Meierjohann, Svenja] Univ Wurzburg, Bioctr, Wurzburg, Germany; [Henkel, Christiaan V.] ZF Screens BV, Leiden, Netherlands; [Spaink, Herman P.] Leiden Univ, Inst Biol, Leiden, Netherlands	University of Wurzburg; Leiden University; Leiden University - Excl LUMC	Schartl, M (corresponding author), Univ Wurzburg, Bioctr, Wurzburg, Germany.	phch1@biozentrum.uni-wuerzburg.de	Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Schartl, Manfred/0000-0001-9882-5948; Henkel, Christiaan/0000-0001-9838-8215	German Research Foundation (DFG) [SFB-Transregio 17]; Melanoma Research Network of the Deutsche Krebshilfe e.V.; DFG; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Melanoma Research Network of the Deutsche Krebshilfe e.V.; DFG(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the German Research Foundation (DFG) through SFB-Transregio 17 (no specific grant number; URL: http://www.imt.uni-marburg.de/tr17/) and by the Melanoma Research Network of the Deutsche Krebshilfe e.V. (German Cancer Aid) (no specific grant number; URL: http://www.melanomverbund.de/), as well as the funding programme Open Access Publishing by the DFG and the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anelli V, 2009, ZEBRAFISH, V6, P417, DOI 10.1089/zeb.2009.0612; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bogenrieder T, 2011, CANCER BIOMARK, V9, P267, DOI 10.3233/CBM-2011-0164; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Ceol CJ, 2008, ZEBRAFISH, V5, P247, DOI 10.1089/zeb.2008.0544; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Herlyn M, 2011, PIGM CELL MELANOMA R, V24, P975, DOI 10.1111/j.1755-148X.2011.00906.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kuphal S, 2011, ARCH BIOCHEM BIOPHYS; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; Lokaj K, 2009, J PROTEOME RES, V8, P1818, DOI 10.1021/pr800578a; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Mitra D, 2009, HEMATOL ONCOL CLIN N, V23, P447, DOI 10.1016/j.hoc.2009.03.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nazarian RM, 2010, J CUTAN PATHOL, V37, P41, DOI 10.1111/j.1600-0560.2010.01505.x; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Perez AN, 2011, COMP BIOCH PHYSL C; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; Rodolfo M, 2005, J INVEST DERMATOL, V125, pXII, DOI 10.1111/j.0022-202X.2005.23965.x; Sauter ER, 2002, CANCER RES, V62, P3200; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Simpson D, 2000, MOL VIS, V6, P178; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokal R. R., 2012, BIOMETRY; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Teutschbein J, 2009, COMP BIOCHEM PHYS C, V149, P168, DOI 10.1016/j.cbpc.2008.09.013; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Wagner TU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028990; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; WELLBROCK C, 1995, ONCOGENE, V10, P2135; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yang GA, 2005, J INVEST DERMATOL, V125, P1242, DOI 10.1111/j.0022-202X.2005.23931.x	50	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37880	10.1371/journal.pone.0037880	http://dx.doi.org/10.1371/journal.pone.0037880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693581	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500062
J	Sharp, JA; Echague, CG; Hair, PS; Ward, MD; Nyalwidhe, JO; Geoghegan, JA; Foster, TJ; Cunnion, KM				Sharp, Julia A.; Echague, Charlene G.; Hair, Pamela S.; Ward, Michael D.; Nyalwidhe, Julius O.; Geoghegan, Joan A.; Foster, Timothy J.; Cunnion, Kenji M.			Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic	PLOS ONE			English	Article							FACTOR-I; CLUMPING FACTOR; BORRELIA-BURGDORFERI; ACQUISITION; ACTIVATION; CLEAVAGE; PATHOGENS; FAMILY; C3B; FHL-1/RECONECTIN	Similar to other highly successful invasive bacterial pathogens, Staphylococcus aureus recruits the complement regulatory protein factor H (fH) to its surface to inhibit the alternative pathway of complement. Here, we report the identification of the surface-associated protein SdrE as a fH-binding protein using purified fH overlay of S. aureus fractionated cell wall proteins and fH cross-linking to S. aureus followed by mass spectrometry. Studies using recombinant SdrE revealed that rSdrE bound significant fH whether from serum or as a purified form, in both a time- and dose-dependent manner. Furthermore, rSdrE-bound fH exhibited cofactor functionality for factor I (fI)-mediated cleavage of C3b to iC3b which correlated positively with increasing amounts of fH. Expression of SdrE on the surface of the surrogate bacterium Lactococcus lactis enhanced recruitment of fH which resulted in increased iC3b generation. Moreover, surface expression of SdrE led to a reduction in C3-fragment deposition, less C5a generation, and reduced killing by polymorphonuclear cells. Thus, we report the first identification of a S. aureus protein associated with the staphylococcal surface that binds factor H as an immune evasion mechanism.	[Sharp, Julia A.; Echague, Charlene G.; Hair, Pamela S.; Nyalwidhe, Julius O.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Ward, Michael D.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Geoghegan, Joan A.; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Trinity College Dublin	Sharp, JA (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.	sharpja@evms.edu		Geoghegan, Joan/0000-0002-3788-0668	National Institutes of Health [R21AI082398]; Science Foundation Ireland Programme Investigator grant [08/IN.1/B1845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland Programme Investigator grant(Science Foundation Ireland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health: R21AI082398 (www.nih.gov) to KM Cunnion and by Science Foundation Ireland Programme Investigator grant 08/IN.1/B1845 to TJ Foster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestebroer J, 2010, CELL MICROBIOL, V12, P1506, DOI 10.1111/j.1462-5822.2010.01486.x; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; CHEUNG AL, 1988, INFECT IMMUN, V56, P1061, DOI 10.1128/IAI.56.5.1061-1065.1988; Cunnion KM, 2005, J LAB CLIN MED, V146, P279, DOI 10.1016/j.lab.2005.07.001; Cunnion KM, 2004, INFECT IMMUN, V72, P2858, DOI 10.1128/IAI.72.5.2858-2863.2004; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Liszewski MK, 2008, VACCINE, V26, pI22, DOI 10.1016/j.vaccine.2008.11.001; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Sharp JA, 2011, MOL IMMUNOL, V48, P683, DOI 10.1016/j.molimm.2010.11.014; Sitkiewicz I, 2010, ANTON LEEUW INT J G, V99, P409; Smith EJ, 2011, INFECT IMMUN; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; Zipfel PF, 1999, IMMUNOL TODAY, V20, P135, DOI 10.1016/S0167-5699(98)01432-7	43	74	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38407	10.1371/journal.pone.0038407	http://dx.doi.org/10.1371/journal.pone.0038407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675461	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500145
J	Hu, YH; Lan, GY; Sha, LQ; Cao, M; Tang, Y; Li, YD; Xu, DP				Hu, Yue-Hua; Lan, Guo-Yu; Sha, Li-Qing; Cao, Min; Tang, Yong; Li, Yi-De; Xu, Da-Ping			Strong Neutral Spatial Effects Shape Tree Species Distributions across Life Stages at Multiple Scales	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HABITAT ASSOCIATIONS; DISPERSAL LIMITATION; NEOTROPICAL FOREST; SUBTROPICAL FOREST; PATTERNS; CHINA; AUTOCORRELATION; XISHUANGBANNA; RECRUITMENT	Traditionally, ecologists use lattice (regional summary) count data to simulate tree species distributions to explore species coexistence. However, no previous study has explicitly compared the difference between using lattice count and basal area data and analyzed species distributions at both individual species and community levels while simultaneously considering the combined scenarios of life stage and scale. In this study, we hypothesized that basal area data are more closely related to environmental variables than are count data because of strong environmental filtering effects. We also address the contribution of niche and the neutral (i.e., solely dependent on distance) factors to species distributions. Specifically, we separately modeled count data and basal area data while considering life stage and scale effects at the two levels with simultaneous autoregressive models and variation partitioning. A principal coordinates of neighbor matrix (PCNM) was used to model neutral spatial effects at the community level. The explained variations of species distribution data did not differ significantly between the two types of data at either the individual species level or the community level, indicating that the two types of data can be used nearly identically to model species distributions. Neutral spatial effects represented by spatial autoregressive parameters and the PCNM eigenfunctions drove species distributions on multiple scales, different life stages and individual species and community levels in this plot. We concluded that strong neutral spatial effects are the principal mechanisms underlying the species distributions and thus shape biodiversity spatial patterns.	[Hu, Yue-Hua; Sha, Li-Qing; Cao, Min; Tang, Yong] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Hu, Yue-Hua; Li, Yi-De; Xu, Da-Ping] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Lan, Guo-Yu] Minist Agr, Danzhou Key Field Stn Observat & Res Trop Agr Res, Danzhou, Hainan, Peoples R China; [Lan, Guo-Yu] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Hu, YH (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	caom@xtbg.ac.cn		Hu, Yue-Hua/0000-0003-3027-1410	National Science Foundation of China [31061160188]; Queensland-Chinese Academy of Science Joint Biotechnology Projects [GJHZ1130]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Queensland-Chinese Academy of Science Joint Biotechnology Projects	This study was supported by a grant from the National Science Foundation of China (31061160188) and a grant from the Queensland-Chinese Academy of Science Joint Biotechnology Projects (GJHZ1130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cao M, 2006, BIOTROPICA, V38, P306, DOI 10.1111/j.1744-7429.2006.00146.x; Cao M., 2008, XISHUANGBANNA TROPIC; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Debarre F, 2011, ECOL LETT, V14, P260, DOI 10.1111/j.1461-0248.2010.01580.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; Etienne RS, 2004, AM NAT, V163, P69, DOI 10.1086/380582; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; He FL, 2002, LANDSCAPE ECOL, V17, P559, DOI 10.1023/A:1021514104193; Hu YH, 2011, OIKOS IN PRESS; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Liu G., 1996, SOIL PHYS CHEM ANAL; Morlon H, 2009, ECOL LETT, V12, P488, DOI 10.1111/j.1461-0248.2009.01318.x; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Paoli GD, 2008, OECOLOGIA, V155, P287, DOI 10.1007/s00442-007-0906-9; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x	41	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38247	10.1371/journal.pone.0038247	http://dx.doi.org/10.1371/journal.pone.0038247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666497	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349600075
J	Han, ZQ; Yanagimoto, T; Zhang, YP; Gao, TX				Han, Zhiqiang; Yanagimoto, Takashi; Zhang, Yaping; Gao, Tianxiang			Phylogeography Study of Ammodytes personatus in Northwestern Pacific: Pleistocene Isolation, Temperature and Current Conducted Secondary Contact	PLOS ONE			English	Article							MARINE FISH; GENETIC-DIVERGENCE; LIMITED DISPERSAL; POPULATIONS; JAPANESE; HISTORY; SEA; DNA; JAPONICUS; SANDEEL	To assess the role of historical process and contemporary factors in shaping population structures in Northwestern Pacific, mitochondrial control region sequences were analyzed to characterize the phylogeography and population structure of the Japanese sand lance Ammodytes personatus. A total of 429 individuals sampled from 17 populations through the species' range are sequenced. Two distinct lineages are detected, which might have been divergent in the Sea of Japan and Pacific costal waters of Japanese Island, during the low sea level. Significant genetic structure is revealed between the Kuroshio and Oyashio Currents. However, significant genetic structure is also detected in the Sea of Japan, contracting expected homogenization hypothesis in Tsushima Current. The haplotype frequency of lineages in both sides of Japanese Island and significant genetic structure between north and south groups revealed that the distribution of lineage B and north group were highly limited by the annual sea temperature. The lack of lineage B in Qingdao population with low sea temperature reflects the sea temperature barrier. Lack of genetic structure in the south group and north group populations indicated that ocean currents within groups facilitated the dispersal of A. personatus.	[Han, Zhiqiang] Zhejiang Ocean Univ, Fishery Coll, Zhoushan, Zhejiang, Peoples R China; [Yanagimoto, Takashi] Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa, Japan; [Zhang, Yaping; Gao, Tianxiang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Han, Zhiqiang; Gao, Tianxiang] Ocean Univ China, Fishery Coll, Qingdao, Shandong, Peoples R China	Zhejiang Ocean University; Japan Fisheries Research & Education Agency (FRA); Chinese Academy of Sciences; Kunming Institute of Zoology; Ocean University of China	Han, ZQ (corresponding author), Zhejiang Ocean Univ, Fishery Coll, Zhoushan, Zhejiang, Peoples R China.	gaozhang@ouc.edu.cn			open funds of State Key Laboratory of Genetic Resources and Evolution [GREKF09-07]; Special Fund for Agro-scientific Research in the Public Interest [201003068]; Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang [20100104]; Department of Education of Zhejiang Province [Y200803409]	open funds of State Key Laboratory of Genetic Resources and Evolution; Special Fund for Agro-scientific Research in the Public Interest; Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang; Department of Education of Zhejiang Province	The study was supported by the open funds of State Key Laboratory of Genetic Resources and Evolution (GREKF09-07), Special Fund for Agro-scientific Research in the Public Interest (201003068), the Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang (20100104), and Grant from the Department of Education of Zhejiang Province (Y200803409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1995, GENETICS, V141, P743; Fauvelot C, 2002, MAR BIOL, V141, P773, DOI 10.1007/s00227-002-0869-7; Fu YX, 1997, GENETICS, V147, P915; Gao TX, 1998, FISHERIES SCI, V64, P198, DOI 10.2331/fishsci.64.198; Hamada T., 1985, FISHERY BIOL SAND LA; HASHIMOTO H, 1991, Journal of the Faculty of Applied Biological Science Hiroshima University, V30, P135; HASHIMOTO H, 1981, Tohoku Journal of Agricultural Research, V31, P173; HASHIMOTO H, 1984, B JPN SOC SCI FISH, V50, P1357; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Inoue A., 1949, B JAPAN SOC SCI FISH, V15, P458; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kitagawa D., 1986, NIPPON SUISAN GAKKI, V50, P205; Kitamura A, 2006, PALAEOGEOGR PALAEOCL, V236, P355, DOI 10.1016/j.palaeo.2005.11.015; LEE WJ, 1995, J MOL EVOL, V41, P54; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2006, MOL PHYLOGENET EVOL, V40, P712, DOI 10.1016/j.ympev.2006.04.019; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Nei M., 1987, MOL EVOLUTIONARY GEN; NEILL WH, 1994, NETH J SEA RES, V32, P135, DOI 10.1016/0077-7579(94)90037-X; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Oba T, 2006, GLOBAL PLANET CHANGE, V53, P5, DOI 10.1016/j.gloplacha.2006.05.002; OKAMOTO H, 1988, NIPPON SUISAN GAKK, V54, P1297; OKAMOTO H, 1989, CAN J FISH AQUAT SCI, V46, P1945, DOI 10.1139/f89-244; Palumbi Stephen R., 1995, P369; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Planes S, 2001, EVOLUTION, V55, P2263; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robards MD, 1999, SAND LANCE REV BIOL; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sassa C, 2004, FISH OCEANOGR, V13, P267, DOI 10.1111/j.1365-2419.2004.00289.x; Schmidt PS, 1999, EVOLUTION, V53, P135, DOI 10.1111/j.1558-5646.1999.tb05339.x; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; Schulte PM, 2001, COMP BIOCHEM PHYS B, V128, P597, DOI 10.1016/S1096-4959(00)00357-2; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tomiyama M, 2004, FISH OCEANOGR, V13, P81, DOI 10.1046/j.1365-2419.2003.00272.x; Yokogawa K, 1997, FISHERIES SCI, V63, P332, DOI 10.2331/fishsci.63.332	44	56	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37425	10.1371/journal.pone.0037425	http://dx.doi.org/10.1371/journal.pone.0037425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685527	Green Submitted, gold, Green Published			2022-12-25	WOS:000305342300043
J	Ferramosca, A; Conte, A; Burri, L; Berge, K; De Nuccio, F; Giudetti, AM; Zara, V				Ferramosca, Alessandra; Conte, Annalea; Burri, Lena; Berge, Kjetil; De Nuccio, Francesco; Giudetti, Anna Maria; Zara, Vincenzo			A Krill Oil Supplemented Diet Suppresses Hepatic Steatosis in High-Fat Fed Rats	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; MITOCHONDRIAL CITRATE CARRIER; DOCOSAHEXAENOIC ACID; INSULIN SENSITIVITY; ADIPOSE-TISSUE; FISH-OIL; MICE; BRAIN; LIVER; PURIFICATION	Krill oil (KO) is a dietary source of n-3 polyunsaturated fatty acids, mainly represented by eicosapentaenoic acid and docosahexaenoic acid bound to phospholipids. The supplementation of a high-fat diet with 2.5% KO efficiently prevented triglyceride and cholesterol accumulation in liver of treated rats. This effect was accompanied by a parallel reduction of the plasma levels of triglycerides and glucose and by the prevention of a plasma insulin increase. The investigation of the molecular mechanisms of KO action in high-fat fed animals revealed a strong decrease in the activities of the mitochondrial citrate carrier and of the cytosolic acetyl-CoA carboxylase and fatty acid synthetase, which are both involved in hepatic de novo lipogenesis. In these animals a significant increase in the activity of carnitine palmitoyl-transferase I and in the levels of carnitine was also observed, suggesting a concomitant stimulation of hepatic fatty acid oxidation. The KO supplemented animals also retained an efficient mitochondrial oxidative phosphorylation, most probably as a consequence of a KO-induced arrest of the uncoupling effects of a high-fat diet. Lastly, the KO supplementation prevented an increase in body weight, as well as oxidative damage of lipids and proteins, which is often found in high-fat fed animals.	[Ferramosca, Alessandra; Conte, Annalea; De Nuccio, Francesco; Giudetti, Anna Maria; Zara, Vincenzo] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Burri, Lena; Berge, Kjetil] Aker BioMarine ASA, Oslo, Norway	University of Salento	Ferramosca, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	vincenzo.zara@unisalento.it	Ferramosca, Alessandra/B-8801-2015; Giudetti, Anna Maria/ABF-4049-2021; Zara, Vincenzo/AAC-2900-2019; De Nuccio, Francesco/GSD-5516-2022	Ferramosca, Alessandra/0000-0002-8251-9652; Zara, Vincenzo/0000-0001-6592-4501; Conte, Annalea/0000-0002-2833-506X; De Nuccio, Francesco/0000-0003-2041-0149; GIUDETTI, ANNA MARIA/0000-0002-9204-040X	Aker BioMarine ASA	Aker BioMarine ASA	This research was supported by Aker BioMarine ASA and by 5x1000 contribution to Univeristy of Salento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amate L, 2001, J NUTR, V131, P1250, DOI 10.1093/jn/131.4.1250; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Bisschop PH, 2001, AM J CLIN NUTR, V73, P554; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; Burri Lena, 2011, Frontiers in Genetics, V2, P45, DOI 10.3389/fgene.2011.00045; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; Di Marzo V, 2010, INT DAIRY J, V20, P231, DOI 10.1016/j.idairyj.2009.11.015; Eslick GD, 2009, INT J CARDIOL, V136, P4, DOI 10.1016/j.ijcard.2008.03.092; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Ferramosca A, 2012, J ANIM PHYSIOL AN N, V96, P295, DOI 10.1111/j.1439-0396.2011.01135.x; Ferramosca A, 2008, J AGR FOOD CHEM, V56, P8148, DOI 10.1021/jf8010728; Ferramosca A, 2008, BIOSCI BIOTECH BIOCH, V72, P62, DOI 10.1271/bbb.70369; Ferramosca A, 2006, J LIPID RES, V47, P1994, DOI 10.1194/jlr.M600138-JLR200; Ferramosca A, 2012, UROLOGY, V79, P809, DOI 10.1016/j.urology.2011.12.042; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Graf BA, 2010, PROSTAG LEUKOTR ESS, V83, P89, DOI 10.1016/j.plefa.2010.05.004; HODGE J, 1993, LIPIDS, V28, P525, DOI 10.1007/BF02536084; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Ide T, 2005, DIABETES, V54, P412, DOI 10.2337/diabetes.54.2.412; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; KOLAKOWSKA A, 1994, NAHRUNG, V38, P128, DOI 10.1002/food.19940380204; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; LINN TC, 1981, ARCH BIOCHEM BIOPHYS, V209, P613, DOI 10.1016/0003-9861(81)90320-9; LONG CS, 1982, NEUROLOGY, V32, P663, DOI 10.1212/WNL.32.6.663; MUCI MR, 1992, INT J VITAM NUTR RES, V62, P330; NAKAMURA GR, 1952, ANAL CHEM, V24, P1372, DOI 10.1021/ac60068a036; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; RUBEN B, 2003, J FOOD ENG, V56, P289; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; Tou JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-179; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Wagner EM, 2004, J LIPID RES, V45, P356, DOI 10.1194/jlr.M300293-JLR200; Wijendran V, 2002, PEDIATR RES, V51, P265, DOI 10.1203/00006450-200203000-00002; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhu JJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-30; Zuliani G, 2009, CURR PHARM DESIGN, V15, P4087, DOI 10.2174/138161209789909773	46	63	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38797	10.1371/journal.pone.0038797	http://dx.doi.org/10.1371/journal.pone.0038797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685607	Green Published, gold, Green Submitted			2022-12-25	WOS:000305351700071
J	Genin, P; Lin, RT; Hiscott, J; Civas, A				Genin, Pierre; Lin, Rongtuan; Hiscott, John; Civas, Ahmet			Recruitment of Histone Deacetylase 3 to the Interferon-A Gene Promoters Attenuates Interferon Expression	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; I INTERFERON; NEGATIVE REGULATION; REGULATORY FACTORS; VIRUS-INFECTION; BETA GENE; INFLAMMATORY RESPONSE; DNA-BINDING	Background: Induction of Type I Interferon (IFN) genes constitutes an essential step leading to innate immune responses during virus infection. Sendai virus (SeV) infection of B lymphoid Namalwa cells transiently induces the transcriptional expression of multiple IFN-A genes. Although transcriptional activation of IFN-A genes has been extensively studied, the mechanism responsible for the attenuation of their expression remains to be determined. Principal Findings: In this study, we demonstrate that virus infection of Namalwa cells induces transient recruitment of HDAC3 (histone deacetylase 3) to IFN-A promoters. Analysis of chromatin-protein association by Chip-QPCR demonstrated that recruitment of interferon regulatory factor (IRF)3 and IRF7, as well as TBP correlated with enhanced histone H3K9 and H3K14 acetylation, whereas recruitment of HDAC3 correlated with inhibition of histone H3K9/K14 acetylation, removal of IRF7 and TATA-binding protein (TBP) from IFN-A promoters and inhibition of virus-induced IFN-A gene transcription. Additionally, HDAC3 overexpression reduced, and HDAC3 depletion by siRNA enhanced IFN-A gene expression. Furthermore, activation of IRF7 enhanced histone H3K9/K14 acetylation and IFN-A gene expression, whereas activation of both IRF7 and IRF3 led to recruitment of HDAC3 to the IFN-A gene promoters, resulting in impaired histone H3K9 acetylation and attenuation of IFN-A gene transcription. Conclusion: Altogether these data indicate that reversal of histone H3K9/K14 acetylation by HDAC3 is required for attenuation of IFN-A gene transcription during viral infection.	[Genin, Pierre; Civas, Ahmet] Paris Descartes Univ, Ctr Natl Rech Sci FRE3235, Paris, France; [Lin, Rongtuan; Hiscott, John] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hiscott, John] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA	UDICE-French Research Universities; Universite Paris Cite; Lady Davis Institute; McGill University; Vaccine & Gene Therapy Institute of Florida	Genin, P (corresponding author), Paris Descartes Univ, Ctr Natl Rech Sci FRE3235, Paris, France.	ahmet.civas@parisdescartes.fr	Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503; Genin, Pierre/0000-0002-7502-3851	Centre National de la Recherche Scientifique; Canadian Institutes of Health Research (CIHR); Canadian Cancer Society; Canadian Foundation for AIDS Research (CANFAR); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [R21CA192185] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Foundation for AIDS Research (CANFAR); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Centre National de la Recherche Scientifique and Universite Paris Descartes. This work was also supported by grants to JH from the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society, and the Canadian Foundation for AIDS Research (CANFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen JB, 2004, J INTERF CYTOK RES, V24, P687, DOI 10.1089/jir.2004.24.687; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Civas A, 2006, J BIOL CHEM, V281, P4856, DOI 10.1074/jbc.M506812200; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liang QM, 2011, J IMMUNOL, V186, P1001, DOI 10.4049/jimmunol.1002240; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Makkonen KM, 2009, J MOL BIOL, V393, P261, DOI 10.1016/j.jmb.2009.08.024; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; PALOMBELLA VJ, 1992, MOL CELL BIOL, V12, P3325, DOI 10.1128/MCB.12.8.3325; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Seto Edward, 2006, P61; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Topalidou I, 2003, MOL CELL BIOL, V23, P7809, DOI 10.1128/MCB.23.21.7809-7817.2003; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; WHITTEMORE LA, 1990, P NATL ACAD SCI USA, V87, P7799, DOI 10.1073/pnas.87.20.7799; Woelk CH, 2007, GENE, V397, P38, DOI 10.1016/j.gene.2007.03.018; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027	77	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38336	10.1371/journal.pone.0038336	http://dx.doi.org/10.1371/journal.pone.0038336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685561	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700024
J	Mayer, FL; Wilson, D; Jacobsen, ID; Miramon, P; Slesiona, S; Bohovych, IM; Brown, AJP; Hube, B				Mayer, Francois L.; Wilson, Duncan; Jacobsen, Ilse D.; Miramon, Pedro; Slesiona, Silvia; Bohovych, Iryna M.; Brown, Alistair J. P.; Hube, Bernhard			Small but Crucial: The Novel Small Heat Shock Protein Hsp21 Mediates Stress Adaptation and Virulence in Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ALPHA-CRYSTALLIN; CELL-WALL; TRANSCRIPTIONAL RESPONSE; DECREASES INFECTIVITY; MOLECULAR CHAPERONES; IN-VIVO; OROPHARYNGEAL CANDIDIASIS; TREHALOSE ACCUMULATION; FUNGAL MORPHOGENESIS	Small heat shock proteins (sHsps) have multiple cellular functions. However, the biological function of sHsps in pathogenic microorganisms is largely unknown. In the present study we identified and characterized the novel sHsp Hsp21 of the human fungal pathogen Candida albicans. Using a reverse genetics approach we demonstrate the importance of Hsp21 for resistance of C. albicans to specific stresses, including thermal and oxidative stress. Furthermore, a hsp21 Delta/Delta mutant was defective in invasive growth and formed significantly shorter filaments compared to the wild type under various filament-inducing conditions. Although adhesion to and invasion into human-derived endothelial and oral epithelial cells was unaltered, the hsp21 Delta/Delta mutant exhibited a strongly reduced capacity to damage both cell lines. Furthermore, Hsp21 was required for resisting killing by human neutrophils. Measurements of intracellular levels of stress protective molecules demonstrated that Hsp21 is involved in both glycerol and glycogen regulation and plays a major role in trehalose homeostasis in response to elevated temperatures. Mutants defective in trehalose and, to a lesser extent, glycerol synthesis phenocopied HSP21 deletion in terms of increased susceptibility to environmental stress, strongly impaired capacity to damage epithelial cells and increased sensitivity to the killing activities of human primary neutrophils. Via systematic analysis of the three main C. albicans stress-responsive kinases (Mkc1, Cek1, Hog1) under a range of stressors, we demonstrate Hsp21-dependent phosphorylation of Cek1 in response to elevated temperatures. Finally, the hsp21 Delta/Delta mutant displayed strongly attenuated virulence in two in vivo infection models. Taken together, Hsp21 mediates adaptation to specific stresses via fine-tuning homeostasis of compatible solutes and activation of the Cek1 pathway, and is crucial for multiple stages of C. albicans pathogenicity. Hsp21 therefore represents the first reported example of a small heat shock protein functioning as a virulence factor in a eukaryotic pathogen.	[Mayer, Francois L.; Wilson, Duncan; Jacobsen, Ilse D.; Miramon, Pedro; Slesiona, Silvia; Hube, Bernhard] Hans Knoell Inst, Dept Microbial Pathogen Mech, Jena, Germany; [Slesiona, Silvia] Hans Knoell Inst, Dept Microbial Biochem & Physiol, Jena, Germany; [Bohovych, Iryna M.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Foresterhill, Aberdeen, Scotland; [Hube, Bernhard] Univ Klinikum Jena, Ctr Sepsis Control & Care, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); University of Aberdeen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Mayer, FL (corresponding author), Hans Knoell Inst, Dept Microbial Pathogen Mech, Jena, Germany.	Bernhard.Hube@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Brown, Alistair J.P./B-6627-2014	Jacobsen, Ilse/0000-0002-6033-9984; Mayer, Francois/0000-0002-6800-9429; Miramon, Pedro/0000-0002-6867-7697; Hube, Bernhard/0000-0002-6028-0425; Wilson, Duncan/0000-0001-6617-0123; Brown, Alistair JP/0000-0003-1406-4251	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC); ERA-NET PathoGenoMics Program (Candicol) [BMBF 0315 901 B]; European Commission through the FINSysB Marie Curie Initial Training Network [PITN-GA-2008-214004]; German Science Foundation (DFG) [BR2216/4-1]; Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute); Federal Ministry of Education and Health (BMBF) [0314108]; Center for Sepsis Control and Care (CSCC) [BMBF 01EO1002]; Deutsche Forschungsgemeinschaft (DFG) [Hu 528/15, Hu 528/16, Hu 528/17]; UK Biotechnology and Biological Sciences Research Council [BB/F00513X/1]; European Reseach Council [STRIFE: ERC-2009-AdG-249793]; BBSRC [BB/D009308/1, BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009308/1, BB/F00513X/1] Funding Source: researchfish	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC); ERA-NET PathoGenoMics Program (Candicol); European Commission through the FINSysB Marie Curie Initial Training Network; German Science Foundation (DFG)(German Research Foundation (DFG)); Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute); Federal Ministry of Education and Health (BMBF)(Federal Ministry of Education & Research (BMBF)); Center for Sepsis Control and Care (CSCC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Reseach Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	FLM and BH were supported by the International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC). DW and BH were supported by the ERA-NET PathoGenoMics Program (Candicol; BMBF 0315 901 B). PM, IMB, AJPB and BH were funded by the European Commission through the FINSysB Marie Curie Initial Training Network (PITN-GA-2008-214004). IDJ and SS were financially supported by a grant from the German Science Foundation (DFG, grant BR2216/4-1) and the Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute). IDJ was also supported by the Federal Ministry of Education and Health (BMBF 0314108). BH was also supported by the Center for Sepsis Control and Care (CSCC; BMBF 01EO1002) and the Deutsche Forschungsgemeinschaft (DFG Hu 528/15, 16 and 17). AJPB was also supported by the UK Biotechnology and Biological Sciences Research Council (BB/F00513X/1) and the European Reseach Council (STRIFE: ERC-2009-AdG-249793).	Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arguelles JC, 1997, FEMS MICROBIOL LETT, V146, P65, DOI 10.1016/S0378-1097(96)00455-7; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Brown AJP, 2005, FUNGAL GENOMICS MYCO, P185; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calderone RA., 2002, CANDIDA CANDIDIASIS; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; CHAPUT M, 1983, BIOCHIMIE, V65, P501, DOI 10.1016/S0300-9084(83)80132-1; CHESTER VE, 1968, J GEN MICROBIOL, V51, P47, DOI 10.1099/00221287-51-1-49; Chiang LY, 2007, CELL MICROBIOL, V9, P233, DOI 10.1111/j.1462-5822.2006.00784.x; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; CRAIG EA, 1989, BIOESSAYS, V11, P48, DOI 10.1002/bies.950110203; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diamant S, 2003, MOL MICROBIOL, V49, P401, DOI 10.1046/j.1365-2958.2003.03553.x; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Elson SL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000664; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Enjalbert B, 2009, MOL MICROBIOL, V72, P216, DOI 10.1111/j.1365-2958.2009.06640.x; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Fan JJ, 2005, FEMS MICROBIOL LETT, V245, P107, DOI 10.1016/j.femsle.2005.02.031; Ferrer J, 2000, INT J GYNECOL OBSTET, V71, pS21, DOI 10.1016/S0020-7292(00)00350-7; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; Filler Scott G., 2002, P341; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Gow NAR, 2009, CURR BIOL, V19, pR333, DOI 10.1016/j.cub.2009.03.027; HARTL A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P926; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hube B, 2001, MICROBIOL-SGM, V147, P1997, DOI 10.1099/00221287-147-8-1997; Hubel A, 1997, MOL CELL BIOL, V17, P5987; Jacobsen ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019741; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KAUFMANN SHE, 1991, SPRINGER SEMIN IMMUN, V13, P25, DOI 10.1007/BF01225276; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lindquist S, 1992, CURR OPIN GENET DEV, V2, P748, DOI 10.1016/S0959-437X(05)80135-2; Lis M, 2010, FEMS YEAST RES, V10, P579, DOI 10.1111/j.1567-1364.2010.00638.x; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Martinez-Esparza M, 2011, GLYCOBIOLOGY, V21, P796, DOI 10.1093/glycob/cwr007; Martinez-Esparza M, 2009, INT J MED MICROBIOL, V299, P453, DOI 10.1016/j.ijmm.2008.12.001; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; MOLLER F, 1974, ANAL BIOCHEM, V59, P248, DOI 10.1016/0003-2697(74)90030-X; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nicholls S, 2010, FUNGAL GENET BIOL; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Nobile CJ, 2008, CELL MICROBIOL, V10, P2180, DOI 10.1111/j.1462-5822.2008.01198.x; ODDS FC, 1987, CRC CR REV MICROBIOL, V15, P1; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; PETKO L, 1986, CELL, V45, P885, DOI 10.1016/0092-8674(86)90563-5; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Ramsdale M, 2008, MOL BIOL CELL, V19, P4393, DOI 10.1091/mbc.E07-09-0946; Ratnakar P, 1996, MICROB PATHOGENESIS, V21, P471, DOI 10.1006/mpat.1996.0077; Ribatti D, 2001, ANAT RECORD, V264, P317, DOI 10.1002/ar.10021; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Ruhnke M, 2002, CANDIDA CANDIDIASIS, P307; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Sheth CC, 2008, FUNGAL GENET BIOL, V45, P1075, DOI 10.1016/j.fgb.2008.04.004; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Tsai YL, 2010, J BIOL CHEM, V285, P19757, DOI 10.1074/jbc.M110.110296; Tsai YL, 2009, MICROBIOL-SGM, V155, P3270, DOI 10.1099/mic.0.030676-0; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yamaguchi H, 1996, J MED MICROBIOL, V45, P270, DOI 10.1099/00222615-45-4-270; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281; Zhu Y, 2009, MOL MICROBIOL, V74, P862, DOI 10.1111/j.1365-2958.2009.06898.x	125	61	66	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38584	10.1371/journal.pone.0038584	http://dx.doi.org/10.1371/journal.pone.0038584			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685587	Green Published, gold			2022-12-25	WOS:000305351700050
J	Graves, HK; Woodfield, SE; Yang, CC; Halder, G; Bergmann, A				Graves, Hillary K.; Woodfield, Sarah E.; Yang, Chih-Chao; Halder, Georg; Bergmann, Andreas			Notch Signaling Activates Yorkie Non-Cell Autonomously in Drosophila	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; IMAGINAL DISC GROWTH; PROLIFERATION ARREST; APOPTOSIS; PROMOTES; JAK/STAT; PATHWAY; FAMILY; CANCER; VPS25	In Drosophila imaginal epithelia, cells mutant for the endocytic neoplastic tumor suppressor gene vps25 stimulate nearby untransformed cells to express Drosophila Inhibitor-of-Apoptosis-Protein-1 (DIAP-1), conferring resistance to apoptosis non-cell autonomously. Here, we show that the non-cell autonomous induction of DIAP-1 is mediated by Yorkie, the conserved downstream effector of Hippo signaling. The non-cell autonomous induction of Yorkie is due to Notch signaling from vps25 mutant cells. Moreover, activated Notch in normal cells is sufficient to induce non-cell autonomous Yorkie activity in wing imaginal discs. Our data identify a novel mechanism by which Notch promotes cell survival non-cell autonomously and by which neoplastic tumor cells generate a supportive microenvironment for tumor growth.	[Graves, Hillary K.; Woodfield, Sarah E.; Yang, Chih-Chao; Halder, Georg; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Woodfield, Sarah E.; Halder, Georg; Bergmann, Andreas] Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; [Yang, Chih-Chao; Halder, Georg; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Graves, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Andreas.Bergmann@umassmed.edu	Halder, Georg/F-2966-2015; Woodfield, Sarah/AAG-9602-2022; Graves, Hillary/K-6690-2012; Woodfield, Sarah/AEW-0563-2022	Halder, Georg/0000-0001-7580-3236; 	National Institutes of Health [GM068016, GM67997]; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067997, R01GM068016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM068016 to AB and GM67997 to GH) and the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Go MJ, 1998, DEVELOPMENT, V125, P2031; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2009, BIOCHEM SOC T, V37, P204, DOI 10.1042/BST0370204; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lee SB, 2005, J CELL SCI, V118, P1851, DOI 10.1242/jcs.02312; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; NOWELL P, 1976, CANCER, V38, P1873, DOI 10.1002/1097-0142(197611)38:5<1873::AID-CNCR2820380502>3.0.CO;2-I; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; RING JM, 1993, DEVELOPMENT, P251; Robinson BS, 2011, CELL CYCLE, V10, P4110, DOI 10.4161/cc.10.23.18243; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006	46	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37615	10.1371/journal.pone.0037615	http://dx.doi.org/10.1371/journal.pone.0037615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679484	Green Published, gold			2022-12-25	WOS:000305343900009
J	Harrison, RD; Ronsted, N; Xu, L; Rasplus, JY; Cruaud, A				Harrison, Rhett D.; Ronsted, Nina; Xu, Lei; Rasplus, Jean-Yves; Cruaud, Astrid			Evolution of Fruit Traits in Ficus Subgenus Sycomorus (Moraceae): To What Extent Do Frugivores Determine Seed Dispersal Mode?	PLOS ONE			English	Article							FIG-POLLINATOR MUTUALISM; COMMUNITY; COEVOLUTION; PHYLOGENY; DIVERSITY; ECOLOGY; DIOECY; WASPS	Fig trees are a ubiquitous component of tropical rain forests and exhibit an enormous diversity of ecologies. Focusing on Ficus subgenus Sycomorus, a phenotypically diverse and ecologically important Old World lineage, we examined the evolution of fruit traits using a molecular phylogeny constructed using 5 kilobases of DNA sequence data from 63 species (50% of global diversity). In particular, we ask whether patterns of trait correlations are consistent with dispersal agents as the primary selective force shaping morphological diversity or if other ecological factors may provide a better explanation? Fig colour, size and placement (axial, cauliflorous, or geocarpic) were all highly evolutionarily liable, and the same fruit traits have evolved in different biogeographic regions with substantially different dispersal agents. After controlling for phylogenetic autocorrelation, we found that fig colour and size were significantly associated with fig placement and plant-life history traits (maximum plant height and leaf area, respectively). However, contrary to prevailing assumptions, fig placement correlated poorly with known dispersal agents and appears more likely determined by other factors, such as flowering phenology, nutrient economy, and habitat preference. Thus, plant life-history, both directly and through its influence on fig placement, appears to have played a prominent role in determining fruit traits in these figs.	[Harrison, Rhett D.; Xu, Lei] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Ronsted, Nina] Nat Hist Museum Denmark, Bot Garden, Copenhagen, Denmark; [Rasplus, Jean-Yves; Cruaud, Astrid] CBGP INRA IRD CIRAD Montpellier SupAgro, INRA UMR Ctr Biol & Gest Populat, Montferrier Sur Lez, France	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Harrison, RD (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	rharrison@xtbg.org.cn	Rønsted, Nina/A-5065-2013; Rasplus, Jean-Yves/O-2873-2017	Rønsted, Nina/0000-0002-2002-5809; Rasplus, Jean-Yves/0000-0001-8614-6665; Harrison, Rhett/0000-0001-9055-3546	330 National Science Foundation China (NSFC) [30972294, 30571507, 30670358]; ANR	330 National Science Foundation China (NSFC); ANR(French National Research Agency (ANR))	This project was supported by 330 National Science Foundation China grants (NSFC Grant No. 30972294) to RDH and Yang Darong (NSFC Grant No. 30571507, 30670358) to LX, and ANR projects "NiceFigs" and "BioFigs" to AC and JYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker NP, 2005, ANN MO BOT GARD, V92, P445; Berg C.C., 1992, AFRICAN FIG TREES FI; Berg CC, 2005, FLORA MALESIANA 1, V17; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P601, DOI 10.1007/BF01975676; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Corlett RT, 2011, ACTA OECOL, V37, P674, DOI 10.1016/j.actao.2011.01.005; Corlett RT, 1998, BIOL REV, V73, P413, DOI 10.1017/S0006323198005234; Corner E. J. H., 1978, Philosophical Transactions of the Royal Society of London, B, V281, P373, DOI 10.1098/rstb.1978.0003; Corner EJH, 1988, WAYSIDE TREES MALAYA, P861; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Hao GY, 2011, ECOLOGY, V92, P2117, DOI 10.1890/11-0269.1; Harrison R.D., 2005, POLLINATION ECOLOGY, V111-127, P246, DOI DOI 10.1093/molbev/mst010; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Harrison RD, 2003, OIKOS, V100, P628, DOI 10.1034/j.1600-0706.2003.11829.x; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Ichie T, 2005, J TROP ECOL, V21, P237, DOI 10.1017/S0266467404002214; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Jousselin E, 2003, EVOLUTION, V57, P1255, DOI 10.1111/j.0014-3820.2003.tb00334.x; Kameyama T, 1999, RES POPUL ECOL, V41, P243, DOI 10.1007/s101440050028; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; Lomascolo SB, 2010, P NATL ACAD SCI USA, V107, P14668, DOI 10.1073/pnas.1008773107; Nylander J. A. A., 2004, MRAIC PL PROGRAM DIS; Patel A, 1996, J ECOL, V84, P667, DOI 10.2307/2261330; PATINO S, 1994, OECOLOGIA, V100, P13, DOI 10.1007/BF00317125; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronsted N, 2008, SYMBIOSIS, V45, P45; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Stamatakis A, 2006, INT PAR DISTR PROC S; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Whitney KD, 2009, P ROY SOC B-BIOL SCI, V276, P2941, DOI 10.1098/rspb.2009.0483	38	19	21	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38432	10.1371/journal.pone.0038432	http://dx.doi.org/10.1371/journal.pone.0038432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679505	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900042
J	Peng, C; Chen, YY; Shan, Y; Zhang, HJ; Guo, ZR; Li, DG; Li, SG				Peng, Cong; Chen, Yaoyu; Shan, Yi; Zhang, Haojian; Guo, Zhiru; Li, Dongguang; Li, Shaoguang			LSK Derived LSK- Cells Have a High Apoptotic Rate Related to Survival Regulation of Hematopoietic and Leukemic Stem Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; COMMON LYMPHOID PROGENITORS; CHRONIC MYELOCYTIC-LEUKEMIA; BINDING-PROTEIN ICSBP; BONE-MARROW; CLONAL ORIGIN; MICE; GENE; PTEN; DIFFERENTIATION	A balanced pool of hematopoietic stem cells (HSCs) in bone marrow is tightly regulated, and this regulation is disturbed in hematopoietic malignancies such as chronic myeloid leukemia (CML). The underlying mechanisms are largely unknown. Here we show that the Lin(-)Sca-1(+) c-Kit(-) (LSK-) cell population derived from HSC-containing Lin(-)Sca-1(+) c-Kit(+) (LSK) cells has significantly higher numbers of apoptotic cells. Depletion of LSK cells by radiation or the cytotoxic chemical 5-fluorouracil results in an expansion of the LSK- population. In contrast, the LSK- population is reduced in CML mice, and depletion of leukemia stem cells (LSCs; BCR-ABL-expressing HSCs) by deleting Alox5 or by inhibiting heat shock protein 90 causes an increase in this LSK- population. The transition of LSK to LSK- cells is controlled by the Icsbp gene and its downstream gene Lyn, and regulation of this cellular transition is critical for the survival of normal LSK cells and LSCs. These results indicate a potential function of the LSK- cells in the regulation of LSK cells and LSCs.	[Peng, Cong; Chen, Yaoyu; Shan, Yi; Zhang, Haojian; Guo, Zhiru; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA; [Li, Dongguang] Edith Cowan Univ, Sch Comp & Secur Sci, Mt Lawley, WA, Australia	University of Massachusetts System; University of Massachusetts Worcester; Edith Cowan University	Peng, C (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	shaoguang.li@umassmed.edu	Zhang, Haojian/H-7897-2013; Shan, Yi/E-3862-2016		Leukemia and Lymphoma Society; National Institutes of Health [R01-CA122142, R01-CA114199]; NATIONAL CANCER INSTITUTE [R01CA122142, R01CA114199] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Leukemia and Lymphoma Society and the National Institutes of Health (R01-CA122142, R01-CA114199) to S.L. S.L. is a Scholar of the Leukemia and Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Chen Y, 2009, LEUKEMIA, V23, P1446, DOI 10.1038/leu.2009.52; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; FINER MH, 1994, BLOOD, V83, P43; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Kabarowski JHS, 2000, STEM CELLS, V18, P399, DOI 10.1002/stem.180399; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Liang Y, 2007, NAT GENET, V39, P178, DOI 10.1038/ng1938; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; OKADA S, 1992, BLOOD, V80, P3044; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Takahashi N, 1998, BLOOD, V92, P4758, DOI 10.1182/blood.V92.12.4758; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	34	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38614	10.1371/journal.pone.0038614	http://dx.doi.org/10.1371/journal.pone.0038614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675576	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700088
J	Qian, F; Reiter, K; Zhang, YL; Shimp, RL; Nguyen, V; Aebig, JA; Rausch, KM; Zhu, DM; Lambert, L; Mullen, GED; Martin, LB; Long, CA; Miller, LH; Narum, DL				Qian, Feng; Reiter, Karine; Zhang, Yanling; Shimp, Richard L., Jr.; Vu Nguyen; Aebig, Joan A.; Rausch, Kelly M.; Zhu, Daming; Lambert, Lynn; Mullen, Gregory E. D.; Martin, Laura B.; Long, Carole A.; Miller, Louis H.; Narum, David L.			Immunogenicity of Self-Associated Aggregates and Chemically Cross-Linked Conjugates of the 42 kDa Plasmodium falciparum Merozoite Surface Protein-1	PLOS ONE			English	Article							AERUGINOSA EXOPROTEIN-A; BLOOD-STAGE VACCINE; MALARIA VACCINE; TERMINAL FRAGMENT; CPG OLIGODEOXYNUCLEOTIDE; ANTIBODY-RESPONSES; AOTUS-NANCYMAI; FUSION PROTEIN; CLINICAL-TRIAL; EFFICACY	Self-associated protein aggregates or cross-linked protein conjugates are, in general, more immunogenic than oligomeric or monomeric forms. In particular, the immunogenicity in mice of a recombinant malaria transmission blocking vaccine candidate, the ookinete specific Plasmodium falciparum 25 kDa protein (Pfs25), was increased more than 1000-fold when evaluated as a chemical cross-linked protein-protein conjugate as compared to a formulated monomer. Whether alternative approaches using protein complexes improve the immunogenicity of other recombinant malaria vaccine candidates is worth assessing. In this work, the immunogenicity of the recombinant 42 kDa processed form of the P. falciparum merozoite surface protein 1 (MSP1(42)) was evaluated as a self-associated, non-covalent aggregate and as a chemical cross-linked protein-protein conjugate to ExoProtein A, which is a recombinant detoxified form of Pseudomonas aeruginosa exotoxin A. MSP1(42) conjugates were prepared and characterized biochemically and biophysically to determine their molar mass in solution and stoichiometry, when relevant. The immunogenicity of the MSP1(42) self-associated aggregates, cross-linked chemical conjugates and monomers were compared in BALB/c mice after adsorption to aluminum hydroxide adjuvant, and in one instance in association with the TLR9 agonist CPG7909 with an aluminum hydroxide formulation. Antibody titers were assessed by ELISA. Unlike observations made for Pfs25, no significant enhancement in MSP1(42) specific antibody titers was observed for any conjugate as compared to the formulated monomer or dimer, except for the addition of the TLR9 agonist CPG7909. Clearly, enhancing the immunogenicity of a recombinant protein vaccine candidate by the formation of protein complexes must be established on an empirical basis.	[Qian, Feng; Reiter, Karine; Zhang, Yanling; Shimp, Richard L., Jr.; Vu Nguyen; Aebig, Joan A.; Rausch, Kelly M.; Zhu, Daming; Lambert, Lynn; Mullen, Gregory E. D.; Martin, Laura B.; Long, Carole A.; Miller, Louis H.; Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Qian, Feng] Second Mil Med Univ, Changzheng Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Long, Carole A.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Mullen, Gregory E. D.] Kings Coll London, Sch Med, Div Imaging Sci, London WC2R 2LS, England; [Martin, Laura B.] Novartis Vaccines Inst Global Hlth Srl NVGH, Siena, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; King's College London; Novartis	Qian, F (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA.	dnarum@niaid.nih.gov	Martin, Laura/N-1789-2013	Martin, Laura/0000-0002-4431-4381; Narum, David/0000-0003-3041-5402	National Institutes of Health; MRC [G0600698] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI001020] Funding Source: NIH RePORTER; Medical Research Council [G0600698] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Aebig JA, 2007, J IMMUNOL METHODS, V323, P139, DOI 10.1016/j.jim.2007.04.003; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Brady CP, 2001, PROTEIN EXPRES PURIF, V23, P468, DOI 10.1006/prep.2001.1526; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Coban C, 2004, INFECT IMMUN, V72, P584, DOI 10.1128/IAI.72.1.584-588.2004; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Faber BW, 2007, INFECT IMMUN, V75, P5947, DOI 10.1128/IAI.01804-06; Hirunpetcharat C, 2003, VACCINE, V21, P2923, DOI 10.1016/S0264-410X(03)00132-4; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Holder AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P409; Huaman MC, 2008, J IMMUNOL, V180, P1451, DOI 10.4049/jimmunol.180.3.1451; Jeamwattanalert P, 2007, CLIN VACCINE IMMUNOL, V14, P342, DOI 10.1128/CVI.00397-06; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar S, 2004, INFECT IMMUN, V72, P949, DOI 10.1128/IAI.72.2.949-957.2004; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Mullen GED, 2006, VACCINE, V24, P2497, DOI 10.1016/j.vaccine.2005.12.034; Near KA, 2002, INFECT IMMUN, V70, P692, DOI 10.1128/IAI.70.2.692-701.2002; Ogun SA, 2008, INFECT IMMUN, V76, P3817, DOI 10.1128/IAI.01369-07; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Pichyangkul S, 2009, VACCINE, V28, P452, DOI 10.1016/j.vaccine.2009.10.022; Poolman J, 2011, CLIN VACCINE IMMUNOL, V18, P327, DOI 10.1128/CVI.00402-10; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; Qian F, 2009, MICROBES INFECT, V11, P408, DOI 10.1016/j.micinf.2008.12.009; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Rosa DS, 2004, IMMUNOL LETT, V92, P259, DOI 10.1016/j.imlet.2004.01.006; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Saul A, 2008, PARASITOLOGY, V135, P1497, DOI 10.1017/S0031182008000280; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Shimp RL, 2006, PROTEIN EXPRES PURIF, V50, P58, DOI 10.1016/j.pep.2006.06.018; SHULER KR, 1992, J IMMUNOL METHODS, V156, P137, DOI 10.1016/0022-1759(92)90020-T; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stanisic DI, 2003, INFECT IMMUN, V71, P5700, DOI 10.1128/IAI.71.10.5700-5713.2003; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Torano G, 2006, CLIN VACCINE IMMUNOL, V13, P1052, DOI 10.1128/CVI.00144-06; Thiem VD, 2011, CLIN VACCINE IMMUNOL, V18, P730, DOI 10.1128/CVI.00532-10; Weiss R, 2010, VACCINE, V28, P4515, DOI 10.1016/j.vaccine.2010.04.054; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Xue XY, 2010, VACCINE, V28, P3152, DOI 10.1016/j.vaccine.2010.02.054	48	17	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36996	10.1371/journal.pone.0036996	http://dx.doi.org/10.1371/journal.pone.0036996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675476	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700009
J	Swingley, WD; Meyer-Dombard, DR; Shock, EL; Alsop, EB; Falenski, HD; Havig, JR; Raymond, J				Swingley, Wesley D.; Meyer-Dombard, D'Arcy R.; Shock, Everett L.; Alsop, Eric B.; Falenski, Heinz D.; Havig, Jeff R.; Raymond, Jason			Coordinating Environmental Genomics and Geochemistry Reveals Metabolic Transitions in a Hot Spring Ecosystem	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; MICROBIAL COMMUNITY; PHYLOGENETIC CLASSIFICATION; RIBOSOMAL-RNA; SEQUENCE; THERMOPHILUS; DIVERSITY; ENERGY; ARCHAEAL; PROGRAM	We have constructed a conceptual model of biogeochemical cycles and metabolic and microbial community shifts within a hot spring ecosystem via coordinated analysis of the "Bison Pool" (BP) Environmental Genome and a complementary contextual geochemical dataset of similar to 75 geochemical parameters. 2,321 16S rRNA clones and 470 megabases of environmental sequence data were produced from biofilms at five sites along the outflow of BP, an alkaline hot spring in Sentinel Meadow (Lower Geyser Basin) of Yellowstone National Park. This channel acts as a >22 m gradient of decreasing temperature, increasing dissolved oxygen, and changing availability of biologically important chemical species, such as those containing nitrogen and sulfur. Microbial life at BP transitions from a 92 degrees C chemotrophic streamer biofilm community in the BP source pool to a 56 degrees C phototrophic mat community. We improved automated annotation of the BP environmental genomes using BLAST-based Markov clustering. We have also assigned environmental genome sequences to individual microbial community members by complementing traditional homology-based assignment with nucleotide word-usage algorithms, allowing more than 70% of all reads to be assigned to source organisms. This assignment yields high genome coverage in dominant community members, facilitating reconstruction of nearly complete metabolic profiles and in-depth analysis of the relation between geochemical and metabolic changes along the outflow. We show that changes in environmental conditions and energy availability are associated with dramatic shifts in microbial communities and metabolic function. We have also identified an organism constituting a novel phylum in a metabolic "transition" community, located physically between the chemotroph- and phototroph-dominated sites. The complementary analysis of biogeochemical and environmental genomic data from BP has allowed us to build ecosystem-based conceptual models for this hot spring, reconstructing whole metabolic networks in order to illuminate community roles in shaping and responding to geochemical variability.	[Swingley, Wesley D.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Meyer-Dombard, D'Arcy R.] Univ Illinois, Dept Earth & Environm Sci, Chicago, IL USA; [Shock, Everett L.; Alsop, Eric B.; Falenski, Heinz D.; Havig, Jeff R.; Raymond, Jason] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Shock, Everett L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	University of California System; University of California Merced; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Swingley, WD (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	jason.raymond@asu.edu		Shock, Everett/0000-0002-4283-0163; Havig, Jeff/0000-0002-1326-3382	NASA Exobiology and Evolutionary Biology Program [NNX08AP61G]; NASA Astrobiology Institute at ASU [08-NAI5-0018]	NASA Exobiology and Evolutionary Biology Program(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute at ASU	WDS and JR acknowledge support from the NASA Exobiology and Evolutionary Biology Program (NNX08AP61G). EBA and JR acknowledge support from the NASA Astrobiology Institute at ASU (08-NAI5-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arai H, 2010, J BACTERIOL, V192, P2651, DOI 10.1128/JB.00158-10; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; BOONE DR, 2001, BERGEYS MANUAL SYSTE, V1; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; D'Imperio S, 2008, APPL ENVIRON MICROB, V74, P5802, DOI 10.1128/AEM.00852-08; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dick JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022782; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Havig JR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001415; Hedlund BP, 2011, GEOBIOLOGY, V9, P471, DOI 10.1111/j.1472-4669.2011.00295.x; Hugenholtz P, 2004, INT J SYST EVOL MICR, V54, P2049, DOI 10.1099/ijs.0.03028-0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kislyuk A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-316; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Krause L, 2008, NUCLEIC ACIDS RES; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Meyer-Dombard DR, 2012, EXTREMOPHILES, V16, P317, DOI 10.1007/s00792-012-0432-5; Meyer-Dombard DR, 2011, ENVIRON MICROBIOL, V13, P2216, DOI 10.1111/j.1462-2920.2011.02476.x; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; Sikorski J, 2010, STAND GENOMIC SCI, V3, P37, DOI 10.4056/sigs.1042812; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tang KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-334; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Windman T, 2007, ASTROBIOLOGY, V7, P873, DOI 10.1089/ast.2007.0127; Wirth R, 2010, STAND GENOMIC SCI, V2, P194, DOI 10.4056/sigs.761490; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08	59	57	58	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38108	10.1371/journal.pone.0038108	http://dx.doi.org/10.1371/journal.pone.0038108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675512	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341700038
J	Talbert, A; Thuo, N; Karisa, J; Chesaro, C; Ohuma, E; Ignas, J; Berkley, JA; Toromo, C; Atkinson, S; Maitland, K				Talbert, Alison; Thuo, Nahashon; Karisa, Japhet; Chesaro, Charles; Ohuma, Eric; Ignas, James; Berkley, James A.; Toromo, Christopher; Atkinson, Sarah; Maitland, Kathryn			Diarrhoea Complicating Severe Acute Malnutrition in Kenyan Children: A Prospective Descriptive Study of Risk Factors and Outcome	PLOS ONE			English	Article							MALNOURISHED CHILDREN; INTESTINAL PERMEABILITY; CRITICAL-APPRAISAL; MANAGEMENT; BACTEREMIA; MORTALITY; KILIFI; REHYDRATION; EFFICACY; SAFETY	Background: Severe acute malnutrition (SAM) accounts for two million deaths worldwide annually. In those hospitalised with SAM, concomitant infections and diarrhoea are frequent complications resulting in adverse outcome. We examined the clinical and laboratory features on admission and outcome of children with SAM and diarrhoea at a Kenyan district hospital. Methods: A 4-year prospective descriptive study involving 1,206 children aged 6 months to 12 years, hospitalized with SAM and managed in accordance with WHO guidelines. Data on clinical features, haematological, biochemical and microbiological findings for children with diarrhoea (>= 3 watery stools/day) were systematically collected and analyzed to identify risk factors associated with poor outcome. Results: At admission 592 children (49%) had diarrhoea of which 122 (21%) died compared to 72/614 (12%) deaths in those without diarrhoea at admission (X-2 = 17.6 p<0.001). A further 187 (16%) children developed diarrhoea after 48 hours of admission and 33 died (18%). Any diarrhoea during admission resulted in a significantly higher mortality 161/852 (19%) than those uncomplicated by diarrhoea 33/351 (9%) (X-2 = 16.6 p<0.001). Features associated with a fatal outcome in children presenting with diarrhoea included bacteraemia, hyponatraemia, low mid-upper arm circumference <10 cm, hypoxia, hypokalaemia and oedema. Bacteraemia had the highest risk of death (adjusted OR 6.1; 95% C.I 2.3, 16.3 p<0.001); and complicated 24 (20%) of fatalities. Positive HIV antibody status was more frequent in cases with diarrhoea at admission (23%) than those without (15%, X-2 = 12.0 p = 0.001) but did not increase the risk of death in diarrhoea cases. Conclusion: Children with SAM complicated by diarrhoea had a higher risk of death than those who did not have diarrhoea during their hospital stay. Further operational and clinical research is needed to reduce mortality in children with SAM in the given setting.	[Talbert, Alison; Thuo, Nahashon; Karisa, Japhet; Chesaro, Charles; Ohuma, Eric; Ignas, James; Berkley, James A.; Toromo, Christopher; Atkinson, Sarah; Maitland, Kathryn] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Berkley, James A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Atkinson, Sarah] Univ Oxford, Dept Paediat, Oxford, England; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Trust Ctr Clin Trop Med, London, England	Kenya Medical Research Institute; University of Oxford; University of Oxford; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Talbert, A (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.	kathryn.maitland@gmail.com		Maitland, Kathryn/0000-0002-0007-0645; Berkley, James/0000-0002-1236-849X; CHESARO, CHARLES/0000-0003-1510-1296; Thuo, Nahashon/0000-0003-3719-6695	Wellcome Trust [077092/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Wellcome Trust grant number 077092/Z/05/Z, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Akech SO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-71; Alam NH, 2003, J PEDIATR-US, V143, P614, DOI 10.1067/S0022-3476(03)00500-6; Alam NH, 2009, J PEDIATR GASTR NUTR, V48, P318, DOI 10.1097/MPG.0b013e318180af27; Amadi B, 2002, J PEDIATR GASTR NUTR, V34, pS54, DOI 10.1097/00005176-200205001-00013; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brewster DR, 2006, J PAEDIATR CHILD H, V42, P583, DOI 10.1111/j.1440-1754.2006.00933.x; Brewster DR, 2006, J PAEDIATR CHILD H, V42, P568, DOI 10.1111/j.1440-1754.2006.00931.x; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Heikens GT, 2007, PLOS MED, V4, P222, DOI 10.1371/journal.pmed.0040045; Irena AH, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-110; Kukuruzovic RH, 2002, J PEDIATR GASTR NUTR, V35, P206, DOI 10.1097/00005176-200208000-00020; Kukuruzovic RH, 2002, J PAEDIATR CHILD H, V38, P571, DOI 10.1046/j.1440-1754.2002.00044.x; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Muchohi SN, 2011, J CHROMATOGR B, V879, P146, DOI 10.1016/j.jchromb.2010.11.032; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Nyeko Richard, 2010, BMC Pediatr, V10, P31, DOI 10.1186/1471-2431-10-31; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Rohner P, 1997, J CLIN MICROBIOL, V35, P1427, DOI 10.1128/JCM.35.6.1427-1432.1997; St-Arnaud-McKenzie D, 2004, PLOS MED, V59, P1304; Thuo N, 2011, J ANTIMICROB CHEMOTH; Waterlow J, 1999, LANCET, V354, P1142, DOI 10.1016/S0140-6736(99)00329-3; World Health Organization, 1999, MAN SEV MALN MAN PHY	29	93	95	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38321	10.1371/journal.pone.0038321	http://dx.doi.org/10.1371/journal.pone.0038321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675542	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700058
J	Berthouly-Salazar, C; van Rensburg, BJ; Le Roux, JJ; van Vuuren, BJ; Hui, C				Berthouly-Salazar, Cecile; van Rensburg, Berndt J.; Le Roux, Johannes J.; van Vuuren, Bettine J.; Hui, Cang			Spatial Sorting Drives Morphological Variation in the Invasive Bird, Acridotheris tristis	PLOS ONE			English	Article							CLIMATE-CHANGE; DISPERSAL STRATEGIES; RANGE EXPANSION; SPECIES RANGE; EVOLUTION; SIZE; CONSEQUENCES; DYNAMICS; DISTANCE; BEHAVIOR	The speed of range expansion in many invasive species is often accelerating because individuals with stronger dispersal abilities are more likely to be found at the range front. This 'spatial sorting' of strong dispersers will drive the acceleration of range expansion. In this study, we test whether the process of spatial sorting is at work in an invasive bird population (Common myna, Acridotheris tristis) in South Africa. Specifically, we sampled individuals across its invasive range and compared morphometric measurements relevant and non-relevant to the dispersal ability. Besides testing for signals of spatial sorting, we further examined the effect of environmental factors on morphological variations. Our results showed that dispersal-relevant traits are significantly correlated with distance from the range core, with strong sexual dimorphism, indicative of sex-biased dispersal. Morphological variations were significant in wing and head traits of females, suggesting females as the primary dispersing sex. In contrast, traits not related to dispersal such as those associated with foraging showed no signs of spatial sorting but were significantly affected by environmental variables such as the vegetation and the intensity of urbanisation. When taken together, our results support the role of spatial sorting in facilitating the expansion of Common myna in South Africa despite its low propensity to disperse in the native range.	[Berthouly-Salazar, Cecile; Le Roux, Johannes J.; Hui, Cang] Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa; [van Rensburg, Berndt J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [van Rensburg, Berndt J.] Univ Pretoria, Ctr Invas Biol, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [van Vuuren, Bettine J.] Univ Johannesburg, Ctr Invas Biol, Dept Zool, Johannesburg, South Africa	Stellenbosch University; University of Queensland; University of Pretoria; University of Johannesburg	Berthouly-Salazar, C (corresponding author), Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa.	c.berthouly@gmail.com	Hui, Cang/A-1781-2008; Jansen van Vuuren, Bettine/E-6227-2013; van Rensburg, Berndt/A-4154-2009; Berthouly-Salazar, Cecile/J-3204-2016	Hui, Cang/0000-0002-3660-8160; Jansen van Vuuren, Bettine/0000-0002-5334-5358; van Rensburg, Berndt/0000-0002-5274-5536; Berthouly-Salazar, Cecile/0000-0002-0685-6745; Le Roux, Johannes/0000-0001-7911-9810	Stellenbosch University Subcommittee B; National Research Foundation (NRF)	Stellenbosch University Subcommittee B; National Research Foundation (NRF)	This study was made possible through the financial support from the Stellenbosch University Subcommittee B and the National Research Foundation (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dawideit BA, 2009, J ANIM ECOL, V78, P388, DOI 10.1111/j.1365-2656.2008.01504.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Forsman A, 2011, P ROY SOC B-BIOL SCI, V278, P225, DOI 10.1098/rspb.2010.1325; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Harrison JA, 1997, ATLAS SO AFRICAN BIR; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hugo S, 2008, GLOBAL ECOL BIOGEOGR, V17, P611, DOI 10.1111/j.1466-8238.2008.00391.x; Jombart T, 2009, ECOGRAPHY, V32, P161, DOI 10.1111/j.1600-0587.2008.05567.x; Kang N, 1992, RADIO TELEMETRY URBA; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Laiolo P, 2001, IBIS, V143, P602, DOI 10.1111/j.1474-919X.2001.tb04888.x; Lee MSY, 2011, P NATL ACAD SCI USA, V108, pE347, DOI 10.1073/pnas.1105702108; Leisler B, 2003, AVIAN MIGRATION, P175; Lockwood JL, 2007, INVASION ECOLOGY; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; Moller AP, 2010, J EVOLUTION BIOL, V23, P625, DOI 10.1111/j.1420-9101.2009.01928.x; Mucina K, 2006, VEGETATION S AFRICA; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; Peacock DS, 2007, S AFR J SCI, V103, P465; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; R Core Development Team, 2006, R LANG ENV STAT COMP; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; RISING JD, 1989, AUK, V106, P666; Saino N, 1997, OECOLOGIA, V110, P186, DOI 10.1007/s004420050148; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Shine R, 2011, P NATL ACAD SCI USA, V108, pE348, DOI 10.1073/pnas.1108240108; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Slocum GL, 1995, THESIS AUSTR NATL U; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thompson M, 1996, S AFR J SCI, V92, P34; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x	61	48	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38145	10.1371/journal.pone.0038145	http://dx.doi.org/10.1371/journal.pone.0038145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693591	Green Published, gold			2022-12-25	WOS:000305338500094
J	Boughter, JD; Mulligan, MK; St John, SJ; Tokita, K; Lu, L; Heck, DH; Williams, RW				Boughter, John D., Jr.; Mulligan, Megan K.; St John, Steven J.; Tokita, Kenichi; Lu, Lu; Heck, Detlef H.; Williams, Robert W.			Genetic Control of a Central Pattern Generator: Rhythmic Oromotor Movement in Mice Is Controlled by a Major Locus near Atp1a2	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; NEURONAL-ACTIVITY; MOUSE STRAINS; ION CHANNELS; KCNJ9 GIRK3; LICKING; MOTOR; C57BL/6J; RAT; BXD	Fluid licking in mice is a rhythmic behavior that is controlled by a central pattern generator (CPG) located in a complex of brainstem nuclei. C57BL/6J (B6) and DBA/2J (D2) strains differ significantly in water-restricted licking, with a highly heritable difference in rates (h(2)>= 0.62) and a corresponding 20% difference in interlick interval (mean +/- SEM = 116.3 +/- 1 vs 95.4 +/- 1.1 ms). We systematically quantified motor output in these strains, their F-1 hybrids, and a set of 64 BXD progeny strains. The mean primary interlick interval (MPI) varied continuously among progeny strains. We detected a significant quantitative trait locus (QTL) for a CPG controlling lick rate on Chr 1 (Lick1), and a suggestive locus on Chr 10 (Lick10). Linkage was verified by testing of B6. D2-1D congenic stock in which a segment of Chr 1 of the D2 strain was introgressed onto the B6 parent. The Lick1 interval on distal Chr 1 contains several strong candidate genes. One of these is a sodium/potassium pump subunit (Atp1a2) with widespread expression in astrocytes, as well as in a restricted population of neurons. Both this subunit and the entire Na+/K+-ATPase molecule have been implicated in rhythmogenesis for respiration and locomotion. Sequence variants in or near Apt1a2 strongly modulate expression of the cognate mRNA in multiple brain regions. This gene region has recently been sequenced exhaustively and we have cataloged over 300 non-coding and synonymous mutations segregating among BXD strains, one or more of which is likely to contribute to differences in central pattern generator tempo.	[Boughter, John D., Jr.; Mulligan, Megan K.; Tokita, Kenichi; Lu, Lu; Heck, Detlef H.; Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [St John, Steven J.] Rollins Coll, Dept Psychol, Winter Pk, FL 32789 USA	University of Tennessee System; University of Tennessee Health Science Center; Rollins College	Boughter, JD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	jboughter@uthsc.edu	Heck, Detlef/GPS-4854-2022; Williams, Robert W./H-8789-2016	Mulligan, Megan/0000-0003-4909-635X; Williams, Robert W./0000-0001-8924-4447; Heck, Detlef/0000-0003-2438-4064	National Institute of Neurological Disorders and Stroke [NS052366, NS060887A]; National Institute on Alcohol Abuse and Alcoholism [U01AA017590, U01AA13499]; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052366, R01NS060887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA013499, U01AA017590] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grants from the National Institute of Neurological Disorders and Stroke to JDB (NS052366) and DHH (NS060887A), and from the National Institute on Alcohol Abuse and Alcoholism to RWW (U01AA017590 and U01AA13499). GeneNetwork is supported in part by the UT Center for Integrative and Translational Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2008, J NEUROCHEM, V105, P497, DOI 10.1111/j.1471-4159.2007.05153.x; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Ballerini L, 1997, J NEUROPHYSIOL, V77, P17, DOI 10.1152/jn.1997.77.1.17; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Boughter JD, 2007, GENES BRAIN BEHAV, V6, P619, DOI 10.1111/j.1601-183X.2006.00293.x; Boughter JD, 2005, CHEM SENSES, V30, pA106; Brocard F, 2010, NEUROSCIENTIST, V16, P139, DOI 10.1177/1073858409346339; Brozek G, 1996, P NATL ACAD SCI USA, V93, P3325, DOI 10.1073/pnas.93.8.3325; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Castro-Alamancos MA, 2007, J NEUROPHYSIOL, V97, P1883, DOI 10.1152/jn.01358.2006; Chen ZX, 2003, AM J PHYSIOL-REG I, V285, pR68, DOI 10.1152/ajpregu.00054.2003; Chen ZX, 2001, AM J PHYSIOL-REG I, V280, pR1085, DOI 10.1152/ajpregu.2001.280.4.R1085; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; Darbon P, 2003, J NEUROPHYSIOL, V90, P3119, DOI 10.1152/jn.00579.2003; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Del Negro CA, 2009, J PHYSIOL-LONDON, V587, P1217, DOI 10.1113/jphysiol.2008.164079; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Ferraro TN, 2007, PHYSIOL GENOMICS, V31, P458, DOI 10.1152/physiolgenomics.00123.2007; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Glendinning JI, 2005, CHEM SENSES, V30, P601, DOI 10.1093/chemse/bji054; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2000, BRAIN RES, V886, P224, DOI 10.1016/S0006-8993(00)03088-2; Grosse G, 2003, MOL CELL NEUROSCI, V24, P709, DOI 10.1016/S1044-7431(03)00234-3; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; Hayar A, 2006, J NEUROSCI METH, V153, P203, DOI 10.1016/j.jneumeth.2005.10.023; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; HOROWITZ GP, 1977, PHYSIOL BEHAV, V19, P493, DOI 10.1016/0031-9384(77)90224-4; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; JUCH PJW, 1985, ARCH ORAL BIOL, V30, P415, DOI 10.1016/0003-9969(85)90069-X; Kelly MA, 2003, MAMM GENOME, V14, P692, DOI 10.1007/s00335-003-2273-0; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Korostynski M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-146; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Lang IM, 2009, DYSPHAGIA, V24, P333, DOI 10.1007/s00455-009-9211-6; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Li ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012181; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lionikas A, 2005, PHYSIOL GENOMICS, V21, P184, DOI 10.1152/physiolgenomics.00209.2004; Ljungberg K, 2004, BIOINFORMATICS, V20, P1887, DOI 10.1093/bioinformatics/bth175; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Lohoff FW, 2005, NEUROSCI LETT, V382, P33, DOI 10.1016/j.neulet.2005.02.057; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nair HK, 2011, PAIN, V152, P599, DOI 10.1016/j.pain.2010.11.029; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Onimaru H, 2007, J PHYSIOL-LONDON, V584, P271, DOI 10.1113/jphysiol.2007.136572; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peng L, 1997, J NEUROSCI, V17, P3488; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Pruss H, 2008, NEUROSCI LETT, V445, P89, DOI 10.1016/j.neulet.2008.08.041; Reiner DJ, 2008, CHEM SENSES, V33, P693, DOI 10.1093/chemse/bjn025; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; Saba L, 2006, MAMM GENOME, V17, P669, DOI 10.1007/s00335-005-0190-0; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; Shires CB, 2011, OTOLARYNG HEAD NECK, V144, P915, DOI 10.1177/0194599811399722; Smith BK, 2001, AM J PHYSIOL-REG I, V281, pR596, DOI 10.1152/ajpregu.2001.281.2.R596; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; STELLAR E, 1952, J COMP PHYSIOL PSYCH, V45, P96, DOI 10.1037/h0062150; Tang XF, 2009, GLIA, V57, P1706, DOI 10.1002/glia.20882; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Tordoff MG, 2007, CHEM SENSES, V32, P655, DOI 10.1093/chemse/bjm034; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Travers JB, 2002, NEUROSCIENCE, V115, P1139, DOI 10.1016/S0306-4522(02)00489-X; Venugopal S, 2010, NEUROSCIENCE, V168, P31, DOI 10.1016/j.neuroscience.2010.03.036; Wang GH, 1999, PSYCHOPHARMACOLOGY, V147, P38, DOI 10.1007/s002130051140; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7; Zhang H, 2008, PHYSIOL BEHAV, V93, P461, DOI 10.1016/j.physbeh.2007.10.004; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	78	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38169	10.1371/journal.pone.0038169	http://dx.doi.org/10.1371/journal.pone.0038169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675444	gold, Green Published			2022-12-25	WOS:000305338500099
J	Shiozaki, A; Bai, XH; Shen-Tu, G; Moodley, S; Takeshita, H; Fung, SY; Wang, YC; Keshavjee, S; Liu, MY				Shiozaki, Atsushi; Bai, Xiao-hui; Shen-Tu, Grace; Moodley, Serisha; Takeshita, Hiroki; Fung, Shan-Yu; Wang, Yingchun; Keshavjee, Shaf; Liu, Mingyao			Claudin 1 Mediates TNF alpha-Induced Gene Expression and Cell Migration in Human Lung Carcinoma Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FACTOR-KAPPA-B; ADAPTER PROTEIN; TIGHT JUNCTIONS; RECEPTOR; XB130; OVEREXPRESSION; LAMELLIPODIA; METASTASIS	Epithelial-mesenchymal transition (EMT) is an important mechanism in carcinogenesis. To determine the mechanisms that are involved in the regulation of EMT, it is crucial to develop new biomarkers and therapeutic targets towards cancers. In this study, when TGF beta 1 and TNF alpha were used to induce EMT in human lung carcinoma A549 cells, we found an increase in an epithelial cell tight junction marker, Claudin 1. We further identified that it was the TNF alpha and not the TGF beta 1 that induced the fibroblast-like morphology changes. TNF alpha also caused the increase in Claudin-1 gene expression and protein levels in Triton X-100 soluble cytoplasm fraction. Down-regulation of Claudin-1, using small interfering RNA (siRNA), inhibited 75% of TNF alpha-induced gene expression changes. Claudin-1 siRNA effectively blocked TNF alpha-induced molecular functional networks related to inflammation and cell movement. Claudin-1 siRNA was able to significantly reduce TNF-enhanced cell migration and fibroblast-like morphology. Furthermore, over expression of Claudin 1 with a Claudin 1-pcDNA3.1/V5-His vector enhanced cell migration. In conclusion, these observations indicate that Claudin 1 acts as a critical signal mediator in TNF alpha-induced gene expression and cell migration in human lung cancer cells. Further analyses of these cellular processes may be helpful in developing novel therapeutic strategies.	[Shiozaki, Atsushi; Bai, Xiao-hui; Shen-Tu, Grace; Moodley, Serisha; Takeshita, Hiroki; Fung, Shan-Yu; Wang, Yingchun; Keshavjee, Shaf; Liu, Mingyao] Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Univ Hlth Network, Toronto, ON, Canada; [Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Shiozaki, A (corresponding author), Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Univ Hlth Network, Toronto, ON, Canada.	mingyao.liu@utoronto.ca	Fung, Shan-Yu/E-3477-2014	Fung, Shan-Yu/0000-0002-4547-8740; Liu, Mingyao/0000-0002-9188-8417; Keshavjee, Shaf/0000-0003-4547-8094	Canadian Institutes of Health Research [MOP-13270, MOP-42546]; Uehara Memorial Foundation; International Society of Heart and Lung Transplantation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); International Society of Heart and Lung Transplantation	This research is funded by Canadian Institutes of Health Research (grants MOP-13270, MOP-42546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Helan Xiao for technical assistance. We also thank Dr. Patricia Pintor dos Reis and Dr. Suzanne Kamel-Reid for giving Claudin 1-pcDNA3.1/V5-His plasmid. Dr. Atsushi Shiozaki was a recipient of Research Fellowship Awards from Uehara Memorial Foundation and International Society of Heart and Lung Transplantation.	Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Baker OJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1191, DOI 10.1152/ajpcell.00144.2008; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Chuang MJ, 2008, CANCER SCI, V99, P905, DOI 10.1111/j.1349-7006.2008.00756.x; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; dos Santos CC, 2008, CRIT CARE MED, V36, P855, DOI 10.1097/CCM.0B013E3181659333; Fujita H, 2011, J ALLERGY CLIN IMMUN, V127, P1612, DOI 10.1016/j.jaci.2011.03.039; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kim KB, 2011, J BIOL CHEM, V286, P23093, DOI 10.1074/jbc.M111.233304; Kitakata H, 2002, CANCER RES, V62, P6682; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Kominsky Scott L., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000056; Kondo J, 2008, INT J MOL MED, V22, P645, DOI 10.3892/ijmm_00000067; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Liu XD, 2008, CELL MOTIL CYTOSKEL, V65, P935, DOI 10.1002/cm.20315; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; MALIK STA, 1990, EUR J CANCER, V26, P1031, DOI 10.1016/0277-5379(90)90044-T; MALIK STA, 1989, INT J CANCER, V44, P918, DOI 10.1002/ijc.2910440529; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Nishiyama R, 2001, J BIOL CHEM, V276, P35571, DOI 10.1074/jbc.M106013200; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Poritz LS, 2004, J SURG RES, V116, P14, DOI 10.1016/S0022-4804(03)00311-1; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tang PS, 2006, J CELL PHYSIOL, V209, P457, DOI 10.1002/jcp.20751; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wu ST, 2011, EXP BIOL MED, V236, P1022, DOI 10.1258/ebm.2011.011058; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamauchi Y, 2010, EXP LUNG RES, V36, P12, DOI 10.3109/01902140903042589; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189	56	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38049	10.1371/journal.pone.0038049	http://dx.doi.org/10.1371/journal.pone.0038049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675434	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500081
J	Banda, K; Gregg, CJ; Chow, R; Varki, NM; Varki, A				Banda, Kalyan; Gregg, Christopher J.; Chow, Renee; Varki, Nissi M.; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups MECHANISMS UNDERLYING GASTROINTESTINAL INCORPORATION OF THE NON-HUMAN SIALIC ACID XENO-AUTOANTIGEN N-GLYCOLYLNEURAMINIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLNEURAMINIC ACID; GLYCOLOYLNEURAMINIC ACID; MOUSE-LIVER; HUMAN-MILK; HYDROXYLASE; EXPRESSION; CELLS; RAT; AUTOANTIBODIES; ANTIBODIES	Although N-acetyl groups are common in nature, N-glycolyl groups are rare. Mammals express two major sialic acids, N-acetylneuraminic acid and N-glycolylneuraminic acid (Neu5Gc). Although humans cannot produce Neu5Gc, it is detected in the epithelial lining of hollow organs, endothelial lining of the vasculature, fetal tissues, and carcinomas. This unexpected expression is hypothesized to result via metabolic incorporation of Neu5Gc from mammalian foods. This accumulation has relevance for diseases associated with such nutrients, via interaction with Neu5Gc-specific antibodies. Little is known about how ingested sialic acids in general and Neu5Gc in particular are metabolized in the gastrointestinal tract. We studied the gastrointestinal and systemic fate of Neu5Gc-containing glycoproteins (Neu5Gc-glycoproteins) or free Neu5Gc in the Neu5Gc-free Cmah(-/-) mouse model. Ingested free Neu5Gc showed rapid absorption into the circulation and urinary excretion. In contrast, ingestion of Neu5Gc-glycoproteins led to Neu5Gc incorporation into the small intestinal wall, appearance in circulation at a steady-state level for several hours, and metabolic incorporation into multiple peripheral tissue glycoproteins and glycolipids, thus conclusively proving that Neu5Gc can be metabolically incorporated from food. Feeding Neu5Gc-glycoproteins but not free Neu5Gc mimics the human condition, causing tissue incorporation into human-like sites in Cmah(-/-) fetal and adult tissues, as well as developing tumors. Thus, glycoproteins containing glycosidically linked Neu5Gc are the likely dietary source for human tissue accumulation, and not the free monosaccharide. This human-like model can be used to elucidate specific mechanisms of Neu5Gc delivery from the gut to tissues, as well as general mechanisms of metabolism of ingested sialic acids.	[Banda, Kalyan; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Gregg, Christopher J.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chow, Renee; Varki, Nissi M.] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu			National Institutes of Health [R01GM32373]; Institut Merieux; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Merieux; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM32373. This work was also supported by a research grant from the Institut Merieux. A. V. and N. M. V. are co-founders of and consultants for Sialix Inc., a biotech startup company interested in the practical implications of Neu5Gc uptake in humans.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld AK, 2012, J BIOL CHEM, V287, P28865, DOI 10.1074/jbc.M112.363549; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; DICKSON JJ, 1978, BIOCHEM J, V170, P407, DOI 10.1042/bj1700407; Eckhardt AE, 1997, J BIOL CHEM, V272, P33204, DOI 10.1074/jbc.272.52.33204; Gottschalk A, 1960, CHEM BIOL SIALIC ACI, P1; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P251; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Lofling JC, 2009, KIDNEY INT, V76, P140, DOI 10.1038/ki.2009.131; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; MORGAN BLG, 1979, P SOC EXP BIOL MED, V161, P534; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; NOHLE U, 1984, H-S Z PHYSIOL CHEM, V365, P1457, DOI 10.1515/bchm2.1984.365.2.1457; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; NORGARD KE, 1993, P NATL ACAD SCI USA, V90, P1068, DOI 10.1073/pnas.90.3.1068; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Pearce OMT, 2010, CARBOHYD RES, V345, P1225, DOI 10.1016/j.carres.2010.04.003; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Schauer R, 1978, Methods Enzymol, V50, P64; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SHAW L, 1994, EUR J BIOCHEM, V219, P1001, DOI 10.1111/j.1432-1033.1994.tb18583.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; TSO P, 1986, AM J PHYSIOL, V250, pG715, DOI 10.1152/ajpgi.1986.250.6.G715; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Wang B, 2001, AM J CLIN NUTR, V74, P510; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615	50	69	73	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28852	28864		10.1074/jbc.M112.364182	http://dx.doi.org/10.1074/jbc.M112.364182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692204	Green Published, hybrid			2022-12-25	WOS:000308074600057
J	Devel, L; Beau, F; Amoura, M; Vera, L; Cassar-Lajeunesse, E; Garcia, S; Czarny, B; Stura, EA; Dive, V				Devel, Laurent; Beau, Fabrice; Amoura, Mehdi; Vera, Laura; Cassar-Lajeunesse, Evelyne; Garcia, Sandra; Czarny, Bertrand; Stura, Enrico A.; Dive, Vincent			Simple Pseudo-dipeptides with a P-2(') Glutamate A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC CHELATING INHIBITORS; CONFORMATIONAL VARIABILITY; SELECTIVE-INHIBITION; POTENTIAL TREATMENT; BINDING INHIBITORS; STRUCTURAL BASIS; DRUG TARGETS; LIGAND; CANCER; 3RD-GENERATION	A series of pseudo-peptides with general formula X-L-Glu-NH2 (with X corresponding to an acyl moiety with a long aryl-alkyl side chain) have been synthesized, evaluated as inhibitors of matrix metalloproteases (MMPs), and found to display remarkable nanomolar affinity. The loss in potency associated with a substitution of the P-2' L-glutamate by a L-glutamine corroborates the importance of a carboxylate at this position. The binding mode of some of these inhibitors was characterized in solution and by x-ray crystallography in complex with various MMPs. The x-ray crystal structures reveal an unusual binding mode with the glutamate side chain chelating the active site zinc ion. Competition experiments between these inhibitors and acetohydroxamic acid, a small zinc-binding molecule, are in accord with the crystallographic results. One of these pseudo-dipeptides displays potency and selectivity toward MMP-12 similar to the best MMP-12 inhibitors reported to date. This novel family of pseudo peptides opens new opportunities to develop potent and selective inhibitors for several metzincins.	[Devel, Laurent; Beau, Fabrice; Amoura, Mehdi; Vera, Laura; Cassar-Lajeunesse, Evelyne; Garcia, Sandra; Czarny, Bertrand; Stura, Enrico A.; Dive, Vincent] CE Saclay, CEA, iBiTec S, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Devel, L (corresponding author), CE Saclay, CEA, iBiTec S, Serv Ingn Mol Prot SIMOPRO, Bat 152, F-91191 Gif Sur Yvette, France.	laurent.devel@cea.fr	Stura, Enrico A./A-2793-2010; CZARNY, bertrand/AAP-6603-2020; Czarny, Bertrand/F-2001-2018	Stura, Enrico A./0000-0001-6718-2118; CZARNY, bertrand/0000-0002-9586-0913; Czarny, Bertrand/0000-0002-9586-0913	Commissariat a l'Energie Atomique (CEA)	Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique (CEA).	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bode W, 2003, BIOCHEM SOC SYMP, V70, P1; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; De Savi C, 2012, BIOORG MED CHEM LETT, V22, P271, DOI 10.1016/j.bmcl.2011.11.034; De Savi C, 2011, BIOORG MED CHEM LETT, V21, P4215, DOI 10.1016/j.bmcl.2011.05.075; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Devel L., 2011, Patent No. [WO2011/023864, 2011023864]; Devel L, 2010, J BIOL CHEM, V285, P35900, DOI 10.1074/jbc.M110.139634; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Gao DA, 2010, BIOORG MED CHEM LETT, V20, P5039, DOI 10.1016/j.bmcl.2010.07.036; Gege C, 2012, J MED CHEM, V55, P709, DOI 10.1021/jm201152u; Heim-Riether A, 2009, BIOORG MED CHEM LETT, V19, P5321, DOI 10.1016/j.bmcl.2009.07.151; Holmes IP, 2009, BIOORG MED CHEM LETT, V19, P5760, DOI 10.1016/j.bmcl.2009.07.155; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Jacobsen JA, 2010, BBA-MOL CELL RES, V1803, P72, DOI 10.1016/j.bbamcr.2009.08.006; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li JJ, 2008, J MED CHEM, V51, P835, DOI 10.1021/jm701274v; Li W, 2009, J MED CHEM, V52, P5408, DOI 10.1021/jm900809r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Piecha D, 2010, INFLAMM RES, V59, P379, DOI 10.1007/s00011-009-0112-9; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Quillard T, 2011, ARTERIOSCL THROM VAS, V31, P2464, DOI 10.1161/ATVBAHA.111.231563; Roth J, 2011, BIOORG MED CHEM LETT, V21, P7180, DOI 10.1016/j.bmcl.2011.09.077; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schnute ME, 2010, BIOORG MED CHEM LETT, V20, P576, DOI 10.1016/j.bmcl.2009.11.081; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tu GG, 2008, CURR MED CHEM, V15, P1388, DOI 10.2174/092986708784567680; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001; YONETANI T, 1982, METHOD ENZYMOL, V87, P500	58	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26647	26656		10.1074/jbc.M112.380782	http://dx.doi.org/10.1074/jbc.M112.380782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689580	Green Published, hybrid			2022-12-25	WOS:000307386000016
J	Li, L; Carrie, C; Nelson, C; Whelan, J; Millar, AH				Li, Lei; Carrie, Chris; Nelson, Clark; Whelan, James; Millar, A. Harvey			Accumulation of Newly Synthesized F-1 in Vivo in Arabidopsis Mitochondria Provides Evidence for Modular Assembly of the Plant F1Fo ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN COMPLEXES; NATIVE ELECTROPHORESIS; GEL-ELECTROPHORESIS; RESPIRATORY-CHAIN; F1F0-ATP SYNTHASE; FUNCTIONAL ASSAYS; SUBUNITS; IDENTIFICATION; SUPERCOMPLEXES; SUBCOMPLEXES	F-1 subcomplex in mitochondrial samples is often considered to be a breakage product of the F1FO ATP synthase during sample handling and electrophoresis. We have used a progressive N-15 incorporation strategy to investigate the plant F1FO ATP synthase assembly model and the apparently free F-1 in plant mitochondria which is found in both the inner membrane and matrix. We show that subunits within F-1 in the inner membrane and matrix had a relatively higher N-15 incorporation rate than corresponding subunits in intact membrane F1FO. This demonstrates that free F-1 was a newer pool with a faster turnover rate consistent with it being an assembly intermediate in vivo. Import of [S-35] Met-labeled F-1 subunit precursors into Arabidopsis mitochondria showed the rapid accumulation of F-1 assembly intermediates. The different N-15 incorporation rate in matrix F-1, inner membrane F-1 and intact F1FO demonstrates these three represent different protein populations and are likely step by step intermediates during the assembly process of plant mitochondrial ATP synthase. The potential biological implications of in vivo accumulation of enzymatically active F-1 in mitochondria are discussed.	[Li, Lei; Carrie, Chris; Nelson, Clark; Whelan, James; Millar, A. Harvey] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Li, Lei; Nelson, Clark; Millar, A. Harvey] Univ Western Australia, Ctr Comparat Anal Biomol Networks, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia	Millar, AH (corresponding author), Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, MCS Bldg M316, Crawley, WA 6009, Australia.	harvey.millar@uwa.edu.au	Li, Lei/A-1631-2012; Whelan, James/F-6402-2011; Millar, A. Harvey/A-5452-2008; Carrie, Chris/A-2638-2010	Li, Lei/0000-0003-1508-5484; Whelan, James/0000-0001-5754-025X; Millar, A. Harvey/0000-0001-9679-1473; Carrie, Chris/0000-0002-4240-4674; Nelson, Clark/0000-0002-8796-8326	ARC Centre of Excellence in Plant Energy Biology [CE0561495]; Scholarship International Research Fees (SIRF); University International Stipend (UIS); Top Up Scholarship	ARC Centre of Excellence in Plant Energy Biology(Australian Research Council); Scholarship International Research Fees (SIRF); University International Stipend (UIS); Top Up Scholarship	This work was funded by the ARC Centre of Excellence in Plant Energy Biology (CE0561495) (to A. H. M. and J. W.).; Funded by Scholarship International Research Fees (SIRF), University International Stipend (UIS), and a Top Up Scholarship for UIS.	ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; Cortes-Hernandez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Diaz F., 2009, CURR PROTOC HUM GENE, V19, P41; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; HAMASUR B, 1992, EUR J BIOCHEM, V205, P409, DOI 10.1111/j.1432-1033.1992.tb16794.x; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Li L., 2012, MOL CELL PROTEOMICS, DOI M111.010025; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; MYERS M, 1993, J CELL PHYSIOL, V156, P35, DOI 10.1002/jcp.1041560106; Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9; Rak M, 2011, FEBS LETT, V585, P2582, DOI 10.1016/j.febslet.2011.07.011; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Sabar M, 2003, EMBO REP, V4, P381, DOI 10.1038/sj.embor.embor800; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Werhahn W, 2002, ELECTROPHORESIS, V23, P640, DOI 10.1002/1522-2683(200202)23:4&lt;640::AID-ELPS640&gt;3.0.CO;2-F; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006	40	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25749	25757		10.1074/jbc.M112.373506	http://dx.doi.org/10.1074/jbc.M112.373506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22674576	hybrid, Green Published			2022-12-25	WOS:000306916300006
J	Kim, TW; Yu, MJ; Zhou, H; Cui, W; Wang, JA; DiCorleto, P; Fox, P; Xiao, H; Li, XX				Kim, Tae Whan; Yu, Minjia; Zhou, Hao; Cui, Wei; Wang, Jianan; DiCorleto, Paul; Fox, Paul; Xiao, Hui; Li, Xiaoxia			Pellino 2 Is critical for Toll-like Receptor/Interleukin-1 Receptor (TLR/IL-1R)-mediated Post-transcriptional Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE PELLINO; KAPPA-B ACTIVATION; INTERLEUKIN-1 RECEPTOR; CYTOKINE PRODUCTION; INNATE IMMUNITY; KINASE; IL-1; IRAK; PROTEINS; FAMILY	Interleukin 1 receptor-associated kinase 1(IRAK1), a key molecule in TLR/IL-1R-mediated signaling, is phosphorylated, ubiquitinated, and degraded upon ligand stimulation. We and others have recently identified Pellino proteins as novel RING E3 ubiquitin ligases involved in IRAK1 polyubiquitination and degradation. However, it remains unclear how each Pellino member distinctly regulates TLR/IL-1R signaling by modulating IRAK1 ubiquitination. In this study we examined the role of Pellino 2 in IL-1- and LPS-mediated signaling and gene expression by knocking down Pellino 2 in human 293-IL-1R cells and primary bone marrow macrophages. Pellino 2 (but not Pellino 1) knockdown abolished IL-1- and LPS-induced Lys-63-linked IRAK1 ubiquitination with reduced Lys-48-linked IRAK1 ubiquitination. Furthermore, Pellino 2 is required for TAK1-dependent NF kappa B activation. However, because of the retained TAK1-independent NF kappa B activation, the levels of IL-1- and LPS-induced NF kappa B activation were not substantially affected in Pellino 2 knockdown 293-IL-1R cells and primary macrophages, respectively. On the other hand, Pellino 2 knockdown reduced the IL-1- and LPS-induced inflammatory gene expression at late time points, which was accompanied by increased decay rates of the mRNAs of the inflammatory genes. Importantly, IL-1- and LPS-mediated JNK and ERK activation were substantially attenuated in Pellino 2 knock-down cells, implicating MAPK activation in TLR/IL-1R-induced mRNA stabilization. Taken together, this study demonstrated that Pellino 2 plays a critical role for TLR/IL-1R-mediated post-transcriptional control.	[Kim, Tae Whan; Yu, Minjia; Zhou, Hao; Cui, Wei; Xiao, Hui; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Yu, Minjia; Wang, Jianan] Zhejiang Univ, Dept Cardiol, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China; [DiCorleto, Paul; Fox, Paul] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Zhejiang University; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org			National Institutes of Health [2PO1 HL 029582-26A1, 2PO1CA062220-16A1]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2PO1 HL 029582-26A1 and 2PO1CA062220-16A1.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rich T, 2000, IMMUNOGENETICS, V52, P145, DOI 10.1007/s002510000249; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	28	25	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25686	25695		10.1074/jbc.M112.352625	http://dx.doi.org/10.1074/jbc.M112.352625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669975	Green Published, hybrid			2022-12-25	WOS:000306651700076
J	Liu, FY; Bardhan, K; Yang, DF; Thangaraju, M; Ganapathy, V; Waller, JL; Liles, GB; Lee, JR; Liu, KB				Liu, Feiyan; Bardhan, Kankana; Yang, Dafeng; Thangaraju, Muthusamy; Ganapathy, Vadivel; Waller, Jennifer L.; Liles, Georgia B.; Lee, Jeffrey R.; Liu, Kebin			NF-kappa B Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPHA-DEPENDENT APOPTOSIS; CELL-DEATH; CANCER DEVELOPMENT; MOUSE MODEL; IFN-GAMMA; IKK-BETA; IN-VIVO; RECEPTOR; CD95	Fas is a member of the death receptor family. Stimulation of Fas leads to induction of apoptotic signals, such as caspase 8 activation, as well as "non-apoptotic" cellular responses, notably NF-kappa B activation. Convincing experimental data have identified NF-kappa B as a critical promoter of cancer development, creating a solid rationale for the development of antitumor therapy that suppresses NF-kappa B activity. On the other hand, compelling data have also shown that NF-kappa B activity enhances tumor cell sensitivity to apoptosis and senescence. Furthermore, although stimulation of Fas activates NF-kappa B, the function of NF-kappa B in the Fas-mediated apoptosis pathway remains largely undefined. In this study, we observed that deficiency of either Fas or FasL resulted in significantly increased incidence of 3-methylcholanthrene-induced spontaneous sarcoma development in mice. Furthermore, Fas-deficient mice also exhibited significantly greater incidence of azoxymethane and dextran sodium sulfate-induced colon carcinoma. In addition, human colorectal cancer patients with high Fas protein in their tumor cells had a longer time before recurrence occurred. Engagement of Fas with FasL triggered NF-kappa B activation. Interestingly, canonical NF-kappa B was found to directly bind to the FAS promoter. Blocking canonical NF-kappa B activation diminished Fas expression, whereas blocking alternate NF-kappa B increased Fas expression in human carcinoma cells. Moreover, although canonical NF-kappa B protected mouse embryo fibroblast (MEF) cells from TNF alpha-induced apoptosis, knocking out p65 diminished Fas expression in MEF cells, resulting in inhibition of FasL-induced caspase 8 activation and apoptosis. In contrast, knocking out p52 increased Fas expression in MEF cells. Our observations suggest that canonical NF-kappa B is a Fas transcription activator and alternate NF-kappa B is a Fas transcription repressor, and Fas functions as a suppressor of spontaneous sarcoma and colon carcinoma.	[Liu, Feiyan; Bardhan, Kankana; Yang, Dafeng; Thangaraju, Muthusamy; Ganapathy, Vadivel; Liu, Kebin] Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Waller, Jennifer L.] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA 30912 USA; [Liles, Georgia B.; Lee, Jeffrey R.] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Liu, Feiyan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Liles, Georgia B.; Lee, Jeffrey R.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30904 USA; [Liu, Kebin] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Zhejiang University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University	Liu, KB (corresponding author), Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, 1410 Laney Walker Blvd, Augusta, GA 30912 USA.	Kliu@georgiahealth.edu		Liu, Kebin/0000-0003-1965-7240	National Institutes of Health Grant [CA133085]; American Cancer Society Grant [RSG-09-209-01-TBG]; Siyuan Foundation; NATIONAL CANCER INSTITUTE [R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); Siyuan Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133085 (to K. L.). This work was also supported by American Cancer Society Grant RSG-09-209-01-TBG (to K. L.) and the Siyuan Foundation (to F. L.).	Ahn EY, 2002, INT J CANCER, V100, P445, DOI 10.1002/ijc.10516; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bista P, 2010, J BIOL CHEM, V285, P12971, DOI 10.1074/jbc.M109.076091; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Caldwell SA, 2003, J IMMUNOL, V171, P2402, DOI 10.4049/jimmunol.171.5.2402; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dowdell KC, 2010, BLOOD, V115, P5164, DOI 10.1182/blood-2010-01-263145; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guillen-Ahlers H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009070; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kew RR, 2012, J IMMUNOL, V188, P2380, DOI 10.4049/jimmunol.1102454; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Klein U, 2011, CANCER CELL, V20, P556, DOI 10.1016/j.ccr.2011.10.026; Kober AMM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.93; Krammer P H, 1999, Adv Immunol, V71, P163; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lei DP, 2010, CANCER EPIDEM BIOMAR, V19, P1484, DOI 10.1158/1055-9965.EPI-10-0030; Lenardo Michael J, 2010, Immunity, V32, P291, DOI 10.1016/j.immuni.2010.03.013; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Neven B, 2011, BLOOD, V118, P4798, DOI 10.1182/blood-2011-04-347641; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Owen-Schaub LB, 1998, J EXP MED, V188, P1717, DOI 10.1084/jem.188.9.1717; Park WS, 2001, J PATHOL, V193, P162; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Qiu LX, 2009, HUM GENET, V125, P431, DOI 10.1007/s00439-009-0639-4; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Ruiz-Ruiz C, 2003, J BIOL CHEM, V278, P31667, DOI 10.1074/jbc.M304397200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schillaci R, 2006, J IMMUNOL, V176, P3426, DOI 10.4049/jimmunol.176.6.3426; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Sibley K, 2003, CANCER RES, V63, P4327; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Sunter NJ, 2012, BLOOD, V119, P196, DOI 10.1182/blood-2011-04-349803; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wingender G, 2010, J IMMUNOL, V185, P2721, DOI 10.4049/jimmunol.1001018; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949; Zimmerman M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014076	60	99	102	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25530	25540		10.1074/jbc.M112.356279	http://dx.doi.org/10.1074/jbc.M112.356279			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669972	Green Published, hybrid			2022-12-25	WOS:000306651700059
J	Kelsch, W; Stolfi, A; Lois, C				Kelsch, Wolfgang; Stolfi, Alberto; Lois, Carlos			Genetic Labeling of Neuronal Subsets through Enhancer Trapping in Mice	PLOS ONE			English	Article							TRANSGENIC MICE; THY-1 GENE; LENTIVIRAL VECTORS; HUMAN GENOME; EXPRESSION; DROSOPHILA; BRAIN; CELLS; INTERNEURONS; INTEGRATION	The ability to label, visualize, and manipulate subsets of neurons is critical for elucidating the structure and function of individual cell types in the brain. Enhancer trapping has proved extremely useful for the genetic manipulation of selective cell types in Drosophila. We have developed an enhancer trap strategy in mammals by generating transgenic mice with lentiviral vectors carrying single-copy enhancer-detector probes encoding either the marker gene lacZ or Cre recombinase. This transgenic strategy allowed us to genetically identify a wide variety of neuronal subpopulations in distinct brain regions. Enhancer detection by lentiviral transgenesis could thus provide a complementary method for generating transgenic mouse libraries for the genetic labeling and manipulation of neuronal subsets.	[Kelsch, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Bernstein Ctr Computat Neurosci, CIMH, Heidelberg, Germany; [Stolfi, Alberto] New York Univ, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Lois, Carlos] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; New York University; University of Massachusetts System; University of Massachusetts Worcester	Kelsch, W (corresponding author), Heidelberg Univ, Med Fac Mannheim, Bernstein Ctr Computat Neurosci, CIMH, Heidelberg, Germany.	Carlos.Lois@umassmed.edu	Stolfi, Alberto/AAS-8031-2021	Kelsch, Wolfgang/0000-0002-3470-8125	David and Lucille Packard Foundation	David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by an award from the David and Lucille Packard Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, PLANT CELL, V1, P623, DOI 10.1105/tpc.1.6.623; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GORDON JW, 1987, CELL, V50, P445, DOI 10.1016/0092-8674(87)90498-3; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCKNIGHT GS, 1983, CELL, V34, P335; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; SPANOPOULOU E, 1988, MOL CELL BIOL, V8, P3847, DOI 10.1128/MCB.8.9.3847; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38593	10.1371/journal.pone.0038593	http://dx.doi.org/10.1371/journal.pone.0038593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685588	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305351700051
J	Rippe, RCA; Meulman, JJ; Eilers, PHC				Rippe, Ralph C. A.; Meulman, Jacqueline J.; Eilers, Paul H. C.			Visualization of Genomic Changes by Segmented Smoothing Using an L-0 Penalty	PLOS ONE			English	Article								Copy number variations (CNV) and allelic imbalance in tumor tissue can show strong segmentation. Their graphical presentation can be enhanced by appropriate smoothing. Existing signal and scatterplot smoothers do not respect segmentation well. We present novel algorithms that use a penalty on the L-0 norm of differences of neighboring values. Visualization is our main goal, but we compare classification performance to that of VEGA.	[Rippe, Ralph C. A.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Meulman, Jacqueline J.] Leiden Univ, Inst Math, NL-2300 RA Leiden, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Rippe, RCA (corresponding author), Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	R.C.A.Rippe@lumc.nl						Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Budinska E, 2009, BIOINFORMATICS, V25, P703, DOI 10.1093/bioinformatics/btp022; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Eilers P, 2005, BIOINFORMATICS; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Fraley C, 2004, J STAT SOFTWARE, P18; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Liu Z, 2010, PLOS ONE, P5; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Morganella S, 2010, BIOINFORMATICS, V21, P1146; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHLOSSMACHER EJ, 1973, J AM STAT ASSOC, V68, P857, DOI 10.2307/2284512; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsuang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014456; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511	21	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38230	10.1371/journal.pone.0038230	http://dx.doi.org/10.1371/journal.pone.0038230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679492	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900022
J	Morgado, A; Almeida, F; Teixeira, A; Silva, AL; Romao, L				Morgado, Ana; Almeida, Fatima; Teixeira, Alexandre; Silva, Ana Luisa; Romao, Luisa			Unspliced Precursors of NMD-Sensitive beta-Globin Transcripts Exhibit Decreased Steady-State Levels in Erythroid Cells	PLOS ONE			English	Article							MESSENGER-RNA DECAY; PREMATURE TERMINATION CODON; NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; OPEN READING FRAME; QUALITY-CONTROL; MAMMALIAN-CELLS; GENE-EXPRESSION; NUCLEAR; MUTATIONS	Nonsense-mediated mRNA decay (NMD) is a quality control mechanism that detects and rapidly degrades mRNAs carrying premature translation-termination codons (PTCs). Mammalian NMD depends on both splicing and translation, and requires recognition of the premature stop codon by the cytoplasmic ribosomes. Surprisingly, some published data have suggested that nonsense codons may also affect the nuclear metabolism of the nonsense-mutated transcripts. To determine if nonsense codons could influence nuclear events, we have directly assessed the steady-state levels of the unspliced transcripts of wild-type and PTC-containing human beta-globin genes stably transfected in mouse erythroleukemia (MEL) cells, after erythroid differentiation induction, or in HeLa cells. Our analyses by ribonuclease protection assays and reverse transcription-coupled quantitative PCR show that beta-globin pre-mRNAs carrying NMD-competent PTCs, but not those containing a NMD-resistant PTC, exhibit a significant decrease in their steady-state levels relatively to the wild-type or to a missense-mutated beta-globin pre-mRNA. On the contrary, in HeLa cells, human beta-globin pre-mRNAs carrying NMD-competent PTCs accumulate at normal levels. Functional analyses of these pre-mRNAs in MEL cells demonstrate that their low steady-state levels do not reflect significantly lower pre-mRNA stabilities when compared to the normal control. Furthermore, our results also provide evidence that the relative splicing efficiencies of intron 1 and 2 are unaffected. This set of data highlights potential nuclear pathways that might be promoter-and/or cell line-specific, which recognize the NMD-sensitive transcripts as abnormal. These specialized nuclear pathway(s) may be superimposed on the general NMD mechanism.	[Morgado, Ana; Almeida, Fatima; Teixeira, Alexandre; Silva, Ana Luisa; Romao, Luisa] Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal; [Teixeira, Alexandre] Univ Nova Lisboa, Fac Ciencias Med, Ctr Invest Genet Mol Humana, P-1200 Lisbon, Portugal; [Morgado, Ana; Silva, Ana Luisa; Romao, Luisa] Univ Lisbon, Fac Ciencias, BioFIG Ctr Biodivers Funct & Integrat Genom, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade Nova de Lisboa; Universidade de Lisboa	Morgado, A (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal.	luisa.romao@insa.min-saude.pt	Romão, Luísa/A-2289-2016; Teixeira, Alexandre/N-9654-2013	Romão, Luísa/0000-0002-5061-5287; Teixeira, Alexandre/0000-0001-8899-9514; Morgado, Ana/0000-0002-8909-3615; Silva, Ana Luisa/0000-0002-4839-8279	Programa de Financiamento Plurianual do Centro de Investigacao em Genetica Molecular Humana (CIGMH); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/31920/2006, PRAXIS XXI/BPD/18880/98, SFRH/BD/8351/2002]	Programa de Financiamento Plurianual do Centro de Investigacao em Genetica Molecular Humana (CIGMH); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia [Programa de Financiamento Plurianual do Centro de Investigacao em Genetica Molecular Humana (CIGMH) and Center for Biodiversity, Functional and Integrative Genomics (BioFIG)]. AM, FA and ALS were supported by fellowships from Fundacao para a Ciencia e a Tecnologia (SFRH/BD/31920/2006, PRAXIS XXI/BPD/18880/98 and SFRH/BD/8351/2002, respectively). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; Bhalla AD, 2009, J BIOL CHEM, V284, P4062, DOI 10.1074/jbc.M805193200; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Custodio N, 2001, J CELL MOL MED, V5, P267, DOI 10.1111/j.1582-4934.2001.tb00160.x; de Turris V, 2011, RNA, V17, P2094, DOI 10.1261/rna.02918111; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Eberle AB, 2009, RNA, V15, P1021, DOI 10.1261/rna.1516409; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gersappe A, 1999, J BIOL CHEM, V274, P22452, DOI 10.1074/jbc.274.32.22452; HALL GW, 1994, BLOOD, V83, P2031; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; HUMPHRIES RK, 1984, BLOOD, V64, P23; Iborra FJ, 2004, J CELL SCI, V117, P899, DOI 10.1242/jcs.00933; Imam JS, 2010, NUCLEIC ACIDS RES, V38, P1559, DOI 10.1093/nar/gkp1115; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kessler O, 1996, MOL CELL BIOL, V16, P4426; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kong J, 2007, NAT STRUCT MOL BIOL, V14, P670, DOI 10.1038/nsmb1256; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lemieux C, 2011, MOL CELL, V44, P108, DOI 10.1016/j.molcel.2011.06.035; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; Liebhaber SA, 1996, MOL CELL BIOL, V16, P2637; LIM SK, 1992, EMBO J, V11, P3271, DOI 10.1002/j.1460-2075.1992.tb05405.x; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Lytle JR, 2004, RNA, V10, P657, DOI 10.1261/rna.5241404; MAQUAT LE, 1985, NUCLEIC ACIDS RES, V13, P2855, DOI 10.1093/nar/13.8.2855; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muhlemann O, 2010, RNA BIOL, V7, P28; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Nicholson P, 2010, BIOCHEM SOC T, V38, P1615, DOI 10.1042/BST0381615; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Romao L, 2000, BLOOD, V96, P2895; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Silva AL, 2006, RNA, V12, P2160, DOI 10.1261/rna.201406; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Stalder L, 2007, J BIOL CHEM, V282, P16079, DOI 10.1074/jbc.M610595200; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	69	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38505	10.1371/journal.pone.0038505	http://dx.doi.org/10.1371/journal.pone.0038505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675570	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341700082
J	Crinelli, R; Carloni, E; Giacomini, E; Penna, A; Dominici, S; Battocchi, C; Ciminiello, P; Dell'Aversano, C; Fattorusso, E; Forino, M; Tartaglione, L; Magnani, M				Crinelli, Rita; Carloni, Elisa; Giacomini, Elisa; Penna, Antonella; Dominici, Sabrina; Battocchi, Cecilia; Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto; Forino, Martino; Tartaglione, Luciana; Magnani, Mauro			Palytoxin and an Ostreopsis Toxin Extract Increase the Levels of mRNAs Encoding Inflammation-Related Proteins in Human Macrophages via p38 MAPK and NF-kappa B	PLOS ONE			English	Article							PUTATIVE PALYTOXIN; TUMOR PROMOTER; GENE-EXPRESSION; KINASE; ACTIVATION; INHIBITION; STRESS; OVATA; SEA; CYCLOOXYGENASE-2	Background: Palytoxin and, likely, its analogues produced by the dinoflagellate genus Ostreopsis, represent a class of nonproteinaceous compounds displaying high toxicity in animals. Owing to the wide distribution and the poisonous effects of these toxins in humans, their chemistry and mechanism of action have generated a growing scientific interest. Depending on the exposure route, palytoxin and its Ostreopsis analogues may cause several adverse effects on human health, including acute inflammatory reactions which seem more typical of cutaneous and inhalation contact. These observations have led us to hypothesize that these toxins may activate pro-inflammatory signalling cascades. Methodology and Principal Findings: Here we demonstrate that palytoxin and a semi-purified Ostreopsis cf. ovata toxin extract obtained from a cultured strain isolated in the NW Adriatic Sea and containing a putative palytoxin and all the ovatoxins so far known - including the recently identified ovatoxin-f - significantly increase the levels of mRNAs encoding inflammation-related proteins in immune cells, i.e. monocyte-derived human macrophages, as assessed by Real-Time PCR analysis. Western immunoblot and electrophoretic mobility shift assays revealed that nuclear transcription factor -kappa B (NF-kappa B) is activated in cells exposed to toxins in coincidence with reduced levels of the inhibitory protein I kappa B-alpha. Moreover, Mitogen-Activated Protein Kinases (MAPK) were phosphorylated in response to palytoxin, as also reported by others, and to the Ostreopsis toxin extract, as shown here for the first time. By using specific chemical inhibitors, the involvement of NF-kappa B and p38 MAPK in the toxin-induced transcription and accumulation of Cycloxigenase-2, Tumor Necrosis Factor-alpha, and Interleukin-8 transcripts has been demonstrated. Conclusions and Significance: The identification of specific molecular targets of palytoxin and its Ostreopsis analogues, besides contributing to expand the still limited knowledge of the intracellular signalling cascades affected by these toxins, may have important implications in setting up focused pharmacological interventions, replacing currently used symptomatic treatments.	[Crinelli, Rita; Carloni, Elisa; Giacomini, Elisa; Dominici, Sabrina; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Sect Biochem & Mol Biol, Urbino, PU, Italy; [Penna, Antonella; Battocchi, Cecilia] Univ Urbino Carlo Bo, Sect Environm Biol, Urbino, PU, Italy; [Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto; Forino, Martino; Tartaglione, Luciana] Univ Naples 2, Dept Chem Nat Prod, Naples, Italy	University of Urbino; University of Urbino; Universita della Campania Vanvitelli	Crinelli, R (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Sect Biochem & Mol Biol, Urbino, PU, Italy.	rita.crinelli@uniurb.it	Tartaglione, Luciana/ABG-1088-2020; Giacomini, Elisa/K-3208-2016; Dell'Aversano, Carmela/H-1803-2013; Tartaglione, Luciana/F-4651-2010; Magnani, Mauro/A-1919-2008	Giacomini, Elisa/0000-0003-3289-3221; Dell'Aversano, Carmela/0000-0001-8337-3029; Carloni, Elisa/0000-0003-1178-9353; Magnani, Mauro/0000-0001-6456-6626; Crinelli, Rita/0000-0002-1235-8910; Forino, Martino/0000-0001-8036-3546; Tartaglione, Luciana/0000-0003-0742-6955	ARPAC-Regione Campania D.D. [133 31/12/2008]; ISPRA Project "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita' microalgale nei mari italiani";  [2008BP25KN_001];  [2009JS5YX9_004]	ARPAC-Regione Campania D.D.; ISPRA Project "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita' microalgale nei mari italiani"; ; 	This work was supported by PRIN 2008 prot. 2008BP25KN_001 granted to M. Magnani, PRIN 2009 prot. 2009JS5YX9_004 granted to P. Ciminiello, ARPAC-Regione Campania D.D. 133 31/12/2008 granted to E. Fattorusso, ISPRA Project 2008-2009 "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita' microalgale nei mari italiani" granted to A. Penna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoroni S, 2011, MAR POLLUT BULL, V62, P2512, DOI 10.1016/j.marpolbul.2011.08.003; ALCALA AC, 1988, TOXICON, V26, P105, DOI 10.1016/0041-0101(88)90142-0; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Battocchi C, 2010, MAR POLLUT BULL, V60, P1074, DOI 10.1016/j.marpolbul.2010.01.017; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Louzao MC, 2007, FEBS J, V274, P1991, DOI 10.1111/j.1742-4658.2007.05743.x; Louzao MC, 2008, FEBS J, V275, P6067, DOI 10.1111/j.1742-4658.2008.06712.x; Charlson AT, 2009, TOXICOL APPL PHARM, V241, P143, DOI 10.1016/j.taap.2009.08.021; Ciminiello P, 2008, J AM SOC MASS SPECTR, V19, P111, DOI 10.1016/j.jasms.2007.11.001; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Ciminiello P, 2011, TOXICON, V57, P362, DOI 10.1016/j.toxicon.2010.09.005; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Crinelli R, 2004, NUCLEIC ACIDS RES, V32, P1874, DOI 10.1093/nar/gkh503; Crinelli R, 2010, ACS NANO, V4, P2791, DOI 10.1021/nn100057c; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Durando P., 2007, EUROSURVEILLANCE, V12, P1, DOI DOI 10.2807/ESW.12.23.03212-EN; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; FUJIKI H, 1986, CARCINOGENESIS, V7, P707, DOI 10.1093/carcin/7.5.707; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gallitelli M, 2005, JAMA-J AM MED ASSOC, V293, P2599, DOI 10.1001/jama.293.21.2599-c; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guo YS, 2002, J BIOL CHEM, V277, P48755, DOI 10.1074/jbc.M209016200; HABERMANN E, 1989, TOXICON, V27, P1171, DOI 10.1016/0041-0101(89)90026-3; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Honsell G, 2011, ENVIRON SCI TECHNOL, V45, P7051, DOI 10.1021/es201373e; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Iordanov MS, 1998, J BIOL CHEM, V273, P3528, DOI 10.1074/jbc.273.6.3528; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LEVINE L, 1985, CARCINOGENESIS, V6, P1631, DOI 10.1093/carcin/6.11.1631; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li SN, 1999, TOXICOL APPL PHARM, V160, P109, DOI 10.1006/taap.1999.8754; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; MONROE JJ, 1995, AM J PHYSIOL-CELL PH, V269, pC582, DOI 10.1152/ajpcell.1995.269.3.C582; MOORE RE, 1971, SCIENCE, V172, P495, DOI 10.1126/science.172.3982.495; MOORE RE, 1981, J AM CHEM SOC, V103, P2491, DOI 10.1021/ja00399a093; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; OHUCHI K, 1985, BIOCHIM BIOPHYS ACTA, V834, P42, DOI 10.1016/0005-2760(85)90174-2; Onuma Y, 1999, TOXICON, V37, P55, DOI 10.1016/S0041-0101(98)00133-0; Pelin M, 2011, TOXICOLOGY, V282, P30, DOI 10.1016/j.tox.2011.01.010; Penna A, 2010, J BIOGEOGR, V37, P830, DOI 10.1111/j.1365-2699.2009.02265.x; Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Prandi S, 2011, CHEM RES TOXICOL, V24, P1283, DOI 10.1021/tx2001866; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sagara T, 2013, J APPL TOXICOL, V33, P120, DOI 10.1002/jat.1728; Sala GL, 2009, CHEM RES TOXICOL, V22, P2009, DOI 10.1021/tx900297g; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Thevenod F, 1999, FASEB J, V13, P1751, DOI 10.1096/fasebj.13.13.1751; THRONDSEN J, 1995, IOC MANUALS GUIDES, V33, P63; Tichadou L, 2010, CLIN TOXICOL, V48, P839, DOI 10.3109/15563650.2010.513687; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; UEMURA D, 1981, TETRAHEDRON LETT, V22, P2781, DOI 10.1016/S0040-4039(01)90551-9; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wattenberg EV, 2007, AM J PHYSIOL-CELL PH, V292, pC24, DOI 10.1152/ajpcell.00254.2006; Wattenberg EV, 2011, TOXICON, V57, P440, DOI 10.1016/j.toxicon.2010.11.003; Westra J, 2004, ARTHRITIS RES THER, V6, pR384, DOI 10.1186/ar1204; WILES JS, 1974, TOXICON, V12, P427, DOI 10.1016/0041-0101(74)90011-7; Xiao C, 2008, BRAIN RES, V1215, P76, DOI 10.1016/j.brainres.2008.03.065	73	27	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38139	10.1371/journal.pone.0038139	http://dx.doi.org/10.1371/journal.pone.0038139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675515	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900014
J	Clendenning, DE; Mortlock, DP				Clendenning, Dawn E.; Mortlock, Douglas P.			The BMP Ligand Gdf6 Prevents Differentiation of Coronal Suture Mesenchyme in Early Cranial Development	PLOS ONE			English	Article							NEURAL CREST; FACIAL SYNDROME; JOINT FORMATION; BONE; MUTATIONS; MORPHOGENESIS; NOGGIN; MICE; CRANIOSYNOSTOSIS; MICRODELETION	Growth Differentiation Factor-6 (Gdf6) is a member of the Bone Morphogenetic Protein (BMP) family of secreted signaling molecules. Previous studies have shown that Gdf6 plays a role in formation of a diverse subset of skeletal joints. In mice, loss of Gdf6 results in fusion of the coronal suture, the intramembranous joint that separates the frontal and parietal bones. Although the role of GDFs in the development of cartilaginous limb joints has been studied, limb joints are developmentally quite distinct from cranial sutures and how Gdf6 controls suture formation has remained unclear. In this study we show that coronal suture fusion in the Gdf6-/- mouse is due to accelerated differentiation of suture mesenchyme, prior to the onset of calvarial ossification. Gdf6 is expressed in the mouse frontal bone primordia from embryonic day (E) 10.5 through 12.5. In the Gdf6-/- embryo, the coronal suture fuses prematurely and concurrently with the initiation of osteogenesis in the cranial bones. Alkaline phosphatase (ALP) activity and Runx2 expression assays both showed that the suture width is reduced in Gdf6+/- embryos and is completely absent in Gdf6-/- embryos by E12.5. ALP activity is also increased in the suture mesenchyme of Gdf6+/- embryos compared to wild-type. This suggests Gdf6 delays differentiation of the mesenchyme occupying the suture, prior to the onset of ossification. Therefore, although BMPs are known to promote bone formation, Gdf6 plays an inhibitory role to prevent the osteogenic differentiation of the coronal suture mesenchyme.	[Clendenning, Dawn E.; Mortlock, Douglas P.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA	Vanderbilt University	Clendenning, DE (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA.	mortlock@chgr.mc.vanderbilt.edu	Morlock, Doug/C-3482-2012; Mortlock, Douglas P/C-9981-2010		United States National Institutes of Health (NIH) [HD047880]; NIH Genetics Training Grant [T32GM080178]; NIH Developmental Biology Training Grant [T32HD07502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DPM was supported by United States National Institutes of Health (NIH) grant HD047880. DEC was supported by NIH Genetics Training Grant T32GM080178 and NIH Developmental Biology Training Grant T32HD07502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Bobacz K, 2006, ANN RHEUM DIS, V65, P169, DOI 10.1136/ard.2004.022756; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Chang CB, 1999, DEVELOPMENT, V126, P3347; Cohen MM, 2005, AM J MED GENET A, V136A, P313, DOI 10.1002/ajmg.a.30757; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; den Hollander AI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-102; Doherty ES, 2007, AM J MED GENET A, V143A, P3204, DOI 10.1002/ajmg.a.32078; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; FURUYA Y, 1984, J NEUROSURG, V61, P53, DOI 10.3171/jns.1984.61.1.0053; Iseki S, 1999, DEVELOPMENT, V126, P5611; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Raas-Rothschild A, 2009, EUR J MED GENET, V52, P140, DOI 10.1016/j.ejmg.2009.03.011; Rice DPC, 1999, EUR J ORAL SCI, V107, P265, DOI 10.1046/j.0909-8836.1999.eos107406.x; Salpietro CD, 2003, AM J MED GENET A, V121A, P283, DOI 10.1002/ajmg.a.20280; Settle S, 2001, DEV BIOL, V234, P138, DOI 10.1006/dbio.2001.0244; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shen BJ, 2009, INT J BIOL SCI, V5, P192; Shieh JTC, 2006, AM J MED GENET A, V140A, P1267, DOI 10.1002/ajmg.a.31262; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Williams LA, 2008, INT J BIOL SCI, V4, P318; Yoshimoto T, 2006, J PERIODONTAL RES, V41, P140, DOI 10.1111/j.1600-0765.2005.00847.x	40	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36789	10.1371/journal.pone.0036789	http://dx.doi.org/10.1371/journal.pone.0036789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693558	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500019
J	De Weirdt, R; Crabbe, A; Roos, S; Vollenweider, S; Lacroix, C; van Pijkeren, JP; Britton, RA; Sarker, S; Van de Wiele, T; Nickerson, CA				De Weirdt, Rosemarie; Crabbe, Aurelie; Roos, Stefan; Vollenweider, Sabine; Lacroix, Christophe; van Pijkeren, Jan Peter; Britton, Robert A.; Sarker, Shameema; Van de Wiele, Tom; Nickerson, Cheryl A.			Glycerol Supplementation Enhances L. reuteri's Protective Effect against S. Typhimurium Colonization in a 3-D Model of Colonic Epithelium	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 1; LACTOBACILLUS-REUTERI; SALMONELLA-TYPHIMURIUM; MUCUS LAYERS; 3-HYDROXYPROPIONALDEHYDE; INVASION; TOLERANCE; VIRULENCE; SAFETY	The probiotic effects of Lactobacillus reuteri have been speculated to partly depend on its capacity to produce the antimicrobial substance reuterin during the reduction of glycerol in the gut. In this study, the potential of this process to protect human intestinal epithelial cells against infection with Salmonella enterica serovar Typhimurium was investigated. We used a three-dimensional (3-D) organotypic model of human colonic epithelium that was previously validated and applied to study interactions between S. Typhimurium and the intestinal epithelium that lead to enteric salmonellosis. Using this model system, we show that L. reuteri protects the intestinal cells against the early stages of Salmonella infection and that this effect is significantly increased when L. reuteri is stimulated to produce reuterin from glycerol. More specifically, the reuterin-containing ferment of L. reuteri caused a reduction in Salmonella adherence and invasion (1 log unit), and intracellular survival (2 log units). In contrast, the L. reuteri ferment without reuterin stimulated growth of the intracellular Salmonella population with 1 log unit. The short-term exposure to reuterin or the reuterin-containing ferment had no observed negative impact on intestinal epithelial cell health. However, long-term exposure (24 h) induced a complete loss of cell-cell contact within the epithelial aggregates and compromised cell viability. Collectively, these results shed light on a potential role for reuterin in inhibiting Salmonella-induced intestinal infections and may support the combined application of glycerol and L. reuteri. While future in vitro and in vivo studies of reuterin on intestinal health should fine-tune our understanding of the mechanistic effects, in particular in the presence of a complex gut microbiota, this the first report of a reuterin effect on the enteric infection process in any mammalian cell type.	[De Weirdt, Rosemarie; Van de Wiele, Tom] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium; [Crabbe, Aurelie; Sarker, Shameema; Nickerson, Cheryl A.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Vollenweider, Sabine; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [van Pijkeren, Jan Peter; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Ghent University; Arizona State University; Arizona State University-Tempe; Swedish University of Agricultural Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Michigan State University	De Weirdt, R (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium.	cheryl.nickerson@asu.edu	Van de Wiele, Tom/C-8638-2011; van Pijkeren, Jan-Peter/H-5333-2019; Lacroix, Christophe/B-5139-2016; De Weirdt, Rosemarie/ABI-6298-2020	Van de Wiele, Tom/0000-0001-6854-5689; Lacroix, Christophe/0000-0003-4360-2020; Roos, Stefan/0000-0002-1606-1794; Crabbe, Aurelie/0000-0003-3084-4418	FWO-Vlaanderen [1526012N]; GOA Project [BOF12/GOA/008]; Special Research Fund of Ghent University; National Aeronautics and Space Administration [NCC2-1362]; Strategic Partnership Grant by Michigan State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER	FWO-Vlaanderen(FWO); GOA Project; Special Research Fund of Ghent University(Ghent University); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Strategic Partnership Grant by Michigan State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an FWO-Vlaanderen travel grant (www.fwo.be), an FWO-Vlaanderen research grant 1526012N and a GOA Project (BOF12/GOA/008) (www.ugent.be). RDW was funded by the Special Research Fund of Ghent University (www.ugent.be). CAN was supported by the National Aeronautics and Space Administration Grant NCC2-1362 (www.nasa.gov). TVDW benefits from an FWO-Vlaanderen postdoctoral grant. RB and JPVP were supported by a Strategic Partnership Grant by Michigan State University (http://msufoundation.msu.edu/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arques JL, 2004, INT J FOOD MICROBIOL, V95, P225, DOI 10.1016/j.ijfoodmicro.2004.03.009; Axelsson L.T., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Bian L, 2011, WORLD J MICROB BIOT, V27, P991, DOI 10.1007/s11274-010-0543-z; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Casas Ivan A., 2000, Microbial Ecology in Health and Disease, V12, P247; Chiu LH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-86; Cleusix V, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-101; Cleusix V, 2008, FEMS MICROBIOL ECOL, V63, P56, DOI 10.1111/j.1574-6941.2007.00412.x; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; De Weirdt R, 2010, FEMS MICROBIOL ECOL, V74, P601, DOI 10.1111/j.1574-6941.2010.00974.x; Desin TS, 2009, INFECT IMMUN, V77, P2866, DOI 10.1128/IAI.00039-09; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hobert ME, 2002, J BIOL CHEM, V277, P51025, DOI 10.1074/jbc.M210466200; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; Hurley BP, 2003, TRENDS MICROBIOL, V11, P562, DOI 10.1016/j.tim.2003.10.002; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kim JY, 2007, FOOD SCI BIOTECHNOL, V16, P778; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Luthi-Peng Q, 2002, APPL MICROBIOL BIOT, V60, P73, DOI 10.1007/s00253-002-1099-0; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Peran L, 2007, BRIT J NUTR, V97, P96, DOI 10.1017/S0007114507257770; Pullinger GD, 2007, INFECT IMMUN, V75, P5191, DOI 10.1128/IAI.00784-07; Radtke AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015750; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Schaefer L, 2010, MICROBIOL-SGM, V156, P1589, DOI 10.1099/mic.0.035642-0; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; TALARICO TL, 1988, ANTIMICROB AGENTS CH, V32, P1854, DOI 10.1128/AAC.32.12.1854; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Todoriki K, 2001, J APPL MICROBIOL, V91, P154, DOI 10.1046/j.1365-2672.2001.01371.x; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Vollenweider S, 2004, APPL MICROBIOL BIOT, V64, P16, DOI 10.1007/s00253-003-1497-y; Vollenweider S, 2003, J AGR FOOD CHEM, V51, P3287, DOI 10.1021/jf021086d; Vollenweider S, 2010, J AGR FOOD CHEM, V58, P10315, DOI 10.1021/jf1010897; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Weizman Z, 2006, J AM COLL NUTR, V25, P415, DOI 10.1080/07315724.2006.10719554; WHO (World Health Organization), 2005, DRUG RES SALM; Wiesner M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-9; WOLF BW, 1995, MICROB ECOL HEALTH D, V8, P41, DOI 10.3109/08910609509141381; Wolf BW, 1998, FOOD CHEM TOXICOL, V36, P1085, DOI 10.1016/S0278-6915(98)00090-8	66	35	38	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37116	10.1371/journal.pone.0037116	http://dx.doi.org/10.1371/journal.pone.0037116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693569	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500031
J	Yamada, T; Park, CS; Burns, A; Nakada, D; Lacorazza, HD				Yamada, Takeshi; Park, Chun Shik; Burns, Audrea; Nakada, Daisuke; Lacorazza, H. Daniel			The Cytosolic Protein G0S2 Maintains Quiescence in Hematopoietic Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION; BONE-MARROW; IN-VIVO; RHEUMATOID-ARTHRITIS; MONONUCLEAR-CELLS; PROGENITOR CELLS; MESSENGER-RNA; TARGET GENE; SWITCH GENE; NUCLEOLIN	Bone marrow hematopoietic stem cells (HSCs) balance proliferation and differentiation by integrating complex transcriptional and post-translational mechanisms regulated by cell intrinsic and extrinsic factors. We found that transcripts of G(0)/G(1) switch gene 2 (G0S2) are enriched in lineage(-)Sca-1(+)c-kit(+) (LSK) CD150(+)CD48(-)CD41(-) cells, a population highly enriched for quiescent HSCs, whereas G0S2 expression is suppressed in dividing LSK CD150(+)CD48(-) cells. Gain-of-function analyses using retroviral expression vectors in bone marrow cells showed that G0S2 localizes to the mitochondria, endoplasmic reticulum, and early endosomes in hematopoietic cells. Co-transplantation of bone marrow cells transduced with the control or G0S2 retrovirus led to increased chimerism of G0S2-overexpressing cells in femurs, although their contribution to the blood was reduced. This finding was correlated with increased quiescence in G0S2-overexpressing HSCs (LSK CD150(+)CD48(-)) and progenitor cells (LS-K). Conversely, silencing of endogenous G0S2 expression in bone marrow cells increased blood chimerism upon transplantation and promoted HSC cell division, supporting an inhibitory role for G0S2 in HSC proliferation. A proteomic study revealed that the hydrophobic domain of G0S2 interacts with a domain of nucleolin that is rich in arginine-glycine-glycine repeats, which results in the retention of nucleolin in the cytosol. We showed that this cytosolic retention of nucleolin occurs in resting, but not proliferating, wild-type LSK CD150(+)CD48(-) cells. Collectively, we propose a novel model of HSC quiescence in which elevated G0S2 expression can sequester nucleolin in the cytosol, precluding its pro-proliferation functions in the nucleolus.	[Yamada, Takeshi; Park, Chun Shik; Burns, Audrea; Lacorazza, H. Daniel] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Nakada, Daisuke] Texas Childrens Hosp, Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lacorazza, H. Daniel] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Yamada, T (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	hdl@bcm.edu		Park, Chun Shik/0000-0002-4329-3953; Nakada, Daisuke/0000-0001-6010-7094; Lacorazza, Daniel/0000-0003-0660-617X	National Institutes of Health, National Institute of Allergy and Infectious Diseases [RO1AI077536, R01AI077536-02S1]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077536] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gabrielle's Angel Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from National Institutes of Health, National Institute of Allergy and Infectious Diseases (RO1AI077536 and R01AI077536-02S1 to HDL) and the Gabrielle's Angel Foundation for Cancer Research (to HDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colmegna I, 2008, ARTHRITIS RHEUM, V58, P990, DOI 10.1002/art.23287; Cristillo AD, 1997, DNA CELL BIOL, V16, P1449, DOI 10.1089/dna.1997.16.1449; DERENZINI M, 1995, EXP CELL RES, V219, P276, DOI 10.1006/excr.1995.1228; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Grinstein E, 2011, CELL SIGNAL, V23, P1358, DOI 10.1016/j.cellsig.2011.03.018; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jerke U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008302; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitareewan S, 2008, INT J ONCOL, V33, P397, DOI 10.3892/ijo_00000021; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Kobayashi S, 2008, DNA RES, V15, P253, DOI 10.1093/dnares/dsn014; Koczan D, 2005, EUR J DERMATOL, V15, P251; Kusakabe M, 2009, BIOCHEM BIOPH RES CO, V390, P1283, DOI 10.1016/j.bbrc.2009.10.137; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakamura N, 2006, DNA RES, V13, P169, DOI 10.1093/dnares/dsl006; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Passegue E, 2006, DEV CELL, V10, P415, DOI 10.1016/j.devcel.2006.03.002; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Thorsteinsdottir U, 1999, BLOOD, V94, P2605, DOI 10.1182/blood.V94.8.2605.420k19_2605_2612; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Visalli G, 2010, CELL CYCLE, V9, P2130, DOI 10.4161/cc.9.11.11754; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang KM, 2009, EUR J DERMATOL, V19, P141, DOI 10.1684/ejd.2008.0618	53	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38280	10.1371/journal.pone.0038280	http://dx.doi.org/10.1371/journal.pone.0038280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693613	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500124
J	Joly, M; Scheumann, M; Zimmermann, E				Joly, Marine; Scheumann, Marina; Zimmermann, Elke			Posture Does Not Matter! Paw Usage and Grasping Paw Preference in a Small-Bodied Rooting Quadrupedal Mammal	PLOS ONE			English	Article							HAND PREFERENCES; MANUAL LATERALITY; EVOLUTION; FORELIMB; METAANALYSIS; TROGLODYTES; ORANGUTANS; LOCOMOTION; MORPHOLOGY; HANDEDNESS	Background: Recent results in birds, marsupials, rodents and nonhuman primates suggest that phylogeny and ecological factors such as body size, diet and postural habit of a species influence limb usage and the direction and strength of limb laterality. To examine to which extent these findings can be generalised to small-bodied rooting quadrupedal mammals, we studied trees shrews (Tupaia belangeri). Methodology/Principal Findings: We established a behavioural test battery for examining paw usage comparable to small-bodied primates and tested 36 Tupaia belangeri. We studied paw usage in a natural foraging situation (simple food grasping task) and measured the influence of varying postural demands (triped, biped, cling, sit) on paw preferences by applying a forced-food grasping task similar to other small-bodied primates. Our findings suggest that rooting tree shrews prefer mouth over paw usage to catch food in a natural foraging situation. Moreover, we demonstrated that despite differences in postural demand, tree shrews show a strong and consistent individual paw preference for grasping across different tasks, but no paw preference at a population level. Conclusions/Significance: Tree shrews showed less paw usage than small-bodied quadrupedal and arboreal primates, but the same paw preference. Our results confirm that individual paw preferences remain constant irrespective of postural demand in some small-bodied quadrupedal non primate and primate mammals which do not require fine motoric control for manipulating food items. Our findings suggest that the lack of paw/hand preference for grasping food at a population level is a universal pattern among those species and that the influence of postural demand on manual lateralisation in quadrupeds may have evolved in large-bodied species specialised in fine manipulations of food items.	[Joly, Marine; Scheumann, Marina; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Zimmermann, Elke] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Joly, M (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	marine.joly@tiho-hannover.de	Joly, Marine/P-5990-2014	Joly, Marine/0000-0002-0784-5167; Scheumann, Marina/0000-0002-4091-9500	DAAD (Deutscher Akademischer Austauschdienst) [D/0811448]	DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by DAAD (Deutscher Akademischer Austauschdienst) (grant number: D/0811448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blois-Heulin C, 2007, J COMP PSYCHOL, V121, P205, DOI 10.1037/0735-7036.121.2.205; Blois-Heulin C, 2006, AM J PRIMATOL, V68, P429, DOI 10.1002/ajp.20239; Blois-Heulin C, 2004, FOLIA PRIMATOL, V75, P237; Braccini S, 2010, J HUM EVOL, V58, P234, DOI 10.1016/j.jhevol.2009.11.008; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Chapelain A, 2006, BEHAV BRAIN RES, V173, P237, DOI 10.1016/j.bbr.2006.06.028; Clarke CM, 2009, BIOL LETTERS, V5, P632, DOI 10.1098/rsbl.2009.0311; DEVLEESCHOUWER K, 1995, J COMP PSYCHOL, V109, P203, DOI 10.1037/0735-7036.109.2.203; DODSON DL, 1992, AM J PRIMATOL, V26, P191, DOI 10.1002/ajp.1350260305; Emmons L.H., 2000, TUPAI FIELD STUDY BO; FORSYTHE C, 1988, J COMP PSYCHOL, V102, P248, DOI 10.1037/0735-7036.102.3.248; Giljov A, 2012, ANIM BEHAV, V83, P525, DOI 10.1016/j.anbehav.2011.11.031; Guven M, 2003, INT J NEUROSCI, V113, P1675, DOI 10.1080/00207450390249258; Hanbury DB, 2010, AM J PRIMATOL, V72, P206, DOI 10.1002/ajp.20769; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P162, DOI 10.1037/0735-7036.107.2.162; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2011, J HUM EVOL, V60, P605, DOI 10.1016/j.jhevol.2010.12.008; Ivanco TL, 1996, BEHAV BRAIN RES, V79, P163, DOI 10.1016/0166-4328(96)00011-3; Iwaniuk AN, 1998, AUST J ZOOL, V46, P235, DOI 10.1071/ZO98004; Iwaniuk AN, 2000, CAN J ZOOL, V78, P1110, DOI 10.1139/cjz-78-7-1110; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Joly M, 2008, AM J PRIMATOL, V70, P892, DOI 10.1002/ajp.20560; Joly M, 2011, BIOL LETTERS, V7, P638, DOI 10.1098/rsbl.2011.0258; Joly-Radko M, 2010, DEV PRIMATOL-PROG PR, P141, DOI 10.1007/978-1-4419-6661-2_7; Konerding WS, 2012, J COMP PSYCHOL, V126, P15, DOI 10.1037/a0024638; LARSON CF, 1989, BRAIN BEHAV EVOLUT, V33, P261, DOI 10.1159/000115934; Laska M, 1996, PRIMATES, V37, P457, DOI 10.1007/BF02381379; Leliveld LMC, 2008, AM J PHYS ANTHROPOL, V137, P156, DOI 10.1002/ajpa.20852; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Milliken GW, 2005, J COMP PSYCHOL, V119, P430, DOI 10.1037/0735-7036.119.4.430; OLSON DA, 1990, AM J PRIMATOL, V20, P83, DOI 10.1002/ajp.1350200203; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; Radespiel U, 2006, INT J PRIMATOL, V27, P311, DOI 10.1007/s10764-005-9005-0; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; ROGERS LJ, 1993, ANIM BEHAV, V45, P409, DOI 10.1006/anbe.1993.1049; RONEY LS, 1993, J COMP PSYCHOL, V107, P380, DOI 10.1037/0735-7036.107.4.380; SANFORD C, 1984, BRAIN BEHAV EVOLUT, V25, P217, DOI 10.1159/000118867; Sargis EJ, 2002, J MORPHOL, V253, P10, DOI 10.1002/jmor.1110; Sargis EJ, 2001, J ZOOL, V253, P485, DOI 10.1017/S0952836901000449; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Scheumann M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-52; Schmitt V, 2008, LATERALITY, V13, P143, DOI 10.1080/13576500701757532; Schweitzer C, 2007, ETHOLOGY, V113, P983, DOI 10.1111/j.1439-0310.2007.01405.x; Singer SS, 1999, BEHAVIOUR, V136, P119, DOI 10.1163/156853999500703; Sovrano VA, 2007, LATERALITY, V12, P458, DOI 10.1080/13576500701479822; Ward Jeannette P., 1993, P43; Ward JP, 1995, CREATURES OF THE DARK, P293; Wells DL, 2009, ANIM BEHAV, V78, P537, DOI 10.1016/j.anbehav.2009.06.010; Wells K, 2011, J TROP ECOL, V27, P347, DOI 10.1017/S0266467411000162; Westergaard G C, 1997, Laterality, V2, P65, DOI 10.1080/135765097397657; Westergaard GC, 1998, J COMP PSYCHOL, V112, P55, DOI 10.1037//0735-7036.112.1.55; Zucca P, 2010, BEHAV PROCESS, V84, P693, DOI 10.1016/j.beproc.2010.04.006	56	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38228	10.1371/journal.pone.0038228	http://dx.doi.org/10.1371/journal.pone.0038228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666494	Green Published, Green Submitted, gold			2022-12-25	WOS:000305353400107
J	Jafarnejad, SM; Ardekani, GS; Ghaffari, M; Martinka, M; Li, G				Jafarnejad, S. M.; Ardekani, G. S.; Ghaffari, M.; Martinka, M.; Li, G.			Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion	ONCOGENE			English	Article						Sox4; Dicer; melanoma; invasion; miRNA	SOX4 EXPRESSION; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPTION FACTOR; METASTASIS; APOPTOSIS; GENE; IDENTIFICATION; MIGRATION; BIOLOGY; DROSHA	We previously reported reduced expression of Sox4 in metastatic melanoma and its role in suppression of cell migration and invasion through inhibition of nuclear factor (NF)-kappa B p50. Sox4 can also bind to the promoter sequence of Dicer, a microRNA (miRNA) biogenesis factor. Interestingly, altered expression of Dicer was also observed in cancers. However, the potential mechanisms that regulate Dicer expression and its potential significance in melanoma progression are unknown. Here, we studied the regulation of Dicer expression by Sox4 and its role in suppression of melanoma invasion. Our data showed that Sox4 positively regulates Dicer expression by binding to its promoter sequences and enhancing its activity. We found that knockdown of Dicer enhances the matrigel invasion of melanoma cells by at least twofold. In addition, we revealed that overexpression of exogenous Dicer reverts the enhanced melanoma cell invasion upon Sox4 knockdown. Furthermore, we examined the expression of Dicer protein in a large set of melanocytic lesions (n = 514) at different stages by tissue microarray and found that Dicer expression is inversely correlated with melanoma progression (P < 0.0001). Consistently, reduced Dicer expression was correlated with a poorer overall and disease-specific 5-year survival of patients (P = 0.015 and 0.0029, respectively). In addition, we found a significant correlation between expression of Sox4 and Dicer proteins in melanoma biopsies (P = 0.009), further indicating the regulation of Dicer expression by Sox4. Finally, we revealed that knockdown of Sox4 induces a major change in the expression pattern of miRNAs in melanoma cells, mainly due to reduced expression of Dicer. Our results pinpoint the regulation of Dicer expression by Sox4 in melanoma and the critical role of Dicer in suppression of melanoma invasion. Our findings on Sox4-regulated miRNA biogenesis pathway may aid toward the development of novel targeted therapeutic approaches for melanoma. Oncogene (2013) 32, 2131-2139; doi:10.1038/onc.2012.239; published online 11 June 2012	[Jafarnejad, S. M.; Ardekani, G. S.; Li, G.] Univ British Columbia, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V6H 3Z6, Canada; [Ghaffari, M.] Univ British Columbia, Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Martinka, M.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Dept Pathol, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Li, G (corresponding author), Univ British Columbia, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	gangli@mail.ubc.ca		Jafarnejad, Seyed Mehdi/0000-0002-5129-7081	Canadian Institutes of Health Research [MOP-93810, MOP-110974, CCI-117958]; Canadian Dermatology Foundation; University of British Columbia Graduate Fellowship; Canadian Institutes of Health Research-Skin Research Training Centre Trainee Awards	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; University of British Columbia Graduate Fellowship; Canadian Institutes of Health Research-Skin Research Training Centre Trainee Awards(Canadian Institutes of Health Research (CIHR))	The authors would like to thank Dr Ian J MacRae for providing the pCDNA3-Flag-Dicer construct, Stephanie Smith, Kate Orchard, Ronald Wong, Ladan Fazli, Larry Tan, Cecilia Sjoestroem, Liang L Liu and Yabin Cheng for technical assistance and Drs Michael Cox, Aziz Ghahary and Vincent Duronio for helpful discussions. This work was supported by grants from the Canadian Institutes of Health Research (MOP-93810, MOP-110974 and CCI-117958) and the Canadian Dermatology Foundation to GL. SMJ is a recipient of University of British Columbia Graduate Fellowship. SMJ and GSA are recipients of Canadian Institutes of Health Research-Skin Research Training Centre Trainee Awards.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Faggad A, 2010, J PATHOL, V220, P382, DOI 10.1002/path.2658; Graham JD, 1999, J MOL ENDOCRINOL, V22, P295, DOI 10.1677/jme.0.0220295; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hunt SMN, 1999, BIOL REPROD, V61, P476, DOI 10.1095/biolreprod61.2.476; Hur EH, 2004, BIOCHEM BIOPH RES CO, V325, P59, DOI 10.1016/j.bbrc.2004.09.215; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Levy C, 2010, CELL, V141, P994, DOI 10.1016/j.cell.2010.05.004; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Spatz A, 2010, CURR OPIN ONCOL, V22, P163, DOI 10.1097/CCO.0b013e328337fe8f; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YM, 2006, J BIOL CHEM, V281, P11887, DOI 10.1074/jbc.M511309200; Wong RPC, 2007, MOL CANCER THER, V6, P1692, DOI 10.1158/1535-7163.MCT-07-0134; WOTTON D, 1995, J BIOL CHEM, V270, P7515, DOI 10.1074/jbc.270.13.7515; Wu JF, 2011, MED ONCOL, V28, P804, DOI 10.1007/s12032-010-9520-5	39	50	53	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2131	2139		10.1038/onc.2012.239	http://dx.doi.org/10.1038/onc.2012.239			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22689055	Green Accepted			2022-12-25	WOS:000318062800002
J	Diaz-Guerra, E; Lillo, MA; Santamaria, S; Garcia-Sanz, JA				Diaz-Guerra, Eva; Lillo, M. Angeles; Santamaria, Silvia; Garcia-Sanz, Jose A.			Intrinsic cues and hormones control mouse mammary epithelial tree size	FASEB JOURNAL			English	Article						stem cell expansion; stem cells; puberty; estrogens	ESTROGEN-RECEPTOR-ALPHA; STEM-CELLS; ORGAN SIZE; GLAND; BREAST; MICE; PROLIFERATION; AMPHIREGULIN; INACTIVATION; EXPRESSION	Organ size control is a long-standing question in biology. In mammals, using conditional cell ablation, two mutually exclusive mechanisms involving either intrinsic or extrinsic programs have been described to control organ size. The mammary gland is an ideal model for such studies, since it undergoes size and morphological changes during puberty and pregnancy. The role of stem cells in controlling mammary epithelial tree size is unclear, although mammary stem cells are able to reconstitute a functional organ on transplantation. Here, we show that mammary gland cellularity was strictly dependent on mammary stem cell number, even following a 20-fold expansion of the mammary stem cell pool at puberty and transient 3-fold expansions with each pregnancy. In addition, the expansion of the mammary stem cell pool was hormone dependent, as demonstrated by female bilateral ovariectomies during puberty and transplants of male-derived cells into female recipients. In these transplants, apart from a mammary stem cell expansion, we also observed the donor cells reconstituting functional mammary glands, developing alveolar structures, and secreting milk after the recipient's parturition. Taken together, these data suggest that in the mammary gland, there is a third organ size control mechanism, combining intrinsic cues throughout the organism's lifetime, with extrinsic hormone signals at particular developmental windows (puberty, pregnancy), where an expansion of the mammary stem cell pool occurs. This mechanism might have strong implications for the understanding of mammary tumorigenesis, since the expansion of the mammary stem cell pool precedes the generation of breast tumors.-Diaz-Guerra, E., Lillo, M. A., Santamaria, S., Garcia-Sanz, J. A. Intrinsic cues and hormones control mouse mammary epithelial tree size. FASEB J. 26, 3844-3853 (2012). www.fasebj.org	[Diaz-Guerra, Eva; Lillo, M. Angeles; Santamaria, Silvia; Garcia-Sanz, Jose A.] Spanish Natl Res Council CIB CSIC, Dept Cellular & Mol Med, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Garcia-Sanz, JA (corresponding author), CIB CSIC, Ramiro Maeztu 9, E-28040 Madrid, Spain.	jasanz@cib.csic.es	Garcia-Sanz, Jose A/E-7684-2011; Garcia-Sanz, Jose A./AAA-2956-2019; Diaz Guerra, Eva/F-8048-2016	Garcia-Sanz, Jose A/0000-0002-1153-6025; Garcia-Sanz, Jose A./0000-0002-1153-6025; Diaz Guerra, Eva/0000-0003-4866-5880	Spanish Ministry of Science and Technology [SAF2009-07974]; ISCIII [RD06/0010/1010]; Spanish National Research Council (CSIC) [PIE200420E240, PIE200420E586]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII(Instituto de Salud Carlos III); Spanish National Research Council (CSIC)	The authors thank E. W. Mullner, Z. Garcia, G. Elvira, P. Perez-Arnaiz, and M. L. Martinez for critically reading the manuscript; A. Silva for helpful comments, critical discussions, and continuous support; C. Brisken and R. Clarke for instruction on purifying and growing mammospheres; M. I. Gallego [Instituto de Salud Carlos III (ISCIII), Madrid, Spain] for helpful comments and sharing reagents; P. Lastres for FACS analyses; and R. Vernal for statistical analyses. The authors are grateful to the personnel at the Centro de Investigaciones Biologicas, Consejo Superior de Investigaciones Cientificas (CIB-CSIC) animal facility for animal care and the CNB-CSIC histology service for sample processing. G. Gimenez (CIB-CSIC, Madrid) kindly provided the bFGF and J. Biber (University of Zurich, Zurich, Switzerland) the NaPi 11b antisera. The work in the authors' laboratory was supported by grants from the Spanish Ministry of Science and Technology, contract SAF2009-07974; ISCIII, contract number RD06/0010/1010; and the Spanish National Research Council (CSIC), contract number PIE200420E240 and PIE200420E586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke RB, 1997, CANCER RES, V57, P4987; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; DEOME KB, 1959, CANCER RES, V19, P515; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Horner MJ, 2009, SEER CANC STAT REV 1; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kanhai RCJ, 2000, AM J SURG PATHOL, V24, P74, DOI 10.1097/00000478-200001000-00009; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stanger BZ, 2008, DIABETES OBES METAB, V10, P16, DOI 10.1111/j.1463-1326.2008.00938.x; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; STEVENSON RD, 1995, P ROY SOC B-BIOL SCI, V259, P105, DOI 10.1098/rspb.1995.0016; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	32	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3844	3853		10.1096/fj.11-200782	http://dx.doi.org/10.1096/fj.11-200782			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22683848	Green Submitted			2022-12-25	WOS:000308391600024
J	Bergfeld, AK; Pearce, OMT; Diaz, SL; Lawrence, R; Vocadlo, DJ; Choudhury, B; Esko, JD; Varki, A				Bergfeld, Anne K.; Pearce, Oliver M. T.; Diaz, Sandra L.; Lawrence, Roger; Vocadlo, David J.; Choudhury, Biswa; Esko, Jeffrey D.; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups INCORPORATION OF N-GLYCOLYLHEXOSAMINES INTO MAMMALIAN GLYCANS BY FEEDING N-GLYCOLYLGALACTOSAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLNEURAMINIC ACID HYDROXYLASE; NONHUMAN SIALIC-ACID; HANGANUTZIU-DEICHER ANTIGEN; GLYCOLYLNEURAMINIC ACID; MOUSE-LIVER; LINKED GLYCOSYLATION; CELL LINE; RAT-LIVER; BIOSYNTHESIS; GALNAC	The outermost positions of mammalian cell-surface glycans are predominantly occupied by the sialic acids N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). To date, hydroxylation of CMP-Neu5Ac resulting in the conversion into CMP-Neu5Gc is the only known enzymatic reaction in mammals to synthesize a monosaccharide carrying an N-glycolyl group. In our accompanying paper (Bergfeld, A. K., Pearce, O. M., Diaz, S. L., Pham, T., and Varki, A. (2012) J. Biol. Chem. 287, jbc.M112.363549), we report a metabolic pathway for degradation of Neu5Gc, demonstrating that N-acetylhexosamine pathways are tolerant toward the N-glycolyl substituent of Neu5Gc breakdown products. In this study, we show that exogenously added N-glycolylgalactosamine (GalNGc) serves as a precursor for Neu5Gc de novo biosynthesis, potentially involving seven distinct mammalian enzymes. Following the GalNAc salvage pathway, UDP-GalNGc is epimerized to UDP-GlcNGc, which might compete with the endogenous UDP-GlcNAc for the sialic acid biosynthetic pathway. Using UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase-deficient cells, we confirm that conversion of GalNGc into Neu5Gc depends on this key enzyme of sialic acid biosynthesis. Furthermore, we demonstrate by mass spectrometry that the metabolic intermediates UDP-GalNGc and UDP-GlcNGc serve as substrates for assembly of most major classes of cellular glycans. We show for the first time incorporation of GalNGc and GlcNGc into chondroitin/dermatan sulfates and heparan sulfates, respectively. As demonstrated by structural analysis, N-glycolylated hexosamines were found in cellular gangliosides and incorporated into Chinese hamster ovary cell O-glycans. Remarkably, GalNAc derivatives altered the overall O-glycosylation pattern as indicated by the occurrence of novel O-glycan structures. This study demonstrates that mammalian N-acetylhexosamine pathways and glycan assembly are surprisingly tolerant toward the N-glycolyl substituent.	[Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Bergfeld, Anne K.; Pearce, Oliver M. T.; Diaz, Sandra L.; Lawrence, Roger; Choudhury, Biswa; Esko, Jeffrey D.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; Simon Fraser University	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Pearce, Oliver/0000-0003-3953-1629	National Institutes of Health [R01GM32373, R01CA38701]; Deutsche Forschungsgemeinschaft [BE 4643/1-1]; Cancer Research Institute/Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute/Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and R01CA38701 (to A. V.). This work was also supported by Deutsche Forschungsgemeinschaft Research Fellowship BE 4643/1-1 (to A. K. B.) and a Cancer Research Institute/Samuel and Ruth Engelberg Fellowship (to O. M. T. P.).	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld A. K., 2012, J BIOL CHEM, V287; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Bulai T, 2002, BIOCHIMIE, V84, P655, DOI 10.1016/S0300-9084(02)01436-0; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; DEVINE PL, 1991, CANCER RES, V51, P5826; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Esko J.D., 2001, CURR PROTOC MOL BIOL, DOI 10.1002/0471142727.mb1702s22; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; GLOWACKA D, 1978, BIOCHEM MED METAB B, V19, P202, DOI 10.1016/0006-2944(78)90021-2; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; HAYES BK, 1993, J BIOL CHEM, V268, P16139; HIGASHI H, 1985, CANCER RES, V45, P3796; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P614; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; JOURDIAN GW, 1962, J BIOL CHEM, V237, P2442; KAWACHI S, 1988, INT ARCH ALLER A IMM, V85, P381, DOI 10.1159/000234536; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KOZUTSUMI Y, 1990, J BIOCHEM, V108, P704, DOI 10.1093/oxfordjournals.jbchem.a123268; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; MENEZES J, 1975, BIOMEDICINE, V22, P276; MIYOSHI I, 1986, MOL IMMUNOL, V23, P631, DOI 10.1016/0161-5890(86)90100-8; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pastuszak I, 1996, J BIOL CHEM, V271, P20776, DOI 10.1074/jbc.271.34.20776; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; Pouilly S, 2012, ACS CHEM BIOL, V7, P753, DOI 10.1021/cb200511t; Pouilly S, 2012, FEBS J, V279, P586, DOI 10.1111/j.1742-4658.2011.08448.x; ROSEMAN S, 1961, P NATL ACAD SCI USA, V47, P958, DOI 10.1073/pnas.47.7.958; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Schauer R, 1999, BIOSCIENCE REP, V19, P373, DOI 10.1023/A:1020256004616; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; Schnaar RL, 2009, ESSENTIALS GLYCOBIOL, P129; SHAW L, 1992, EUR J BIOCHEM, V206, P269, DOI 10.1111/j.1432-1033.1992.tb16925.x; SHAW L, 1994, EUR J BIOCHEM, V219, P1001, DOI 10.1111/j.1432-1033.1994.tb18583.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Stanley P., 2009, ESSENTIALS GLYCOBIOL; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wang-Gillam A, 2000, J BIOL CHEM, V275, P1433, DOI 10.1074/jbc.275.2.1433	69	21	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28898	28916		10.1074/jbc.M112.363499	http://dx.doi.org/10.1074/jbc.M112.363499			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692203	Green Published, hybrid			2022-12-25	WOS:000308074600060
J	Li, J; Motlagh, HN; Chakuroff, C; Thompson, EB; Hilser, VJ				Li, Jing; Motlagh, Hesam N.; Chakuroff, Carolyn; Thompson, E. Brad; Hilser, Vincent J.			Thermodynamic Dissection of the Intrinsically Disordered N-terminal Domain of Human Glucocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSTRUCTURED PROTEINS; UNFOLDED PROTEINS; BINDING; COOPERATIVITY; OSMOLYTES; TRANSACTIVATION; INDUCTION; MECHANISM; ALLOSTERY; FRAGMENT	Intrinsically disordered (ID) sequence segments are abundant in cell signaling proteins and transcription factors. Because ID regions commonly fold as part of their intracellular function, it is crucial to understand the folded states as well as the transitions between the unfolded and folded states. Specifically, it is important to determine 1) whether large ID segments contain different thermodynamically and/or functionally distinct regions, 2) whether any ID regions fold upon activation, 3) the degree of coupling between the different ID regions, and 4) whether the stability of ID domains is a determinant of function. In this study, we thermodynamically characterized the full-length ID N-terminal domain (NTD) of human glucocorticoid receptor (GR) and two of its naturally occurring translational isoforms. The protective osmolyte trimethylamine N-oxide (TMAO) was used to induce folding transitions. Each of the three NTD isoforms was found to undergo a cooperative folding transition that is thermodynamically indistinguishable (based on m-values) from that of a globular protein of similar size. The extrapolated stabilities for the NTD isoforms showed clear correlation with the known activities of their corresponding GR translational isoforms. The data reveal that the full-length NTD can be viewed as having at least two thermodynamically coupled regions, a functional region, which is indispensable for GR transcriptional activity, and a regulatory region, the length of which serves to regulate the stability of NTD and thus the activity of GR. These results suggest a new functional paradigm whereby steroid hormone receptors in particular and ID proteins in general can have multiple functionally distinct ID regions that interact and modulate the stability of important functional sites.	[Li, Jing; Chakuroff, Carolyn; Hilser, Vincent J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Li, Jing; Motlagh, Hesam N.; Hilser, Vincent J.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Thompson, E. Brad] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX 77204 USA; [Thompson, E. Brad] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Johns Hopkins University; Johns Hopkins University; University of Houston System; University of Houston; University of Texas System; University of Texas Medical Branch Galveston	Hilser, VJ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	hilser@jhu.edu		Motlagh, Hesam/0000-0003-3834-926X	National Science Foundation [MCB-0446050, DBI-1005027]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB-0446050 (to V. J. H.) and DBI-1005027 (to C. C.).	Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Auton M, 2007, METHOD ENZYMOL, V428, P397, DOI 10.1016/S0076-6879(07)28023-1; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Bray PJ, 2003, HUM MUTAT, V21, P557, DOI 10.1002/humu.10213; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Ghosh K, 2009, P NATL ACAD SCI USA, V106, P10649, DOI 10.1073/pnas.0903995106; Griekspoor A., 2007, NUCL RECEPT SIGNAL, V9, pE003, DOI DOI 10.1621/NRS.05003; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henkels CH, 2001, BIOCHEMISTRY-US, V40, P2777, DOI 10.1021/bi002078y; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar R, 2007, ARCH BIOCHEM BIOPHYS, V465, P452, DOI 10.1016/j.abb.2007.06.019; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Midic U., 2009, P KDD 09 WORKSH STAT, P27; Midic U, 2009, PROTEIN PEPTIDE LETT, V16, P1533, DOI 10.2174/092986609789839377; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Pradeep L, 2004, J BIOL CHEM, V279, P40303, DOI 10.1074/jbc.M406323200; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SHORTLE D, 1995, ADV PROTEIN CHEM, V46, P217, DOI 10.1016/S0065-3233(08)60336-8; TANFORD C, 1964, J AM CHEM SOC, V86, P2050, DOI 10.1021/ja01064a028; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Whitmore L, 2011, NUCLEIC ACIDS RES, V39, pD480, DOI 10.1093/nar/gkq1026; Whitten ST, 2001, J MOL BIOL, V309, P1165, DOI 10.1006/jmbi.2001.4726; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu P, 2006, PROTEINS, V63, P290, DOI 10.1002/prot.20868	55	37	37	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26777	26787		10.1074/jbc.M112.355651	http://dx.doi.org/10.1074/jbc.M112.355651			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22669939	Green Published, hybrid			2022-12-25	WOS:000307386000027
J	Nakamura, K; Man, ZQ; Xie, Y; Hanai, A; Makyio, H; Kawasaki, M; Kato, R; Shin, HW; Nakayama, K; Wakatsuki, S				Nakamura, Kensuke; Man, Zhiqiu; Xie, Yong; Hanai, Ayako; Makyio, Hisayoshi; Kawasaki, Masato; Kato, Ryuichi; Shin, Hye-Won; Nakayama, Kazuhisa; Wakatsuki, Soichi			Structural Basis for Membrane Binding Specificity of the Bin/Amphiphysin/Rvs (BAR) Domain of Arfaptin-2 Determined by Arl1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; RAC1-INTERACTING PROTEIN; TRAFFICKING; RECRUITMENT; COMPARTMENT; CURVATURE; ARFRP1; RAB5; PX	Membrane-sculpting BAR (Bin/Amphiphysin/Rvs) domains form a crescent-shaped homodimer that can sense and induce membrane curvature through its positively charged concave face. We have recently shown that Arfaptin-2, which was originally identified as a binding partner for the Arf and Rac1 GTPases, binds to Arl1 through its BAR domain and is recruited onto Golgi membranes. There, Arfaptin-2 induces membrane tubules. Here, we report the crystal structure of the Arfaptin-2 BAR homodimer in complex with two Arl1 molecules bound symmetrically to each side, leaving the concave face open for membrane association. The overall structure of the Arl1.Arfaptin-2 BAR complex closely resembles that of the PX-BAR domain of sorting nexin 9, suggesting similar mechanisms underlying BAR domain targeting to specific organellar membranes. The Arl1.Arfaptin-2 BAR structure suggests that one of the two Arl1 molecules competes with Rac1, which binds to the concave face of the Arfaptin-2 BAR homodimer and may hinder its membrane association.	[Man, Zhiqiu; Hanai, Ayako; Shin, Hye-Won; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Nakamura, Kensuke; Xie, Yong; Makyio, Hisayoshi; Kawasaki, Masato; Kato, Ryuichi; Wakatsuki, Soichi] High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Kawasaki, Masato; Kato, Ryuichi; Wakatsuki, Soichi] Grad Univ Adv Studies, Sch High Energy Accelerator Sci, Tsukuba, Ibaraki 3050801, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp; soichi.wakatsuki@kek.jp	Makyio, Hisayoshi/E-1166-2014; Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Makyio, Hisayoshi/0000-0002-0611-6544; Shin, Hye-Won/0000-0002-9138-9554; Kato, Ryuichi/0000-0003-2087-2896; Nakayama, Kazuhisa/0000-0001-7701-7183; Kawasaki, Masato/0000-0002-8319-2102; Wakatsuki, Soichi/0000-0001-5896-7968	Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science; Grants-in-Aid for Scientific Research [10J03618] Funding Source: KAKEN	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Targeted Proteins Research Program, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for Promotion of Science.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Sahin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001620; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2012, MEMBRANES-BASEL, V2, DOI 10.3390/membranes2010118; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	36	29	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25478	25489		10.1074/jbc.M112.365783	http://dx.doi.org/10.1074/jbc.M112.365783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679020	Green Published, hybrid			2022-12-25	WOS:000306651700054
J	Nakayama, Y; Matsui, Y; Takeda, Y; Okamoto, M; Abe, K; Fukumoto, Y; Yamaguchi, N				Nakayama, Yuji; Matsui, Yuki; Takeda, Yumi; Okamoto, Mai; Abe, Kohei; Fukumoto, Yasunori; Yamaguchi, Naoto			c-Src but Not Fyn Promotes Proper Spindle Orientation in Early Prometaphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; AURORA-A KINASE; MITOTIC SPINDLE; FAMILY KINASES; CENTROSOME MATURATION; NUCLEAR-LOCALIZATION; PROTEIN-KINASES; CELL-CYCLE; ACTIVATION; PHOSPHORYLATION	Src family tyrosine kinases (SFKs) participate in mitotic signal transduction events, including mitotic entry, cleavage furrow ingression, and cytokinesis abscission. Although SFKs have been shown to associate with the mitotic spindle, the role of SFKs in mitotic spindle formation remains unclear. Here, we show that c-Src promotes proper spindle orientation in early prometaphase. Src localizes close to spindle poles in a manner independent of Src kinase activity. Three-dimensional analyses showed that Src inhibition induced spindle misorientation, exhibiting a tilting spindle in early prometaphase. Spindle misorientation is frequently seen in SYF cells, which harbor triple knock-out mutations of c-Src, c-Yes, and Fyn, and reintroduction of c-Src but not Fyn into SYF cells rescued spindle misorientation. Spindle misorientation was also observed upon Src inhibition under conditions in which Aurora B was inhibited. Inducible expression of c-Src promoted a properly oriented bipolar spindle, which was suppressed by Src inhibition. Aster formation was severely inhibited in SYF cells upon Aurora B inhibition, which was rescued by reintroduction of c-Src into SYF cells. Furthermore, reintroduction of c-Src facilitated microtubule regrowth from cold-induced depolymerization and accelerated M phase progression. These results suggest that c-Src is involved in spindle orientation through centrosome-mediated aster formation.	[Nakayama, Yuji] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Chiba University	Nakayama, Y (corresponding author), Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nakayama@p.chiba-u.ac.jp; nyama@faculty.chiba-u.jp		Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Chiba University; Futaba Electronics Memorial Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Chiba University; Futaba Electronics Memorial Foundation	This work was supported in part by grants-in-aid for scientific research and special funds for education and research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; a research grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research; and a research grant from the Nanohana Competition 2011 Award of Chiba University and the Futaba Electronics Memorial Foundation (to Y. F.).	Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEIDER H, 1994, EUR J BIOCHEM, V219, P513, DOI 10.1111/j.1432-1033.1994.tb19966.x; Horne MM, 2003, J CELL BIOL, V161, P1021, DOI 10.1083/jcb.200304144; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kesavan KP, 2002, J BIOL CHEM, V277, P14666, DOI 10.1074/jbc.M111911200; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kikuchi I, 2010, CELL BIOL INT, V34, P645, DOI 10.1042/CBI20090398; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kuga T, 2008, EXP CELL RES, V314, P2040, DOI 10.1016/j.yexcr.2008.03.018; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; McGinnis LK, 2007, DEV BIOL, V306, P241, DOI 10.1016/j.ydbio.2007.03.024; Moasser MM, 1999, CANCER RES, V59, P6145; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Perez Y, 2009, J MOL BIOL, V391, P136, DOI 10.1016/j.jmb.2009.06.018; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Talmor-Cohen A, 2004, REPRODUCTION, V128, P387, DOI 10.1530/rep.1.00266; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Wang LH, 2008, CELL CYCLE, V7, P1104, DOI 10.4161/cc.7.8.5738; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	65	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24905	24915		10.1074/jbc.M112.341578	http://dx.doi.org/10.1074/jbc.M112.341578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22689581	Green Published, hybrid			2022-12-25	WOS:000306651700005
J	Hadrys, H; Simon, S; Kaune, B; Schmitt, O; Schoner, A; Jakob, W; Schierwater, B				Hadrys, Heike; Simon, Sabrina; Kaune, Barbara; Schmitt, Oliver; Schoener, Anja; Jakob, Wolfgang; Schierwater, Bernd			Isolation of Hox Cluster Genes from Insects Reveals an Accelerated Sequence Evolution Rate	PLOS ONE			English	Article							LARVAL DEVELOPMENT; HOMEOBOX GENES; BODY PLANS; ULTRABITHORAX; BEETLE; ANTENNAPEDIA; ORGANIZATION; EXPRESSION; PHYLOGENY; PARAHOX	Among gene families it is the Hox genes and among metazoan animals it is the insects (Hexapoda) that have attracted particular attention for studying the evolution of development. Surprisingly though, no Hox genes have been isolated from 26 out of 35 insect orders yet, and the existing sequences derive mainly from only two orders (61% from Hymenoptera and 22% from Diptera). We have designed insect specific primers and isolated 37 new partial homeobox sequences of Hox cluster genes (lab, pb, Hox3, ftz, Antp, Scr, abd-a, Abd-B, Dfd, and Ubx) from six insect orders, which are crucial to insect phylogenetics. These new gene sequences provide a first step towards comparative Hox gene studies in insects. Furthermore, comparative distance analyses of homeobox sequences reveal a correlation between gene divergence rate and species radiation success with insects showing the highest rate of homeobox sequence evolution.	[Hadrys, Heike; Simon, Sabrina; Kaune, Barbara; Schmitt, Oliver; Schoener, Anja; Jakob, Wolfgang; Schierwater, Bernd] Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, ITZ, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Hadrys, Heike; Schierwater, Bernd] Amer Museum Nat Hist, New York, NY 10024 USA	University of Veterinary Medicine Hannover, Foundation; Yale University; American Museum of Natural History (AMNH)	Hadrys, H (corresponding author), Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, ITZ, Hannover, Germany.	heike.hadrys@ecolevol.de		Simon, Sabrina/0000-0001-8560-0985	German Research Foundation (DFG) [SP1174, DFG HA 1947/5]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a German Research Foundation (DFG) special priority program "Deep Metazoan Phylogeny" SP1174 grant given to H. H. (DFG HA 1947/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angelini DR, 2005, ANNU REV GENET, V39, P95, DOI 10.1146/annurev.genet.39.073003.112310; Angelini DR, 2005, DEV BIOL, V287, P440, DOI 10.1016/j.ydbio.2005.08.010; BEEMAN RW, 1993, BIOESSAYS, V15, P439, DOI 10.1002/bies.950150702; Brown SJ, 2002, GENETICS, V160, P1067; Casillas S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-106; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Damen WGM, 2010, ADV EXP MED BIOL, V689, P125; Deutsch J, 2005, BIOESSAYS, V27, P673, DOI 10.1002/bies.20260; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Ferrier DEK, 2010, ADV EXP MED BIOL, V689, P91; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; Hadrys H, 1992, MOL ECOL, V1, P55, DOI 10.1111/j.1365-294X.1992.tb00155.x; HADRYS H, 1993, MOL ECOL, V2, P79, DOI 10.1111/j.1365-294X.1993.tb00002.x; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Jakob W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000694; Jockusch EL, 2004, J HERED, V95, P382, DOI 10.1093/jhered/esh064; Kamm K, 2006, J EXP ZOOL PART B, V306B, P589, DOI 10.1002/jez.b.21123; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Marden JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P751, DOI 10.1086/318109; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Michaut L, 2011, DEV GROWTH DIFFER, V53, P982, DOI 10.1111/j.1440-169X.2011.01307.x; Mulley JF, 2006, P NATL ACAD SCI USA, V103, P10369, DOI 10.1073/pnas.0600341103; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Ober KA, 2006, DEV BIOL, V294, P391, DOI 10.1016/j.ydbio.2006.02.053; Ogishima S, 2007, GENE, V387, P21, DOI 10.1016/j.gene.2006.08.011; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; Peel AD, 2006, P ROY SOC B-BIOL SCI, V273, P1733, DOI 10.1098/rspb.2006.3497; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Pernice M, 2006, MOL PHYLOGENET EVOL, V40, P872, DOI 10.1016/j.ympev.2006.04.004; Prohaska SJ, 2006, J EXP ZOOL PART B, V306B, P481, DOI 10.1002/jez.b.21099; Rogers BT, 1997, DEVELOPMENT, V124, P149; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Saenko SV, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-9; Samadi L, 2010, DEV GENES EVOL, V220, P161, DOI 10.1007/s00427-010-0338-0; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sandhall A, 1974, INSEKTEN WEICHTIERE; Schierwater B, 2002, MOL PHYLOGENET EVOL, V24, P374, DOI 10.1016/S1055-7903(02)00238-5; Schierwater B, 2010, ADV EXP MED BIOL, V689, P81; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; SCOTT MP, 1993, NUCLEIC ACIDS RES, V21, P1687, DOI 10.1093/nar/21.8.1687; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Swalla BJ, 2006, HEREDITY, V97, P235, DOI 10.1038/sj.hdy.6800872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Yasukochi Y, 2004, DEV GENES EVOL, V214, P606, DOI 10.1007/s00427-004-0441-1; Yeates DK, 2012, AUSTR J ENTOMOLOGY; ZUCKERKANDL EMILE, 1965, P97	59	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e34682	10.1371/journal.pone.0034682	http://dx.doi.org/10.1371/journal.pone.0034682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685537	gold, Green Published, Green Submitted			2022-12-25	WOS:000305351700001
J	Tutarel, O; Golla, P; Beutel, G; Bauersachs, J; David, S; Schmidt, BMW; Lichtinghagen, R; Kielstein, JT				Tutarel, Oktay; Golla, Paulina; Beutel, Gernot; Bauersachs, Johann; David, Sascha; Schmidt, Bernhard M. W.; Lichtinghagen, Ralf; Kielstein, Jan T.			Therapeutic Plasma Exchange Decreases Levels of Routinely Used Cardiac and Inflammatory Biomarkers	PLOS ONE			English	Article							HEART-TRANSPLANTATION; REJECTION; APHERESIS; PARAMETERS; FAILURE	Background: Therapeutic plasma exchange (TPE) plays a key role in the management of various diseases, from thrombotic thrombocytopenic purpura and Goodpasture's syndrome to cardiac allograft rejection. In many of these disease states cardiac and inflammatory involvement is common and biomarkers are routinely used for diagnosis or assessment of therapeutic success. The effect of TPE on biomarkers used in the clinical routine has not been investigated. Methods: TPE was initiated for established clinical conditions in 21 patients. Troponin T, NT-proBNP, C-reactive protein, procalcitonin and routine chemistry were drawn before and after TPE, as well as before and after the 2nd TPE. The total amount of these markers in the waste bag was also analyzed. Results: In 21 patients 42 TPEs were performed. The procedure reduced plasma levels of the examined biomarkers: 23% for NT-proBNP (pre vs. post: 4637 +/- 10234 ng/l to 3565 +/- 8295 ng/l, p < 0.001), 64% for CRP (21.9 +/- 47.0 mg/l vs. 7.8 +/- 15.8 mg/l, p < 0.001) and 31% for procalcitonin (0.39 +/- 1.1 mu g/l vs. 0.27 +/- 0.72 mu g/l, p = 0.004). TPE also tended to reduce plasma levels of troponin T by about 14% (60.7 +/- 175.5 ng/l vs. 52.2 +/- 141.3 ng/l), however this difference was not statistical significant (p = 0.95). There was a significant correlation between the difference of pre TPE levels to post TPE levels of all examined biomarkers and the total amount of the removed biomarker in the collected removed plasma. Conclusions: TPE significantly reduces plasma levels of inflammatory and cardiac biomarkers. Therefore, post TPE levels of cardiac and inflammatory biomarkers should be viewed with caution.	[Tutarel, Oktay; Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Golla, Paulina; David, Sascha; Schmidt, Bernhard M. W.; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, D-3000 Hannover, Germany; [Beutel, Gernot] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, D-3000 Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Dept Clin Chem, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Tutarel, O (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	kielstein@yahoo.com	Kielstein, Jan T./I-2956-2019; David, Sascha/AAL-6909-2021	Kielstein, Jan T./0000-0001-8110-9064; Tutarel, Oktay/0000-0002-5201-5509	Deutsche Forschungsgemeinsschaft; Caridian BCT	Deutsche Forschungsgemeinsschaft(German Research Foundation (DFG)); Caridian BCT	Publication costs are covered by the program "Open Access Publication" of the Deutsche Forschungsgemeinsschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JTK has received research funding from Caridian BCT for an investigator-initiated study with unrestricted research support, i.e. no influence on the current study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no other competing interests.	Abel JJ, 1914, J PHARMACOL EXP THER, V5, P625; Bektas M, 2008, J CLIN GASTROENTEROL, V42, P517, DOI 10.1097/MCG.0b013e31815878ff; Dengler TJ, 1998, J AM COLL CARDIOL, V32, P405, DOI 10.1016/S0735-1097(98)00257-5; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Grauhan O, 2001, J HEART LUNG TRANSPL, V20, P316, DOI 10.1016/S1053-2498(00)00211-4; Hamm CW, 2011, EUR HEART J; Hershcovici T, 2004, J CLIN APHERESIS, V19, P90, DOI 10.1002/jca.20006; Kielstein JT, 2011, NEPHROL DIAL TRANSPL, V26, P2723, DOI 10.1093/ndt/gfr462; Kittleson MM, 2009, J HEART LUNG TRANSPL, V28, P704, DOI 10.1016/j.healun.2009.04.019; Morath C, 2007, NEPHROL DIAL TRANSPL, V22, P2701, DOI 10.1093/ndt/gfm353; Okafor C, 2010, J CLIN APHERESIS, V25, P240, DOI 10.1002/jca.20247; Patschan D, 2006, NEPHROL DIAL TRANSPL, V21, P1549, DOI 10.1093/ndt/gfl127; Szczepiorkowski ZM, 2010, J CLIN APHERESIS, V25, P83, DOI 10.1002/jca.20240; Ward DM, 2011, J CLIN APHERESIS, V26, P230, DOI 10.1002/jca.20302	14	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38573	10.1371/journal.pone.0038573	http://dx.doi.org/10.1371/journal.pone.0038573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685586	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700049
J	Ionescu, D; Siebert, C; Polerecky, L; Munwes, YY; Lott, C; Hausler, S; Bizic-Ionescu, M; Quast, C; Peplies, J; Glockner, FO; Ramette, A; Rodiger, T; Dittmar, T; Oren, A; Geyer, S; Stark, HJ; Sauter, M; Licha, T; Laronne, JB; de Beer, D				Ionescu, Danny; Siebert, Christian; Polerecky, Lubos; Munwes, Yaniv Y.; Lott, Christian; Haeusler, Stefan; Bizic-Ionescu, Mina; Quast, Christian; Peplies, Joerg; Gloeckner, Frank Oliver; Ramette, Alban; Roediger, Tino; Dittmar, Thorsten; Oren, Aharon; Geyer, Stefan; Staerk, Hans-Joachim; Sauter, Martin; Licha, Tobias; Laronne, Jonathan B.; de Beer, Dirk			Microbial and Chemical Characterization of Underwater Fresh Water Springs in the Dead Sea	PLOS ONE			English	Article							HALOPHILIC ARCHAEA; GROUNDWATER-FLOW; HYDROGEN-SULFIDE; RARE-EARTHS; BACTERIA; IRON; DIVERSITY; OXIDATION; SYSTEM; IDENTIFICATION	Due to its extreme salinity and high Mg concentration the Dead Sea is characterized by a very low density of cells most of which are Archaea. We discovered several underwater fresh to brackish water springs in the Dead Sea harboring dense microbial communities. We provide the first characterization of these communities, discuss their possible origin, hydrochemical environment, energetic resources and the putative biogeochemical pathways they are mediating. Pyrosequencing of the 16S rRNA gene and community fingerprinting methods showed that the spring community originates from the Dead Sea sediments and not from the aquifer. Furthermore, it suggested that there is a dense Archaeal community in the shoreline pore water of the lake. Sequences of bacterial sulfate reducers, nitrifiers iron oxidizers and iron reducers were identified as well. Analysis of white and green biofilms suggested that sulfide oxidation through chemolitotrophy and phototrophy is highly significant. Hyperspectral analysis showed a tight association between abundant green sulfur bacteria and cyanobacteria in the green biofilms. Together, our findings show that the Dead Sea floor harbors diverse microbial communities, part of which is not known from other hypersaline environments. Analysis of the water's chemistry shows evidence of microbial activity along the path and suggests that the springs supply nitrogen, phosphorus and organic matter to the microbial communities in the Dead Sea. The underwater springs are a newly recognized water source for the Dead Sea. Their input of microorganisms and nutrients needs to be considered in the assessment of possible impact of dilution events of the lake surface waters, such as those that will occur in the future due to the intended establishment of the Red Sea-Dead Sea water conduit.	[Ionescu, Danny; Polerecky, Lubos; Lott, Christian; Haeusler, Stefan; Bizic-Ionescu, Mina; Quast, Christian; Gloeckner, Frank Oliver; Ramette, Alban; Dittmar, Thorsten; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Siebert, Christian; Roediger, Tino; Geyer, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Catchment Hydrol, Halle, Germany; [Munwes, Yaniv Y.; Laronne, Jonathan B.] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Lott, Christian] Elba Field Stn, HYDRA Inst Marine Sci, Campo Nellelba, LI, Italy; [Bizic-Ionescu, Mina] Leibniz Inst Freshwater Ecol & Inland Fisheries B, Dept Stratified Lakes, Stechlin, Germany; [Peplies, Joerg] Ribocon GmbH, Bremen, Germany; [Gloeckner, Frank Oliver] Jacobs Univ Bremen GmbH, Bremen, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-2900 Oldenburg, Germany; [Oren, Aharon] Hebrew Univ Jerusalem, Inst Life Sci, Dept Plant & Environm Sci, IL-91904 Jerusalem, Israel; [Staerk, Hans-Joachim] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany; [Sauter, Martin; Licha, Tobias] Univ Gottingen, Geosci Ctr, Gottingen, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ben Gurion University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Jacobs University; Carl von Ossietzky Universitat Oldenburg; Hebrew University of Jerusalem; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen	Ionescu, D (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	dionescu@mpi-bremen.de	Geyer, Stefan/D-4785-2015; Siebert, Christian/D-3380-2013; Bizic, Mina/AAC-4802-2022; Dittmar, Thorsten/L-7796-2013; Ionescu, Danny/P-3261-2017; de Beer, Dirk/L-4840-2013; Bizic, Mina/AEB-9802-2022; Ramette, Alban/E-9197-2016; Polerecky, Lubos/E-1134-2014	Geyer, Stefan/0000-0003-1746-9019; Siebert, Christian/0000-0001-7266-8112; Bizic, Mina/0000-0002-6870-4018; Dittmar, Thorsten/0000-0002-3462-0107; Ionescu, Danny/0000-0002-4658-8597; de Beer, Dirk/0000-0001-5274-1781; Bizic, Mina/0000-0002-6870-4018; Ramette, Alban/0000-0002-3437-4639; Polerecky, Lubos/0000-0003-4425-585X; Licha, Tobias/0000-0003-3122-6048; Quast, Christian/0000-0001-6409-2352	German Federal Ministry of Education and Science through the project SUMAR [02WM0848]	German Federal Ministry of Education and Science through the project SUMAR	Funding for this study was obtained from the German Federal Ministry of Education and Science through the project SUMAR (grant code: 02WM0848). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akawwi Emad, 2008, American Journal of Environmental Sciences, V4, P693, DOI 10.3844/ajessp.2008.693.700; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANATI DA, 1987, EARTH PLANET SC LETT, V84, P109, DOI 10.1016/0012-821X(87)90181-6; Barkan E, 2001, GEOCHIM COSMOCHIM AC, V65, P355, DOI 10.1016/S0016-7037(00)00540-8; Bau M, 1999, GEOCHIM COSMOCHIM AC, V63, P67, DOI 10.1016/S0016-7037(99)00014-9; Ben-Itzhak LL, 2005, J HYDROL, V312, P51, DOI 10.1016/j.jhydrol.2005.02.009; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Bosecker K, 1997, FEMS MICROBIOL REV, V20, P591, DOI 10.1111/j.1574-6976.1997.tb00340.x; Caccavo F, 1996, ARCH MICROBIOL, V165, P370, DOI 10.1007/s002030050340; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Closson D, 2009, EARTH SURF PROC LAND, V34, P1408, DOI 10.1002/esp.1829; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dulski P, 2001, GEOSTANDARD NEWSLETT, V25, P87, DOI 10.1111/j.1751-908X.2001.tb00790.x; DULSKI P, 1994, FRESEN J ANAL CHEM, V350, P194, DOI 10.1007/BF00322470; ELAZARIVOLCANI B, 1940, NATURE, V145, P975; Elshahed MS, 2004, APPL ENVIRON MICROB, V70, P2230, DOI 10.1128/AEM.70.4.2230-2239.2004; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; Frigaard NU, 2004, ARCH MICROBIOL, V182, P265, DOI 10.1007/s00203-004-0718-9; Gavrieli I, 2001, EARTH PLANET SC LETT, V186, P199, DOI 10.1016/S0012-821X(01)00247-3; Goldscheider N, 2006, HYDROGEOL J, V14, P926, DOI 10.1007/s10040-005-0009-9; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Gracas DA, 2011, MICROB ECOL, V62, P853, DOI 10.1007/s00248-011-9906-8; Greene AC, 1997, INT J SYST BACTERIOL, V47, P505, DOI 10.1099/00207713-47-2-505; Gross H., 1977, GEOLOGICAL SURVEY IS, V70, P1; Gvirtzman H, 2000, J GEOCHEM EXPLOR, V69, P207, DOI 10.1016/S0375-6742(00)00057-1; Hammer O, 2009, PALAEONTOL ELECT, P4; Hannigan RE, 2001, CHEM GEOL, V175, P495, DOI 10.1016/S0009-2541(00)00355-7; Hansell DA., 2002, BIOGEOCHEMISTRY MARI, V1; Haveman SA, 2010, MOL BIOL, P37; Huber H, 2002, BERGEYS MANUAL SYSTE, P465; Ionescu D, 2009, FEMS MICROBIOL ECOL, V69, P425, DOI 10.1111/j.1574-6941.2009.00721.x; Johannesson KH, 1999, GEOCHIM COSMOCHIM AC, V63, P2697, DOI 10.1016/S0016-7037(99)00184-2; Katz A, 2009, EARTH PLANET SC LETT, V286, P219, DOI 10.1016/j.epsl.2009.06.031; Katz A, 2009, AQUAT GEOCHEM, V15, P159, DOI 10.1007/s10498-008-9045-0; Keough BP, 2003, MICROBIAL ECOL, V46, P238, DOI 10.1007/s00248-003-1003-1; La Cono V, 2011, ENVIRON MICROBIOL, V13, P2250, DOI 10.1111/j.1462-2920.2011.02478.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lazar Michael, 2002, Israel Journal of Earth Sciences, V51, P211, DOI 10.1560/5MPK-UJDN-L6CV-024K; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P2132, DOI 10.1128/AEM.61.6.2132-2138.1995; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Moller P, 2007, CHEM GEOL, V239, P27, DOI 10.1016/j.chemgeo.2006.12.004; Moller P, 2003, APPL GEOCHEM, V18, P1613, DOI 10.1016/S0883-2927(03)00044-1; NISHRI A, 1984, EARTH PLANET SC LETT, V71, P405, DOI 10.1016/0012-821X(84)90106-7; NISSENBA.A, 1972, GEOCHIM COSMOCHIM AC, V37, P709; O'Connell SP, 2003, FEMS MICROBIOL ECOL, V44, P165, DOI 10.1016/S0168-6496(02)00465-8; Oren A, 1995, HYDROBIOLOGIA, V315, P149, DOI 10.1007/BF00033627; Oren A, 2004, J MARINE SYST, V46, P121, DOI 10.1016/j.jmarsys.2003.11.017; Oren A., 2002, HALOPHILIC MICROORGA; Oren A, 2005, ARCH HYDROBIOL S, V117, P339, DOI DOI 10.1127/1864-1318/2005/0117-0339; Oren Aharon, 2010, Lakes & Reservoirs Research and Management, V15, P215, DOI 10.1111/j.1440-1770.2010.00435.x; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; PEDERSEN K, 1990, MICROBIAL ECOL, V20, P37, DOI 10.1007/BF02543865; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Reznik IJ, 2009, GEOCHIM COSMOCHIM AC, V73, P6218, DOI 10.1016/j.gca.2009.07.018; Rhodes ME, 2010, ENVIRON MICROBIOL, V12, P2613, DOI 10.1111/j.1462-2920.2010.02232.x; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; SAND W, 1995, APPL MICROBIOL BIOT, V43, P961, DOI 10.1007/BF00166909; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Semenza M, 2002, LAT AM APPL RES, V32, P303; Shalev E., 2008, ASSESSMENT GEOTHERMA; Shatkay M., 1993, INT J SALT LAKE RES, V2, P93, DOI 10.1007/BF02905903.; Shen YN, 2004, EARTH-SCI REV, V64, P243, DOI 10.1016/S0012-8252(03)00054-0; Siebert C, 2006, THESIS FREIEI U BERL; Siebert C, 2009, WATER JORDAN VALLEY, P219; SIEGEL AF, 1982, BIOMETRICS, V38, P235; Stein M, 2004, RADIOCARBON, V46, P649, DOI 10.1017/S0033822200035700; STEINHORN I, 1979, SCIENCE, V206, P55, DOI 10.1126/science.206.4414.55; Stiller M, 1999, GEOCHIM COSMOCHIM AC, V63, P3467, DOI 10.1016/S0016-7037(99)00272-0; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Swarieh A., 2000, P WORLD GEOTH C KYUS, P469; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Tujula NA, 2006, J MICROBIOL METH, V65, P604, DOI 10.1016/j.mimet.2005.09.006; USDOWSKI E, 1973, CONTRIB MINERAL PETR, V38, P177, DOI 10.1007/BF00374765; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; Volcani BE, 1944, NATURE, V154, P335; Volcani BE, 1943, NATURE, V152, P301; Waddell EJ, 2010, ENVIRON TECHNOL, V31, P979, DOI 10.1080/09593331003789511; Wilransky B, 1936, NATURE, V138, P467; Yechieli Y, 1997, CHEM GEOL, V138, P93, DOI 10.1016/S0009-2541(97)00002-8	91	104	105	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38319	10.1371/journal.pone.0038319	http://dx.doi.org/10.1371/journal.pone.0038319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679498	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900029
J	Cankorur-Cetinkaya, A; Dereli, E; Eraslan, S; Karabekmez, E; Dikicioglu, D; Kirdar, B				Cankorur-Cetinkaya, Ayca; Dereli, Elif; Eraslan, Serpil; Karabekmez, Erkan; Dikicioglu, Duygu; Kirdar, Betul			A Novel Strategy for Selection and Validation of Reference Genes in Dynamic Multidimensional Experimental Design in Yeast	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE RT-PCR; POLYMERASE-CHAIN-REACTION; RELIABLE REFERENCE GENES; SACCHAROMYCES-CEREVISIAE; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; COLON-CANCER; NORMALIZATION; IDENTIFICATION	Background: Understanding the dynamic mechanism behind the transcriptional organization of genes in response to varying environmental conditions requires time-dependent data. The dynamic transcriptional response obtained by real-time RT-qPCR experiments could only be correctly interpreted if suitable reference genes are used in the analysis. The lack of available studies on the identification of candidate reference genes in dynamic gene expression studies necessitates the identification and the verification of a suitable gene set for the analysis of transient gene expression response. Principal Findings: In this study, a candidate reference gene set for RT-qPCR analysis of dynamic transcriptional changes in Saccharomyces cerevisiae was determined using 31 different publicly available time series transcriptome datasets. Ten of the twelve candidates (TPI1, FBA1, CCW12, CDC19, ADH1, PGK1, GCN4, PDC1, RPS26A and ARF1) we identified were not previously reported as potential reference genes. Our method also identified the commonly used reference genes ACT1 and TDH3. The most stable reference genes from this pool were determined as TPI1, FBA1, CDC19 and ACT1 in response to a perturbation in the amount of available glucose and as FBA1, TDH3, CCW12 and ACT1 in response to a perturbation in the amount of available ammonium. The use of these newly proposed gene sets outperformed the use of common reference genes in the determination of dynamic transcriptional response of the target genes, HAP4 and MEP2, in response to relaxation from glucose and ammonium limitations, respectively. Conclusions: A candidate reference gene set to be used in dynamic real-time RT-qPCR expression profiling in yeast was proposed for the first time in the present study. Suitable pools of stable reference genes to be used under different experimental conditions could be selected from this candidate set in order to successfully determine the expression profiles for the genes of interest.	[Cankorur-Cetinkaya, Ayca; Dereli, Elif; Eraslan, Serpil; Karabekmez, Erkan; Dikicioglu, Duygu; Kirdar, Betul] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey	Bogazici University	Cankorur-Cetinkaya, A (corresponding author), Bogazici Univ, Dept Chem Engn, Istanbul, Turkey.	kirdar@boun.edu.tr	Dikicioglu, Duygu/W-4354-2019; Kirdar, Betul/ABI-7250-2020	Dikicioglu, Duygu/0000-0002-3018-4790; DERELI EKE, Elif/0000-0002-7576-9864; Karabekmez, Muhammed Erkan/0000-0002-0517-5227; Cankorur Cetinkaya, Ayca/0000-0002-4431-7259; Eraslan, Serpil/0000-0002-7674-7384	Bogazici University [07M106, 5562]; TUBITAK [106M444]; Turkish State Planning Organization [DPT 09K120520]	Bogazici University(Bogazici University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish State Planning Organization	The research was financially supported by Bogazici University Research Fund through Projects No 07M106 and 5562, TUBITAK through Project No 106M444, and Turkish State Planning Organization through Project No DPT 09K120520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brachmann CB, 1998, YEAST, V14, P115; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Ling DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029788; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Liu ZL, 2007, J MICROBIOL METH, V68, P486, DOI 10.1016/j.mimet.2006.10.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marini AM, 1997, MOL CELL BIOL, V17, P8; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Passmore M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-72; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rozen S, 2000, Methods Mol Biol, V132, P365; *SGD PROJ, SACCH GEN DAT; Sirakov M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-70; Sorby LA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-144; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J., 2009, REFERENCE GENE VALID; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaudano E, 2009, INT J FOOD MICROBIOL, V129, P30, DOI 10.1016/j.ijfoodmicro.2008.10.027; Vaudano E, 2011, BIOTECHNOL LETT, V33, P1593, DOI 10.1007/s10529-011-0603-y; Vincent S, 1993, NUCLEIC ACIDS RES, V21, P6; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008	40	40	43	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38351	10.1371/journal.pone.0038351	http://dx.doi.org/10.1371/journal.pone.0038351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675547	Green Published, gold			2022-12-25	WOS:000305341700062
J	Sann, SB; Crane, MM; Lu, H; Jin, YS				Sann, Sharon B.; Crane, Matthew M.; Lu, Hang; Jin, Yishi			Rabx-5 Regulates RAB-5 Early Endosomal Compartments and Synaptic Vesicles in C. elegans	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; EXCHANGE FACTOR RABEX-5; CAENORHABDITIS-ELEGANS; HIPPOCAMPAL-NEURONS; NEUROTRANSMITTER RELEASE; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; STRUCTURAL BASIS; FINGER DOMAIN; PATHWAY	Early endosomal membrane compartments are required for the formation and recycling of synaptic vesicles, but how these compartments are regulated is incompletely understood. We performed a forward genetic screen in C. elegans for mutations that affect RAB-5 labeled early endosomal compartments in GABAergic motoneurons. Here we report the isolation and characterization of one mutation, rabx-5. The rabx-5 mutation leads to decreased intensity of YFP::RAB-5 in the cell soma but increased intensity in the synaptic and intersynaptic regions of the axon. This effect is due to the bias of the cycling state of RAB-5, and results from a change in the organization of the early endosomal compartment as well as the membrane binding state of RAB-5. Synaptic vesicle accumulation is altered in rabx-5 mutants, and synaptic transmission from cholinergic neurons is decreased. Early endosomal membrane compartments show disorganization with ageing and rabx-5 mutant animals age faster. These results suggest that rabx-5 regulation of RAB-5 compartments is important for maintaining proper synaptic function throughout the lifetime.	[Sann, Sharon B.; Jin, Yishi] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Crane, Matthew M.; Lu, Hang] Georgia Inst Technol, Interdisciplinary Program Bioengn, Atlanta, GA 30332 USA; [Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University System of Georgia; Georgia Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Diego	Sann, SB (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ssann@ucsd.edu; yijin@ucsd.edu		Lu, Hang/0000-0002-6881-660X; Jin, Yishi/0000-0002-9371-9860	National Institute of Health (NIH) [R01 NS035546]; NIH [R01 GM088333, R01 AG035317, R21 EB012803]; National Science Foundation (NSF) [CBET-0954578]; Alfred P. Sloan Foundation; NIH NINDS [F32NS067891]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067891, R01NS035546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035317] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the following funding sources: National Institute of Health (NIH) R01 NS035546 to YJ; NIH R01 GM088333, NIH R01 AG035317, NIH R21 EB012803, National Science Foundation (NSF) CBET-0954578, and Alfred P. Sloan Foundation to HL; and NIH NINDS F32NS067891 to SS. YJ is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://grants.nih.gov/grants/funding/r01.htm http://grants.nih.gov/training/nrsa.htm http://www.nsf.gov/div/index.jsp?div = cbet http://www.sloan.org/program/1 http://www.hhmi.org/research/investigators/.	Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; BRENNER S, 1974, GENETICS, V77, P71; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Fuenzalida LC, 2011, ENDOCRINOLOGY, V152, P4310, DOI 10.1210/en.2011-1416; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Laifenfeld D, 2007, J NEUROSCI, V27, P7141, DOI 10.1523/JNEUROSCI.4599-06.2007; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; MATTEOLI M, 1991, J CELL BIOL, V115, P625, DOI 10.1083/jcb.115.3.625; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pal A, 2008, METHOD ENZYMOL, V438, P239, DOI 10.1016/S0076-6879(07)38017-8; Pavlos NJ, J NEUROSCI, V30, P13441; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Prekeris R, 1999, J NEUROSCI, V19, P10324; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Royle SJ, TRAFFIC; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang M, 2008, FRONT BIOSCI-LANDMRK, V13, P6086, DOI 10.2741/3140; Zou L, 2010, INT J MOL MED, V25, P401, DOI 10.3892/ijmm_00000358	58	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37930	10.1371/journal.pone.0037930	http://dx.doi.org/10.1371/journal.pone.0037930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675499	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700028
J	Matthews, PR; Eastwood, SL; Harrison, PJ				Matthews, Paul R.; Eastwood, Sharon L.; Harrison, Paul J.			Reduced Myelin Basic Protein and Actin-Related Gene Expression in Visual Cortex in Schizophrenia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RECEPTOR MESSENGER-RNAS; BINDING-SITE DENSITIES; BIPOLAR DISORDER; DENDRITIC SPINES; HUMAN BRAIN; NEUROPATHOLOGY-CONSORTIUM; MITOCHONDRIAL DYSFUNCTION; HIPPOCAMPAL-FORMATION; PREFRONTAL CORTEX	Most brain gene expression studies of schizophrenia have been conducted in the frontal cortex or hippocampus. The extent to which alterations occur in other cortical regions is not well established. We investigated primary visual cortex (Brodmann area 17) from the Stanley Neuropathology Consortium collection of tissue from 60 subjects with schizophrenia, bipolar disorder, major depression, or controls. We first carried out a preliminary array screen of pooled RNA, and then used RT-PCR to quantify five mRNAs which the array identified as differentially expressed in schizophrenia (myelin basic protein [MBP], myelin-oligodendrocyte glycoprotein [MOG], beta-actin [ACTB], thymosin beta-10 [TB10], and superior cervical ganglion-10 [SCG10]). Reduced mRNA levels were confirmed by RT-PCR for MBP, ACTB and TB10. The MBP reduction was limited to transcripts containing exon 2. ACTB and TB10 mRNAs were also decreased in bipolar disorder. None of the transcripts were altered in subjects with major depression. Reduced MBP mRNA in schizophrenia replicates findings in other brain regions and is consistent with oligodendrocyte involvement in the disorder. The decreases in expression of ACTB, and the actin-binding protein gene TB10, suggest changes in cytoskeletal organisation. The findings confirm that the primary visual cortex shows molecular alterations in schizophrenia and extend the evidence for a widespread, rather than focal, cortical pathophysiology.	[Matthews, Paul R.; Eastwood, Sharon L.; Harrison, Paul J.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford	Matthews, PR (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	paul.harrison@psych.ox.ac.uk		Harrison, Paul/0000-0002-6719-1126	Wellcome Trust; Stanley Medical Research Institute Center award	Wellcome Trust(Wellcome TrustEuropean Commission); Stanley Medical Research Institute Center award	Supported by a Wellcome Trust studentship to PRM, with additional funding from a Stanley Medical Research Institute Center award to PJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Boggs JM, 2011, BBA-BIOMEMBRANES, V1808, P761, DOI 10.1016/j.bbamem.2010.12.016; BORDER BG, 1993, J NEUROCHEM, V61, P2104, DOI 10.1111/j.1471-4159.1993.tb07448.x; Burnet PWJ, 1996, NEUROPSYCHOPHARMACOL, V15, P442, DOI 10.1016/S0893-133X(96)00053-X; BURNET PWJ, 1994, NEUROSCI LETT, V178, P85, DOI 10.1016/0304-3940(94)90296-8; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Campagnoni CW, 2001, DEV NEUROSCI-BASEL, V23, P452, DOI 10.1159/000048732; Carpintero P, 1999, MOL BRAIN RES, V70, P141, DOI 10.1016/S0169-328X(99)00115-1; Chen L, 1999, BRAIN RES PROTOC, V4, P132, DOI 10.1016/S1385-299X(99)00009-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Dean B, 2007, AUST NZ J PSYCHIAT, V41, P308, DOI 10.1080/00048670701213245; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dorph-Petersen KA, 2007, J COMP NEUROL, V501, P290, DOI 10.1002/cne.21243; Dorph-Petersen KA, 2011, BIOL PSYCHIAT, V69, P113, DOI 10.1016/j.biopsych.2010.04.030; Dunaevsky A, 2004, NEURON, V44, P216, DOI 10.1016/j.neuron.2004.10.003; Eastwood SL, 2007, J PSYCHOPHARMACOL, V21, P635, DOI 10.1177/0269881106068825; Eastwood SL, 1998, NEUROSCIENCE, V86, P437, DOI 10.1016/S0306-4522(98)00040-2; Eastwood SL, 2000, BRIT J PSYCHIAT, V176, P236, DOI 10.1192/bjp.176.3.236; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; HALL AK, 1991, MOL BRAIN RES, V9, P9, DOI 10.1016/0169-328X(91)90124-G; Halpain S, 1998, J NEUROSCI, V18, P9835; Harrison P.J., 2011, SCHIZOPHRENIA, P372; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Harrison PJ, 2002, BRAIN, V125, P1428, DOI 10.1093/brain/awf149; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Horvath S, 2011, BIOL PSYCHIAT, V69, P157, DOI 10.1016/j.biopsych.2010.07.017; KAMHOLZ J, 1988, J NEUROSCI RES, V21, P62, DOI 10.1002/jnr.490210110; Karoutzou G, 2008, MOL PSYCHIATR, V13, P245, DOI 10.1038/sj.mp.4002096; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lauriat TL, 2006, NEUROSCIENCE, V137, P843, DOI 10.1016/j.neuroscience.2005.10.003; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P149, DOI 10.1016/j.jpsychires.2009.07.007; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; MILLS JW, 1994, FASEB J, V8, P1161, DOI 10.1096/fasebj.8.14.7958622; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Sequeira PA, 2012, NEUROBIOL DIS, V45, P23, DOI 10.1016/j.nbd.2011.03.001; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Silberberg G, 2009, ANAL BIOCHEM, V391, P91, DOI 10.1016/j.ab.2009.05.026; Sribenja S, 2009, CANCER INVEST, V27, P1016, DOI 10.3109/07357900902849640; Sun HQ, 2007, ANN NY ACAD SCI, V1112, P45, DOI 10.1196/annals.1415.021; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; TANAKA J, 1993, DEV BRAIN RES, V76, P268, DOI 10.1016/0165-3806(93)90217-X; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger R, 1996, J NEUROSCI, V16, P238; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	74	39	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38211	10.1371/journal.pone.0038211	http://dx.doi.org/10.1371/journal.pone.0038211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675524	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900017
J	Cohen, HS; Cox, C; Springer, G; Hoffman, HJ; Young, MA; Margolick, JB; Plankey, MW				Cohen, Helen S.; Cox, Christopher; Springer, Gayle; Hoffman, Howard J.; Young, Mary A.; Margolick, Joseph B.; Plankey, Michael W.			Prevalence of Abnormalities in Vestibular Function and Balance among HIV-Seropositive and HIV-Seronegative Women and Men	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; PAROXYSMAL POSITIONAL VERTIGO; ACTIVE ANTIRETROVIRAL THERAPY; MULTICENTER AIDS COHORT; SENSORY INTERACTION; VESTIBULOOCULAR REFLEX; POSTURAL CONTROL; INTERAGENCY HIV; CLINICAL-TEST; VIRUS	Background: Most HIV-seropositive subjects in western countries receive highly active antiretroviral therapy (HAART). Although many aspects of their health have been studied, little is known about their vestibular and balance function. The goals of this study were to determine the prevalences of vestibular and balance impairments among HIV-seropositive and comparable seronegative men and women and to determine if those groups differed. Methods: Standard screening tests of vestibular and balance function, including head thrusts, Dix-Hallpike maneuvers, and Romberg balance tests on compliant foam were performed during semiannual study visits of participants who were enrolled in the Baltimore and Washington, D. C. sites of the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Results: No significant differences by HIV status were found on most tests, but HIV-seropositive subjects who were using HAART had a lower frequency of abnormal Dix-Hallpike nystagmus than HIV-seronegative subjects. A significant number of nonclassical Dix-Hallpike responses were found. Age was associated with Romberg scores on foam with eyes closed. Sex was not associated with any of the test scores. Conclusion: These findings suggest that HAART-treated HIV infection has no harmful association with vestibular function in community-dwelling, ambulatory men and women. The association with age was expected, but the lack of association with sex was unexpected. The presence of nonclassical Dix-Hallpike responses might be consistent with central nervous system lesions.	[Cohen, Helen S.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Cox, Christopher; Springer, Gayle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hoffman, Howard J.] Natl Inst Deafness & Other Commun Disorders, Epidemiol & Stat Program, NIH, Bethesda, MD USA; [Young, Mary A.; Plankey, Michael W.] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cohen, HS (corresponding author), Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA.	mwp23@georgetown.edu		Cohen, Helen/0000-0002-1605-640X; Hoffman, Howard/0000-0003-4105-0808	National Institute on Deafness and Other Communication Disorders (NIDCD) [U01 AI-035042-18, U01 AI-034994-17]; Baltimore-Washington, D.C.; National Cancer Institute [UO1-AI-35042, UL1RR025005]; Metropolitan Washington, D.C.; National Institute on Drug Abuse; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, U01AI034994] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Baltimore-Washington, D.C.; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Metropolitan Washington, D.C.; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute on Deafness and Other Communication Disorders (NIDCD) via interagency agreement with NIAID for Cooperative Agreements U01 AI-035042-18 (MACS) and U01 AI-034994-17 (WIHS). Support of the Baltimore-Washington, D.C. MAC site was provided by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute (UO1-AI-35042, UL1RR025005)(GCRC). Support of the Metropolitan Washington, D.C. WIHS site was provided by the National Institute of Allergy and Infectious Diseases (UO1-AI34994) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study was co-funded by the National Cancer Institute, the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw ST, 1999, J VESTIBUL RES-EQUIL, V9, P173; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bronstein AM, 2010, RESTOR NEUROL NEUROS, V28, P83, DOI 10.3233/RNN-2010-0530; Bronstein AM, 2007, DIZZINESS PRACTICAL; Castello E, 1998, ANN OTO RHINOL LARYN, V107, P1054, DOI 10.1177/000348949810701210; Celebisoy N, 2008, EUR NEUROL, V59, P315, DOI 10.1159/000121422; CHANDRASEKHAR SS, 1992, AM J OTOL, V13, P207; COATS AC, 1986, EAR HEARING, V7, P143, DOI 10.1097/00003446-198606000-00005; Coats AC, 1975, PHYSL MEASURES AUDIO, P37; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Cohen H, 1996, AGE AGEING, V25, P39, DOI 10.1093/ageing/25.1.39; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; Dellepiane M, 2005, Acta Otorhinolaryngol Ital, V25, P353; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; FREGLY A R, 1970, Acta Oto-Laryngologica, V69, P216, DOI 10.3109/00016487009123356; FREGLY AR, 1972, AEROSPACE MED, V43, P395; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; HAUSLER R, 1991, ACTA OTO-LARYNGOL, P515; Heinze B, 2011, J LARYNGOL OTOL, V125, P881, DOI 10.1017/S0022215111001423; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Hultin LE, 2007, CYTOM PART B-CLIN CY, V72B, P249, DOI 10.1002/cyto.b.20176; Jackson LE, 2007, OTOL NEUROTOL, V28, P218, DOI 10.1097/01.mao.0000247825.90774.6b; Johnston JL, 1996, NEUROLOGY, V46, P451, DOI 10.1212/WNL.46.2.451; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KOHAN D, 1988, ANN OTO RHINOL LARYN, V97, P636, DOI 10.1177/000348948809700611; Kohan D, 1991, LARYNGOSCOPE, V100, P1326; MICHAELS L, 1994, AM J OTOL, V15, P515; NASHNER LM, 1982, J NEUROSCI, V2, P536; National Institutes of Health, 2011, GUID US ANT AG HIV 1, P1; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Paige G D, 1992, J Vestib Res, V2, P133; Palacios GC, 2008, INT J PEDIATR OTORHI, V72, P1671, DOI 10.1016/j.ijporl.2008.08.002; PAPPAS DG, 1995, AM J OTOL, V16, P140; Peterka R J, 1990, J Vestib Res, V1, P73; Peterka R J, 1990, J Vestib Res, V1, P49; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Teggi R, 2008, J LARYNGOL OTOL, V122, P1289, DOI 10.1017/S0022215107001624; Teggi R, 2006, Acta Otorhinolaryngol Ital, V26, P140; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Whitney SL, 2004, ARCH PHYS MED REHAB, V85, P439, DOI 10.1016/j.apmr.2003.05.005	47	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38419	10.1371/journal.pone.0038419	http://dx.doi.org/10.1371/journal.pone.0038419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675462	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500146
J	Garrido-Laguna, I; Hong, DS; Janku, F; Nguyen, LM; Falchook, GS; Fu, SQ; Wheler, JJ; Luthra, R; Naing, A; Wang, XM; Kurzrock, R				Garrido-Laguna, Ignacio; Hong, David S.; Janku, Filip; Nguyen, Ly M.; Falchook, Gerald S.; Fu, Siqing; Wheler, Jenifer J.; Luthra, Rajyalakshmi; Naing, Aung; Wang, Xuemei; Kurzrock, Razelle			KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors	PLOS ONE			English	Article							CETUXIMAB PLUS IRINOTECAN; MUTATION STATUS; CHEMOTHERAPY; METASTASES; PREDICTION; RESISTANCE; TUMORS	Purpose: To evaluate clinicopathologic and molecular features of patients with metastatic colorectal cancer (mCRC) and their outcomes in early-phase trials using pathway-targeting agents. Patients and Methods: We analyzed characteristics of 238 patients with mCRC referred to the phase 1 trials unit at MD Anderson Cancer Center. KRAS, PIK3CA and BRAF status were tested using PCR-based DNA sequencing. Results: Fifty-one percent of patients harbored KRAS mutations; 15% had PIK3CA mutations. In the multivariate regression model for clinical characteristics KRAS mutations were associated with an increased incidence of lung and bone metastases and decreased incidence of adrenal metastases; PIK3CA mutations were marginally correlated with mucinous tumors (p = 0.05). In the univariate analysis, KRAS and PIK3CA mutations were strongly associated. Advanced Duke's stage (p < 0.0001) and KRAS mutations (p = 0.01) were the only significant independent predictors of poor survival (Cox proportional hazards model). Patients with PIK3CA mutations had a trend toward shorter progression-free survival when treated with anti-EGFR therapies (p = 0.07). Eighteen of 78 assessable patients (23%) treated with PI3K/Akt/mTOR axis inhibitors achieved stable disease [SD] >= 6 months or complete response/partial response (CR/PR), only one of whom were in the subgroup (N = 15) with PIK3CA mutations, perhaps because 10 of these 15 patients (67%) had coexisting KRAS mutations. No SD >= 6 months/CR/PR was observed in the 10 patients treated with mitogen-activating protein kinase (MAPK) pathway targeting drugs. Conclusions: KRAS and PIK3CA mutations frequently coexist in patients with colorectal cancer, and are associated with clinical characteristics and outcome. Overcoming resistance may require targeting both pathways.	[Garrido-Laguna, Ignacio; Hong, David S.; Janku, Filip; Nguyen, Ly M.; Falchook, Gerald S.; Fu, Siqing; Wheler, Jenifer J.; Naing, Aung; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Luthra, Rajyalakshmi] Univ Texas MD Anderson Canc Ctr, Dept Mol Diagnost Lab, Houston, TX 77030 USA; [Wang, Xuemei] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Garrido-Laguna, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA.	Ignacio.garrido-laguna@hci.utah.edu	Janku, Filip/ABB-9136-2020; Kurzrock, Razelle/AAU-9782-2020; Wang, Xuemei/GXF-3702-2022; Garrido-Laguna, Ignacio/ABD-1875-2020	Garrido-Laguna, Ignacio/0000-0003-2273-9028; Naing, Aung/0000-0002-4803-8513; Fu, Siqing/0000-0002-1933-0419	National Center for Research Resources, NIH Roadmap for Medical Research [RR024148]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Grant Number RR024148 from the National Center for Research Resources, a component of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Cejas P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008199; COX DR, 1972, J R STAT SOC B, V34, P187; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; MANTEL N, 1966, CANC CHEMOTHER REP, V60, P163; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Tie J, 2011, CLIN CANCER RES, V17, P1122, DOI 10.1158/1078-0432.CCR-10-1720; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	19	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38033	10.1371/journal.pone.0038033	http://dx.doi.org/10.1371/journal.pone.0038033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675430	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500077
J	Leclerque, A; Kleespies, RG				Leclerque, Andreas; Kleespies, Regina G.			A Rickettsiella Bacterium from the Hard Tick, Ixodes woodi: Molecular Taxonomy Combining Multilocus Sequence Typing (MLST) with Significance Testing	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC CHARACTERIZATION; LARGE PHYLOGENIES; POSITION; GENUS; TOPOLOGIES; GENERATION; ALGORITHM; GENETICS; ORDER; RATES	Hard ticks (Acari: Ixodidae) are known to harbour intracellular bacteria from several phylogenetic groups that can develop both mutualistic and pathogenic relationships to the host. This is of particular importance for public health as tick derived bacteria can potentially be transmitted to mammals, including humans, where e. g. Rickettsia or Coxiella act as severe pathogens. Exact molecular taxonomic identification of tick associated prokaryotes is a necessary prerequisite of the investigation of their relationship to both the tick and possible vertebrate hosts. Previously, an intracellular bacterium had been isolated from a monosexual, parthenogenetically reproducing laboratory colony of females of the hard tick, Ixodes woodi Bishopp, and had preliminarily been characterized as a "Rickettsiella-related bacterium". In the present molecular taxonomic study that is based on phylogenetic reconstruction from both 16 S ribosomal RNA and protein-encoding marker sequences complemented with likelihood-based significance testing, the bacterium from I. woodi has been identified as a strain of the taxonomic species Rickettsiella grylli. It is the first time that a multilocus sequence typing (MLST) approach based on a four genes comprising MLST scheme has been implemented in order to classify a Rickettsiella-like bacterium to this species. The study demonstrated that MLST holds potential for a better resolution of phylogenetic relationships within the genus Rickettsiella, but requires sequence determination from further Rickettsiella-like bacteria in order to complete the current still fragmentary picture of Rickettsiella systematics.	[Leclerque, Andreas; Kleespies, Regina G.] Fed Res Ctr Cultivated Plants, JKI, Inst Biol Control, Darmstadt, Germany	Julius Kuhn-Institut	Leclerque, A (corresponding author), Fed Res Ctr Cultivated Plants, JKI, Inst Biol Control, Darmstadt, Germany.	leclerque@hotmail.com		LECLERQUE, ANDREAS/0000-0003-0688-4137				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fournier P-E, 2005, BERGEYS MANUAL SYSTE, V2, P241; Fournier PE, 2006, INT J SYST EVOL MICR, V56, P1025, DOI 10.1099/ijs.0.63903-0; FRUTOS R, 1994, J INVERTEBR PATHOL, V63, P294, DOI 10.1006/jipa.1994.1054; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gomez-Valero L, 2009, INFECT GENET EVOL, V9, P727, DOI 10.1016/j.meegid.2009.05.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kleespies RG, 2011, J INVERTEBR PATHOL, V107, P206, DOI 10.1016/j.jip.2011.05.017; Kurtti TJ, 2002, J MED ENTOMOL, V39, P534, DOI 10.1603/0022-2585-39.3.534; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leclerque A, 2008, FEMS MICROBIOL LETT, V283, P117, DOI 10.1111/j.1574-6968.2008.01158.x; Leclerque A, 2008, J INVERTEBR PATHOL, V98, P329, DOI 10.1016/j.jip.2008.02.005; Leclerque A, 2008, FEMS MICROBIOL LETT, V279, P167, DOI 10.1111/j.1574-6968.2007.01025.x; Leclerque A, 2008, INT J SYST EVOL MICR, V58, P749, DOI 10.1099/ijs.0.65359-0; Leclerque A, 2011, FEMS MICROBIOL LETT, V324, P125, DOI 10.1111/j.1574-6968.2011.02396.x; Leclerque A, 2011, CURR MICROBIOL, V63, P158, DOI 10.1007/s00284-011-9958-5; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mediannikov O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011478; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; NEI M, 1986, MOL BIOL EVOL, V3, P418; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roux V, 1997, INT J SYST BACTERIOL, V47, P1255, DOI 10.1099/00207713-47-4-1255; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sekeyova Z, 1999, FEMS MICROBIOL LETT, V180, P61, DOI 10.1016/S0378-1097(99)00462-0; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanada Y, 1993, INSECT PATHOL, P153; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vilcins IME, 2009, EXP APPL ACAROL, V49, P229, DOI 10.1007/s10493-009-9260-4; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weiss E, 1984, BERGEYS MANUAL SYSTE, VI, P713; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; Wille H, 1952, Z ALLG PATHOL BAKTER, V15, P470; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38062	10.1371/journal.pone.0038062	http://dx.doi.org/10.1371/journal.pone.0038062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675436	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500084
J	Schrier, RD; Gupta, S; Riggs, P; Cysique, LA; Letendre, S; Jin, H; Spector, SA; Singh, KK; Wolfson, T; Wu, ZY; Hong, KX; Yu, X; Shi, CA; Heaton, RK				Schrier, Rachel D.; Gupta, Saurabh; Riggs, Patricia; Cysique, Lucette A.; Letendre, Scott; Jin, Hua; Spector, Stephen A.; Singh, Kumud K.; Wolfson, Tanya; Wu, Zunyou; Hong, Kun Xue; Yu, Xin; Shi, Chuan; Heaton, Robert K.		HNRC Grp	The Influence of HLA on HIV-Associated Neurocognitive Impairment in Anhui, China	PLOS ONE			English	Article							CLASS-I ALLELES; DISEASE PROGRESSION; APOLIPOPROTEIN-E; PLASMA DONORS; T-CELLS; INFECTION; AIDS; GAG; INDIVIDUALS; RESPONSES	Background: HLA-DR*04 was identified as a predictor of HIV-Associated neurocognitive disorder (HAND), low CD4 T-cell responses to HIV, and low plasma HIV RNA levels in a U.S. cohort. We hypothesized that low CD4 T-cell activation leads to poor immune control of HIV in the CNS, predisposing to HAND, but also provided fewer target (activated CD4 T-cells) for HIV replication. To assess the consistency of these HLA Class II associations in a new cohort and extend analysis to HLA Class I, HLA types, neurocognitive, and virologic status were examined in a cohort of former plasma donors in China. Methods: 178 HIV infected individuals in Anhui China, were HLA typed and underwent neurocognitive evaluations (using locally standardized norms), neuromedical, treatment and virologic assessments at baseline and at 12 months. Results: HLA DR*04 was associated with a higher rate of baseline neurocognitive impairment (p = 0.04), neurocognitive decline (p = 0.04), and lower levels of HIV RNA in plasma (p = 0.05). HLA Class I alleles (B*27,57,58,A*03,33) that specify a CD8 T-cell response to conserved HIV sequences were neuroprotective, associated with less impairment at baseline (p = 0.037), at month 012 (p = 0.013) and less neurocognitive decline (p = 0.023) in the interval. Consistent with the theory that effective CD8 T-cell responses require CD4 T-cell support, the HLA DR*04 allele reduced the neuroprotective effect of the Class I alleles. The presence of HLA-DR*04 and the Alzheimer associated allele ApoE4 in the same individual had a synergistic negative effect on cognition (p = 0.003). Conclusions: Despite major background differences between U. S. and Anhui China cohorts, HLA DR*04 predicted neurocognitive impairment and lower plasma HIV RNA levels in both populations. HLA Class I alleles associated with CD8 T-cell control of HIV were associated with protection from HAND, but protection was reduced in the presence of HLA-DR*04.	[Schrier, Rachel D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gupta, Saurabh; Jin, Hua; Wolfson, Tanya; Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Riggs, Patricia; Letendre, Scott] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Spector, Stephen A.; Singh, Kumud K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cysique, Lucette A.] Univ New S Wales, Sydney, NSW, Australia; [Wu, Zunyou; Hong, Kun Xue; Yu, Xin] Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Shi, Chuan] Peking Univ, Beijing Mental Hlth Inst, Beijing 100871, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of New South Wales Sydney; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University	Schrier, RD (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	rschrier@ucsd.edu	Cysique, Lucette A./U-1357-2017; Letendre, Scott L./GLU-6874-2022; jin, hua/AAX-1569-2020	Cysique, Lucette A./0000-0002-7711-6373; Riggs, Patricia Katherine/0000-0003-2870-8468	National Institute of Mental Health [5 R01 MH073433-04]; Center award from the National Institute of Mental Health [MH 62512];  [MH083552]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH073433, R01MH083552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077874] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center award from the National Institute of Mental Health; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Mental Health grant 5 R01 MH073433-04 (RKH, P.I.). The HIV Neurobehavioral Research Center is supported by Center award MH 62512 from the National Institute of Mental Health. Clade analysis for this cohort is supported by MH083552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Asquith B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003486; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Borghans JAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000920; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Cysique LA, 2007, J INT NEUROPSYCH SOC, V13, P781, DOI 10.1017/S1355617707071007; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Gudmundsdotter L, 2008, VACCINE, V26, P5182, DOI 10.1016/j.vaccine.2008.03.094; Heaton RK, 2008, J NEUROVIROL, P1, DOI [10.1080/13550280701802543, DOI 10.1080/13550280701802543]; Huang X, 2009, MICROBIOL IMMUNOL, V53, P512, DOI 10.1111/j.1348-0421.2009.00150.x; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; Navis M, 2008, J INFECT DIS, V197, P871, DOI 10.1086/528695; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Qing ML, 2006, JAIDS-J ACQ IMM DEF, V41, P137, DOI 10.1097/01.qai.0000195607.25262.92; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Schaubert KL, 2007, J IMMUNOL, V178, P7756, DOI 10.4049/jimmunol.178.12.7756; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; SCHRIER RD, 1989, J IMMUNOL, V142, P1166; Schrier RD, 1996, J CLIN INVEST, V98, P731, DOI 10.1172/JCI118845; Spector SA, 2010, AIDS, V24, P1471, DOI 10.1097/QAD.0b013e328339e25c; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Torres AR, 2002, HUM IMMUNOL, V63, P311, DOI 10.1016/S0198-8859(02)00374-9; Xu KY, 2006, DU XUE ZA ZHI, V20, P72; Xu MY, 2004, BIOMED ENVIRON SCI, V17, P203; Yu XG, 2004, AIDS RES HUM RETROV, V20, P557, DOI 10.1089/088922204323087813; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e32303	10.1371/journal.pone.0032303	http://dx.doi.org/10.1371/journal.pone.0032303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693541	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500003
J	Lin, PH; Lan, WM; Chau, LY				Lin, P-H; Lan, W-M; Chau, L-Y			TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation	ONCOGENE			English	Article						TRC8; heme oxygenase-1; tumor suppressor; ubiquitination	RENAL-CANCER CELLS; TUMOR-SUPPRESSOR; UP-REGULATION; GENE; EXPRESSION; OVEREXPRESSION; RESISTANCE; APOPTOSIS; PATHWAY; GROWTH	The TRC8 gene, which was previously shown to be disrupted by a 3; 8 chromosomal translocation in hereditary kidney cancer, encodes for an endoplasmic reticulum-resident E3 ligase. Studies have shown that TRC8 exhibits a tumor-suppressive effect through its E3-ligase activity. Therefore, the identification of its physiological substrates will provide important insights into the molecular mechanism underlying TRC8-mediated tumor suppression. Here we show that TRC8 targets heme oxygenase-1 (HO-1), an antioxidant enzyme highly expressed in various cancers, for ubiquitination and degradation. Ectopic TRC8 expression suppresses HO-1-induced cancer cell growth and migration/invasion. Conversely, HO-1 depletion reduced the tumorigenic and invasive capacities promoted by TRC8 knockdown. HO-1 downregulation in renal carcinoma cells induces a mitotic delay at G2/M phase by increasing the intracellular reactive oxygen species and the DNA-damage-induced checkpoint activation. These results highlight the tumorigenic role of HO-1 and the importance of TRC8-mediated HO-1 degradation in the control of cancer growth.	[Lin, P-H; Lan, W-M; Chau, L-Y] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lin, P-H; Lan, W-M; Chau, L-Y] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018	Chau, Lee-Young/0000-0002-6316-2328	Academia Sinica Investigatorship; National Science Council of Taiwan [NSC 100-2320-B-100-009MY3]	Academia Sinica Investigatorship(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by an Academia Sinica Investigatorship to LYC and a grant from the National Science Council of Taiwan (NSC 100-2320-B-100-009MY3).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Flad T, 2006, PROTEOMICS, V6, P364, DOI 10.1002/pmic.200500099; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Gimelli S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-52; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Hill-Kapturczak N, 2003, ARTERIOSCL THROM VAS, V23, P1416, DOI 10.1161/01.ATV.0000081656.76378.A7; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kocanova S, 2007, APOPTOSIS, V12, P731, DOI 10.1007/s10495-006-0016-x; Koizumi S, 2007, J BIOL CHEM, V282, P8715, DOI 10.1074/jbc.M609427200; Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Li MY, 2008, EUR RESPIR J, V32, P911, DOI 10.1183/09031936.00064508; Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Mayerhofer M, 2008, BLOOD, V111, P2200, DOI 10.1182/blood-2006-11-055723; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Otterbein LE, 2011, P NATL ACAD SCI USA, V108, P14491, DOI 10.1073/pnas.1102295108; Poland KS, 2007, GENE CHROMOSOME CANC, V46, P805, DOI 10.1002/gcc.20466; Pouponnot C, 2006, ONCOGENE, V25, P1299, DOI 10.1038/sj.onc.1209171; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yang ZZ, 2001, AM J PHYSIOL-RENAL, V281, pF900, DOI 10.1152/ajprenal.2001.281.5.F900	44	44	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2013	32	18					2325	2334		10.1038/onc.2012.244	http://dx.doi.org/10.1038/onc.2012.244			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22689053				2022-12-25	WOS:000318683600009
J	Ryder, C; McColl, K; Zhong, F; Distelhorst, CW				Ryder, Christopher; McColl, Karen; Zhong, Fei; Distelhorst, Clark W.			Acidosis Promotes Bcl-2 Family-mediated Evasion of Apoptosis INVOLVEMENT OF ACID-SENSING G PROTEIN-COUPLED RECEPTOR GPR65 SIGNALING TO MEK/ERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BONE-MARROW MICROENVIRONMENT; ACUTE MYELOID-LEUKEMIA; CELL-DEATH; MESSENGER-RNA; CHEMOTHERAPEUTIC DRUGS; KINASE PATHWAYS; CANCER-THERAPY; AMINO-ACID; B-CELLS	Acidosis arises in solid and lymphoid malignancies secondary to altered nutrient supply and utilization. Tumor acidosis correlates with therapeutic resistance, although the mechanism behind this effect is not fully understood. Here we show that incubation of lymphoma cell lines in acidic conditions (pH 6.5) blocks apoptosis induced by multiple cytotoxic metabolic stresses, including deprivation of glucose or glutamine and treatment with dexamethasone. We sought to examine the role of the Bcl-2 family of apoptosis regulators in this process. Interestingly, we found that acidic culture causes elevation of both Bcl-2 and Bcl-xL, while also attenuating glutamine starvation-induced elevation of p53-up-regulated modulator of apoptosis (PUMA) and Bim. We confirmed with knockdown studies that these shifts direct survival decisions during starvation and acidosis. Importantly, the promotion of a high anti- to pro-apoptotic Bcl-2 family member ratio by acidosis renders cells exquisitely sensitive to the Bcl-2/Bcl-xL antagonist ABT-737, suggesting that acidosis causes Bcl-2 family dependence. This dependence appears to be mediated, in part, by the acid-sensing G protein-coupled receptor, GPR65, via a MEK/ERK pathway.	[Ryder, Christopher; Distelhorst, Clark W.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Pharmacol, Cleveland, OH 44106 USA; [Ryder, Christopher; McColl, Karen; Zhong, Fei; Distelhorst, Clark W.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Med, Cleveland, OH 44106 USA; [Ryder, Christopher; McColl, Karen; Zhong, Fei; Distelhorst, Clark W.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	cwd@case.edu			National Institutes of Health [R01 CA42755, R01 CA085804, T32 GM08803]; Leukemia and Lymphoma Society Translational Research Program; Flow Cytometry Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA085804, R01CA042755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803, T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Flow Cytometry Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA42755, R01 CA085804, and T32 GM08803. This work was also supported by a Leukemia and Lymphoma Society Translational Research Program grant and by the Flow Cytometry Core Facility of the Case Comprehensive Cancer Center Grant P30 CA43703.	Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; DOWD DR, 1992, MOL CELL BIOL, V12, P3600, DOI 10.1128/MCB.12.8.3600; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Evelhoch J L, 2001, Novartis Found Symp, V240, P68; Evelhoch J. L., 2001, NOVART FDN SYMP, V240, P80; Evelhoch J. L., 2001, NOVART FDN SYMP, V240, P152; Flacke JP, 2009, APOPTOSIS, V14, P90, DOI 10.1007/s10495-008-0287-5; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hockenbery DM, 2010, ENVIRON MOL MUTAGEN, V51, P476, DOI 10.1002/em.20552; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Ihara Y, 2010, P NATL ACAD SCI USA, V107, P17309, DOI 10.1073/pnas.1001165107; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jeong DW, 2001, BIOCHEM BIOPH RES CO, V289, P1141, DOI 10.1006/bbrc.2001.6091; Klymenko T, 2011, MOL CANCER THER, V10, P2373, DOI 10.1158/1535-7163.MCT-11-0326; Kottyan LC, 2009, BLOOD, V114, P2774, DOI 10.1182/blood-2009-05-220681; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Lapucci A, 2010, FASEB J, V24, P1852, DOI 10.1096/fj.09-140459; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; Letai A, 2005, J CLIN INVEST, V115, P2648, DOI 10.1172/JCI26250; Li SY, 2005, INT J ONCOL, V27, P1329; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; McCarty MF, 2010, ALTERN MED REV, V15, P264; McGuire J, 2009, BIOCHEM BIOPH RES CO, V386, P420, DOI 10.1016/j.bbrc.2009.05.133; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Mortensen BT, 1998, BRIT J HAEMATOL, V102, P458; MOYER GH, 1974, CANCER RES, V34, P2647; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Radu CG, 2006, MOL CELL BIOL, V26, P668, DOI 10.1128/MCB.26.2.668-677.2006; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; REED JC, 1989, ONCOGENE RES, V4, P271; Reichert M, 2002, CANCER, V95, P1113, DOI 10.1002/cncr.10767; ROSEN J M, 1970, Biochimica et Biophysica Acta, V219, P447, DOI 10.1016/0005-2736(70)90222-1; SAUER LA, 1982, CANCER RES, V42, P4090; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Thews O, 2007, ADV EXP MED BIOL, V599, P155; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; VAUPEL P, 1989, CANCER RES, V49, P6449; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; Wensveen FM, 2011, APOPTOSIS, V16, P708, DOI 10.1007/s10495-011-0599-8; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang WG, 2010, CANCER RES, V70, P2424, DOI 10.1158/0008-5472.CAN-09-0878	77	45	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27863	27875		10.1074/jbc.M112.384685	http://dx.doi.org/10.1074/jbc.M112.384685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22685289	hybrid, Green Published			2022-12-25	WOS:000307840700060
J	Ghosh, A; Pahan, K				Ghosh, Arunava; Pahan, Kalipada			Gemfibrozil, a Lipid-lowering Drug, Induces Suppressor of Cytokine Signaling 3 in Glial Cells IMPLICATIONS FOR NEURODEGENERATIVE DISORDERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENSITY-LIPOPROTEIN-CHOLESTEROL; ALZHEIMERS-DISEASE; GENE-EXPRESSION; KAPPA-B; RAW264.7 MACROPHAGES; HUMAN ASTROCYTES; SOCS PROTEINS; UP-REGULATION; MICROGLIA	Glial inflammation is an important feature of several neurodegenerative disorders. Suppressor of cytokine signaling (SOCS) proteins play a crucial role in inhibiting cytokine signaling and inflammatory gene expression in various cell types, including glial cells. However, mechanisms by which SOCS genes could be up-regulated are poorly understood. This study underlines the importance of gemfibrozil, a Food and Drug Administration-approved lipid-lowering drug, in up-regulating the expression of SOCS3 in glial cells. Gemfibrozil increased the expression of Socs3 mRNA and protein in mouse astroglia and microglia in both a time- and dose-dependent manner. Interestingly, gemfibrozil induced the activation of type IA phosphatidylinositol (PI) 3-kinase and AKT. Accordingly, inhibition of PI 3-kinase and AKT by chemical inhibitors abrogated gemfibrozil-mediated up-regulation of SOCS3. Furthermore, we demonstrated that gemfibrozil induced the activation of Kruppel-like factor 4 (KLF4) via the PI 3-kinase-AKT pathway and that siRNA knockdown of KLF4 abrogated gemfibrozil-mediated up-regulation of SOCS3. Gemfibrozil also induced the recruitment of KLF4 to the distal, but not proximal, KLF4-binding site of the Socs3 promoter. This study delineates a novel property of gemfibrozil in up-regulating SOCS3 in glial cells via PI 3-kinase-AKT-mediated activation of KLF4 and suggests that gemfibrozil may find therapeutic application in neuroinflammatory and neurodegenerative disorders.	[Ghosh, Arunava; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		GHOSH, ARUNAVA/0000-0002-8471-8161	National Institutes of Health Grants [AT6681, NS64564, NS71479]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071479, R21NS064564] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479.	Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; ANDREWS S, 2007, SCI STKE, pCM2; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Barclay JL, 2007, MOL ENDOCRINOL, V21, P2516, DOI 10.1210/me.2007-0030; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fukushima A, 2010, J ENDODONT, V36, P1004, DOI 10.1016/j.joen.2010.02.027; Gatto L, 2004, J BIOL CHEM, V279, P13746, DOI 10.1074/jbc.M308999200; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hagos EG, 2011, AM J CANCER RES, V1, P85; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hannan KM, 2003, BIOCHEM J, V370, P469, DOI 10.1042/BJ20021709; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Liu JW, 2008, SHOCK, V30, P260, DOI 10.1097/shk.0b013e318162bef7; Liu JW, 2007, BIOCHEM BIOPH RES CO, V362, P575, DOI 10.1016/j.bbrc.2007.07.157; Liu Y, 2010, CELL STRESS CHAPERON, V15, P211, DOI 10.1007/s12192-009-0135-8; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Peraldi P, 2001, J BIOL CHEM, V276, P24614, DOI 10.1074/jbc.M102209200; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Ramgolam V. S., 2011, J SIGNAL TRANSDUCT; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; RUBINS HB, 1992, J INTERN MED, V231, P421, DOI 10.1111/j.1365-2796.1992.tb00954.x; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Stark JL, 2006, INT IMMUNOL, V18, P347, DOI 10.1093/intimm/dxh373; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Yan FF, 2008, MED HYPOTHESES, V70, P845, DOI 10.1016/j.mehy.2007.07.031; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303	53	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27189	27203		10.1074/jbc.M112.346932	http://dx.doi.org/10.1074/jbc.M112.346932			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685291	hybrid, Green Published			2022-12-25	WOS:000307386000071
J	van Eijk, M; Rynkiewicz, MJ; White, MR; Hartshorn, KL; Zou, XQ; Schulten, K; Luo, D; Crouch, EC; Cafarella, TR; Head, JF; Haagsman, HP; Seaton, BA				van Eijk, Martin; Rynkiewicz, Michael J.; White, Mitchell R.; Hartshorn, Kevan L.; Zou, Xueqing; Schulten, Klaus; Luo, Dong; Crouch, Erika C.; Cafarella, Tanya R.; Head, James F.; Haagsman, Henk P.; Seaton, Barbara A.			A Unique Sugar-binding Site Mediates the Distinct Anti-influenza Activity of Pig Surfactant Protein D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUSES; INNATE IMMUNE PROTEINS; CARBOHYDRATE-RECOGNITION; MOLECULAR-DYNAMICS; ANTIVIRAL ACTIVITY; COLLECTINS; DOMAIN; MODEL; HEMAGGLUTININ; TRANSMISSION	Pigs can act as intermediate hosts by which reassorted influenza A virus (IAV) strains can be transmitted to humans and cause pandemic influenza outbreaks. The innate host defense component surfactant protein D (SP-D) interacts with glycans on the hemagglutinin of IAV and contributes to protection against IAV infection in mammals. This study shows that a recombinant trimeric neck lectin fragment derived from porcine SP-D (pSP-D) exhibits profound inhibitory activity against IAV, in contrast to comparable fragments derived from human SP-D. Crystallographic analysis of the pSP-D fragment complexed with a viral sugar component shows that a unique tripeptide loop alters the lectin site conformation of pSP-D. Molecular dynamics simulations highlight the role of this flexible loop, which adopts a more stable conformation upon sugar binding and may facilitate binding to viral glycans through contact with distal portions of the branched mannoside. The combined data demonstrate that porcine-specific structural features of SP-D contribute significantly to its distinct anti-IAV activity. These findings could help explain why pigs serve as important reservoirs for newly emerging pathogenic IAV strains.	[Rynkiewicz, Michael J.; Luo, Dong; Cafarella, Tanya R.; Head, James F.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [White, Mitchell R.; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Zou, Xueqing; Schulten, Klaus] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Crouch, Erika C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Boston University; Boston University; Utrecht University; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL)	Seaton, BA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 715 Albany St, Boston, MA 02118 USA.	seatonba@bu.edu	Haagsman, Henk P/F-8919-2010	Hartshorn, Kevan/0000-0002-7196-7433; Zou, Xueqing/0000-0003-1143-1028; Rynkiewicz, Michael/0000-0002-4717-5700; Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709	Texas Advanced Computing Center via TeraGrid Resource Allocation Committee [MCA93S028]; National Institutes of Health [AI083222, HL069031, P41-RR005969]; European Union FP6 Grant Specific Targeted Research Project [LSHM-CT-2004-512093]; Human Frontier Science Program [RGP0016/2009-C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	Texas Advanced Computing Center via TeraGrid Resource Allocation Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union FP6 Grant Specific Targeted Research Project; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M. V. E. and H. P. H. thank Sanne Raadsveld for technical support. Supercomputer time was provided by Texas Advanced Computing Center via TeraGrid Resource Allocation Committee Grant MCA93S028.; This work was supported, in whole or in part, by National Institutes of Health Grants AI083222 (to B. A. S.) and HL069031 (to K. L. H.). This work was also supported by European Union FP6 Grant Specific Targeted Research Project Contract LSHM-CT-2004-512093 (to H. P. H.) and Human Frontier Science Program Grant RGP0016/2009-C (to H. P. H.); Recipient of National Institutes of Health Grant P41-RR005969.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cason C., 2005, PERSISTENCE VISION; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch E, 2011, J BIOL CHEM, V286, P40681, DOI 10.1074/jbc.M111.300673; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 2010, SCAND J IMMUNOL, V72, P22, DOI 10.1111/j.1365-3083.2010.02409.x; Hartshorn KL, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-9; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Liu W, 2011, VET J, V187, P200, DOI 10.1016/j.tvjl.2009.10.026; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Morlot C, 2007, ACTA CRYSTALLOGR D, V63, P961, DOI 10.1107/S0907444907035470; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reading PC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-117; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Tecle T, 2008, BIOCHEM J, V412, P323, DOI 10.1042/BJ20071663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; van Eijk M, 2011, J BIOL CHEM, V286, P20137, DOI 10.1074/jbc.M111.224469; Van Reeth K, 2007, VET RES, V38, P243, DOI 10.1051/vetres:2006062; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Webster RG, 1997, ARCH VIROL, P105; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; White M, 2008, J IMMUNOL, V181, P7936, DOI 10.4049/jimmunol.181.11.7936; White MR, 2008, EXPERT REV CLIN IMMU, V4, P497, DOI 10.1586/1744666X.4.4.497; White MR, 2005, AM J PHYSIOL-LUNG C, V289, pL606, DOI 10.1152/ajplung.00130.2005	65	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26666	26677		10.1074/jbc.M112.368571	http://dx.doi.org/10.1074/jbc.M112.368571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685299	Green Published, hybrid			2022-12-25	WOS:000307386000018
J	Singh, A; Ram, H; Abbas, N; Chattopadhyay, S				Singh, Aparna; Ram, Hathi; Abbas, Nazia; Chattopadhyay, Sudip			Molecular Interactions of GBF1 with HY5 and HYH Proteins during Light-mediated Seedling Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX BINDING-FACTORS; TRANSCRIPTION-FACTOR; GENE-EXPRESSION; BLUE-LIGHT; PHYTOCHROME-A; PHOTOMORPHOGENIC GROWTH; BZIP PROTEINS; COP1; PROMOTERS; HYPOCOTYL	Arabidopsis bZIP transcription factor, GBF1, acts as a differential regulator of cryptochrome-mediated blue light signaling. Whereas the bZIP proteins, HY5 (elongated hypocotyl 5) and HYH (HY5 homologue), are degraded by COP1-mediated proteasomal pathways, GBF1 is degraded by a proteasomal pathway independent of COP1. In this study, we have investigated the functional interrelations of GBF1 with HY5 and HYH in Arabidopsis seedling development. The genetic studies using double and triple mutants reveal that GBF1 largely acts antagonistically with HY5 and HYH in Arabidopsis seedling development. Further, GBF1 and HY5 play more important roles than HYH in blue light-mediated photomorphogenic growth. This study reveals that GBF1 is able to form a G-box-binding heterodimer with HY5 but not with HYH. The in vitro and in vivo studies demonstrate that GBF1 co-localizes with HY5 or HYH in the nucleus and physically interacts with both of the proteins. The protein-protein interaction studies further reveal that the bZIP domain of GBF1 is essential and sufficient for the interaction with HY5 or HYH. Taken together, these data demonstrate the functional interrelations of GBF1 with HY5 and HYH in Arabidopsis seedling development.	[Chattopadhyay, Sudip] Natl Inst Technol, Dept Biotechnol, Durgapur 713209, W Bengal, India; [Singh, Aparna; Ram, Hathi; Abbas, Nazia] Natl Inst Plant Genome Res, New Delhi 10067, India	National Institute of Technology (NIT System); National Institute of Technology Durgapur; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, S (corresponding author), Natl Inst Technol, Dept Biotechnol, Mahatma Gandhi Ave, Durgapur 713209, W Bengal, India.	sudipchatto@gmail.com	Chattopadhyay, Sudip/P-8491-2014	Ram, Dr Hasthi/0000-0003-0893-3895	J.C. Bose National Fellowship Award Grant; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	J.C. Bose National Fellowship Award Grant; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is supported by a J.C. Bose National Fellowship Award Grant and in part by a research grant from the Department of Science and Technology, Government of India (to S. C.).; Both authors contributed equally to this work and are recipients of fellowships from the Council of Scientific and Industrial Research, Government of India.; Recipient of a fellowship from the Department of Biotechnology, Government of India.	ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bhatia S, 2008, PLANT PHYSIOL, V147, P169, DOI 10.1104/pp.108.118174; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT J, V15, P69, DOI 10.1046/j.1365-313X.1998.00180.x; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; HARTER K, 1994, PLANT CELL, V6, P545, DOI 10.1105/tpc.6.4.545; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kirby J, 2002, PLANT J, V32, P391, DOI 10.1046/j.1365-313X.2002.01422.x; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kushwaha R, 2008, PLANT CELL, V20, P1747, DOI 10.1105/tpc.107.057612; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lin C, 2002, SCI STKE, V2002, ppe5; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mallappa C, 2008, J BIOL CHEM, V283, P35772, DOI 10.1074/jbc.M803437200; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Neff MM, 2000, GENE DEV, V14, P257; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1998, PLANT J, V16, P201, DOI 10.1046/j.1365-313x.1998.00290.x; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Pepper AE, 1997, GENETICS, V145, P1125; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Schepens I, 2004, CURR OPIN PLANT BIOL, V7, P564, DOI 10.1016/j.pbi.2004.07.004; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yadav V, 2002, PLANT J, V31, P741, DOI 10.1046/j.1365-313X.2002.01395.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x	45	63	73	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25995	26009		10.1074/jbc.M111.333906	http://dx.doi.org/10.1074/jbc.M111.333906			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692212	hybrid, Green Published			2022-12-25	WOS:000306916300027
J	Vaiyapuri, S; Hutchinson, EG; Ali, MS; Dannoura, A; Stanley, RG; Harrison, RA; Bicknell, AB; Gibbins, JM				Vaiyapuri, Sakthivel; Hutchinson, E. Gail; Ali, Marfoua S.; Dannoura, Abeer; Stanley, Ronald G.; Harrison, Robert A.; Bicknell, Andrew B.; Gibbins, Jonathan M.			Rhinocetin, a Venom-derived Integrin-specific Antagonist Inhibits Collagen-induced Platelet and Endothelial Cell Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; CROTALUS-DURISSUS-TERRIFICUS; BITIS-GABONICA-RHINOCEROS; ALPHA-2-BETA-1 INTEGRIN; VONWILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; SNAKE-VENOMS; BINDING; PROTEIN; VIPER	Snaclecs are small non-enzymatic proteins present in viper venoms reported to modulate hemostasis of victims through effects on platelets, vascular endothelial, and smooth muscle cells. In this study, we have isolated and functionally characterized a snaclec that we named "rhinocetin" from the venom of West African gaboon viper, Bitis gabonica rhinoceros. Rhinocetin was shown to comprise alpha and beta chains with the molecular masses of 13.5 and 13 kDa, respectively. Sequence and immunoblot analysis of rhinocetin confirmed this to be a novel snaclec. Rhinocetin inhibited collagen-stimulated activation of human platelets in a dose-dependent manner but displayed no inhibitory effects on glycoprotein VI (collagen receptor) selective agonist, CRP-XL-, ADP-, or thrombin-induced platelet activation. Rhinocetin antagonized the binding of monoclonal antibodies against the alpha 2 subunit of integrin alpha 2 beta 1 to platelets and coimmunoprecipitation analysis confirmed integrin alpha 2 beta 1 as a target for this venom protein. Rhinocetin inhibited a range of collagen-induced platelet functions such as fibrinogen binding, calcium mobilization, granule secretion, aggregation, and thrombus formation. It also inhibited integrin alpha 2 beta 1-dependent functions of human endothelial cells. Together, our data suggest rhinocetin to be a modulator of integrin alpha 2 beta 1 function and thus may provide valuable insights into the role of this integrin in physiological and pathophysiological scenarios, including hemostasis, thrombosis, and envenomation.	[Vaiyapuri, Sakthivel; Hutchinson, E. Gail; Ali, Marfoua S.; Stanley, Ronald G.; Bicknell, Andrew B.; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading RG6 6UB, Berks, England; [Dannoura, Abeer] Univ Reading, Sch Pharm Food Biosci & Chem, Reading RG6 6UB, Berks, England; [Harrison, Robert A.] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England	University of Reading; University of Reading; Liverpool School of Tropical Medicine; University of Liverpool	Gibbins, JM (corresponding author), Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading RG6 6UB, Berks, England.	j.m.gibbins@reading.ac.uk	Vaiyapuri, Sakthivel/M-4198-2013; ali, marfoua saleh/H-9824-2019	Vaiyapuri, Sakthivel/0000-0002-6006-6517; Gibbins, Jonathan/0000-0002-0372-5352	British Heart Foundation [PG/08/100/26125, PG/11/125/29320]; Medical Research Council UK [G0701399]; Biotechnology and Biological Sciences Research Council [BB/F012675/1]; Medical Research Council [G0701399] Funding Source: researchfish; BBSRC [BB/F012675/1] Funding Source: UKRI; MRC [G0701399] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Grants PG/08/100/26125 and PG/11/125/29320, Medical Research Council UK Grant G0701399, and Biotechnology and Biological Sciences Research Council Grant BB/F012675/1.	Aird SD, 2002, TOXICON, V40, P335, DOI 10.1016/S0041-0101(01)00232-X; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Clemetson K. J., 2002, PLATELET RECEPTORS P, P117; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; COLLER BS, 1989, BLOOD, V74, P182; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Du XY, 2002, J BIOL CHEM, V277, P35124, DOI 10.1074/jbc.M204372200; Eble JA, 2009, FASEB J, V23, P2917, DOI 10.1096/fj.08-126763; Fox JW, 2007, CURR PHARM DESIGN, V13, P2927, DOI 10.2174/138161207782023739; Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693; Harrison RA, 2003, GENE, V315, P95, DOI 10.1016/S0378-1119(03)00716-9; HATHAWAY DR, 1979, P NATL ACAD SCI USA, V76, P1653, DOI 10.1073/pnas.76.4.1653; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Kaiser WJ, 2009, J PROTEOME RES, V8, P2903, DOI 10.1021/pr900027j; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latallo Z. S., 1971, SCAND J HAEMAT     S, V13, P261; Marcinkiewicz C, 2005, CURR PHARM DESIGN, V11, P815, DOI 10.2174/1381612053381765; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016; MARSH NA, 1974, BRIT J HAEMATOL, V26, P295, DOI 10.1111/j.1365-2141.1974.tb00474.x; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Murakami MT, 2003, BIOCHEM BIOPH RES CO, V310, P478, DOI 10.1016/j.bbrc.2003.09.032; PENG ML, 1993, BLOOD, V81, P2321; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; READ MS, 1983, J LAB CLIN MED, V101, P74; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sajevic T, 2011, TOXICON, V57, P627, DOI 10.1016/j.toxicon.2011.01.006; Sarray S, 2003, BBA-PROTEINS PROTEOM, V1651, P30, DOI 10.1016/S1570-9639(03)00232-2; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Smith RA, 1997, J BIOL CHEM, V272, P22080, DOI 10.1074/jbc.272.35.22080; Spyridon M, 2011, BLOOD, V117, P5751, DOI 10.1182/blood-2010-09-306142; Staniszewska I, 2009, CANCER BIOL THER, V8, P1507, DOI 10.4161/cbt.8.15.8999; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Vaiyapuri S, 2012, CIRCULATION, V125, P2479, DOI 10.1161/CIRCULATIONAHA.112.101246; Vaiyapuri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021532; Vaiyapuri S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000796; Vaiyapuri S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009687; Wang RH, 1999, BIOCHEMISTRY-US, V38, P7584, DOI 10.1021/bi982132z; White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhong SR, 2006, TOXICON, V47, P104, DOI 10.1016/j.toxicon.2005.10.002	53	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26235	26244		10.1074/jbc.M112.381483	http://dx.doi.org/10.1074/jbc.M112.381483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689571	Green Published, hybrid			2022-12-25	WOS:000306916300050
J	Esteves, TC; Psathaki, OE; Pfeiffer, MJ; Balbach, ST; Zeuschner, D; Shitara, H; Yonekawa, H; Siatkowski, M; Fuellen, G; Boiani, M				Esteves, Telma C.; Psathaki, Olympia E.; Pfeiffer, Martin J.; Balbach, Sebastian T.; Zeuschner, Dagmar; Shitara, Hiroshi; Yonekawa, Hiromichi; Siatkowski, Marcin; Fuellen, Georg; Boiani, Michele			Mitochondrial Physiology and Gene Expression Analyses Reveal Metabolic and Translational Dysregulation in Oocyte-Induced Somatic Nuclear Reprogramming	PLOS ONE			English	Article							CLONED MOUSE EMBRYOS; ENDOPLASMIC-RETICULUM-STRESS; GREEN FLUORESCENT PROTEIN; REDOX REGULATION; POSTTRANSCRIPTIONAL REGULATION; TRANSGENIC MICE; BOVINE EMBRYOS; IN-VITRO; ACTIVATION; CYTOPLASM	While reprogramming a foreign nucleus after somatic cell nuclear transfer (SCNT), the enucleated oocyte (ooplasm) must signal that biomass and cellular requirements changed compared to the nucleus donor cell. Using cells expressing nuclear-encoded but mitochondria-targeted EGFP, a strategy was developed to directly distinguish maternal and embryonic products, testing ooplasm demands on transcriptional and post-transcriptional activity during reprogramming. Specifically, we compared transcript and protein levels for EGFP and other products in pre-implantation SCNT embryos, side-by-side to fertilized controls (embryos produced from the same oocyte pool, by intracytoplasmic injection of sperm containing the EGFP transgene). We observed that while EGFP transcript abundance is not different, protein levels are significantly lower in SCNT compared to fertilized blastocysts. This was not observed for Gapdh and Actb, whose protein reflected mRNA. This transcript-protein relationship indicates that the somatic nucleus can keep up with ooplasm transcript demands, whilst transcription and translation mismatch occurs after SCNT for certain mRNAs. We further detected metabolic disturbances after SCNT, suggesting a place among forces regulating post-transcriptional changes during reprogramming. Our observations ascribe oocyte-induced reprogramming with previously unsuspected regulatory dimensions, in that presence of functional proteins may no longer be inferred from mRNA, but rather depend on post-transcriptional regulation possibly modulated through metabolism.	[Esteves, Telma C.; Psathaki, Olympia E.; Pfeiffer, Martin J.; Balbach, Sebastian T.; Zeuschner, Dagmar; Boiani, Michele] Max Planck Inst Mol Biomed, Munster, Germany; [Shitara, Hiroshi; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Lab Transgen Technol, Tokyo 113, Japan; [Shitara, Hiroshi; Yonekawa, Hiromichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Siatkowski, Marcin] German Ctr Neurodegenerat Disorders, Rostock, Germany; [Siatkowski, Marcin; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany	Max Planck Society; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rostock	Esteves, TC (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	mboiani@mpi-muenster.mpg.de	Balbach, Sebastian Thomas/A-1107-2009; Pfeiffer, Martin Johannes/A-9332-2011; Boiani, Michele/M-3519-2015	Balbach, Sebastian Thomas/0000-0003-0212-5758; Pfeiffer, Martin Johannes/0000-0001-9264-9218; Boiani, Michele/0000-0003-2765-2781; Esteves, Telma Cristina/0000-0002-8642-4722	Max-Planck Society; Deutsche Forschungsgemeinschaft [BO 2540/4-1]	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Max-Planck Society, and the Deutsche Forschungsgemeinschaft (BO 2540/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2008, CURR PHARM DESIGN, V14, P2651, DOI 10.2174/138161208786264052; Amarnath D, 2011, REPRODUCTION, V142, P295, DOI 10.1530/REP-11-0044; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; EBERT KM, 1988, J REPROD FERTIL, V82, P145, DOI 10.1530/jrf.0.0820145; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Guo Y, 2004, STEM CELLS, V22, P259, DOI 10.1634/stemcells.22-3-259; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hao LP, 2009, BIOL REPROD, V80, P944, DOI 10.1095/biolreprod.108.072546; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Hiendleder S, 2005, REPROD FERT DEVELOP, V17, P69, DOI 10.1071/RD04115; HOWLETT SK, 1987, DEVELOPMENT, V101, P915; Hua S, 2011, ANIM REPROD SCI, V126, P37, DOI 10.1016/j.anireprosci.2011.05.002; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Lloyd RE, 2006, GENETICS, V172, P2515, DOI 10.1534/genetics.105.055145; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Metzler D E, 2003, BIOCH CHEM REACTIONS; Ng RK, 2005, CELL CYCLE, V4, P760, DOI 10.4161/cc.4.6.1743; Paciolla M, 2011, HUM REPROD, V26, P1191, DOI 10.1093/humrep/der040; Peura TT, 1998, MOL REPROD DEV, V50, P185, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;185::AID-MRD9&gt;3.0.CO;2-G; Pfeiffer MJ, 2010, INT J DEV BIOL, V54, P1649, DOI 10.1387/ijdb.103197mp; Ross PJ, 2010, CELL REPROGRAM, V12, P709, DOI 10.1089/cell.2010.0036; Ross PJ, 2009, REPRODUCTION, V137, P427, DOI 10.1530/REP-08-0419; Sayaka W, 2008, ZYGOTE, V16, P211, DOI 10.1017/S0967199408004620; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Sebastiano V, 2005, MOL REPROD DEV, V70, P146, DOI 10.1002/mrd.20144; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sheikh MS, 1999, ONCOGENE, V18, P6121, DOI 10.1038/sj.onc.1203131; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Shitara H, 2010, EXP ANIM TOKYO, V59, P99, DOI 10.1538/expanim.59.99; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Song BS, 2011, REPROD FERT DEVELOP, V23, P826, DOI 10.1071/RD10194; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519	50	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36850	10.1371/journal.pone.0036850	http://dx.doi.org/10.1371/journal.pone.0036850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693623	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900002
J	Han, YS; Yambot, AV; Zhang, H; Hung, CL				Han, Yu-San; Yambot, Apolinario V.; Zhang, Heng; Hung, Chia-Ling			Sympatric Spawning but Allopatric Distribution of Anguilla japonica and Anguilla marmorata: Temperature- and Oceanic Current-Dependent Sieving	PLOS ONE			English	Article							TROPICAL EELS ANGUILLA; FRESH-WATER EELS; EARLY-LIFE-HISTORY; GIANT MOTTLED EEL; GLASS-EELS; JAPANESE EEL; WESTERN PACIFIC; SEASONAL OCCURRENCE; INSHORE MIGRATION; EUROPEAN EEL	Anguilla japonica and Anguilla marmorata share overlapping spawning sites, similar drifting routes, and comparable larval durations. However, they exhibit allopatric geographical distributions in East Asia. To clarify this ecological discrepancy, glass eels from estuaries in Taiwan, the Philippines, Indonesia, and China were collected monthly, and the survival rate of A. marmorata under varying water salinities and temperatures was examined. The composition ratio of these 2 eel species showed a significant latitude cline, matching the 24 degrees C sea surface temperature isotherm in winter. Both species had opposing temperature preferences for recruitment. A. marmorata prefer high water temperatures and die at low water temperatures. In contrast, A. japonica can endure low water temperatures, but their recruitment is inhibited by high water temperatures. Thus, A. japonica glass eels, which mainly spawn in summer, are preferably recruited to Taiwan, China, Korea, and Japan by the Kuroshio and its branch waters in winter. Meanwhile, A. marmorata glass eels, which spawn throughout the year, are mostly screened out in East Asia in areas with low-temperature coastal waters in winter. During summer, the strong northward currents from the South China Sea and Changjiang River discharge markedly block the Kuroshio invasion and thus restrict the approach of A. marmorata glass eels to the coasts of China and Korea. The differences in the preferences of the recruitment temperature for glass eels combined with the availability of oceanic currents shape the real geographic distribution of Anguilla japonica and Anguilla marmorata, making them "temperate" and "tropical" eels, respectively.	[Han, Yu-San; Hung, Chia-Ling] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan; [Yambot, Apolinario V.] Cent Luzon State Univ, Coll Fisheries, Freshwater Aquaculture Ctr, Sci City Munoz, Philippines; [Zhang, Heng] Chinese Acad Fishery Sci, E China Sea Fisheries Res Inst, Shanghai, Peoples R China	National Taiwan University; Central Luzon State University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Han, YS (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan.	yshan@ntu.edu.tw		HAN, YU-SAN/0000-0002-9236-9045	National Science Council (NSC) of the Executive Yuan, Taiwan [NSC 99-2923-B-002-005-MY3, NSC 99-2313-B-002-021-MY3]; Council of Agriculture of the Executive Yuan, Taiwan [98 AS-10.3.1-F2-5, 99 AS-9.1-F-01-15-2]	National Science Council (NSC) of the Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Council of Agriculture of the Executive Yuan, Taiwan	This study was funded by the National Science Council (NSC) of the Executive Yuan, Taiwan (NSC 99-2923-B-002-005-MY3 and NSC 99-2313-B-002-021-MY3), and by the Council of Agriculture of the Executive Yuan, Taiwan (98 AS-10.3.1-F2-5 and 99 AS-9.1-F-01-15-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; Arai T, 2002, FISHERIES SCI, V68, P152, DOI 10.1046/j.1444-2906.2002.00401.x; Arai T, 2001, MAR BIOL, V138, P887; Arai T, 2001, MAR ECOL PROG SER, V216, P253, DOI 10.3354/meps216253; August SM, 2008, ENVIRON BIOL FISH, V81, P195, DOI 10.1007/s10641-007-9191-z; BEUMER J, 1990, INT REV GES HYDROBIO, V75, P721, DOI 10.1002/iroh.19900750606; Beumer JP, 1996, FRESHWATER FISHES SE; Bruton NM, 1987, AM FISH SOC S, V1, P104; Chen CTA, 2008, J OCEANOGR, V64, P737, DOI 10.1007/s10872-008-0062-9; Chen CTA, 2009, J MARINE SYST, V78, P394, DOI 10.1016/j.jmarsys.2008.11.016; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Dou S, 2003, J FISH BIOL, V63, P152, DOI 10.1111/j.1095-8649.2003.00211.x; Ege V., 1939, DANA REP, V16, P1, DOI DOI 10.1007/S11160-005-7431-X; Fukuda N, 2009, J FISH BIOL, V74, P1915, DOI 10.1111/j.1095-8649.2009.02287.x; GUAN B.X., 1994, OCEANOLOGY CHINA SEA, V1, P17, DOI DOI 10.1007/978-94-011-0862-1_3; Han YS, 2002, J FISH BIOL, V60, P1608, DOI 10.1006/jfbi.2002.2022; Han YS, 2012, FISH OCEANO IN PRESS; Han YS, 2012, EELS PHYSL IN PRESS; Han YS, 2011, MAR BIOL, V158, P2349, DOI 10.1007/s00227-011-1739-y; Han YS, 2010, MAR ECOL PROG SER, V401, P221, DOI 10.3354/meps08422; Hsueh Y, 1996, J GEOPHYS RES-OCEANS, V101, P3851, DOI 10.1029/95JC03754; Hsueh Y, 2000, J MARINE SYST, V24, P131, DOI 10.1016/S0924-7963(99)00083-4; Ishikawa S, 2004, ICHTHYOL RES, V51, P343, DOI 10.1007/s10228-004-0241-7; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Jubb R. A., 1964, Monographiae Biologicae, V14, P186; Kim WS, 2002, MAR ECOL PROG SER, V243, P209, DOI 10.3354/meps243209; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; Kuroki M, 2006, MAR ECOL PROG SER, V309, P233, DOI 10.3354/meps309233; Kuroki M, 2009, J FISH BIOL, V74, P1853, DOI 10.1111/j.1095-8649.2009.02299.x; Kuroki M, 2008, MAR FRESHWATER RES, V59, P1035, DOI 10.1071/MF08041; Matsui I., 1952, Journal of the Shimonoseki College of Fisheries, VNo.2, P1; Minegishi Y, 2008, MOL ECOL, V17, P3109, DOI 10.1111/j.1365-294X.2008.03822.x; Pous S, 2010, PROG OCEANOGR, V86, P396, DOI 10.1016/j.pocean.2010.06.002; Robinet T, 2008, MAR BIOL, V154, P453, DOI 10.1007/s00227-008-0938-7; Robinet T, 2003, MAR ECOL PROG SER, V259, P263, DOI 10.3354/meps259263; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Shiao JC, 2002, MAR FRESHWATER RES, V53, P687, DOI 10.1071/MF01037; Sinclair M, 1988, MARINE POPULATIONS E; SU JL, 1990, OCEANOGR MAR BIOL, V28, P11; Sugeha HY, 2001, MAR ECOL PROG SER, V221, P233, DOI 10.3354/meps221233; TABETA O, 1976, B JPN SOC SCI FISH, V42, P421; Teng HY, 2009, ZOOL STUD, V48, P808; Tesch FW, 2003, EEL, P100; Tsukamoto K, 2001, MAR ECOL PROG SER, V220, P265, DOI 10.3354/meps220265; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2009, MAR BIOL, V156, P835, DOI 10.1007/s00227-008-1123-8; Tzeng WN, 2002, MAR ECOL PROG SER, V245, P213, DOI 10.3354/meps245213; Wang CH, 2000, FISH RES, V46, P191, DOI 10.1016/S0165-7836(00)00146-6; Watanabe S, 2008, COPEIA, P680, DOI 10.1643/CG-07-080; Watanabe S, 2009, FISHERIES SCI, V75, P387, DOI 10.1007/s12562-009-0087-z; Xiong Guo-Qiang, 1992, Acta Zoologica Sinica, V38, P254; Yamamoto T, 2001, FISHERIES SCI, V67, P530, DOI 10.1046/j.1444-2906.2001.00285.x; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x	57	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37484	10.1371/journal.pone.0037484	http://dx.doi.org/10.1371/journal.pone.0037484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675481	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341700014
J	Kraiselburd, I; Alet, AI; Tondo, ML; Petrocelli, S; Daurelio, LD; Monzon, J; Ruiz, OA; Losi, A; Orellano, EG				Kraiselburd, Ivana; Alet, Analia I.; Laura Tondo, Maria; Petrocelli, Silvana; Daurelio, Lucas D.; Monzon, Jesica; Ruiz, Oscar A.; Losi, Aba; Orellano, Elena G.			A LOV Protein Modulates the Physiological Attributes of Xanthomonas axonopodis pv. citri Relevant for Host Plant Colonization	PLOS ONE			English	Article							BLUE-LIGHT RECEPTOR; PHOTOTROPIN-RELATED PROTEIN; BIOFILM FORMATION; SIGNALING MECHANISM; TWITCHING MOTILITY; BACILLUS-SUBTILIS; DOMAIN; CAMPESTRIS; BACTERIA; BINDING	Recent studies have demonstrated that an appropriate light environment is required for the establishment of efficient vegetal resistance responses in several plant-pathogen interactions. The photoreceptors implicated in such responses are mainly those belonging to the phytochrome family. Data obtained from bacterial genome sequences revealed the presence of photosensory proteins of the BLUF (Blue Light sensing Using FAD), LOV (Light, Oxygen, Voltage) and phytochrome families with no known functions. Xanthomonas axonopodis pv. citri is a Gram-negative bacterium responsible for citrus canker. The in silico analysis of the X. axonopodis pv. citri genome sequence revealed the presence of a gene encoding a putative LOV photoreceptor, in addition to two genes encoding BLUF proteins. This suggests that blue light sensing could play a role in X. axonopodis pv. citri physiology. We obtained the recombinant Xac-LOV protein by expression in Escherichia coli and performed a spectroscopic analysis of the purified protein, which demonstrated that it has a canonical LOV photochemistry. We also constructed a mutant strain of X. axonopodis pv. citri lacking the LOV protein and found that the loss of this protein altered bacterial motility, exopolysaccharide production and biofilm formation. Moreover, we observed that the adhesion of the mutant strain to abiotic and biotic surfaces was significantly diminished compared to the wild-type. Finally, inoculation of orange (Citrus sinensis) leaves with the mutant strain of X. axonopodis pv. citri resulted in marked differences in the development of symptoms in plant tissues relative to the wild-type, suggesting a role for the Xac-LOV protein in the pathogenic process. Altogether, these results suggest the novel involvement of a photosensory system in the regulation of physiological attributes of a phytopathogenic bacterium. A functional blue light receptor in Xanthomonas spp. has been described for the first time, showing an important role in virulence during citrus canker disease.	[Kraiselburd, Ivana; Alet, Analia I.; Laura Tondo, Maria; Petrocelli, Silvana; Daurelio, Lucas D.; Monzon, Jesica; Orellano, Elena G.] Univ Nacl Rosario, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR, CONICET,Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina; [Ruiz, Oscar A.] IIB INTECH, Unidad Biotecnol, Buenos Aires, DF, Argentina; [Losi, Aba] Univ Parma, Dept Phys, I-43100 Parma, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Parma	Kraiselburd, I (corresponding author), Univ Nacl Rosario, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR, CONICET,Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina.	orellano@ibr.gov.ar	Losi, Aba/M-8709-2015; Daurelio, Lucas/AAT-6969-2020; Kraiselburd, Ivana/AAI-8743-2020	Losi, Aba/0000-0003-0497-2723; Kraiselburd, Ivana/0000-0002-9677-6094; Tondo, Maria Laura/0000-0002-0160-1882; Daurelio, Lucas Damian/0000-0002-1156-2266	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1762]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 112-2009-01-00873]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants PICT 2010-1762, Agencia Nacional de Promocion Cientifica y Tecnologica to EGO; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina (www.agencia.mincyt.gov.ar); and PIP 112-2009-01-00873 to EGO from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. EGO, LDD, and OAR are staff members and IK, AA, MLT, and SP are Fellows of the CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Bechtold U, 2005, PLANT CELL ENVIRON, V28, P1046, DOI 10.1111/j.1365-3040.2005.01340.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio Lucas D., 2009, P187; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Griebel T, 2008, PLANT PHYSIOL, V147, P790, DOI 10.1104/pp.108.119503; GUO A, 1993, PHYSIOL MOL PLANT P, V42, P413, DOI 10.1006/pmpp.1993.1031; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hellingwerf KJ, 1996, MOL MICROBIOL, V21, P683, DOI 10.1046/j.1365-2958.1996.411402.x; Hendrischk AK, 2009, PHOTOCHEM PHOTOBIOL, V85, P1254, DOI 10.1111/j.1751-1097.2009.00554.x; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Kanazawa T, 2010, BIOCHEMISTRY-US, V49, P10647, DOI 10.1021/bi101448t; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Losi A, 2004, PHOTOCHEM PHOTOBIOL, V80, P150, DOI 10.1562/2004-03-17-RC-116.1; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oberpichler I, 2008, ENVIRON MICROBIOL, V10, P2020, DOI 10.1111/j.1462-2920.2008.01618.x; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Purcell EB, 2008, ADV EXP MED BIOL, V631, P122, DOI 10.1007/978-0-387-78885-2_8; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Qian W, 2008, MOL PLANT MICROBE IN, V21, P151, DOI 10.1094/MPMI-21-2-0151; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Romling U, 1998, J BACTERIOL, V180, P722; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song SH, 2011, BIOCHEMISTRY-US, V50, P2411, DOI 10.1021/bi200198x; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	86	48	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38226	10.1371/journal.pone.0038226	http://dx.doi.org/10.1371/journal.pone.0038226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675525	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341700047
J	Domingues, N; Matos, AR; da Silva, JM; Cartaxana, P				Domingues, Nuno; Matos, Ana Rita; da Silva, Jorge Marques; Cartaxana, Paulo			Response of the Diatom Phaeodactylum tricornutum to Photooxidative Stress Resulting from High Light Exposure	PLOS ONE			English	Article							PHOTOSYSTEM-II; DIADINOXANTHIN CYCLE; PLANKTONIC DIATOMS; ENERGY-DISSIPATION; PROTEIN; PHOTOPROTECTION; PHYTOPLANKTON; PHOTOINHIBITION; FLUORESCENCE; PHOTOSYNTHESIS	The response of microalgae to photooxidative stress resulting from high light exposure is a well-studied phenomenon. However, direct analyses of photosystem II (PSII) D1 protein (the main target of photoinhibition) in diatoms are scarce. In this study, the response of the diatom model species Phaeodactylum tricornutum to short-term exposure to high light was examined and the levels of D1 protein determined immunochemically. Low light (LL) acclimated cells (40 mu mol photons m(-2) s(-1)) subjected to high light (HL, 1,250 mmol photons m(-2) s(-1)) showed rapid induction of non-photochemical quenching (NPQ) and ca. 20-fold increase in diatoxanthin (DT) concentration. This resulted from the conversion of diadinoxanthin (DD) to DT through the activation of the DD-cycle. D1 protein levels under LL decreased about 30% after 1 h of the addition of lincomycin (LINC), a chloroplast protein synthesis inhibitor, showing significant D1 degradation and repair under low irradiance. Exposure to HL lead to a 3.2-fold increase in D1 degradation rate, whereas average D1 repair rate was 1.3-x higher under HL than LL, leading to decreased levels of D1 protein under HL. There were significant effects of both HL and LINC on P. tricornutum maximum quantum yield of PSII (F-v/F-m), showing a reduction of active PSII reaction centres. Partial recovery of F-v/F-m in the dark demonstrates the photosynthetic resilience of this diatom to changes in the light regime. P. tricornutum showed high allocation of total protein to D1 and an active D1-repair cycle to limit photoinhibition.	[Domingues, Nuno; Matos, Ana Rita; da Silva, Jorge Marques] Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Integrat & Func, Lisbon, Portugal; [Domingues, Nuno; Cartaxana, Paulo] Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Domingues, N (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Integrat & Func, Lisbon, Portugal.	pcartaxana@fc.ul.pt	Domingues, Nuno/H-2482-2017; da Silva, Jorge M L Marques/A-4905-2012; Cartaxana, Paulo/A-2063-2012	Domingues, Nuno/0000-0002-0692-9270; da Silva, Jorge M L Marques/0000-0002-5583-2715; Cartaxana, Paulo/0000-0001-5088-843X; Matos, Ana Rita/0000-0002-3495-2195	project MigROS [PTDC/MAR/112473/2009]; Portuguese Foundation for Science and Technology (FCT)	project MigROS; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by project MigROS (PTDC/MAR/112473/2009) funded by the Portuguese Foundation for Science and Technology (FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bouchard JN, 2005, J PHYCOL, V41, P273, DOI 10.1111/j.1529-8817.2005.04126.x; Cruz S, 2008, AQUAT BOT, V88, P256, DOI 10.1016/j.aquabot.2007.11.001; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Jansen MAK, 1999, EUR J BIOCHEM, V260, P527, DOI 10.1046/j.1432-1327.1999.00196.x; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; KRAAY GW, 1992, J PHYCOL, V28, P708, DOI 10.1111/j.0022-3646.1992.00708.x; Kropuenske LR, 2009, LIMNOL OCEANOGR, V54, P1176, DOI 10.4319/lo.2009.54.4.1176; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Petrou K, 2010, LIMNOL OCEANOGR, V55, P1400, DOI 10.4319/lo.2010.55.3.1400; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Ruivo M, 2011, J PLANKTON RES, V33, P1012, DOI 10.1093/plankt/fbr019; TING CS, 1994, PLANT PHYSIOL, V106, P763, DOI 10.1104/pp.106.2.763; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772	29	52	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38162	10.1371/journal.pone.0038162	http://dx.doi.org/10.1371/journal.pone.0038162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675519	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339900016
J	Hill, S; Yang, AN; Bero, L				Hill, Suzanne; Yang, Annie; Bero, Lisa			Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists	PLOS ONE			English	Article							COUNTRIES; AVAILABILITY	Background: In April 2011, the World Health Organization (WHO) published a list of "priority medicines" for maternal and child health based on 1) the global burden of disease and 2) evidence of efficacy and safety. The objective of this study was to examine the occurrence of these priority medicines on national essential medicines lists. Methods and Findings: All essential medicines lists published since 1999 were selected from the WHO website collection. The most-up-to date list for each country was then selected, resulting in 89 unique country lists. Each list was evaluated for inclusion of medicines (chemical entity, concentration, and dosage form) on the Priority Medicines List. There was global variation in the listing of the Priority Medicines. The most frequently listed medicine was paracetamol, on 94% (84/89) of lists. Sodium chloride, gentamicin and oral rehydration solution were on 93% (83/89) of lists. The least frequently listed medicine was the children's antimalarial rectal artesunate, on 8% of lists (7/89); artesunate injection was on 16% (14/89) of lists. Pediatric artemisinin combination therapy, as dispersible tablets or flexible oral solid dosage form, appeared on 36% (32/89) of lists. Procaine benzylpenicillin, for treatment of pediatric pneumonia and neonatal sepsis, was on 50% (45/89) of the lists. Zinc, for treatment of diarrhoea in children, was included on only 15% (13/89) of lists. For prevention and treatment of postpartum hemorrhage in women, oxytocin was more prevalent on the lists than misoprostol; they were included on 55 (62%) and 31 (35%) of lists, respectively. Cefixime, for treatment of uncomplicated anogenital gonococcal infection in woman was on 26% (23/89) of lists. Magnesium sulfate injection for treatment of severe pre-eclampsia and eclampsia was on 50% (45/89) of the lists. Conclusions: The findings suggest that countries need to urgently amend their lists to provide all priority medicines as part of the efforts to improve maternal and child health.	[Hill, Suzanne] World Hlth Org, Dept Essential Med & Pharmaceut Policies, Geneva, Switzerland; [Yang, Annie] Stanford Hosp & Clin, Stanford, CA USA; [Bero, Lisa] Univ Calif San Francisco, San Francisco, CA 94143 USA	World Health Organization; Stanford University; University of California System; University of California San Francisco	Hill, S (corresponding author), Australian Pharmaceut Benefits Advisory Comm, Dept Hlth & Aging, Canberra, ACT, Australia.	berol@pharmacy.ucsf.edu		Bero, Lisa/0000-0003-1893-6651	World Health Organization	World Health Organization(World Health Organization)	The study was partially funded by the World Health Organization. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Cham Mamady, 2009, Reprod Health, V6, P5, DOI 10.1186/1742-4755-6-5; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Gitanjali B, 2011, J PHARMACOL PHARMACO, V2, P95, DOI 10.4103/0976-500X.81900; Hill S, 2011, B WHO; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Hoppu K, 2011, ARCH DIS CHILD, V96, P764, DOI 10.1136/adc.2009.180000; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Oshikoya KA, 2010, ANN AFR MED, V9, P203, DOI 10.4103/1596-3519.70954; Ridge AL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-340; Robertson J, 2007, CLIN PHARMACOL THER, V82, P498, DOI 10.1038/sj.clpt.6100392; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2011, PRIOR MED MOTH CHILD; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2010, RAP ADV US ANT DRUGS; World Health Organization, 2010, DEF CONC ESS MED	17	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38055	10.1371/journal.pone.0038055	http://dx.doi.org/10.1371/journal.pone.0038055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675435	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500082
J	McAuley, EZ; Scimone, A; Tiwari, Y; Agahi, G; Mowry, BJ; Holliday, EG; Donald, JA; Weickert, CS; Mitchell, PB; Schofield, PR; Fullerton, JM				McAuley, Erica Z.; Scimone, Anna; Tiwari, Yash; Agahi, Giti; Mowry, Bryan J.; Holliday, Elizabeth G.; Donald, Jennifer A.; Weickert, Cynthia Shannon; Mitchell, Phillip B.; Schofield, Peter R.; Fullerton, Janice M.			Identification of Sialyltransferase 8B as a Generalized Susceptibility Gene for Psychotic and Mood Disorders on Chromosome 15q25-26	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; BIPOLAR AFFECTIVE-DISORDER; GENOME-WIDE SCAN; POLYSIALIC ACID; DIAGNOSTIC INTERVIEW; EMBRYONIC FORM; SCHIZOPHRENIA; ASSOCIATION; LINKAGE; POLYSIALYLTRANSFERASE	We previously identified a significant bipolar spectrum disorder linkage peak on 15q25-26 using 35 extended families with a broad clinical phenotype, including bipolar disorder (types I and II), recurrent unipolar depression and schizoaffective disorder. However, the specific gene(s) contributing to this signal had not been identified. By a fine mapping association study in an Australian case-control cohort (n = 385), we find that the sialyltransferase 8B (ST8SIA2) gene, coding for an enzyme that glycosylates proteins involved in neuronal plasticity which has previously shown association to both schizophrenia and autism, is associated with increased risk to bipolar spectrum disorder. Nominal single point association was observed with SNPs in ST8SIA2 (rs4586379, P = 0.0043; rs2168351, P = 0.0045), and a specific risk haplotype was identified (frequency: bipolar vs controls = 0.41 vs 0.31; chi(2) = 6.46, P = 0.011, OR = 1.47). Over-representation of the specific risk haplotype was also observed in an Australian schizophrenia case-control cohort (n = 256) (chi(2) = 8.41, P = 0.004, OR = 1.82). Using GWAS data from the NIMH bipolar disorder (n = 2055) and NIMH schizophrenia (n = 2550) cohorts, the equivalent haplotype was significantly over-represented in bipolar disorder (chi(2) = 5.91, P = 0.015, OR = 1.29), with the same direction of effect in schizophrenia, albeit non-significant (chi(2) = 2.3, P = 0.129, OR = 1.09). We demonstrate marked down-regulation of ST8SIA2 gene expression across human brain development and show a significant haplotype x diagnosis effect on ST8SIA2 mRNA levels in adult cortex (ANOVA: F(1,87) = 6.031, P = 0.016). These findings suggest that variation the ST8SIA2 gene is associated with increased risk to mental illness, acting to restrict neuronal plasticity and disrupt early neuronal network formation, rendering the developing and adult brain more vulnerable to secondary genetic or environmental insults.	[McAuley, Erica Z.; Scimone, Anna; Tiwari, Yash; Agahi, Giti; Weickert, Cynthia Shannon; Schofield, Peter R.; Fullerton, Janice M.] Neurosci Res Australia, Psychiat Genet, Sydney, NSW, Australia; [McAuley, Erica Z.; Tiwari, Yash; Schofield, Peter R.; Fullerton, Janice M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Tiwari, Yash; Weickert, Cynthia Shannon; Schofield, Peter R.; Fullerton, Janice M.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Mowry, Bryan J.; Holliday, Elizabeth G.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Mowry, Bryan J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Donald, Jennifer A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Weickert, Cynthia Shannon; Mitchell, Phillip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Mitchell, Phillip B.] Prince Wales Hosp, Black Dog Inst, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Queensland Centre for Mental Health Research; University of Queensland; Macquarie University; University of New South Wales Sydney; Black Dog Institute	McAuley, EZ (corresponding author), Neurosci Res Australia, Psychiat Genet, Sydney, NSW, Australia.	p.schofield@neura.edu.au; j.fullerton@neura.edu.au	Fullerton, Janice/F-8485-2013; Mowry, Bryan/G-5046-2010; Schofield, Peter/C-9669-2011	Fullerton, Janice/0000-0003-4014-4490; Mowry, Bryan/0000-0002-4115-5645; Donald, Jennifer/0000-0002-2732-1379; Mitchell, Philip/0000-0002-7954-5235; Shannon Weickert, Cynthia/0000-0002-4560-0259; Schofield, Peter/0000-0003-2967-9662	Schizophrenia Research Institute (Australia); National Health and Medical Research Council (Australia) [510216, 630574, 510135]; Dora Lush Scholarship [325641]; Howard Florey Centenary Fellowship [325643]; Senior Principal Research Fellowship [157209]	Schizophrenia Research Institute (Australia); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush Scholarship; Howard Florey Centenary Fellowship; Senior Principal Research Fellowship	This study was supported by the Schizophrenia Research Institute (Australia), and the National Health and Medical Research Council (Australia) via project grants (510216, 630574), program grant (510135), and personnel support of Dora Lush Scholarship (325641) to EZM, Howard Florey Centenary Fellowship (325643) to JMF, Senior Principal Research Fellowship (157209) to PRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; APA, 1987, DIAGN STAT MAN MENT, V3rd; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Castillo-Gomez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029516; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McAuley EZ, 2009, MOL PSYCHIATR, V14, P492, DOI 10.1038/sj.mp.4002146; Mitchell PB, 2009, AUST NZ J PSYCHIAT, V43, P109, DOI 10.1080/00048670802607220; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Vazza G, 2007, MOL PSYCHIATR, V12, P87, DOI 10.1038/sj.mp.4001895; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36	45	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38172	10.1371/journal.pone.0038172	http://dx.doi.org/10.1371/journal.pone.0038172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22693595	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500101
J	Weber, CM; Martindale, MQ; Tapscott, SJ; Unguez, GA				Weber, Christopher M.; Martindale, Mark Q.; Tapscott, Stephen J.; Unguez, Graciela A.			Activation of Pax7-Positive Cells in a Non-Contractile Tissue Contributes to Regeneration of Myogenic Tissues in the Electric Fish S. macrurus	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; SKELETAL-MUSCLE; SPINAL-CORD; STEM-CELLS; LIMB REGENERATION; URODELE LIMB; PAX7; EXPRESSION; DIFFERENTIATION; DEDIFFERENTIATION	The ability to regenerate tissues is shared across many metazoan taxa, yet the type and extent to which multiple cellular mechanisms come into play can differ across species. For example, urodele amphibians can completely regenerate all lost tissues, including skeletal muscles after limb amputation. This remarkable ability of urodeles to restore entire limbs has been largely linked to a dedifferentiation-dependent mechanism of regeneration. However, whether cell dedifferentiation is the fundamental factor that triggers a robust regeneration capacity, and whether the loss or inhibition of this process explains the limited regeneration potential in other vertebrates is not known. Here, we studied the cellular mechanisms underlying the repetitive regeneration of myogenic tissues in the electric fish S. macrurus. Our in vivo microinjection studies of high molecular weight cell lineage tracers into single identified adult myogenic cells (muscle or noncontractile muscle-derived electrocytes) revealed no fragmentation or cellularization proximal to the amputation plane. In contrast, ultrastructural and immunolabeling studies verified the presence of myogenic stem cells that express the satellite cell marker Pax7 in mature muscle fibers and electrocytes of S. macrurus. These data provide the first example of Pax-7 positive muscle stem cells localized within a non-contractile electrogenic tissue. Moreover, upon amputation, Pax-7 positive cells underwent a robust replication and were detected exclusively in regions that give rise to myogenic cells and dorsal spinal cord components revealing a regeneration process in S. macrurus that is dependent on the activation of myogenic stem cells for the renewal of both skeletal muscle and the muscle-derived electric organ. These data are consistent with the emergent concept in vertebrate regeneration that different tissues provide a distinct progenitor cell population to the regeneration blastema, and these progenitor cells subsequently restore the original tissue.	[Weber, Christopher M.; Unguez, Graciela A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, Honolulu, HI 96822 USA; [Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA	New Mexico State University; University of Hawaii System; Fred Hutchinson Cancer Center	Weber, CM (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98195 USA.	gunguez@nmsu.edu		Tapscott, Stephen/0000-0002-0319-0968; Weber, Christopher/0000-0002-4285-8131	National Institutes of Health [S06-GM008136, RR16480, U56-CA96286]; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092297, S06GM008136, R25GM061222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health grants S06-GM008136 (GAU), RR16480 (GAU), and U56-CA96286 (GAU and SJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; ANDERSON MJ, 1981, CELL TISSUE RES, V219, P1; Archer E, 2008, DIFFERENTIAL POTENTI; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; BAILLETDERBIN C, 1978, BIOL CELLULAIRE, V33, P15; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonavaud S, 2001, NEUROMUSCULAR DISORD, V11, P747, DOI 10.1016/S0960-8966(01)00222-X; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brockes JP, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P63; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Brusca R.C., 1990, INVERTEBRATES; Carlson Bruce M., 2005, Anatomical Record Part B:The New Anatomist, V287, P4, DOI 10.1002/ar.b.20079; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cuellar H, 2006, FASEB J, V20, P2540, DOI 10.1096/fj.06-6474fje; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; DUSTERHOFT S, 1993, DIFFERENTIATION, V53, P25, DOI 10.1111/j.1432-0436.1993.tb00642.x; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; FELDMAN JL, 1993, PROG CLIN BIOL RES, V383, P563; FELDMAN JL, 1991, DEV BIOL, V143, P320, DOI 10.1016/0012-1606(91)90083-F; Gabillard JC, 2010, CELL TISSUE RES, V342, P471, DOI 10.1007/s00441-010-1071-8; Gotensparre SM, 2006, GENE, V373, P8, DOI 10.1016/j.gene.2005.12.026; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Ishido M, 2009, ACTA PHYSIOL, V195, P459, DOI 10.1111/j.1748-1716.2008.01905.x; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kim JA, 2004, DEV GENES EVOL, V214, P380, DOI 10.1007/s00427-004-0421-5; Kim JA, 2008, J EXP BIOL, V211, P2172, DOI 10.1242/jeb.016592; Kirschbaum F., 1988, Monographs in Developmental Biology, V21, P112; KIRSCHBAUM F, 1981, J MORPHOL, V168, P121, DOI 10.1002/jmor.1051680202; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Meunier FJ, 1979, COMP ANATOMY AXIAL C; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; PATTERSON JM, 1993, J NEUROBIOL, V24, P660, DOI 10.1002/neu.480240510; Redshaw Z, 2010, CELL BIOCHEM FUNCT, V28, P403, DOI 10.1002/cbf.1670; Rosenblatt JD, 1996, DIFFERENTIATION, V60, P39, DOI 10.1046/j.1432-0436.1996.6010039.x; Schnapp E, 2005, DEV DYNAM, V232, P162, DOI 10.1002/dvdy.20203; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seo HC, 1998, MECH DEVELOP, V70, P49, DOI 10.1016/S0925-4773(97)00175-5; Shadd V, 2009, CULTURE MYOGENIC CEL; Shimotori T, 2001, DEV GROWTH DIFFER, V43, P371; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; Sirbulescu RF, 2009, J COMP PHYSIOL A, V195, P699, DOI 10.1007/s00359-009-0445-4; Steinbacher P, 2007, DEV DYNAM, V236, P1106, DOI 10.1002/dvdy.21103; Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Unguez GA, 1998, J COMP NEUROL, V399, P20; Unguez GA, 2002, J NEUROBIOL, V53, P391, DOI 10.1002/neu.10121; van Bekkum DW, 2004, BLOOD CELL MOL DIS, V32, P11, DOI 10.1016/j.bcmd.2003.09.009; Wada MR, 2002, DEVELOPMENT, V129, P2987; ZAKON HH, 1991, CIBA F SYMP, V160, P294; Zakon HH, 1999, J EXP BIOL, V202, P1427; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Ziman MR, 1997, INT J BIOCHEM CELL B, V29, P1029, DOI 10.1016/S1357-2725(97)00023-X	71	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36819	10.1371/journal.pone.0036819	http://dx.doi.org/10.1371/journal.pone.0036819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22685526	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500020
J	Wang, Y; Guo, LH; Cai, SP; Dai, MZ; Yang, QN; Yu, WH; Yan, NH; Zhou, XM; Fu, J; Guo, XW; Han, PF; Wang, J; Liu, XY				Wang, Yun; Guo, Liheng; Cai, Su-Ping; Dai, Meizhi; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun; Liu, Xuyang			Exome Sequencing Identifies Compound Heterozygous Mutations in CYP4V2 in a Pedigree with Retinitis Pigmentosa	PLOS ONE			English	Article							CORNEO-RETINAL DYSTROPHY; FATTY-ACID; CRYSTALLINE DYSTROPHY; DOCOSAHEXAENOIC ACID; CLINICAL-TRIAL; METABOLISM; GENE; DEFICIENCY; CAPTURE	Retinitis pigmentosa (RP) is a heterogeneous group of progressive retinal degenerations characterized by pigmentation and atrophy in the mid-periphery of the retina. Twenty two subjects from a four-generation Chinese family with RP and thin cornea, congenital cataract and high myopia is reported in this study. All family members underwent complete ophthalmologic examinations. Patients of the family presented with bone spicule-shaped pigment deposits in retina, retinal vascular attenuation, retinal and choroidal dystrophy, as well as punctate opacity of the lens, reduced cornea thickness and high myopia. Peripheral venous blood was obtained from all patients and their family members for genetic analysis. After mutation analysis in a few known RP candidate genes, exome sequencing was used to analyze the exomes of 3 patients III2, III4, III6 and the unaffected mother II2. A total of 34,693 variations shared by 3 patients were subjected to several filtering steps against existing variation databases. Identified variations were verified in the rest family members by PCR and Sanger sequencing. Compound heterozygous c. 802-8_810del17insGC and c. 1091-2A>G mutations of the CYP4V2 gene, known as genetic defects for Bietti crystalline corneoretinal dystrophy, were identified as causative mutations for RP of this family.	[Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Dept Ophthalmol, Chengdu, Sichuan Provinc, Peoples R China; [Cai, Su-Ping; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China; [Dai, Meizhi; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sichuan University; Sichuan University; Jinan University; Beijing Genomics Institute (BGI)	Wang, Y (corresponding author), W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China.	wangj@genomics.org.cn; xliu1213@yahoo.com.cn	Wang, Jun/A-7261-2013; Cai, Shanqing/F-6880-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Beal, Deryk S./0000-0001-9488-4326; Yu, Wenhan/0000-0002-0125-4358; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Ghosh, Satrajit/0000-0002-5312-6729	National Natural Science Foundation of China (NSFC) [81000370]; National Basic Research Program of China (973 Program) [2011CB510201]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81000370) and the National Basic Research Program of China (973 Program, 2011CB510201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1987, EXP EYE RES, V44, P155, DOI 10.1016/S0014-4835(87)80034-9; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1297, DOI 10.1001/archopht.122.9.1297; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CONVERSE CA, 1983, T OPHTHAL SOC UK, V103, P508; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; GONG JX, 1992, INVEST OPHTH VIS SCI, V33, P2596; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045; HOFFMAN DR, 1995, EXP EYE RES, V60, P279, DOI 10.1016/S0014-4835(05)80110-1; HOFFMAN DR, 1993, EXP EYE RES, V57, P359, DOI 10.1006/exer.1993.1135; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jin ZB, 2006, JPN J OPHTHALMOL, V50, P426, DOI 10.1007/s10384-006-0350-0; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; Kelly EJ, 2011, MOL INTERV, V11, P124, DOI 10.1124/mi.11.2.10; Lai TYY, 2007, INVEST OPHTH VIS SCI, V48, P5212, DOI 10.1167/iovs.07-0660; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Lee J, 1998, MOL GENET METAB, V65, P143, DOI 10.1006/mgme.1998.2723; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; Lee KYC, 2005, INVEST OPHTH VIS SCI, V46, P3812, DOI 10.1167/iovs.05-0378; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Li GQ, 2009, NUCLEIC ACIDS RES, V37, pD1025, DOI 10.1093/nar/gkn966; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029066; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Shan MG, 2005, MOL VIS, V11, P738	29	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e33673	10.1371/journal.pone.0033673	http://dx.doi.org/10.1371/journal.pone.0033673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22911857	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500004
J	Kim, YS; Kim, KS; Han, I; Kim, MH; Jung, MH; Park, HK				Kim, Young-Sun; Kim, Kyung Sook; Han, Ihn; Kim, Mi-Hyun; Jung, Min Hyung; Park, Hun-Kuk			Quantitative and Qualitative Analysis of the Antifungal Activity of Allicin Alone and in Combination with Antifungal Drugs	PLOS ONE			English	Article							CANDIDA-ALBICANS; AMPHOTERICIN-B; INHIBITION; CELLS	The antifungal activity of allicin and its synergistic effects with the antifungal agents flucytosine and amphotericin B (AmB) were investigated in Candida albicans (C. albicans). C. albicans was treated with different conditions of compounds alone and in combination (allicin, AmB, flucytosine, allicin + AmB, allicin + flucytosine, allicin + AmB + flucytosine). After a 24-hour treatment, cells were examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM) to measure morphological and biophysical properties associated with cell death. The clearing assay was conducted to confirm the effects of allicin. The viability of C. albicans treated by allicin alone or with one antifungal drug (AmB, flucytosine) in addition was more than 40% after a 24-hr treatment, but the viability of groups treated with combinations of more than two drugs was less than 32%. When the cells were treated with allicin alone or one type of drug, the morphology of the cells did not change noticeably, but when cells were treated with combinations of drugs, there were noticeable morphological changes. In particular, cells treated with allicin + AmB had significant membrane damage (burst or collapsed membranes). Classification of cells according to their cell death phase (CDP) allowed us to determine the relationship between cell viability and treatment conditions in detail. The adhesive force was decreased by the treatment in all groups compare to the control. Cells treated with AmB + allicin had a greater adhesive force than cells treated with AmB alone because of the secretion of molecules due to collapsed membranes. All cells treated with allicin or drugs were softer than the control cells. These results suggest that allicin can reduce MIC of AmB while keeping the same efficacy.	[Kim, Young-Sun; Jung, Min Hyung] Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Han, Ihn] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Program Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, YS (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea.	webhospital@naver.com; sigmoidus@khu.ac.kr	Kim, Youngsun/AAY-5946-2021; Han, Ihn/ABH-6275-2020	Kim, Youngsun/0000-0002-1725-0968; Han, Ihn/0000-0002-1372-7319	Kyung Hee University [KHU-20110093]; Seoul Research and Business Development program [CR070054]	Kyung Hee University; Seoul Research and Business Development program(Seoul RBD program)	This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADETUMBI M, 1986, ANTIMICROB AGENTS CH, V30, P499, DOI 10.1128/AAC.30.3.499; An MM, 2009, INT J ANTIMICROB AG, V33, P258, DOI 10.1016/j.ijantimicag.2008.09.014; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aplin AE, 1998, PHARMACOL REV, V50, P197; Brito GNB, 2011, BRAZ ORAL RES, V25, P28, DOI 10.1590/S1806-83242011005000001; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Borjihan H, 2009, J ANTIBIOT, V62, P691, DOI 10.1038/ja.2009.103; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Davis SR, 2005, MYCOSES, V48, P95, DOI 10.1111/j.1439-0507.2004.01076.x; GHANNOUM MA, 1990, J APPL BACTERIOL, V68, P163, DOI 10.1111/j.1365-2672.1990.tb02562.x; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Khodavandi A, 2010, MYCOPATHOLOGIA, V169, P287, DOI 10.1007/s11046-009-9251-3; Kim KSKim, PLOS ONE, V6; Lee Jeong Ah, 2010, Mycobiology, V38, P328, DOI 10.4489/MYCO.2010.38.4.328; Low CF, 2008, J APPL MICROBIOL, V105, P2169, DOI 10.1111/j.1365-2672.2008.03912.x; Lyon GM, 2010, J CLIN MICROBIOL, V48, P1270, DOI 10.1128/JCM.02363-09; Na G, 2010, FEMS IMMUNOL MED MIC, V58, P193; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ogita A, 2005, TOXICOLOGY, V215, P205, DOI 10.1016/j.tox.2005.07.006; Okamoto Y, 2004, MYCOPATHOLOGIA, V158, P9, DOI 10.1023/B:MYCO.0000038430.20669.80; Shuford JA, 2005, ANTIMICROB AGENTS CH, V49, P473, DOI 10.1128/AAC.49.1.473.2005; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; YAMADA Y, 1977, ANTIMICROB AGENTS CH, V11, P743, DOI 10.1128/AAC.11.4.743; Zakaria Z, 2011, ASIAN PACIFIC J TROP, V1, P20; Zhang JD, 2006, J ETHNOPHARMACOL, V103, P76, DOI 10.1016/j.jep.2005.07.006	26	38	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38242	10.1371/journal.pone.0038242	http://dx.doi.org/10.1371/journal.pone.0038242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	23144990	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900023
J	Dent, R; Blackmore, A; Peterson, J; Habib, R; Kay, GP; Gervais, A; Taylor, V; Wells, G				Dent, Robert; Blackmore, Angelique; Peterson, Joan; Habib, Rami; Kay, Gary Peter; Gervais, Alan; Taylor, Valerie; Wells, George			Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature	PLOS ONE			English	Review							LONG-TERM TREATMENT; DOUBLE-BLIND; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; 2ND-GENERATION ANTIDEPRESSANTS; SCHIZOAFFECTIVE DISORDER; DIABETES-MELLITUS; EXTENDED-RELEASE; HALOPERIDOL DECANOATE; MONITORING PRACTICES	Introduction: Psychotropic medication use is associated with weight gain. While there are studies and reviews comparing weight gain for psychotropics within some classes, clinicians frequently use drugs from different classes to treat psychiatric disorders. Objective: To undertake a systematic review of all classes of psychotropics to provide an all encompassing evidence-based tool that would allow clinicians to determine the risks of weight gain in making both intra-class and interclass choices of psychotropics. Methodology and Results: We developed a novel hierarchical search strategy that made use of systematic reviews that were already available. When such evidence was not available we went on to evaluate randomly controlled trials, followed by cohort and other clinical trials, narrative reviews, and, where necessary, clinical opinion and anecdotal evidence. The data from the publication with the highest level of evidence based on our hierarchical classification was presented. Recommendations from an expert panel supplemented the evidence used to rank these drugs within their respective classes. Approximately 9500 articles were identified in our literature search of which 666 citations were retrieved. We were able to rank most of the psychotropics based on the available evidence and recommendations from subject matter experts. There were few discrepancies between published evidence and the expert panel in ranking these drugs. Conclusion: Potential for weight gain is an important consideration in choice of any psychotropic. This tool will help clinicians select psychotropics on a case-by-case basis in order to minimize the impact of weight gain when making both intra-class and interclass choices.	[Dent, Robert; Blackmore, Angelique; Gervais, Alan] Ottawa Hosp, Weight Management Clin, Toronto, ON, Canada; [Peterson, Joan] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Dent, Robert; Habib, Rami; Kay, Gary Peter] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Taylor, Valerie] Univ Toronto, Toronto, ON, Canada; [Wells, George] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Ottawa; University of Ottawa Heart Institute	Dent, R (corresponding author), Ottawa Hosp, Weight Management Clin, Toronto, ON, Canada.	bdent@ottawahospital.on.ca	Wells, George A/M-4549-2017; Taylor, Valerie H/H-6242-2015; Hoekstra, Hopi/I-6690-2012	Wells, George A/0000-0002-2289-9139; Fisher, Heidi S./0000-0001-5622-4335; Weber, Jesse/0000-0003-4839-6684; Taylor, Valerie/0000-0002-8948-638X; Hoekstra, Hopi/0000-0003-1431-1769; Peterson, Brant/0000-0002-0433-3035; Delaney, Emily/0000-0003-3609-5702	NIGMS NIH HHS [F32 GM084719] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmer S, 2005, PSYCHIATR BULL, V29, P302, DOI 10.1192/pb.29.8.302; Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; Allison DB, 2003, PSYCHIAT SERV, V54, P565, DOI 10.1176/appi.ps.54.4.565; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Allison DB, 2001, J CLIN PSYCHIAT, V62, P22; Alvarez-Jimenez M, 2008, CNS DRUGS, V22, P547, DOI 10.2165/00023210-200822070-00002; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; Anderson T, 2004, PRIM PSYCHIAT, V11, P48; Aronne LJ, 2003, J CLIN PSYCHIAT, V64, P22; Ashton AK, 2005, CURR THER RES CLIN E, V66, P96, DOI 10.1016/j.curtheres.2005.04.006; Bagnall A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002083.pub2; Barbui C, 2004, J CLIN PSYCHOPHARM, V24, P126, DOI 10.1097/01.jcp.0000115665.45074.0d; Beasley CM, 2007, J CLIN PSYCHOPHARM, V27, P252, DOI 10.1097/JCP.0b013e3180582426; BECHELLI LPC, 1985, CURR THER RES CLIN E, V37, P662; Benazzi F, 1998, PSYCHOTHER PSYCHOSOM, V67, P271, DOI 10.1159/000012291; Bergman RN, 2005, J CLIN PSYCHIAT, V66, P504, DOI 10.4088/JCP.v66n0414; Bisol LW, 2008, J CLIN PSYCHIAT, V69, P1572, DOI 10.4088/JCP.v69n1007; Bitter I, 2004, PROG NEURO-PSYCHOPH, V28, P173, DOI 10.1016/j.pnpbp.2003.09.033; BJERTNAES A, 1982, ACTA PSYCHIAT SCAND, V66, P199, DOI 10.1111/j.1600-0447.1982.tb00928.x; Boilson M, 2003, PSYCHIAT B, V27, P424; Bowden CL, 2006, AM J PSYCHIAT, V163, P1199, DOI 10.1176/appi.ajp.163.7.1199; Bowden CL, 2010, INT CLIN PSYCHOPHARM, V25, P60, DOI 10.1097/YIC.0b013e328333ac1b; Bramlage P, 2004, INT J OBESITY, V28, P1299, DOI 10.1038/sj.ijo.0802752; Buckley PF, 2005, SCHIZOPHR RES, V79, P281, DOI 10.1016/j.schres.2005.04.010; Canas F, 2010, EXPERT OPIN DRUG SAF, V9, P683, DOI 10.1517/14740338.2010.506712; CANTU TG, 1988, DRUG INTEL CLIN PHAR, V22, P755, DOI 10.1177/106002808802201002; Cash TF, 2000, PERCEPT MOTOR SKILL, V90, P453, DOI 10.2466/PMS.90.2.453-456; Chakrabarti A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001943.pub2; Chwieduk CM, 2010, DRUGS, V70, P1295, DOI 10.2165/11204840-000000000-00000; Citrome L, 2010, INT J CLIN PRACT, V64, P216, DOI 10.1111/j.1742-1241.2009.02240.x; Citrome L, 2009, INT J CLIN PRACT, V63, P1762, DOI 10.1111/j.1742-1241.2009.02228.x; Citrome L, 2007, J CLIN PSYCHIAT, V68, P12; Davidson J, 2004, J CLIN PSYCHOPHARM, V24, P118, DOI 10.1097/01.jcp.0000106222.36344.96; El-Khayat R, 1998, J PSYCHOPHARMACOL, V12, P323, DOI 10.1177/026988119801200401; Feeney Larkin, 2006, Irish Journal of Psychological Medicine, V23, P100, DOI [10.1017/S0790966700009113, 10.1017/S0790966700009721]; FEIGHNER J, 1986, J CLIN PSYCHOPHARM, V6, P27; Fenton M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001944.pub2; Fontaine KR, 2001, PSYCHIAT RES, V101, P277, DOI 10.1016/S0165-1781(01)00234-7; Gao KM, 2006, J CLIN PSYCHIAT, V67, P1327, DOI 10.4088/JCP.v67n0902; GARLAND EJ, 1988, J CLIN PSYCHOPHARM, V8, P323; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gartlehner G, 2010, J CLIN EPIDEMIOL, V63, P117, DOI 10.1016/j.jclinepi.2008.09.019; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Gebhardt S, 2009, J PSYCHIATR RES, V43, P620, DOI 10.1016/j.jpsychires.2008.11.001; Gentile S, 2009, OBES REV, V10, P527, DOI 10.1111/j.1467-789X.2009.00589.x; GITLIN MJ, 1989, J CLIN PSYCHIAT, V50, P127; Goethe JW, 2007, J CLIN PSYCHOPHARM, V27, P451, DOI 10.1097/jcp.0b013e31815152a5; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Hale Katherine S., 2010, JOURNAL OF PHARMACY TECHNOLOGY, V26, P193; Hamer S, 2007, BRIT J PSYCHIAT, V191, pS64, DOI 10.1192/bjp.191.50.s64; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; HARRIS B, 1986, BRIT J PSYCHIAT, V148, P590, DOI 10.1192/bjp.148.5.590; Hedenmalm K, 2002, DRUG SAFETY, V25, P1107, DOI 10.2165/00002018-200225150-00005; Henderson DC, 2007, J CLIN PSYCHIAT, V68, P18; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Jeste DV, 2004, J PSYCHIATR RES, V38, P73, DOI 10.1016/S0022-3956(03)00094-3; Johnsen E, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-31; JOHNSON DAW, 1979, ACTA PSYCHIAT SCAND, V59, P525, DOI 10.1111/j.1600-0447.1979.tb00252.x; Karagianis J, 2008, HUM PSYCHOPHARM CLIN, V23, P275, DOI 10.1002/hup.933; Ketter TA, 2004, J CLIN PSYCHIAT, V65, P668; Kinon BJ, 2001, J CLIN PSYCHIAT, V62, P92, DOI 10.4088/JCP.v62n0204; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006624.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006625.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006627.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006569.pub3; Kumar A, 2009, SCHIZOPHRENIA BULL, V35, P855, DOI 10.1093/schbul/sbp077; Kurzthaler I, 2001, J CLIN PSYCHIAT, V62, P32; Kwon JS, 2009, PSYCHIAT CLIN NEUROS, V63, P73, DOI 10.1111/j.1440-1819.2008.01907.x; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Lencz Todd, 2009, Dialogues Clin Neurosci, V11, P405; Leslie DL, 2004, AM J PSYCHIAT, V161, P1709, DOI 10.1176/appi.ajp.161.9.1709; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2003, NEUROPSYCHOPHARMACOL, V28, P995, DOI 10.1038/sj.npp.1300157; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lindenmayer JP, 2009, J CLIN PSYCHIAT, V70, P990, DOI 10.4088/JCP.08m04221; Lindenmayer JP, 2004, J CLIN PSYCHIAT, V65, P1084; Mackin P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-28; Malone M, 2005, ANN PHARMACOTHER, V39, P2046, DOI 10.1345/aph.1G333; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Marino J, 2010, ANN PHARMACOTHER, V44, P863, DOI 10.1345/aph.1M603; Marques L.O., 2004, COCHRANE DB SYST REV; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; Melvin CL, 2008, J PSYCHIATR PRACT, V14, P9, DOI 10.1097/01.pra.0000333583.75741.8b; Montgomery SA, 1998, INT CLIN PSYCHOPHARM, V13, P63, DOI 10.1097/00004850-199803000-00002; Morrato EH, 2009, DIABETES CARE, V32, P1037, DOI 10.2337/dc08-1720; Nasrallah HA, 2003, CNS SPECTRUMS, V8, P23, DOI 10.1017/S1092852900008166; Nasrallah HA, 2007, J CLIN PSYCHIAT, V68, P5; Nasrallah Henry A, 2004, J Clin Psychopharmacol, V24, pS7, DOI 10.1097/01.jcp.0000142282.62336.e9; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Nguyen D, 2009, AUSTRALAS PSYCHIATRY, V17, P295, DOI 10.1080/10398560902842519; Okugawa G, 2009, PSYCHIAT CLIN NEUROS, V63, P322, DOI 10.1111/j.1440-1819.2009.01947.x; OSWALD I, 1980, BRIT MED J, V281, P1039, DOI 10.1136/bmj.281.6247.1039-a; Perkins DO, 2002, J CLIN PSYCHIAT, V63, P1121, DOI 10.4088/JCP.v63n1206; Perry R, 2009, CLIN THER, V31, P1374, DOI 10.1016/j.clinthera.2009.07.012; Perucca E, 2005, ACTA NEUROL SCAND, V112, P30, DOI 10.1111/j.1600-0404.2005.00506.x; Reinstein MJ, 2003, CLIN DRUG INVEST, V23, P671, DOI 10.2165/00044011-200323100-00006; Rosenheck RA, 2009, SCHIZOPHR RES, V107, P22, DOI 10.1016/j.schres.2008.09.031; Sachs GS, 1999, J CLIN PSYCHIAT, V60, P16; Schatzberg AF, 2007, J CLIN PSYCHIAT, V68, P26; Seeman MV, 2009, SCHIZOPHRENIA BULL, V35, P937, DOI 10.1093/schbul/sbn023; Sernyak MJ, 2002, AM J PSYCHIAT, V159, P561, DOI 10.1176/appi.ajp.159.4.561; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shelton RC, 2007, PRIMARY PSYCHIAT, V14, P42; Simpson GM, 2005, AM J PSYCHIAT, V162, P1535, DOI 10.1176/appi.ajp.162.8.1535; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Sivaraman P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007779.pub2; Smith MC, 2004, EPILEPSY BEHAV, V5, P746, DOI 10.1016/j.yebeh.2004.07.007; Smits JAJ, 2010, J PSYCHIATR RES, V44, P1010, DOI 10.1016/j.jpsychires.2010.04.007; Spina E, 2000, PSYCHOPHARMACOLOGY, V148, P83, DOI 10.1007/s002130050028; Stoffers J, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005653.pub2, 10.1002/1465185.CD005653.pub2]; Sun SX, 2007, CURR MED RES OPIN, V23, P2305, DOI 10.1185/030079907X226050; Suppes T, 2007, PSYCHOPHARMACOL BULL, V40, P22; Sussman N, 2003, J CLIN PSYCHOPHARM, V23, pS21, DOI 10.1097/00004714-200306001-00005; Taylor DM, 2000, ACTA PSYCHIAT SCAND, V101, P416, DOI 10.1034/j.1600-0447.2000.101006416.x; Tham M.S.P., 2007, J MENT HEALTH, V16, P771, DOI [DOI 10.1080/09638230701496352, 10.1080/09638230701496352]; Thieda P, 2003, PSYCHIAT SERV, V54, P508, DOI 10.1176/appi.ps.54.4.508; Tran PV, 1999, BRIT J PSYCHIAT, V174, P15, DOI 10.1192/bjp.174.1.15; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; Weiden PJ, 2007, J CLIN PSYCHIAT, V68, P34; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Westenberg HGM, 2004, J CLIN PSYCHOPHARM, V24, P49, DOI 10.1097/01.jcp.0000104906.75206.8b; WISTEDT B, 1984, CURR THER RES CLIN E, V35, P804; Yuanguang CC, 1998, CHINESE J PSYCHIAT, V31, P43; Zipursky RB, 2005, BRIT J PSYCHIAT, V187, P537, DOI 10.1192/bjp.187.6.537	131	1070	1079	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e36889	10.1371/journal.pone.0036889	http://dx.doi.org/10.1371/journal.pone.0036889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719834	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000002
J	Zhou, BY; Buckley, ST; Patel, V; Liu, YX; Luo, J; Krishnaveni, MS; Ivan, M; DeMaio, L; Kim, KJ; Ehrhardt, C; Crandall, ED; Borok, Z				Zhou, Beiyun; Buckley, Stephen T.; Patel, Vipul; Liu, Yixin; Luo, Jiao; Krishnaveni, Manda Sai; Ivan, Mihaela; DeMaio, Lucas; Kim, Kwang-Jin; Ehrhardt, Carsten; Crandall, Edward D.; Borok, Zea			Troglitazone Attenuates TGF-beta 1-Induced EMT in Alveolar Epithelial Cells via a PPAR gamma-Independent Mechanism	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; IDIOPATHIC PULMONARY-FIBROSIS; GLYCOGEN-SYNTHASE KINASE-3; ACUTE LUNG INJURY; MESENCHYMAL TRANSITION; BETA-CATENIN; CARCINOMA-CELLS; IN-VIVO; EXPRESSION; AGONISTS	Peroxisome proliferator activated receptor gamma (PPAR gamma) agonists are effective antifibrotic agents in a number of tissues. Effects of these agents on epithelial-mesenchymal transition (EMT) of primary alveolar epithelial cells (AEC) and potential mechanisms underlying effects on EMT have not been well delineated. We examined effects of troglitazone, a synthetic PPAR gamma agonist, on transforming growth factor (TGF)-beta 1-induced EMT in primary rat AEC and an alveolar epithelial type II (AT2) cell line (RLE-6TN). TGF-beta 1 (2.5 ng/mL) induced EMT in both cell types, as evidenced by acquisition of spindle-like morphology, increased expression of the mesenchymal marker a-smooth muscle actin (alpha-SMA) and downregulation of the tight junctional protein zonula occludens-1 (ZO-1). Concurrent treatment with troglitazone (or rosiglitazone), ameliorated effects of TGF-beta 1. Furthermore, following stimulation with TGF-beta 1 for 6 days, troglitazone reversed EMT-related morphological changes and restored both epithelial and mesenchymal markers to control levels. Treatment with GW9662 (an irreversible PPAR gamma antagonist), or overexpression of a PPAR gamma dominant negative construct, failed to inhibit these effects of troglitazone in AEC. Troglitazone not only attenuated TGF-beta 1-induced phosphorylation of Akt and glycogen synthase kinase (GSK)-3 beta, but also inhibited nuclear translocation of beta-catenin, phosphorylation of Smad2 and Smad3 and upregulation of the EMT-associated transcription factor SNAI1. These results demonstrate inhibitory actions of troglitazone on TGF-beta 1-induced EMT in AEC via a PPAR gamma-independent mechanism likely through inhibition of beta-catenin-dependent signaling downstream of TGF-beta 1, supporting a role for interactions between TGF-beta and Wnt/beta-catenin signaling pathways in EMT.	[Zhou, Beiyun; Patel, Vipul; Liu, Yixin; Luo, Jiao; Krishnaveni, Manda Sai; Ivan, Mihaela; DeMaio, Lucas; Kim, Kwang-Jin; Crandall, Edward D.; Borok, Zea] Univ So Calif, Dept Med, Will Rogers Inst Pulm Res Ctr, Div Pulm Crit Care & Sleep Med, Los Angeles, CA 90089 USA; [Buckley, Stephen T.; Ehrhardt, Carsten] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [Borok, Zea] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of Southern California; Trinity College Dublin; University of Southern California	Zhou, BY (corresponding author), Univ So Calif, Dept Med, Will Rogers Inst Pulm Res Ctr, Div Pulm Crit Care & Sleep Med, Los Angeles, CA 90089 USA.	boro@usc.edu	Borok, Zea/J-9015-2013; Ehrhardt, Carsten/B-1259-2010; CRANDALL, EDWARD/AAD-8382-2020	Ehrhardt, Carsten/0000-0003-0730-1829; sun, jian/0000-0001-5320-227X; Tanaka, Yasuhito/0000-0002-2473-6966; Borok, Zea/0000-0001-8673-8177	United States National Institutes of Health [HL038578, HL062569, HL089445, ES017034, ES018782, HL038621]; Whittier Foundation; Hastings Foundation; American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038578, R37HL062569, R01HL038621, R01HL089445, R01HL062569, R37HL038578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018782, R01ES017034] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whittier Foundation; Hastings Foundation; American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants HL038578 (ZB), HL062569 (ZB), HL089445 (ZB), ES017034 (EDC), ES018782 (EDC) and HL038621 (EDC) from the United States National Institutes of Health, as well as the Whittier Foundation and the Hastings Foundation. B. Zhou is supported by an American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belvisi MG, 2006, EUR J PHARMACOL, V533, P101, DOI 10.1016/j.ejphar.2005.12.048; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Cao LQ, 2007, ACTA PHARMACOL SIN, V28, P879, DOI 10.1111/j.1745-7254.2007.00571.x; Cheng HC, 2008, MOL VIS, V14, P95; Chojkier M, 2005, HEPATOLOGY, V41, P237, DOI 10.1002/hep.20567; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Frankel SK, 2009, CURR OPIN PULM MED, V15, P463, DOI 10.1097/MCP.0b013e32832ea4b3; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; KAO WWY, 1977, NATURE, V266, P63, DOI 10.1038/266063a0; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim Robert, 2008, Ther Adv Respir Dis, V2, P319, DOI 10.1177/1753465808096948; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Liu D, 2006, PHYSIOL RES, V55, P291, DOI 10.33549/physiolres.930822; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Mughal RS, 2009, CLIN EXP PHARMACOL P, V36, P478, DOI 10.1111/j.1440-1681.2008.05088.x; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Reka AK, 2010, MOL CANCER THER, V9, P3221, DOI 10.1158/1535-7163.MCT-10-0570; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Tan XH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-21; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	120	123	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38827	10.1371/journal.pone.0038827	http://dx.doi.org/10.1371/journal.pone.0038827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22675528	Green Published, Green Submitted, gold			2022-12-25	WOS:000305693200024
J	Yin, X; Yin, Y; Cao, FL; Chen, YF; Peng, Y; Hou, WG; Sun, SK; Luo, ZJ				Yin, Xin; Yin, Yue; Cao, Fa-Le; Chen, Yu-Fei; Peng, Ye; Hou, Wu-Gang; Sun, Shu-Kai; Luo, Zhuo-Jing			Tanshinone IIA Attenuates the Inflammatory Response and Apoptosis after Traumatic Injury of the Spinal Cord in Adult Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; GLIAL APOPTOSIS; FACTOR-ALPHA; CELL-DEATH; EXPRESSION; CYTOKINES; INHIBITION; ASTROCYTES	Background: Spinal cord injury (SCI), including immediate mechanical injury and secondary injury, is associated with the inflammatory response, apoptosis and oxidative stress in response to traumatic injury. Tanshinone IIA (TIIA) is one of the major extracts obtained from Salvia miltiorrhiza BUNGE, which has anti-inflammatory and anti-apoptotic effects on many diseases. However, little is known about the effects of TIIA treatment on SCI. Therefore, the aim of the present study is to evaluate the pharmacological action of TIIA on secondary damage and the underlying mechanisms of experimental SCI in rats. Methodology/Principal Findings: SCI was generated using a weight drop device on the dorsal spinal cord via a two-level T9-T11 laminectomy. SCI in rats resulted in severe trauma, characterized by locomotor disturbance, edema, neutrophil infiltration, the production of astrocytes and inflammatory mediators, apoptosis and oxidative stress. TIIA treatment (20 mg/kg, i.p.) after SCI induced significant effects: (1) improved motor function (Basso, Beattie and Bresnahan scores), (2) reduced the degree of tissue injury (histological score), neutrophil infiltration (myeloperoxidase activity) and the expression of astrocytes, (3) inhibited the activation of SCI-related pathways, such as NF-kappa B and MAPK signaling pathways, (4) decreased the production of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6) and iNOS, (5) reduced apoptosis (TUNEL staining, and Bcl-2 and caspase-3 expression) and (6) reversed the redox state imbalance. Conclusions/Significance: The results clearly show that TIIA has a prominent protective effect against SCI through inhibiting the inflammatory response and apoptosis in the spinal cord tissue after SCI.	[Yin, Xin; Chen, Yu-Fei; Peng, Ye; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China; [Yin, Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China; [Cao, Fa-Le] 222th Hosp CPLA, Dept Neurol & Respirat, Jilin, Peoples R China; [Hou, Wu-Gang] Xijing Hosp, Dept Anesthesia, Xian, Shaanxi, Peoples R China; [Sun, Shu-Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yin, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China.	zjluo@fmmu.edu.cn	peng, ye/GXZ-9245-2022	, Chen/0000-0003-3224-5662	Istitute of Orthopaedics, Fourth Military Medical University	Istitute of Orthopaedics, Fourth Military Medical University	This study was supported by a grant from the Istitute of Orthopaedics, Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen F, 1999, CLIN CHEM, V45, P7; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Esposito E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012170; Fang ZY, 2008, J ETHNOPHARMACOL, V115, P217, DOI 10.1016/j.jep.2007.09.025; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu XZ, 1997, J NEUROSCI, V17, P5395; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	40	146	172	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38381	10.1371/journal.pone.0038381	http://dx.doi.org/10.1371/journal.pone.0038381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	23251642	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900026
J	Zhang, Y; Luo, Y; Deng, YH; Mu, YG; Wei, GH				Zhang, Yun; Luo, Yin; Deng, Yonghua; Mu, Yuguang; Wei, Guanghong			Lipid Interaction and Membrane Perturbation of Human Islet Amyloid Polypeptide Monomer and Dimer by Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBER FORMATION; HUMAN AMYLIN; MECHANISM; BILAYERS; AGGREGATION; RECOGNITION; DISRUPTION; OLIGOMERS; TOXICITY; PEPTIDE	The aggregation of human islet amyloid polypeptide (hIAPP or amylin) is associated with the pathogenesis of type 2 diabetes mellitus. Increasing evidence suggests that the interaction of hIAPP with beta-cell membranes plays a crucial role in cytotoxicity. However, the hIAPP-lipid interaction and subsequent membrane perturbation is not well understood at atomic level. In this study, as a first step to gain insight into the mechanism of hIAPP-induced cytotoxicity, we have investigated the detailed interactions of hIAPP monomer and dimer with anionic palmitoyloleolyophosphatidylglycerol (POPG) bilayer using all-atom molecular dynamics (MD) simulations. Multiple MD simulations have been performed by employing the initial configurations where the N-terminal region of hIAPP is pre-inserted in POPG bilayer. Our simulations show that electrostatic interaction between hIAPP and POPG bilayer plays a major role in peptide-lipid interaction. In particular, the N-terminal positively-charged residues Lys1 and Arg11 make a dominant contribution to the interaction. During peptide-lipid interaction process, peptide dimerization occurs mostly through the C-terminal 20-37 region containing the amyloidogenic 20-29-residue segment. Membrane-bound hIAPP dimers display a pronounced ability of membrane perturbation than monomers. The higher bilayer perturbation propensity of hIAPP dimer likely results from the cooperativity of the peptide-peptide interaction (or peptide aggregation). This study provides insight into the hIAPP-membrane interaction and the molecular mechanism of membrane disruption by hIAPP oligomers.	[Zhang, Yun; Luo, Yin; Deng, Yonghua; Wei, Guanghong] Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci MOE, Shanghai 200433, Peoples R China; [Zhang, Yun; Luo, Yin; Deng, Yonghua; Wei, Guanghong] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Fudan University; Fudan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhang, Y (corresponding author), Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci MOE, Shanghai 200433, Peoples R China.	ghwei@fudan.edu.cn		Wei, Guanghong/0000-0001-5814-3328; Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	National Natural Science Foundation of China [11074047]; Research Fund for the Doctoral Program of Higher Education of China [RFDP-20100071110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 11074047) and Research Fund for the Doctoral Program of Higher Education of China (RFDP-20100071110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Colombo G, 2005, PROTEINS, V59, P519, DOI 10.1002/prot.20426; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Elmore DE, 2006, FEBS LETT, V580, P144, DOI 10.1016/j.febslet.2005.11.064; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Laghaei R, 2010, J PHYS CHEM B, V114, P7071, DOI 10.1021/jp100205w; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mo YX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3097982; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Rivera E, 2009, BIOPHYS J, V96, P4552, DOI 10.1016/j.bpj.2009.03.039; Sciacca MFM, 2010, NEW J CHEM, V34, P200, DOI 10.1039/b9nj00253g; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Tolokh IS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031911; van Gunsteren WF, GROMOS 87 MANUAL; Vermeer LS, 2007, EUR BIOPHYS J BIOPHY, V36, P919, DOI 10.1007/s00249-007-0192-9; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; WIEDMANN T, 1993, BIOCHIM BIOPHYS ACTA, V1167, P114, DOI 10.1016/0005-2760(93)90150-8; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Yu X, 2011, J MOL BIOL, DOI [10.1016/j.jmb.2011.1011.1006, DOI 10.1016/J.JMB.2011.1011.1006]	54	89	97	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38191	10.1371/journal.pone.0038191	http://dx.doi.org/10.1371/journal.pone.0038191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22412829	Green Published, gold			2022-12-25	WOS:000305338500105
J	Zhang, YS; Xu, P; Liu, TJ; Hu, J; Zhang, R; Yao, DZ				Zhang, Yangsong; Xu, Peng; Liu, Tiejun; Hu, Jun; Zhang, Rui; Yao, Dezhong			Multiple Frequencies Sequential Coding for SSVEP-Based Brain-Computer Interface	PLOS ONE			English	Article							FLICKER	Background: Steady-state visual evoked potential (SSVEP)-based brain-computer interface (BCI) has become one of the most promising modalities for a practical noninvasive BCI system. Owing to both the limitation of refresh rate of liquid crystal display (LCD) or cathode ray tube (CRT) monitor, and the specific physiological response property that only a very small number of stimuli at certain frequencies could evoke strong SSVEPs, the available frequencies for SSVEP stimuli are limited. Therefore, it may not be enough to code multiple targets with the traditional frequencies coding protocols, which poses a big challenge for the design of a practical SSVEP-based BCI. This study aimed to provide an innovative coding method to tackle this problem. Methodology/Principal Findings: In this study, we present a novel protocol termed multiple frequencies sequential coding (MFSC) for SSVEP-based BCI. In MFSC, multiple frequencies are sequentially used in each cycle to code the targets. To fulfill the sequential coding, each cycle is divided into several coding epochs, and during each epoch, certain frequency is used. Obviously, different frequencies or the same frequency can be presented in the coding epochs, and the different epoch sequence corresponds to the different targets. To show the feasibility of MFSC, we used two frequencies to realize four targets and carried on an offline experiment. The current study shows that: 1) MFSC is feasible and efficient; 2) the performance of SSVEP-based BCI based on MFSC can be comparable to some existed systems. Conclusions/Significance: The proposed protocol could potentially implement much more targets with the limited available frequencies compared with the traditional frequencies coding protocol. The efficiency of the new protocol was confirmed by real data experiment. We propose that the SSVEP-based BCI under MFSC might be a promising choice in the future.	[Zhang, Yangsong; Xu, Peng; Liu, Tiejun; Hu, Jun; Zhang, Rui; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Zhang, YS (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	xupeng@uestc.edu.cn; dyao@uestc.edu.cn		Wei, Guanghong/0000-0001-5814-3328; Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	National Natural Science Foundation of China [31070881]; Program for Changjiang Scholars and Innovative Research Team in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China under Grant No. 31070881, and in part by the project of the Program for Changjiang Scholars and Innovative Research Team in University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Cecotti H, 2010, C COMP NEUR, P215; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Friman O, 2001, MAGNET RESON MED, V45, P323, DOI 10.1002/1522-2594(200102)45:2<323::AID-MRM1041>3.0.CO;2-#; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Melzer T, 2003, PATTERN RECOGN, V36, P1961, DOI 10.1016/S0031-3203(03)00058-X; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Mukesh TMS, 2006, PHYSIOL MEAS, V27, P61, DOI 10.1088/0967-3334/27/1/006; Panicker R, 2011, IEEE T BIOMED ENG; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; Pfurtscheller G, 2010, FRONTIERS NEUROSCIEN, V4; Pfurtscheller G, 2010, IEEE T NEUR SYS REH, V18, P409, DOI 10.1109/TNSRE.2010.2040837; Regan D., 1989, HUMAN BRAIN ELECTROP; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; Teng F, 2010, P 48 ACM SE C, P50; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2008, MED ENG PHYS, V30, P1079, DOI 10.1016/j.medengphy.2008.01.004; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Xu Peng, 2011, PLoS One, V6, pe14634, DOI 10.1371/journal.pone.0014634; Yan Z, 2011, NEUROSCIENCE LETT; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	35	89	97	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e29519	10.1371/journal.pone.0029519	http://dx.doi.org/10.1371/journal.pone.0029519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412829	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100001
